PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Flanigan, TJ; Cook, MN				Flanigan, Timothy J.; Cook, Melloni N.			Effects of an Early Handling-Like Procedure and Individual Housing on Anxiety-Like Behavior in Adult C57BL/6J and DBA/2J Mice	PLOS ONE			English	Article							ELEVATED ZERO-MAZE; EARLY-LIFE EVENTS; MATERNAL SEPARATION; SOCIAL-ISOLATION; PLUS-MAZE; ISOLATION STRESS; RATS; MOUSE; CORTICOSTERONE; CONSEQUENCES	Manipulations of rearing conditions have been used to examine the effects of early experience on adult behavior with varying results. Evidence suggests that postnatal days (PND) 15-21 are a time of particular susceptibility to environmental influences on anxiety-like behavior in mice. To examine this, we subjected C57BL/6J and DBA/2J mice to an early handling-like procedure. Pups were separated from dams from PND 12-20 for 30 minutes daily or received standard care. On PND 21, pups were weaned and either individually- or group-housed. On PND 60, anxiety-like behavior was examined on the elevated zero-maze. Although individually- housed animals took longer to enter an open quadrant of the maze, they spent more time in the open than group-housed animals. Additionally, we observed a trend of reduced anxiety-like behavior in C57BL/6J, but not DBA/2J mice that underwent the handling-like procedure.	[Flanigan, Timothy J.; Cook, Melloni N.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA	University of Memphis	Flanigan, TJ (corresponding author), Univ Memphis, Dept Psychol, Memphis, TN 38152 USA.	mcook1@memphis.edu		Flanigan, Timothy/0000-0003-0284-2503	Early Career Research Award; INIA	Early Career Research Award; INIA(Instituto de Investigacion Agropecuaria (INIA))	This research was supported in part by an Early Career Research Award and an INIA (http://www.scripps.edu/cnad/inia/index.html) pilot project award to MNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABBEY H, 1973, DEV PSYCHOBIOL, V6, P329, DOI 10.1002/dev.420060406; Advani T, 2007, INT J NEUROPSYCHOPH, V10, P595, DOI 10.1017/S1461145706007401; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; BARNETT SA, 1974, DEV PSYCHOBIOL, V7, P563; Bolivar VJ, 2000, BEHAV GENET, V30, P285, DOI 10.1023/A:1026545316455; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Cabib S, 1996, BRAIN RES, V729, P110, DOI 10.1016/0006-8993(96)00418-0; Cook MN, 2002, BEHAV GENET, V32, P113, DOI 10.1023/A:1015249706579; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; CORTINA J, 2000, SAGE U PAPERS SERIES; D'Amato FR, 1998, DEV PSYCHOBIOL, V32, P225, DOI 10.1002/(SICI)1098-2302(199804)32:3<225::AID-DEV6>3.0.CO;2-Q; Dai HM, 2004, ANN NY ACAD SCI, V1025, P257, DOI 10.1196/annals.1316.032; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; FOXWM, 1965, ANIM BEHAV, V13, P234; Francis DD, 2002, J NEUROSCI, V22, P7840; Gariepy JL, 2002, PHARMACOL BIOCHEM BE, V73, P7, DOI 10.1016/S0091-3057(02)00789-X; Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7; Gutman David A, 2002, Semin Clin Neuropsychiatry, V7, P89, DOI 10.1053/scnp.2002.31781; HILAKIVI LA, 1989, PHARMACOL BIOCHEM BE, V33, P371, DOI 10.1016/0091-3057(89)90516-9; Holmes A, 2005, NEUROSCI BIOBEHAV R, V29, P1335, DOI 10.1016/j.neubiorev.2005.04.012; HOUT RL, 2001, PSYCHOPHARMACOLOGY B, V158, P366; JANKOWSKA E, 1991, BEHAV BRAIN RES, V43, P155, DOI 10.1016/S0166-4328(05)80065-8; Jones BC, 1998, PSYCHONEUROENDOCRINO, V23, P505; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; LEVINE S, 1969, STIMULATION EARLY IN; Lim S, 2003, NEUROSCI LETT, V343, P49, DOI 10.1016/S0304-3940(03)00317-3; Macri S, 2004, BEHAV BRAIN RES, V154, P231, DOI 10.1016/j.bbr.2004.02.009; Martinez JC, 2002, BEHAV PROCESS, V60, P15, DOI 10.1016/S0376-6357(02)00102-X; Matto V, 1997, NEUROPHARMACOLOGY, V36, P389, DOI 10.1016/S0028-3908(97)00011-7; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; MORINAN A, 1992, PSYCHOPHARMACOLOGY, V106, P565, DOI 10.1007/BF02244831; MORSE AC, 1995, PHYSIOL BEHAV, V58, P891, DOI 10.1016/0031-9384(95)00144-8; Parfitt DB, 2007, HORM BEHAV, V52, P417, DOI 10.1016/j.yhbeh.2007.06.002; Parfitt DB, 2004, BRAIN RES, V1016, P111, DOI 10.1016/j.brainres.2004.04.077; Patchev VK, 1997, J CLIN INVEST, V99, P962, DOI 10.1172/JCI119261; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sandstrom NJ, 2005, HORM BEHAV, V47, P556, DOI 10.1016/j.yhbeh.2004.12.008; Smith JK, 1998, PHARMACOL BIOCHEM BE, V59, P379, DOI 10.1016/S0091-3057(97)00370-5; Tang XD, 2002, BEHAV BRAIN RES, V136, P555, DOI 10.1016/S0166-4328(02)00228-0; Tarantino LM, 2000, HUM MOL GENET, V9, P953, DOI 10.1093/hmg/9.6.953; Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weiss IC, 2001, PHARMACOL BIOCHEM BE, V70, P397, DOI 10.1016/S0091-3057(01)00626-8; WILLIAMS E, 1953, BEHAVIOUR, V6, P35, DOI 10.1163/156853954X00031; WRIGHT IK, 1991, PHYSIOL BEHAV, V50, P1129, DOI 10.1016/0031-9384(91)90572-6	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19058	10.1371/journal.pone.0019058	http://dx.doi.org/10.1371/journal.pone.0019058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533042	Green Published, Green Submitted, gold			2022-12-27	WOS:000290014500021
J	Kraepiel, Y; Pedron, J; Patrit, O; Simond-Cote, E; Hermand, V; Van Gijsegem, F				Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique			Analysis of the Plant bos1 Mutant Highlights Necrosis as an Efficient Defence Mechanism during D. dadantii/Arabidospis thaliana Interaction	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; ERWINIA-CHRYSANTHEMI STRAIN-3937; CAROTOVORA SUBSP CAROTOVORA; SOFT-ROT PATHOGENESIS; ARABIDOPSIS-THALIANA; CELL-DEATH; HYPERSENSITIVE RESPONSE; BOTRYTIS-CINEREA; TRANSCRIPTION FACTOR; VIRULENCE FACTORS	Dickeya dadantii is a broad host range phytopathogenic bacterium provoking soft rot disease on many plants including Arabidopsis. We showed that, after D. dadantii infection, the expression of the Arabidopsis BOS1 gene was specifically induced by the production of the bacterial PelB/C pectinases able to degrade pectin. This prompted us to analyze the interaction between the bos1 mutant and D. dadantii. The phenotype of the infected bos1 mutant is complex. Indeed, maceration symptoms occurred more rapidly in the bos1 mutant than in the wild type parent but at a later stage of infection, a necrosis developed around the inoculation site that provoked a halt in the progression of the maceration. This necrosis became systemic and spread throughout the whole plant, a phenotype reminiscent of that observed in some lesion mimic mutants. In accordance with the progression of maceration symptoms, bacterial population began to grow more rapidly in the bos1 mutant than in the wild type plant but, when necrosis appeared in the bos1 mutant, a reduction in bacterial population was observed. From the plant side, this complex interaction between D. dadantii and its host includes an early plant defence response that comprises reactive oxygen species (ROS) production accompanied by the reinforcement of the plant cell wall by protein cross-linking. At later timepoints, another plant defence is raised by the death of the plant cells surrounding the inoculation site. This plant cell death appears to constitute an efficient defence mechanism induced by D. dadantii during Arabidopsis infection.	[Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique] INRA, UMR217, Paris, France; [Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique] Univ Paris 06, UMR217, Paris, France; [Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique] AgroParisTech, UMR217, Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech	Kraepiel, Y (corresponding author), INRA, UMR217, Paris, France.	vangijse@agroparistech.fr	Kraepiel, Yvan/D-5056-2017; Hermand, Victor/AAD-4414-2022; Van Gijsegem, Frederique/D-1103-2017	Kraepiel, Yvan/0000-0003-4043-5896; 	INRA (Institut National de la REcherche Agronomique); UPMC (Universite Pierre et Marie Curie)	INRA (Institut National de la REcherche Agronomique); UPMC (Universite Pierre et Marie Curie)	INRA (Institut National de la REcherche Agronomique) and UPMC (Universite Pierre et Marie Curie) supported the cost of the complete project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRO T, 1984, J BACTERIOL, V160, P1199, DOI 10.1128/JB.160.3.1199-1203.1984; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/j.1364-3703.2007.00437.x, 10.1111/J.1364-3703.2007.00437.X]; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; BAUER DW, 1994, MOL PLANT MICROBE IN, V7, P573, DOI 10.1094/MPMI-7-0573; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; BEAULIEU C, 1993, MOL PLANT MICROBE IN, V6, P197, DOI 10.1094/MPMI-6-197; BOCCARA M, 1988, PHYSIOL MOL PLANT P, V33, P95, DOI 10.1016/0885-5765(88)90046-X; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; CONDEMINE G, 1995, MOL PLANT MICROBE IN, V8, P632, DOI 10.1094/MPMI-8-0632; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Dellagi A, 2009, PLANT PHYSIOL, V150, P1687, DOI 10.1104/pp.109.138636; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; DIOLEZ A, 1986, SYMBIOSIS, V2, P323; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307; Fagard M, 2007, MOL PLANT MICROBE IN, V20, P794, DOI 10.1094/MPMI-20-7-0794; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; Hugouvieux-Cotte-Pattat N., 1996, ANNU REV MICROBIOL, V50, P213; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lebeau A, 2008, ENVIRON MICROBIOL, V10, P545, DOI 10.1111/j.1462-2920.2007.01473.x; LETOFFE S, 1990, EMBO J, V9, P1375, DOI 10.1002/j.1460-2075.1990.tb08252.x; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYON GD, 1989, PLANT PATHOL, V38, P20; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; MAUCHMANI B, 1994, MOL PLANT MICROBE IN, V7, P378, DOI 10.1094/MPMI-7-0378; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Miguel E, 2000, MOL PLANT MICROBE IN, V13, P421, DOI 10.1094/MPMI.2000.13.4.421; Norman C, 1999, MOL PLANT MICROBE IN, V12, P640, DOI 10.1094/MPMI.1999.12.7.640; Norman-Setterblad C, 2000, MOL PLANT MICROBE IN, V13, P430, DOI 10.1094/MPMI.2000.13.4.430; PALVA TK, 1994, MOL PLANT MICROBE IN, V7, P356, DOI 10.1094/MPMI-7-0356; PEROMBELON M C M, 1975, Potato Research, V18, P64, DOI 10.1007/BF02361776; PEROMBELON MCM, 1980, ANNU REV PHYTOPATHOL, V18, P361, DOI 10.1146/annurev.py.18.090180.002045; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; REIGNAULT P, 1994, MICROBIOL-SGM, V140, P3249, DOI 10.1099/13500872-140-12-3249; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Roy C, 1999, J BACTERIOL, V181, P3705, DOI 10.1128/JB.181.12.3705-3709.1999; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Segond D, 2009, PLANT J, V58, P195, DOI 10.1111/j.1365-313X.2008.03775.x; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Soulie MC, 2003, FUNGAL GENET BIOL, V40, P38, DOI 10.1016/S1087-1845(03)00065-3; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; VANGIJSEGEM F, 1995, EUR J PLANT PATHOL, V101, P549, DOI 10.1007/BF01874480; Veronese P, 2004, PLANT J, V40, P558, DOI 10.1111/j.1365-313X.2004.02232.x; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Zhang C, 2004, MOL PLANT MICROBE IN, V17, P357, DOI 10.1094/MPMI.2004.17.4.357	58	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18991	10.1371/journal.pone.0018991	http://dx.doi.org/10.1371/journal.pone.0018991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533045	Green Published, Green Submitted, gold			2022-12-27	WOS:000290014500018
J	Draube, A; Klein-Gonzalez, N; Mattheus, S; Brillant, C; Hellmich, M; Engert, A; von Bergwelt-Baildon, M				Draube, Andreas; Klein-Gonzalez, Nela; Mattheus, Stefanie; Brillant, Corinne; Hellmich, Martin; Engert, Andreas; von Bergwelt-Baildon, Michael			Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							REGULATORY T-CELLS; CLINICAL-RESPONSE; SIPULEUCEL-T; PSMA PEPTIDES; LYMPH-NODES; PHASE-I/II; IMMUNOTHERAPY; CARCINOMA; IMMUNITY; THERAPY	Background: More than 200 clinical trials have been performed using dendritic cells (DC) as cellular adjuvants in cancer. Yet the key question whether there is a link between immune and clinical response remains unanswered. Prostate and renal cell cancer (RCC) have been extensively studied for DC-based immunotherapeutic interventions and were therefore chosen to address the above question by means of a systematic review and meta-analysis. Methodology/Principal Findings: Data was obtained after a systematic literature search from clinical trials that enrolled at least 6 patients. Individual patient data meta-analysis was performed by means of conditional logistic regression grouped by study. Twenty nine trials involving a total of 906 patients were identified in prostate cancer (17) and RCC (12). Objective response rates were 7.7% in prostate cancer and 12.7% in RCC. The combined percentages of objective responses and stable diseases (SD) amounted to a clinical benefit rate (CBR) of 54% in prostate cancer and 48% in RCC. Meta-analysis of individual patient data (n = 403) revealed the cellular immune response to have a significant influence on CBR, both in prostate cancer (OR 10.6, 95% CI 2.5-44.1) and in RCC (OR 8.4, 95% CI 1.3-53.0). Furthermore, DC dose was found to have a significant influence on CBR in both entities. Finally, for the larger cohort of prostate cancer patients, an influence of DC maturity and DC subtype (density enriched versus monocyte derived DC) as well as access to draining lymph nodes on clinical outcome could be demonstrated. Conclusions/Significance: As a 'proof of principle' a statistically significant effect of DC-mediated cellular immune response and of DC dose on CBR could be demonstrated. Further findings concerning vaccine composition, quality control, and the effect of DC maturation status are relevant for the immunological development of DC-based vaccines.	[Draube, Andreas; Klein-Gonzalez, Nela; Mattheus, Stefanie; von Bergwelt-Baildon, Michael] Univ Hosp Cologne, Dept Internal Med 1, Lab Tumor & Transplantat Immunol, Cologne, Germany; [Brillant, Corinne; Engert, Andreas] Univ Hosp Cologne, Dept Internal Med 1, Cochrane Hematol Malignancies Grp, Cologne, Germany; [Hellmich, Martin] Univ Cologne, IMSIE, Cologne, Germany; [Klein-Gonzalez, Nela] Univ Cologne, Ctr Mol Med CMMC, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Draube, A (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Lab Tumor & Transplantat Immunol, Cologne, Germany.	michael.bergwelt@uk-koeln.de		Hellmich, Martin/0000-0001-5174-928X	'la Caixa' Foundation; German Academic Exchange Service (DAAD); Deutsche Krebshilfe	'la Caixa' Foundation(La Caixa Foundation); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Krebshilfe(Deutsche Krebshilfe)	Nela Klein-Gonzalez was supported by a fellowship from 'la Caixa' Foundation and the German Academic Exchange Service (DAAD). Michael von Bergwelt-Baildon was supported within the Max-Eder Young Investigator Program of the Deutsche Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JC, 2004, J CLIN IMMUNOL, V24, P86, DOI 10.1023/B:JOCI.0000018067.71622.fb; Asemissen AM, 2009, CANCER IMMUNOL IMMUN, V58, P1169, DOI 10.1007/s00262-009-0706-7; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrou B, 2004, CANCER IMMUNOL IMMUN, V53, P453, DOI 10.1007/s00262-003-0451-2; Berntsen A, 2006, EUR UROL, V50, P34, DOI 10.1016/j.eururo.2006.03.061; Berntsen A, 2008, J IMMUNOTHER, V31, P771, DOI 10.1097/CJI.0b013e3181833818; Bleumer I, 2007, J IMMUNOTHER, V30, P116, DOI 10.1097/01.cji.0000211318.22902.ec; Britten CM, 2008, CANCER IMMUNOL IMMUN, V57, P285, DOI 10.1007/s00262-007-0379-z; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; Burch PA, 2000, CLIN CANCER RES, V6, P2175; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Copier J, 2009, EUR J CANCER, V45, P1424, DOI 10.1016/j.ejca.2008.12.017; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Vries IJM, 2003, CANCER RES, V63, P12; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Engell-Noerregaard L, 2009, CANCER IMMUNOL IMMUN, V58, P1, DOI 10.1007/s00262-008-0568-4; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fong L, 2001, J IMMUNOL, V167, P7150, DOI 10.4049/jimmunol.167.12.7150; Fong L, 2001, J IMMUNOL, V166, P4254, DOI 10.4049/jimmunol.166.6.4254; Fuessel S, 2006, PROSTATE, V66, P811, DOI 10.1002/pros.20404; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gitlitz BJ, 2003, J IMMUNOTHER, V26, P412, DOI 10.1097/00002371-200309000-00004; Heiser A, 2002, J CLIN INVEST, V109, P409, DOI 10.1172/JCI14364; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Hildenbrand B, 2007, PROSTATE, V67, P500, DOI 10.1002/pros.20539; Holtl L, 2005, CANCER IMMUNOL IMMUN, V54, P663, DOI 10.1007/s00262-004-0629-2; Holtl L, 2002, CLIN CANCER RES, V8, P3369; Hoos A, 2007, J IMMUNOTHER, V30, P1, DOI 10.1097/01.cji.0000211341.88835.ae; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jahnisch H, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/517493; Jocham D, 2004, LANCET, V363, P594, DOI 10.1016/S0140-6736(04)15590-6; Jonuleit H, 2001, INT J CANCER, V93, P243, DOI 10.1002/ijc.1323; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Kim JH, 2007, CLIN IMMUNOL, V125, P257, DOI 10.1016/j.clim.2007.07.014; Kraemer M, 2010, ANTICANCER RES, V30, P2081; Lee David, 2003, Clin Prostate Cancer, V2, P81; Lee DC, 2004, CANCER IMMUNOL IMMUN, V53, P275, DOI 10.1007/s00262-003-0432-5; Lemoine FM, 2009, INT J ONCOL, V35, P569, DOI 10.3892/ijo_00000368; Lodge PA, 2000, CANCER RES, V60, P829; Marten A, 2002, CANCER IMMUNOL IMMUN, V51, P637, DOI 10.1007/s00262-002-0324-0; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matsumoto A, 2007, INT J UROL, V14, P277, DOI 10.1111/j.1442-2042.2006.01723.x; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mu LJ, 2005, BRIT J CANCER, V93, P749, DOI 10.1038/sj.bjc.6602761; Murphy GP, 2000, PROSTATE, V43, P59, DOI 10.1002/(SICI)1097-0045(20000401)43:1<59::AID-PROS8>3.0.CO;2-D; Murphy GP, 2000, PROSTATE, V42, P67, DOI 10.1002/(SICI)1097-0045(20000101)42:1<67::AID-PROS8>3.0.CO;2-I; Nagorsen D, 2006, CLIN CANCER RES, V12, P3064, DOI 10.1158/1078-0432.CCR-05-2788; Oosterwijk-Wakka JC, 2002, J IMMUNOTHER, V25, P500, DOI 10.1097/00002371-200211000-00006; Osada T, 2006, INT REV IMMUNOL, V25, P377, DOI 10.1080/08830180600992456; Pandha HS, 2004, BJU INT, V94, P412, DOI 10.1111/j.1464-410X.2004.04922.x; Perambakam S, 2006, CANCER IMMUNOL IMMUN, V55, P1033, DOI 10.1007/s00262-005-0090-x; Putz T, 2004, J CLIN IMMUNOL, V24, P653, DOI 10.1007/s10875-004-6237-2; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Robert C, 2003, GENE THER, V10, P1479, DOI 10.1038/sj.gt.3302008; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schlom J, 2008, EXP BIOL MED, V233, P522, DOI 10.3181/0708-MR-226; Schwaab T, 2009, CLIN CANCER RES, V15, P4986, DOI 10.1158/1078-0432.CCR-08-3240; Small EJ, 2000, J CLIN ONCOL, V18, P3894, DOI 10.1200/JCO.2000.18.23.3894; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; Su Z, 2003, CANCER RES, V63, P2127; Thomas-Kaskel AK, 2007, INT J CANCER, V121, P467, DOI 10.1002/ijc.22859; Thomas-Kaskell AK, 2006, INT J CANCER, V119, P2428, DOI 10.1002/ijc.22097; Tuyaerts S, 2007, CANCER IMMUNOL IMMUN, V56, P1513, DOI 10.1007/s00262-007-0334-z; Van Poppel H, 2009, EUR UROL, V55, P1333, DOI 10.1016/j.eururo.2009.01.043; Verdijk P, 2009, CLIN CANCER RES, V15, P2531, DOI 10.1158/1078-0432.CCR-08-2729; Verra N, 2005, EUR UROL, V48, P527, DOI 10.1016/j.eururo.2005.03.031; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Bergwelt-Baildon M, 2006, BLOOD, V107, P2786, DOI 10.1182/blood-2004-01-0113; Waeckerle-Men Y, 2006, CANCER IMMUNOL IMMUN, V55, P1524, DOI 10.1007/s00262-006-0157-3; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wang Huan, 2006, Ai Zheng, V25, P625; Wei YC, 2007, ONCOL REP, V18, P665; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	89	155	172	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18801	10.1371/journal.pone.0018801	http://dx.doi.org/10.1371/journal.pone.0018801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533099	Green Submitted, Green Published, gold			2022-12-27	WOS:000289719400025
J	Groenheit, R; Ghebremichael, S; Svensson, J; Rabna, P; Colombatti, R; Riccardi, F; Couvin, D; Hill, V; Rastogi, N; Koivula, T; Kallenius, G				Groenheit, Ramona; Ghebremichael, Solomon; Svensson, Jenny; Rabna, Paulo; Colombatti, Raffaella; Riccardi, Fabio; Couvin, David; Hill, Veronique; Rastogi, Nalin; Koivula, Tuija; Kallenius, Gunilla			The Guinea-Bissau Family of Mycobacterium tuberculosis Complex Revisited	PLOS ONE			English	Article							NITRATE REDUCTASE NARGHJI; PULMONARY TUBERCULOSIS; POLYMORPHIC NUCLEOTIDE; BURKINA-FASO; AFRICANUM; STRAINS; EPIDEMIOLOGY; PREDOMINANCE; RESISTANCE; PHYLOGENY	The Guinea-Bissau family of strains is a unique group of the Mycobacterium tuberculosis complex that, although genotypically closely related, phenotypically demonstrates considerable heterogeneity. We have investigated 414 M. tuberculosis complex strains collected in Guinea-Bissau between 1989 and 2008 in order to further characterize the Guinea-Bissau family of strains. To determine the strain lineages present in the study sample, binary outcomes of spoligotyping were compared with spoligotypes existing in the international database SITVIT2. The major circulating M. tuberculosis clades ranked in the following order: AFRI (n = 195, 47.10%), Latin-American-Mediterranean (LAM) (n = 75, 18.12%), ill-defined T clade (n = 53, 12.8%), Haarlem (n = 37, 8.85%), East-African-Indian (EAI) (n = 25, 6.04%), Unknown (n = 12, 2.87%), Beijing (n = 7, 1.68%), X clade (n = 4, 0.96%), Manu (n = 4, 0.97%), CAS (n = 2, 0.48%). Two strains of the LAM clade isolated in 2007 belonged to the Cameroon family (SIT61). All AFRI isolates except one belonged to the Guinea-Bissau family, i.e. they have an AFRI_1 spoligotype pattern, they have a distinct RFLP pattern with low numbers of IS6110 insertions, and they lack the regions of difference RD7, RD8, RD9 and RD10, RD701 and RD702. This profile classifies the Guinea-Bissau family, irrespective of phenotypic biovar, as part of the M. africanum West African 2 lineage, or the AFRI_1 sublineage according to the spoligtyping nomenclature. Guinea-Bissau family strains display a variation of biochemical traits classically used to differentiate M. tuberculosis from M. bovis. Yet, the differential expression of these biochemical traits was not related to any genes so far investigated (narGHJI and pncA). Guinea-Bissau has the highest prevalence of M. africanum recorded in the African continent, and the Guinea-Bissau family shows a high phylogeographical specificity for Western Africa, with Guinea-Bissau being the epicenter. Trends over time however indicate that this family of strains is waning in most parts of Western Africa, including Guinea-Bissau (p = 0.048).	[Groenheit, Ramona; Ghebremichael, Solomon; Svensson, Jenny; Koivula, Tuija] Swedish Inst Infect Dis Control, Dept Preparedness, Solna, Sweden; [Groenheit, Ramona] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Rabna, Paulo] Lab Nacl Saude Publ, Bissau, Guinea Bissau; [Rabna, Paulo] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Colombatti, Raffaella] Hosp Raoul Follereau, Bissau, Guinea Bissau; [Colombatti, Raffaella] Azienda Osped Univ Padova, Dept Pediat, Padua, Italy; [Riccardi, Fabio] Univ Roma Tor Vergata, Dept Publ Hlth, Rome, Italy; [Koivula, Tuija; Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Rome Tor Vergata; Karolinska Institutet	Groenheit, R (corresponding author), Swedish Inst Infect Dis Control, Dept Preparedness, Solna, Sweden.	gunilla.kallenius@ki.se	Colombatti, Raffaella/D-2910-2017; RASTOGI, NALIN/AAP-1958-2020; Källenius, Gunilla/AGZ-3956-2022	Colombatti, Raffaella/0000-0001-9797-0457; RASTOGI, NALIN/0000-0002-7199-7747; Groenheit, Ramona/0000-0003-2696-437X; Couvin, David/0000-0002-7897-9023; RICCARDI, Fabio/0000-0003-4523-3556; Kallenius, Gunilla/0000-0002-8921-0551	Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation; Swedish Research Council; Regional Council of Guadeloupe [CR/08-1612]; United States National Institutes of Health [R01LM009731]; NATIONAL LIBRARY OF MEDICINE [R01LM009731] Funding Source: NIH RePORTER	Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Regional Council of Guadeloupe; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by grants from the Swedish International Development Cooperation Agency, the Swedish Heart-Lung Foundation, and the Swedish Research Council. The SITVIT2 database project benefited from research grants from the Regional Council of Guadeloupe (grant CR/08-1612), and by United States National Institutes of Health (grant R01LM009731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2007, INT J TUBERC LUNG D, V11, P450; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2005, AIDS, V19, P1714, DOI 10.1097/01.aids.0000185991.54595.41; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; DIAS F, 1993, TUBERCLE LUNG DIS, V74, P129, DOI 10.1016/0962-8479(93)90040-5; Ferdinand Severine, 2005, Infection Genetics and Evolution, V5, P340, DOI 10.1016/j.meegid.2004.10.002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Goh KS, 2005, J CLIN MICROBIOL, V43, P4010, DOI 10.1128/JCM.43.8.4010-4014.2005; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Haas WH, 1997, J CLIN MICROBIOL, V35, P663, DOI 10.1128/JCM.35.3.663-666.1997; Helal ZH, 2009, J CLIN MICROBIOL, V47, P2794, DOI 10.1128/JCM.00360-09; HOFFNER SE, 1993, J CLIN MICROBIOL, V31, P2215, DOI 10.1128/JCM.31.8.2215-2217.1993; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; HUET M, 1971, Revue de Tuberculose et de Pneumologie, V35, P413; Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koivula T, 2004, MICROBES INFECT, V6, P272, DOI 10.1016/j.micinf.2003.12.006; Ledru S, 1996, TUBERCLE LUNG DIS, V77, P429, DOI 10.1016/S0962-8479(96)90116-1; Meyer CG, 2008, TUBERCULOSIS, V88, P482, DOI 10.1016/j.tube.2008.05.004; MOLINATORRES CA, J CLIN MICROBIOL, V48, P448; Mostowy S, 2004, J CLIN MICROBIOL, V42, P3594, DOI 10.1128/jcm.42.8.3594-3599.2004; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Namouchi A, 2008, J MED MICROBIOL, V57, P864, DOI 10.1099/jmm.0.47483-0; Naucler A, 1996, TUBERCLE LUNG DIS, V77, P226, DOI 10.1016/S0962-8479(96)90005-2; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Rey J L, 1979, Med Trop (Mars), V39, P149; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stermann M, 2003, J CLIN MICROBIOL, V41, P3252, DOI 10.1128/JCM.41.7.3252-3259.2003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; VIEGAS SO, BMC MICROBIOL, V10, P195	44	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18601	10.1371/journal.pone.0018601	http://dx.doi.org/10.1371/journal.pone.0018601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533101	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400015
J	Kothapalli, NR; Norton, DD; Fugmann, SD				Kothapalli, Naga Rama; Norton, Darrell D.; Fugmann, Sebastian D.			Classical Mus musculus Ig kappa Enhancers Support Transcription but not High Level Somatic Hypermutation from a V-Lambda Promoter in Chicken DT40 Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN GENE CONVERSION; CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; LOCUS; DNA; DOWNSTREAM; TARGETS; DIVERSIFICATION; ELEMENTS; REGION	Somatic hypermutation (SHM) of immunoglobulin genes is initiated by activation-induced cytidine deaminase (AID) in activated B cells. This process is strictly dependent on transcription. Hence, cis-acting transcriptional control elements have been proposed to target SHM to immunoglobulin loci. The Mus musculus Ig kappa locus is regulated by the intronic enhancer (iE/MAR) and the 3' enhancer (3'E), and multiple studies using transgenic and knock-out approaches in mice and cell lines have reported somewhat contradictory results about the function of these enhancers in AID-mediated sequence diversification. Here we show that the M. musculus iE/MAR and 3'E elements are active solely as transcriptional enhancer when placed in the context of the IGL locus in Gallus gallus DT40 cells, but they are very inefficient in targeting AID-mediated mutation events to this locus. This suggests that either key components of the cis-regulatory targeting elements reside outside the murine Igk transcriptional enhancer sequences, or that the targeting of AID activity to Ig loci occurs by largely species-specific mechanisms.	[Kothapalli, Naga Rama; Norton, Darrell D.; Fugmann, Sebastian D.] NIA, Lab Mol Biol & Immunol, Mol Immunol Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kothapalli, NR (corresponding author), NIA, Lab Mol Biol & Immunol, Mol Immunol Unit, NIH, Baltimore, MD 21224 USA.	fugmanns@grc.nia.nih.gov	Kothapalli, Naga Rama/E-5229-2017	Kothapalli, Naga Rama/0000-0001-7993-8525	National Institute on Aging/National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000387] Funding Source: NIH RePORTER	National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was entirely funded by the intramural program of the National Institute on Aging/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Diaz M, 2001, PHILOS T R SOC B, V356, P67, DOI 10.1098/rstb.2000.0750; Gopal AAR, 2008, MOL IMMUNOL, V45, P2062, DOI 10.1016/j.molimm.2007.10.017; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Kim Y, 2009, MOL IMMUNOL, V46, P3283, DOI 10.1016/j.molimm.2009.07.027; Kothapalli N, 2008, J IMMUNOL, V180, P2019, DOI 10.4049/jimmunol.180.4.2019; Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu ZM, 2002, J BIOL CHEM, V277, P32640, DOI 10.1074/jbc.M204065200; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Saribasak H, 2009, PHILOS T R SOC B, V364, P605, DOI 10.1098/rstb.2008.0188; Tanaka A, 2010, J EXP MED, V207, P405, DOI 10.1084/jem.20090821; Xiang YG, 2008, J IMMUNOL, V180, P6725, DOI 10.4049/jimmunol.180.10.6725; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18955	10.1371/journal.pone.0018955	http://dx.doi.org/10.1371/journal.pone.0018955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533098	Green Submitted, gold, Green Published			2022-12-27	WOS:000289719400038
J	Swenson, JJ; Carter, CE; Domec, JC; Delgado, CI				Swenson, Jennifer J.; Carter, Catherine E.; Domec, Jean-Christophe; Delgado, Cesar I.			Gold Mining in the Peruvian Amazon: Global Prices, Deforestation, and Mercury Imports	PLOS ONE			English	Article							BRAZILIAN AMAZON; CONSERVATION	Many factors such as poverty, ineffective institutions and environmental regulations may prevent developing countries from managing how natural resources are extracted to meet a strong market demand. Extraction for some resources has reached such proportions that evidence is measurable from space. We present recent evidence of the global demand for a single commodity and the ecosystem destruction resulting from commodity extraction, recorded by satellites for one of the most biodiverse areas of the world. We find that since 2003, recent mining deforestation in Madre de Dios, Peru is increasing nonlinearly alongside a constant annual rate of increase in international gold price (similar to 18%/yr). We detect that the new pattern of mining deforestation (1915 ha/year, 2006-2009) is outpacing that of nearby settlement deforestation. We show that gold price is linked with exponential increases in Peruvian national mercury imports over time (R-2 = 0.93, p = 0.04, 2003-2009). Given the past rates of increase we predict that mercury imports may more than double for 2011 (similar to 500 t/year). Virtually all of Peru's mercury imports are used in artisanal gold mining. Much of the mining increase is unregulated/artisanal in nature, lacking environmental impact analysis or miner education. As a result, large quantities of mercury are being released into the atmosphere, sediments and waterways. Other developing countries endowed with gold deposits are likely experiencing similar environmental destruction in response to recent record high gold prices. The increasing availability of satellite imagery ought to evoke further studies linking economic variables with land use and cover changes on the ground.	[Swenson, Jennifer J.; Carter, Catherine E.; Domec, Jean-Christophe] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Domec, Jean-Christophe] Ecole Natl Ingenieurs Travaux Agr Bordeaux, Unite Mixte Rech Transfert & Cycle Elements Miner, Gradignan, France; [Delgado, Cesar I.] CESEL SA, Environm Affairs Off, Lima, Peru	Duke University	Swenson, JJ (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	jswenson@duke.edu	domec, jean-christophe/P-9251-2019; Domec, Jean-Christophe/AFV-5999-2022	domec, jean-christophe/0000-0003-0478-2559; Domec, Jean-Christophe/0000-0003-0478-2559; Swenson, Jennifer J./0000-0002-2069-667X	Duke University	Duke University	J. Swenson and J.C. Domec are supported by Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBACETE C, 2007, PARKSWATCH DATABASE; Alvarez NL, 2003, AMBIO, V32, P269, DOI 10.1639/0044-7447(2003)032[0269:LNAPTD]2.0.CO;2; ASTER GDEM, 2009, ASTER GLOB DIG EL MO; Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks WE, 2007, 20071252 US GEOL SUR; BUTLER R, 2009, HIGH GOLD PRICES ARM; BUTLER R, 2006, ILLEGAL MINING THREA; Cleary David, 1990, ANATOMY AMAZON GOLD; *COM, 2009, SUB PREC OR IMP MIN; *COM, 2009, SEP MERC; Crompton P, 2002, ENVIRON RES, V90, P69, DOI 10.1006/enrs.2002.4358; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DELGADO CI, 2008, IS INTEROCEANIC HIGH; Dudley N., 1999, CONVERSION PAPER PAR; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Fraser B, 2009, ENVIRON SCI TECHNOL, V43, P7162, DOI 10.1021/es902347z; Friedli HR, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P193, DOI 10.1007/978-0-387-93958-2_8; Graham D, 2006, WORLD DEV, V34, P868, DOI 10.1016/j.worlddev.2005.04.022; Harvard Law School, 2007, ALL GLITT GOLD MIN G; *IIRSA, 2009, IND TERR PLANN IIRSA; IUCN, 2008, GLOB AMPH ASS; *IUCN, 2008, GLOB MAMM ASS; Keane L, 2009, RISING PRICES SPARK; Killeen TJ, 2007, PERFECT STORM AMAZON; Kirkby CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013015; Kumah A, 2006, J CLEAN PROD, V14, P315, DOI 10.1016/j.jclepro.2004.08.007; LARMER B, 2009, NAT GEO          JAN; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Pachas V., 2009, ESTUDIO DIAGNOSTICO; *PER MIN ENV, 2009, MIN INF MADR DIOS; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Shrum P., 2009, THESIS CLEMSON U CLE; Sousa RN, 2009, AMBIO, V38, P40, DOI 10.1579/0044-7447-38.1.40; Telmer KM, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P131, DOI 10.1007/978-0-387-93958-2_6; TORRES C, 2007, MINERIA ARTISANAL GR; *UN ENV PROGR, 2009, HIST TREAT TACKL TOX; Veiga M.M., 1997, INTRO NEW TECHNOLOGI; Veiga MM, 2006, J CLEAN PROD, V14, P436, DOI 10.1016/j.jclepro.2004.08.010; Vieira R, 2006, J CLEAN PROD, V14, P448, DOI 10.1016/j.jclepro.2004.09.007; Wessendorf K., 2008, INDIGENOUS WORLD 200; WHO, 1989, ENV HLTH CRIT 86 MER; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Yu DW, 2010, BIOTROPICA, V42, P569, DOI 10.1111/j.1744-7429.2010.00680.x; 2010, PERU POISED BECOME 5	46	196	204	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18875	10.1371/journal.pone.0018875	http://dx.doi.org/10.1371/journal.pone.0018875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526143	Green Published, gold			2022-12-27	WOS:000289671100033
J	Zhao, L; Tang, YL; You, ZR; Wang, QX; Liang, SW; Han, XF; Qiu, DK; Wei, J; Liu, Y; Shen, L; Chen, XY; Peng, YS; Li, ZP; Ma, X				Zhao, Li; Tang, Yanli; You, Zhengrui; Wang, Qixia; Liang, Shuwen; Han, Xiaofeng; Qiu, Dekai; Wei, Jue; Liu, Yuan; Shen, Lei; Chen, Xiaoyu; Peng, Yanshen; Li, Zhiping; Ma, Xiong			Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression	PLOS ONE			English	Article							REGULATORY T-CELLS; SUPPRESSION; GENERATION; INDUCTION; T(H)17; IL-17	T helper cells that produce IL-17 (Th17 cells) have recently been identified as the third distinct subset of effector T cells. Emerging data suggests that Th17 cells play an important role in the pathogenesis of many liver diseases by regulating innate immunity, adaptive immunity, and autoimmunity. In this study, we examine the role and mechanism of Th17 cells in the pathogenesis of autoimmune hepatitis (AIH). The serum levels of IL-17 and IL-23, as well as the frequency of IL-17+ cells in the liver, were significantly elevated in patients with AIH, compared to other chronic hepatitis and healthy controls. The hepatic expressions of IL-17, IL-23, ROR-gamma t, IL-6 and IL-1 beta in patients with AIH were also significantly increased and were associated with increased inflammation and fibrosis. IL-17 induces IL-6 expression via the MAPK signaling pathway in hepatocytes, which, in turn, may further stimulate Th17 cells and forms a positive feedback loop. In conclusion, Th17 cells are key effector T cells that regulate the pathogenesis of AIH, via induction of MAPK dependent hepatic IL-6 expression. Blocking the signaling pathway and interrupting the positive feedback loop are potential therapeutic targets for autoimmune hepatitis.	[Zhao, Li; Tang, Yanli; You, Zhengrui; Wang, Qixia; Han, Xiaofeng; Qiu, Dekai; Wei, Jue; Liu, Yuan; Shen, Lei; Chen, Xiaoyu; Peng, Yanshen; Ma, Xiong] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Dept Gastroenterol,Renji Hosp, Shanghai 200030, Peoples R China; [Liang, Shuwen; Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Shanghai Jiao Tong University; Johns Hopkins University	Zhao, L (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Dept Gastroenterol,Renji Hosp, Shanghai 200030, Peoples R China.	zhipingli@jhmi.edu; maxiongmd@hotmail.com		Ma, Xiong/0000-0001-9616-4672	National Natural Science Foundation of China [30770963, 30972751]; Shanghai Pujiang program; Shanghai Municipal Education Commission; NIH/NIDDK [R01DK075990]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075990] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Awards from National Natural Science Foundation of China (#30770963, 30972751, XM), Shanghai Pujiang program, Program for Innovative Research Team of Shanghai Municipal Education Commission (XM), and a research grant from NIH/NIDDK R01DK075990 (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bertolino Patrick, 2008, Hepatology, V47, P345, DOI 10.1002/hep.22154; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Dai JS, 2004, TOXICOLOGY, V203, P199, DOI 10.1016/j.tox.2004.06.009; Fisher NC, 1999, GUT, V45, P416, DOI 10.1136/gut.45.3.416; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jiang SP, 2003, AM J TRANSPLANT, V3, P516, DOI 10.1034/j.1600-6143.2003.00124.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Longhi MS, 2008, HEPATOLOGY, V47, P581, DOI 10.1002/hep.22071; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; SENALDI G, 1992, ARCH DIS CHILD, V67, P1447, DOI 10.1136/adc.67.12.1447; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Vergani D, 2007, SEMIN LIVER DIS, V27, P140, DOI 10.1055/s-2007-979467; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	30	136	153	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18909	10.1371/journal.pone.0018909	http://dx.doi.org/10.1371/journal.pone.0018909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526159	Green Submitted, Green Published, gold			2022-12-27	WOS:000289671100036
J	Guellai, B; Streri, A				Guellai, Bahia; Streri, Arlette			Cues for Early Social Skills: Direct Gaze Modulates Newborns' Recognition of Talking Faces	PLOS ONE			English	Article							EYE-CONTACT; NATIVE-LANGUAGE; YOUNG INFANTS; MOTHERS FACE; 4-MONTH-OLD INFANTS; VISUAL-ATTENTION; MATERNAL SPEECH; RACE FACES; PREFERENCE; PERCEPTION	Previous studies showed that, from birth, speech and eye gaze are two important cues in guiding early face processing and social cognition. These studies tested the role of each cue independently; however, infants normally perceive speech and eye gaze together. Using a familiarization-test procedure, we first familiarized newborn infants (n = 24) with videos of unfamiliar talking faces with either direct gaze or averted gaze. Newborns were then tested with photographs of the previously seen face and of a new one. The newborns looked longer at the face that previously talked to them, but only in the direct gaze condition. These results highlight the importance of both speech and eye gaze as socio-communicative cues by which infants identify others. They suggest that gaze and infant-directed speech, experienced together, are powerful cues for the development of early social skills.	[Guellai, Bahia] Univ Paris 05, Paris, France; Ctr Biomed St Peres, CNRS, Lab Psychol Percept, Unite Mixte Rech 8158, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Guellai, B (corresponding author), Univ Paris 05, Paris, France.	bahia.guellai@gmail.com			Institut Universitaire de France (I.U.F.); French Ministry of Research	Institut Universitaire de France (I.U.F.); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	The work was supported by grants from the Institut Universitaire de France (I.U.F.) and the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Argyle M., 1976, GAZE MUTUAL GAZE; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1994, CAH PSYCHOL COGN, V13, P513; Batki A, 2000, INFANT BEHAV DEV, V23, P223, DOI 10.1016/S0163-6383(01)00037-6; BEIER JS, CHILD DEV IN PRESS; Best CT, 2009, PSYCHOL SCI, V20, P539, DOI 10.1111/j.1467-9280.2009.02327.x; Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BRUCE V, 1987, APPL COGNITIVE PSYCH, V1, P109, DOI 10.1002/acp.2350010204; Bruce V., 1998, EYE BEHOLDER SCI FAC; Bulf H, 2010, VIS COGN, V18, P504, DOI 10.1080/13506280903272037; Burnham D, 2002, SCIENCE, V296, P1435, DOI 10.1126/science.1069587; BURNHAM D, 1993, PERCEPTION, V22, P1133, DOI 10.1068/p221133; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; COULON M, INT J BEHAV IN PRESS; de Heering A, 2008, COGNITION, V106, P444, DOI 10.1016/j.cognition.2006.12.012; DECASPER AJ, 1986, INFANT BEHAV DEV, V9, P133, DOI 10.1016/0163-6383(86)90025-1; DECASPER AJ, 1994, INFANT BEHAV DEV, V17, P159, DOI 10.1016/0163-6383(94)90051-5; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gava L, 2008, DEVELOPMENTAL SCI, V11, P563, DOI 10.1111/j.1467-7687.2008.00702.x; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Hood BM, 2003, DEVELOPMENTAL SCI, V6, P67, DOI 10.1111/1467-7687.00256; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kinzler KD, 2007, PROG BRAIN RES, V164, P257, DOI 10.1016/S0079-6123(07)64014-X; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Panneton-Cooper R. P., 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; PASCALIS O, 1994, NEUROREPORT, V5, P1721, DOI 10.1097/00001756-199409080-00008; PEGG JE, 1992, INFANT BEHAV DEV, V15, P325, DOI 10.1016/0163-6383(92)80003-D; Quinn PC, 2010, INFANT BEHAV DEV, V33, P357, DOI 10.1016/j.infbeh.2010.03.001; Quinn PC, 2008, J NEUROPSYCHOL, V2, P15, DOI 10.1348/174866407X231029; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Sai FZ, 2005, INFANT CHILD DEV, V14, P29, DOI 10.1002/icd.376; Sanefuji W, 2006, INFANT BEHAV DEV, V29, P584, DOI 10.1016/j.infbeh.2006.07.007; Soderstrom M, 2007, DEV REV, V27, P501, DOI 10.1016/j.dr.2007.06.002; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Vouloumanos A, 2010, CHILD DEV, V81, P517, DOI 10.1111/j.1467-8624.2009.01412.x; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686	59	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18610	10.1371/journal.pone.0018610	http://dx.doi.org/10.1371/journal.pone.0018610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525972	Green Submitted, Green Published, gold			2022-12-27	WOS:000289578600017
J	Mueller, K; Anwander, A; Moller, HE; Horstmann, A; Lepsien, J; Busse, F; Mohammadi, S; Schroeter, ML; Stumvoll, M; Villringer, A; Pleger, B				Mueller, Karsten; Anwander, Alfred; Moeller, Harald E.; Horstmann, Annette; Lepsien, Joeran; Busse, Franziska; Mohammadi, Siawoosh; Schroeter, Matthias L.; Stumvoll, Michael; Villringer, Arno; Pleger, Burkhard			Sex-Dependent Influences of Obesity on Cerebral White Matter Investigated by Diffusion-Tensor Imaging	PLOS ONE			English	Article							BODY-MASS INDEX; PLASMA LEPTIN CONCENTRATIONS; LATE-LIFE DEPRESSION; CORPUS-CALLOSUM; BRAIN STRUCTURE; SPATIAL STATISTICS; EDDY-CURRENT; INTEGRITY; GENDER; MICROSTRUCTURE	Several studies have shown that obesity is associated with changes in human brain function and structure. Since women are more susceptible to obesity than men, it seems plausible that neural correlates may also be different. However, this has not been demonstrated so far. To address this issue, we systematically investigated the brain's white matter (WM) structure in 23 lean to obese women (mean age 25.5 y, std 5.1 y; mean body mass index (BMI) 29.5 kg/m(2), std 7.3 kg/m(2)) and 26 lean to obese men (mean age 27.1 y, std 5.0 y; mean BMI 28.8 kg/m(2), std 6.8 kg/m(2)) with diffusion-weighted magnetic resonance imaging (MRI). There was no significant age (p > 0.2) or BMI (p > 0.7) difference between female and male participants. Using tract-based spatial statistics, we correlated several diffusion parameters including the apparent diffusion coefficient, fractional anisotropy (FA), as well as axial (lambda(parallel to)) and radial diffusivity (lambda(perpendicular to)) with BMI and serum leptin levels. In female and male subjects, the putative axon marker lambda(parallel to) was consistently reduced throughout the corpus callosum, particularly in the splenium (r = -0.62, p < 0.005). This suggests that obesity may be associated with axonal degeneration. Only in women, the putative myelin marker lambda(perpendicular to) significantly increased with increasing BMI (r = 0.57, p < 0.005) and serum leptin levels (r = 0.62, p < 0.005) predominantly in the genu of the corpus callosum, suggesting additional myelin degeneration. Comparable structural changes were reported for the aging brain, which may point to accelerated aging of WM structure in obese subjects. In conclusion, we demonstrate structural WM changes related to an elevated body weight, but with differences between men and women. Future studies on obesity-related functional and structural brain changes should therefore account for sex-related differences.	[Mueller, Karsten; Anwander, Alfred; Moeller, Harald E.; Horstmann, Annette; Lepsien, Joeran; Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Mohammadi, Siawoosh] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Busse, Franziska; Stumvoll, Michael] Univ Hosp Leipzig, Dept Med, Leipzig, Germany; [Horstmann, Annette; Stumvoll, Michael; Villringer, Arno] Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany	Max Planck Society; University of London; University College London; Leipzig University; Leipzig University	Mueller, K (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	karstenm@cbs.mpg.de	Moller, Harald E/A-1565-2008; Anwander, Alfred/B-5874-2011; Möller, Harald/AAB-4679-2019; Stumvoll, Michael/ABE-1121-2021; Horstmann, Annette/C-9083-2011; Mohammadi, Siawoosh/AFL-8250-2022; Mohammadi, Siawoosh/H-9539-2012; Mohammadi, Siawoosh/AAG-8251-2022	Moller, Harald E/0000-0002-5659-1925; Anwander, Alfred/0000-0002-4861-4808; Möller, Harald/0000-0002-5659-1925; Stumvoll, Michael/0000-0001-6225-8240; Horstmann, Annette/0000-0001-6184-8484; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Villringer, Arno/0000-0003-2604-2404	German Federal Ministry of Education and Research [FKZ: 01EO1001]; European Union; Wellcome Trust	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the German Federal Ministry of Education and Research (Neurocircuits in obesity to MS; IFB Adiposity Diseases [FKZ: 01EO1001] to AH, AV, MS) and the European Union (GIPIO to MS). SM was supported by the Wellcome Trust. Part of this work is supported by the FET project CONNECT of the European Union (http://neuroimaging.tau.ac.il/CONNECT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Alkan A, 2008, MAGN RESON IMAGING, V26, P446, DOI 10.1016/j.mri.2007.10.004; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen TF, 2009, HUM BRAIN MAPP, V30, P3826, DOI 10.1002/hbm.20810; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Descoteaux M, 2006, MAGN RESON MED, V56, P395, DOI 10.1002/mrm.20948; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Gazdzinski S, 2008, ANN NEUROL, V63, P652, DOI 10.1002/ana.21377; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Haltia LT, 2007, J CLIN ENDOCR METAB, V92, P3278, DOI 10.1210/jc.2006-2495; Hamilton LS, 2008, NEUROREPORT, V19, P1705, DOI 10.1097/WNR.0b013e3283174415; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hiltunen J, 2006, NEUROIMAGE, V32, P93, DOI 10.1016/j.neuroimage.2006.03.004; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; MARKS BL, 2010, BR J SPORTS IN PRESS; Matochik JA, 2005, J CLIN ENDOCR METAB, V90, P2851, DOI 10.1210/jc.2004-1979; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Miller GD, 2001, NUTRITION, V17, P105, DOI 10.1016/S0899-9007(00)00511-6; MOHAMMADI S, 2010, P INT SOC MAGN RESON, V18, P3103; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Novakova L, 2007, NEUROENDOCRINOL LETT, V28, P21; Oh JS, 2007, NEUROIMAGE, V36, P606, DOI 10.1016/j.neuroimage.2007.03.020; Oishi K, 2011, MRI ATLAS HUMAN WHIT, VSecond; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Pannacciulli N, 2007, NEUROSCI LETT, V412, P248, DOI 10.1016/j.neulet.2006.11.019; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; SENA A, 1985, J NEUROL SCI, V68, P233, DOI 10.1016/0022-510X(85)90104-2; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Soreca I, 2009, PSYCHOSOM MED, V71, P485, DOI 10.1097/PSY.0b013e3181a5429d; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Wang F, 2008, BIOL PSYCHIAT, V64, P730, DOI 10.1016/j.biopsych.2008.06.001; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; Westerhausen R, 2004, COGNITIVE BRAIN RES, V21, P418, DOI 10.1016/j.cogbrainres.2004.07.002; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	72	98	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18544	10.1371/journal.pone.0018544	http://dx.doi.org/10.1371/journal.pone.0018544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494606	Green Submitted, Green Published, gold			2022-12-27	WOS:000289354100021
J	Hagg, S; Salehpour, M; Noori, P; Lundstrom, J; Possnert, G; Takolander, R; Konrad, P; Rosfors, S; Ruusalepp, A; Skogsberg, J; Tegner, J; Bjorkegren, J				Hagg, Sara; Salehpour, Mehran; Noori, Peri; Lundstrom, Jesper; Possnert, Goran; Takolander, Rabbe; Konrad, Peter; Rosfors, Stefan; Ruusalepp, Arno; Skogsberg, Josefin; Tegner, Jesper; Bjorkegren, Johan			Carotid Plaque Age Is a Feature of Plaque Stability Inversely Related to Levels of Plasma Insulin	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACCELERATOR MASS-SPECTROMETRY; CORONARY-HEART-DISEASE; ARTERY; ATHEROSCLEROSIS; HUMANS; ECHOGENICITY; ULTRASOUND; SYMPTOMS; GENE	Background: The stability of atherosclerotic plaques determines the risk for rupture, which may lead to thrombus formation and potentially severe clinical complications such as myocardial infarction and stroke. Although the rate of plaque formation may be important for plaque stability, this process is not well understood. We took advantage of the atmospheric (14)C-declination curve (a result of the atomic bomb tests in the 1950s and 1960s) to determine the average biological age of carotid plaques. Methodology/Principal Finding: The cores of carotid plaques were dissected from 29 well-characterized, symptomatic patients with carotid stenosis and analyzed for (14)C content by accelerator mass spectrometry. The average plaque age (i.e. formation time) was 9.6+/-3.3 years. All but two plaques had formed within 5-15 years before surgery. Plaque age was not associated with the chronological ages of the patients but was inversely related to plasma insulin levels (p=0.0014). Most plaques were echo-lucent rather than echo-rich (2.2460.97, range 1-5). However, plaques in the lowest tercile of plaque age (most recently formed) were characterized by further instability with a higher content of lipids and macrophages (67.8+/-12.4 vs. 50.4+/-6.2, p=0.00005; 57.6+/-26.1 vs. 39.8+/-25.7, p<0.0005, respectively), less collagen (45.3+/-6.1 vs. 51.1+/-9.8, p<0.05), and fewer smooth muscle cells (130+/-31 vs. 141+/-21, p<0.05) than plaques in the highest tercile. Microarray analysis of plaques in the lowest tercile also showed increased activity of genes involved in immune responses and oxidative phosphorylation. Conclusions/Significance: Our results show, for the first time, that plaque age, as judge by relative incorporation of (14)C, can improve our understanding of carotid plaque stability and therefore risk for clinical complications. Our results also suggest that levels of plasma insulin might be involved in determining carotid plaque age.	[Hagg, Sara; Lundstrom, Jesper; Skogsberg, Josefin; Bjorkegren, Johan] Karolinska Inst, Dept Med Biochem & Biophys, Cardiovasc Genom Grp, Stockholm, Sweden; [Hagg, Sara; Lundstrom, Jesper; Skogsberg, Josefin; Bjorkegren, Johan] Clin Gene Networks AB, Stockholm, Sweden; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, Uppsala, Sweden; [Noori, Peri; Tegner, Jesper] Karolinska Inst, Dept Med, Ctr Mol Med, Computat Med Grp, Stockholm, Sweden; [Takolander, Rabbe; Konrad, Peter] Soder Sjukhuset, Karolinska Inst, Dept Surg, Stockholm, Sweden; [Rosfors, Stefan] Soder Sjukhuset, Karolinska Inst, Dept Clin Physiol, Stockholm, Sweden; [Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, Tartu, Estonia	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital	Hagg, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Cardiovasc Genom Grp, Stockholm, Sweden.	Johan.Bjorkegren@ki.se	tegner, jesper N/R-5095-2017	tegner, jesper N/0000-0002-9568-5588; Rosfors, Stefan/0000-0001-9920-5791; Ruusalepp, Arno/0000-0001-5816-8613; Hagg, Sara/0000-0002-2452-1500	Swedish research Council; Karolinska Institutet; Stockholm County Council; ALF; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; King Gustaf V and Queen Victoria Foundation; Swedish Society of Medicine; Hans and Loo Osterman Foundation for Geriatric Research; Wennergren Foundation; Vinnova Sweden-Japan; Vinnova research grant; PhD Programme in Medical Bioinformatics; Carl Tryggers Foundation; Clinical Gene Networks	Swedish research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); ALF; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V and Queen Victoria Foundation; Swedish Society of Medicine; Hans and Loo Osterman Foundation for Geriatric Research; Wennergren Foundation; Vinnova Sweden-Japan(Vinnova); Vinnova research grant(Vinnova); PhD Programme in Medical Bioinformatics; Carl Tryggers Foundation; Clinical Gene Networks	This work was supported by grants from the Swedish research Council (JB, JS), the Karolinska Institutet (JB, JS), the Stockholm County Council, ALF-grant (JB), the Swedish Foundation for Strategic Research (JB, JT), the Swedish Heart-Lung Foundation (JB), the King Gustaf V and Queen Victoria Foundation (JB), the Swedish Society of Medicine (JB, JS, JT), the Hans and Loo Osterman Foundation for Geriatric Research (JS, JB), Wennergren Foundation (JT), Vinnova Sweden-Japan (JB, JT), Vinnova research grant (JT, JB), the PhD Programme in Medical Bioinformatics (SH, JB, JT), Carl Tryggers Foundation (JT), Clinical Gene Networks (JB, JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agewall S, 2006, PATHOPHYSIOL HAEMO T, V35, P440, DOI 10.1159/000102051; Andersson J, 2009, ATHEROSCLEROSIS, V204, P612, DOI 10.1016/j.atherosclerosis.2008.10.038; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bonfoco E, 2001, J BIOL CHEM, V276, P29242, DOI 10.1074/jbc.M100684200; Bots ML, 2002, CARDIOVASC DRUG THER, V16, P341, DOI 10.1023/A:1021738111273; CAVE EM, 1995, EUR J VASC ENDOVASC, V10, P77, DOI 10.1016/S1078-5884(05)80201-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Finsterer J, 2007, VASA-J VASCULAR DIS, V36, P229, DOI 10.1024/0301-1526.36.4.229; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; GONCALVES I, CIRC RES, V106, P1174; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; GRAYWEALE AC, 1988, J CARDIOVASC SURG, V29, P676; Gronholdt MLM, 1999, ARTERIOSCL THROM VAS, V19, P2, DOI 10.1161/01.ATV.19.1.2; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Hallerstam S, 2000, EUR J VASC ENDOVASC, V19, P356, DOI 10.1053/ejvs.1999.1010; Handberg A, 2008, STROKE, V39, P3092, DOI 10.1161/STROKEAHA.108.517128; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Henareh L, 2005, DIABETIC MED, V22, P1212, DOI 10.1111/j.1464-5491.2005.01577.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalogeropoulos A, 2007, ATHEROSCLEROSIS, V192, P190, DOI 10.1016/j.atherosclerosis.2006.05.002; Levin I, 2008, SCI TOTAL ENVIRON, V391, P211, DOI 10.1016/j.scitotenv.2007.10.019; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Montecucco F, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/767623; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002; Sabetai MM, 2000, J VASC SURG, V31, P39, DOI 10.1016/S0741-5214(00)70066-8; Sabetai MM, 2000, STROKE, V31, P2189, DOI 10.1161/01.STR.31.9.2189; Salehpour M, 2008, ANAL CHEM, V80, P3515, DOI 10.1021/ac800174j; Salehpour M, 2008, RAPID COMMUN MASS SP, V22, P3928, DOI 10.1002/rcm.3808; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STOTZ E, 1986, STAIN TECHNOL, V61, P187, DOI 10.3109/10520298609110730; Tetko IV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-82; Wendelhag I, 1997, STROKE, V28, P2195, DOI 10.1161/01.STR.28.11.2195; 2009, CALIBOMB	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18248	10.1371/journal.pone.0018248	http://dx.doi.org/10.1371/journal.pone.0018248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490968	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700006
J	Leknes, S; Lee, M; Berna, C; Andersson, J; Tracey, I				Leknes, Siri; Lee, Michael; Berna, Chantal; Andersson, Jesper; Tracey, Irene			Relief as a Reward: Hedonic and Neural Responses to Safety from Pain	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; EVENT-RELATED FMRI; NUCLEUS-ACCUMBENS; OPIOID ANALGESIA; OPPONENT-PROCESS; BRAIN IMAGES; PLACEBO; EXPECTATIONS; ANTICIPATION; ACTIVATION	Relief fits the definition of a reward. Unlike other reward types the pleasantness of relief depends on the violation of a negative expectation, yet this has not been investigated using neuroimaging approaches. We hypothesized that the degree of negative expectation depends on state (dread) and trait (pessimism) sensitivity. Of the brain regions that are involved in mediating pleasure, the nucleus accumbens also signals unexpected reward and positive prediction error. We hypothesized that accumbens activity reflects the level of negative expectation and subsequent pleasant relief. Using fMRI and two purpose-made tasks, we compared hedonic and BOLD responses to relief with responses during an appetitive reward task in 18 healthy volunteers. We expected some similarities in task responses, reflecting common neural substrates implicated across reward types. However, we also hypothesized that relief responses would differ from appetitive rewards in the nucleus accumbens, since only relief pleasantness depends on negative expectations. The results confirmed these hypotheses. Relief and appetitive reward task activity converged in the ventromedial prefrontal cortex, which also correlated with appetitive reward pleasantness ratings. In contrast, dread and pessimism scores correlated with relief but not with appetitive reward hedonics. Moreover, only relief pleasantness covaried with accumbens activation. Importantly, the accumbens signal appeared to specifically reflect individual differences in anticipation of the adverse event (dread, pessimism) but was uncorrelated to appetitive reward hedonics. In conclusion, relief differs from appetitive rewards due to its reliance on negative expectations, the violation of which is reflected in relief-related accumbens activation.	[Leknes, Siri; Lee, Michael; Berna, Chantal; Andersson, Jesper; Tracey, Irene] Univ Oxford, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Ctr Funct Magnet Resonance Imaging Brain FMRIB, Oxford, England	University of Oxford	Leknes, S (corresponding author), Univ Oxford, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Ctr Funct Magnet Resonance Imaging Brain FMRIB, Oxford, England.	Siri.leknes@psykologi.uio.no	Leknes, Siri/ABF-1621-2021	Leknes, Siri/0000-0002-6667-4601; Lee, Michael/0000-0002-5838-2916; Tracey, Irene/0000-0003-4134-6115; Berna, Chantal/0000-0001-8258-7412	Wellcome Trust; Medical Research Council of Great Britain; Medical Research Council of Northern Ireland; MRC [G0700399, G0601340] Funding Source: UKRI; Medical Research Council [G0601340, G0700399] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council of Northern Ireland(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (SL and IT) and the Medical Research Council of Great Britain and Northern Ireland (FMRIB Centre). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2007, J PSYCHIATR RES, V41, P511, DOI 10.1016/j.jpsychires.2006.07.020; Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Andreatta M, 2010, P ROY SOC B-BIOL SCI, V277, P2411, DOI 10.1098/rspb.2010.0103; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; CABANAC M, 1979, Q REV BIOL, V54, P1, DOI 10.1086/410981; Carver C.S., 2005, HDB POSITIVE PSYCHOL, P231; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Leknes S, 2008, EUR J NEUROSCI, V28, P794, DOI 10.1111/j.1460-9568.2008.06380.x; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2007, NEUROIMAGE, V34, P310, DOI 10.1016/j.neuroimage.2006.08.037; Rauch WA, 2007, PERS INDIV DIFFER, V42, P1597, DOI 10.1016/j.paid.2006.10.035; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Seymour B, 2008, CURR OPIN NEUROBIOL, V18, P173, DOI 10.1016/j.conb.2008.07.010; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wagner KJ, 2007, ANESTHESIOLOGY, V106, P548, DOI 10.1097/00000542-200703000-00020; Wise RG, 2002, NEUROIMAGE, V16, P999, DOI 10.1006/nimg.2002.1146; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Worsley KJ, 2001, FUNCTIONAL MRI INTRO	52	126	130	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e17870	10.1371/journal.pone.0017870	http://dx.doi.org/10.1371/journal.pone.0017870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490964	Green Published, gold			2022-12-27	WOS:000289238700002
J	Piao, XY; Cai, PF; Liu, SA; Hou, N; Hao, LL; Yang, F; Wang, H; Wang, JW; Jin, Q; Chen, QJ				Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Hao, Lili; Yang, Fan; Wang, Heng; Wang, Jianwei; Jin, Qi; Chen, Qijun			Global Expression Analysis Revealed Novel Gender-Specific Gene Expression Features in the Blood Fluke Parasite Schistosoma japonicum	PLOS ONE			English	Article							MANSONI; GENOME; TRANSCRIPTOMICS; DIFFERENTIATION; PERSPECTIVES; INTERPLAY; TOOL	Background: Schistosoma japonicum is one of the remarkable Platyhelminths that are endemic in China and Southeast Asian countries. The parasite is dioecious and can reside inside the host for many years. Rapid reproduction by producing large number of eggs and count-react host anti-parasite responses are the strategies that benefit long term survival of the parasite. Praziquantel is currently the only drug that is effective against the worms. Development of novel antiparasite reagents and immune-prevention measures rely on the deciphering of parasite biology. The decoding of the genomic sequence of the parasite has made it possible to dissect the functions of genes that govern the development of the parasite. In this study, the polyadenylated transcripts from male and female S. japonicum were isolated for deep sequencing and the sequences were systematically analysed. Results: First, the number of genes actively expressed in the two sexes of S. japonicum was similar, but around 50% of genes were biased to either male or female in expression. Secondly, it was, at the first time, found that more than 50% of the coding region of the genome was transcribed from both strands. Among them, 65% of the genes had sense and their cognate antisense transcripts co-expressed, whereas 35% had inverse relationship between sense and antisense transcript abundance. Further, based on gene ontological analysis, more than 2,000 genes were functionally categorized and biological pathways that are differentially functional in male or female parasites were elucidated. Conclusions: Male and female schistosomal parasites differ in gene expression patterns, many metabolic and biological pathways have been identified in this study and genes differentially expressed in gender specific manner were presented. Importantly, more than 50% of the coding regions of the S. japonicum genome transcribed from both strands, antisense RNA-mediated gene regulation might play a critical role in the parasite biology.	[Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Wang, Heng; Chen, Qijun] Chinese Acad Med Sci, Inst Basic Med Sci, Inst Pathogen Biol, Parasitol Lab, Beijing 100730, Peoples R China; [Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Yang, Fan; Wang, Heng; Wang, Jianwei; Jin, Qi; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Yang, Fan; Wang, Jianwei; Jin, Qi; Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China; [Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Hao, Lili] SW Univ Nationalities, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Jilin University; Southwest Minzu University	Piao, XY (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Inst Pathogen Biol, Parasitol Lab, Beijing 100730, Peoples R China.	qijun.chen@ipbcams.ac.cn	Wang, Jianwei/W-5916-2019; Cai, Pengfe/AAF-2759-2020; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559; Cai, Pengfei/0000-0003-4975-4615	Chinese Academy of Medical Sciences (CAMS); Jilin University, China; National Science and Technology (ST) Key project [2008zc1004-011]; Chinese Natural Scientific Foundation [30625029];  [2007IPB002];  [2007IPB13]	Chinese Academy of Medical Sciences (CAMS); Jilin University, China(Jilin University); National Science and Technology (ST) Key project; Chinese Natural Scientific Foundation; ; 	This study was carried out with support to Q. Chen from grants (2007IPB002, 2007IPB13) to invited professor of the Institute of Pathogen Biology (IPB), Chinese Academy of Medical Sciences (CAMS) and Jilin University, China; the National Science and Technology (S&T) Key project (2008zc1004-011) and the Young Distinguished Scientist Grant (30625029) of the Chinese Natural Scientific Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brindley PJ, 2007, INT J PARASITOL, V37, P465, DOI 10.1016/j.ijpara.2006.12.012; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Cai PF, 2008, BIOCHEM BIOPH RES CO, V372, P197, DOI 10.1016/j.bbrc.2008.05.042; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chuan J, 2010, ADV PARASIT, V73, P327, DOI 10.1016/S0065-308X(10)73011-6; Fan JJ, 1998, BIOCHEM BIOPH RES CO, V252, P348, DOI 10.1006/bbrc.1998.9491; Fitzpatrick JM, 2004, MOL BIOCHEM PARASIT, V136, P191, DOI 10.1016/j.molbiopara.2004.03.014; Fung MC, 2002, ACTA TROP, V82, P215, DOI 10.1016/S0001-706X(02)00013-X; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gu XM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-48; Han ZG, 2009, ANNU REV GENOM HUM G, V10, P211, DOI 10.1146/annurev-genom-082908-150036; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu SX, 1997, VET PARASITOL, V69, P39, DOI 10.1016/S0304-4017(96)01092-8; Moertel L, 2006, MOL CELL PROBE, V20, P280, DOI 10.1016/j.mcp.2006.02.002; Muro EM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-338; Murphy PJ, 2001, DRUG METAB DISPOS, V29, P779; Rudge JW, 2009, MOL ECOL, V18, P2134, DOI 10.1111/j.1365-294X.2009.04181.x; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; VANDEWAA EA, 1993, ARCH BIOCHEM BIOPHYS, V303, P15, DOI 10.1006/abbi.1993.1249; Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005; Wang TP, 2006, INT J PARASITOL, V36, P1317, DOI 10.1016/j.ijpara.2006.06.011; Webster JP, 2010, TRENDS PARASITOL, V26, P103, DOI 10.1016/j.pt.2009.12.006; Wylie T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-525; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	34	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18267	10.1371/journal.pone.0018267	http://dx.doi.org/10.1371/journal.pone.0018267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494327	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400011
J	Fukuda, D; Haines, AS; Song, ZS; Murphy, AC; Hothersall, J; Stephens, ER; Gurney, R; Cox, RJ; Crosby, J; Willis, CL; Simpson, TJ; Thomas, CM				Fukuda, Daisuke; Haines, Anthony S.; Song, Zhongshu; Murphy, Annabel C.; Hothersall, Joanne; Stephens, Elton R.; Gurney, Rachel; Cox, Russell J.; Crosby, John; Willis, Christine L.; Simpson, Thomas J.; Thomas, Christopher M.			A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA Antibiotic	PLOS ONE			English	Article							PSEUDOMONIC-ACID; GENE-CLUSTER; POLYKETIDE SYNTHASE; BACTERIAL SYMBIONT; MARINE BACTERIUM; SYNTHETASE; MUPIROCIN; FLUORESCENS; SIMOCYCLINONE; MUTATION	Background: Understanding how complex antibiotics are synthesised by their producer bacteria is essential for creation of new families of bioactive compounds. Thiomarinols, produced by marine bacteria belonging to the genus Pseudoalteromonas, are hybrids of two independently active species: the pseudomonic acid mixture, mupirocin, which is used clinically against MRSA, and the pyrrothine core of holomycin. Methodology/Principal Findings: High throughput DNA sequencing of the complete genome of the producer bacterium revealed a novel 97 kb plasmid, pTML1, consisting almost entirely of two distinct gene clusters. Targeted gene knockouts confirmed the role of these clusters in biosynthesis of the two separate components, pseudomonic acid and the pyrrothine, and identified a putative amide synthetase that joins them together. Feeding mupirocin to a mutant unable to make the endogenous pseudomonic acid created a novel hybrid with the pyrrothine via "mutasynthesis" that allows inhibition of mupirocin-resistant isoleucyl-tRNA synthetase, the mupirocin target. A mutant defective in pyrrothine biosynthesis was also able to incorporate alternative amine substrates. Conclusions/Significance: Plasmid pTML1 provides a paradigm for combining independent antibiotic biosynthetic pathways or using mutasynthesis to develop a new family of hybrid derivatives that may extend the effective use of mupirocin against MRSA.	[Fukuda, Daisuke; Haines, Anthony S.; Hothersall, Joanne; Stephens, Elton R.; Gurney, Rachel; Thomas, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Song, Zhongshu; Murphy, Annabel C.; Cox, Russell J.; Crosby, John; Willis, Christine L.; Simpson, Thomas J.] Univ Bristol, Sch Chem, Bristol, Avon, England	University of Birmingham; University of Bristol	Fukuda, D (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	C.M.THOMAS@bham.ac.uk	Simpson, Thomas J/P-5058-2015; Cox, Russell John/F-9190-2015	Cox, Russell John/0000-0002-1844-0157; Haines, Anthony/0000-0003-2736-6371; Fukuda, Daisuke/0000-0003-2306-0121	BBSRC/EPSRC [E021611]; EPSRC [EP/F066104]; company Daiichi-Sankyo; UK Research Council BBSRC; UK Research Council EPSRC; BBSRC [BB/E021611/1, BB/E022367/1] Funding Source: UKRI; EPSRC [EP/F066104/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021611/1, BB/E022367/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F066104/1] Funding Source: researchfish	BBSRC/EPSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); company Daiichi-Sankyo; UK Research Council BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Research Council EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by BBSRC/EPSRC grant E021611. LCMS equipment was funded by EPSRC grant EP/F066104. Daisuke Fukuda was funded to work on this project in Birmingham by the company Daiichi-Sankyo, which also made a financial contribution to the running costs of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant from the UK Research Councils BBSRC and EPSRC. Daisuke Fukuda was still an employee of the company Daiichi-Sankyo while he was seconded to the University of Birmingham.	Aron ZD, 2007, CHEMBIOCHEM, V8, P613, DOI 10.1002/cbic.200600575; Bentley SD, 2004, MOL MICROBIOL, V51, P1615, DOI 10.1111/j.1365-2958.2003.03949.x; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brown P, 1997, J MED CHEM, V40, P2563, DOI 10.1021/jm960738k; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Cooper SM, 2005, CHEM BIOL, V12, P825, DOI 10.1016/j.chembiol.2005.05.015; Cooper SM, 2005, CHEM COMMUN, P1179, DOI 10.1039/b414781b; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Galm U, 2004, CHEM BIOL, V11, P173, DOI 10.1016/j.chembiol.2004.01.012; Geng HF, 2008, APPL ENVIRON MICROB, V74, P1535, DOI 10.1128/AEM.02339-07; Hothersall J, 2007, J BIOL CHEM, V282, P15451, DOI 10.1074/jbc.M701490200; HUGHES J, 1978, BIOCHEM J, V176, P305, DOI 10.1042/bj1760305; Jeziorowski A, 2007, J BACTERIOL, V189, P7045, DOI 10.1128/JB.00243-07; Li B, 2010, P NATL ACAD SCI USA, V107, P19731, DOI 10.1073/pnas.1014140107; Luft T, 2005, ARCH MICROBIOL, V183, P277, DOI 10.1007/s00203-005-0770-0; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Medema MH, 2010, GENOME BIOL EVOL, V2, P212, DOI 10.1093/gbe/evq013; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x; MURPHY AC, 2011, ANGEW CHEM IN PRESS, V50; OKAMURA K, 1977, J ANTIBIOT, V30, P334, DOI 10.7164/antibiotics.30.334; Oliva B, 2001, ANTIMICROB AGENTS CH, V45, P532, DOI 10.1128/AAC.45.2.532-539.2001; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P4949, DOI 10.1021/bi047303g; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Rahman AS, 2005, J BIOL CHEM, V280, P6399, DOI 10.1074/jbc.M409814200; Sambrook J, 2001, MOL CLONING LAB MANU; SHIOZAWA H, 1994, J ANTIBIOT, V47, P851, DOI 10.7164/antibiotics.47.851; Shiozawa H, 1997, J ANTIBIOT, V50, P449, DOI 10.7164/antibiotics.50.449; SHIOZAWA H, 1995, J ANTIBIOT, V48, P907, DOI 10.7164/antibiotics.48.907; SHIOZAWA H, 1993, J ANTIBIOT, V46, P1834, DOI 10.7164/antibiotics.46.1834; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Song JY, 2010, J BACTERIOL, V192, P6317, DOI 10.1128/JB.00859-10; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Trefzer A, 2002, ANTIMICROB AGENTS CH, V46, P1174, DOI 10.1128/AAC.46.5.1174-1182.2002; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Wu J, 2007, CHEM COMMUN, P2040, DOI 10.1039/b700613f; Yanagisawa T, 2003, J BIOL CHEM, V278, P25887, DOI 10.1074/jbc.M302633200	44	50	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18031	10.1371/journal.pone.0018031	http://dx.doi.org/10.1371/journal.pone.0018031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483852	Green Published, gold			2022-12-27	WOS:000289057200020
J	Lower, M; Geppert, T; Schneider, P; Hoy, B; Wessler, S; Schneider, G				Loewer, Martin; Geppert, Tim; Schneider, Petra; Hoy, Benjamin; Wessler, Silja; Schneider, Gisbert			Inhibitors of Helicobacter pylori Protease HtrA Found by 'Virtual Ligand' Screening Combat Bacterial Invasion of Epithelia	PLOS ONE			English	Article							E-CADHERIN; STRUCTURAL BASIS; PHARMACOPHORES; DOCKING; LIBRARY; ALIGNMENT; CAVITIES; MODEL	Background: The human pathogen Helicobacter pylori (H. pylori) is a main cause for gastric inflammation and cancer. Increasing bacterial resistance against antibiotics demands for innovative strategies for therapeutic intervention. Methodology/Principal Findings: We present a method for structure-based virtual screening that is based on the comprehensive prediction of ligand binding sites on a protein model and automated construction of a ligand-receptor interaction map. Pharmacophoric features of the map are clustered and transformed in a correlation vector ('virtual ligand') for rapid virtual screening of compound databases. This computer-based technique was validated for 18 different targets of pharmaceutical interest in a retrospective screening experiment. Prospective screening for inhibitory agents was performed for the protease HtrA from the human pathogen H. pylori using a homology model of the target protein. Among 22 tested compounds six block E-cadherin cleavage by HtrA in vitro and result in reduced scattering and wound healing of gastric epithelial cells, thereby preventing bacterial infiltration of the epithelium. Conclusions/Significance: This study demonstrates that receptor-based virtual screening with a permissive ('fuzzy') pharmacophore model can help identify small bioactive agents for combating bacterial infection.	[Loewer, Martin] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [Hoy, Benjamin; Wessler, Silja] Salzburg Univ, Div Microbiol, A-5020 Salzburg, Austria; [Geppert, Tim; Schneider, Petra; Schneider, Gisbert] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland	Goethe University Frankfurt; Salzburg University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lower, M (corresponding author), Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany.	gisbert.schneider@pharma.ethz.ch	Wessler, Silja/C-6309-2015	Wessler, Silja/0000-0001-7011-6162; Schneider, Petra/0000-0001-8296-6105; Schneider, Gisbert/0000-0001-6706-1084	OPO Foundation, Zurich	OPO Foundation, Zurich	We thank Dr. Christiane Weydig for her help with immunofluorescence experiments, and Dr. Heiko Zettl for technical support. This research was supported by the OPO Foundation, Zurich.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barillari C, 2008, J CHEM INF MODEL, V48, P1396, DOI 10.1021/ci800064z; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Bissantz C, 2010, J MED CHEM, V53, P6241, DOI 10.1021/jm100950p; BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/bf00124387; Chan AOO, 2006, WORLD J GASTROENTERO, V12, P199, DOI 10.3748/wjg.v12.i2.199; Cole JC, 2005, VIRTUAL SCREENING IN DRUG DISCOVERY, P379; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gosling J, 2005, JAVA LANGUAGE SPECIF; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Guha R, 2008, J CHEM INF MODEL, V48, P646, DOI 10.1021/ci7004093; Hawkins PCD, 2008, J COMPUT AID MOL DES, V22, P179, DOI 10.1007/s10822-007-9166-3; Hocker M, 2003, LANCET, V362, P1231, DOI 10.1016/S0140-6736(03)14547-3; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kortagere S, 2010, J PHARMACOL TOX MET, V61, P67, DOI 10.1016/j.vascn.2010.02.005; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; LOWER M, 2009, THESIS GOETHE U FRAN; Mandelbrot B., 1968, PATTERN CLASSIFICATI, V10, P422; Peach ML, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-6; PERONA JJ, 1995, PROTEIN SCI, V4, P337; PICKETT S, 2003, BIOPHORE CONCEPT PRO, P73; Rarey M, 2005, METH PRIN MED CHEM, V22, P59, DOI 10.1002/3527603743.ch4; Rohrer SG, 2008, J CHEM INF MODEL, V48, P704, DOI 10.1021/ci700099u; Ruppert J, 1997, PROTEIN SCI, V6, P524; Schneider G., 2008, MOL DESIGN CONCEPTS; Schneider P, 2003, QSAR COMB SCI, V22, P713, DOI 10.1002/qsar.200330825; Schuller A, 2006, COMB CHEM HIGH T SCR, V9, P359, DOI 10.2174/138620706777452375; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seifert MHJ, 2008, MINI-REV MED CHEM, V8, P63, DOI 10.2174/138955708783331540; Senderowitz H, 2009, CURR PHARM DESIGN, V15, P4049, DOI 10.2174/138161209789824821; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Tanrikulu Y, 2007, CHEMBIOCHEM, V8, P1932, DOI 10.1002/cbic.200700195; Tintori C, 2008, J CHEM INF MODEL, V48, P2166, DOI 10.1021/ci800105p; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; UGI I, 1959, ANGEW CHEM INT EDIT, V71, P386; UGI I, 1960, ANGEW CHEM INT EDIT, V72, P267, DOI 10.1002/ange.19600720709; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Weisel M, 2009, PROTEOMICS, V9, P451, DOI 10.1002/pmic.200800092; Weydig C, 2007, EXP CELL RES, V313, P3459, DOI 10.1016/j.yexcr.2007.07.015; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhong SJ, 2010, CURR OPIN DRUG DISC, V13, P326	48	46	49	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17986	10.1371/journal.pone.0017986	http://dx.doi.org/10.1371/journal.pone.0017986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483848	Green Submitted, gold, Green Published			2022-12-27	WOS:000289057200016
J	Rossi, C; Doumiati, S; Lazzarelli, C; Davi, M; Meddar, F; Ladant, D; Chopineau, J				Rossi, Claire; Doumiati, Samah; Lazzarelli, Clarine; Davi, Marilyne; Meddar, Fetta; Ladant, Daniel; Chopineau, Joel			A Tethered Bilayer Assembled on Top of Immobilized Calmodulin to Mimic Cellular Compartmentalization	PLOS ONE			English	Article							PERTUSSIS ADENYLATE-CYCLASE; SUPPORTED MEMBRANES; BINDING; SURFACE	Background: Biomimetic membrane models tethered on solid supports are important tools for membrane protein biochemistry and biotechnology. The supported membrane systems described up to now are composed of a lipid bilayer tethered or not to a surface separating two compartments: a ''trans'' side, one to a few nanometer thick, located between the supporting surface and the membrane; and a "cis'' side, above the synthetic membrane, exposed to the bulk medium. We describe here a novel biomimetic design composed of a tethered bilayer membrane that is assembled over a surface derivatized with a specific intracellular protein marker. This multilayered biomimetic assembly exhibits the fundamental characteristics of an authentic biological membrane in creating a continuous yet fluid phospholipidic barrier between two distinct compartments: a "cis'' side corresponding to the extracellular milieu and a "trans'' side marked by a key cytosolic signaling protein, calmodulin. Methodology/Principal Findings: We established and validated the experimental conditions to construct a multilayered structure consisting in a planar tethered bilayer assembled over a surface derivatized with calmodulin. We demonstrated the following: (i) the grafted calmodulin molecules (in trans side) were fully functional in binding and activating a calmodulin-dependent enzyme, the adenylate cyclase from Bordetella pertussis; and (ii) the assembled bilayer formed a continuous, protein-impermeable boundary that fully separated the underlying calmodulin (trans side) from the above medium (cis side). Conclusions: The simplicity and robustness of the tethered bilayer structure described here should facilitate the elaboration of biomimetic membrane models incorporating membrane embedded proteins and key cytoplasmic constituents. Such biomimetic structures will also be an attractive tool to study translocation across biological membranes of proteins or other macromolecules.	[Rossi, Claire; Doumiati, Samah; Meddar, Fetta] Univ Technol Compiegne, CNRS, UMR 6022, F-60206 Compiegne, France; [Lazzarelli, Clarine; Chopineau, Joel] Univ Nimes, Nimes, France; [Davi, Marilyne; Ladant, Daniel] Inst Pasteur, Unite Biochim Interact Macromol, CNRS, URA 2185, Paris, France; [Chopineau, Joel] Ecole Natl Super Chim, Inst Charles Gerhardt Montpellier, UMR 5253, CNRS ENSCM UM2 UM1, Montpellier, France	Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Universite de Nimes; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Rossi, C (corresponding author), Univ Technol Compiegne, CNRS, UMR 6022, F-60206 Compiegne, France.	daniel.ladant@pasteur.fr; joel.chopineau@unimes.fr	chopineau, joel/J-6674-2015	chopineau, joel/0000-0001-8307-0167; LADANT, Daniel/0000-0003-1955-548X	CNRS; Pasteur Institute; European Union	CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute; European Union(European Commission)	This work was funded by CNRS and by Pasteur Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Chenal and S. Ouellette for critical reading of the manuscript, and the European Union for co-funding of equipment within the CPER 2007-2013.	Carton I, 2010, ANAL CHEM, V82, P9275, DOI 10.1021/ac102495q; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Csucs G, 1998, BBA-BIOMEMBRANES, V1369, P304, DOI 10.1016/S0005-2736(97)00233-2; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; Fang Y, 2002, J AM CHEM SOC, V124, P2394, DOI 10.1021/ja017346+; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Jelinek R, 2009, MOL BIOSYST, V5, P811, DOI 10.1039/b907223n; Kiesslling V., 2008, WILEY ENCY CHEM BIOL, V4, P411; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1986, J BIOL CHEM, V261, P6264; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Leroueil PR, 2008, NANO LETT, V8, P420, DOI 10.1021/nl0722929; Loose M, 2009, J STRUCT BIOL, V168, P143, DOI 10.1016/j.jsb.2009.03.016; Rossi C, 2003, BIOCHEMISTRY-US, V42, P15273, DOI 10.1021/bi035336a; Rossi C, 2007, EUR BIOPHYS J BIOPHY, V36, P955, DOI 10.1007/s00249-007-0202-y; Rossi C, 2007, J PHYS CHEM B, V111, P7567, DOI 10.1021/jp0686792; Tamm LK, 2009, J STRUCT BIOL, V168, P1, DOI 10.1016/j.jsb.2009.07.016; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Yu CH, 2010, MED BIOL ENG COMPUT, V48, P955, DOI 10.1007/s11517-010-0634-x	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19101	10.1371/journal.pone.0019101	http://dx.doi.org/10.1371/journal.pone.0019101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533059	Green Published, gold			2022-12-27	WOS:000289719400058
J	Bazzini, S; Udine, C; Sass, A; Pasca, MR; Longo, F; Emiliani, G; Fondi, M; Perrin, E; Decorosi, F; Viti, C; Giovannetti, L; Leoni, L; Fani, R; Riccardi, G; Mahenthiralingam, E; Buroni, S				Bazzini, Silvia; Udine, Claudia; Sass, Andrea; Pasca, Maria Rosalia; Longo, Francesca; Emiliani, Giovanni; Fondi, Marco; Perrin, Elena; Decorosi, Francesca; Viti, Carlo; Giovannetti, Luciana; Leoni, Livia; Fani, Renato; Riccardi, Giovanna; Mahenthiralingam, Eshwar; Buroni, Silvia			Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; MULTIDRUG EFFLUX; MEMBRANE PROTEIN; CYSTIC-FIBROSIS; FLAGELLIN; MICROBIOLOGY; EXPRESSION; RESISTANCE; INFECTION	Burkholderia cenocepacia J2315 is representative of a highly problematic group of cystic fibrosis (CF) pathogens. Eradication of B. cenocepacia is very difficult with the antimicrobial therapy being ineffective due to its high resistance to clinically relevant antimicrobial agents and disinfectants. RND (Resistance-Nodulation-Cell Division) efflux pumps are known to be among the mediators of multidrug resistance in Gram-negative bacteria. Since the significance of the 16 RND efflux systems present in B. cenocepacia (named RND-1 to -16) has been only partially determined, the aim of this work was to analyze mutants of B. cenocepacia strain J2315 impaired in RND-4 and RND-9 efflux systems, and assess their role in the efflux of toxic compounds. The transcriptomes of mutants deleted individually in RND-4 and RND-9 (named D4 and D9), and a double-mutant in both efflux pumps (named D4-D9), were compared to that of the wild-type B. cenocepacia using microarray analysis. Microarray data were confirmed by qRT-PCR, phenotypic experiments, and by Phenotype MicroArray analysis. The data revealed that RND-4 made a significant contribution to the antibiotic resistance of B. cenocepacia, whereas RND-9 was only marginally involved in this process. Moreover, the double mutant D4-D9 showed a phenotype and an expression profile similar to D4. The microarray data showed that motility and chemotaxis-related genes appeared to be up-regulated in both D4 and D4-D9 strains. In contrast, these gene sets were down-regulated or expressed at levels similar to J2315 in the D9 mutant. Biofilm production was enhanced in all mutants. Overall, these results indicate that in B. cenocepacia RND pumps play a wider role than just in drug resistance, influencing additional phenotypic traits important for pathogenesis.	[Bazzini, Silvia; Udine, Claudia; Pasca, Maria Rosalia; Riccardi, Giovanna; Buroni, Silvia] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Sass, Andrea; Mahenthiralingam, Eshwar] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Longo, Francesca; Leoni, Livia] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [Emiliani, Giovanni] CNR, Trees & Timber Inst, San Michele All Adige, Italy; [Fondi, Marco; Perrin, Elena; Fani, Renato] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Decorosi, Francesca; Viti, Carlo; Giovannetti, Luciana] Univ Florence, Dipartimento Biotecnol Agr, Florence, Italy	University of Pavia; Cardiff University; Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); University of Florence; University of Florence	Bazzini, S (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	silvia.buroni@unipv.it	riccardi, gabriele/A-9269-2012; Mahenthiralingam, Eshwar/D-3333-2009; Leoni, Livia/F-2919-2013; Perrin, Elena/AAX-2762-2020; Emiliani, Giovanni/G-5023-2016; Sass, Andrea Michaela/G-6537-2014; Pasca, Maria Rosalia/J-8752-2016; Buroni, Silvia/AAX-5454-2020	Mahenthiralingam, Eshwar/0000-0001-9014-3790; Emiliani, Giovanni/0000-0002-1264-8002; Sass, Andrea Michaela/0000-0001-9396-7648; Pasca, Maria Rosalia/0000-0002-8906-4937; Fondi, Marco/0000-0001-9291-5467; RICCARDI, Giovanna/0000-0003-3295-0070; VITI, CARLO/0000-0001-7188-549X; Buroni, Silvia/0000-0002-6979-2275; Longo, Francesca/0000-0002-8733-5959; Perrin, Elena/0000-0001-5148-3178	Italian Cystic Fibrosis Research Foundation (FFC) [15/2009, 14/2010]; US Cystic Fibrosis Therapeutics [MAHENT06V0]	Italian Cystic Fibrosis Research Foundation (FFC)(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); US Cystic Fibrosis Therapeutics	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FFC) to G.R. (Project FFC#15/2009, adopted by Pastificio Rana S.p.A.) and to L.L. (Project FFC#14/2010). A.S. and E.M. acknowledge support for the microarray analysis by the US Cystic Fibrosis Therapeutics program (grant number MAHENT06V0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Bochner BR, 2008, MOL MICROBIOL, V70, P274, DOI 10.1111/j.1365-2958.2008.06383.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; COENYE T, 2011, ANTIMICROB IN PRESS; Coenye T, 2010, FEMS IMMUNOL MED MIC, V59, P239, DOI 10.1111/j.1574-695X.2010.00682.x; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunha LG, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-4; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Foweraker J, 2009, BRIT MED BULL, V89, P93, DOI 10.1093/bmb/ldn050; Guglierame P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-66; Hales BA, 1998, J BACTERIOL, V180, P1110, DOI 10.1128/JB.180.5.1110-1118.1998; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Leungsakul T, 2005, APPL MICROBIOL BIOT, V69, P321, DOI 10.1007/s00253-005-1983-5; Liaudet L, 2003, SHOCK, V19, P131, DOI 10.1097/00024382-200302000-00008; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; MONTIE TC, 1983, J CLIN MICROBIOL, V18, P452, DOI 10.1128/JCM.18.3.452-456.1983; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NIKAIDO H, 2009, BIOCHIM BIOPHYS ACTA, V179, P769; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Perrin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-164; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rose H, 2009, J ANTIMICROB CHEMOTH, V63, P502, DOI 10.1093/jac/dkn540; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Sambrook J, 2001, MOL CLONING LAB MANU; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09	47	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18902	10.1371/journal.pone.0018902	http://dx.doi.org/10.1371/journal.pone.0018902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526150	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100035
J	Cornelissen, A; Ceyssens, PJ; T'Syen, J; Van Praet, H; Noben, JP; Shaburova, OV; Krylov, VN; Volckaert, G; Lavigne, R				Cornelissen, Anneleen; Ceyssens, Pieter-Jan; T'Syen, Jeroen; Van Praet, Helena; Noben, Jean-Paul; Shaburova, Olga V.; Krylov, Victor N.; Volckaert, Guido; Lavigne, Rob			The T7-Related Pseudomonas putida Phage phi 15 Displays Virion-Associated Biofilm Degradation Properties	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; BACTERIAL BIOFILMS; POLYSACCHARIDE DEPOLYMERASE; CAPSULAR POLYSACCHARIDE; BACTERIOPHAGE INFECTION; AERUGINOSA; RESISTANT; ENZYME; VIM-2	Formation of a protected biofilm environment is recognized as one of the major causes of the increasing antibiotic resistance development and emphasizes the need to develop alternative antibacterial strategies, like phage therapy. This study investigates the in vitro degradation of single-species Pseudomonas putida biofilms, PpG1 and RD5PR2, by the novel phage phi 15, a 'T7-like virus' with a virion-associated exopolysaccharide (EPS) depolymerase. Phage phi 15 forms plaques surrounded by growing opaque halo zones, indicative for EPS degradation, on seven out of 53 P. putida strains. The absence of haloes on infection resistant strains suggests that the EPS probably act as a primary bacterial receptor for phage infection. Independent of bacterial strain or biofilm age, a time and dose dependent response of phi 15-mediated biofilm degradation was observed with generally a maximum biofilm degradation 8 h after addition of the higher phage doses (10(4) and 10(6) pfu) and resistance development after 24 h. Biofilm age, an in vivo very variable parameter, reduced markedly phage-mediated degradation of PpG1 biofilms, while degradation of RD5PR2 biofilms and phi 15 amplification were unaffected. Killing of the planktonic culture occurred in parallel with but was always more pronounced than biofilm degradation, accentuating the need for evaluating phages for therapeutic purposes in biofilm conditions. EPS degrading activity of recombinantly expressed viral tail spike was confirmed by capsule staining. These data suggests that the addition of high initial titers of specifically selected phages with a proper EPS depolymerase are crucial criteria in the development of phage therapy.	[Cornelissen, Anneleen; Ceyssens, Pieter-Jan; T'Syen, Jeroen; Van Praet, Helena; Volckaert, Guido; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium; [Noben, Jean-Paul] Hasselt Univ, Sch Life Sci, Biomed Res Inst, Diepenbeek, Belgium; [Noben, Jean-Paul] Hasselt Univ, Transnat Univ Limburg, Diepenbeek, Belgium; [Shaburova, Olga V.; Krylov, Victor N.] State Inst Genet Ind Microorganisms, Moscow, Russia	KU Leuven; Hasselt University; Hasselt University	Cornelissen, A (corresponding author), Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium.	rob.lavigne@biw.kuleuven.be	Shaburova, Olga/AAK-2332-2021; Noben, Jean-Paul/E-8066-2011	Noben, Jean-Paul/0000-0003-3368-5686; Ceyssens, Pieter-Jan/0000-0001-7735-8316; , Olga/0000-0003-0368-3794; Lavigne, Rob/0000-0001-7377-1314	K.U. Leuven [STRT1/10/021TBA]; 'Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen' (I.W.T., Belgium)	K.U. Leuven(KU Leuven); 'Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen' (I.W.T., Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was partially supported by the K.U. Leuven (STRT1/10/021TBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors thank Prof. M. Vaneechoutte (Laboratory Bacteriology, Ghent University Hospital, Belgium), Prof. R. De Mot (Centre of Microbial and Plant Genetics, K.U.Leuven, Belgium) and Prof. D. Springael (Division Soil and Water Management, K.U.Leuven, Belgium) for providing bacteria for this study. The authors are also grateful to Dr. Hans-W. Ackermann (Laval University, Quebec, Canada) for expert electron microscopy and to Dr. Y. Briers and Y. Born for providing information on the capsule staining assay (Institute of Food Science and Nutrition, ETH Zurich, Switzerland). Anneleen Cornelissen holds a predoctoral fellowship of the 'Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen' (I.W.T., Belgium). Pieter-Jan Ceyssens is a postdoctoral fellow of the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen, Belgium).	ADAMS MH, 1959, BACTERIOPHAGES, P19; ANAISSIE E, 1987, AM J MED, V82, P1191, DOI 10.1016/0002-9343(87)90223-3; BARTELL PF, 1966, J BACTERIOL, V92, P56, DOI 10.1128/JB.92.1.56-62.1966; BARTELL PF, 1968, J BIOL CHEM, V243, P2077; BAYER ME, 1979, VIROLOGY, V94, P95, DOI 10.1016/0042-6822(79)90441-0; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P291, DOI 10.1111/j.1574-6976.1997.tb00315.x; Bogaerts P, 2008, J ANTIMICROB CHEMOTH, V61, P749, DOI 10.1093/jac/dkm529; Bouallegue O, 2004, J HOSP INFECT, V57, P88, DOI 10.1016/j.jhin.2004.01.024; Briers Y, 2006, CELL MOL LIFE SCI, V63, P1899, DOI 10.1007/s00018-006-6183-7; Bull JJ, 2010, VIROLOGY, V398, P79, DOI 10.1016/j.virol.2009.11.040; Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x; CASTILLO FJ, 1974, J VIROL, V14, P904, DOI 10.1128/JVI.14.4.904-909.1974; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Ceyssens PJ, 2008, J BACTERIOL, V190, P1429, DOI 10.1128/JB.01441-07; Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003; Corbin BD, 2001, CAN J MICROBIOL, V47, P680, DOI 10.1139/cjm-47-7-680; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; CRAIG BA, 2006, TRENDS MICROBIOL, V14, P176; Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111; EKLUND C, 1962, J BACTERIOL, V84, P1209, DOI 10.1128/JB.84.6.1209-1215.1962; Francis T, 1934, J EXP MED, V59, P641, DOI 10.1084/jem.59.5.641; GEYER H, 1983, PURE APPL CHEM, V55, P637, DOI 10.1351/pac198855040637; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; GOODNER KENNETH, 1932, JOUR EXP MED, V55, P393, DOI 10.1084/jem.55.3.393; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kovalyova IV, 2003, VIROLOGY, V311, P305, DOI 10.1016/S0042-6822(03)00124-7; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Ladhani S, 1998, EUR J CLIN MICROBIOL, V17, P642, DOI 10.1007/s100960050148; Lee K, 2009, YONSEI MED J, V50, P335, DOI 10.3349/ymj.2009.50.3.335; LENSKI RE, 1988, ADV MICROB ECOL, P1; Linnerborg M, 2001, CARBOHYD RES, V333, P263, DOI 10.1016/S0008-6215(01)00159-8; Lombardi G, 2002, J CLIN MICROBIOL, V40, P4051, DOI 10.1128/JCM.40.11.4051-4055.2002; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maneval WE, 1941, STAIN TECHNOL, V16, P13, DOI 10.3109/10520294109106189; Martino R, 1996, EUR J CLIN MICROBIOL, V15, P610, DOI 10.1007/BF01709374; MOLLINEUX IJ, 2006, BACTERIOPHAGES, P277; Monzon M, 2002, DIAGN MICR INFEC DIS, V44, P319, DOI 10.1016/S0732-8893(02)00464-9; NIMMICH W, 1994, J CLIN MICROBIOL, V32, P2843, DOI 10.1128/JCM.32.11.2843-2845.1994; Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; PELKONEN S, 1992, J BACTERIOL, V174, P7757, DOI 10.1128/JB.174.23.7757-7761.1992; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; PREHM P, 1976, J MOL BIOL, V101, P277, DOI 10.1016/0022-2836(76)90377-6; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Shaburova OV, 2009, RUSS J GENET+, V45, P161, DOI 10.1134/S1022795409020057; Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-79; Steindler L, 2008, FEMS MICROBIOL LETT, V288, P102, DOI 10.1111/j.1574-6968.2008.01344.x; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Sutherland IW, 1999, CARBOHYD POLYM, V38, P319, DOI 10.1016/S0144-8617(98)00114-3; SUTHERLAND IW, 1995, FEMS MICROBIOL REV, V16, P323, DOI 10.1016/0168-6445(95)00020-D; Sutherland IW, 1977, SURFACE CARBOHYDRATE, P209; TOMLINSON S, 1985, J VIROL, V55, P374, DOI 10.1128/JVI.55.2.374-378.1985; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Yan JJ, 2001, ANTIMICROB AGENTS CH, V45, P2224, DOI 10.1128/AAC.45.8.2224-2228.2001	61	119	123	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18597	10.1371/journal.pone.0018597	http://dx.doi.org/10.1371/journal.pone.0018597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526174	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100010
J	Guilini, K; Soltwedel, T; van Oevelen, D; Vanreusel, A				Guilini, Katja; Soltwedel, Thomas; van Oevelen, Dick; Vanreusel, Ann			Deep-Sea Nematodes Actively Colonise Sediments, Irrespective of the Presence of a Pulse of Organic Matter: Results from an In-Situ Experiment	PLOS ONE			English	Article							LIVING MARINE NEMATODES; MEIOFAUNAL COLONIZATION; VERTICAL-DISTRIBUTION; BENTHIC RESPONSE; ANTARCTIC SHELF; SOUTHERN BIGHT; DISTURBANCE; PHYTODETRITUS; MEIOBENTHOS; MARGIN	A colonisation experiment was performed in situ at 2500 m water depth at the Arctic deep-sea long-term observatory HAUSGARTEN to determine the response of deep-sea nematodes to disturbed, newly available patches, enriched with organic matter. Cylindrical tubes, laterally covered with a 500 mm mesh, were filled with azoic deep-sea sediment and C-13-labelled food sources (diatoms and bacteria). After 10 days of incubation the tubes were analysed for nematode response in terms of colonisation and uptake. Nematodes actively colonised the tubes, however with densities that only accounted for a maximum of 2.13% (51 ind. 10 cm(-2)) of the ambient nematode assemblages. Densities did not differ according to the presence or absence of organic matter, nor according to the type of organic matter added. The fact that the organic matter did not function as an attractant to nematodes was confirmed by the absence of notable C-13 assimilation by the colonising nematodes. Overall, colonisationappears to be a process that yields reproducible abundance and diversity patterns, with certain taxa showing more efficiency. Together with the high variability between the colonising nematode assemblages, this lends experimental support to the existence of a spatio-temporal mosaic that emerges from highly localised, partially stochastic community dynamics.	[Guilini, Katja; Vanreusel, Ann] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; [Soltwedel, Thomas] Alfred Wegener Inst, Dept Deep Sea Ecol & Technol, Bremerhaven, Germany; [van Oevelen, Dick] Netherlands Inst Ecol NIOO KNAW, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands	Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Guilini, K (corresponding author), Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium.	Katja.Guilini@UGent.be	Soltwedel, Thomas/P-1852-2016	Soltwedel, Thomas/0000-0002-8214-5937	European Community [GOCE-CT-2005- 511234, 226354]; Flanders Fund for Scientific Research (FWO) [3G0346]; FUNDEEP [01J14909]	European Community(European Commission); Flanders Fund for Scientific Research (FWO)(FWO); FUNDEEP	The research leading to the results presented in this manuscript received funding from the European Community's Sixth Framework Program under the Hotspot Ecosystem Research on the Margins of European Seas project (HERMES, http://www.eu-hermes.net), contract number GOCE-CT-2005- 511234, from the European Community's Seventh Framework Program under the Hotspot Ecosystem Research and Man's Impact on European Seas project (HERMIONE, http://www.eu-hermione.net), grant agreement number 226354, and from the Flanders Fund for Scientific Research (FWO, project number 3G0346, http://www.fwo.be) and Special Research Fund (BOF, the relation between function and biodiversity of Nematoda in the deep sea [FUNDEEP], project number 01J14909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1983, MAR BIOL, V72, P325, DOI 10.1007/BF00396839; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Bauerfeind E, 2009, DEEP-SEA RES PT I, V56, P1471, DOI 10.1016/j.dsr.2009.04.011; Beaulieu SE, 2002, OCEANOGR MAR BIOL, V40, P171; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; BILLHEIMER LE, 1988, ESTUAR COAST SHELF S, V27, P335, DOI 10.1016/0272-7714(88)90060-1; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; CHANDLER GT, 1983, J EXP MAR BIOL ECOL, V69, P175, DOI 10.1016/0022-0981(83)90066-7; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clarke K.R., 2001, PRIMER V5 PLYMOUTH R, P91; DEBOVEE F, 1993, MAR ECOL-P S Z N I, V14, P159; Forest A, 2010, POLAR BIOL, V33, P1733, DOI 10.1007/s00300-010-0855-3; Franco MA, 2008, MAR ECOL PROG SER, V358, P51, DOI 10.3354/meps07361; GAGE JD, 1991, REV AQUAT SCI, V5, P49; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; Gooday AJ, 1996, J MAR BIOL ASSOC UK, V76, P297, DOI 10.1017/S0025315400030563; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; GRASSLE JF, 1987, DEEP-SEA RES, V34, P1911, DOI 10.1016/0198-0149(87)90091-4; GRASSLE JF, 1973, DEEP-SEA RES, V20, P643; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HENDELBERG M, 1993, OPHELIA, V37, P83, DOI 10.1080/00785326.1993.10429909; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; HORN HS, 1981, THEORETICAL ECOLOGY, P253; HOSTE E, 2006, THESIS GHENT U; Hoste E, 2007, DEEP-SEA RES PT I, V54, P109, DOI 10.1016/j.dsr.2006.09.007; Ingels J, 2011, J EXP MAR BIOL ECOL, V396, P185, DOI 10.1016/j.jembe.2010.10.018; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; JOHNSON RG, 1970, AM NAT, V104, P285, DOI 10.1086/282662; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; LEE JJ, 1977, HELGOLAND WISS MEER, V30, P272, DOI 10.1007/BF02207841; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 1999, MAR ECOL PROG SER, V182, P37, DOI 10.3354/meps182037; Menot L, 2009, DEEP-SEA RES PT II, V56, P2313, DOI 10.1016/j.dsr2.2009.04.012; Mincks SL, 2005, MAR ECOL PROG SER, V300, P3, DOI 10.3354/meps300003; Moens T, 2007, POLAR BIOL, V31, P1, DOI 10.1007/s00300-007-0323-x; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Nedwell DB, 1999, FEMS MICROBIOL ECOL, V30, P101; Neira C, 2001, DEEP-SEA RES PT I, V48, P2453, DOI 10.1016/S0967-0637(01)00018-8; Nomaki H, 2005, LIMNOL OCEANOGR, V50, P134, DOI 10.4319/lo.2005.50.1.0134; OLAFSSON E, 1990, MAR ECOL PROG SER, V65, P241, DOI 10.3354/meps065241; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quijon PA, 2008, J EXP MAR BIOL ECOL, V366, P134, DOI 10.1016/j.jembe.2008.07.017; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Riemann F., 1974, MIKROFAUNA MEERESBOD, V40, P1; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Sachs O, 2009, DEEP-SEA RES PT I, V56, P1319, DOI 10.1016/j.dsr.2009.02.003; Sauter EJ, 2001, DEEP-SEA RES PT I, V48, P529, DOI 10.1016/S0967-0637(00)00061-3; SAVIDGE WB, 1988, J EXP MAR BIOL ECOL, V115, P137, DOI 10.1016/0022-0981(88)90099-8; Schewe I, 2003, POLAR BIOL, V26, P610, DOI 10.1007/s00300-003-0526-8; Schratzberger M, 2004, MAR BIOL, V145, P69, DOI 10.1007/s00227-004-1302-1; Seinhorst J. W., 1959, Nematologica, V4, P67; SHERMAN KM, 1980, J EXP MAR BIOL ECOL, V46, P59, DOI 10.1016/0022-0981(80)90091-X; SHERMAN KM, 1983, MAR ECOL PROG SER, V11, P23, DOI 10.3354/meps011023; SMITH CR, 1989, LIMNOL OCEANOGR, V34, P1263, DOI 10.4319/lo.1989.34.7.1263; SMITH CR, 1986, J MAR RES, V44, P567, DOI 10.1357/002224086788403015; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; SNELGROVE PVR, 1992, LIMNOL OCEANOGR, V37, P1543, DOI 10.4319/lo.1992.37.7.1543; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soltwedel T, 1997, OCEANOL ACTA, V20, P871; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; *STATSOFT INC, 2010, EL STAT TXB; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; THISTLE D, 1981, MAR ECOL PROG SER, V6, P223, DOI 10.3354/meps006223; Tita G, 1999, J MAR BIOL ASSOC UK, V79, P1007, DOI 10.1017/S0025315499001241; Ullberg J, 2003, MAR ECOL PROG SER, V260, P141, DOI 10.3354/meps260141; Ullberg J, 2003, MAR BIOL, V143, P867, DOI 10.1007/s00227-003-1139-z; VANREUSEL A, 1990, CAH BIOL MAR, V31, P439; VINCX M, 1990, CAH BIOL MAR, V31, P107; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; WIDBOM B, 1983, OCEANOL ACTA SPEC, V213; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Zhou H, 2001, J EXP MAR BIOL ECOL, V256, P99, DOI 10.1016/S0022-0981(00)00310-5	80	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18912	10.1371/journal.pone.0018912	http://dx.doi.org/10.1371/journal.pone.0018912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526147	Green Published, gold			2022-12-27	WOS:000289671100037
J	Hoogerhout, P; Kamphuis, W; Brugghe, HF; Sluijs, JA; Timmermans, HAM; Westdijk, J; Zomer, G; Boog, CJP; Hol, EM; van den Dobbelsteen, GPJM				Hoogerhout, Peter; Kamphuis, Willem; Brugghe, Humphrey F.; Sluijs, Jacqueline A.; Timmermans, Hans A. M.; Westdijk, Janny; Zomer, Gijsbert; Boog, Claire J. P.; Hol, Elly M.; van den Dobbelsteen, Germie P. J. M.			A Cyclic Undecamer Peptide Mimics a Turn in Folded Alzheimer Amyloid beta and Elicits Antibodies against Oligomeric and Fibrillar Amyloid and Plaques	PLOS ONE			English	Article							DISEASE; IMMUNIZATION; VACCINATION; AD; IMMUNOTHERAPY; ASSEMBLIES; GENERATION; VACCINES; LESSONS; PROTEIN	The 39- to 42-residue amyloid beta (A beta) peptide is deposited in extracellular fibrillar plaques in the brain of patients suffering from Alzheimer's Disease (AD). Vaccination with these peptides seems to be a promising approach to reduce the plaque load but results in a dominant antibody response directed against the N-terminus. Antibodies against the N-terminus will capture A beta immediately after normal physiological processing of the amyloid precursor protein and therefore will also reduce the levels of non-misfolded A beta, which might have a physiologically relevant function. Therefore, we have targeted an immune response on a conformational neo-epitope in misfolded amyloid that is formed in advance of A beta-aggregation. A tetanus toxoid-conjugate of the 11-meric cyclic peptide A beta(22-28)-YNGK' elicited specific antibodies in Balb/c mice. These antibodies bound strongly to the homologous cyclic peptide-bovine serum albumin conjugate, but not to the homologous linear peptide-conjugate, as detected in vitro by enzyme-linked immunosorbent assay. The antibodies also bound-although more weakly-to A beta(1-42) oligomers as well as fibrils in this assay. Finally, the antibodies recognized A beta deposits in AD mouse and human brain tissue as established by immunohistological staining. We propose that the cyclic peptide conjugate might provide a lead towards a vaccine that could be administered before the onset of AD symptoms. Further investigation of this hypothesis requires immunization of transgenic AD model mice.	[Hoogerhout, Peter; Brugghe, Humphrey F.; Timmermans, Hans A. M.; Westdijk, Janny; Zomer, Gijsbert; Boog, Claire J. P.; van den Dobbelsteen, Germie P. J. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Dept Vaccinol, Bilthoven, Netherlands; [Kamphuis, Willem; Sluijs, Jacqueline A.; Hol, Elly M.] Royal Netherlands Acad Arts & Sci, NIN, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Hoogerhout, P (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Dept Vaccinol, Bilthoven, Netherlands.	Peter.Hoogerhout@rivm.nl	Hol, Elly/J-2025-2019; Hol, Elly M/F-1891-2013	Hol, Elly/0000-0001-5604-2603; Hol, Elly M/0000-0001-5604-2603				Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; BRUGGHE HF, 1994, INT J PEPT PROT RES, V43, P166; Cao CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-25; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Drijfhout JW, 2000, PRACT APPROACH SER, V222, P229; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Ghochikyan A, 2006, VACCINE, V24, P2275, DOI 10.1016/j.vaccine.2005.11.039; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hawkes Cheryl A, 2007, Expert Rev Neurother, V7, P1535, DOI 10.1586/14737175.7.11.1535; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Huitinga I, 2008, J NEURAL TRANSM, V115, P1715; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Lemere CA, 2006, REJUV RES, V9, P77, DOI 10.1089/rej.2006.9.77; Lemere CA, 2004, AM J PATHOL, V165, P283, DOI 10.1016/S0002-9440(10)63296-8; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lemere CA, 2009, PROG BRAIN RES, V175, P83, DOI 10.1016/S0079-6123(09)17506-4; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Oomen CJ, 2005, J MOL BIOL, V351, P1070, DOI 10.1016/j.jmb.2005.06.061; Oomen CJ, 2003, J MOL BIOL, V328, P1083, DOI 10.1016/S0022-2836(03)00377-2; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; SARRIA AJ, 1994, J CELL SCI, V107, P1593; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schneeberger A, 2009, J NUTR HEALTH AGING, V13, P264, DOI 10.1007/s12603-009-0070-5; Solomon B, 2008, REJUV RES, V11, P349, DOI 10.1089/rej.2008.0689; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Vasilevko V, 2010, NEUROBIOL DIS, V39, P301, DOI 10.1016/j.nbd.2010.04.014; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Westdijk J, 1997, J IMMUNOASSAY, V18, P267, DOI 10.1080/01971529708005819; Wisniewski T, 2009, CNS NEUROL DISORD-DR, V8, P160, DOI 10.2174/187152709787847289; Woodhouse A, 2007, DRUG AGING, V24, P107, DOI 10.2165/00002512-200724020-00003; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zeng H, 2001, BIOL PSYCHIAT, V49, P248, DOI 10.1016/S0006-3223(00)01111-2; Zomer G, 2009, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P287, DOI 10.1142/9789812839589_0066	43	11	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19110	10.1371/journal.pone.0019110	http://dx.doi.org/10.1371/journal.pone.0019110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526148	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100053
J	Jeong, HW; Cui, W; Yang, YY; Lu, JY; He, J; Li, AL; Song, D; Guo, Y; Liu, BH; Chai, L				Jeong, Ha-Won; Cui, Wei; Yang, Youyang; Lu, Jiayun; He, Jie; Li, Ailing; Song, David; Guo, Ye; Liu, Bee H.; Chai, Li			SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP-Binding Cassette Drug Transport Genes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HUMAN TUMOR-CELLS; SLAM FAMILY RECEPTORS; HEMATOPOIETIC STEM; MULTIDRUG-RESISTANCE; EFFLUX CAPACITY; IN-VIVO; EXPRESSION; MARKER; SEQUESTRATION	Our previous work shows that the stem cell factor SALL4 plays a central role in embryonic and leukemic stem cells. In this study, we report that SALL4 expression was higher in drug resistant primary acute myeloid leukemic patients than those from drug-responsive cases. In addition, while overexpression of SALL4 led to drug resistance in cell lines, cells with decreased SALL4 expression were more sensitive to drug treatments than the parental cells. This led to our investigation of the implication of SALL4 in drug resistance and its role in side population (SP) cancer stem cells. SALL4 expression was higher in SP cells compared to non-SP cells by 2-4 fold in various malignant hematopoietic cell lines. Knocking down of SALL4 in isolated SP cells resulted in a reduction of SP cells, indicating that SALL4 is required for their self-renewal. The SP phenotype is known to be mediated by members of the ATP-binding cassette (ABC) drug transport protein family, such as ABCG2 and ABCA3. Using chromatin-immunoprecipitation (ChIP), quantitative reverse transcription polymerase chain reaction (qRT-PCR) and electrophoretic mobility shift assay(EMSA), we demonstrated that SALL4 was able to bind to the promoter region of ABCA3 and activate its expression while regulating the expression of ABCG2 indirectly. Furthermore, SALL4 expression was positively correlated to those of ABCG2 and ABCA3 in primary leukemic patient samples. Taken together, our results suggest a novel role for SALL4 in drug sensitivity, at least in part through the maintenance of SP cells, and therefore may be responsible for drug-resistance in leukemia. We are the first to demonstrate a direct link between stem cell factor SALL4, SP and drug resistance in leukemia.	[Jeong, Ha-Won; Yang, Youyang; Lu, Jiayun; He, Jie; Li, Ailing; Song, David; Chai, Li] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Cui, Wei; Guo, Ye] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100037, Peoples R China; [Liu, Bee H.] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117548, Singapore	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; National University of Singapore	Jeong, HW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA.	lchai@partners.org		Chai, Li/0000-0003-1937-4750	National Institutes of Health [RO1HL092437, RO1HL092437-A1S1, PO1 DK080665, PO1HL095489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092437, P01HL095489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK080665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part through National Institutes of Health grants RO1HL092437, RO1HL092437-A1S1, PO1 DK080665 and PO1HL095489 (to Dr. Li Chai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chapuy B, 2008, LEUKEMIA, V22, P1576, DOI 10.1038/leu.2008.103; Chapuy B, 2009, HAEMATOL-HEMATOL J, V94, P1528, DOI 10.3324/haematol.2009.008631; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Huntly BJP, 2004, CANCER CELL, V6, P199, DOI 10.1016/j.ccr.2004.09.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Norwood K, 2004, LEUKEMIA RES, V28, P295, DOI 10.1016/j.leukres.2003.08.006; Steinbach D, 2002, LEUKEMIA, V16, P1443, DOI 10.1038/sj.leu.2402541; Steinbach D, 2007, LEUKEMIA, V21, P1172, DOI 10.1038/sj.leu.2404692; Steinbach D, 2006, CLIN CANCER RES, V12, P4357, DOI 10.1158/1078-0432.CCR-05-2587; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uchida N, 1996, EXP HEMATOL, V24, P649; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	38	60	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18372	10.1371/journal.pone.0018372	http://dx.doi.org/10.1371/journal.pone.0018372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526180	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100003
J	Perera, TD; Dwork, AJ; Keegan, KA; Thirumangalakudi, L; Lipira, CM; Joyce, N; Lange, C; Higley, JD; Rosoklija, G; Hen, R; Sackeim, HA; Coplan, JD				Perera, Tarique D.; Dwork, Andrew J.; Keegan, Kathryn A.; Thirumangalakudi, Lakshmi; Lipira, Cecilia M.; Joyce, Niamh; Lange, Christopher; Higley, J. Dee; Rosoklija, Gorazd; Hen, Rene; Sackeim, Harold A.; Coplan, Jeremy D.			Necessity of Hippocampal Neurogenesis for the Therapeutic Action of Antidepressants in Adult Nonhuman Primates	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; CHRONIC MILD STRESS; RAT DENTATE GYRUS; CHRONIC FLUOXETINE; RHESUS-MONKEYS; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; DECLARATIVE MEMORY; MACAQUE MONKEYS; GRANULE CELLS	Background: Rodent studies show that neurogenesis is necessary for mediating the salutary effects of antidepressants. Nonhuman primate (NHP) studies may bridge important rodent findings to the clinical realm since NHP-depression shares significant homology with human depression and kinetics of primate neurogenesis differ from those in rodents. After demonstrating that antidepressants can stimulate neurogenesis in NHPs, our present study examines whether neurogenesis is required for antidepressant efficacy in NHPs. Materials/Methodology: Adult female bonnets were randomized to three social pens (N = 6 each). Pen-1 subjects were exposed to control-conditions for 15 weeks with half receiving the antidepressant fluoxetine and the rest receiving saline-placebo. Pen-2 subjects were exposed to 15 weeks of separation-stress with half receiving fluoxetine and half receiving placebo. Pen-3 subjects 2 weeks of irradiation (N = 4) or sham-irradiation (N = 2) and then exposed to 15 weeks of stress and fluoxetine. Dependent measures were weekly behavioral observations and postmortem neurogenesis levels. Results: Exposing NHPs to repeated separation stress resulted in depression-like behaviors (anhedonia and subordinance) accompanied by reduced hippocampal neurogenesis. Treatment with fluoxetine stimulated neurogenesis and prevented the emergence of depression-like behaviors. Ablation of neurogenesis with irradiation abolished the therapeutic effects of fluoxetine. Non-stressed controls had normative behaviors although the fluoxetine-treated controls had higher neurogenesis rates. Across all groups, depression-like behaviors were associated with decreased rates of neurogenesis but this inverse correlation was only significant for new neurons in the anterior dentate gyrus that were at the threshold of completing maturation. Conclusion: We provide evidence that induction of neurogenesis is integral to the therapeutic effects of fluoxetine in NHPs. Given the similarity between monkeys and humans, hippocampal neurogenesis likely plays a similar role in the treatment of clinical depression. Future studies will examine several outstanding questions such as whether neuro-suppression is sufficient for producing depression and whether therapeutic neuroplastic effects of fluoxetine are specific to antidepressants.	[Perera, Tarique D.; Dwork, Andrew J.; Keegan, Kathryn A.; Thirumangalakudi, Lakshmi; Lipira, Cecilia M.; Joyce, Niamh; Rosoklija, Gorazd; Hen, Rene; Sackeim, Harold A.] Columbia Univ, Dept Psychiat, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA; [Perera, Tarique D.; Dwork, Andrew J.; Keegan, Kathryn A.; Thirumangalakudi, Lakshmi; Lipira, Cecilia M.; Joyce, Niamh; Rosoklija, Gorazd; Hen, Rene; Sackeim, Harold A.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Lange, Christopher] SUNY Brooklyn, Dept Radiol, Brooklyn, NY USA; [Coplan, Jeremy D.] SUNY Brooklyn, Dept Psychiat, Brooklyn, NY USA; [Higley, J. Dee] Brigham Young Univ, Provo, UT 84602 USA; [Dwork, Andrew J.; Rosoklija, Gorazd] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, Med Ctr, New York, NY USA; [Rosoklija, Gorazd] Macedonian Acad Sci & Arts, Skopje, Macedonia	Columbia University; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) System; Brigham Young University; Columbia University	Perera, TD (corresponding author), Columbia Univ, Dept Psychiat, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA.	tp119@columbia.edu			National Institute of Mental Health (NIMH) [KO8 MH70954, RO1MH59990]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064168, K08MH070954, R01MH059990] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided to Dr. Perera from the National Institute of Mental Health (NIMH) (KO8 MH70954) and NARSAD (Young Investigator Award) and to Dr. Coplan from NIMH (RO1MH59990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bremner JD, 2004, AM J PSYCHIAT, V161, P637, DOI 10.1176/appi.ajp.161.4.637; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Clewell T, 2004, J AM PSYCHOANAL ASS, V52, P43, DOI 10.1177/00030651040520010601; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Deuschle M, 2004, PHARMACOPSYCHIATRY, V37, P147, DOI 10.1055/s-2004-827168; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gu L, 1999, Chem Immunol, V72, P7, DOI 10.1159/000058723; Higley J, 1998, NEUROPSYCHOPHARMACOL, V18, P431; HOEHNSARIC R, 1990, J CLIN PSYCHOPHARM, V10, P343; Hoffman GE, 2002, J NEUROENDOCRINOL, V14, P259, DOI 10.1046/j.1365-2826.2002.00775.x; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Jayatissa MN, 2008, NEUROPHARMACOLOGY, V54, P530, DOI 10.1016/j.neuropharm.2007.11.009; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Ngwenya LB, 2006, J COMP NEUROL, V498, P204, DOI 10.1002/cne.21045; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Perera TD, 2008, NEUROSCIENTIST, V14, P326, DOI 10.1177/1073858408317242; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Roche M, 2007, NEUROPSYCHOPHARMACOL, V32, P1312, DOI 10.1038/sj.npp.1301253; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosenblum LA, 2001, DEV PSYCHOBIOL, V39, P40, DOI 10.1002/dev.1026; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schindler MK, 2002, BIOL PSYCHIAT, V51, P827, DOI 10.1016/S0006-3223(01)01341-5; SEGMAN RH, 1995, PSYCHOPHARMACOLOGY, V119, P440, DOI 10.1007/BF02245860; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shively CA, 2005, BIOL PSYCHOL, V69, P67, DOI 10.1016/j.biopsycho.2004.11.006; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; STEELE VE, 1976, RADIAT RES, V67, P21, DOI 10.2307/3574492; SUOMI SJ, 1991, CIBA F SYMP, V156, P171; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Trivedi Madhukar H, 2009, J Clin Psychiatry, V70, pe01; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Verwer RWH, 2007, BRAIN, V130, P3321, DOI 10.1093/brain/awm264; Vollmayr B, 2003, BIOL PSYCHIAT, V54, P1035, DOI 10.1016/S0006-3223(03)00527-4; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167	62	171	177	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e17600	10.1371/journal.pone.0017600	http://dx.doi.org/10.1371/journal.pone.0017600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525974	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600006
J	Wang, P; Lu, YL; Zheng, MM; Rong, TZ; Tang, QL				Wang, Pei; Lu, Yanli; Zheng, Mingmin; Rong, Tingzhao; Tang, Qilin			RAPD and Internal Transcribed Spacer Sequence Analyses Reveal Zea nicaraguensis as a Section Luxuriantes Species Close to Zea luxurians	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; PHYLOGENETIC-RELATIONSHIPS; GENETIC DIVERSITY; TEOSINTE; MAIZE; IDENTIFICATION; TAXONOMY; POACEAE; HYBRIDIZATION; SYSTEMATICS	Genetic relationship of a newly discovered teosinte from Nicaragua, Zea nicaraguensis with waterlogging tolerance, was determined based on randomly amplified polymorphic DNA (RAPD) markers and the internal transcribed spacer (ITS) sequences of nuclear ribosomal DNA using 14 accessions from Zea species. RAPD analysis showed that a total of 5,303 fragments were produced by 136 random decamer primers, of which 84.86% bands were polymorphic. RAPD-based UPGMA analysis demonstrated that the genus Zea can be divided into section Luxuriantes including Zea diploperennis, Zea luxurians, Zea perennis and Zea nicaraguensis, and section Zea including Zea mays ssp. mexicana, Zea mays ssp. parviglumis, Zea mays ssp. huehuetenangensis and Zea mays ssp. mays. ITS sequence analysis showed the lengths of the entire ITS region of the 14 taxa in Zea varied from 597 to 605 bp. The average GC content was 67.8%. In addition to the insertion/deletions, 78 variable sites were recorded in the total ITS region with 47 in ITS1, 5 in 5.8S, and 26 in ITS2. Sequences of these taxa were analyzed with neighbor-joining (NJ) and maximum parsimony (MP) methods to construct the phylogenetic trees, selecting Tripsacum dactyloides L. as the outgroup. The phylogenetic relationships of Zea species inferred from the ITS sequences are highly concordant with the RAPD evidence that resolved two major subgenus clades. Both RAPD and ITS sequence analyses indicate that Zea nicaraguensis is more closely related to Zea luxurians than the other teosintes and cultivated maize, which should be regarded as a section Luxuriantes species.	[Wang, Pei; Lu, Yanli; Zheng, Mingmin; Rong, Tingzhao; Tang, Qilin] Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Wang, P (corresponding author), Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China.	tangql@sicau.edu.cn			National Program on Key Basic Research Project of China (973 Program) [2007CB108900]; National Natural Science Foundation of China [31071432]; Science and Technology Foundation for Youths of Sichuan Province [2007Q14-032]; Forage Breeding Project of Sichuan Province	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation for Youths of Sichuan Province; Forage Breeding Project of Sichuan Province	This work was supported by National Program on Key Basic Research Project of China (973 Program) (2007CB108900), National Natural Science Foundation of China (31071432), Science and Technology Foundation for Youths of Sichuan Province (2007Q14-032), and Forage Breeding Project of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN BG, 1993, AM J BOT, V80, P222, DOI 10.2307/2445043; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Baltazar BM, 2005, THEOR APPL GENET, V110, P519, DOI 10.1007/s00122-004-1859-6; Baral J, 2002, J AM SOC HORTIC SCI, V127, P318, DOI 10.21273/JASHS.127.3.318; BEADLE G. W., 1932, Zeitschrift fur induktive Abstammungs- und Vererbungslehre, V62, P291, DOI 10.1007/BF01948608; Buckler ES, 1996, MOL BIOL EVOL, V13, P612, DOI 10.1093/oxfordjournals.molbev.a025621; Conti E, 1999, MOL PHYLOGENET EVOL, V13, P536, DOI 10.1006/mpev.1999.0673; DOEBLEY J, 1990, MAYDICA, V35, P143; DOEBLEY J, 1987, GENETICS, V117, P139; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; DOEBLEY JF, 1984, SYST BOT, V9, P203, DOI 10.2307/2418824; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Ellstrand NC, 2007, J HERED, V98, P183, DOI 10.1093/jhered/esm002; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gaut BS, 2000, PLANT SYST EVOL, V224, P33, DOI 10.1007/BF00985265; Holderegger R, 2003, AM J BOT, V90, P931, DOI 10.3732/ajb.90.6.931; HSIAO C, 1994, GENOME, V37, P112, DOI 10.1139/g94-014; HSIAO C, 1995, THEOR APPL GENET, V90, P389, DOI 10.1007/BF00221981; Iltis HH, 2000, NOVON, V10, P382, DOI 10.2307/3392992; ILTIS HH, 1980, AM J BOT, V67, P994, DOI 10.2307/2442442; Jorgensen JL, 2003, AM J BOT, V90, P1470, DOI 10.3732/ajb.90.10.1470; Kermicle JL, 2006, MAYDICA, V51, P219; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lausser A, 2010, J EXP BOT, V61, P673, DOI 10.1093/jxb/erp330; Li YG, 1999, ANN BOT-LONDON, V84, P695, DOI 10.1006/anbo.1999.0973; Mano Y, 2006, PLANT SOIL, V281, P269, DOI 10.1007/s11104-005-4268-y; Mano Y, 2008, MOL BREEDING, V21, P327, DOI 10.1007/s11032-007-9132-8; Orr AR, 2004, AM J BOT, V91, P165, DOI 10.3732/ajb.91.2.165; PERNILLA ES, 2007, HEREDITAS, V144, P96; Rasul MG, 2007, SCI HORTIC-AMSTERDAM, V111, P271, DOI 10.1016/j.scienta.2006.10.023; ROHLF FJ, 1998, APPL BIOSTATISTICS; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Tang QiLin, 2000, Scientia Agricultura Sinica, V33, P62; Tang QiLin, 2006, Acta Agronomica Sinica, V32, P144; Tang QL, 2005, CROP SCI, V45, P717, DOI 10.2135/cropsci2005.0717; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vollbrecht E, 2005, BIOCHEM SOC T, V33, P1502, DOI 10.1042/BST20051502; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wilson CA, 2003, SYST BOT, V28, P39; Zhang LB, 2001, AM J BOT, V88, P2331, DOI 10.2307/3558393	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e16728	10.1371/journal.pone.0016728	http://dx.doi.org/10.1371/journal.pone.0016728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525982	gold, Green Submitted, Green Published			2022-12-27	WOS:000289578600003
J	Tian, X; Vroom, C; Ghofrani, HA; Weissmann, N; Bieniek, E; Grimminger, F; Seeger, W; Schermuly, RT; Pullamsetti, SS				Tian, Xia; Vroom, Christina; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Bieniek, Ewa; Grimminger, Friedrich; Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai			Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-A; NUCLEOTIDE PHOSPHODIESTERASE; ARTERIAL-HYPERTENSION; CAMP; PROLIFERATION; INHIBITION; RECEPTOR; PAPAVERINE; ILOPROST	Phosphodiesterases (PDEs) modulate the cellular proliferation involved in the pathophysiology of pulmonary hypertension (PH) by hydrolyzing cAMP and cGMP. The present study was designed to determine whether any of the recently identified PDEs (PDE7-PDE11) contribute to progressive pulmonary vascular remodeling in PH. All in vitro experiments were performed with lung tissue or pulmonary arterial smooth muscle cells (PASMCs) obtained from control rats or monocrotaline (MCT)-induced pulmonary hypertensive (MCT-PH) rats, and we examined the effects of the PDE10 inhibitor papaverine (Pap) and specific small interfering RNA (siRNA). In addition, papaverine was administrated to MCT-induced PH rats from day 21 to day 35 by continuous intravenous infusion to examine the in vivo effects of PDE10A inhibition. We found that PDE10A was predominantly present in the lung vasculature, and the mRNA, protein, and activity levels of PDE10A were all significantly increased in MCT PASMCs compared with control PASMCs. Papaverine and PDE10A siRNA induced an accumulation of intracellular cAMP, activated cAMP response element binding protein and attenuated PASMC proliferation. Intravenous infusion of papaverine in MCT-PH rats resulted in a 40%-50% attenuation of the effects on pulmonary hypertensive hemodynamic parameters and pulmonary vascular remodeling. The present study is the first to demonstrate a central role of PDE10A in progressive pulmonary vascular remodeling, and the results suggest a novel therapeutic approach for the treatment of PH.	[Tian, Xia; Vroom, Christina; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Bieniek, Ewa; Grimminger, Friedrich; Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai] Univ Hosp, Med Clin 2 5, Giessen, Germany; [Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Max Planck Society	Tian, X (corresponding author), Univ Hosp, Med Clin 2 5, Giessen, Germany.	soni.pullamsetti@mpi-bn.mpg.de	Ghofrani, Hossein Ardeschir/AAD-2856-2022; Ghofrani, Ardeschir/AAD-5293-2020	Ghofrani, Ardeschir/0000-0002-2029-4419; Seeger, Werner/0000-0003-1946-0894; Weissmann, Norbert/0000-0003-2675-3871; Pullamsetti, Soni Savai/0000-0003-0440-8831; Grimminger, Friedrich/0000-0001-8725-6276; Schermuly, Ralph/0000-0002-5167-6970	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 547]; European Commission [LSHM-CT-2005-018725]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 547 "Kardiopulmonales Gefasssystem'', Projekt C6 and by the European Commission under the Sixth Frame work Programme (contract No. LSHM-CT-2005-018725, PULMOTENSION). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI H, 1994, BRIT J PHARMACOL, V111, P489, DOI 10.1111/j.1476-5381.1994.tb14763.x; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; BAUER AC, 1980, N-S ARCH PHARMACOL, V311, P193, DOI 10.1007/BF00510259; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; Cantin LD, 2007, BIOORG MED CHEM LETT, V17, P2869, DOI 10.1016/j.bmcl.2007.02.061; CHRISTENSEN CW, 1991, CIRCULATION, V83, P294, DOI 10.1161/01.CIR.83.1.294; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dahal BK, 2010, EUR RESPIR J, V36, P808, DOI 10.1183/09031936.00140309; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; Hebb ALO, 2007, CURR OPIN PHARMACOL, V7, P86, DOI 10.1016/j.coph.2006.08.014; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Koyama H, 2001, J CELL PHYSIOL, V186, P1; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacLean MR, 1997, J PHARMACOL EXP THER, V283, P619; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Murray F, 2007, AM J PHYSIOL-LUNG C, V292, pL294, DOI 10.1152/ajplung.00190.2006; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Phillips PG, 2005, AM J PHYSIOL-LUNG C, V288, pL103, DOI 10.1152/ajplung.00095.2004; Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Stenmark KR, 1997, ANNU REV PHYSIOL, V59, P89, DOI 10.1146/annurev.physiol.59.1.89; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Torres-Flores V, 2008, J ANDROL, V29, P549, DOI 10.2164/jandrol.107.004614; Vadiveloo PK, 1997, ATHEROSCLEROSIS, V133, P61, DOI 10.1016/S0021-9150(97)00116-0; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	46	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18136	10.1371/journal.pone.0018136	http://dx.doi.org/10.1371/journal.pone.0018136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494592	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100004
J	Yeh, CM; Liu, YC; Chang, CJ; Lai, SL; Hsiao, CD; Lee, SJ				Yeh, Chen-Min; Liu, Yi-Ching; Chang, Ching-Jen; Lai, Shih-Lei; Hsiao, Chung-Der; Lee, Shyh-Jye			Ptenb Mediates Gastrulation Cell Movements via Cdc42/AKT1 in Zebrafish	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC-DEVELOPMENT; PHOSPHATASE-ACTIVITY; GERMLINE MUTATIONS; FILAMENTOUS ACTIN; CANCER SYNDROME; MYOSIN-II; WILD-TYPE; NO TAIL	Phosphatidylinositol 3-kinase (PI3 kinase) mediates gastrulation cell migration in zebrafish via its regulation of PIP(2)/PIP(3) balance. Although PI3 kinase counter enzyme PTEN has also been reported to be essential for gastrulation, its role in zebrafish gastrulation has been controversial due to the lack of gastrulation defects in pten-null mutants. To clarify this issue, we knocked down a pten isoform, ptenb by using anti-sense morpholino oligos (MOs) in zebrafish embryos and found that ptenb MOs inhibit convergent extension by affecting cell motility and protrusion during gastrulation. The ptenb MO-induced convergence defect could be rescued by a PI3-kinase inhibitor, LY294002 and by overexpressing dominant negative Cdc42. Overexpression of human constitutively active akt1 showed similar convergent extension defects in zebrafish embryos. We also observed a clear enhancement of actin polymerization in ptenb morphants under cofocal microscopy and in actin polymerization assay. These results suggest that Ptenb by antagonizing PI3 kinase and its downstream Akt1 and Cdc42 to regulate actin polymerization that is critical for proper cell motility and migration control during gastrulation in zebrafish.	[Yeh, Chen-Min; Liu, Yi-Ching; Chang, Ching-Jen; Lai, Shih-Lei; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Yeh, Chen-Min; Liu, Yi-Ching; Lee, Shyh-Jye] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; Chung Yuan Christian University	Yeh, CM (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	jefflee@ntu.edu.tw	Lai, Ben/AAD-1628-2019; Hsiao, Chung-Der/W-4535-2019; Lee, Shyh-Jye/C-6092-2008; Lai, Shih-Lei/O-1562-2018	Hsiao, Chung-Der/0000-0002-6398-8672; Lee, Shyh-Jye/0000-0001-8452-9152; Lai, Shih-Lei/0000-0002-1409-4701	National Science Council, Taiwan, Republic of China [98-2311-B-002-006-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan, Republic of China, grant number 98-2311-B-002-006-MY3 (URL:http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Becker KA, 1999, J CELL SCI, V112, P97; Becker KA, 1996, MOL REPROD DEV, V43, P536; Besson A, 1999, EUR J BIOCHEM, V263, P605, DOI 10.1046/j.1432-1327.1999.00542.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cantrell DA, 2001, J CELL SCI, V114, P1439; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Fu CT, 2010, BLOOD, V115, P4715, DOI 10.1182/blood-2009-11-255778; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOWARD TH, 1985, CELL MOTIL CYTOSKEL, V5, P545, DOI 10.1002/cm.970050609; Huang H, 1999, DEVELOPMENT, V126, P5365; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Ro H, 2004, MOL CELLS, V17, P373; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Solnica-Krezel L, 2002, RES PRO CEL, V40, P136; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; THISSE C, 1993, DEVELOPMENT, V119, P1203; Ueno S, 2006, DEV BIOL, V297, P274, DOI 10.1016/j.ydbio.2006.06.001; WARGA RM, 1990, DEVELOPMENT, V108, P569; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Zhou XP, 2003, AM J HUM GENET, V73, P1191, DOI 10.1086/379382; Zhou XP, 2002, HUM MOL GENET, V11, P445, DOI 10.1093/hmg/11.4.445; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	50	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18702	10.1371/journal.pone.0018702	http://dx.doi.org/10.1371/journal.pone.0018702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494560	Green Submitted, gold, Green Published			2022-12-27	WOS:000289354100031
J	Jayakrishnan, B; Hoke, DE; Langendorf, CG; Buckle, AM; Rowley, MJ				Jayakrishnan, Bindu; Hoke, David E.; Langendorf, Christopher G.; Buckle, Ashley M.; Rowley, Merrill J.			An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; STIFF-MAN SYNDROME; MONOCLONAL-ANTIBODIES; SACCHAROMYCES-CEREVISIAE; EPITOPE; AUTOANTIGEN; MELLITUS; ASSOCIATION; EXPRESSION; ISOFORM	Background: Autoantibodies to GAD65 (anti-GAD65) are present in the sera of 70-80% of patients with type 1 diabetes (T1D), but antibodies to the structurally similar 67 kDa isoform GAD67 are rare. Antibodies to GAD67 may represent a cross-reactive population of anti-GAD65, but this has not been formally tested. Methodology/Principal Findings: In this study we examined the frequency, levels and affinity of anti-GAD67 in diabetes sera that contained anti-GAD65, and compared the specificity of GAD65 and GAD67 reactivity. Anti-GAD65 and anti-GAD67 were measured by radioimmunoprecipitation (RIP) using (125)I labeled recombinant GAD65 and GAD67. For each antibody population, the specificity of the binding was measured by incubation with 100-fold excess of unlabeled GAD in homologous and heterologous inhibition assays, and the affinity of binding with GAD65 and GAD67 was measured in selected sera. Sera were also tested for reactivity to GAD65 and GAD67 by immunoblotting. Of the 85 sera that contained antibodies to GAD65, 28 contained anti-GAD67 measured by RIP. Inhibition with unlabeled GAD65 substantially or completely reduced antibody reactivity with both (125)I GAD65 and with (125)I GAD67. In contrast, unlabeled GAD67 reduced autoantibody reactivity with (125)I GAD67 but not with (125)I GAD65. Both populations of antibodies were of high affinity (>10(10) l/mol). Conclusions: Our findings show that autoantibodies to GAD67 represent a minor population of anti-GAD65 that are reactive with a cross-reactive epitope found also on GAD67. Experimental results confirm that GAD65 is the major autoantigen in T1D, and that GAD67 per se has very low immunogenicity. We discuss our findings in light of the known similarities between the structures of the GAD isoforms, in particular the location of a minor cross-reactive epitope that could be induced by epitope spreading.	[Jayakrishnan, Bindu; Hoke, David E.; Langendorf, Christopher G.; Buckle, Ashley M.; Rowley, Merrill J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University	Jayakrishnan, B (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	ashley.buckle@monash.edu; Merrill.rowley@monash.edu	Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Langendorf, Christopher/0000-0002-9049-5283	National Health and Medical Research Council (NHMRC); Diabetes Australia Research Trust	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by grants from the National Health and Medical Research Council (NHMRC) and the Diabetes Australia Research Trust. AMB is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bukhari TAMA, 2002, CLIN EXP IMMUNOL, V130, P131, DOI 10.1046/j.1365-2249.2002.01960.x; Arafat Y, 2009, MOL IMMUNOL, V47, P493, DOI 10.1016/j.molimm.2009.08.022; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; CHANG YC, 1988, J NEUROSCI, V8, P2123; Fenalti G, 2008, DIABETES, V57, P1293, DOI 10.2337/db07-1461; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fenalti G, 2010, AUTOIMMUN REV, V9, P148, DOI 10.1016/j.autrev.2009.05.003; Fenalti G, 2008, J AUTOIMMUN, V31, P228, DOI 10.1016/j.jaut.2008.04.013; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; HAGOPIAN WA, 1993, DIABETES, V42, P631, DOI 10.2337/diabetes.42.4.631; KIM J, 1994, J EXP MED, V180, P595, DOI 10.1084/jem.180.2.595; Law RHP, 1998, J BIOTECHNOL, V61, P57, DOI 10.1016/S0168-1656(98)00013-3; Lernmark A, 1996, J INTERN MED, V240, P259, DOI 10.1046/j.1365-2796.1996.27859000.x; Mayr A, 2007, DIABETES, V56, P1527, DOI 10.2337/db06-1715; Mueller Patricia W, 2002, Diabetes Technol Ther, V4, P397, DOI 10.1089/152091502760098537; O'Connor KH, 2006, J AUTOIMMUN, V26, P172, DOI 10.1016/j.jaut.2006.02.001; Papakonstantinou T, 2000, ENZYME MICROB TECH, V26, P645, DOI 10.1016/S0141-0229(00)00154-X; PETERSEN JS, 1994, DIABETES, V43, P459, DOI 10.2337/diabetes.43.3.459; Piquer S, 2005, CLIN IMMUNOL, V117, P31, DOI 10.1016/j.clim.2005.06.009; Pittock SJ, 2006, MAYO CLIN PROC, V81, P1207, DOI 10.4065/81.9.1207; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; SEISSLER J, 1994, AUTOIMMUNITY, V19, P231, DOI 10.3109/08916939409071348; SOLIMENA M, 1991, TRENDS NEUROSCI, V14, P452, DOI 10.1016/0166-2236(91)90044-U; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150; VELLOSO LA, 1993, J CLIN INVEST, V91, P2084, DOI 10.1172/JCI116431; Vianello M, 2006, EXP NEUROL, V202, P514, DOI 10.1016/j.expneurol.2006.06.012; Ziegler B, 1996, ACTA DIABETOL, V33, P225	35	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18411	10.1371/journal.pone.0018411	http://dx.doi.org/10.1371/journal.pone.0018411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494613	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800014
J	Kiebala, M; Maggirwar, SB				Kiebala, Michelle; Maggirwar, Sanjay B.			Ibudilast, a Pharmacologic Phosphodiesterase Inhibitor, Prevents Human Immunodeficiency Virus-1 Tat-Mediated Activation of Microglial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN FETAL MICROGLIA; HIV-1 TAT; TNF-ALPHA; CYTOKINE PRODUCTION; COGNITIVE IMPAIRMENT; AIDS PATIENTS; T-CELLS	Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorders ( HAND) occur, in part, due to the inflammatory response to viral proteins, such as the HIV-1 transactivator of transcription ( Tat), in the central nervous system (CNS). Given the need for novel adjunctive therapies for HAND, we hypothesized that ibudilast would inhibit Tat-induced excess production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF alpha) in microglial cells. Ibudilast is a non-selective cyclic AMP phosphodiesterase inhibitor that has recently shown promise as a treatment for neuropathic pain via its ability to attenuate glial cell activation. Accordingly, here we demonstrate that pre-treatment of both human and mouse microglial cells with increasing doses of ibudilast inhibited Tat-induced synthesis of TNF alpha by microglial cells in a manner dependent on serine/threonine protein phosphatase activity. Ibudilast had no effect on Tat-induced p38 MAP kinase activation, and blockade of adenosine A(2A) receptor activation did not reverse ibudilast's inhibition of Tat-induced TNF alpha production. Interestingly, ibudilast reduced Tat-mediated transcription of TNF alpha, via modulation of nuclear factor-kappa B (NF-kappa B) signaling, as shown by transcriptional activity of NF-kappa B and analysis of inhibitor of kappa B alpha (I kappa B alpha) stability. Together, our findings shed light on the mechanism of ibudilast's inhibition of Tat-induced TNFa production in microglial cells and may implicate ibudilast as a potential novel adjunctive therapy for the management of HAND.	[Kiebala, Michelle; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu			National Institutes of Health [RO1 NS054578, RO1 NS066801, T32 AI49105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following National Institutes of Health grants: RO1 NS054578 and RO1 NS066801 (to SBM) and T32 AI49105 (to MK) (URL: http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL JB, 1995, AIDS, V9, P1137, DOI 10.1097/00002030-199510000-00004; Archibald SL, 2004, ARCH NEUROL-CHICAGO, V61, P369, DOI 10.1001/archneur.61.3.369; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; Beardsley PM, 2010, EUR J PHARMACOL, V637, P102, DOI 10.1016/j.ejphar.2010.04.010; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; CARDENAS V, 2009, J NEUROVIROL, P1; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; Cherry CL, 2003, J CLIN VIROL, V26, P195, DOI 10.1016/S1386-6532(02)00118-X; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Coimbra R, 2005, J TRAUMA, V59, P575, DOI 10.1097/01.ta.0000177787.48608.b6; Costantini TW, 2010, IMMUNOPHARM IMMUNOT, V32, P74, DOI [10.3109/08923970903143965, 10.1080/08923970903143965]; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Deree J, 2008, CLINICS, V63, P321, DOI 10.1590/S1807-59322008000300006; DEZUBE BJ, 1995, J INFECT DIS, V171, P1628, DOI 10.1093/infdis/171.6.1628; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fine SM, 1999, J NEUROIMMUNOL, V95, P55, DOI 10.1016/S0165-5728(98)00267-7; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fotheringham J, 2004, VIROLOGY, V327, P186, DOI 10.1016/j.virol.2004.07.007; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Heijligenberg R, 1998, AIDS RES HUM RETROV, V14, P299, DOI 10.1089/aid.1998.14.299; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; Ji Q, 2006, OPHTHALMOLOGICA, V220, P217, DOI 10.1159/000093074; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kovacs AD, 2004, EUR J NEUROSCI, V20, P345, DOI 10.1111/j.1460-9568.2004.03493.x; Kreth S, 2010, SHOCK, V34, P10, DOI 10.1097/SHK.0b013e3181cdc3e2; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Langford TD, 2003, BRAIN PATHOL, V13, P195; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Lysandropoulos AP, 2010, CURR OPIN NEUROL, V23, P226, DOI 10.1097/WCO.0b013e3283398c96; MAJOR EO, 2009, ANN REV MED; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McWhinney CD, 1996, EUR J PHARMACOL, V310, P209, DOI 10.1016/0014-2999(96)00272-5; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; Navarro J, 1998, J VIROL, V72, P4712, DOI 10.1128/JVI.72.6.4712-4720.1998; NEUNER P, 1994, IMMUNOLOGY, V83, P262; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Oh YT, 2010, NEUROSCI LETT, V474, P148, DOI 10.1016/j.neulet.2010.03.026; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Saha RN, 2003, J NEUROCHEM, V86, P1057, DOI 10.1046/j.1471-4159.2003.01942.x; Sandoval J, 2009, J PHARMACOL EXP THER, V331, P609, DOI 10.1124/jpet.109.157537; Schifitto G, 2007, NEUROLOGY, V69, P1314, DOI 10.1212/01.wnl.0000268487.78753.0f; Schifitto G, 2009, NEUROLOGY, V73, P1975, DOI 10.1212/WNL.0b013e3181c51a48; Schifitto G, 2007, AIDS, V21, P1877, DOI 10.1097/QAD.0b013e32813384e8; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui ZY, 2006, EUR J NEUROSCI, V23, P2623, DOI 10.1111/j.1460-9568.2006.04813.x; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Sun WJ, 2010, J BIOL CHEM, V285, P21341, DOI 10.1074/jbc.M110.104224; Suzumura A, 1999, BRAIN RES, V837, P203, DOI 10.1016/S0006-8993(99)01666-2; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Turchan-Cholewo J, 2009, J NEUROCHEM, V108, P202, DOI 10.1111/j.1471-4159.2008.05756.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vidal F, 2010, AIDS REV, V12, P15; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yasui K, 2000, J LEUKOCYTE BIOL, V67, P529, DOI 10.1002/jlb.67.4.529; Yasui K, 2009, CLIN EXP ALLERGY, V39, P1857, DOI 10.1111/j.1365-2222.2009.03365.x; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1177/135245859900500210; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZEN K, 1994, EXP CELL RES, V215, P172, DOI 10.1006/excr.1994.1329	96	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18633	10.1371/journal.pone.0018633	http://dx.doi.org/10.1371/journal.pone.0018633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494611	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800032
J	Dick, CA; Buenrostro, J; Butler, T; Carlson, ML; Kliebenstein, DJ; Whittall, JB				Dick, Cynthia A.; Buenrostro, Jason; Butler, Timothy; Carlson, Matthew L.; Kliebenstein, Daniel J.; Whittall, Justen B.			Arctic Mustard Flower Color Polymorphism Controlled by Petal-Specific Downregulation at the Threshold of the Anthocyanin Biosynthetic Pathway	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; EVOLUTION; TRANSCRIPTION; POLLINATION; TEMPERATURE; UV; ACCUMULATION; PIGMENTATION	Intra- and interspecific variation in flower color is a hallmark of angiosperm diversity. The evolutionary forces underlying the variety of flower colors can be nearly as diverse as the colors themselves. In addition to pollinator preferences, non-pollinator agents of selection can have a major influence on the evolution of flower color polymorphisms, especially when the pigments in question are also expressed in vegetative tissues. In such cases, identifying the target(s) of selection starts with determining the biochemical and molecular basis for the flower color variation and examining any pleiotropic effects manifested in vegetative tissues. Herein, we describe a widespread purple-white flower color polymorphism in the mustard Parrya nudicaulis spanning Alaska. The frequency of white-flowered individuals increases with increasing growing-season temperature, consistent with the role of anthocyanin pigments in stress tolerance. White petals fail to produce the stress responsive flavonoid intermediates in the anthocyanin biosynthetic pathway (ABP), suggesting an early pathway blockage. Petal cDNA sequences did not reveal blockages in any of the eight enzyme-coding genes in white-flowered individuals, nor any color differentiating SNPs. A qRT-PCR analysis of white petals identified a 24-fold reduction in chalcone synthase (CHS) at the threshold of the ABP, but no change in CHS expression in leaves and sepals. This arctic species has avoided the deleterious effects associated with the loss of flavonoid intermediates in vegetative tissues by decoupling CHS expression in petals and leaves, yet the correlation of flower color and climate suggests that the loss of flavonoids in the petals alone may affect the tolerance of white-flowered individuals to colder environments.	[Dick, Cynthia A.; Buenrostro, Jason; Butler, Timothy; Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Carlson, Matthew L.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Santa Clara University; University of Alaska System; University of Alaska Anchorage; University of California System; University of California Davis	Dick, CA (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	jwhittall@scu.edu		Kliebenstein, Daniel/0000-0001-5759-3175; Butler, Timothy/0000-0001-5803-1035	NSF IPY; Santa Clara University Department of Biology Technology; DeNardo Senior Prize; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NSF IPY(National Science Foundation (NSF)); Santa Clara University Department of Biology Technology; DeNardo Senior Prize; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by NSF IPY (to JBW & MLC), Santa Clara University Department of Biology & Technology Funds (JBW), and the DeNardo Senior Prize (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, DOI [10.4135/9781412961288.n178, DOI 10.4135/9781412961288.N178]; Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; BLISS L. C., 1962, ARCTIC, V15, P117; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Choi S, 2009, PLANT SCI, V176, P678, DOI 10.1016/j.plantsci.2009.02.010; Coberly LC, 2008, EVOLUTION, V62, P1076, DOI 10.1111/j.1558-5646.2008.00355.x; Coberly LC, 2003, MOL ECOL, V12, P1113, DOI 10.1046/j.1365-294X.2003.01786.x; Durbin ML, 2003, MOL PHYLOGENET EVOL, V29, P507, DOI 10.1016/S1055-7903(03)00196-9; Durbin ML, 2000, PLANT MOL BIOL, V42, P79, DOI 10.1023/A:1006375904820; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Faegri K., 1979, PRINCIPLES POLLINATI; Faktor O, 1996, PLANT MOL BIOL, V32, P849, DOI 10.1007/BF00020482; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fineblum WL, 1997, ECOLOGY, V78, P1646, DOI 10.1890/0012-9658(1997)078[1646:DFPGAI]2.0.CO;2; GRANT V, 1993, P NATL ACAD SCI USA, V90, P990, DOI 10.1073/pnas.90.3.990; Habu Y, 1998, PLANT J, V16, P371, DOI 10.1046/j.1365-313x.1998.00308.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; KJELLBERG B, 1982, OECOLOGIA, V54, P10, DOI 10.1007/BF00541101; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Koch MA, 2001, MOL BIOL EVOL, V18, P1882, DOI 10.1093/oxfordjournals.molbev.a003729; Lankinen A, 2009, J GENET, V88, P205, DOI 10.1007/s12041-009-0029-7; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majetic CJ, 2008, ANN BOT-LONDON, V102, P911, DOI 10.1093/aob/mcn181; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Merken HM, 2000, J AGR FOOD CHEM, V48, P577, DOI 10.1021/jf990872o; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; MOLGAARD P, 1989, ARCTIC ALPINE RES, V21, P83, DOI 10.2307/1551519; MOSQUIN T, 1966, EVOLUTION CANADAS FL, P41; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rozen S, 2000, Methods Mol Biol, V132, P365; SABLOWSKI RWM, 1994, EMBO J, V13, P128, DOI 10.1002/j.1460-2075.1994.tb06242.x; Saito R, 2006, PLANT SCI, V170, P828, DOI 10.1016/j.plantsci.2005.12.003; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Simms EL, 1996, EVOLUTION, V50, P957, DOI 10.1111/j.1558-5646.1996.tb03908.x; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERMEER IM, 1990, PLANT MOL BIOL, V15, P95, DOI 10.1007/BF00017727; WETTBERG EV, 2010, EVOLUTIONARY ECOLOGY, V12, P457; Whittall J, 2009, NEW PHYTOL, V182, P5, DOI 10.1111/j.1469-8137.2009.02796.x; Whittall JB, 2006, MOL ECOL, V15, P4645, DOI 10.1111/j.1365-294X.2006.03114.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; WINKELSHIRLEY B, 2004, PLANT PHYSIOL, V127, P1399; Wright S, 1943, GENETICS, V28, P139	57	57	63	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18230	10.1371/journal.pone.0018230	http://dx.doi.org/10.1371/journal.pone.0018230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490971	gold, Green Published			2022-12-27	WOS:000289238700005
J	Hong, SK; Dawid, IB				Hong, Sung-Kook; Dawid, Igor B.			The Transcriptional Mediator Component Med12 Is Required for Hindbrain Boundary Formation	PLOS ONE			English	Article							ZEBRAFISH HINDBRAIN; GENE-EXPRESSION; NEURAL CREST; RHOMBOMERE BOUNDARIES; RETINOIC ACID; COMPLEX; SEGMENTATION; VERTEBRATE; MOUSE; NOTCH	Background: Rhombomere boundaries form during hindbrain segmentation and are critical for maintaining segmental integrity and regulating migration in the hindbrain. Some genetic models affecting hindbrain boundary formation have been described, but involvement of components of the transcriptional mediator complex in boundary formation has not reported so far. Principal Findings: The kto/med12 mutant zebrafish, which affects the Mediator component Med12, causes specific loss of rhombomere boundary cells even though segmentation of the hindbrain takes place at least in part. In kto mutant embryos, cells forming rhombomere boundaries were largely absent as indicated by the use of several marker genes. While no obvious increase in cell death was observed, we found a notable reduction of cell proliferation in the hindbrain of kto mutant zebrafish. Conclusions: The kto/med12 mutation results in specific defects of boundary cell formation in the zebrafish hindbrain.	[Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child & Human De, Mol Genet Lab, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Hong, Sung-Kook] NHGRI, Mol Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Hong, SK (corresponding author), Eunice Kennedy Shriver Natl Inst Child & Human De, Mol Genet Lab, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov			Division of Intramural Research of the National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded in its entirety by the Division of Intramural Research of the National Institute of Child Health and Human Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blair SS, 2004, CURR BIOL, V14, pR570, DOI 10.1016/j.cub.2004.07.015; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Cooke JE, 2002, TRENDS NEUROSCI, V25, P260, DOI 10.1016/S0166-2236(02)02134-3; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lecaudey V, 2004, DEVELOPMENT, V131, P3121, DOI 10.1242/dev.01190; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; McClintock JM, 2002, DEVELOPMENT, V129, P2339; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; Moens CB, 1998, DEVELOPMENT, V125, P381; Moens CB, 1996, DEVELOPMENT, V122, P3981; Nittenberg R, 1997, DEVELOPMENT, V124, P2297; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Picker A, 2002, DEVELOPMENT, V129, P3227; Qiu XH, 2009, DEV GENES EVOL, V219, P339, DOI 10.1007/s00427-009-0296-6; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Riley BB, 2004, DEV DYNAM, V231, P278, DOI 10.1002/dvdy.20133; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Sassa T, 2007, DEV DYNAM, V236, P706, DOI 10.1002/dvdy.21084; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Thisse B., 2001, EXPRESSION ZEBRAFISH; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19076	10.1371/journal.pone.0019076	http://dx.doi.org/10.1371/journal.pone.0019076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533047	Green Submitted, gold, Green Published			2022-12-27	WOS:000290014500022
J	Jolij, J; Meurs, M				Jolij, Jacob; Meurs, Maaike			Music Alters Visual Perception	PLOS ONE			English	Article							MOOD; EMOTION; FACES	Background: Visual perception is not a passive process: in order to efficiently process visual input, the brain actively uses previous knowledge (e. g., memory) and expectations about what the world should look like. However, perception is not only influenced by previous knowledge. Especially the perception of emotional stimuli is influenced by the emotional state of the observer. In other words, how we perceive the world does not only depend on what we know of the world, but also by how we feel. In this study, we further investigated the relation between mood and perception. Methods and Findings: We let observers do a difficult stimulus detection task, in which they had to detect schematic happy and sad faces embedded in noise. Mood was manipulated by means of music. We found that observers were more accurate in detecting faces congruent with their mood, corroborating earlier research. However, in trials in which no actual face was presented, observers made a significant number of false alarms. The content of these false alarms, or illusory percepts, was strongly influenced by the observers' mood. Conclusions: As illusory percepts are believed to reflect the content of internal representations that are employed by the brain during top-down processing of visual input, we conclude that top-down modulation of visual processing is not purely predictive in nature: mood, in this case manipulated by music, may also directly alter the way we perceive the world.	[Jolij, Jacob; Meurs, Maaike] Univ Groningen, Vis & Cognit Grp, Dept Expt Psychol, Fac Behav & Social Sci, Groningen, Netherlands	University of Groningen	Jolij, J (corresponding author), Univ Groningen, Vis & Cognit Grp, Dept Expt Psychol, Fac Behav & Social Sci, Groningen, Netherlands.	j.jolij@rug.nl	Jolij, Jacob/A-9560-2009	Jolij, Jacob/0000-0002-9137-052X	University of Groningen	University of Groningen	This work is funded by the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; BOUHUYS AL, 1995, J AFFECT DISORDERS, V33, P215, DOI 10.1016/0165-0327(94)00092-N; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Hansen T, 2006, NAT NEUROSCI, V9, P1367, DOI 10.1038/nn1794; HELMOLTZ H, 1866, TREATISE PHYSL OPTIC; Jeong JW, 2011, NEUROIMAGE, V54, P2973, DOI 10.1016/j.neuroimage.2010.11.017; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Jolij J, 2010, NEUROSCI LETT, V484, P178, DOI 10.1016/j.neulet.2010.08.045; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Loth E, 2010, NEUROPSYCHOLOGIA, V48, P1227, DOI 10.1016/j.neuropsychologia.2009.12.023; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; NIEDENTHAL PM, 1994, PERS SOC PSYCHOL B, V20, P401, DOI 10.1177/0146167294204007; Pessoa L, 2010, FRONT NEUROSCI, V4, P17; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Van den Stock J, 2009, BRAIN TOPOGR, V21, P216, DOI 10.1007/s10548-009-0099-0; Zhang HC, 2008, NEUROREPORT, V19, P229, DOI 10.1097/WNR.0b013e3282f49083	23	27	27	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18861	10.1371/journal.pone.0018861	http://dx.doi.org/10.1371/journal.pone.0018861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756ME	21533041	Green Published, gold, Green Submitted			2022-12-27	WOS:000290014500014
J	Agapakis, CM; Niederholtmeyer, H; Noche, RR; Lieberman, TD; Megason, SG; Way, JC; Silver, PA				Agapakis, Christina M.; Niederholtmeyer, Henrike; Noche, Ramil R.; Lieberman, Tami D.; Megason, Sean G.; Way, Jeffrey C.; Silver, Pamela A.			Towards a Synthetic Chloroplast	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; AMBYSTOMA-MACULATUM; BACTERIA; VIRULENCE; GROWTH; METABOLISM; SYMBIOSES; DYNAMICS; PROTEIN; SYSTEM	Background: The evolution of eukaryotic cells is widely agreed to have proceeded through a series of endosymbiotic events between larger cells and proteobacteria or cyanobacteria, leading to the formation of mitochondria or chloroplasts, respectively. Engineered endosymbiotic relationships between different species of cells are a valuable tool for synthetic biology, where engineered pathways based on two species could take advantage of the unique abilities of each mutualistic partner. Results: We explored the possibility of using the photosynthetic bacterium Synechococcus elongatus PCC 7942 as a platform for studying evolutionary dynamics and for designing two-species synthetic biological systems. We observed that the cyanobacteria were relatively harmless to eukaryotic host cells compared to Escherichia coli when injected into the embryos of zebrafish, Danio rerio, or taken up by mammalian macrophages. In addition, when engineered with invasin from Yersinia pestis and listeriolysin O from Listeria monocytogenes, S. elongatus was able to invade cultured mammalian cells and divide inside macrophages. Conclusion: Our results show that it is possible to engineer photosynthetic bacteria to invade the cytoplasm of mammalian cells for further engineering and applications in synthetic biology. Engineered invasive but non-pathogenic or immunogenic photosynthetic bacteria have great potential as synthetic biological devices.	[Agapakis, Christina M.; Niederholtmeyer, Henrike; Noche, Ramil R.; Lieberman, Tami D.; Megason, Sean G.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Way, Jeffrey C.; Silver, Pamela A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Agapakis, CM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu		Niederholtmeyer, Henrike/0000-0002-1375-0287; Noche, Ramil R./0000-0002-4894-5682; /0000-0001-5430-3937	Wyss Institute for Biologically Inspired Engineering; National Science Foundation; Synthetic Biology Engineering Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER	Wyss Institute for Biologically Inspired Engineering; National Science Foundation(National Science Foundation (NSF)); Synthetic Biology Engineering Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by grants from the Wyss Institute for Biologically Inspired Engineering, the National Science Foundation, and the Synthetic Biology Engineering Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Bermudes D, 2002, CURR OPIN DRUG DISC, V5, P194; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; BUCHSBAUM RALPH, 1934, SCIENCE, V80, P408, DOI 10.1126/science.80.2079.408; BUCHSBAUM RALPH, 1937, PHYSIOL ZOOL, V10, P373; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Cirillo JD, 1999, TRENDS MICROBIOL, V7, P96, DOI 10.1016/S0966-842X(99)01456-0; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; FORBES NS, 2010, NAT REV CANCER, P1; Gilbert PW, 1944, ECOLOGY, V25, P366, DOI 10.2307/1931284; Goetz M, 2001, P NATL ACAD SCI USA, V98, P12221, DOI 10.1073/pnas.211106398; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Howe CJ, 2008, PHILOS T R SOC B, V363, P2675, DOI 10.1098/rstb.2008.0050; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; JEON KW, 1987, ANN NY ACAD SCI, V503, P359, DOI 10.1111/j.1749-6632.1987.tb40622.x; Kenny B, 2009, CURR OPIN MICROBIOL, V12, P1, DOI 10.1016/j.mib.2009.01.002; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; MARGULIS L, 1990, BIOSCIENCE, V40, P673, DOI 10.2307/1311435; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; MARQUIS H, 1993, INFECT IMMUN, V61, P3756, DOI 10.1128/IAI.61.9.3756-3760.1993; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; NIEDERHOLTMEYER H, 2010, APPL ENVIRON MICROB, P1; Pelz O, 1999, ENVIRON MICROBIOL, V1, P167, DOI 10.1046/j.1462-2920.1999.00023.x; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Stritzker J, 2004, INFECT IMMUN, V72, P5622, DOI 10.1128/IAI.72.10.5622-5629.2004; Tattersall GJ, 2008, CAN J ZOOL, V86, P1289, DOI 10.1139/Z08-115; TAYLOR DL, 1978, J PROTOZOOL, V25, P77, DOI 10.1111/j.1550-7408.1978.tb03871.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211	47	47	53	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18877	10.1371/journal.pone.0018877	http://dx.doi.org/10.1371/journal.pone.0018877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533097	Green Submitted, gold, Green Published			2022-12-27	WOS:000289719400032
J	Penny, RH; Montgomery, BR; Delph, LF				Penny, Rebecca H.; Montgomery, Benjamin R.; Delph, Lynda F.			X Linkage of AP3A, a Homolog of the Y-Linked MADS-Box Gene AP3Y in Silene latifolia and S-dioica	PLOS ONE			English	Article							SEX-CHROMOSOMES; EVOLUTION; REARRANGEMENTS	Background: The duplication of autosomal genes onto the Y chromosome may be an important element in the evolution of sexual dimorphism. A previous cytological study reported on a putative example of such a duplication event in a dioecious tribe of Silene (Caryophyllaceae): it was inferred that the Y-linked MADS-box gene AP3Y originated from a duplication of the reportedly autosomal orthologAP3A. However, a recent study, also using cytological methods, indicated that AP3A is X-linked in Silenelatifolia. Methodology/Principal Findings: In this study, we hybridized S. latifolia and S. dioicato investigate whether the pattern of X linkage is consistent among distinct populations, occurs in both species, and is robust to genetic methods. We found inheritance patterns indicative of X linkage of AP3A in widely distributed populations of both species. Conclusions/Significance: X linkage ofAP3A and Y linkage of AP3Yin both species indicates that the genes' ancestral progenitor resided on the autosomes that gave rise to the sex chromosomesand that neither gene has moved between chromosomes since species divergence. Consequently, our results do not support the contention that inter-chromosomal gene transfer occurred in the evolution of SlAP3Y from SlAP3A.	[Penny, Rebecca H.; Montgomery, Benjamin R.; Delph, Lynda F.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Penny, RH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	rhpenny@indiana.edu	Montgomery, Benjamin/G-5851-2013		National Science Foundation [0813766]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant 0813766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; BROSSEAU GE, 1960, GENETICS, V45, P257; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Cegan R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-180; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Fairbairn DJ, 2006, HEREDITY, V97, P319, DOI 10.1038/sj.hdy.6800895; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Filatov DA, 2005, METHOD ENZYMOL, V395, P418, DOI 10.1016/S0076-6879(05)95023-4; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Kaiser VB, 2009, MOL BIOL EVOL, V26, P2343, DOI 10.1093/molbev/msp141; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Matsunaga S, 2006, GENES GENET SYST, V81, P219, DOI 10.1266/ggs.81.219; Montgomery BR, 2010, ANN BOT-LONDON, V105, P595, DOI 10.1093/aob/mcq013	14	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18972	10.1371/journal.pone.0018972	http://dx.doi.org/10.1371/journal.pone.0018972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533056	gold, Green Submitted, Green Published			2022-12-27	WOS:000289719400042
J	Li, L; Sun, JH				Li, Li; Sun, Jianghua			Host Suitability of a Gregarious Parasitoid on Beetle Hosts: Flexibility between Fitness of Adult and Offspring	PLOS ONE			English	Article							STEPHANODERIS BETREM HYMENOPTERA; STAGE SELECTION; SIZE; BETHYLIDAE; PREFERENCE; EVOLUTION; GROWTH; WASPS; TEMPERATURE; PERFORMANCE	Behavioral tactics play a crucial role in the evolution of species and are likely to be found in host-parasitoid interactions where host quality may differ between host developmental stages. We investigated foraging decisions, parasitism and related fitness in a gregarious ectoparasitoid, Sclerodermus harmandi in relation to two distinct host developmental stages: larvae and pupae. Two colonies of parasitoids were reared on larvae of Monochamus alternatus and Saperda populnea (Cerambycidae: Lamiinae). Paired-choice and non-choice experiments were used to evaluate the preference and performance of S. harmandi on larvae and pupae of the two species. Foraging decisions and offspring fitness-related consequences of S. harmandi led to the selection of the most profitable host stage for parasitoid development. Adult females from the two colonies oviposited more quickly on pupae as compared to larvae of M. alternatus. Subsequently, their offspring development time was faster and they gained higher body weight on the pupal hosts. This study demonstrates optimal foraging of intraspecific detente that can occur during host-parasitoid interactions, of which the quality of the parasitism (highest fitness benefit and profitability) is related to the host developmental stage utilized. We conclude that S. harmandi is able to perfectly discriminate among host species or stages in a manner that maximizes its offspring fitness. The results indicated that foraging potential of adults may not be driven by its maternal effects, also induced flexibly with encountering prior host quality.	[Li, Li; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Li, Li] Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Guizhou Normal University	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Nature Science Foundation of China [30730074, 30921063]; National Basic Research Program [2009CB119200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	The research was supported by the National Nature Science Foundation of China (30730074 and 30921063) and the National Basic Research Program (2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chau A, 2001, CAN ENTOMOL, V133, P549, DOI 10.4039/Ent133549-4; Chong JH, 2006, ENVIRON ENTOMOL, V35, P1188, DOI 10.1603/0046-225X(2006)35[1188:IOTAMS]2.0.CO;2; Chong JH, 2006, ENTOMOL EXP APPL, V121, P39, DOI 10.1111/j.1570-8703.2006.00460.x; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Ding Y, 2001, CHIN J APPL ECOL, V12, P351; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Gauld Ian D., 1995, P464; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Lauziere I, 2000, ANN ENTOMOL SOC AM, V93, P103, DOI 10.1603/0013-8746(2000)093[0103:EOFBSA]2.0.CO;2; Lauziere I, 2000, J INSECT BEHAV, V13, P375, DOI 10.1023/A:1007762202679; Lauziere I, 2001, BIOL CONTROL, V21, P128, DOI 10.1006/bcon.2000.0909; Li BP, 2004, ENTOMOL EXP APPL, V110, P249, DOI 10.1111/j.0013-8703.2004.00144.x; Li L, 2010, BIOCONTROL, V55, P465, DOI 10.1007/s10526-010-9270-5; Li L, 2009, ECOL ENTOMOL, V34, P725, DOI 10.1111/j.1365-2311.2009.01120.x; Mackauer M., 1997, Ecological Studies, V130, P191; Mackauer M., 1993, P1; Nofemela RS, 2008, ENTOMOL EXP APPL, V126, P9, DOI 10.1111/j.1570-7458.2007.00632.x; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; Otto M, 1998, OECOLOGIA, V117, P353, DOI 10.1007/s004420050668; Stephens D.W., 1986, pi; STRAND MR, 1983, ENVIRON ENTOMOL, V12, P1114, DOI 10.1093/ee/12.4.1114; Strand MR, 2000, PARASITOID POPULATION BIOLOGY, P139; Waage JK., 1986, INSECT PARASITOIDS, P63; ZHANG WG, 2004, THESIS U SHANDONG AG	31	14	20	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18563	10.1371/journal.pone.0018563	http://dx.doi.org/10.1371/journal.pone.0018563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526176	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100008
J	Saunders, SE; Yuan, Q; Bartz, JC; Bartelt-Hunt, S				Saunders, Samuel E.; Yuan, Qi; Bartz, Jason C.; Bartelt-Hunt, Shannon			Effects of Solution Chemistry and Aging Time on Prion Protein Adsorption and Replication of Soil-Bound Prions	PLOS ONE			English	Article							ENVIRONMENTAL SOURCES; FATE; SCRAPIE; PRPSC; TRANSMISSION; INFECTIVITY; EXTRACTION; DIGESTION; KINETICS; SURVIVAL	Prion interactions with soil may play an important role in the transmission of chronic wasting disease (CWD) and scrapie. Prions are known to bind to a wide range of soil surfaces, but the effects of adsorption solution chemistry and long-term soil binding on prion fate and transmission risk are unknown. We investigated HY TME prion protein (PrPSc) adsorption to soil minerals in aqueous solutions of phosphate buffered saline (PBS), sodium chloride, calcium chloride, and deionized water using western blotting. The replication efficiency of bound prions following adsorption in these solutions was also evaluated by protein misfolding cyclic amplification (PMCA). Aging studies investigated PrPSc desorption and replication efficiency up to one year following adsorption in PBS or DI water. Results indicate that adsorption solution chemistry can affect subsequent prion replication or desorption ability, especially after incubation periods of 30 d or longer. Observed effects were minor over the short-term (7 d or less). Results of long-term aging experiments demonstrate that unbound prions or prions bound to a diverse range of soil surfaces can readily replicate after one year. Our results suggest that while prion-soil interactions can vary with solution chemistry, prions bound to soil could remain a risk for transmitting prion diseases after months in the environment.	[Saunders, Samuel E.; Yuan, Qi; Bartelt-Hunt, Shannon] Univ Nebraska Lincoln, Dept Civil Engn, Peter Kiewit Inst, Omaha, NE USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Lincoln; Creighton University	Saunders, SE (corresponding author), Univ Nebraska Lincoln, Dept Civil Engn, Peter Kiewit Inst, Omaha, NE USA.	sbartelt2@unl.edu		Bartz, Jason/0000-0003-4081-7886	University of Nebraska-Lincoln; Creighton University; National Center for Research Resources [P20 RR0115635-6, C06 RR17417-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER	University of Nebraska-Lincoln; Creighton University; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported in part by the University of Nebraska-Lincoln, Creighton University, and the National Center for Research Resources (P20 RR0115635-6 and C06 RR17417-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Czajkowsky DM, 2003, J MICROSC-OXFORD, V211, P1, DOI 10.1046/j.1365-2818.2003.01208.x; de Motes CM, 2008, WATER RES, V42, P2465, DOI 10.1016/j.watres.2008.01.031; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Khare N, 2006, J COLLOID INTERF SCI, V303, P404, DOI 10.1016/j.jcis.2006.07.070; Kramer ML, 2009, PRION, V3, P44, DOI 10.4161/pri.3.1.8442; Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528; Lee L, 2003, APPL ENVIRON MICROB, V69, P4111, DOI 10.1128/AEM.69.7.4111-4115.2003; Ma X, 2007, ENVIRON SCI TECHNOL, V41, P2324, DOI 10.1021/es062122i; Maddison BC, 2010, ENVIRON SCI TECHNOL, V44, P8503, DOI 10.1021/es101591a; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Prusiner Stanley B., 2004, VVolume 41, P1; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; SAUNDERS SE, 2011, J VIROLOGY IN PRESS; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Szabo G, 2006, RADIOCHIM ACTA, V94, P553, DOI 10.1524/ract.2006.94.9.553; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wei T, 2009, J PHYS CHEM C, V113, P2053, DOI 10.1021/jp806586n	39	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18752	10.1371/journal.pone.0018752	http://dx.doi.org/10.1371/journal.pone.0018752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526178	Green Published, gold			2022-12-27	WOS:000289671100018
J	Amaratunga, C; Lopera-Mesa, TM; Brittain, NJ; Cholera, R; Arie, T; Fujioka, H; Keefer, JR; Fairhurst, RM				Amaratunga, Chanaki; Lopera-Mesa, Tatiana M.; Brittain, Nathaniel J.; Cholera, Rushina; Arie, Takayuki; Fujioka, Hisashi; Keefer, Jeffrey R.; Fairhurst, Rick M.			A Role for Fetal Hemoglobin and Maternal Immune IgG in Infant Resistance to Plasmodium falciparum Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFECTED ERYTHROCYTES; CEREBRAL MALARIA; ACQUIRED-IMMUNITY; RED-CELLS; SEQUESTRATION; SURFACE; PROTECTION; ANTIBODIES; CHILDREN	Background: In Africa, infant susceptibility to Plasmodium falciparum malaria increases substantially as fetal hemoglobin (HbF) and maternal immune IgG disappear from circulation. During the first few months of life, however, resistance to malaria is evidenced by extremely low parasitemias, the absence of fever, and the almost complete lack of severe disease. This resistance has previously been attributed in part to poor parasite growth in HbF-containing red blood cells (RBCs). A specific role for maternal immune IgG in infant resistance to malaria has been hypothesized but not yet identified. Methods and Findings: We found that P. falciparum parasites invade and develop normally in fetal (cord blood, CB) RBCs, which contain up to 95% HbF. However, these parasitized CB RBCs are impaired in their binding to human microvascular endothelial cells (MVECs), monocytes, and nonparasitized RBCs -cytoadherence interactions that have been implicated in the development of high parasite densities and the symptoms of malaria. Abnormal display of the parasite's cytoadherence antigen P. falciparum erythrocyte membrane protein-1 (PfEMP-1) on CB RBCs accounts for these findings and is reminiscent of that on HbC and HbS RBCs. IgG purified from the plasma of immune Malian adults almost completely abolishes the adherence of parasitized CB RBCs to MVECs. Conclusions: Our data suggest a model of malaria protection in which HbF and maternal IgG act cooperatively to impair the cytoadherence of parasitized RBCs in the first few months of life. In highly malarious areas of Africa, an infant's contemporaneous expression of HbC or HbS and development of an immune IgG repertoire may effectively reconstitute the waning protective effects of HbF and maternal immune IgG, thereby extending the malaria resistance of infancy into early childhood.	[Amaratunga, Chanaki; Lopera-Mesa, Tatiana M.; Brittain, Nathaniel J.; Cholera, Rushina; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Arie, Takayuki] Osaka Prefecture Univ, Sch Engn, Dept Phys & Elect, Osaka, Japan; [Fujioka, Hisashi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Keefer, Jeffrey R.] Johns Hopkins Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Osaka Metropolitan University; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Medicine	Amaratunga, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov			National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZIAAI001000] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	ADVANI R, 1992, PEDIATR RES, V32, P165, DOI 10.1203/00006450-199208000-00008; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Brittain NJ, 2007, BRIT J HAEMATOL, V136, P491, DOI 10.1111/j.1365-2141.2006.06446.x; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COLOMBO B, 1976, BRIT J HAEMATOL, V32, P79, DOI 10.1111/j.1365-2141.1976.tb01877.x; Covell Sir G., 1950, Tropical Diseases Bulletin, V47, P1147; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; FRIEDMAN MJ, 1979, NATURE, V280, P245, DOI 10.1038/280245a0; Glikman D, 2007, PEDIATRICS, V120, pE745, DOI 10.1542/peds.2007-0041; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Hviid L, 2004, TRENDS PARASITOL, V20, P66, DOI 10.1016/j.pt.2003.11.009; Khattab A, 2007, PARASITOL RES, V101, P767, DOI 10.1007/s00436-007-0548-1; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; LOGIE DE, 1973, B WORLD HEALTH ORGAN, V49, P547; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Nagao T, 1996, AM J TROP MED HYG, V55, P562, DOI 10.4269/ajtmh.1996.55.562; OCKENHOUSE CF, 1989, J CLIN INVEST, V84, P468, DOI 10.1172/JCI114188; PASVOL G, 1977, NATURE, V270, P171, DOI 10.1038/270171a0; PASVOL G, 1976, LANCET, V1, P1269; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Shear HL, 1998, BLOOD, V92, P2520, DOI 10.1182/blood.V92.7.2520.2520_2520_2526; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tena-Tomas C, 2007, PARASITOL RES, V101, P1045, DOI 10.1007/s00436-007-0585-9; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; WILSON RJM, 1977, B WORLD HEALTH ORGAN, V55, P179	47	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e14798	10.1371/journal.pone.0014798	http://dx.doi.org/10.1371/journal.pone.0014798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532754	gold, Green Published, Green Submitted			2022-12-27	WOS:000289404700003
J	Budinger, GRS; McKell, JL; Urich, D; Foiles, N; Weiss, I; Chiarella, SE; Gonzalez, A; Soberanes, S; Ghio, AJ; Nigdelioglu, R; Mutlu, EA; Radigan, KA; Green, D; Kwaan, HC; Mutlu, GM				Budinger, G. R. Scott; McKell, Joanne L.; Urich, Daniela; Foiles, Nancy; Weiss, Ivy; Chiarella, Sergio E.; Gonzalez, Angel; Soberanes, Saul; Ghio, Andrew J.; Nigdelioglu, Recep; Mutlu, Ece A.; Radigan, Kathryn A.; Green, David; Kwaan, Hau C.; Mutlu, Goekhan M.			Particulate Matter-Induced Lung Inflammation Increases Systemic Levels of PAI-1 and Activates Coagulation Through Distinct Mechanisms	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DIESEL-EXHAUST INHALATION; FACTOR PATHWAY INHIBITOR; AIR-POLLUTION; PLASMINOGEN-ACTIVATOR; MYOCARDIAL-INFARCTION; TISSUE FACTOR; EXPOSURE; PARTICLES; FINE	Background: Exposure of human populations to ambient particulate matter (PM) air pollution significantly contributes to the mortality attributable to ischemic cardiovascular events. We reported that mice treated with intratracheally instilled PM develop a prothrombotic state that requires the release of IL-6 by alveolar macrophages. We sought to determine whether exposure of mice to PM increases the levels of PAI-1, a major regulator of thrombolysis, via a similar or distinct mechanism. Methods and Principal Findings: Adult, male C57BL/6 and IL-6 knock out (IL-6(-/-)) mice were exposed to either concentrated ambient PM less than 2.5 mu m (CAPs) or filtered air 8 hours daily for 3 days or were exposed to either urban particulate matter or PBS via intratracheal instillation and examined 24 hours later. Exposure to CAPs or urban PM resulted in the IL-6 dependent activation of coagulation in the lung and systemically. PAI-1 mRNA and protein levels were higher in the lung and adipose tissue of mice treated with CAPs or PM compared with filtered air or PBS controls. The increase in PAI-1 was similar in wild-type and IL-6(-/-) mice but was absent in mice treated with etanercept, a TNF-alpha inhibitor. Treatment with etanercept did not prevent the PM-induced tendency toward thrombus formation. Conclusions: Mice exposed to inhaled PM exhibited a TNF-alpha-dependent increase in PAI-1 and an IL-6-dependent activation of coagulation. These results suggest that multiple mechanisms link PM-induced lung inflammation with the development of a prothrombotic state.	[Budinger, G. R. Scott; McKell, Joanne L.; Urich, Daniela; Chiarella, Sergio E.; Gonzalez, Angel; Soberanes, Saul; Nigdelioglu, Recep; Radigan, Kathryn A.; Mutlu, Goekhan M.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Foiles, Nancy; Weiss, Ivy; Green, David; Kwaan, Hau C.] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghio, Andrew J.] US EPA, Res Triangle Pk, NC 27711 USA; [Mutlu, Ece A.] Rush Univ, Sect Gastroenterol & Nutr, Coll Med, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; United States Environmental Protection Agency; Rush University	Budinger, GRS (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	g-mutlu@northwestern.edu	Mutlu, Gokhan/HIR-2545-2022	Chiarella, Sergio/0000-0002-0445-4929	NIH [ES015024, ES013995, P01HL071643]; Northwestern University Clinical and Translational Sciences Institute (NUCATS) [UL1 RR025741]; NMH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, R01HL092963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Clinical and Translational Sciences Institute (NUCATS); NMH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	Sources of funding: NIH ES015024 (GMM), ES013995 (GRSB) and P01HL071643 (GMM and GRSB) and the Northwestern University Clinical and Translational Sciences Institute (NUCATS) CTI Pilot Award (GMM) (UL1 RR025741) and NMH Dixon Young Investigator Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; BASTARACHE J, 2007, THORAX; Bastarache JA, 2008, AM J PHYSIOL-LUNG C, V294, pL874, DOI 10.1152/ajplung.00372.2007; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; BONZINI M, 2009, J THROMB HAEMOST; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P984, DOI 10.1160/TH08-08-0524; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; Iochmann S, 1999, THROMB RES, V94, P165, DOI 10.1016/S0049-3848(98)00209-6; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Ljungman P, 2009, ENVIRON HEALTH PERSP, V117, P1373, DOI 10.1289/ehp.0800370; Maciejczyk P, 2005, INHAL TOXICOL, V17, P189, DOI 10.1080/08958370590912743; Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034; MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Mutlu GM, 2006, AM J RESP CELL MOL, V34, P670, DOI 10.1165/rcmb.2005-0329OC; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Peters A, 2001, CIRCULATION, V103, P2810; Plomgaard P, 2005, J APPL PHYSIOL, V98, P2019, DOI 10.1152/japplphysiol.01220.2004; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Renckens R, 2005, J THROMB HAEMOST, V3, P1018, DOI 10.1111/j.1538-7836.2005.01311.x; Rothwarf D.M., 1999, SCI STKE 1999; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587; SIOUTAS C, 1995, ENVIRON HEALTH PERSP, V103, P172, DOI 10.2307/3432274; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI [10.1080/08958370701821482, 10.1080/08958370701821482 ]; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JCI200419569; Yan C, 2002, J BIOL CHEM, V277, P10967, DOI 10.1074/jbc.M109986200	47	77	77	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18525	10.1371/journal.pone.0018525	http://dx.doi.org/10.1371/journal.pone.0018525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494547	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100016
J	Xu, JA; Wang, MZ; Gao, XX; Hu, BA; Du, YN; Zhou, JK; Tian, XM; Huang, XX				Xu, Juan; Wang, Meizhi; Gao, Xinxing; Hu, Bian; Du, Yinan; Zhou, Jiankui; Tian, Xuemei; Huang, Xingxu			Separase Phosphosite Mutation Leads to Genome Instability and Primordial Germ Cell Depletion during Oogenesis	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; HUMAN FEMALE MEIOSIS; CHROMOSOMAL STABILITY; ANAPHASE TRANSITION; SPINDLE CHECKPOINT; CYCLE PROGRESSION; HUMAN ANEUPLOIDY; BUDDING YEAST; MICE LACKING; METAPHASE	To ensure equal chromosome segregation and the stability of the genome during cell division, Separase is strictly regulated primarily by Securin binding and inhibitory phosphorylation. By generating a mouse model that contained a mutation to the inhibitory phosphosite of Separase, we demonstrated that mice of both sexes are infertile. We showed that Separase deregulation leads to chromosome mis-segregation, genome instability, and eventually apoptosis of primordial germ cells (PGCs) during embryonic oogenesis. Although the PGCs of mutant male mice were completely depleted, a population of PGCs from mutant females survived Separase deregulation. The surviving PGCs completed oogenesis but produced deficient initial follicles. These results indicate a sexual dimorphism effect on PGCs from Separase deregulation, which may be correlated with a gender-specific discrepancy of Securin. Our results reveal that Separase phospho-regulation is critical for genome stability in oogenesis. Furthermore, we provided the first evidence of a pre-zygotic mitotic chromosome segregation error resulting from Separase deregulation, whose sex-specific differences may be a reason for the sexual dimorphism of aneuploidy in gametogenesis.	[Xu, Juan; Gao, Xinxing; Hu, Bian; Du, Yinan; Zhou, Jiankui; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China; [Wang, Meizhi] So Med Univ, Dept Anat Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Tian, Xuemei] S China Normal Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Nanjing University; Southern Medical University - China; South China Normal University	Xu, JA (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China.	xmtian05@yahoo.com; huangxingxu@yahoo.com	Du, Yinan/GPK-0826-2022	Du, Yinan/0000-0002-7678-7546; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [30871429]; 973 program [2010CB945101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China (30871429) and the 973 program (2010CB945101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Clift D, 2009, GENE DEV, V23, P766, DOI 10.1101/gad.507509; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang XX, 2008, PLOS BIOL, V6, P52, DOI 10.1371/journal.pbio.0060015; Huang XX, 2009, MOL CELL BIOL, V29, P1498, DOI 10.1128/MCB.01778-08; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; JONES KT, 2007, HUMAN REPROD, P1; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Mailhes JB, 2008, ENVIRON MOL MUTAGEN, V49, P642, DOI 10.1002/em.20412; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Pacchierotti F, 2007, ENVIRON RES, V104, P46, DOI 10.1016/j.envres.2006.12.001; Pellestor F, 2002, HUM REPROD, V17, P2134, DOI 10.1093/humrep/17.8.2134; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; UZAWA S, 1990, CELL, V62, P913, DOI 10.1016/0092-8674(90)90266-H; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wolstenholme J, 2000, CHROMOSOMA, V109, P435, DOI 10.1007/s004120000088; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zhao GQ, 2002, DEV CELL, V2, P537, DOI 10.1016/S1534-5807(02)00173-9; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18763	10.1371/journal.pone.0018763	http://dx.doi.org/10.1371/journal.pone.0018763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494564	gold, Green Published, Green Submitted			2022-12-27	WOS:000289354100039
J	Deplagne, C; Peuchant, E; Moranvillier, I; Dubus, P; Dabernat, S				Deplagne, Camille; Peuchant, Evelyne; Moranvillier, Isabelle; Dubus, Pierre; Dabernat, Sandrine			The Anti-Metastatic nm23-1 Gene Is Needed for the Final Step of Mammary Duct Maturation of the Mouse Nipple	PLOS ONE			English	Article							NM23/NUCLEOSIDE DIPHOSPHATE-KINASE; METASTASIS SUPPRESSOR; REPRODUCTIVE-CYCLE; ESCHERICHIA-COLI; TUMOR-SUPPRESSOR; KNOCKOUT MICE; EXPRESSION; APOPTOSIS; MIGRATION; GLAND	Nm23/NDP kinases are multifunctional enzymes involved in the general homeostasis of triphosphate nucleosides. Numerous studies have shown that NDPKs also serve as regulatory factors of various cell activities, not always connected to nucleotide phosphorylation. In particular, the nme-1 gene, encoding the NM23-1/NDPKA protein, has been reported as a metastasis suppressor gene. This activity was validated in hepatocellular tumors induced in nm23-1 deficient mice. Yet, data describing the primary physiological functions of nm23-1/NDPKA is still scarce. We have characterized in depth the phenotype of nm23-1 deletion in the mammary gland in mice carrying whole body nm23-M1 invalidation. We also asked why the nm23-M1(-/-) mutant females displayed severe nursing disability. We found that the growth retardation of mutant virgin glands was due to reduced proliferation and apoptosis of the epithelial cells within the terminal end buds. The balance of pro/anti-apoptotic factors was impaired in comparison with wild type glands. In the lactating glands, the reduced proliferation rate persisted, but the apoptotic factors were unchanged. However, those defects did not seem to affect the gland maturation since the glands lacking nm23-1/NDPKA appeared morphologically normal. Thorough examination of all the functional aspects of the mammary glands revealed that lack of nm23-1/NDPKA does not impact the production or the ejection of milk in the lumen of lobuloalveolae. Interestingly, an epithelial plug was found to obstruct the extremity of the unique lactiferous duct delivering the milk out of the nipple. These cells, normally disappearing after lactation takes place, persisted in the mutant nipples. This work provides a rare instance of nm23-1/NDPKA physiological functions in the mammary glands and reveals its implication as a modulator factor of proliferation and apoptosis in this tissue.	[Deplagne, Camille; Peuchant, Evelyne; Moranvillier, Isabelle; Dabernat, Sandrine] INSERM, Unite U1035, Bordeaux, France; [Dubus, Pierre] Univ Segalen Bordeaux, Equipe Histol & Pathol Mol Tumeurs 2406, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Deplagne, C (corresponding author), INSERM, Unite U1035, Bordeaux, France.	sandrine.dabernat@u-bordeaux2.fr		Dubus, Pierre/0000-0003-1803-4711	French Ligue contre le cancer	French Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the French Ligue contre le cancer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Dabernat S, 2003, J BIOENERG BIOMEMBR, V35, P19, DOI 10.1023/A:1023561821551; Boissan M, 2005, JNCI-J NATL CANCER I, V97, P836, DOI 10.1093/jnci/dji143; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; CHOUDHURI T, CANC BIOL THER, V9; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fournier HN, 2003, J BIOENERG BIOMEMBR, V35, P81, DOI 10.1023/A:1023450008347; FUKUCHI T, 1993, GENE, V129, P141; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; HOWLETT AR, 1994, J NATL CANCER I, V86, P1838, DOI 10.1093/jnci/86.24.1838; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Hynes NE, 1997, J MAMMARY GLAND BIOL, V2, P19, DOI 10.1023/A:1026317428542; Jin L, 2009, LIFE SCI, V84, P458, DOI 10.1016/j.lfs.2009.01.010; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kimura T, 1998, HUM REPROD, V13, P2645, DOI 10.1093/humrep/13.9.2645; Kobayashi T, 2005, DEV DYNAM, V233, P794, DOI 10.1002/dvdy.20406; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; Mahler B, 2004, CELLS TISSUES ORGANS, V176, P169, DOI 10.1159/000077033; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Masse K, 2002, GENE, V296, P87, DOI 10.1016/S0378-1119(02)00836-3; Miller JH, 2002, GENETICS, V162, P5; Murakami M, 2008, CANCER BIOL THER, V7, P677, DOI 10.4161/cbt.7.5.5665; Murakami M, 2008, INT J CANCER, V123, P500, DOI 10.1002/ijc.23568; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Postel EH, 2009, DEV DYNAM, V238, P775, DOI 10.1002/dvdy.21887; Steeg P S, 1991, Basic Life Sci, V57, P355; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg PS, 2004, JNCI-J NATL CANCER I, V96, DOI 10.1093/jnci/djh107; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; Toyoshima Y, 1998, EXP ANIM TOKYO, V47, P29, DOI 10.1538/expanim.47.29; Toyoshima Y, 1998, J VET MED SCI, V60, P405, DOI 10.1292/jvms.60.405; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18645	10.1371/journal.pone.0018645	http://dx.doi.org/10.1371/journal.pone.0018645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490937	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700032
J	Loizou, L; Andersen, KG; Betz, AG				Loizou, Louiza; Andersen, Kristian G.; Betz, Alexander G.			Foxp3 Interacts with c-Rel to Mediate NF-kappa B Repression	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; CD28 RESPONSE ELEMENT; ROR-GAMMA-T; IMMUNE-RESPONSES; NUCLEAR-FACTOR; TARGET GENES; EXPRESSION; ACTIVATION; PROTEINS	Expression of the lineage-specific DNA-binding factor Foxp3 controls the development and function of naturally occurring regulatory T cells. Foxp3 has been shown to interact with a multitude of transcriptional regulators including NFAT, NF-kappa B (p65), Runx1 and ROR gamma t, as well as the histone modification enzymes TIP60, HDAC7 and HDAC9. The sum of these interactions is believed to cause the change in the transcriptional program of regulatory T cells. Here we show that Foxp3 directly or as part of a multimeric complex engages with the NF-kappa B component c-Rel. We demonstrate that the N-terminal region of Foxp3 is required for the binding of c-Rel, but not NFAT. Conversely, deletion of the forkhead domain causes a loss of interaction with NFAT, but not c-Rel. Our findings are of particular interest, as c-Rel is crucial for the induction of Foxp3 in regulatory T cells during thymic development, but has to be repressed in mature regulatory T cells to maintain their suppressive phenotype.	[Loizou, Louiza; Andersen, Kristian G.; Betz, Alexander G.] MRC Lab Mol Biol, Cambridge, England; [Andersen, Kristian G.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Andersen, Kristian G.] Broad Inst, Cambridge, MA USA	MRC Laboratory Molecular Biology; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Loizou, L (corresponding author), MRC Lab Mol Biol, Cambridge, England.	betz@mrc-lmb.cam.ac.uk	Andersen, Kristian/D-5006-2009; Betz, Alexander/GQQ-2221-2022	Andersen, Kristian/0000-0001-6431-5982; 	Medical Research Council; Carlsberg Foundation; MRC [MC_U105184296] Funding Source: UKRI; Medical Research Council [MC_U105184296] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carlsberg Foundation(Carlsberg Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All work was performed at the Laboratory of Molecular Biology and funded by the Medical Research Council (http://www.mrc.ac.uk/). KGA is the recipient of a fellowship from the Carlsberg Foundation (http://www.carlsbergfondet.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KG, 2008, PLOS BIOL, V6, P2401, DOI 10.1371/journal.pbio.0060276; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Butscher WG, 1998, J BIOL CHEM, V273, P552, DOI 10.1074/jbc.273.1.552; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18670	10.1371/journal.pone.0018670	http://dx.doi.org/10.1371/journal.pone.0018670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490927	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700037
J	Swiss, VA; Nguyen, T; Dugas, J; Ibrahim, A; Barres, B; Androulakis, IP; Casaccia, P				Swiss, Victoria A.; Nguyen, Tung; Dugas, Jason; Ibrahim, Adiljan; Barres, Ben; Androulakis, Ioannis P.; Casaccia, Patrizia			Identification of a Gene Regulatory Network Necessary for the Initiation of Oligodendrocyte Differentiation	PLOS ONE			English	Article							HISTONE DEACETYLASE ACTIVITY; FUNCTIONAL GENOMIC ANALYSIS; TRANSCRIPTION FACTOR; CLUSTERING METHODS; MESSENGER-RNA; EXPRESSION; MYELIN; PROTEINS; REMYELINATION; BIOLOGY	Differentiation of oligodendrocyte progenitor cells (OPCs) into mature oligodendrocytes requires extensive changes in gene expression, which are partly mediated by post-translational modifications of nucleosomal histones. An essential modification for oligodendrocyte differentiation is the removal of acetyl groups from lysine residues which is catalyzed by histone deacetylases (HDACs). The transcriptional targets of HDAC activity within OPCs however, have remained elusive and have been identified in this study by interrogating the oligodendrocyte transcriptome. Using a novel algorithm that allows clustering of gene transcripts according to expression kinetics and expression levels, we defined major waves of coregulated genes. The initial overall decrease in gene expression was followed by the up-regulation of genes involved in lipid metabolism and myelination. Functional annotation of the down-regulated gene clusters identified transcripts involved in cell cycle regulation, transcription, and RNA processing. To define whether these genes were the targets of HDAC activity, we cultured rat OPCs in the presence of trichostatin A (TSA), an HDAC inhibitor previously shown to inhibit oligodendrocyte differentiation. By overlaying the defined oligodendrocyte transcriptome with the list of 'TSA sensitive' genes, we determined that a high percentage of 'TSA sensitive' genes are part of a normal program of oligodendrocyte differentiation. TSA treatment increased the expression of genes whose down-regulation occurs very early after induction of OPC differentiation, but did not affect the expression of genes with a slower kinetic. Among the increased 'TSA sensitive' genes we detected several transcription factors including Id2, Egr1, and Sox11, whose down-regulation is critical for OPC differentiation. Thus, HDAC target genes include clusters of co-regulated genes involved in transcriptional repression. These results support a de-repression model of oligodendrocyte lineage progression that relies on the concurrent down-regulation of several inhibitors of differentiation.	[Swiss, Victoria A.; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci & Genet, New York, NY 10029 USA; [Swiss, Victoria A.; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Genom, New York, NY USA; [Nguyen, Tung] Rutgers State Univ, BioMAPS Inst Quantitat Biol, Piscataway, NJ USA; [Nguyen, Tung; Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Nguyen, Tung; Androulakis, Ioannis P.] Rutgers State Univ, Dept Chem Biochem Engn, Piscataway, NJ USA; [Dugas, Jason; Ibrahim, Adiljan; Barres, Ben] Stanford Univ, Sch Med, Dept Neurosci, Stanford, CA 94305 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Stanford University	Swiss, VA (corresponding author), Mt Sinai Sch Med, Dept Neurosci & Genet, New York, NY 10029 USA.	patrizia.casaccia@mssm.edu			NIH [R01-NS42925-8]; ARRA [NS42925-S1]; Myelin Repair Foundation; National Multiple Sclerosis Society [RG-4059/A8]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925, R37NS042925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA; Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Grant NIH R01-NS42925-8 and ARRA funds NS42925-S1 (to P. C.). J.C.D. and B. A. B. were supported by the Myelin Repair Foundation and the National Multiple Sclerosis Society, grant RG-4059/A8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett HA, 2003, J NEUROSCI, V23, P9824; Baranzini SE, 2005, J IMMUNOL, V174, P7412, DOI 10.4049/jimmunol.174.11.7412; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Belacel N, 2006, OMICS, V10, P507, DOI 10.1089/omi.2006.10.507; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carson JH, 2008, BBA-GENE REGUL MECH, V1779, P453, DOI 10.1016/j.bbagrm.2008.04.002; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fields RD, 2008, NEUROSCIENTIST, V14, P540, DOI 10.1177/1073858408320294; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Gielen E, 2006, GLIA, V54, P499, DOI 10.1002/glia.20406; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Golan N, 2008, GLIA, V56, P1176, DOI 10.1002/glia.20688; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kondo T, 2000, DEVELOPMENT, V127, P2989; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Larocca JN, 2002, NEUROCHEM RES, V27, P1313, DOI 10.1023/A:1021667515030; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu AX, 2006, EMBO J, V25, P4833, DOI 10.1038/sj.emboj.7601352; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nave KA, 2010, NEURON, V65, P577, DOI 10.1016/j.neuron.2010.02.026; Nguyen L, 2006, MENT RETARD DEV D R, V12, P85, DOI 10.1002/mrdd.20103; Nguyen TT, 2009, OMICS, V13, P219, DOI 10.1089/omi.2008.0074; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potzner MR, 2007, MOL CELL BIOL, V27, P5316, DOI 10.1128/MCB.00339-07; Raff M, 2007, COLD SPRING HARB SYM, V72, P431, DOI 10.1101/sqb.2007.72.007; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Sock E, 1997, J NEUROCHEM, V68, P1911; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Taylor CM, 2004, P NATL ACAD SCI USA, V101, P4643, DOI 10.1073/pnas.0400922101; Tur G, 2010, CELL MOL LIFE SCI, V67, P4065, DOI 10.1007/s00018-010-0426-3; Vanrobaeys F, 2005, J PROTEOME RES, V4, P2283, DOI 10.1021/pr050205c; WANG B, 2001, ARTERIOSCLER THROMB, V30, P536; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	64	75	75	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18088	10.1371/journal.pone.0018088	http://dx.doi.org/10.1371/journal.pone.0018088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490970	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700004
J	Bi, FC; Zhang, QF; Liu, Z; Fang, C; Li, JA; Su, JB; Greenberg, JT; Wang, HB; Yao, N				Bi, Fang-Cheng; Zhang, Quan-Fang; Liu, Zhe; Fang, Ce; Li, Jian; Su, Jian-Bin; Greenberg, Jean T.; Wang, Hong-Bin; Yao, Nan			A Conserved Cysteine Motif Is Critical for Rice Ceramide Kinase Activity and Function	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; SERINE PALMITOYLTRANSFERASE; SPHINGOSINE KINASE; MOLECULAR-CLONING; LIPID KINASE; KEY ENZYME; ARABIDOPSIS; SPHINGOLIPIDS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION	Background: Ceramide kinase (CERK) is a key regulator of cell survival in dicotyledonous plants and animals. Much less is known about the roles of CERK and ceramides in mediating cellular processes in monocot plants. Here, we report the characterization of a ceramide kinase, OsCERK, from rice (Oryza sativa spp. Japonica cv. Nipponbare) and investigate the effects of ceramides on rice cell viability. Principal Findings: OsCERK can complement the Arabidopsis CERK mutant acd5. Recombinant OsCERK has ceramide kinase activity with Michaelis-Menten kinetics and optimal activity at 7.0 pH and 40 degrees C. Mg2+ activates OsCERK in a concentration-dependent manner. Importantly, a CXXXCXXC motif, conserved in all ceramide kinases and important for the activity of the human enzyme, is critical for OsCERK enzyme activity and in planta function. In a rice protoplast system, inhibition of CERK leads to cell death and the ratio of added ceramide and ceramide-1-phosphate, CERK's substrate and product, respectively, influences cell survival. Ceramide-induced rice cell death has apoptotic features and is an active process that requires both de novo protein synthesis and phosphorylation, respectively. Finally, mitochondria membrane potential loss previously associated with ceramide-induced cell death in Arabidopsis was also found in rice, but it occurred with different timing. Conclusions: OsCERK is a bona fide ceramide kinase with a functionally and evolutionarily conserved Cys-rich motif that plays an important role in modulating cell fate in plants. The vital function of the conserved motif in both human and rice CERKs suggests that the biochemical mechanism of CERKs is similar in animals and plants. Furthermore, ceramides induce cell death with similar features in monocot and dicot plants.	[Bi, Fang-Cheng; Zhang, Quan-Fang; Liu, Zhe; Fang, Ce; Li, Jian; Su, Jian-Bin; Wang, Hong-Bin; Yao, Nan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Sun Yat Sen University; University of Chicago	Bi, FC (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	yaonan@mail.sysu.edu.cn	LI, RUIJIAN/GYJ-0470-2022; yao, nan/F-2095-2011; Su, Jianbin/L-6647-2019	yao, nan/0000-0002-2045-5462; Greenberg, Jean/0000-0002-7213-7618	National Natural Science Foundation of China [30871604]; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Special Fund for Agro-scientific Research in the Public Interest [200803008]; Program for New Century Excellent Talents in University; National Institutes of Health [R01GM54292];  [SKLBC08B02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054292] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Special Fund for Agro-scientific Research in the Public Interest; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (30871604), the New Energy and Industrial Technology Development Organization (NEDO) of Japan in 2009, Special Fund for Agro-scientific Research in the Public Interest (200803008), Project of SKLBC08B02 and Program for New Century Excellent Talents in University to NY and National Institutes of Health R01GM54292 to JTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Bajjalieh S, 2000, METHOD ENZYMOL, V311, P207; BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961; Carre A, 2004, BIOCHEM BIOPH RES CO, V324, P1215, DOI 10.1016/j.bbrc.2004.09.181; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chen M, 2008, PLANT CELL, V20, P1862, DOI 10.1105/tpc.107.057851; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Coursol S, 2005, PLANT PHYSIOL, V137, P724, DOI 10.1104/pp.104.055806; Don AS, 2008, ANAL BIOCHEM, V375, P265, DOI 10.1016/j.ab.2007.12.024; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Greenberg JT, 2000, GENETICS, V156, P341; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kim JW, 2005, BBA-MOL CELL BIOL L, V1738, P82, DOI 10.1016/j.bbalip.2005.10.007; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lidome E, 2008, BIOCHIMIE, V90, P1560, DOI 10.1016/j.biochi.2008.07.001; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Nagano M, 2009, PLANT J, V58, P122, DOI 10.1111/j.1365-313X.2008.03765.x; Nishiura H, 2000, BIOCHEM SOC T, V28, P747, DOI 10.1042/BST0280747; Niu Y, 2007, J INTEGR PLANT BIOL, V49, P323, DOI 10.1111/j.1744-7909.2007.00446.x; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Pata MO, 2008, PLANT J, V55, P1000, DOI 10.1111/j.1365-313X.2008.03569.x; Rovina P, 2009, BBA-MOL CELL BIOL L, V1791, P1023, DOI 10.1016/j.bbalip.2009.05.009; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng C, 2008, PLANT PHYSIOL, V146, P1322, DOI 10.1104/pp.107.113506; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Townley HE, 2005, BIOL CHEM, V386, P161, DOI 10.1515/BC.2005.020; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Van Overloop H, 2006, J LIPID RES, V47, P268, DOI 10.1194/jlr.M500321-JLR200; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yao N, 2004, PLANT J, V40, P596, DOI 10.1111/j.1365-313X.2004.02239.x; Yao N, 2001, PLANT J, V28, P13, DOI 10.1046/j.1365-313X.2001.01109.x	46	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18079	10.1371/journal.pone.0018079	http://dx.doi.org/10.1371/journal.pone.0018079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483860	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200024
J	de-Wit, LH; Lefevre, CE; Kentridge, RW; Rees, G; Saygin, AP				de-Wit, Lee H.; Lefevre, Carmen E.; Kentridge, Robert W.; Rees, Geraint; Saygin, Ayse P.			Investigating the Status of Biological Stimuli as Objects of Attention in Multiple Object Tracking	PLOS ONE			English	Article							NEURAL MECHANISMS; MOTION PERCEPTION; FACE-INVERSION; PARIETAL; ORIENTATION; SHAPE	Background: Humans are able to track multiple simultaneously moving objects. A number of factors have been identified that can influence the ease with which objects can be attended and tracked. Here, we explored the possibility that object tracking abilities may be specialized for tracking biological targets such as people. Methodology/Principal Findings: We used the Multiple Object Tracking (MOT) paradigm to explore whether the high-level biological status of the targets affects the efficiency of attentional selection and tracking. In Experiment 1, we assessed the tracking of point-light biological motion figures. As controls, we used either the same stimuli or point-light letters, presented in upright, inverted or scrambled configurations. While scrambling significantly affected performance for both letters and point-light figures, there was an effect of inversion restricted to biological motion, inverted figures being harder to track. In Experiment 2, we found that tracking performance was equivalent for natural point-light walkers and 'moon-walkers', whose implied direction was incongruent with their actual direction of motion. In Experiment 3, we found higher tracking accuracy for inverted faces compared with upright faces. Thus, there was a double dissociation between inversion effects for biological motion and faces, with no inversion effect for our non-biological stimuli (letters, houses). Conclusions/Significance: MOT is sensitive to some, but not all naturalistic aspects of biological stimuli. There does not appear to be a highly specialized role for tracking people. However, MOT appears constrained by principles of object segmentation and grouping, where effectively grouped, coherent objects, but not necessarily biological objects, are tracked most successfully.	[de-Wit, Lee H.] Univ Louvain, Louvain, Belgium; [de-Wit, Lee H.; Lefevre, Carmen E.; Kentridge, Robert W.] Univ Durham, Durham, England; [de-Wit, Lee H.; Rees, Geraint] UCL, London, England; [Saygin, Ayse P.] Univ Calif San Diego, La Jolla, CA 92093 USA	Durham University; University of London; University College London; University of California System; University of California San Diego	de-Wit, LH (corresponding author), Univ Louvain, Louvain, Belgium.	saygin@cogsci.ucsd.edu	Rees, Geraint/C-1493-2008; Kentridge, Robert W/A-5430-2008; Saygin, Ayse Pinar/A-7126-2009	Rees, Geraint/0000-0002-9623-7007; Kentridge, Robert W/0000-0003-3688-3899; Saygin, Ayse Pinar/0000-0002-0859-9500	Experimental Psychology Society; Economic and Social Research Council; European Commission; Wellcome Trust; Flemish government [METH/08/02]	Experimental Psychology Society; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Flemish government(European Commission)	This work was supported by an Experimental Psychology Society study visit grant (LHD), an Economic and Social Research Council 1+3 studentship (LHD), a European Commission Marie-Curie Fellowship (APS), the Wellcome Trust (GR) and a Methusalem grant (METH/08/02) from the Flemish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; Albrecht AR, 2008, J VISION, V8, DOI 10.1167/8.13.8; Avrahami J, 1999, PERCEPT PSYCHOPHYS, V61, P1604, DOI 10.3758/BF03213121; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; Ben-Shahar O, 2007, VISION RES, V47, P845, DOI 10.1016/j.visres.2006.10.019; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cook J, 2009, NEUROPSYCHOLOGIA, V47, P3275, DOI 10.1016/j.neuropsychologia.2009.07.010; de-Wit LH, 2009, NEUROPSYCHOLOGIA, V47, P1483, DOI 10.1016/j.neuropsychologia.2008.11.002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; GILAIEDOTAN S, 2011, BIOL NONBIO IN PRESS; Gilchrist ID, 2006, EXP BRAIN RES, V173, P708, DOI 10.1007/s00221-006-0455-1; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Marino AC, 2005, PERCEPT PSYCHOPHYS, V67, P1140, DOI 10.3758/BF03193547; Martinez A, 2006, J COGNITIVE NEUROSCI, V18, P298, DOI 10.1162/089892906775783642; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McLeod P, 1996, VIS COGN, V3, P363, DOI 10.1080/135062896395634; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; O'Hearn K, 2005, PSYCHOL SCI, V16, P905, DOI 10.1111/j.1467-9280.2005.01635.x; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2006, VIS COGN, V14, P175, DOI 10.1080/13506280544000200; Pylyshyn ZW, 2001, COGNITION, V80, P127, DOI 10.1016/S0010-0277(00)00156-6; Ren DG, 2009, J VISION, V9, DOI 10.1167/9.5.18; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Saygin AP, 2008, PSYCHOL SCI, V19, P469, DOI 10.1111/j.1467-9280.2008.02111.x; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Scholl BJ, 2001, COGNITION, V80, P159, DOI 10.1016/S0010-0277(00)00157-8; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; Shipley TF, 2003, PSYCHOL SCI, V14, P377, DOI 10.1111/1467-9280.24471; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; STCLAIR R, 2010, J VIS           0418; Sterzer P, 2008, J COGNITIVE NEUROSCI, V20, P389, DOI 10.1162/jocn.2008.20039; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Tombu M, 2008, COGNITION, V108, P1, DOI 10.1016/j.cognition.2007.12.014; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; vanMarle K, 2003, PSYCHOL SCI, V14, P498, DOI 10.1111/1467-9280.03451; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; Xu YD, 2009, TRENDS COGN SCI, V13, P167, DOI 10.1016/j.tics.2009.01.008; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Zelinsky GJ, 2008, VIS COGN, V16, P553, DOI 10.1080/13506280802000752	57	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e16232	10.1371/journal.pone.0016232	http://dx.doi.org/10.1371/journal.pone.0016232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YU	21483844	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000289057200004
J	Bae, JS; Cheong, HS; Kim, JH; Park, BL; Kim, JH; Park, TJ; Kim, JY; Pasaje, CFA; Lee, JS; Park, YJ; Park, M; Park, C; Koh, I; Chung, YJ; Lee, JY; Shin, HD				Bae, Joon Seol; Cheong, Hyun Sub; Kim, Ji-Hong; Park, Byung Lae; Kim, Jeong-Hyun; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Park, Yun-Ju; Park, Miey; Park, Chan; Koh, InSong; Chung, Yeun-Jun; Lee, Jong-Young; Shin, Hyoung Doo			The Genetic Effect of Copy Number Variations on the Risk of Type 2 Diabetes in a Korean Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFICATION; VARIANTS; CNVS	Background: Unlike Caucasian populations, genetic factors contributing to the risk of type 2 diabetes mellitus (T2DM) are not well studied in Asian populations. In light of this, and the fact that copy number variation (CNV) is emerging as a new way to understand human genomic variation, the objective of this study was to identify type 2 diabetes-associated CNV in a Korean cohort. Methodology/Principal Findings: Using the Illumina HumanHap300 BeadChip (317,503 markers), genome-wide genotyping was performed to obtain signal and allelic intensities from 275 patients with type 2 diabetes mellitus (T2DM) and 496 nondiabetic subjects (Total n = 771). To increase the sensitivity of CNV identification, we incorporated multiple factors using PennCNV, a program that is based on the hidden Markov model (HMM). To assess the genetic effect of CNV on T2DM, a multivariate logistic regression model controlling for age and gender was used. We identified a total of 7,478 CNVs (average of 9.7 CNVs per individual) and 2,554 CNV regions (CNVRs; 164 common CNVRs for frequency>1%) in this study. Although we failed to demonstrate robust associations between CNVs and the risk of T2DM, our results revealed a putative association between several CNVRs including chr15:45994758-45999227 (P = 8.6E-04, P-corr = 0.01) and the risk of T2DM. The identified CNVs in this study were validated using overlapping analysis with the Database of Genomic Variants (DGV; 71.7% overlap), and quantitative PCR (qPCR). The identified variations, which encompassed functional genes, were significantly enriched in the cellular part, in the membrane-bound organelle, in the development process, in cell communication, in signal transduction, and in biological regulation. Conclusion/Significance: We expect that the methods and findings in this study will contribute in particular to genome studies of Asian populations.	[Bae, Joon Seol; Kim, Jeong-Hyun; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Shin, Hyoung Doo] Sogang Univ, Lab Genom Divers, Dept Life Sci, Seoul, South Korea; [Cheong, Hyun Sub; Park, Byung Lae; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Cheong, Hyun Sub] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kim, Ji-Hong; Chung, Yeun-Jun] Catholic Univ Korea, Integrated Res Ctr Genome Polymorphism, Sch Med, Seoul, South Korea; [Kim, Ji-Hong; Chung, Yeun-Jun] Catholic Univ Korea, Dept Hosp Pathol, Seoul St Marys Hosp, Sch Med, Seoul, South Korea; [Park, Yun-Ju; Park, Miey; Lee, Jong-Young] NIH, Ctr Genome Sci, Osong, South Korea; [Park, Chan] NIH, Ctr Immunol & Pathol, Osong, South Korea; [Koh, InSong] Hanyang Univ, Dept Physiol, Coll Med, Seoul 133791, South Korea	Sogang University; SNP Genetics; Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Hanyang University	Bae, JS (corresponding author), Sogang Univ, Lab Genom Divers, Dept Life Sci, Seoul, South Korea.	leejy63@nih.go.kr; hdshin@sogang.ac.kr	Lee, Jong-Young/M-6319-2013; Pasaje, Charisse Flerida A./J-7990-2014; Pasaje, Charisse Flerida A./AAY-8793-2020	Lee, Jong-Young/0000-0002-0092-9958; Pasaje, Charisse Flerida A./0000-0002-9780-3680; Pasaje, Charisse Flerida A./0000-0002-9780-3680	Korea government (MEST) [2009-0080157, 2010-0011206]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Korea Science and Engineering Foundation (KOSEF) funded by the Korea government (MEST) (No. 2009-0080157), and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0011206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQVIST E, 2011, CLIN CHEM, P57; Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Bae JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011417; Bae JS, 2010, OPHTHALMOLOGY, V117, P1306, DOI 10.1016/j.ophtha.2009.11.021; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; BAE JS, 2010, J HUM GENET; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Beissbarth T, 2006, METHOD ENZYMOL, V411, P340, DOI 10.1016/S0076-6879(06)11018-6; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Elbein SC, 2002, ENDOCRINOLOGY, V143, P2012, DOI 10.1210/en.143.6.2012; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Groop LC, 1997, ANN MED, V29, P37, DOI 10.3109/07853899708998742; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-426; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KWAK SH, 2010, HORM RES PAEDIAT; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shtir Corina, 2009, BMC Proc, V3 Suppl 7, pS133; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	40	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19091	10.1371/journal.pone.0019091	http://dx.doi.org/10.1371/journal.pone.0019091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526130	gold, Green Published, Green Submitted			2022-12-27	WOS:000290015800039
J	Narayanaswamy, BE; Bett, BJ				Narayanaswamy, Bhavani E.; Bett, Brian J.			Macrobenthic Biomass Relations in the Faroe-Shetland Channel: An Arctic-Atlantic Boundary Environment	PLOS ONE			English	Article							DEEP-SEA MEIOBENTHOS; NORTHEAST ATLANTIC; SIZE STRUCTURE; BODY-SIZE; OCEAN; WATER; MARGIN; SLOPE; DIVERSITY; PACIFIC	The Faroe-Shetland Channel, located in the NE Atlantic, ranges in depth from 0-1700 m and is an unusual deep-sea environment because of its complex and dynamic hydrographic regime, as well as having numerous different seafloor habitats. Macrofaunal samples have been collected on a 0.5 mm mesh sieve from over 300 stations in a wide area survey and on nested 0.5 and 0.25 mm mesh sieves along a specific depth transect. Contrary to general expectation, macrofauanl biomass in the Channel did not decline with increasing depth. When examined at phylum level, two main biomass patterns with depth were apparent: (a) polychaetes showed little change in biomass on the upper slope then increased markedly below 500 m to a depth of 1100 m before declining; and (b) other phyla showed enhanced biomass between 300-500 m. The polychaete response may be linked with a seafloor environment change to relatively quiescent hydrodynamic conditions and an increasing sediment mud content that occurs at c. 500 m. In contrast, the mid-slope enhancement of other phyla biomass may reflect the hydrodynamically active interface between the warm and cold water masses present in the Channel at c. 300-500 m. Again contrary to expectation, mean macrofaunal body size did not decline with depth, and the relative contribution of smaller (>0.25 mm <0.5 mm) to total (>0.25 mm) macrobenthos did not increase with depth. Overall our total biomass and average individual biomass estimates appear to be greater than those predicted from global analyses. It is clear that global models of benthic biomass distribution may mask significant variations at the local and regional scale.	[Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Bett, Brian J.] Natl Oceanog Ctr, Southampton, Hants, England	UHI Millennium Institute; NERC National Oceanography Centre	Narayanaswamy, BE (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	Bhavani.Narayanaswamy@sams.ac.uk		Narayanaswamy, Bhavani/0000-0002-5810-9127	Atlantic Frontier Environmental Network (AFEN); Natural Environmental Research Council [NER/D/S/2001/00659]; NERC [noc010004, noc010009, dml010004] Funding Source: UKRI; Natural Environment Research Council [noc010004, noc010009, dml010004] Funding Source: researchfish	Atlantic Frontier Environmental Network (AFEN); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors would like to thank the Atlantic Frontier Environmental Network (AFEN) and the Natural Environmental Research Council (Grant No: NER/D/S/2001/00659) for funding this study. AFEN comprised: AGIP (UK) Ltd., Amerada Hess Ltd., BG E&P Ltd., BP Amoco, Chevron UK Ltd., Conoco (UK) Ltd., Enterprise Oil plc., Marathon Oil UK Ltd., Phillips Petroleum Company UK Ltd., Shell UK Exploration and Production Ltd., Statoil Ltd., Texaco North Sea UK Company, TotalFina, Veba Oil and Gas UK Ltd., Department of Trade and Industry, Joint Nature Conservation Committee and the Scottish Executive's Environment and Rural Affairs Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berelson WM, 2001, DEEP-SEA RES PT II, V49, P237, DOI 10.1016/S0967-0645(01)00102-3; BETT BJ, 1994, MAR ECOL PROG SER, V104, P197, DOI 10.3354/meps104197; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; Blake JA, 2004, DEEP-SEA RES PT II, V51, P1797, DOI 10.1016/j.dsr2.2004.07.014; Brandt Angelika, 2003, Berichte zur Polar- und Meeresforschung, V470, P45; Bullough LW, 1998, FISH RES, V39, P33, DOI 10.1016/S0165-7836(98)00170-2; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CLARKE ARTHUR H., 1960, NAT HIST PAPERS, V7, P1; Dooley H. D., 1981, DTSCH HYDROGR Z, V34, P41, DOI DOI 10.1007/BF02226585; Gage J.D., 2005, P273, DOI 10.1002/9780470995129.ch7; Gage JD, 2002, MAR ECOL PROG SER, V225, P97, DOI 10.3354/meps225097; GAGE JD, 1977, BIOL BENTHIC ORGANIS, P247; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; HANSEN B, 1985, RIT FISKIDEILDAR, V9, P110; HESSLER RR, 1974, DEEP-SEA RES, V21, P185, DOI 10.1016/0011-7471(74)90058-8; HESSLER RR, 1972, SCIENCE, V175, P636, DOI 10.1126/science.175.4022.636; Hosegood P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019544; Hosegood P, 2004, DEEP-SEA RES PT II, V51, P2943, DOI 10.1016/j.dsr2.2004.09.016; Hughes DJ, 2004, PROG OCEANOGR, V63, P29, DOI 10.1016/j.pocean.2004.09.002; Kaariainen JI, 2006, J MAR BIOL ASSOC UK, V86, P1339, DOI 10.1017/S0025315406014366; Masson DG, 2010, MAR GEOL, V268, P85, DOI 10.1016/j.margeo.2009.10.014; Masson DG, 2004, SEDIMENTOLOGY, V51, P1207, DOI 10.1111/j.1365-3091.2004.00668.x; Masson DG, 2001, CONT SHELF RES, V21, P825, DOI 10.1016/S0278-4343(00)00115-1; McIntyre AD, 1984, METHODS STUDY MARINE, P217; Narayanaswamy BE, 2010, MAR ECOL-EVOL PERSP, V31, P237, DOI 10.1111/j.1439-0485.2010.00360.x; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rowe G.T., 1979, AMBIO SPEC REP, P19; Rowe GT, 2003, AM FISH S S, V36, P225; Sherwin T., 1991, TIDAL HYDRODYNAMICS, P469; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SOETAERT K, 1989, DEEP-SEA RES, V36, P93, DOI 10.1016/0198-0149(89)90020-4; Soltwedel T, 1996, J MAR BIOL ASSOC UK, V76, P327, DOI 10.1017/S0025315400030587; Steel RGD, 1981, PRINCIPLES PROCEDURE; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Thiel H., 1979, Ambio Special Report, P25; Thiel H, 1975, INT REV GES HYDROBIO, V60, P576; THURSTON MH, 1979, MAR BIOL, V51, P55, DOI 10.1007/BF00389031; TIETJEN JH, 1989, DEEP-SEA RES, V36, P1579, DOI 10.1016/0198-0149(89)90059-9; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Turrell WR, 1999, DEEP-SEA RES PT I, V46, P1, DOI 10.1016/S0967-0637(98)00067-3; TYLER P, 1978, ESTUAR COAST MAR SCI, V6, P439, DOI 10.1016/0302-3524(78)90134-2; VELLEMAN PF, 1977, P NATL ACAD SCI USA, V74, P434, DOI 10.1073/pnas.74.2.434; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wolff T., 1962, Galathea Report, V6, P1; Wynn RB, 2002, MAR GEOL, V192, P309, DOI 10.1016/S0025-3227(02)00561-3; Zar J.H., 1999, BIOSTAT ANAL, V4th; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	53	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18602	10.1371/journal.pone.0018602	http://dx.doi.org/10.1371/journal.pone.0018602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526171	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000290015800010
J	Yamazaki, S; Okada, K; Maruyama, A; Matsumoto, M; Yagita, H; Seya, T				Yamazaki, Sayuri; Okada, Kohei; Maruyama, Akira; Matsumoto, Misako; Yagita, Hideo; Seya, Tsukasa			TLR2-Dependent Induction of IL-10 and Foxp3(+)CD25(+)CD4(+) Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo	PLOS ONE			English	Article							MACROPHAGE-ACTIVATING LIPOPEPTIDE-2; BACILLUS-CALMETTE-GUERIN; NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTOR-2; GROWTH-FACTOR-BETA; DENDRITIC CELLS; TGF-BETA; WALL SKELETON; NK CELLS; INTERLEUKIN-10	16 S-[2,3-bis(palmitoyl)propyl] cysteine (Pam2) lipopeptides act as toll-like receptor (TLR)2/6 ligands and activate natural killer (NK) cells and dendritic cells (DCs) to produce inflammatory cytokines and cytotoxic NK activity in vitro. However, in this study, we found that systemic injection of Pam2 lipopeptides was not effective for the suppression of NK-sensitive B16 melanomas in vivo. When we investigated the immune suppressive mechanisms, systemic injection of Pam2 lipopeptides induced IL-10 in a TLR2-dependent manner. The Pam2 lipopeptides increased the frequencies of Foxp3(+)CD4(+) regulatory T (T reg) cells in a TLR2- and IL-10-dependent manner. The T reg cells from Pam2-lipopeptide injected mice maintained suppressor activity. Pam2 lipopeptides, plus the depletion of T reg with an anti-CD25 monoclonal antibody, improved tumor growth compared with Pam2 lipopeptides alone. In conclusion, our data suggested that systemic treatment of Pam2 lipopeptides promoted IL-10 production and T reg function, which suppressed the effective induction of anti-tumor immunity in vivo. It is necessary to develop an adjuvant that does not promote IL-10 and T reg function in vivo for the future establishment of an anti-cancer vaccine.	[Yamazaki, Sayuri; Okada, Kohei; Maruyama, Akira; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Hokkaido University; Juntendo University	Yamazaki, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	yamazas@med.hokudai.ac.jp; seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Seya, Tsukasa/A-4336-2012		Japan Society for The Promotion of Science; Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Yakult Foundation; Waxman Foundation; Grants-in-Aid for Scientific Research [23390088, 23590558, 22114008] Funding Source: KAKEN	Japan Society for The Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Yakult Foundation; Waxman Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grant for challenging exploratory research, Japan Society for The Promotion of Science Challenging Grand (SY), Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (SY), the Yakult Foundation, and the Waxman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akazawa T, 2010, CANCER SCI, V101, P1596, DOI 10.1111/j.1349-7006.2010.01583.x; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Aramaki O, 2005, TRANSPLANTATION, V79, P568, DOI 10.1097/01.TP.0000153151.16350.53; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Azuma I, 2001, INT IMMUNOPHARMACOL, V1, P1249, DOI 10.1016/S1567-5769(01)00055-8; Azuma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012550; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Giroux M, 2007, J IMMUNOL, V179, P4492, DOI 10.4049/jimmunol.179.7.4492; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murata M, 2008, CANCER SCI, V99, P1435, DOI 10.1111/j.1349-7006.2008.00832.x; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Onizuka S, 1999, CANCER RES, V59, P3128; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schmidt J, 2007, BRIT J CANCER, V97, P598, DOI 10.1038/sj.bjc.6603903; Schulz U, 2010, SCAND J IMMUNOL, V72, P319, DOI 10.1111/j.1365-3083.2010.02435.x; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shingu K, 2003, AM J RESP CELL MOL, V28, P316, DOI 10.1165/rcmb.2002-0106OC; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Terme M, 2008, J IMMUNOL, V180, P4679, DOI 10.4049/jimmunol.180.7.4679; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831	55	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18833	10.1371/journal.pone.0018833	http://dx.doi.org/10.1371/journal.pone.0018833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533081	gold, Green Submitted, Green Published			2022-12-27	WOS:000289719400029
J	Lau, T; Zochowski, M				Lau, Troy; Zochowski, Michal			The Resonance Frequency Shift, Pattern Formation, and Dynamical Network Reorganization via Sub-Threshold Input	PLOS ONE			English	Article							GAMMA-OSCILLATIONS; THETA-OSCILLATIONS; NEURONS; MEMORY; HIPPOCAMPUS; PERFORMANCE; MECHANISMS; RESPONSES; RHYTHM; ALPHA	We describe a novel mechanism that mediates the rapid and selective pattern formation of neuronal network activity in response to changing correlations of sub-threshold level input. The mechanism is based on the classical resonance and experimentally observed phenomena that the resonance frequency of a neuron shifts as a function of membrane depolarization. As the neurons receive varying sub-threshold input, their natural frequency is shifted in and out of its resonance range. In response, the neuron fires a sequence of action potentials, corresponding to the specific values of signal currents, in a highly organized manner. We show that this mechanism provides for the selective activation and phase locking of the cells in the network, underlying input-correlated spatio-temporal pattern formation, and could be the basis for reliable spike-timing dependent plasticity. We compare the selectivity and efficiency of this pattern formation to a supra-threshold network activation and a non-resonating network/neuron model to demonstrate that the resonance mechanism is the most effective. Finally we show that this process might be the basis of the phase precession phenomenon observed during firing of hippocampal place cells, and that it may underlie the active switching of neuronal networks to locking at various frequencies.	[Lau, Troy; Zochowski, Michal] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Zochowski, Michal] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lau, T (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	michalz@umich.edu		Zochowski, Michal/0000-0002-1722-986X	NIH [EB008163]; NSF [CMMI1029388]; Molecular Biophysics training grant [T32GM008270]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Molecular Biophysics training grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH EB008163(MZ), NSF CMMI1029388 (MZ) and Molecular Biophysics training grant T32GM008270 (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Clemens Z, 2009, NEUROSCIENCE, V163, P388, DOI 10.1016/j.neuroscience.2009.06.044; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Feng HF, 2001, NEURAL NETWORKS, V14, P955, DOI 10.1016/S0893-6080(01)00074-0; Fernandez T, 1998, NEUROREPORT, V9, P3681; FLORIAN M, 2000, PHYSICA D, V144, P358; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lee S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000602; Mathes B, 2010, NEUROSCI LETT, V478, P14, DOI 10.1016/j.neulet.2010.04.057; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Miura K, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021914; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Pikovsky A, 1997, CHAOS, V7, P680, DOI 10.1063/1.166265; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sanhueza M, 2005, EUR J NEUROSCI, V22, P1618, DOI 10.1111/j.1460-9568.2005.04341.x; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sun MK, 2001, J NEUROPHYSIOL, V85, P269, DOI 10.1152/jn.2001.85.1.269; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001	26	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18983	10.1371/journal.pone.0018983	http://dx.doi.org/10.1371/journal.pone.0018983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526162	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100044
J	Strother, L; Mathuranath, PS; Aldcroft, A; Lavell, C; Goodale, MA; Vilis, T				Strother, Lars; Mathuranath, Pavagada S.; Aldcroft, Adrian; Lavell, Cheryl; Goodale, Melvyn A.; Vilis, Tutis			Face Inversion Reduces the Persistence of Global Form and Its Neural Correlates	PLOS ONE			English	Article							HUMAN OCCIPITOTEMPORAL CORTEX; LATERAL OCCIPITAL COMPLEX; HUMAN BRAIN; PERCEPTUAL PERSISTENCE; FUSIFORM GYRUS; INVERTED FACES; VISUAL AREAS; RECOGNITION; SELECTIVITY; NETWORK	Face inversion produces a detrimental effect on face recognition. The extent to which the inversion of faces and other kinds of objects influences the perceptual binding of visual information into global forms is not known. We used a behavioral method and functional MRI (fMRI) to measure the effect of face inversion on visual persistence, a type of perceptual memory that reflects sustained awareness of global form. We found that upright faces persisted longer than inverted versions of the same images; we observed a similar effect of inversion on the persistence of animal stimuli. This effect of inversion on persistence was evident in sustained fMRI activity throughout the ventral visual hierarchy, including the lateral occipital area (LO), two face-selective visual areas-the fusiform face area (FFA) and the occipital face area (OFA)-and several early visual areas. V1 showed the same initial fMRI activation to upright and inverted forms but this activation lasted longer for upright stimuli. The inversion effect on persistence-related fMRI activity in V1 and other retinotopic visual areas demonstrates that higher-tier visual areas influence early visual processing via feedback. This feedback effect on figure-ground processing is sensitive to the orientation of the figure.	[Strother, Lars; Mathuranath, Pavagada S.; Aldcroft, Adrian; Lavell, Cheryl; Goodale, Melvyn A.; Vilis, Tutis] Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada; [Strother, Lars; Lavell, Cheryl; Vilis, Tutis] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Mathuranath, Pavagada S.] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum, Kerala, India	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Strother, L (corresponding author), Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada.	lstroth@uwo.ca	Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Aldcroft, Adrian/0000-0003-0106-720X; Mathuranath, P S/0000-0002-3055-9134	Canadian Institutes of Health Research (CIHR) [9335, 36036]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants 9335 to T. Vilis and 36036 to M. A. Goodale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Caldara R, 2009, HUM BRAIN MAPP, V30, P1615, DOI 10.1002/hbm.20626; Chen CC, 2007, CEREB CORTEX, V17, P1423, DOI 10.1093/cercor/bhl054; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.4.2; de Heering A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002317; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Goffaux V, 2009, J NEUROPSYCHOL, V3, P45, DOI 10.1348/174866408X292670; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Large ME, 2005, J NEUROPHYSIOL, V93, P3453, DOI 10.1152/jn.00934.2004; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Mazard A, 2006, NEUROPSYCHOLOGIA, V44, P912, DOI 10.1016/j.neuropsychologia.2005.08.015; Meeren HKM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003503; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; RAMSAY JO, 2005, FUNCTIONAL DATA ANAL, pR19; REGAN D, 1986, Spatial Vision, V1, P305, DOI 10.1163/156856886X00106; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rosburg T, 2010, PSYCHOPHYSIOLOGY, V47, P147, DOI 10.1111/j.1469-8986.2009.00881.x; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schwarzkopf DS, 2008, CURR BIOL, V18, P1162, DOI 10.1016/j.cub.2008.06.072; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Strother L, 2010, J NEUROPHYSIOL, V104, P2075, DOI 10.1152/jn.00462.2010; SUNG YW, 2010, BRAIN RES; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Van Belle G, 2010, J VISION, V10, DOI 10.1167/10.5.10; Wong YJ, 2009, J NEUROPHYSIOL, V102, P3461, DOI 10.1152/jn.00243.2009; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2005, J COGNITIVE NEUROSCI, P112; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Zhang JX, 2010, P NATL ACAD SCI USA, V107, P13503, DOI 10.1073/pnas.1002506107	54	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18705	10.1371/journal.pone.0018705	http://dx.doi.org/10.1371/journal.pone.0018705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525978	Green Submitted, Green Published, gold			2022-12-27	WOS:000289578600023
J	Rouse, MN; Saleh, AA; Seck, A; Keeler, KH; Travers, SE; Hulbert, SH; Garrett, KA				Rouse, Matthew N.; Saleh, Amgad A.; Seck, Amadou; Keeler, Kathleen H.; Travers, Steven E.; Hulbert, Scot H.; Garrett, Karen A.			Genomic and Resistance Gene Homolog Diversity of the Dominant Tallgrass Prairie Species across the US Great Plains Precipitation Gradient	PLOS ONE			English	Article							BLUESTEM ANDROPOGON-GERARDII; DISEASE RESISTANCE; BIG BLUESTEM; DROSOPHILA-MELANOGASTER; POLYPLOID VARIATION; PLANT-DISEASE; RED QUEEN; POPULATIONS; SELECTION; PATTERNS	Background: Environmental variables such as moisture availability are often important in determining species prevalence and intraspecific diversity. The population genetic structure of dominant plant species in response to a cline of these variables has rarely been addressed. We evaluated the spatial genetic structure and diversity of Andropogon gerardii populations across the U.S. Great Plains precipitation gradient, ranging from approximately 48 cm/year to 105 cm/year. Methodology/Principal Findings: Genomic diversity was evaluated with AFLP markers and diversity of a disease resistance gene homolog was evaluated by PCR-amplification and digestion with restriction enzymes. We determined the degree of spatial genetic structure using Mantel tests. Genomic and resistance gene homolog diversity were evaluated across prairies using Shannon's index and by averaging haplotype dissimilarity. Trends in diversity across prairies were determined using linear regression of diversity on average precipitation for each prairie. We identified significant spatial genetic structure, with genomic similarity decreasing as a function of distance between samples. However, our data indicated that genome-wide diversity did not vary consistently across the precipitation gradient. In contrast, we found that disease resistance gene homolog diversity was positively correlated with precipitation. Significance: Prairie remnants differ in the genetic resources they maintain. Selection and evolution in this disease resistance homolog is environmentally dependent. Overall, we found that, though this environmental gradient may not predict genomic diversity, individual traits such as disease resistance genes may vary significantly.	[Rouse, Matthew N.; Saleh, Amgad A.; Seck, Amadou; Travers, Steven E.; Hulbert, Scot H.; Garrett, Karen A.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Keeler, Kathleen H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	Kansas State University; University of Nebraska System; University of Nebraska Lincoln	Rouse, MN (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	kgarrett@ksu.edu	Saleh, Amgad A/B-4783-2015; Saleh, Amgad/A-8697-2012; Rouse, Matthew N/G-5474-2011	Saleh, Amgad A/0000-0002-2354-0144; Saleh, Amgad/0000-0002-2354-0144; 	Land Institute; Ecological Genomics Institute at Kansas State University; US National Science Foundation [EF-0525712]; NSF [DEB-0516046]; Kansas Agricultural Experiment Station; Direct For Biological Sciences [0823341] Funding Source: National Science Foundation	Land Institute; Ecological Genomics Institute at Kansas State University; US National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Kansas Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors appreciate the support provided by The Land Institute (http://www.landinstitute.org/), The Ecological Genomics Institute at Kansas State University, the US National Science Foundation under Grants EF-0525712 (as part of the joint NSF-NIH Ecology of Infectious Disease program) and NSF DEB-0516046, and the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2007, J ECOL, V95, P446, DOI 10.1111/j.1365-2745.2007.01228.x; [Anonymous], 2010, R LANG ENV STAT COMP; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P17444, DOI 10.1073/pnas.0407899101; Caicedo AL, 2008, AM J BOT, V95, P393, DOI 10.3732/ajb.95.3.393; Cheatham MR, 2009, PHYTOPATHOLOGY, V99, P1228, DOI 10.1094/PHYTO-99-11-1228; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; Collinge JE, 2006, J EVOLUTION BIOL, V19, P473, DOI 10.1111/j.1420-9101.2005.01016.x; COX TS, 1992, PLANT DIS, V76, P1061, DOI 10.1094/PD-76-1061; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Doyle J. J., 1987, PHYTOCHEM B, P11; Duan YP, 2009, PLANT DIS, V93, P607, DOI 10.1094/PDIS-93-6-0607; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Garrett KA, 2009, ECOL APPL, V19, P1868, DOI 10.1890/08-0942.1; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Green DM, 1996, EVOLUTION, V50, P374, DOI 10.1111/j.1558-5646.1996.tb04500.x; Gustafson DJ, 2004, J APPL ECOL, V41, P389, DOI 10.1111/j.0021-8901.2004.00904.x; Gustafson DJ, 1999, MOL ECOL, V8, P1693, DOI 10.1046/j.1365-294x.1999.00756.x; Hammerli A, 2003, HEREDITY, V91, P448, DOI 10.1038/sj.hdy.6800310; HUBER L, 1992, ANNU REV PHYTOPATHOL, V30, P553, DOI 10.1146/annurev.py.30.090192.003005; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; KEELER KH, 1992, AM J BOT, V79, P1229, DOI 10.2307/2445049; Keeler KH, 2004, AM MIDL NAT, V152, P63, DOI 10.1674/0003-0031(2004)152[0063:IOIPIA]2.0.CO;2; Keeler KH, 2002, AM MIDL NAT, V147, P295, DOI 10.1674/0003-0031(2002)147[0295:CSOAGV]2.0.CO;2; KEELER KH, 1990, GENOME, V33, P95, DOI 10.1139/g90-015; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Lane DR, 2000, J VEG SCI, V11, P359, DOI 10.2307/3236628; LEONARD KJ, 1969, PHYTOPATHOLOGY, V59, P1858; LEONARD KJ, 1977, ANN NY ACAD SCI, V287, P207, DOI 10.1111/j.1749-6632.1977.tb34240.x; LEONARD KJ, 1980, ANNU REV PHYTOPATHOL, V18, P237, DOI 10.1146/annurev.py.18.090180.001321; LEONARD KJ, 1994, PHYTOPATHOLOGY, V84, P70, DOI 10.1094/Phyto-84-70; Lythgoe KA, 1998, TRENDS ECOL EVOL, V13, P473, DOI 10.1016/S0169-5347(98)01486-4; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Muriithi LM, 1997, EUPHYTICA, V98, P129, DOI 10.1023/A:1003025624950; NEVO E, 1984, PLANT SYST EVOL, V145, P79, DOI 10.1007/BF00984032; Norrmann GA, 2003, BOT J LINN SOC, V141, P95, DOI 10.1046/j.1095-8339.2003.00116.x; Norrmann GA, 1997, AM J BOT, V84, P201, DOI 10.2307/2446081; Nuismer SL, 2000, EVOLUTION, V54, P1102; Ouborg NJ, 2010, CONSERV GENET, V11, P643, DOI 10.1007/s10592-009-0016-9; Randolph LF, 1932, P NATL ACAD SCI USA, V18, P222, DOI 10.1073/pnas.18.3.222; Richards CL, 2004, ECOL LETT, V7, P1155, DOI 10.1111/j.1461-0248.2004.00674.x; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Saleh AA, 2010, MOL ECOL, V19, P79, DOI 10.1111/j.1365-294X.2009.04433.x; SORK VL, 1993, AM NAT, V142, P928, DOI 10.1086/285581; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Travers SE, 2007, FRONT ECOL ENVIRON, V5, P19, DOI 10.1890/1540-9295(2007)5[19:EGMTLF]2.0.CO;2; Travers SE, 2010, J ECOL, V98, P374, DOI 10.1111/j.1365-2745.2009.01618.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weeks AR, 2002, ECOL LETT, V5, P756, DOI 10.1046/j.1461-0248.2002.00380.x; Wright S, 1943, GENETICS, V28, P114; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e17641	10.1371/journal.pone.0017641	http://dx.doi.org/10.1371/journal.pone.0017641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532756	Green Published, gold			2022-12-27	WOS:000289404700005
J	Altindal, T; Chattopadhyay, S; Wu, XL				Altindal, Tuba; Chattopadhyay, Suddhashil; Wu, Xiao-Lun			Bacterial Chemotaxis in an Optical Trap	PLOS ONE			English	Article							ESCHERICHIA-COLI; FLAGELLAR ROTATION; RHODOBACTER-SPHAEROIDES; VIBRIO-ALGINOLYTICUS; SINGLE CELLS; STIMULI; POLAR; MOTOR; SENSITIVITY; ATTRACTANT	An optical trapping technique is implemented to investigate the chemotactic behavior of a marine bacterial strain Vibrio alginolyticus. The technique takes the advantage that the bacterium has only a single polar flagellum, which can rotate either in the counter-clock-wise or clock-wise direction. The two rotation states of the motor can be readily and instantaneously resolved in the optical trap, allowing the flagellar motor switching rate S(t) to be measured under different chemical stimulations. In this paper the focus will be on the bacterial response to an impulsive change of chemoattractant serine. Despite different propulsion apparati and motility patterns, cells of V. alginolyticus apparently use a similar response as Escherichia coli to regulate their chemotactic behavior. Specifically, we found that the switching rate S(t) of the bacterial motor exhibits a biphasic behavior, showing a fast initial response followed by a slow relaxation to the steady-state switching rate S(0). The measured S(t) can be mimicked by a model that has been recently proposed for chemotaxis in E. coli. The similarity in the response to the brief chemical stimulation in these two different bacteria is striking, suggesting that the biphasic response may be evolutionarily conserved. This study also demonstrated that optical tweezers can be a useful tool for chemotaxis studies and should be applicable to other polarly flagellated bacteria.	[Altindal, Tuba; Chattopadhyay, Suddhashil; Wu, Xiao-Lun] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altindal, T (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	xlwu@pitt.edu			National Science Foundation [BP-0646573]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant No. BP-0646573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; ALLEN RD, 1971, J BACTERIOL, V107, P295, DOI 10.1128/JB.107.1.295-302.1971; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1971, REV SCI INSTRUM, V42, P868, DOI 10.1063/1.1685246; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Chen XB, 2000, BIOPHYS J, V78, P1036, DOI 10.1016/S0006-3495(00)76662-8; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Endres RG, 2008, P NATL ACAD SCI USA, V105, P15749, DOI 10.1073/pnas.0804688105; FOLLETT EAC, 1963, J GEN MICROBIOL, V32, P235, DOI 10.1099/00221287-32-2-235; FUTRELLE RP, 1972, NATURE, V239, P517, DOI 10.1038/239517a0; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Homma M, 1996, MICROBIOL-UK, V142, P2777, DOI 10.1099/13500872-142-10-2777; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kojima M, 2007, MOL MICROBIOL, V64, P57, DOI 10.1111/j.1365-2958.2007.05623.x; KOSHLAND DE, 1980, ANNU REV NEUROSCI, V3, P43, DOI 10.1146/annurev.ne.03.030180.000355; LANDAU LD, 1982, FLUID MECH; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Porter SL, 2008, TRENDS MICROBIOL, V16, P251, DOI 10.1016/j.tim.2008.02.006; SAMUEL ADT, 1995, P NATL ACAD SCI USA, V92, P3502, DOI 10.1073/pnas.92.8.3502; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; SOCKETT RE, 1987, J BACTERIOL, V169, P5808, DOI 10.1128/jb.169.12.5808-5814.1987; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	41	23	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18231	10.1371/journal.pone.0018231	http://dx.doi.org/10.1371/journal.pone.0018231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494608	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000289292800006
J	Dixon, E; Clubb, C; Pittman, S; Ammann, L; Rasheed, Z; Kazmi, N; Keshavarzian, A; Gillevet, P; Rangwala, H; Couch, RD				Dixon, Emma; Clubb, Cynthia; Pittman, Sara; Ammann, Larry; Rasheed, Zeehasham; Kazmi, Nazia; Keshavarzian, Ali; Gillevet, Pat; Rangwala, Huzefa; Couch, Robin D.			Solid-Phase Microextraction and the Human Fecal VOC Metabolome	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; LUNG-CANCER; BREATH; BIOMARKERS; FIBERS	The diagnostic potential and health implications of volatile organic compounds (VOCs) present in human feces has begun to receive considerable attention. Headspace solid-phase microextraction (SPME) has greatly facilitated the isolation and analysis of VOCs from human feces. Pioneering human fecal VOC metabolomic investigations have utilized a single SPME fiber type for analyte extraction and analysis. However, we hypothesized that the multifarious nature of metabolites present in human feces dictates the use of several diverse SPME fiber coatings for more comprehensive metabolomic coverage. We report here an evaluation of eight different commercially available SPME fibers, in combination with both GC-MS and GC-FID, and identify the 50/30 mu m CAR-DVB-PDMS, 85 mu m CAR-PDMS, 65 mu m DVB-PDMS, 7 mu m PDMS, and 60 mu m PEG SPME fibers as a minimal set of fibers appropriate for human fecal VOC metabolomics, collectively isolating approximately 90% of the total metabolites obtained when using all eight fibers. We also evaluate the effect of extraction duration on metabolite isolation and illustrate that ex vivo enteric microbial fermentation has no effect on metabolite composition during prolonged extractions if the SPME is performed as described herein.	[Dixon, Emma; Clubb, Cynthia; Pittman, Sara; Ammann, Larry; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA; [Rasheed, Zeehasham; Rangwala, Huzefa] George Mason Univ, Dept Comp Sci & Engn, Fairfax, VA 22030 USA; [Gillevet, Pat] George Mason Univ, Dept Environm Sci & Policy, Manassas, VA USA; [Kazmi, Nazia; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Dixon, Emma; Clubb, Cynthia; Pittman, Sara; Ammann, Larry; Rasheed, Zeehasham; Gillevet, Pat; Rangwala, Huzefa; Couch, Robin D.] George Mason Univ, Microbiome Anal Ctr, Manassas, VA USA	George Mason University; George Mason University; George Mason University; Rush University; George Mason University	Dixon, E (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA USA.	rcouch@gmu.edu			NIH [1RC 2 AA019405]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019405] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0905117] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was supported by NIH grant 1RC 2 AA019405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI J, 1999, QUANTITATION SPME RE; Alpendurada MD, 2000, J CHROMATOGR A, V889, P3; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Boland W., 1984, ANAL VOLATILES, P371; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; Dallinga JW, 2010, CLIN EXP ALLERGY, V40, P68, DOI 10.1111/j.1365-2222.2009.03343.x; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; Koziel J, 2000, ANAL CHEM, V72, P5178, DOI 10.1021/ac000518l; PAWLISZYN J, 1999, QUANTITATIVE ASPECTS; Phillips M, 2004, CLIN CHIM ACTA, V344, P189, DOI 10.1016/j.cccn.2004.02.025; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005	16	53	54	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18471	10.1371/journal.pone.0018471	http://dx.doi.org/10.1371/journal.pone.0018471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494609	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800020
J	Vicari, E; La Vignera, S; Arcoria, D; Condorelli, R; Vicari, LO; Castiglione, R; Mangiameli, A; Calogero, AE				Vicari, Enzo; La Vignera, Sandro; Arcoria, Domenico; Condorelli, Rosita; Vicari, Lucia O.; Castiglione, Roberto; Mangiameli, Andrea; Calogero, Aldo E.			High Frequency of Chronic Bacterial and Non-Inflammatory Prostatitis in Infertile Patients with Prostatitis Syndrome Plus Irritable Bowel Syndrome	PLOS ONE			English	Article							CHRONIC PELVIC PAIN; SEMINAL LEUKOCYTE CONCENTRATION; OXYGEN SPECIES PRODUCTION; PREVALENCE; SYMPTOMS; ENDOMETRIOSIS; SEVERITY; PATTERNS; WOMEN; MEN	Background: Although prostatitis syndrome (PS) and irritable bowel syndrome (IBS) are common disorders, information on the prevalence of IBS in infertile patients with PS is relatively scanty. Therefore, this study was undertaken to estimate the frequency of PS and IBS and to evaluate the prevalence of the various diagnostic categories of prostatitis. Methodology/Principal Findings: This study enrolled 152 patients with PS, diagnosed by the NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) in an andrological setting, and 204 patients with IBS, diagnosed according to the Rome III diagnostic criteria in a gastroenterological setting. The patients with PS were asked to fulfill the Rome III questionnaire for IBS, whereas patients with IBS were asked to complete the NIH-CPSI. The simultaneous presence of PS and IBS was observed in 30.2% and 31.8% of the patients screened by andrologists and gastroenterologists, respectively. Altogether, 111 patients had PS plus IBS (31.2%). They had a total NIH-CPSI and pain subscale scores significantly higher than patients with PS alone. Gastrointestinal symptoms in patients with PS plus IBS were similar to those reported by patients with IBS alone and significantly greater in patients with PS alone. Patients with PS plus IBS had a significantly higher frequency of chronic bacterial prostatitis (category II) and lower of non-inflammatory prostatitis (category IIIB), compared to patients with PS alone. The frequency of inflammatory prostatitis (category IIIA) resulted similar. Conclusions/Significance: Prostatitis syndromes and IBS are frequently associated in patients with PS- or IBS-related symptoms. These patients have an increased prevalence of chronic bacterial and non-inflammatory prostatitis.	[Vicari, Enzo; La Vignera, Sandro; Condorelli, Rosita; Vicari, Lucia O.; Castiglione, Roberto; Calogero, Aldo E.] Univ Catania, Dept Internal Med & Syst Dis, Sect Endocrinol Androl & Internal Med, Catania, Italy; [Arcoria, Domenico; Mangiameli, Andrea] Univ Catania, Dept Internal Med, Gastroenterol Sect, Catania, Italy	University of Catania; University of Catania	Vicari, E (corresponding author), Univ Catania, Dept Internal Med & Syst Dis, Sect Endocrinol Androl & Internal Med, Catania, Italy.	acaloger@unict.it	La Vignera, Sandro/AAR-1589-2020; Vicari, Enzo Saretto Dante/AAC-2118-2019; Calogero, Aldo E./AAA-9538-2021	Calogero, Aldo E./0000-0001-6950-335X; La Vignera, Sandro/0000-0002-7113-2372; Condorelli, Rosita Angela/0000-0002-5217-9343; VICARI, Enzo Saretto Dante/0000-0003-0243-2942				Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Rodriguez MAB, 2009, J UROLOGY, V182, P2123, DOI 10.1016/j.juro.2009.07.036; Clemens JQ, 2006, J UROLOGY, V175, P963, DOI 10.1016/S0022-5347(05)00351-4; Collins MM, 2002, J UROLOGY, V167, P1363, DOI 10.1016/S0022-5347(05)65301-3; Collins MM, 2001, J GEN INTERN MED, V16, P656; Diemer T, 2003, ANDROLOGIA, V35, P55, DOI 10.1046/j.1439-0272.2003.00537.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1559; Ehlert U, 1999, PSYCHOTHER PSYCHOSOM, V68, P87, DOI 10.1159/000012318; Endicott NA, 1998, PSYCHOSOM MED, V60, P744, DOI 10.1097/00006842-199811000-00017; Frissora Christine L, 2005, Curr Gastroenterol Rep, V7, P264, DOI 10.1007/s11894-005-0018-9; Gunnarsson J, 2009, DIGEST LIVER DIS, V41, P788, DOI 10.1016/j.dld.2009.07.006; Guo SW, 2006, GYNECOL OBSTET INVES, V62, P121, DOI 10.1159/000093019; Hungin APS, 2005, ALIMENT PHARM THER, V21, P1365, DOI 10.1111/j.1365-2036.2005.02463.x; Kennedy TM, 1998, GUT, V43, P770, DOI 10.1136/gut.43.6.770; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 1996, UROLOGY, V48, P715, DOI 10.1016/S0090-4295(96)00421-9; Lembo AJ, 2009, AM J GASTROENTEROL, V104, P686, DOI 10.1038/ajg.2009.23; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Li Hong-Jun, 2002, Zhonghua Nan Ke Xue, V8, P338; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Maxwell PR, 1997, LANCET, V350, P1691, DOI 10.1016/S0140-6736(97)05276-8; MEARES EM, 1968, INVEST UROL, V5, P492; Milingos S, 2006, GYNECOL OBSTET INVES, V62, P48, DOI 10.1159/000092023; Patrick J., 1993, WHO MANUAL STANDARDI; Posserud I, 2006, WORLD J GASTROENTERO, V12, P2830, DOI 10.3748/wjg.v12.i18.2830; Roberts RO, 1998, UROLOGY, V51, P578, DOI 10.1016/S0090-4295(98)00034-X; Schaeffer AJ, 2002, J UROLOGY, V168, P1048, DOI 10.1016/S0022-5347(05)64572-7; Schiefer HG, 1998, ANDROLOGIA, V30, P7; Sperber AD, 1999, AM J GASTROENTEROL, V94, P3541, DOI 10.1111/j.1572-0241.1999.01643.x; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Vicari E, 1999, HUM REPROD, V14, P2025, DOI 10.1093/humrep/14.8.2025; Vicari E, 2000, HUM REPROD, V15, P2536, DOI 10.1093/humrep/15.12.2536; VICARI E, 2004, MALE INFERTILITY TOD, V4, P139; Walker EA, 1996, J PSYCHOSOM OBST GYN, V17, P39, DOI 10.3109/01674829609025662; Weidner W, 1999, HUM REPROD UPDATE, V5, P421, DOI 10.1093/humupd/5.5.421; WEIDNER W, 1991, INFECTION, V19, pS119, DOI 10.1007/BF01643680; Wenninger K, 1996, J UROLOGY, V155, P965, DOI 10.1016/S0022-5347(01)66359-6; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392	39	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18647	10.1371/journal.pone.0018647	http://dx.doi.org/10.1371/journal.pone.0018647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494624	Green Submitted, Green Published, gold			2022-12-27	WOS:000289292800034
J	Wang, ZJ; Xu, Y; Shao, JH; Wang, J; Li, RH				Wang, Zhongjie; Xu, Yao; Shao, Jihai; Wang, Jie; Li, Renhui			Genes Associated with 2-Methylisoborneol Biosynthesis in Cyanobacteria: Isolation, Characterization, and Expression in Response to Light	PLOS ONE			English	Article							GEOSMIN PRODUCTION; ODOROUS COMPOUNDS; IDENTIFICATION; TASTE; GROWTH; LAKE	The volatile microbial metabolite 2-methylisoborneol (2-MIB) is a root cause of taste and odor issues in freshwater. Although current evidence suggests that 2-MIB is not toxic, this compound degrades water quality and presents problems for water treatment. To address these issues, cyanobacteria and actinomycetes, the major producers of 2-MIB, have been investigated extensively. In this study, two 2-MIB producing strains, coded as Pseudanabaena sp. and Planktothricoids raciborskii, were used in order to elucidate the genetic background, light regulation, and biochemical mechanisms of 2-MIB biosynthesis in cyanobacteria. Genome walking and PCR methods revealed that two adjacent genes, SAM-dependent methyltransferanse gene and monoterpene cyclase gene, are responsible for GPP methylation and subsequent cyclization to 2-MIB in cyanobacteria. These two genes are located in between two homologous cyclic nucleotide-binding protein genes that may be members of the Crp-Fnr regulator family. Together, this sequence of genes forms a putative operon. The synthesis of 2-MIB is similar in cyanobacteria and actinomycetes. Comparison of the gene arrangement and functional sites between cyanobacteria and other organisms revealed that gene recombination and gene transfer probably occurred during the evolution of 2-MIB-associated genes. All the microorganisms examined have a common origin of 2-MIB biosynthesis capacity, but cyanobacteria represent a unique evolutionary lineage. Gene expression analysis suggested that light is a crucial, but not the only, active regulatory factor for the transcription of 2-MIB synthesis genes. This light-regulated process is immediate and transient. This study is the first to identify the genetic background and evolution of 2-MIB biosynthesis in cyanobacteria, thus enhancing current knowledge on 2-MIB contamination of freshwater.	[Wang, Zhongjie; Li, Renhui] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Wang, Zhongjie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Yao] Nanjing Normal Univ, Coll Geog Sci, Nanjing, Peoples R China; [Shao, Jihai] Hunan Agr Univ, Resources & Environm Coll, Changsha, Hunan, Peoples R China; [Wang, Jie] Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Normal University; Hunan Agricultural University; Shanxi University	Wang, ZJ (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	reli@ihb.ac.cn	Wang, Zhongjie/T-9055-2019	Wang, Zhongjie/0000-0003-3491-417X	State Key Basic Research and Development Plan of China [2008CB418002]; National Water Science and Technology Projects [2008ZX07105-006, 2009ZX07101-013]; Chinese Academy of Science [082303-1-501]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Water Science and Technology Projects; Chinese Academy of Science(Chinese Academy of Sciences)	This work was funded by the State Key Basic Research and Development Plan of China (2008CB418002), the National Water Science and Technology Projects (2008ZX07105-006) (2009ZX07101-013), and the Hundred Talent Research Project of the Chinese Academy of Science (082303-1-501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY R, 1981, FEBS LETT, V125, P220, DOI 10.1016/0014-5793(81)80723-5; BORJESSON TS, 1993, J AGR FOOD CHEM, V41, P2104; BOWMER KH, 1992, WATER SCI TECHNOL, V25, P259, DOI 10.2166/wst.1992.0060; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Dickschat JS, 2007, ANGEW CHEM INT EDIT, V46, P8287, DOI 10.1002/anie.200702496; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Giglio S, 2011, ENVIRON SCI TECHNOL, V45, P992, DOI 10.1021/es102992p; Giglio S, 2008, ENVIRON SCI TECHNOL, V42, P8027, DOI 10.1021/es801465w; Graham JL, 2010, ENVIRON SCI TECHNOL, V44, P7361, DOI 10.1021/es1008938; Izaguirre G, 2004, WATER SCI TECHNOL, V49, P19, DOI 10.2166/wst.2004.0524; Izaguirre G, 1998, WATER RES, V32, P1673, DOI 10.1016/S0043-1354(97)00379-5; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Juttner F, 2007, APPL ENVIRON MICROB, V73, P4395, DOI 10.1128/AEM.02250-06; King JM, 2003, ACS SYM SER, V848, P31; Komarek J, 2005, CYANOPROKARYOTA 2; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Li L, 2007, WATER SCI TECHNOL, V55, P43, DOI 10.2166/wst.2007.160; Ludwig F, 2007, APPL ENVIRON MICROB, V73, P6988, DOI 10.1128/AEM.01197-07; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MEDSKER LL, 1969, ENVIRON SCI TECHNOL, V3, P476, DOI 10.1021/es60028a008; NAES H, 1988, ARCH MICROBIOL, V150, P333, DOI 10.1007/BF00408303; Saadoun IMK, 2001, WATER RES, V35, P1209, DOI 10.1016/S0043-1354(00)00381-X; Spiteller D, 2002, PHYTOCHEMISTRY, V61, P827, DOI 10.1016/S0031-9422(02)00282-0; TABACHEK JAL, 1976, J FISH RES BOARD CAN, V33, P25, DOI 10.1139/f76-004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang CM, 2008, J AM CHEM SOC, V130, P8908, DOI 10.1021/ja803639g; Watson SB, 2004, WATER SCI TECHNOL, V49, P33, DOI 10.2166/wst.2004.0527; WNOROWSKI AU, 1992, WATER SA, V18, P203; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5; Zhang T, 2009, J APPL PHYCOL, V21, P279, DOI 10.1007/s10811-008-9363-z; Zimba PV, 1999, J PHYCOL, V35, P1422, DOI 10.1046/j.1529-8817.1999.3561422.x	33	49	55	7	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18665	10.1371/journal.pone.0018665	http://dx.doi.org/10.1371/journal.pone.0018665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490938	gold, Green Published, Green Submitted			2022-12-27	WOS:000289238700035
J	Pfueller, CF; Brandt, AU; Schubert, F; Bock, M; Walaszek, B; Waiczies, H; Schwenteck, T; Dorr, J; Bellmann-Strobl, J; Mohr, C; Weinges-Evers, N; Ittermann, B; Wuerfel, JT; Paul, F				Pfueller, Caspar F.; Brandt, Alexander U.; Schubert, Florian; Bock, Markus; Walaszek, Bernadeta; Waiczies, Helmar; Schwenteck, Thomas; Doerr, Jan; Bellmann-Strobl, Judith; Mohr, Christian; Weinges-Evers, Nicholetta; Ittermann, Bernd; Wuerfel, Jens T.; Paul, Friedemann			Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MAGNETIC-RESONANCE-SPECTROSCOPY; APPEARING WHITE-MATTER; BRAIN ATROPHY; CLINICAL-RELEVANCE; IMPAIRMENT; ROBUST; DISABILITY; ACCURATE; LESIONS	Objective: To investigate the damage to the retinal nerve fiber layer as part of the anterior visual pathway as well as an impairment of the neuronal and axonal integrity in the visual cortex as part of the posterior visual pathway with complementary neuroimaging techniques, and to correlate our results to patients' clinical symptoms concerning the visual pathway. Design, Subjects and Methods: Survey of 86 patients with relapsing-remitting multiple sclerosis that were subjected to retinal nerve fiber layer thickness (RNFLT) measurement by optical coherence tomography, to a routine MRI scan including the calculation of the brain parenchymal fraction (BPF), and to magnetic resonance spectroscopy at 3 tesla, quantifying N-acetyl aspartate (NAA) concentrations in the visual cortex and normal-appearing white matter. Results: RNFLT correlated significantly with BPF and visual cortex NAA, but not with normal-appearing white matter NAA. This was connected with the patients' history of a previous optic neuritis. In a combined model, both BPF and visual cortex NAA were independently associated with RNFLT. Conclusions: Our data suggest the existence of functional pathway-specific damage patterns exceeding global neurodegeneration. They suggest a strong interrelationship between damage to the anterior and the posterior visual pathway.	[Pfueller, Caspar F.; Brandt, Alexander U.; Bock, Markus; Doerr, Jan; Weinges-Evers, Nicholetta; Wuerfel, Jens T.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Brandt, Alexander U.] Gfnmediber GmbH, Berlin, Germany; [Mohr, Christian; Wuerfel, Jens T.] Univ Lubeck, Inst Neuroradiol, Lubeck, Germany; [Schubert, Florian; Walaszek, Bernadeta; Waiczies, Helmar; Schwenteck, Thomas; Ittermann, Bernd] Phys Tech Bundesanstalt, D-3300 Braunschweig, Germany; [Schubert, Florian; Walaszek, Bernadeta; Waiczies, Helmar; Schwenteck, Thomas; Ittermann, Bernd] Phys Tech Bundesanstalt, Berlin, Germany; [Waiczies, Helmar; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Waiczies, Helmar; Bellmann-Strobl, Judith; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Physikalisch-Technische Bundesanstalt (PTB); Physikalisch-Technische Bundesanstalt (PTB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pfueller, CF (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	caspar.pfueller@charite.de	Paul, Friedemann/ABF-9415-2020	Wuerfel, Jens/0000-0002-0034-8053; Waiczies, Helmar/0000-0001-6651-4790; paul, friedemann/0000-0002-6378-0070; Bellmann-Strobl, Judith/0000-0003-2615-1643	German Research Foundation; German Ministry of Economics [KF2286101FO9]; gfnmediber; gfnmediber GmbH, Berlin, Germany	German Research Foundation(German Research Foundation (DFG)); German Ministry of Economics; gfnmediber; gfnmediber GmbH, Berlin, Germany	This work was supported by grants from the Excellence Cluster 257 of the German Research Foundation to NeuroCure Clinical Research Center and the grant KF2286101FO9 from the German Ministry of Economics awarded both to NeuroCure Clinical Research Center and gfnmediber, a company co-managed by Alexander U Brandt, who is also a guest scientist in the NeuroCure Clinical Research Center. Therefore the authors mention gfnmediber as a funder of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alexander U Brandt is the deputy CEO of gfnmediber and a guest scientist in the NeuroCure Clinical Research Center (NCRC). There is no conflict of gfnmediber's company interests with the current study; Alexander U Brandt contributed to the study merely in his role of a guest scientist in the NCRC. As the grant KF2286101FO9 from the German Ministry of Economics was awarded both to NeuroCure Clinical Research Center and gfnmediber and gfnmediber is employing Alexander U Brandt, the authors include gfnmediber GmbH, Berlin, Germany as a funding source. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Audoin B, 2006, BRAIN, V129, P1031, DOI 10.1093/brain/awl039; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; CHARCOT JM, 1968, GAZETTE HOPITAUX, V141, P554; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; Elster C, 2005, MAGN RESON MED, V53, P1288, DOI 10.1002/mrm.20500; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fink F, 2010, MULT SCLER J, V16, P332, DOI 10.1177/1352458509356367; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gupta N, 2003, EUR J OPHTHALMOL, V13, pS32; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reich DS, 2009, ARCH NEUROL-CHICAGO, V66, P998, DOI 10.1001/archneurol.2009.107; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Schubert F, 2002, MAGN RESON MATER PHY, V14, P213, DOI 10.1007/BF02668215; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	47	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18019	10.1371/journal.pone.0018019	http://dx.doi.org/10.1371/journal.pone.0018019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494672	Green Published, Green Accepted, gold			2022-12-27	WOS:000289192400006
J	Wang, J; Tong, P; Lu, L; Zhou, LL; Xu, LL; Jiang, SB; Chen, YH				Wang, Ji; Tong, Pei; Lu, Lu; Zhou, Leilei; Xu, Liling; Jiang, Shibo; Chen, Ying-hua			HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EPITOPE-SPECIFIC ANTIBODIES; B-CELL EPITOPES; GLYCOPROTEIN GP41; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; TYPE-1 ENVELOPE; VIRAL MEMBRANE; VACCINE DESIGN	The membrane-proximal external region (MPER) of the HIV-1 gp41 consists of epitopes for the broadly cross-neutralizing monoclonal antibodies 2F5 and 4E10. However, antigens containing the linear sequence of these epitopes are unable to elicit potent and broad neutralizing antibody responses in vaccinated hosts, possibly because of inappropriate conformation of these epitopes. Here we designed a recombinant antigen, designated NCM, which comprises the N-and C-terminal heptad repeats that can form a six-helix bundle (6HB) core and the MPER domain of gp41. Two mutations (T569A and I675V) previously reported to expose the neutralization epitopes were introduced into NCM to generate mutants named NCM(TA), NCM(IV), and NCM(TAIV). Our results showed that NCM and its mutants could react with antibodies specific for 6HB and MPER of gp41, suggesting that these antigens are in the form of a trimer of heterodimer (i. e., 6HB) with three exposed MPER tails. Antigen with double mutations, NCM(TAIV), elicited much stronger antibody response in rabbits than immunogens with single mutation, NCM(TA) and NCM(IV), or no mutation, NCM. The purified MPER-specific antibodies induced by NCM(TAIV) exhibited broad neutralizing activity, while the purified 6HB-specific antibodies showed no detectable neutralizing activity. Our recombinant antigen design supported by an investigation of its underlying molecular mechanisms provides a strong scientific platform for the discovery of a gp41 MPER-based AIDS vaccine.	[Wang, Ji; Tong, Pei; Zhou, Leilei; Xu, Liling; Chen, Ying-hua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Lu, Lu; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Lu, Lu; Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Hlth, Minist Educ,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Tsinghua University; New York Blood Center; Fudan University; Fudan University	Wang, J (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	sjiang@nybloodcenter.org; chenyh@mail.tsinghua.edu.cn	chen, ying/HHS-8254-2022; Lu, Lu/K-7070-2014; lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014; lu, lu/HII-7530-2022	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135; 	Ministry of Health of China [2008zx10001-011]; National Institutes of Health (NIH) [AI046221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER	Ministry of Health of China; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Ministry of Health of China (2008zx10001-011) to YHC and a National Institutes of Health (NIH) grant (AI046221) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Haynes Barton F., 2005, Human Antibodies, V14, P59; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Ho J, 2002, VACCINE, V20, P1169, DOI 10.1016/S0264-410X(01)00441-8; Huang JH, 2008, J BIOL CHEM, V283, P14994, DOI 10.1074/jbc.M800525200; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Li H, 2002, IMMUNOL LETT, V84, P153, DOI 10.1016/S0165-2478(02)00175-X; Li J, 2008, BIOCHEM BIOPH RES CO, V376, P60, DOI 10.1016/j.bbrc.2008.08.105; Li L, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-37; Li L, 2010, ANTIMICROB AGENTS CH, V54, P1700, DOI 10.1128/AAC.01046-09; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lu Y, 2000, SCAND J IMMUNOL, V51, P497; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Mische CC, 2005, VIROLOGY, V338, P133, DOI 10.1016/j.virol.2005.05.001; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; NEURATH AR, 2002, BMC INFECT DIS, V2, P41; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; ROBINSON WE, 1990, P NATL ACAD SCI USA, V87, P3185, DOI 10.1073/pnas.87.8.3185; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shi WX, 2010, J BIOL CHEM, V285, P24290, DOI 10.1074/jbc.M110.111351; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian HJ, 2001, INT IMMUNOPHARMACOL, V1, P763, DOI 10.1016/S1567-5769(01)00017-0; Veiga AS, 2009, CHEMBIOCHEM, V10, P1032, DOI 10.1002/cbic.200800609; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang ZG, 2005, MICROBIOL IMMUNOL, V49, P703, DOI 10.1111/j.1348-0421.2005.tb03657.x; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhu Y, 2010, J VIROL, V84, P9359, DOI 10.1128/JVI.00644-10; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	52	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18233	10.1371/journal.pone.0018233	http://dx.doi.org/10.1371/journal.pone.0018233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483871	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200046
J	Subramanian, SV; Ozaltin, E; Finlay, JE				Subramanian, S. V.; Oezaltin, Emre; Finlay, Jocelyn E.			Height of Nations: A Socioeconomic Analysis of Cohort Differences and Patterns among Women in 54 Low- to Middle-Income Countries	PLOS ONE			English	Article							ADULT HEIGHT; SECULAR TREND; ASSOCIATION; MORTALITY; MEN; STATURE; RISK	Background: Adult height is a useful biological measure of long term population health and well being. We examined the cohort differences and socioeconomic patterning in adult height in low-to middle-income countries. Methods/Findings: We analyzed cross-sectional, representative samples of 364538 women aged 25-49 years drawn from 54 Demographic and Health Surveys (DHS) conducted between 1994 and 2008. Linear multilevel regression models included year of birth, household wealth, education, and area of residence, and accounted for clustering by primary sampling units and countries. Attained height was measured using an adjustable measuring board. A yearly change in birth cohorts starting with those born in 1945 was associated with a 0.0138 cm (95% CI 0.0107, 0.0169) increase in height. Increases in heights in more recent birth year cohorts were largely concentrated in women from the richer wealth quintiles. 35 of the 54 countries experienced a decline (14) or stagnation (21) in height. The decline in heights was largely concentrated among the poorest wealth quintiles. There was a strong positive association between height and household wealth; those in two richest quintiles of household wealth were 1.988 cm (95% CI 1.886, 2.090) and 1.018 cm (95% CI 0.916, 1.120) taller, compared to those in the poorest wealth quintile. The strength of the association between wealth and height was positive (0.05 to 1.16) in 96% (52/54) countries. Conclusions: Socioeconomic inequalities in height remain persistent. Height has stagnated or declined over the last decades in low-to middle-income countries, particularly in Africa, suggesting worsening nutritional and environmental circumstances during childhood.	[Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Oezaltin, Emre; Finlay, Jocelyn E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Finlay, Jocelyn/AAS-9588-2021	Finlay, Jocelyn/0000-0002-3077-5515	National Institutes of Health [NHLBI K25 HL081275]; Robert Wood Johnson Investigator Award in Health Policy Research; Harvard Center for Population and Development Studies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Investigator Award in Health Policy Research; Harvard Center for Population and Development Studies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Subramanian is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275) and the Robert Wood Johnson Investigator Award in Health Policy Research. The authors also acknowledge the support of Harvard Center for Population and Development Studies for research assistance for a related work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2010, ECON HUM BIOL, V8, P273, DOI 10.1016/j.ehb.2010.05.015; Baynouna LM, 2009, ECON HUM BIOL, V7, P405, DOI 10.1016/j.ehb.2009.07.004; Bozzoli C, 2009, DEMOGRAPHY, V46, P647; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Croft T, 1991, DEMOGRAPHIC HLTH SUR, VII, P1337; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; DHS, 2009, DEM HLTH SURV; Ethiopia CSA, 2006, DEMOGRAPHIC HLTH SUR; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garcia J, 2007, ECON HUM BIOL, V5, P340, DOI 10.1016/j.ehb.2007.02.002; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Haghdoost AA, 2008, IRAN J PUBLIC HEALTH, V37, P1; Hatton TJ, 2010, ECON HUM BIOL, V8, P405, DOI 10.1016/j.ehb.2010.03.001; Komlos J, 2004, SOC SCI HIST, V28, P191, DOI 10.1215/01455532-28-2-191; KOMLOS J, 2009, RECENT TRENDS HEIGHT; Komlos J, 2010, ECON HUM BIOL, V8, P58, DOI 10.1016/j.ehb.2009.12.004; Kues AB, 2010, ECON HUM BIOL, V8, P67, DOI 10.1016/j.ehb.2009.09.002; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Ozer BK, 2008, ANTHROPOL SCI, V116, P191, DOI 10.1537/ase.061213; Perkins JM, 2011, ECON HUM BIOL, V9, P184, DOI 10.1016/j.ehb.2010.10.001; Pullum T. W., 2006, ASSESSMENT AGE DATE; Pullum TW, 2008, ASSESSMENT QUALITY D; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rutstein SO, 2004, DHS WEALTH ASSET IND, V6; Rutstein SO, 2003, GUIDE DHS STAT; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Singh-Manoux A, 2010, ECON HUM BIOL, V8, P396, DOI 10.1016/j.ehb.2010.03.002; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Smith GD, 2002, WESTERN J MED, V176, P209, DOI 10.1136/ewjm.176.3.209; Sorkin JD, 1999, EPIDEMIOL REV, V21, P247, DOI 10.1093/oxfordjournals.epirev.a018000; *STATACORP, 2008, STAT SOFTW REL 10SE; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Strauss J, 2008, HBK ECON, V9, P3375, DOI 10.1016/S1573-4471(07)04054-5; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; *SURV DAH, 1996, SAMPL MAN; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; Tucker-Seeley RD, 2011, ECON HUM BIOL, V9, P194, DOI 10.1016/j.ehb.2010.11.002; VAESSEN M, 1996, DEMOGRAPHIC EVALUATI; Webb EA, 2008, ECON HUM BIOL, V6, P228, DOI 10.1016/j.ehb.2008.03.001; Wirth M., 2006, MONITORING HLTH EQUI	46	93	97	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18962	10.1371/journal.pone.0018962	http://dx.doi.org/10.1371/journal.pone.0018962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533104	Green Published, gold			2022-12-27	WOS:000289719400040
J	van Loosdregt, J; Brunen, D; Fleskens, V; Pals, CEGM; Lam, EWF; Coffer, PJ				van Loosdregt, Jorg; Brunen, Diede; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Lam, Eric W. F.; Coffer, Paul J.			Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1	PLOS ONE			English	Article							REGULATORY T-CELLS; ACETYLATION; DEACETYLASE; EXPRESSION; GENERATION; STABILITY; P53; INHIBITION; OCCUPANCY; ARTHRITIS	Maintenance of Foxp3 protein expression in regulatory T cells (Treg) is crucial for a balanced immune response. We have previously demonstrated that Foxp3 protein stability can be regulated through acetylation, however the specific mechanisms underlying this observation remain unclear. Here we demonstrate that SIRT1 a member of the lysine deacetylase Sirtuin (SIRT) family, but not the related SIRTs 2-7, co-localize with Foxp3 in the nucleus. Ectopic expression of SIRT1, but not SIRTs 2-7 results in decreased Foxp3 acetylation, while conversely inhibition of endogenous SIRT activity increased Foxp3 acetylation. We show that SIRT1 inhibition decreases Foxp3 poly-ubiquitination, thereby increasing Foxp3 protein levels. Co-transfection of SIRT1 with Foxp3 results in increased Foxp3 proteasomal degradation, while SIRT inhibition increases FOXP3 transcriptional activity in human Treg. Taken together, these data support a central role for SIRT1 in the regulation of Foxp3 protein levels and thereby in regulation of Treg suppressive capacity. Pharmacological modulation of SIRT1 activity in Treg may therefore provide a novel therapeutic strategy for controlling immune responses.	[van Loosdregt, Jorg; Brunen, Diede; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [van Loosdregt, Jorg; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [Brunen, Diede; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Lam, Eric W. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, CR UK Labs, London, England; [Lam, Eric W. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Imperial College London; Imperial College London	van Loosdregt, J (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Lam, Eric W-F/AAW-8566-2020; Coffer, Paul/AAF-7970-2020	Lam, Eric W-F/0000-0003-1274-3576; van Loosdregt, Jorg/0000-0003-1411-3754	Dutch Rheumatology Foundation; Cancer Research UK [12011] Funding Source: researchfish	Dutch Rheumatology Foundation; Cancer Research UK(Cancer Research UK)	V. F. was supported by a grant from the Dutch Rheumatology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; BEIER UH, 2011, MOL CELL BIOL; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Greenbaum CJ, 1996, DIABETES, V45, P1631, DOI 10.2337/diabetes.45.11.1631; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; HOFFER A, 1959, Can Med Assoc J, V80, P736; Jonas WB, 1996, INFLAMM RES, V45, P330, DOI 10.1007/BF02252945; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lampeter EF, 1998, DIABETES, V47, P980, DOI 10.2337/diabetes.47.6.980; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; van Loosdregt J, 2006, CIRCULATION, V114, P1599, DOI 10.1161/CIRCULATIONAHA.105.597526; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Zhang HS, 2010, J CELL BIOCHEM, V110, P1464, DOI 10.1002/jcb.22704; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	39	90	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19047	10.1371/journal.pone.0019047	http://dx.doi.org/10.1371/journal.pone.0019047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533107	Green Submitted, Green Published, gold			2022-12-27	WOS:000289719400055
J	Coltri, P; Effenberger, K; Chalkley, RJ; Burlingame, AL; Jurica, MS				Coltri, Patricia; Effenberger, Kerstin; Chalkley, Robert J.; Burlingame, A. L.; Jurica, Melissa S.			Breaking Up the C Complex Spliceosome Shows Stable Association of Proteins with the Lariat Intron Intermediate	PLOS ONE			English	Article							PRE-MESSENGER-RNA; U2 SNRNP; MASS-SPECTROMETRY; BRANCH SITE; ACTIVATION; REARRANGEMENT; FIDELITY; RELEASE; BINDING; STEPS	Spliceosome assembly requires several structural rearrangements to position the components of the catalytic core. Many of these rearrangements involve successive strengthening and weakening of different RNA: RNA and RNA: proteins interactions within the complex. To gain insight into the organization of the catalytic core of the spliceosome arrested between the two steps of splicing chemistry (C complex), we investigated the effects of exposing C complex to low concentrations of urea. We find that in the presence of 3M urea C complex separates into at least three sub-complexes. One sub-complex contains the 5`exon, another contains the intron-lariat intermediate, and U2/U5/U6 snRNAs likely comprise a third sub-complex. We purified the intron-lariat intermediate sub-complex and identified several proteins, including U2 snRNP and PRP19 complex (NTC) components. The data from our study indicate that U2 snRNP proteins in C complex are more stably associated with the lariat-intron intermediate than the U2 snRNA. The results also suggest a set of candidate proteins that hold the lariat-intron intermediate together in C complex. This information is critical for further interpreting the complex architecture of the mammalian spliceosome.	[Coltri, Patricia; Effenberger, Kerstin; Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Coltri, Patricia; Effenberger, Kerstin; Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol, RNA, Santa Cruz, CA 95064 USA; [Chalkley, Robert J.; Burlingame, A. L.] Univ Calif Santa Cruz, Dept Pharmaceut Chem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Coltri, P (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	jurica@biology.ucsc.edu	Coltri, Patricia P./E-6294-2014	Coltri, Patricia P./0000-0001-8447-7516; Chalkley, Robert/0000-0002-9757-7302	National Institutes of Health [5R01GM72649]; National Center for Research Resources [RR001614, RR015804, RR019934]; CAPES; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019934, S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072649, P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant 5R01GM72649 to MSJ. RJC and ALB were supported by National Center for Research Resources grants RR001614, RR015804, and RR019934. PPC was supported by a CAPES fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Jurica MS, 2004, NAT STRUCT MOL BIOL, V11, P265, DOI 10.1038/nsmb728; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Smith DJ, 2009, MOL CELL, V34, P333, DOI 10.1016/j.molcel.2009.03.012; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; Yan D, 1996, MOL CELL BIOL, V16, P818	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19061	10.1371/journal.pone.0019061	http://dx.doi.org/10.1371/journal.pone.0019061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526149	Green Published, gold			2022-12-27	WOS:000289671100047
J	Errington, AC; Gibson, KM; Crunelli, V; Cope, DW				Errington, Adam C.; Gibson, K. Michael; Crunelli, Vincenzo; Cope, David W.			Aberrant GABA(A) Receptor-Mediated Inhibition in Cortico-Thalamic Networks of Succinic Semialdehyde Dehydrogenase Deficient Mice	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; SSADH DEFICIENCY; GENETIC MODEL; WAVE DISCHARGES; SEIZURES; NEURONS; NUCLEUS; RATS; MECHANISMS; SPIKE	Aberrant gamma-aminobutyric acid type A (GABA(A)) receptor-mediated inhibition in cortico-thalamic networks remains an attractive mechanism for typical absence seizure genesis. Using the whole-cell patch clamp technique we examined 'phasic' and 'tonic' GABA(A) inhibition in thalamocortical neurons of somatosensory (ventrobasal, VB) thalamus, nucleus reticularis thalami (NRT) neurons, and layer 5/6 pyramidal neurons of the somatosensory (barrel) cortex of succinic semialdehyde dehydrogenase (SSADH) knock-out (SSADH(-/-)) mice that replicate human SSADH deficiency and exhibit typical absence seizures. We found increased sIPSC frequency in both VB and NRT neurons and larger sIPSC amplitude in VB neurons of SSADH(-/-) mice compared to wild-type animals, demonstrating an increase in total phasic inhibition in thalamus of SSADH(-/-) mice. mIPSCs in both VB and NRT neurons were no different between genotypes, although there remained a trend toward more events in SSADH(-/-) mice. In cortical layer 5/6 pyramidal neurons, sIPSCs were fewer but larger in SSADH(-/-) mice, a feature retained by mIPSCs. Tonic currents were larger in both thalamocortical neurons and layer 5/6 pyramidal neurons from SSADH(-/-) mice compared to WTs. These data show that enhanced, rather than compromised, GABAA receptor-mediated inhibition occurs in cortico-thalamic networks of SSADH(-/-) mice. In agreement with previous studies, GABAA receptor-mediated inhibitory gain-of-function may be a common feature in models of typical absence seizures, and could be of pathological importance in patients with SSADH deficiency.	[Errington, Adam C.; Crunelli, Vincenzo; Cope, David W.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Gibson, K. Michael] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Cardiff University; Michigan Technological University	Errington, AC (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	erringtonac@cf.ac.uk	Errington, Adam/D-1678-2011	Errington, Adam/0000-0002-2171-389X; Crunelli, Vincenzo/0000-0001-7154-9752	Wellcome Trust [091882]; NIH [NS40270-09, HD58553-02/02S2/03]; Pediatric Neurotransmitter Disease Association; Epilepsy Research U.K. [P0802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040270] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Neurotransmitter Disease Association; Epilepsy Research U.K.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Wellcome Trust (grant 091882 to V.C.), NIH (grants NS40270-09 and HD58553-02/02S2/03 to K.M.G.), and a grant from the Pediatric Neurotransmitter Disease Association (to K.M.G.). D.W.C. was a research fellow of Epilepsy Research U.K. (grant P0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bessaih T, 2006, J NEUROPHYSIOL, V96, P3074, DOI 10.1152/jn.00682.2006; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Cortez MA, 2004, PHARMACOL BIOCHEM BE, V79, P547, DOI 10.1016/j.pbb.2004.09.008; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Dosa Z, 2010, EPILEPSY RES, V90, P39, DOI 10.1016/j.eplepsyres.2010.03.005; Drasbek K, 2008, J INHERIT METAB DIS, V31, P662, DOI 10.1007/s10545-008-0941-7; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gibson KM, 2003, BIOL PSYCHIAT, V54, P763, DOI 10.1016/S0006-3223(03)00113-6; Gibson KM, 1997, PEDIATRICS, V99, P567, DOI 10.1542/peds.99.4.567; Gupta M, 2004, NEUROBIOL DIS, V16, P556, DOI 10.1016/j.nbd.2004.04.008; HARRIS RM, 1987, NEUROSCIENCE, V21, P229, DOI 10.1016/0306-4522(87)90335-6; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; Huntsman MM, 2000, J NEUROPHYSIOL, V83, P350, DOI 10.1152/jn.2000.83.1.350; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Nylen K, 2008, EXP NEUROL, V210, P449, DOI 10.1016/j.expneurol.2007.11.015; Payne HL, 2006, J NEUROSCI, V26, P8600, DOI 10.1523/JNEUROSCI.1088-06.2006; Pearl PL, 2009, J INHERIT METAB DIS, V32, P343, DOI 10.1007/s10545-009-1034-y; Pearl PL, 2003, ANN NEUROL, V54, pS73, DOI 10.1002/ana.10629; Pearl PL, 2003, NEUROLOGY, V60, P1413, DOI 10.1212/01.WNL.0000059549.70717.80; PEETERS BWMM, 1989, LIFE SCI, V45, P1171, DOI 10.1016/0024-3205(89)90505-5; Pinault D, 1997, J NEUROSCI, V17, P3215; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; Sohal VS, 2003, J NEUROSCI, V23, P3649; SPREAFICO R, 1991, J COMP NEUROL, V304, P478, DOI 10.1002/cne.903040311; Stewart LS, 2008, EPILEPSY BEHAV, V13, P290, DOI 10.1016/j.yebeh.2008.04.012; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Toth TI, 2007, EUR J NEUROSCI, V26, P1832, DOI 10.1111/j.1460-9568.2007.05800.x; VERGNES M, 1984, NEUROSCI LETT, V44, P91, DOI 10.1016/0304-3940(84)90226-X; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wu Y, 2006, ANN NEUROL, V59, P42, DOI 10.1002/ana.20686; WU Y, 2008, SOC NEUR ABS	43	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19021	10.1371/journal.pone.0019021	http://dx.doi.org/10.1371/journal.pone.0019021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526163	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000289671100046
J	Wang, A; Zocchi, G				Wang, Andrew; Zocchi, Giovanni			Artificial Modulation of the Gating Behavior of a K+ Channel in a KvAP-DNA Chimera	PLOS ONE			English	Article							VOLTAGE; RECONSTITUTION; CHEMISTRY	We present experiments where the gating behavior of a voltage-gated ion channel is modulated by artificial ligand binding. We construct a channel-DNA chimera with the KvAP potassium channel reconstituted in an artificial membrane. The channel is functional and the single channel ion conductivity unperturbed by the presence of the DNA. However, the channel opening probability vs. bias voltage, i.e., the gating, can be shifted considerably by the electrostatic force between the charges on the DNA and the voltage sensing domain of the protein. Different hybridization states of the chimera DNA thus lead to different response curves of the channel.	[Wang, Andrew; Zocchi, Giovanni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, A (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	zocchi@physics.ucla.edu			University of California; National Science Foundation [DMR-1006162]	University of California(University of California System); National Science Foundation(National Science Foundation (NSF))	This work was supported by the University of California Lab Research Program and by National Science Foundation grant DMR-1006162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Choi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.078102; Choi B, 2006, J AM CHEM SOC, V128, P8541, DOI 10.1021/ja060903d; COHEN FS, 1989, J GEN PHYSIOL, V93, P201, DOI 10.1085/jgp.93.2.201; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Godfraind T., 2004, MIL DRUG TH; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Ohndorf UM, 2005, J MOL BIOL, V350, P857, DOI 10.1016/j.jmb.2005.05.050; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PEROZO E, 1990, NEURON, V5, P685, DOI 10.1016/0896-6273(90)90222-2; Rant U, 2006, ORG BIOMOL CHEM, V4, P3448, DOI 10.1039/b605712h; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; RAUDINO A, 1986, BIOPHYS J, V50, P441, DOI 10.1016/S0006-3495(86)83480-4; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Treptow W, 2006, BIOPHYS J, V90, pL64, DOI 10.1529/biophysj.106.080754; Tseng CY, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/18005; VEREECKE, 1995, POTASSIUM CHANNELS N; WONDERLIN WF, 1990, BIOPHYS J, V58, P289, DOI 10.1016/S0006-3495(90)82376-6; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18598	10.1371/journal.pone.0018598	http://dx.doi.org/10.1371/journal.pone.0018598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526187	gold, Green Submitted, Green Published			2022-12-27	WOS:000289671100011
J	Catellani, S; Pierri, I; Gobbi, M; Poggi, A; Zocchi, MR				Catellani, Silvia; Pierri, Ivana; Gobbi, Marco; Poggi, Alessandro; Zocchi, Maria Raffaella			Imatinib Treatment Induces CD5+B Lymphocytes and IgM Natural Antibodies with Anti-Leukemic Reactivity in Patients with Chronic Myelogenous Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MEMORY B-CELLS; TYROSINE KINASE; STROMAL CELLS; TERMINAL DIFFERENTIATION; PLASMA-CELLS; MECHANISMS; EXPRESSION; RESISTANCE; INHIBITOR	Imatinib mesylate is a first line treatment of Chronic Myelogenous Leukemia and of a rare form of gastrointestinal stromal cancer, where the response to the drug is also linked to the immune system activation with production of antineoplastic cytokines. In this study, forty patients in the chronic phase of disease, treated with imatinib mesylate, were analyzed. Bone marrow aspirates were drawn at diagnosis, after 3, 6, 12, 18 months for haematological, cytofluorimetric, cytogenetic, biomolecular evaluation and cytokine measurement. Responder and non responder patients were defined according to the European LeukemiaNet recommendations. In responder patients (n = 32), the percentage of bone marrow CD20(+) CD5(+) sIgM(+) lymphocytes, and the plasma levels of IgM, were significantly higher, at 3 months and up to 9 months, than in non responders. These IgM reacted with O-linked sugars expressed by leukemic cells and could induce tumor cell apoptosis. In responeider patients the stromal-derived factor-1 and the B-lymphocyte-activating factor of the tumor necrosis factor family significantly raised in the bone marrow after imatinib administration, together with the bone morphogenetic proteins-2 and -7. All patients with high number of CD20(+) CD5(+) sIgM(+) cells and high stromal-derived factor-1 and B lymphocyte activating factor levels, underwent complete cytogenetic and/or molecular remission by 12 months. We propose that CD20(+) CD5(+) sIgM(+) lymphocytes producing anti-carbohydrate antibodies with anti-tumor activity, might contribute to the response to imatinib treatment. As in multivariate analysis bone marrow CD20(+) CD5(+) sIgM(+) cells and stromal-derived factor-1 and B-lymphocyte-activating factor levels were significantly related to cytogenetical and molecular changes, they might contribute to the definition of the pharmacological response.	[Catellani, Silvia; Pierri, Ivana; Gobbi, Marco] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Poggi, Alessandro] Natl Inst Canc Res, Unit Mol Oncol & Angiogenesis, Genoa, Italy; [Zocchi, Maria Raffaella] Ist Sci San Raffaele, Div Immunol Transplants & Infect Dis, I-20132 Milan, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Catellani, S (corresponding author), Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.	alessandro.poggi@istge.it; zocchi.maria@hsr.it	Poggi, Alessandro/K-6664-2016	Poggi, Alessandro/0000-0002-1860-430X; Zocchi, Maria Raffaella/0000-0002-0022-8385	Italian Ministero della Salute; Novartis Pharma S.p.A.	Italian Ministero della Salute(Ministry of Health, Italy); Novartis Pharma S.p.A.	This work was partially supported by the Italian Ministero della Salute Coordinated Grant Special Project 2008 (Innovative therapeutic models for the treatment of haematological malignancies) (to A. P. and M.R.Z.), and by Novartis Pharma S.p.A. We also thank Novartis Pharma AG (Basel, Switzerland) for providing the purified imatinib for in vitro experiments (MTA31812). EUDRACT 2007-005102-42; EUDRACT 2008-004384-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein Stephanie, 2002, Hum Antibodies, V11, P107; Carulli G, 2010, LEUKEMIA RES, V34, P1336, DOI 10.1016/j.leukres.2010.01.012; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Dono M, 2007, EUR J IMMUNOL, V37, P2138, DOI 10.1002/eji.200636887; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Durig J, 2000, LEUKEMIA, V14, P1652, DOI 10.1038/sj.leu.2401875; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Hochhaus A, 2004, LEUKEMIA, V18, P1321, DOI 10.1038/sj.leu.2403426; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Jabbour E, 2010, LEUKEMIA, V24, P6, DOI 10.1038/leu.2009.193; Kantarjian HM, 2009, CANCER-AM CANCER SOC, V115, P551, DOI 10.1002/cncr.24066; Kindler V, 1997, J IMMUNOL, V159, P2085; Larkin JMG, 2006, MELANOMA RES, V16, P157, DOI 10.1097/01.cmr.0000200490.62723.b0; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; MERVILLE P, 1995, INT IMMUNOL, V7, P635, DOI 10.1093/intimm/7.4.635; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Mueller L, 2007, CANCER LETT, V250, P329, DOI 10.1016/j.canlet.2006.10.024; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; O'Brien S, 2009, J NATL COMPR CANC NE, V7, P984, DOI 10.6004/jnccn.2009.0065; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pellegrino A, 2005, BRIT J HAEMATOL, V129, P248, DOI 10.1111/j.1365-2141.2005.05443.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; ROLDAN E, 1991, EUR J IMMUNOL, V21, P2671, DOI 10.1002/eji.1830211105; Sato N, 2003, HEMATOL ONCOL, V21, P67, DOI 10.1002/hon.705; Schaumann DHS, 2007, MOL IMMUNOL, V44, P1606, DOI 10.1016/j.molimm.2006.08.021; Schwartz-Albiez R, 2008, AUTOIMMUN REV, V7, P491, DOI 10.1016/j.autrev.2008.03.012; Smyth MJ, 2006, NEW ENGL J MED, V354, P2282, DOI 10.1056/NEJMcibr061878; Tibullo D, 2009, EXP HEMATOL, V37, P461, DOI 10.1016/j.exphem.2008.12.008; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074	40	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18925	10.1371/journal.pone.0018925	http://dx.doi.org/10.1371/journal.pone.0018925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533122	Green Published, gold, Green Submitted			2022-12-27	WOS:000289620100030
J	Gleicher, N; Weghofer, A; Lee, IH; Barad, DH				Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.			Association of FMR1 Genotypes with In Vitro Fertilization (IVF) Outcomes Based on Ethnicity/Race	PLOS ONE			English	Article							ASIAN ETHNICITY; PREGNANCY; WOMEN; REPEAT; GENE; DISPARITY; REGION; COHORT	The FMR1 gene, mapping to an area of the X chromosome closely associated with autoimmunity also affects ovarian reserve, with specific genotypes associated with distinct ovarian aging patterns. They, therefore, could also be associated with differences of in vitro fertilization (IVF) outcomes, reported between races/ethnicities. We analyzed 339 consecutive IVF patients, 232 Caucasian, 59 African and 48 Asian, for FMR1 genotypes, and tested by multiple logistic regressions for associations between race/ethnicity, FMR1 genotype, autoimmunity and pregnancy chances with IVF. FMR1 genotypes were predictive of pregnancy (P = 0.046), het-norm/low most significantly and with decreasing chance in comparison to norm genotypes (OR 0.44; 95% CI 0.23-0.85; P = 0.014). Race/ethnicity was, overall, independently associated (P = 0.03), African demonstrating decreased odds in comparison to Caucasian (OR 0.33. 95% CI 0.13-0.79; P = 0.014). Autoimmunity did not differ but interaction of autoimmunity with FMR1 genotype almost reached significance (P = 0.07). Logistic regression with race/ethnicity and interaction between FMR1 genotype and autoimmunity in the model, demonstrated 2.5-times the odds of being associated with autoimmune positivity (OR 2.5, 1.34-4.55; P = 0.004). FMR1 genotypes offer a possible explanation for differences in IVF outcomes between races/ethnicities.	[Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] CHR, New York, NY USA; [Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] Fdn Reprod Med, New York, NY USA; [Gleicher, Norbert] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Weghofer, Andrea] Univ Vienna, Sch Med, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA	Yale University; University of Vienna; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gleicher, N (corresponding author), CHR, New York, NY USA.	ngleicher@thechr.com; dbarad@thechr.com	Barad, David/AAF-4332-2021		Foundation for Reproductive Medicine; Center for Human Reproduction (CHR)	Foundation for Reproductive Medicine; Center for Human Reproduction (CHR)	This work was supported by the Foundation for Reproductive Medicine, a not-for-profit research foundation, and intramural funds from the Center for Human Reproduction (CHR). CHR's principal contribution to the here reported (and other research efforts) is two-fold: It supplies clinical materials (patients, laboratory results, etc.) and it supplies financial support, both in way of facilities, staff and also in assuming outright expenses for many studies, which are not funded via extramural funds. As owner of CHR and as one of its principal investigators, NG is ultimately responsible for all economic decisions made at CHR.	Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Barad D, 2007, J ASSIST REPROD GEN, V24, P629, DOI 10.1007/s10815-007-9178-x; Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; BARAD DH, 2010, HUM REPROD S1, V25, P82; Barad DH, 2009, FERTIL STERIL, V92, pS105; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Bretherick KL, 2005, HUM GENET, V117, P376, DOI 10.1007/s00439-005-1326-8; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Dayal MB, 2009, FERTIL STERIL, V91, P2414, DOI 10.1016/j.fertnstert.2008.03.055; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Fujimoto VY, 2010, FERTIL STERIL, V93, P382, DOI 10.1016/j.fertnstert.2008.10.061; Gleicher N, 2002, HUM REPROD, V17, P539, DOI 10.1093/humrep/17.3.539; GLEICHER N, 2010, FERTIL STERIL   0602; GLEICHER N, 2010, PLOS ONE IN PRESS; Gleicher N, 2007, HUM REPROD, V22, P2879, DOI 10.1093/humrep/dem289; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, HUM REPROD, V24, P2395, DOI 10.1093/humrep/dep256; Gleicher N, 2009, FERTIL STERIL, V91, P1707, DOI 10.1016/j.fertnstert.2008.01.099; Grainger DA, 2004, FERTIL STERIL, V82, pS37, DOI 10.1016/j.fertnstert.2004.07.098; Hagerman RJ, 2008, JAMA-J AM MED ASSOC, V300, P2419, DOI 10.1001/jama.2008.684; Huddleston HG, 2010, FERTIL STERIL, V94, P2059, DOI 10.1016/j.fertnstert.2009.11.019; Lamb JD, 2009, REPROD BIOMED ONLINE, V19, P252, DOI 10.1016/S1472-6483(10)60081-8; Langen ES, 2010, OBSTET GYNECOL, V115, P591, DOI 10.1097/AOG.0b013e3181cf45c1; Legro RS, 2006, FERTIL STERIL, V86, P914, DOI 10.1016/j.fertnstert.2006.03.037; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004; Purcell K, 2007, FERTIL STERIL, V87, P297, DOI 10.1016/j.fertnstert.2006.06.031; Purcell KJ, 2004, FERTIL STERIL, V82, pS40, DOI 10.1016/j.fertnstert.2004.07.103; Seifer DB, 2008, FERTIL STERIL, V90, P1701, DOI 10.1016/j.fertnstert.2007.08.024; Seifer DB, 2010, FERTIL STERIL, V93, P626, DOI 10.1016/j.fertnstert.2009.02.084; Shahine LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007599; Wellons MF, 2008, FERTIL STERIL, V90, P1640, DOI 10.1016/j.fertnstert.2007.09.056; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	36	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18781	10.1371/journal.pone.0018781	http://dx.doi.org/10.1371/journal.pone.0018781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526209	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600032
J	Huang, TT; Liu, FG; Wei, CF; Lu, CC; Chen, CC; Lin, HC; Ojcius, DM; Lai, HC				Huang, Tsung-Teng; Liu, Fu-Guo; Wei, Chia-Fong; Lu, Chia-Chen; Chen, Chang-Chieh; Lin, Hung-Chi; Ojcius, David M.; Lai, Hsin-Chih			Activation of Multiple Apoptotic Pathways in Human Nasopharyngeal Carcinoma Cells by the Prenylated Isoflavone, Osajin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MACLURA-POMIFERA; CANCER; DEATH; BCL-2; TUMOR; FLAVONOIDS; INDUCTION; LINES; BAX	Osajin is a prenylated isoflavone showing antitumor activity in different tumor cell lines. The underlying mechanism of osajin-induced cancer cell death is not clearly understood. In the present study, the mechanisms of osajin-induced cell death of human nasopharyngeal carcinoma (NPC) cells were explored. Osajin was found to significantly induce apoptosis of NPC cells in a dose-and time-dependent manner. Multiple molecular effects were observed during osajin treatment including a significant loss of mitochondrial transmembrane potential, release of cytochrome c into the cytosol, enhanced expression of Fas ligand (FasL), suppression of glucose-regulated protein 78 kDa (GRP78), and activation of caspases-9, -8, -4 and -3. In addition, up-regulation of proapoptotic Bax protein and down-regulation of antiapoptotic Bcl-2 protein were also observed. Taken together, osajin induces apoptosis in human NPC cells through multiple apoptotic pathways, including the extrinsic death receptor pathway, and intrinsic pathways relying on mitochondria and endoplasmic reticulum stress. Thus, osajin could be developed as a new effective and chemopreventive compound for human NPC.	[Huang, Tsung-Teng; Liu, Fu-Guo] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Wei, Chia-Fong; Chen, Chang-Chieh; Lin, Hung-Chi; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.; Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan	National Central University; Chang Gung University; Fu Jen Catholic University; University of California System; University of California Merced; University of California System; University of California Merced; Chang Gung University	Huang, TT (corresponding author), Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan.	liur@cc.ncu.edu.tw; dojcius@ucmerced.edu; hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC96-2628-B-033-MY3]; Chang Gung Memorial Hospital [CMRPD160273]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council (NSC96-2628-B-033-MY3) and Chang Gung Memorial Hospital (CMRPD160273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bellosillo B, 2002, BLOOD, V100, P1810, DOI 10.1182/blood-2001-12-0327; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; CHANG YS, 1989, CANCER RES, V49, P6752; Chen GG, 2002, CLIN EXP METASTAS, V19, P457, DOI 10.1023/A:1016336724463; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Erkal HS, 2001, RADIOTHER ONCOL, V61, P247, DOI 10.1016/S0167-8140(01)00448-0; Fadeel B, 1997, INT IMMUNOL, V9, P201, DOI 10.1093/intimm/9.2.201; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Florian Tomas, 2006, Biomedical Papers (Olomouc), V150, P93; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Licitra L, 2003, CRIT REV ONCOL HEMAT, V45, P199, DOI 10.1016/S1040-8428(01)00210-4; LIN CT, 1990, LAB INVEST, V62, P713; LIN CT, 1993, LAB INVEST, V68, P716; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; METHA U, 2002, GEN PHYSL BIOPHYS, V21, P15; Michels G, 2005, TOXICOLOGY, V206, P337, DOI 10.1016/j.tox.2004.07.022; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nishino H, 2004, BIOFACTORS, V22, P57, DOI 10.1002/biof.5520220110; O'Sullivan B, 2007, INT J RADIAT ONCOL, V69, pS118, DOI 10.1016/j.ijrobp.2007.04.085; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Son IH, 2007, BIOORG MED CHEM LETT, V17, P4753, DOI 10.1016/j.bmcl.2007.06.060; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tombal B, 2000, PROSTATE, V43, P303; Tsao R, 2003, J AGR FOOD CHEM, V51, P6445, DOI 10.1021/jf0342369; Van Hoorn DEC, 2002, EUR J PHARMACOL, V451, P111, DOI 10.1016/S0014-2999(02)02192-1; Vesela D, 2004, FITOTERAPIA, V75, P209, DOI 10.1016/j.fitote.2003.12.005; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	52	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18308	10.1371/journal.pone.0018308	http://dx.doi.org/10.1371/journal.pone.0018308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532751	Green Published, gold, Green Submitted			2022-12-27	WOS:000289404700010
J	Takalo, J; Ignatova, I; Weckstrom, M; Vahasoyrinki, M				Takalo, Jouni; Ignatova, Irina; Weckstrom, Matti; Vahasoyrinki, Mikko			A Novel Estimator for the Rate of Information Transfer by Continuous Signals	PLOS ONE			English	Article							GAIN	The information transfer rate provides an objective and rigorous way to quantify how much information is being transmitted through a communications channel whose input and output consist of time-varying signals. However, current estimators of information content in continuous signals are typically based on assumptions about the system's linearity and signal statistics, or they require prohibitive amounts of data. Here we present a novel information rate estimator without these limitations that is also optimized for computational efficiency. We validate the method with a simulated Gaussian information channel and demonstrate its performance with two example applications. Information transfer between the input and output signals of a nonlinear system is analyzed using a sensory receptor neuron as the model system. Then, a climate data set is analyzed to demonstrate that the method can be applied to a system based on two outputs generated by interrelated random processes. These analyses also demonstrate that the new method offers consistent performance in situations where classical methods fail. In addition to these examples, the method is applicable to a wide range of continuous time series commonly observed in the natural sciences, economics and engineering.	[Takalo, Jouni; Ignatova, Irina; Weckstrom, Matti; Vahasoyrinki, Mikko] Univ Oulu, Dept Phys, Biophys & Bioctr Oulu, Oulu, Finland	University of Oulu	Takalo, J (corresponding author), Univ Oulu, Dept Phys, Biophys & Bioctr Oulu, Oulu, Finland.	mikko.vahasoyrinki@oulu.fi		Ignatova, Irina/0000-0002-9861-2640; Takalo, Jouni/0000-0002-1638-0808	Sigrid Juselius Foundation; Academy of Finland [118480, 129762, 117637]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	The work was supported by the Sigrid Juselius Foundation (MV, MW), Academy of Finland grants 118480 (MV), 129762 (MV, JT) and 117637 (MW, II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov R, 2005, J ATMOS SCI, V62, P65, DOI 10.1175/JAS-3373.1; FRENCH AS, 1980, NATURE, V283, P200, DOI 10.1038/283200a0; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Khinchin AI., 1957, MATH FDN INFORM THEO; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Niven JE, 2004, J NEUROPHYSIOL, V91, P2696, DOI 10.1152/jn.01163.2003; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Roulston MS, 2002, MON WEATHER REV, V130, P1653, DOI 10.1175/1520-0493(2002)130<1653:EPFUIT>2.0.CO;2; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Vahasoyrinki M, 2006, J NEUROSCI, V26, P2652, DOI 10.1523/JNEUROSCI.3316-05.2006; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0	20	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18792	10.1371/journal.pone.0018792	http://dx.doi.org/10.1371/journal.pone.0018792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494562	Green Submitted, gold, Green Published			2022-12-27	WOS:000289354100040
J	Almendinger, J; Doukoumetzidis, K; Kinchen, JM; Kaech, A; Ravichandran, KS; Hengartner, MO				Almendinger, Johann; Doukoumetzidis, Kimon; Kinchen, Jason M.; Kaech, Andres; Ravichandran, Kodi S.; Hengartner, Michael O.			A Conserved Role for SNX9-Family Members in the Regulation of Phagosome Maturation during Engulfment of Apoptotic Cells	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; DEGRADATION; REMOVAL; PROMOTES; MUTATION; RECEPTOR; DOMAINS; PATHWAY; NEUROPATHY	Clearance of apoptotic cells is of key importance during development, tissue homeostasis and wound healing in multicellular animals. Genetic studies in the nematode Caenorhabditis elegans have identified a set of genes involved in the early steps of cell clearance, in particular the recognition and internalization of apoptotic cells. A pathway that orchestrates the maturation of phagosomes containing ingested apoptotic cells in the worm has recently been described. However, many steps in this pathway remain elusive. Here we show that the C. elegans SNX9-family member LST-4 (lateral signaling target) and its closest mammalian orthologue SNX33 play an evolutionary conserved role during apoptotic cell corpse clearance. In lst-4 deficient worms, internalized apoptotic cells accumulated within non-acidified, DYN-1-positive but RAB-5-negative phagosomes. Genetically, we show that LST-4 functions at the same step as DYN-1 during corpse removal, upstream of the GTPase RAB-5. We further show that mammalian SNX33 rescue C. elegans lst-4 mutants and that overexpression of truncated SNX33 fragments interfered with phagosome maturation in a mammalian cell system. Taken together, our genetic and cell biological analyses suggest that LST-4 is recruited through a combined activity of DYN-1 and VPS-34 to the early phagosome membrane, where it cooperates with DYN-1 to promote recruitment/retention of RAB-5 on the early phagosomal membrane during cell corpse clearance. The functional conservation between LST-4 and SNX33 indicate that these early steps of apoptotic phagosome maturation are likely conserved through evolution.	[Almendinger, Johann; Doukoumetzidis, Kimon; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kaech, Andres] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Almendinger, Johann] UZH ETHZ, Life Sci Zurich Grad Sch, Mol Life Sci PhD Program, Zurich, Switzerland	University of Zurich; University of Virginia; University of Virginia; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Almendinger, J (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	johann.almendinger@imls.uzh.ch	Kinchen, Jason/ABC-5663-2021; Hengartner, Michael O/E-6235-2011	Hengartner, Michael/0000-0002-7584-596X; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410	Kanton of Zurich; Swiss National Science Foundation; Ernst Hadorn Foundation; National Institutes of Health; American Heart Association	Kanton of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst Hadorn Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the Kanton of Zurich, the Swiss National Science Foundation and the Ernst Hadorn Foundation (MOH), grants from the National Institutes of Health (KSR) and a Scientist Development Grant from the American Heart Association (JMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; BRENNER S, 1974, GENETICS, V77, P71; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Huynh KK, 2008, CURR BIOL, V18, pR563, DOI 10.1016/j.cub.2008.05.032; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; KINCHEN JM, 2010, NATURE; KINCHEN JM, 2010, APOPTOSIS; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; LU N, 2010, MOL BIOL CELL; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Neukomm LJ, 2011, NAT CELL BIOL, V13, P79, DOI 10.1038/ncb2138; Nieto C, 2010, J CELL SCI, V123, P2000, DOI 10.1242/jcs.062331; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Peplowska K, 2008, NAT CELL BIOL, V10, P759, DOI 10.1038/ncb0708-759; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zhou Z, 2008, TRENDS CELL BIOL, V18, P474, DOI 10.1016/j.tcb.2008.08.002	49	24	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18325	10.1371/journal.pone.0018325	http://dx.doi.org/10.1371/journal.pone.0018325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494661	Green Published, Green Submitted, gold			2022-12-27	WOS:000289292800009
J	Dechartres, A; Albaladejo, P; Mantz, J; Samama, CM; Collet, JP; Steg, PG; Ravaud, P; Tubach, F				Dechartres, Agnes; Albaladejo, Pierre; Mantz, Jean; Samama, Charles Marc; Collet, Jean-Philippe; Steg, Philippe Gabriel; Ravaud, Philippe; Tubach, Florence			Delphi-Consensus Weights for Ischemic and Bleeding Events to Be Included in a Composite Outcome for RCTs in Thrombosis Prevention	PLOS ONE			English	Article							END-POINTS; CARDIOVASCULAR TRIALS; THROMBOLYTIC THERAPY; SELECTION; BENEFITS	Background and Objectives: To weight ischemic and bleeding events according to their severity to be used in a composite outcome in RCTs in the field of thrombosis prevention. Method: Using a Delphi consensus method, a panel of anaesthesiology and cardiology experts rated the severity of thrombotic and bleeding clinical events. The ratings were expressed on a 10-point scale. The median and quartiles of the ratings of each item were returned to the experts. Then, the panel members evaluated the events a second time with knowledge of the group responses from the first round. Cronbach's a was used as a measure of homogeneity for the ratings. The final rating for each event corresponded to the median rating obtained at the last Delphi round. Results: Of 70 experts invited, 32 (46%) accepted to participate. Consensus was reached at the second round as indicated by Cronbach's a value (0.99 (95% CI 0.98-1.00)) so the Delphi was stopped. Severity ranged from under-popliteal venous thrombosis (median = 3, Q1 = 2; Q3 = 3) to ischemic stroke or intracerebral hemorrhage with severe disability at 7 days and massive pulmonary embolism (median = 9, Q1 = 9; Q3 = 9). Ratings did not differ according to the medical specialty of experts. Conclusions: These ratings could be used to weight ischemic and bleeding events of various severity comprising a composite outcome in the field of thrombosis prevention.	[Dechartres, Agnes; Ravaud, Philippe; Tubach, Florence] INSERM, UMR S 738, Paris, France; [Dechartres, Agnes; Ravaud, Philippe; Tubach, Florence] Univ Paris Diderot, UMR S 738, Paris, France; [Dechartres, Agnes; Samama, Charles Marc; Ravaud, Philippe] Univ Paris 05, Paris, France; [Dechartres, Agnes; Ravaud, Philippe] Hop Hotel Dieu, APHP, Ctr Epidemiol Clin, F-75181 Paris, France; [Albaladejo, Pierre] Ctr Hosp Univ, Grenoble, France; [Albaladejo, Pierre] Univ Grenoble 1, Grenoble, France; [Mantz, Jean] Hop Beaujon, APHP, Serv Anesthesie Reanimat & SMUR, Clichy, France; [Mantz, Jean; Steg, Philippe Gabriel; Tubach, Florence] Univ Paris Diderot, Paris, France; [Samama, Charles Marc] Hop Hotel Dieu, APHP, Serv Anesthesie Reanimat, F-75181 Paris, France; [Collet, Jean-Philippe] Hop La Pitie Salpetriere, Serv Cardiol, Paris, France; [Collet, Jean-Philippe] Univ Paris 06, F-75252 Paris 05, France; [Steg, Philippe Gabriel] INSERM, U 698, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, APHP, Serv Cardiol, F-75877 Paris 18, France; [Tubach, Florence] INSERM, CIE 801, Paris, France; [Tubach, Florence] Hop Bichat Claude Bernard, APHP, Dept Biostat Epidemiol, F-75877 Paris 18, France; [Tubach, Florence] Hop Bichat Claude Bernard, APHP, Rech Clin, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Dechartres, A (corresponding author), INSERM, UMR S 738, Paris, France.	florence.tubach@bch.aphp.fr	albaladejo, pierre/M-6901-2014; STEG, Philippe Gabriel/Z-1567-2019; ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; STEG, Philippe Gabriel/0000-0001-6896-2941	Bristol Myers Squibb; Pfizer; Daiichi Sankyo; Eli-Lilly; Boehringer Ingelheim; LFB; Bayer; Bristol-Myers Squibb; Daichi-Sankyo; Pall Medical; Orionpharma; NovoNordisk; CSL Behring; AstraZeneca; GSK; Abbott Vascular; Boston Scientific; Cordis; Federation Francaise de Cardiologie; Fondation de France; Guerbet Medical; INSERM; Medtronic; Societe Francaise de Cardiologie; Zsra-Zeneca; Servier; Schering Plough	Bristol Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli-Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); LFB; Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daichi-Sankyo; Pall Medical; Orionpharma; NovoNordisk(Novo Nordisk); CSL Behring; AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Federation Francaise de Cardiologie; Fondation de France(Fondation de France); Guerbet Medical; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Medtronic(Medtronic); Societe Francaise de Cardiologie; Zsra-Zeneca; Servier(Servier); Schering Plough(Merck & CompanySchering Plough Corporation)	P. Albaladejo: Research grants (to the institution) from Bristol Myers Squibb, Pfizer, Daiichi Sankyo, Eli-Lilly, Boehringer Ingelheim, LFB, consulting or lecture fees from Bayer, Bristol-Myers Squibb, Pfizer, Daichi-Sankyo, Eli-Lilly, Boehringer Ingelheim, Sanofi-Aventis, LFB, and Vifor. J. Mantz: Consulting fees from Baxter, Pall Medical and Orionpharma. C. M. Samama: Research grants (to the institution) from LFB, NovoNordisk, CSL Behring, SanofiAventis, Bayer, consulting or lecture fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Daichi-Sankyo, Eli-Lilly, Sanofi-Aventis Group, Pfizer, Boehringer-Ingelheim, and GSK. J. P. Collet: Research grants (to the institution) from Abbott Vascular, Bristol-Myers Squibb, Boston Scientific, Cordis, Eli-Lilly, Federation Francaise de Cardiologie, Fondation de France, Guerbet Medical, INSERM, Medtronic, Sanofi-Aventis Group, Societe Francaise de Cardiologie, consulting or lecture fees from Zsra-Zeneca, Bayer, Bristol-Myers Squibb, Daichi-Sankyo, Eli-Lilly, Sanofi-Aventis Group, and Servier. P. G. Steg: Hamilton Health Services Astellas, AstraZeneca, Boerhinger-Ingelheim, Bristol-Myers Squibb, GSK, Daiichi-Sankyio/Eli-Lilly Alliance, Medtronic, Merck Sharpe Dohme, Roche, Sanofi-Aventis, Servier, The Medicines Company, and Aterovax. P. Ravaud: None. F. Tubach: Research grants (to the institution) from Abbott, AstraZeneca, Pfizer, and Schering Plough.	Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; BRAUNWALD E, 1992, CIRCULATION, V86, P683, DOI 10.1161/01.CIR.86.2.683; BRAVO G, 1991, J CLIN EPIDEMIOL, V44, P381, DOI 10.1016/0895-4356(91)90076-L; CALIFF RM, 1990, CIRCULATION, V82, P1847, DOI 10.1161/01.CIR.82.5.1847; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Dalkey N., 1963, MANAGE SCI; Dalkey NC, 1969, DELPHI METHOD EXPT S; Delbecq AL, 1975, J HUMAN SCI; Felker GM, 2008, J CARD FAIL, V14, P368, DOI 10.1016/j.cardfail.2008.01.009; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Ferreira-Gonzalez I, 2007, J CLIN EPIDEMIOL, V60, P651, DOI 10.1016/j.jclinepi.2006.10.020; Ferreira-Gonzalez I, 2009, ANN INTERN MED, V150, P566, DOI 10.7326/0003-4819-150-8-200904210-00016; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Freemantle N, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3529; Kraemer HC, 2010, JAMA-J AM MED ASSOC, V304, P683, DOI 10.1001/jama.2010.1133; Lim E, 2008, ANN INTERN MED, V149, P612, DOI 10.7326/0003-4819-149-9-200811040-00004; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Neaton JD, 2005, J CARD FAIL, V11, P567, DOI 10.1016/j.cardfail.2005.08.350; PILL J, 1971, SOCIO ECON PLAN SCI, V5, P57, DOI 10.1016/0038-0121(71)90041-3; Pogue J, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-49; Program CTE, 2006, COMM TERM CRIT ADV E; R Core Team, 2020, R LANG ENV STAT COMP; Rahimi K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5707; ROSS S, 2007, AM J OBSTET GYNECOL, V196; Sampson UKA, 2010, J CLIN EPIDEMIOL, V63, P1156, DOI 10.1016/j.jclinepi.2010.01.019; Tugwell P, 2005, J CLIN EPIDEMIOL, V58, P785, DOI 10.1016/j.jclinepi.2004.11.028	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18461	10.1371/journal.pone.0018461	http://dx.doi.org/10.1371/journal.pone.0018461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490920	gold, Green Published, Green Submitted			2022-12-27	WOS:000289238700015
J	de Boer, OJ; Teeling, P; Jansen, M; Ploegmakers, H; van der Loos, CM; Kummer, JA; Florquin, S; van der Wal, AC				de Boer, Onno J.; Teeling, Peter; Jansen, Marcel; Ploegmakers, Hanneke; van der Loos, Chris M.; Kummer, J. Alain; Florquin, Sandrine; van der Wal, Allard C.			Spatial Differences in the Presence of FOXP3(+) and GranzymeB(+) T Cells between the Intra- and Extravascular Compartments in Renal Allograft Vasculopathy	PLOS ONE			English	Article							ATHEROSCLEROSIS; DISEASE; ARTERIOSCLEROSIS; TRANSPLANTATION; EXPRESSION; REJECTION; CLASSIFICATION; INFLAMMATION; ASSOCIATION; LYMPHOCYTES	Background: Allograft vasculopathy (AV) and native atherosclerosis (NA) share the presence of a T-cell mediated inflammatory response, but differ in overall plaque morphology and growth rate. We studied the distribution and frequency of regulatory-and cytotoxic T cells in the arterial intima lesions in both conditions. Methodology/Principal Findings: The study is based on vessels of 15 explanted human renal allografts with AV and 10 carotid artery plaques obtained at surgery. Distribution and frequency of cytotoxic-and regulatory T cells, as identified by the expression of Granzyme B (GrB) and FOXP3 was established in NA and AV. Furthermore, we compared the distribution of these cells in AV with the perivascular, interstitial renal tissue using immunohistochemistry. The total number of T cells was much higher in AV than in NA lesions (711 +/- 135 and 37 +/- 8 CD3/mm(2) respectively, p<0.005, mean, +/- SEM). Total numbers of FOXP3(+) regulatory cells were also significantly increased in AV (36 +/- 10 and 0.9 +/- 0.3 FOXP3(+)/mm(2) p<0.05), but relative numbers, expressed as a percentage of the total number of CD3(+) T cells ((FOXP3(+)/CD3(+)) 6100), were not significantly different (4.6%+/- 0.9 and 2.7%+/- 0.6). GrB(+) cells were rare in NA, but significantly increased numbers of GrB(+) cells were found in AV lesions (85 +/- 24 and 0.2 +/- 0.1 GrB(+)/mm(2), p<0.05). Perivascular tissues in the allografts showed a higher relative frequency of FOXP3(+) cells than adjacent intimal lesions (14.0%+/- 2.7 and 4.6%+/- 0.9, respectively, p<0.05), but a lower frequency of GrB(+) cytotoxic T cells (16.1%+/- 2.7 and 22.6%+/- 3.6, p<0.05). Conclusions: Similar to NA, AV is characterized by a low frequency of intimal FOXP3+ regulatory T cells. Moreover, significant spatial differences exist in the distribution of functional T cell subsets between the intra-and extravascular micro-environments of the graft.	[de Boer, Onno J.; Teeling, Peter; Jansen, Marcel; Ploegmakers, Hanneke; van der Loos, Chris M.; Florquin, Sandrine; van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Kummer, J. Alain] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht	de Boer, OJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	o.j.deboer@amc.uva.nl	Florquin, Sandrine/B-8242-2012	van der Wal, Allard/0000-0001-5590-3758; de Boer, Onno/0000-0001-8844-1326; Florquin, Sandrine/0000-0002-9676-1722	Academic Medical Center	Academic Medical Center	This work was supported by the Academic Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton-Chess J, 2009, J AM SOC NEPHROL, V20, P1113, DOI 10.1681/ASN.2008050450; Boros P, 2009, AM J TRANSPLANT, V9, P1719, DOI 10.1111/j.1600-6143.2009.02704.x; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; Colvin RB, 1996, KIDNEY INT, V50, P1069, DOI 10.1038/ki.1996.410; de Boer OJ, 2003, CARDIOVASC RES, V60, P78, DOI 10.1016/S0008-6363(03)00341-9; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; de Boer OJ, 2007, J HISTOCHEM CYTOCHEM, V55, P891, DOI 10.1369/jhc.6A7119.2007; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Dong CM, 1996, LAB INVEST, V74, P921; FOX WM, 1993, HUM PATHOL, V24, P477, DOI 10.1016/0046-8177(93)90159-E; Hagemeijer MC, 2008, AM J TRANSPLANT, V8, P1040, DOI 10.1111/j.1600-6143.2008.02198.x; Hosono M, 2003, ATHEROSCLEROSIS, V168, P73, DOI 10.1016/S0021-9150(03)00024-8; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Kobashigawa JA, 1997, TRANSPLANTATION, V63, P331, DOI 10.1097/00007890-199702150-00001; KUMMER JA, 1993, J IMMUNOL METHODS, V163, P77, DOI 10.1016/0022-1759(93)90241-X; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; PAUL LC, 1993, TRANSPLANT P, V25, P2024; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Ronday HK, 2001, RHEUMATOLOGY, V40, P55, DOI 10.1093/rheumatology/40.1.55; SHARPLES LD, 1991, TRANSPLANTATION, V52, P244, DOI 10.1097/00007890-199108000-00012; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Waltner-Romen M, 1998, J HISTOCHEM CYTOCHEM, V46, P1347, DOI 10.1177/002215549804601202; Yapici U, 2009, TRANSPLANTATION, V87, P1377, DOI 10.1097/TP.0b013e3181a24a4b	27	0	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18656	10.1371/journal.pone.0018656	http://dx.doi.org/10.1371/journal.pone.0018656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494640	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400042
J	Ebefors, K; Granqvist, A; Ingelsten, M; Molne, J; Haraldsson, B; Nystrom, J				Ebefors, Kerstin; Granqvist, Anna; Ingelsten, Madeleine; Molne, Johan; Haraldsson, Borje; Nystrom, Jenny			Role of Glomerular Proteoglycans in IgA Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FOOT PROCESS EFFACEMENT; HEPARAN-SULFATE; OXFORD CLASSIFICATION; EXTRACELLULAR-MATRIX; NEPHROTIC SYNDROME; BASEMENT-MEMBRANE; MESANGIAL CELLS; FILTRATION-RATE; RENAL-DISEASE	Mesangial matrix expansion is a prominent feature of the most common form of glomerulonephritis, IgA nephropathy (IgAN). To find molecular markers and improve the understanding of the disease, the gene and protein expression of proteoglycans were investigated in biopsies from IgAN patients and correlated to clinical and morphological data. We collected and microdissected renal biopsies from IgAN patients (n = 19) and from healthy kidney donors (n = 14). Patients were followed for an average time of 4 years and blood pressure was according to target guidelines. Distinct patterns of gene expression were seen in glomerular and tubulo-interstitial cells. Three of the proteoglycans investigated were found to be of special interest and upregulated in glomeruli: perlecan, decorin and biglycan. Perlecan gene expression negatively correlated to albumin excretion and progress of the disease. Abundant decorin protein expression was found in sclerotic glomeruli, but not in unaffected glomeruli from IgAN patients or in controls. Transforming growth factor beta (TGF-beta), known to interact with perlecan, decorin and biglycan, were upregulated both on gene and protein level in the glomeruli. This study provides further insight into the molecular mechanisms involved in mesangial matrix expansion in IgAN. We conclude that perlecan is a possible prognostic marker for patients with IgAN. In addition, the up-regulation of biglycan and decorin, as well as TGF-beta itself, indicate that regulation of TGF-beta, and other profibrotic markers plays a role in IgAN pathology.	[Ebefors, Kerstin; Granqvist, Anna; Haraldsson, Borje] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Ingelsten, Madeleine] Univ Gothenburg, Inst Biomed, Dept Infect Med, Sahlgrenska Acad, Gothenburg, Sweden; [Molne, Johan] Univ Gothenburg, Inst Biomed, Dept Pathol, Sahlgrenska Acad, Gothenburg, Sweden; [Nystrom, Jenny] Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Ebefors, K (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden.	kerstin.ebefors@wlab.gu.se	Haraldsson, Borje/B-3871-2010	Haraldsson, Borje/0000-0002-7536-973X; Molne, Johan/0000-0001-6241-7117	Swedish Medical Research Council [9898, 14764]; VINNOVA; National Association for Kidney Diseases; Inga Britt and Arne Lundberg Research Foundation; Wennerstrom Foundation; Sahlgrenska University Hospital [LUA-7545]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); VINNOVA(Vinnova); National Association for Kidney Diseases; Inga Britt and Arne Lundberg Research Foundation; Wennerstrom Foundation; Sahlgrenska University Hospital	This study was supported by the Swedish Medical Research Council 9898 and 14764, VINNOVA, the National Association for Kidney Diseases, the Inga Britt and Arne Lundberg Research Foundation, Wennerstrom Foundation and the Sahlgrenska University Hospital Grant LUA-7545. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Amore A, 2000, AM J KIDNEY DIS, V36, P1242, DOI 10.1053/ajkd.2000.19840; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007; Chihara Y, 2006, CLIN NEPHROL, V65, P385; Choi SY, 2010, ULTRASTRUCT PATHOL, V34, P195, DOI 10.3109/01913121003648402; Coppo R, 2010, CLIN EXP IMMUNOL, V159, P73, DOI 10.1111/j.1365-2249.2009.04045.x; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Gambichler T, 2009, AM J CLIN PATHOL, V132, P139, DOI 10.1309/AJCPGB55YDURJXZC; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harvey SJ, 2008, CURR OPIN NEPHROL HY, V17, P393, DOI 10.1097/MNH.0b013e32830464de; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jeansson M, 2003, J AM SOC NEPHROL, V14, P1756, DOI 10.1097/01.ASN.0000072742.02714.6E; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jones GRD, 2009, PATHOLOGY, V41, P379, DOI 10.1080/00313020902884980; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; KANWAR YS, 1979, P NATL ACAD SCI USA, V76, P1303, DOI 10.1073/pnas.76.3.1303; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387; NAKAMURA T, 1992, KIDNEY INT, V41, P1213, DOI 10.1038/ki.1992.183; OKADA K, 1989, CLIN NEPHROL, V31, P96; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Rupprecht HD, 1996, KIDNEY INT, V49, P1575, DOI 10.1038/ki.1996.228; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; TOMINO Y, 1989, J CLIN LAB ANAL, V3, P101, DOI 10.1002/jcla.1860030207; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; Waga I, 2003, KIDNEY INT, V64, P1253, DOI 10.1046/j.1523-1755.2003.00220.x; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Xu L, 2010, MODERN PATHOL, V23, P1241, DOI 10.1038/modpathol.2010.110; Yung S, 2001, FASEB J, V15, P1631, DOI 10.1096/fj.00-0794fje	50	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18575	10.1371/journal.pone.0018575	http://dx.doi.org/10.1371/journal.pone.0018575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494642	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400040
J	Chazenbalk, G; Bertolotto, C; Heneidi, S; Jumabay, M; Trivax, B; Aronowitz, J; Yoshimura, K; Simmons, CF; Dumesic, DA; Azziz, R				Chazenbalk, Gregorio; Bertolotto, Cristina; Heneidi, Saleh; Jumabay, Medet; Trivax, Bradley; Aronowitz, Joel; Yoshimura, Kotaro; Simmons, Charles F.; Dumesic, Daniel A.; Azziz, Ricardo			Novel Pathway of Adipogenesis through Cross-Talk between Adipose Tissue Macrophages, Adipose Stem Cells and Adipocytes: Evidence of Cell Plasticity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; S-100 PROTEIN; STROMAL CELLS; FAT-CELLS; DIFFERENTIATION; EXPRESSION; OBESITY; PREADIPOCYTES; REQUIRES	Introduction: Previous studies highlight a complex relationship between lineage and phenotype for adipose tissue macrophages (ATMs), adipose stem cells (ASCs), and adipocytes, suggesting a high degree of plasticity of these cells. In the present study, using a novel co-culture system, we further characterized the interaction between ATMs, ASCs and adipocytes. Research Design and Methods: Human adipocytes and the stromal vascular fraction containing ATMs and ASCs were isolated from human adipose tissue and co-cultured for 24 hours. FACS was used to characterize ATMs and ASCs before and after co-culture. Preadipocytes generated after co-culture were characterized by immunostaining for DLK (preadipocytes), CD14 and CD68 (ATMs), CD34 (ASCs), and Nile Red staining for lipid drops. qRT-PCR was used to quantify adipogenic markers such as C/EBP alpha and PPAR gamma. A novel fluorescent nanobead lineage tracing method was utilized before co-culture where fluorescent nanobeads were internalized by CD68 (+) ATMs. Results: Co-culture of adipocytes with ATMs and ASCs increased the formation of new preadipocytes, thereby increasing lipid accumulation and C/EBP alpha and PPAR gamma gene expression. Preadipocytes originating after co-culture were positive for markers of preadipocytes, ATMs and ASCs. Moreover, fluorescent nanobeads were internalized by ATMs before co-culture and the new preadipocytes formed after co-culture also contained fluorescent nanobeads, suggesting that new preadipocytes originated in part from ATMs. The formation of CD34(+)/CD68(+)/DLK(+) cell spheres supported the interaction of ATMs, ASCs and preadipocytes. Conclusions: Cross-talk between adipocytes, ATMs and ASCs promotes preadipocyte formation. The regulation of this novel adipogenic pathway involves differentiation of ATMs to preadipocytes. The presence of CD34(+)/CD68(+)/DLK(+) cells grouped in spheres suggest that paracrine interactions between these cell types plays an important role in the generation and proliferation of new preadipocytes. This phenomenon may reflect the in vivo plasticity of adipose tissue in which ATMs play an additional role during inflammation and other disease states. Understanding this novel pathway could influence adipogenesis, leading to new treatments for obesity, inflammation, and type 2 diabetes.	[Chazenbalk, Gregorio; Trivax, Bradley; Dumesic, Daniel A.] Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Bertolotto, Cristina; Simmons, Charles F.] Cedars Sinai Med Ctr, Dept Pediat, Div Neonatol, Los Angeles, CA 90048 USA; [Bertolotto, Cristina; Simmons, Charles F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neonatol, Los Angeles, CA 90095 USA; [Heneidi, Saleh; Azziz, Ricardo] Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Jumabay, Medet] Univ Calif Los Angeles, David Geffen Sch Med, Dept Cardiol, Los Angeles, CA 90095 USA; [Aronowitz, Joel] Cedars Sinai Med Ctr, Dept Surg, Div Plast Surg, Los Angeles, CA 90048 USA; [Aronowitz, Joel] Univ So Calif, Los Angeles, CA USA; [Yoshimura, Kotaro] Univ Tokyo, Dept Plast Surg, Tokyo, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Georgia; Augusta University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of Southern California; University of Tokyo	Chazenbalk, G (corresponding author), Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA.	gchazenbalk@mednet.ucla.edu	Bertolotto, Corine/AAF-6634-2021; Azziz, Ricardo/N-7229-2014	Bertolotto, Corine/0000-0001-6971-7753; Azziz, Ricardo/0000-0002-3917-0483; Yoshimura, Kotaro/0000-0002-7152-5475; Dumesic, Daniel/0000-0003-0387-1277	Helping Hand of Los Angeles; Ruth and Harry Roman Chair in Neonatology; National Institutes of Health [R01-DK073632]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073632] Funding Source: NIH RePORTER	Helping Hand of Los Angeles; Ruth and Harry Roman Chair in Neonatology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Helping Hand of Los Angeles, by the Ruth and Harry Roman Chair in Neonatology, and by the National Institutes of Health grant R01-DK073632 (to RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova P, 2001, CELLS TISSUES ORGANS, V169, P355, DOI 10.1159/000047902; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Charriere GM, 2006, EXP CELL RES, V312, P3205, DOI 10.1016/j.yexcr.2006.06.034; CINTI S, 1989, ANAT REC, V224, P466, DOI 10.1002/ar.1092240403; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Festy F, 2005, HISTOCHEM CELL BIOL, V124, P113, DOI 10.1007/s00418-005-0014-z; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jumabay M, 2010, CARDIOVASC RES, V85, P17, DOI 10.1093/cvr/cvp267; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41; SIMMONS PJ, 1992, BLOOD, V80, P388; Soilleux EJ, 2002, J PATHOL, V198, P511, DOI 10.1002/path.1205; Sonoda E, 2008, ENDOCRINOLOGY, V149, P4794, DOI 10.1210/en.2008-0525; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; VADAS MA, 1979, J IMMUNOL, V122, P1228; Vakkila J, 2005, PEDIATR DEVEL PATHOL, V8, P43, DOI 10.1007/s10024-004-5045-2; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055; Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	44	67	73	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17834	10.1371/journal.pone.0017834	http://dx.doi.org/10.1371/journal.pone.0017834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483855	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200011
J	Lim, TP; Tan, TY; Lee, W; Sasikala, S; Tan, TT; Hsu, LY; Kwa, AL				Lim, Tze-Peng; Tan, Thean-Yen; Lee, Winnie; Sasikala, S.; Tan, Thuan-Tong; Hsu, Li-Yang; Kwa, Andrea L.			In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PSEUDOMONAS-AERUGINOSA; COLISTIN; STRAINS; HETERORESISTANCE; INFECTIONS; PNEUMONIA; IMIPENEM; FEATURES; THERAPY	Objective: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available. The objective of this study is to identify potential antimicrobial combinations against CR-AB isolated from our local hospitals. Methods: AB isolates from all public hospitals in Singapore were systematically collected between 2006 and 2007. MICs were determined according to CLSI guidelines. All CR-AB isolates were genotyped using a PCR-based method. Clonal relationship was elucidated. Time-kill studies (TKS) were conducted with polymyxin B, rifampicin and tigecycline alone and in combination using clinically relevant (achievable) unbound concentrations. Results: 31 CR AB isolates were identified. They are multidrug-resistant, but are susceptible to polymyxin B. From clonal typing, 8 clonal groups were identified and 11 isolates exhibited clonal diversity. In single TKS, polymyxin B, rifampicin and tigecycline alone did not exhibit bactericidal activity at 24 hours. In combination TKS, polymyxin plus rifampicin, polymyxin B plus tigecycline and tigecycline plus rifampicin exhibited bactericidal killing in 13/31, 9/31 and 7/31 isolates respectively at 24 hours. Within a clonal group, there may be no consensus with the types of antibiotics combinations that could still kill effectively. Conclusion: Monotherapy with polymyxin B may not be adequate against polymyxin B susceptible AB isolates. These findings demonstrate that in-vitro synergy of antibiotic combinations in CR AB may be strain dependant. It may guide us in choosing a pre-emptive therapy for CR AB infections and warrants further investigations.	[Lim, Tze-Peng; Lee, Winnie; Kwa, Andrea L.] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Tan, Thean-Yen; Sasikala, S.] Changi Gen Hosp, Dept Microbiol, Singapore, Singapore; [Lim, Tze-Peng; Hsu, Li-Yang] Natl Univ Singapore, Yong Loo Lin Sch Med, Div Infect Dis, Dept Med, Singapore 117595, Singapore	Singapore General Hospital; Changi General Hospital; National University of Singapore	Lim, TP (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	andrea.kwa.l.h@sgh.com.sg		Hsu, Li Yang/0000-0002-0396-066X; Tan, Thean Yen/0000-0003-4358-1098	National Medical Research Council, Singapore [NMRC 06May038]; SingHealth Foundation [SHF/FG385S/2008, SHF/FG355P/2007]; Wyeth Pharmaceuticals; Pfizer; Janssen-Cilag; Merck Sharp & Dohme (I.A.) Corp.	National Medical Research Council, Singapore(National Medical Research Council, Singapore); SingHealth Foundation(SingHealth); Wyeth Pharmaceuticals(Wyeth); Pfizer(Pfizer); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Sharp & Dohme (I.A.) Corp.(Merck & Company)	This study was supported by National Medical Research Council, Singapore (NMRC 06May038), and SingHealth Foundation (SHF/FG385S/2008, SHF/FG355P/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Transparency Declaration: on other occasions TTY and HLY have received funding for research from, and have been an invited as speakers for Wyeth Pharmaceuticals and Pfizer. ALK, WL and LTP have received funding for research from Janssen-Cilag and Merck Sharp & Dohme (I.A.) Corp. None of these companies provided any funding for this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Clinical and Laboratory Standards Institute, 1999, METH DET BACT ACT AN; Grundmann HJ, 1997, J CLIN MICROBIOL, V35, P3071, DOI 10.1128/JCM.35.12.3071-3077.1997; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hawley JS, 2008, ANTIMICROB AGENTS CH, V52, P351, DOI 10.1128/AAC.00766-07; Hogg GM, 1998, J ANTIMICROB CHEMOTH, V41, P494, DOI 10.1093/jac/41.4.494; KUNIN CM, 1973, ANN NY ACAD SCI, V226, P214, DOI 10.1111/j.1749-6632.1973.tb20483.x; Kuo LC, 2007, CLIN MICROBIOL INFEC, V13, P196, DOI 10.1111/j.1469-0691.2006.01601.x; Kwa ALH, 2007, DIAGN MICR INFEC DIS, V58, P99, DOI 10.1016/j.diagmicrobio.2006.11.014; Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06; LIM TP, 2009, J ANTIBIOT TOKYO; Lolans K, 2006, ANTIMICROB AGENTS CH, V50, P2941, DOI 10.1128/AAC.00116-06; Mendes RE, 2008, CLIN INFECT DIS, V46, P1324, DOI 10.1086/533476; Montero A, 2004, J ANTIMICROB CHEMOTH, V54, P1085, DOI 10.1093/jac/dkh485; Pachon-Ibanez ME, 2004, ANTIMICROB AGENTS CH, V48, P4479, DOI 10.1128/AAC.48.11.4479-4481.2004; Pantopoulou A, 2007, INT J ANTIMICROB AG, V29, P51, DOI 10.1016/j.ijantimicag.2006.09.009; Paterson DL, 2007, CLIN INFECT DIS, V45, P1179, DOI 10.1086/522287; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Rodvold KA, 2006, J ANTIMICROB CHEMOTH, V58, P1221, DOI 10.1093/jac/dkl403; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; Sopirala MM, 2010, ANTIMICROB AGENTS CH, V54, P4678, DOI 10.1128/AAC.00497-10; TAN LW, 2008, CHARACTERIZATION RES; Tascini C, 1998, J ANTIMICROB CHEMOTH, V42, P270, DOI 10.1093/jac/42.2.270; Timurkaynak F, 2006, INT J ANTIMICROB AG, V27, P224, DOI 10.1016/j.ijantimicag.2005.10.012; Tygacil (tigecycline) prescribing information, 2010, TYG TIG PRESCR INF; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P2001, DOI 10.1128/AAC.00226-07; Yoon J, 2004, ANTIMICROB AGENTS CH, V48, P753, DOI 10.1128/AAC.48.3.753-757.2004; Zavascki AP, 2008, CLIN INFECT DIS, V47, P1298, DOI 10.1086/592577	32	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18485	10.1371/journal.pone.0018485	http://dx.doi.org/10.1371/journal.pone.0018485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533030	gold, Green Published, Green Submitted			2022-12-27	WOS:000290014500004
J	Belaunzaran, OM; Cordero, MI; Setola, V; Bianchi, S; Galli, C; Bouche, N; Mlynarik, V; Gruetter, R; Sandi, C; Bensadoun, JC; Molinari, M; Aebischer, P				Belaunzaran, Osiris Marroquin; Cordero, Maria Isabel; Setola, Veronica; Bianchi, Siro; Galli, Carmela; Bouche, Nicolas; Mlynarik, Vladimir; Gruetter, Rolf; Sandi, Carmen; Bensadoun, Jean-Charles; Molinari, Maurizio; Aebischer, Patrick			Chronic Delivery of Antibody Fragments Using Immunoisolated Cell Implants as a Passive Vaccination Tool	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; ADENOASSOCIATED VIRUS; BETA IMMUNOTHERAPY; TRANSGENIC MOUSE; MICE; DEPOSITION; MODEL; ANGIOPATHY; IMPAIRMENT	Background: Monoclonal antibodies and antibody fragments are powerful biotherapeutics for various debilitating diseases. However, high production costs, functional limitations such as inadequate pharmacokinetics and tissue accessibility are the current principal disadvantages for broadening their use in clinic. Methodology and Principal Findings: We report a novel method for the long-term delivery of antibody fragments. We designed an allogenous immunoisolated implant consisting of polymer encapsulated myoblasts engineered to chronically release scFv antibodies targeted against the N-terminus of the Ab peptide. Following a 6-month intracerebral therapy we observed a significant reduction of the production and aggregation of the Ab peptide in the APP23 transgenic mouse model of Alzheimer's disease. In addition, functional assessment showed prevention of behavioral deficits related to anxiety and memory traits. Conclusions and Significance: The chronic local release of antibodies using immunoisolated polymer cell implants represents an alternative passive vaccination strategy in Alzheimer's disease. This novel technique could potentially benefit other diseases presently treated by local and systemic antibody administration.	[Belaunzaran, Osiris Marroquin; Setola, Veronica; Bouche, Nicolas; Bensadoun, Jean-Charles; Aebischer, Patrick] Ecole Polytech Fed Lausanne, Brain Mind Inst, Neurodegenerat Studies Lab, Lausanne, Switzerland; [Cordero, Maria Isabel; Sandi, Carmen] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland; [Bianchi, Siro; Galli, Carmela; Molinari, Maurizio] Inst Biomed Res, Bellinzona, Switzerland; [Mlynarik, Vladimir; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Belaunzaran, OM (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Neurodegenerat Studies Lab, Lausanne, Switzerland.	patrick.aebischer@epfl.ch	Molinari, Maurizio/N-2587-2019; Cordero, Maria Isabel/A-2532-2013; Cordero, Maria Isabel/AAF-2935-2019; Aebischer, Patrick/E-1387-2013; Mlynarik, Vladimir/D-8884-2011; Dunnett, Stephen B/A-5869-2010; Gruetter, Rolf/H-6260-2011	Molinari, Maurizio/0000-0002-7636-5829; Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Mlynarik, Vladimir/0000-0002-5789-8179; Dunnett, Stephen B/0000-0003-1826-1578; Gruetter, Rolf/0000-0003-1870-4025; Sandi, Carmen/0000-0001-7713-8321; Bianchi, Siro/0000-0002-5100-8905	Swiss National Science Foundation; Consejo Nacional de Ciencia y Tecnologia of Mexico; Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair; ONELIFE Advisors SA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); ONELIFE Advisors SA	This work was supported by the Swiss National Science Foundation, Consejo Nacional de Ciencia y Tecnologia of Mexico, the Foundation for Research on Neurodegenerative Diseases, the Fondazione San Salvatore, the Swiss National Center of Competence in Research on Neural Plasticity and Repair, the Swiss National Science Foundation, and ONELIFE Advisors SA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Deyev SM, 2008, BIOESSAYS, V30, P904, DOI 10.1002/bies.20805; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Fukuchi K, 2006, NEUROBIOL DIS, V23, P502, DOI 10.1016/j.nbd.2006.04.012; Furrer E, 2009, J NEUROIMMUNOL, V215, P65, DOI 10.1016/j.jneuroim.2009.08.005; Geylis V, 2006, AUTOIMMUN REV, V5, P33, DOI 10.1016/j.autrev.2005.06.007; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Kishima H, 2004, NEUROBIOL DIS, V16, P428, DOI 10.1016/j.nbd.2004.03.012; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Le Cudennec C, 2008, GENES BRAIN BEHAV, V7, P83, DOI 10.1111/j.1601-183X.2007.00374.x; Lee KW, 2004, J NEUROSCI RES, V76, P572, DOI 10.1002/jnr.20127; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Lichtlen P, 2008, J NEUROCHEM, V104, P859, DOI 10.1111/j.1471-4159.2007.05064.x; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nieri P, 2009, CURR MED CHEM, V16, P753, DOI 10.2174/092986709787458380; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Relkin NR, 2008, NEUROBIOL AGING; Sajadi A, 2006, NEUROBIOL DIS, V22, P119, DOI 10.1016/j.nbd.2005.10.006; Schneider BL, 2003, MOL THER, V7, P506, DOI 10.1016/S1525-0016(03)00055-8; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Wang YJ, 2009, NEUROBIOL AGING, V30, P364, DOI 10.1016/j.neurobiolaging.2007.06.013; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Wilcock DM, 2008, J ALZHEIMERS DIS, V15, P555; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	37	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18268	10.1371/journal.pone.0018268	http://dx.doi.org/10.1371/journal.pone.0018268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533130	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400007
J	Li, YJ; Minear, MA; Rimmler, J; Zhao, B; Balajonda, E; Hauser, MA; Allingham, RR; Eghrari, AO; Riazuddin, SA; Katsanis, N; Gottsch, JD; Gregory, SG; Klintworth, GK; Afshari, NA				Li, Yi-Ju; Minear, Mollie A.; Rimmler, Jacqueline; Zhao, Bei; Balajonda, Elmer; Hauser, Michael A.; Allingham, R. Rand; Eghrari, Allen O.; Riazuddin, S. Amer; Katsanis, Nicholas; Gottsch, John D.; Gregory, Simon G.; Klintworth, Gordon K.; Afshari, Natalie A.			Replication of TCF4 through Association and Linkage Studies in Late-Onset Fuchs Endothelial Corneal Dystrophy	PLOS ONE			English	Article							MISSENSE MUTATIONS; COL8A2; GENE; INHERITANCE; LOCUS; EXPRESSION; CHROMATIN; TESTS; MAPS	Fuchs endothelial corneal dystrophy (FECD) is a common, late-onset disorder of the corneal endothelium. Although progress has been made in understanding the genetic basis of FECD by studying large families in which the phenotype is transmitted in an autosomal dominant fashion, a recently reported genome-wide association study identified common alleles at a locus on chromosome 18 near TCF4 which confer susceptibility to FECD. Here, we report the findings of our independent validation study for TCF4 using the largest FECD dataset to date (450 FECD cases and 340 normal controls). Logistic regression with sex as a covariate was performed for three genetic models: dominant (DOM), additive (ADD), and recessive (REC). We found significant association with rs613872, the target marker reported by Baratz et al.(2010), for all three genetic models (DOM: P = 9.33 x 10(-35); ADD: P = 7.48 x 10(-30); REC: P = 5.27 x 10(-6)). To strengthen the association study, we also conducted a genome-wide linkage scan on 64 multiplex families, composed primarily of affected sibling pairs (ASPs), using both parametric and non-parametric two-point and multipoint analyses. The most significant linkage region localizes to chromosome 18 from 69.94cM to 85.29cM, with a peak multipoint HLOD = 2.5 at rs1145315 (75.58cM) under the DOM model, mapping 1.5 Mb proximal to rs613872. In summary, our study presents evidence to support the role of the intronic TCF4 single nucleotide polymorphism rs613872 in late-onset FECD through both association and linkage studies.	[Li, Yi-Ju] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Li, Yi-Ju; Minear, Mollie A.; Rimmler, Jacqueline; Zhao, Bei; Hauser, Michael A.; Gregory, Simon G.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Balajonda, Elmer; Allingham, R. Rand; Klintworth, Gordon K.; Afshari, Natalie A.] Duke Univ, Med Ctr, Ctr Eye, Durham, NC 27710 USA; [Eghrari, Allen O.; Riazuddin, S. Amer; Gottsch, John D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Klintworth, Gordon K.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Duke University	Li, YJ (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA.	yiju.li@duke.edu	Eghrari, Allen/ABH-4964-2020; Eghrari, Allen/AAI-9282-2021; Katsanis, Nicholas/E-1837-2012	Eghrari, Allen/0000-0003-2798-038X; Gregory, Simon/0000-0002-7805-1743; Li, Yi-Ju/0000-0001-6996-4834; Katsanis, Nicholas/0000-0002-2480-0171	NEI R01 [EY016514, EY016835, EY015543, EY019126, EY013315]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY019126, R01EY015543, R01EY016514, R01EY013315, R01EY016835] Funding Source: NIH RePORTER	NEI R01; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by NEI R01 grants EY016514 (GKK), EY016835 (JDG and NK), EY015543 (RRA), EY019126 (MAH) and EY013315 (MAH); and Research to Prevent Blindness (NAA; http://www.rpbusa.org/rpb/). NK is a Distinguished Brumley Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Afshari NA, 2006, ARCH OPHTHALMOL-CHIC, V124, P777, DOI 10.1001/archopht.124.6.777; Afshari NA, 2009, INVEST OPHTH VIS SCI, V50, P1093, DOI 10.1167/iovs.08-1839; Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P3787, DOI 10.1167/iovs.05-1635; [Anonymous], MOUS GEN DAT MGD MOU; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Borboli Sheila, 2002, Ophthalmol Clin North Am, V15, P17, DOI 10.1016/S0896-1549(01)00016-5; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CHANG S, 1998, GENETIC DIS EYE TXB; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROSS HE, 1971, ARCH OPHTHALMOL-CHIC, V85, P268; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46; Hemadevi B, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-3; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Kobayashi A, 2004, JPN J OPHTHALMOL, V48, P195, DOI 10.1007/s10384-003-0063-6; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liskova P, 2007, BRIT J OPHTHALMOL, V91, P1717, DOI 10.1136/bjo.2007.115154; Liu YT, 2010, AM J HUM GENET, V86, P498, DOI 10.1016/j.ajhg.2009.11.018; MAGOVERN M, 1979, OPHTHALMOLOGY, V86, P1897; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1986, GENET EPIDEMIOL, P251; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; RIAZUDDIN SA, 2011, INVEST OPHTHALMOL VI; RIAZUDDIN SA, 2010, HUM MUTAT; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; ROSENBLUM P, 1980, AM J OPHTHALMOL, V90, P455, DOI 10.1016/S0002-9394(14)75011-1; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	47	55	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18044	10.1371/journal.pone.0018044	http://dx.doi.org/10.1371/journal.pone.0018044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533127	gold, Green Submitted, Green Published			2022-12-27	WOS:000289719400005
J	Taylor, M; Banerjee, T; Navarro-Garcia, F; Huerta, J; Massey, S; Burlingame, M; Pande, AH; Tatulian, SA; Teter, K				Taylor, Michael; Banerjee, Tuhina; Navarro-Garcia, Fernando; Huerta, Jazmin; Massey, Shane; Burlingame, Mansfield; Pande, Abhay H.; Tatulian, Suren A.; Teter, Ken			A Therapeutic Chemical Chaperone Inhibits Cholera Intoxication and Unfolding/Translocation of the Cholera Toxin A1 Subunit	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; AMYOTROPHIC-LATERAL-SCLEROSIS; CHO-CELLS RESISTANT; ENDOPLASMIC-RETICULUM; INTRACELLULAR TRAFFICKING; THERMAL-STABILITY; EPITHELIAL-CELLS; MAMMALIAN-CELLS; PROTEIN TOXINS; CYTOSOL	Cholera toxin (CT) travels as an intact AB(5) protein toxin from the cell surface to the endoplasmic reticulum (ER) of an intoxicated cell. In the ER, the catalytic A1 subunit dissociates from the rest of the toxin. Translocation of CTA1 from the ER to the cytosol is then facilitated by the quality control mechanism of ER-associated degradation (ERAD). Thermal instability in the isolated CTA1 subunit generates an unfolded toxin conformation that acts as the trigger for ERAD-mediated translocation to the cytosol. In this work, we show by circular dichroism and fluorescence spectroscopy that exposure to 4-phenylbutyric acid (PBA) inhibited the thermal unfolding of CTA1. This, in turn, blocked the ER-to-cytosol export of CTA1 and productive intoxication of either cultured cells or rat ileal loops. In cell culture studies PBA did not affect CT trafficking to the ER, CTA1 dissociation from the holotoxin, or functioning of the ERAD system. PBA is currently used as a therapeutic agent to treat urea cycle disorders. Our data suggest PBA could also be used in a new application to prevent or possibly treat cholera.	[Taylor, Michael; Banerjee, Tuhina; Massey, Shane; Burlingame, Mansfield; Pande, Abhay H.; Teter, Ken] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Navarro-Garcia, Fernando; Huerta, Jazmin] IPN CINVESTAV Zacatenco, Dept Cell Biol, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; State University System of Florida; University of Central Florida	Taylor, M (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	kteter@mail.ucf.edu	Navarro-Garcia, Fernando/A-3980-2011	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R03 AI067987, R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI067987, R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants R03 AI067987 and R01 AI073783 to K. Teter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; BECH E, 1994, CLIN CHEM, V40, P1331; Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; CHANG FH, 1989, J BIOL CHEM, V264, P5352; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Lin Liang-Ping, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P61, DOI 10.2174/1568008053174697; Loffing J, 1999, AM J PHYSIOL-LUNG C, V277, pL700, DOI 10.1152/ajplung.1999.277.4.L700; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Paton JC, 2006, KIDNEY INT, V70, P2049, DOI 10.1038/sj.ki.5001954; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teckman JH, 2004, J PEDIATR GASTR NUTR, V39, P34, DOI 10.1097/00005176-200407000-00007; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06	50	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18825	10.1371/journal.pone.0018825	http://dx.doi.org/10.1371/journal.pone.0018825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526142	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100025
J	Beyerlein, A; von Kries, R; Ness, AR; Ong, KK				Beyerlein, Andreas; von Kries, Ruediger; Ness, Andrew R.; Ong, Ken K.			Genetic Markers of Obesity Risk: Stronger Associations with Body Composition in Overweight Compared to Normal-Weight Children	PLOS ONE			English	Article							CHILDHOOD OVERWEIGHT; MASS INDEX; FAT MASS; WORLDWIDE; VARIANTS; SHIFT	Background: Genetic factors are important determinants of overweight. We examined whether there are differential effect sizes depending on children's body composition. Methods: We analysed data of n = 4,837 children recorded in the Avon Longitudinal Study of Parents and Children (ALSPAC), applying quantile regression with sex-and age-specific standard deviation scores (SDS) of body mass index (BMI) or with body fat mass index and fat-free mass index at 9 years as outcome variables and an "obesity-risk-allele score" based on eight genetic variants known to be associated with childhood BMI as the explanatory variable. Results: The quantile regression coefficients increased with increasing child's BMI-SDS and fat mass index percentiles, indicating larger effects of the genetic factors at higher percentiles. While the associations with BMI-SDS were of similar size in medium and high BMI quantiles (40th percentile and above), effect sizes with fat mass index increased over the whole fat mass index distribution. For example, the fat mass index of a normal-weight (50th percentile) child was increased by 0.13 kg/m(2) (95% confidence interval (CI): 0.09, 0.16) per additional allele, compared to 0.24 kg/m(2) per allele (95% CI: 0.15, 0.32) in children at the 90th percentile. The genetic associations with fat-free mass index were weaker and the quantile regression effects less pronounced than those on fat mass index. Conclusions: Genetic risk factors for childhood overweight appear to have greater effects on fatter children. Interaction of known genetic factors with environmental or unknown genetic factors might provide a potential explanation of these findings.	[Beyerlein, Andreas; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Ness, Andrew R.] Sch Oral & Dent Sci, Bristol, Avon, England; [Ong, Ken K.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	University of Munich; University of Bristol; University of Cambridge	Beyerlein, A (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany.	andreas.beyerlein@med.uni-muenchen.de	Beyerlein, Andreas/I-7504-2019; Berryman, Katie/J-4236-2014; Ness, Andy R/M-7612-2013	Beyerlein, Andreas/0000-0001-6603-5036; Ness, Andy R/0000-0003-3548-9523	Deutsche Forschungsgemeinschaft (DFG); MRC [MC_U106179472] Funding Source: UKRI; Medical Research Council [MC_U106179472, G9815508] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This publication has been funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyerlein A, 2010, INT J OBESITY, V34, P642, DOI 10.1038/ijo.2009.301; Beyerlein A, 2008, OBESITY, V16, P2730, DOI 10.1038/oby.2008.432; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bressler J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010521; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Golding J, 2004, EUR J ENDOCRINOL, V151, pU119, DOI 10.1530/eje.0.151U119; Koenker R., 1994, ASYMPTOTIC STAT, P349, DOI [10.1007/978-3-642-57984-4_29, DOI 10.1007/978-3-642-57984-4_29]; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; LIU C, 2011, HUM GENET; LOCARD E, 1992, INT J OBESITY, V16, P721; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Reinehr T, 2009, OBESITY, V17, P382, DOI 10.1038/oby.2008.422; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Toschke AM, 2005, OBES RES, V13, P1270, DOI 10.1038/oby.2005.151; Toschke AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-115; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	24	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e19057	10.1371/journal.pone.0019057	http://dx.doi.org/10.1371/journal.pone.0019057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526213	gold, Green Published			2022-12-27	WOS:000289578600042
J	Claro, T; Widaa, A; O'Seaghdha, M; Miajlovic, H; Foster, TJ; O'Brien, FJ; Kerrigan, SW				Claro, Tania; Widaa, Amro; O'Seaghdha, Maghnus; Miajlovic, Helen; Foster, Timothy J.; O'Brien, Fergal J.; Kerrigan, Steven W.			Staphylococcus aureus Protein A Binds to Osteoblasts and Triggers Signals That Weaken Bone in Osteomyelitis	PLOS ONE			English	Article							APOPTOSIS; EXPRESSION; INTERNALIZATION; INTERLEUKIN-6; INFECTION; DOMAIN; MOUSE; HOST; TNF	Osteomyelitis is a debilitating infectious disease of the bone. It is predominantly caused by S. aureus and is associated with significant morbidity and mortality. It is characterised by weakened bones associated with progressive bone loss. Currently the mechanism through which either bone loss or bone destruction occurs in osteomyelitis patients is poorly understood. We describe here for the first time that the major virulence factor of S. aureus, protein A (SpA) binds directly to osteoblasts. This interaction prevents proliferation, induces apoptosis and inhibits mineralisation of cultured osteoblasts. Infected osteoblasts also increase the expression of RANKL, a key protein involved in initiating bone resorption. None of these effects was seen in a mutant of S. aureus lacking SpA. Complementing the SpA-defective mutant with a plasmid expressing spa or using purified protein A resulted in attachment to osteoblasts, inhibited proliferation and induced apoptosis to a similar extent as wildtype S. aureus. These events demonstrate mechanisms through which loss of bone formation and bone weakening may occur in osteomyelitis patients. This new information may pave the way for the development of new and improved therapeutic agents to treat this disease.	[Claro, Tania; Widaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [O'Seaghdha, Maghnus; Miajlovic, Helen; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dublin, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Kerrigan, Steven W.] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Claro, T (corresponding author), Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland.	skerrigan@rcsi.ie	Kerrigan, Steven/C-3922-2012; O'Brien, Fergal/F-9485-2011	O'Brien, Fergal/0000-0003-2030-8005; O'Seaghdha, Maghnus/0000-0002-0232-0556; Miajlovic, Helen/0000-0001-8854-4309	Science Foundation of Ireland [BMT/2008/1709]; Health Research Board of Ireland [RP/2006/2]; Royal College of Surgeons in Ireland	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board of Ireland; Royal College of Surgeons in Ireland	This work was supported by a grant from the Science Foundation of Ireland Research Frontiers Programme awarded to SWK (no. BMT/2008/1709), a Health Research Board of Ireland project grant RP/2006/2 to TJF and the Royal College of Surgeons in Ireland Alumni Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Alexander EH, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-5; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bost KL, 1999, J INFECT DIS, V180, P1912, DOI 10.1086/315138; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Bu RF, 2003, BONE, V33, P760, DOI 10.1016/j.bone.2003.07.006; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; CEDERGREN L, 1993, PROTEIN ENG, V6, P441, DOI 10.1093/protein/6.4.441; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Have KLV, 2009, J PEDIATR ORTHOPED, V29, P927, DOI 10.1097/BPO.0b013e3181bd1e0c; Hill P A, 1998, Br J Orthod, V25, P101; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Klosterhalfen B, 1996, J TRAUMA, V40, P372, DOI 10.1097/00005373-199603000-00008; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luong TT, 2002, INFECT IMMUN, V70, P3389, DOI 10.1128/IAI.70.7.3389-3395.2002; Marriott I, 2004, AM J PATHOL, V164, P1399, DOI 10.1016/S0002-9440(10)63226-9; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nilsson IM, 1997, INFECT IMMUN, V65, P4216, DOI 10.1128/IAI.65.10.4216-4221.1997; O'Seaghdha M, 2006, FEBS J, V273, P4831, DOI 10.1111/j.1742-4658.2006.05482.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Plunkett NA, 2010, TISSUE ENG PT A, V16, P943, DOI 10.1089/ten.TEA.2009.0345; Reilly SS, 2000, BONE, V26, P63, DOI 10.1016/S8756-3282(99)00239-2; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207; Tucker KA, 2000, FEMS MICROBIOL LETT, V186, P151, DOI 10.1016/S0378-1097(00)00125-7; UHLEN M, 1984, J BACTERIOL, V159, P713; Viau M, 2005, MOL IMMUNOL, V42, P849, DOI 10.1016/j.molimm.2004.07.047; vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003	44	114	122	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18748	10.1371/journal.pone.0018748	http://dx.doi.org/10.1371/journal.pone.0018748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525984	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600028
J	Lengyel, C; Orosz, A; Hegyi, P; Komka, Z; Udvardy, A; Bosnyak, E; Trajer, E; Pavlik, G; Toth, M; Wittmann, T; Papp, JG; Varro, A; Baczko, I				Lengyel, Csaba; Orosz, Andrea; Hegyi, Peter; Komka, Zsolt; Udvardy, Anna; Bosnyak, Edit; Trajer, Emese; Pavlik, Gabor; Toth, Miklos; Wittmann, Tibor; Papp, Julius Gy; Varro, Andras; Baczko, Istvan			Increased Short-Term Variability of the QT Interval in Professional Soccer Players: Possible Implications for Arrhythmia Prediction	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; TO-BEAT VARIABILITY; TORSADES-DE-POINTES; HEART-FAILURE; VENTRICULAR-ARRHYTHMIAS; CELLULAR BASIS; I-KS; REPOLARIZATION; BLOCK; DOGS	Background: Sudden cardiac death in competitive athletes is rare but it is significantly more frequent than in the normal population. The exact cause is seldom established and is mostly attributed to ventricular fibrillation. Myocardial hypertrophy and slow heart rate, both characteristic changes in top athletes in response to physical conditioning, could be associated with increased propensity for ventricular arrhythmias. We investigated conventional ECG parameters and temporal shortterm beat-to-beat variability of repolarization (STVQT), a presumptive novel parameter for arrhythmia prediction, in professional soccer players. Methods: Five-minute 12-lead electrocardiograms were recorded from professional soccer players (n = 76, all males, age 22.0 +/- 0.61 years) and age-matched healthy volunteers who do not participate in competitive sports (n = 76, all males, age 22.0 +/- 0.54 years). The ECGs were digitized and evaluated off-line. The temporal instability of beat-to-beat heart rate and repolarization were characterized by the calculation of short-term variability of the RR and QT intervals. Results: Heart rate was significantly lower in professional soccer players at rest (61 +/- 1.2 vs. 72 +/- 1.5/min in controls). The QT interval was prolonged in players at rest (419 +/- 3.1 vs. 390 +/- 3.6 in controls, p<0.001). QTc was significantly longer in players compared to controls calculated with Fridericia and Hodges correction formulas. Importantly, STVQT was significantly higher in players both at rest and immediately after the game compared to controls (4.8 +/- 0.14 and 4.3 +/- 0.14 vs. 3.5 +/- 0.10 ms, both p<0.001, respectively). Conclusions: STVQT is significantly higher in professional soccer players compared to age-matched controls, however, further studies are needed to relate this finding to increased arrhythmia propensity in this population.	[Lengyel, Csaba; Hegyi, Peter; Wittmann, Tibor] Univ Szeged, Fac Med, Dept Internal Med 1, Szeged, Hungary; [Orosz, Andrea; Papp, Julius Gy; Varro, Andras; Baczko, Istvan] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Komka, Zsolt; Udvardy, Anna; Bosnyak, Edit; Trajer, Emese; Pavlik, Gabor; Toth, Miklos] Semmelweis Univ, Fac Phys Educ & Sports Sci, Dept Hlth Sci & Sports Med, Budapest, Hungary; [Papp, Julius Gy; Varro, Andras] Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary	Szeged University; Szeged University; Semmelweis University; Hungarian Academy of Sciences	Lengyel, C (corresponding author), Univ Szeged, Fac Med, Dept Internal Med 1, Szeged, Hungary.	ibaczko@phcol.szote.u-szeged.hu	Udvardy, Andor/AAA-1473-2022; Varro, Andras/M-2647-2016; Baczko, István/I-7752-2019	Baczko, István/0000-0002-9588-0797; Bosnyak, Edit/0000-0003-0632-4279; Orosz, Andrea/0000-0002-0750-4741	National Office for Research and Technology [NKTH CARDIO 08]; Hungarian Academy of Sciences; Hungarian Scientific Research Fund (OTKA) [CNK-77855]; European Commission [EUGeneHeart-LSHM-CT-2005-118833, preDiCT - DG-INFSO - 224381]	National Office for Research and Technology(National Office for Research and Technology); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the National Office for Research and Technology (NKTH CARDIO 08), Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to I. B. and Cs.L.), Hungarian Scientific Research Fund (OTKA CNK-77855) and by the European Commission grants (EUGeneHeart-LSHM-CT-2005-118833 and preDiCT - DG-INFSO - 224381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy WB, 2003, J AM COLL CARDIOL, V41, P280, DOI 10.1016/S0735-1097(02)02633-5; Abi-Gerges N, 2010, BRIT J PHARMACOL, V159, P77, DOI 10.1111/j.1476-5381.2009.00338.x; Akar FG, 2003, CIRC RES, V93, P638, DOI 10.1161/01.RES.0000092248.59479.AE; Atchley AE, 2007, CARDIOL CLIN, V25, P371, DOI 10.1016/j.ccl.2007.06.009; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Biffi A, 2004, J AM COLL CARDIOL, V44, P1053, DOI 10.1016/j.jacc.2004.05.065; CONSTABLE PD, 1994, J APPL PHYSIOL, V76, P433, DOI 10.1152/jappl.1994.76.1.433; Constable PD, 2000, AM J VET RES, V61, P582, DOI 10.2460/ajvr.2000.61.582; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2007, CARDIOL CLIN, V25, P391, DOI 10.1016/j.ccl.2007.07.008; Corrado D, 2008, J AM COLL CARDIOL, V52, P1981, DOI 10.1016/j.jacc.2008.06.053; DiFrancesco D, 2007, DRUGS, V67, P15, DOI 10.2165/00003495-200767002-00003; Fridericia LS, 1920, ACTA MED SCAND, V53, P489; Frolov RV, 2008, J BIOL CHEM, V283, P1518, DOI 10.1074/jbc.M708100200; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; Hanton G., 2008, Journal of Pharmacological and Toxicological Methods, V57, P194, DOI 10.1016/j.vascn.2008.03.001; Hart G, 2003, EXP PHYSIOL, V88, P639, DOI 10.1113/eph8802619; Hinterseer M, 2008, EUR HEART J, V29, P185, DOI 10.1093/eurheartj/ehm586; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; Hinterseer M, 2009, AM J CARDIOL, V103, P1244, DOI 10.1016/j.amjcard.2009.01.011; Indik JH, 2006, HEART RHYTHM, V3, P1003, DOI 10.1016/j.hrthm.2006.05.023; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Jost N, 2007, ANN NONINVAS ELECTRO, V12, P64, DOI 10.1111/j.1542-474X.2007.00140.x; Kavazis AN, 2009, SPORTS MED, V39, P923, DOI 10.2165/11317870-000000000-00000; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Madias C, 2007, J CARDIOVASC ELECTR, V18, P115, DOI 10.1111/j.1540-8167.2006.00684.x; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; MARON BJ, 1980, CIRCULATION, V62, P218, DOI 10.1161/01.CIR.62.2.218; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nuss HB, 1999, AM J PHYSIOL-HEART C, V277, pH80, DOI 10.1152/ajpheart.1999.277.1.H80; PAOLO FM, 2007, CARDIOL CLIN, V25, P383; Parratt J, 1997, HEART, V78, P423, DOI 10.1136/hrt.78.5.423; Paylik G, 1996, Acta Physiol Hung, V84, P171; Pigozzi F, 2008, CLIN SPORT MED, V27, P153, DOI 10.1016/j.csm.2007.09.004; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Roden DM, 2005, CIRCULATION, V112, P1376, DOI 10.1161/CIRCULATIONAHA.105.562777; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; SHAPIRO LM, 1984, BRIT HEART J, V52, P130; So PS, 2008, BRIT J PHARMACOL, V155, P1185, DOI 10.1038/bjp.2008.354; Sperelakis N, 1996, MOL CELL BIOCHEM, V164, P85, DOI 10.1007/BF00408644; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Thomsen MB, 2005, BASIC RES CARDIOL, V100, P279, DOI 10.1007/s00395-005-0519-6; Thomsen MB, 2007, CARDIOVASC RES, V73, P521, DOI 10.1016/j.cardiores.2006.11.025; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Vago H, 2010, CIRCULATION, V121, P2456, DOI 10.1161/CIRCULATIONAHA.109.917724; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Varro A, 2006, CARDIOVASC RES, V70, P404, DOI 10.1016/j.cardiores.2006.04.006; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Volders PGA, 1999, CIRCULATION, V100, P2455, DOI 10.1161/01.CIR.100.24.2455; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Zitron E, 2005, CIRCULATION, V111, P835, DOI 10.1161/01.CIR.0000155617.54749.09; MOTHERWELL CAPTAIN O; BENFICA STRIKER DIES; CAM STAR FOE DIES CA	60	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18751	10.1371/journal.pone.0018751	http://dx.doi.org/10.1371/journal.pone.0018751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526208	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000289578600030
J	Papasergi, S; Brega, S; Mistou, MY; Firon, A; Oxaran, V; Dover, R; Teti, G; Shai, Y; Trieu-Cuot, P; Dramsi, S				Papasergi, Salvatore; Brega, Sara; Mistou, Michel-Yves; Firon, Arnaud; Oxaran, Virginie; Dover, Ron; Teti, Giuseppe; Shai, Yechiel; Trieu-Cuot, Patrick; Dramsi, Shaynoor			The GBS PI-2a Pilus Is Required for Virulence in Mice Neonates	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-AGALACTIAE; PROTEIN; SURFACE; SUSCEPTIBILITY; TRANSLOCATION; CONTRIBUTES; INVOLVEMENT; INFECTIONS; EXPRESSION	Background: Streptococcus agalactiae (Group B Streptococcus) is a leading cause of sepsis and meningitis in newborns. Most bacterial pathogens, including gram-positive bacteria, have long filamentous structures known as pili extending from their surface. Although pili are described as adhesive organelles, they have been also implicated in many other functions including thwarting the host immune responses. We previously characterized the pilus-encoding operon PI-2a (gbs14791474) in strain NEM316. This pilus is composed of three structural subunit proteins: PilA (Gbs1478), PilB (Gbs1477), and PilC (Gbs1474), and its assembly involves two class C sortases (SrtC3 and SrtC4). PilB, the bona fide pilin, is the major component whereas PilA, the pilus associated adhesin, and PilC the pilus anchor are both accessory proteins incorporated into the pilus backbone. Methodology/Principal Findings: In this study, the role of the major pilin subunit PilB was tested in systemic virulence using 6-weeks old and newborn mice. Notably, the non-piliated Delta pilB mutant was less virulent than its wild-type counterpart in the newborn mice model. Next, we investigated the possible role(s) of PilB in resistance to innate immune host defenses, i.e. resistance to macrophage killing and to antimicrobial peptides. Phagocytosis and survival of wild-type NEM316 and its isogenic Delta pilB mutant in immortalized RAW 264.7 murine macrophages were not significantly different whereas the isogenic Delta sodA mutant was more susceptible to killing. These results were confirmed using primary peritoneal macrophages. We also tested the activities of five cationic antimicrobial peptides (AMP-1D, LL-37, colistin, polymyxin B, and mCRAMP) and found no significant difference between WT and Delta pilB strains whereas the isogenic dltA mutant showed increased sensitivity. Conclusions/Significance: These results question the previously described role of PilB pilus in resistance to the host immune defenses. Interestingly, PilB was found to be important for virulence in the neonatal context.	[Papasergi, Salvatore; Brega, Sara; Mistou, Michel-Yves; Firon, Arnaud; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Papasergi, Salvatore; Brega, Sara; Mistou, Michel-Yves; Firon, Arnaud; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, URA 2172, Paris, France; [Papasergi, Salvatore; Teti, Giuseppe] Univ Messina, Elie Metchnikoff Dept, Messina, Italy; [Mistou, Michel-Yves] INRA, MICALIS, UMR 1319, Equipe Paroi, Jouy En Josas, France; [Oxaran, Virginie] INRA, MICALIS, UMR1319, Equipe Prot Surface Utiles, Jouy En Josas, France; [Dover, Ron; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Messina; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Weizmann Institute of Science	Papasergi, S (corresponding author), Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France.	shaynoor.dramsi@pasteur.fr	Mistou, Michel-Yves/AAY-2688-2021; papasergi, salvatore/AAE-8818-2021; Dover, Ron Saar/ABC-4574-2020	Brega, Sara/0000-0001-6378-842X; Oxaran, Virginie/0000-0001-6766-6497; Mistou, Michel-Yves/0000-0001-9732-3970; FIRON, Arnaud/0000-0002-5323-5212; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Agence Nationale de la Recherche "ERA-NET PathoGenoMics" [ANR-06-PATHO-001-01]; Network of Excellence "Europathogenomics" [LSHB-CT-2005-512061]; WIS [720047]; National Institute of Health (NIH) [R01 AI052455-06A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052455] Funding Source: NIH RePORTER	Agence Nationale de la Recherche "ERA-NET PathoGenoMics"(French National Research Agency (ANR)); Network of Excellence "Europathogenomics"; WIS; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants ANR-06-PATHO-001-01 from the Agence Nationale de la Recherche "ERA-NET PathoGenoMics" (to P. T.-C.), LSHB-CT-2005-512061 from the Network of Excellence "Europathogenomics" (to P. T.-C. and S. P), and WIS Project Number 720047 from Pasteur-Weizmann (to P. T.-C. and Y. S). This work was also supported in part by funding from the *National Institute of Health (NIH) Grant R01 AI052455-06A1* to P. T.-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Burns-Guydish SM, 2005, PEDIATR RES, V58, P153, DOI 10.1203/01.PDR.0000157725.44213.C4; Costakos Dennis T, 2009, WMJ, V108, P176; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Eichenbaum Z, 1998, APPL ENVIRON MICROB, V64, P2763; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; KREIKEMEYER B, 2010, INT J MED MICROBIOL; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Sambrook J, 1989, MOL CLONING LABORATO; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Urao M, 1996, J PEDIATR SURG, V31, P1482, DOI 10.1016/S0022-3468(96)90160-8; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987	42	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18747	10.1371/journal.pone.0018747	http://dx.doi.org/10.1371/journal.pone.0018747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525979	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600027
J	Wang, GZ; Lercher, MJ				Wang, Guang-Zhong; Lercher, Martin J.			The Effects of Network Neighbours on Protein Evolution	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SIMPLE DEPENDENCE; NUMBER; COEVOLUTION; EXPRESSION	Interacting proteins may often experience similar selection pressures. Thus, we may expect that neighbouring proteins in biological interaction networks evolve at similar rates. This has been previously shown for protein-protein interaction networks. Similarly, we find correlated rates of evolution of neighbours in networks based on co-expression, metabolism, and synthetic lethal genetic interactions. While the correlations are statistically significant, their magnitude is small, with network effects explaining only between 2% and 7% of the variation. The strongest known predictor of the rate of protein evolution remains expression level. We confirmed the previous observation that similar expression levels of neighbours indeed explain their similar evolution rates in protein-protein networks, and showed that the same is true for metabolic networks. In co-expression and synthetic lethal genetic interaction networks, however, neighbouring genes still show somewhat similar evolutionary rates even after simultaneously controlling for expression level, gene essentiality and gene length. Thus, similar expression levels and related functions (as inferred from co-expression and synthetic lethal interactions) seem to explain correlated evolutionary rates of network neighbours across all currently available types of biological networks.	[Wang, Guang-Zhong; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wang, GZ (corresponding author), Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany.	lercher@cs.uni-duesseldorf.de	Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621				Agrafioti I, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-23; [Anonymous], 2010, R LANG ENV STAT COMP; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bloom JD, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-14; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Jovelin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r35; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Lin YS, 2007, MOL BIOL EVOL, V24, P1005, DOI 10.1093/molbev/msm019; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Pal C, 2001, GENETICS, V158, P927; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; [No title captured]	42	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18288	10.1371/journal.pone.0018288	http://dx.doi.org/10.1371/journal.pone.0018288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532755	gold, Green Submitted, Green Published			2022-12-27	WOS:000289404700009
J	Beristain, AG; Zhu, H; Leung, PCK				Beristain, Alexander G.; Zhu, Hua; Leung, Peter C. K.			Regulated Expression of ADAMTS-12 in Human Trophoblastic Cells: A Role for ADAMTS-12 in Epithelial Cell Invasion?	PLOS ONE			English	Article							HUMAN EXTRAVILLOUS CYTOTROPHOBLASTS; VASCULAR INTEGRIN ALPHA(V)BETA(3); SMOOTH-MUSCLE-CELLS; GROWTH; METALLOPROTEINASES; DIFFERENTIATION; DISINTEGRIN; ADHESION; MATRIX; IMPLANTATION	Metastatic carcinoma cells exploit the same molecular machinery that allows human placental cytotrophoblasts to develop an invasive phenotype. As altered expression levels of ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin repeats) subtypes have been associated with cancer progression, we have examined the function and regulation of members of this gene family in epithelial cell invasion using cultures of highly invasive extravillous cytotrophoblasts and the poorly invasive JEG-3 cytotrophoblast cell line as model systems. Of the multiple ADAMTS subtypes identified in first trimester human placenta and these two trophoblastic cell types, only ADAMTS-12 was preferentially expressed by extravillous cytotrophoblasts. Transforming growth factor-beta 1 and interleukin-1 beta, two cytokines that promote and restrain cytotrophoblast invasion in vitro, were also found to differentially regulate trophoblastic ADAMTS-12 mRNA levels. Loss-or gain-of-function studies confirmed that ADAMTS-12, independent of its proteolytic activity, plays a specific, non-redundant role in trophoblast invasion. Furthermore, we demonstrated that ADAMTS-12 regulated cell-extracellular matrix adhesion and invasion through a mechanism involving the alpha v beta 3 integrin heterodimer. This study identifies a novel biological role for ADAMTS-12, and highlights the importance and complexity of its non-proteolytic domain(s) pertaining to its function.	[Beristain, Alexander G.] Ontario Canc Inst, Div Cell Signaling Biol, Toronto, ON M4X 1K9, Canada; [Beristain, Alexander G.; Zhu, Hua; Leung, Peter C. K.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia	Beristain, AG (corresponding author), Ontario Canc Inst, Div Cell Signaling Biol, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	aberista@uhnres.utoronto.ca		Leung, Peter/0000-0003-3152-3800; Beristain, Alexander/0000-0002-1117-6242	Canadian Institutes for Health Research [MOP-102578]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a research grant (#MOP-102578) to Dr. Colin D. MacCalman and PCKL from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; APLIN JD, 1991, J CELL SCI, V99, P681; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Bai XH, 2009, CELL MOL LIFE SCI, V66, P667, DOI 10.1007/s00018-008-8633-x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Chou CS, 2002, J CLIN ENDOCR METAB, V87, P5594, DOI 10.1210/jc.2002-020883; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9; Farina A, 2006, PRENATAL DIAG, V26, P128, DOI 10.1002/pd.1373; Gasparini G, 1998, CLIN CANCER RES, V4, P2625; Getsios S, 1998, J REPROD FERTIL, V114, P357; GOSPODAROWICZ D, 1981, J CELL BIOL, V89, P568, DOI 10.1083/jcb.89.3.568; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; GRAHAM CH, 1993, TROPHOBLAST RES, V7, P237; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hamel MG, 2008, EXP NEUROL, V210, P428, DOI 10.1016/j.expneurol.2007.11.014; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Iwahashi M, 1996, J REPROD FERTIL, V108, P147; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kabir-Salmani M, 2003, ENDOCRINOLOGY, V144, P1620, DOI 10.1210/en.2002-220886; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Knofler M, 2008, PLACENTA, V29, pS26, DOI 10.1016/j.placenta.2007.11.008; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 2004, BIOCHEM BIOPH RES CO, V319, P1327, DOI 10.1016/j.bbrc.2004.05.105; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; LaMarca HL, 2005, PLACENTA, V26, P709, DOI 10.1016/j.placenta.2004.11.003; Lessey BA, 2002, J REPROD IMMUNOL, V55, P101, DOI 10.1016/S0165-0378(01)00139-5; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; MacCalman CD, 1996, DEV DYNAM, V206, P201; MacCalman CD, 1998, AM J REPROD IMMUNOL, V39, P96; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; Masui T, 2001, CLIN CANCER RES, V7, P3437; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Porter S, 2006, INT J CANCER, V118, P1241, DOI 10.1002/ijc.21476; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; ZHOU Y, 1993, J CLIN INVEST, V89, P210	62	41	42	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18473	10.1371/journal.pone.0018473	http://dx.doi.org/10.1371/journal.pone.0018473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494557	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100015
J	Sormo, CG; Brembu, T; Winge, P; Bones, AM				Sormo, Christopher G.; Brembu, Tore; Winge, Per; Bones, Atle M.			Arabidopsis thaliana MIRO1 and MIRO2 GTPases Are Unequally Redundant in Pollen Tube Growth and Fusion of Polar Nuclei during Female Gametogenesis	PLOS ONE			English	Article							GAMETOPHYTE DEVELOPMENT; MITOCHONDRIAL MORPHOLOGY; EMBRYO DEVELOPMENT; AXONAL-TRANSPORT; RHO GTPASES; GENES; IDENTIFICATION; EMBRYOGENESIS; MUTAGENESIS; MUTATIONS	MIRO GTPases have evolved to regulate mitochondrial trafficking and morphology in eukaryotic organisms. A previous study showed that T-DNA insertion in the Arabidopsis MIRO1 gene is lethal during embryogenesis and affects pollen tube growth and mitochondrial morphology in pollen, whereas T-DNA insertion in MIRO2 does not affect plant development visibly. Phylogenetic analysis of MIRO from plants revealed that MIRO 1 and 2 orthologs in dicots cluster in two separate groups due to a gene/genome duplication event, suggesting that functional redundancy may exists between the two MIRO genes. To investigate this possibility, we generated miro1((+/-))/miro2-2((-/-)) plants. Compared to miro1((+/-)) plants, the miro1((+/-))/miro2-2((-/-)) plants showed increased segregation distortion. miro1((+/-))/miro2-2((-/-)) siliques contained less aborted seeds, but more than 3 times the number of undeveloped ovules. In addition, reciprocal crosses showed that co-transmission through the male gametes was nearly absent, whereas co-transmission through the female gametes was severely reduced in miro1((+/-))/miro2-2((-/-)) plants. Further investigations revealed that loss of MIRO2 (miro2((-/-))) function in the miro1((+/-)) background enhanced pollen tube growth defects. In developing miro1((+/-))/miro2((-/-)) embryo sacs, fusion of polar nuclei was further delayed or impaired compared to miro1 plants. This phenotype has not been reported previously for miro1 plants and coincides with studies showing that defects in some mitochondria-targeted genes results in the same phenotype. Our observations show that loss of function in MIRO2 in a miro1((+/-)) background enhances the miro1((+/-)) phenotype significantly, even though miro2((-/-)) plants alone does not display any phenotypes. Based on these findings, we conclude that MIRO1 and MIRO2 are unequally redundant and that a proportion of the miro1((+/-))/miro2((-/-)) plants haploid gametes displays the complete null phenotype of MIRO GTPase function at key developmental stages.	[Sormo, Christopher G.; Brembu, Tore; Winge, Per; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Sormo, CG (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	atle.bones@bio.ntnu.no	Brembu, Tore/J-7166-2015; Bones, Atle M/C-6202-2014	Brembu, Tore/0000-0001-5622-8037; Bones, Atle M/0000-0003-0544-7437	Norwegian Research Council [164583/V40, 184146/S10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (grants #164583/V40 and 184146/S10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, METH MOL B, V236, P177; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Briggs GC, 2006, TRENDS PLANT SCI, V11, P492, DOI 10.1016/j.tplants.2006.08.005; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Force A, 1999, GENETICS, V151, P1531; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Fujimoto M, 2009, PLANT J, V58, P388, DOI 10.1111/j.1365-313X.2009.03786.x; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Jayasekaran K, 2006, PLANT CELL REP, V25, P1255, DOI 10.1007/s00299-006-0195-5; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Logan DC, 2006, BBA-MOL CELL RES, V1763, P430, DOI 10.1016/j.bbamcr.2006.01.003; Logan DC, 2010, BIOCHEM SOC T, V38, P789, DOI 10.1042/BST0380789; Logan DC, 2006, J EXP BOT, V57, P1225, DOI 10.1093/jxb/erj151; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; McElver J, 2001, GENETICS, V159, P1751; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Portereiko MF, 2006, PLANT PHYSIOL, V141, P957, DOI 10.1104/pp.106.079319; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; SAOTOME M, 2008, CONTROL, V105, P20728; Tadege M, 1997, PLANT MOL BIOL, V35, P343, DOI 10.1023/A:1005837112653; Tan XY, 2010, PLANT CELL PHYSIOL, V51, P635, DOI 10.1093/pcp/pcq029; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Weinig C, 2003, GENETICS, V165, P321; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; WINGE P, 2002, EVOLUTION SMALL GTP; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yamaoka S, 2011, PLANT CELL REP, V30, P239, DOI 10.1007/s00299-010-0926-5	44	15	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18530	10.1371/journal.pone.0018530	http://dx.doi.org/10.1371/journal.pone.0018530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494602	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100018
J	Cerchietti, L; Damm-Welk, C; Vater, I; Klapper, W; Harder, L; Pott, C; Yang, SN; Reiter, A; Siebert, R; Melnick, A; Woessmann, W				Cerchietti, Leandro; Damm-Welk, Christine; Vater, Inga; Klapper, Wolfram; Harder, Lana; Pott, Christiane; Yang, Shao Ning; Reiter, Alfred; Siebert, Reiner; Melnick, Ari; Woessmann, Willi			Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas	PLOS ONE			English	Article							NPM-ALK; FUSION; STAT3; TRANSFORMATION; PROTEINS; CHILDREN; CANCER	ALK positive diffuse large B-cell lymphomas (DLBCL) are a distinct lymphoma subtype associated with a poor outcome. Most of them feature a t(2;17) encoding a clathrin (CLTC)-ALK fusion protein. The contribution of deregulated ALK-activity in the pathogenesis and maintenance of these DLBCLs is not yet known. We established and characterized the first CLTC-ALK positive DLBCL cell line (LM1). LM1 formed tumors in NOD-SCID mice. The selective ALK inhibitor NVP-TAE684 inhibited growth of LM1 cells in vitro at nanomolar concentrations. NVP-TAE684 repressed ALK-activated signalling pathways and induced apoptosis of LM1 DLBCL cells. Inhibition of ALK-activity resulted in sustained tumor regression in the xenotransplant tumor model. These data indicate a role of CLTC-ALK in the maintenance of the malignant phenotype thereby providing a rationale therapeutic target for these otherwise refractory tumors.	[Cerchietti, Leandro; Yang, Shao Ning; Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10021 USA; [Cerchietti, Leandro; Yang, Shao Ning; Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Damm-Welk, Christine; Reiter, Alfred; Woessmann, Willi] Univ Giessen, Dept Pediat Hematol & Oncol, Giessen, Germany; [Vater, Inga; Harder, Lana] Univ Kiel, Inst Human Genet, Kiel, Germany; [Klapper, Wolfram; Siebert, Reiner] Univ Hosp Schleswig Holstein, Dept Pathol, Hematopathol Sect, Kiel, Germany; [Klapper, Wolfram; Siebert, Reiner] Univ Hosp Schleswig Holstein, Lymph Node Registry, Kiel, Germany; [Pott, Christiane] Univ Kiel, Dept Med 2, Kiel, Germany	Cornell University; Cornell University; Justus Liebig University Giessen; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Cerchietti, L (corresponding author), Cornell Univ, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10021 USA.	lec2010@med.cornell.edu; wilhelm.woessmann@paediat.med.uni-giessen.de	Siebert, Reiner/A-8049-2010; Klapper, Wolfram/S-6314-2016; Melnick, Ari/AAA-5763-2020	Cerchietti, Leandro/0000-0003-0608-1350	Forschungshilfe Peiper; Deutsche Jose-Carreras Leukamiestiftung [DJCLS R 08/09]; Leukemia and Lymphoma Society [SCOR 7017-09]; Kinderkrebsinitiative Buchholz; Holm-Seppensen	Forschungshilfe Peiper; Deutsche Jose-Carreras Leukamiestiftung; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Kinderkrebsinitiative Buchholz; Holm-Seppensen	C.D., A.R. and W.W. were supported by the Forschungshilfe Peiper, W.K. and R.S. by the Kinderkrebsinitiative Buchholz, Holm-Seppensen. A. M. is a Scholar of the Leukemia and Lymphoma Society and a Burroughs Wellcome Clinical Translational Scientist. This work was supported in part by a grant from the Deutsche Jose-Carreras Leukamiestiftung (DJCLS R 08/09) and by Leukemia and Lymphoma Society (SCOR 7017-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Beltran B, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-11; Brugieres L, 1998, BLOOD, V92, P3591; Brugieres L, 2009, J CLIN ONCOL, V27, P897, DOI 10.1200/JCO.2008.18.1487; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cussac D, 2004, BLOOD, V103, P1464; Damm-Welk C, 2009, BRIT J HAEMATOL, V146, P306, DOI 10.1111/j.1365-2141.2009.07754.x; De Paepe P, 2003, BLOOD, V102, P2638, DOI 10.1182/blood-2003-04-1050; Delsol G, 1997, BLOOD, V89, P1483, DOI 10.1182/blood.V89.5.1483.1483_1483_1490; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gascoyne RD, 2003, BLOOD, V102, P2568, DOI 10.1182/blood-2003-03-0786; Gesk S, 2005, LEUKEMIA, V19, P1839, DOI 10.1038/sj.leu.2403921; Laurent C, 2009, J CLIN ONCOL, V27, P4211, DOI 10.1200/JCO.2008.21.5020; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; Momose S, 2009, HUM PATHOL, V40, P75, DOI 10.1016/j.humpath.2008.06.009; Nieborowska-Skorska M, 2001, CANCER RES, V61, P6517; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Swerdlow SH, 2008, WHO CLASSIFICATION T; Turner SD, 2005, LEUKEMIA, V19, P1128, DOI 10.1038/sj.leu.2403797; Woessmann W, 2006, BRIT J HAEMATOL, V133, P176, DOI 10.1111/j.1365-2141.2006.06004.x; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152	23	36	40	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18436	10.1371/journal.pone.0018436	http://dx.doi.org/10.1371/journal.pone.0018436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494621	Green Published, Green Submitted, gold			2022-12-27	WOS:000289292800017
J	Krstic, G				Krstic, Goran			Asthma Prevalence Associated with Geographical Latitude and Regional Insolation in the United States of America and Australia	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; EMERGENCY-DEPARTMENT VISITS; RESPIRATORY SYMPTOMS; ALLERGIC RHINITIS; VARIABILITY; PREGNANCY; CHILDREN; CLIMATE; IL-10; BLOOD	Background: It has been proposed that vitamin D deficiency may be responsible for an increase in the prevalence of allergic diseases and asthma worldwide. Human ability to generate physiologically required quantities of vitamin D through sun exposure is decreasing with increasing geographical latitude. Objectives: Considering that vitamin D deficiency is usually due to lack of outdoor sun exposure, this study is designed to test the hypothesis that a higher prevalence of asthma should be expected at high relative to low geographical latitudes. Methods: Linear regression analyses are performed on asthma prevalence in the U. S. adult population vs. geographical latitude, insolation, air temperature, and air pollution (PM2.5) for 97 major metropolitan/micropolitan statistical areas of the continental United States of America and on general population asthma prevalence vs. geographical latitude in eight metropolitan areas of Australia. Results: A 10 degrees change in geographical latitude from southern to northern regions of the Eastern Seaboard is associated with a 2% increase in adult asthma prevalence (p < 0.001). Total insolation in winter months is almost as strong as latitude in its ability to explain the observed spatial variation in the prevalence of asthma (r(2) = 0.43; p < 0.001). Similar results are obtained using the Australian data (r(2) = 0.73; p < 0.01), suggesting a consistent association between the latitude/insolation and asthma prevalence worldwide. Conclusions: The results of this study suggest that, as a known modulator of the immune response closely linked with the geographical latitude and erythemal UV irradiation, vitamin D may play an important role in the development/exacerbation of asthma.	Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada		Krstic, G (corresponding author), Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada.	Goran.Krstic@fraserhealth.ca						Aiba Setsuya, 2007, Allergol Int, V56, P201, DOI 10.2332/allergolint.R-07-147; Akinbami L., 2006, ADV DATA VITAL HLTH; Allan K, 2010, P NUTR SOC, V69, pE475, DOI 10.1017/S0029665110003381; [Anonymous], 2008, BEH RISK FACT SURV S; Bharadwaj AS, 2007, CAN J PHYSIOL PHARM, V85, P686, DOI 10.1139/Y07-062; *C STURT U, 1996, GUID AUSTR LAT LONG; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cutolo M, 2009, RHEUMATOLOGY, V48, P210, DOI 10.1093/rheumatology/ken394; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Fioletov VE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004820; Franco JM, 2009, ALLERGOL IMMUNOPATH, V37, P116, DOI 10.1016/S0301-0546(09)71722-7; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Genuis SJ, 2009, INT J ENV RES PUB HE, V6, P151, DOI 10.3390/ijerph6010151; George R B, 1991, Dis Mon, V37, P137; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Grant EN, 2000, AM J PUBLIC HEALTH, V90, P1923, DOI 10.2105/AJPH.90.12.1923; Grant WB, 2007, EXPERT REV DERMATOL, V2, P563; Hintzpeter B, 2008, J NUTR, V138, P1482, DOI 10.1093/jn/138.8.1482; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; Koskela HO, 2007, INT J CIRCUMPOL HEAL, V66, P91, DOI 10.3402/ijch.v66i2.18237; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Matsumoto K, 2004, INT ARCH ALLERGY IMM, V134, P295, DOI 10.1159/000079167; Mead MN, 2008, ENVIRON HEALTH PERSP, V116, pA22, DOI 10.1289/ehp.116-a22b; Meng Ying-Ying, 2007, Policy Brief UCLA Cent Health Policy Res, P1; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Murillo W, 2003, RENEW ENERG, V28, P409, DOI 10.1016/S0960-1481(02)00039-3; *NASA ATM SCI DAT, SURF MET SOL EN INT; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; *PUBL HLTH INF DEV, 2010, SOC HLTH ATL AUSTR L; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V104, P413, DOI 10.1016/j.anai.2010.01.022; Schauber J, 2008, J ALLERGY CLIN IMMUN, V121, P782, DOI 10.1016/j.jaci.2007.12.1170; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Tomita K, 2002, CLIN IMMUNOL, V102, P258, DOI 10.1006/clim.2001.5176; Trabea A. A., 2001, Egyptian Journal of Solids, V24, P123; *US EPA, 2009, AIR TRENDS AIR QUAL; *USGS, 2010, MICR RES MSR MAPS; Wang XL, 2007, P SOC PHOTO-OPT INS, V6679, P67903, DOI 10.1117/12.735284; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Wjst M, 1999, ALLERGY, V54, P757, DOI 10.1034/j.1398-9995.1999.00193.x; Wjst M, 2006, PEDIAT ALLERG IMM-UK, V17, P477, DOI 10.1111/j.1399-3038.2006.00456.x; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Zanolin ME, 2004, ALLERGY, V59, P306, DOI 10.1046/j.1398-9995.2003.00391.x	49	53	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18492	10.1371/journal.pone.0018492	http://dx.doi.org/10.1371/journal.pone.0018492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	747AP	21494627	Green Published, Green Submitted, gold			2022-12-27	WOS:000289292800025
J	Hendrickson, ML; Rao, AJ; Demerdash, ONA; Kalil, RE				Hendrickson, Michael L.; Rao, Abigail J.; Demerdash, Omar N. A.; Kalil, Ronald E.			Expression of Nestin by Neural Cells in the Adult Rat and Human Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTERMEDIATE-FILAMENT PROTEIN; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; BASAL FOREBRAIN; STEM-CELLS; IMMUNOREACTIVE NEURONS; PURKINJE-CELLS; NEUROGENESIS; PHOSPHORYLATION	Neurons and glial cells in the developing brain arise from neural progenitor cells (NPCs). Nestin, an intermediate filament protein, is thought to be expressed exclusively by NPCs in the normal brain, and is replaced by the expression of proteins specific for neurons or glia in differentiated cells. Nestin expressing NPCs are found in the adult brain in the subventricular zone (SVZ) of the lateral ventricle and the subgranular zone (SGZ) of the dentate gyrus. While significant attention has been paid to studying NPCs in the SVZ and SGZ in the adult brain, relatively little attention has been paid to determining whether nestin-expressing neural cells (NECs) exist outside of the SVZ and SGZ. We therefore stained sections immunocytochemically from the adult rat and human brain for NECs, observed four distinct classes of these cells, and present here the first comprehensive report on these cells. Class I cells are among the smallest neural cells in the brain and are widely distributed. Class II cells are located in the walls of the aqueduct and third ventricle. Class IV cells are found throughout the forebrain and typically reside immediately adjacent to a neuron. Class III cells are observed only in the basal forebrain and closely related areas such as the hippocampus and corpus striatum. Class III cells resemble neurons structurally and co-express markers associated exclusively with neurons. Cell proliferation experiments demonstrate that Class III cells are not recently born. Instead, these cells appear to be mature neurons in the adult brain that express nestin. Neurons that express nestin are not supposed to exist in the brain at any stage of development. That these unique neurons are found only in brain regions involved in higher order cognitive function suggests that they may be remodeling their cytoskeleton in supporting the neural plasticity required for these functions.	[Hendrickson, Michael L.] Univ Wisconsin, WM Keck Lab Biol Imaging, Madison, WI 53706 USA; [Rao, Abigail J.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Demerdash, Omar N. A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Kalil, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hendrickson, ML (corresponding author), Univ Wisconsin, WM Keck Lab Biol Imaging, Madison, WI 53706 USA.	rekalil@wisc.edu		Hendrickson, Michael/0000-0002-4555-765X	University of Wisconsin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	University of Wisconsin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the University of Wisconsin Foundation (http://www.supportuw.org/) and by various intramural awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; BRAAK H, 1994, NEURODEGENER DIS, P585; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Chouaf-Lakhdar L, 2003, NEUROREPORT, V14, P633, DOI 10.1097/00001756-200303240-00022; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duggal N, 2001, J NEUROSURG, V95, P459, DOI 10.3171/jns.2001.95.3.0459; Ernst C, 2006, NEUROSCIENCE, V138, P183, DOI 10.1016/j.neuroscience.2005.10.065; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Gu HY, 2002, BRAIN RES, V943, P174, DOI 10.1016/S0006-8993(02)02615-X; Guo KH, 2010, NEUROCHEM INT, V56, P694, DOI 10.1016/j.neuint.2010.02.005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Krupkova O, 2010, NEOPLASMA, V57, P291, DOI 10.4149/neo_2010_04_291; LEHERICY S, 1993, J COMP NEUROL, V330, P15, DOI 10.1002/cne.903300103; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li DP, 2008, NEUROCHEM INT, V53, P270, DOI 10.1016/j.neuint.2008.08.006; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Mai JK., 2007, ATLAS HUMAN BRAIN; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizuno Y, 2006, J NEUROL SCI, V246, P131, DOI 10.1016/j.jns.2006.02.019; Mizuno Y, 2004, NEUROSCI LETT, V366, P144, DOI 10.1016/j.neulet.2004.05.033; Mizuno Y, 2003, NEUROSCI LETT, V352, P109, DOI 10.1016/j.neulet.2003.08.056; Muir JL, 1997, PHARMACOL BIOCHEM BE, V56, P687, DOI 10.1016/S0091-3057(96)00431-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Rao MS, 1999, ANAT RECORD, V257, P137; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Takamori Y, 2009, BRAIN RES, V1270, P10, DOI 10.1016/j.brainres.2009.03.014; VINORES SA, 1985, NEUROPATH APPL NEURO, V11, P349, DOI 10.1111/j.1365-2990.1985.tb00031.x; Wang S, 2006, NEUROSCIENCE, V142, P1209, DOI 10.1016/j.neuroscience.2006.07.059; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	51	105	120	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18535	10.1371/journal.pone.0018535	http://dx.doi.org/10.1371/journal.pone.0018535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490921	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700021
J	Varcoe, TJ; Wight, N; Voultsios, A; Salkeld, MD; Kennaway, DJ				Varcoe, Tamara J.; Wight, Nicole; Voultsios, Athena; Salkeld, Mark D.; Kennaway, David J.			Chronic Phase Shifts of the Photoperiod throughout Pregnancy Programs Glucose Intolerance and Insulin Resistance in the Rat	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; PITUITARY-ADRENAL AXIS; PRENATAL STRESS; BODY-WEIGHT; ADULT RATS; GLUCOCORTICOID EXPOSURE; BEHAVIORAL ALTERATIONS; LATE-GESTATION; DIABETIC-RATS; BIRTH-WEIGHT	Shift work during pregnancy is associated with an increased risk for preterm birth and low birth weight. However, the impact upon the long term health of the children is currently unknown. In this study, we used an animal model to determine the consequences of maternal shift work exposure on the health of the adult offspring. Pregnant rats were exposed to chronic phase shifts (CPS) in their photoperiod every 3-4 days throughout gestation and the first week after birth. Adult offspring were assessed for a range of metabolic, endocrine, circadian and neurobehavioural parameters. At 3 months of age, male pups exposed to the CPS schedule in utero had increased adiposity (+29%) and hyperleptinaemia (+99% at 0700h). By 12 months of age, both male and female rats displayed hyperleptinaemia (+26% and +41% respectively) and hyperinsulinaemia (+110% and +83% respectively). 12 month old female CPS rats displayed poor glucose tolerance (+18%) and increased insulin secretion (+29%) in response to an intraperitoneal glucose tolerance test. In CPS males the glucose response was unaltered, but the insulin response was reduced by 35%. The glucose response to an insulin tolerance test was decreased by 21% in CPS females but unaltered in males. Disruption of circadian rhythmicity during gestation resulted in gender dependent metabolic consequences for the adult offspring. These results highlight the need for a thorough analysis of shift work exposure in utero on the health of the adult offspring in humans.	[Varcoe, Tamara J.; Wight, Nicole; Voultsios, Athena; Salkeld, Mark D.; Kennaway, David J.] Univ Adelaide, Res Ctr Reprod Hlth, Robinson Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Varcoe, TJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Robinson Inst, Adelaide, SA, Australia.	tamara.varcoe@adelaide.edu.au	Kennaway, David J/B-8955-2009; Varcoe, Tamara/H-2785-2014	Kennaway, David J/0000-0002-5864-3514; Varcoe, Tamara/0000-0002-9462-1830	Women's and Children's Hospital Foundation	Women's and Children's Hospital Foundation	This project was funded through a project grant to TJV from the Women's and Children's Hospital Foundation (http://www.wchfoundation.org.au/Contentaspx?p=120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Aerts L, 1997, DIABETES RES CLIN PR, V38, P9, DOI 10.1016/S0168-8227(97)00080-6; Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Cabrera RJ, 1999, BRAZ J MED BIOL RES, V32, P1229, DOI 10.1590/S0100-879X1999001000009; Carrapato MRG, 2003, J PERINAT MED, V31, P5, DOI 10.1515/JPM.2003.001; Choi GY, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.024; D'mello AP, 2006, PSYCHONEUROENDOCRINO, V31, P395, DOI 10.1016/j.psyneuen.2005.10.003; Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899; Drago F, 1999, EUR NEUROPSYCHOPHARM, V9, P239, DOI 10.1016/S0924-977X(98)00032-7; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Estanislau C, 2005, BEHAV BRAIN RES, V163, P70, DOI 10.1016/j.bbr.2005.04.003; Ferguson SA, 2000, NEUROREPORT, V11, P1539, DOI 10.1097/00001756-200005150-00034; GAUGUIER D, 1990, DIABETES, V39, P734, DOI 10.2337/diabetes.39.6.734; Gerardin DCC, 2005, PHYSIOL BEHAV, V84, P97, DOI 10.1016/j.physbeh.2004.10.014; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; HOLEMANS K, 1991, DIABETOLOGIA, V34, P81, DOI 10.1007/BF00500377; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Joseph V, 2002, J PHYSIOL-LONDON, V543, P387, DOI 10.1113/jphysiol.2002.022236; Kennaway DJ, 2001, J PINEAL RES, V30, P188, DOI 10.1034/j.1600-079X.2001.300308.x; Kiss ACI, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-21; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Koehl M, 1999, J NEUROBIOL, V40, P302, DOI 10.1002/(SICI)1097-4695(19990905)40:3<302::AID-NEU3>3.0.CO;2-7; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lawson CC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.006; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; LETURQUE A, 1984, AM J PHYSIOL, V246, pE25, DOI 10.1152/ajpendo.1984.246.1.E25; MCDONALD AD, 1988, BRIT J IND MED, V45, P56; Merzouk H, 2001, J LIPID RES, V42, P1152; MUNOZ C, 1995, BIOL NEONATE, V68, P282, DOI 10.1159/000244248; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; OH W, 1988, METABOLISM, V37, P1146, DOI 10.1016/0026-0495(88)90192-8; OROZCOSOLIS R, 2010, INT J OBES LOND; Patin V, 2002, DEV BRAIN RES, V139, P1, DOI 10.1016/S0165-3806(02)00491-1; Saito FH, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-26; Soulimane-Mokhtari NA, 2005, CLIN SCI, V109, P287, DOI 10.1042/CS20050028; Sugden MC, 2002, J ENDOCRINOL, V175, P757, DOI 10.1677/joe.0.1750757; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; SZANTOOVA K, 2010, MOL CELL BIOCH; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Tsai LL, 2005, AM J PHYSIOL-ENDOC M, V289, pE212, DOI 10.1152/ajpendo.00603.2004; Whelan EA, 2007, EPIDEMIOLOGY, V18, P350, DOI 10.1097/01.ede.0000259988.77314.a4; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhu JL, 2004, AM J OBSTET GYNECOL, V191, P285, DOI 10.1016/j.ajog.2003.12.002; 2006, AUSTR BUREAU STAT, P6342	50	76	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18504	10.1371/journal.pone.0018504	http://dx.doi.org/10.1371/journal.pone.0018504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494686	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400033
J	Rizvi, F; Heimann, T; Herrnreiter, A; O'Brien, WJ				Rizvi, Farhan; Heimann, Tom; Herrnreiter, Anja; O'Brien, William J.			Mitochondrial Dysfunction Links Ceramide Activated HRK Expression and Cell Death	PLOS ONE			English	Article							APOPTOSIS; MEMBRANE; STRESS; OXIDASE; PROTEIN; BCL-2; BAX; SPHINGOMYELINASE; SUPEROXIDE; SURVIVAL	Purpose: Cell death is an essential process in normal development and homeostasis. In eyes, corneal epithelial injury leads to the death of cells in underlying stroma, an event believed to initiate corneal wound healing. The molecular basis of wound induced corneal stromal cell death is not understood in detail. Studies of others have indicated that ceramide may play significant role in stromal cell death following LASIK surgery. We have undertaken the present study to investigate the mechanism of death induced by C6 ceramide in cultures of human corneal stromal (HCSF) fibroblasts. Methods: Cultures of HCSF were established from freshly excised corneas. Cell death was induced in low passage (p<4) cultures of HCSF by treating the cells with C6 ceramide or C6 dihydroceramide as a control. Cell death was assessed by Live/Dead cell staining with calcein AM and ethidium homodimer-1 as well as Annexin V staining, caspase activation and TUNEL staining Mitochondrial dysfunction was assessed by Mito Sox Red, JC-1 and cytochrome C release Gene expression was examined by qPCR and western blotting. Results: Our data demonstrate ceramide caused mitochondrial dysfunction as evident from reduced MTT staining, cyto c release from mitochondria, enhanced generation of ROS, and loss in mitochondrial membrane potential (Delta Psi(m)). Cell death was evident from Live -Dead Cell staining and the inability to reestablish cultures from detached cells. Ceramide induced the expression of the harikari gene(HRK) and up-regulated JNK phosphorylation. In ceramide treated cells HRK was translocated to mitochondria, where it was found to interact with mitochondrial protein p32. The data also demonstrated HRK, p32 and BAD interaction. Ceramide-induced expression of HRK, mitochondrial dysfunction and cell death were reduced by HRK knockdown with HRK siRNA. Conclusion: Our data document that ceramide is capable of inducing death of corneal stromal fibroblasts through the induction of HRK mediated mitochondria dysfunction.	[Rizvi, Farhan; Heimann, Tom; Herrnreiter, Anja; O'Brien, William J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [O'Brien, William J.] Med Coll Wisconsin, Dept Microbiol Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Rizvi, F (corresponding author), Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA.	frizvi@mcw.edu; wjob@mcw.edu			National Institutes of Health (NIH) [R01-EY017079, P30-EY01931, C06-RR016511]; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016511] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017079, P30EY001931] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by National Institutes of Health (NIH) Grants R01-EY017079 and P30-EY01931 and an unrestricted grant from Research to Prevent Blindness. Research was conducted in facilities constructed in part by Construction Grant C06-RR016511 from NIH. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basu S, 1998, J BIOL CHEM, V273, P30419, DOI 10.1074/jbc.273.46.30419; Basu S, 1998, ONCOGENE, V17, P3277, DOI 10.1038/sj.onc.1202570; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Chen SW, 2006, J NEUROCHEM, V97, P631, DOI 10.1111/j.1471-4159.2006.03774.x; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Freimoser FM, 1999, APPL ENVIRON MICROB, V65, P3727; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim TI, 2005, CORNEA, V24, P72, DOI 10.1097/01.ico.0000134000.52886.c3; Loughlin DT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011093; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Nakamura M, 2008, ONCOGENE, V27, pS105, DOI 10.1038/onc.2009.48; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; O'Brien WJ, 2009, MOL VIS, V15, P2535; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; PNG E, 2010, J CELL PHYSL; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Wei MC, 2000, GENE DEV, V14, P2060; Yi F, 2004, KIDNEY INT, V66, P1977, DOI 10.1111/j.1523-1755.2004.00968.x; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	43	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18137	10.1371/journal.pone.0018137	http://dx.doi.org/10.1371/journal.pone.0018137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483866	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200031
J	Menon, R; Farina, C				Menon, Ramesh; Farina, Cinthia			Shared Molecular and Functional Frameworks among Five Complex Human Disorders: A Comparative Study on Interactomes Linked to Susceptibility Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; RHEUMATOID-ARTHRITIS; GROWTH; PATHWAY; AUTOIMMUNITY; INFLAMMATION; RECEPTOR; INSULIN	Background: Genome-wide association studies (gwas) are invaluable in revealing the common variants predisposing to complex human diseases. Yet, until now, the large volumes of data generated from such analyses have not been explored extensively enough to identify the molecular and functional framework hosting the susceptibility genes. Methodology/Principal Findings: We investigated the relationships among five neurodegenerative and/or autoimmune complex human diseases (Parkinson's disease-Park, Alzheimer's disease-Alz, multiple sclerosis-MS, rheumatoid arthritis-RA and Type 1 diabetes-T1D) by characterising the interactomes linked to their gwas-genes. An initial study on the MS interactome indicated that several genes predisposing to the other autoimmune or neurodegenerative disorders may come into contact with it, suggesting that susceptibility to distinct diseases may converge towards common molecular and biological networks. In order to test this hypothesis, we performed pathway enrichment analyses on each disease interactome independently. Several issues related to immune function and growth factor signalling pathways appeared in all autoimmune diseases, and, surprisingly, in Alzheimer's disease. Furthermore, the paired analyses of disease interactomes revealed significant molecular and functional relatedness among autoimmune diseases, and, unexpectedly, between T1D and Alz. Conclusions/Significance: The systems biology approach highlighted several known pathogenic processes, indicating that changes in these functions might be driven or sustained by the framework linked to genetic susceptibility. Moreover, the comparative analyses among the five genetic interactomes revealed unexpected genetic relationships, which await further biological validation. Overall, this study outlines the potential of systems biology to uncover links between genetics and pathogenesis of complex human disorders.	[Menon, Ramesh; Farina, Cinthia] Fdn IRCCS Neurol Inst Carlo Besta, Neuroimmunol & Neuromuscular Disorders Unit, Milan, Italy; [Menon, Ramesh; Farina, Cinthia] Ist Sci San Raffaele, Inst Expt Neurol INSpe, I-20132 Milan, Italy	IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Menon, R (corresponding author), Fdn IRCCS Neurol Inst Carlo Besta, Neuroimmunol & Neuromuscular Disorders Unit, Milan, Italy.	farina.cinthia@hsr.it	Farina, Cinthia/G-8911-2014	Farina, Cinthia/0000-0002-4466-9676; Menon, Ramesh/0000-0002-8145-8886	Fondazione Cariplo [2006.0721/10.4898]; Italian Ministry for Health [RFPS-2007-1-637146]	Fondazione Cariplo(Fondazione Cariplo); Italian Ministry for Health(Ministry of Health, Italy)	This study was supported by Fondazione Cariplo [Project 2006.0721/10.4898 to CF] and by Italian Ministry for Health [Ricerca Finalizzata RFPS-2007-1-637146 to CF]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2009, CURR OPIN IMMUNOL, V21, P596, DOI 10.1016/j.coi.2009.09.014; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chervonsky AV, 1999, CURR OPIN IMMUNOL, V11, P684, DOI 10.1016/S0952-7915(99)00037-0; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fisher A., 1932, STAT METHODS RES WOR; Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527; Gatzka M, 2007, AUTOIMMUNITY, V40, P442, DOI 10.1080/08916930701464962; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu ZJ, 2008, BRIEF BIOINFORM, V9, P317, DOI 10.1093/bib/bbn020; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Jolivalt CG, 2010, EXP NEUROL, V223, P422, DOI 10.1016/j.expneurol.2009.11.005; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Mashayekhi F, 2010, J CLIN NEUROSCI, V17, P623, DOI 10.1016/j.jocn.2009.08.013; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Nah SS, 2010, RHEUMATOL INT, V30, P443, DOI 10.1007/s00296-009-0976-6; REFOLO LM, 1989, BIOCHEM BIOPH RES CO, V164, P664, DOI 10.1016/0006-291X(89)91511-8; Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003; Scalabrino G, 2010, BRAIN RES, V1333, P64, DOI 10.1016/j.brainres.2010.03.073; Seldin MF, 2009, GENES IMMUN, V10, P1, DOI 10.1038/gene.2008.92; SHARIEF MK, 1991, NEW ENGL J MED, V325, P749, DOI 10.1056/NEJM199109123251101; Taguchi A, 2009, J ALZHEIMERS DIS, V16, P859, DOI 10.3233/JAD-2009-0975; Taylor PC, 2009, NAT CLIN PRACT RHEUM, V5, P126, DOI 10.1038/ncprheum1022; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84; 1999, NEUROLOGY, V53, P457	40	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18660	10.1371/journal.pone.0018660	http://dx.doi.org/10.1371/journal.pone.0018660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533026	Green Submitted, gold, Green Published			2022-12-27	WOS:000290014500009
J	Jaeger, JJ; Soe, AN; Chavasseau, O; Coster, P; Emonet, EG; Guy, F; Lebrun, R; Maung, A; Khyaw, AA; Shwe, H; Tun, ST; Oo, KL; Rugbumrung, M; Bocherens, H; Benammi, M; Chaivanich, K; Tafforeau, P; Chaimanee, Y				Jaeger, Jean-Jacques; Soe, Aung Naing; Chavasseau, Olivier; Coster, Pauline; Emonet, Edouard-Georges; Guy, Franck; Lebrun, Renaud; Maung, Aye; Khyaw, Aung Aung; Shwe, Hla; Tun, Soe Thura; Oo, Kyaw Linn; Rugbumrung, Mana; Bocherens, Herve; Benammi, Mouloud; Chaivanich, Kamol; Tafforeau, Paul; Chaimanee, Yaowalak			First Hominoid from the Late Miocene of the Irrawaddy Formation (Myanmar)	PLOS ONE			English	Article							MAGNETIC-POLARITY STRATIGRAPHY; MIDDLE MIOCENE; NORTHERN THAILAND; POTWAR PLATEAU; SIWALIK GROUP; TOOTH ENAMEL; DIAGENESIS; ANTHRACOTHERIIDAE; CARBONATE; PASALAR	For over a century, a Neogene fossil mammal fauna has been known in the Irrawaddy Formation in central Myanmar. Unfortunately, the lack of accurately located fossiliferous sites and the absence of hominoid fossils have impeded paleontological studies. Here we describe the first hominoid found in Myanmar together with a Hipparion (s.l.) associated mammal fauna from Irrawaddy Formation deposits dated between 10.4 and 8.8 Ma by biochronology and magnetostratigraphy. This hominoid documents a new species of Khoratpithecus, increasing thereby the Miocene diversity of southern Asian hominoids. The composition of the associated fauna as well as stable isotope data on Hipparion (s.l.) indicate that it inhabited an evergreen forest in a C3-plant environment. Our results enlighten that late Miocene hominoids were more regionally diversified than other large mammals, pointing towards regionally-bounded evolution of the representatives of this group in Southeast Asia. The Irrawaddy Formation, with its extensive outcrops and long temporal range, has a great potential for improving our knowledge of hominoid evolution in Asia.	[Jaeger, Jean-Jacques; Chavasseau, Olivier; Coster, Pauline; Emonet, Edouard-Georges; Guy, Franck; Benammi, Mouloud; Chaimanee, Yaowalak] Univ Poitiers, CNRS, Inst Int Paleoprimatol & Paleontol Humaine, UMR 6046, Poitiers, France; [Soe, Aung Naing] Dagon Univ, Dept Geol, Yangon, Myanmar; [Lebrun, Renaud] Univ Montpellier 2, Inst Sci Evolut Montpellier, Montpellier, France; [Maung, Aye; Khyaw, Aung Aung; Shwe, Hla] Natl Museum & Lib, Dept Archaeol, Mandalay, Myanmar; [Tun, Soe Thura] Myanmar Geosci Soc, Yangon, France; [Oo, Kyaw Linn] Univ Yangon, Dept Geol, Yangon, Myanmar; [Rugbumrung, Mana; Chaimanee, Yaowalak] Dept Mineral Resources, Paleontol Sect, Bangkok, Thailand; [Bocherens, Herve] Univ Tubingen, Inst Geowissensch, Tubingen, Germany; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Yangon; Department of Mineral Resources - Thailand; Eberhard Karls University of Tubingen; European Synchrotron Radiation Facility (ESRF)	Jaeger, JJ (corresponding author), Univ Poitiers, CNRS, Inst Int Paleoprimatol & Paleontol Humaine, UMR 6046, Poitiers, France.	olivier.chavasseau@univ-poitiers.fr	BOCHERENS, Hervé/F-3580-2011; Oo, Kyaw Linn/V-9084-2019	BOCHERENS, Hervé/0000-0002-0494-0126; Lebrun, Renaud/0000-0002-5819-2653; Tafforeau, Paul/0000-0002-5962-1683; Chavasseau, Olivier/0000-0001-8638-4583; Coster, Pauline/0000-0003-4015-252X; Benammi, Mouloud/0000-0003-4707-7518; GUY, Franck/0000-0001-7032-7963; chaimanee, yaowalak/0000-0002-8432-3880	CNRS; Agence Nationale de la Recherche [05-BLAN-235]; Fyssen foundation; Ministry of Culture of the Union of Myanmar	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fyssen foundation; Ministry of Culture of the Union of Myanmar	This work was supported by a CNRS Eclipse II program grant (http://www.cnrs.fr/), an Agence Nationale de la Recherche 05-BLAN-235 grant (http://www.agence-nationale-recherche.fr/), and a Fyssen foundation grant (http://www.fondation-fyssen.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ministry of Culture of the Union of Myanmar for supporting the project and the organization of the fieldwork campaigns, MM. Stephane Dovert, Fabrice Etienne and Emmanuel Mouriez, Mrs Wah Wah Tin and Shwe Zin Nyunt from the French Embassy in Yangon for their help to our project, Jay Kelley (Arizona State University) for fruitful discussions and comments, J. Baruchel and the ID 17 and 19 beamline staff of the ESRF (Grenoble) for their assistance in X-ray imaging, J. Barry (Harvard University) for discussion and providing comparative material, X. Valentin (iPIIEP, Univ. Poitiers) for material preparation, C. Fontaine and A. Decarreau (HydrASA, Univ. Poitiers) for providing X-Ray diffraction data, B. Steinhilber (Univ. Tubingen) for technical assistance in stable isotope analysis of Hipparion material, H. Cappetta (Univ. Montpellier II) for identification of the shark teeth, L. de Bonis (iPHEP, Univ. Poitiers) for giving us access to the Ouranopithecus material, Yves Gallet and Maxime Legoff (IPGP, Paris) for access to paleomagnetism equipment and technical help.	ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; Benammi M, 2004, INT GEOL REV, V46, P646, DOI 10.2747/0020-6814.46.7.646; Bender F., 1983, GEOLOGY BURMA; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; BROWN B, 1989, MANDIBLES SIVAPITHEC; Brown Barbara, 1997, P153; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chaimanee Y, 2004, NATURE, V427, P439, DOI 10.1038/nature02245; Chaimanee Y, 2003, NATURE, V422, P61, DOI 10.1038/nature01449; Chaimanee Y, 2006, AM J PHYS ANTHROPOL, V131, P311, DOI 10.1002/ajpa.20437; Chavasseau O, 2006, J ASIAN EARTH SCI, V28, P354, DOI 10.1016/j.jseaes.2005.10.012; Chhibber H.L., 1934, GEOLOGY BURMA; Coster P, 2010, GEOL SOC AM BULL, V122, P1180, DOI 10.1130/B26568.1; COTTER GD, 1938, MEMOIRS GEOLOGICAL S, V72, P1; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; FORTELIUS M, GEOLOGY PALEONTOLOGY; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Gradstein F.M., 2004, A; Gulec E, 2003, COUR FOR SEKENBG, V240, P89; Guy F, 2008, J HUM EVOL, V55, P37, DOI 10.1016/j.jhevol.2007.12.003; Jacques L, 2008, PALAEOGEOGR PALAEOCL, V266, P200, DOI 10.1016/j.palaeo.2008.03.040; JOHNSON NM, 1982, PALAEOGEOGR PALAEOCL, V37, P17, DOI 10.1016/0031-0182(82)90056-6; KELLEY J, 2002, PRIMATE FOSSIL RECOR, P385; Kelley J, 2008, J HUM EVOL, V54, P455, DOI 10.1016/j.jhevol.2007.08.007; KHIN A, 1969, UNION BURMA J SCI TE, V2, P53; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Koufs GD, 2006, GEOBIOS-LYON, V39, P223, DOI 10.1016/j.geobios.2004.11.009; Lee-Thorp J, 2003, J ANTHROPOL ARCHAEOL, V22, P208, DOI 10.1016/S0278-4165(03)00035-7; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; Lihoreau F, 2007, PALAEONTOLOGY, V50, P503, DOI 10.1111/j.1475-4983.2006.00643.x; Lihoreau F, 2004, CR PALEVOL, V3, P653, DOI 10.1016/j.crpv.2004.07.001; MCCROSSIN ML, 1993, P NATL ACAD SCI USA, V90, P1962, DOI 10.1073/pnas.90.5.1962; Nelson SV, 2007, PALAEOGEOGR PALAEOCL, V243, P204, DOI 10.1016/j.palaeo.2006.07.017; Nelson SV, 2005, PALAEOGEOGR PALAEOCL, V222, P122, DOI 10.1016/j.palaeo.2005.03.012; NOETLING F., 1901, MEMOIRS GEOLOGICAL S, V1, P1; Noetling F., 1895, RECORDS GEOLOGICAL S, V28, P59; Pascoe E. H, 1964, MANUAL GEOLOGY INDIA, V1; PILGRIM GE, 1904, RECORDS GEOLOGICAL S, V31, P103; PILGRIM GUY E., 1927, REC GEOL SURV INDIA, V60, P160; QI GQ, 2005, LUFENGPITHECUS HUDIE; Qi Guoqin, 2006, Chinese Science Bulletin, V51, P704, DOI 10.1007/s11434-006-0704-5; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; RINK WJ, 1995, J ARCHAEOL SCI, V22, P251, DOI 10.1006/jasc.1995.0026; SCHUMACHER GH, 1983, ANATOMIE BIOCH ZAHNE; SEN S, 1988, B SOC GEOL FR, V4, P161; Sepulchre P, 2010, CLIM PAST, V6, P461, DOI 10.5194/cp-6-461-2010; Stamp L.D., 1922, GEOL MAG, V59, P481, DOI DOI 10.1017/S001675680010915X; Suganuma Y, 2006, PALAEOGEOGR PALAEOCL, V239, P75, DOI 10.1016/j.palaeo.2006.01.010; Takai M., 2006, ASIAN PALEOPRIMATOLO, V4, P143; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Woo J. K., 1957, Vertebrata Palasiatica, V1, P25; WOO JU-KANG, 1958, VERTEBR PALASIATI [CHINA], V2, P38; XU Q, 2008, LUFENG HOMINOID FAUN	59	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e17065	10.1371/journal.pone.0017065	http://dx.doi.org/10.1371/journal.pone.0017065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533131	Green Published, gold			2022-12-27	WOS:000289719400001
J	Merhi, A; Gerard, N; Lauwers, E; Prevost, M; Andre, B				Merhi, Ahmad; Gerard, Nicolas; Lauwers, Elsa; Prevost, Martine; Andre, Bruno			Systematic Mutational Analysis of the Intracellular Regions of Yeast Gap1 Permease	PLOS ONE			English	Article							AMINO-ACID PERMEASE; NITROGEN CATABOLITE REPRESSION; MULTIVESICULAR BODY PATHWAY; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; SHUTTLE VECTORS; PROTEIN; UBIQUITIN; GENE; TRANSPORTERS	Background: The yeast general amino acid permease Gap1 is a convenient model for studying the intracellular trafficking of membrane proteins. Present at the plasma membrane when the nitrogen source is poor, it undergoes ubiquitin-dependent endocytosis and degradation upon addition of a good nitrogen source, e. g., ammonium. It comprises 12 transmembrane domains (TM) flanked by cytosol-facing N- and C-terminal tails (NT, CT). The NT of Gap1 contains the acceptor lysines for ubiquitylation and its CT includes a sequence essential to exit from the endoplasmic reticulum (ER). Principal Findings: We used alanine-scanning mutagenesis to isolate 64 mutant Gap1 proteins altered in the NT, the CT, or one of the five TM-connecting intracellular loops (L2, -4, -6, -8 and -10). We found 17 mutations (in L2, L8, L10 and CT) impairing Gap1 exit from the ER. Of the 47 mutant proteins reaching the plasma membrane normally, two are unstable and rapidly down-regulated even when the nitrogen source is poor. Six others are totally inactive and another four, altered in a 16-amino-acid sequence in the NT, are resistant to ammonium-induced down-regulation. Finally, a mutation in L6 causes missorting of Gap1 from the secretory pathway to the vacuole. Interestingly, this direct vacuolar sorting seems to be independent of Gap1 ubiquitylation. Conclusions: This study illustrates the importance of multiple intracellular regions of Gap1 in its secretion, transport activity, and down-regulation.	[Merhi, Ahmad; Gerard, Nicolas; Lauwers, Elsa; Andre, Bruno] Univ Libre Bruxelles, Gosselies, Belgium; [Prevost, Martine] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Merhi, A (corresponding author), Univ Libre Bruxelles, Gosselies, Belgium.	bran@ulb.ac.be	André, Bruno/D-1725-2010	Lauwers, Elsa/0000-0002-0283-1911; Merhi, Ahmad/0000-0001-7046-2508	Fonds de la Recherche Scientifique Medicale [3.4.592.08.F]; Region Wallonne [716760]; Communaute Francaise de Belgique; FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture)	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Region Wallonne; Communaute Francaise de Belgique(Australian Research Council); FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by a "Fonds de la Recherche Scientifique Medicale" grant (3.4.592.08.F), a "Region Wallonne" grant 716760, and an "Actions de Recherche Concertee" grant of the Communaute Francaise de Belgique. A. M. is a recipient of a FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SIKORSKI RS, 1989, GENETICS, V122, P19; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X	47	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18457	10.1371/journal.pone.0018457	http://dx.doi.org/10.1371/journal.pone.0018457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526172	Green Submitted, Green Published, gold			2022-12-27	WOS:000289671100004
J	Palkovacs, EP; Wasserman, BA; Kinnison, MT				Palkovacs, Eric P.; Wasserman, Ben A.; Kinnison, Michael T.			Eco-Evolutionary Trophic Dynamics: Loss of Top Predators Drives Trophic Evolution and Ecology of Prey	PLOS ONE			English	Article							GUPPIES POECILIA-RETICULATA; LIFE-HISTORY EVOLUTION; RAPID EVOLUTION; TRADE-OFF; FOOD-WEB; SWIMMING PERFORMANCE; FISH COMMUNITIES; GAMBUSIA-AFFINIS; SHAPE; SELECTION	Ecosystems are being altered on a global scale by the extirpation of top predators. The ecological effects of predator removal have been investigated widely; however, predator removal can also change natural selection acting on prey, resulting in contemporary evolution. Here we tested the role of predator removal on the contemporary evolution of trophic traits in prey. We utilized a historical introduction experiment where Trinidadian guppies (Poecilia reticulata) were relocated from a site with predatory fishes to a site lacking predators. To assess the trophic consequences of predator release, we linked individual morphology (cranial, jaw, and body) to foraging performance. Our results show that predator release caused an increase in guppy density and a "sharpening" of guppy trophic traits, which enhanced food consumption rates. Predator release appears to have shifted natural selection away from predator escape ability and towards resource acquisition ability. Related diet and mesocosm studies suggest that this shift enhances the impact of guppies on lower trophic levels in a fashion nuanced by the omnivorous feeding ecology of the species. We conclude that extirpation of top predators may commonly select for enhanced feeding performance in prey, with important cascading consequences for communities and ecosystems.	[Palkovacs, Eric P.; Wasserman, Ben A.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Palkovacs, Eric P.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Wasserman, Ben A.; Kinnison, Michael T.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	Duke University; Duke University; University of Maine System; University of Maine Orono	Palkovacs, EP (corresponding author), Duke Univ, Marine Lab, Beaufort, NC 28516 USA.	eric.palkovacs@duke.edu	Wasserman, Ben/AAD-5957-2019	Kinnison, Michael/0000-0003-4211-2118; Wasserman, Ben/0000-0002-9997-4934	U.S.A. National Science Foundation [EF 0623632]; Maine Agricultural and Forest Experiment Station [3172]; Duke University Marine Laboratory McCurdy Endowment	U.S.A. National Science Foundation(National Science Foundation (NSF)); Maine Agricultural and Forest Experiment Station; Duke University Marine Laboratory McCurdy Endowment	Funding was provided by the U.S.A. National Science Foundation (EF 0623632), the Maine Agricultural and Forest Experiment Station (contribution 3172), and the Duke University Marine Laboratory McCurdy Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Adams DC, 1999, EVOL ECOL RES, V1, P959; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Arendt JD, 2005, P ROY SOC B-BIOL SCI, V272, P333, DOI 10.1098/rspb.2004.2899; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Becks L, 2010, ECOL LETT, V13, P989, DOI 10.1111/j.1461-0248.2010.01490.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein F.L., 1996, ADV MORPHOMETRICS, V284, P131; Burns JG, 2009, J FISH BIOL, V75, P1144, DOI 10.1111/j.1095-8649.2009.02314.x; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; DELURY DB, 1947, BIOMETRICS, V3, P145, DOI 10.2307/3001390; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Dunlop ES, 2009, EVOL APPL, V2, P246, DOI 10.1111/j.1752-4571.2009.00087.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Fischer-Rousseau L, 2010, J EXP ZOOL PART B, V314B, P67, DOI 10.1002/jez.b.21311; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2003, INTEGR COMP BIOL, V43, P431, DOI 10.1093/icb/43.3.431; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Grunbaum T, 2007, J EXP ZOOL PART B, V308B, P396, DOI 10.1002/jez.b.21163; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; KLINGENBERG CP, 1996, ADV MORPHOMETRICS, V284, P23; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 2008, MOL ECOL, V17, P97, DOI 10.1111/j.1365-294X.2007.03474.x; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Reznick DN, 2005, CAN J FISH AQUAT SCI, V62, P791, DOI 10.1139/F05-079; ROBINSON BW, 1995, COPEIA, P294; Rohlf F.J., 2009, TPSDIG VERSION 214; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ., 2008, TPSRELW VERSION 146; Rohlf FJ, 2009, TPSUTIL VERSION 1 44; Rohlf FJ, 2004, TPSSPLINE VERSION 1; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Strong DR, 2010, ANNU REV ENV RESOUR, V35, P1, DOI 10.1146/annurev-environ-031809-133103; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Van Buskirk J, 1998, OIKOS, V82, P20; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; WASSERSUG RJ, 1976, STAIN TECHNOL, V51, P131, DOI 10.3109/10520297609116684; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	63	61	61	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18879	10.1371/journal.pone.0018879	http://dx.doi.org/10.1371/journal.pone.0018879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526156	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100034
J	Varkuti, B; Cavusoglu, M; Kullik, A; Schiffler, B; Veit, R; Yilmaz, O; Rosenstiel, W; Braun, C; Uludag, K; Birbaumer, N; Sitaram, R				Varkuti, Balint; Cavusoglu, Mustafa; Kullik, Alexander; Schiffler, Bjoern; Veit, Ralf; Yilmaz, Oezge; Rosenstiel, Wolfgang; Braun, Christoph; Uludag, Kamil; Birbaumer, Niels; Sitaram, Ranganatha			Quantifying the Link between Anatomical Connectivity, Gray Matter Volume and Regional Cerebral Blood Flow: An Integrative MRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN BRAIN; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; STRUCTURAL CONNECTIVITY; CORTICAL THICKNESS; DEFAULT MODE; WHITE-MATTER; PERFUSION	Background: In the graph theoretical analysis of anatomical brain connectivity, the white matter connections between regions of the brain are identified and serve as basis for the assessment of regional connectivity profiles, for example, to locate the hubs of the brain. But regions of the brain can be characterised further with respect to their gray matter volume or resting state perfusion. Local anatomical connectivity, gray matter volume and perfusion are traits of each brain region that are likely to be interdependent, however, particular patterns of systematic covariation have not yet been identified. Methodology/Principal Findings: We quantified the covariation of these traits by conducting an integrative MRI study on 23 subjects, utilising a combination of Diffusion Tensor Imaging, Arterial Spin Labeling and anatomical imaging. Based on our hypothesis that local connectivity, gray matter volume and perfusion are linked, we correlated these measures and particularly isolated the covariation of connectivity and perfusion by statistically controlling for gray matter volume. We found significant levels of covariation on the group-and regionwise level, particularly in regions of the Default Brain Mode Network. Conclusions/Significance: Connectivity and perfusion are systematically linked throughout a number of brain regions, thus we discuss these results as a starting point for further research on the role of homology in the formation of functional connectivity networks and on how structure/function relationships can manifest in the form of such trait interdependency.	[Varkuti, Balint; Veit, Ralf; Yilmaz, Oezge; Braun, Christoph; Birbaumer, Niels; Sitaram, Ranganatha] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Baden Wurttembe, Germany; [Cavusoglu, Mustafa; Uludag, Kamil] Max Planck Inst Biol Cybernet, Tubingen, Baden Wurttembe, Germany; [Varkuti, Balint] Int Max Planck Res Sch, Grad Training Ctr Neurosci, Tubingen, Baden Wurttembe, Germany; [Kullik, Alexander; Rosenstiel, Wolfgang] Univ Tubingen, Wilhelm Schickard Inst Comp Engn, Tubingen, Baden Wurttembe, Germany; [Schiffler, Bjoern] Univ Freiburg, Inst Psychol, Freiburg, Baden Wurttembe, Germany; [Braun, Christoph] CIMeC Ctr Interdipartimentale Mente Cervello, Rovereto, Trento, Italy; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Veneto, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Max Planck Society; Eberhard Karls University of Tubingen; University of Freiburg	Varkuti, B (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Baden Wurttembe, Germany.	balint.varkuti@medizin.uni-tuebingen.de	Braun, Christoph/E-4561-2010; Veit, Ralf/F-8907-2012; yilmaz, ozge/B-3866-2014; Braun, Christoph/J-4160-2014	Braun, Christoph/0000-0002-7836-4010; Veit, Ralf/0000-0001-9860-642X; Braun, Christoph/0000-0002-7836-4010; Schiffler, Bjorn/0000-0003-2347-4965; Sitaram, Ranganatha/0000-0002-8577-8035; Uludag, Kamil/0000-0002-2813-5930; Birbaumer, Niels/0000-0002-6786-5127	Werner Reichardt Centre for Integrative Neuroscience [PP: 2009-15]; Deutsche Forschungsgemeinschaft (DFG) [BI 195/59-1]; European Union [HUMOUR 231724]	Werner Reichardt Centre for Integrative Neuroscience; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission)	This work was partially funded by the Werner Reichardt Centre for Integrative Neuroscience (Poolproject: Implementation of an Integrative Connectivity Toolbox for Investigation of Cortical Plasticity and Reorganization after Stroke, PP: 2009-15), the Deutsche Forschungsgemeinschaft (DFG BI 195/59-1) and the European Union (HUMOUR 231724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Arthurs OJ, 2002, TRENDS NEUROSCI, V25, P27, DOI 10.1016/S0166-2236(00)01995-0; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Barab?si AL., 2002, AM J PHYS, V71, P409, DOI [10.1119/1.1538577, DOI 10.1119/1.1538577]; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun V. D., 2003, P INT WORKSH IND COM, DOI 10.1.1.3.7473; Cammoun L., 2009, NEUROIMAGE, V47, pS157, DOI [10.1016/S1053-8119(09)71653-2, DOI 10.1016/S1053-8119(09)71653-2]; Cavusoglu M, 2009, MAGN RESON IMAGING, V27, P1039, DOI 10.1016/j.mri.2009.04.002; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; GJEDDE A, 1985, J CEREBR BLOOD F MET, V5, P282, DOI 10.1038/jcbfm.1985.36; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GREICIUS MD, 2008, CEREBRAL CORTEX; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jahng GH, 2007, IFMBE PROC, V14, P1380; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; KAWAMURA J, 1993, J NEUROL NEUROSUR PS, V56, P182, DOI 10.1136/jnnp.56.2.182; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; KUSCHINSKY W, 1991, NEUROSURG REV, V14, P163, DOI 10.1007/BF00310651; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Nordberg A, 2010, NEURODEGENER DIS, V7, P136, DOI 10.1159/000289223; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RUBINOV M, 2009, NEUROIMAGE; Schuff N, 2007, BRIT J RADIOL, V80, pS109, DOI 10.1259/bjr/63830887; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sotiropoulos SN, 2010, NEUROIMAGE, V49, P2444, DOI 10.1016/j.neuroimage.2009.10.001; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X	52	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e14801	10.1371/journal.pone.0014801	http://dx.doi.org/10.1371/journal.pone.0014801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525993	gold, Green Submitted, Green Published			2022-12-27	WOS:000289578600002
J	Mangano, C; Paino, F; d'Aquino, R; De Rosa, A; Iezzi, G; Piattelli, A; Laino, L; Mitsiadis, T; Desiderio, V; Mangano, F; Papaccio, G; Tirino, V				Mangano, Carlo; Paino, Francesca; d'Aquino, Riccardo; De Rosa, Alfredo; Iezzi, Giovanna; Piattelli, Adriano; Laino, Luigi; Mitsiadis, Thimios; Desiderio, Vincenzo; Mangano, Francesco; Papaccio, Gianpaolo; Tirino, Virginia			Human Dental Pulp Stem Cells Hook into Biocoral Scaffold Forming an Engineered Biocomplex	PLOS ONE			English	Article							BONE; DIFFERENTIATION; REGENERATION; POROSITY; REPAIR	The aim of this study was to evaluate the behavior of human Dental Pulp Stem Cells (DPSCs), as well as human osteoblasts, when challenged on a Biocoral scaffold, which is a porous natural hydroxyapatite. For this purpose, human DPSCs were seeded onto a three-dimensional (3D) Biocoral scaffold or on flask surface (control). Either normal or rotative (3D) cultures were performed. Scanning electron microscopic analyses, at 8, 24 and 48 h of culture showed that cells did not adhere on the external surface, but moved into the cavities inside the Biocoral structure. After 7, 15 and 30 days of culture, morphological and molecular analyses suggested that the Biocoral scaffold leads DPSCs to hook into the cavities where these cells quickly start to secrete the extra cellular matrix (ECM) and differentiate into osteoblasts. Control human osteoblasts also moved into the internal cavities where they secreted the ECM. Histological sections revealed a diffuse bone formation inside the Biocoral samples seeded with DPSCs or human osteoblasts, where the original scaffold and the new secreted biomaterial were completely integrated and cells were found within the remaining cavities. In addition, RT-PCR analyses showed a significant increase of osteoblast-related gene expression and, above all, of those genes highly expressed in mineralized tissues, including osteocalcin, OPN and BSP. Furthermore, the effects on the interaction between osteogenesis and angiogenesis were observed and substantiated by ELISA assays. Taken together, our results provide clear evidence that DPSCs differentiated into osteoblasts, forming a biocomplex made of Biocoral, ECM and differentiated cells.	[Mangano, Carlo; Mangano, Francesco] Univ Insubria, Dept Biomat Sci, Varese, Italy; [Paino, Francesca; d'Aquino, Riccardo; Desiderio, Vincenzo; Papaccio, Gianpaolo; Tirino, Virginia] Univ Naples 2, Dept Expt Med, Sect Histol & Embryol, Tissue Engn & Regenerat Med TERM Div, Naples, Italy; [De Rosa, Alfredo; Laino, Luigi] Univ Naples 2, Dept Odontol, Naples, Italy; [Iezzi, Giovanna; Piattelli, Adriano] Univ G dAnnunzio, Dept Odontol, Chieti, Italy; [Mitsiadis, Thimios] Univ Zurich, Inst Oral Biol, Zurich, Switzerland	University of Insubria; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; G d'Annunzio University of Chieti-Pescara; University of Zurich	Mangano, C (corresponding author), Univ Insubria, Dept Biomat Sci, Varese, Italy.	gianpaolo.papaccio@unina2.it	Mitsiadis, Thimios/B-5564-2016; desiderio, vincenzo/K-4244-2018; paino, francesca/AAC-8150-2019; LAINO, LUIGI/AAB-8203-2022; Mitsiadis, Thimios A/B-9249-2008; Iezzi, Giovanna/K-9403-2016; Mangano, Francesco/AAG-6184-2019; Papaccio, Gianpaolo/B-7150-2014	Mitsiadis, Thimios/0000-0002-9812-9982; paino, francesca/0000-0002-3186-1888; LAINO, LUIGI/0000-0003-2372-7109; Iezzi, Giovanna/0000-0002-2391-6594; Tirino, Virginia/0000-0003-2731-5718; desiderio, vincenzo/0000-0003-1819-6083; Papaccio, Gianpaolo/0000-0002-4014-5306; Mangano, Francesco/0000-0001-5488-4268	Leader Italia (Cinisello Balsamo, Milan, Italy)	Leader Italia (Cinisello Balsamo, Milan, Italy)	The authors kindly acknowledge Leader Italia (Cinisello Balsamo, Milan, Italy) for funding (to GP) and assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.0.CO;2-C; Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x; Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1; Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056; Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Spath L, 2010, J CELL MOL MED, V14, P1635, DOI 10.1111/j.1582-4934.2009.00848.x; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Zhang YF, 2007, BIOMATERIALS, V28, P1515, DOI 10.1016/j.biomaterials.2006.11.040; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	21	49	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18721	10.1371/journal.pone.0018721	http://dx.doi.org/10.1371/journal.pone.0018721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494568	Green Published, Green Accepted, gold			2022-12-27	WOS:000289354100034
J	Matthews, LT; Giddy, J; Ghebremichael, M; Hampton, J; Guarino, AJ; Ewusi, A; Carver, E; Axten, K; Geary, MC; Gandhi, RT; Bangsberg, DR				Matthews, Lynn T.; Giddy, Janet; Ghebremichael, Musie; Hampton, Jane; Guarino, Anthony J.; Ewusi, Aba; Carver, Emma; Axten, Karen; Geary, Meghan C.; Gandhi, Rajesh T.; Bangsberg, David R.			A Risk-Factor Guided Approach to Reducing Lactic Acidosis and Hyperlactatemia in Patients on Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SYMPTOMATIC HYPERLACTATEMIA; COMPLICATIONS; MANAGEMENT; STAVUDINE; LACTATE; WOMEN	Background: Stavudine continues to be used in antiretroviral treatment (ART) regimens in many resource-limited settings. The use of zidovudine instead of stavudine in higher-risk patients to reduce the likelihood of lactic acidosis and hyperlactatemia (LAHL) has not been examined. Methods: Antiretroviral-naive, HIV-infected adults initiating ART between 2004 and 2007 were divided into cohorts of those initiated on stavudine- or zidovudine-containing therapy. We evaluated stavudine or zidovudine use, age, sex, body mass index (BMI), baseline CD4 cell count, creatinine, hemoglobin, alanine aminotransferase, and albumin as predictors of time to LAHL with Cox Proportional Hazards (PH) regression models. Results: Among 2062 patients contributing 2747 patient years (PY), the combined incidence of LAHL was 3.2/100 PY in those initiating stavudine- and 0.34/100 PY in those initiating zidovudine-containing ART (RR 9.26, 95% CI: 1.28-66.93). In multivariable Cox PH analysis, stavudine exposure (HR 14.31, 95% CI: 5.79-35.30), female sex (HR 3.41, 95% CI: 1.89-6.19), higher BMI (HR 3.21, 95% CI: 2.16-4.77), higher creatinine (1.63, 95% CI: 1.12-2.36), higher albumin (HR 1.04, 95% CI: 1.011.07), and lower CD4 cell count (HR 0.96, 95% CI: 0.92-1.0) at baseline were associated with higher LAHL rates. Among participants who started on stavudine, switching to zidovudine was associated with lower LAHL rates (HR 0.15, 95% CI: 0.06-0.35). Subgroup analysis limited to women with higher BMI >= 25 kg/m(2) initiated on stavudine also showed that switch to zidovudine was protective when controlling for other risk factors (HR 0.21, 95% CI.07-0.64). Conclusions: Stavudine exposure, female sex, and higher BMI are strong, independent predictors for developing LAHL. Patients with risk factors for lactic acidosis have less LAHL while on zidovudine-rather than stavudine-containing ART. Switching patients from stavudine to zidovudine is protective. Countries continuing to use stavudine should avoid this drug in women and patients with higher BMI.	[Matthews, Lynn T.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Giddy, Janet; Hampton, Jane] McCord Hosp, HIV Program, Durban, South Africa; [Ghebremichael, Musie; Axten, Karen; Gandhi, Rajesh T.; Bangsberg, David R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Guarino, Anthony J.] Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA; [Ewusi, Aba] Harvard Vanguard Med Associates, Div Internal Med, Boston, MA USA; [Carver, Emma] Univ Wales Hosp, Dept Emergency Med, Cardiff CF4 4XW, S Glam, Wales; [Geary, Meghan C.] Albany Med Coll, Albany, NY 12208 USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard Vanguard Medical Associates; Cardiff University; Albany Medical College; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital	Matthews, LT (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	ltmatthe@bidmc.harvard.edu			Mark and Lisa Schwartz Family Foundation; Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene; NIH [R01 AI066992-04A1, NIH G08LM008830-01, MH K-24 87227]; Harvard University Center for AIDS Research [NIH 2P30 AI06035406];  [NIH U01 AI 694722]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066992, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM008830] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Family Foundation; Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. Matthews' work was supported by the Mark and Lisa Schwartz Family Foundation and by a postdoctoral fellowship in tropical infectious diseases from the Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene. Dr. Gandhi is supported by NIH R01 AI066992-04A1 and NIH G08LM008830-01 and by grants to the AIDS Clinical Trials Group (NIH U01 AI 694722) and the Harvard University Center for AIDS Research (NIH 2P30 AI06035406). Dr. Bangsberg was supported by NIH grant MH K-24 87227. The authors are also grateful to Dr. Heather Ribaudo of the Harvard University Center for AIDS Research Biostatistical Core (NIH #AI060354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AD AIDS CLIN TRIA, 2003, AACTG TOX EV GROUP C; Arenas-Pinto A, 2007, AIDS, V21, P2455, DOI 10.1097/QAD.0b013e3282f08cdc; Bellomo R, 2002, CRIT CARE, V6, P322; Bolhaar MG, 2007, CLIN INFECT DIS, V45, P254, DOI 10.1086/518976; Bonnet F, 2003, CLIN INFECT DIS, V36, P1324, DOI 10.1086/374601; Boubaker K, 2001, CLIN INFECT DIS, V33, P1931, DOI 10.1086/324353; Boulle A, 2007, ANTIVIR THER, V12, P753; Cox DR., 1989, ANAL BINARY DATA; Fabian J, 2008, SAMJ S AFR MED J, V98, P795; Geddes R, 2006, SAMJ S AFR MED J, V96, P722; Harrell FE, 2001, REGRESSION MODELING; HILL A, 2007, EXPERT OPINION PHAMA, V8; Ivers LC, 2006, AIDS, V20, P779, DOI 10.1097/01.aids.0000216382.37679.b2; Kiragga AK, 2008, JAIDS-J ACQ IMM DEF, V49, P564, DOI 10.1097/QAI.0b013e31817e6391; Kumarasamy N, 2008, J WOMENS HEALTH, V17, P1471, DOI 10.1089/jwh.2007.0670; Lonergan JT, 2003, AIDS, V17, P2495, DOI 10.1097/00002030-200311210-00012; Moyle GJ, 2002, AIDS, V16, P1341, DOI 10.1097/00002030-200207050-00005; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; Osler M, 2010, HIV MED, V11, P121, DOI 10.1111/j.1468-1293.2009.00754.x; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Shibuyama S, 2006, CURR PHARM DESIGN, V12, P1075, DOI 10.2174/138161206776055796; South Africa National AIDS Council, 2010, S AFR ANT TREATM GUI; SPAULDING A, COCHRANE DATABASE SY; Stead D, 2008, ANTIVIR THER, V13, P937; Stenzel MS, 2000, INFECT DIS CLIN N AM, V14, P851, DOI 10.1016/S0891-5520(05)70137-9; VANGRIENSVEN J, T R SOC TROP MED HYG, V104, P148; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; WHO, 2010, ANT THER HIV INF AD; Wohl DA, 2006, CLIN INFECT DIS, V43, P645, DOI 10.1086/507333	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18736	10.1371/journal.pone.0018736	http://dx.doi.org/10.1371/journal.pone.0018736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494566	Green Submitted, gold, Green Published			2022-12-27	WOS:000289354100037
J	Panneels, V; Kock, I; Krijnse-Locker, J; Rezgaoui, M; Sinning, I				Panneels, Valerie; Kock, Ines; Krijnse-Locker, Jacomine; Rezgaoui, Meriem; Sinning, Irmgard			Drosophila Photoreceptor Cells Exploited for the Production of Eukaryotic Membrane Proteins: Receptors, Transporters and Channels	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LARGE-SCALE PRODUCTION; DNA-BINDING PROTEIN; ALLOSTERIC MODULATORS; SEROTONIN TRANSPORTER; EXPRESSION SYSTEM; NEUROTRANSMITTER TRANSPORTERS; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; GENE	Membrane proteins (MPs) play key roles in signal transduction. However, understanding their function at a molecular level is mostly hampered by the lack of protein in suitable amount and quality. Despite impressive developments in the expression of prokaryotic MPs, eukaryotic MP production has lagged behind and there is a need for new expression strategies. In a pilot study, we produced a Drosophila glutamate receptor specifically in the eyes of transgenic flies, exploiting the naturally abundant membrane stacks in the photoreceptor cells (PRCs). Now we address the question whether the PRCs also process different classes of medically relevant target MPs which were so far notoriously difficult to handle with conventional expression strategies. Principal Findings: We describe the homologous and heterologous expression of 10 different targets from the three major MP classes - G protein-coupled receptors (GPCRs), transporters and channels in Drosophila eyes. PRCs offered an extraordinary capacity to produce, fold and accommodate massive amounts of MPs. The expression of some MPs reached similar levels as the endogenous rhodopsin, indicating that the PRC membranes were almost unsaturable. Expression of endogenous rhodopsin was not affected by the target MPs and both could coexist in the membrane stacks. Heterologous expression levels reached about 270 to 500 pmol/mg total MP, resulting in 0.2-0.4 mg purified target MP from 1 g of fly heads. The metabotropic glutamate receptor and human serotonin transporter - both involved in synaptic transmission showed native pharmacological characteristics and could be purified to homogeneity as a prerequisite for further studies. Significance: We demonstrate expression in Drosophila PRCs as an efficient and inexpensive tool for the large scale production of functional eukaryotic MPs. The fly eye system offers a number of advantages over conventional expression systems and paves the way for in-depth analyses of eukaryotic MPs that have so far not been accessible to biochemical and biophysical studies.	[Panneels, Valerie; Kock, Ines; Rezgaoui, Meriem; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr BZH, Dept Biol Struct, Heidelberg, Germany; [Krijnse-Locker, Jacomine] Univ Heidelberg, Dept Infect Dis, Heidelberg, Germany; [Krijnse-Locker, Jacomine] Univ Heidelberg, Core Facil Electron Microscopy EMCF, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Panneels, V (corresponding author), Univ Heidelberg, Biochem Ctr BZH, Dept Biol Struct, Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Locker, Jacomine Krijnse/AAX-1185-2020; Locker, Jacomine Krijnse/E-1009-2016	Panneels, Valerie/0000-0001-8899-3366	European Community [FP6-2003-LifeSciHealth 513770]	European Community(European Commission)	This work was supported by the European Community Specific Targeted Research Project grant IMPS (FP6-2003-LifeSciHealth 513770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ST, 2006, INVEST OPHTH VIS SCI, V47, P3722, DOI 10.1167/iovs.06-0281; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Bartesaghi A, 2009, CURR OPIN STRUC BIOL, V19, P402, DOI 10.1016/j.sbi.2009.06.005; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fraley ME, 2009, EXPERT OPIN THER PAT, V19, P1259, DOI 10.1517/13543770903045009; Gasparini F, 2002, CURR OPIN PHARMACOL, V2, P43, DOI 10.1016/S1471-4892(01)00119-9; Griffith DA, 2003, FEBS LETT, V553, P45, DOI 10.1016/S0014-5793(03)00952-9; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2001, J EXP BIOL, V204, P3403; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Klaassen CHW, 1999, BIOCHEM J, V342, P293, DOI 10.1042/0264-6021:3420293; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; KOENIG J, 1977, DROS INF SERV, V42, P50; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MISMER D, 1987, GENETICS, V116, P565; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674; NICHOLS R, 1985, J BIOL CHEM, V260, P12670; NISWENDER CM, ANN REV PHARM TOXICO, V50, P295; Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X; Oksche A, 1998, J MOL MED, V76, P326, DOI 10.1007/s001090050224; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Panneels V, 2003, PROTEIN EXPRES PURIF, V30, P275, DOI 10.1016/S1046-5928(03)00100-1; Panneels V, 2010, METHODS MOL BIOL, V601, P135, DOI 10.1007/978-1-60761-344-2_9; PAULSEN R, 1983, EUR J BIOCHEM, V137, P609, DOI 10.1111/j.1432-1033.1983.tb07869.x; Pichaud F, 2001, DEVELOPMENT, V128, P815; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; SCHEURING S, 2009, PHOTOSYNTH RES; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Voie AM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P510; Vought BW, 2000, BIOCHEMISTRY-US, V39, P14128, DOI 10.1021/bi001135k; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAO KM, 1994, J NEUROCHEM, V63, P41; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18478	10.1371/journal.pone.0018478	http://dx.doi.org/10.1371/journal.pone.0018478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494623	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800022
J	Cooper, C; Thorne, A; Klein, M; Conway, B; Boivin, G; Haase, D; Shafran, S; Zubyk, W; Singer, J; Halperin, S; Walmsley, S				Cooper, Curtis; Thorne, Anona; Klein, Marina; Conway, Brian; Boivin, Guy; Haase, David; Shafran, Stephen; Zubyk, Wendy; Singer, Joel; Halperin, Scott; Walmsley, Sharon		CIHR HIV Trials Network Influenza	Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBODY-RESPONSES; HEPATITIS-B; SEROPROTECTION; IMMUNIZATION; INDIVIDUALS; MORTALITY	Introduction: The risk of poor vaccine immunogenicity and more severe influenza disease in HIV necessitate strategies to improve vaccine efficacy. Methods: A randomized, multi-centered, controlled, vaccine trial with three parallel groups was conducted at 12 CIHR Canadian HIV Trials Network sites. Three dosing strategies were used in HIV infected adults (18 to 60 years): two standard doses over 28 days, two double doses over 28 days and a single standard dose of influenza vaccine, administered prior to the 2008 influenza season. A trivalent killed split non-adjuvanted influenza vaccine (Fluviral (TM)) was used. Serum hemagglutinin inhibition (HAI) activity for the three influenza strains in the vaccine was measured to assess immunogenicity. Results: 297 of 298 participants received at least one injection. Baseline CD4 (median 470 cells/mu L) and HIV RNA (76% of patients with viral load < 50 copies/mL) were similar between groups. 89% were on HAART. The overall immunogenicity of influenza vaccine across time points and the three influenza strains assessed was poor (Range HAI >= 40 = 31-58%). Double dose plus double dose booster slightly increased the proportion achieving HAI titre doubling from baseline for A/Brisbane and B/Florida at weeks 4, 8 and 20 compared to standard vaccine dose. Increased immunogenicity with increased antigen dose and booster dosing was most apparent in participants with unsuppressed HIV RNA at baseline. None of 8 serious adverse events were thought to be immunization-related. Conclusion: Even with increased antigen dose and booster dosing, non-adjuvanted influenza vaccine immunogenicity is poor in HIV infected individuals. Alternative influenza vaccines are required in this hyporesponsive population.	[Cooper, Curtis] Univ Ottawa, Div Infect Dis, Ottawa, ON, Canada; [Thorne, Anona; Zubyk, Wendy; Singer, Joel] Canadian HIV Trials Network, Vancouver, BC, Canada; [Klein, Marina] McGill Univ, Montreal, PQ, Canada; [Conway, Brian] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Boivin, Guy] Univ Laval, Quebec City, PQ, Canada; [Haase, David; Halperin, Scott] Dalhousie Univ, Halifax, NS, Canada; [Shafran, Stephen] Univ Alberta, Edmonton, AB, Canada; [Walmsley, Sharon] Univ Toronto, Toronto, ON, Canada	University of Ottawa; McGill University; University of British Columbia; Laval University; Dalhousie University; University of Alberta; University of Toronto	Cooper, C (corresponding author), Univ Ottawa, Div Infect Dis, Ottawa, ON, Canada.	ccooper@ottawahospital.on.ca	Cooper, Curtis/M-9320-2019	Klein, Marina/0000-0002-3063-8430; Halperin, Scott/0000-0003-0525-589X; Boivin, Guy/0000-0003-3027-4662; Walmsley, Sharon/0000-0002-3959-5692	Public Health Agency of Canada; Canadian Institutes of Health Research; GlaxoSmithKline	Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline(GlaxoSmithKline)	The funding agencies for this study are the Public Health Agency of Canada, the Canadian Institutes of Health Research, and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Beck James M., 2001, American Journal of Respiratory and Critical Care Medicine, V164, P2120; Boivin G, 2003, EMERG INFECT DIS, V9, P634; CHADWICK EG, 1994, PEDIATR INFECT DIS J, V13, P206, DOI 10.1097/00006454-199403000-00008; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Cooper CL, 2008, CLIN INFECT DIS, V46, P1310, DOI 10.1086/533467; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; [CPMP Unit TEAftEoMP-HME], 1997, UN TEAFTEOMPHME; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; HUANG KL, 1987, JAMA-J AM MED ASSOC, V257, P2047, DOI 10.1001/jama.257.15.2047; Iorio AM, 1997, VACCINE, V15, P97, DOI 10.1016/S0264-410X(96)00057-6; Klein MB, 2007, CLIN INFECT DIS, V45, P234, DOI 10.1086/518986; Kroon FP, 2000, VACCINE, V18, P3040, DOI 10.1016/S0264-410X(00)00079-7; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; Nichol KL, 1996, JAMA-J AM MED ASSOC, V276, P1857, DOI 10.1001/jama.1996.03540230007002; Radwan HM, 2000, CLIN INFECT DIS, V31, P604, DOI 10.1086/313985; RAGNI MV, 1987, J LAB CLIN MED, V109, P545; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; SAFRIN S, 1990, CHEST, V98, P33, DOI 10.1378/chest.98.1.33; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; World Health Organization, 2002, WHO MAN AN INFL DIAG; Zanetti AR, 2002, VACCINE, V20, pB29, DOI 10.1016/S0264-410X(02)00511-X	28	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e17758	10.1371/journal.pone.0017758	http://dx.doi.org/10.1371/journal.pone.0017758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21512577	Green Published, gold, Green Submitted			2022-12-27	WOS:000288813900010
J	Aoyagi, K; Minashi, K; Igaki, H; Tachimori, Y; Nishimura, T; Hokamura, N; Ashida, A; Daiko, H; Ochiai, A; Muto, M; Ohtsu, A; Yoshida, T; Sasaki, H				Aoyagi, Kazuhiko; Minashi, Keiko; Igaki, Hiroyasu; Tachimori, Yuji; Nishimura, Takao; Hokamura, Norikazu; Ashida, Akio; Daiko, Hiroyuki; Ochiai, Atsushi; Muto, Manabu; Ohtsu, Atsushi; Yoshida, Teruhiko; Sasaki, Hiroki			Artificially Induced Epithelial-Mesenchymal Transition in Surgical Subjects: Its Implications in Clinical and Basic Cancer Research	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NF-KAPPA-B; GASTRIC-CANCER; DEFINITIVE CHEMORADIOTHERAPY; PREOPERATIVE CHEMORADIATION; EXPRESSION PATTERNS; ESOPHAGEAL CANCER; METASTASIS; MICROARRAYS; HEDGEHOG	Background: Surgical samples have long been used as important subjects for cancer research. In accordance with an increase of neoadjuvant therapy, biopsy samples have recently become imperative for cancer transcriptome. On the other hand, both biopsy and surgical samples are available for expression profiling for predicting clinical outcome by adjuvant therapy; however, it is still unclear whether surgical sample expression profiles are useful for prediction via biopsy samples, because little has been done about comparative gene expression profiling between the two kinds of samples. Methodology and Findings: A total of 166 samples (77 biopsy and 89 surgical) of normal and malignant lesions of the esophagus were analyzed by microarrays. Gene expression profiles were compared between biopsy and surgical samples. Artificially induced epithelial-mesenchymal transition (aiEMT) was found in the surgical samples, and also occurred in mouse esophageal epithelial cell layers under an ischemic condition. Identification of clinically significant subgroups was thought to be disrupted by the disorder of the expression profile through this aiEMT. Conclusion and Significance: This study will evoke the fundamental misinterpretation including underestimation of the prognostic evaluation power of markers by overestimation of EMT in past cancer research, and will furnish some advice for the near future as follows: 1) Understanding how long the tissues were under an ischemic condition. 2) Prevalence of biopsy samples for in vivo expression profiling with low biases on basic and clinical research. 3) Checking cancer cell contents and normal- or necrotic-tissue contamination in biopsy samples for prevalence.	[Aoyagi, Kazuhiko; Nishimura, Takao; Ashida, Akio; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Integrat Omics & Bioinformat, Chuo Ku, Tokyo 104, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan; [Igaki, Hiroyasu; Tachimori, Yuji; Hokamura, Norikazu] Natl Canc Ctr, Dept Surg, Chuo Ku, Tokyo, Japan; [Daiko, Hiroyuki] Natl Canc Ctr Hosp E, Dept Surg, Chiba, Japan; [Ochiai, Atsushi] Natl Canc Ctr Hosp E, Dept Pathol, Chiba, Japan; [Ohtsu, Atsushi] Natl Canc Ctr Hosp E, Dept Endoscopy, Chiba, Japan; [Muto, Manabu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sakyo Ku, Kyoto, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Kyoto University	Aoyagi, K (corresponding author), Natl Canc Ctr, Res Inst, Div Integrat Omics & Bioinformat, Chuo Ku, Tokyo 104, Japan.	hksasaki@ncc.go.jp			National Institute of Biomedical Innovation; Ministry of Health, Labour and Welfare of Japan; Princess Takamatsu Cancer Research Fund; Foundation for Promotion of Cancer Research	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Princess Takamatsu Cancer Research Fund; Foundation for Promotion of Cancer Research	This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; a Grant-in-Aid for the Third Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan; Princess Takamatsu Cancer Research Fund, and Foundation for Promotion of Cancer Research (RR: T.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aoyagi K, 2003, BIOCHEM BIOPH RES CO, V300, P915, DOI 10.1016/S0006-291X(02)02967-4; Ashida A, 2006, INT J ONCOL, V28, P1345; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chengyin M., 2008, J CELL BIOCHEM, V104, P733; Cormac T.T., 2009, ANN NY ACAD SCI, V1177, P178; DeRisi J, 1996, NAT GENET, V14, P457; Duong C, 2007, ANN SURG ONCOL, V14, P3602, DOI 10.1245/s10434-007-9550-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eoin P.C., 2006, P NATL ACAD SCI USA, V103, P18154; FORDOR SPA, 1991, SCIENCE, V251, P767; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Isohata N, 2009, INT J CANCER, V125, P1212, DOI 10.1002/ijc.24400; Izzo JG, 2009, DIS ESOPHAGUS, V22, P127, DOI 10.1111/j.1442-2050.2008.00884.x; Katoh M, 2009, INT J ONCOL, V34, P1737, DOI 10.3892/ijo_00000304; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luthra R, 2006, J CLIN ONCOL, V24, P259, DOI 10.1200/JCO.2005.03.3688; Maher SG, 2009, ANN SURG, V250, P729, DOI 10.1097/SLA.0b013e3181bce7e1; Nakamura N, 2006, ONCOGENE, V25, P4245, DOI 10.1038/sj.onc.1209442; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Tachimori Y, 2009, J THORAC CARDIOV SUR, V137, P49, DOI 10.1016/j.jtcvs.2008.05.016; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	29	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18196	10.1371/journal.pone.0018196	http://dx.doi.org/10.1371/journal.pone.0018196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533028	Green Published, Green Submitted, gold			2022-12-27	WOS:000290014500002
J	Rockx, B; Feldmann, F; Brining, D; Gardner, D; LaCasse, R; Kercher, L; Long, D; Rosenke, R; Virtaneva, K; Sturdevant, DE; Porcella, SF; Mattoon, J; Parnell, M; Baric, RS; Feldmann, H				Rockx, Barry; Feldmann, Friederike; Brining, Douglas; Gardner, Don; LaCasse, Rachel; Kercher, Lisa; Long, Dan; Rosenke, Rebecca; Virtaneva, Kimmo; Sturdevant, Daniel E.; Porcella, Stephen F.; Mattoon, John; Parnell, Michael; Baric, Ralph S.; Feldmann, Heinz			Comparative Pathogenesis of Three Human and Zoonotic SARS-CoV Strains in Cynomolgus Macaques	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; CYTOKINE/CHEMOKINE PROFILES; CORONAVIRUS INFECTION; ANIMAL-MODEL; TRANSMISSION; EXPRESSION; RECEPTOR; DISEASE; CHEMOKINES; CYTOKINES	The severe acute respiratory syndrome (SARS) epidemic was characterized by increased pathogenicity in the elderly due to an early exacerbated innate host response. SARS-CoV is a zoonotic pathogen that entered the human population through an intermediate host like the palm civet. To prevent future introductions of zoonotic SARS-CoV strains and subsequent transmission into the human population, heterologous disease models are needed to test the efficacy of vaccines and therapeutics against both late human and zoonotic isolates. Here we show that both human and zoonotic SARS-CoV strains can infect cynomolgus macaques and resulted in radiological as well as histopathological changes similar to those seen in mild human cases. Viral replication was higher in animals infected with a late human phase isolate compared to a zoonotic isolate. While there were significant differences in the number of host genes differentially regulated during the host responses between the three SARS-CoV strains, the top pathways and functions were similar and only apparent early during infection with the majority of genes associated with interferon signaling pathways. This study characterizes critical disease models in the evaluation and licensure of therapeutic strategies against SARS-CoV for human use.	[Rockx, Barry; Feldmann, Friederike; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Brining, Douglas; Gardner, Don; LaCasse, Rachel; Kercher, Lisa; Long, Dan; Rosenke, Rebecca; Parnell, Michael] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT USA; [Virtaneva, Kimmo; Sturdevant, Daniel E.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Div Intramural Res,NIH, Hamilton, MT USA; [Mattoon, John] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Rockx, Barry] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Rockx, Barry] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington State University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rockx, B (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA.	barry.rockx@utmb.edu		Tripp, Ralph/0000-0002-2924-9956	NIH NIAID [U54 AI081680, AI075297]; Division of Intramural Research (DIR), NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680, R01AI075297, ZIAAI001089, ZICAI001052, ZIGAI001048] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research (DIR), NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was financially supported by NIH NIAID grants U54 AI081680 and AI075297 to R. B. and the Division of Intramural Research (DIR), NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x; Chien JY, 2006, RESPIROLOGY, V11, P715, DOI 10.1111/j.1440-1843.2006.00942.x; CHINESE SME, 2004, SCIENCE, V303, P1666, DOI DOI 10.1126/SCIENCE.1092002; De Lang A, 2007, PLOS PATHOG, V3, P1129, DOI 10.1371/journal.ppat.0030112; de Lang A, 2006, VIROLOGY, V353, P474, DOI 10.1016/j.virol.2006.06.011; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; ENJUANES L, 2007, VIRUS RES; Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09; Holmes EC, 2004, PHILOS T R SOC B, V359, P1059, DOI 10.1098/rstb.2004.1478; Isakbaeva ET, 2004, EMERG INFECT DIS, V10, P225, DOI 10.3201/eid1002.030734; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Lawler JV, 2006, PLOS MED, V3, P677, DOI 10.1371/journal.pmed.0030149; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Liu M, 2006, BIOMED ENVIRON SCI, V19, P336; McAuliffe J, 2004, VIROLOGY, V330, P8, DOI 10.1016/j.virol.2004.09.030; Nicholls J, 2003, RESPIROLOGY, V8, pS6, DOI 10.1046/j.1440-1843.2003.00517.x; Osterhaus ADME, 2004, PHILOS T ROY SOC B, V359, P1081, DOI 10.1098/rstb.2004.1489; Qin C, 2005, J PATHOL, V206, P251, DOI 10.1002/path.1769; Roberts A, 2005, J VIROL, V79, P503, DOI 10.1128/JVI.79.1.503-511.2005; ROBERTS A, 2007, VIRUS RES; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Rockx Barry, 2007, P257; Rockx B, 2007, J VIROL, V81, P7410, DOI 10.1128/JVI.00505-07; Rockx B, 2010, J INFECT DIS, V201, P946, DOI 10.1086/651022; Rockx B, 2009, J VIROL, V83, P7062, DOI 10.1128/JVI.00127-09; Rowe T, 2004, J VIROL, V78, P11401, DOI 10.1128/JVI.78.20.11401-11404.2004; SAFRONETZ D, 2010, J VIROL; Sheahan T, 2008, J VIROL, V82, P8721, DOI 10.1128/JVI.00818-08; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756; Tang NLS, 2005, CLIN CHEM, V51, P2333, DOI 10.1373/clinchem.2005.054460; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wang B, 2005, J BIOMECH ENG-T ASME, V127, P32, DOI 10.1115/1.1835350; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Xue XY, 2003, CHINESE MED J-PEKING, V116, P819; Yu SY, 2005, WORLD J GASTROENTERO, V11, P5037, DOI 10.3748/wjg.v11.i32.5037; Zeng FY, 2003, EXP BIOL MED, V228, P866, DOI 10.1177/15353702-0322807-13	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18558	10.1371/journal.pone.0018558	http://dx.doi.org/10.1371/journal.pone.0018558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533129	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400013
J	Scrosati, RA; Patten, RD; Lauff, RF				Scrosati, Ricardo A.; Patten, Ruth D.; Lauff, Randolph F.			Positive Interspecific Relationship between Temporal Occurrence and Abundance in Insects	PLOS ONE			English	Article							-3/2 POWER RULE; OCCUPANCY RELATIONSHIPS; MACROINVERTEBRATES	One of the most studied macroecological patterns is the interspecific abundance-occupancy relationship, which relates species distribution and abundance across space. Interspecific relationships between temporal distribution and abundance, however, remain largely unexplored. Using data for a natural assemblage of tabanid flies measured daily during spring and summer in Nova Scotia, we found that temporal occurrence (proportion of sampling dates in which a species occurred in an experimental trap) was positively related to temporal mean abundance (number of individuals collected for a species during the study period divided by the total number of sampling dates). Moreover, two models that often describe spatial abundance-occupancy relationships well, the He-Gaston and negative binomial models, explained a high amount of the variation in our temporal data. As for the spatial abundance-occupancy relationship, the (temporal) aggregation parameter, k, emerged as an important component of the hereby named interspecific temporal abundance-occurrence relationship. This may be another case in which a macroecological pattern shows similarities across space and time, and it deserves further research because it may improve our ability to forecast colonization dynamics and biological impacts.	[Scrosati, Ricardo A.; Patten, Ruth D.; Lauff, Randolph F.] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada	Saint Francis Xavier University - Canada	Scrosati, RA (corresponding author), St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada.	rscrosat@stfx.ca	Scrosati, Ricardo A/K-6172-2016	Scrosati, Ricardo A/0000-0002-3050-132X; Patten, Ruth/0000-0002-2593-1296	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Canada Research Chairs program (CRC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs program (CRC)(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding was provided through grants to RAS from the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca), the Canada Foundation for Innovation (CFI, www.innovation.ca), and the Canada Research Chairs program (CRC, www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; FRENCH FE, 1995, J MED ENTOMOL, V32, P197, DOI 10.1093/jmedent/32.2.197; Guo QF, 2000, J ECOL, V88, P551, DOI 10.1046/j.1365-2745.2000.00466.x; He FL, 2000, AM NAT, V156, P553, DOI 10.1086/303403; Holt AR, 2002, BASIC APPL ECOL, V3, P1, DOI 10.1078/1439-1791-00083; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lampinen R, 1996, ATLAS FLORAE EUROPAE; Mullen G. R., 2009, MED VET ENTOMOLOGY; Quinn GP, 2003, EXPT DESIGN DATA ANA; TESKEY HJ, 1990, INSECTS ARACHNIDS CA, V16; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Webb TJ, 2009, MAR ECOL PROG SER, V396, P293, DOI 10.3354/meps08253; WELLER DE, 1989, AM NAT, V133, P20, DOI 10.1086/284899; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637; Wilson PD, 2011, GLOBAL ECOL BIOGEOGR, V20, P193, DOI 10.1111/j.1466-8238.2010.00569.x	18	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18982	10.1371/journal.pone.0018982	http://dx.doi.org/10.1371/journal.pone.0018982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533057	Green Published, gold			2022-12-27	WOS:000289719400045
J	Hofmann, RW; Jahufer, MZZ				Hofmann, Rainer W.; Jahufer, M. Z. Zulfiqhar			Tradeoff between Biomass and Flavonoid Accumulation in White Clover Reflects Contrasting Plant Strategies	PLOS ONE			English	Article							TRIFOLIUM-REPENS L.; UV-B RADIATION; WATER AVAILABILITY; RESPONSES; PRODUCTIVITY; CULTIVARS; STRESS; ROLES	An outdoor study was conducted to examine relationships between plant productivity and stress-protective phenolic plant metabolites. Twenty-two populations of the pasture legume white clover were grown for 4 1/2 months during spring and summer in Palmerston North, New Zealand. The major phenolic compounds identified and quantified by HPLC analysis were glycosides of the flavonoids quercetin and kaempferol. Multivariate analysis revealed a trade-off between flavonoid accumulation and plant productivity attributes. White clover populations with high biomass production, large leaves and thick tap roots showed low levels of quercetin glycoside accumulation and low quercetin: kaempferol ratios, while the opposite was true for less productive populations. The latter included stress-resistant ecotypes from Turkey and China, and the analysis also identified highly significant positive relationships of quercetin glycoside accumulation with plant morphology (root: shoot ratio). Importantly, a high degree of genetic variation was detected for most of the measured traits. These findings suggest merit for considering flavonoids such as quercetin as potential selection criteria in the genetic improvement of white clover and other crops.	[Hofmann, Rainer W.] Lincoln Univ, Fac Agr & Life Sci, Lincoln, New Zealand; [Hofmann, Rainer W.; Jahufer, M. Z. Zulfiqhar] AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand	Lincoln University - New Zealand; AgResearch - New Zealand	Hofmann, RW (corresponding author), Lincoln Univ, Fac Agr & Life Sci, Lincoln, New Zealand.	Rainer.Hofmann@lincoln.ac.nz	Hofmann, Rainer W/D-2686-2018	Hofmann, Rainer W/0000-0002-1804-2319	Agricultural and Marketing Research and Development Trust (AGMARDT) of New Zealand [20390]	Agricultural and Marketing Research and Development Trust (AGMARDT) of New Zealand	Funding is acknowledged from the Agricultural and Marketing Research and Development Trust (AGMARDT) of New Zealand, grant number 20390, http://www.agmardt.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Agati G, 2009, ANN BOT-LONDON, V104, P853, DOI 10.1093/aob/mcp177; Albert A, 2009, OECOLOGIA, V160, P1, DOI 10.1007/s00442-009-1277-1; Andrews M, 2007, ANN APPL BIOL, V151, P11, DOI 10.1111/j.1744-7348.2007.00137.x; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Caradus JR, 1996, CROP SCI, V36, P900, DOI 10.2135/cropsci1996.0011183X0036000400014x; Carlsen SCK, 2008, CHEMOECOLOGY, V18, P129, DOI 10.1007/s00049-008-0402-7; Falconer D. S., 1996, INTRO QUANTITATIVE G; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Genstat, 2003, GENST WIND REL 7 1 R; Grime J. P., 2001, PLANT STRATEGIES VEG; Hofmann RW, 2011, PLANT BIOLOGY, V13, P896, DOI 10.1111/j.1438-8677.2011.00458.x; Hofmann RW, 2003, PLANT CELL ENVIRON, V26, P603, DOI 10.1046/j.1365-3040.2003.00996.x; Hofmann RW, 2003, GLOBAL CHANGE BIOL, V9, P473, DOI 10.1046/j.1365-2486.2003.00578.x; Hofmann RW, 2001, PLANT CELL ENVIRON, V24, P917, DOI 10.1046/j.1365-3040.2001.00749.x; Hofmann RW, 2000, ANN BOT-LONDON, V86, P527, DOI 10.1006/anbo.2000.1216; Jahufer MZZ, 2009, NEW ZEAL J AGR RES, V52, P407, DOI 10.1080/00288230909510523; KROONENBERG PM, 1994, COMPUT STAT DATA AN, V18, P73, DOI 10.1016/0167-9473(94)90133-3; LUKE J, 1968, NZ SOIL BUREAU B 3, V26; Maggio A, 2007, ENVIRON EXP BOT, V59, P276, DOI 10.1016/j.envexpbot.2006.02.002; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Smith GJ, 1998, J PHOTOCH PHOTOBIO A, V118, P99, DOI 10.1016/S1010-6030(98)00354-2; Watson SL., 1995, GEBEIL ANAL PACKAGE; Wery J, 2005, AUST J AGR RES, V56, P1201, DOI 10.1071/AR05066; White T. L., 1989, PREDICTING BREEDING, V1st; Wittenmyer L, 2005, J PLANT NUTR SOIL SC, V168, P531, DOI 10.1002/jpln.200520507; Woodfield D. R., 2001, Proceedings of the New Zealand Grassland Association, V63, P103	27	35	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18949	10.1371/journal.pone.0018949	http://dx.doi.org/10.1371/journal.pone.0018949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526153	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100039
J	Paino, A; Tuominen, H; Jaaskelainen, M; Alanko, J; Nuutila, J; Asikainen, SE; Pelliniemi, LJ; Pollanen, MT; Chen, C; Ihalin, R				Paino, Annamari; Tuominen, Heidi; Jaaskelainen, Mari; Alanko, Jonna; Nuutila, Jari; Asikainen, Sirkka E.; Pelliniemi, Lauri J.; Pollanen, Marja T.; Chen, Casey; Ihalin, Riikka			Trimeric Form of Intracellular ATP Synthase Subunit beta of Aggregatibacter actinomycetemcomitans Binds Human Interleukin-1 beta	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; CORONARY-HEART-DISEASE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; ESCHERICHIA-COLI; YERSINIA-PESTIS; GROWTH; CELLS; MODEL	Bacterial biofilms resist host defenses and antibiotics partly because of their decreased metabolism. Some bacteria use proinflammatory cytokines, such as interleukin (IL)-1 beta, as cues to promote biofilm formation and to alter virulence. Although one potential bacterial IL-1 beta receptor has been identified, current knowledge of the bacterial IL-1 beta sensing mechanism is limited. In chronic biofilm infection, periodontitis, Aggregatibacter actinomycetemcomitans requires tight adherence (tad)locus to form biofilms, and tissue destroying active lesions contain more IL-1 beta than inactive ones. The effect of IL-1 beta on the metabolic activity of A. actinomycetemcomitans biofilm was tested using alamarBlue (TM). The binding of IL-1 beta to A. actinomycetemcomitans cells was investigated using transmission electron microscopy and flow cytometry. To identify the proteins which interacted with IL-1 beta, different protein fractions from A. actinomycetemcomitans were run in native-PAGE and blotted using biotinylated IL-1 beta and avidin-HRP, and identified using mass spectroscopy. We show that although IL-1 beta slightly increases the biofilm formation of A. actinomycetemcomitans, it reduces the metabolic activity of the biofilm. A similar reduction was observed with all tad-locus mutants except the secretin mutant, although all tested mutant strains as well as wild type strains bound IL-1 beta. Our results suggest that IL-1 beta might be transported into the A. actinomycetemcomitans cells, and the trimeric form of intracellular ATP synthase subunit beta interacted with IL-1 beta, possibly explaining the decreased metabolic activity. Because ATP synthase is highly conserved, it might universally enhance biofilm resistance to host defense by binding IL-1 beta during inflammation.	[Paino, Annamari; Tuominen, Heidi; Jaaskelainen, Mari; Alanko, Jonna; Nuutila, Jari; Ihalin, Riikka] Univ Turku, Dept Biochem & Food Chem, Turku, Finland; [Alanko, Jonna; Asikainen, Sirkka E.] Umea Univ, Dept Odontol, Umea, Sweden; [Pelliniemi, Lauri J.] Univ Turku, Lab Electron Microscopy, Turku, Finland; [Pollanen, Marja T.] Univ Turku, Inst Dent, Dept Periodontol, Turku, Finland; [Chen, Casey] Univ So Calif, Div Periodontol Diagnost Sci & Dent Hyg, USC Sch Dent, Los Angeles, CA USA	University of Turku; Umea University; University of Turku; University of Turku; University of Southern California	Paino, A (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	riikka.ihalin@utu.fi	Ihalin, Riikka/I-4411-2019; Tuominen, Heidi/A-7075-2010	Ihalin, Riikka/0000-0003-4118-0370; Tuominen, Heidi/0000-0003-2412-7658; Nuutila, Jari/0000-0002-9077-0273; Alanko, Jonna/0000-0002-7698-3061	Academy of Finland [126557]; Turku University Foundation; Ella & Georg Ehrnrooth Foundation; Finnish Cultural Foundation; Paulo Foundation; Emil and Blida Maunula Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012212] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Turku University Foundation; Ella & Georg Ehrnrooth Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paulo Foundation; Emil and Blida Maunula Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the grants from the Academy of Finland (126557) (http://www.aka.fi/en-gb/A/), Turku University Foundation, (http://www.turunyliopistosaatio.fi/engframes.htm), Ella & Georg Ehrnrooth Foundation (http://www.ellageorg.fi/en/about), The Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId=12256), Paulo Foundation (http://www.paulo.fi/foundation.html) and Emil and Blida Maunula Fund to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; ASSELINEAU D, 1984, BRIT J DERMATOL, V111, P219, DOI 10.1111/j.1365-2133.1984.tb15608.x; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Buhlin K, 2009, ATHEROSCLEROSIS, V206, P518, DOI 10.1016/j.atherosclerosis.2009.03.035; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; FROJDMAN K, 1992, DIFFERENTIATION, V50, P113, DOI 10.1111/j.1432-0436.1992.tb00492.x; Gursoy UK, 2010, J PERIODONTOL, V81, P1084, DOI 10.1902/jop.2010.090664; Haase EM, 1999, INFECT IMMUN, V67, P2901, DOI 10.1128/IAI.67.6.2901-2908.1999; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Ihalin R, 2006, J MICROBIOL METH, V65, P417, DOI 10.1016/j.mimet.2005.08.016; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Kanangat S, 2001, J INFECT DIS, V183, P65, DOI 10.1086/317645; Kanangat S, 2007, MICROBES INFECT, V9, P408, DOI 10.1016/j.micinf.2006.12.018; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; Karched M, 2007, J MICROBIOL METH, V68, P46, DOI 10.1016/j.mimet.2006.06.004; Laughlin TF, 2010, INT J BIOL MACROMOL, V46, P367, DOI 10.1016/j.ijbiomac.2010.01.015; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makela M, 1998, BIOCHEM BIOPH RES CO, V253, P325, DOI 10.1006/bbrc.1998.9641; McLaughlin RA, 2006, MICROB PATHOGENESIS, V41, P67, DOI 10.1016/j.micpath.2006.04.005; Montebugnoli L, 2005, J CLIN PERIODONTOL, V32, P188, DOI 10.1111/j.1600-051X.2005.00641.x; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Oksanen J, 2002, J PERIODONTOL, V73, P86, DOI 10.1902/jop.2002.73.1.86; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Perez BA, 2006, J BACTERIOL, V188, P6361, DOI 10.1128/JB.00496-06; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Pussinen PJ, 2004, J LIPID RES, V45, P139, DOI 10.1194/jlr.M300250-JLR200; Runco LM, 2008, J BACTERIOL, V190, P3381, DOI 10.1128/JB.01840-07; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; STASHENKO P, 1991, J CLIN PERIODONTOL, V18, P548, DOI 10.1111/j.1600-051X.1991.tb00088.x; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Wang Y, 2005, GENE, V351, P61, DOI 10.1016/j.gene.2005.02.010; Wang Y, 2005, INFECT IMMUN, V73, P3749, DOI 10.1128/IAI.73.6.3749-3753.2005; Wang Y, 2003, GENE, V312, P249, DOI 10.1016/S0378-1119(03)00620-6; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; ZAVYALOV VP, 1995, FEBS LETT, V371, P65, DOI 10.1016/0014-5793(95)00878-D	43	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18929	10.1371/journal.pone.0018929	http://dx.doi.org/10.1371/journal.pone.0018929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533109	gold, Green Published, Green Submitted			2022-12-27	WOS:000289620100032
J	Eifuku, S; De Souza, WC; Nakata, R; Ono, T; Tamura, R				Eifuku, Satoshi; De Souza, Wania C.; Nakata, Ryuzaburo; Ono, Taketoshi; Tamura, Ryoi			Neural Representations of Personally Familiar and Unfamiliar Faces in the Anterior Inferior Temporal Cortex of Monkeys	PLOS ONE			English	Article							RECOGNITION MEMORY; PERIRHINAL NEURONS; RESPONSES; ACTIVATION; IDENTITY; SYSTEM; CELLS; AREA; TERM	To investigate the neural representations of faces in primates, particularly in relation to their personal familiarity or unfamiliarity, neuronal activities were chronically recorded from the ventral portion of the anterior inferior temporal cortex (AITv) of macaque monkeys during the performance of a facial identification task using either personally familiar or unfamiliar faces as stimuli. By calculating the correlation coefficients between neuronal responses to the faces for all possible pairs of faces given in the task and then using the coefficients as neuronal population-based similarity measures between the faces in pairs, we analyzed the similarity/dissimilarity relationship between the faces, which were potentially represented by the activities of a population of the face-responsive neurons recorded in the area AITv. The results showed that, for personally familiar faces, different identities were represented by different patterns of activities of the population of AITv neurons irrespective of the view (e. g., front, 90 degrees left, etc.), while different views were not represented independently of their facial identities, which was consistent with our previous report. In the case of personally unfamiliar faces, the faces possessing different identities but presented in the same frontal view were represented as similar, which contrasts with the results for personally familiar faces. These results, taken together, outline the neuronal representations of personally familiar and unfamiliar faces in the AITv neuronal population.	[Eifuku, Satoshi; De Souza, Wania C.; Nakata, Ryuzaburo; Tamura, Ryoi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Integrat Neurosci, Toyama 930, Japan; [Ono, Taketoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Neurophysiotherapy, Toyama 930, Japan	University of Toyama; University of Toyama	Eifuku, S (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Integrat Neurosci, Toyama 930, Japan.	se@med.u-toyama.ac.jp; rtamura@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Sports, Science and Technology, Japan [19500348, 18020012, 20119006]	Ministry of Education, Culture, Sports, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research (C) (19500348), Grant-in-Aid for Scientific Research on Priority Areas, "System study on higher-order brain functions", (18020012), and Grant-in-Aid for Scientific Research on Innovative Areas, "Face perception and recognition", (20119006) from the Ministry of Education, Culture, Sports, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi T, 2003, NEUROSCI RES, V47, P255, DOI 10.1016/S0168-0102(03)00202-5; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Balas B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001223; Balas Benjamin J, 2010, Front Hum Neurosci, V4, P1, DOI 10.3389/neuro.09.001.2010; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BRUCE V, 1986, PERCEPTION, V15, P387, DOI 10.1068/p150387; Bruce V, 1988, RECOGNISING FACES; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Eifuku S, 2010, J NEUROSCI, V30, P15085, DOI 10.1523/JNEUROSCI.0471-10.2010; Ellis HD, 1997, P ROY SOC B-BIOL SCI, V264, P1085, DOI 10.1098/rspb.1997.0150; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hays AV, 1982, WESCON C P, V2, P1; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Hirstein W, 1997, P ROY SOC B-BIOL SCI, V264, P437, DOI 10.1098/rspb.1997.0062; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MACPHERSON JM, 1979, BRAIN RES, V175, P183, DOI 10.1016/0006-8993(79)90530-4; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	53	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18913	10.1371/journal.pone.0018913	http://dx.doi.org/10.1371/journal.pone.0018913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526206	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600037
J	Fisher, EM; Williams, JL; Shaffer, RE				Fisher, Edward M.; Williams, Jessica L.; Shaffer, Ronald E.			Evaluation of Microwave Steam Bags for the Decontamination of Filtering Facepiece Respirators	PLOS ONE			English	Article								Reusing filtering facepiece respirators (FFRs) has been suggested as a strategy to conserve available supplies for home and healthcare environments during an influenza pandemic. For reuse to be possible, used FFRs must be decontaminated before redonning to reduce the risk of virus transmission; however, there are no approved methods for FFR decontamination. An effective method must reduce the microbial threat, maintain the function of the FFR, and present no residual chemical hazard. The method should be readily available, inexpensive and easily implemented by healthcare workers and the general public. Many of the general decontamination protocols used in healthcare and home settings are unable to address all of the desired qualities of an efficient FFR decontamination protocol. The goal of this study is to evaluate the use of two commercially available steam bags, marketed to the public for disinfecting infant feeding equipment, for FFR decontamination. The FFRs were decontaminated with microwave generated steam following the manufacturers' instructions then evaluated for water absorption and filtration efficiency for up to three steam exposures. Water absorption of the FFR was found to be model specific as FFRs constructed with hydrophilic materials absorbed more water. The steam had little effect on FFR performance as filtration efficiency of the treated FFRs remained above 95%. The decontamination efficacy of the steam bag was assessed using bacteriophage MS2 as a surrogate for a pathogenic virus. The tested steam bags were found to be 99.9% effective for inactivating MS2 on FFRs; however, more research is required to determine the effectiveness against respiratory pathogens.	[Fisher, Edward M.; Williams, Jessica L.; Shaffer, Ronald E.] NIOSH, Natl Personal Protect Technol Lab, Pittsburgh, PA USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Fisher, EM (corresponding author), NIOSH, Natl Personal Protect Technol Lab, Pittsburgh, PA USA.	EFisher@cdc.gov	Shaffer, Ronald E/I-2134-2012; Fisher, Edward/K-4418-2012; Shaffer, Ronald/ABI-6508-2020	Shaffer, Ronald/0000-0001-6352-7967	National Institute for Occupational Safety and Health (NIOSH); US Centers for Disease Control and Prevention	National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by internal funds from the National Institute for Occupational Safety and Health (NIOSH), part of the US Centers for Disease Control and Prevention. NIOSH employees were involved in conducting the study, analyzing the results, and preparing the manuscript.	*ASTM INT, 2010, E27212010 ASTM; Bergman MS, 2010, J ENG FIBER FABR, V5, P33; CDC, 2010, QUEST ANSW REG RESP QUEST ANSW REG RESP; CDC, 1999, TB RESP PROT PROGR H; Fisher E., 2010, J INT SOC RESP PROT, V27, P16; Fisher EM, 2011, J APPL MICROBIOL, V110, P287, DOI 10.1111/j.1365-2672.2010.04881.x; Fisher E, 2009, APPL ENVIRON MICROB, V75, P1500, DOI 10.1128/AEM.01653-08; GRIESBACH HC, 2008, DECONTAMINATION FILT; Heimbuch BK, 2011, AM J INFECT CONTROL, V39, pE1, DOI 10.1016/j.ajic.2010.07.004; *I MED US COMM DEV, 2006, REUS FAC INFL PAND F; Mardimae A, 2006, ANN EMERG MED, V48, P391, DOI 10.1016/j.annemergmed.2006.06.039; Occupational Safety and Health Administration, 2008, PROP GUID WORKPL STO; Rengasamy S, 2010, AM J INFECT CONTROL, V38, P9, DOI 10.1016/j.ajic.2009.08.006; Roberge RJ, 2010, ANN OCCUP HYG, V54, P671, DOI 10.1093/annhyg/meq042; Rutala W.A., 2019, GUIDELINE DISINFECTI; Salter WB, 2010, J OCCUP ENVIRON HYG, V7, P437, DOI [10.1080/15459624.2010.484794, 10.1080/15459624.2010484794]; U.S. Environmental Protection Agency, 2001, 821R01029 EPA; *US DEP HHS, 2006, MED DEV US FEE MOD A; *US GOV ACC OFF, 2008, GAO08147 US GOV ACC; Viscusi DJ, 2009, ANN OCCUP HYG, V53, P815, DOI 10.1093/annhyg/mep070; Viscusi DJ, 2009, AM J INFECT CONTROL, V37, P381, DOI 10.1016/j.ajic.2008.09.021; Viscusi DJ, 2007, J INT SOC RESP PROT, V24, P93; VISCUSI DJ, 2010, IMPACT 3 BIOL DECONT; Vo E, 2009, APPL ENVIRON MICROB, V75, P7303, DOI 10.1128/AEM.00799-09; Weiss Martin Meyer, 2007, Am J Public Health, V97 Suppl 1, pS32, DOI 10.2105/AJPH.2006.096214; Woo MH, 2010, J AEROSOL SCI, V41, P944, DOI 10.1016/j.jaerosci.2010.07.003	26	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18585	10.1371/journal.pone.0018585	http://dx.doi.org/10.1371/journal.pone.0018585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525995	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600015
J	Ekstrom, EJ; Sherwood, V; Andersson, T				Ekstrom, Elin J.; Sherwood, Victoria; Andersson, Tommy			Methylation and Loss of Secreted Frizzled-Related Protein 3 Enhances Melanoma Cell Migration and Invasion	PLOS ONE			English	Article							WNT ANTAGONIST; EPIGENETIC INACTIVATION; BETA-CATENIN; EXPRESSION; GENES; INHIBITION; PATHWAY; GROWTH; TRANSCRIPTION; PROGRESSION	Background: Wnt signaling is important in development and can also contribute to the initiation and progression of cancer. The Secreted Frizzled Related Proteins (SFRPs) constitute a family of Wnt modulators, crucial for controlling Wnt signaling. Here we investigate the expression and role of SFRP3 in melanoma. Methodology/Principal Findings: We show that SFRP3 mRNA is down-regulated in malignant melanoma tumors as compared to normal/benign tissue. Furthermore, we found that SFRP3 expression was lost in the malignant melanoma cell lines, A2058, HTB63 and A375, but not in the non-transformed melanocyte cell line, Hermes 3A. Methylated CpG rich areas were detected in the SFRP3 gene in melanoma cell lines and their SFRP3 expression could be restored using the demethylating agent, 5'aza-deoxycytidine. Addition of recombinant SFRP3 to melanoma cells had no effect on viable cell numbers, but decreased cell migration and invasion. Wnt5a signaling has been shown to increase the migration and invasion of malignant melanoma cells, and high expression of Wnt5a in melanoma tumors has been connected to a poor prognosis. We found that recombinant SFRP3 could inhibit Wnt5a signaling, and that it inhibited melanoma cell migration and invasion in a Wnt5a-dependent manner. Conclusion/Significance: We conclude that SFRP3 functions as a melanoma migration and invasion suppressor by interfering with Wnt5a signaling.	[Ekstrom, Elin J.; Sherwood, Victoria; Andersson, Tommy] Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden	Lund University; Skane University Hospital	Ekstrom, EJ (corresponding author), Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden.	Tommy.Andersson@med.lu.se		Sherwood, Victoria/0000-0001-6193-2571; Andersson, Tommy/0000-0003-4032-5769; Pietras, Elin Josefina/0000-0003-1645-8916	Swedish Cancer Foundation; Swedish Research Council; Soderberg foundations; Malmo University Hospital Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society; Knut & Alice Wallenberg Foundation; Wellcome Trust Cell Bank	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg foundations; Malmo University Hospital Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wellcome Trust Cell Bank(Wellcome Trust)	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the Soderberg foundations, Malmo University Hospital Research Foundations, the Gunnar Nilsson's Cancer Foundation (to TA), the Royal Physiographic Society (to EE and VS), the Knut & Alice Wallenberg Foundation, and the Wellcome Trust Cell Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Jonsson M, 2002, CANCER RES, V62, P409; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Larue L, 2003, PIGM CELL RES, V16, P312, DOI 10.1034/j.1600-0749.2003.00050.x; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu W, 2008, GROWTH FACTORS, V26, P343, DOI 10.1080/08977190802442013; Mandal D, 2007, GENE, V386, P131, DOI 10.1016/j.gene.2006.08.030; Marsit CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012334; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	44	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18674	10.1371/journal.pone.0018674	http://dx.doi.org/10.1371/journal.pone.0018674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494614	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800035
J	Nunez, F; Bravo, S; Cruzat, F; Montecino, M; De Ferrari, GV				Nunez, Felipe; Bravo, Soraya; Cruzat, Fernando; Montecino, Martin; De Ferrari, Giancarlo V.			Wnt/beta-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer Cells	PLOS ONE			English	Article							PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE-2; BETA-CATENIN; TARGET GENES; COLON-CARCINOMA; EXPRESSION; WNT; ACTIVATION; PATHWAY; APC; LINES	Background: Increased expression of the cyclooxygenase-2 enzyme (COX2) is one of the main characteristics of gastric cancer (GC), which is a leading cause of death in the world, particularly in Asia and South America. Although the Wnt/beta-catenin signaling pathway has been involved in the transcriptional activation of the COX2 gene, the precise mechanism modulating this response is still unknown. Methodology/Principal Findings: Here we studied the transcriptional regulation of the COX2 gene in GC cell lines and assessed whether this phenomenon is modulated by Wnt/beta-catenin signaling. We first examined the expression of COX2 mRNA in GC cells and found that there is a differential expression pattern consistent with high levels of nuclear-localized beta-catenin. Pharmacological treatment with either lithium or valproic acid and molecular induction with purified canonical Wnt3a significantly enhanced COX2 mRNA expression in a dose-and time-dependent manner. Serial deletion of a 1.6 Kbp COX2 promoter fragment and gain-or loss-of-function experiments allowed us to identify a minimal Wnt/beta-catenin responsive region consisting of 0.8 Kbp of the COX2 promoter (pCOX2-0.8), which showed maximal response in gene-reporter assays. The activity of this pCOX2-0.8 promoter region was further confirmed by site-directed mutagenesis and DNA-protein binding assays. Conclusions/Significance: We conclude that the pCOX2-0.8 minimal promoter contains a novel functional T-cell factor/lymphoid enhancer factor (TCF/LEF)-response element (TBE Site II; -689/-684) that responds directly to enhanced Wnt/beta-catenin signaling and which may be important for the onset/progression of GC.	[Nunez, Felipe; Bravo, Soraya; Cruzat, Fernando; Montecino, Martin; De Ferrari, Giancarlo V.] Univ Concepcion, Fac Biol Sci, Dept Biochem & Mol Biol, Ctr Tecnol & Innovac Canc, Concepcion, Chile; [Montecino, Martin; De Ferrari, Giancarlo V.] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Montecino, Martin; De Ferrari, Giancarlo V.] Univ Andres Bello, Fac Med, Santiago, Chile	Universidad de Concepcion; Universidad Andres Bello; Universidad Andres Bello	Nunez, F (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Biochem & Mol Biol, Ctr Tecnol & Innovac Canc, Concepcion, Chile.	gdeferrari@unab.cl		Nunez, Felipe J/0000-0002-4962-3642; De Ferrari, Giancarlo/0000-0003-0932-125X	CTI-Cancer; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) from the Chilean government [PBCT-6]	CTI-Cancer; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) from the Chilean government(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by CTI-Cancer, Programa Bicentenario en Ciencia y Tecnologia (PBCT) - Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) grant number PBCT-6 from the Chilean government (M. M. and G. V. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ackerman VE, 2004, BIOL REPROD, V71, P2079, DOI 10.1095/biolreprod.104.030841; Araki Y, 2003, CANCER RES, V63, P728; Avila ME, 2010, J BIOL CHEM, V285, P18939, DOI 10.1074/jbc.M110.103028; BARRANCO SC, 1983, CANCER RES, V43, P1703; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Carlson Mary L, 2003, Mol Cancer, V2, P42, DOI 10.1186/1476-4598-2-42; Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x; Cho SJ, 2007, DIGEST DIS SCI, V52, P1713, DOI 10.1007/s10620-007-9787-3; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Clements WM, 2002, CANCER RES, V62, P3503; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Han SW, 2003, CLIN CANCER RES, V9, P4627; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; INOUE H, 1994, FEBS LETT, V350, P51, DOI 10.1016/0014-5793(94)00731-4; Katoh M, 2001, INT J ONCOL, V19, P1003; Kim B, 2006, CLIN CANCER RES, V12, P3541, DOI 10.1158/1078-0432.CCR-05-2440; Kim H, 2001, SCAND J GASTROENTERO, V36, P706, DOI 10.1080/003655201300191969; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P51; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; Lee JH, 2002, AM J PATHOL, V161, P611, DOI 10.1016/S0002-9440(10)64216-2; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; PARK JG, 1990, CANCER RES, V50, P2773; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Ristimaki A, 1997, CANCER RES, V57, P1276; Satiroglu-Tufan NL, 2006, WORLD J GASTROENTERO, V12, P3283, DOI 10.3748/wjg.v12.i20.3283; Saukkonen K, 2003, APMIS, V111, P915, DOI 10.1034/j.1600-0463.2003.1111001.x; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiel A, 2006, J BIOL CHEM, V281, P4564, DOI 10.1074/jbc.M512722200; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838	54	86	87	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18562	10.1371/journal.pone.0018562	http://dx.doi.org/10.1371/journal.pone.0018562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494638	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400038
J	Pan, XS; Houser, D				Pan, Xiaofei Sophia; Houser, Daniel			Competition for Trophies Triggers Male Generosity	PLOS ONE			English	Article							HUMAN ALTRUISM; COOPERATION; PUNISHMENT; EVOLUTION; RECIPROCITY; INCENTIVES; STRATEGIES; SANCTIONS; HANDICAP; FAIRNESS	Background: Cooperation is indispensable in human societies, and much progress has been made towards understanding human pro-social decisions. Formal incentives, such as punishment, are suggested as potential effective approaches despite the fact that punishment can crowd out intrinsic motives for cooperation and detrimentally impact efficiency. At the same time, evolutionary biologists have long recognized that cooperation, especially food sharing, is typically efficiently organized in groups living on wild foods, even absent formal economic incentives. Despite its evident importance, the source of this voluntary compliance remains largely uninformed. Drawing on costly signaling theory, and in light of the widely established competitive nature of males, we hypothesize that unique and displayable rewards (trophies) out of competition may trigger male generosity in competitive social environments. Principal Findings: Here, we use a controlled laboratory experiment to show that cooperation is sustained in a generosity competition with trophy rewards, but breaks down in the same environment with equally valuable but non-unique and non-displayable rewards. Further, we find that males' competition for trophies is the driving force behind treatment differences. In contrast, it appears that female competitiveness is not modulated by trophy rewards. Significance: Our results suggest new approaches to promoting cooperation in human groups that, unlike punishment mechanisms, do not sacrifice efficiency. This could have important implications in any domain where voluntary compliance matters - including relations between spouses, employers and employees, market transactions, and conformity to legal standards.	[Pan, Xiaofei Sophia; Houser, Daniel] George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA	George Mason University	Pan, XS (corresponding author), George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA.	xfeipan@gmail.com		Houser, Daniel/0000-0003-3583-8201				Abbink K, 2010, AM ECON REV, V100, P420, DOI 10.1257/aer.100.1.420; Ariely D, 2009, AM ECON REV, V99, P544, DOI 10.1257/aer.99.1.544; Ball S, 2001, Q J ECON, V116, P161, DOI 10.1162/003355301556374; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bird RLB, 1997, CURR ANTHROPOL, V38, P49, DOI 10.1086/204581; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Duffy J, 2010, J ECON BEHAV ORGAN, V74, P82, DOI 10.1016/j.jebo.2010.02.001; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E, 2004, J EUR ECON ASSOC, V2, DOI 10.1162/1542476042782297; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Gneezy U, 2003, Q J ECON, V118, P1049, DOI 10.1162/00335530360698496; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; Hawkes K, 2001, EVOL HUM BEHAV, V22, P113, DOI 10.1016/S1090-5138(00)00066-0; Houser D, 2008, GAME ECON BEHAV, V62, P509, DOI 10.1016/j.geb.2007.05.001; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; RABIN M, 1993, AM ECON REV, V83, P1281; Smith EA, 2003, BEHAV ECOL, V14, P116, DOI 10.1093/beheco/14.1.116; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	30	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18050	10.1371/journal.pone.0018050	http://dx.doi.org/10.1371/journal.pone.0018050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494668	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400008
J	Dembele, L; Gego, A; Zeeman, AM; Franetich, JF; Silvie, O; Rametti, A; Le Grand, R; Dereuddre-Bosquet, N; Sauerwein, R; van Gemert, GJ; Vaillant, JC; Thomas, AW; Snounou, G; Kocken, CHM; Mazier, D				Dembele, Laurent; Gego, Audrey; Zeeman, Anne-Marie; Franetich, Jean-Francois; Silvie, Olivier; Rametti, Armelle; Le Grand, Roger; Dereuddre-Bosquet, Nathalie; Sauerwein, Robert; van Gemert, Geert-Jan; Vaillant, Jean-Christophe; Thomas, Alan W.; Snounou, Georges; Kocken, Clemens H. M.; Mazier, Dominique			Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug Discovery	PLOS ONE			English	Article							TROPHOZOITE-INDUCED INFECTIONS; VIVAX MALARIA; EXOERYTHROCYTIC PARASITES; CYNOMOLGI-BASTIANELLI; ANTIMALARIAL-DRUGS; HUMAN HEPATOCYTES; INVITRO CULTURE; PRIMAQUINE; SCHIZONTS; FORMS	Background: Amongst the Plasmodium species in humans, only P. vivax and P. ovale produce latent hepatic stages called hypnozoites, which are responsible for malaria episodes long after a mosquito bite. Relapses contribute to increased morbidity, and complicate malaria elimination programs. A single drug effective against hypnozoites, primaquine, is available, but its deployment is curtailed by its haemolytic potential in glucose-6-phosphate dehydrogenase deficient persons. Novel compounds are thus urgently needed to replace primaquine. Discovery of compounds active against hypnozoites is restricted to the in vivo P. cynomolgi-rhesus monkey model. Slow growing hepatic parasites reminiscent of hypnozoites had been noted in cultured P. vivax-infected hepatoma cells, but similar forms are also observed in vitro by other species including P. falciparum that do not produce hypnozoites. Methodology: P. falciparum or P. cynomolgi sporozoites were used to infect human or Macaca fascicularis primary hepatocytes, respectively. The susceptibility of the slow and normally growing hepatic forms obtained in vitro to three antimalarial drugs, one active against hepatic forms including hypnozoites and two only against the growing forms, was measured. Results: The non-dividing slow growing P. cynomolgi hepatic forms, observed in vitro in primary hepatocytes from the natural host Macaca fascicularis, can be distinguished from similar forms seen in P. falciparum-infected human primary hepatocytes by the differential action of selected anti-malarial drugs. Whereas atovaquone and pyrimethamine are active on all the dividing hepatic forms observed, the P. cynomolgi slow growing forms are highly resistant to treatment by these drugs, but remain susceptible to primaquine. Conclusion: Resistance of the non-dividing P. cynomolgi forms to atovaquone and pyrimethamine, which do not prevent relapses, strongly suggests that these slow growing forms are hypnozoites. This represents a first step towards the development of a practical medium-throughput in vitro screening assay for novel hypnozoiticidal drugs.	[Dembele, Laurent; Gego, Audrey; Franetich, Jean-Francois; Silvie, Olivier; Rametti, Armelle; Snounou, Georges; Mazier, Dominique] Univ Paris 06, UMR S945, Paris, France; [Dembele, Laurent; Gego, Audrey; Franetich, Jean-Francois; Silvie, Olivier; Rametti, Armelle; Snounou, Georges; Mazier, Dominique] INSERM, U945, Paris, France; [Zeeman, Anne-Marie; Thomas, Alan W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] CEA, Div Immunovirol, Inst Emerging Dis & Innovat Therapies IMETI, Fontenay Aux Roses, France; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] Univ Paris 11, UMR E01, Orsay, France; [Sauerwein, Robert; van Gemert, Geert-Jan] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vaillant, Jean-Christophe] Hop La Pitie Salpetriere, Serv Chirurg Digest Hepatobiliopancreat & Transpl, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Dembele, L (corresponding author), Univ Paris 06, UMR S945, Paris, France.	dominique.mazier@upmc.fr	Snounou, Georges/F-3352-2011; Sauerwein, Robert/C-8519-2013; Silvie, Olivier/AAF-5437-2021; Franetich, Jean-François/GZA-9674-2022; Silvie, Olivier/K-7290-2017	Snounou, Georges/0000-0002-6133-6398; Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; DEMBELE, LAURENT/0000-0001-9087-8439; Zeeman, Anne-Marie/0000-0002-0157-4669; Kocken, Clemens/0000-0002-4784-1734	Medicines for Malaria Venture; Wellcome Trust [WT078285]; Biomedical Primates Research Center; Universite Pierre et Marie Curie	Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Primates Research Center; Universite Pierre et Marie Curie	This work was supported by a grant from the Medicines for Malaria Venture and a translational research grant (WT078285) from the Wellcome Trust to the Novartis Institute for Tropical Diseases, the Biomedical Primates Research Center and the Universite Pierre et Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Chattopadhyay R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014275; Coatney G.R., 1971, PRIMATE MALARIAS, P1; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; GARNHAM PCC, 1966, MALARIA PARASITES OT, P1; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; HOLLINGDALE MR, 1986, AM J TROP MED HYG, V35, P275, DOI 10.4269/ajtmh.1986.35.275; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; JIANG JB, 1988, T ROY SOC TROP MED H, V82, P56, DOI 10.1016/0035-9203(88)90262-3; Jimenez BC, 2006, J TRAVEL MED, V13, P373, DOI 10.1111/j.1708-8305.2006.00073.x; Kocken CHM, 2009, ANTIMICROB AGENTS CH, V53, P421, DOI 10.1128/AAC.00576-08; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; Maguire JD, 2007, J TRAVEL MED, V14, P411, DOI 10.1111/j.1708-8305.2007.00153.x; MATTEI D, 1989, EUR J IMMUNOL, V19, P1823, DOI 10.1002/eji.1830191010; MAZIER D, 1983, ANN PARASIT HUM COMP, V58, P405, DOI 10.1051/parasite/1983584405; MAZIER D, 1984, NATURE, V307, P367, DOI 10.1038/307367a0; Mazier D, 2009, NAT REV DRUG DISCOV, V8, P854, DOI 10.1038/nrd2960; MILLET P, 1987, ANN PARASIT HUM COMP, V62, P5, DOI 10.1051/parasite/19876215; MILLET P, 1988, AM J TROP MED HYG, V39, P529, DOI 10.4269/ajtmh.1988.39.529; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Povinelli L, 2003, J TRAVEL MED, V10, P353, DOI 10.2310/7060.2003.9318; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P646, DOI 10.4269/ajtmh.1982.31.646; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P609, DOI 10.4269/ajtmh.1982.31.609; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P612, DOI 10.4269/ajtmh.1982.31.612; Shu H, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P185; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240	27	102	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18162	10.1371/journal.pone.0018162	http://dx.doi.org/10.1371/journal.pone.0018162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483865	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200036
J	Tumminello, M; Micciche, S; Lillo, F; Piilo, J; Mantegna, RN				Tumminello, Michele; Micciche, Salvatore; Lillo, Fabrizio; Piilo, Jyrki; Mantegna, Rosario N.			Statistically Validated Networks in Bipartite Complex Systems	PLOS ONE			English	Article							DISCOVERY	Many complex systems present an intrinsic bipartite structure where elements of one set link to elements of the second set. In these complex systems, such as the system of actors and movies, elements of one set are qualitatively different than elements of the other set. The properties of these complex systems are typically investigated by constructing and analyzing a projected network on one of the two sets (for example the actor network or the movie network). Complex systems are often very heterogeneous in the number of relationships that the elements of one set establish with the elements of the other set, and this heterogeneity makes it very difficult to discriminate links of the projected network that are just reflecting system's heterogeneity from links relevant to unveil the properties of the system. Here we introduce an unsupervised method to statistically validate each link of a projected network against a null hypothesis that takes into account system heterogeneity. We apply the method to a biological, an economic and a social complex system. The method we propose is able to detect network structures which are very informative about the organization and specialization of the investigated systems, and identifies those relationships between elements of the projected network that cannot be explained simply by system heterogeneity. We also show that our method applies to bipartite systems in which different relationships might have different qualitative nature, generating statistically validated networks in which such difference is preserved.	[Tumminello, Michele] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Tumminello, Michele; Micciche, Salvatore; Lillo, Fabrizio; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis, Palermo, Italy; [Lillo, Fabrizio] Santa Fe Inst, Santa Fe, NM 87501 USA; [Lillo, Fabrizio] Scuola Normale Super Pisa, Pisa, Italy; [Piilo, Jyrki] Univ Turku, Ctr Quantum Phys, Dept Phys & Astron, Turun, Finland	Carnegie Mellon University; University of Palermo; The Santa Fe Institute; Scuola Normale Superiore di Pisa; University of Turku	Tumminello, M (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	rn.mantegna@gmail.com	Miccichè, Salvatore/B-6575-2008; Tumminello, Michele/G-4492-2011; Mantegna, Rosario N/H-3652-2014; Lillo, Fabrizio/E-6793-2014; Piilo, Jyrki/D-3043-2011	Miccichè, Salvatore/0000-0003-3779-592X; Tumminello, Michele/0000-0001-6045-6761; Mantegna, Rosario N/0000-0003-4177-171X; Piilo, Jyrki/0000-0002-5595-873X	Magnus Ehrnrooth Foundation; Vilho, Yrjo, and Kalle Vaisala Foundation; EUROCONTROL under the SESAR Work Package E framework [10-220210-C3]	Magnus Ehrnrooth Foundation; Vilho, Yrjo, and Kalle Vaisala Foundation; EUROCONTROL under the SESAR Work Package E framework	J.P. acknowledges financial support by the Magnus Ehrnrooth Foundation and the Vilho, Yrjo, and Kalle Vaisala Foundation. F.L., S.M. and R.N.M. acknowledge partial support from the Complex World Network funded by EUROCONTROL under the SESAR Work Package E framework, Contract Ref. 10-220210-C3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Feller W., 1968, INTRO PROBABILITY TH, V1; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; McCallum A, 2007, J ARTIF INTELL RES, V30, P249, DOI 10.1613/jair.2229; Miller R.G., 1981, SIMULTANEOUS STAT IN, Ved 2nd, DOI DOI 10.1007/s11263-015-0816-y; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Tumminello M, 2007, INT J BIFURCAT CHAOS, V17, P2319, DOI 10.1142/S0218127407018415; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	31	111	111	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17994	10.1371/journal.pone.0017994	http://dx.doi.org/10.1371/journal.pone.0017994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483858	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200017
J	Zamudio, NM; Scott, HS; Wolski, K; Lo, CY; Law, C; Leong, D; Kinkel, SA; Chong, SY; Jolley, D; Smyth, GK; de Kretser, D; Whitelaw, E; O'Bryan, MK				Zamudio, Natasha M.; Scott, Hamish S.; Wolski, Katja; Lo, Chi-Yi; Law, Charity; Leong, Dillon; Kinkel, Sarah A.; Chong, Suyinn; Jolley, Damien; Smyth, Gordon K.; de Kretser, David; Whitelaw, Emma; O'Bryan, Moira K.			DNMT3L Is a Regulator of X Chromosome Compaction and Post-Meiotic Gene Transcription	PLOS ONE			English	Article							NOVO DNA METHYLTRANSFERASES; PESTICIDE FACTORY-WORKERS; HUMAN SPERM; KLINEFELTER-SYNDROME; SPERMATOGENIC CELLS; TURNER-SYNDROME; INFERTILE MEN; GERM-CELLS; MOUSE; ANEUPLOIDY	Previous studies on the epigenetic regulator DNA methyltransferase 3-Like (DNMT3L), have demonstrated it is an essential regulator of paternal imprinting and early male meiosis. Dnmt3L is also a paternal effect gene, i. e., wild type offspring of heterozygous mutant sires display abnormal phenotypes suggesting the inheritance of aberrant epigenetic marks on the paternal chromosomes. In order to reveal the mechanisms underlying these paternal effects, we have assessed X chromosome meiotic compaction, XY chromosome aneuploidy rates and global transcription in meiotic and haploid germ cells from male mice heterozygous for Dnmt3L. XY bodies from Dnmt3L heterozygous males were significantly longer than those from wild types, and were associated with a three-fold increase in XY bearing sperm. Loss of a Dnmt3L allele resulted in deregulated expression of a large number of both X-linked and autosomal genes within meiotic cells, but more prominently in haploid germ cells. Data demonstrate that similar to embryonic stem cells, DNMT3L is involved in an autoregulatory loop in germ cells wherein the loss of a Dnmt3L allele resulted in increased transcription from the remaining wild type allele. In contrast, however, within round spermatids, this auto-regulatory loop incorporated the alternative noncoding alternative transcripts. Consistent with the mRNA data, we have localized DNMT3L within spermatids and sperm and shown that the loss of a Dnmt3L allele results in a decreased DNMT3L content within sperm. These data demonstrate previously unrecognised roles for DNMT3L in late meiosis and in the transcriptional regulation of meiotic and post-meiotic germ cells. These data provide a potential mechanism for some cases of human Klinefelter's and Turner's syndromes.	[Zamudio, Natasha M.; Wolski, Katja; Lo, Chi-Yi; de Kretser, David; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Zamudio, Natasha M.; O'Bryan, Moira K.] Monash Univ, Australian Res Council Ctr Excellence Biotechnol, Clayton, Vic 3800, Australia; [Jolley, Damien] Monash Univ, Monash Inst Hlth Serv Res, Clayton, Vic 3800, Australia; [Scott, Hamish S.] Univ Adelaide, Inst Med & Vet Sci, Adelaide, SA, Australia; [Law, Charity; Leong, Dillon; Kinkel, Sarah A.; Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Law, Charity; Chong, Suyinn; Whitelaw, Emma] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Kinkel, Sarah A.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	Monash University; Monash University; Monash University; Institute Medical & Veterinary Science Australia; University of Adelaide; Royal Melbourne Hospital; Walter & Eliza Hall Institute; QIMR Berghofer Medical Research Institute; University of Melbourne	Zamudio, NM (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	Moira.O'Bryan@monash.edu	O'Bryan, Moira K/F-8256-2012; Scott, Hamish/B-2122-2009; Chong, Suyinn/B-6715-2012; Smyth, Gordon/B-5276-2008	O'Bryan, Moira K/0000-0001-7298-4940; Scott, Hamish/0000-0002-5813-631X; Chong, Suyinn/0000-0001-8062-7281; Smyth, Gordon/0000-0001-9221-2892; Law, Charity W/0000-0001-6082-6814; Zamudio, Natasha/0000-0002-2532-5931	National Health and Medical Research Council of Australia; Australian Postgraduate Awards	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government)	This study was supported by National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) grants and fellowships to Moira O'Bryan, Emma Whitelaw, David de Kretser, Hamish Scott, Damien Jolley; an Australian Research Council (http://www.arc.gov.au/) grant to Moira O'Bryan. Natasha Zamudio and Charity Law and Sarah Kinkel were supported by Australian Postgraduate Awards. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Frias S, 2003, CANCER RES, V63, P44; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guttenbach M, 1997, HUM GENET, V100, P1, DOI 10.1007/s004390050459; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hassold T, 1990, Birth Defects Orig Artic Ser, V26, P297; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Hata K, 2002, DEVELOPMENT, V129, P1983; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Hu YG, 2008, HUM MOL GENET, V17, P2654, DOI 10.1093/hmg/ddn165; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Hubert FX, 2009, J IMMUNOL, V182, P3902, DOI 10.4049/jimmunol.0802124; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; Jamsai D, 2008, REPRODUCTION, V135, P751, DOI 10.1530/REP-07-0485; La Salle S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-104; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Martin RH, 2003, BIOL REPROD, V69, P535, DOI 10.1095/biolreprod.102.015149; Martinez-Pasarell O, 1999, HUM GENET, V104, P345, DOI 10.1007/s004390050964; MEISTRICH ML, 1981, BIOL REPROD, V25, P1065, DOI 10.1095/biolreprod25.5.1065; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Morris JK, 2008, EUR J HUM GENET, V16, P163, DOI 10.1038/sj.ejhg.5201956; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Oppedisano L, 2002, HUM REPROD, V17, P710, DOI 10.1093/humrep/17.3.710; Paduch DA, 2009, SEMIN REPROD MED, V27, P137, DOI 10.1055/s-0029-1202302; Padungtod C, 1999, AM J IND MED, V36, P230, DOI 10.1002/(SICI)1097-0274(199908)36:2&lt;230::AID-AJIM2&gt;3.0.CO;2-6; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Schaller CE, 2008, J IMMUNOL, V180, P1338, DOI 10.4049/jimmunol.180.3.1338; Shovlin TC, 2007, HUM REPROD, V22, P457, DOI 10.1093/humrep/del379; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Templado C, 2002, MOL REPROD DEV, V61, P200, DOI 10.1002/mrd.1148; TRES LL, 1977, J CELL SCI, V25, P1; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Uchida K, 2000, BIOL REPROD, V63, P993, DOI 10.1095/biolreprod63.4.993; van der Laan R, 2004, J CELL SCI, V117, P5023, DOI 10.1242/jcs.01368; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Whyte JJ, 2007, THERIOGENOLOGY, V67, P1022, DOI 10.1016/j.theriogenology.2006.11.014; Xia YK, 2004, TOXICOLOGY, V203, P49, DOI 10.1016/j.tox.2004.05.018	52	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18276	10.1371/journal.pone.0018276	http://dx.doi.org/10.1371/journal.pone.0018276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483837	Green Published, gold			2022-12-27	WOS:000289057200050
J	Albinsson, S; Skoura, A; Yu, J; DiLorenzo, A; Fernandez-Hernando, C; Offermanns, S; Miano, JM; Sessa, WC				Albinsson, Sebastian; Skoura, Athanasia; Yu, Jun; DiLorenzo, Annarita; Fernandez-Hernando, Carlos; Offermanns, Stefan; Miano, Joseph M.; Sessa, William C.			Smooth Muscle miRNAs Are Critical for Post-Natal Regulation of Blood Pressure and Vascular Function	PLOS ONE			English	Article							NEOINTIMAL LESION FORMATION; STRETCH-DEPENDENT GROWTH; SERUM RESPONSE FACTOR; ACTIN POLYMERIZATION; CELL-SURVIVAL; DIFFERENTIATION; DICER; MICRORNAS; ANGIOGENESIS; CYTOSKELETON	Phenotypic modulation of smooth muscle cells (SMCs) plays a key role in vascular disease, including atherosclerosis. Several transcription factors have been suggested to regulate phenotypic modulation of SMCs but the decisive mechanisms remain unknown. Recent reports suggest that specific microRNAs (miRNAs) are involved in SMC differentiation and vascular disease but the global role of miRNAs in postnatal vascular SMC has not been elucidated. Thus, the objective of this study was to identify the role of Dicer-dependent miRNAs for blood pressure regulation and vascular SMC contractile function and differentiation in vivo. Tamoxifen-inducible and SMC specific deletion of Dicer was achieved by Cre-Lox recombination. Deletion of Dicer resulted in a global loss of miRNAs in aortic SMC. Furthermore, Dicer-deficient mice exhibited a dramatic reduction in blood pressure due to significant loss of vascular contractile function and SMC contractile differentiation as well as vascular remodeling. Several of these results are consistent with our previous observations in SM-Dicer deficient embryos. Therefore, miRNAs are essential for maintaining blood pressure and contractile function in resistance vessels. Although the phenotype of miR-143/145 deficient mice resembles the loss of Dicer, the phenotypes of SM-Dicer KO mice were far more severe suggesting that additional miRNAs are involved in maintaining postnatal SMC differentiation.	[Albinsson, Sebastian; Skoura, Athanasia; Yu, Jun; DiLorenzo, Annarita; Fernandez-Hernando, Carlos; Sessa, William C.] Yale Univ Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Miano, Joseph M.] Univ Rochester Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	Yale University; Max Planck Society; University of Rochester	Albinsson, S (corresponding author), Yale Univ Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011; Albinsson, Sebastian/B-4105-2010; Offermanns, Stefan/L-3313-2017; Miano, Joseph/L-5634-2018	Sessa, William C/0000-0001-5759-1938; Albinsson, Sebastian/0000-0001-6936-3967; Di Lorenzo, Annarita/0000-0003-1239-4222; Offermanns, Stefan/0000-0001-8676-6805; Miano, Joseph/0000-0001-7522-3207	Swedish Research Council; Swedish Heart Lung Foundation;  [R01 HL64793];  [R01 HL61371];  [R01 HL081190];  [RO1 HL096670];  [P01 HL70295];  [HL-62572];  [HL-091168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295, R01HL064793, R01HL081190, R01HL061371, R01HL096670, R01HL091168, R01HL062572] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R01 HL64793, R01 HL61371, R01 HL081190, RO1 HL096670, P01 HL70295 to W. C. Sessa; HL-62572 and HL-091168 to JMM; a post-doctoral fellowship from the Swedish Research Council and Swedish Heart Lung Foundation to S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; ALBINSSON S, 2010, PHYSL GENOMICS; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Murphy RA, 2005, CAN J PHYSIOL PHARM, V83, P857, DOI 10.1139/Y05-090; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Small EM, CIRCULATION, V121, P1022; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	100	104	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18869	10.1371/journal.pone.0018869	http://dx.doi.org/10.1371/journal.pone.0018869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526127	Green Submitted, gold, Green Published			2022-12-27	WOS:000290015800017
J	Alagramam, KN; Goodyear, RJ; Geng, RS; Furness, DN; van Aken, AFJ; Marcotti, W; Kros, CJ; Richardson, GP				Alagramam, Kumar N.; Goodyear, Richard J.; Geng, Ruishuang; Furness, David N.; van Aken, Alexander F. J.; Marcotti, Walter; Kros, Corne J.; Richardson, Guy P.			Mutations in Protocadherin 15 and Cadherin 23 Affect Tip Links and Mechanotransduction in Mammalian Sensory Hair Cells	PLOS ONE			English	Article							MECHANOELECTRICAL TRANSDUCER CHANNELS; SYNDROME TYPE 1F; HEARING-LOSS; MOUSE COCHLEA; MYOSIN VIIA; FUNCTIONAL INTERACTION; ORGANOTYPIC CULTURES; STEREOCILIARY BUNDLE; ELECTRON-MICROSCOPY; KINOCILIAL LINKS	Immunocytochemical studies have shown that protocadherin-15 (PCDH15) and cadherin-23 (CDH23) are associated with tip links, structures thought to gate the mechanotransducer channels of hair cells in the sensory epithelia of the inner ear. The present report describes functional and structural analyses of hair cells from Pcdh15(av3J) (av3J), Pcdh15(av6J) (av6J) and Cdh23(v2J) (v2J) mice. The av3J and v2J mice carry point mutations that are predicted to introduce premature stop codons in the transcripts for Pcdh15 and Cdh23, respectively, and av6J mice have an in-frame deletion predicted to remove most of the 9th cadherin ectodomain from PCDH15. Severe disruption of hair-bundle morphology is observed throughout the early-postnatal cochlea in av3J/av3J and v2J/v2J mice. In contrast, only mild-to-moderate bundle disruption is evident in the av6J/av6J mice. Hair cells from av3J/av3J mice are unaffected by aminoglycosides and fail to load with [(3)H]-gentamicin or FM1-43, compounds that permeate the hair cell's mechanotransducer channels. In contrast, hair cells from av6J/av6J mice load with both FM1-43 and [(3)H]-gentamicin, and are aminoglycoside sensitive. Transducer currents can be recorded from hair cells of all three mutants but are reduced in amplitude in all mutants and have abnormal directional sensitivity in the av3J/av3J and v2J/v2J mutants. Scanning electron microscopy of early postnatal cochlear hair cells reveals tip-link like links in av6J/av6J mice, substantially reduced numbers of links in the av3J/av3J mice and virtually none in the v2J/v2J mice. Analysis of mature vestibular hair bundles reveals an absence of tip links in the av3J/av3J and v2J/v2J mice and a reduction in av6J/av6J mice. These results therefore provide genetic evidence consistent with PCDH15 and CDH23 being part of the tip-link complex and necessary for normal mechanotransduction.	[Alagramam, Kumar N.; Geng, Ruishuang] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Goodyear, Richard J.; van Aken, Alexander F. J.; Marcotti, Walter; Kros, Corne J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Furness, David N.] Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Keele, Staffs, England; [Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Case Western Reserve University; Case Western Reserve University Hospital; University of Sussex; Keele University; University of Sheffield	Alagramam, KN (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	c.j.kros@sussex.ac.uk; g.p.richardson@sussex.ac.uk	Geng, Ruishuang/F-8255-2013		NIH [R01 DC05385]; Maniglia Endowed Chair; University Hospitals Case Medical Center; Wellcome Trust [087737]; Medical Research Council [ID 59565]; Henry Smith Charity; EU; MRC [G0100798] Funding Source: UKRI; Medical Research Council [G0100798] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010816, R01DC005385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maniglia Endowed Chair; University Hospitals Case Medical Center; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Henry Smith Charity; EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grants from the NIH (R01 DC05385 to KA) and funds from the Maniglia Endowed Chair, University Hospitals Case Medical Center (to KA), The Wellcome Trust (grant reference number 087737 to GPR), the Medical Research Council (grant ID 59565 to CJK), the Henry Smith Charity (to DNF) and the EU (FP6 Integrated Project EuroHear to GPR and CJK). WM is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Furness DN, 2008, NEUROSCIENCE, V154, P10, DOI 10.1016/j.neuroscience.2008.02.010; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; Furness DN, 1997, P ROY SOC B-BIOL SCI, V264, P45, DOI 10.1098/rspb.1997.0007; FURNESS DN, 1986, HEARING RES, V21, P243, DOI 10.1016/0378-5955(86)90222-4; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2003, J NEUROSCI, V23, P4878; HACKNEY CM, 1991, SCANNING MICROSCOPY, V5, P741; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; HACKNEY CM, 1992, P ROY SOC B-BIOL SCI, V248, P215, DOI 10.1098/rspb.1992.0064; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pawlowski KS, 2006, JARO-J ASSOC RES OTO, V7, P83, DOI 10.1007/s10162-005-0024-5; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Richardson GP, 1997, J NEUROSCI, V17, P9506; RUSSELL IJ, 1987, HEARING RES, V31, P9, DOI 10.1016/0378-5955(87)90210-3; Rzadzinska AK, 2009, NEUROSCIENCE, V158, P365, DOI 10.1016/j.neuroscience.2008.10.012; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; Tsuprun V, 2004, BIOPHYS J, V87, P4106, DOI 10.1529/biophysj.104.049031; Zheng QY, 2006, HEARING RES, V219, P110, DOI 10.1016/j.heares.2006.06.010	51	95	96	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19183	10.1371/journal.pone.0019183	http://dx.doi.org/10.1371/journal.pone.0019183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532990	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000290014500024
J	Boufassa, F; Saez-Cirion, A; Lechenadec, J; Zucman, D; Avettand-Fenoel, V; Venet, A; Rouzioux, C; Delfraissy, JF; Lambotte, O; Meyer, L				Boufassa, Faroudy; Saez-Cirion, Asier; Lechenadec, Jerome; Zucman, David; Avettand-Fenoel, Veronique; Venet, Alain; Rouzioux, Christine; Delfraissy, Jean-Francois; Lambotte, Olivier; Meyer, Laurence		ANRS EP36 HIV Controllers Study Gr	CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory	PLOS ONE			English	Article							LONG-TERM NONPROGRESSORS; IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-HISTORY; ANTIRETROVIRAL THERAPY; VIRAL LOAD; CELL COUNT; RNA LEVELS; PROGRESSION; INFECTION; SEROCONVERSION	Background: There are few large published studies of HIV controllers with long-term undetectable viral load (VL). We describe the characteristics and outcomes of 81 French HIV controllers. Methods and Results: HIV controllers were defined as asymptomatic, antiretroviral-naive persons infected >= 10 years previously, with HIV-RNA < 400 copies/mL in > 90% of plasma samples. All available CD4 and VL values were collected at enrolment. Mixed-effect linear models were used to analyze CD4 cell count slopes since diagnosis. HIV controllers represented 0.31% of all patients managed in French hospitals. Patients infected through intravenous drug use were overrepresented (31%) and homosexual men were under represented (26% of men) relative to the ANRS SEROCO cohort of subjects diagnosed during the same period. HIV controllers whose VL values were always below the detection limit of the assays were compared with those who had rare "blips" (< 50% of VL values above the detection limit) or frequent blips (< 50% of VL values above the detection limit). Estimated CD4 cell counts at HIV diagnosis were similar in the three groups. CD4 cell counts remained stable after HIV diagnosis in the "no blip" group, while they fell significantly in the two other groups (-0.26 root CD4 and -0.28 root CD4/mm(3)/year in the rare and frequent blip groups, respectively). No clinical, immunological or virological progression was observed in the no blip group, while 3 immunological and/or virological events and 4 cancers were observed in the blip subgroups. Conclusions: Viral blips in HIV controllers are associated with a significant decline in CD4 T cells and may be associated with an increased risk of pathological events, possibly owing to chronic inflammation/immune activation.	[Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Epidemiol HIV & STI Team, F-94275 Le Kremlin Bicetre, France; [Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence] Univ Paris 11, UMRS 1018, Le Kremlin Bicetre, France; [Saez-Cirion, Asier] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Zucman, David] Hop Foch, AP HP, Serv Med Interne, Suresnes, France; [Avettand-Fenoel, Veronique; Rouzioux, Christine] Univ Paris 05, Hop Necker, AP HP, EA3620, Paris, France; [Venet, Alain] Univ Paris 11, INSERM, U1012, Le Kremlin Bicetre, France; [Delfraissy, Jean-Francois; Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France; [Meyer, Laurence] Hop Bicetre, AP HP, Serv Sante Publ, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Boufassa, F (corresponding author), INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Epidemiol HIV & STI Team, F-94275 Le Kremlin Bicetre, France.	faroudy.boufassa@inserm.fr	Lambotte, Olivier/GRT-0160-2022; Avettand-Fenoel, Véronique/O-6285-2017; Saez-Cirion, Asier/A-8640-2008	Avettand-Fenoel, Véronique/0000-0002-7022-2990; Saez-Cirion, Asier/0000-0003-2406-7536; ABEL, Sylvie/0000-0002-3351-0547; Scott-Algara, Daniel/0000-0003-1851-503X; Cabie, Andre/0000-0003-0117-3061	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites virales)	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites virales)(ANRSFrench National Research Agency (ANR))	This study was funded by ANRS (Agence Nationale de Recherches sur le Sida et les hepatites virales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Djomand G, 2006, JAIDS-J ACQ IMM DEF, V43, P401, DOI 10.1097/01.qai.0000243117.21788.90; EASTERBROOK PJ, 1994, AIDS, V8, P1179, DOI 10.1097/00002030-199408000-00023; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hull M, 2010, 17 C RETR OPP INF SA; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2005, CLIN INFECT DIS, V40, P1350, DOI 10.1086/429318; Madec Y, 2009, JAIDS-J ACQ IMM DEF, V50, P19, DOI 10.1097/QAI.0b013e31818ce709; NOVITSKY V, 2009, J ACQ IMMUN DEF SYND, V50, P60; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sajadi MM, 2009, JAIDS-J ACQ IMM DEF, V50, P403, DOI 10.1097/QAI.0b013e3181945f1e; Seng R, 2008, JAIDS-J ACQ IMM DEF, V49, P251, DOI 10.1097/QAI.0b013e318189a739	31	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18726	10.1371/journal.pone.0018726	http://dx.doi.org/10.1371/journal.pone.0018726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533035	gold, Green Published, Green Submitted			2022-12-27	WOS:000290014500010
J	Yochum, GS				Yochum, Gregory S.			Multiple Wnt/beta-Catenin Responsive Enhancers Align with the MYC Promoter through Long-Range Chromatin Loops	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; RNA-POLYMERASE-II; BETA-CATENIN; C-MYC; GENE-EXPRESSION; TARGET GENES; HUMAN GENOME; TRANSCRIPTION; APC; ACTIVATION	Inappropriate activation of c-Myc (MYC) gene expression by the Wnt/beta-catenin signaling pathway is required for colorectal carcinogenesis. The elevated MYC levels in colon cancer cells are attributed in part to beta-catenin/TCF4 transcription complexes that are assembled at proximal Wnt/beta-catenin responsive enhancers (WREs). Recent studies suggest that additional WREs that control MYC expression reside far upstream of the MYC transcription start site. Here, I report the characterization of five novel WREs that localize to a region over 400 kb upstream from MYC. These WREs harbor nucleosomes with post-translational histone modifications that demarcate enhancer and gene promoter regions. Using quantitative chromatin conformation capture, I show that the distal WREs are aligned with the MYC promoter through large chromatin loops. The chromatin loops are not restricted to colon cancer cells, but are also found in kidney epithelial and lung fibroblast cell lines that lack de-regulated Wnt signaling and nuclear beta-catenin/TCF4 complexes. While each chromatin loop is detected in quiescent cells, the positioning of three of the five distal enhancers with the MYC promoter is induced by serum mitogens. These findings suggest that the architecture of the MYC promoter is comprised of distal elements that are juxtaposed through large chromatin loops and that beta-catenin/TCF4 complexes utilize this conformation to activate MYC expression in colon cancer cells.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA.	gsy3@psu.edu			National Institutes of Health [R01DK080805]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by National Institutes of Health grant number R01DK080805 to GSY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KELLY K, 1985, J CLIN IMMUNOL, V5, P65, DOI 10.1007/BF00915003; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Polakis P, 2000, GENE DEV, V14, P1837; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Yochum GS, 2010, P NATL ACAD SCI USA, V107, P145, DOI 10.1073/pnas.0912294107; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08	52	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18966	10.1371/journal.pone.0018966	http://dx.doi.org/10.1371/journal.pone.0018966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533051	gold, Green Published, Green Submitted			2022-12-27	WOS:000289719400041
J	Carrete, M; Tella, JL				Carrete, Martina; Tella, Jose L.			Inter-Individual Variability in Fear of Humans and Relative Brain Size of the Species Are Related to Contemporary Urban Invasion in Birds	PLOS ONE			English	Article							BEHAVIORAL FLEXIBILITY; ECOLOGY; SUCCESS; URBANIZATION; EVOLUTION; PREDICTS; HERITABILITY; INNOVATIONS	Background: Urbanization is the most prevailing cause of habitat transformation worldwide, differing from others by its intense levels of human activity. Despite its obvious impact on wildlife, it is still unclear why and how some species are able to adapt to urban settings. One possibility is that fear of humans and vehicles could preclude most species from invading cities. Species entering urban environments might be those that are more tolerant of human disturbance (i.e., tame species). Alternatively or in addition, urban invaders could be a fraction of variable species, with "tame" individuals invading urban habitats and other individuals remaining in rural areas. Methodology: Using the contemporary urban invasion by birds in a recently established South American city, we tested both hypotheses by relating interspecific differences in invasiveness to their flight initiation distances (i.e., the distances at which birds flee from approaching cars, FID), as well as to their relative brain size (RBS), a correlate of measures of behavioral flexibility. Principal Findings: Urban invasiveness was not significantly related to species' average rural FIDs but positively related to their RBS and inter-individual variability in FID. Moreover, FIDs were consistently lower in urban than in rural conspecifics, and the FIDs of urban individuals were within the lower-range distribution of their rural conspecifics. RBS indirectly influenced urban invasion through its positive effect on inter-individual variability in FID. Conclusions/Significance: Urban invaders do not appear to be individuals from apparently tame species, but rather tame individuals from species with a variable response regarding fear of people. Given the positive relationship between RBS and inter-individual variability in FID, our results suggest that behavioural flexibility should be regarded as a specific trait encompassing variability among individuals. Further research is needed to ascertain the neurophysiological mechanisms underlying the relationship between brain size and inter-individual variability in behavioural traits.	[Carrete, Martina; Tella, Jose L.] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide	Carrete, M (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	mcarrete@upo.es	Carrete, Martina/D-2618-2017; Carrete, Martina/A-6376-2009; Tella, José L/I-3707-2015	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424	Canal Sur Television and Repsol-YPF Foundation; Junta de AndalucA-a [P07RNM 02918]	Canal Sur Television and Repsol-YPF Foundation; Junta de AndalucA-a	This study was partially supported by Canal Sur Television and Repsol-YPF Foundation. MC was supported by an Excellence post-doctoral contract (P07RNM 02918 Project, Junta de AndalucA-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J.M., 1999, EVOLVING BRAINS; Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Bouchard J, 2009, ECOL SOC, V14; Canevari M., 1991, NUEVA GUIA AVES ARGE, VII, P517; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Carter AJ, 2010, BEHAV ECOL, V21, P655, DOI 10.1093/beheco/arq036; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; COOKE AS, 1980, BIOL CONSERV, V18, P85, DOI 10.1016/0006-3207(80)90072-5; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; DIAMOND JM, 1986, NATURE, V324, P107, DOI 10.1038/324107a0; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P261, DOI 10.1016/j.tree.2010.01.008; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; FAHRIG L, 2009, ECOL SOC, V14; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Greenberg Russell, 2003, P175; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rodriguez-Prieto I, 2009, BEHAV ECOL, V20, P371, DOI 10.1093/beheco/arn151; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; SALVADOR S A, 1988, Hornero, V13, P78; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Travaini A, 2004, ORNITOL NEOTROP, V15, P513; White C.M., 1994, NEW WORLD VULTURES G	49	142	147	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18859	10.1371/journal.pone.0018859	http://dx.doi.org/10.1371/journal.pone.0018859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526193	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100031
J	Colin, L; Vandenhoudt, N; de Walque, S; van Driessche, B; Bergamaschi, A; Martinelli, V; Cherrier, T; Vanhulle, C; Guiguen, A; David, A; Burny, A; Herbein, G; Pancino, G; Rohr, O; Van Lint, C				Colin, Laurence; Vandenhoudt, Nathalie; de Walque, Stephane; van Driessche, Benoit; Bergamaschi, Anna; Martinelli, Valerie; Cherrier, Thomas; Vanhulle, Caroline; Guiguen, Allan; David, Annie; Burny, Arsene; Herbein, Georges; Pancino, Gianfranco; Rohr, Olivier; Van Lint, Carine			The AP-1 Binding Sites Located in the pol Gene Intragenic Regulatory Region of HIV-1 Are Important for Viral Replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; TRANSCRIPTION FACTOR AP-1; SARCOMA-ASSOCIATED HERPESVIRUS; NF-KAPPA-B; T-LYMPHOCYTES; DNA-BINDING; C-JUN; TAT PROTEIN; ACTIVATION	Our laboratory has previously identified an important intragenic region in the human immunodeficiency virus type 1 (HIV-1) genome, whose complete functional unit is composed of the 5103 fragment, the DNaseI-hypersensitive site HS7 and the 5105 fragment. These fragments (5103 and 5105) both exhibit a phorbol 12-myristate 13-acetate (PMA)-inducible enhancer activity on the herpes simplex virus thymidine kinase promoter. Here, we characterized the three previously identified AP-1 binding sites of fragment 5103 by showing the PMA-inducible in vitro binding and in vivo recruitment of c-Fos, JunB and JunD to this fragment located at the end of the pol gene. Functional analyses demonstrated that the intragenic AP-1 binding sites are fully responsible for the PMA-dependent enhancer activity of fragment 5103. Moreover, infection of T-lymphoid Jurkat and promonocytic U937 cells with wild-type and mutant viruses demonstrated that mutations of the intragenic AP-1 sites individually or in combination altered HIV-1 replication. Importantly, mutations of the three intragenic AP-1 sites led to a decreased in vivo recruitment of RNA polymerase II to the viral promoter, strongly supporting that the deleterious effect of these mutations on viral replication occurs, at least partly, at the transcriptional level. Single-round infections of monocyte-derived macrophages confirmed the importance of intragenic AP-1 sites for HIV-1 infectivity.	[Colin, Laurence; Vandenhoudt, Nathalie; de Walque, Stephane; van Driessche, Benoit; Martinelli, Valerie; Vanhulle, Caroline; Guiguen, Allan; Burny, Arsene; Van Lint, Carine] ULB, IBMM, Mol Virol Lab, Gosselies, Belgium; [Bergamaschi, Anna; David, Annie; Pancino, Gianfranco] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Cherrier, Thomas; Rohr, Olivier] Univ Strasbourg, IUT Louis Pasteur de Schiltigheim, Schiltigheim, France; [Herbein, Georges] Univ Franche Comte, Hop St Jacques, EA3186, Dept Virol,IFR133, F-25030 Besancon, France	Universite Libre de Bruxelles; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte; CHU Besancon	Colin, L (corresponding author), ULB, IBMM, Mol Virol Lab, Gosselies, Belgium.	olivier.rohr@iutlpa.u-strasbg.fr; cvlint@ulb.ac.be	CHERRIER, Thomas/F-8727-2018	CHERRIER, Thomas/0000-0002-0707-9204; ROHR, Olivier/0000-0001-8992-2025; Colin, Laurence/0000-0002-8544-7746	FRS-FNRS, Belgium; Action de Recherche Concertee du Ministere de la Communaute Francaise (Universite Libre de Bruxelles, ARC) [04/09-309]; Programme d'Excellence "Cibles" of the Region Wallonne; Internationale Brachet Stiftung; Agence Nationale de Recherches sur le SIDA (ANRS); French Ministry of Research and "Sidaction"; Region Wallonne [WALEO2 616295]	FRS-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee du Ministere de la Communaute Francaise (Universite Libre de Bruxelles, ARC); Programme d'Excellence "Cibles" of the Region Wallonne; Internationale Brachet Stiftung; Agence Nationale de Recherches sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); French Ministry of Research and "Sidaction"; Region Wallonne	This work was supported by grants from the Belgian National Fund for Scientific Research (FRS-FNRS, Belgium), the Televie-Program of the FRS-FNRS, the Action de Recherche Concertee du Ministere de la Communaute Francaise (Universite Libre de Bruxelles, ARC [program no. 04/09-309]), the Programme d'Excellence "Cibles" of the Region Wallonne, the Internationale Brachet Stiftung, the Agence Nationale de Recherches sur le SIDA (ANRS), the French Ministry of Research and "Sidaction". L.C. is a Research fellow of the FRS-FNRS. N.V. was a fellow of the FRIA/FNRS. S.d.W. was supported by a post-doctoral fellowship from the Region Wallonne (Program WALEO2 616295). B.V.D and A.G are Postdoctoral fellows of the FRS-FNRS. C.V.L. is Research Director of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calomme C, 2002, J BIOL CHEM, V277, P8775, DOI 10.1074/jbc.M107441200; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Chen PF, 2000, J BIOL CHEM, V275, P20382, DOI 10.1074/jbc.M001149200; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Goffin W, 2005, NUCLEIC ACIDS RES, V33, P4285, DOI 10.1093/nar/gki720; HARRICH D, 1994, J VIROL, V68, P5899, DOI 10.1128/JVI.68.9.5899-5910.1994; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hidalgo-Estevez AM, 2006, J GEN VIROL, V87, P1603, DOI 10.1099/vir.0.81637-0; Inoshima Y, 1996, J VIROL, V70, P8518, DOI 10.1128/JVI.70.12.8518-8526.1996; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; KIM JYH, 1993, J VIROL, V67, P1658, DOI 10.1128/JVI.67.3.1658-1662.1993; Krylov D, 1997, P NATL ACAD SCI USA, V94, P12274, DOI 10.1073/pnas.94.23.12274; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Li YQ, 1999, IMMUNOLOGY, V96, P524; Liebermann DA, 1998, INT J ONCOL, V12, P685; Liu YZ, 1996, AIDS, V10, P1323, DOI 10.1097/00002030-199610000-00003; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marcello A, 2001, IUBMB LIFE, V51, P175, DOI 10.1080/152165401753544241; Marks RE, 2003, BIOCHEM BIOPH RES CO, V312, P691, DOI 10.1016/j.bbrc.2003.10.168; MARODER M, 1993, MOL ENDOCRINOL, V7, P570, DOI 10.1210/me.7.4.570; MAURER B, 1991, J VIROL, V65, P6353, DOI 10.1128/JVI.65.11.6353-6357.1991; Meiering CD, 2001, J VIROL, V75, P6547, DOI 10.1128/JVI.75.14.6547-6557.2001; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Morse BA, 1999, J VIROL, V73, P37, DOI 10.1128/JVI.73.1.37-45.1999; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Perez-Bercoff D, 2003, J VIROL, V77, P4081, DOI 10.1128/JVI.77.7.4081-4094.2003; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; SMITH SD, 1984, CANCER RES, V44, P5657; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; Ueda K, 1996, VIROLOGY, V217, P413, DOI 10.1006/viro.1996.0133; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; VANLINT C, 1991, J VIROL, V65, P7066, DOI 10.1128/JVI.65.12.7066-7072.1991; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1990, P NATL ACAD SCI USA, V87, P4874, DOI 10.1073/pnas.87.12.4874; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wei P, 2005, J BIOCHEM, V138, P399, DOI 10.1093/jb/mvi136; WEISS A, 1984, J IMMUNOL, V133, P123; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; ZEICHNER SL, 1991, GENE EXPRESSION, V1, P15	64	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19084	10.1371/journal.pone.0019084	http://dx.doi.org/10.1371/journal.pone.0019084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526160	gold, Green Submitted, Green Published			2022-12-27	WOS:000289671100049
J	Dong, X; Wang, YS; Dou, GR; Hou, HY; Shi, YY; Zhang, R; Ma, K; Wu, L; Yao, LB; Cai, Y; Zhang, J				Dong, Xiao; Wang, Yu-Sheng; Dou, Guo-Rui; Hou, Hui-Yuan; Shi, Yuan-Yuan; Zhang, Rui; Ma, Ke; Wu, Lin; Yao, Li-Bo; Cai, Yan; Zhang, Jian			Influence of Dll4 via HIF-1 alpha-VEGF Signaling on the Angiogenesis of Choroidal Neovascularization under Hypoxic Conditions	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; HUMAN RPE CELLS; TARGETING HIF-1-ALPHA; VASCULAR DEVELOPMENT; EMBRYONIC LETHALITY; TUMOR ANGIOGENESIS; VEGF EXPRESSION; TUBE FORMATION; UP-REGULATION	Choroidal neovascularization (CNV) is the common pathological basis of irreversible visual impairment encountered in a variety of chorioretinal diseases; the pathogenesis of its development is complicated and still imperfectly understood. Recent studies indicated that delta-like ligand 4 (Dll4), one of the Notch family ligands might participate in the HIF-1 alpha-VEGF pathway to regulate CNV angiogenesis. But little is known about the influence and potential mechanism of Dll4/Notch signals on CNV angiogenesis. Real-time RT-PCR, Western blotting were used to analyze the expression alteration of Dll4, VEGF and HIF-1 alpha in hypoxic RF/6A cells. Immunofluorescence staining, a laser-induced rat CNV model and intravitreal injection techniques were used to confirm the relationships among these molecules in vitro and in vivo. RPE-RF/6A cell co-culture systems were used to investigate the effects of Dll4/Notch signals on CNV angiogenesis. We found that the Dll4 was involved in hypoxia signaling in CNV angiogenesis. Results from the co-culture system showed that the enhancement of Dll4 expression in RF/6A cells led to the significantly faster proliferation and stronger tube forming ability, but inhibited cells migration and invasion across a monolayer of RPE cells in hypoxic environment, while siRNA-mediated Dll4 silencing caused the opposite effects. Pharmacological disruption of Notch signaling using gamma-secretase inhibitor (GSI) produced similar, but not identical effects, to that caused by the Dll4 siRNA. In addition, the expression of several key molecules involved in the angiogenesis of CNV was altered in RF/6A cells showing constitutively active Dll4 expression. These results suggest that Dll4 play an important role in CNV angiogenesis, which appears to be regulated by HIF-1 alpha and VEGF during the progression of CNV under hypoxic conditions. Targeting Dll4/Notch signaling may facilitate further understanding of the mechanisms that underlie CNV angiogenesis.	[Dong, Xiao; Wang, Yu-Sheng; Dou, Guo-Rui; Hou, Hui-Yuan; Shi, Yuan-Yuan; Ma, Ke; Cai, Yan] Fourth Mil Med Univ, Dept Ophthalmol, Xijing Hosp, Xian 710032, Peoples R China; [Zhang, Rui; Wu, Lin; Yao, Li-Bo; Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, X (corresponding author), Fourth Mil Med Univ, Dept Ophthalmol, Xijing Hosp, Xian 710032, Peoples R China.	wangys003@126.com; biozhangj@yahoo.com.cn	Hou, Huiyuan/AAI-3718-2020	Hou, Huiyuan/0000-0003-0082-8353	National Natural Science Foundation of China [30872818]; National Basic Research Program of China (973 Program) [2011CB510200]; Alexander Von Humboldt Foundation in Germany [v-81551/02085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Alexander Von Humboldt Foundation in Germany(Alexander von Humboldt Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 30872818) and National Basic Research Program of China (973 Program/2011CB510200). The project was sponsored partly by the equipment donation from the Alexander Von Humboldt Foundation in Germany (to Y.S.W., v-81551/02085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Chen Lin, 2009, Zhonghua Yi Xue Za Zhi, V89, P3106; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hartnett ME, 2003, EXP EYE RES, V77, P593, DOI 10.1016/S0014-4835(03)00189-1; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hofmann JJ, 2007, GENE EXPR PATTERNS, V7, P461, DOI 10.1016/j.modgep.2006.11.002; Hou HY, 2010, MOL THER, V18, P1837, DOI 10.1038/mt.2010.144; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lu F, 2009, GRAEF ARCH CLIN EXP, V247, P171, DOI 10.1007/s00417-008-0936-y; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Noguera-Troise I, 2007, NOVART FDN SYMP, V283, P238; Noguera-Troise I, 2007, NOVART FDN SYMP, V283, P121; Noguera-Troise Irene, 2007, Novartis Found Symp, V283, P106; Ottino P, 2004, MOL VIS, V10, P341; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; SAKAMOTO T, 1995, ARCH OPHTHALMOL-CHIC, V113, P512, DOI 10.1001/archopht.1995.01100040134039; Sancho-Tello M, 2009, OPHTHALMIC RES, V41, P28, DOI 10.1159/000162263; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shutter JR, 2000, GENE DEV, V14, P1313; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Wang YS, 2002, J OCUL PHARMACOL TH, V18, P377, DOI 10.1089/10807680260218542; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Zhang P, 2007, OPHTHALMOLOGICA, V221, P411, DOI 10.1159/000107502; Zhang P, 2009, GRAEF ARCH CLIN EXP, V247, P633, DOI 10.1007/s00417-008-1031-0; Zhao W, 2008, GRAEF ARCH CLIN EXP, V246, P1413, DOI 10.1007/s00417-008-0858-8; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	54	49	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18481	10.1371/journal.pone.0018481	http://dx.doi.org/10.1371/journal.pone.0018481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526177	Green Submitted, Green Published, gold			2022-12-27	WOS:000289671100005
J	Mills, DS; Redgate, SE; Landsberg, GM				Mills, Daniel S.; Redgate, Sarah E.; Landsberg, Gary M.			A Meta-Analysis of Studies of Treatments for Feline Urine Spraying	PLOS ONE			English	Article							FACIAL PHEROMONE; CATS; CLOMIPRAMINE; BEHAVIOR; MARKING; ANALOG; PROGESTIN	Feline urine spraying inside the home is a common problem behaviour that owners seek advice for from veterinarians. Individual trials relating to a variety of interventions produce variable results, and to date, no consensus on the value of different treatments has emerged. This study therefore aimed to meta-analyse, current data from appropriate published clinical trials that evaluate treatments for feline urine spraying. Inclusion and exclusion criteria for study selection were predefined and methodological quality was assessed by two independent reviewers. Ten studies in nine publications that either evaluated pharmacotherapy or pheromonatherapy (the use of a synthetic analogue of the F3 facial fraction in the cat) were suitable for analysis. There was a significant (P < 0.001) association between the use of any intervention and the number of cats that ceased or reduced urine spraying by at least 90%. Analysis by intervention type indicated that fluoxetine, clomipramine and pheromonatherapy may each assist in managing urine spraying beyond a placebo based intervention. This is the first time meta-analytical techniques have been used and reported to evaluate the efficacy of interventions used in veterinary behavioural medicine, and it has established confidence in the value of both conventional treatments (pharmacotherapy) and a more recently developed treatment modality (pheromonatherapy) as an adjunct to the management of this problem. It is suggested that future research into treatment efficacy for this problem uses the benchmark standard of randomised, controlled trials lasting for at least 8 weeks, with the outcome criteria of cessation of feline urine spraying or reduction by at least 90%.	[Mills, Daniel S.; Redgate, Sarah E.] Lincoln Univ, Anim Behav Cognit & Welf Grp, Dept Biol Sci, Lincoln, England; [Landsberg, Gary M.] N Toronto Anim Clin, Thornhill, ON, Canada	University of Lincoln	Mills, DS (corresponding author), Lincoln Univ, Anim Behav Cognit & Welf Grp, Dept Biol Sci, Lincoln, England.	dmills@lincoln.ac.uk		Landsberg, Gary/0000-0003-0501-6397; Mills, Daniel/0000-0002-4765-9625; Redgate, Sarah/0000-0002-3122-0343	Ceva Animal Health; Elanco Animal Health	Ceva Animal Health; Elanco Animal Health	This meta-analysis and review was conceived by DSM and proposed to Ceva Animal Health (http://www.ceva.com, manufacturers of Feliway), who subsequently agreed to fund the work without interference from the sponsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts to declare: Ceva Animal Health, manufacturers of feline facial pheromones, have provided funding for this study which allowed the employment of SER on this work. Technical advice concerning the analysis and its interpretation was sought from Bruno Combes, a statistical consultant who has worked for Ceva Animal Health. Ceva Animal Health has also provided support for the research of DSM and GML at other times. DSM acts as a scientific consultant to Ceva Animal Health through a University contract. Novartis Animal Health, manufacturers of a veterinary formulation of clomipramine, have provided support for the research of GML at other times. Elanco Animal Health, manufacturers of a veterinary formulation of fluoxetine, have provided support for the research of DSM and GML at other times. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	*ASS PET BEH COUNS, 2005, ANN REV CAS; BORENSTEIN M, 2009, INTRO META ANAL; Bradshaw J. W. S., 1992, BEHAV DOMESTIC CAT; COOPER L, 1992, J AM VET MED ASSOC, V200, P797; Dehasse J, 1997, APPL ANIM BEHAV SCI, V52, P365, DOI 10.1016/S0168-1591(96)01135-5; Frank DF, 1999, APPL ANIM BEHAV SCI, V61, P263, DOI 10.1016/S0168-1591(98)00195-6; Hart BL, 2005, JAVMA-J AM VET MED A, V226, P378, DOI 10.2460/javma.2005.226.378; HART BL, 1980, J AM VET MED ASSOC, V177, P529; HART BL, 1993, J AM VET MED ASSOC, V203, P254; HART BL, 1973, J AM VET MED ASSOC, V53, P331; Horwitz DF, 1997, APPL ANIM BEHAV SCI, V52, P129, DOI 10.1016/S0168-1591(96)01073-8; Hunthausen W, 2000, VET MED-US, V95, P151; King JN, 2004, JAVMA-J AM VET MED A, V225, P881, DOI 10.2460/javma.2004.225.881; KROLL T, 2001, P 3 INT C VET BEH ME, P184; Landsberg GM, 2005, J AM ANIM HOSP ASSOC, V41, P3, DOI 10.5326/0410003; Levine E, 2005, APPL ANIM BEHAV SCI, V90, P325, DOI 10.1016/j.applanim.2004.07.006; MARDER AR, 1991, VET CLIN N AM-SMALL, V21, P329, DOI 10.1016/S0195-5616(91)50036-X; Mills DS, 2001, VET REC, V149, P197, DOI 10.1136/vr.149.7.197; MILLS DS, 2000, VET REC, V147, P476; Neilson JC, 2009, BSAVA MANUAL CANINE, V2nd, P117; New J. C. Jr., 2000, Journal of Applied Animal Welfare Science, V3, P179, DOI 10.1207/S15327604JAWS0303_1; Ogata N, 2001, J VET MED SCI, V63, P157, DOI 10.1292/jvms.63.157; Osborne CA, 1996, VET CLIN N AM-SMALL, V26, P369, DOI 10.1016/S0195-5616(96)50217-2; Oxford Centre for Evidence-Based Medicine, 2009, LEVELS EVIDENCE; Pageat P., 1997, Journal of Veterinary Pharmacology and Therapeutics, V20, P169; PAGEAT P, 1996, 21 C WORLD SMALL AN; PAGEAT P, 1997, P 1 INT C VET BEH ME; PAGEAT P, 1997, P 7 INT EUR ASS VET; Patronek GJ, 1996, J AM VET MED ASSOC, V209, P582; Pryor PA, 2001, J AM VET MED ASSOC, V219, P1709, DOI 10.2460/javma.2001.219.1709; Pryor PA, 2001, J AM VET MED ASSOC, V219, P1557, DOI 10.2460/javma.2001.219.1557; Schwartz S, 1999, J AM VET MED ASSOC, V215, P501; Seksel K, 1998, AUST VET J, V76, P317, DOI 10.1111/j.1751-0813.1998.tb12353.x; WHITE JC, 1997, P 1 INT C VET BEH ME	34	29	29	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18448	10.1371/journal.pone.0018448	http://dx.doi.org/10.1371/journal.pone.0018448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525994	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000289578600009
J	Roiz, D; Neteler, M; Castellani, C; Arnoldi, D; Rizzoli, A				Roiz, David; Neteler, Markus; Castellani, Cristina; Arnoldi, Daniele; Rizzoli, Annapaola			Climatic Factors Driving Invasion of the Tiger Mosquito (Aedes albopictus) into New Areas of Trentino, Northern Italy	PLOS ONE			English	Article							WEST-NILE-VIRUS; SEASONAL ACTIVITY; CULICIDAE; DIPTERA; TEMPERATURE; SPREAD; ESTABLISHMENT; PRECIPITATION; VARIABILITY; POPULATIONS	Background: The tiger mosquito (Aedes albopictus), vector of several emerging diseases, is expanding into more northerly latitudes as well as into higher altitudes in northern Italy. Changes in the pattern of distribution of the tiger mosquito may affect the potential spread of infectious diseases transmitted by this species in Europe. Therefore, predicting suitable areas of future establishment and spread is essential for planning early prevention and control strategies. Methodology/Principal Findings: To identify the areas currently most suitable for the occurrence of the tiger mosquito in the Province of Trento, we combined field entomological observations with analyses of satellite temperature data (MODIS Land Surface Temperature: LST) and human population data. We determine threshold conditions for the survival of overwintering eggs and for adult survival using both January mean temperatures and annual mean temperatures. We show that the 0 degrees C LST threshold for January mean temperatures and the 11 degrees C threshold for annual mean temperatures provide the best predictors for identifying the areas that could potentially support populations of this mosquito. In fact, human population density and distance to human settlements appear to be less important variables affecting mosquito distribution in this area. Finally, we evaluated the future establishment and spread of this species in relation to predicted climate warming by considering the A2 scenario for 2050 statistically downscaled at regional level in which winter and annual temperatures increase by 1.5 and 1 degrees C, respectively. Conclusions/Significance: MODIS satellite LST data are useful for accurately predicting potential areas of tiger mosquito distribution and for revealing the range limits of this species in mountainous areas, predictions which could be extended to an European scale. We show that the observed trend of increasing temperatures due to climate change could facilitate further invasion of Ae. albopictus into new areas.	[Roiz, David; Neteler, Markus; Castellani, Cristina; Arnoldi, Daniele; Rizzoli, Annapaola] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, Res & Innovat Ctr, San Michele All Adige, Italy; [Roiz, David] CSIC, Wetland Ecol Dept, Donana Biol Stn, E-41080 Seville, Spain	Fondazione Edmund Mach; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Roiz, D (corresponding author), Fdn Edmund Mach, Dept Biodivers & Mol Ecol, Res & Innovat Ctr, San Michele All Adige, Italy.	davidroiz@gmail.com	Rizzoli, Annapaola/J-2439-2012; Rizzoli, Annapaola/B-8583-2011; Roiz, David/F-2082-2011; Neteler, Markus/C-6328-2008	Rizzoli, Annapaola/0000-0003-3997-6783; Roiz, David/0000-0002-5819-3648; Neteler, Markus/0000-0003-1916-1966	Autonomous Province of Trento	Autonomous Province of Trento(Autonomous Province of Trento)	This work was supported by The Autonomous Province of Trento, postdoctoral project Risktiger: Risk Assessment of New Arbovirus Diseases Transmitted by Aedes albopictus (Diptera: Culicidae) in the Autonomous Province of Trento, Principal Investigator and Researcher: David Roiz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; Andreadis TG, 2009, J AM MOSQUITO CONTR, V25, P25, DOI 10.2987/08-5813.1; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bohm R, 2001, INT J CLIMATOL, V21, P1779, DOI 10.1002/joc.689; Brunetti M, 2006, INT J CLIMATOL, V26, P345, DOI 10.1002/joc.1251; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caffarra A, 2011, AUST J GRAPE WINE R, V17, P52, DOI 10.1111/j.1755-0238.2010.00118.x; Colombi A., 2007, EARSeL eProceedings, V6, P38; Eby M, 2009, J CLIMATE, V22, P2501, DOI 10.1175/2008JCLI2554.1; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; *EUR CTR DIS PREV, 2009, DEV AED ALB RISK MAP; Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x; Ferrarese Uberto, 2004, Annali dei Musei Civici Rovereto, V19, P281; Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P35; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Holick J, 2002, J AM MOSQUITO CONTR, V18, P131; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; Neteler M., 2005, INT J GEOINFORMATICS, V1, P133; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; R Core Team, 2018, R LANG ENV STAT COMP; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2006, J MED ENTOMOL, V43, P976, DOI 10.1603/0022-2585(2006)43[976:SAOAAD]2.0.CO;2; Roiz D., 2007, Boletin de la SEA, V40, P523; Roiz D, 2008, J MED ENTOMOL, V45, P347, DOI 10.1603/0022-2585(2008)45[347:IDAOAA]2.0.CO;2; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2; Romi R., 2008, EUR INF DIS, V2, P98; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Schaffner F, 2001, MOUSTIQUES EUROPE; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038; Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x; ZAMBURLINI R, 2003, DISINFESTAZIONE, V3, P8	46	89	92	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e14800	10.1371/journal.pone.0014800	http://dx.doi.org/10.1371/journal.pone.0014800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525991	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600001
J	Xu, B; Sun, ZL; Liu, ZJ; Guo, HY; Liu, QA; Jiang, HY; Zou, YX; Gong, YQ; Tischfield, JA; Shao, CS				Xu, Bing; Sun, Zhaoliang; Liu, Zhaojian; Guo, Haiyang; Liu, Qiao; Jiang, Haiyan; Zou, Yongxin; Gong, Yaoqin; Tischfield, Jay A.; Shao, Changshun			Replication Stress Induces Micronuclei Comprising of Aggregated DNA Double-Strand Breaks	PLOS ONE			English	Article							CELL-CYCLE PHASE; HISTONE H2AX; POLYMERASE-ALPHA; PROTEIN-A; IN-VIVO; REPAIR; APOPTOSIS; MICE; ATM; PHOSPHORYLATION	Background: Micronuclei (MN) in mammalian cells serve as a reliable biomarker of genomic instability and genotoxic exposure. Elevation of MN is commonly observed in cells bearing intrinsic genomic instability and in normal cells exposed to genotoxic agents. DNA double-strand breaks are marked by phosphorylation of H2AX at serine 139 (gamma-H2AX). One subclass of MN contains massive and uniform gamma-H2AX signals. This study tested whether this subclass of MN can be induced by replication stress. Principal Findings: We observed that a large proportion of MN, from 20% to nearly 50%, showed uniform staining by antibodies against gamma-H2AX, a marker of DNA double-strand breaks (DSBs). Such micronuclei were designated as MN-gamma-H2AX (+). We showed that such MN can be induced by chemicals that are known to cause DNA replication stress and S phase arrest. Hydroxyurea, aphidicolin and thymidine could all significantly induce MN-gamma-H2AX (+), which were formed during S phase and appeared to be derived from aggregation of DSBs. MN-gamma-H2AX (-), MN that were devoid of uniform gamma-H2AX signals, were induced to a lesser extent in terms of fold change. Paclitaxel, which inhibits the disassembly of microtubules, only induced MN-gamma-H2AX (-). The frequency of MN-gamma-H2AX (+), but not that of MN-gamma-H2AX (-), was also significantly increased in cells that experience S phase prolongation due to depletion of cell cycle regulator CUL4B. Depletion of replication protein A1 (RPA1) by RNA interference resulted in an elevation of both MN-gamma-H2AX (+) and MN-gamma-H2AX (-). Conclusions/Significance: A subclass of MN, MN-gamma-H2AX (+), can be preferentially induced by replication stress. Classification of MN according to their gamma-H2AX status may provide a more refined evaluation of intrinsic genomic instabilities and the various environmental genotoxicants.	[Xu, Bing; Sun, Zhaoliang; Liu, Zhaojian; Guo, Haiyang; Liu, Qiao; Jiang, Haiyan; Zou, Yongxin; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Shandong, Peoples R China; [Xu, Bing; Sun, Zhaoliang; Liu, Zhaojian; Guo, Haiyang; Liu, Qiao; Jiang, Haiyan; Zou, Yongxin; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China; [Tischfield, Jay A.; Shao, Changshun] Rutgers State Univ, Dept Genet, Piscataway, NJ USA	Shandong University; Shandong University; Rutgers State University New Brunswick	Xu, B (corresponding author), Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Shandong, Peoples R China.	changshun.shao@gmail.com	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Tischfield, Jay/0000-0003-3217-8287; guo, haiyang/0000-0001-5503-6922	National Natural Science Foundation of China [30771231, 30900804]; National Basic Research Program [2011CB966201]; National Natural Science Foundation of China for Innovative Research Group [81021001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grants (30771231, 30900804), National Basic Research Program grant (2011CB966201) and State Program of National Natural Science Foundation of China for Innovative Research Group (81021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Bonassi S, 2005, ENVIRON MOL MUTAGEN, V45, P258, DOI 10.1002/em.20115; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Decordier I, 2002, MUTAGENESIS, V17, P337, DOI 10.1093/mutage/17.4.337; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Fan T, 2003, CANCER RES, V63, P4677; Fauth E, 1999, MUTAT RES-GEN TOX EN, V440, P147, DOI 10.1016/S1383-5718(99)00021-2; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GRAWE J, 1992, CYTOMETRY, V13, P750, DOI 10.1002/cyto.990130711; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; HILL AB, 1985, CANCER RES, V45, P5050; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; ISHII Y, 1980, MUTAT RES, V79, P19, DOI 10.1016/0165-1218(80)90144-5; Kurose A, 2006, CYTOM PART A, V69A, P212, DOI 10.1002/cyto.a.20241; Kurose A, 2005, CYTOM PART A, V68A, P1, DOI 10.1002/cyto.a.20186; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MARASCHIO P, 1992, ANN HUM GENET, V56, P273, DOI 10.1111/j.1469-1809.1992.tb01152.x; Meintieres S, 2001, MUTAGENESIS, V16, P243, DOI 10.1093/mutage/16.3.243; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Shima N, 2003, GENETICS, V163, P1031; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; SPEICHER LA, 1992, CANCER RES, V52, P4433; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; TINWELL H, 1994, CARCINOGENESIS, V15, P1499, DOI 10.1093/carcin/15.8.1499; Turner JMA, 2001, J CELL SCI, V114, P3367; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; YANG SJ, 1966, EXP CELL RES, V42, P130, DOI 10.1016/0014-4827(66)90326-0; Yasui M, 2010, MUTAT RES-FUND MOL M, V692, P12, DOI 10.1016/j.mrfmmm.2010.07.009; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	45	62	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18618	10.1371/journal.pone.0018618	http://dx.doi.org/10.1371/journal.pone.0018618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525980	Green Submitted, Green Published, gold			2022-12-27	WOS:000289578600019
J	Britos, L; Abeliuk, E; Taverner, T; Lipton, M; McAdams, H; Shapiro, L				Britos, Leticia; Abeliuk, Eduardo; Taverner, Thomas; Lipton, Mary; McAdams, Harley; Shapiro, Lucy			Regulatory Response to Carbon Starvation in Caulobacter crescentus	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; HIGH-THROUGHPUT IDENTIFICATION; CELL-CYCLE REGULATION; ESCHERICHIA-COLI; PROTEOMIC ANALYSIS; BACILLUS-SUBTILIS; 2-DIMENSIONAL ELECTROPHORESIS; MEMBRANE PROTEOME; STATIONARY-PHASE; OXIDATIVE STRESS	Bacteria adapt to shifts from rapid to slow growth, and have developed strategies for long-term survival during prolonged starvation and stress conditions. We report the regulatory response of C. crescentus to carbon starvation, based on combined high-throughput proteome and transcriptome analyses. Our results identify cell cycle changes in gene expression in response to carbon starvation that involve the prominent role of the FixK FNR/CAP family transcription factor and the CtrA cell cycle regulator. Notably, the SigT ECF sigma factor mediates the carbon starvation-induced degradation of CtrA, while activating a core set of general starvation-stress genes that respond to carbon starvation, osmotic stress, and exposure to heavy metals. Comparison of the response of swarmer cells and stalked cells to carbon starvation revealed four groups of genes that exhibit different expression profiles. Also, cell pole morphogenesis and initiation of chromosome replication normally occurring at the swarmer-to-stalked cell transition are uncoupled in carbon-starved cells.	[Britos, Leticia; Abeliuk, Eduardo; McAdams, Harley; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Abeliuk, Eduardo] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Taverner, Thomas; Lipton, Mary] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Britos, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	shapiro@cmgm.stanford.edu	Lipton, Mary S/H-3913-2012		National Institutes of Health (NIH) [GM32506]; Department of Energy (DOE) [DE-FG02ER64136, DE-AC05-76RL01830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R01GM032506] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH - http://nih.gov/) grant GM32506 to LS and by Department of Energy (DOE - http://www.energy.gov/) grant DE-FG02ER64136 to LS and HM. Proteomic analyses were performed in the Environmental Molecular Sciences Laboratory, a Department of Energy/Office of Biological and Environmental Research (DOE/BER) national scientific user facility on the Pacific Northwest National Laboratory (PNNL) campus in Richland, Washington. PNNL is a multiprogram national laboratory operated by Battelle for the DOE under Contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Alvarez-Martinez CE, 2006, J BACTERIOL, V188, P1835, DOI 10.1128/JB.188.5.1835-1846.2006; Alvarez-Martinez CE, 2007, MOL MICROBIOL, V66, P1240, DOI 10.1111/j.1365-2958.2007.06005.x; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bowman GR, 2010, MOL MICROBIOL, V76, P173, DOI 10.1111/j.1365-2958.2010.07088.x; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Chiang SM, 2010, J MOL EVOL, V70, P557, DOI 10.1007/s00239-010-9352-0; Christen B, 2010, P NATL ACAD SCI USA, V107, P4681, DOI 10.1073/pnas.1000846107; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; da Rocha RP, 2008, J BACTERIOL, V190, P1209, DOI 10.1128/JB.01419-07; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Du X, 2008, J PROTEOME RES, V7, P2595, DOI 10.1021/pr0704837; England JC, 2010, J BACTERIOL, V192, P819, DOI 10.1128/JB.01240-09; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fischer B, 2002, MOL MICROBIOL, V44, P461, DOI 10.1046/j.1365-2958.2002.02887.x; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; Hecker M, 2001, ADV MICROB PHYSIOL, V44, P35, DOI 10.1016/S0065-2911(01)44011-2; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Herrou J, 2010, MOL MICROBIOL, V78, P290, DOI 10.1111/j.1365-2958.2010.07323.x; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs-Wagner C, 2004, MOL MICROBIOL, V51, P7, DOI 10.1046/j.1365-2958.2003.03828.x; JENKINS DE, 1990, J BACTERIOL, V172, P2779, DOI 10.1128/jb.172.5.2779-2781.1990; JENKINS DE, 1991, J BACTERIOL, V173, P1992, DOI 10.1128/jb.173.6.1992-1996.1991; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; KIM SK, 1993, J BACTERIOL, V175, P1316, DOI 10.1128/JB.175.5.1316-1324.1993; Landt Stephen G, 2010, J Bacteriol, V192, P4763, DOI 10.1128/JB.00343-10; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lee PS, 2003, BIOTECHNOL BIOENG, V84, P834, DOI 10.1002/bit.10841; Lesley JA, 2008, J BACTERIOL, V190, P6867, DOI 10.1128/JB.00700-08; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; MALAKOOTI J, 1995, J BACTERIOL, V177, P4372, DOI 10.1128/jb.177.15.4372-4376.1995; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Miller J.H, 1972, EXPT MOL GENETICS, pxvi; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; Molloy MP, 2002, PROTEOMICS, V2, P899, DOI 10.1002/1615-9861(200207)2:7<899::AID-PROT899>3.0.CO;2-Y; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Phadke ND, 2001, PROTEOMICS, V1, P705, DOI 10.1002/1615-9861(200104)1:5<705::AID-PROT705>3.3.CO;2-E; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Quardokus E, 1996, P NATL ACAD SCI USA, V93, P6314, DOI 10.1073/pnas.93.13.6314; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volker U, 1999, J BACTERIOL, V181, P3942; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	79	46	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18179	10.1371/journal.pone.0018179	http://dx.doi.org/10.1371/journal.pone.0018179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494595	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100006
J	Simoes, MR; Ribeiro, RF; Vescovi, MVA; de Jesus, HC; Padilha, AS; Stefanon, I; Vassallo, DV; Salaices, M; Fioresi, M				Simoes, Maylla Ronacher; Ribeiro Junior, Rogerio F.; Vescovi, Marcos Vinicius A.; de Jesus, Honerio C.; Padilha, Alessandra S.; Stefanon, Ivanita; Vassallo, Dalton V.; Salaices, Mercedes; Fioresi, Mirian			Acute Lead Exposure Increases Arterial Pressure: Role of the Renin-Angiotensin System	PLOS ONE			English	Article							K+-ATPASE ACTIVITY; INDUCED HYPERTENSION; BLOOD-PRESSURE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; CONVERTING ENZYME; RATS; ASSOCIATION; SUPEROXIDE	Background: Chronic lead exposure causes hypertension and cardiovascular disease. Our purpose was to evaluate the effects of acute exposure to lead on arterial pressure and elucidate the early mechanisms involved in the development of lead-induced hypertension. Methodology/Principal Findings: Wistar rats were treated with lead acetate (i.v. bolus dose of 320 mu g/Kg), and systolic arterial pressure, diastolic arterial pressure and heart rate were measured during 120 min. An increase in arterial pressure was found, and potential roles of the renin-angiotensin system, Na+, K+-ATPase and the autonomic reflexes in this change in the increase of arterial pressure found were evaluated. In anesthetized rats, lead exposure: 1) produced blood lead levels of 37 +/- 1.7 mu g/dL, which is below the reference blood concentration (60 mu g/dL); 2) increased systolic arterial pressure (Ct: 109 +/- 3 mmHg vs Pb: 120 +/- 4 mmHg); 3) increased ACE activity (27% compared to Ct) and Na+, K+-ATPase activity (125% compared to Ct); and 4) did not change the protein expression of the alpha 1-subunit of Na+, K+-ATPase, AT(1) and AT(2). Pretreatment with an AT(1) receptor blocker (losartan, 10 mg/Kg) or an ACE inhibitor (enalapril, 5 mg/Kg) blocked the lead-induced increase of arterial pressure. However, a ganglionic blockade (hexamethonium, 20 mg/Kg) did not prevent lead's hypertensive effect. Conclusion: Acute exposure to lead below the reference blood concentration increases systolic arterial pressure by increasing angiotensin II levels due to ACE activation. These findings offer further evidence that acute exposure to lead can trigger early mechanisms of hypertension development and might be an environmental risk factor for cardiovascular disease.	[Simoes, Maylla Ronacher; Ribeiro Junior, Rogerio F.; Padilha, Alessandra S.; Stefanon, Ivanita; Vassallo, Dalton V.; Fioresi, Mirian] Univ Fed Espirito Santo, Physiol Sci Postgrad Program, Vitoria, ES, Brazil; [Vescovi, Marcos Vinicius A.; de Jesus, Honerio C.] Univ Fed Espirito Santo, Dept Chem, Vitoria, ES, Brazil; [Fioresi, Mirian] Univ Fed Espirito Santo, Dept Nursing, Vitoria, ES, Brazil; [Vassallo, Dalton V.] Hlth Sci Ctr Vitoria EMESCAM, Vitoria, ES, Brazil; [Salaices, Mercedes] Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Autonomous University of Madrid	Simoes, MR (corresponding author), Univ Fed Espirito Santo, Physiol Sci Postgrad Program, Vitoria, ES, Brazil.	daltonv2@terra.com.br	Fioresi, Mirian/O-6625-2019; Ribeiro, Rogerio/F-7116-2012; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Stefanon, Ivanita/0000-0003-2638-5183; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Vassallo, Dalton/0000-0002-4463-4174	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia), Brazil [39767531/07]; MCINN (Ministerio de Ciencia e Innovacion) [SAF 2009-07201]; ISCIII (Instituto de Salud Carlos III) (Red RECAVA- Red Tematica de Investigacion en Enfermedades Cardiovasculares del Instituto de Salud Carlos III, Spain [RD06/0014/0011]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII (Instituto de Salud Carlos III) (Red RECAVA- Red Tematica de Investigacion en Enfermedades Cardiovasculares del Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This study was supported by grants from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia)(39767531/07), Brazil and from MCINN (Ministerio de Ciencia e Innovacion) (SAF 2009-07201) and ISCIII (Instituto de Salud Carlos III) (Red RECAVA- Red Tematica de Investigacion en Enfermedades Cardiovasculares del Instituto de Salud Carlos III, RD06/0014/0011), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejak Ryszard, 2004, Medycyna Pracy, V55, P139; *ATSDR, 2005, TOX PROF LEAD, V78, P101; BOSCOLO P, 1988, ENVIRON HEALTH PERSP, V78, P101, DOI 10.2307/3430508; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TA, 1982, P NATL ACAD SCI-BIOL, V79, P1438, DOI 10.1073/pnas.79.5.1438; Carmignani M, 2000, LIFE SCI, V68, P401, DOI 10.1016/S0024-3205(00)00954-1; Carmignani M, 1999, IMMUNOPHARMACOLOGY, V44, P105, DOI 10.1016/S0162-3109(99)00115-0; Cheng YW, 1998, AM J CARDIOL, V82, P594, DOI 10.1016/S0002-9149(98)00402-0; Farmand F, 2005, ENVIRON RES, V98, P33, DOI 10.1016/j.envres.2004.05.016; FIORESI M, 2009, BIOL RES SA, V42, pR104; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fujiwara Y, 1998, TOXICOL LETT, V94, P181, DOI 10.1016/S0378-4274(98)00004-6; GELBAND H, 1975, CIRC RES, V37, P542, DOI 10.1161/01.RES.37.5.542; GOLDSTEIN GW, 1993, NEUROTOXICOLOGY, V14, P97; Gonick HC, 1997, HYPERTENSION, V30, P1487, DOI 10.1161/01.HYP.30.6.1487; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; KARAI I, 1982, BRIT J IND MED, V39, P290; KHALILMANESH F, 1993, AM J HYPERTENS, V6, P723, DOI 10.1093/ajh/6.9.723; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; Lee DI, 2009, MOL PHARMACOL, V75, P774, DOI 10.1124/mol.108.052597; Levin SM, 2000, AM J IND MED, V37, P23, DOI 10.1002/(SICI)1097-0274(200001)37:1<23::AID-AJIM4>3.0.CO;2-U; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; MAHESWARAN R, 1993, AM J EPIDEMIOL, V137, P645, DOI 10.1093/oxfordjournals.aje.a116722; Malvezzi CK, 2001, BRAZ J MED BIOL RES, V34, P1341, DOI 10.1590/S0100-879X2001001000016; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091, DOI 10.1093/oxfordjournals.aje.a116574; Muscella A, 1997, J ENDOCRINOL, V155, P587, DOI 10.1677/joe.0.1550587; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Oliveira EM, 2000, BRAZ J MED BIOL RES, V33, P755, DOI 10.1590/S0100-879X2000000700005; Patrick L, 2006, ALTERN MED REV, V11, P2; Renner R, 2009, ENVIRON HEALTH PERSP, V117, pA542, DOI 10.1289/ehp.117-a542; Roncal C, 2007, AM J PHYSIOL-RENAL, V293, pF1391, DOI 10.1152/ajprenal.00216.2007; SCHWARTZ J, 1991, ENVIRON HEALTH PERSP, V91, P71, DOI 10.2307/3430985; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Silveira EA, 2010, BRAZ J MED BIOL RES, V43, P492, DOI 10.1590/S0100-879X2010007500027; Stefanon I, 2009, BRAZ J MED BIOL RES, V42, P902, DOI 10.1590/S0100-879X2009005000015; SYSALOVA JK, 1997, BIOL TRACE ELEM RES, V56, P321; Tsao DA, 2000, TOXICOL APPL PHARM, V164, P127, DOI 10.1006/taap.1999.8871; VANDER AJ, 1988, ENVIRON HEALTH PERSP, V78, P77, DOI 10.2307/3430505; Vassallo DV, 2008, BRAZ J MED BIOL RES, V41, P789, DOI 10.1590/S0100-879X2008000900008; Vaziri ND, 2001, HYPERTENSION, V37, P223, DOI 10.1161/01.HYP.37.2.223; Vaziri ND, 2008, AM J PHYSIOL-HEART C, V295, pH454, DOI 10.1152/ajpheart.00158.2008; WATTS SW, 1995, TOXICOLOGY, V99, P55, DOI 10.1016/0300-483X(94)03003-K; WEILER E, 1990, CLIN SCI, V79, P185, DOI 10.1042/cs0790185; Xie YX, 1998, IND HEALTH, V36, P234, DOI 10.2486/indhealth.36.234; Zhang CJ, 2001, AM J PHYSIOL-RENAL, V280, pF474, DOI 10.1152/ajprenal.2001.280.3.F474	46	43	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18730	10.1371/journal.pone.0018730	http://dx.doi.org/10.1371/journal.pone.0018730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494558	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100036
J	Banerjee, N; Sengupta, S; Roy, A; Ghosh, P; Das, K; Das, S				Banerjee, Nilanjana; Sengupta, Subhadipa; Roy, Amit; Ghosh, Prithwi; Das, Kalipada; Das, Sampa			Functional Alteration of a Dimeric Insecticidal Lectin to a Monomeric Antifungal Protein Correlated to Its Oligomeric Status	PLOS ONE			English	Article							SATIVUM LEAF AGGLUTININ; MANNOSE-BINDING LECTIN; PLANT-LECTINS; SWISS-MODEL; ASAL; EXPRESSION; RESISTANCE; SEQUENCE	Background Allium sativum leaf agglutinin (ASAL) is a 25-kDa homodimeric, insecticidal, mannose binding lectin whose subunits are assembled by the C-terminal exchange process. An attempt was made to convert dimeric ASAL into a monomeric form to correlate the relevance of quaternary association of subunits and their functional specificity. Using SWISS-MODEL program a stable monomer was designed by altering five amino acid residues near the C-terminus of ASAL. Methodology/Principal Findings: By introduction of 5 site-specific mutations (-DNSNN-), a beta turn was incorporated between the 11(th) and 12(th) b strands of subunits of ASAL, resulting in a stable monomeric mutant ASAL (mASAL). mASAL was cloned and subsequently purified from a pMAL-c2X system. CD spectroscopic analysis confirmed the conservation of secondary structure in mASAL. Mannose binding assay confirmed that molecular mannose binds efficiently to both mASAL and ASAL. In contrast to ASAL, the hemagglutination activity of purified mASAL against rabbit erythrocytes was lost. An artificial diet bioassay of Lipaphis erysimi with mASAL displayed an insignificant level of insecticidal activity compared to ASAL. Fascinatingly, mASAL exhibited strong antifungal activity against the pathogenic fungi Fusarium oxysporum, Rhizoctonia solani and Alternaria brassicicola in a disc diffusion assay. A propidium iodide uptake assay suggested that the inhibitory activity of mASAL might be associated with the alteration of the membrane permeability of the fungus. Furthermore, a ligand blot assay of the membrane subproteome of R. solani with mASAL detected a glycoprotein receptor having interaction with mASAL. Conclusions/Significance: Conversion of ASAL into a stable monomer resulted in antifungal activity. From an evolutionary aspect, these data implied that variable quaternary organization of lectins might be the outcome of defense-related adaptations to diverse situations in plants. Incorporation of mASAL into agronomically-important crops could be an alternative method to protect them from dramatic yield losses from pathogenic fungi in an effective manner.	[Banerjee, Nilanjana; Sengupta, Subhadipa; Roy, Amit; Ghosh, Prithwi; Das, Sampa] Bose Inst, Div Plant Biol, Kolkata, India; [Das, Kalipada] Bose Inst, Dept Chem, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Banerjee, N (corresponding author), Bose Inst, Div Plant Biol, Kolkata, India.	sampa@bic.boseinst.ernet.in	Roy, Amit/N-4761-2015; Roy, Amit/X-7485-2019; Ghosh, Prithwi/I-6450-2019	Roy, Amit/0000-0003-3237-3525; Roy, Amit/0000-0003-3237-3525; Ghosh, Prithwi/0000-0001-5243-751X; Das, Kali/0000-0001-7686-9077	Bose Institute	Bose Institute(Department of Science & Technology (India))	Bose Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Bachhawat K, 2001, BIOCHEMISTRY-US, V40, P7291, DOI 10.1021/bi0027783; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Banerjee S, 2004, J BIOL CHEM, V279, P23782, DOI 10.1074/jbc.M401405200; Barre A, 1996, PLANT PHYSIOL, V112, P1531, DOI 10.1104/pp.112.4.1531; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakraborti D, 2009, TRANSGENIC RES, V18, P529, DOI 10.1007/s11248-009-9242-7; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Chandra NR, 2001, PROTEIN ENG, V14, P857, DOI 10.1093/protein/14.11.857; Chi H, 1997, COMPUTER PROGRAM PRO; Dam TK, 1998, J BIOL CHEM, V273, P5528, DOI 10.1074/jbc.273.10.5528; de Beer A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-75; Dutta I, 2005, PLANT SCI, V169, P996, DOI 10.1016/j.plantsci.2005.05.016; Dutta I, 2005, PLANT BIOTECHNOL J, V3, P601, DOI 10.1111/j.1467-7652.2005.00151.x; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gangwar M, 2006, MYCOPATHOLOGIA, V162, P103, DOI 10.1007/s11046-006-0040-y; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; Jiang SY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-79; Kim Y, 2007, TRENDS BIOTECHNOL, V25, P395, DOI 10.1016/j.tibtech.2007.07.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu W, 2005, J BIOL CHEM, V280, P14865, DOI 10.1074/jbc.M411634200; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Natarajan S, 2005, ANAL BIOCHEM, V342, P214, DOI 10.1016/j.ab.2005.04.046; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Roy A, 2002, J AGR FOOD CHEM, V50, P6775, DOI 10.1021/jf025660x; Saha P, 2006, PLANTA, V223, P1329, DOI 10.1007/s00425-005-0182-z; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Van Damme EJM, 2007, BIOCHEM J, V404, P51, DOI 10.1042/BJ20061819; VANPARIJS J, 1991, PLANTA, V183, P258, DOI 10.1007/BF00197797; VANPARIJS J, 1992, ARCH MICROBIOL, V158, P19, DOI 10.1007/BF00249060; VIGERS AJ, 1991, MOL PLANT MICROBE IN, V4, P315, DOI 10.1094/MPMI-4-315; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2	42	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18593	10.1371/journal.pone.0018593	http://dx.doi.org/10.1371/journal.pone.0018593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490929	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700026
J	Esguerra, JLS; Bolmeson, C; Cilio, CM; Eliasson, L				Esguerra, Jonathan Lou S.; Bolmeson, Caroline; Cilio, Corrado M.; Eliasson, Lena			Differential Glucose-Regulation of MicroRNAs in Pancreatic Islets of Non-Obese Type 2 Diabetes Model Goto-Kakizaki Rat	PLOS ONE			English	Article							INSULIN-SECRETION; GENE-EXPRESSION; BETA-CELLS; PROTEINS; IDENTIFICATION; SYNTAXIN; TARGETS; RNAS	Background: The Goto-Kakizaki (GK) rat is a well-studied non-obese spontaneous type 2 diabetes (T2D) animal model characterized by impaired glucose-stimulated insulin secretion (GSIS) in the pancreatic beta cells. MicroRNAs (miRNAs) are short regulatory RNAs involved in many fundamental biological processes. We aim to identify miRNAs that are differentially-expressed in the pancreatic islets of the GK rats and investigate both their short-and long term glucose-dependence during glucose-stimulatory conditions. Methodology/Principal Findings: Global profiling of 348 miRNAs in the islets of GK rats and Wistar controls (females, 60 days, N = 6 for both sets) using locked nucleic acid (LNA)-based microarrays allowed for the clear separation of the two groups. Significant analysis of microarrays (SAM) identified 30 differentially-expressed miRNAs, 24 of which are predominantly upregulated in the GK rat islets. Monitoring of qPCR-validated miRNAs during GSIS experiments on isolated islets showed disparate expression trajectories between GK and controls indicating distinct short-and long-term glucose dependence. We specifically found expression of rno-miR-130a, rno-miR-132, rno-miR-212 and rno-miR-335 to be regulated by hyperglycaemia. The putative targets of upregulated miRNAs in the GK, filtered with glucose-regulated mRNAs, were found to be enriched for insulin-secretion genes known to be downregulated in T2D patients. Finally, the binding of rno-miR-335 to a fragment of the 3'UTR of one of known down-regulated exocytotic genes in GK islets, Stxbp1 was shown by luciferase assay. Conclusions/Significance: The perturbed miRNA network found in the GK rat islets is indicative of a system-wide impairment in the regulation of genes important for the normal functions of pancreatic islets, particularly in processes involving insulin secretion during glucose stimulatory conditions. Our findings suggest that the reduced insulin secretion observed in the GK rat may be partly due to upregulated miRNA expression leading to decreased production of key proteins of the insulin exocytotic machinery.	[Esguerra, Jonathan Lou S.; Bolmeson, Caroline; Cilio, Corrado M.] Lund Univ, Dept Clin Sci Malmo, Cellular Autoimmun Unit, Malmo, Sweden	Lund University	Esguerra, JLS (corresponding author), Lund Univ, Dept Clin Sci Malmo, Cellular Autoimmun Unit, Malmo, Sweden.	jonathan.esguerra@med.lu.se	Eliasson, Lena/E-9294-2012; Esguerra, Jonathan/M-2366-2014	Eliasson, Lena/0000-0002-6467-5029; Esguerra, Jonathan/0000-0001-8454-6606	Albert Pahlsson's Foundation; Knut and Alice Wallenberg Foundation; Swedish Medical Research Council; Novo Nordisk Foundation; Swedish Diabetes Association; Lund University Diabetes Centre	Albert Pahlsson's Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Lund University Diabetes Centre	This work was supported by Albert Pahlsson's Foundation, Knut and Alice Wallenberg Foundation, Swedish Medical Research Council, Novo Nordisk Foundation and Swedish Diabetes Association. J.L.S. Esguerra is funded through Lund University Diabetes Centre Linnaeus grant. L. Eliasson is a senior researcher at the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dong YM, 2007, BIOCHEM BIOPH RES CO, V360, P609, DOI 10.1016/j.bbrc.2007.06.107; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; WILLENBROCK H, 2009, QUANTITATIVE MIRNA E; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang W, 2002, BIOCHEM BIOPH RES CO, V291, P1038, DOI 10.1006/bbrc.2002.6555; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	44	130	137	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18613	10.1371/journal.pone.0018613	http://dx.doi.org/10.1371/journal.pone.0018613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490936	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700029
J	Malkani, N; Schmid, JA				Malkani, Naila; Schmid, Johannes A.			Some Secrets of Fluorescent Proteins: Distinct Bleaching in Various Mounting Fluids and Photoactivation of Cyan Fluorescent Proteins at YFP-Excitation	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; NF-KAPPA-B; IMAGING MICROSCOPY; FRET; RECEPTOR; PHOTOCONVERSION; OLIGOMERIZATION; VARIANT; RED	Background: The use of spectrally distinct variants of green fluorescent protein (GFP) such as cyan or yellow mutants (CFP and YFP, respectively) is very common in all different fields of life sciences, e. g. for marking specific proteins or cells or to determine protein interactions. In the latter case, the quantum physical phenomenon of fluorescence resonance energy transfer (FRET) is exploited by specific microscopy techniques to visualize proximity of proteins. Methodology/Principal Findings: When we applied a commonly used FRET microscopy technique - the increase in donor (CFP)-fluorescence after bleaching of acceptor fluorophores (YFP), we obtained good signals in live cells, but very weak signals for the same samples after fixation and mounting in commercial microscopy mounting fluids. This observation could be traced back to much faster bleaching of CFP in these mounting media. Strikingly, the opposite effect of the mounting fluid was observed for YFP and also for other proteins such as Cerulean, TFP or Venus. The changes in photostability of CFP and YFP were not caused by the fixation but directly dependent on the mounting fluid. Furthermore we made the interesting observation that the CFP-fluorescence intensity increases by about 10 - 15% after illumination at the YFP-excitation wavelength - a phenomenon, which was also observed for Cerulean. This photoactivation of cyan fluorescent proteins at the YFP-excitation can cause false-positive signals in the FRET-microscopy technique that is based on bleaching of a yellow FRET acceptor. Conclusions/Significance: Our results show that photostability of fluorescent proteins differs significantly for various media and that CFP bleaches significantly faster in commercial mounting fluids, while the opposite is observed for YFP and some other proteins. Moreover, we show that the FRET microscopy technique that is based on bleaching of the YFP is prone to artifacts due to photoactivation of cyan fluorescent proteins under these conditions.	[Malkani, Naila; Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Malkani, N (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	Johannes.Schmid@meduniwien.ac.at	Malkani, Naila/AAA-9224-2022; Schmid, Johannes A./C-7659-2009	Malkani, Naila/0000-0001-6454-1525; Schmid, Johannes A./0000-0002-6586-3507	Medical University Vienna, Austria	Medical University Vienna, Austria	The work was funded by the Medical University Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMI L, 1995, PFLUG ARCH EUR J PHY, V430, P447, DOI 10.1007/BF00373921; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Fradkov AF, 2002, BIOCHEM J, V368, P17, DOI 10.1042/BJ20021191; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Harpur AG, 2001, NAT BIOTECHNOL, V19, P167, DOI 10.1038/84443; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Karpova Tatiana, 2006, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1207s35; Kirber MT, 2007, NAT METHODS, V4, P767, DOI 10.1038/nmeth1007-767; LINGBECK JM, 2008, FASEB J; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; MEVRWVABH CCD, 2008, J MICROSCOPY, V231, P97; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PISTON DW, 2007, TRENDS BIOCH SCI; Raarup MK, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103338; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Thaler C, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491A; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Verrier SE, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491B; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; WOUTERS FS, 2006, CURR PROTOC NEUROSCI, pCH5	31	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18586	10.1371/journal.pone.0018586	http://dx.doi.org/10.1371/journal.pone.0018586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490932	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700025
J	Barathi, VA; Weon, SR; Tan, QSW; Lin, KJ; Tong, L; Beuerman, RW				Barathi, V. A.; Weon, Sung R.; Tan, Queenie S. W.; Lin, Kwan J.; Tong, Louis; Beuerman, Roger W.			Transglutaminases (TGs) in Ocular and Periocular Tissues: Effect of Muscarinic Agents on TGs in Scleral Fibroblasts	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; CROSS-LINKING; RETINOIC ACID; EXTRACELLULAR-MATRIX; CELL-GROWTH; EXPRESSION; DIFFERENTIATION; FIBRONECTIN; HYPERPROLIFERATION; CONJUNCTIVA	Objective: To investigate the expression of transglutaminases (TGs) in the ocular surface, the eyelid margin and associated glands and to determine effect of muscarinic agents on TGs in scleral fibroblasts (SF). Materials and Methods: Primary SFs cultured from mouse and human sclera were treated with atropine and carbachol for 5 days. Lysed cell RNA was used for real-time PCR, protein was used for Western blot analysis and TG-2 transamidase activity was measured by ELISA. Immunohistochemistry was done to determine the expression of TGases. Results: Immunohistochemistry and western blot confirmed the expression of TGs-1, 2, 3 and 5 proteins in cultured SFs and eye tissues. Real time PCR showed TG-1, 2, 5 transcript levels to be down regulated 3 fold (p < 0.05) in cultured human and mouse SFs after incubation with atropine and this was reversed by carbachol. However, TG-3 expression was increased with atropine and decreased with carbachol at all concentrations. Atropine abrogated the carbachol-induced activation of SF in a dose-dependent manner. TGs-1, 3, 5 were localized in the entire mouse corneal epithelium, stroma and endothelium but TG-2 was present only in the corneal subepithelium and stroma. All TGs were localized in mouse Meibomian glands however TG-2 had a weak expression. Conclusions: Our results confirm that TGs-1, 2, 3 and 5 are expressed in human SF and murine ocular tissues, eyelid and associated Meibomian glands. Real-time PCR and Western blot results showed that muscarinic antagonist down-regulates TGs-1, 2 and 5 in both cultured human and mouse SFs and upregulates TG-3. Atropine abrogated the carbachol-induced activation of SF in a dose-dependent manner. These results suggest that manipulation of TGs by way of muscarinic receptor acting drugs may be a plausible method of intervention in wound healing and scleral remodeling.	[Barathi, V. A.; Weon, Sung R.; Tan, Queenie S. W.; Lin, Kwan J.; Tong, Louis; Beuerman, Roger W.] Singapore Eye Res Inst, Ocular Dis Model Res Grp, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Tong, Louis; Beuerman, Roger W.] DUKE NUS Grad Med Sch, SRP Neurosci & Behav Disorder, Singapore, Singapore; [Beuerman, Roger W.] Natl Univ Singapore Hosp, Natl Univ Hlth Sci, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117548, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore	Barathi, VA (corresponding author), Singapore Eye Res Inst, Ocular Dis Model Res Grp, Singapore, Singapore.	vabarathi97@mac.com		Tong, Louis/0000-0002-3986-6552	National Medical Research Council of Singapore [NIG/NMRC/003/2007, NIG/NMRC/1178/2008]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This study is supported by NIG/NMRC/003/2007 and NIG/NMRC/1178/2008 from the National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Brink N, 2000, INFLAMM RES, V49, P290, DOI 10.1007/PL00000209; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; ELALAOUI S, 1991, INT J CANCER, V48, P221; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; JEON WM, 1989, ANAL BIOCHEM, V182, P170, DOI 10.1016/0003-2697(89)90737-9; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kantola AK, 2008, EXP CELL RES, V314, P2488, DOI 10.1016/j.yexcr.2008.05.010; Kim Y J, 1998, Korean J Ophthalmol, V12, P6; Lind GJ, 1998, INVEST OPHTH VIS SCI, V39, P2217; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nishida K, 1999, AM J PATHOL, V154, P331, DOI 10.1016/S0002-9440(10)65279-0; Ohtake Y, 2006, BIOMED RES-TOKYO, V27, P75, DOI 10.2220/biomedres.27.75; Priglinger SG, 2003, INVEST OPHTH VIS SCI, V44, P355, DOI 10.1167/iovs.02-0224; Priglinger SG, 2006, INVEST OPHTH VIS SCI, V47, P4990, DOI 10.1167/iovs.06-0273; Priglinger SG, 2006, INVEST OPHTH VIS SCI, V47, P3835, DOI 10.1167/iovs.05-0960; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Raghunath M, 1999, INVEST OPHTH VIS SCI, V40, P2780; SAUNDERS NA, 1993, MOL ENDOCRINOL, V7, P387, DOI 10.1210/me.7.3.387; SAUNDERS NA, 1994, J BIOL CHEM, V269, P2016; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Toshino A, 2005, CURR EYE RES, V30, P731, DOI 10.1080/02713680591005940; Tsubota K, 1999, INVEST OPHTH VIS SCI, V40, P28; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang W, 2004, CURR EYE RES, V28, P37, DOI 10.1076/ceyr.28.1.37.23493	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18326	10.1371/journal.pone.0018326	http://dx.doi.org/10.1371/journal.pone.0018326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494676	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400019
J	Haefeli, RH; Erb, M; Gemperli, AC; Robay, D; Fruh, IC; Anklin, C; Dallmann, R; Gueven, N				Haefeli, Roman H.; Erb, Michael; Gemperli, Anja C.; Robay, Dimitri; Fruh, Isabelle Courdier; Anklin, Corinne; Dallmann, Robert; Gueven, Nuri			NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels	PLOS ONE			English	Article							NAD(P)H QUINONE OXIDOREDUCTASE; BRAIN MITOCHONDRIA; LIPID-PEROXIDATION; FRIEDREICH ATAXIA; DT-DIAPHORASE; COENZYME-Q; RESPIRATORY-CHAIN; INHIBITION; CYTOTOXICITY; ANTIOXIDANT	Short-chain quinones are described as potent antioxidants and in the case of idebenone have already been under clinical investigation for the treatment of neuromuscular disorders. Due to their analogy to coenzyme Q(10) (CoQ(10)), a long-chain quinone, they are widely regarded as a substitute for CoQ(10). However, apart from their antioxidant function, this provides no clear rationale for their use in disorders with normal CoQ(10) levels. Using recombinant NAD(P)H:quinone oxidoreductase (NQO) enzymes, we observed that contrary to CoQ(10) short-chain quinones such as idebenone are good substrates for both NQO1 and NQO2. Furthermore, the reduction of short-chain quinones by NQOs enabled an antimycin A-sensitive transfer of electrons from cytosolic NAD(P) H to the mitochondrial respiratory chain in both human hepatoma cells (HepG2) and freshly isolated mouse hepatocytes. Consistent with the substrate selectivity of NQOs, both idebenone and CoQ(1), but not CoQ(10), partially restored cellular ATP levels under conditions of impaired complex I function. The observed cytosolic-mitochondrial shuttling of idebenone and CoQ(1) was also associated with reduced lactate production by cybrid cells from mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) patients. Thus, the observed activities separate the effectiveness of short-chain quinones from the related long-chain CoQ(10) and provide the rationale for the use of short-chain quinones such as idebenone for the treatment of mitochondrial disorders.	[Haefeli, Roman H.; Erb, Michael; Robay, Dimitri; Anklin, Corinne; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland; [Haefeli, Roman H.] Univ Basel, Biozentrum, Basel, Switzerland; [Gemperli, Anja C.] Inst Straumann AG, Basel, Switzerland; [Fruh, Isabelle Courdier] Novartis Pharma AG, Basel, Switzerland; [Dallmann, Robert] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Basel; Institut Straumann AG; Novartis; University of Zurich	Haefeli, RH (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.	nuri.gueven@santhera.com	Dallmann, Bob/AAA-4929-2022	Dallmann, Robert/0000-0002-7490-0218; Guven, Nuri/0000-0003-3782-767X	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd. (www.santhera.com) funded and approved the publication of this work.	Adikesavan AK, 2007, CANCER RES, V67, P7966, DOI 10.1158/0008-5472.CAN-06-4480; Audi SH, 2003, FREE RADICAL BIO MED, V34, P892, DOI 10.1016/S0891-5849(03)00025-X; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Boutin JA, 2005, CHEM-BIOL INTERACT, V151, P213, DOI 10.1016/j.cbi.2005.01.002; Briere JJ, 2004, BIOCHEM BIOPH RES CO, V316, P1138, DOI 10.1016/j.bbrc.2004.03.002; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; Chapela SP, 2008, CELL BIOL INT, V32, P146, DOI 10.1016/j.cellbi.2007.08.003; CIVENNI G, 2009, EUR J PHARMACOL, V370, P161; Colucci MA, 2008, ORG BIOMOL CHEM, V6, P637, DOI 10.1039/b715270a; Degli Esposti Mauro, 1996, Archives of Biochemistry and Biophysics, V330, P395; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dragan M, 2006, BRAIN RES, V1078, P9, DOI 10.1016/j.brainres.2006.01.068; ERNSTER L, 1962, BIOCHIM BIOPHYS ACTA, V58, P171, DOI 10.1016/0006-3002(62)90997-6; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; FATO R, 2008, BIOCHIM BIOPHYS ACTA, V1787, P384; GASDASKA PY, 1995, CANCER RES, V55, P2542; Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008; HOUCHI H, 1991, JPN J PHARMACOL, V57, P553, DOI 10.1254/jjp.57.553; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Knox RJ, 2000, CANCER RES, V60, P4179; Kutz K, 2009, J NEUROL, V256, P31, DOI 10.1007/s00415-009-1006-z; Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6; Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Myers L, 2008, J NEUROL SCI, V267, P174, DOI 10.1016/j.jns.2007.10.008; Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; OKAMOTO K, 1998, CHEM PHARM BULL, V36, P178; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Paolino D, 2004, J PHARM SCI-US, V93, P1815, DOI 10.1002/jps.20088; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1; Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; SUGIYAMA Y, 1985, J PHARMACOBIO-DYNAM, V8, P1006; SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5; SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1; Takuma K, 2000, EUR J PHARMACOL, V406, P333, DOI 10.1016/S0014-2999(00)00701-9; Tan AS, 2010, FREE RADICAL BIO MED, V48, P421, DOI 10.1016/j.freeradbiomed.2009.11.016; Tonon C, 2008, EXPERT OPIN PHARMACO, V9, P2327, DOI 10.1517/14656566.9.13.2327 ; Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344	49	122	127	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17963	10.1371/journal.pone.0017963	http://dx.doi.org/10.1371/journal.pone.0017963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483849	Green Accepted, gold, Green Published			2022-12-27	WOS:000289057200014
J	Thompson, JD; Linard, B; Lecompte, O; Poch, O				Thompson, Julie D.; Linard, Benjamin; Lecompte, Odile; Poch, Olivier			A Comprehensive Benchmark Study of Multiple Sequence Alignment Methods: Current Challenges and Future Perspectives	PLOS ONE			English	Article							DISTANTLY RELATED PROTEINS; FUNCTIONAL SPECIFICITY; PHYLOGENETIC TREES; DATABASE SEARCHES; HIGH-THROUGHPUT; T-COFFEE; ACCURACY; INFORMATION; PROGRAMS; IDENTIFICATION	Multiple comparison or alignment of protein sequences has become a fundamental tool in many different domains in modern molecular biology, from evolutionary studies to prediction of 2D/3D structure, molecular function and intermolecular interactions etc. By placing the sequence in the framework of the overall family, multiple alignments can be used to identify conserved features and to highlight differences or specificities. In this paper, we describe a comprehensive evaluation of many of the most popular methods for multiple sequence alignment (MSA), based on a new benchmark test set. The benchmark is designed to represent typical problems encountered when aligning the large protein sequence sets that result from today's high throughput biotechnologies. We show that alignment methods have significantly progressed and can now identify most of the shared sequence features that determine the broad molecular function(s) of a protein family, even for divergent sequences. However, we have identified a number of important challenges. First, the locally conserved regions, that reflect functional specificities or that modulate a protein's function in a given cellular context, are less well aligned. Second, motifs in natively disordered regions are often misaligned. Third, the badly predicted or fragmentary protein sequences, which make up a large proportion of today's databases, lead to a significant number of alignment errors. Based on this study, we demonstrate that the existing MSA methods can be exploited in combination to improve alignment accuracy, although novel approaches will still be needed to fully explore the most difficult regions. We then propose knowledge-enabled, dynamic solutions that will hopefully pave the way to enhanced alignment construction and exploitation in future evolutionary systems biology studies.	[Thompson, Julie D.; Linard, Benjamin; Lecompte, Odile; Poch, Olivier] Univ Strasbourg, CNRS, INSERM, Dept Biol Struct & Genom,IGBMC, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Thompson, JD (corresponding author), Univ Strasbourg, CNRS, INSERM, Dept Biol Struct & Genom,IGBMC, Illkirch Graffenstaden, France.	julie@igbmc.fr	Lecompte, Odile/F-4741-2011; linard, benjamin/B-7985-2014; Thompson, Julie D/F-3208-2010; Lecompte, Odile/N-7992-2019	Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; Linard, Benjamin/0000-0002-5555-898X	Agence Nationale de la Recherche [EvolHHuPro: BLAN07-1-198915]; Association Francaise contre les Myopathies [DDC/KBM: 14390]; IGBMC; CNRS; INSERM; Universite de Strasbourg	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); IGBMC; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg	This work was funded by the Agence Nationale de la Recherche (EvolHHuPro: BLAN07-1-198915) project, the Association Francaise contre les Myopathies (DDC/KBM: 14390) project and Institute funds from the IGBMC, CNRS, INSERM, and the Universite de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aniba MR, 2010, NUCLEIC ACIDS RES, V38, P7353, DOI 10.1093/nar/gkq625; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Bianchetti Laurent, 2005, Journal of Bioinformatics and Computational Biology, V3, P929, DOI 10.1142/S0219720005001326; Blackshields Gordon, 2006, In Silico Biol, V6, P321; Brandt BW, 2010, NUCLEIC ACIDS RES, V38, pW35, DOI 10.1093/nar/gkq415; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Chakrabarti S, 2006, NUCLEIC ACIDS RES, V34, P2598, DOI 10.1093/nar/gkl274; Chica C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-229; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eaton MJ, 2009, MOL PHYLOGENET EVOL, V50, P496, DOI 10.1016/j.ympev.2008.11.009; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GUIGO R, 2006, GENOME BIOL S1, V7, pNIL4; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Keller O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-278; Koh YS., 2009, RARE ASS RULE MINING; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Krause L, 2006, BIOINFORMATICS, V22, pE281, DOI 10.1093/bioinformatics/btl247; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Levasseur A, 2008, EVOL BIOINFORM, V4, P121; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Notredame C, 1996, NUCLEIC ACIDS RES, V24, P1515, DOI 10.1093/nar/24.8.1515; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Plewniak F, 2000, BIOINFORMATICS, V16, P750, DOI 10.1093/bioinformatics/16.9.750; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Taylor WR, 2000, METH MOL B, V143, P19; Thompson JD, 1999, BIOINFORMATICS, V15, P87, DOI 10.1093/bioinformatics/15.1.87; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Thompson JD, 2005, NUCLEIC ACIDS RES, V33, P4164, DOI 10.1093/nar/gki735; Thompson JD, 2004, NUCLEIC ACIDS RES, V32, P1298, DOI 10.1093/nar/gkh294; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Thompson JD, 2001, J MOL BIOL, V314, P937, DOI 10.1006/jmbi.2001.5187; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Thompson JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-318; *UNIPROT CONS, 2009, NUCL ACIDS IN PRESS; VINGRON M, 1993, P NATL ACAD SCI USA, V90, P8777, DOI 10.1073/pnas.90.19.8777; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Wong WC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000867; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347	71	134	134	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18093	10.1371/journal.pone.0018093	http://dx.doi.org/10.1371/journal.pone.0018093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483869	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200027
J	Bostrom, J; Haber, L; Koenig, P; Kelley, RF; Fuh, G				Bostrom, Jenny; Haber, Lauric; Koenig, Patrick; Kelley, Robert F.; Fuh, Germaine			High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity	PLOS ONE			English	Article							HIV-1 MONOCLONAL-ANTIBODY; MOLECULAR RECOGNITION; THERMODYNAMIC ANALYSIS; MUTATIONAL ANALYSIS; BINDING INTERFACES; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; PROTEIN DYNAMICS; RECEPTOR-BINDING; FAB	The antigen-binding site of Herceptin, an anti-human Epidermal Growth Factor Receptor 2 (HER2) antibody, was engineered to add a second specificity toward Vascular Endothelial Growth Factor (VEGF) to create a high affinity two-in-one antibody bH1. Crystal structures of bH1 in complex with either antigen showed that, in comparison to Herceptin, this antibody exhibited greater conformational variability, also called "structural plasticity''. Here, we analyzed the biophysical and thermodynamic properties of the dual specific variants of Herceptin to understand how a single antibody binds two unrelated protein antigens. We showed that while bH1 and the affinity-improved bH1-44, in particular, maintained many properties of Herceptin including binding affinity, kinetics and the use of residues for antigen recognition, they differed in the binding thermodynamics. The interactions of bH1 and its variants with both antigens were characterized by large favorable entropy changes whereas the Herceptin/HER2 interaction involved a large favorable enthalpy change. By dissecting the total entropy change and the energy barrier for dual interaction, we determined that the significant structural plasticity of the bH1 antibodies demanded by the dual specificity did not translate into the expected increase of entropic penalty relative to Herceptin. Clearly, dual antigen recognition of the Herceptin variants involves divergent antibody conformations of nearly equivalent energetic states. Hence, increasing the structural plasticity of an antigen-binding site without increasing the entropic cost may play a role for antibodies to evolve multi-specificity. Our report represents the first comprehensive biophysical analysis of a high affinity dual specific antibody binding two unrelated protein antigens, furthering our understanding of the thermodynamics that drive the vast antigen recognition capacity of the antibody repertoire.	[Bostrom, Jenny; Haber, Lauric; Koenig, Patrick; Kelley, Robert F.; Fuh, Germaine] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Bostrom, Jenny; Haber, Lauric; Koenig, Patrick; Kelley, Robert F.; Fuh, Germaine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Bostrom, J (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	gml@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. supported and funded the research described in the report. As a company, Genentech encourages publication and plays a role of determining and issuing the approval for the authors to release and submit the manuscript to journals. Besides this role, the company did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREVALO JH, 1993, NATURE, V365, P859, DOI 10.1038/365859a0; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; FASMAN GD, 1976, HDB BIOCH MOL BIOL; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; Jimenez R, 2004, P NATL ACAD SCI USA, V101, P3803, DOI 10.1073/pnas.0305745101; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; KELLEY RF, 1992, BIOCHEMISTRY-US, V31, P5434, DOI 10.1021/bi00139a003; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; Kramer A, 1997, CELL, V91, P799, DOI 10.1016/S0092-8674(00)80468-7; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lee CV, 2006, BLOOD, V108, P3103, DOI 10.1182/blood-2006-03-011031; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Mohan S, 2009, BIOCHEMISTRY-US, V48, P1390, DOI 10.1021/bi801901d; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; PETRI V, 1995, BIOCHEMISTRY-US, V34, P9977, DOI 10.1021/bi00031a020; PRABHAKAR BS, 1984, J IMMUNOL, V133, P2815; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; vanderMerwe PA, 1996, CURR OPIN IMMUNOL, V8, P257, DOI 10.1016/S0952-7915(96)80065-3; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; Winzor DJ, 2005, ANAL BIOCHEM, V337, P289, DOI 10.1016/j.ab.2004.10.049	55	61	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17887	10.1371/journal.pone.0017887	http://dx.doi.org/10.1371/journal.pone.0017887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526167	gold, Green Submitted, Green Published			2022-12-27	WOS:000290015800004
J	Xi, XY; Zhang, XY; Wang, B; Wang, J; Huang, H; Cui, LX; Han, XQ; Li, L; He, W; Zhao, ZD				Xi, XueYan; Zhang, XiaoYan; Wang, Bei; Wang, Ji; Huang, He; Cui, LianXian; Han, XiQin; Li, Liang; He, Wei; Zhao, ZhenDong			A Novel Strategy to Screen Bacillus Calmette-Guerin Protein Antigen Recognized by gamma delta TCR	PLOS ONE			English	Article							PRENYL PYROPHOSPHATE ANTIGENS; T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; NONPEPTIDE ANTIGENS; TUMOR-CELLS; IDENTIFICATION; CDR3-DELTA; PEPTIDE; LYMPHOCYTES; LIBRARIES	BACKGROUND: Phosphoantigen was originally identified as the main gamma delta TCR-recognized antigen that could activate gamma delta T cells to promote immune protection against mycobacterial infection. However, new evidence shows that the gamma delta T cells activated by phosphoantigen can only provide partial immune protection against mycobacterial infection. In contrast, whole lysates of Mycobacterium could activate immune protection more potently, implying that other gamma delta TCR-recognized antigens that elicit protective immune responses. To date, only a few distinct mycobacterial antigens recognized by the gamma delta TCR have been characterized. METHODOLOGY/PRINCIPAL FINDINGS: In the present study, we established a new approach to screen epitopes or protein antigens recognized by the gamma delta TCR using Bacillus Calmette-Guerin- (BCG-) specific gamma delta TCR transfected cells as probes to pan a 12-mer random-peptide phage-displayed library. Through binding assays and functional analysis, we identified a peptide (BP3) that not only binds to the BCG-specific gamma delta TCR but also effectively activates gamma delta T cells isolated from human subjects inoculated with BCG. Importantly, the gamma delta T cells activated by peptide BP3 had a cytotoxic effect on THP-1 cells infected with BCG. Moreover, the oxidative stress response regulatory protein (OXYS), a BCG protein that matches perfectly with peptide BP3 according to bioinformatics analysis, was confirmed as a ligand for the gamma delta TCR and was found to activate gamma delta T cells from human subjects inoculated with BCG. CONCLUSIONS/SIGNIFICANCE: In conclusion, our study provides a novel strategy to identify epitopes or protein antigens for the gamma delta TCR, and provides a potential means to screen mycobacterial vaccines or candidates for adjuvant.	[Xi, XueYan; Zhang, XiaoYan; Wang, Bei; Wang, Ji; Huang, He; Zhao, ZhenDong] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Cui, LianXian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100037, Peoples R China; [Xi, XueYan; Zhang, XiaoYan; Wang, Bei; Wang, Ji; Huang, He; Cui, LianXian; He, Wei; Zhao, ZhenDong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Han, XiQin; Li, Liang] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xi, XY (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China.	heweiimu@public.bta.net.cn; timjszzd@163.com	huang, he/GLT-7903-2022	Huang, He/0000-0002-4887-2671	Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' from China PR [2008ZX10003-012, 2009ZX10004-303]; National Natural Science Foundation of China PR [30901314]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2008IPB207]	Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' from China PR; National Natural Science Foundation of China PR(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology, Chinese Academy of Medical Sciences	This work is sponsored by grants (2008ZX10003-012, 2009ZX10004-303) Eleven-fifth Mega-Scientific project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' from China PR, Grant (30901314) from the National Natural Science Foundation of China PR and grant (2008IPB207) Basic R & D expenses from the Institute of Pathogen Biology, Chinese Academy of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; BALBI B, 1993, AM REV RESPIR DIS, V148, P1685, DOI 10.1164/ajrccm/148.6_Pt_1.1685; Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; BOOM WH, 1994, INFECT IMMUN, V62, P5511, DOI 10.1128/IAI.62.12.5511-5518.1994; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Brown KC, 2000, CURR OPIN CHEM BIOL, V4, P16, DOI 10.1016/S1367-5931(99)00045-9; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Cao W, 2005, FRONT BIOSCI-LANDMRK, V10, P2676, DOI 10.2741/1729; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Lee J, 2004, INFECT IMMUN, V72, P1504, DOI 10.1128/IAI.72.3.1504-1511.2004; Li L, 2008, BLOOD, V111, P5629, DOI 10.1182/blood-2008-02-139899; Martino A, 2007, J IMMUNOL, V179, P3057, DOI 10.4049/jimmunol.179.5.3057; Miyagawa F, 2001, J IMMUNOL, V167, P6773, DOI 10.4049/jimmunol.167.12.6773; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 1999, MICROBES INFECT, V1, P175, DOI 10.1016/S1286-4579(99)80032-X; Morita CT, 2001, J IMMUNOL, V167, P36, DOI 10.4049/jimmunol.167.1.36; Nishimura H, 2004, INT J HEMATOL, V79, P369, DOI 10.1532/IJH97.03157; SALLY JP, 2008, IMMUNOLOGY, V126, P201; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Spencer CT, 2008, J IMMUNOL, V181, P4471, DOI 10.4049/jimmunol.181.7.4471; Wang Jing, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P588; Xi XY, 2010, INT IMMUNOL, V22, P299, DOI 10.1093/intimm/dxq011; Xi XY, 2009, J BIOL CHEM, V284, P27449, DOI 10.1074/jbc.M109.011684; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Zhang BH, 2007, MOL MED, V13, P246, DOI 10.2119/2006-00115.Zhang; Zhang RJ, 2006, J IMMUNOL, V176, P2610, DOI 10.4049/jimmunol.176.4.2610	28	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18809	10.1371/journal.pone.0018809	http://dx.doi.org/10.1371/journal.pone.0018809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526117	Green Published, gold, Green Submitted			2022-12-27	WOS:000290015800013
J	McGrail, M; Hatler, JM; Kuang, XY; Liao, HK; Nannapaneni, K; Watt, KEN; Uhl, JD; Largaespada, DA; Vollbrecht, E; Scheetz, TE; Dupuy, AJ; Hostetter, JM; Essner, JJ				McGrail, Maura; Hatler, Julia M.; Kuang, Xianyan; Liao, Hsin-Kai; Nannapaneni, Kishore; Watt, Kristin E. Noack; Uhl, Juli D.; Largaespada, David A.; Vollbrecht, Erik; Scheetz, Todd E.; Dupuy, Adam J.; Hostetter, Jesse M.; Essner, Jeffrey J.			Somatic Mutagenesis with a Sleeping Beauty Transposon System Leads to Solid Tumor Formation in Zebrafish	PLOS ONE			English	Article							CANCER GENE DISCOVERY; T-CELL LEUKEMIA; COLORECTAL CANCERS; INSERTIONAL MUTAGENESIS; TRANSGENIC ZEBRAFISH; GENOMIC INSTABILITY; HUMAN BREAST; MOUSE; EXPRESSION; PATHWAYS	Large-scale sequencing of human cancer genomes and mouse transposon-induced tumors has identified a vast number of genes mutated in different cancers. One of the outstanding challenges in this field is to determine which genes, when mutated, contribute to cellular transformation and tumor progression. To identify new and conserved genes that drive tumorigenesis we have developed a novel cancer model in a distantly related vertebrate species, the zebrafish, Danio rerio. The Sleeping Beauty (SB) T2/Onc transposon system was adapted for somatic mutagenesis in zebrafish. The carp beta-actin promoter was cloned into T2/Onc to create T2/OncZ. Two transgenic zebrafish lines that contain large concatemers of T2/OncZ were isolated by injection of linear DNA into the zebrafish embryo. The T2/OncZ transposons were mobilized throughout the zebrafish genome from the transgene array by injecting SB11 transposase RNA at the 1-cell stage. Alternatively, the T2/OncZ zebrafish were crossed to a transgenic line that constitutively expresses SB11 transposase. T2/OncZ transposon integration sites were cloned by ligation-mediated PCR and sequenced on a Genome Analyzer II. Between 700-6800 unique integration events in individual fish were mapped to the zebrafish genome. The data show that introduction of transposase by transgene expression or RNA injection results in an even distribution of transposon reintegration events across the zebrafish genome. SB11 mRNA injection resulted in neoplasms in 10% of adult fish at similar to 10 months of age. T2/OncZ-induced zebrafish tumors contain many mutated genes in common with human and mouse cancer genes. These analyses validate our mutagenesis approach and provide additional support for the involvement of these genes in human cancers. The zebrafish T2/OncZ cancer model will be useful for identifying novel and conserved genetic drivers of human cancers.	[McGrail, Maura; Kuang, Xianyan; Liao, Hsin-Kai; Watt, Kristin E. Noack; Uhl, Juli D.; Vollbrecht, Erik; Essner, Jeffrey J.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Hatler, Julia M.; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Masonic Canc Ctr, Ctr Genome Engn, Minneapolis, MN USA; [Nannapaneni, Kishore; Scheetz, Todd E.] Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; [Nannapaneni, Kishore; Scheetz, Todd E.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Hostetter, Jesse M.] Iowa State Univ, Dept Vet Pathol, Ames, IA USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Iowa; University of Iowa; Iowa State University	McGrail, M (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	mmcgrail@iastate.edu	Largaespada, David/C-9832-2014; McGrail, Maura/AAA-5610-2021; Liao, Hsin-Kai/H-9608-2015	McGrail, Maura/0000-0001-9308-6189; Scheetz, Todd/0000-0002-1965-5811; Dupuy, Adam/0000-0002-8561-4911; Essner, Jeffrey/0000-0001-8816-3848; Hostetter, Jesse/0000-0002-5555-5121; Nannapaneni, Kishore/0000-0002-5559-9378	Roy J. Carver Charitable Trust [07-2991]; NIH-NCRR [P40 RR012546]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Roy J. Carver Charitable Trust Grant #07-2991, https://www.carvertrust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Jenny Groeltz of the Histopathology Laboratory (College of Veterinary Medicine, ISU) for histopathology slide preparations, and Ting Li and Justin Breitbach for technical assistance. Dr. Steve Ekker, Dr. Darius Balciunas and Dr. Chi-Bin Chien kindly provided constructs. Some strains of zebrafish used in this study were obtained from the Zebrafish International Resource Center, which is supported by grant P40 RR012546 from the NIH-NCRR.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Amatruda JF, 2008, INT REV CEL MOL BIO, V271, P1, DOI 10.1016/S1937-6448(08)01201-X; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carlson CM, 2003, GENETICS, V165, P243; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dupuy AJ, 2010, SEMIN CANCER BIOL, V20, P261, DOI 10.1016/j.semcancer.2010.05.003; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, PLOS GENET, V2, P1413, DOI 10.1371/journal.pgen.0020156; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Geurts AM, 2006, NUCLEIC ACIDS RES, V34, P2803, DOI 10.1093/nar/gkl301; Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; Hong WY, 2004, CANCER RES, V64, P7256, DOI 10.1158/0008-5472.CAN-04-0931; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kent ML, 2002, COMPARATIVE MED, V52, P354; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LIU ZJ, 1991, GENE, V108, P211, DOI 10.1016/0378-1119(91)90436-F; LIU ZJ, 1990, MOL CELL BIOL, V10, P3432, DOI 10.1128/MCB.10.7.3432; LIU ZJ, 1990, BIO-TECHNOL, V8, P1268, DOI 10.1038/nbt1290-1268; Matthews JL, 2004, METHOD CELL BIOL, V77, P617; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Preacher K.J., 2001, CALCULATION CHI SQUA; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smolowitz R, 2002, BIOL BULL, V203, P265, DOI 10.2307/1543433; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yergeau DA, 2009, DEV DYNAM, V238, P1727, DOI 10.1002/dvdy.21994	58	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18826	10.1371/journal.pone.0018826	http://dx.doi.org/10.1371/journal.pone.0018826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533036	Green Published, Green Submitted, gold			2022-12-27	WOS:000290014500012
J	Engrav, LH; Tuggle, CK; Kerr, KF; Zhu, KQ; Numhom, S; Couture, OP; Beyer, RP; Hocking, AM; Carrougher, GJ; Ramos, MLC; Klein, MB; Gibran, NS				Engrav, Loren H.; Tuggle, Christopher K.; Kerr, Kathleen F.; Zhu, Kathy Q.; Numhom, Surawej; Couture, Oliver P.; Beyer, Richard P.; Hocking, Anne M.; Carrougher, Gretchen J.; Ramos, Maria Luiza C.; Klein, Matthew B.; Gibran, Nicole S.			Functional Genomics Unique to Week 20 Post Wounding in the Deep Cone/Fat Dome of the Duroc/Yorkshire Porcine Model of Fibroproliferative Scarring	PLOS ONE			English	Article							RED DUROC PIG; HUMAN HYPERTROPHIC SCAR; SET ENRICHMENT ANALYSIS; GROWTH-FACTOR; PROLIFERATIVE SCAR; EXPRESSION PATTERNS; HEALING PHENOTYPE; MAST-CELL; BURN SCAR; SKIN	Background: Hypertrophic scar was first described over 100 years ago; PubMed has more than 1,000 references on the topic. Nevertheless prevention and treatment remains poor, because 1) there has been no validated animal model; 2) human scar tissue, which is impossible to obtain in a controlled manner, has been the only source for study; 3) tissues typically have been homogenized, mixing cell populations; and 4) gene-by-gene studies are incomplete. Methodology/Principal Findings: We have assembled a system that overcomes these barriers and permits the study of genome-wide gene expression in microanatomical locations, in shallow and deep partial-thickness wounds, and pigmented and non-pigmented skin, using the Duroc( pigmented fibroproliferative)/Yorkshire( non-pigmented non-fibroproliferative) porcine model. We used this system to obtain the differential transcriptome at 1, 2, 3, 12 and 20 weeks post wounding. It is not clear when fibroproliferation begins, but it is fully developed in humans and the Duroc breed at 20 weeks. Therefore we obtained the derivative functional genomics unique to 20 weeks post wounding. We also obtained long-term, forty-six week follow-up with the model. Conclusions/Significance: 1) The scars are still thick at forty-six weeks post wounding further validating the model. 2) The differential transcriptome provides new insights into the fibroproliferative process as several genes thought fundamental to fibroproliferation are absent and others differentially expressed are newly implicated. 3) The findings in the derivative functional genomics support old concepts, which further validates the model, and suggests new avenues for reductionist exploration. In the future, these findings will be searched for directed networks likely involved in cutaneous fibroproliferation. These clues may lead to a better understanding of the systems biology of cutaneous fibroproliferation, and ultimately prevention and treatment of hypertrophic scarring.	[Engrav, Loren H.; Zhu, Kathy Q.; Numhom, Surawej; Hocking, Anne M.; Carrougher, Gretchen J.; Ramos, Maria Luiza C.; Klein, Matthew B.] Univ Washington, Dept Surg, Div Plast Surg, Seattle, WA 98195 USA; [Tuggle, Christopher K.; Couture, Oliver P.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Kerr, Kathleen F.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Numhom, Surawej] Mahidol Univ, Ramathibodi Hosp, Dept Surg, Bangkok 10700, Thailand; [Beyer, Richard P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Ramos, Maria Luiza C.] Univ Fed Sao Paulo, Div Plast Surg, Dept Surg, Sao Paulo, Brazil	University of Washington; University of Washington Seattle; Iowa State University; University of Washington; University of Washington Seattle; Mahidol University; University of Washington; University of Washington Seattle; Universidade Federal de Sao Paulo (UNIFESP)	Engrav, LH (corresponding author), Univ Washington, Dept Surg, Div Plast Surg, Seattle, WA 98195 USA.	engrav@u.washington.edu	Kerr, Kathleen F./A-2893-2013	Kerr, Kathleen F./0000-0002-6438-9583; Hocking, Anne/0000-0003-2130-3732	The National Institute on Disability and Rehabilitation Research [H133G050022]; The National Institutes of Health [1R21GM074673, 5U54GM062119-09]; The Washington State Council of Fire Fighters Burn Foundation; The Northwest Burn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM074673, U54GM062119] Funding Source: NIH RePORTER	The National Institute on Disability and Rehabilitation Research; The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Washington State Council of Fire Fighters Burn Foundation; The Northwest Burn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	1) The National Institute on Disability and Rehabilitation Research, # H133G050022, http://www2.ed.gov/about/offices/list/osers/nidrr/index.html 2) The National Institutes of Health, # 1R21GM074673 and # 5U54GM062119-09, http://www.nih.gov/3) The Washington State Council of Fire Fighters Burn Foundation, and http://www.wscff.org/?zone=/unionactive/view_page.cfm&page = Burn20Foundation 4) The Northwest Burn Foundation. http://www.nwburn.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Aksoy HM, 2002, AESTHET PLAST SURG, V26, P388, DOI 10.1007/s00266-002-1121-z; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Bombaro KM, 2003, BURNS, V29, P299, DOI 10.1016/S0305-4179(03)00067-6; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Broerse JEW, 2010, BURNS, V36, P217, DOI 10.1016/j.burns.2009.04.004; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Couture O, 2009, MAMM GENOME, V20, P768, DOI 10.1007/s00335-009-9234-1; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; Cuttle L, 2006, BURNS, V32, P806, DOI 10.1016/j.burns.2006.02.023; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; de Hemptinne I, 2008, WOUND REPAIR REGEN, V16, P132, DOI 10.1111/j.1524-475X.2007.00340.x; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gallant CL, 2004, WOUND REPAIR REGEN, V12, P305, DOI 10.1111/j.1067-1927.2004.012311.x; GALLANT CL, 2001, RED DUROC PIG MODEL; GALLANT CL, 2002, SKIN WOUND HEALING R; GALLANT CL, 2002, FULL PARTIAL THICKNE; Gallant-Behm CL, 2006, BURNS, V32, P180, DOI 10.1016/j.burns.2005.10.012; Gallant-Behm CL, 2006, WOUND REPAIR REGEN, V14, P46, DOI 10.1111/j.1524-475X.2005.00087.x; Gallant-Behm CL, 2008, WOUND REPAIR REGEN, V16, P226, DOI 10.1111/j.1524-475X.2008.00363.x; Gallant-Behm CL, 2007, J INVEST DERMATOL, V127, P233, DOI 10.1038/sj.jid.5700482; Gallant-Behm CL, 2005, J CUTAN MED SURG, V9, P165, DOI 10.1007/s10227-005-0105-4; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GENTLEMAN RC, 2009, BIOCONDUCTOR FAQ; Ha XQ, 2003, CHINESE MED J-PEKING, V116, P1029; Harunari N, 2006, BURNS, V32, P669, DOI 10.1016/j.burns.2006.03.015; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; King CL, 2005, J MOL DIAGN, V7, P57, DOI 10.1016/S1525-1578(10)60009-8; KISCHER CW, 1982, SCAN ELECTRON MICROS, P1699; KISCHER CW, 1972, TEX REP BIOL MED, V30, P327; KISCHER CW, 1989, ANAT REC, V225, P189; KISCHER CW, 1989, J TRAUMA, V29, P672, DOI 10.1097/00005373-198905000-00023; Ladak A, 2009, CLIN PLAST SURG, V36, P661, DOI 10.1016/j.cps.2009.05.014; Liang Z, 2004, BURNS, V30, P57, DOI 10.1016/j.burns.2003.09.004; MAK K, 2009, J DERMATOL SCI; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MAST BA, 1992, WOUND HEALING BIOCH; Matsumura H, 2001, WOUND REPAIR REGEN, V9, P269, DOI 10.1046/j.1524-475X.2001.00269.x; MATSUMURA H, 1998, CONES FAT DOMES HYPE, P47; MCDONALD WS, 1987, J TRAUMA, V27, P147, DOI 10.1097/00005373-198702000-00008; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Polo M, 1998, J SURG RES, V74, P187, DOI 10.1006/jsre.1997.5251; Polo M, 1999, ANN PLAS SURG, V43, P185; Reiken SR, 1997, LASER SURG MED, V21, P7, DOI 10.1002/(SICI)1096-9101(1997)21:1<7::AID-LSM2>3.0.CO;2-U; Robb E C, 1987, J Burn Care Rehabil, V8, P371, DOI 10.1097/00004630-198709000-00006; Robson MC, 2001, CURR PROB SURG, V38, P65; Ryge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003415; Santucci M, 2001, VIRCHOWS ARCH, V438, P457, DOI 10.1007/s004280000335; SHETLAR MR, 1991, CONNECT TISSUE RES, V26, P23, DOI 10.3109/03008209109152161; SHETLAR MR, 1985, P SOC EXP BIOL MED, V179, P549; SHOEMAKER JV, 2005, PRACTICAL TREATISE D; Silverstein P, 1976, ULTRASTRUCTURE COLLA, P213, DOI DOI 10.4103/09700358.101319; Silverstein P., 1972, ANN RES PROG REP US, V37, P1; SPURR ED, 1990, BURNS, V16, P179, DOI 10.1016/0305-4179(90)90034-T; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; TREDGET EE, 1994, ANN PLAS SURG, V33, P152; Wang X, 1999, J SURG RES, V87, P194, DOI 10.1006/jsre.1999.5757; WARREN JC, 1893, T AM S A, V11, P41; Wassermann RJ, 1998, J SURG RES, V75, P74, DOI 10.1006/jsre.1998.5267; Wolfort SF, 1996, J SURG RES, V62, P17, DOI 10.1006/jsre.1996.0166; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xie YF, 2007, J BURN CARE RES, V28, P500, DOI 10.1097/BCR.0B013E318053DAFE; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhu KQ, 2008, J BURN CARE RES, V29, P815, DOI 10.1097/BCR.0b013e3181848141; Zhu KQ, 2007, WOUND REPAIR REGEN, V15, pS32, DOI 10.1111/j.1524-475X.2007.00223.x; Zhu KQ, 2005, BURNS, V31, P5, DOI 10.1016/j.burns.2004.08.010; Zhu KQ, 2004, BURNS, V30, P518, DOI 10.1016/j.burns.2004.02.005; Zhu KQ, 2003, BURNS, V29, P649, DOI 10.1016/S0305-4179(03)00205-5; [No title captured]	78	20	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19024	10.1371/journal.pone.0019024	http://dx.doi.org/10.1371/journal.pone.0019024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533106	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400051
J	Sun, CK; Ng, KT; Lim, ZX; Cheng, Q; Lo, CM; Poon, RT; Man, K; Wong, N; Fan, ST				Sun, Chris K.; Ng, Kevin T.; Lim, Zophia X.; Cheng, Qiao; Lo, Chung Mau; Poon, Ronnie T.; Man, Kwan; Wong, Nathalie; Fan, Sheung Tat			Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							CADHERIN EXPRESSION; TUMOR PROGRESSION; SIGNAL TRANSDUCERS; CANCER; HIC-5; TRANSFORMATION; METASTASIS; INVASIVENESS; PROTEIN; TRANSCRIPTION	Aims: Proline-rich tyrosine kinase 2 (Pyk2), a non-receptor tyrosine kinase of the focal adhesion kinase (FAK) family, is up-regulated in more than 60% of the tumors of hepatocellular carcinoma (HCC) patients. Forced overexpression of Pyk2 can promote the proliferation and invasion of HCC cells. In this study, we aimed to explore the underlying molecular mechanism of Pyk2-mediated cell migration of HCC cells. Methodology/Principal Findings: We demonstrated that Pyk2 transformed the epithelial HCC cell line Hep3B into a mesenchymal phenotype via the induction of epithelial to mesenchymal transition (EMT), signified by the up-regulation of membrane ruffle formation, activation of Rac/Rho GTPases, down-regulation of epithelial genes E-cadherin and cytokeratin as well as promotion of cell motility in presence of lysophosphatidic acid (LPA). Suppression of Pyk2 by overexpression of dominant negative PRNK domain in the metastatic HCC cell line MHCC97L transformed its fibroblastoid phenotype to an epithelial phenotype with up-regulation of epithelial genes, down-regulation of mesenchymal genes N-cadherin and STAT5b, and reduction of LPA-induced membrane ruffle formation and cell motility. Moreover, overexpression of Pyk2 in Hep3B cells promoted the phosphorylation and localization of mesenchymal gene Hic-5 onto cell membrane while suppression of Pyk2 in MHCC97L cells attenuated its phosphorylation and localization. Conclusion: These data provided new evidence of the underlying mechanism of Pyk2 in controlling cell motility of HCC cells through regulation of genes associated with EMT.	[Sun, Chris K.; Ng, Kevin T.; Lim, Zophia X.; Cheng, Qiao; Lo, Chung Mau; Poon, Ronnie T.; Man, Kwan; Fan, Sheung Tat] Univ Hong Kong, Dept Surg, Ctr Canc Res, LKS Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wong, Nathalie] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Sun, CK (corresponding author), Univ Hong Kong, Dept Surg, Ctr Canc Res, LKS Fac Med, Pokfulam, Hong Kong, Peoples R China.	kwanman@hku.hk	NG, Kevin Tak-Pan/J-1510-2018	NG, Kevin Tak-Pan/0000-0001-9822-1335	Research Grant Council Hong Kong [7574/06M, HKU5/CRF/08]	Research Grant Council Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (7574/06M) and Collaborative Research Fund (HKU5/CRF/08) of the Research Grant Council Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiostratidou G, 2007, J MAMMARY GLAND BIOL, V12, P127, DOI 10.1007/s10911-007-9044-6; Avraamides C, 2007, AM J PHYSIOL-HEART C, V293, pH193, DOI 10.1152/ajpheart.00728.2006; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Boivin D, 1996, CAN J PHYSIOL PHARM, V74, P801, DOI 10.1139/cjpp-74-7-801; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; DEAKIN NO, 2010, MOL BIOL CELL; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hay ED, 1995, ACTA ANAT, V154, P8; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ishino M, 2000, FEBS LETT, V474, P179, DOI 10.1016/S0014-5793(00)01597-0; KAWANO Y, 2008, EUR J SURG ONCOL; Klampfer L, 2008, FRONT BIOSCI-LANDMRK, V13, P2888, DOI 10.2741/2893; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Liotta L A, 1985, Important Adv Oncol, P28; Mathurin P, 1998, ALIMENT PHARM THERAP, V12, P111; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nishiya N, 1998, NUCLEIC ACIDS RES, V26, P4267, DOI 10.1093/nar/26.18.4267; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Stracke M L, 1992, In Vivo, V6, P309; Sun CK, 2007, BRIT J CANCER, V97, P50, DOI 10.1038/sj.bjc.6603827; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M	37	29	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18878	10.1371/journal.pone.0018878	http://dx.doi.org/10.1371/journal.pone.0018878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533080	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400033
J	Sawyer, EB; Claessen, D; Haas, M; Hurgobin, B; Gras, SL				Sawyer, Elizabeth B.; Claessen, Dennis; Haas, Maria; Hurgobin, Bhavna; Gras, Sally L.			The Assembly of Individual Chaplin Peptides from Streptomyces coelicolor into Functional Amyloid Fibrils	PLOS ONE			English	Article							CELL-SURFACE PROTEINS; AERIAL HYPHAE; AGGREGATION; PREDICTION; DISEASE; SERVER; ICE	The self-association of proteins into amyloid fibrils offers an alternative to the natively folded state of many polypeptides. Although commonly associated with disease, amyloid fibrils represent the natural functional state of some proteins, such as the chaplins from the soil-dwelling bacterium Streptomyces coelicolor, which coat the aerial mycelium and spores rendering them hydrophobic. We have undertaken a biophysical characterisation of the five short chaplin peptides ChpD-H to probe the mechanism by which these peptides self-assemble in solution to form fibrils. Each of the five chaplin peptides produced synthetically or isolated from the cell wall is individually surface-active and capable of forming fibrils under a range of solution conditions in vitro. These fibrils contain a highly similar cross-beta core structure and a secondary structure that resembles fibrils formed in vivo on the spore and mycelium surface. They can also restore the growth of aerial hyphae to a chaplin mutant strain. We show that cysteine residues are not required for fibril formation in vitro and propose a role for the cysteine residues conserved in four of the five short chaplin peptides.	[Sawyer, Elizabeth B.; Haas, Maria; Hurgobin, Bhavna; Gras, Sally L.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia; [Sawyer, Elizabeth B.; Haas, Maria; Hurgobin, Bhavna; Gras, Sally L.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Claessen, Dennis] Leiden Univ, Inst Biol, Dept Mol & Dev Genet, Leiden, Netherlands	University of Melbourne; University of Melbourne; Leiden University; Leiden University - Excl LUMC	Sawyer, EB (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia.	sgras@unimelb.edu.au	Sawyer, Elizabeth/J-6962-2012; Hurgobin, Bhavna/AAZ-3428-2020; Gras, Sally L/G-2025-2014; Claessen, Dennis/J-1903-2014	Hurgobin, Bhavna/0000-0001-9603-2493; Gras, Sally L/0000-0002-4660-1245; Claessen, Dennis/0000-0002-0789-2633; Sawyer, Elizabeth/0000-0003-0389-2692	Endeavour Research Award (Austraining International); Marie Curie Reintegration Grant [FP7-PEOPLE-ERG-230944]	Endeavour Research Award (Austraining International); Marie Curie Reintegration Grant(European Commission)	EBS was supported by an Endeavour Research Award (Austraining International). DC was supported by a Marie Curie Reintegration Grant (FP7-PEOPLE-ERG-230944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Baumketner A, 2005, BIOPHYS J, V89, P1493, DOI 10.1529/biophysj.105.059196; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crilly JF, 2008, IND ENG CHEM RES, V47, P6362, DOI 10.1021/ie701773z; de Jong W, 2009, MOL MICROBIOL, V73, P1128, DOI 10.1111/j.1365-2958.2009.06838.x; Di Berardo C, 2008, J BACTERIOL, V190, P5879, DOI 10.1128/JB.00685-08; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Elliot MA, 2004, CURR OPIN MICROBIOL, V7, P594, DOI 10.1016/j.mib.2004.10.013; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028; Gras SL, 2007, AUST J CHEM, V60, P333, DOI 10.1071/CH06485; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; KEISER T, 2000, GEN INTRO ACTINOMYCE, P1; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Squires AM, 2006, J AM CHEM SOC, V128, P11738, DOI 10.1021/ja063751v; Stefani M, 2010, CURR PROTEIN PEPT SC, V11, P343, DOI 10.2174/138920310791330631; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; WESSELS JGH, 1991, PLANT CELL, V3, P793; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	36	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18839	10.1371/journal.pone.0018839	http://dx.doi.org/10.1371/journal.pone.0018839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526199	gold, Green Published, Green Accepted			2022-12-27	WOS:000289671100027
J	Ramgolam, K; Lauriol, J; Lalou, C; Lauden, L; Michel, L; de la Grange, P; Khatib, AM; Aoudjit, F; Charron, D; Alcaide-Loridan, C; Al-Daccak, R				Ramgolam, Kiran; Lauriol, Jessica; Lalou, Claude; Lauden, Laura; Michel, Laurence; de la Grange, Pierre; Khatib, Abdel-Majid; Aoudjit, Fawzi; Charron, Dominique; Alcaide-Loridan, Catherine; Al-Daccak, Reem			Melanoma Spheroids Grown Under Neural Crest Cell Conditions Are Highly Plastic Migratory/Invasive Tumor Cells Endowed with Immunomodulator Function	PLOS ONE			English	Article							CANCER STEM-CELLS; MHC CLASS-II; IN-VITRO; INITIATING CELLS; B-16 MELANOMA; EXPRESSION; METASTASIS; ACTIVATION; PHENOTYPE; LIGAND	Background: The aggressiveness of melanoma tumors is likely to rely on their well-recognized heterogeneity and plasticity. Melanoma comprises multi-subpopulations of cancer cells some of which may possess stem cell-like properties. Although useful, the sphere-formation assay to identify stem cell-like or tumor initiating cell subpopulations in melanoma has been challenged, and it is unclear if this model can predict a functional phenotype associated with aggressive tumor cells. Methodology/Principal Findings: We analyzed the molecular and functional phenotypes of melanoma spheroids formed in neural crest cell medium. Whether from metastatic or advanced primary tumors, spheroid cells expressed melanoma-associated markers. They displayed higher capacity to differentiate along mesenchymal lineages and enhanced expression of SOX2, NANOG, KLF4, and/or OCT4 transcription factors, but not enhanced self-renewal or tumorigenicity when compared to their adherent counterparts. Gene expression profiling attributed a neural crest cell signature to these spheroids and indicated that a migratory/invasive and immune-function modulating program could be associated with these cells. In vitro assays confirmed that spheroids display enhanced migratory/invasive capacities. In immune activation assays, spheroid cells elicited a poorer allogenic response from immune cells and inhibited mitogen-dependent T cells activation and proliferation more efficiently than their adherent counterparts. Our findings reveal a novel immune-modulator function of melanoma spheroids and suggest specific roles for spheroids in invasion and in evasion of antitumor immunity. Conclusion/Significance: The association of a more plastic, invasive and evasive, thus a more aggressive tumor phenotype with melanoma spheroids reveals a previously unrecognized aspect of tumor cells expanded as spheroid cultures. While of limited efficiency for melanoma initiating cell identification, our melanoma spheroid model predicted aggressive phenotype and suggested that aggressiveness and heterogeneity of melanoma tumors can be supported by subpopulations other than cancer stem cells. Therefore, it could be constructive to investigate melanoma aggressiveness, relevant to patients and clinical transferability.	[Ramgolam, Kiran; Lalou, Claude; Lauden, Laura; Khatib, Abdel-Majid; Charron, Dominique; Al-Daccak, Reem] Univ Paris 07, INSERM, Hop St Louis, Inst Univ Hematol,UMRS 940, Paris, France; [Lauriol, Jessica; Alcaide-Loridan, Catherine] Univ Paris 07, Inst Jacques Monod, UMRS 7592, CNRS, F-75251 Paris, France; [Michel, Laurence] Univ Paris 07, INSERM, Hop St Louis, UMRS976, Paris, France; [Aoudjit, Fawzi] Univ Laval, CRCHUQ, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Charron, Dominique] Hop St Louis, AP HP, CIB HOG, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Ramgolam, K (corresponding author), Univ Paris 07, INSERM, Hop St Louis, Inst Univ Hematol,UMRS 940, Paris, France.	reem.al-daccak@inserm.fr	Al-Daccak, Reem/L-8804-2018; KHATIB, Abdel-Majid/A-9948-2015; Michel, Laurence/E-8605-2017	KHATIB, Abdel-Majid/0000-0001-6957-0384; de la Grange, Pierre/0000-0001-6361-1878; Al-Daccak, Reem/0000-0002-6146-2845; LALOU, Claude/0000-0002-5271-7439	Association de la Recherche sur le Cancer; Institut National du Cancer (Reseau des cellules souches) - France; La Ligue contre le Cancer, France; Conseil Regional d'Ile-de-France; Ministere de la Recherche	Association de la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (Reseau des cellules souches) - France(Institut National du Cancer (INCA) France); La Ligue contre le Cancer, France; Conseil Regional d'Ile-de-France(Region Ile-de-France); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by grants to R. D. from Association de la Recherche sur le Cancer and Institut National du Cancer (Reseau des cellules souches) - France. K. R. is supported by a postdoctoral fellowship from La Ligue contre le Cancer, France. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Didier Auboeuf for microarray platform, Dr. Ryad Tamouza and Wahid Boukouaci (UMRS 940) for effective discussions, and Carine Deruyfellaere and Stephanie Ghislin (Institut Jacques Monod) for technical support. Particular thanks for Dr M. Pla (UMRS 940 and Departement d'experimentation animale, Hopital Saint-Louis) and Martine Chopin (Departement d'experimentation animale, Hopital Saint-Louis) for their help in conducting animal studies. We also thank the Imagery Department of the Institut Universitaire d'Hematologie. The imagery department is supported by grants from the Conseil Regional d'Ile-de-France and the Ministere de la Recherche.	Aoudjit F, 2004, EXP CELL RES, V299, P79, DOI 10.1016/j.yexcr.2004.05.011; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Banerjee SS, 2000, HISTOPATHOLOGY, V36, P387; Byrne SN, 2003, CANCER IMMUNOL IMMUN, V52, P396, DOI 10.1007/s00262-003-0380-0; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Coucke Paul H. A., 1994, In Vivo (Attiki), V8, P333; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hofmann UB, 2000, INT J CANCER, V87, P12, DOI 10.1002/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; JIANG X, 2008, STEM CELLS DEV; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; LEVENE A, 1980, J CLIN PATHOL, V33, P101, DOI 10.1136/jcp.33.2.101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Martins I, 2007, EUR J IMMUNOL, V37, P788, DOI 10.1002/eji.200636620; Martins I, 2009, MELANOMA RES, V19, P226, DOI 10.1097/CMR.0b013e32832e0bc3; Matsumoto Y, 2009, BURNS, V35, P383, DOI 10.1016/j.burns.2008.06.017; McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439; Mills L, 2002, CANCER RES, V62, P5106; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Ostmeier H, 2001, BRIT J DERMATOL, V145, P203, DOI 10.1046/j.1365-2133.2001.04335.x; Palacios R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001222; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; RAZ A, 1983, SCIENCE, V221, P1307, DOI 10.1126/science.6612347; REFAELI Y, 2009, EMBO REP; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2010, J INVEST DERMATOL, V130, P1769, DOI 10.1038/jid.2010.135; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; STACKPOLE CW, 1985, INT J CANCER, V35, P667, DOI 10.1002/ijc.2910350516; Strizzi L, 2008, CELL CYCLE, V7, P1931, DOI 10.4161/cc.7.13.6236; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; WIDERA D, 2009, STEM CELLS; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yu SC, 2009, STEM CELL REV REP, V5, P66, DOI 10.1007/s12015-008-9047-8	71	72	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18784	10.1371/journal.pone.0018784	http://dx.doi.org/10.1371/journal.pone.0018784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526207	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600033
J	Altrichter, S; Peter, HJ; Pisarevskaja, D; Metz, M; Martus, P; Maurer, M				Altrichter, Sabine; Peter, Hans-Juergen; Pisarevskaja, Dina; Metz, Martin; Martus, Peter; Maurer, Marcus			IgE Mediated Autoallergy against Thyroid Peroxidase - A Novel Pathomechanism of Chronic Spontaneous Urticaria?	PLOS ONE			English	Article							SERUM SKIN-TEST; FC-EPSILON-RI; ANTI-IGE; AUTOANTIBODIES; IDENTIFICATION; CLASSIFICATION; AUTOANTIGENS; ASSOCIATION; ALLERGEN	Background: Chronic spontaneous urticaria (csU), which is characterized by recurrent episodes of mast cell-driven wheal and flare-type skin reactions, is often associated with elevated total IgE levels and thyroid autoimmunity. We speculate that some csU patients express IgE autoantibodies against thyroid antigens such as thyroid peroxidase (TPO), which could bind to skin mast cells and induce their activation. Methods: We developed and used a site-directed human IgE capture ELISA to quantify IgE-anti-TPO. We used this assay and investigated csU patients (n = 478) and healthy control subjects (n = 127) for IgE-anti-TPO and then assessed IgE-anti-TPO-positive and -negative csU patients for clinical and serological differences. Principal Findings: CsU patients were found to express more than 2fold higher IgE-anti-TPO serum levels as compared to healthy control subjects (p < 0.001). 54% of csU patients had serum levels higher than the cut off (= 5 IU/ml). By distribution analyses we identified two distinct subpopulations of csU patients: 1) IgE-anti-TPOlow (= 39%, IgE-anti-TPO: median 2.17 interquartile range 0.86-5.44, = comparable to healthy controls) and 2) IgE-anti-TPOhigh (= 61%, IgE-anti-TPO: median 6.67, interquartile range 5.39-8.24). IgE-anti-TPO-positive and -negative csU patients had very similar distributions of age and gender as well as disease activity and duration. IgE-anti-TPO-positive csU patients exhibited significantly higher IgG-anti-TPO levels and lymphocyte counts as well as decreased C4 complement levels. Conclusion: Our findings show that a sizeable subgroup of csU patients expresses IgE antibodies against thyroid peroxidase. These autoantibodies could cause "autoallergic" mast cell activation, a novel pathomechanism of chronic spontaneous urticaria.	[Altrichter, Sabine; Peter, Hans-Juergen; Pisarevskaja, Dina; Metz, Martin; Maurer, Marcus] Charite, ECARF, Allergie Ctr Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Martus, Peter] Charite, Dept Biometry & Clin Epidemiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Altrichter, S (corresponding author), Charite, ECARF, Allergie Ctr Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany.	marcus.maurer@charite.de	Metz, Martin/M-5237-2013; Metz, Martin/B-8799-2009; Maurer, Marcus/ABG-2174-2020	Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Altrichter, Sabine/0000-0001-9955-385X	Innovationsstiftung Rheinland-Pfalz; European Centre of Allergy Research Foundation (ECARF)	Innovationsstiftung Rheinland-Pfalz; European Centre of Allergy Research Foundation (ECARF)	This work was funded in part by grants from Innovationsstiftung Rheinland-Pfalz and the European Centre of Allergy Research Foundation (ECARF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller U, 1999, INT ARCH ALLERGY IMM, V118, P193, DOI 10.1159/000024064; Bar-Sela S, 1999, J ALLERGY CLIN IMMUN, V103, P1216, DOI 10.1016/S0091-6749(99)70204-6; Bohning D, 1998, BIOMETRICS, V54, P525, DOI 10.2307/3109760; Bunder R, 2004, J ALLERGY CLIN IMMUN, V114, P422, DOI 10.1016/j.jaci.2004.05.029; Dimson OG, 2003, J INVEST DERMATOL, V120, P784, DOI 10.1046/j.1523-1747.2003.12146.x; Dopp R, 2000, J AM ACAD DERMATOL, V42, P577, DOI 10.1067/mjd.2000.103986; Fairley JA, 2005, J INVEST DERMATOL, V125, P467, DOI 10.1111/j.0022-202X.2005.23853.x; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; Gangemi S, 2009, J ENDOCRINOL INVEST, V32, P107, DOI 10.1007/BF03345696; Grattan CEH, 2004, IMMUNOL ALLERGY CLIN, V24, P163, DOI 10.1016/j.iac.2004.01.003; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; Greaves MW, 2003, CURR OPIN ALLERGY CL, V3, P363, DOI 10.1097/01.all.0000092607.76804.f1; Haapala AM, 1997, SCAND J IMMUNOL, V46, P78, DOI 10.1046/j.1365-3083.1997.d01-90.x; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Levy Y, 2003, ARCH DIS CHILD, V88, P517, DOI 10.1136/adc.88.6.517; LEZNOFF A, 1983, ARCH DERMATOL, V119, P636, DOI 10.1001/archderm.119.8.636; Mlynek A, 2008, CURR OPIN ALLERGY CL, V8, P433, DOI 10.1097/ACI.0b013e32830f9119; Natter S, 1998, FASEB J, V12, P1559, DOI 10.1096/fasebj.12.14.1559; PALMACARLOS AG, 2005, ALLERG IMMUNOL PARIS, V37, P143; Sabroe RA, 2002, J ALLERGY CLIN IMMUN, V110, P492, DOI 10.1067/mai.2002.126782; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Staubach P, 2006, DERMATOLOGY, V212, P150, DOI 10.1159/000090656; Staubach P, 2009, MYCOSES, V52, P334, DOI 10.1111/j.1439-0507.2008.01601.x; Tedeschi A, 2001, J ALLERGY CLIN IMMUN, V108, P467; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Valenta R, 1998, J INVEST DERMATOL, V111, P1178, DOI 10.1046/j.1523-1747.1998.00413.x; Zauli D, 2001, ALLERGY ASTHMA PROC, V22, P93, DOI 10.2500/108854101778250625; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	28	184	197	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e14794	10.1371/journal.pone.0014794	http://dx.doi.org/10.1371/journal.pone.0014794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532759	gold, Green Published, Green Submitted			2022-12-27	WOS:000289404700001
J	Agnandji, ST; Fendel, R; Mestre, M; Janssens, M; Vekemans, J; Held, J; Gnansounou, F; Haertle, S; von Glasenapp, I; Oyakhirome, S; Mewono, L; Moris, P; Lievens, M; Demoitie, MA; Dubois, PM; Villafana, T; Jongert, E; Olivier, A; Cohen, J; Esen, M; Kremsner, PG; Lell, B; Mordmuller, B				Agnandji, Selidji T.; Fendel, Rolf; Mestre, Michael; Janssens, Michel; Vekemans, Johan; Held, Jana; Gnansounou, Ferdinand; Haertle, Sonja; von Glasenapp, Isabel; Oyakhirome, Sunny; Mewono, Ludovic; Moris, Philippe; Lievens, Marc; Demoitie, Marie-Ange; Dubois, Patrice M.; Villafana, Tonya; Jongert, Erik; Olivier, Aurelie; Cohen, Joe; Esen, Meral; Kremsner, Peter G.; Lell, Bertrand; Mordmueller, Benjamin			Induction of Plasmodium falciparum-Specific CD4(+) T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)	PLOS ONE			English	Article							ACELLULAR PERTUSSIS-VACCINE; CANDIDATE MALARIA VACCINE; IMMUNE ADULT MEN; CIRCUMSPOROZOITE-PROTEIN; SURFACE-ANTIGEN; PLASMA-CELLS; GAMMA-INTERFERON; HUMAN INFANTS; IMMUNOGENICITY; EFFICACY	The recombinant circumsporozoite protein (CS) based vaccine, RTS,S, confers protection against Plasmodium falciparum infection in controlled challenge trials and in field studies. The RTS, S recombinant antigen has been formulated with two adjuvant systems, AS01 and AS02, which have both been shown to induce strong specific antibody responses and CD4 T cell responses in adults. As infants and young children are particularly susceptible to malaria infection and constitute the main target population for a malaria vaccine, we have evaluated the induction of adaptive immune responses in young children living in malaria endemic regions following vaccination with RTS,S/AS01(E) and RTS,S/AS02(D). Our data show that a CS-specific memory B cell response is induced one month after the second and third vaccine dose and that CS-specific antibodies and memory B cells persist up to 12 months after the last vaccine injection. Both formulations also induced low but significant amounts of CS-specific IL-2(+) CD4(+) T cells one month after the second and third vaccine dose, upon short-term in vitro stimulation of whole blood cells with peptides covering the entire CS derived sequence in RTS, S. These results provide evidence that both RTS,S/AS01(E) and RTS,S/AS02(D) induced adaptive immune responses including antibodies, circulating memory B cells and CD4(+) T cells directed against P. falciparum CS protein.	[Agnandji, Selidji T.; Fendel, Rolf; Held, Jana; Gnansounou, Ferdinand; Haertle, Sonja; von Glasenapp, Isabel; Oyakhirome, Sunny; Mewono, Ludovic; Esen, Meral; Kremsner, Peter G.; Lell, Bertrand; Mordmueller, Benjamin] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Agnandji, Selidji T.; Fendel, Rolf; Held, Jana; Gnansounou, Ferdinand; Haertle, Sonja; von Glasenapp, Isabel; Oyakhirome, Sunny; Mewono, Ludovic; Esen, Meral; Kremsner, Peter G.; Lell, Bertrand; Mordmueller, Benjamin] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Mestre, Michael; Janssens, Michel; Vekemans, Johan; Moris, Philippe; Lievens, Marc; Demoitie, Marie-Ange; Jongert, Erik; Olivier, Aurelie] GlaxoSmithKline Biol, Wavre, Belgium; [Dubois, Patrice M.] ImmunoVacc Consulting, Brussels, Belgium; [Villafana, Tonya] PATH Malaria Vaccine Initiat, Bethesda, MD USA	Eberhard Karls University of Tubingen; GlaxoSmithKline	Agnandji, ST (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	agnandjis@yahoo.fr	Mordmüller, Benjamin/A-5749-2010; Fendel, Rolf/K-3985-2013; Held, Jana/L-7827-2013; Held, Jana/AAO-5823-2021	Mordmüller, Benjamin/0000-0001-9101-2768; Fendel, Rolf/0000-0003-4716-0311; Held, Jana/0000-0002-7970-1429; Held, Jana/0000-0002-7970-1429	PATH - Malaria Vaccine Initiative; GSK Biologicals	PATH - Malaria Vaccine Initiative; GSK Biologicals(GlaxoSmithKline)	This study was supported by a grant from the PATH - Malaria Vaccine Initiative (http://www.malariavaccine.org/). GSK Biologicals sponsored the study and GSK-employed authors played a role in the study design, data analysis, and preparation of the manuscript. PD is an employee of ImmunoVacc Consulting, and was involved in study design, data analysis and manuscript preparation.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2006, INFECT IMMUN, V74, P6331, DOI 10.1128/IAI.00774-06; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang K, 2009, HUM VACCINES, V5, P242, DOI 10.4161/hv.5.4.7050; Cambron P, 2009, CLIN VACCINE IMMUNOL, V16, P1236, DOI 10.1128/CVI.00431-08; DELGIUDICE G, 1990, IMMUNOL LETT, V25, P59, DOI 10.1016/0165-2478(90)90092-5; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, pE35, DOI 10.1097/INF.0b013e3181daf921; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; GRAY D, 1994, J EXP MED, V180, P141, DOI 10.1084/jem.180.1.141; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Litjens NHR, 2008, J IMMUNOL, V181, P3665, DOI 10.4049/jimmunol.181.5.3665; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Minigo G, 2007, TRENDS PARASITOL, V23, P341, DOI 10.1016/j.pt.2007.06.006; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RENIA L, 1993, J IMMUNOL, V150, P1471; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Rowe J, 2000, INFECT IMMUN, V68, P3873, DOI 10.1128/IAI.68.7.3873-3877.2000; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Slifka MK, 1996, ANN NY ACAD SCI, V797, P166, DOI 10.1111/j.1749-6632.1996.tb52958.x; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; TSUJI M, 1990, J EXP MED, V172, P1353, DOI 10.1084/jem.172.5.1353; Upham JW, 2006, INFECT IMMUN, V74, P1106, DOI 10.1128/IAI.74.2.1106-1112.2006; WEISS WR, 1993, J IMMUNOL, V151, P2690; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	50	36	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18559	10.1371/journal.pone.0018559	http://dx.doi.org/10.1371/journal.pone.0018559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494604	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100022
J	Boelte, KC; Gordy, LE; Joyce, S; Thompson, MA; Yang, L; Lin, PC				Boelte, Kimberly C.; Gordy, Laura E.; Joyce, Sebastian; Thompson, Mary Ann; Yang, Li; Lin, P. Charles			Rgs2 Mediates Pro-Angiogenic Function of Myeloid Derived Suppressor Cells in the Tumor Microenvironment via Upregulation of MCP-1	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESSENGER-RNA; EXPRESSION; FAMILY; GENE; LOCALIZATION; LYMPHOCYTES; CHEMOTAXIS; ACTIVATION; CHEMOKINES	Background: Tumor growth is intimately linked with stromal interactions. Myeloid derived suppressor cells (MDSCs) are dramatically elevated in cancer patients and tumor bearing mice. MDSCs modulate the tumor microenvironment through attenuating host immune response and increasing vascularization. Methodology/Principal Findings: In searching for molecular mediators responsible for pro-tumor functions, we found that regulator of G protein signaling-2 (Rgs2) is highly increased in tumor-derived MDSCs compared to control MDSCs. We further demonstrate that hypoxia, a common feature associated with solid tumors, upregulates the gene expression. Genetic deletion of Rgs2 in mice resulted in a significant retardation of tumor growth, and the tumors exhibit decreased vascular density and increased cell death. Interestingly, deletion of Rgs2 in MDSCs completely abolished their tumor promoting function, suggesting that Rgs2 signaling in MDSCs is responsible for the tumor promoting function. Cytokine array profiling identified that Rgs2-/- tumor MDSCs produce less MCP-1, leading to decreased angiogenesis, which could be restored with addition of recombinant MCP-1. Conclusion: Our data reveal Rgs2 as a critical regulator of the pro-angiogenic function of MDSCs in the tumor microenvironment, through regulating MCP-1 production.	[Boelte, Kimberly C.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Gordy, Laura E.; Joyce, Sebastian] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN USA; [Thompson, Mary Ann] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Yang, Li; Lin, P. Charles] NIH, Ctr Canc Res, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Boelte, KC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA.	p.lin@nih.gov		JOYCE, Sebastian/0000-0002-3183-1451	National Institutes of Health [CA108856, NS45888, AR053718, HL054977, AI061721, AI042284, T32CA009582, T32HL069765, T32AI007611]; NATIONAL CANCER INSTITUTE [ZIABC011390, R01CA108856, T32CA009582] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054977, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042284, T32AI007611, R01AI061721, R21AI042284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from National Institutes of Health to PCL (CA108856, NS45888 and AR053718) and SJ (HL054977, AI061721 and AI042284) as well as training grants to KCB (T32CA009582) and LEG (T32HL069765 and T32AI007611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; ROLLINS BJ, 1991, BLOOD, V78, P1112; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Schwable J, 2005, BLOOD, V105, P2107, DOI 10.1182/blood-2004-03-0940; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Song L, 2001, BIOCHEM BIOPH RES CO, V283, P102, DOI 10.1006/bbrc.2001.4742; Song L, 2006, NEUROSCI LETT, V402, P205, DOI 10.1016/j.neulet.2006.03.023; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zmijewski JW, 2001, ARCH BIOCHEM BIOPHYS, V392, P192, DOI 10.1006/abbi.2001.2430	33	51	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18534	10.1371/journal.pone.0018534	http://dx.doi.org/10.1371/journal.pone.0018534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494556	gold, Green Submitted, Green Published			2022-12-27	WOS:000289354100019
J	Liu, ZH; Naranjo, A; Thiele, CJ				Liu, Zhihui; Naranjo, Arlene; Thiele, Carol J.			CASZ1b, the Short Isoform of CASZ1 Gene, Coexpresses with CASZ1a during Neurogenesis and Suppresses Neuroblastoma Cell Growth	PLOS ONE			English	Article							CASTOR; EXPRESSION; IDENTITY	In Drosophila, the CASZ1 (castor) gene encodes a zinc finger transcription factor and is a neural fate-determination gene. In mammals, the CASZ1 gene encodes two major isoforms, CASZ1a with 11 zinc fingers and CASZ1b with 5 zinc fingers. CASZ1b is more evolutionally conserved since it is the only homologue found in drosophila and Xenopus. Our previous study showed that full length CASZ1 (CASZ1a) functions to suppress growth in neuroblastoma tumor. However, the function of CASZ1b isoform in mammals is unknown. In this study, realtime PCR analyses indicate that mouse CASZ1b (mCASZ1b) is dynamically expressed during neurogenesis. CASZ1b and CASZ1a co-exist in all the neuronal tissues but exhibit distinct expression patterns spatially and temporally during brain development. CASZ1b and CASZ1a expression is coordinately upregulated by the differentiation agent Retinoic Acid, as well as agents that modify the epigenome in neural crest derived neuroblastoma cell lines. In contrast CASZ1b is down regulated while CASZ1a is upregulated by agents that raise intracellular cAMP levels. CASZ1b and CASZ1a have no synergistic or antagonistic activities on the regulation of their target NGFR gene transcription. Specific restoration of CASZ1b in NB cells suppresses tumor growth in vitro and in vivo. Consistent with its function role, we find that low CASZ1b expression is significantly associated with decreased survival probability of neuroblastoma patients (p<0.02). This study indicates that although their mechanisms of regulation may be distinct, both CASZ1b and CASZ1a have largely redundant but critical roles in suppressing tumor cell growth.	[Liu, Zhihui; Thiele, Carol J.] NCI, Ctr Canc Res, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Naranjo, Arlene] Univ Florida, Childrens Oncol Grp Stat, Gainesville, FL USA; [Naranjo, Arlene] Univ Florida, Ctr Data, Gainesville, FL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's Oncology Group (COG); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liu, ZH (corresponding author), NCI, Ctr Canc Res, Pediat Oncol Branch, Bethesda, MD 20892 USA.	ct47a@nih.gov			National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010788] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Cancer Institute intramural program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Christinel KS, 2008, DEV CELL, V14, P616, DOI 10.1016/j.devcel.2008.01.009; COX DR, 1972, J R STAT SOC B, V34, P187; CUI X, 1992, DEVELOPMENT, V116, P943; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kusy S, 2003, MOL CELL NEUROSCI, V24, P409, DOI 10.1016/S1044-7431(03)00197-0; Lin YC, 2007, ONCOGENE, V26, P7017, DOI 10.1038/sj.onc.1210507; LIU Z, 2011, CELL DEATH DIFFER; Liu ZH, 2006, BIOCHEM BIOPH RES CO, V344, P834, DOI 10.1016/j.bbrc.2006.03.207; Lovat PE, 2002, CANCER RES, V62, P5158; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Vacalla CMH, 2002, MECH DEVELOP, V118, P265, DOI 10.1016/S0925-4773(02)00282-4; von Hilchen CM, 2008, MECH DEVELOP, V125, P337, DOI 10.1016/j.mod.2007.10.010; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Warner LR, 2009, BRAIN RES, V1288, P1, DOI 10.1016/j.brainres.2009.06.086; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18557	10.1371/journal.pone.0018557	http://dx.doi.org/10.1371/journal.pone.0018557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490919	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700023
J	Wu, LX; Shao, LJ; An, NF; Wang, JR; Pazhanisamy, S; Feng, W; Hauer-Jensen, M; Miyamoto, S; Zhou, DH				Wu, Lixian; Shao, Lijian; An, Ningfei; Wang, Junru; Pazhanisamy, Senthil; Feng, Wei; Hauer-Jensen, Martin; Miyamoto, Shigeki; Zhou, Daohong			IKK beta Regulates the Repair of DNA Double-Strand Breaks Induced by Ionizing Radiation in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; HIGHLY SELECTIVE INHIBITOR; COLLAGEN-INDUCED ARTHRITIS; KINASE ATM; BMS-345541; THERAPY; TARGET; PHOSPHORYLATION; ACTIVATION; PATHWAYS	Activation of the IKK-NF kappa B pathway increases the resistance of cancer cells to ionizing radiation (IR). This effect has been largely attributed to the induction of anti-apoptotic proteins by NF kappa B. Since efficient repair of DNA double strand breaks (DSBs) is required for the clonogenic survival of irradiated cells, we investigated if activation of the IKK-NF kappa B pathway also regulates DSB repair to promote cell survival after IR. We found that inhibition of the IKK-NF kappa B pathway with a specific IKK beta inhibitor significantly reduced the repair of IR-induced DSBs in MCF-7 cells. The repair of DSBs was also significantly inhibited by silencing IKK beta expression with IKK beta shRNA. However, down-regulation of IKK alpha expression with IKK alpha shRNA had no significant effect on the repair of IR-induced DSBs. Similar findings were also observed in IKK alpha and/or IKK beta knockout mouse embryonic fibroblasts (MEFs). More importantly, inhibition of IKK beta with an inhibitor or down-regulation of IKK beta with IKK beta shRNA sensitized MCF-7 cells to IR-induced clonogenic cell death. DSB repair function and resistance to IR were completely restored by IKK beta reconstitution in IKK beta-knockdown MCF-7 cells. These findings demonstrate that IKK beta can regulate the repair of DSBs, a previously undescribed and important IKK beta kinase function; and inhibition of DSB repair may contribute to cance cell radiosensitization induced by IKK beta inhibition. As such, specific inhibition of IKK beta may represents a more effective approach to sensitize cancer cells to radiotherapy.	[Wu, Lixian; Shao, Lijian; Wang, Junru; Pazhanisamy, Senthil; Feng, Wei; Hauer-Jensen, Martin; Zhou, Daohong] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Wu, Lixian] Fujian Med Univ, Dept Pharmacol, Fuzhou, Peoples R China; [An, Ningfei] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Miyamoto, Shigeki] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Arkansas System; University of Arkansas Medical Sciences; Fujian Medical University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Wisconsin System; University of Wisconsin Madison	Zhou, DH (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	dzhou@uams.edu	PAZHANISAMY, SENTHIL KUMAR/G-4359-2012; Shao, Lijian/AAA-1074-2020		National Institutes of Health [R01CA086688, CA102558, AI080421]; Winthrop W. Rockefeller Endowment for Leukemia Research; Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE [R01CA077474, R01CA086860, R01CA102558, R01CA122023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winthrop W. Rockefeller Endowment for Leukemia Research; Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by grants from the National Institutes of Health (R01CA086688, CA102558 and AI080421), the Winthrop W. Rockefeller Endowment for Leukemia Research and the Arkansas Research Alliance Scholarship from the Arkansas Science & Technology Authority to DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2007, CURR CANCER DRUG TAR, V7, P335; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bednarski BK, 2008, MOL CANCER THER, V7, P1827, DOI 10.1158/1535-7163.MCT-08-0321; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Gillooly KM, 2009, J PHARMACOL EXP THER, V331, P349, DOI 10.1124/jpet.109.156018; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Kenneth NS, 2010, EMBO J, V29, P2966, DOI 10.1038/emboj.2010.171; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Saeki T, 2009, INT J BIOL SCI, V5, P722; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Townsend RM, 2004, TRANSPLANTATION, V77, P1090, DOI 10.1097/01.TP.0000118407.05205.05; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9	30	27	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18447	10.1371/journal.pone.0018447	http://dx.doi.org/10.1371/journal.pone.0018447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490922	gold, Green Submitted, Green Published			2022-12-27	WOS:000289238700014
J	Farrell, ME; Briefer, E; McElligott, AG				Farrell, Mary E.; Briefer, Elodie; McElligott, Alan G.			Assortative Mating in Fallow Deer Reduces the Strength of Sexual Selection	PLOS ONE			English	Article							FEMALE MATE CHOICE; RED DEER; DAMA-DAMA; BUCKS; AGE; SUCCESS; QUALITY; COMPETITION; EXPERIENCE; MODELS	Background: Assortative mating can help explain how genetic variation for male quality is maintained even in highly polygynous species. Here, we present a longitudinal study examining how female and male ages, as well as male social dominance, affect assortative mating in fallow deer (Dama dama) over 10 years. Assortative mating could help explain the substantial proportion of females that do not mate with prime-aged, high ranking males, despite very high mating skew. We investigated the temporal pattern of female and male matings, and the relationship between female age and the age and dominance of their mates. Results: The peak of yearling female matings was four days later than the peak for older females. Younger females, and especially yearlings, mated with younger and lower-ranking males than older females. Similarly, young males and lower-ranking males mated with younger females than older males and higher-ranking males. Furthermore, the timing of matings by young males coincided with the peak of yearling female matings, whereas the timing of older male matings (irrespective of rank) coincided with the peak of older female matings. Conclusions: Assortative mating, through a combination of indirect and/or direct female mate choice, can help explain the persistence of genetic variation for male traits associated with reproductive success.	[Farrell, Mary E.] Univ W England, Hartpury Coll, Gloucester, England; [Briefer, Elodie; McElligott, Alan G.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of West England; University of London; Queen Mary University London	Farrell, ME (corresponding author), Univ W England, Hartpury Coll, Gloucester, England.	e.briefer@qmul.ac.uk; a.g.mcelligott@qmul.ac.uk	McElligott, Alan G./ABC-1179-2020; Briefer, Elodie/A-3584-2010	McElligott, Alan G./0000-0001-5770-4568; Farrell, Mary/0000-0002-6232-0654	Office of Public Works; Department of Education Ireland; Swiss National Science Foundation	Office of Public Works; Department of Education Ireland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors acknowledge the financial support of the Office of Public Works (http://www.opw.ie/), the Department of Education Ireland (http://www.education.ie/; M. E. Farrell) during some of the data collection and the Swiss National Science Foundation (http://www.snf.ch/; E. Briefer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Apollonio M, 2003, NATURWISSENSCHAFTEN, V90, P553, DOI 10.1007/s00114-003-0475-7; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; Bang A, 2010, ANIM BEHAV, V79, P631, DOI 10.1016/j.anbehav.2009.12.009; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Bebie N, 2006, MAMM BIOL, V71, P347, DOI 10.1016/j.mambio.2006.02.008; Birgersson B, 1997, BEHAV ECOL, V8, P493, DOI 10.1093/beheco/8.5.493; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carranza J, 2009, MOL ECOL, V18, P4964, DOI 10.1111/j.1365-294X.2009.04401.x; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Charlton BD, 2008, ETHOLOGY, V114, P1023, DOI 10.1111/j.1439-0310.2008.01539.x; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Ciuti S, 2011, ETHOLOGY, V117, P133, DOI 10.1111/j.1439-0310.2010.01862.x; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Darwin C., 1871, P423; Farrell M. E., 2001, THESIS U COLL DUBLIN; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Harty H. C., 2002, THESIS U COLL DUBLIN; Higginson AD, 2009, P ROY SOC B-BIOL SCI, V276, P1153, DOI 10.1098/rspb.2008.1592; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hosken DJ, 2001, CURR BIOL, V11, P489, DOI 10.1016/S0960-9822(01)00146-4; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; Jabbour HN, 1997, J ZOOL, V243, P461, DOI 10.1111/j.1469-7998.1997.tb02795.x; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Komers PE, 1999, AM NAT, V153, P431, DOI 10.1086/303185; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; Langbein Jochen, 1992, P293; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Mainguy J, 2009, P ROY SOC B-BIOL SCI, V276, P4067, DOI 10.1098/rspb.2009.1231; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; McElligott AG, 1998, ETHOLOGY, V104, P789; McElligott AG, 2003, EVOL ECOL RES, V5, P1239; McElligott AG, 2002, P ROY SOC B-BIOL SCI, V269, P1129, DOI 10.1098/rspb.2002.1993; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; McElligott AG, 2000, BEHAV ECOL SOCIOBIOL, V48, P203, DOI 10.1007/s002650000234; MOORE NP, 1995, BEHAV ECOL SOCIOBIOL, V36, P91, DOI 10.1007/s002650050128; OCONNELL JM, 1993, THESIS U COLL DUBLIN; Petrie M, 2007, HEREDITY, V98, P198, DOI 10.1038/sj.hdy.6800921; Preston BT, 2005, P ROY SOC B-BIOL SCI, V272, P365, DOI 10.1098/rspb.2004.2977; R- Development-Core-Team, 2009, R FDN STAT COMP; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; Rossiter SJ, 2005, NATURE, V437, P408, DOI 10.1038/nature03965; San Jose C, 1999, CAN J ZOOL, V77, P1717, DOI 10.1139/cjz-77-11-1717; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; Tudor MS, 2009, ETHOLOGY, V115, P812, DOI 10.1111/j.1439-0310.2009.01676.x; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Wiley RH, 1996, EVOLUTION, V50, P1371, DOI 10.1111/j.1558-5646.1996.tb03911.x; Wilson AJ, 2005, AM NAT, V166, pE177, DOI 10.1086/497441; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	60	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18533	10.1371/journal.pone.0018533	http://dx.doi.org/10.1371/journal.pone.0018533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494678	Green Published, gold			2022-12-27	WOS:000289192400037
J	Kong, JP; Crissey, MA; Funakoshi, S; Kreindler, JL; Lynch, JP				Kong, Jianping; Crissey, Mary Ann; Funakoshi, Shinsuke; Kreindler, James L.; Lynch, John P.			Ectopic Cdx2 Expression in Murine Esophagus Models an Intermediate Stage in the Emergence of Barrett's Esophagus	PLOS ONE			English	Article							DILATED INTERCELLULAR SPACES; SCANNING-ELECTRON-MICROSCOPY; TRANSCRIPTION FACTORS CDX1; COLUMNAR-LINED ESOPHAGUS; IN-VITRO MODEL; INTESTINAL METAPLASIA; TRANSGENIC MICE; MULTILAYERED EPITHELIUM; GENE-EXPRESSION; DUODENOESOPHAGEAL REFLUX	Barrett's esophagus (BE) is an intestinal metaplasia that occurs in the setting of chronic acid and bile reflux and is associated with a risk for adenocarcinoma. Expression of intestine-specific transcription factors in the esophagus likely contributes to metaplasia development. Our objective was to explore the effects of an intestine-specific transcription factor when expressed in the mouse esophageal epithelium. Transgenic mice were derived in which the transcription factor Cdx2 is expressed in squamous epithelium using the murine Keratin-14 gene promoter. Effects of the transgene upon cell proliferation and differentiation, gene expression, and barrier integrity were explored. K14-Cdx2 mice express the Cdx2 transgene in esophageal squamous tissues. Cdx2 expression was associated with reduced basal epithelial cell proliferation and altered cell morphology. Ultrastructurally two changes were noted. Cdx2 expression was associated with dilated space between the basal cells and diminished cell-cell adhesion caused by reduced Desmocollin-3 mRNA and protein expression. This compromised epithelial barrier function, as the measured trans-epithelial electrical resistance (TEER) of the K14-Cdx2 epithelium was significantly reduced compared to controls (1189 Ohm* cm(2) +/- 343.5 to 508 Ohm* cm(2) +/- 92.48, p = 0.0532). Secondly, basal cells with features of a transitional cell type, intermediate between keratinocytes and columnar Barrett's epithelial cells, were observed. These cells had reduced keratin bundles and increased endoplasmic reticulum levels, suggesting the adoption of secretory-cell features. Moreover, at the ultrastructural level they resembled "Distinctive" cells associated with multilayered epithelium. Treatment of the K14-Cdx2 mice with 5'-Azacytidine elicited expression of BE-associated genes including Cdx1, Krt18, and Slc26a3/Dra, suggesting the phenotype could be advanced under certain conditions. We conclude that ectopic Cdx2 expression in keratinocytes alters cell proliferation, barrier function, and differentiation. These altered cells represent a transitional cell type between normal squamous and columnar BE cells. The K14-Cdx2 mice represent a useful model to study progression from squamous epithelium to BE.	[Kong, Jianping; Crissey, Mary Ann; Funakoshi, Shinsuke; Lynch, John P.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Kreindler, James L.] Childrens Hosp Philadelphia, Dept Pediat, Div Pulm Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kong, JP (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	lynchj@mail.med.upenn.edu		Crissey, Mary Ann/0000-0002-6952-5601	National Institutes of Health, NIDDK [DK068366]; NCI [P01 CA098101]; Morphology, Cell Culture, and Molecular Biology Core Facilities of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania [P30-DK50306]; NATIONAL CANCER INSTITUTE [P01CA098101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK068366] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Morphology, Cell Culture, and Molecular Biology Core Facilities of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Institutes of Health research awards including NIDDK Grant DK068366 (J. Lynch), an NCI Program Project P01 CA098101, and the Morphology, Cell Culture, and Molecular Biology Core Facilities of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania (P30-DK50306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch JA, 1997, GASTROENTEROLOGY, V112, P760, DOI 10.1053/gast.1997.v112.pm9041237; Chen XX, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-1; CLARK GWB, 1994, ANN SURG ONCOL, V1, P252, DOI 10.1007/BF02303531; Clement G, 2006, J PATHOL, V208, P100, DOI 10.1002/path.1884; Colleypriest BJ, 2009, TRENDS MOL MED, V15, P313, DOI 10.1016/j.molmed.2009.05.001; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Eda A, 2003, J GASTROENTEROL, V38, P14, DOI 10.1007/s005350300001; Ezaki T, 2007, AM J PHYSIOL-GASTR L, V293, pG54, DOI 10.1152/ajpgi.00533.2006; Farre R, 2008, GUT, V57, P1366, DOI 10.1136/gut.2007.141804; Fitzgerald RC, 2006, GUT, V55, P1810, DOI 10.1136/gut.2005.089144; Fitzgerald RC, 1997, J CELL SCI, V110, P663; FUNAKOSHI S, 2010, AM J PHYSL IN PRESS; Funakoshi S, 2008, MOL CANCER RES, V6, P1478, DOI 10.1158/1541-7786.MCR-07-2161; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Groisman GM, 2004, MODERN PATHOL, V17, P1282, DOI 10.1038/modpathol.3800182; Guillem PG, 2005, DIGEST DIS SCI, V50, P415, DOI 10.1007/s10620-005-2451-x; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Guo RJ, 2004, J BIOL CHEM, V279, P36865, DOI 10.1074/jbc.M405213200; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hao J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-59; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Ingravallo G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-108; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; KALABIS J, 2008, J CLIN INVEST; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; Keller MS, 2004, AM J PHYSIOL-GASTR L, V287, pG104, DOI 10.1152/ajpgi.00484.2003; Khan K, 2006, BRIT J CANCER, V95, P1367, DOI 10.1038/sj.bjc.6603453; Kong J, 2009, CARCINOGENESIS, V30, P122, DOI 10.1093/carcin/bgn227; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Lynch J, 2000, J BIOL CHEM, V275, P4499, DOI 10.1074/jbc.275.6.4499; Lynch JP, 2008, NEOPLASIA, V10, P8, DOI 10.1593/neo.07703; Marchetti M, 2003, J CELL SCI, V116, P1429, DOI 10.1242/jcs.00338; Moons LMG, 2004, J CLIN PATHOL, V57, P1063, DOI 10.1136/jcp.2003.015727; Morales CP, 2002, LANCET, V360, P1587, DOI 10.1016/S0140-6736(02)11569-8; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; Nishijima K, 2004, ANN SURG, V240, P57, DOI 10.1097/01.sla.0000130850.31178.8c; Nozawa K, 2004, ARTHRITIS RES THER, V6, pR95, DOI 10.1186/ar1035; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Pera M, 2007, J GASTROINTEST SURG, V11, P869, DOI 10.1007/s11605-007-0162-7; Phillips RW, 2003, AM J SURG PATHOL, V27, P1442, DOI 10.1097/00000478-200311000-00006; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Sawhney RA, 1996, DIGEST DIS SCI, V41, P1088, DOI 10.1007/BF02088224; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shafa M, 2010, BIOESSAYS, V32, P791, DOI 10.1002/bies.201000033; SHIELDS HM, 1995, MICROSC RES TECHNIQ, V31, P248, DOI 10.1002/jemt.1070310308; Shields HM, 2001, AM J GASTROENTEROL, V96, P3268; SHIELDS HM, 1993, DIGEST DIS SCI, V38, P97, DOI 10.1007/BF01296780; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Spechler SJ, 2010, GASTROENTEROLOGY, V138, P854, DOI 10.1053/j.gastro.2010.01.002; Stairs DB, 2010, PROG MOL BIOL TRANSL, V96, P231, DOI 10.1016/S1877-1173(10)96010-9; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Su YH, 2004, LAB INVEST, V84, P753, DOI 10.1038/labinvest.3700079; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Theisen J, 2005, ANN SURG, V241, P63, DOI 10.1097/01.sla.0000150072.55037.e3; Tobey NA, 2004, AM J GASTROENTEROL, V99, P13, DOI 10.1046/j.1572-0241.2003.04018.x; Tobey NA, 1996, GASTROENTEROLOGY, V111, P1200, DOI 10.1053/gast.1996.v111.pm8898633; Troelsen JT, 1997, BIOCHEM J, V322, P833, DOI 10.1042/bj3220833; Upton MP, 2006, DIGEST DIS SCI, V51, P1783, DOI 10.1007/s10620-006-9243-9; Vaninetti N, 2009, MOL CARCINOGEN, V48, P965, DOI 10.1002/mc.20549; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	68	56	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18280	10.1371/journal.pone.0018280	http://dx.doi.org/10.1371/journal.pone.0018280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494671	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400015
J	Ni, JG; Jiang, HH; Jin, YX; Chen, NH; Wang, JH; Wang, ZB; Luo, YJ; Ma, YY; Hu, XT				Ni, Jianguang; Jiang, Huihui; Jin, Yixiang; Chen, Nanhui; Wang, Jianhong; Wang, Zhengbo; Luo, Yuejia; Ma, Yuanye; Hu, Xintian			Dissociable Modulation of Overt Visual Attention in Valence and Arousal Revealed by Topology of Scan Path	PLOS ONE			English	Article							EMOTIONAL AROUSAL; HUMAN AMYGDALA; EYE-MOVEMENTS; SCENE PERCEPTION; POWER SPECTRA; PICTURES; ACTIVATION; INTENSITY; COGNITION; MEMORY	Emotional stimuli have evolutionary significance for the survival of organisms; therefore, they are attention-grabbing and are processed preferentially. The neural underpinnings of two principle emotional dimensions in affective space, valence (degree of pleasantness) and arousal (intensity of evoked emotion), have been shown to be dissociable in the olfactory, gustatory and memory systems. However, the separable roles of valence and arousal in scene perception are poorly understood. In this study, we asked how these two emotional dimensions modulate overt visual attention. Twenty-two healthy volunteers freely viewed images from the International Affective Picture System (IAPS) that were graded for affective levels of valence and arousal (high, medium, and low). Subjects' heads were immobilized and eye movements were recorded by camera to track overt shifts of visual attention. Algebraic graph-based approaches were introduced to model scan paths as weighted undirected path graphs, generating global topology metrics that characterize the algebraic connectivity of scan paths. Our data suggest that human subjects show different scanning patterns to stimuli with different affective ratings. Valence salient stimuli (with neutral arousal) elicited faster and larger shifts of attention, while arousal salient stimuli (with neutral valence) elicited local scanning, dense attention allocation and deep processing. Furthermore, our model revealed that the modulatory effect of valence was linearly related to the valence level, whereas the relation between the modulatory effect and the level of arousal was nonlinear. Hence, visual attention seems to be modulated by mechanisms that are separate for valence and arousal.	[Ni, Jianguang; Jiang, Huihui; Chen, Nanhui; Wang, Jianhong; Wang, Zhengbo; Ma, Yuanye; Hu, Xintian] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Ma, Yuanye; Hu, Xintian] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Ma, Yuanye; Hu, Xintian] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Ni, Jianguang; Jiang, Huihui; Jin, Yixiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Jin, Yixiang] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Luo, Yuejia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing Normal University	Ni, JG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com; xthu@mail.kiz.ac.cn	Ni, Jiuangang/E-2956-2012; wang, jian/GVS-0711-2022	wang, zhengbo/0000-0002-4717-5137; Ni, Jianguang/0000-0003-2023-9230; Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation of China (NSFC) [30530270, 30670669, 31070965, 30870825, 31070963, 30921064, 30770700, 30930031]; 973 program [2007CB947703, S2010071114, 2011CB711001]; Major State Basic Research of China [NO2003CB716600]; CASC [KSCX1-YW-R-33, KSCX2-EW-J-23, KSCX2-EW-R-11, KSCX2-YW-R-261]; Yunnan Development and Reform Commission [2009-1988]; West Light Foundation of the Chinese Academy of Sciences [292008312D11035]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Major State Basic Research of China; CASC; Yunnan Development and Reform Commission; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Science Foundation of China (NSFC 30530270, 30670669, 31070965, 30870825, 31070963, 30921064, 30770700 and 30930031), 973 program (2007CB947703, S2010071114 and 2011CB711001), the Major State Basic Research of China (NO2003CB716600), Program of CASC (KSCX1-YW-R-33, KSCX2-EW-J-23, KSCX2-EW-R-11 and KSCX2-YW-R-261), Yunnan Development and Reform Commission No. 2009-1988 and West Light Foundation of the Chinese Academy of Sciences (292008312D11035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Anders S, 2008, SOC COGN AFFECT NEUR, V3, P233, DOI 10.1093/scan/nsn017; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Arana FS, 2003, J NEUROSCI, V23, P9632; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Brockmann D, 1999, IEE CONF PUBL, P263, DOI 10.1049/cp:19991119; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cuthbert B. N, 2005, A6 U FLOR; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; FIEDLER M, 1973, CZECH MATH J, V23, P298; FIEDLER M, 1975, CZECH MATH J, V25, P619; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Findlay JM, 2009, PSYCHOL RES-PSYCH FO, V73, P127, DOI 10.1007/s00426-008-0201-3; Gianotti LRR, 2008, BRAIN TOPOGR, V20, P143, DOI 10.1007/s10548-007-0041-2; Glascher J, 2003, J NEUROSCI, V23, P10274; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Greene HH, 2001, VISION RES, V41, P3763, DOI 10.1016/S0042-6989(01)00154-7; Gronau N, 2003, J EXP PSYCHOL GEN, V132, P512, DOI 10.1037/0096-3445.132.4.512; Heilman KM, 1997, J NEUROPSYCH CLIN N, V9, P439, DOI 10.1176/jnp.9.3.439; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hsiao WH, 2005, J OPT SOC AM A, V22, P1789, DOI 10.1364/JOSAA.22.001789; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Keil A, 2003, COGN AFFECT BEHAV NE, V3, P195, DOI 10.3758/CABN.3.3.195; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; KENSINGER E, 2006, J MEMO LANG; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Ludwig CJH, 2002, BEHAV RES METH INS C, V34, P618, DOI 10.3758/BF03195490; Maljkovic V, 2005, J VISION, V5, P215, DOI 10.1167/5.3.6; Mannan SK, 1997, PERCEPTION, V26, P1059, DOI 10.1068/p261059; MOHAR B, 1991, GRAPH COMBINATOR, V7, P53, DOI 10.1007/BF01789463; Mourao-Miranda J, 2003, NEUROIMAGE, V20, P1955, DOI 10.1016/j.neuroimage.2003.08.011; Ochsner KN, 2007, TRENDS COGN SCI, V11, P317, DOI 10.1016/j.tics.2007.06.008; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Privitera CM, 2006, P SOC PHOTO-OPT INS, V6057, pA570, DOI 10.1117/12.674146; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Sharot T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002884; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; SMIT AC, 1987, VISION RES, V27, P1745, DOI 10.1016/0042-6989(87)90104-0; SMIT AC, 1990, EXP BRAIN RES, V81, P335, DOI 10.1007/BF00228124; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; van der Linde I, 2009, SPATIAL VISION, V22, P161, DOI 10.1163/156856809787465636; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wedel M, 2008, J EXP PSYCHOL-APPL, V14, P129, DOI 10.1037/1076-898X.14.2.129; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	73	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18262	10.1371/journal.pone.0018262	http://dx.doi.org/10.1371/journal.pone.0018262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494331	gold, Green Submitted, Green Published			2022-12-27	WOS:000289192400010
J	Goel, A; Xu, LDW; Snyder, KP; Song, LH; Goenaga-Vazquez, Y; Megill, A; Takamiya, K; Huganir, RL; Lee, HK				Goel, Anubhuti; Xu, Linda W.; Snyder, Kevin P.; Song, Lihua; Goenaga-Vazquez, Yamila; Megill, Andrea; Takamiya, Kogo; Huganir, Richard L.; Lee, Hey-Kyoung			Phosphorylation of AMPA Receptors Is Required for Sensory Deprivation-Induced Homeostatic Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-A; VISUAL CORTICAL PLASTICITY; GLUTAMATE RECEPTORS; RETINOIC ACID; GLUR1 SUBUNIT; IN-VIVO; CA1 REGION; RAR-ALPHA; CORTEX	Sensory experience, and the lack thereof, can alter the function of excitatory synapses in the primary sensory cortices. Recent evidence suggests that changes in sensory experience can regulate the synaptic level of Ca(2+)-permeable AMPA receptors (CP-AMPARs). However, the molecular mechanisms underlying such a process have not been determined. We found that binocular visual deprivation, which is a well-established in vivo model to produce multiplicative synaptic scaling in visual cortex of juvenile rodents, is accompanied by an increase in the phosphorylation of AMPAR GluR1 (or GluA1) subunit at the serine 845 (S845) site and the appearance of CP-AMPARs at synapses. To address the role of GluR1-S845 in visual deprivation-induced homeostatic synaptic plasticity, we used mice lacking key phosphorylation sites on the GluR1 subunit. We found that mice specifically lacking the GluR1-S845 site (GluR1-S845A mutants), which is a substrate of cAMP-dependent kinase (PKA), show abnormal basal excitatory synaptic transmission and lack visual deprivation-induced homeostatic synaptic plasticity. We also found evidence that increasing GluR1-S845 phosphorylation alone is not sufficient to produce normal multiplicative synaptic scaling. Our study provides concrete evidence that a GluR1 dependent mechanism, especially S845 phosphorylation, is a necessary pre-requisite step for in vivo homeostatic synaptic plasticity.	[Goel, Anubhuti; Xu, Linda W.; Snyder, Kevin P.; Song, Lihua; Goenaga-Vazquez, Yamila; Megill, Andrea; Lee, Hey-Kyoung] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Goel, Anubhuti; Goenaga-Vazquez, Yamila; Lee, Hey-Kyoung] Univ Maryland, Neurosci & Cognit Sci NACS Program, College Pk, MD 20742 USA; [Megill, Andrea] Univ Maryland, Cell Biol & Mol Genet CBMG Program, College Pk, MD 20742 USA; [Takamiya, Kogo] Miyazaki Univ, Dept Integrat Physiol, Fac Med, Miyazaki, Japan; [Takamiya, Kogo; Huganir, Richard L.] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Miyazaki; Johns Hopkins University; Johns Hopkins Medicine	Goel, A (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	hlee21@umd.edu		Takamiya, Kogo/0000-0001-7240-6307; Snyder, Kevin/0000-0003-3029-4815; Lee, Hey-Kyoung/0000-0002-5554-983X	National Institutes of Health [R01-EY014882, R01-NS036715]; Howard Hughes Medical Institute (HHMI); University of Maryland Neuroscience and Cognitive Science (NACS); NATIONAL EYE INSTITUTE [R01EY014882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); University of Maryland Neuroscience and Cognitive Science (NACS); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grant (R01-EY014882) to H-KL, the National Institutes of Health Grant (R01-NS036715) and the Howard Hughes Medical Institute (HHMI) Investigator Award to RLH, the HHMI Undergraduate Research Fellowships to LWX and KPS, and the University of Maryland Neuroscience and Cognitive Science (NACS) Summer Internship to YG-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SL, 2003, CEREB CORTEX, V13, P864, DOI 10.1093/cercor/13.8.864; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005	62	71	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18264	10.1371/journal.pone.0018264	http://dx.doi.org/10.1371/journal.pone.0018264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483826	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200048
J	Goris, MGA; Wagenaar, JFP; Hartskeerl, RA; van Gorp, ECM; Schuller, S; Monahan, AM; Nally, JE; van der Poll, T; van 't Veer, C				Goris, Marga G. A.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.; van Gorp, Eric C. M.; Schuller, Simone; Monahan, Avril M.; Nally, Jarlath E.; van der Poll, Tom; van 't Veer, Cornelis			Potent Innate Immune Response to Pathogenic Leptospira in Human Whole Blood	PLOS ONE			English	Article							PULMONARY HEMORRHAGE; LETHAL INFECTION; INTERROGANS; COMPLEMENT; CELLS; LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN; INFLAMMATION; RECOGNITION; MACROPHAGES	Background: Leptospirosis is caused by pathogenic spirochetes of the genus Leptospira. The bacteria enter the human body via abraded skin or mucous membranes and may disseminate throughout. In general the clinical picture is mild but some patients develop rapidly progressive, severe disease with a high case fatality rate. Not much is known about the innate immune response to leptospires during haematogenous dissemination. Previous work showed that a human THP-1 cell line recognized heat-killed leptospires and leptospiral LPS through TLR2 instead of TLR4. The LPS of virulent leptospires displayed a lower potency to trigger TNF production by THP-1 cells compared to LPS of non-virulent leptospires. Methodology/Principal Findings: We investigated the host response and killing of virulent and non-virulent Leptospira of different serovars by human THP-1 cells, human PBMC's and human whole blood. Virulence of each leptospiral strain was tested in a well accepted standard guinea pig model. Virulent leptospires displayed complement resistance in human serum and whole blood while in-vitro attenuated non-virulent leptospires were rapidly killed in a complement dependent manner. In vitro stimulation of THP-1 and PBMC's with heat-killed and living leptospires showed differential serovar and cell type dependence of cytokine induction. However, at low, physiological, leptospiral dose, living virulent complement resistant strains were consistently more potent in whole blood stimulations than the corresponding non-virulent complement sensitive strains. At higher dose living virulent and non-virulent leptospires were equipotent in whole blood. Inhibition of different TLRs indicated that both TLR2 and TLR4 as well as TLR5 play a role in the whole blood cytokine response to living leptospires. Conclusions/Significance: Thus, in a minimally altered system as human whole blood, highly virulent Leptospira are potent inducers of the cytokine response.	[Goris, Marga G. A.; Hartskeerl, Rudy A.] KIT Biomed Res, Royal Trop Inst KIT, Amsterdam, Netherlands; [Wagenaar, Jiri F. P.; van Gorp, Eric C. M.] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands; [Schuller, Simone; Monahan, Avril M.; Nally, Jarlath E.] Univ Coll Dublin, Coll Life Sci, Vet Sci Ctr, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [van der Poll, Tom; van 't Veer, Cornelis] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands; [van der Poll, Tom; van 't Veer, Cornelis] Univ Amsterdam, CINIMA, Amsterdam, Netherlands; [van Gorp, Eric C. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Slotervaart Hospital; University College Dublin; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Goris, MGA (corresponding author), KIT Biomed Res, Royal Trop Inst KIT, Amsterdam, Netherlands.	m.goris@kit.nl						Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; ANDERSON DL, 1968, J BACTERIOL, V95, P2293, DOI 10.1128/JB.95.6.2293-2309.1968; AREAN VM, 1962, AM J PATHOL, V40, P393; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; Chierakul W, 2004, CLIN IMMUNOL, V113, P140, DOI 10.1016/j.clim.2004.08.006; CINCO M, 1983, ZBL BAKT-INT J MED M, V254, P261; de Fost M, 2003, CLIN DIAGN LAB IMMUN, V10, P332, DOI 10.1128/CDLI.10.2.332-335.2003; DESOUZA L, 1992, CAN J MICROBIOL, V38, P284, DOI 10.1139/m92-047; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; FAINE S, 1982, GUIDELINES CONTROL L, P67; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Hartskeerl R., 2003, NED TIJDSCHR MED MIC, V11, P94; Kmety E., 1993, CLASSIFICATION SPECI; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Silva João José Pereira da, 2002, Rev. Soc. Bras. Med. Trop., V35, P395, DOI 10.1590/S0037-86822002000400017; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Truccolo J, 2001, FEMS MICROBIOL LETT, V204, P317, DOI 10.1111/j.1574-6968.2001.tb10904.x; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006; Wagenaar JFP, 2004, J TRAVEL MED, V11, P379, DOI 10.2310/7060.2004.19208; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; WANG B, 1984, INFECT IMMUN, V46, P809, DOI 10.1128/IAI.46.3.809-813.1984; WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119	42	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18279	10.1371/journal.pone.0018279	http://dx.doi.org/10.1371/journal.pone.0018279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483834	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200051
J	Burghaus, R; Coboeken, K; Gaub, T; Kuepfer, L; Sensse, A; Siegmund, HU; Weiss, W; Mueck, W; Lippert, J				Burghaus, Rolf; Coboeken, Katrin; Gaub, Thomas; Kuepfer, Lars; Sensse, Anke; Siegmund, Hans-Ulrich; Weiss, Wolfgang; Mueck, Wolfgang; Lippert, Joerg			Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation	PLOS ONE			English	Article							FACTOR-XA INHIBITOR; ACTIVATED PROTEIN-C; DEEP-VEIN THROMBOSIS; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-REPLACEMENT; VENOUS THROMBOEMBOLISM; PROTHROMBINASE COMPLEX; POTENT ANTICOAGULANT; FACTOR-VIII; PHARMACOKINETICS	Rivaroxaban is an oral, direct Factor Xa inhibitor approved in the European Union and several other countries for the prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery and is in advanced clinical development for the treatment of thromboembolic disorders. Its mechanism of action is antithrombin independent and differs from that of other anticoagulants, such as warfarin (a vitamin K antagonist), enoxaparin (an indirect thrombin/Factor Xa inhibitor) and dabigatran (a direct thrombin inhibitor). A blood coagulation computer model has been developed, based on several published models and preclinical and clinical data. Unlike previous models, the current model takes into account both the intrinsic and extrinsic pathways of the coagulation cascade, and possesses some unique features, including a blood flow component and a portfolio of drug action mechanisms. This study aimed to use the model to compare the mechanism of action of rivaroxaban with that of warfarin, and to evaluate the efficacy and safety of different rivaroxaban doses with other anticoagulants included in the model. Rather than reproducing known standard clinical measurements, such as the prothrombin time and activated partial thromboplastin time clotting tests, the anticoagulant benchmarking was based on a simulation of physiologically plausible clotting scenarios. Compared with warfarin, rivaroxaban showed a favourable sensitivity for tissue factor concentration inducing clotting, and a steep concentration-effect relationship, rapidly flattening towards higher inhibitor concentrations, both suggesting a broad therapeutic window. The predicted dosing window is highly accordant with the final dose recommendation based upon extensive clinical studies.	[Burghaus, Rolf; Mueck, Wolfgang] Bayer Schering Pharma AG, Wuppertal, Germany; [Coboeken, Katrin; Gaub, Thomas; Kuepfer, Lars; Siegmund, Hans-Ulrich; Weiss, Wolfgang; Lippert, Joerg] Bayer Technol Serv GmbH, Leverkusen, Germany; [Sensse, Anke] Bayer Schering Pharma AG, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer AG; Bayer Healthcare Pharmaceuticals	Burghaus, R (corresponding author), Bayer Schering Pharma AG, Wuppertal, Germany.	joerg.lippert@bayer.com	Kuepfer, Lars/F-5795-2012; Kuepfer, Lars/AAD-5884-2022; Kuepfer, Lars/A-5762-2012	Kuepfer, Lars/0000-0002-8741-7786; Burghaus, Rolf/0000-0001-7843-427X	Bayer Schering Pharma AG; Johnson & Johnson Pharmaceutical Research Development	Bayer Schering Pharma AG(Bayer AG); Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA)	The authors would like to acknowledge Chandrabala Shah who provided medical writing services with funding from Bayer Schering Pharma AG and Johnson & Johnson Pharmaceutical Research & Development.	Adams TE, 2003, J THROMB HAEMOST, V1, P1024, DOI 10.1046/j.1538-7836.2003.00127.x; Agnelli G, 2007, CIRCULATION, V116, P180, DOI 10.1161/CIRCULATIONAHA.106.668020; Alexander JH, 2005, J THROMB HAEMOST, V3, P439, DOI 10.1111/j.1538-7836.2004.01081.x; Anand M., 2003, J THEOR MED, V5, P183, DOI [10.1080/10273660412331317415, DOI 10.1080/10273660412331317415]; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; *BAY TECHN SER, 2009, MOBI; BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P397; Brufatto N, 2003, J THROMB HAEMOST, V1, P1258, DOI 10.1046/j.1538-7836.2003.00254.x; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Bungay SD, 2003, MATH MED BIOL, V20, P105, DOI 10.1093/imammb20.1.105; Cullberg M, 2005, CLIN PHARMACOL THER, V77, P279, DOI 10.1016/j.clpt.2004.11.001; Elisen MGLM, 1998, BLOOD, V91, P1542, DOI 10.1182/blood.V91.5.1542.1542_1542_1547; ELLIS V, 1982, BIOCHIM BIOPHYS ACTA, V701, P24; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Eriksson BI, 2006, J THROMB HAEMOST, V4, P121, DOI 10.1111/j.1538-7836.2005.01657.x; Eriksson UG, 2003, EUR J CLIN PHARMACOL, V59, P35, DOI 10.1007/s00228-003-0565-7; Ferreira CN, 2002, BLOOD COAGUL FIBRIN, V13, P129, DOI 10.1097/00001721-200203000-00008; *FISH DIAGN, 1999, THROMB CORR STUD; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Gustafsson D, 2003, THROMB RES, V109, pS9, DOI 10.1016/S0049-3848(03)00249-4; Haas S, 2008, J THROMB THROMBOLYS, V25, P52, DOI 10.1007/s11239-007-0108-7; HARA T, 1994, THROMB HAEMOSTASIS, V71, P314; HEEB MJ, 1991, J BIOL CHEM, V266, P17606; HERMANS JM, 1993, BIOCHEM J, V295, P239, DOI 10.1042/bj2950239; Hirsh J, 2008, CHEST, V133, p71S, DOI 10.1378/chest.08-0693; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Ieko M, 2004, J THROMB HAEMOST, V2, P612, DOI 10.1111/j.1538-7933.2004.00649.x; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; KAPPERT G, 2002, VERGLEICHBARKEIT MET; Kubitza D, 2005, CLIN PHARMACOL THER, V78, P412, DOI 10.1016/j.clpt.2005.06.011; Kubitza D, 2006, EXPERT OPIN INV DRUG, V15, P843, DOI 10.1517/13543784.15.8.843; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mattsson C, 2001, THROMB HAEMOSTASIS, V86, P611; Mattsson Christer, 2005, Semin Vasc Med, V5, P235, DOI 10.1055/s-2005-916162; Mauray S, 1998, BBA-PROTEIN STRUCT M, V1387, P184, DOI 10.1016/S0167-4838(98)00120-4; *MEDS, 2010, CLEX CLEX FORT; Mueck W, 2008, CLIN PHARMACOKINET, V47, P203, DOI 10.2165/00003088-200847030-00006; Murayama N, 1999, CLIN PHARMACOL THER, V66, P258, DOI 10.1016/S0009-9236(99)70033-0; Nagashima H, 2002, J BIOL CHEM, V277, P50439, DOI 10.1074/jbc.M208222200; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; Rezaie AR, 2003, THROMB HAEMOSTASIS, V89, P112; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; *SAN, 2009, LOV EN SOD PRESCR IN; Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004; Stevens WK, 1996, J BIOL CHEM, V271, P8062, DOI 10.1074/jbc.271.14.8062; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Tobu M, 2003, CLIN APPL THROMB-HEM, V9, P1, DOI 10.1177/107602960300900101; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; VANDERMEER FJM, 1989, THROMB HAEMOSTASIS, V62, P756; Wittkowsky Ann K, 2003, Semin Vasc Med, V3, P221	55	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17626	10.1371/journal.pone.0017626	http://dx.doi.org/10.1371/journal.pone.0017626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526168	gold, Green Published, Green Submitted			2022-12-27	WOS:000290015800002
J	ten Hove, CA; de Jong, M; Lapin, D; Andel, A; Sanchez-Perez, GF; Tarutani, Y; Suzuki, Y; Heidstra, R; van den Ackerveken, G				ten Hove, Colette A.; de Jong, Mark; Lapin, Dmitry; Andel, Annemiek; Sanchez-Perez, Gabino F.; Tarutani, Yoshiaki; Suzuki, Yoshihito; Heidstra, Renze; van den Ackerveken, Guido			Trans-Repression of Gene Activity Upstream of T-DNA Tagged RLK902 Links Arabidopsis Root Growth Inhibition and Downy Mildew Resistance	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; AGROBACTERIUM-MEDIATED TRANSFORMATION; ASYMMETRIC CELL-DIVISION; REVERSE GENETICS; PLANT TRANSFORMATION; FUNCTIONAL-ANALYSIS; THALIANA; MERISTEM; EXPRESSION; MICROARRAY	Receptor-like kinases (RLKs) constitute a large family of signal perception molecules in Arabidopsis. The largest group of RLKs is the leucine-rich repeat (LRR) class that has been described to function in development and defense. Of these, CLAVATA1 (CLV1) and ERECTA (ER) receptors function in maintaining shoot meristem homeostasis and organ growth, but LRR RLKs with similar function in the root remain unknown. For the interaction of Arabidopsis with the oomycete pathogen Hyaloperonospora arabidopsidis the involvement of LRR RLKs has not been demonstrated. A set of homozygous T-DNA insertion lines mutated in LRR RLKs was investigated to assess the potential role of these receptors in root meristem maintenance and compatibility. One mutant line, rlk902, was discovered that showed both reduced root growth and resistance to downy mildew in a recessive manner. The phenotypes of this mutated line could not be rescued by complementation, but are nevertheless linked to the T-DNA insertion. Microarray studies showed that gene expression spanning a region of approximately 84 kb upstream of the mutated gene was downregulated. The results suggest T-DNA mediated trans-repression of multiple genes upstream of the RLK902 locus links both phenotypes.	[ten Hove, Colette A.; de Jong, Mark; Lapin, Dmitry; Andel, Annemiek; Sanchez-Perez, Gabino F.; van den Ackerveken, Guido] Univ Utrecht, Utrecht, Netherlands; [de Jong, Mark] Swammerdam Inst Life Sci, Integrat Bioinformat Unit, Amsterdam, Netherlands; [de Jong, Mark] Swammerdam Inst Life Sci, MicroArray Dept, Amsterdam, Netherlands; [Sanchez-Perez, Gabino F.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Tarutani, Yoshiaki; Suzuki, Yoshihito] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Tarutani, Yoshiaki] Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 411, Japan; [Suzuki, Yoshihito] Ibaraki Univ, Dept Bioresource Sci, Ibaraki, Japan	Utrecht University; University of Amsterdam; University of Amsterdam; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Ibaraki University	ten Hove, CA (corresponding author), Univ Utrecht, Utrecht, Netherlands.	r.heidstra@uu.nl	Sanchez-Perez, Gabino/E-3597-2010; Van den Ackerveken, Guido/B-8568-2011	Sanchez-Perez, Gabino/0000-0002-2692-9892; Van den Ackerveken, Guido/0000-0002-0183-8978; Lapin, Dmitry/0000-0001-9591-3950; Suzuki, Yoshihito/0000-0002-4574-9504	Centre for BioSystems Genomics (CBSG); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO); NWO	Centre for BioSystems Genomics (CBSG); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Centre for BioSystems Genomics (CBSG) (CAtH and RH) and the Netherlands Consortium for Systems Biology (NCSB) (GFSP), which are part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO), and by a VIDI innovational grant from NWO (GVdA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemeersch J, 2005, PLANT PHYSIOL, V137, P588, DOI 10.1104/pp.104.051300; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Bechtold N, 1998, METH MOL B, V82, P259; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Jong M, 2006, PLANT J, V46, P708, DOI 10.1111/j.1365-313X.2006.02724.x; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hejatko J, 2006, NAT PROTOC, V1, P1939, DOI 10.1038/nprot.2006.333; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Merli C, 1996, GENE DEV, V10, P1260, DOI 10.1101/gad.10.10.1260; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Ohtake Y, 2000, PLANT CELL PHYSIOL, V41, P1038, DOI 10.1093/pcp/pcd028; Ren SX, 2004, PLANT CELL, V16, P2910, DOI 10.1105/tpc.104.025072; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Tarutani Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1935, DOI 10.1271/bbb.68.1935; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Willemsen V, 1998, DEVELOPMENT, V125, P521; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	51	7	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19028	10.1371/journal.pone.0019028	http://dx.doi.org/10.1371/journal.pone.0019028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532992	Green Submitted, gold, Green Published			2022-12-27	WOS:000290014500019
J	Radovanovic, I; Mullick, A; Gros, P				Radovanovic, Irena; Mullick, Alaka; Gros, Philippe			Genetic Control of Susceptibility to Infection with Candida albicans in Mice	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INBRED MOUSE STRAINS; INTERFERON-GAMMA; FUNGAL-INFECTIONS; IMMUNE-RESPONSES; TH17-ASSOCIATED CYTOKINES; SYSTEMIC CANDIDIASIS; TISSUE-DAMAGE; RESISTANCE; TRANSCRIPTION	Candida albicans is an opportunistic pathogen that causes acute disseminated infections in immunocompromised hosts, representing an important cause of morbidity and mortality in these patients. To study the genetic control of susceptibility to disseminated C. albicans in mice, we phenotyped a group of 23 phylogenetically distant inbred strains for susceptibility to infection as measured by extent of fungal replication in the kidney 48 hours following infection. Susceptibility was strongly associated with the loss-of-function mutant complement component 5 (C5/Hc) allele, which is known to be inherited by approximately 40% of inbred strains. Our survey identified 2 discordant strains, AKR/J (C5-deficient, resistant) and SM/J (C5-sufficient, susceptible), suggesting that additional genetic effects may control response to systemic candidiasis in these strains. Haplotype association mapping in the 23 strains using high density SNP maps revealed several putative loci regulating the extent of C. albicans replication, amongst which the most significant were C5 (P value = 2.43x10(-11)) and a novel effect on distal chromosome 11 (P value = 7.63x10(-9)). Compared to other C5-deficient strains, infected AKR/J strain displays a reduced fungal burden in the brain, heart and kidney, and increased survival, concomitant with uniquely high levels of serum IFN gamma. C5-independent genetic effects were further investigated by linkage analysis in an [A/JxAKR/J] F2 cross (n = 158) where the mutant Hc allele is fixed. These studies identified a chromosome 11 locus (Carg4, Candida albicans resistance gene 4; LOD = 4.59), and a chromosome 8 locus (Carg3; LOD = 3.95), both initially detected by haplotype association mapping. Alleles at both loci were inherited in a co-dominant manner. Our results verify the important effect of C5-deficiency in inbred mouse strains, and further identify two novel loci, Carg3 and Carg4, which regulate resistance to C. albicans infection in a C5-independent manner.	[Radovanovic, Irena; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Mullick, Alaka] Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; National Research Council Canada	Radovanovic, I (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca		Radovanovic, Irena/0000-0002-3823-3729	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a Team Grant in Fungal Pahtogenesis from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman RB, 1998, MICROB PATHOGENESIS, V25, P333, DOI 10.1006/mpat.1998.0240; Ashman RB, 1996, INFECT IMMUN, V64, P1866, DOI 10.1128/IAI.64.5.1866-1869.1996; Ashman RB, 1998, MICROB PATHOGENESIS, V25, P349, DOI 10.1006/mpat.1998.0248; Ashman RB, 2003, MICROB PATHOGENESIS, V34, P103, DOI 10.1016/S0882-4010(02)00211-5; Ashman RB, 1997, MICROB PATHOGENESIS, V22, P187, DOI 10.1006/mpat.1996.0102; ASHMAN RB, 1993, IMMUNOL CELL BIOL, V71, P221, DOI 10.1038/icb.1993.25; Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Balish E, 1998, J INFECT DIS, V178, P478, DOI 10.1086/515645; BANGE FC, 1994, J BIOL CHEM, V269, P1091; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BRUMMER E, 1994, CELL IMMUNOL, V157, P1, DOI 10.1006/cimm.1994.1200; BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; Cenci E, 1998, J IMMUNOL, V161, P3543; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; COHEN MS, 1981, AM J MED, V71, P59, DOI 10.1016/0002-9343(81)90259-X; DJEU JY, 1986, J IMMUNOL, V137, P2980; Duan BY, 2010, J IMMUNOL, V185, P335, DOI 10.4049/jimmunol.0903474; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HECTOR RF, 1982, INFECT IMMUN, V38, P1020, DOI 10.1128/IAI.38.3.1020-1028.1982; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kitsios GD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013782; KULLBERG BJ, 1993, J INFECT DIS, V168, P436, DOI 10.1093/infdis/168.2.436; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LANDER ES, 1989, GENETICS, V121, P185; Lanza F, 1998, J MOL MED-JMM, V76, P676, DOI 10.1007/s001090050267; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Manenti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000331; MARODI L, 1993, J CLIN INVEST, V91, P2596, DOI 10.1172/JCI116498; Mathews Herbert L., 2002, P179; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; RHODES JC, 1980, INFECT IMMUN, V29, P494; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; ROMANI L, 1994, J IMMUNOL, V152, P3514; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; SHEPHERD MG, 1985, ANNU REV MICROBIOL, V39, P579, DOI 10.1146/annurev.mi.39.100185.003051; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Su WL, 2010, MAMM GENOME, V21, P143, DOI 10.1007/s00335-010-9249-7; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Tuite A, 2004, GENES IMMUN, V5, P576, DOI 10.1038/sj.gene.6364130; Vazquez-Torres A, 1999, INFECT IMMUN, V67, P670, DOI 10.1128/IAI.67.2.670-674.1999; Wang XY, 1996, BIOCHEM BIOPH RES CO, V229, P316, DOI 10.1006/bbrc.1996.1799; WATSON PA, 1994, J BIOL CHEM, V269, P28893; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; ZELLER R, 2001, FIXATION EMBEDDING S, pCH14; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005	71	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18957	10.1371/journal.pone.0018957	http://dx.doi.org/10.1371/journal.pone.0018957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533108	Green Submitted, Green Published, gold			2022-12-27	WOS:000289719400039
J	Sun, Y; Ran, HM; Liou, B; Quinn, B; Zamzow, M; Zhang, WJ; Bielawski, J; Kitatani, K; Setchell, KDR; Hannun, YA; Grabowski, GA				Sun, Ying; Ran, Huimin; Liou, Benjamin; Quinn, Brian; Zamzow, Matt; Zhang, Wujuan; Bielawski, Jacek; Kitatani, Kazuyuki; Setchell, Kenneth D. R.; Hannun, Yusuf A.; Grabowski, Gregory A.			Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; ENZYME REPLACEMENT THERAPY; SAPOSIN C DEFICIENCY; GLUCOSYLCERAMIDE SYNTHASE; NEUROLOGICAL DEFICITS; TYPE-1; MODELS; ACCUMULATION; INFLAMMATION; INHIBITION	The pharmacological chaperone, isofagomine (IFG), enhances acid beta-glucosidase (GCase) function by altering folding, trafficking, and activity in wild-type and Gaucher disease fibroblasts. The in vivo effects of IFG on GCase activity, its substrate levels, and phenotype were evaluated using a neuronopathic Gaucher disease mouse model, 4L;C* (V394L/V394L + saposin C-/-) that has CNS accumulation of glucosylceramide (GC) and glucosylsphingosine (GS) as well as progressive neurological deterioration. IFG administration to 4L;C* mice at 20 or 600 mg/kg/day resulted in life span extensions of 10 or 20 days, respectively, and increases in GCase activity and protein levels in the brain and visceral tissues. Cerebral cortical GC and GS levels showed no significant reductions with IFG treatment. Increases of GC or GS levels were detected in the visceral tissues of IFG treated (600 mg/kg/day) mice. The attenuations of brain proinflammatory responses in the treated mice were evidenced by reductions in astrogliosis and microglial cell activation, and decreased p38 phosphorylation and TNF alpha levels. Terminally, axonal degeneration was present in the brain and spinal cord from untreated and treated 4L;C* mice. These data demonstrate that IFG exerts in vivo effects by enhancing V394L GCase protein and activity levels, and in mediating suppression of proinflammation, which led to delayed onset of neurological disease and extension of the life span of 4L;C* mice. However, this was not correlated with a reduction in the accumulation of lipid substrates.	[Sun, Ying; Ran, Huimin; Liou, Benjamin; Quinn, Brian; Zamzow, Matt; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH 45221 USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH USA; [Sun, Ying; Ran, Huimin; Liou, Benjamin; Quinn, Brian; Zamzow, Matt; Zhang, Wujuan; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Bielawski, Jacek; Kitatani, Kazuyuki; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Kitatani, Kazuyuki] Tottori Univ, Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori, Japan	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Medical University of South Carolina; Tottori University	Sun, Y (corresponding author), Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH 45221 USA.	Greg.Grabowski@cchmc.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135	Japan Society for the Promotion of Science [21890144];  [R01 NS/DK36681];  [R21 HD059823];  [CA087584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059823] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to GAG (R01 NS/DK36681 and R21 HD059823) and YAH (CA087584), and to KK, the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists-Start-up, 21890144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrow TA, 2007, J PEDIATR-US, V150, P202, DOI 10.1016/j.jpeds.2006.10.062; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Grabowski GA, 2010, ONLINE METABOLIC MOL; Grabowski GA, 2009, GENET MED, V11, P92, DOI 10.1097/GIM.0b013e31818e2c19; GUPTA N, 2010, BLOOD CELLS MOL DIS; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; KHANNA R, 2010, FEBS J; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Luzi P, 2009, BRAIN RES, V1300, P146, DOI 10.1016/j.brainres.2009.09.017; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Nishimura Y, 2009, J ANTIBIOT, V62, P407, DOI 10.1038/ja.2009.53; RADIN NS, 1994, MOL CHEM NEUROPATHOL, V21, P111, DOI 10.1007/BF02815346; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Sun Y, 2008, HUM MOL GENET, V17, P2345, DOI 10.1093/hmg/ddn135; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Sun Y, 2010, HUM MOL GENET, V19, P634, DOI 10.1093/hmg/ddp531; Weinreb NJ, 2005, AM J HEMATOL, V80, P223, DOI 10.1002/ajh.20504; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2007, J BONE MINER RES, V22, P119, DOI 10.1359/JBMR.061004; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; XU YH, 2008, MOL GENET METAB; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	38	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19037	10.1371/journal.pone.0019037	http://dx.doi.org/10.1371/journal.pone.0019037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533102	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400054
J	Lin, CH; Liao, KC; Pu, SJ; Chen, YC; Liu, MS				Lin, Chung-Hao; Liao, Kuo-Chen; Pu, Shou-Jin; Chen, Yung-Chang; Liu, Maw-Sen			Associated Factors for Falls among the Community-Dwelling Older People Assessed by Annual Geriatric Health Examinations	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; COGNITIVE IMPAIRMENT; VISUAL IMPAIRMENT; OBESITY; EPIDEMIOLOGY; FRAILTY; ADULTS	Background: Falls are very common among the older people. Nearly one-third older people living in a community fall each year. However, few studies have examined factors associated with falls in a community-dwelling population of older Taiwanese adults. Objectives: To identify the associated factors for falls during the previous 12 months among the community-dwelling Taiwanese older people receiving annual geriatric health examinations. Participants: People aged sixty-five years or older, living in the community, assessed by annual geriatric health examinations Methods: 1377 community-dwellers aged >= 65 years who received annual geriatric health examinations at one hospital in northern Taiwan between March and November of 2008. They were asked about their history of falls during the year prior to their most recent health examination. Results: The average age of the 1377 participants was 74.9 +/- 6.8 years, 48.9% of which were women. Three-hundred and thirteen of the participants (22.7%) had at least one fall during the previous year. Multivariate analysis showed that odds ratio for the risk of falling was 1.94 (95% CI 1.36-2.76) when the female gender group is compared with the male gender group. The adjusted odds ratios of age and waist circumference were 1.03 (95% CI 1.00-1.06) and 1.03 (95% CI 1.01-1.05) respectively. The adjusted odds ratios of visual acuity, Karnofsky scale, and serum albumin level were 0.34 (95% CI 0.15-0.76), 0.94 (95% CI 0.89-0.98), and 0.37 (95% CI 0.18-0.76) respectively. Larger waist circumference, older age, female gender, poorer visual acuity, lower score on the Karnofsky Performance Scale, and lower serum albumin level were the independent associated factors for falls. Conclusion: In addition to other associated factors, waist circumference should be included as a novel risk factor for falls.	[Lin, Chung-Hao; Liao, Kuo-Chen; Pu, Shou-Jin; Chen, Yung-Chang; Liu, Maw-Sen] Chang Gung Mem Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Chen, Yung-Chang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lin, CH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Tao Yuan, Taiwan.	enzhou.lin@gmail.com						Anstey KJ, 2008, J GERONTOL B-PSYCHOL, V63, pP249, DOI 10.1093/geronb/63.4.P249; Bauer JD, 2007, J HUM NUTR DIET, V20, P558, DOI 10.1111/j.1365-277X.2007.00832.x; Blaum CS, 2005, J AM GERIATR SOC, V53, P927, DOI 10.1111/j.1532-5415.2005.53300.x; Carey BJ, 2001, AGE AGEING, V30, P19, DOI 10.1093/ageing/30.suppl_4.19; Chan K. M., 1997, SMJ, V38, P427; Chen HC, 2005, J FORMOS MED ASSOC, V104, P824; Chu LW, 2005, ANN ACAD MED SINGAP, V34, P60; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Dennison AC, 2007, AM J PHYS MED REHAB, V86, P621, DOI 10.1097/PHM.0b013e311611583; Duh MS, 2008, DRUG AGING, V25, P325, DOI 10.2165/00002512-200825040-00005; GALLO JJ, 2003, HDB GERIATRIC ASSESS, P56; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Gleason CE, 2009, DEMENT GERIATR COGN, V27, P557, DOI 10.1159/000228257; Gray Len C, 2004, Aust Fam Physician, V33, P795; GROOKS V, 1991, J GERONTOL, V46, pM139; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Harlein J, 2009, J ADV NURS, V65, P922, DOI 10.1111/j.1365-2648.2008.04950.x; Han SS, 2010, J AM GERIATR SOC, V58, P312, DOI 10.1111/j.1532-5415.2009.02672.x; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Horton K, 2007, J ADV NURS, V57, P69, DOI 10.1111/j.1365-2648.2006.04061.x; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Ishimoto Y, 2009, J AM GERIATR SOC, V57, P930, DOI 10.1111/j.1532-5415.2009.02242.x; Kuang TM, 2008, J CHIN MED ASSOC, V71, P467, DOI 10.1016/S1726-4901(08)70150-3; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Liu M. T., 2005, FORMOSA J PHYS THER, V30, P105; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Moylan KC, 2007, AM J MED, V120, P493, DOI 10.1016/j.amjmed.2006.07.022; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Soriano TA, 2007, CLIN INTERV AGING, V2, P545; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vaapio S, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-20; Wang JT, 2010, AGEING RES REV, V9, pS13, DOI 10.1016/j.arr.2010.07.002	35	43	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18976	10.1371/journal.pone.0018976	http://dx.doi.org/10.1371/journal.pone.0018976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526155	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100043
J	Sklepkiewicz, P; Schermuly, RT; Tian, X; Ghofrani, HA; Weissmann, N; Sedding, D; Kashour, T; Seeger, W; Grimminger, F; Pullamsetti, SS				Sklepkiewicz, Piotr; Schermuly, Ralph Theo; Tian, Xia; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Sedding, Daniel; Kashour, Tarek; Seeger, Werner; Grimminger, Friedrich; Pullamsetti, Soni Savai			Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; BETA-CATENIN; WNT/BETA-CATENIN; UP-REGULATION; CYCLIN D1; INHIBITION; THERAPY; GROWTH; PATHWAYS; SURVIVAL	Rationale: Pulmonary arterial hypertension (PAH) is a rare progressive pulmonary vascular disorder associated with vascular remodeling and right heart failure. Vascular remodeling involves numerous signaling cascades governing pulmonary arterial smooth muscle cell (PASMC) proliferation, migration and differentiation. Glycogen synthase kinase 3beta (GSK3 beta) is a serine/threonine kinase and can act as a downstream regulatory switch for numerous signaling pathways. Hence, we hypothesized that GSK3 beta plays a crucial role in pulmonary vascular remodeling. Methods: All experiments were done with lung tissue or isolated PASMCs in a well-established monocrotaline (MCT)-induced PAH rat model. The mRNA expression of Wnt ligands (Wnt1, Wnt3a, Wnt5a), upstream Wnt signaling regulator genes (Frizzled Receptors 1, 2 and secreted Frizzled related protein sFRP-1) and canonical Wnt intracellular effectors (GSK3 beta, Axin1) were assessed by real-time polymerase chain reaction and protein levels of GSK3 beta, phospho-GSK3 beta (ser 9) by western blotting and localization by immunohistochemistry. The role of GSK3 beta in PASMCs proliferation was assessed by overexpression of wild-type GSK3 beta (WT) and constitutively active GSK3 beta S9A by [3H]-thymidine incorporation assay. Results: Increased levels of total and phosphorylated GSK3 beta (inhibitory phosphorylation) were observed in lungs and PASMCs isolated from MCT-induced PAH rats compared to controls. Further, stimulation of MCT-PASMCs with growth factors induced GSK3 beta inactivation. Most importantly, treatment with the PDGFR inhibitor, Imatinib, attenuated PDGF-BB and FCS induced GSK3 beta phosphorylation. Increased expression of GSK3 beta observed in lungs and PASMC isolated from MCT-induced PAH rats was confirmed to be clinically relevant as the same observation was identified in human iPAH lung explants. Overexpression of GSK3 beta significantly increased MCT-PASMCs proliferation by regulating ERK phosphorylation. Constitutive activation of GSK3 beta (GSK3 beta S9A, 9th serine replaced to alanine) inhibited MCT-PASMCs proliferation by decreasing ERK phosphorylation. Conclusion: This study supports a central role for GSK3 beta in vascular remodeling processes and suggests a novel therapeutic opportunity for the treatment of PAH.	[Sklepkiewicz, Piotr; Schermuly, Ralph Theo; Tian, Xia; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Seeger, Werner; Grimminger, Friedrich; Pullamsetti, Soni Savai] Univ Hosp, Med Clin 2 5, Giessen, Germany; [Schermuly, Ralph Theo; Seeger, Werner; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Sedding, Daniel] Univ Hosp, Med Clin 1, Giessen, Germany; [Kashour, Tarek] King Fahad Med City, Riyadh, Saudi Arabia	Max Planck Society	Sklepkiewicz, P (corresponding author), Univ Hosp, Med Clin 2 5, Giessen, Germany.	soni.pullamsetti@mpi-bn.mpg.de	Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Ghofrani, Ardeschir/0000-0002-2029-4419; Pullamsetti, Soni Savai/0000-0003-0440-8831; Schermuly, Ralph/0000-0002-5167-6970; Weissmann, Norbert/0000-0003-2675-3871; Seeger, Werner/0000-0003-1946-0894	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 547, B11, C6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 547 "Kardiopulmonales Gefasssystem'', Projekt B11 and C6 (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BENDEY JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176; Bonnet S, 2009, CIRCULATION, V120, P1231, DOI 10.1161/CIRCULATIONAHA.109.848911; Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; George SJ, 2006, ATHEROSCLEROSIS, V188, P1, DOI 10.1016/j.atherosclerosis.2005.12.017; GOODE N, 1992, J BIOL CHEM, V267, P16878; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC; Li FH, 2009, PEDIATR CARDIOL, V30, P363, DOI 10.1007/s00246-008-9315-z; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Park KW, 2003, ARTERIOSCL THROM VAS, V23, P1364, DOI 10.1161/01.ATV.0000081633.53390.B4; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Savai R, 2005, INT J ONCOL, V27, P393; Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Tsakiridis T, 2001, BIOCHEM BIOPH RES CO, V288, P205, DOI 10.1006/bbrc.2001.5762; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Wedgwood S, 2007, PEDIATR RES, V61, P32, DOI 10.1203/01.pdr.0000250013.77008.28; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC613, DOI 10.1152/ajpcell.00421.2006	49	31	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18883	10.1371/journal.pone.0018883	http://dx.doi.org/10.1371/journal.pone.0018883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533110	Green Published, Green Submitted, gold			2022-12-27	WOS:000289620100027
J	Stein, DC; Miller, CJ; Bhoopalan, SV; Sommer, DD				Stein, Daniel C.; Miller, Clinton J.; Bhoopalan, Senthil V.; Sommer, Daniel D.			Sequence-Based Predictions of Lipooligosaccharide Diversity in the Neisseriaceae and Their Implication in Pathogenicity	PLOS ONE			English	Article							3-DEOXY-D-MANNO-OCTULOSONIC ACID TRANSFERASE; LIPOPOLYSACCHARIDE CORE OLIGOSACCHARIDES; ADHESION MOLECULE EXPRESSION; R-TYPE LIPOPOLYSACCHARIDES; STRUCTURAL HETEROGENEITY; PYOCIN RESISTANCE; KDO TRANSFERASE; GENETIC-LOCUS; GONORRHOEAE; MENINGITIDIS	Endotoxin [Lipopolysaccharide (LPS)/Lipooligosaccharide (LOS)] is an important virulence determinant in gram negative bacteria. While the genetic basis of endotoxin production and its role in disease in the pathogenic Neisseria has been extensively studied, little research has focused on the genetic basis of LOS biosynthesis in commensal Neisseria. We determined the genomic sequences of a variety of commensal Neisseria strains, and compared these sequences, along with other genomic sequences available from various sequencing centers from commensal and pathogenic strains, to identify genes involved in LOS biosynthesis. This allowed us to make structural predictions as to differences in LOS seen between commensal and pathogenic strains. We determined that all neisserial strains possess a conserved set of genes needed to make a common 3-Deoxy-D-manno-octulosonic acid -heptose core structure. However, significant genomic differences in glycosyl transferase genes support the published literature indicating compositional differences in the terminal oligosaccharides. This was most pronounced in commensal strains that were distally related to the gonococcus and meningococcus. These strains possessed a homolog of heptosyltransferase III, suggesting that they differ from the pathogenic strains by the presence a third heptose. Furthermore, most commensal strains possess homologs of genes needed to synthesize lipopolysaccharide (LPS). N. cinerea, a commensal species that is highly related to the gonococcus has lost the ability to make sialyltransferase. Overall genomic comparisons of various neisserial strains indicate that significant recombination/genetic acquisition/loss has occurred within the genus, and this muddles proper speciation.	[Stein, Daniel C.; Miller, Clinton J.; Bhoopalan, Senthil V.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Sommer, Daniel D.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Stein, DC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dcstein@umd.edu	Bhoopalan, Senthil Velan/U-8477-2018	Bhoopalan, Senthil Velan/0000-0002-1402-6549; Stein, Daniel/0000-0003-3397-5720	National Institutes of Health [AI073667, LM006845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024452, R01AI073667] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from the National Institutes of Health to DCS, grant number AI073667 and DDS LM006845. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APICELLA MA, 1987, INFECT IMMUN, V55, P1755, DOI 10.1128/IAI.55.8.1755-1761.1987; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; Buttcher V, 1999, BBA-PROTEIN STRUCT M, V1432, P406, DOI 10.1016/S0167-4838(99)00101-6; DANAHER RJ, 1995, J BACTERIOL, V177, P7275, DOI 10.1128/jb.177.24.7275-7279.1995; Delcher AL, 2003, CURRENT PROTOCOLS BI, DOI DOI 10.13.11-10.13.18; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; DRUMMOND AJ, 2009, GENEIOUS V4 7; Feil E, 1996, J MOL EVOL, V43, P631, DOI 10.1007/BF02202111; GAMIAN A, 1992, J BIOL CHEM, V267, P922; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GIBSON BW, 1989, P NATL ACAD SCI USA, V86, P17, DOI 10.1073/pnas.86.1.17; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; JANTZEN E, 1976, ACTA PATH MICRO IM B, V84, P177; JENNINGS HJ, 1980, CAN J BIOCHEM CELL B, V58, P128, DOI 10.1139/o80-018; JOHN CM, 1991, J BIOL CHEM, V266, P19303; Kahler CM, 1996, J BACTERIOL, V178, P6677, DOI 10.1128/jb.178.23.6677-6684.1996; KERWOOD DE, 1992, BIOCHEMISTRY-US, V31, P12760, DOI 10.1021/bi00166a008; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; LAIRSON LL, 2004, J BIOL CHEM; Linz B, 2000, MOL MICROBIOL, V36, P1049, DOI 10.1046/j.1365-2958.2000.01932.x; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; MANDRELL RE, 1990, J EXP MED, V171, P1649, DOI 10.1084/jem.171.5.1649; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; MICHON F, 1990, J BIOL CHEM, V265, P7243; O'Connor ET, 2009, J BACTERIOL, V191, P3311, DOI 10.1128/JB.01433-08; O'Connor ET, 2006, J BACTERIOL, V188, P1039, DOI 10.1128/JB.188.3.1039-1048.2006; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; PETRICOIN EF, 1991, J BACTERIOL, V173, P7896, DOI 10.1128/jb.173.24.7896-7902.1991; PETRICOIN EF, 1989, INFECT IMMUN, V57, P2847, DOI 10.1128/IAI.57.9.2847-2852.1989; Piekarowicz A, 2002, J BACTERIOL, V184, P6410, DOI 10.1128/JB.184.23.6410-6416.2002; Plant L, 2006, INFECT IMMUN, V74, P1360, DOI 10.1128/IAI.74.2.1360-1367.2006; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SANDLIN R, 1991, FEMS MICROBIOL LETT, V90, P69, DOI 10.1016/0378-1097(91)90648-T; SANDLIN RC, 1994, J BACTERIOL, V176, P6869, DOI 10.1128/JB.176.22.6869-6876.1994; Smith H, 1995, MICROB PATHOGENESIS, V19, P365, DOI 10.1006/mpat.1995.0071; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Tong YH, 2002, GLYCOBIOLOGY, V12, P523, DOI 10.1093/glycob/cwf047; TSAI CM, 1987, INFECT IMMUN, V55, P1652, DOI 10.1128/IAI.55.7.1652-1656.1987; Tzeng YL, 2002, J BACTERIOL, V184, P2379, DOI 10.1128/JB.184.9.2379-2388.2002; van Passel MWJ, 2006, FEMS MICROBIOL LETT, V262, P77, DOI 10.1111/j.1574-6968.2006.00366.x; Wakarchuk W, 1996, J BIOL CHEM, V271, P19166, DOI 10.1074/jbc.271.32.19166; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wang XY, 2010, OPT ENG, V49, DOI 10.1117/1.3281669; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; YAMASAKI R, 1994, J BIOL CHEM, V269, P30345; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P10566, DOI 10.1021/bi00107a028; Yamasaki R, 1999, J BIOL CHEM, V274, P36550, DOI 10.1074/jbc.274.51.36550; Zhang P, 2006, J LEUKOCYTE BIOL, V79, P731, DOI 10.1189/jlb.0405184; ZHOU DG, 1994, MOL MICROBIOL, V14, P609, DOI 10.1111/j.1365-2958.1994.tb01300.x; Zhu PX, 2002, MICROBIOL-SGM, V148, P1833, DOI 10.1099/00221287-148-6-1833; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18923	10.1371/journal.pone.0018923	http://dx.doi.org/10.1371/journal.pone.0018923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533118	Green Submitted, Green Published, gold			2022-12-27	WOS:000289620100029
J	Desdevises, Y; Maillet, V; Fuentes, M; Escriva, H				Desdevises, Yves; Maillet, Vincent; Fuentes, Michael; Escriva, Hector			A Snapshot of the Population Structure of Branchiostoma lanceolatum in the Racou Beach, France, during Its Spawning Season	PLOS ONE			English	Article							LAGOS LAGOON; SECONDARY PRODUCTION; SEDIMENT DYNAMICS; FLORIDA LANCELET; LIFE-HISTORY; INNER-SHELF; AMPHIOXUS; ECOLOGY; GROWTH; TUNICATES	A methodology for inducing spawning in captivity of the lancelet Branchiostoma lanceolatum has been developed recently with animals collected at the Racou beach, in the southern coast of France. An increasing amount of laboratories around the world are now working on the evolution of developmental mechanisms (Evo-Devo) using amphioxus collected in this site. Thus, today, the development of new aquaculture techniques for keeping amphioxus in captivity is needed and the study of the natural conditions at which amphioxus is exposed in the Racou beach during their spawning season becomes necessary. We have investigated the amphioxus distribution, size frequency, and population structure in the Racou beach during its natural spawning season using multivariate methods (redundancy analysis and multiple regression). We found a clear preference of amphioxus for sandy sites, something that seems to be a general behaviour of different amphioxus species around the world. We have also estimated the amphioxus growth rate and we show how the animals are preferentially localized in shallow waters during April and June.	[Desdevises, Yves; Maillet, Vincent; Fuentes, Michael; Escriva, Hector] Univ Paris 06, CNRS, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Desdevises, Y (corresponding author), Univ Paris 06, CNRS, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France.	hector.escriva@obs-banyuls.fr	Desdevises, Yves/D-5528-2011; Escriva, Hector/K-8325-2013; Desdevises, Yves/H-5334-2019; Desdevises, Yves/AAH-2097-2019	Desdevises, Yves/0000-0001-9774-0336; Escriva, Hector/0000-0001-7577-5028; Desdevises, Yves/0000-0001-9774-0336	L'Agence Nationale de la Recherche (ANR) [BLAN 171601, BLAN 123402]; CNRS [SDV-D-2009-1926]	L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by L'Agence Nationale de la Recherche (ANR) BLAN 171601 and BLAN 123402 and by CNRS PEPS (Projet Exploratoire Premier Soutien) SDV-D-2009-1926 (http://www.cnrs.fr/insb/carrieresemplois/peps-2009.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand Stephanie, 2007, Journal de la Societe de Biologie, V201, P51, DOI 10.1051/jbio:2007006; BOSCHUNG HERBERT V., 1962, TULANE STUD ZOOL, V9, P245; CAILLEUX A, 1969, QUATERNARY PERIGLACI, P285; Chen Y, 2008, J EXP MAR BIOL ECOL, V357, P64, DOI 10.1016/j.jembe.2007.12.028; CHIN T. G., 1941, PHILADELPHIA JOUR SCI, V75, P369; CORY RL, 1967, LIMNOL OCEANOGR, V12, P650, DOI 10.4319/lo.1967.12.4.0650; Courtney W.A.M., 1975, Symposia Zool Soc Lond, VNo. 36, P213; da Silva LFB, 2008, REV BRAS ZOOL, V25, P617, DOI 10.1590/S0101-81752008000400006; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; EISMA D, 1970, Netherlands Journal of Sea Research, V5, P101, DOI 10.1016/0077-7579(70)90006-2; Ferre B, 2005, CONT SHELF RES, V25, P2410, DOI 10.1016/j.csr.2005.08.017; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; FRANKENBERG D, 1968, BIOSCIENCE, V18, P877, DOI 10.2307/1294155; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; FUENTES M, 2007, J EXP ZOOLOG B; FUTCH C R, 1977, Florida Marine Research Publications, V24, P1; GOSSELCK F, 1979, INT REV GES HYDROBIO, V64, P541, DOI 10.1002/iroh.19790640418; GOSSELCK F, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P199, DOI 10.1002/iroh.19750600204; GUENO Y, 1968, CAHIERS ORSTOM O, V6, P69; Guillen J, 2006, MAR GEOL, V234, P129, DOI 10.1016/j.margeo.2006.09.018; Holland LZ, 2004, METHOD CELL BIOL, V74, P195; Kubokawa K, 2003, ZOOL SCI, V20, P889, DOI 10.2108/zsj.20.889; Legendre P., 2012, NUMERICAL ECOLOGY; MONNIOT F, 1962, VIE MILIEU, V13, P232; Nelson G. E., 1969, Quarterly Journal of the Florida Academy of Sciences, V31, P93; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Poss SG, 1996, ISRAEL J ZOOL, V42, pS13; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Somorjai IML, 2008, AQUACULTURE, V281, P145, DOI 10.1016/j.aquaculture.2008.05.023; Soto CG, 1995, AQUACULTURE, V136, P149, DOI 10.1016/0044-8486(95)01051-3; Stokes MD, 1996, ISRAEL J ZOOL, V42, pS67; Stokes MD, 1996, MAR ECOL PROG SER, V130, P71, DOI 10.3354/meps130071; Team RDC, 2008, COMP RFFS; THEODOSIOU M, 2011, J EXP ZOO B IN PRESS; Webb J.E., 1975, Symposia Zool Soc Lond, VNo. 36, P179; WEBB J. E., 1956, PROC ZOOL SOC LONDON, V127, P119; Webb J. E., 1971, Vie et Milieu, VNo. 22, P827; WEBB J. E., 1956, PROC ZOOL SOC LONDON, V127, P125; WEBB JE, 1958, PHILOS T ROY SOC B, V241, P335, DOI 10.1098/rstb.1958.0007; WEBB JE, 1958, PHILOS T ROY SOC B, V241, P355, DOI 10.1098/rstb.1958.0008; WEBB JE, 1958, PHILOS T ROY SOC B, V241, P393, DOI 10.1098/rstb.1958.0009; Wells M M, 1926, Science, V64, P187, DOI 10.1126/science.64.1651.187; Wu Xian-han, 2000, Chinese Journal of Oceanology and Limnology, V18, P334; Yasui K, 2007, ZOOL SCI, V24, P514, DOI 10.2108/zsj.24.514; Zhou Ren-jie, 2007, Journal of Oceanography in Taiwan Strait, V26, P121	47	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18520	10.1371/journal.pone.0018520	http://dx.doi.org/10.1371/journal.pone.0018520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525973	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600012
J	Drogemuller, C; Reichart, U; Seuberlich, T; Oevermann, A; Baumgartner, M; Boghenbor, KK; Stoffel, MH; Syring, C; Meylan, M; Muller, S; Muller, M; Gredler, B; Solkner, J; Leeb, T				Drogemuller, Cord; Reichart, Ursula; Seuberlich, Torsten; Oevermann, Anna; Baumgartner, Martin; Boghenbor, Kathrin Kuhni; Stoffel, Michael H.; Syring, Claudia; Meylan, Mireille; Mueller, Simone; Mueller, Mathias; Gredler, Birgit; Soelkner, Johann; Leeb, Tosso			An Unusual Splice Defect in the Mitofusin 2 Gene (MFN2) Is Associated with Degenerative Axonopathy in Tyrolean Grey Cattle	PLOS ONE			English	Article							MITOCHONDRIAL FUSION; MISSENSE MUTATION; EXONIC MUTATIONS; DISEASE; NEUROPATHY; ANIMALS; TYPE-2A; MODEL; MOTOR	Tyrolean Grey cattle represent a local breed with a population size of,5000 registered cows. In 2003, a previously unknown neurological disorder was recognized in Tyrolean Grey cattle. The clinical signs of the disorder are similar to those of bovine progressive degenerative myeloencephalopathy (weaver syndrome) in Brown Swiss cattle but occur much earlier in life. The neuropathological investigation of an affected calf showed axonal degeneration in the central nervous system (CNS) and femoral nerve. The pedigrees of the affected calves suggested a monogenic autosomal recessive inheritance. We localized the responsible mutation to a 1.9 Mb interval on chromosome 16 by genome-wide association and haplotype mapping. The MFN2 gene located in this interval encodes mitofusin 2, a mitochondrial membrane protein. A heritable human axonal neuropathy, Charcot-Marie-Tooth disease-2A2 (CMT2A2), is caused by MFN2 mutations. Therefore, we considered MFN2 a positional and functional candidate gene and performed mutation analysis in affected and control Tyrolean Grey cattle. We did not find any non-synonymous variants. However, we identified a perfectly associated silent SNP in the coding region of exon 20 of the MFN2 gene. This SNP is located within a putative exonic splice enhancer (ESE) and the variant allele leads to partial retention of the entire intron 19 and a premature stop codon in the aberrant MFN2 transcript. Thus we have identified a highly unusual splicing defect, where an exonic single base exchange leads to the retention of the preceding intron. This splicing defect represents a potential explanation for the observed degenerative axonopathy. Marker assisted selection can now be used to eliminate degenerative axonopathy from Tyrolean Grey cattle.	[Drogemuller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Reichart, Ursula; Mueller, Simone; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Seuberlich, Torsten; Oevermann, Anna] Univ Bern, Neuroctr, Div Expt Clin Res, Bern, Switzerland; [Baumgartner, Martin] Univ Bern, Div Mol Pathobiol, Bern, Switzerland; [Boghenbor, Kathrin Kuhni; Stoffel, Michael H.] Univ Bern, Div Vet Anat, Bern, Switzerland; [Syring, Claudia; Meylan, Mireille] Univ Bern, Clin Ruminants, Bern, Switzerland; [Gredler, Birgit; Soelkner, Johann] Univ Nat Resources & Appl Life Sci, Div Livestock Sci, Vienna, Austria	University of Bern; University of Veterinary Medicine Vienna; University of Bern; University of Bern; University of Bern; University of Bern; University of Natural Resources & Life Sciences, Vienna	Drogemuller, C (corresponding author), Univ Bern, Inst Genet, Bern, Switzerland.	Johann.Soelkner@boku.ac.at; Tosso.Leeb@itz.unibe.ch	Leeb, Tosso/G-3187-2014; Stoffel, Michael Hubert/I-6939-2015	Leeb, Tosso/0000-0003-0553-4880; Stoffel, Michael Hubert/0000-0002-4699-5125; Muller, Mathias/0000-0002-7879-3552; Drogemuller, Cord/0000-0001-9773-522X; Solkner, Johann/0000-0002-1517-5829; Baumgartner, Martin/0000-0001-9539-7204; Reichart, Ursula/0000-0001-9709-0919; Oevermann, Anna/0000-0002-3569-8547	ONGENE	ONGENE	This work was funded in part by ONGENE, the Austrian national body responsible for the conservation of endangered livestock breeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Defesche JC, 2008, CLIN GENET, V73, P573, DOI 10.1111/j.1399-0004.2008.00999.x; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Krebs S, 2007, P NATL ACAD SCI USA, V104, P6746, DOI 10.1073/pnas.0607721104; Maimaiti M, 2009, J HUM GENET, V54, P493, DOI 10.1038/jhg.2009.66; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2001, J CELL SCI, V114, P867; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Syring C, 2010, J VET INTERN MED, V24, P1519, DOI 10.1111/j.1939-1676.2010.0607.x; Thomsen B, 2010, NEUROGENETICS, V11, P175, DOI 10.1007/s10048-009-0214-0; Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Windsor PA, 2009, AUST VET J, V87, P193, DOI 10.1111/j.1751-0813.2009.00422.x; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	30	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18931	10.1371/journal.pone.0018931	http://dx.doi.org/10.1371/journal.pone.0018931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526202	Green Submitted, Green Published, gold			2022-12-27	WOS:000289578600040
J	Liu, SA; Piatigorsky, J				Liu, Shuang; Piatigorsky, Joram			Regulation of Mouse Small Heat Shock Protein alpha b-Crystallin Gene by Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							DIOXIN-RESPONSIVE ENHANCER; LIGANDED AH RECEPTOR; DEVELOPMENTAL EXPRESSION; TRANSCRIPTION FACTORS; DNA INTERACTIONS; 2 MEMBERS; LENS; IDENTIFICATION; PROMOTER; MICE	The stress-inducible small heat shock protein (shsp)/alpha B-crystallin gene is expressed highly in the lens and moderately in other tissues. Here we provide evidence that it is a target gene of the aryl hydrocarbon receptor (AhR) transcription factor. A sequence (-329/-323, CATGCGA) similar to the consensus xenobiotic responsive element (XRE), called here XRE-like, is present in the alpha BE2 region of alpha B-crystallin enhancer and can bind AhR in vitro and in vivo. alpha B-crystallin protein levels were reduced in retina, lens, cornea, heart, skeletal muscle and cultured muscle fibroblasts of AhR(-/-) mice; alpha B-crystallin mRNA levels were reduced in the eye, heart and skeletal muscle of AhR(-/-) mice. Increased AhR stimulated alpha B-crystallin expression in transfection experiments conducted in conjunction with the aryl hydrocarbon receptor nuclear translocator (ARNT) and decreased AhR reduced alpha B-crystallin expression. AhR effect on aB-crystallin promoter activity was cell-dependent in transfection experiments. AhR up-regulated alpha B-crystallin promoter activity in transfected HeLa, NIH3T3 and COS-7 cells in the absence of exogenously added ligand (TCDD), but had no effect on the alpha B-crystallin promoter in C2C12, CV-1 or Hepa-1 cells with or without TCDD. TCDD enhanced AhR-stimulated alpha B-crystallin promoter activity in transfected alpha TN4 cells. AhR could bind to an XRE-like site in the alpha B-crystallin enhancer in vitro and in vivo. Finally, site-specific mutagenesis experiments showed that the XRE-like motif was necessary for both basal and maximal AhR-induction of alpha B-crystallin promoter activity. Our data strongly suggest that AhR is a regulator of alpha B-crystallin gene expression and provide new avenues of research for the mechanism of tissue-specific alpha B-crystallin gene regulation under normal and physiologically stressed conditions.	[Liu, Shuang; Piatigorsky, Joram] NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Shuang] NCI, Expt Immunol Lab, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, SA (corresponding author), NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA.	liushuang1999@yahoo.com; joramp@nei.nih.gov			NIH, NEI	NIH, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program of the NIH, NEI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BD, 1995, DEV DYNAM, V204, P144, DOI 10.1002/aja.1002040205; ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; Andreasen EA, 2002, TOXICOL SCI, V68, P403, DOI 10.1093/toxsci/68.2.403; ARRIGO AP, 2002, SMALL STRESS PROTEIN, pR15; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Boutros PC, 2004, BIOCHEM BIOPH RES CO, V321, P707, DOI 10.1016/j.bbrc.2004.06.177; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; DERETIC D, 1994, J BIOL CHEM, V269, P16853; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Duncan B, 2007, DNA CELL BIOL, V26, P745, DOI 10.1089/dna.2007.0629; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Gopal-Srivastava R, 1998, J BIOL CHEM, V273, P17954, DOI 10.1074/jbc.273.28.17954; GopalSrivastava R, 1996, J BIOL CHEM, V271, P23029, DOI 10.1074/jbc.271.38.23029; GOPALSRIVASTAVA R, 1993, MOL CELL BIOL, V13, P7144, DOI 10.1128/MCB.13.11.7144; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; Matsumura F, 2006, BIOL CHEM, V387, P1189, DOI 10.1515/BC.2006.146; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Piatigorsky J, 2007, GENE SHARING EVOLUTI, pxv; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; SHEN ES, 1992, J BIOL CHEM, V267, P6815; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; Sogawa K, 2004, BIOCHEM BIOPH RES CO, V318, P746, DOI 10.1016/j.bbrc.2004.04.090; Swamynathan SK, 2007, INT J DEV BIOL, V51, P689, DOI 10.1387/ijdb.072302ss; Swamynathan SK, 2002, J BIOL CHEM, V277, P49700, DOI 10.1074/jbc.M209700200; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Xi JH, 2003, MOL VIS, V9, P410	40	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e17904	10.1371/journal.pone.0017904	http://dx.doi.org/10.1371/journal.pone.0017904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494593	gold, Green Published, Green Submitted			2022-12-27	WOS:000289354100003
J	Thomsen, KR; Lou, HC; Joensson, M; Hyam, JA; Holland, P; Parsons, CE; Young, KS; Moller, A; Stein, A; Green, AL; Kringelbach, ML; Aziz, TZ				Thomsen, Kristine Romer; Lou, Hans C.; Joensson, Morten; Hyam, Jonathan A.; Holland, Peter; Parsons, Christine E.; Young, Katherine S.; Moller, Arne; Stein, Alan; Green, Alex L.; Kringelbach, Morten L.; Aziz, Tipu Z.			Impact of Emotion on Consciousness: Positive Stimuli Enhance Conscious Reportability	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; AWARENESS; WORDS; PAIN; DISCRIMINATION	Emotion and reward have been proposed to be closely linked to conscious experience, but empirical data are lacking. The anterior cingulate cortex (ACC) plays a central role in the hedonic dimension of conscious experience; thus potentially a key region in interactions between emotion and consciousness. Here we tested the impact of emotion on conscious experience, and directly investigated the role of the ACC. We used a masked paradigm that measures conscious reportability in terms of subjective confidence and objective accuracy in identifying the briefly presented stimulus in a forced-choice test. By manipulating the emotional valence (positive, neutral, negative) and the presentation time (16 ms, 32 ms, 80 ms) we measured the impact of these variables on conscious and subliminal (i.e. below threshold) processing. First, we tested normal participants using face and word stimuli. Results showed that participants were more confident and accurate when consciously seeing happy versus sad/neutral faces and words. When stimuli were presented subliminally, we found no effect of emotion. To investigate the neural basis of this impact of emotion, we recorded local field potentials (LFPs) directly in the ACC in a chronic pain patient. Behavioural findings were replicated: the patient was more confident and accurate when (consciously) seeing happy versus sad faces, while no effect was seen in subliminal trials. Mirroring behavioural findings, we found significant differences in the LFPs after around 500 ms (lasting 30 ms) in conscious trials between happy and sad faces, while no effect was found in subliminal trials. We thus demonstrate a striking impact of emotion on conscious experience, with positive emotional stimuli enhancing conscious reportability. In line with previous studies, the data indicate a key role of the ACC, but goes beyond earlier work by providing the first direct evidence of interaction between emotion and conscious experience in the human ACC.	[Thomsen, Kristine Romer; Joensson, Morten; Parsons, Christine E.; Young, Katherine S.; Stein, Alan; Kringelbach, Morten L.] Univ Oxford, Dept Psychiat, Oxford, England; [Thomsen, Kristine Romer; Lou, Hans C.; Joensson, Morten; Moller, Arne; Kringelbach, Morten L.] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Hyam, Jonathan A.; Holland, Peter; Green, Alex L.; Kringelbach, Morten L.; Aziz, Tipu Z.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England	University of Oxford; Aarhus University; University of Oxford	Thomsen, KR (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	Morten.Kringelbach@queens.ox.ac.uk	Kringelbach, Morten/AAW-5847-2021; Young, Katherine/O-9198-2017; Kringelbach, Morten L/AAF-5508-2020; Parsons, Christine/V-3571-2019; Parsons, Christine/G-9286-2016	Kringelbach, Morten/0000-0002-3908-6898; Young, Katherine/0000-0002-1378-6415; Parsons, Christine/0000-0003-2856-6308; Parsons, Christine/0000-0003-2856-6308; Stein, Alan/0000-0001-8207-2822	Wellcome Trust, UK [017571]; Medical Research Council; Norman Collisson Foundation; Charles Wolfson Charitable Foundation; TrygFonden Charitable Foundation	Wellcome Trust, UK(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norman Collisson Foundation; Charles Wolfson Charitable Foundation; TrygFonden Charitable Foundation	This research was supported by funding from the Wellcome Trust, UK (017571), Medical Research Council, Norman Collisson Foundation and Charles Wolfson Charitable Foundation, and the TrygFonden Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Ekman P., 2003, UNMASKING FACE GUIDE; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Kjaer TW, 2001, CONSCIOUS COGN, V10, P356, DOI 10.1006/ccog.2001.0509; Kringelbach ML, 2009, J PAIN MANAGEMENT, V2, P301; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lang, 2017, AFFECTIVE NORMS ENGL; LOU HC, J VISION IN PRESS; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RUIZCABALLERO JA, 1994, COGNITION EMOTION, V8, P555, DOI 10.1080/02699939408408959; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; STRAUSS E, 1983, NEUROPSYCHOLOGIA, V21, P99, DOI 10.1016/0028-3932(83)90104-5; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; WEISKRANTZ L, 1995, P NATL ACAD SCI USA, V92, P6122, DOI 10.1073/pnas.92.13.6122; WILLIAMSON S, 1991, PSYCHOPHYSIOLOGY, V28, P260, DOI 10.1111/j.1469-8986.1991.tb02192.x	26	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18686	10.1371/journal.pone.0018686	http://dx.doi.org/10.1371/journal.pone.0018686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	747XH	21494569	gold, Green Published, Green Submitted			2022-12-27	WOS:000289354100030
J	Chen, Z; Buki, K; Vaaraniemi, J; Gu, GL; Vaananen, HK				Chen, Zhi; Buki, Kalman; Vaaraniemi, Jukka; Gu, Guoliang; Vaananen, H. Kalervo			The Critical Role of IL-34 in Osteoclastogenesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; OP/OP MICE; DIFFERENTIATION; CELLS; EXPRESSION; CYTOKINE; RECEPTOR; GENE	It has been widely believed that the cytokines required for osteoclast formation are M-CSF (also known as CSF-1) and RANKL. Recently, a novel cytokine, designated IL-34, has been identified as another ligand of CSF1R. This study was to explore the biological function, specifically osteoclastogenesis and bone metabolism, of the new cytokine. We produced recombinant mouse IL-34 and found that together with RANKL it induces the formation of osteoclasts both from splenocytes as well as dose-dependently from bone marrow cells in mouse and these cells also revealed bone resorption activity. It also promotes osteoclast differentiation from human peripheral blood mononucleated cells. Finally, we show that systemic administration of IL-34 to mice increases the proportion of CD11b+ cells and reduces trabecular bone mass. Our data indicate that IL-34 is another important player in osteoclastogenesis and thus may have a role in bone diseases. Strategies of targeting CSF1/CSF1R have been developed and some of them are already in preclinical and clinical studies for treatment of inflammatory diseases. Our results strongly suggest the need to revisit these strategies as they may provide a new potential pharmaceutical target for the regulation of bone metabolism in addition to their role in the treatment of inflammatory diseases.	[Chen, Zhi; Buki, Kalman; Vaaraniemi, Jukka; Gu, Guoliang] Univ Turku, Dept Cell Biol & Anat, Inst Biomed, Turku, Finland; [Vaananen, H. Kalervo] Univ Eastern Finland, Kuopio, Finland	University of Turku; University of Eastern Finland	Chen, Z (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	zchen@utu.fi		Chen, Zhi/0000-0002-4658-7463	Academy of Finland [122330]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland (www.aka.fi. Decision No. 122330) and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; SELANDER K, 1994, CALCIFIED TISSUE INT, V55, P368, DOI 10.1007/BF00299317; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	29	73	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18689	10.1371/journal.pone.0018689	http://dx.doi.org/10.1371/journal.pone.0018689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494622	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800037
J	D'Amato, FR; Zanettini, C; Lampis, V; Coccurello, R; Pascucci, T; Ventura, R; Puglisi-Allegra, S; Spatola, CAM; Pesenti-Gritti, P; Oddi, D; Moles, A; Battaglia, M				D'Amato, Francesca R.; Zanettini, Claudio; Lampis, Valentina; Coccurello, Roberto; Pascucci, Tiziana; Ventura, Rossella; Puglisi-Allegra, Stefano; Spatola, Chiara A. M.; Pesenti-Gritti, Paola; Oddi, Diego; Moles, Anna; Battaglia, Marco			Unstable Maternal Environment, Separation Anxiety, and Heightened CO2 Sensitivity Induced by Gene-by-Environment Interplay	PLOS ONE			English	Article							CARBON-DIOXIDE; PANIC DISORDER; VENTILATORY RESPONSE; INBRED STRAINS; BEHAVIOR; MICE; MOUSE; TWIN; PSYCHOPATHOLOGY; HYPERCAPNIA	Background: In man, many different events implying childhood separation from caregivers/unstable parental environment are associated with heightened risk for panic disorder in adulthood. Twin data show that the occurrence of such events in childhood contributes to explaining the covariation between separation anxiety disorder, panic, and the related psychobiological trait of CO2 hypersensitivity. We hypothesized that early interference with infant-mother interaction could moderate the interspecific trait of response to CO2 through genetic control of sensitivity to the environment. Methodology: Having spent the first 24 hours after birth with their biological mother, outbred NMRI mice were cross-fostered to adoptive mothers for the following 4 post-natal days. They were successively compared to normally-reared individuals for: number of ultrasonic vocalizations during isolation, respiratory physiology responses to normal air (20%O-2), CO2-enriched air (6% CO2), hypoxic air (10%O-2), and avoidance of CO2-enriched environments. Results: Cross-fostered pups showed significantly more ultrasonic vocalizations, more pronounced hyperventilatory responses (larger tidal volume and minute volume increments) to CO2-enriched air and heightened aversion towards CO2-enriched environments, than normally-reared individuals. Enhanced tidal volume increment response to 6% CO2 was present at 16-20, and 75-90 postnatal days, implying the trait's stability. Quantitative genetic analyses of unrelated individuals, sibs and half-sibs, showed that the genetic variance for tidal volume increment during 6% CO2 breathing was significantly higher (Bartlett chi = 8.3, p = 0.004) among the cross-fostered than the normally-reared individuals, yielding heritability of 0.37 and 0.21 respectively. These results support a stress-diathesis model whereby the genetic influences underlying the response to 6% CO2 increase their contribution in the presence of an environmental adversity. Maternal grooming/licking behaviour, and corticosterone basal levels were similar among cross-fostered and normally-reared individuals. Conclusions: A mechanism of gene-by-environment interplay connects this form of early perturbation of infant-mother interaction, heightened CO2 sensitivity and anxiety. Some non-inferential physiological measurements can enhance animal models of human neurodevelopmental anxiety disorders.	[Lampis, Valentina; Spatola, Chiara A. M.; Pesenti-Gritti, Paola; Battaglia, Marco] Univ Vita Salute San Raffaele, Acad Ctr Study Behav Plast, Milan, Italy; [Pascucci, Tiziana; Ventura, Rossella; Puglisi-Allegra, Stefano] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy; [Pascucci, Tiziana; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Ventura, Rossella] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy; [Moles, Anna] Genomnia, Lainate, Italy; [Battaglia, Marco] Ist Sci San Raffaele, Dept Clin Neurosci, Milan, Italy; [D'Amato, Francesca R.; Zanettini, Claudio; Coccurello, Roberto; Oddi, Diego; Moles, Anna] CNR, Cell Biol & Neurobiol Inst, Rome, Italy	Vita-Salute San Raffaele University; IRCCS Santa Lucia; Sapienza University Rome; University of L'Aquila; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR)	D'Amato, FR (corresponding author), CNR, Cell Biol & Neurobiol Inst, Rome, Italy.	marco.battaglia@unisr.it	Coccurello, Roberto/F-8460-2015; Lampis, Valentina/AAA-9001-2022; Puglisi-Allegra, Stefano/ABI-7468-2020; Pascucci, Tiziana/AAB-9706-2019; Ventura, Rossella/AAA-8816-2019	Lampis, Valentina/0000-0003-0895-7918; Puglisi-Allegra, Stefano/0000-0002-9433-2000; Ventura, Rossella/0000-0002-7601-8683; COCCURELLO, ROBERTO/0000-0001-7059-7015; D'Amato, Francesca/0000-0002-4577-4574; Spatola, Chiara/0000-0003-4807-9566; Pascucci, Tiziana/0000-0003-1520-7373; Moles, Anna/0000-0002-5805-5763	Italian Ministry of University; Fondazione Telethon Funding Source: Custom	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Fondazione Telethon(Fondazione Telethon)	Supported in part by grants from the Italian Ministry of University and Research PRIN 2008 grant (MB and FRD), from The Region Lombardy Grant Funding for Scientific and Technological Partnerships grant SAL-25/16848 (MB), and by an award granted by the Anna Villa & Felice Rusconi Foundation (MB). FRD, AM, CZ, RC and DO were supported by funds from Regione Lazio for "Sviluppo della Ricerca sul Cervello"; FRD and AM were also partially supported by Telethon, Italy (Grant no. GGP05220). VL, CAMS, and PP-G are in the San Raffaele University PhD Program in Developmental Psychopathology, supported in part by the CARIPLO Foundation "Human Talents" Grant for Academic Centres of Excellence in Post-Graduate Teaching (Dr. Battaglia, recipient). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSON DJ, 1984, AM J PSYCHIAT, V141, P572; Barbazanges A, 1996, J NEUROSCI, V16, P7783; Bartolomucci A, 2004, GENES BRAIN BEHAV, V3, P115, DOI 10.1111/j.1601-183X.2003.00059.x; BATTAGLIA M, 1995, AM J PSYCHIAT, V152, P1362; Battaglia M, 2005, NEUROSCI BIOBEHAV R, V29, P169, DOI 10.1016/j.neubiorev.2004.06.013; Battaglia M, 2008, AM J MED GENET B, V147B, P586, DOI 10.1002/ajmg.b.30647; Battaglia M, 2007, J PSYCHIATR RES, V41, P906, DOI 10.1016/j.jpsychires.2006.12.002; Battaglia M, 2009, ARCH GEN PSYCHIAT, V66, P64, DOI 10.1001/archgenpsychiatry.2008.513; Bavis RW, 2008, J APPL PHYSIOL, V104, P1220, DOI 10.1152/japplphysiol.01086.2007; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Falconer D. S., 1996, INTRO QUANTITATIVE G; Forman EM, 2003, J CLIN CHILD ADOLESC, V32, P94, DOI 10.1207/S15374424JCCP3201_09; Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.0.CO;2-#; Gaultier C, 2008, J APPL PHYSIOL, V104, P1522, DOI 10.1152/japplphysiol.01266.2007; Genest SE, 2004, J PHYSIOL-LONDON, V554, P543, DOI 10.1113/jphysiol.2003.052894; Genest SE, 2007, J APPL PHYSIOL, V102, P1416, DOI 10.1152/japplphysiol.00454.2006; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Griez EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000987; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Han F, 2000, RESP PHYSIOL, V121, P247, DOI 10.1016/S0034-5687(00)00132-8; Jacob RG, 1996, AM J PSYCHIAT, V153, P503; Kas MJH, 2007, MOL PSYCHIATR, V12, P324, DOI 10.1038/sj.mp.4001979; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Klein RG, 1995, CLIN NEUROPHARMACOL, V18, pS7; MACLEAN PD, 1985, ARCH GEN PSYCHIAT, V42, P405; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Mather K, 1982, BIOMETRICAL GENETICS; MILLHORN DE, 1986, J APPL PHYSIOL, V61, P1249, DOI 10.1152/jappl.1986.61.4.1249; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Ogliari A, 2010, PSYCHOTHER PSYCHOSOM, V79, P48, DOI 10.1159/000259417; Pine DS, 2000, ARCH GEN PSYCHIAT, V57, P960, DOI 10.1001/archpsyc.57.10.960; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Ricceri L, 2007, BEHAV BRAIN RES, V176, P40, DOI 10.1016/j.bbr.2006.08.024; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012; Shoji H, 2009, DEV PSYCHOBIOL, V51, P345, DOI 10.1002/dev.20375; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Smoller JW, 1998, AM J PSYCHIAT, V155, P1152, DOI 10.1176/ajp.155.9.1152; Spatola CAM, 2011, AM J MED GENET B, V156B, P79, DOI 10.1002/ajmg.b.31144; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; TANKERSLEY CG, 1994, AM J PHYSIOL-REG I, V267, pR1371, DOI 10.1152/ajpregu.1994.267.5.R1371; Terleph TA, 2006, AM J PSYCHIAT, V163, P738, DOI 10.1176/appi.ajp.163.4.738; Upton KJ, 2010, DEV PSYCHOBIOL, V52, P453, DOI 10.1002/dev.20448; van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769; WESTBERG P, 1991, BIOL PSYCHIAT, V30, P247, DOI 10.1016/0006-3223(91)90109-Y; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	59	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18637	10.1371/journal.pone.0018637	http://dx.doi.org/10.1371/journal.pone.0018637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494633	Green Published, gold, Green Accepted			2022-12-27	WOS:000289292800033
J	Duncan, DS; Miller, SD				Duncan, D'Anne S.; Miller, Stephen D.			CNS Expression of B7-H1 Regulates Pro-Inflammatory Cytokine Production and Alters Severity of Theiler's Virus-Induced Demyelinating Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ADAPTIVE IMMUNE-RESPONSES; SELF MYELIN EPITOPES; B7 FAMILY; MULTIPLE-SCLEROSIS; ENDOGENOUS PRESENTATION; CELL-PROLIFERATION; RESIDENT APCS; INFECTED MICE	The CNS is a unique organ due to its limited capacity for immune surveillance. As macrophages of the CNS, microglia represent a population originally known for the ability to assist neuronal stability, are now appreciated for their role in initiating and regulating immune responses in the brain. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease is a mouse model of multiple sclerosis ( MS). In response to TMEV infection in vitro, microglia produce high levels of inflammatory cytokines and chemokines, and are efficient antigen-presenting cells (APCs) for activating CD4(+) T cells. However, the regulatory function of microglia and other CNS-infiltrating APCs in response to TMEV in vivo remains unclear. Here we demonstrate that microglia increase expression of proliferating cell nuclear antigen ( PCNA), and phenotypically express high levels of major histocompatibility complex (MHC)-Class I and II in response to acute infection with TMEV in SJL/J mice. Microglia increase expression of the inhibitory co-stimulatory molecule, B7-H1 as early as day 5 post-infection, while CNS-infiltrating CD11b(+)CD11c(-)CD45(HIGH) monocytes/macrophages and CD11b(+)CD11c(+)CD45(HIGH) dendritic cells upregulate expression of B7-H1 by day 3 post-infection. Utilizing a neutralizing antibody, we demonstrate that B7-H1 negatively regulates TMEV-specific ex vivo production of interferon (IFN)-gamma, interleukin (IL)-17, IL-10, and IL-2 from CD4(+) and CD8(+) T cells. In vivo blockade of B7-H1 in SJL/J mice significantly exacerbates clinical disease symptoms during the chronic autoimmune stage of TMEV-IDD, but only has minimal effects on viral clearance. Collectively, these results suggest that CNS expression of B7-H1 regulates activation of TMEV-specific T cells, which affects protection against TMEV-IDD.	[Duncan, D'Anne S.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Duncan, DS (corresponding author), Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu			National Institutes of Health [NS-062365]; National Multiple Sclerosis Society [RG 4294A9/1]; Northwestern University [T32 AI060523-04]; NRSA [F31 NS061621]; Northwestern University Alliance for Graduate Education and the Professoriate (AGEP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062365, F31NS061621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Northwestern University; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Alliance for Graduate Education and the Professoriate (AGEP)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health R01 Grant NS-062365 and National Multiple Sclerosis Society Grant RG 4294A9/1. DSD was supported by Northwestern University Viral Replication Training Grant (T32 AI060523-04), NRSA Predoctoral Fellowship (F31 NS061621), and the Northwestern University Alliance for Graduate Education and the Professoriate (AGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bowen JL, 2009, J IMMUNOL, V183, P6971, DOI 10.4049/jimmunol.0902193; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Carson MJ, 1999, J NEUROSCI RES, V55, P1; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hamo L, 2007, GLIA, V55, P1169, DOI 10.1002/glia.20538; Katz-Levy Y, 1999, J CLIN INVEST, V104, P599, DOI 10.1172/JCI7292; Katz-Levy Y, 2000, J IMMUNOL, V165, P5304, DOI 10.4049/jimmunol.165.9.5304; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Lafon M, 2008, J IMMUNOL, V180, P7506, DOI 10.4049/jimmunol.180.11.7506; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Miller SD, 2001, J AUTOIMMUN, V16, P219, DOI 10.1006/jaut.2000.0489; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Olson JK, 2001, J VIROL, V75, P9780, DOI 10.1128/JVI.75.20.9780-9789.2001; Phares TW, 2009, J IMMUNOL, V182, P5430, DOI 10.4049/jimmunol.0803557; Ponomarev ED, 2005, J IMMUNOL METHODS, V300, P32, DOI 10.1016/j.jim.2005.02.011; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; SCHREINER B, 2008, EUR J IMMUNOL; Williams K, 2002, AM J PATHOL, V161, P575, DOI 10.1016/S0002-9440(10)64213-7	30	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18548	10.1371/journal.pone.0018548	http://dx.doi.org/10.1371/journal.pone.0018548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494618	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800028
J	Sun, SC; Wang, ZB; Xu, YN; Lee, SE; Cui, XS; Kim, NH				Sun, Shao-Chen; Wang, Zhen-Bo; Xu, Yong-Nan; Lee, Seung-Eun; Cui, Xiang-Shun; Kim, Nam-Hyung			Arp2/3 Complex Regulates Asymmetric Division and Cytokinesis in Mouse Oocytes	PLOS ONE			English	Article							POLAR BODY FORMATION; ACTIN-BASED MOTILITY; N-WASP; MEIOTIC SPINDLE; F-ACTIN; CORTACTIN; CDC42; POLYMERIZATION; ACTIVATION; NUCLEATOR	Mammalian oocyte meiotic maturation involves oocyte polarization and a unique asymmetric division, but until now, the underlying mechanisms have been poorly understood. Arp2/3 complex has been shown to regulate actin nucleation and is widely involved in a diverse range of processes such as cell locomotion, phagocytosis and the establishment of cell polarity. Whether Arp2/3 complex participates in oocyte polarization and asymmetric division is unknown. The present study investigated the expression and functions of Arp2/3 complex during mouse oocyte meiotic maturation. Immunofluorescent staining showed that the Arp2/3 complex was restricted to the cortex, with a thickened cap above the meiotic apparatus, and that this localization pattern was depended on actin. Disruption of Arp2/3 complex by a newly-found specific inhibitor CK666, as well as by Arpc2 and Arpc3 RNAi, resulted in a range of effects. These included the failure of asymmetric division, spindle migration, and the formation and completion of oocyte cytokinesis. The formation of the actin cap and cortical granule-free domain (CGFD) was also disrupted, which further confirmed the disruption of spindle migration. Our data suggest that the Arp2/3 complex probably regulates oocyte polarization through its effect on spindle migration, asymmetric division and cytokinesis during mouse oocyte meiotic maturation.	[Sun, Shao-Chen; Xu, Yong-Nan; Lee, Seung-Eun; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Wang, Zhen-Bo] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Chungbuk National University; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, SC (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.	nhkim@chungbuk.ac.kr			Biogreen 21 Program, RDA, Republic of Korea [PJ007124201005, PJ007076201004, PJ007076201005]	Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	The funding for this work was provided by Biogreen 21 Program (PJ007124201005, PJ007076201004 and PJ007076201005), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; BRUNET S, HUM REPROD UPDATE; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Dahl JP, 2003, J NEUROSCI, V23, P3343; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Johnston SA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-65; Kutsuna H, 2004, AM J PHYSIOL-CELL PH, V286, pC55, DOI 10.1152/ajpcell.00131.2003; Lin Sheng-Li, 2010, Front Biosci (Elite Ed), V2, P1254; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Ma CQ, 2006, CURR BIOL, V16, P214, DOI 10.1016/j.cub.2005.11.067; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; SUN SC, 2011, MOL HUM REP IN PRESS; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	45	142	145	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18392	10.1371/journal.pone.0018392	http://dx.doi.org/10.1371/journal.pone.0018392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494665	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800012
J	Troszak, GD; Rubinsky, B				Troszak, Gregory D.; Rubinsky, Boris			A Theoretical Analysis of the Feasibility of a Singularity-Induced Micro-Electroporation System	PLOS ONE			English	Article							HIGH ELECTRIC-FIELDS; MEMBRANE ELECTROPORATION; CELL-MEMBRANES; GENE-TRANSFER; MICROORGANISMS; SIMULATION; MECHANISM; PULSES; MODEL	Electroporation, the permeabilization of the cell membrane lipid bilayer due to a pulsed electric field, has important implications in the biotechnology, medicine, and food industries. Traditional macro and micro-electroporation devices have facing electrodes, and require significant potential differences to induce electroporation. The goal of this theoretical study is to investigate the feasibility of singularity-induced micro-electroporation; an electroporation configuration aimed at minimizing the potential differences required to induce electroporation by separating adjacent electrodes with a nanometer-scale insulator. In particular, this study aims to understand the effect of ( 1) insulator thickness and ( 2) electrode kinetics on electric field distributions in the singularity-induced micro-electroporation configuration. A non-dimensional primary current distribution model of the micro-electroporation channel shows that while increasing insulator thickness results in smaller electric field magnitudes, electroporation can still be performed with insulators thick enough to be made with microfabrication techniques. Furthermore, a secondary current distribution model of the singularity-induced micro-electroporation configuration with inert platinum electrodes and water electrolyte indicates that electrode kinetics do not inhibit charge transfer to the extent that prohibitively large potential differences are required to perform electroporation. These results indicate that singularity-induced micro-electroporation could be used to develop an electroporation system that consumes minimal power, making it suitable for remote applications such as the sterilization of water and other liquids.	[Troszak, Gregory D.; Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Grad Program Biophys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Troszak, GD (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	gdtroszak@berkeley.edu			Arnold and Barbara Silverman Distinguished Professorship in Bioengineering	Arnold and Barbara Silverman Distinguished Professorship in Bioengineering	This research was supported by funds provided by the Arnold and Barbara Silverman Distinguished Professorship in Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidor I. G., 1979, J ELECTROANAL CHEM, V104, P37, DOI DOI 10.1016/S0022-0728(79)81006-2; Andreason Grai L., 1993, Journal of Tissue Culture Methods, V15, P56, DOI 10.1007/BF01667362; BARD AJ, 2001, ELECTROCHEMICAL METH, pCH6; Broers AN, 1996, MICROELECTRON ENG, V32, P131, DOI 10.1016/0167-9317(95)00368-1; Chen C, 2006, MED BIOL ENG COMPUT, V44, P5, DOI 10.1007/s11517-005-0020-2; DeZuane J., 1997, HDB DRINKING WATER Q; Diaz-Rivera RE, 2006, BIOMED MICRODEVICES, V8, P25, DOI 10.1007/s10544-006-6379-5; Fox MB, 2006, ANAL BIOANAL CHEM, V385, P474, DOI 10.1007/s00216-006-0327-3; Golberg A, 2010, IEEE T PLASMA SCI, V38, P3211, DOI 10.1109/TPS.2010.2065246; Golberg A, 2009, AAPS PHARMSCITECH, V10, P881, DOI 10.1208/s12249-009-9277-3; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; Ho SY, 1997, J FOOD ENG, V31, P69, DOI 10.1016/S0260-8774(96)00052-0; Ho SY, 1996, CRIT REV BIOTECHNOL, V16, P349, DOI 10.3109/07388559609147426; Huang Y, 1999, BIOMED MICRODEVICES, V2, P145, DOI 10.1023/A:1009901821588; Knorr D, 2001, TRENDS FOOD SCI TECH, V12, P129, DOI 10.1016/S0924-2244(01)00069-3; MASTWIJK HC, 2004, INT REV FOOD SCI TEC, V3, P106; Neu WK, 2010, SER BIOMED ENG, P85, DOI 10.1007/978-3-642-05420-4_4; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; NEWMAN E, 2010, ADV ELECTROPORATION; Owa S., 2008, P SPIE, V7140; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Prasanna GL, 1997, BIOPROCESS ENG, V16, P261, DOI 10.1007/s004490050319; Prentice G., 1991, ELECTROCHEMICAL ENG; SALE AJH, 1968, BIOCHIM BIOPHYS ACTA, V163, P37, DOI 10.1016/0005-2736(68)90030-8; SALE AJH, 1967, BIOCHIM BIOPHYS ACTA, V148, P781, DOI 10.1016/0304-4165(67)90052-9; Saulis G, 2005, BIOELECTROCHEMISTRY, V67, P101, DOI 10.1016/j.bioelechem.2005.03.001; SUGAR IP, 1987, BIOPHYS CHEM, V26, P321, DOI 10.1016/0301-4622(87)80033-9; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Troszak GD, 2010, BIOMED MICRODEVICES, V12, P833, DOI 10.1007/s10544-010-9437-y; Tsong T Y, 1985, Bibl Haematol, P108; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; WHO, 2009, DIARRH DIS; WHO and United Nations Children's Fund, 2000, GLOB WAT SUPPL SAN A; WONG TK, 1982, BIOCHEM BIOPH RES CO, V107, P584, DOI 10.1016/0006-291X(82)91531-5; Wouters PC, 1999, APPL ENVIRON MICROB, V65, P5364; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4	38	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18523	10.1371/journal.pone.0018523	http://dx.doi.org/10.1371/journal.pone.0018523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494612	gold, Green Published			2022-12-27	WOS:000289292800027
J	Xu, J; Mao, ZG; Kong, M; Hu, LH; Ye, CY; Xu, CG; Rong, S; Sun, LJ; Wu, J; Dai, B; Chen, DP; Zhu, YX; Zhang, YX; Zhang, YQ; Zhao, XZ; Mei, CL				Xu, Jing; Mao, Zhi-Guo; Kong, Mei; Hu, Liang-Hao; Ye, Chao-Yang; Xu, Cheng-Gang; Rong, Shu; Sun, Li-Jun; Wu, Jun; Dai, Bing; Chen, Dong-Ping; Zhu, Yu-Xian; Zhang, Yi-Xiang; Zhang, Yu-Qiang; Zhao, Xue-Zhi; Mei, Chang-Lin			Scientific Publications in Nephrology and Urology Journals from Chinese Authors in East Asia: A 10-Year Survey of the Literature	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS	Background: Diseases of the kidneys and genitourinary tract are common health problems that affect people of all ages and demographic backgrounds. In this study, we compared the quantity and quality of nephrological and urological articles published in international journals from the three major regions of China: the mainland (ML), Hong Kong (HK), and Taiwan (TW). Methods: Nephrological and urological articles originating from ML, TW, and HK that were published in 61 journals from 1999-2008 were retrieved from the PubMed database. We recorded the numbers of total articles, clinical trials, randomized controlled trials, case reports, impact factors (IF), citations, and articles published in the leading general-medicine journals. We used these data to compare the quantity and quality of publication output from the three regions. Results: The total number of articles increased significantly from 1999 to 2008 in the three regions. The number of articles from ML has exceeded that from HK since 2004, and surpassed that from TW in 2008. Publications from TW had the highest accumulated IF, total citations of articles, and the most articles published in leading general-medicine journals. However, HK publications had the highest average IF. Although ML produced the largest quantity of articles, it exhibited the lowest quality among the three regions. Conclusion: The number of nephrological and urological publications originating from the three major regions of China increased significantly from 1999 to 2008. The annual number of publications by ML researchers exceeded those from TW and HK. However, the quality of articles from TW and HK was higher than that from ML.	[Xu, Jing; Mao, Zhi-Guo; Ye, Chao-Yang; Xu, Cheng-Gang; Rong, Shu; Sun, Li-Jun; Wu, Jun; Dai, Bing; Chen, Dong-Ping; Zhu, Yu-Xian; Zhang, Yi-Xiang; Zhang, Yu-Qiang; Zhao, Xue-Zhi; Mei, Chang-Lin] Second Mil Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R China; [Kong, Mei] Sun Yat Sen Univ, Affiliated Hosp 5, Clin Lab, Zhuhai, Guangdong, Peoples R China; [Hu, Liang-Hao] Second Mil Med Univ, Changhai Hosp, Dept Internal Med, Shanghai, Peoples R China	Naval Medical University; Sun Yat Sen University; Naval Medical University	Xu, J (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R China.	chlmei@hotmail.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Zhang, Yuqiang/0000-0003-4175-600X	National Nature Science Fund of China [81000281]; Medical Educational Reforming and Research Grant; Changzheng Hospital; Second Military Medical University; Second Military Medical University, Shanghai, China	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Medical Educational Reforming and Research Grant; Changzheng Hospital; Second Military Medical University; Second Military Medical University, Shanghai, China	Z. Mao is a Fellow of the International Society of Nephrology (ISN), and this work was funded in part by the National Nature Science Fund of China (No. 81000281), Medical Educational Reforming and Research Grant, Changzheng Hospital, Second Military Medical University and the Outstanding Young Investigator Fund of Second Military Medical University, Shanghai, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chuang AY, 2007, UROLOGY, V69, P915, DOI 10.1016/j.urology.2007.01.051; D'Amico G, 2005, KIDNEY INT, V68, pS46, DOI 10.1111/j.1523-1755.2005.09809.x; Institute for Scientific Information, ISI J CIT REP; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lin JL, 1999, ANN INTERN MED, V130, P7, DOI 10.7326/0003-4819-130-1-199901050-00003; Lin SY, 2003, KIDNEY INT, V63, P108, DOI 10.1046/j.1523-1755.63.s83.22.x; Oh HC, 2009, SINGAP MED J, V50, P749; *STATA CORP, STATA STAT SOFTW VER; Wang Y, 2009, HYPERTENS RES, V32, P444, DOI 10.1038/hr.2009.38; Xie YS, 2008, AM J NEPHROL, V28, P1, DOI 10.1159/000108755; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Zuo L, 2010, CLIN NEPHROL, V74, pS20; J SEARCH SCI CITATIO; TOP 20 COUNTRY RANKI	17	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e14781	10.1371/journal.pone.0014781	http://dx.doi.org/10.1371/journal.pone.0014781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494662	Green Published, Green Submitted, gold			2022-12-27	WOS:000289292800001
J	Chiang, J; Hodes, RJ				Chiang, Jeffrey; Hodes, Richard J.			Cbl Enforces Vav1 Dependence and a Restricted Pathway of T Cell Development	PLOS ONE			English	Article							ADAPTER PROTEIN SLP-76; C-CBL; DIFFERENTIAL REQUIREMENT; TYROSINE PHOSPHORYLATION; LYMPHOCYTE DEVELOPMENT; NEGATIVE REGULATION; RECEPTOR SIGNALS; ACTIVATION; ZAP-70; FAMILY	Extensive studies of pre-TCR- and TCR-dependent signaling have led to characterization of a pathway deemed essential for efficient T cell development, and comprised of a cascade of sequential events involving phosphorylation of Lck and ZAP-70, followed by phosphorylation of LAT and SLP-76, and subsequent additional downstream events. Of interest, however, reports from our lab as well as others have indicated that the requirements for ZAP-70, LAT, and SLP-76 are partially reversed by inactivation of c-Cbl (Cbl), an E3 ubiquitin ligase that targets multiple molecules for ubiquitination and degradation. Analysis of signaling events in these Cbl knockout models, including the recently reported analysis of SLP-76 transgenes defective in interaction with Vav1, suggested that activation of Vav1 might be a critical event in alternative pathways of T cell development. To extend the analysis of signaling requirements for thymic development, we have therefore assessed the effect of Cbl inactivation on the T cell developmental defects that occur in Vav1-deficient mice. The defects in Vav1-deficient thymic development, including a marked defect in DN3-DN4 transition, were completely reversed by Cbl inactivation, accompanied by enhanced phosphorylation of PLC-gamma 1 and ERKs in response to pre-TCR/TCR cross-linking of Vav1(-/-)Cbl(-/-)DP thymocytes. Taken together, these results suggest a substantially modified paradigm for pre-TCR/TCR signaling and T cell development. The observed consensus pathways of T cell development, including requirements for ZAP-70, LAT, SLP-76, and Vav1, appear to reflect the restriction by Cbl of an otherwise much broader set of molecular pathways capable of mediating T cell development.	[Chiang, Jeffrey; Hodes, Richard J.] NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; [Hodes, Richard J.] NIA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chiang, J (corresponding author), NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov			National Institutes of Health (NIH), National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC009281] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; Chiang YJ, 2009, J BIOL CHEM, V284, P4429, DOI 10.1074/jbc.M808679200; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; FitzerAttas CJ, 1997, J BIOL CHEM, V272, P8551, DOI 10.1074/jbc.272.13.8551; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; QI Q, 2007, SCI STKE, pPE39; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; Thien CBF, 1999, J IMMUNOL, V162, P7133; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Vacchio MS, 2005, J IMMUNOL, V174, P4657, DOI 10.4049/jimmunol.174.8.4657; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18542	10.1371/journal.pone.0018542	http://dx.doi.org/10.1371/journal.pone.0018542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490975	Green Submitted, Green Published, gold			2022-12-27	WOS:000289238700022
J	Lenz, KM; Wright, CL; Martin, RC; McCarthy, MM				Lenz, Kathryn M.; Wright, Christopher L.; Martin, Ryan C.; McCarthy, Margaret M.			Prostaglandin E-2 Regulates AMPA Receptor Phosphorylation and Promotes Membrane Insertion in Preoptic Area Neurons and Glia during Sexual Differentiation	PLOS ONE			English	Article							PROTEIN-KINASE-A; DENDRITIC SPINE PROLIFERATION; SYNAPTIC-TRANSMISSION; PLASTICITY; BEHAVIOR; MASCULINIZATION; INDUCTION; ESTRADIOL; BRAIN; ASTROCYTES	Sexual differentiation of the rodent brain is dependent upon the organizing actions of the steroid hormone, estradiol. In the preoptic area, a brain region critical for the expression of adult reproductive behavior, there are twice as many dendritic spine synapses per unit length on newborn male neurons compared to female neurons and this sex difference correlates with the expression of adult male copulatory behavior. The sex difference in the POA is achieved via estradiol's upregulation of the membrane-derived lipid signaling molecule prostaglandin E-2 (PGE(2)); PGE(2) is necessary and sufficient to masculinize both dendritic spine density and adult sexual behavior in rats. We have previously shown that PGE(2) activates EP2 and EP4 receptors which increases protein kinase A (PKA) activity and that masculinized dendritic spine density and sex behavior are both dependent upon PKA as well as activation of AMPA type glutamate receptors. In the current experiments, we build upon this signaling cascade by determining that PGE(2) induces phosphorylation of the AMPA receptor subunit, GluR1, which leads to increased AMPA receptor insertion at the membrane. Treating female pups on the day of birth with PGE(2) induced the phosphorylation of GluR1 at the PKA-sensitive site within 2 hours of treatment, an effect that was blocked by co-administration of the PKA/AKAP inhibitor, HT31 with PGE(2). Brief treatment of mixed neuronal/glial POA cultures with PGE(2) or the cAMP/PKA stimulator, forskolin, increased membrane associated GluR1 in both neurons and glia. We speculate that PGE(2) induced increases in AMPA receptor associated with the membrane underlies our previously observed increase in dendritic spine density and is a critical component in the masculinization of rodent sex behavior.	[Lenz, Kathryn M.; Martin, Ryan C.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Lenz, Kathryn M.; Martin, Ryan C.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Wright, Christopher L.] Loyola Univ Maryland, Dept Biol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Loyola University Maryland	Lenz, KM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	kmlenz@umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726	U.S. National Institutes of Health [R01 MH052716, T32 NS007375]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the U.S. National Institutes of Health R01 MH052716 (MMM) and T32 NS007375. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Amateau SK, 2002, J NEUROSCI, V22, P8586; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; Dziedzic B, 2003, J NEUROSCI, V23, P915; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Koch H, 2010, J NEUROSCI, V30, P11678, DOI 10.1523/JNEUROSCI.4665-09.2010; Ma YJ, 1997, ENDOCRINOLOGY, V138, P19, DOI 10.1210/en.138.1.19; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Perrot-Sinal TS, 2001, BRAIN RES, V922, P201, DOI 10.1016/S0006-8993(01)03167-5; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; SEIL FJ, 1992, EXP NEUROL, V117, P85, DOI 10.1016/0014-4886(92)90114-6; Seil Fredrick J., 1997, Journal of Neural Transplantation and Plasticity, V6, P1; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Wright CL, 2008, DEV NEUROBIOL, V68, P1406, DOI 10.1002/dneu.20665; Wright CL, 2009, J NEUROSCI, V29, P13274, DOI 10.1523/JNEUROSCI.3603-09.2009; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	25	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18500	10.1371/journal.pone.0018500	http://dx.doi.org/10.1371/journal.pone.0018500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490976	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700017
J	Wang, R; Ahmed, J; Wang, GQ; Hassan, I; Strulovici-Barel, Y; Hackett, NR; Crystal, RG				Wang, Rui; Ahmed, Joumana; Wang, Guoqing; Hassan, Ibrahim; Strulovici-Barel, Yael; Hackett, Neil R.; Crystal, Ronald G.			Down-Regulation of the Canonical Wnt beta-Catenin Pathway in the Airway Epithelium of Healthy Smokers and Smokers with COPD	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEINS; STEM-CELLS; GENE-EXPRESSION; LUNG DEVELOPMENT; CIGARETTE-SMOKE; OVINE UTERUS; BASAL-CELLS; DIFFERENTIATION; ACTIVATION; INHIBITION	Background: The Wnt pathway mediates differentiation of epithelial tissues; depending on the tissue types, Wnt can either drive or inhibit the differentiation process. We hypothesized that key genes in the Wnt pathway are suppressed in the human airway epithelium under the stress of cigarette smoking, a stress associated with dysregulation of the epithelial differentiated state. Methodology/Principal Findings: Microarrays were used to assess the expression of Wnt-related genes in the small airway epithelium (SAE) obtained via bronchoscopy and brushing of healthy nonsmokers, healthy smokers, and smokers with COPD. Thirty-three of 56 known Wnt-related genes were expressed in the SAE. Wnt pathway downstream mediators beta-catenin and the transcription factor 7-like 1 were down-regulated in healthy smokers and smokers with COPD, as were many Wnt target genes. Among the extracellular regulators that suppress the Wnt pathway, secreted frizzled-related protein 2 (SFRP2), was up-regulated 4.3-fold in healthy smokers and 4.9-fold in COPD smokers, an observation confirmed by TaqMan Real-time PCR, Western analysis and immunohistochemistry. Finally, cigarette smoke extract mediated up-regulation of SFRP2 and down-regulation of Wnt target genes in airway epithelial cells in vitro. Conclusions/Significance: Smoking down-regulates the Wnt pathway in the human airway epithelium. In the context that Wnt pathway plays an important role in differentiation of epithelial tissues, the down-regulation of Wnt pathway may contribute to the dysregulation of airway epithelium differentiation observed in smoking-related airway disorders.	[Wang, Rui; Ahmed, Joumana; Wang, Guoqing; Hassan, Ibrahim; Strulovici-Barel, Yael; Hackett, Neil R.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University	Wang, R (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	Hassan, Ibrahim/ABH-1285-2020	Hassan, Ibrahim/0000-0001-6863-4593	National Institutes of Health [R01 HL074326, P50 HL084936, UL1-RR024996, 1T32HL094284]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936, R01HL074326, T32HL094284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by National Institutes of Health R01 HL074326, P50 HL084936; UL1-RR024996; and 1T32HL094284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bishop AE, 2004, CELL PROLIFERAT, V37, P89, DOI 10.1111/j.1365-2184.2004.00302.x; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; COSIO MG, 1980, AM REV RESPIR DIS, V122, P265; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Das AV, 2008, DEV NEUROSCI-BASEL, V30, P389, DOI 10.1159/000178017; De Langhe Stijn P, 2008, Organogenesis, V4, P100; Deb A, 2008, STEM CELLS, V26, P35, DOI 10.1634/stemcells.2007-0475; DEMOLY P, 1994, AM J RESP CRIT CARE, V150, P214, DOI 10.1164/ajrccm.150.1.7912988; Descamps S, 2008, CELL TISSUE RES, V332, P299, DOI 10.1007/s00441-008-0574-z; Esteve P, 2003, J CELL SCI, V116, P2471, DOI 10.1242/jcs.00452; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hayashi K, 2006, BIOL REPROD, V74, P721, DOI 10.1095/biolreprod.105.049718; He B, 2006, Ernst Schering Found Symp Proc, P27; He B, 2005, CLIN LUNG CANCER, V7, P54, DOI 10.3816/CLC.2005.n.022; Heguy A, 2007, PHYSIOL GENOMICS, V29, P139, DOI 10.1152/physiolgenomics.00167.2006; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; Imai K, 2002, CHEST, V121, p7S, DOI 10.1378/chest.121.3_suppl.7S; Jaluria P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-71; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kinnula VL, 2005, THORAX, V60, P693, DOI 10.1136/thx.2004.037473; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; KONIGSHOFF M, 2009, AM J RESP CELL MOL B; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee JL, 2006, BREAST CANCER RES TR, V100, P49, DOI 10.1007/s10549-006-9233-9; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rennard SI, 2007, EUR RESPIR REV, V16, P91, DOI 10.1183/09059180.00010502; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Takayasu H, 2007, J PEDIATR SURG, V42, P426, DOI 10.1016/j.jpedsurg.2006.10.018; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Wagatsuma A, 2007, MOL CELL BIOCHEM, V304, P25, DOI 10.1007/s11010-007-9482-x; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	74	90	97	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e14793	10.1371/journal.pone.0014793	http://dx.doi.org/10.1371/journal.pone.0014793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490961	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700001
J	Levary, DA; Parthasarathy, R; Boder, ET; Ackerman, ME				Levary, David A.; Parthasarathy, Ranganath; Boder, Eric T.; Ackerman, Margaret E.			Protein-Protein Fusion Catalyzed by Sortase A	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; LIGATION; TRANSPEPTIDASE; ACIDS	Chimeric proteins boast widespread use in areas ranging from cell biology to drug delivery. Post-translational protein fusion using the bacterial transpeptidase sortase A provides an attractive alternative when traditional gene fusion fails. We describe use of this enzyme for in vitro protein ligation and report the successful fusion of 10 pairs of protein domains with preserved functionality - demonstrating the robust and facile nature of this reaction.	[Levary, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Parthasarathy, Ranganath; Boder, Eric T.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [Parthasarathy, Ranganath; Boder, Eric T.] Univ Tennessee, Dept Biomol Engn, Knoxville, TN USA	Harvard University; Dartmouth College; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Levary, DA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	Margaret.E.Ackerman@Dartmouth.edu	Boder, Eric T./E-9635-2015; Ackerman, Margaret/B-5944-2012	Boder, Eric T./0000-0003-4095-5680; 	MIT Portugal Program; Harvard University PRISE; Herchel Smith Fellowships	MIT Portugal Program; Harvard University PRISE; Herchel Smith Fellowships	The authors wish to acknowledge funding from the MIT Portugal Program, Harvard University PRISE and Herchel Smith Fellowships and laboratory materials and space kindly provided by Dr. K. Dane Wittrup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Ayers B, 1999, BIOPOLYMERS, V51, P343, DOI 10.1002/(SICI)1097-0282(1999)51:5<343::AID-BIP4>3.0.CO;2-W; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Blaschke UK, 2000, METHOD ENZYMOL, V328, P478, DOI 10.1016/S0076-6879(00)28414-0; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Orcutt KD, 2010, PROTEIN ENG DES SEL, V23, P221, DOI 10.1093/protein/gzp077; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; POPP MW, 2011, P NATL ACAD SCI US; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Pritz S, 2009, ADV EXP MED BIOL, V611, P107, DOI 10.1007/978-0-387-73657-0_47; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Refaei MA, 2011, J BIOMOL NMR, V49, P3, DOI 10.1007/s10858-010-9464-2; SAKAMOTO T, 2010, BIOCONJUG CHEM; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Wu S, 2010, BIOTECHNOL LETT, V32, P1713, DOI 10.1007/s10529-010-0349-y; Wu ZM, 2010, J AM CHEM SOC, V132, P1567, DOI 10.1021/ja906611x	28	73	111	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18342	10.1371/journal.pone.0018342	http://dx.doi.org/10.1371/journal.pone.0018342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494692	Green Submitted, gold, Green Published			2022-12-27	WOS:000289192400022
J	Petersen, TR; Sika-Paotonu, D; Knight, DA; Simkins, HMA; Hermans, IF				Petersen, Troels R.; Sika-Paotonu, Dianne; Knight, Deborah A.; Simkins, Helen M. A.; Hermans, Ian F.			Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+T Cells to Dendritic Cell-Based Vaccines	PLOS ONE			English	Article							KILLER T-CELLS; INNATE IMMUNE-SYSTEM; ANTIGEN IN-VIVO; ALPHA-GALACTOSYLCERAMIDE; CROSS-PRESENTATION; CUTTING EDGE; SOLUBLE-ANTIGEN; MARGINAL ZONE; STEADY-STATE; CD8(+)	Transfer of antigen between antigen-presenting cells (APCs) is potentially a physiologically relevant mechanism to spread antigen to cells with specialized stimulatory functions. Here we show that specific CD8(+) T cell responses induced in response to intravenous administration of antigen-loaded bone marrow-derived dendritic cells (BM-DCs), were ablated in mice selectively depleted of endogenous lymphoid-resident langerin(+) CD8 alpha(+) dendritic cells (DCs), suggesting that the antigen is transferred from the injected cells to resident APCs. In contrast, antigen-specific CD4(+) T cells were primed predominantly by the injected BM-DCs, with only very weak contribution of resident APCs. Crucially, resident langerin(+) CD8 alpha(+) DCs only contributed to the priming of CD8(+) T cells in the presence of maturation stimuli such as intravenous injection of TLR ligands, or by loading the BM-DCs with the glycolipid alpha-galactosylceramide (alpha-GalCer) to recruit the adjuvant activity of activated invariant natural killer-like T (iNKT) cells. In fact, injection of alpha-GalCer-loaded CD1d(-/-) BM-DCs resulted in potent iNKT cell activation, suggesting that this glycolipid antigen can also be transferred to resident CD1d(+) APCs. While iNKT cell activation per se was independent of langerin(+) CD8 alpha(+) DCs, some iNKT cell-mediated activities were reduced, notably release of IL-12p70 and transactivation of NK cells. We conclude that both protein and glycolipid antigens can be exchanged between distinct DC species. These data suggest that the efficacy of DC-based vaccination strategies may be improved by the incorporation of a systemic maturation signal aimed to engage resident APCs in CD8+ T cell priming, and a-GalCer may be particularly well suited to this purpose.	[Petersen, Troels R.; Sika-Paotonu, Dianne; Knight, Deborah A.; Simkins, Helen M. A.; Hermans, Ian F.] Malaghan Inst Med Res, Wellington, New Zealand; [Hermans, Ian F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington	Petersen, TR (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	tpetersen@malaghan.org.nz	Hermans, Ian/I-3961-2013	Hermans, Ian/0000-0002-7584-887X; Sika-Paotonu, Dianne/0000-0003-1930-1551; Petersen, Troels/0000-0002-6378-352X	Health Research Council of New Zealand [06/316, 09/105D]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded by Health Research Council of New Zealand (http://www.hrc.govt.nz) project grants 06/316 and 09/105D. I.F.H. was supported by a New Zealand Health Research Council Sir Charles Hercus Fellowship and DSP was supported by a Health Research Council of New Zealand Pacific Health Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BARRAL P, 2010, NAT IMMUNOL, P1; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Finkelman FD, 1996, J IMMUNOL, V157, P1406; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hermans IF, 2007, J IMMUNOL, V178, P2721, DOI 10.4049/jimmunol.178.5.2721; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hoshino K, 1999, J IMMUNOL, V162, P3749; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lee A, 2006, CARBOHYD RES, V341, P2785, DOI 10.1016/j.carres.2006.09.006; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Millrain M, 2005, J IMMUNOL, V175, P7209, DOI 10.4049/jimmunol.175.11.7209; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shimizu K, 2007, J EXP MED, V204, P2641, DOI 10.1084/jem.20070458; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Stober D, 2003, J IMMUNOL, V170, P2540, DOI 10.4049/jimmunol.170.5.2540; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Taraban VY, 2008, J IMMUNOL, V180, P4615, DOI 10.4049/jimmunol.180.7.4615; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Tomura M, 1999, J IMMUNOL, V163, P93; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; YEWDALL AW, PLOS ONE, V5	57	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17657	10.1371/journal.pone.0017657	http://dx.doi.org/10.1371/journal.pone.0017657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483862	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200009
J	Smith, ST; Chadwick, RS				Smith, Sonya T.; Chadwick, Richard S.			Simulation of the Response of the Inner Hair Cell Stereocilia Bundle to an Acoustical Stimulus	PLOS ONE			English	Article							IMMERSED BOUNDARY METHOD; MECHANOELECTRICAL TRANSDUCTION; CHANNELS; FORCES; MOTION; SPEED	Mammalian hearing relies on a cochlear hydrodynamic sensor embodied in the inner hair cell stereocilia bundle. It is presumed that acoustical stimuli induce a fluid shear-driven motion between the tectorial membrane and the reticular lamina to deflect the bundle. It is hypothesized that ion channels are opened by molecular gates that sense tension in tip-links, which connect adjacent stepped rows of stereocilia. Yet almost nothing is known about how the fluid and bundle interact. Here we show using our microfluidics model how each row of stereocilia and their associated tip links and gates move in response to an acoustical input that induces an orbital motion of the reticular lamina. The model confirms the crucial role of the positioning of the tectorial membrane in hearing, and explains how this membrane amplifies and synchronizes the timing of peak tension in the tip links. Both stereocilia rotation and length change are needed for synchronization of peak tip link tension. Stereocilia length change occurs in response to accelerations perpendicular to the oscillatory fluid shear flow. Simulations indicate that nanovortices form between rows to facilitate diffusion of ions into channels, showing how nature has devised a way to solve the diffusive mixing problem that persists in engineered microfluidic devices.	[Smith, Sonya T.] Howard Univ, Dept Mech Engn, Washington, DC 20059 USA; [Smith, Sonya T.; Chadwick, Richard S.] Natl Inst Deafness & Other Commun Disorders, Sect Auditory Mech, NIH, Bethesda, MD USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Smith, ST (corresponding author), Howard Univ, Dept Mech Engn, Washington, DC 20059 USA.	chadwick@helix.nih.gov			National Institute on Deafness and Other Communication Disorders [DC00033-15]; ORISE fellowship through the NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000033, Z01DC000033, ZIADC000033] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ORISE fellowship through the NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the intramural program project DC00033-15 in the National Institute on Deafness and Other Communication Disorders. STS' sabbatical was funded as an ORISE fellowship through the NIDCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; BILLONE M, 1973, J ACOUST SOC AM, V54, P1143, DOI 10.1121/1.1914361; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; FREEMAN DM, 1990, HEARING RES, V48, P17, DOI 10.1016/0378-5955(90)90196-V; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Karavitaki KD, 2010, J NEUROSCI, V30, P9051, DOI 10.1523/JNEUROSCI.4864-09.2010; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; Rayleigh L, 1911, PHILOS MAG, V21, P697, DOI 10.1080/14786440608637084; Stockie JM, 1998, J COMPUT PHYS, V147, P147, DOI 10.1006/jcph.1998.6086	18	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18161	10.1371/journal.pone.0018161	http://dx.doi.org/10.1371/journal.pone.0018161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483823	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200035
J	Vouldoukis, I; Mazier, D; Moynet, D; Thiolat, D; Malvy, D; Mossalayi, MD				Vouldoukis, Ioannis; Mazier, Dominique; Moynet, Daniel; Thiolat, Denis; Malvy, Denis; Mossalayi, M. Djavad			IgE Mediates Killing of Intracellular Toxoplasma gondii by Human Macrophages through CD23-Dependent, Interleukin-10 Sensitive Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IMMUNOGLOBULIN-E; IFN-GAMMA; LEISHMANIA-MAJOR; IMMUNE-RESPONSE; HUMAN MONOCYTES; CYCLIC-AMP; ACTIVATION; INFECTION; CELLS	BACKGROUND: In addition to helminthic infections, elevated serum IgE levels were observed in many protozoal infections, while their contribution during immune response to these pathogens remained unclear. As IgE/antigen immune complexes (IgE-IC) bind to human cells through FceRI or FceRII/CD23 surface molecules, the present study aimed to identify which functional receptor may be involved in IgE-IC interaction with human macrophages, the major effector cell during parasite infection. METHODOLOGY/PRINCIPAL FINDINGS: Human monocyte-derived macrophages were infected with Toxoplasma gondii before being incubated with IgE-IC. IgE receptors were then identified using appropriate blocking antibodies. The activation of cells and parasiticidal activity were evaluated by mediator quantification and direct counting of infected macrophages. RNAs were extracted and cell supernatants were also collected for their content in tumor necrosis factor (TNF)-alpha, interleukin-10 (IL-10) and nitrites. Sera from symptomatic infected atients were also tested for their content of IgE, IL-10 and nitrites, and compared to values found in healthy donors. Results showed that IgE-IC induced intracellular elimination of parasites by human macrophages. IgE-mediated effect was FceRI-independent, but required cross-linking of surface FceRII/CD23, cell activation and the generation of nitric oxide (NO). Although TNF-alpha was shown to be produced during cell activation, this cytokine had minor contribution in this phenomenon while endogenous and exogenous IL-10 down-regulated parasite killing. Inverse relationship was found between IL-10 and NO expression by infected human macrophages at both mRNA and mediator levels. The relationship between these in vitro data and in vivo levels of various factors in T. gondii infected patients supports the involvement of CD23 antigen and IL-10 expression in disease control. CONCLUSION: Thus, IgE may be considered as immune mediator during antiprotozoal activity of human macrophages through its ability to trigger CD23 signaling. Increased cell activation by IgE-IC may also account for chronic inflammatory diseases observed in some patients.	[Vouldoukis, Ioannis; Mazier, Dominique] Univ Paris 06, Inserm U511, Paris, France; [Moynet, Daniel; Thiolat, Denis; Malvy, Denis; Mossalayi, M. Djavad] Univ Bordeaux, UFR Sci Pharmaceut, Inserm U1035, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Vouldoukis, I (corresponding author), Univ Paris 06, Inserm U511, Paris, France.	djavad.mossalayi@imparph.u-bordeaux2.fr	MALVY, Denis/T-7930-2019					Ahn HJ, 2009, PARASITOL RES, V105, P1445, DOI 10.1007/s00436-009-1577-8; Alexander J, 1998, CHEM IMMUNOL, V70, P81; Alexander J, 1997, PHILOS T ROY SOC B, V352, P1355, DOI 10.1098/rstb.1997.0120; ALONSO A, 1995, J IMMUNOL, V154, P6475; AROCK M, 1994, BIOCHEM BIOPH RES CO, V203, P265, DOI 10.1006/bbrc.1994.2177; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Bahia-Oliveira LMG, 2009, MEM I OSWALDO CRUZ, V104, P273, DOI 10.1590/S0074-02762009000200021; BECHEREL PA, 1994, J CLIN INVEST, V93, P2275, DOI 10.1172/JCI117227; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Coura-Vital W, 2008, EXP PARASITOL, V120, P269, DOI 10.1016/j.exppara.2008.08.001; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dunay IR, 2010, CURR OPIN IMMUNOL, V22, P461, DOI 10.1016/j.coi.2010.04.008; Ege MJ, 2008, ALLERGY, V63, P1505, DOI 10.1111/j.1398-9995.2008.01793.x; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Finkelman FD, 2001, J ALLERGY CLIN IMMUN, V107, P772, DOI 10.1067/mai.2001.114989; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Kim L, 2004, J IMMUNOL, V172, P3003, DOI 10.4049/jimmunol.172.5.3003; KOLB JP, 1994, J BIOL CHEM, V269, P9811; LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Marshall LA, 1998, J IMMUNOL, V161, P6005; Mossalayi M D, 1997, Int Rev Immunol, V16, P129, DOI 10.3109/08830189709045706; Mossalayi MD, 2009, INFECT IMMUN, V77, P5537, DOI 10.1128/IAI.01457-08; Nacher M, 2004, CLIN REV ALLERG IMMU, V26, P85, DOI 10.1007/s12016-004-0003-3; OUAAZ F, 1994, BLOOD, V84, P3095; Perlmann P, 1997, INFECT IMMUN, V65, P116, DOI 10.1128/IAI.65.1.116-121.1997; Prandota Joseph, 2007, Am J Ther, V14, P63, DOI 10.1097/01.mjt.0000208272.42379.aa; Rambert J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004834; Safeukui I, 2008, MICROBES INFECT, V10, P1411, DOI 10.1016/j.micinf.2008.07.033; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sousa-Atta MLB, 2002, CLIN DIAGN LAB IMMUN, V9, P101, DOI 10.1128/CDLI.9.1.101-104.2002; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; WANG AM, 1985, SCIENCE, V228, P149, DOI 10.1126/science.3856324; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Yarovinsky F, 2008, IMMUNOL LETT, V119, P17, DOI 10.1016/j.imlet.2008.05.007	43	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18289	10.1371/journal.pone.0018289	http://dx.doi.org/10.1371/journal.pone.0018289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526166	Green Submitted, Green Published, gold			2022-12-27	WOS:000290015800006
J	Yasukochi, Y; Miura, N; Nakano, R; Sahara, K; Ishikawa, Y				Yasukochi, Yuji; Miura, Nami; Nakano, Ryo; Sahara, Ken; Ishikawa, Yukio			Sex-Linked Pheromone Receptor Genes of the European Corn Borer, Ostrinia nubilalis, Are in Tandem Arrays	PLOS ONE			English	Article							SILKMOTH BOMBYX-MORI; ADZUKI BEAN BORER; MOLECULAR EVOLUTION; LEPIDOPTERA; ODORANT; MOTHS; INSECT; BIOSYNTHESIS; SCAPULALIS; CRAMBIDAE	BACKGROUND: Tuning of the olfactory system of male moths to conspecific female sex pheromones is crucial for correct species recognition; however, little is known about the genetic changes that drive speciation in this system. Moths of the genus Ostrinia are good models to elucidate this question, since significant differences in pheromone blends are observed within and among species. Odorant receptors (ORs) play a critical role in recognition of female sex pheromones; eight types of OR genes expressed in male antennae were previously reported in Ostrinia moths. METHODOLOGY/PRINCIPAL FINDINGS: We screened an O. nubilalis bacterial artificial chromosome (BAC) library by PCR, and constructed three contigs from isolated clones containing the reported OR genes. Fluorescence in situ hybridization (FISH) analysis using these clones as probes demonstrated that the largest contig, which contained eight OR genes, was located on the Z chromosome; two others harboring two and one OR genes were found on two autosomes. Sequence determination of BAC clones revealed the Z-linked OR genes were closely related and tandemly arrayed; moreover, four of them shared 181-bp direct repeats spanning exon 7 and intron 7. CONCLUSIONS/SIGNIFICANCE: This is the first report of tandemly arrayed sex pheromone receptor genes in Lepidoptera. The localization of an OR gene cluster on the Z chromosome agrees with previous findings for a Z-linked locus responsible for O. nubilalis male behavioral response to sex pheromone. The 181-bp direct repeats might enhance gene duplications by unequal crossovers. An autosomal locus responsible for male response to sex pheromone in Heliothis virescens and H. subflexa was recently reported to contain at least four OR genes. Taken together, these findings support the hypothesis that generation of additional copies of OR genes can increase the potential for male moths to acquire altered specificity for pheromone components, and accordingly, facilitate differentiation of sex pheromones.	[Yasukochi, Yuji] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan; [Miura, Nami; Nakano, Ryo; Ishikawa, Yukio] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Sahara, Ken] Hokkaido Univ, Lab Appl Mol Entomol, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; Hokkaido University	Yasukochi, Y (corresponding author), Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan.	yaskoch@affrc.go.jp	Ishikawa, Yukio/J-5676-2019; Sahara, Ken/A-4266-2012	Ishikawa, Yukio/0000-0003-3067-2513; 	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science (JSPS) [22380040/19208005]	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and grants 22380040/19208005 from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carde RT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P283, DOI 10.1017/CBO9780511542664.009; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P1063, DOI 10.1016/j.jinsphys.2007.05.013; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P488, DOI 10.1016/j.jinsphys.2007.01.009; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Fukuzawa M, 2006, J INSECT PHYSIOL, V52, P430, DOI 10.1016/j.jinsphys.2005.11.004; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Heckel DG, 2010, P NATL ACAD SCI USA, V107, P9481, DOI 10.1073/pnas.1004511107; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang YP, 2002, J CHEM ECOL, V28, P533, DOI 10.1023/A:1014540011854; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Linn CE, 2007, J CHEM ECOL, V33, P199, DOI 10.1007/s10886-006-9204-y; Linn C, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.15; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Olsson SB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-285; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; ROELOFS WL, 1985, J CHEM ECOL, V11, P829, DOI 10.1007/BF01012071; Sakai R, 2009, INSECT BIOCHEM MOLEC, V39, P62, DOI 10.1016/j.ibmb.2008.10.001; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Tabata F, 2005, J CHEM ECOL, V31, P1111, DOI 10.1007/s10886-005-4251-3; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; Takanashi T, 2000, CHEMOECOLOGY, V10, P143, DOI 10.1007/PL00001816; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Yasukochi Y, 1999, MOL GEN GENET, V261, P796, DOI 10.1007/s004380050023; Yasukochi Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165894; Yasukochi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007465	51	34	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18843	10.1371/journal.pone.0018843	http://dx.doi.org/10.1371/journal.pone.0018843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526121	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800016
J	Hamazaki, T; Leung, WY; Cain, BD; Ostrov, DA; Thorsness, PE; Terada, N				Hamazaki, Takashi; Leung, Wai-Yee; Cain, Brian D.; Ostrov, David A.; Thorsness, Peter E.; Terada, Naohiro			Functional Expression of Human Adenine Nucleotide Translocase 4 in Saccharomyces Cerevisiae	PLOS ONE			English	Article							MITOCHONDRIAL ADP/ATP CARRIER; N-TERMINAL REGION; YEAST MITOCHONDRIA; GERM-CELLS; PROTEINS; GENE; IDENTIFICATION; TRANSPORT; SYSTEM	The adenine nucleotide translocase (ANT) mediates the exchange of ADP and ATP across the inner mitochondrial membrane. The human genome encodes multiple ANT isoforms that are expressed in a tissue-specific manner. Recently a novel germ cell-specific member of the ANT family, ANT4 (SLC25A31) was identified. Although it is known that targeted depletion of ANT4 in mice resulted in male infertility, the functional biochemical differences between ANT4 and other somatic ANT isoforms remain undetermined. To gain insight into ANT4, we expressed human ANT4 (hANT4) in yeast mitochondria. Unlike the somatic ANT proteins, expression of hANT4 failed to complement an AAC-deficient yeast strain for growth on media requiring mitochondrial respiration. Moreover, overexpression of hANT4 from a multi-copy plasmid interfered with optimal yeast growth. However, mutation of specific amino acids of hANT4 improved yeast mitochondrial expression and supported growth of the AAC-deficient yeast on non-fermentable carbon sources. The mutations affected amino acids predicted to interact with phospholipids, suggesting the importance of lipid interactions for function of this protein. Each mutant hANT4 and the somatic hANTs exhibited similar ADP/ATP exchange kinetics. These data define common and distinct biochemical characteristics of ANT4 in comparison to ANT1, 2 and 3 providing a basis for study of its unique adaptation to germ cells.	[Hamazaki, Takashi; Leung, Wai-Yee; Ostrov, David A.; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; [Cain, Brian D.] Univ Florida, Dept Biochem, Gainesville, FL USA; [Thorsness, Peter E.] Univ Wyoming, Coll Agr, Dept Mol Biol, Laramie, WY 82071 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Wyoming	Hamazaki, T (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA.	hamazaki@pathology.ufl.edu			National Institutes of Health (NIH) [UO1 HD060474]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060474] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health (NIH) grants UO1 HD060474 to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; DURBIN RM, 2010, NATURE ENGLAND, P1061; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Hatanaka T, 2001, BIOL PHARM BULL, V24, P595, DOI 10.1248/bpb.24.595; Hatanaka T, 2001, J BIOL CHEM, V276, P28881, DOI 10.1074/jbc.M102535200; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KU CS, 2010, J HUM GENET JAPAN, P403; Kucejova B, 2008, MOL GENET GENOMICS, V280, P25, DOI 10.1007/s00438-008-0342-5; Lousa CD, 2005, BIOCHEMISTRY-US, V44, P4342, DOI 10.1021/bi0475370; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; RO DK, 2006, NATURE ENGLAND, P940; Rodic N, 2005, STEM CELLS, V23, P1314, DOI 10.1634/stemcells.2005-0119; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Trezeguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2; WOLDEGIORGIS G, 1985, J BIOL CHEM, V260, P7585; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627	31	13	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19250	10.1371/journal.pone.0019250	http://dx.doi.org/10.1371/journal.pone.0019250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532989	gold, Green Published, Green Submitted			2022-12-27	WOS:000290014500026
J	Schneider, KL; Marrero, G; Alvarez, AM; Presting, GG				Schneider, Kevin L.; Marrero, Glorimar; Alvarez, Anne M.; Presting, Gernot G.			Classification of Plant Associated Bacteria Using RIF, a Computationally Derived DNA Marker	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; 16S RIBOSOMAL-RNA; COMB-NOV; GENOME SEQUENCE; RECLASSIFICATION; PECTOBACTERIUM; IDENTIFICATION; PATHOGENICITY; CHRYSANTHEMI; ALIGNMENT	A DNA marker that distinguishes plant associated bacteria at the species level and below was derived by comparing six sequenced genomes of Xanthomonas, a genus that contains many important phytopathogens. This DNA marker comprises a portion of the dnaA replication initiation factor (RIF). Unlike the rRNA genes, dnaA is a single copy gene in the vast majority of sequenced bacterial genomes, and amplification of RIF requires genus-specific primers. In silico analysis revealed that RIF has equal or greater ability to differentiate closely related species of Xanthomonas than the widely used ribosomal intergenic spacer region (ITS). Furthermore, in a set of 263 Xanthomonas, Ralstonia and Clavibacter strains, the RIF marker was directly sequenced in both directions with a success rate approximately 16% higher than that for ITS. RIF frameworks for Xanthomonas, Ralstonia and Clavibacter were constructed using 682 reference strains representing different species, subspecies, pathovars, races, hosts and geographic regions, and contain a total of 109 different RIF sequences. RIF sequences showed subspecific groupings but did not place strains of X. campestris or X. axonopodis into currently named pathovars nor R. solanacearum strains into their respective races, confirming previous conclusions that pathovar and race designations do not necessarily reflect genetic relationships. The RIF marker also was sequenced for 24 reference strains from three genera in the Enterobacteriaceae: Pectobacterium, Pantoea and Dickeya. RIF sequences of 70 previously uncharacterized strains of Ralstonia, Clavibacter, Pectobacterium and Dickeya matched, or were similar to, those of known reference strains, illustrating the utility of the frameworks to classify bacteria below the species level and rapidly match unknown isolates to reference strains. The RIF sequence frameworks are available at the online RIF database, RIFdb, and can be queried for diagnostic purposes with RIF sequences obtained from unknown strains in both chromatogram and FASTA format.	[Schneider, Kevin L.; Marrero, Glorimar; Alvarez, Anne M.; Presting, Gernot G.] Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Schneider, KL (corresponding author), Univ Hawaii Manoa, Honolulu, HI 96822 USA.	gernot@hawaii.edu			USDA [2008-34135-19370, 2005-34135-15972]	USDA(United States Department of Agriculture (USDA))	This work was funded by USDA grants 2008-34135-19370 and 2005-34135-15972. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; BUDDENHAGEN IVAN, 1964, ANN REV PHYTOPATHOL, V2, P203, DOI 10.1146/annurev.py.02.090164.001223; Castillo JA, 2007, APPL ENVIRON MICROB, V73, P1225, DOI 10.1128/AEM.01253-06; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; EICHENLAUB R, 2006, PLANT ASS BACTERIA, P131; EWING A, 2008, THESIS U HAWAII MANO; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Fegan M, 1998, BACTERIAL WILT DISEASE, P19; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Garcia-Martinez J, 1999, J MICROBIOL METH, V36, P55, DOI 10.1016/S0167-7012(99)00011-1; GAVINI F, 1989, INT J SYST BACTERIOL, V39, P337, DOI 10.1099/00207713-39-3-337; Gottwald TR, 2001, PHYTOPATHOLOGY, V91, P30, DOI 10.1094/PHYTO.2001.91.1.30; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9; HAWKS B, 2005, FED REGISTER, V70, P13241; Hayward A. C., 1993, Xanthomonas., P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IMHOFF JF, 2005, BERGEYS MANUAL SYSTE, V2, P1, DOI DOI 10.1099/00207713-34-3-338; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kang YJ, 2010, MICROBIOLOGY+, V79, P655, DOI 10.1134/S0026261710050103; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Nassar A, 1996, APPL ENVIRON MICROB, V62, P2228, DOI 10.1128/AEM.62.7.2228-2235.1996; NORMAND P, 1996, MOL MICROBIAL ECOLOG, P1; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Prior P, 2005, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.2005.695.14; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schaad Norman W, 2006, Syst Appl Microbiol, V29, P690, DOI 10.1016/j.syapm.2006.08.001; Sherwood AR, 2008, MOL ECOL RESOUR, V8, P1011, DOI 10.1111/j.1755-0998.2008.02138.x; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; Wang N, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-117; Wilton SD, 1997, BIOTECHNIQUES, V22, P642, DOI 10.2144/97224bm14; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Young JM, 2007, SYST APPL MICROBIOL, V30, P343, DOI 10.1016/j.syapm.2007.03.002; YOUNG JM, 2001, COMMITTEE TAXONOMY P; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	61	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18496	10.1371/journal.pone.0018496	http://dx.doi.org/10.1371/journal.pone.0018496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533033	gold, Green Submitted, Green Published			2022-12-27	WOS:000290014500005
J	Wang, Z; Nilsson, RH; Lopez-Giraldez, F; Zhuang, WY; Dai, YC; Johnston, PR; Townsend, JP				Wang, Zheng; Nilsson, R. Henrik; Lopez-Giraldez, Francesc; Zhuang, Wen-ying; Dai, Yu-cheng; Johnston, Peter R.; Townsend, Jeffrey P.			Tasting Soil Fungal Diversity with Earth Tongues: Phylogenetic Test of SATe Alignments for Environmental ITS Data	PLOS ONE			English	Article							ASCOMYCOTA TREE; SEQUENCE; EVOLUTION; CLASSIFICATION; IDENTIFICATION; DATABASES; PROGRESS; ECOLOGY; SEARCH; LIFE	An abundance of novel fungal lineages have been indicated by DNA sequencing of the nuclear ribosomal ITS region from environmental samples such as soil and wood. Although phylogenetic analysis of these novel lineages is a key component of unveiling the structure and diversity of complex communities, such analyses are rare for environmental ITS data due to the difficulties of aligning this locus across significantly divergent taxa. One potential approach to this issue is simultaneous alignment and tree estimation. We targeted divergent ITS sequences of the earth tongue fungi (Geoglossomycetes), a basal class in the Ascomycota, to assess the performance of SATe, recent software that combines progressive alignment and tree building. We found that SATe performed well in generating high-quality alignments and in accurately estimating the phylogeny of earth tongue fungi. Drawing from a data set of 300 sequences of earth tongues and progressively more distant fungal lineages, 30 insufficiently identified ITS sequences from the public sequence databases were assigned to the Geoglossomycetes. The association between earth tongues and plants has been hypothesized for a long time, but hard evidence is yet to be collected. The ITS phylogeny showed that four ectomycorrhizal isolates shared a clade with Geoglossum but not with Trichoglossum earth tongues, pointing to the significant potential inherent to ecological data mining of environmental samples. Environmental sampling holds the key to many focal questions in mycology, and simultaneous alignment and tree estimation, as performed by SATe, can be a highly efficient companion in that pursuit.	[Wang, Zheng; Lopez-Giraldez, Francesc; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Nilsson, R. Henrik] Gothenburg Univ, Dept Plant & Environm Sci, Gothenburg, Sweden; [Nilsson, R. Henrik] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Zhuang, Wen-ying] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Dai, Yu-cheng] Beijing Forestry Univ, Inst Microbiol, Beijing, Peoples R China; [Johnston, Peter R.] Landcare Res, Herbarium PDD, Auckland, New Zealand	Yale University; University of Gothenburg; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Beijing Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Landcare Research - New Zealand	Wang, Z (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	wang.zheng@yale.edu	Nilsson, R. Henrik/A-6062-2009; Wang, Zheng/A-2318-2011; López-Giráldez, Francesc/A-5251-2011; Johnston, Peter/AAP-6300-2021; Johnston, Peter/GZL-2513-2022; Townsend, Jeffrey/H-2747-2019; Dai, Yu-Cheng/A-6589-2015	Nilsson, R. Henrik/0000-0002-8052-0107; Wang, Zheng/0000-0002-8849-8549; López-Giráldez, Francesc/0000-0001-7476-9822; Johnston, Peter/0000-0003-0761-9116; Townsend, Jeffrey/0000-0002-9890-3907; 	Yale University	Yale University	ZW was supported by a Yale University internal postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; BIDARTONDO MI, 2005, FUNGAL COMMUNITY, P215; Blair C, 2011, J HERED, V102, P130, DOI 10.1093/jhered/esq092; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Eberhardt U, 2010, NEW PHYTOL, V187, P266, DOI 10.1111/j.1469-8137.2010.03329.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kirk PM., 2008, DICT FUNGI, V10th ed; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loytynoja A, 2009, SCIENCE, V324, P1528, DOI 10.1126/science.1175949; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; MADDISON DR, 2000, MACCLADE VERSION 4; Morris MH, 2008, MYCORRHIZA, V18, P375, DOI 10.1007/s00572-008-0186-1; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Napoli C, 2010, NEW PHYTOL, V185, P237, DOI 10.1111/j.1469-8137.2009.03053.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2011, MYCOSCIENCE, V52, P278, DOI 10.1007/s10267-010-0086-z; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Ohenoja E, 2010, MYCOLOGIA, V102, P1089, DOI 10.3852/09-317; Peay KG, 2008, BIOSCIENCE, V58, P799, DOI 10.1641/B580907; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schoch CL, 2009, PERSOONIA, V22, P129, DOI 10.3767/003158509X461486; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SEAVER FJ, 1951, N AM CUP FUNGI IN OP; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shenoy BD, 2007, FUNGAL DIVERS, V26, P1; Taylor DL, 2007, ENVIRON MICROBIOL, V9, P1329, DOI 10.1111/j.1462-2920.2007.01253.x; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; ZHUANG WY, 1998, FLORA FUNGORUM SINIC, V8	50	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19039	10.1371/journal.pone.0019039	http://dx.doi.org/10.1371/journal.pone.0019039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533038	gold, Green Published			2022-12-27	WOS:000290014500020
J	Roegner, GC; Needoba, JA; Baptista, AM				Roegner, G. Curtis; Needoba, Joseph A.; Baptista, Antonio M.			Coastal Upwelling Supplies Oxygen-Depleted Water to the Columbia River Estuary	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; PASSIVE INTEGRATED TRANSPONDERS; LOW DISSOLVED-OXYGEN; CALIFORNIA CURRENT; ONCORHYNCHUS-TSHAWYTSCHA; CANCER-MAGISTER; DUNGENESS CRAB; AVIAN PREDATION; COLD HALOCLINE; WILLAPA BAY	Low dissolved oxygen (DO) is a common feature of many estuarine and shallow-water environments, and is often attributed to anthropogenic nutrient enrichment from terrestrial-fluvial pathways. However, recent events in the U. S. Pacific Northwest have highlighted that wind-forced upwelling can cause naturally occurring low DO water to move onto the continental shelf, leading to mortalities of benthic fish and invertebrates. Coastal estuaries in the Pacific Northwest are strongly linked to ocean forcings, and here we report observations on the spatial and temporal patterns of oxygen concentration in the Columbia River estuary. Hydrographic measurements were made from transect (spatial survey) or anchor station (temporal survey) deployments over a variety of wind stresses and tidal states during the upwelling seasons of 2006 through 2008. During this period, biologically stressful levels of dissolved oxygen were observed to enter the Columbia River estuary from oceanic sources, with minimum values close to the hypoxic threshold of 2.0 mg L-1. Riverine water was consistently normoxic. Upwelling wind stress controlled the timing and magnitude of low DO events, while tidal-modulated estuarine circulation patterns influenced the spatial extent and duration of exposure to low DO water. Strong upwelling during neap tides produced the largest impact on the estuary. The observed oxygen concentrations likely had deleterious behavioral and physiological consequences for migrating juvenile salmon and benthic crabs. Based on a wind-forced supply mechanism, low DO events are probably common to the Columbia River and other regional estuaries and if conditions on the shelf deteriorate further, as observations and models predict, Pacific Northwest estuarine habitats could experience a decrease in environmental quality.	[Roegner, G. Curtis] NOAA Fisheries, NW Fisheries Sci Ctr, Point Adams Res Stn, Hammond, OR USA; [Needoba, Joseph A.; Baptista, Antonio M.] Oregon Hlth & Sci Univ, Sci & Technol Ctr Coastal Margin Observat & Predi, Beaverton, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon Health & Science University	Roegner, GC (corresponding author), NOAA Fisheries, NW Fisheries Sci Ctr, Point Adams Res Stn, Hammond, OR USA.	curtis.roegner@noaa.gov	Roegner, G. Curtis/D-8964-2011	Roegner, G. Curtis/0000-0003-0621-343X; Baptista, Antonio/0000-0002-7641-5937	Bonneville Power Association; National Science Foundation through the Science and Technology Center for Coastal Margin Observation and Prediction [OCE-0424602]	Bonneville Power Association; National Science Foundation through the Science and Technology Center for Coastal Margin Observation and Prediction(National Science Foundation (NSF))	Funding was provided by the Bonneville Power Association (GCR) and the National Science Foundation (JN and AMB) through the Science and Technology Center for Coastal Margin Observation and Prediction (OCE-0424602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABASTER JS, 1988, J FISH BIOL, V32, P635, DOI 10.1111/j.1095-8649.1988.tb05402.x; Armstrong DA, 2003, ESTUARIES, V26, P1174, DOI 10.1007/BF02803372; Banas NS, 2007, MAR ECOL PROG SER, V341, P123, DOI 10.3354/meps341123; Beeman JW, 2006, T AM FISH SOC, V135, P584, DOI 10.1577/T05-193.1; Bernatis JL, 2007, MAR BIOL, V150, P941, DOI 10.1007/s00227-006-0392-3; BIRTWELL IK, 1989, HYDROBIOLOGIA, V188, P543, DOI 10.1007/BF00027822; BIRTWELL IK, 1989, CAN TECH REP FISH AQ, V1695; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; Bricker S, 2007, NOAA COASTAL OCEAN P, V26; Bricker SB, 2003, ECOL MODEL, V169, P39, DOI 10.1016/S0304-3800(03)00199-6; Bruland KW, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004702; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Colbert D, 2003, ESTUARIES, V26, P1205, DOI 10.1007/BF02803625; Collis K, 2001, T AM FISH SOC, V130, P385, DOI 10.1577/1548-8659(2001)130<0385:CWPOJS>2.0.CO;2; Curtis DL, 2010, MAR BIOL, V157, P603, DOI 10.1007/s00227-009-1345-4; DAHLBERG ML, 1968, J FISH RES BOARD CAN, V25, P49, DOI 10.1139/f68-005; DAUBLE DD, 1989, FISH B-NOAA, V87, P775; DAVIS GERALD E., 1963, TRANS AMER FISH SOC, V92, P111, DOI 10.1577/1548-8659(1963)92[111:TIOOCO]2.0.CO;2; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; DEANGELIS MA, 1985, ESTUAR COAST SHELF S, V20, P375, DOI 10.1016/0272-7714(85)90082-4; Deutsch C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023190; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Diaz RJ, 2009, FISH PHYSIOL, V27, P1, DOI 10.1016/S1546-5098(08)00001-0; *ENV PROT AG, 1986, 440586003 EPA; *ENV PROT AG, 2000, EPA822R00012; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Freeland HJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016663; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; HAERTEL L, 1969, ECOLOGY, V50, P962, DOI 10.2307/1936889; Hales B, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002517; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hazen EL, 2009, MAR ECOL PROG SER, V375, P195, DOI 10.3354/meps07791; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Herfort L, 2011, AQUAT MICROB ECOL, V62, P85, DOI 10.3354/ame01460; Hickey B. M., 1989, COASTAL OCEANOGRAPHY, P41, DOI DOI 10.1016/S0422-9894(08)70346-5; Hickey BM, 2003, ESTUARIES, V26, P1010, DOI 10.1007/BF02803360; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; JARVI T, 1989, ENVIRON BIOL FISH, V26, P149, DOI 10.1007/BF00001031; JAY DA, 1990, PROG OCEANOGR, V25, P81, DOI 10.1016/0079-6611(90)90004-L; Kaplan DM, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005382; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Kennedy BM, 2007, CAN J FISH AQUAT SCI, V64, P1506, DOI 10.1139/F07-117; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; Lohan MC, 2008, ENVIRON SCI TECHNOL, V42, P6462, DOI 10.1021/es800144j; Ludsin SA, 2009, J EXP MAR BIOL ECOL, V381, pS121, DOI 10.1016/j.jembe.2009.07.016; Mcgaw IJ, 1999, BIOL BULL-US, V196, P163, DOI 10.2307/1542562; MESA MG, 1994, T AM FISH SOC, V123, P786, DOI 10.1577/1548-8659(1994)123<0786:EOMASO>2.3.CO;2; Nezlin NP, 2009, ESTUAR COAST SHELF S, V82, P139, DOI 10.1016/j.ecss.2009.01.004; PAULMIER A, 2009, PROG OCEANOGR, V80, P113, DOI DOI 10.1016/J.POCEAN.2008.08.001; Prahl FG, 1998, HYDROBIOLOGIA, V361, P37; Price CS, 2003, CAN J FISH AQUAT SCI, V60, P910, DOI 10.1139/F03-080; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Roby DD, 2003, CAN J ZOOL, V81, P250, DOI 10.1139/Z02-242; Roegner GC, 2007, MAR ECOL PROG SER, V351, P177, DOI 10.3354/meps07130; Roegner GC, 2003, ESTUARIES, V26, P1058; Roegner GC, 2002, LIMNOL OCEANOGR, V47, P1033; Roegner GC, 2001, ESTUARIES, V24, P244, DOI 10.2307/1352948; ROEGNER GC, 2010, ESTUAR COASTS; Ryan BA, 2003, T AM FISH SOC, V132, P275, DOI 10.1577/1548-8659(2003)132<0275:RVTAPO>2.0.CO;2; Seitz RD, 2003, MAR ECOL PROG SER, V257, P179, DOI 10.3354/meps257179; Sigleo AC, 2005, ESTUAR COAST SHELF S, V64, P211, DOI 10.1016/j.ecss.2005.02.018; Stone RP, 2001, MAR ECOL PROG SER, V214, P167, DOI 10.3354/meps214167; STRAMMA L, 2010, DEEP SEA RES 1; SUGARMAN PC, 1983, ESTUARIES, V6, P380, DOI 10.2307/1351397; Sullivan BE, 2001, GEOCHIM COSMOCHIM AC, V65, P1125, DOI 10.1016/S0016-7037(00)00565-2; Takahashi T, 2009, J OCEANOGR, V65, P113, DOI 10.1007/s10872-009-0011-2; Tyler RM, 2007, MAR ECOL PROG SER, V333, P257, DOI 10.3354/meps333257; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; VARGO SL, 1977, MAR BIOL, V40, P165, DOI 10.1007/BF00396263; WARREN CE, 1973, EPAR373019; *WASH STAT DEP EC, 2006, PUBL WASH STAT DEP E; Webster SJ, 2007, J FISH BIOL, V71, P842, DOI 10.1111/j.1095-8649.2007.01553.x; Wheeler PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017395; WHITMORE CECIL M., 1960, TRANS AMER FISH SOC, V89, P17, DOI 10.1577/1548-8659(1960)89[17:AROSAC]2.0.CO;2; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007	78	46	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18672	10.1371/journal.pone.0018672	http://dx.doi.org/10.1371/journal.pone.0018672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533083	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400018
J	Schlatter, R; Schmich, K; Lutz, A; Trefzger, J; Sawodny, O; Ederer, M; Merfort, I				Schlatter, Rebekka; Schmich, Kathrin; Lutz, Anna; Trefzger, Judith; Sawodny, Oliver; Ederer, Michael; Merfort, Irmgard			Modeling the TNF alpha-Induced Apoptosis Pathway in Hepatocytes	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; JNK ACTIVATION; CELL-DEATH; MEDIATED APOPTOSIS; SYSTEMS BIOLOGY; LIVER-INJURY; CASPASE-8 ACTIVATION; MATHEMATICAL-MODEL; SIGNALING PATHWAY	The proinflammatory cytokine TNF alpha fails to provoke cell death in isolated hepatocytes but has been implicated in hepatocyte apoptosis during liver diseases associated with chronic inflammation. Recently, we showed that TNF alpha is able to sensitize primary murine hepatocytes cultured on collagen to Fas ligand-induced apoptosis and presented a mathematical model of the sensitizing effect. Here, we analyze how TNF alpha induces apoptosis in combination with the transcriptional inhibitor actinomycin D (ActD). Accumulation of reactive oxygen species ( ROS) in response to TNFR activation turns out to be critical for sustained activation of JNK which then triggers mitochondrial pathway-dependent apoptosis. In addition, the amount of JNK is strongly upregulated in a ROS-dependent way. In contrast to TNF alpha plus cycloheximide no cFLIP degradation is observed suggesting a different apoptosis pathway in which the Itch-mediated cFLIP degradation and predominantly caspase-8 activation is not involved. Time-resolved data of the respective pro-and antiapoptotic factors are obtained and subjected to mathematical modeling. On the basis of these data we developed a mathematical model which reproduces the complex interplay regulating the phosphorylation status of JNK and generation of ROS. This model was fully integrated with our model of TNF alpha/Fas ligand sensitizing as well as with a published NF-kappa B-model. The resulting comprehensive model delivers insight in the dynamical interplay between the TNF alpha and FasL pathways, NF-kappa B and ROS and gives an example for successful model integration.	[Schlatter, Rebekka; Sawodny, Oliver; Ederer, Michael] Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany; [Schmich, Kathrin; Lutz, Anna; Trefzger, Judith; Merfort, Irmgard] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, Freiburg, Germany	University of Stuttgart; University of Freiburg	Schlatter, R (corresponding author), Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany.	michael.ederer@isys.uni-stuttgart.de; irmgard.merfort@pharmazie.uni-freiburg.de			BMBF	BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (http://www.bmbf.de/) research grant Virtual Liver (RS, KS, AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dussmann H, 2010, CELL DEATH DIFFER, V17, P278, DOI 10.1038/cdd.2009.123; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kiessling MK, 2010, FEBS LETT, V584, P4679, DOI 10.1016/j.febslet.2010.10.047; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Krause F, 2010, BIOINFORMATICS, V26, P421, DOI 10.1093/bioinformatics/btp642; Lavrik IN, 2010, CURR OPIN BIOTECH, V21, P551, DOI 10.1016/j.copbio.2010.07.001; Lavrik IN, 2009, MOL BIOSYST, V5, P1105, DOI 10.1039/b905129p; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; OYAMA Y, 1994, BRAIN RES, V635, P113, DOI 10.1016/0006-8993(94)91429-X; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Papa S, 2009, BIOL CHEM, V390, P965, DOI 10.1515/BC.2009.111; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schmich K, 2011, HEPATOLOGY, V53, P282, DOI 10.1002/hep.23987; Schmidt C, 2009, J ETHNOPHARMACOL, V122, P523, DOI 10.1016/j.jep.2009.01.022; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; TRAYNER ID, 1995, J IMMUNOL METHODS, V186, P275, DOI 10.1016/0022-1759(95)00152-Z; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou LF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000657	63	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18646	10.1371/journal.pone.0018646	http://dx.doi.org/10.1371/journal.pone.0018646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533085	Green Submitted, gold, Green Published			2022-12-27	WOS:000289719400017
J	Chen, ZH; Zhu, YZ; Ren, YL; Tong, YM; Hua, X; Zhu, FH; Huang, LB; Liu, Y; Luo, Y; Lu, W; Zhao, P; Qi, ZT				Chen, Zhihui; Zhu, Yongzhe; Ren, Yanli; Tong, Yimin; Hua, Xian; Zhu, Fenghui; Huang, Libin; Liu, Yuan; Luo, Yuan; Lu, Wei; Zhao, Ping; Qi, Zhongtian			Hepatitis C Virus Protects Human B Lymphocytes from Fas-Mediated Apoptosis via E2-CD81 Engagement	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MIXED CRYOGLOBULINEMIA; T-CELLS; COSTIMULATORY SIGNAL; IMMUNOGLOBULIN GENE; INFECTED PATIENTS; E2 GLYCOPROTEIN; HCV INFECTION; VIRAL ENTRY; KAPPA-B	HCV infection is often associated with B-cell regulatory control disturbance and delayed appearance of neutralizing antibodies. CD81 is a cellular receptor for HCV and can bind to HCV envelope protein 2 (E2). CD81 also participates to form a B cell costimulatory complex. To investigate whether HCV influences B cell activation and immune function through E2 CD81 engagement, here, human Burkitt's lymphoma cell line Raji cells and primary human B lymphocytes (PHB) were treated with HCV E2 protein and cell culture produced HCV particles (HCVcc), and then the related cell phenotypes were assayed. The results showed that both E2 and HCVcc triggered phosphorylation of IkBa, enhanced the expression of antiapoptosis Bcl-2 family proteins, and protected Raji cells and PHB cells from Fas-mediated death. In addition, both E2 protein and HCVcc increased the expression of costimulatory molecules CD80, CD86 and CD81 itself, and decreased the expression of complement receptor CD21. The effects were dependent on E2-CD81 interaction on the cell surface, since CD81-silenced Raji cells did not respond to both treatments; and an E2 mutant that lose the CD81 binding activity, could not trigger the responses of both Raji cells and PHB cells. The effects were not associated with HCV replication in cells, for HCV pseudoparticle (HCVpp) and HCVcc failed to infect Raji cells. Hence, E2-CD81 engagement may contribute to HCV-associated B cell lymphoproliferative disorders and insufficient neutralizing antibody production.	[Chen, Zhihui; Zhu, Yongzhe; Ren, Yanli; Tong, Yimin; Hua, Xian; Zhu, Fenghui; Huang, Libin; Liu, Yuan; Luo, Yuan; Zhao, Ping; Qi, Zhongtian] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China; [Chen, Zhihui] Second Mil Med Univ, Affiliated Changhai Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Lu, Wei] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Chen, ZH (corresponding author), Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China.	pnzhao@163.com; qizt@smmu.edu.cn			973 Programme of China [2009CB522501, 2009CB522503]; Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases [2008ZX10002-013]; Natural Science Foundation of China [81071364, 30901348]; New Drugs Creation Special Projects of China [2009ZX09103-688]; Shanghai LAD [B901]	973 Programme of China(National Basic Research Program of China); Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Drugs Creation Special Projects of China; Shanghai LAD	This work was supported by research grants from 973 Programme of China (2009CB522501 and 2009CB522503), Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases (2008ZX10002-013), Natural Science Foundation of China (81071364, 30901348) and New Drugs Creation Special Projects of China (2009ZX09103-688), and Shanghai LAD Project (B901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2002, ARCH IMMUNOL THER EX, V50, P307; Bando M, 2003, J BIOL CHEM, V278, P5786, DOI 10.1074/jbc.M204178200; Bare P, 2005, J GEN VIROL, V86, P1717, DOI 10.1099/vir.0.80882-0; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bernardin F, 2008, HEPATOLOGY, V47, P1446, DOI 10.1002/hep.22184; Bukh J, 2008, J VIROL, V82, P8183, DOI 10.1128/JVI.00142-08; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Casato M, 2002, BLOOD, V99, P2259, DOI 10.1182/blood.V99.6.2259; Chang LL, 2007, ANTIVIR RES, V75, P43, DOI 10.1016/j.antiviral.2006.11.009; Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Crotta S, 2006, EUR J IMMUNOL, V36, P919, DOI 10.1002/eji.200535527; Ding H, 2008, HEPAT MON, V8, P267; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hinshaw JA, 2003, EUR J IMMUNOL, V33, P2490, DOI 10.1002/eji.200323194; Hu Y, 2003, AM J CLIN PATHOL, V119, P95, DOI 10.1309/33TAJLB748KLMXVG; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Komurian-Pradel F, 2004, J VIROL METHODS, V116, P103, DOI 10.1016/j.jviromet.2003.10.004; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Laporte J, 2003, BLOOD, V101, P52, DOI 10.1182/blood-2002-03-0818; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lucas M, 2003, J GEN VIROL, V84, P545, DOI 10.1099/vir.0.18775-0; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Masilamani M, 2003, EUR J IMMUNOL, V33, P2391, DOI 10.1002/eji.200323843; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Mizuochi T, 2011, VIRUS RES, V155, P349, DOI 10.1016/j.virusres.2010.09.017; Mongini PKA, 2003, J IMMUNOL, V171, P5244, DOI 10.4049/jimmunol.171.10.5244; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Sansonno D, 2007, CLIN EXP IMMUNOL, V147, P241, DOI 10.1111/j.1365-2249.2006.03272.x; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simula MP, 2007, ANN NY ACAD SCI, V1110, P121, DOI 10.1196/annals.1423.014; Soldaini E, 2003, EUR J IMMUNOL, V33, P455, DOI 10.1002/immu.200310021; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; Sugalski JM, 2010, J IMMUNOL, V185, P3019, DOI 10.4049/jimmunol.1000879; Sung VMH, 2003, J VIROL, V77, P2134, DOI 10.1128/JVI.77.3.2134-2146.2003; Tardif MR, 2005, J VIROL, V79, P4316, DOI 10.1128/JVI.79.7.4316-4328.2005; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Wack A, 2001, EUR J IMMUNOL, V31, P166, DOI 10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L; Weng WK, 2003, LEUKEMIA LYMPHOMA, V44, P1113, DOI 10.1080/1042819031000076972; Zehender G, 1997, J INFECT DIS, V176, P1209, DOI 10.1086/514114; Zignego AL, 2002, ANN INTERN MED, V137, P571, DOI 10.7326/0003-4819-137-7-200210010-00008; Zuckerman E, 2001, BRIT J HAEMATOL, V112, P364, DOI 10.1046/j.1365-2141.2001.02573.x; Zuckerman E, 2002, CLIN EXP IMMUNOL, V128, P353, DOI 10.1046/j.1365-2249.2002.01844.x	59	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18933	10.1371/journal.pone.0018933	http://dx.doi.org/10.1371/journal.pone.0018933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526201	gold, Green Submitted, Green Published			2022-12-27	WOS:000289671100038
J	Lu, TZ; Feng, ZP				Lu, Tom Z.; Feng, Zhong-Ping			A Sodium Leak Current Regulates Pacemaker Activity of Adult Central Pattern Generator Neurons in Lymnaea Stagnalis	PLOS ONE			English	Article							RESPIRATORY RHYTHM GENERATION; PRE-BOTZINGER COMPLEX; IN-VITRO; SMALL-CONDUCTANCE; CALCIUM-CHANNELS; PERSISTENT NA+; IONIC CURRENTS; MODULATION; BEHAVIOR; NETWORK	The resting membrane potential of the pacemaker neurons is one of the essential mechanisms underlying rhythm generation. In this study, we described the biophysical properties of an uncharacterized channel (U-type channel) and investigated the role of the channel in the rhythmic activity of a respiratory pacemaker neuron and the respiratory behaviour in adult freshwater snail Lymnaea stagnalis. Our results show that the channel conducts an inward leak current carried by Na(+) (I(Leak-Na)). The I(Leak-Na) contributed to the resting membrane potential and was required for maintaining rhythmic action potential bursting activity of the identified pacemaker RPeD1 neurons. Partial knockdown of the U-type channel suppressed the aerial respiratory behaviour of the adult snail in vivo. These findings identified the Na(+) leak conductance via the U-type channel, likely a NALCN-like channel, as one of the fundamental mechanisms regulating rhythm activity of pacemaker neurons and respiratory behaviour in adult animals.	[Lu, Tom Z.; Feng, Zhong-Ping] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Lu, TZ (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	zp.feng@utoronto.ca			National Sciences and Engineering Research Council of Canada [NSERC-249962-09]; Heart and Stroke Foundation of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The work was supported by an operating grant to ZPF from the National Sciences and Engineering Research Council of Canada (NSERC-249962-09). TZL is a recipient of a Graduate Studentship of Natural Sciences and Engineering Research Council of Canada; ZPF holds a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Coumoul X, 2006, BIOCHIMIE, V88, P637, DOI 10.1016/j.biochi.2005.11.010; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Dickinson PS, 2006, CURR OPIN NEUROBIOL, V16, P604, DOI 10.1016/j.conb.2006.10.007; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Fei GH, 2007, J NEUROCHEM, V100, P50, DOI 10.1111/j.1471-4159.2006.04194.x; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Feng ZP, 1997, J NEUROSCI, V17, P7839; Feng ZP, 2002, J PHYSIOL-LONDON, V539, P53, DOI 10.1113/jphysiol.2001.013125; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Guo CH, 2010, BEHAV GENET, V40, P680, DOI 10.1007/s10519-010-9374-9; Hallworth NE, 2003, J NEUROSCI, V23, P7525; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; JONES JD, 1961, COMP BIOCHEM PHYSIOL, V4, P1, DOI 10.1016/0010-406X(61)90042-1; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; KANDEL E. R., 1977, CELLULAR BASIS BEHAV; KEYNES RD, 1951, J PHYSIOL-LONDON, V114, P119, DOI 10.1113/jphysiol.1951.sp004608; Koizumi H, 2008, J NEUROSCI, V28, P1773, DOI 10.1523/JNEUROSCI.3916-07.2008; Korneev SA, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0003.2002; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; LU TZ, 2009, SOC NEUR 39 ANN M; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Raman IM, 2000, J NEUROSCI, V20, P9004; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sipila ST, 2006, EUR J NEUROSCI, V23, P2330, DOI 10.1111/j.1460-9568.2006.04757.x; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Spencer GE, 1999, J NEUROSCI, V19, P1836; Staras K, 2002, EUR J NEUROSCI, V15, P109, DOI 10.1046/j.0953-816x.2001.01845.x; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; SYED NI, 1991, J COMP PHYSIOL A, V169, P541; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Taylor BE, 2000, RESP PHYSIOL, V122, P197, DOI 10.1016/S0034-5687(00)00159-6; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; Tryba AK, 2004, J NEUROBIOL, V60, P481, DOI 10.1002/neu.20050; van Diepen MT, 2005, MOL CELL NEUROSCI, V29, P74, DOI 10.1016/j.mcn.2005.01.005; VANDEN TM, 2003, J PHYSL, V549, P809; WINLOW W, 1992, ACTA BIOL HUNG, V43, P399; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644	53	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18745	10.1371/journal.pone.0018745	http://dx.doi.org/10.1371/journal.pone.0018745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526173	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100016
J	Bezerra, PGM; Britto, MCA; Correia, JB; Duarte, MDMB; Fonceca, AM; Rose, K; Hopkins, MJ; Cuevas, LE; McNamara, PS				Bezerra, Patricia G. M.; Britto, Murilo C. A.; Correia, Jailson B.; Duarte, Maria do Carmo M. B.; Fonceca, Angela M.; Rose, Katie; Hopkins, Mark J.; Cuevas, Luis E.; McNamara, Paul S.			Viral and Atypical Bacterial Detection in Acute Respiratory Infection in Children Under Five Years	PLOS ONE			English	Article							REAL-TIME PCR; SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; TRACT DISEASE; HUMAN BOCAVIRUS; RISK-FACTORS; PATHOGENS; IDENTIFICATION; BRONCHIOLITIS; SURVEILLANCE	Background: Acute respiratory infection (ARI) is a leading cause of morbidity and mortality in children worldwide. This study aimed to determine the viral and atypical bacterial causes of different severities and clinical manifestations of ARI in preschool children from low-income families in North-East Brazil. Methods: Clinical/demographic data and nasopharyngeal aspirates (NPA) were prospectively collected from children,5 years presenting with ARI over one year to a paediatric A&E department. Disease severity was grouped according to presence of lower respiratory tract signs, need for hospital admission and need for oxygen. Clinical manifestation of ARI was based on discharge diagnosis from hospital with four conditions predominating: bronchiolitis, pneumonia, episodic viral wheeze/asthma and upper respiratory tract infection. Multiplex PCR was used to detect 17 common respiratory viral and atypical bacterial pathogens in NPA. Findings: 407 children with a median age of eight months were recruited. Pathogens were detected in 85. 5% samples with co-infection being particularly common (39. 5%). Respiratory Syncytial Virus (RSV; 37%), Adenoviruses (AdV; 25%), Rhinoviruses (hRV; 19%), Bocavirus (hBoV; 19%), human Meta-pneumovirus (hMPV; 10%) and Mycoplasma pneumoniae (Mpp; 10%) were most prevalent. Detection and co-infection rates were similar in all severities and clinical manifestations of ARI apart from RSV, which was associated with more severe disease and specifically more severe cases of bronchiolitis, and Mpp, which was associated with more severe cases of pneumonia. Mpp was detected in 17% of children admitted to hospital with pneumonia. Interpretation: This study underlines the importance of viral and atypical bacterial pathogens in ARI in pre-school children and highlights the complex epidemiology of these pathogens in this age group. Generally, viruses and atypical bacteria were detected in all severities and clinical manifestations of ARI but RSV and Mpp were associated with more severe cases of bronchiolitis and pneumonia respectively.	[Bezerra, Patricia G. M.; Britto, Murilo C. A.; Correia, Jailson B.; Duarte, Maria do Carmo M. B.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil; [Bezerra, Patricia G. M.; Britto, Murilo C. A.] Fac Pernambucana Saude, Recife, PE, Brazil; [Correia, Jailson B.] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil; [Fonceca, Angela M.; Rose, Katie; McNamara, Paul S.] Univ Liverpool, Dept Child Hlth, Inst Child Hlth, Alder Hey Childrens Hosp, Liverpool L69 3BX, Merseyside, England; [Hopkins, Mark J.] Royal Liverpool Univ Hosp, Liverpool Specialist Virol Ctr, Liverpool, Merseyside, England; [Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade de Pernambuco (UPE); Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Bezerra, PGM (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.	mcnamp@liv.ac.uk	Britto, Murilo/AAQ-2951-2020; Correia, Jailson B./J-4331-2015; Cuevas, Luis E/I-3697-2015; Britto, Murilo/S-5543-2019	Cuevas, Luis E/0000-0002-6581-0587; Tripp, Ralph/0000-0002-2924-9956; de Barros Correia, Jailson/0000-0002-0927-2219; McNamara, Paul/0000-0002-7055-6034	Brazil's National Council for Scientific and Technological Development [479381/2006-2]; IMIP; Wellcome Trust	Brazil's National Council for Scientific and Technological Development; IMIP; Wellcome Trust(Wellcome TrustEuropean Commission)	Brazil's National Council for Scientific and Technological Development (Grant number 479381/2006-2) and IMIP's Fund for Teaching and Research supported this study. The Wellcome Trust also provided some funding for PMc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; *COMM BTSSOC, 2002, THORAX S1, V57, P1; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Gunson RN, 2005, J CLIN VIROL, V33, P341, DOI 10.1016/j.jcv.2004.11.025; Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2; Hopkins MJ, 2011, INFLUENZA OTHER RESP, V5, P110, DOI 10.1111/j.1750-2659.2010.00178.x; Kaplan NM, 2008, J MED VIROL, V80, P168, DOI 10.1002/jmv.21067; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Peat J K, 2001, Paediatr Respir Rev, V2, P207, DOI 10.1053/prrv.2001.0142; Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Russell KL, 2006, J INFECT DIS, V194, P877, DOI 10.1086/507426; Semple MG, 2007, J CLIN VIROL, V40, P241, DOI 10.1016/j.jcv.2007.08.019; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Sung RYT, 2009, J MED VIROL, V81, P153, DOI 10.1002/jmv.21364; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Weigl JAI, 2007, EUR J PEDIATR, V166, P957, DOI 10.1007/s00431-007-0496-x; WHO (World Health Organization), 1999, LEAD INF KILL	32	132	151	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18928	10.1371/journal.pone.0018928	http://dx.doi.org/10.1371/journal.pone.0018928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533115	Green Submitted, Green Published, gold			2022-12-27	WOS:000289620100031
J	Pettingill, LN; Wise, AK; Geaney, MS; Shepherd, RK				Pettingill, Lisa N.; Wise, Andrew K.; Geaney, Marilyn S.; Shepherd, Robert K.			Enhanced Auditory Neuron Survival Following Cell-Based BDNF Treatment in the Deaf Guinea Pig	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; ROUND WINDOW MEMBRANE; NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; RAT INNER-EAR; NEUROTROPHIC FACTOR; SCHWANN-CELLS; ELECTRICAL-STIMULATION; DRUG-DELIVERY	Exogenous neurotrophin delivery to the deaf cochlea can prevent deafness-induced auditory neuron degeneration, however, we have previously reported that these survival effects are rapidly lost if the treatment stops. In addition, there are concerns that current experimental techniques are not safe enough to be used clinically. Therefore, for such treatments to be clinically transferable, methods of neurotrophin treatment that are safe, biocompatible and can support long-term auditory neuron survival are necessary. Cell transplantation and gene transfer, combined with encapsulation technologies, have the potential to address these issues. This study investigated the survival-promoting effects of encapsulated BDNF over-expressing Schwann cells on auditory neurons in the deaf guinea pig. In comparison to control (empty) capsules, there was significantly greater auditory neuron survival following the cell-based BDNF treatment. Concurrent use of a cochlear implant is expected to result in even greater auditory neuron survival, and provide a clinically relevant method to support auditory neuron survival that may lead to improved speech perception and language outcomes for cochlear implant patients.	[Pettingill, Lisa N.; Wise, Andrew K.; Shepherd, Robert K.] Bion Ear Inst, Melbourne, Vic, Australia; [Wise, Andrew K.; Shepherd, Robert K.] Univ Melbourne, Dept Otolaryngol, Parkville, Vic 3052, Australia; [Geaney, Marilyn S.] Living Cell Technol Ltd, Auckland, New Zealand	University of Melbourne	Pettingill, LN (corresponding author), Bion Ear Inst, Melbourne, Vic, Australia.	lpettingill@bionicear.org	Wise, Andrew/B-5943-2014; Shepherd, Robert/I-6276-2012; Shepherd, Robert/G-1332-2013	Wise, Andrew/0000-0001-9715-8784; Shepherd, Robert/0000-0002-4239-3362	The Macquarie Bank Foundation; Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council of Australia; State Government of Victoria Operational Infrastructure Program; National Institutes of Health [HHS-N-263-2007-00053-C]; Living Cell Technologies, Limited (LCT)	The Macquarie Bank Foundation; Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria Operational Infrastructure Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Living Cell Technologies, Limited (LCT)	Funding for this research was provided by: The Macquarie Bank Foundation, The Garnett Passe and Rodney Williams Memorial Foundation, The National Health and Medical Research Council of Australia, The State Government of Victoria Operational Infrastructure Program, The National Institutes of Health (HHS-N-263-2007-00053-C) and Living Cell Technologies, Limited (LCT). MSG is employed by LCT and played a role in the cell encapsulation aspects of the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chen ZQ, 2005, J CONTROL RELEASE, V110, P1, DOI 10.1016/j.jconrel.2005.09.003; Chikar JA, 2008, HEARING RES, V245, P24, DOI 10.1016/j.heares.2008.08.005; Coleman B, 2006, CELL TRANSPLANT, V15, P369, DOI 10.3727/000000006783981819; Cureoglu S, 2005, ACTA OTO-LARYNGOL, V125, P9, DOI 10.1080/00016480410022534; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463; Fiering J, 2009, BIOMED MICRODEVICES, V11, P571, DOI 10.1007/s10544-008-9265-5; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gillespie LN, 2004, NEUROREPORT, V15, P1121, DOI 10.1097/00001756-200405190-00008; Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x; Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-04.2005; Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Haubensak W, 1998, J CELL SCI, V111, P1483; Hu Y, 2005, MOL THER, V11, P906, DOI 10.1016/j.ymthe.2005.01.016; Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480; Lalwani AK, 1997, HEARING RES, V114, P139, DOI 10.1016/S0378-5955(97)00151-2; Makar TK, 2009, J NEUROIMMUNOL, V210, P40, DOI 10.1016/j.jneuroim.2009.02.017; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7; MONTERO CN, 1988, J NEUROSCI, V8, P2986; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Noushi F, 2005, OTOL NEUROTOL, V26, P528, DOI 10.1097/01.mao.0000169780.84588.a5; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Pettingill LN, 2007, IEEE T BIO-MED ENG, V54, P1138, DOI 10.1109/TBME.2007.895375; PIRVOLA U, 1994, HEARING RES, V75, P131, DOI 10.1016/0378-5955(94)90064-7; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Richardson RT, 2008, EXPERT OPIN DRUG DEL, V5, P1059, DOI 10.1517/17425247.5.10.1059 ; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; SAIJO S, 1984, ACTA OTO-LARYNGOL, V97, P593, DOI 10.3109/00016488409132937; Salt AN, 2001, HEARING RES, V154, P88, DOI 10.1016/S0378-5955(01)00223-4; SALT AN, 2010, COCHLEAR FLUIDS VOLU; SCHECTERSON LC, 1994, HEARING RES, V73, P92, DOI 10.1016/0378-5955(94)90286-0; Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Skinner SJM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065001; Staecker H, 1996, NEUROREPORT, V7, P889, DOI 10.1097/00001756-199603220-00011; Staecker H, 1998, OTOLARYNG HEAD NECK, V119, P7, DOI 10.1016/S0194-5998(98)70194-9; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stover T, 2000, GENE THER, V7, P377, DOI 10.1038/sj.gt.3301108; Tan J, 2006, AM J PATHOL, V169, P528, DOI 10.2353/ajpath.2006.060122; Thanos Christopher G, 2008, Recent Pat Drug Deliv Formul, V2, P19, DOI 10.2174/187221108783331384; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Winn SR, 1996, EXP NEUROL, V140, P126, DOI 10.1006/exnr.1996.0123; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Yagi M, 2000, JARO-J ASSOC RES OTO, V1, P315, DOI 10.1007/s101620010011; Yamagata T, 2004, J NEUROSCI RES, V78, P75, DOI 10.1002/jnr.20239; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1	62	61	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18733	10.1371/journal.pone.0018733	http://dx.doi.org/10.1371/journal.pone.0018733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525998	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600025
J	Shan, TL; Lan, DL; Li, LL; Wang, CM; Cui, L; Zhang, W; Hua, XG; Zhu, CX; Zhao, W; Delwart, E				Shan, Tongling; Lan, Daoliang; Li, Linlin; Wang, Chunmei; Cui, Li; Zhang, Wen; Hua, Xiuguo; Zhu, Caixia; Zhao, Wei; Delwart, Eric			Genomic Characterization and High Prevalence of Bocaviruses in Swine	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; INFECTION; IDENTIFICATION; PARVOVIRUS; VIRUS; CARDIOVIRUSES; PICORNAVIRUS; DISCOVERY; DIVERSE; CLONING	Using random PCR amplification followed by plasmid subcloning and DNA sequencing, we detected bocavirus related sequences in 9 out of 17 porcine stool samples. Using primer walking, we sequenced the nearly complete genomes of two highly divergent bocaviruses we provisionally named porcine bocavirus 1 isolate H18 (PBoV1-H18) and porcine bocavirus 2 isolate A6 (PBoV2-A6) which differed by 51.8% in their NS1 protein. Phylogenetic analysis indicated that PBoV1-H18 was very closely related to a similar to 2 Kb central region of a porcine bocavirus-like virus (PBo-LikeV) from Sweden described in 2009. PBoV2-A6 was very closely related to the porcine bocavirus genomes PBoV-1 and PBoV2 from China described in 2010. Among 340 fecal samples collected from different age, asymptomatic swine in five Chinese provinces, the prevalence of PBoV1-H18 and PBoV2-A6 related viruses were 45-75% and 55-70% respectively, with 30-47% of pigs co-infected. PBoV1-A6 related strains were highly conserved, while PBoV2-H18 related strains were more diverse, grouping into two genotypes corresponding to the previously described PBoV1 and PBoV2. Together with the recently described partial bocavirus genomes labeled V6 and V7, a total of three major porcine bocavirus clades have therefore been described to date. Further studies will be required to elucidate the possible pathogenic impact of these diverse bocaviruses either alone or in combination with other porcine viruses.	[Shan, Tongling; Lan, Daoliang; Cui, Li; Hua, Xiuguo; Zhu, Caixia; Zhao, Wei] Shanghai Jiao Tong Univ, Zoonosis & Comparat Med Grp, Shanghai 200030, Peoples R China; [Shan, Tongling; Li, Linlin; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Shan, Tongling; Li, Linlin; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Wang, Chunmei] Huazhong Agr Univ, Coll Vet Med, Wuhan, Huibei, Peoples R China; [Zhang, Wen] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Huazhong Agricultural University; Jiangsu University	Shan, TL (corresponding author), Shanghai Jiao Tong Univ, Zoonosis & Comparat Med Grp, Shanghai 200030, Peoples R China.	hxg@sjtu.edu.cn	Shan, Tongling/AFG-8328-2022; Li, Linlin/E-3335-2010	Shan, Tongling/0000-0002-5329-6349; Delwart, Eric/0000-0002-6296-4484	Shanghai Science and Technology Committee of China [063919121]	Shanghai Science and Technology Committee of China(Shanghai Science & Technology Committee)	This work was supported by Key Project of Shanghai Science and Technology Committee of China under Grant No. 063919121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; BINN L N, 1970, Infection and Immunity, V1, P503; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; CHEN KC, 1986, J VIROL, V60, P1085, DOI 10.1128/JVI.60.3.1085-1097.1986; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Claude M., 2004, VIRUS TAXONOMY; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Vries JJC, 2009, J CLIN MICROBIOL, V47, P1241, DOI 10.1128/JCM.01703-08; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lipkin WI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000002; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Shan TL, 2009, J CLIN VIROL, V46, P196, DOI 10.1016/j.jcv.2009.07.012; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9; Ziegler S, 2008, J CLIN VIROL, V43, P349, DOI 10.1016/j.jcv.2008.07.006	59	57	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e17292	10.1371/journal.pone.0017292	http://dx.doi.org/10.1371/journal.pone.0017292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525999	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600005
J	Bratzler, DW; Normand, SLT; Wang, Y; O'Donnell, WJ; Metersky, M; Han, LF; Rapp, MT; Krumholz, HM				Bratzler, Dale W.; Normand, Sharon-Lise T.; Wang, Yun; O'Donnell, Walter J.; Metersky, Mark; Han, Lein F.; Rapp, Michael T.; Krumholz, Harlan M.			An Administrative Claims Model for Profiling Hospital 30-Day Mortality Rates for Pneumonia Patients	PLOS ONE			English	Article							QUALITY-OF-CARE; COMMUNITY-ACQUIRED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; PERFORMANCE-MEASURES; ELDERLY-PATIENTS; HEART-FAILURE; US HOSPITALS; OUTCOMES; ISSUES	Background: Outcome measures for patients hospitalized with pneumonia may complement process measures in characterizing quality of care. We sought to develop and validate a hierarchical regression model using Medicare claims data that produces hospital-level, risk-standardized 30-day mortality rates useful for public reporting for patients hospitalized with pneumonia. Methodology/Principal Findings: Retrospective study of fee-for-service Medicare beneficiaries age 66 years and older with a principal discharge diagnosis of pneumonia. Candidate risk-adjustment variables included patient demographics, administrative diagnosis codes from the index hospitalization, and all inpatient and outpatient encounters from the year before admission. The model derivation cohort included 224,608 pneumonia cases admitted to 4,664 hospitals in 2000, and validation cohorts included cases from each of years 1998-2003. We compared model-derived state-level standardized mortality estimates with medical record-derived state-level standardized mortality estimates using data from the Medicare National Pneumonia Project on 50,858 patients hospitalized from 1998-2001. The final model included 31 variables and had an area under the Receiver Operating Characteristic curve of 0.72. In each administrative claims validation cohort, model fit was similar to the derivation cohort. The distribution of standardized mortality rates among hospitals ranged from 13.0% to 23.7%, with 25(th), 50(th), and 75(th) percentiles of 16.5%, 17.4%, and 18.3%, respectively. Comparing model-derived risk-standardized state mortality rates with medical record-derived estimates, the correlation coefficient was 0.86 (Standard Error = 0.032). Conclusions/Significance: An administrative claims-based model for profiling hospitals for pneumonia mortality performs consistently over several years and produces hospital estimates close to those using a medical record model.	[Bratzler, Dale W.] Oklahoma Fdn Med Qual, Oklahoma City, OK 73134 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Wang, Yun; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Wang, Yun; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [O'Donnell, Walter J.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Metersky, Mark] Univ Connecticut, Sch Med, Div Pulm & Crit Care Med, Farmington, CT USA; [Rapp, Michael T.] George Washington Univ, Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC 20052 USA; [Han, Lein F.; Rapp, Michael T.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sch Publ Hlth,Robert Wood Johnson Clin Scholars P, New Haven, CT 06510 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Yale University; Yale University; Harvard University; Massachusetts General Hospital; University of Connecticut; George Washington University; Centers for Medicare & Medicaid Services; Yale University; Yale University	Bratzler, DW (corresponding author), Oklahoma Fdn Med Qual, Oklahoma City, OK 73134 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769; Bratzler, Dale/0000-0002-8033-7521	Centers for Medicare and Medicaid Services, an agency of the U.S. Department of Health and Human Services [500-02-OK-03, 500-05-CO01]; National Heart, Lung, and Blood Institute [U01 HL105270-01]; Massachusetts Department of Public Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Centers for Medicare and Medicaid Services, an agency of the U.S. Department of Health and Human Services; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts Department of Public Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The analyses upon which this publication is based were performed in part under Contract Numbers 500-02-OK-03 and Subcontract #500-05-CO01, funded by the Centers for Medicare and Medicaid Services, an agency of the U.S. Department of Health and Human Services. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The authors assume full responsibility for the accuracy and completeness of the ideas presented. (025_HQMSS_OK0402_0407) CMS reviewed and approved the use of its data for this work and approved submission of the manuscript. The funder had no role in study design, data collection and analysis, or manuscript preparation. Dr. Krumholz reports that he is a consultant to UnitedHealthcare, and that he is supported by grant U01 HL105270-01 from the National Heart, Lung, and Blood Institute. Dr. Normand reports that she is funded by the Massachusetts Department of Public Health to monitor the quality of care following cardiac surgery or percutaneous coronary intervention. The other authors report no conflicts.	Anderson RN, 2005, DEATHS LEADING CAUSE, V53; Bratzler DW, 2007, CURR OPIN INFECT DIS, V20, P182, DOI 10.1097/QCO.0b013e3280495468; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Krumholz HM, 2007, HEALTH AFFAIR, V26, P75, DOI 10.1377/hlthaff.26.1.75; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Milenkovic M, 2006, HEALTHCARE COST UTIL; Normand SLT, 2007, HEALTH SERV OUTCOME, V7, P79, DOI 10.1007/s10742-006-0018-8; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; Shahian DM, 2001, ANN THORAC SURG, V72, P2155, DOI 10.1016/S0003-4975(01)03222-2; Wang OJ, 2007, ARCH INTERN MED, V167, P1345, DOI 10.1001/archinte.167.13.1345; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Whittle J, 1997, Am J Med Qual, V12, P187, DOI 10.1177/0885713X9701200404; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	24	106	106	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e17401	10.1371/journal.pone.0017401	http://dx.doi.org/10.1371/journal.pone.0017401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532758	Green Published, Green Submitted, gold			2022-12-27	WOS:000289404700004
J	Braunstein, SL; Nash, D; Kim, AA; Ford, K; Mwambarangwe, L; Ingabire, CM; Vyankandondera, J; van de Wijgert, JHHM				Braunstein, Sarah L.; Nash, Denis; Kim, Andrea A.; Ford, Ken; Mwambarangwe, Lambert; Ingabire, Chantal M.; Vyankandondera, Joseph; van de Wijgert, Janneke H. H. M.			Dual Testing Algorithm of BED-CEIA and AxSYM Avidity Index Assays Performs Best in Identifying Recent HIV Infection in a Sample of Rwandan Sex Workers	PLOS ONE			English	Article							CAPTURE ENZYME-IMMUNOASSAY; SEROCONVERSION; SURVEILLANCE	Background: To assess the performance of BED-CEIA (BED) and AxSYM Avidity Index (Ax-AI) assays in estimating HIV incidence among female sex workers (FSW) in Kigali, Rwanda. Methodology and Findings: Eight hundred FSW of unknown HIV status were HIV tested; HIV-positive women had BED and Ax-AI testing at baseline and >= 12 months later to estimate assay false-recent rates (FRR). STARHS-based HIV incidence was estimated using the McWalter/Welte formula, and adjusted with locally derived FRR and CD4 results. HIV incidence and local assay window periods were estimated from a prospective cohort of FSW. At baseline, 190 HIV-positive women were BED and Ax-AI tested; 23 were classified as recent infection (RI). Assay FRR with 95% confidence intervals were: 3.6% (1.2-8.1) (BED); 10.6% (6.1-17.0) (Ax-AI); and 2.1% (0.4-6.1) (BED/Ax-AI combined). After FRR-adjustment, incidence estimates by BED, Ax-AI, and BED/Ax-AI were: 5.5/100 person-years (95% CI 2.2-8.7); 7.7 (3.2-12.3); and 4.4 (1.4-7.3). After CD4-adjustment, BED, Ax-AI, and BED/Ax-AI incidence estimates were: 5.6 (2.6-8.6); 9.7 (5.0-14.4); and 4.7 (2.0-7.5). HIV incidence rates in the first and second 6 months of the cohort were 4.6 (1.6-7.7) and 2.2 (0.1-4.4). Conclusions: Adjusted incidence estimates by BED/Ax-AI combined were similar to incidence in the first 6 months of the cohort. Furthermore, false-recent rate on the combined BED/Ax-AI algorithm was low and substantially lower than for either assay alone. Improved assay specificity with time since seroconversion suggests that specificity would be higher in population-based testing where more individuals have long-term infection.	[Braunstein, Sarah L.; Nash, Denis] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Kim, Andrea A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ford, Ken; Mwambarangwe, Lambert; Ingabire, Chantal M.; Vyankandondera, Joseph; van de Wijgert, Janneke H. H. M.] Projet Ubuzima, Kigali, Rwanda; [Vyankandondera, Joseph] Belgian Dev Agcy, Kigali, Rwanda; [van de Wijgert, Janneke H. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke H. H. M.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Columbia University; Centers for Disease Control & Prevention - USA; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Braunstein, SL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	braunstein.sarah@gmail.com	Nash, Denis/AFI-7485-2022	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Nash, Denis/0000-0002-3280-5386	International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention; US National Institutes of Health	International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention; and US National Institutes of Health-Institutional Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Blackwelder W C, 2004, J Dent Res, V83 Spec No C, pC113; Brookmeyer R, 2009, AIDS, V23, P2066, DOI 10.1097/QAD.0b013e32832f3dbb; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; CDC, 2006, INT REC US BED CAPT; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; Constantine NT, 2003, JAIDS-J ACQ IMM DEF, V32, P94, DOI 10.1097/00126334-200301010-00014; Dieltjens T, 2009, AIDS RES HUM RETROV, V25, P1165, DOI 10.1089/aid.2008.0161; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hargrove JW, 2009, AIDS, V23, P2061, DOI 10.1097/QAD.0b013e32832f3d8b; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Martro E, 2005, J CLIN MICROBIOL, V43, P6197, DOI 10.1128/JCM.43.12.6197-6199.2005; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; MURPHY G, 2004, INT AIDS C; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2001, AIDS REV, V3, P183; PAREKH BS, 2010, AIDS RES HUM RETROVI; Rutherford GW, 2000, J ACQ IMMUN DEF SYND, V25, pS115, DOI 10.1097/00126334-200012152-00005; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; *UNAIDS, 2008, EP FACT SHEET RWAND; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Welte A, 2009, AIDS, V23, P2062, DOI 10.1097/QAD.0b013e32832eff59; *WHO, 2009, P M DEV ASS EST HIV; Yang OO, 2005, J VIROL, V79, P860, DOI 10.1128/JVI.79.2.860-868.2005	35	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18402	10.1371/journal.pone.0018402	http://dx.doi.org/10.1371/journal.pone.0018402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532753	Green Published, gold			2022-12-27	WOS:000289404700012
J	Claser, C; Malleret, B; Gun, SY; Wong, AYW; Chang, ZW; Teo, P; See, PCE; Howland, SW; Ginhoux, F; Renia, L				Claser, Carla; Malleret, Benoit; Gun, Sin Yee; Wong, Alicia Yoke Wei; Chang, Zi Wei; Teo, Pearline; See, Peter Chi Ee; Howland, Shanshan Wu; Ginhoux, Florent; Renia, Laurent			CD8(+) T Cells and IFN-gamma Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PARASITE SEQUESTRATION; C-FMS; BRAIN; PATHOGENESIS; RECEPTOR; PHAGOCYTOSIS; PATHOLOGY; IMMUNITY; ALPHA	Background: Infection with Plasmodium berghei ANKA (PbA) in susceptible mice induces a syndrome called experimental cerebral malaria (ECM) with severe pathologies occurring in various mouse organs. Immune mediators such as T cells or cytokines have been implicated in the pathogenesis of ECM. Red blood cells infected with PbA parasites have been shown to accumulate in the brain and other tissues during infection. This accumulation is thought to be involved in PbA-induced pathologies, which mechanisms are poorly understood. Methods and Findings: Using transgenic PbA parasites expressing the luciferase protein, we have assessed by real-time in vivo imaging the dynamic and temporal contribution of different immune factors in infected red blood cell (IRBC) accumulation and distribution in different organs during PbA infection. Using deficient mice or depleting antibodies, we observed that CD8(+) T cells and IFN-gamma drive the rapid increase in total parasite biomass and accumulation of IRBC in the brain and in different organs 6-12 days post-infection, at a time when mice develop ECM. Other cells types like CD4(+) T cells, monocytes or neutrophils or cytokines such as IL-12 and TNF-alpha did not influence the early increase of total parasite biomass and IRBC accumulation in different organs. Conclusions: CD8(+) T cells and IFN-gamma are the major immune mediators controlling the time-dependent accumulation of P. berghei-infected red blood cells in tissues.	[Claser, Carla; Malleret, Benoit; Gun, Sin Yee; Wong, Alicia Yoke Wei; Chang, Zi Wei; Teo, Pearline; See, Peter Chi Ee; Howland, Shanshan Wu; Ginhoux, Florent; Renia, Laurent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Claser, C (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	renia_laurent@immunol.a-star.edu.sg	Malleret, Benoit/E-9159-2011; Renia, Laurent/E-2117-2011; Claser, Carla/P-2736-2018; Howland, Shanshan W/I-2245-2014	Malleret, Benoit/0000-0001-9658-7528; Renia, Laurent/0000-0003-0349-1557; Claser, Carla/0000-0002-5395-9632; Howland, Shanshan W/0000-0003-4794-1564; See, Peter/0000-0003-4428-7763; Wong, Alicia Yoke Wei/0000-0003-1169-7766; Teo, Pearline/0000-0002-8283-6308; Gun, Sin Yee/0000-0001-6158-6293	A*STAR	A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by an intramural grant from A*STAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 1998, INFECT IMMUN, V66, P4093; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; [Anonymous], REFORMA MED; Bagot S, 2004, INFECT IMMUN, V72, P2817, DOI 10.1128/IAI.72.5.2817-2826.2004; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BROSNAN CF, 1993, ADV NEUROL, V59, P349; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; CELADA A, 1983, J PARASITOL, V69, P49, DOI 10.2307/3281273; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Ewing J, 1901, J EXP MED, V6, P119; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hulier E, 1996, MOL BIOCHEM PARASIT, V77, P127, DOI 10.1016/0166-6851(96)02584-4; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Jose MD, 2003, AM J TRANSPLANT, V3, P294, DOI 10.1034/j.1600-6143.2003.00068.x; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; Murayama T, 1999, CIRCULATION, V99, P1740, DOI 10.1161/01.CIR.99.13.1740; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; SCHETTERS TPM, 1983, CELL BIOL INT REP, V7, P402, DOI 10.1016/0309-1651(83)90124-8; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Sudo T, 1995, ONCOGENE, V11, P2469; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Togbe D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002608; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wang YQ, 1999, J NEUROSCI RES, V57, P616, DOI 10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E; Yanez DM, 1996, J IMMUNOL, V157, P1620	53	111	114	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18720	10.1371/journal.pone.0018720	http://dx.doi.org/10.1371/journal.pone.0018720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494565	gold, Green Published, Green Submitted			2022-12-27	WOS:000289354100033
J	Wang, DV; Wang, F; Liu, J; Zhang, L; Wang, ZR; Lin, LN				Wang, Dong V.; Wang, Fang; Liu, Jun; Zhang, Lu; Wang, Zhiru; Lin, Longnian			Neurons in the Amygdala with Response-Selectivity for Anxiety in Two Ethologically Based Tests	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; OPEN-FIELD TEST; BASOLATERAL AMYGDALA; INDIVIDUAL-DIFFERENCES; RAT AMYGDALA; FEAR; BEHAVIOR; EXPOSURE; RECEPTORS; STRESS	The amygdala is a key area in the brain for detecting potential threats or dangers, and further mediating anxiety. However, the neuronal mechanisms of anxiety in the amygdala have not been well characterized. Here we report that in freely-behaving mice, a group of neurons in the basolateral amygdala (BLA) fires tonically under anxiety conditions in both open-field and elevated plus-maze tests. The firing patterns of these neurons displayed a characteristic slow onset and progressively increased firing rates. Specifically, these firing patterns were correlated to a gradual development of anxiety-like behaviors in the open-field test. Moreover, these neurons could be activated by any impoverished environment similar to an open-field; and introduction of both comfortable and uncomfortable stimuli temporarily suppressed the activity of these BLA neurons. Importantly, the excitability of these BLA neurons correlated well with levels of anxiety. These results demonstrate that this type of BLA neuron is likely to represent anxiety and/or emotional values of anxiety elicited by anxiogenic environmental stressors.	[Wang, Dong V.; Wang, Fang; Liu, Jun; Zhang, Lu; Wang, Zhiru; Lin, Longnian] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Inst Brain Funct Genom, Shanghai 200062, Peoples R China	East China Normal University	Wang, DV (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Inst Brain Funct Genom, Shanghai 200062, Peoples R China.	lnlin@brain.ecnu.edu.cn		Zhang, Lu/0000-0001-7300-1037	National Natural Science Foundation of China [30990262, 30570584]; Shanghai Municipal Education Commission [09ZZ44]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the National Natural Science Foundation of China (No. 30990262, 30570584) and the Innovation Program of Shanghai Municipal Education Commission (No. 09ZZ44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec RE, 1999, PHYSIOL BEHAV, V65, P723; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Clement Y, 1998, NEUROSCI BIOBEHAV R, V22, P623, DOI 10.1016/S0149-7634(97)00058-4; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Hale MW, 2006, BRAIN RES BULL, V71, P174, DOI 10.1016/j.brainresbull.2006.09.001; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Johnstone KA, 2004, BEHAV RES THER, V42, P249, DOI 10.1016/S0005-7967(03)00137-2; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kwekkeboom Kristine L, 2003, Oncol Nurs Forum, V30, P433, DOI 10.1188/03.ONF.433-440; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mitra R, 2009, MOL PSYCHIATR, V14, P847, DOI 10.1038/mp.2009.9; NISHIJO H, 1988, J NEUROSCI, V8, P3570; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Sajdyk TJ, 1997, BRAIN RES, V764, P262, DOI 10.1016/S0006-8993(97)00594-5; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Shearer SL, 2007, PRIMARY CARE, V34, P475, DOI 10.1016/j.pop.2007.05.002; SILVEIRA MCL, 1993, BEHAV BRAIN RES, V56, P115, DOI 10.1016/0166-4328(93)90028-O; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WILSON FAW, 1993, EXP BRAIN RES, V93, P367; Wu LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000167; Wunderlich GR, 2002, PSYCHOPHARMACOLOGY, V164, P193, DOI 10.1007/s00213-002-1181-4	37	47	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18739	10.1371/journal.pone.0018739	http://dx.doi.org/10.1371/journal.pone.0018739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494567	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100038
J	Zhou, B; Xiao, L; Wang, ZH; Chang, ET; Chen, JJ; Hou, JL				Zhou, Bin; Xiao, Lei; Wang, Zhanhui; Chang, Ellen T.; Chen, Jinjun; Hou, Jinlin			Geographical and Ethnic Distribution of the HBV C/D Recombinant on the Qinghai-Tibet Plateau	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; E-ANTIGEN; HEPATOCELLULAR-CARCINOMA; CORE PROMOTER; GENOTYPE-A; VIROLOGICAL CHARACTERISTICS; NATURAL-HISTORY; MUTATIONS; SUBGENOTYPES; INFECTION	Two forms of hepatitis B virus (HBV) C/D recombinant have been identified in western China, but little is known about their geographical and ethnic distributions, and particularly the clinical significance and specific mutations in the pre-core region. To address these questions, a total of 624 chronic HBV carriers from four ethnic populations representing five provinces in western China were enrolled in this study. Genotypes were firstly determined by restriction fragment length polymorphism, and then confirmed by full or partial genome nucleotide sequencing. The distribution of HBV genotypes was as follows: HBV/B: 40 (6.4%); HBV/C: 221 (35.4%); HBV/D: 39 (6.3%); HBV/CD: 324 (51.9%). In the 324 HBV C/D recombinant infections, 244 (75.3%) were infected with the "CD1'' and 80 (24.7%) were infected with the "CD2.'' The distribution of HBV genotypes exhibited distinct patterns in different regions and ethnic populations. Geographically, the C/D recombinant was the most prevalent HBV strain on the Qinghai-Tibet Plateau. Ethnically, the C/D recombinant had a higher prevalence in Tibetan patients than in other populations. Clinically, patients with HBV/CD1 showed significantly lower levels of serum total bilirubin than patients with HBV/C2. The prevalence of HBeAg was comparable between patients with HBV/CD1 and HBV/C2 (63.3% vs 50.0%, P = 0.118) whether patients were taken together or stratified by age into three groups (65.6% vs 58.8% in < 30 years, P = 0.758; 61.9% vs 48.0% in 30-50 years, P = 0.244; 64.3% vs 33.3%, P = 0.336). Virologically HBV/CD1 had a significantly lower frequency of G1896A than HBV/C2. In conclusion, the HBV C/D recombinant is restricted to the Qinghai-Tibet Plateau in western China and is found predominantly in Tibetans. The predominance of the premature pre-core stop mutation G1896A in patients with the HBV C/D recombinant may account for the higher prevalence of HBeAg in these patients.	[Zhou, Bin; Xiao, Lei; Wang, Zhanhui; Chen, Jinjun; Hou, Jinlin] So Med Univ, Nanfang Hosp, Inst Hepatol, Guangzhou, Guangdong, Peoples R China; [Zhou, Bin; Xiao, Lei; Wang, Zhanhui; Chen, Jinjun; Hou, Jinlin] So Med Univ, Nanfang Hosp, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Xiao, Lei] Eighth Peoples Hosp Guangzhou, Dept Severe Hepatopathy, Guangzhou, Guangdong, Peoples R China; [Chang, Ellen T.] Stanford Univ, Asian Liver Ctr, Dept Surg, Sch Med, Stanford, CA 94305 USA	Southern Medical University - China; Southern Medical University - China; Stanford University	Zhou, B (corresponding author), So Med Univ, Nanfang Hosp, Inst Hepatol, Guangzhou, Guangdong, Peoples R China.	wangzhhsu@gmail.com; jlhousmu@yahoo.com.cn	Shen, Jianzhong/AAH-8184-2019		National eleven-five project of China [2008ZX10002-004]; Major 973 [2007CB512901]; National Natural Science Foundation of China [30730082]	National eleven-five project of China; Major 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National eleven-five project of China (2008ZX10002-004), the Major 973 (No. 2007CB512901) and National Natural Science Foundation of China (Grant number: 30730082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CS, 2009, J GASTROEN HEPATOL, V24, P569, DOI 10.1111/j.1440-1746.2008.05642.x; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Bartholomeusz A, 2004, REV MED VIROL, V14, P3, DOI 10.1002/rmv.400; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chattopadhyay S, 2006, HEPATOL RES, V35, P79, DOI 10.1016/j.hepres.2006.03.002; Chauhan R, 2008, WORLD J GASTROENTERO, V14, P6228, DOI 10.3748/wjg.14.6228; Chen S, 2006, INT J IMMUNOGENET, V33, P439, DOI 10.1111/j.1744-313X.2006.00637.x; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Davaalkham D, 2007, ARCH VIROL, V152, P575, DOI 10.1007/s00705-006-0863-3; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; GUNTHER S, 1995, J VIROL, V69, P5437; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Kato H, 2002, HEPATOLOGY, V35, P922, DOI 10.1053/jhep.2002.32096; Kato H, 2003, J VIROL METHODS, V110, P29, DOI 10.1016/S0166-0934(03)00095-8; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lai S P, 1999, Yi Chuan Xue Bao, V26, P447; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luo KX, 2004, VIRUS GENES, V29, P31, DOI 10.1023/B:VIRU.0000032787.77837.09; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Okwiredu WKBA, 2001, J MED VIROL, V65, P485, DOI 10.1002/jmv.2062; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Osiowy C, 2003, J CLIN MICROBIOL, V41, P5473, DOI 10.1128/JCM.41.12.5473-5477.2003; Osiowy C, 2008, J GEN VIROL, V89, P3009, DOI 10.1099/vir.0.2008/005124-0; Raimondi S, 2010, J HEPATOL, V52, P441, DOI 10.1016/j.jhep.2009.12.014; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Shrestha SM, 2007, J GASTROEN HEPATOL, V22, P1921, DOI 10.1111/j.1440-1746.2006.04611.x; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Sugauchi F, 2003, GASTROENTEROLOGY, V124, P925, DOI 10.1053/gast.2003.50140; Szmaragd C, 2007, MOL ECOL, V16, P4747, DOI 10.1111/j.1365-294X.2007.03564.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Tsatsralt-Od B, 2006, J MED VIROL, V78, P542, DOI 10.1002/jmv.20574; Wang Z, 2007, J VIRAL HEPATITIS, V14, P426, DOI 10.1111/j.1365-2893.2006.00813.x; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yano Y, 2007, HEPATOL RES, V37, P1095, DOI 10.1111/j.1872-034X.2007.00161.x; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x; Zeng GB, 2004, WORLD J GASTROENTERO, V10, P3132	49	36	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18708	10.1371/journal.pone.0018708	http://dx.doi.org/10.1371/journal.pone.0018708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494570	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100032
J	Martin, R; Moran, GP; Jacobsen, ID; Heyken, A; Domey, J; Sullivan, DJ; Kurzai, O; Hube, B				Martin, Ronny; Moran, Gary P.; Jacobsen, Ilse D.; Heyken, Antje; Domey, Jenny; Sullivan, Derek J.; Kurzai, Oliver; Hube, Bernhard			The Candida albicans-Specific Gene EED1 Encodes a Key Regulator of Hyphal Extension	PLOS ONE			English	Article							FILAMENTOUS GROWTH; TRANSCRIPTIONAL REGULATOR; MORPHOGENESIS; EXPRESSION; PHOSPHORYLATION; CYCLIN; YEAST; EFG1; UME6; INTERNALIZATION	The extension of germ tubes into elongated hyphae by Candida albicans is essential for damage of host cells. The C. albicans-specific gene EED1 plays a crucial role in this extension and maintenance of filamentous growth. eed1 Delta cells failed to extend germ tubes into long filaments and switched back to yeast growth after 3 h of incubation during growth on plastic surfaces. Expression of EED1 is regulated by the transcription factor Efg1 and ectopic overexpression of EED1 restored filamentation in efg1 Delta. Transcriptional profiling of eed1 Delta during infection of oral tissue revealed down-regulation of hyphal associated genes including UME6, encoding another key transcriptional factor. Ectopic overexpression of EED1 or UME6 rescued filamentation and damage potential in eed1 Delta. Transcriptional profiling during overexpression of UME6 identified subsets of genes regulated by Eed1 or Ume6. These data suggest that Eed1 and Ume6 act in a pathway regulating maintenance of hyphal growth thereby repressing hyphal-to-yeast transition and permitting dissemination of C. albicans within epithelial tissues.	[Martin, Ronny; Jacobsen, Ilse D.; Heyken, Antje; Domey, Jenny; Hube, Bernhard] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogenic Mech, Jena, Germany; [Martin, Ronny; Kurzai, Oliver] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Grp Fungal Sept, Ctr Innovat Competence Sept, Jena, Germany; [Martin, Ronny; Kurzai, Oliver; Hube, Bernhard] Univ Jena, Jena, Germany; [Moran, Gary P.; Sullivan, Derek J.] Univ Dublin, Microbiol Res Unit, Div Oral Biosci, Sch Dent Sci, Dublin, Ireland; [Moran, Gary P.; Sullivan, Derek J.] Univ Dublin, Dublin Dent Univ Hosp, Trin Coll Dublin, Dublin, Ireland	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Trinity College Dublin; Trinity College Dublin	Martin, R (corresponding author), Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogenic Mech, Jena, Germany.	bernhard.hube@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Moran, Gary/F-3116-2012; Sullivan, Derek/A-8269-2008	Jacobsen, Ilse/0000-0002-6033-9984; Moran, Gary/0000-0003-0469-1788; Kurzai, Oliver/0000-0002-7277-2646; Hube, Bernhard/0000-0002-6028-0425; Sullivan, Derek/0000-0003-0195-9697	Deutsche Forschungsgemeinschaft [Hu528/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially supported by the Deutsche Forschungsgemeinschaft Hu528/10 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Bishop A, 2010, EMBO J, V29, P2930, DOI 10.1038/emboj.2010.158; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Braun BR, 2000, GENETICS, V155, P57; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Carlisle PL, 2010, EUKARYOT CELL, V9, P1320, DOI 10.1128/EC.00046-10; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Leng P, 2001, J BACTERIOL, V183, P4090, DOI 10.1128/JB.183.13.4090-4093.2001; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shen JQ, 2008, P NATL ACAD SCI USA, V105, P20918, DOI 10.1073/pnas.0809147105; Skrzypek MS, 2010, NUCLEIC ACIDS RES, V38, pD428, DOI 10.1093/nar/gkp836; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang A, 2009, MOL CELL BIOL, V29, P4406, DOI 10.1128/MCB.01502-08; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; ZHU W, 2009, CELL MICROBIOL	56	64	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18394	10.1371/journal.pone.0018394	http://dx.doi.org/10.1371/journal.pone.0018394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21512583	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700010
J	Nazarenko, I; Hedren, A; Sjodin, H; Orrego, A; Andrae, J; Afink, GB; Nister, M; Lindstrom, MS				Nazarenko, Inga; Hedren, Anna; Sjodin, Hanna; Orrego, Abiel; Andrae, Johanna; Afink, Gijs B.; Nister, Monica; Lindstrom, Mikael S.			Brain Abnormalities and Glioma-Like Lesions in Mice Overexpressing the Long Isoform of PDGF-A in Astrocytic Cells	PLOS ONE			English	Article							GROWTH-FACTOR-A; NEURAL STEM-CELLS; RAT OPTIC-NERVE; IN-VIVO; OLIGODENDROCYTE DEVELOPMENT; SUBVENTRICULAR ZONE; PROGENITOR-CELL; B-CHAIN; GENE; EXPRESSION	Background: Deregulation of platelet-derived growth factor (PDGF) signaling is a hallmark of malignant glioma. Two alternatively spliced PDGF-A mRNAs have been described, corresponding to a long (L) and a short (S) isoform of PDGF-A. In contrast to PDGF-A(S), the PDGF-A(L) isoform has a lysine and arginine rich carboxy-terminal extension that acts as an extracellular matrix retention motif. However, the exact role of PDGF-A(L) and how it functionally differs from the shorter isoform is not well understood. Methodology/Principal Findings: We overexpressed PDGF-A(L) as a transgene under control of the glial fibrillary acidic protein (GFAP) promoter in the mouse brain. This directs expression of the transgene to astrocytic cells and GFAP expressing neural stem cells throughout the developing and adult central nervous system. Transgenic mice exhibited a phenotype with enlarged skull at approximately 6-16 weeks of age and they died between 1.5 months and 2 years of age. We detected an increased number of undifferentiated cells in all areas of transgene expression, such as in the subependymal zone around the lateral ventricle and in the cerebellar medulla. The cells stained positive for Pdgfr-alpha, Olig2 and NG2 but this population did only partially overlap with cells positive for Gfap and the transgene reporter. Interestingly, a few mice presented with overt neoplastic glioma-like lesions composed of both Olig2 and Gfap positive cell populations and with microvascular proliferation, in a wild-type p53 background. Conclusions: Our findings show that PDGF-A(L) can induce accumulation of immature cells in the mouse brain. The strong expression of NG2, Pdgfr-alpha and Olig2 in PDGF-A(L) brains suggests that a fraction of these cells are oligodendrocyte progenitors. In addition, accumulation of fluid in the subarachnoid space and skull enlargement indicate that an increased intracranial pressure contributed to the observed lethality.	[Nazarenko, Inga; Hedren, Anna; Orrego, Abiel; Nister, Monica; Lindstrom, Mikael S.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Sjodin, Hanna] Univ Pittsburgh, Pittsburgh, PA USA; [Andrae, Johanna] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Afink, Gijs B.] Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, NL-1105 AZ Amsterdam, Netherlands; [Andrae, Johanna] Karolinska Inst, Ludwig Inst Canc Res, Stockholm Branch, Stockholm, Sweden	Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Ludwig Institute for Cancer Research	Nazarenko, I (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	mikael.lindstrom@ki.se	Andrae, Johanna/L-3875-2014; Afink, Gijs/A-2025-2009; Lindström, Mikael S/AAA-1451-2019; Afink, Gijs/AAB-2832-2021	Afink, Gijs/0000-0002-2155-725X; Lindström, Mikael S/0000-0003-1148-8497; 	Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council (VR Medicine); Karolinska Institutet; Cancer Society in Stockholm; James S. McDonnell Foundation; Swedish Institute; Swedish Cancer Society (Cancerfonden); Ake Wiberg's foundation; Magnus Bergvall's foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council (VR Medicine)(Swedish Research Council); Karolinska Institutet(Karolinska Institutet); Cancer Society in Stockholm; James S. McDonnell Foundation; Swedish Institute; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Ake Wiberg's foundation; Magnus Bergvall's foundation	Financial support for this work was provided by the Swedish Cancer Society (M.N.), the Swedish Childhood Cancer Foundation (M.N.), the Swedish Research Council (VR Medicine) (M.N.), Karolinska Institutet (M.N.), the Cancer Society in Stockholm (M.N.), the James S. McDonnell Foundation (M.N., G. B. A.), and the Swedish Institute/Visby program (scholarship to I.N.). M. L. was supported by a fellowship from the Swedish Cancer Society (Cancerfonden), the Karolinska Institutet funds, Ake Wiberg's foundation and Magnus Bergvall's foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSSON M, 1994, J BIOL CHEM, V269, P926; Andrae J, 2001, MECH DEVELOP, V107, P181, DOI 10.1016/S0925-4773(01)00460-9; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Barami K, 2007, J CLIN NEUROSCI, V14, P1143, DOI 10.1016/j.jocn.2007.04.009; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1990, NATURE, V344, P299, DOI 10.1038/344299a0; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; Crews L, 2004, BRAIN PATHOL, V14, P312; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; DELBIGIO MR, DEV DISABIL RES REV, V16, P16; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Emerich DF, 2004, EXPERT OPIN BIOL TH, V4, P1191, DOI 10.1517/14712598.4.8.1191; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; HART IK, 1989, DEVELOPMENT, V105, P595; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jackson EL, 2008, CELLS TISSUES ORGANS, V188, P212, DOI 10.1159/000114541; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; MAGLIONE D, 1993, ONCOGENE, V8, P925; MATOSKOVA B, 1989, MOL CELL BIOL, V9, P3148, DOI 10.1128/MCB.9.7.3148; MERCOLA M, 1988, SCIENCE, V241, P1223, DOI 10.1126/science.3413486; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Niklasson M, 2010, EXP CELL RES, V316, P2779, DOI 10.1016/j.yexcr.2010.07.009; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; Rorsman F, 1992, GROWTH FACTORS, V7, DOI 10.3109/08977199209046928; Uhrbom L, 1998, CANCER RES, V58, P5275; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; YOUNG RM, 1990, MOL CELL BIOL, V10, P6051, DOI 10.1128/MCB.10.11.6051; Zhang XQ, 1998, MECH DEVELOP, V70, P167, DOI 10.1016/S0925-4773(97)00190-1	50	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18303	10.1371/journal.pone.0018303	http://dx.doi.org/10.1371/journal.pone.0018303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490965	Green Accepted, Green Published, gold			2022-12-27	WOS:000289238700007
J	Achenbach, JE; Bowen, RA				Achenbach, Jenna E.; Bowen, Richard A.			Transmission of Avian Influenza A Viruses among Species in an Artificial Barnyard	PLOS ONE			English	Article							WATERBORNE TRANSMISSION; COTTON RAT; HONG-KONG; H5N1; PATHOGENICITY; EVOLUTION; OUTBREAK; PIGEONS; DUCKS; PERSISTENCE	Waterfowl and shorebirds harbor and shed all hemagglutinin and neuraminidase subtypes of influenza A viruses and interact in nature with a broad range of other avian and mammalian species to which they might transmit such viruses. Estimating the efficiency and importance of such cross-species transmission using epidemiological approaches is difficult. We therefore addressed this question by studying transmission of low pathogenic H5 and H7 viruses from infected ducks to other common animals in a quasi-natural laboratory environment designed to mimic a common barnyard. Mallards (Anas platyrhynchos) recently infected with H5N2 or H7N3 viruses were introduced into a room housing other mallards plus chickens, blackbirds, rats and pigeons, and transmission was assessed by monitoring virus shedding (ducks) or seroconversion (other species) over the following 4 weeks. Additional animals of each species were directly inoculated with virus to characterize the effect of a known exposure. In both barnyard experiments, virus accumulated to high titers in the shared water pool. The H5N2 virus was transmitted from infected ducks to other ducks and chickens in the room either directly or through environmental contamination, but not to rats or blackbirds. Ducks infected with the H7N2 virus transmitted directly or indirectly to all other species present. Chickens and blackbirds directly inoculated with these viruses shed significant amounts of virus and seroconverted; rats and pigeons developed antiviral antibodies, but, except for one pigeon, failed to shed virus.	[Achenbach, Jenna E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Achenbach, JE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	rbowen@colostate.edu		Achenbach, Jenna/0000-0002-5367-6413	Centers for Disease Control and Prevention [1 U19 CI00419-01]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U19CI000419] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	These studies were supported through cooperative agreement 1 U19 CI00419-01 from the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENAS A, 1990, AVIAN PATHOL, V19, P539, DOI 10.1080/03079459008418706; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brochet AL, 2009, ECOHEALTH, V6, P449, DOI 10.1007/s10393-010-0275-4; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Eichelberger MC, 2007, VIRAL IMMUNOL, V20, P243, DOI 10.1089/vim.2007.0017; Fang TH, 2006, AVIAN DIS, V50, P269, DOI 10.1637/7437-090905R.1; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Forrest HL, 2010, J VIROL, V84, P3718, DOI 10.1128/JVI.02017-09; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Jia BB, 2008, ARCH VIROL, V153, P1821, DOI 10.1007/s00705-008-0193-8; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; LATORREMARGALEF N, 2008, P ROY SOC LOND B BIO, V276, P1029; LAUDERT E, 1993, AVIAN DIS, V37, P793, DOI 10.2307/1592031; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; Niqueux E, 2010, AVIAN DIS, V54, P502, DOI 10.1637/8804-040109-ResNote.1; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Rice EW, 2007, EMERG INFECT DIS, V13, P1568, DOI 10.3201/eid1310.070323; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; SHORTRIDGE KF, 1982, B WORLD HEALTH ORGAN, V60, P129; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; TYRRELL DAJ, 1952, J IMMUNOL, V69, P563; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Werner O, 2007, J GEN VIROL, V88, P3089, DOI 10.1099/vir.0.83105-0	40	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17643	10.1371/journal.pone.0017643	http://dx.doi.org/10.1371/journal.pone.0017643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483843	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200008
J	Kelsen, J; Dige, A; Schwindt, H; D'Amore, F; Pedersen, FS; Agnholt, J; Christensen, LA; Dahlerup, JF; Hvas, CL				Kelsen, Jens; Dige, Anders; Schwindt, Heinrich; D'Amore, Francesco; Pedersen, Finn S.; Agnholt, Jorgen; Christensen, Lisbet A.; Dahlerup, Jens F.; Hvas, Christian L.			Infliximab Induces Clonal Expansion of gamma delta-T Cells in Crohn's Disease: A Predictor of Lymphoma Risk?	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THERAPY; AZATHIOPRINE; DIAGNOSIS; PATIENT; BLOOD; IBD	Background: Concominant with the widespread use of combined immunotherapy in the management of Crohn's disease (CD), the incidence of hepato-splenic gamma-delta (gamma delta)-T cell lymphoma has increased sharply in CD patients. Malignant transformation of lymphocytes is believed to be a multistep process resulting in the selection of malignant gamma delta-T cell clones. We hypothesised that repeated infusion of anti-TNF-alpha agents may induce clonal selection and that concurrent treatment with immunomodulators further predisposes patients to gamma delta-T cell expansion. Methodology/Principal Findings: We investigated dynamic changes in the gamma delta-T cells of patient with CD following treatment with infliximab (Remicade (R); n = 20) or adalimumab (Humira (R); n = 26) using flow cytometry. In patients with a high gamma delta-T cell level, the gamma delta-T cells were assessed for clonality. Of these 46 CD patients, 35 had a gamma delta-T cells level (mean 1.6%) comparable to healthy individuals (mean 2.2%), and 11 CD patients (24%) exhibited an increased level of gamma delta-T cells (5-15%). In the 18 patients also receiving thiopurines or methotrexate, the average baseline gamma delta-T cell level was 4.4%. In three male CD patients with a high baseline value, the gamma delta-T cell population increased dramatically following infliximab therapy. A fourth male patient also on infliximab monotherapy presented with 20% gamma delta-T cells, which increased to 25% shortly after treatment and was 36% between infusions. Clonality studies revealed an oligoclonal gamma delta-T cell pattern with dominant gamma delta-T cell clones. In support of our clinical findings, in vitro experiments showed a dose-dependent proliferative effect of anti-TNF-alpha agents on gamma delta-T cells. Conclusion/Significance: CD patients treated with immunomodulators had constitutively high levels of gamma delta-T cells. Infliximab exacerbated clonal gamma delta-T cell expansion in vivo and induced gamma delta-T cell proliferation in vitro. Overall, young, male CD patients with high baseline gamma delta-T cell levels may be at an increased risk of developing malignant gamma delta-T cell lymphomas following treatment with anti-TNF-alpha agents.	[Kelsen, Jens; Dige, Anders; Agnholt, Jorgen; Christensen, Lisbet A.; Dahlerup, Jens F.; Hvas, Christian L.] Aarhus Univ Hosp, Dept Med 5, GIRL, DK-8000 Aarhus, Denmark; [Schwindt, Heinrich; Pedersen, Finn S.] Aarhus Univ, Inst Mol Biol, Aarhus, Denmark; [D'Amore, Francesco] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kelsen, J (corresponding author), Aarhus Univ Hosp, Dept Med 5, GIRL, DK-8000 Aarhus, Denmark.	jenskels@rm.dk		Dahlerup, Jens Frederik/0000-0002-1587-7636; Agnholt, Jorgen/0000-0003-2822-6442	Karen Elise Jensen Foundation; Beckett Foundation; Desiree and Niels Ydes Foundation; Danish Colitis-Crohn Foundation; Toyota Foundation, Denmark; Abbott	Karen Elise Jensen Foundation; Beckett Foundation; Desiree and Niels Ydes Foundation; Danish Colitis-Crohn Foundation; Toyota Foundation, Denmark; Abbott(Abbott Laboratories)	The study was supported by research funding from the Karen Elise Jensen Foundation, the Beckett Foundation, the Desiree and Niels Ydes Foundation, the Danish Colitis-Crohn Foundation, and the Toyota Foundation, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Jorgen Agnholt is member of the Abbott Advisory Board, Denmark. Lisbet Ambrosius Christensen is a member of the MSD Advisory Board, Denmark. Anders Dige has received an unrestricted grant from Abbott. Abbott was not involved in the study design, collection, analysis and interpretation of data, writing of the paper, and/or decision to submit for publication. The authors declare full adherence to all the PLoS ONE policies on sharing data and materials.	Atreya I, 2009, GUT, V58, P325, DOI 10.1136/gut.2008.163485; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Belhadj K, 2003, BLOOD, V102, P4261, DOI 10.1182/blood-2003-05-1675; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Mackey AC, 2007, J PEDIATR GASTR NUTR, V44, P265, DOI 10.1097/MPG.0b013e31802f6424; D'Haens G, 2009, LANCET, V374, P1572, DOI 10.1016/S0140-6736(09)61487-2; Dige A, 2010, J IMMUNOL METHODS, V353, P141, DOI 10.1016/j.jim.2009.11.019; GIACOMELLI R, 1994, CLIN EXP IMMUNOL, V98, P83; HARVEY RF, 1980, LANCET, V1, P514; Holtmeier W, 2002, AM J PHYSIOL-GASTR L, V282, pG1024, DOI 10.1152/ajpgi.00224.2001; Hvas CL, 2010, AUTOIMMUNITY, V43, P325, DOI 10.3109/08916930903509064; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Iqbal J, 2009, BEST PRACT RES CL HA, V22, P191, DOI 10.1016/j.beha.2009.05.001; Mackey AC, 2009, J PEDIATR GASTR NUTR, V48, P386, DOI 10.1097/MPG.0b013e3181957a11; Miyazaki K, 2009, BLOOD, V113, P1071, DOI 10.1182/blood-2008-07-166363; Moran G, 2009, INFLAMM BOWEL DIS, V15, P1281, DOI 10.1002/ibd.20802; Navarro JT, 2003, LEUKEMIA LYMPHOMA, V44, P531, DOI 10.1080/1042819021000035662; Ochenrider MG, 2010, CL LYMPH MYELOM LEUK, V10, P144, DOI 10.3816/CLML.2010.n.021; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Rosh JR, 2007, INFLAMM BOWEL DIS, V13, P1024, DOI 10.1002/ibd.20169; Shale M, 2008, GUT, V57, P1639, DOI 10.1136/gut.2008.163279; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P1392, DOI 10.1002/ibd.20490; Soderstrom K, 1996, J IMMUNOL, V156, P2331; Sokol H, 2009, GUT, V58, P1427, DOI 10.1136/gut.2009.181982; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Thayu M, 2005, J PEDIATR GASTR NUTR, V40, P220, DOI 10.1097/00005176-200502000-00026; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	28	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17890	10.1371/journal.pone.0017890	http://dx.doi.org/10.1371/journal.pone.0017890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483853	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200012
J	Matar-Merheb, R; Rhimi, M; Leydier, A; Huche, F; Galian, C; Desuzinges-Mandon, E; Ficheux, D; Flot, D; Aghajari, N; Kahn, R; Di Pietro, A; Jault, JM; Coleman, AW; Falson, P				Matar-Merheb, Rima; Rhimi, Moez; Leydier, Antoine; Huche, Frederic; Galian, Carmen; Desuzinges-Mandon, Elodie; Ficheux, Damien; Flot, David; Aghajari, Nushin; Kahn, Richard; Di Pietro, Attilio; Jault, Jean-Michel; Coleman, Anthony W.; Falson, Pierre			Structuring Detergents for Extracting and Stabilizing Functional Membrane Proteins	PLOS ONE			English	Article							MULTIDRUG ABC TRANSPORTER; BACILLUS-SUBTILIS; RESISTANCE; BINDING; ACID; ATP; CA2+-ATPASE; DERIVATIVES; EXPRESSION; AMPHIPOLS	Background: Membrane proteins are privileged pharmaceutical targets for which the development of structure-based drug design is challenging. One underlying reason is the fact that detergents do not stabilize membrane domains as efficiently as natural lipids in membranes, often leading to a partial to complete loss of activity/stability during protein extraction and purification and preventing crystallization in an active conformation. Methodology/Principal Findings: Anionic calix[4] arene based detergents (C4Cn, n = 1-12) were designed to structure the membrane domains through hydrophobic interactions and a network of salt bridges with the basic residues found at the cytosol-membrane interface of membrane proteins. These compounds behave as surfactants, forming micelles of 5-24 nm, with the critical micellar concentration (CMC) being as expected sensitive to pH ranging from 0.05 to 1.5 mM. Both by (1)H NMR titration and Surface Tension titration experiments, the interaction of these molecules with the basic amino acids was confirmed. They extract membrane proteins from different origins behaving as mild detergents, leading to partial extraction in some cases. They also retain protein functionality, as shown for BmrA (Bacillus multidrug resistance ATP protein), a membrane multidrug-transporting ATPase, which is particularly sensitive to detergent extraction. These new detergents allow BmrA to bind daunorubicin with a Kd of 12 mu M, a value similar to that observed after purification using dodecyl maltoside (DDM). They preserve the ATPase activity of BmrA (which resets the protein to its initial state after drug efflux) much more efficiently than SDS (sodium dodecyl sulphate), FC12 (Foscholine 12) or DDM. They also maintain in a functional state the C4Cn-extracted protein upon detergent exchange with FC12. Finally, they promote 3D-crystallization of the membrane protein. Conclusion/Significance: These compounds seem promising to extract in a functional state membrane proteins obeying the positive inside rule. In that context, they may contribute to the membrane protein crystallization field.	[Matar-Merheb, Rima; Rhimi, Moez; Huche, Frederic; Desuzinges-Mandon, Elodie; Ficheux, Damien; Di Pietro, Attilio; Falson, Pierre] CNRS, Drug Resistance Mech & Modulat Lab, Ligue Labeled Team 2009, Lyon, France; [Rhimi, Moez; Huche, Frederic; Aghajari, Nushin] Univ Lyon 1, Lab BioCristallog & Biol Struct Cibles Therapeut, CNRS, UMR 5086,IBCP, F-69365 Lyon, France; [Leydier, Antoine] CEA DEN DRCP SCPS LEPS, Bagnols Sur Ceze, France; [Galian, Carmen; Kahn, Richard; Jault, Jean-Michel] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, Grenoble, France; [Coleman, Anthony W.] Univ Lyon 1, CNRS, UMR 5615, Lab Multimat & Interfaces, F-69365 Lyon, France; [Flot, David] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF)	Matar-Merheb, R (corresponding author), CNRS, Drug Resistance Mech & Modulat Lab, Ligue Labeled Team 2009, Lyon, France.	anthony.coleman@univ-lyon1.fr; p.falson@ibcp.fr	Coleman, Anthony William/K-2208-2019; Kahn, Richard/ABD-2666-2020; Leydier, Antoine/AAK-1685-2020; Aghajari, Nushin B.H./P-1906-2016; jault, jean-michel/G-2086-2012	Kahn, Richard/0000-0002-0259-0601; Leydier, Antoine/0000-0002-1997-9664; Aghajari, Nushin B.H./0000-0002-2245-2679; jault, jean-michel/0000-0003-1743-2777; Falson, Pierre/0000-0002-9760-4577; RHIMI, Moez/0000-0001-8067-6526	CNRS (Centre National de la Recherche Scientifique); ANR (Agence Nationale de la Recherche) [ANR-06-PCVI-0019-01, ANR-09-PIRI-0002-01, ANR-06-BLANC-0420]; CIBLE [06 022966 01/02]; PRIME (Projets de Recherche Interne Multi-Equipes)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); CIBLE(Region Auvergne-Rhone-Alpes); PRIME (Projets de Recherche Interne Multi-Equipes)	This work was supported by CNRS (Centre National de la Recherche Scientifique, www.cnrs.fr); ANR (Agence Nationale de la Recherche, www.agence-nationale-recherche.fr) ANR-06-PCVI-0019-01, ANR-09-PIRI-0002-01, ANR-06-BLANC-0420; CIBLE (www.rhonealpes.fr) Cible no 06 022966 01/02; PRIME (Projets de Recherche Interne Multi-Equipes, www.ibcp.fr) IBCP-Prime 2006, IBCP Prime 2007; Ligue Nationale contre le Cancer (www.ligue-cancer.net), labelled team:"Laboratoire des Proteines de Resistance aux Agents Chimiotherapeutiques". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Boumendjel A, 2007, BIOORGAN MED CHEM, V15, P2892, DOI 10.1016/j.bmc.2007.02.017; CHAE PS, 2010, NAT METH; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deniaud A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006214; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; DRUECKES P, 1995, ANAL BIOCHEM, V230, P173, DOI 10.1006/abio.1995.1453; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; FALSON P, 1993, BIOCHEMISTRY-US, V32, P10387, DOI 10.1021/bi00090a014; HAMADA H, 1988, CANCER RES, V48, P4926; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; Kalchenko OI, 2001, J CHEM SOC PERK T 2, P258, DOI 10.1039/b005497f; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Litman T, 2000, J CELL SCI, V113, P2011; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; MCGREGOR CL, 2003, NAT BIOTECHNOL; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Suwinska K, 2008, NEW J CHEM, V32, P1988, DOI 10.1039/b806342g; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Trometer C, 2010, METHODS MOL BIOL, V601, P105, DOI 10.1007/978-1-60761-344-2_7; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; White S., 2009, MEMBRANE PROTEINS KN; Zhang QH, 2007, ANGEW CHEM INT EDIT, V46, P7023, DOI 10.1002/anie.200701556	38	65	67	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18036	10.1371/journal.pone.0018036	http://dx.doi.org/10.1371/journal.pone.0018036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483854	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200021
J	Dai, F; Qiu, L; Ye, LZ; Wu, DZ; Zhou, MX; Zhang, GP				Dai, Fei; Qiu, Long; Ye, Lingzhen; Wu, Dezhi; Zhou, Meixue; Zhang, Guoping			Identification of a Phytase Gene in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							PHYTIC ACID CONTENT; MYOINOSITOL HEXAKISPHOSPHATE PHOSPHOHYDROLASES; INOSITOL PHOSPHATE-ESTERS; BIOCHEMICAL-CHARACTERIZATION; GERMINATION CONDITIONS; DEGRADING ENZYME; IRON-ABSORPTION; TOTAL-P; PURIFICATION; LOCALIZATION	Background: Endogenous phytase plays a crucial role in phytate degradation and is thus closely related to nutrient efficiency in barley products. The understanding of genetic information of phytase in barley can provide a useful tool for breeding new barley varieties with high phytase activity. Methodology/Principal Findings: Quantitative trait loci (QTL) analysis for phytase activity was conducted using a doubled haploid population. Phytase protein was purified and identified by the LC-ESI MS/MS Shotgun method. Purple acid phosphatase (PAP) gene was sequenced and the position was compared with the QTL controlling phytase activity. A major QTL for phytase activity was mapped to chromosome 5 H in barley. The gene controlling phytase activity in the region was named as mqPhy. The gene HvPAP a was mapped to the same position as mqPhy, supporting the colinearity between HvPAP a and mqPhy. Conclusions/Significance: It is the first report on QTLs for phytase activity and the results showed that HvPAP a, which shares a same position with the QTL, is a major phytase gene in barley grains.	[Dai, Fei; Qiu, Long; Ye, Lingzhen; Wu, Dezhi; Zhang, Guoping] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr Res, Launceston, Tas 7250, Australia	Zhejiang University; University of Tasmania	Dai, F (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	mzhou@utas.edu.au; zhanggp@zju.edu.cn	Wu, Dezhi/AAO-9316-2020; Dai, Fei/F-6512-2010; wu, dezhi/C-2735-2011; , Meixue/C-2387-2014	Wu, Dezhi/0000-0002-7900-0542; , Meixue/0000-0003-3009-7854	China Natural Science Foundation [30971719]; Grains Research and Development Corporation of Australia	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Grains Research and Development Corporation of Australia(Grains R&D Corp)	The project was supported by China Natural Science Foundation (30971719) and "Australia China Collaboration on Barley Germplasm" funded by Grains Research and Development Corporation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Bergman EL, 2000, J AGR FOOD CHEM, V48, P4647, DOI 10.1021/jf000525a; Bilgicli N, 2006, FOOD CHEM, V98, P329, DOI 10.1016/j.foodchem.2005.05.078; BRUNE M, 1992, J NUTR, V122, P442, DOI 10.1093/jn/122.3.442; Cashikar AG, 1997, PLANT PHYSIOL, V114, P907, DOI 10.1104/pp.114.3.907; Centeno C, 2003, J AGR SCI, V141, P313, DOI 10.1017/S0021859603003666; Centeno C, 2001, J AGR FOOD CHEM, V49, P3208, DOI 10.1021/jf010023c; COSGROVE DJ, 1970, AUST J BIOL SCI, V23, P1207, DOI 10.1071/BI9701207; Dai F, 2010, J AGR FOOD CHEM, V58, P11821, DOI 10.1021/jf1029948; Dai F, 2007, FOOD CHEM, V105, P606, DOI 10.1016/j.foodchem.2007.04.019; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; Greiner R, 1999, J SCI FOOD AGR, V79, P1453, DOI [10.1002/(SICI)1097-0010(199908)79:11<1453::AID-JSFA386>3.0.CO;2-R, 10.1002/(SICI)1097-0010(199908)79:11&lt;1453::AID-JSFA386&gt;3.0.CO;2-R]; Greiner R, 2000, J CEREAL SCI, V31, P127, DOI 10.1006/jcrs.1999.0254; Greiner R, 2001, J AGR FOOD CHEM, V49, P2234, DOI 10.1021/jf0100806; Greiner R, 2006, FOOD TECHNOL BIOTECH, V44, P125; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Hegeman CE, 2001, PLANT PHYSIOL, V126, P1598, DOI 10.1104/pp.126.4.1598; Hubel F, 1996, PLANT PHYSIOL, V112, P1429, DOI 10.1104/pp.112.4.1429; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; KONIETZNY U, 1995, J FOOD BIOCHEM, V18, P165, DOI 10.1111/j.1745-4514.1994.tb00495.x; Konietzny U, 2002, INT J FOOD SCI TECH, V37, P791, DOI 10.1046/j.1365-2621.2002.00617.x; Kouas S, 2009, AFR J BIOTECHNOL, V8, P5301; Kuang RB, 2009, PLANT PHYSIOL, V151, P199, DOI 10.1104/pp.109.143180; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; LABOURE AM, 1993, BIOCHEM J, V295, P413, DOI 10.1042/bj2950413; Larsson M, 1996, BRIT J NUTR, V76, P677, DOI 10.1079/BJN19960075; Lei X.G., 2007, IND ENZYMES STRUCTUR, P505, DOI DOI 10.1007/1-4020-5377-0_; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Lung SC, 2008, PHYTOCHEMISTRY, V69, P365, DOI 10.1016/j.phytochem.2007.06.036; Ockenden I, 2004, PLANT SCI, V167, P1131, DOI 10.1016/j.plantsci.2004.06.008; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; Rickard SE, 1997, ACS SYM SER, V662, P294, DOI 10.1021/bk-1997-0662.ch017; SANDBERG AS, 1988, J NUTR, V118, P469, DOI 10.1093/jn/118.4.469; Tye AJ, 2002, APPL MICROBIOL BIOT, V59, P190, DOI 10.1007/s00253-002-1033-5; Van Ooijen JW, 2004, MAPQTLH 5 SOFTWARE M; Vats P, 2005, J IND MICROBIOL BIOT, V32, P141, DOI 10.1007/s10295-005-0214-5; Vohra A, 2003, CRIT REV BIOTECHNOL, V23, P29, DOI 10.1080/713609297; Wang JM, 2007, CEREAL RES COMMUN, V35, P129, DOI 10.1556/CRC.35.2007.1.15; Wang JM, 2010, GENETICA, V138, P1191, DOI 10.1007/s10709-010-9511-7; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Wyss M, 1999, APPL ENVIRON MICROB, V65, P367; Zhou MX, 2009, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-01279-2_1	45	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18829	10.1371/journal.pone.0018829	http://dx.doi.org/10.1371/journal.pone.0018829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533044	gold, Green Published, Green Submitted			2022-12-27	WOS:000290014500013
J	Gomez-Carballa, A; Cerezo, M; Balboa, E; Heredia, C; Castro-Feijoo, L; Rica, I; Barreiro, J; Eiris, J; Cabanas, P; Martinez-Soto, I; Fernandez-Toral, J; Castro-Gago, M; Pombo, M; Carracedo, A; Barros, F; Salas, A				Gomez-Carballa, Alberto; Cerezo, Maria; Balboa, Emilia; Heredia, Claudia; Castro-Feijoo, Lidia; Rica, Itxaso; Barreiro, Jesus; Eiris, Jesus; Cabanas, Paloma; Martinez-Soto, Isabel; Fernandez-Toral, Joaquin; Castro-Gago, Manuel; Pombo, Manuel; Carracedo, Angel; Barros, Francisco; Salas, Antonio			Evolutionary Analyses of Entire Genomes Do Not Support the Association of mtDNA Mutations with Ras/MAPK Pathway Syndromes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; OF-FUNCTION MUTATIONS; NOONAN-SYNDROME; POPULATION-GENETICS; REGION SEQUENCES; HAPLOGROUP-H; PTPN11; SOS1; DISORDERS; PHYLOGENY	Background: There are several known autosomal genes responsible for Ras/MAPK pathway syndromes, including Noonan syndrome (NS) and related disorders (such as LEOPARD, neurofibromatosis type 1), although mutations of these genes do not explain all cases. Due to the important role played by the mitochondrion in the energetic metabolism of cardiac muscle, it was recently proposed that variation in the mitochondrial DNA (mtDNA) genome could be a risk factor in the Noonan phenotype and in hypertrophic cardiomyopathy (HCM), which is a common clinical feature in Ras/MAPK pathway syndromes. In order to test these hypotheses, we sequenced entire mtDNA genomes in the largest series of patients suffering from Ras/MAPK pathway syndromes analyzed to date (n = 45), most of them classified as NS patients (n = 42). Methods/Principal Findings: The results indicate that the observed mtDNA lineages were mostly of European ancestry, reproducing in a nutshell the expected haplogroup (hg) patterns of a typical Iberian dataset (including hgs H, T, J, and U). Three new branches of the mtDNA phylogeny (H1j1, U5b1e, and L2a5) are described for the first time, but none of these are likely to be related to NS or Ras/MAPK pathway syndromes when observed under an evolutionary perspective. Patterns of variation in tRNA and protein genes, as well as redundant, private and heteroplasmic variants, in the mtDNA genomes of patients were as expected when compared with the patterns inferred from a worldwide mtDNA phylogeny based on more than 8700 entire genomes. Moreover, most of the mtDNA variants found in patients had already been reported in healthy individuals and constitute common polymorphisms in human population groups. Conclusions/Significance: As a whole, the observed mtDNA genome variation in the NS patients was difficult to reconcile with previous findings that indicated a pathogenic role of mtDNA variants in NS.	[Gomez-Carballa, Alberto; Cerezo, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain; [Gomez-Carballa, Alberto; Cerezo, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Inst Med Legal, Fac Med, Santiago De Compostela, Galicia, Spain; [Balboa, Emilia; Carracedo, Angel; Barros, Francisco] CIBERER, Unidad Med Mol, Fdn Publ Galega Med Xenom, Santiago De Compostela, Galicia, Spain; [Heredia, Claudia; Castro-Feijoo, Lidia; Barreiro, Jesus; Cabanas, Paloma; Pombo, Manuel] Hosp Clin Univ, Unidad Endocrinol Pediat Crecimiento & Adolescenc, Dept Pediat, Santiago De Compostela, Galicia, Spain; [Rica, Itxaso] Hosp Cruces, Serv Endocrinol Infantil, Baracaldo, Basque Country, Spain; [Eiris, Jesus; Castro-Gago, Manuel] Hosp Clin Univ, Unidad Neurol Pediat, Dept Pediat, Santiago De Compostela, Galicia, Spain; [Martinez-Soto, Isabel] Hosp Clin Univ Santiago de Compostela, Unidad Cardiol Infantil, Dept Pediat, Santiago De Compostela, Galicia, Spain; [Fernandez-Toral, Joaquin] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Asturias, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario Cruces; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Central University Hospital Asturias; University of Oviedo	Gomez-Carballa, A (corresponding author), Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Rica, Itxaso/E-7645-2012; Carracedo, Angel/D-4257-2012; Salas, Antonio/E-3977-2012; Gómez-Carballa, Alberto/I-4610-2014; Salas, Antonio/U-2029-2019	Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Salas, Antonio/0000-0002-2336-702X; Eiris, Jesus/0000-0003-4835-6674; Barros, Francisco/0000-0001-6895-4140; Cerezo Fernandez, Maria/0000-0003-3073-1130; Balboa Beltran, Emilia/0000-0003-3395-8672	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion [SAF2008-02971]	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research received support from two grants from the Fundacion de Investigacion Medica Mutua Madrilena, and a grant from the Ministerio de Ciencia e Innovacion (SAF2008-02971), given to AS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Attimonelli M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S4; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2006, J HUM GENET, V51, P1073, DOI 10.1007/s10038-006-0066-5; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bertola D R, 2000, Arq Bras Cardiol, V75, P409, DOI 10.1590/S0066-782X2000001100005; BURCH M, 1993, J AM COLL CARDIOL, V22, P1189, DOI 10.1016/0735-1097(93)90436-5; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Dhandapany PS, 2007, INT J CARDIOL, V120, P284, DOI 10.1016/j.ijcard.2006.07.229; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Gasparre G, 2008, HUM MOL GENET, V17, P986, DOI 10.1093/hmg/ddm371; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Heredia CE, 2009, HORM RES, V72, P317; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; NOONAN JA, 1963, J PEDIATR-US, V63, P468; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566; Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065; Rani DS, 2010, MITOCHONDRION, V10, P166, DOI 10.1016/j.mito.2009.12.146; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Salas A, 2007, REV CLIN ESP, V207, P563, DOI 10.1157/13111575; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Shchelochkov OA, 2008, AM J MED GENET A, V146A, P1042, DOI 10.1002/ajmg.a.32215; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Takahashi K, 2005, EUR J PEDIATR, V164, P497, DOI 10.1007/s00431-005-1679-y; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012	66	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18348	10.1371/journal.pone.0018348	http://dx.doi.org/10.1371/journal.pone.0018348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526175	Green Submitted, Green Published, gold			2022-12-27	WOS:000289671100002
J	Sorrells, TR; Kuritzky, LY; Kauhanen, PG; Fitzgerald, K; Sturgis, SJ; Chen, J; Dijamco, CA; Basurto, KN; Gordon, DM				Sorrells, Trevor R.; Kuritzky, Leah Y.; Kauhanen, Peter G.; Fitzgerald, Katherine; Sturgis, Shelby J.; Chen, Jimmy; Dijamco, Cheri A.; Basurto, Kimberly N.; Gordon, Deborah M.			Chemical Defense by the Native Winter Ant (Prenolepis imparis) against the Invasive Argentine Ant (Linepithema humile)	PLOS ONE			English	Article							IRIDOMYRMEX-HUMILIS; ABIOTIC FACTORS; HYMENOPTERA; SUCCESS; INTERFERENCE; EXPLOITATION; COMMUNITIES; AGGRESSION; ARTHROPODS; MECHANISMS	The invasive Argentine ant (Linepithema humile) is established worldwide and displaces native ant species. In northern California, however, the native winter ant (Prenolepis imparis) persists in invaded areas. We found that in aggressive interactions between the two species, P. imparis employs a potent defensive secretion. Field observations were conducted at P. imparis nest sites both in the presence and absence of L. humile. These observations suggested and laboratory assays confirmed that P. imparis workers are more likely to secrete when outnumbered by L. humile. Workers of P. imparis were also more likely to secrete near their nest entrances than when foraging on trees. One-on-one laboratory trials showed that the P. imparis secretion is highly lethal to L. humile, causing 79% mortality. The nonpolar fraction of the secretion was chemically analyzed with gas chromatography/mass spectrometry, and found to be composed of long-chain and cyclic hydrocarbons. Chemical analysis of dissected P. imparis workers showed that the nonpolar fraction is derived from the Dufour's gland. Based on these conclusions, we hypothesize that this chemical defense may help P. imparis to resist displacement by L. humile.	[Sorrells, Trevor R.; Kuritzky, Leah Y.; Kauhanen, Peter G.; Fitzgerald, Katherine; Sturgis, Shelby J.; Chen, Jimmy; Dijamco, Cheri A.; Basurto, Kimberly N.; Gordon, Deborah M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Sorrells, TR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	trevor.sorrells@ucsf.edu			Stanford University Office of the Vice Provost for Undergraduate Education	Stanford University Office of the Vice Provost for Undergraduate Education	This research was funded by the Stanford University Office of the Vice Provost for Undergraduate Education. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abril S, 2009, SOCIOBIOLOGY, V53, P559; ANDERSEN AN, 1991, OECOLOGIA, V88, P157, DOI 10.1007/BF00320805; BERGSTROM G, 1973, J INSECT PHYSIOL, V19, P877, DOI 10.1016/0022-1910(73)90159-5; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; Burnam K. P., 2002, MODEL SELECTION MULT, V2nd; Carpintero S, 2008, BIOL INVASIONS, V10, P25, DOI 10.1007/s10530-007-9103-3; DiGirolamo LA, 2006, BIOL INVASIONS, V8, P125, DOI 10.1007/s10530-004-1572-z; EISNER T, 1961, J INSECT PHYSIOL, V6, P272, DOI 10.1016/0022-1910(61)90054-3; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 1998, OECOLOGIA, V116, P252, DOI 10.1007/s004420050586; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Human KG, 1997, CONSERV BIOL, V11, P1242, DOI 10.1046/j.1523-1739.1997.96264.x; Human KG, 1999, INSECT SOC, V46, P159, DOI 10.1007/s000400050127; Kabashima JN, 2007, J ECON ENTOMOL, V100, P148, DOI 10.1603/0022-0493(2007)100[148:AIBSIA]2.0.CO;2; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; LaPolla JS, 2002, INSECT SOC, V49, P251, DOI 10.1007/s00040-002-8310-2; Laurent P, 2005, TOP CURR CHEM, V240, P167; LYNCH JF, 1980, ECOL ENTOMOL, V5, P353, DOI 10.1111/j.1365-2311.1980.tb01160.x; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Nygard JP, 2008, ECOL ENTOMOL, V33, P789, DOI 10.1111/j.1365-2311.2008.01035.x; O'Donnell S, 1997, J KANSAS ENTOMOL SOC, V70, P175; Palmer TM, 2004, ANIM BEHAV, V68, P993, DOI 10.1016/j.anbehav.2004.02.005; ROTH LM, 1962, ANNU REV ENTOMOL, V7, P107, DOI 10.1146/annurev.en.07.010162.000543; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; Sakata H, 2001, ECOL RES, V16, P395, DOI 10.1046/j.1440-1703.2001.00404.x; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Talbot M, 1943, ECOLOGY, V24, P31, DOI 10.2307/1929858; Tanner CJ, 2009, INSECT SOC, V56, P64, DOI 10.1007/s00040-008-1039-9; Tanner CJ, 2006, P ROY SOC B-BIOL SCI, V273, P2737, DOI 10.1098/rspb.2006.3626; Tanner CJ, 2009, ANIM BEHAV, V77, P297, DOI 10.1016/j.anbehav.2008.10.016; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; WARD PS, 1987, HILGARDIA, V55, P1; WHEELER WILLIAM MORTON, 1930, ANN ENT SOC AMER, V23, P1; Zee J, 2006, INSECT SOC, V53, P161, DOI 10.1007/s00040-005-0853-6	43	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18717	10.1371/journal.pone.0018717	http://dx.doi.org/10.1371/journal.pone.0018717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526231	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100015
J	Abbas, UL; Hood, G; Wetzel, AW; Mellors, JW				Abbas, Ume L.; Hood, Gregory; Wetzel, Arthur W.; Mellors, John W.			Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP)	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 POPULATIONS; UNITED-STATES; VIRAL LOAD; IN-VIVO; TRANSMISSION; MUTATIONS; INTERRUPTION; K65R; CHEMOPROPHYLAXIS	Background: The potential for emergence and spread of HIV drug resistance from rollout of antiretroviral (ARV) pre-exposure prophylaxis (PrEP) is an important public health concern. We investigated determinants of HIV drug resistance prevalence after PrEP implementation through mathematical modeling. Methodology: A model incorporating heterogeneity in age, gender, sexual activity, HIV infection status, stage of disease, PrEP coverage/discontinuation, and HIV drug susceptibility, was designed to simulate the impact of PrEP on HIV prevention and drug resistance in a sub-Saharan epidemic. Principal Findings: Analyses suggest that the prevalence of HIV drug resistance is influenced most by the extent and duration of inadvertent PrEP use in individuals already infected with HIV. Other key factors affecting drug resistance prevalence include the persistence time of transmitted resistance and the duration of inadvertent PrEP use in individuals who become infected on PrEP. From uncertainty analysis, the median overall prevalence of drug resistance at 10 years was predicted to be 9.2% (interquartile range 6.9%-12.2%). An optimistic scenario of 75% PrEP efficacy, 60% coverage of the susceptible population, and 5% inadvertent PrEP use predicts a rise in HIV drug resistance prevalence to only 2.5% after 10 years. By contrast, in a pessimistic scenario of 25% PrEP efficacy, 15% population coverage, and 25% inadvertent PrEP use, resistance prevalence increased to over 40%. Conclusions: Inadvertent PrEP use in previously-infected individuals is the major determinant of HIV drug resistance prevalence arising from PrEP. Both the rate and duration of inadvertent PrEP use are key factors. PrEP rollout programs should include routine monitoring of HIV infection status to limit the spread of drug resistance.	[Abbas, Ume L.] Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH 44195 USA; [Hood, Gregory; Wetzel, Arthur W.] Pittsburgh Supercomp Ctr, Pittsburgh, PA USA; [Mellors, John W.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Abbas, UL (corresponding author), Cleveland Clin Fdn, Dept Infect Dis, 9500 Euclid Ave, Cleveland, OH 44195 USA.	abbasu@ccf.org	Abbas, Ume/AAW-4590-2021		National Institute of Allergy and Infectious Diseases [R21AI078789]; Bill and Melinda Gates Foundation [OPP1005974]; AIDS Clinical Trials Group (NIAID) [U01AI38858]; Microbicide Trials Network (NIAID) [U01AI068633]; National Cancer Institute (SAIC) [20XS190A]; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633, R21AI078789, U01AI038858] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); AIDS Clinical Trials Group (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Microbicide Trials Network (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (SAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases (R21AI078789) and the Bill and Melinda Gates Foundation. Ume L. Abbas acknowledges grant support from the National Institute of Allergy and Infectious Diseases (R21AI078789) and the Bill and Melinda Gates Foundation (OPP1005974). John W. Mellors acknowledges support from the AIDS Clinical Trials Group (NIAID U01AI38858), the Microbicide Trials Network (NIAID U01AI068633) and the National Cancer Institute (SAIC contract 20XS190A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; John W. Mellors reports that he is a consultant to Gilead Sciences, Merck, and RFS Pharmaceuticals, has received grant support from Merck, and owns share options in RFS Pharmaceuticals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; ANDERSON R M, 1991; Atchison RE, 2005, ANTIVIR THER, V10, pS45; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Delaugerre C, 2001, AIDS, V15, P2189, DOI 10.1097/00002030-200111090-00016; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Garcia-Lerma JG, 2006, ANTIVIR THER, V11, pS52; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, TRENDS PHARMACOL SCI, V31, P74, DOI 10.1016/j.tips.2009.10.009; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; GRANT R, 2006, 16 INT AIDS C TOR CA; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hofer E, 1999, COMPUT PHYS COMMUN, V117, P21, DOI 10.1016/S0010-4655(98)00153-2; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P131, DOI 10.1016/S0951-8320(02)00133-3; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P147, DOI 10.1016/S0951-8320(02)00134-5; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; JOHNSON J, 2006, 13 C RETR OPP INF DE; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; May R., 2001, VIRUS DYNAMICS MATH; MILLER DK, 1994, MED DECIS MAKING, V14, P52, DOI 10.1177/0272989X9401400107; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Rey D, 1998, J ACQ IMMUN DEF SYND, V17, P203, DOI 10.1097/00042560-199803010-00003; SALTELLI A, 2000, SENSITIVITY ANAL, P475; SMITH D, 2006, ANTIRETROVIRAL RESIS; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tedder RS, 1998, J CLIN MICROBIOL, V36, P1056, DOI 10.1128/JCM.36.4.1056-1063.1998; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; van de Vijver DAMC, 2009, J INFECT DIS, V199, P1310, DOI 10.1086/597804; Van Rompay KKA, 2006, J VIROL, V80, P6399, DOI 10.1128/JVI.02308-05; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Yerly S, 2004, ANTIVIR THER, V9, P375; AIDS VACCINE ADVOCAC	46	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18165	10.1371/journal.pone.0018165	http://dx.doi.org/10.1371/journal.pone.0018165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525976	Green Published, gold, Green Accepted			2022-12-27	WOS:000289578600007
J	Lambert, JC; Dallongeville, J; Ellis, KA; Schraen-Maschke, S; Lui, J; Laws, S; Dumont, J; Richard, F; Cottel, D; Berr, C; Ames, D; Masters, CL; Rowe, CC; Szoeke, C; Tzourio, C; Dartigues, JF; Buee, L; Martins, R; Amouyel, P				Lambert, Jean-Charles; Dallongeville, Jean; Ellis, Kathryn A.; Schraen-Maschke, Susanna; Lui, James; Laws, Simon; Dumont, Julie; Richard, Florence; Cottel, Dominique; Berr, Claudine; Ames, David; Masters, Colin L.; Rowe, Christopher C.; Szoeke, Cassandra; Tzourio, Christophe; Dartigues, Jean-Francois; Buee, Luc; Martins, Ralph; Amouyel, Philippe			Association of Plasma A beta Peptides with Blood Pressure in the Elderly	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BASE-LINE CHARACTERISTICS; ALZHEIMERS-DISEASE; RISK-FACTORS; DEMENTIA; BRAIN; VASOACTIVITY; LIPOPROTEINS; POPULATION; TRANSPORT	Background: A beta peptides are often considered as catabolic by-products of the amyloid beta protein precursor (APP), with unknown physiological functions. However, several biological properties have been tentatively attributed to these peptides, including a role in vasomotion. We assess whether plasma A beta peptide levels might be associated with systolic and diastolic blood pressure values (SBP and DBP, respectively). Methodology/Principal Findings: Plasma A beta(1-40) and A beta(1-42) levels were measured using an xMAP-based assay in 1,972 individuals (none of whom were taking antihypertensive drugs) from 3 independent studies: the French population-based 3C and MONA-LISA (Lille) studies (n = 627 and n = 769, respectively) and the Australian, longitudinal AIBL study (n = 576). In the combined sample, the A beta(1-42)/ A beta(1-40) ratio was significantly and inversely associated with SBP (p = 0.03) and a similar trend was observed for DBP (p = 0.06). Using the median age (69) as a cut-off, the A beta(1-42)/A beta(1-40) ratio was strongly associated with both SBP and DBP in elderly individuals (p = 0.002 and p = 0.03, respectively). Consistently, a high A beta(1-42)/ A beta(1-40) ratio was associated with a lower risk of hypertension in both the combined whole sample (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.56-0.90) and (to an even greater extent) in the elderly subjects (OR, 0.53; 95% CI, 0.37-0.75). Lastly, all these associations appeared to be primarily driven by the level of plasma A beta(1-40). Conclusion: The plasma A beta(1-42)/A beta(1-40) ratio is inversely associated with SBP, DBP and the risk of hypertension in elderly subjects, suggesting that A beta peptides affect blood pressure in vivo. These results may be particularly relevant in Alzheimer's disease, in which a high A beta(1-42)/A beta(1-40) plasma ratio is reportedly associated with a decreased risk of incident disease.	[Lambert, Jean-Charles; Dallongeville, Jean; Dumont, Julie; Richard, Florence; Cottel, Dominique; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Dallongeville, Jean; Dumont, Julie; Richard, Florence; Cottel, Dominique; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Dallongeville, Jean; Schraen-Maschke, Susanna; Dumont, Julie; Richard, Florence; Cottel, Dominique; Buee, Luc; Amouyel, Philippe] Univ Lille Nord France, UDSL, Lille, France; [Ellis, Kathryn A.; Ames, David] Univ Melbourne, St Georges Hosp, Dept Psychiat, Melbourne, Vic 3010, Australia; [Ellis, Kathryn A.; Masters, Colin L.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Ellis, Kathryn A.; Ames, David; Szoeke, Cassandra] Natl Ageing Res Inst, Parkville, Vic, Australia; [Schraen-Maschke, Susanna; Buee, Luc] INSERM, U837, F-59045 Lille, France; [Lui, James; Laws, Simon; Martins, Ralph] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA, Australia; [Lui, James; Laws, Simon; Martins, Ralph] Sir James McCusker Alzheimers Res Unit, Perth, WA, Australia; [Schraen-Maschke, Susanna; Richard, Florence; Buee, Luc; Amouyel, Philippe] Ctr Hosp Reg Univ, Lille, France; [Berr, Claudine] Univ Montpellier 1, INSERM, U888, Montpellier, France; [Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Rowe, Christopher C.] Austin Hlth, Heidelberg, Vic, Australia; [Szoeke, Cassandra] Australian Commonwealth Sci & Res Org CSIRO, Parkville, Vic, Australia; [Tzourio, Christophe] INSERM, U708, Paris, France; [Dartigues, Jean-Francois] Victor Segalen Univ, INSERM, U593, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; St George Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; National Ageing Research Institute; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Edith Cowan University; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Lambert, JC (corresponding author), INSERM, U744, F-59045 Lille, France.	jean-charles.lambert@pasteur-lille.fr	Lambert, jean-charles/A-9553-2014; berr, Claudine/D-5238-2014; Szoeke, Cassandra/AAI-8631-2021; Szoeke, CAssandra/AAE-8715-2019; Dumont, Julie/AAD-9763-2022; Laws, Simon/C-2858-2014; Dumont, Julie/F-4687-2018; IBL, A/C-8408-2013; Tzourio, christophe/B-4015-2009; DARTIGUES, Jean François/T-4513-2019; Rowe, Christopher/AAX-8748-2021; lambert, jean-charles/F-8787-2013; BUEE, Luc/B-3126-2010; Tzourio, christophe/L-6344-2019	Lambert, jean-charles/0000-0003-0829-7817; berr, Claudine/0000-0001-5254-7655; Szoeke, Cassandra/0000-0002-3698-2590; Laws, Simon/0000-0002-4355-7082; Dumont, Julie/0000-0002-6009-0111; Tzourio, christophe/0000-0002-6517-2984; lambert, jean-charles/0000-0003-0829-7817; BUEE, Luc/0000-0002-6261-4230; Tzourio, christophe/0000-0002-6517-2984; Ellis, Kathryn/0000-0001-9097-9037; SCHRAEN, Susanna/0000-0002-7247-4809; Martins, Ralph/0000-0002-4828-9363; Amouyel, Philippe/0000-0001-9088-234X	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Aquitaine Regional Council; Fondation de France; French Ministry of Research/INSERM; Sanofi-Synthelabo; Eisai; CNRS; Nord Pas-de-Calais Regional Council; European Regional Development Fund; INSERM-DHOS-INCA [A08037ECS]; European Community [LSHM-CT-2007-037950]; Bourgogne Regional Councils	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Aquitaine Regional Council(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); French Ministry of Research/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Ministry of Research, France); Sanofi-Synthelabo; Eisai(Eisai Co Ltd); CNRS(Centre National de la Recherche Scientifique (CNRS)); Nord Pas-de-Calais Regional Council(Region Hauts-de-France); European Regional Development Fund(European Commission); INSERM-DHOS-INCA; European Community(European Commission); Bourgogne Regional Councils	The 3C Study was performed as part of a collaboration between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM "Cohortes et collections de donnees biologiques" programme. Sanofi-Synthelabo provided funding for this study. Lille Genopole received an unconditional grant from Eisai. This work was additionally funded by the CNRS, the Nord Pas-de-Calais Regional Council, the European Regional Development Fund and grants from INSERM-DHOS-INCA (Project A08037ECS) and the European Community's cNEUPRO programme (contract LSHM-CT-2007-037950). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdullah L, 2009, MOL MED, V15, P95, DOI 10.2119/molmed.2008.00118; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Casiglia Edoardo, 2009, Expert Rev Cardiovasc Ther, V7, P659, DOI 10.1586/erc.09.17; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Feldstein CA, 2010, NEUROEPIDEMIOLOGY, V35, P202, DOI 10.1159/000316872; Ferrieres J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002; Frackowiak J, 2004, BRAIN RES, V1002, P67, DOI 10.1016/j.brainres.2003.12.015; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kontush A, 2001, CELL MOL NEUROBIOL, V21, P299, DOI 10.1023/A:1012629603390; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Li QX, 1998, LAB INVEST, V78, P461; Lui JK, 2010, J ALZHEIMERS DIS, V20, P1233, DOI 10.3233/JAD-2010-090249; Luo F, 2008, NEUROSCIENCE, V155, P263, DOI 10.1016/j.neuroscience.2008.04.021; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Nagai M, 2010, AM J HYPERTENS, V23, P116, DOI 10.1038/ajh.2009.212; Paris D, 1998, EXP NEUROL, V152, P116, DOI 10.1006/exnr.1998.6828; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Qiu CX, 2003, ARCH NEUROL-CHICAGO, V60, P223, DOI 10.1001/archneur.60.2.223; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	30	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18536	10.1371/journal.pone.0018536	http://dx.doi.org/10.1371/journal.pone.0018536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525986	gold, Green Published			2022-12-27	WOS:000289578600013
J	Solodova, E; Jablonska, J; Weiss, S; Lienenklaus, S				Solodova, Evgenia; Jablonska, Jadwiga; Weiss, Siegfried; Lienenklaus, Stefan			Production of IFN-beta during Listeria monocytogenes Infection Is Restricted to Monocyte/Macrophage Lineage	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; I INTERFERON RESPONSE; INTRACELLULAR PATHOGENS; BACTERIAL-INFECTION; MOUSE FIBROBLASTS; MICE; EXPRESSION; IMMUNITY; INNATE	The family of type I interferons (IFN), which consists of several IFN-alpha and one IFN-beta, are produced not only after stimulation by viruses, but also after infection with non-viral pathogens. In the course of bacterial infections, these cytokines could be beneficial or detrimental. IFN-beta is the primary member of type I IFN that initiates a cascade of IFN-alpha production. Here we addressed the question which cells are responsible for IFN-beta expression after infection with the intracellular pathogen Listeria monocytogenes by using a genetic approach. By means of newly established reporter mice, maximum of IFN-beta expression was observed at 24 hours post infection in spleen and, surprisingly, 48 hours post infection in colonized cervical and inguinal lymph nodes. Colonization of lymph nodes was independent of the type I IFN signaling, as well as bacterial dose and strain. Using cell specific reporter function and conditional deletions we could define cells expressing LysM as the major IFN-beta producers, with cells formerly defined as Tip-DCs being the highest. Neutrophilic granulocytes, dendritic cells and plasmacytoid dendritic cells did not significantly contribute to type I IFN production.	[Solodova, Evgenia; Jablonska, Jadwiga; Weiss, Siegfried; Lienenklaus, Stefan] Helmholtz Ctr Infect Res, Dept Mol Biotechnol, Braunschweig, ME, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Solodova, E (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Biotechnol, Braunschweig, ME, Germany.	eso07@helmholtz-hzi.de	Jablonska, Jadwiga/S-8278-2019; Lienenklaus, Stefan/HIK-0899-2022	Jablonska, Jadwiga/0000-0003-1490-2542; Lienenklaus, Stefan/0000-0003-4790-3445	German Research Council [SFB 566]; Hannover Biomedical Research School; DAAD	German Research Council(German Research Foundation (DFG)); Hannover Biomedical Research School; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the German Research Council via SFB 566, the Hannover Biomedical Research School and the DAAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Banks TA, 2005, J IMMUNOL, V174, P7217, DOI 10.4049/jimmunol.174.11.7217; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COHEN MS, 1988, REV INFECT DIS, V10, P1088; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CORR SC, 2009, CELL MICROBIOL; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; CROSS M, 1990, EMBO J, V9, P1283, DOI 10.1002/j.1460-2075.1990.tb08237.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Deny P, 2010, PATHOL BIOL, V58, P245, DOI 10.1016/j.patbio.2010.05.002; Dresing P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015567; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gregory SH, 1996, J IMMUNOL, V157, P2514; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; HUME DA, 2010, J LEUKOC BIOL; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; ISAACS A, 1987, J INTERFERON RES, V7, P429, DOI 10.1089/jir.1987.7.429; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LEIMEISTERWACHTER M, 1989, INFECT IMMUN, V57, P2350; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Merrick JC, 1997, AM J PATHOL, V151, P785; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roche SM, 2003, INFECT IMMUN, V71, P3429, DOI 10.1128/IAI.71.6.3429-3436.2003; Rogers HW, 1996, J IMMUNOL, V156, P679; Samuelsson CV, 2005, BIOCHEM BIOPH RES CO, V335, P584, DOI 10.1016/j.bbrc.2005.07.124; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; SEEBACH J, 1995, J IMMUNOL, V155, P4367; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Smith D, 2009, J NEUROIMMUNOL, V215, P117, DOI 10.1016/j.jneuroim.2009.08.011; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Tam MA, 2006, CELL MICROBIOL, V8, P1172, DOI 10.1111/j.1462-5822.2006.00700.x; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; XING Z, 1994, AM J RESP CELL MOL, V10, P148, DOI 10.1165/ajrcmb.10.2.8110470; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	66	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18543	10.1371/journal.pone.0018543	http://dx.doi.org/10.1371/journal.pone.0018543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494554	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100020
J	Jainta, S; Kapoula, Z				Jainta, Stephanie; Kapoula, Zoi			Dyslexic Children Are Confronted with Unstable Binocular Fixation while Reading	PLOS ONE			English	Article							DIFFERENT VIEWING DISTANCES; SACCADIC EYE-MOVEMENTS; VISUAL-DISPLAY; GAZE-SHIFTS; VERGENCE DYNAMICS; COORDINATION; DISPARITY; ADULTS; CONJUGATE	Reading requires three-dimensional motor control: saccades bring the eyes from left to right, fixating word after word; and oblique saccades bring the eyes to the next line of the text. The angle of vergence of the two optic axes should be adjusted to the depth of the book or screen and - most importantly - should be maintained in a sustained manner during saccades and fixations. Maintenance of vergence is important as it is a prerequisite for a single clear image of each word to be projected onto the fovea of the eyes. Deficits in the binocular control of saccades and of vergence in dyslexics have been reported previously but only for tasks using single targets. This study examines saccades and vergence control during real text reading. Thirteen dyslexic and seven non-dyslexic children read the French text "L'Allouette" in two viewing distances (40 cm vs. 100 cm), while binocular eye movements were measured with the Chronos Eye-tracking system. We found that the binocular yoking of reading saccades was poor in dyslexic children (relative to non-dyslexics) resulting in vergence errors; their disconjugate drift during fixations was not correlated with the disconjugacy during their saccades, causing considerable variability of vergence angle from fixation to fixation. Due to such poor oculomotor adjustments during reading, the overall fixation disparity was larger for dyslexic children, putting larger demand on their sensory fusion processes. Moreover, for dyslexics the standard deviation of fixation disparity was larger particularly when reading at near distance. We conclude that besides documented phoneme processing disorders, visual/ocular motor imperfections may exist in dyslexics that lead to fixation instability and thus, to instability of the letters or words during reading; such instability may perturb fusional processes and might - in part - complicate letter/word identification.	[Jainta, Stephanie; Kapoula, Zoi] AP HP, CNRS, IRIS Lab, Paris, France	Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS)	Jainta, S (corresponding author), AP HP, CNRS, IRIS Lab, Paris, France.	jainta@ifado.de; zoi.kapoula@egp-aphp.fr			Deutsche Forschungsgemeinschaft [DFG Ja 1921/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG Ja 1921/1-1). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; Collewijn H, 1990, Rev Oculomot Res, V4, P213; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; Collewijn H, 2001, VISION RES, V41, P3413, DOI 10.1016/S0042-6989(01)00047-5; CORNELISSEN P, 1993, DEV MED CHILD NEUROL, V35, P777; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Heller D, 1998, CURRENT OCULOMOTOR R; HOWARD IP, 2002, SEEING DEPTH DEPTH P, P92; Jainta S, 2002, HUM FACTORS, V44, P443, DOI 10.1518/0018720024497736; Jainta S, 2010, VISION RES, V50, P1775, DOI 10.1016/j.visres.2010.05.033; Jaschinski W, 2004, KLIN MONATSBL AUGENH, V221, P854, DOI 10.1055/s-2004-813712; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 1998, OPHTHAL PHYSL OPT, V18, P30, DOI 10.1016/S0275-5408(97)00039-2; Jaschinski W, 1998, ERGONOMICS, V41, P1034, DOI 10.1080/001401398186586; JASCHINSKIKRUZA W, 1993, OPHTHAL PHYSL OPT, V13, P27, DOI 10.1111/j.1475-1313.1993.tb00422.x; Kapoula Z, 2007, GRAEF ARCH CLIN EXP, V245, P931, DOI 10.1007/s00417-006-0490-4; Kapoula Z, 2009, DYSLEXIA, V15, P243, DOI 10.1002/dys.377; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Lefavrais P., 1967, TEST ALOUETTE; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; R Core Team, 2018, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein JF., 1993, J RES READ, V16, P30, DOI [DOI 10.1111/J.1467-9817.1993.TB00033.X, 10.1111/j.1467-9817.1993.tb00033.x]; StuddertKennedy M, 1995, PSYCHON B REV, V2, P508, DOI 10.3758/BF03210986; Sylvestre PA, 2002, J NEUROPHYSIOL, V87, P257, DOI 10.1152/jn.00919.2000; Vernet M, 2009, J VISION, V9, DOI 10.1167/9.7.2; Yang Q, 2003, J VISION, V3, P554, DOI 10.1167/3.8.3; Yang Q, 2004, EXP BRAIN RES, V156, P212, DOI 10.1007/s00221-003-1773-1	39	61	62	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18694	10.1371/journal.pone.0018694	http://dx.doi.org/10.1371/journal.pone.0018694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494641	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400044
J	Xu, MB; He, XL				Xu, Meibo; He, Xionglei			Genetic Incompatibility Dampens Hybrid Fertility More Than Hybrid Viability: Yeast as a Case Study	PLOS ONE			English	Article							STERILITY; SPECIATION; DROSOPHILA; EVOLUTION; PROTEIN; SACCHAROMYCES; RESOLUTION; EPISTASIS; THALIANA; NUCLEAR	Genetic incompatibility is believed to be the major cause of postzygotic reproductive isolation. Despite huge efforts seeking for speciation-related incompatibilities in the past several decades, a general understanding of how genetic incompatibility evolves in affecting hybrid fitness is not available, primarily due to the fact that the number of known incompatibilities is small. Instead of further mapping specific incompatible genes, in this paper we aimed to know the overall effects of incompatibility on fertility and viability, the two aspects of fitness, by examining 89 gametes produced by yeast S. cerevisiae - S. paradoxus F1 hybrids. Homozygous F2 hybrids formed by autodiploidization of F1 gametes were subject to tests for growth rate and sporulation efficiency. We observed much stronger defects in sporulation than in clonal growth for every single F2 hybrid strain, indicating that genetic incompatibility affects hybrid fertility more than hybrid viability in yeast. We related this finding in part to the fast-evolving nature of meiosis-related genes, and proposed that the generally low expression levels of these genes might be a cause of the observation.	[Xu, Meibo; He, Xionglei] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, MB (corresponding author), Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	hexiongl@mail.sysu.edu.cn			National Natural Science Foundation of China [30871371, 40930212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (#30871371 and #40930212 to XH). The agency did not influence the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Chou JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000432; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dobzhansky T, 1936, GENETICS, V21, P113; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Greig D, 2007, PLOS GENET, V3, P281, DOI 10.1371/journal.pgen.0030021; Greig D, 2009, CURR BIOL, V19, pR886, DOI 10.1016/j.cub.2009.07.037; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Muller HJ, 1942, BIOL S, V6, P71; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Zhang JZ, 2005, MOL BIOL EVOL, V22, P1147, DOI 10.1093/molbev/msi101	36	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18341	10.1371/journal.pone.0018341	http://dx.doi.org/10.1371/journal.pone.0018341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494679	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400021
J	Certain, G; Skarpaas, O; Bjerke, JW; Framstad, E; Lindholm, M; Nilsen, JE; Norderhaug, A; Oug, E; Pedersen, HC; Schartau, AK; van der Meeren, GI; Aslaksen, I; Engen, S; Garnasjordet, PA; Kvaloy, P; Lillegard, M; Yoccoz, NG; Nybo, S				Certain, Gregoire; Skarpaas, Olav; Bjerke, Jarle-Werner; Framstad, Erik; Lindholm, Markus; Nilsen, Jan-Erik; Norderhaug, Ann; Oug, Eivind; Pedersen, Hans-Christian; Schartau, Ann-Kristin; van der Meeren, Gro I.; Aslaksen, Iulie; Engen, Steinar; Garnasjordet, Per-Arild; Kvaloy, Pal; Lillegard, Magnar; Yoccoz, Nigel G.; Nybo, Signe			The Nature Index: A General Framework for Synthesizing Knowledge on the State of Biodiversity	PLOS ONE			English	Article							INDICATORS; CONSERVATION; DIVERSITY; ACIDIFICATION; MANAGEMENT; VEGETATION; RICHNESS; SPACE; LONG	The magnitude and urgency of the biodiversity crisis is widely recognized within scientific and political organizations. However, a lack of integrated measures for biodiversity has greatly constrained the national and international response to the biodiversity crisis. Thus, integrated biodiversity indexes will greatly facilitate information transfer from science toward other areas of human society. The Nature Index framework samples scientific information on biodiversity from a variety of sources, synthesizes this information, and then transmits it in a simplified form to environmental managers, policymakers, and the public. The Nature Index optimizes information use by incorporating expert judgment, monitoring-based estimates, and model-based estimates. The index relies on a network of scientific experts, each of whom is responsible for one or more biodiversity indicators. The resulting set of indicators is supposed to represent the best available knowledge on the state of biodiversity and ecosystems in any given area. The value of each indicator is scaled relative to a reference state, i.e., a predicted value assessed by each expert for a hypothetical undisturbed or sustainably managed ecosystem. Scaled indicator values can be aggregated or disaggregated over different axes representing spatiotemporal dimensions or thematic groups. A range of scaling models can be applied to allow for different ways of interpreting the reference states, e.g., optimal situations or minimum sustainable levels. Statistical testing for differences in space or time can be implemented using Monte-Carlo simulations. This study presents the Nature Index framework and details its implementation in Norway. The results suggest that the framework is a functional, efficient, and pragmatic approach for gathering and synthesizing scientific knowledge on the state of biodiversity in any marine or terrestrial ecosystem and has general applicability worldwide.	[Certain, Gregoire; Pedersen, Hans-Christian; Engen, Steinar; Kvaloy, Pal; Nybo, Signe] Norwegian Inst Nat Res NINA, Trondheim, Norway; [Skarpaas, Olav; Framstad, Erik; Schartau, Ann-Kristin] Norwegian Inst Nat Res NINA, Oslo, Norway; [Bjerke, Jarle-Werner; Yoccoz, Nigel G.] Norwegian Inst Nat Res NINA, Tromso, Norway; [Lindholm, Markus; Oug, Eivind] Norwegian Inst Water Res NIVA, Oslo, Norway; [Nilsen, Jan-Erik] Norwegian Forest & Landscape Inst, As, Norway; [Norderhaug, Ann] Norwegian Inst Agr & Environm Res BIOFORSK, Stjordal, Norway; [van der Meeren, Gro I.] IMR, Bergen, Norway; [Aslaksen, Iulie; Garnasjordet, Per-Arild; Lillegard, Magnar] Stat Norway SSB, Oslo, Norway; [Engen, Steinar] Ctr Conservat Biol, Dept Math Sci, Trondheim, Norway; [Yoccoz, Nigel G.] Univ Tromso UiT, Tromso, Norway; [Nybo, Signe] Directorate Nat Management, Trondheim, Norway	Norwegian Institute Nature Research; Norwegian Institute Nature Research; Norwegian Institute Nature Research; Norwegian Institute for Water Research (NIVA); The Norwegian Forest & Landscape Institute; Bioforsk; Institute of Marine Research - Norway; Statistics Norway; UiT The Arctic University of Tromso	Certain, G (corresponding author), Inst Marine Res, Tromso, Norway.	Gregoire.Certain@imr.no	Yoccoz, Nigel/C-8561-2014	Yoccoz, Nigel/0000-0003-2192-1039; Bjerke, Jarle W./0000-0003-2721-1492; Skarpaas, Olav/0000-0001-9727-1672	Norwegian Ministry of Environment; Research Council of Norway [190054]	Norwegian Ministry of Environment; Research Council of Norway(Research Council of Norway)	This study was financed by the Norwegian Ministry of Environment and organized and overseen by the Directorate for Nature Management. The interdisciplinary research was financed by the Research Council of Norway, grant 190054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; Arts GHP, 2002, AQUAT BOT, V73, P373, DOI 10.1016/S0304-3770(02)00031-1; BLUMENRATH S, 2010, DATAGRUNNLAG NATURIN, P8; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CERTAIN G, 2010, 542 NINA, P1; CHAPMAN AD, 2009, CSIRO, V2, P1; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Faiths DP, 2008, GLOBAL CHANGE BIOL, V14, P207, DOI 10.1111/j.1365-2486.2007.01500.x; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fonderflick J, 2010, BIOL CONSERV, V143, P737, DOI 10.1016/j.biocon.2009.12.014; Frank DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010688; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Garthwaite PH, 2005, J AM STAT ASSOC, V100, P680, DOI 10.1198/016214505000000105; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Henry PY, 2008, BIODIVERS CONSERV, V17, P3357, DOI 10.1007/s10531-008-9417-1; HESTHAGEN T, 1995, BIOL CONSERV, V74, P115, DOI 10.1016/0006-3207(95)00020-5; HINDAR K, 2010, ATLANTIC SALMON ECOL, P299; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson CJ, 2004, J APPL ECOL, V41, P1032, DOI 10.1111/j.0021-8901.2004.00975.x; Kaennel M, 1998, FOR SCI, V51, P71; Kell LT, 1999, ICES J MAR SCI, V56, P834, DOI 10.1006/jmsc.1999.0544; Larsen FW, 2009, DIVERS DISTRIB, V15, P70, DOI 10.1111/j.1472-4642.2008.00507.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; Manley PN, 2004, ECOL APPL, V14, P296, DOI 10.1890/02-5249; Nielsen SE, 2007, BIOL CONSERV, V137, P403, DOI 10.1016/j.biocon.2007.02.024; Nilsen EB, 2009, WILDLIFE BIOL, V15, P10, DOI 10.2981/06-084; Norderhaug KM, 2009, MAR BIOL RES, V5, P515, DOI 10.1080/17451000902932985; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; NYBO S, 2008, 425 NINA, P1; NYBO S, 2010, NATURINDEKS NORGE 20, P1; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Rouget M, 2006, GLOBAL CHANGE BIOL, V12, P2032, DOI 10.1111/j.1365-2486.2006.01238.x; Rounsevell MDA, 2006, AGR ECOSYST ENVIRON, V114, P57, DOI 10.1016/j.agee.2005.11.027; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Samhouri JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008907; Samper C., 2009, NAT CLIM CHANGE, V1, P118; Schindler DW, 2010, BIOL CONSERV, V143, P1571, DOI 10.1016/j.biocon.2010.04.003; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SOLIMINI AG, 2006, INDICATORS METHODS E, P1; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stuart SN, 2010, SCIENCE, V328, P177, DOI 10.1126/science.1188606; Suominen O, 2008, ECOGRAPHY, V31, P636, DOI 10.1111/j.0906-7590.2008.05480.x; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Teder T, 2007, CONSERV BIOL, V21, P313, DOI 10.1111/j.1523-1739.2006.00575.x; Ten Brink B.J.E., 2002, 402001014 RIVM; UNEP and IOC-UNESCO, 2009, ASS ASS FIND GROUP E; van Strien AJ, 2009, ECOL INDIC, V9, P1041, DOI 10.1016/j.ecolind.2008.12.001; Veiberg V, 2007, OIKOS, V116, P1805, DOI 10.1111/j.2007.0030-1299.16159.x; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	63	33	33	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18930	10.1371/journal.pone.0018930	http://dx.doi.org/10.1371/journal.pone.0018930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526118	Green Published, gold, Green Submitted			2022-12-27	WOS:000290015800023
J	Iwanczyk, J; Leong, V; Ortega, J				Iwanczyk, Jack; Leong, Vivian; Ortega, Joaquin			Factors Defining the Functional Oligomeric State of Escherichia coli DegP Protease	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ELEVATED-TEMPERATURES; PROTEOLYTIC ACTIVITY; ELECTRON-MICROSCOPY; HTRA GENE; CHAPERONE; ACTIVATION; MECHANISM; GROWTH	Escherichia coli DegP protein is a periplasmic protein that functions both as a protease and as a chaperone. In the absence of substrate, DegP oligomerizes as a hexameric cage but in its presence DegP reorganizes into 12 and 24-mer cages with large chambers that house the substrate for degradation or refolding. Here, we studied the factors that determine the oligomeric state adopted by DegP in the presence of substrate. Using size exclusion chromatography and electron microscopy, we found that the size of the substrate molecule is the main factor conditioning the oligomeric state adopted by the enzyme. Other factors such as temperature, a major regulatory factor of the activity of this enzyme, did not influence the oligomeric state adopted by DegP. In addition, we observed that substrate concentration exerted an effect only when large substrates (full-length proteins) were used. However, small substrate molecules (peptides) always triggered the same oligomeric state regardless of their concentration. These results clarify important aspects of the regulation of the oligomeric state of DegP.	[Iwanczyk, Jack; Leong, Vivian; Ortega, Joaquin] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Iwanczyk, Jack; Leong, Vivian; Ortega, Joaquin] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Iwanczyk, J (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	ortegaj@mcmaster.ca	Ortega, Joaquin/AAS-1322-2020		Canadian Institutes of Health Research (CIHR) [MOP-82930]; Ministry of Research and Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to J.O. (MOP-82930). J.O. is a recipient of a CIHR salary award and an Early Researcher Award from the Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Jomaa A, 2009, J BACTERIOL, V191, P1924, DOI 10.1128/JB.01187-08; Kim KI, 1999, J MOL BIOL, V294, P1363, DOI 10.1006/jmbi.1999.3320; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; Ruprecht J, 2001, PROG BIOPHYS MOL BIO, V75, P121, DOI 10.1016/S0079-6107(01)00004-9; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; SKORKOGLONEK J, 1995, GENE, V163, P47, DOI 10.1016/0378-1119(95)00406-V; Sobiecka-Szkatula A, 2009, BBA-PROTEINS PROTEOM, V1794, P1573, DOI 10.1016/j.bbapap.2009.07.002; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989	22	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18944	10.1371/journal.pone.0018944	http://dx.doi.org/10.1371/journal.pone.0018944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526129	Green Submitted, gold, Green Published			2022-12-27	WOS:000290015800025
J	Woolf, PJ; Fu, LL; Basu, A				Woolf, Peter J.; Fu, Leeann L.; Basu, Avik			vProtein: Identifying Optimal Amino Acid Complements from Plant-Based Foods	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; CHILDREN; MAINTENANCE; QUALITY; LEUCINE; INFANTS; GROWTH; HEALTH; IMPACT; MUSCLE	BACKGROUND: Indispensible amino acids (IAAs) are used by the body in different proportions. Most animal-based foods provide these IAAs in roughly the needed proportions, but many plant-based foods provide different proportions of IAAs. To explore how these plant-based foods can be better used in human nutrition, we have created the computational tool vProtein to identify optimal food complements to satisfy human protein needs. METHODS: vProtein uses 1251 plant-based foods listed in the United States Department of Agriculture standard release 22 database to determine the quantity of each food or pair of foods required to satisfy human IAA needs as determined by the 2005 daily recommended intake. The quantity of food in a pair is found using a linear programming approach that minimizes total calories, total excess IAAs, or the total weight of the combination. RESULTS: For single foods, vProtein identifies foods with particularly balanced IAA patterns such as wheat germ, quinoa, and cauliflower. vProtein also i entifies foods with particularly unbalanced IAA patterns such as macadamia nuts, degermed corn products, and wakame seaweed. Although less useful alone, some unbalanced foods provide unusually good complements, such as Brazil nuts to legumes. Interestingly, vProtein finds no statistically significant bias toward grain/legume pairings for protein complementation. These analyses suggest that pairings of plant-based foods should be based on the individual foods themselves instead of based on broader food group-food group pairings. Overall, the most efficient pairings include sweet corn/tomatoes, apple/coconut, and sweet corn/cherry. The top pairings also highlight the utility of less common protein sources such as the seaweeds laver and spirulina, pumpkin leaves, and lambsquarters. From a public health perspective, many of the food pairings represent novel, low cost food sources to combat malnutrition. Full analysis results are available online at http://www.foodwiki.com/vprotein.	[Woolf, Peter J.; Fu, Leeann L.; Basu, Avik] Foodwiki, Ann Arbor, MI USA		Woolf, PJ (corresponding author), Foodwiki, Ann Arbor, MI USA.	pwoolf@foodwiki.com			Foodwiki	Foodwiki	Funding for this article was provided by Foodwiki, and Foodwiki was also responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alizadeh F, 2003, MATH PROGRAM, V95, P3, DOI 10.1007/s10107-002-0339-5; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Dahl J., CVXOPT PYTHON SOFTWA; DIPIERRO M, 2009, WEB2PY ENTERPRISE WE; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Lutter CK, 2008, J NUTR, V138, P379, DOI 10.3945/jn.108.095406; Lutter CK, 2003, J NUTR, V133, p2940S, DOI 10.1093/jn/133.9.2940S; Millward DJ, 2008, AM J CLIN NUTR, V87, p1576S, DOI 10.1093/ajcn/87.5.1576S; MILLWARD DJ, 1990, P NUTR SOC, V49, P473, DOI 10.1079/PNS19900056; Mintz SW, 2001, ETHNOLOGY, V40, P113, DOI 10.2307/3773926; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737; Paul KH, 2008, J NUTR, V138, P1963; Rennie MJ, 2007, BIOCHEM SOC T, V35, P1302, DOI 10.1042/BST0351302; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Sarwar G, 1997, J NUTR, V127, P758, DOI 10.1093/jn/127.5.758; Schaafsma G, 2000, J NUTR, V130, p1865S, DOI 10.1093/jn/130.7.1865S; Simpore J, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-3; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Teufel Nicolette I., 1996, Journal of Nutritional and Environmental Medicine (Abingdon), V6, P273, DOI 10.3109/13590849609007254; USDA Agricultural Research Service, 2009, USDA NAT NUTR DAT ST; Viteri FE, 2010, FOOD NUTR BULL, V31, P42, DOI 10.1177/156482651003100106; WESTRICH BJ, 1994, INT NETWORK FOOD DAT, V7, P223; *WHO, 1985, JOINT FAO WHO UNO ED; YOUNG V R, 1990, Food and Nutrition Bulletin, V12, P289; YOUNG VR, 1994, AM J CLIN NUTR, V59, p1203S, DOI 10.1093/ajcn/59.5.1203S; 2005, PROTEIN AMINO ACIDS	30	27	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18836	10.1371/journal.pone.0018836	http://dx.doi.org/10.1371/journal.pone.0018836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526128	Green Published, gold, Green Submitted			2022-12-27	WOS:000290015800015
J	Clavero, M; Villero, D; Brotons, L				Clavero, Miguel; Villero, Daniel; Brotons, Lluis			Climate Change or Land Use Dynamics: Do We Know What Climate Change Indicators Indicate?	PLOS ONE			English	Article							BIODIVERSITY; LANDSCAPE; RESPONSES; BIRDS	Different components of global change can have interacting effects on biodiversity and this may influence our ability to detect the specific consequences of climate change through biodiversity indicators. Here, we analyze whether climate change indicators can be affected by land use dynamics that are not directly determined by climate change. To this aim, we analyzed three community-level indicators of climate change impacts that are based on the optimal thermal environment and average latitude of the distribution of bird species present at local communities. We used multiple regression models to relate the variation in climate change indicators to: i) environmental temperature; and ii) three landscape gradients reflecting important current land use change processes (land abandonment, fire impacts and urbanization), all of them having forest areas at their positive extremes. We found that, with few exceptions, landscape gradients determined the figures of climate change indicators as strongly as temperature. Bird communities in forest habitats had colder-dwelling bird species with more northern distributions than farmland, burnt or urban areas. Our results show that land use changes can reverse, hide or exacerbate our perception of climate change impacts when measured through community-level climate change indicators. We stress the need of an explicit incorporation of the interactions between climate change and land use dynamics to understand what are current climate change indicators indicating and be able to isolate real climate change impacts.	[Clavero, Miguel; Villero, Daniel; Brotons, Lluis] Ctr Tecnol Forestal Catalunya, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain; [Clavero, Miguel] Univ Girona, Dept Ciencies Ambientals, Girona, Catalonia, Spain; [Brotons, Lluis] European Bird Census Council, Barcelona, Spain; [Brotons, Lluis] Museu Ciencies Nat, Inst Catala Ornitol, Barcelona, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Universitat de Girona; Museu de Ciencies Naturals de Barcelona	Clavero, M (corresponding author), Ctr Tecnol Forestal Catalunya, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain.	miguelito.clavero@gmail.com	Brotons, Lluís/D-1570-2009; Clavero, Miguel/A-9040-2015; Villero, Dani/E-1761-2014	Brotons, Lluís/0000-0002-4826-4457; Clavero, Miguel/0000-0002-5186-0153; Villero, Dani/0000-0002-5562-3809	Spanish Ministry of Education and Science (MEC) [CGL2005- 2000031/BOS, CGL2008-05506-C02-01/BOS, CSD2008-00040]; Catalan Government [SGR2009-531]; MEC	Spanish Ministry of Education and Science (MEC)(Spanish Government); Catalan Government; MEC(European Commission)	This work has received financial support from the projects CGL2005- 2000031/BOS, CGL2008-05506-C02-01/BOS and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC). Partial funding was also provided by the Catalan Government grant SGR2009-531. LB benefited from a Ramon y Cajal contract and MC from a Juan de la Cierva contract, both funded by MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Covas R, 1998, IBIS, V140, P395, DOI 10.1111/j.1474-919X.1998.tb04600.x; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Estrada J., 2004, ATLES DELS OCELLS NI; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Fidell L.S., 2001, COMPUTER ASSISTED RE; Gil-Tena A, 2010, FOREST ECOL MANAG, V259, P1338, DOI 10.1016/j.foreco.2009.10.026; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Mazzoleni S., 2004, RECENT DYNAMICS MEDI; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pimm SL, 2009, CURR BIOL, V19, pR595, DOI 10.1016/j.cub.2009.05.055; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Prodon R., 1993, ALAUDA, V62, P83; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Vallecillo S, 2009, ECOL APPL, V19, P538, DOI 10.1890/08-0348.1; [No title captured]; [No title captured]; [No title captured]	30	107	107	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18581	10.1371/journal.pone.0018581	http://dx.doi.org/10.1371/journal.pone.0018581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533025	Green Published, gold, Green Submitted			2022-12-27	WOS:000290014500007
J	Haberer, JE; Cook, A; Walker, AS; Ngambi, M; Ferrier, A; Mulenga, V; Kityo, C; Thomason, M; Kabamba, D; Chintu, C; Gibb, DM; Bangsberg, DR				Haberer, Jessica E.; Cook, Adrian; Walker, A. Sarah; Ngambi, Marjorie; Ferrier, Alex; Mulenga, Veronica; Kityo, Cissy; Thomason, Margaret; Kabamba, Desiree; Chintu, Chifumbe; Gibb, Diana M.; Bangsberg, David R.			Excellent Adherence to Antiretrovirals in HIV plus Zambian Children Is Compromised by Disrupted Routine, HIV Nondisclosure, and Paradoxical Income Effects	PLOS ONE			English	Article							THERAPY ADHERENCE; IMMUNOLOGICAL OUTCOMES; MEDICATION ADHERENCE; VIRAL SUPPRESSION; INFECTED CHILDREN; TRIAL; DISCLOSURE; HISTORY; AFRICA	Introduction: A better understanding of pediatric antiretroviral therapy (ART) adherence in sub-Saharan Africa is necessary to develop interventions to sustain high levels of adherence. Methodology/Principal Findings: Adherence among 96 HIV-infected Zambian children (median age 6, interquartile range [IQR] 2,9) initiating fixed-dose combination ART was measured prospectively (median 23 months; IQR 20,26) with caregiver report, clinic and unannounced home-based pill counts, and medication event monitoring systems (MEMS). HIV-1 RNA was determined at 48 weeks. Child and caregiver characteristics, socio-demographic status, and treatment-related factors were assessed as predictors of adherence. Median adherence was 97.4% (IQR 96.1,98.4%) by visual analog scale, 94.8% (IQR 86,100%) by caregiver-reported last missed dose, 96.9% (IQR 94.5,98.2%) by clinic pill count, 93.4% (IQR 90.2,96.7%) by unannounced home-based pill count, and 94.8% (IQR 87.8,97.7%) by MEMS. At 48 weeks, 72.6% of children had HIV-1 RNA < 50 copies/ml. Agreement among adherence measures was poor; only MEMS was significantly associated with viral suppression (p = 0.013). Predictors of poor adherence included changing residence, school attendance, lack of HIV disclosure to children aged nine to 15 years, and increasing household income. Conclusions/Significance: Adherence among children taking fixed-dose combination ART in sub-Saharan Africa is high and sustained over two years. However, certain groups are at risk for treatment failure, including children with disrupted routines, no knowledge of their HIV diagnosis among older children, and relatively high household income, possibly reflecting greater social support in the setting of greater poverty.	[Haberer, Jessica E.; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Cook, Adrian; Walker, A. Sarah; Ferrier, Alex; Thomason, Margaret; Gibb, Diana M.] MRC, Clin Trials Unit, London, England; [Ngambi, Marjorie; Mulenga, Veronica; Kabamba, Desiree; Chintu, Chifumbe] Univ Teaching Hosp, Lusaka, Zambia; [Kityo, Cissy] Joint Clin Res Ctr, Kampala, Uganda	Harvard University; Massachusetts General Hospital; Medical Research Council Clinical Trials Unit; University of Zambia; Joint Clinic Research Center - United Arab Emirates	Haberer, JE (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.	jhaberer@partners.org	Walker, Sarah/HDM-8717-2022; Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190; Mulenga, Veronica/0000-0003-1843-8169; Gibb, Diana/0000-0002-9738-5490; Thomason, Margaret/0000-0003-3590-0140	European and Developing Countries Clinical Trials Partnership (EDCTP) [EDCTP 2004.01.H.d2.33011]; US National Institute of Mental Health [K23-87228, K24-87227]; Mark and Lisa Schwartz Foundation; MRC [MC_U122886353] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087228] Funding Source: NIH RePORTER; Medical Research Council [MC_U122886353] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership (EDCTP); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mark and Lisa Schwartz Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CHAPAS-1 is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP 2004.01.H.d2.33011). Cipla Ltd donated the first-line drugs. Drs. Haberer and Bangsberg are supported by the US National Institute of Mental Health (K23-87228 and K24-87227, respectively) and the Mark and Lisa Schwartz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bova CA, 2005, AIDS BEHAV, V9, P103, DOI 10.1007/s10461-005-1685-0; Burns DN, 1999, LANCET, V354, pS1, DOI 10.1016/S0140-6736(99)90249-0; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; Deschamps AE, 2006, JAIDS-J ACQ IMM DEF, V43, P247, DOI 10.1097/01.qai.0000246034.86135.89; Flynn PM, 2004, J INFECT DIS, V190, P271, DOI 10.1086/421521; Gao X, 2000, AIDS CARE, V12, P387, DOI 10.1080/09540120050123783; Gibb DM, 2003, PEDIATR INFECT DIS J, V22, P56, DOI 10.1097/00006454-200301000-00015; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; HESS KR, 1994, STAT MED, V13, P1045, DOI 10.1002/sim.4780131007; *JOINT UN PROGR AI, 2009, REP GLOB AIDS EP; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Maitland D, 2008, HIV MED, V9, P667, DOI 10.1111/j.1468-1293.2008.00618.x; Mulenga V, 2010, CLIN INFECT DIS, V51, P1081, DOI 10.1086/656628; Nabukeera-Barungi N, 2007, ANN TROP PAEDIATR, V27, P123, DOI 10.1179/146532807X192499; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Paterson DL, 2002, JAIDS, V31, pS103, DOI 10.1097/00126334-200212153-00003; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Rosenthal R., 1966, EXPT EFFECTS BEHAV R; RUDD P, 1989, CLIN PHARMACOL THER, V46, P169, DOI 10.1038/clpt.1989.122; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; UNFPA UUW, 2009, CHILDR AIDS 4 STOCKT; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilson Ira B, 2009, Curr HIV/AIDS Rep, V6, P177, DOI 10.1007/s11904-009-0024-x; World Health Organization, 2010, ANT THER HIV INF INF	32	77	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18505	10.1371/journal.pone.0018505	http://dx.doi.org/10.1371/journal.pone.0018505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756ME	21533031	Green Published, gold, Green Submitted			2022-12-27	WOS:000290014500006
J	Reboul, CF; Andrews, DA; Nahar, MF; Buckle, AM; Roujeinikova, A				Reboul, Cyril F.; Andrews, Daniel A.; Nahar, Musammat F.; Buckle, Ashley M.; Roujeinikova, Anna			Crystallographic and Molecular Dynamics Analysis of Loop Motions Unmasking the Peptidoglycan-Binding Site in Stator Protein MotB of Flagellar Motor	PLOS ONE			English	Article							DOMAIN; PAL	Background: The C-terminal domain of MotB (MotB-C) shows high sequence similarity to outer membrane protein A and related peptidoglycan (PG)-binding proteins. It is believed to anchor the power-generating MotA/MotB stator unit of the bacterial flagellar motor to the peptidoglycan layer of the cell wall. We previously reported the first crystal structure of this domain and made a puzzling observation that all conserved residues that are thought to be essential for PG recognition are buried and inaccessible in the crystal structure. In this study, we tested a hypothesis that peptidoglycan binding is preceded by, or accompanied by, some structural reorganization that exposes the key conserved residues. Methodology/Principal Findings: We determined the structure of a new crystalline form (Form B) of Helicobacter pylori MotB-C. Comparisons with the existing Form A revealed conformational variations in the petal-like loops around the carbohydrate binding site near one end of the beta-sheet. These variations are thought to reflect natural flexibility at this site required for insertion into the peptidoglycan mesh. In order to understand the nature of this flexibility we have performed molecular dynamics simulations of the MotB-C dimer. The results are consistent with the crystallographic data and provide evidence that the three loops move in a concerted fashion, exposing conserved MotB residues that have previously been implicated in binding of the peptide moiety of peptidoglycan. Conclusion/Significance: Our structural analysis provides a new insight into the mechanism by which MotB inserts into the peptidoglycan mesh, thus anchoring the power-generating complex to the cell wall.	[Reboul, Cyril F.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	Monash University; Monash University	Reboul, CF (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	Anna.Roujeinikova@monash.edu	Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Roujeinikova, Anna/0000-0001-8478-4751; Reboul, Cyril/0000-0002-6258-2697	Australian Research Council; NHMRC	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council Discovery grant and a Research Fellowship to AR and a NHMRC Senior Research Fellowship to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hizukuri Y, 2009, J BIOCHEM, V146, P219, DOI 10.1093/jb/mvp061; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KEMPNER ES, 1993, FEBS LETT, V326, P4, DOI 10.1016/0014-5793(93)81749-P; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nguyen CC, 1996, RES MICROBIOL, V147, P317, DOI 10.1016/0923-2508(96)84707-3; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roujeinikova A, 1999, J BIOL CHEM, V274, P30811, DOI 10.1074/jbc.274.43.30811; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Roujeinikova A, 2008, ACTA CRYSTALLOGR F, V64, P277, DOI 10.1107/S1744309108005277; TEETER MM, 1990, J PHYS CHEM-US, V94, P8091, DOI 10.1021/j100384a021; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332	29	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18981	10.1371/journal.pone.0018981	http://dx.doi.org/10.1371/journal.pone.0018981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533052	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400044
J	Wu, C; Cai, PF; Chang, QC; Hao, LL; Peng, SA; Sun, XJ; Lu, HJ; Yin, JG; Jiang, N; Chen, QJ				Wu, Chuang; Cai, Pengfei; Chang, Qiaocheng; Hao, Lili; Peng, Shuai; Sun, Xiaojing; Lu, Huijun; Yin, Jigang; Jiang, Ning; Chen, Qijun			Mapping the Binding between the Tetraspanin Molecule (Sjc23) of Schistosoma japonicum and Human Non-Immune IgG	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; MONOCLONAL-ANTIBODY; MANSONI; ANTIGEN; SURFACE; IMMUNIZATION; PARAMYOSIN; SM23; SJ23; SUPERFAMILY	Background: Schistosomal parasites can establish parasitization in a human host for decades; evasion of host immunorecognition including surface masking by acquisition of host serum components is one of the strategies explored by the parasites. Parasite molecules anchored on the membrane are the main elements in the interaction. Sjc23, a member of the tetraspanin (TSP) family of Schistosoma japonicum, was previously found to be highly immunogenic and regarded as a vaccine candidate against schistosomiasis. However, studies indicated that immunization with Sjc23 generated rapid antibody responses which were less protective than that with other antigens. The biological function of this membrane-anchored molecule has not been defined after decades of vaccination studies. Methodology and Principal Findings: In this study, we explored affinity pull-down and peptide competition assays to investigate the potential binding between Sjc23 molecule and human non-immune IgG. We determined that Sjc23 could bind human non-immune IgG and the binding was through the interaction of the large extra-cellular domain (LED) of Sjc23 (named Sjc23-LED) with the Fc domain of human IgG. Sjc23 had no affinity to other immunoglobulin types. Affinity precipitation (pull-down assay) in the presence of overlapping peptides further pinpointed to a 9-amino acid motif within Sjc23-LED that mediated the binding to human IgG. Conclusion and Significance: S. japonicum parasites cloak themselves through interaction with human non-immune IgG, and a member of the tetraspanin family, Sjc23, mediated the acquisition of human IgG via the interaction of a motif of 9 amino acids with the Fc domain of the IgG molecule. The consequence of this interaction will likely benefit parasitism of S. japonicum by evasion of host immune recognition or immunoresponses. This is the first report that an epitope of schistosomal ligand and its immunoglobulin receptor are defined, which provides further evidence of immune evasion strategy adopted by S. japonicum.	[Wu, Chuang; Chang, Qiaocheng; Peng, Shuai; Sun, Xiaojing; Lu, Huijun; Yin, Jigang; Jiang, Ning; Chen, Qijun] Jilin Univ, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Cai, Pengfei; Chen, Qijun] Chinese Acad Med Sci, Parasitol Lab, Inst Basic Med, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Cai, Pengfei; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hao, Lili] SW Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China	Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southwest Minzu University	Wu, C (corresponding author), Jilin Univ, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China.	jiangning@jlu.edu.cn; cqj@jlu.edu.cn	yin, jigang/GWV-1397-2022; Cai, Pengfe/AAF-2759-2020; Chang, Qiao-Cheng/GPF-6176-2022	Cai, Pengfei/0000-0003-4975-4615	National Natural Science Foundation of China [30901254]; Institute of Pathogen Biology, CAMS [2008IPB204]; national science and technology specific projects [2008ZX10401]; NSFC [30625029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology, CAMS; national science and technology specific projects; NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (#30901254), the intramural grant from Institute of Pathogen Biology, CAMS (2008IPB204), and the national science and technology specific projects (2008ZX10401), and the Grant for Young Distinguished Scientist to QC (NSFC, 30625029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN D, 1987, MOL BIOCHEM PARASIT, V23, P123, DOI 10.1016/0166-6851(87)90147-2; Bergquist R, 2002, ACTA TROP, V82, P183, DOI 10.1016/S0001-706X(02)00048-7; Cai PF, 2008, BIOCHEM BIOPH RES CO, V372, P197, DOI 10.1016/j.bbrc.2008.05.042; Da'dara AA, 2002, PARASITE IMMUNOL, V24, P179, DOI 10.1046/j.1365-3024.2002.00453.x; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; DAVERN KM, 1991, MOL BIOCHEM PARASIT, V48, P67, DOI 10.1016/0166-6851(91)90165-3; Deng JS, 2007, INT J PARASITOL, V37, P67, DOI 10.1016/j.ijpara.2006.09.011; Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a; Gobert GN, 1997, PARASITOLOGY, V114, P45, DOI 10.1017/S0031182096008001; HARN DA, 1985, J IMMUNOL, V135, P2115; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hu Y, 2007, EXP PARASITOL, V115, P379, DOI 10.1016/j.exppara.2006.09.022; Jiang N, 2010, ACTA TROP, V116, P9, DOI 10.1016/j.actatropica.2010.04.015; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Loukas A, 2001, INFECT IMMUN, V69, P3646, DOI 10.1128/IAI.69.6.3646-3651.2001; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mcintosh RS, 2006, PARASITE IMMUNOL, V28, P407, DOI 10.1111/j.1365-3024.2006.00829.x; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; PEARCE EJ, 1988, P NATL ACAD SCI USA, V85, P5678, DOI 10.1073/pnas.85.15.5678; Ren L, 2003, ANAL BIOCHEM, V322, P164, DOI 10.1016/j.ab.2003.07.023; REYNOLDS SR, 1992, J IMMUNOL, V149, P3995; ROGERS MV, 1988, MOL BIOCHEM PARASIT, V29, P77, DOI 10.1016/0166-6851(88)90122-3; Shi FH, 2001, VACCINE, V20, P462, DOI 10.1016/S0264-410X(01)00340-1; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Waine GJ, 1999, PARASITE IMMUNOL, V21, P377, DOI 10.1046/j.1365-3024.1999.00221.x; WRIGHT MD, 1991, J IMMUNOL, V147, P4338; Zhou D, 1994, World Health Forum, V15, P387	30	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19112	10.1371/journal.pone.0019112	http://dx.doi.org/10.1371/journal.pone.0019112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533061	gold, Green Published, Green Submitted			2022-12-27	WOS:000289719400060
J	Buehler, DM; Versteegh, MA; Matson, KD; Tieleman, I				Buehler, Deborah M.; Versteegh, Maaike A.; Matson, Kevin D.; Tieleman, Irene			One Problem, Many Solutions: Simple Statistical Approaches Help Unravel the Complexity of the Immune System in an Ecological Context	PLOS ONE			English	Article							PHENOTYPIC COVARIANCE STRUCTURE; MATRIX CORRELATION; LIFE-HISTORY; ANNUAL-CYCLE; TRADE-OFFS; GREENFINCHES; ENVIRONMENTS; IMMUNOLOGY; CHALLENGE; PATTERNS	The immune system is a complex collection of interrelated and overlapping solutions to the problem of disease. To deal with this complexity, researchers have devised multiple ways to measure immune function and to analyze the resulting data. In this way both organisms and researchers employ many tactics to solve a complex problem. One challenge facing ecological immunologists is the question of how these many dimensions of immune function can be synthesized to facilitate meaningful interpretations and conclusions. We tackle this challenge by employing and comparing several statistical methods, which we used to test assumptions about how multiple aspects of immune function are related at different organizational levels. We analyzed three distinct datasets that characterized 1) species, 2) subspecies, and 3) among-and within-individual level differences in the relationships among multiple immune indices. Specifically, we used common principal components analysis (CPCA) and two simpler approaches, pair-wise correlations and correlation circles. We also provide a simple example of how these techniques could be used to analyze data from multiple studies. Our findings lead to several general conclusions. First, relationships among indices of immune function may be consistent among some organizational groups (e. g. months over the annual cycle) but not others (e. g. species); therefore any assumption of consistency requires testing before further analyses. Second, simple statistical techniques used in conjunction with more complex multivariate methods give a clearer and more robust picture of immune function than using complex statistics alone. Moreover, these simpler approaches have potential for analyzing comparable data from multiple studies, especially as the field of ecological immunology moves towards greater methodological standardization.	[Buehler, Deborah M.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Buehler, Deborah M.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Versteegh, Maaike A.; Matson, Kevin D.; Tieleman, Irene] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Toronto; Royal Ontario Museum; University of Groningen	Buehler, DM (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	m.a.versteegh@rug.nl	Matson, Kevin/G-3855-2010; Tieleman, Irene/H-4296-2011; Matson, Kevin D./R-1986-2019; Buehler, Deborah/ABB-2088-2021	Matson, Kevin/0000-0002-4373-5926; Buehler, Deborah/0000-0003-3669-6364	Natural Science and Engineering Council of Canada (NSERC) [PDF-373488-2009]; Netherlands Organization for Scientific Research (NWO) [Rubicon 825.09.019, 863.08.026]; VENI fellowship [863.04.023]; Rosalind Franklin fellowship	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VENI fellowship; Rosalind Franklin fellowship	Financial support came from grants to DMB from the Natural Science and Engineering Council of Canada (NSERC; PDF-373488-2009) and the Netherlands Organization for Scientific Research (NWO; Rubicon 825.09.019); to KDM from a VENI fellowship (863.08.026) from NWO; to BIT from a VENI fellowship (863.04.023) and a Rosalind Franklin fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI H, 2010, WILEY INTER IN PRESS, V2; Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Buehler DM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P561, DOI 10.1086/603635; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Clark W.R., 2008, DEFENSE SELF IMMUNE; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duckworth RA, 2010, AUK, V127, P752, DOI 10.1525/auk.2010.127.4.752; Flury B, 1988, COMMON PRINCIPAL COM; Gonzalez G, 1999, BEHAV ECOL SOCIOBIOL, V46, P117, DOI 10.1007/s002650050600; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Houle D, 2002, EVOLUTION, V56, P433; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Martin LB, 2006, INTEGR COMP BIOL, V46, P1030, DOI 10.1093/icb/icl039; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P815, DOI 10.1098/rspb.2005.3376; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; PHILLIPS P, 2000, CPC COMMON PRINCIPAL; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2018, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sokal R.R., 2012, BIOMETRY; Sparkman AM, 2009, J ANIM ECOL, V78, P1242, DOI 10.1111/j.1365-2656.2009.01587.x; Steppan SJ, 1997, EVOLUTION, V51, P571, DOI 10.1111/j.1558-5646.1997.tb02444.x; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239	35	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18592	10.1371/journal.pone.0018592	http://dx.doi.org/10.1371/journal.pone.0018592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526186	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100009
J	Kwon, Y; Cukierman, E; Godwin, AK				Kwon, Youngjoo; Cukierman, Edna; Godwin, Andrew K.			Differential Expressions of Adhesive Molecules and Proteases Define Mechanisms of Ovarian Tumor Cell Matrix Penetration/Invasion	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; COHORT MIGRATION; CARCINOMA-CELLS; METALLOPROTEINASE INHIBITOR; PHENOTYPIC PLASTICITY; SURFACE EPITHELIUM; CANCER; INVASION; COLLAGEN	Epithelial ovarian cancer is an aggressive and deadly disease and understanding its invasion mechanisms is critical for its treatment. We sought to study the penetration/invasion of ovarian tumor cells into extracellular matrices (ECMs) using a fibroblast-derived three-dimensional (3D) culture model and time-lapse and confocal imaging. Twelve ovarian tumor cells were evaluated and classified into distinct groups based on their ECM remodeling phenotypes; those that degraded the ECM (represented by OVCAR5 cells) and those that did not (represented by OVCAR10 cells). Cells exhibiting a distinct ECM modifying behavior were also segregated by epithelial- or mesenchymal-like phenotypes and uPA or MMP-2/MMP-9 expression. The cells, which presented epithelial- like phenotypes, penetrated the ECM using proteases and maintained intact cell-cell interactions, while cells exhibiting mesenchymal phenotypes modified the matrices via Rho-associated serine/threonine kinase (ROCK) in the absence of apparent cell-cell interactions. Overall, this study demonstrates that different mechanisms of modifying matrices by ovarian tumor cells may reflect heterogeneity among tumors and emphasize the need to systematically assess these mechanisms to better design effective therapies.	[Kwon, Youngjoo; Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Cukierman, Edna] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center	Kwon, Y (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	Edna.Cukierman@FCCC.edu; AGodwin@kumc.edu	cukierman, edna/AAU-8932-2020; Cukierman, Edna/A-3951-2013	cukierman, edna/0000-0002-1452-9576; Kwon, Youngjoo/0000-0003-3582-4192	Ovarian Cancer Research Fund; National Cancer Institute (NCI); National Institutes of Health (NIH) [CA113451, CA140323]; NATIONAL CANCER INSTITUTE [R01CA113451, R01CA140323] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a program project grant from Ovarian Cancer Research Fund (http://www.ocrf.org to A.K.G.) and grants from the National Cancer Institute (NCI) and National Institutes of Health (NIH) (CA113451 to E.C. and CA140323 to A.K.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; AUERSPERG N, 1994, LAB INVEST, V71, P510; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Cai KQ, 2007, MOL CARCINOGEN, V46, P130, DOI 10.1002/mc.20273; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; EHRLICH HP, 1991, J CELL PHYSIOL, V146, P1, DOI 10.1002/jcp.1041460102; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GEISLER JP, 1995, GYNECOL ONCOL, V57, P246, DOI 10.1006/gyno.1995.1134; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jankun J, 1999, Cancer Biochem Biophys, V17, P109; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; LANGDON SP, 1988, CANCER RES, V48, P6166; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Mirastschijski U, 2004, EXP CELL RES, V299, P465, DOI 10.1016/j.yexcr.2004.06.007; Nabeshima K, 2000, CANCER RES, V60, P3364; Nabeshima K, 1999, HISTOL HISTOPATHOL, V14, P1183, DOI 10.14670/HH-14.1183; Nabeshima K, 1997, LAB INVEST, V76, P139; Nabeshima K, 1998, INT J CANCER, V78, P750, DOI 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-#; OZOLS RF, 1991, SEMIN ONCOL, V18, P222; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; SCHULTZ DC, 1995, CANCER RES, V55, P2150; Scott KA, 1998, FEBS LETT, V441, P137, DOI 10.1016/S0014-5793(98)01542-7; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Sood AK, 1999, CLIN CANCER RES, V5, P2485; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; YAMATO M, 1995, J BIOCHEM-TOKYO, V117, P940, DOI 10.1093/oxfordjournals.jbchem.a124824; Zuo JH, 2010, MOL CANCER RES, V8, P170, DOI 10.1158/1541-7786.MCR-09-0354	64	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18872	10.1371/journal.pone.0018872	http://dx.doi.org/10.1371/journal.pone.0018872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526198	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100032
J	Porto-Pazos, AB; Veiguela, N; Mesejo, P; Navarrete, M; Alvarellos, A; Ibanez, O; Pazos, A; Araque, A				Porto-Pazos, Ana B.; Veiguela, Noha; Mesejo, Pablo; Navarrete, Marta; Alvarellos, Alberto; Ibanez, Oscar; Pazos, Alejandro; Araque, Alfonso			Artificial Astrocytes Improve Neural Network Performance	PLOS ONE			English	Article								Compelling evidence indicates the existence of bidirectional communication between astrocytes and neurons. Astrocytes, a type of glial cells classically considered to be passive supportive cells, have been recently demonstrated to be actively involved in the processing and regulation of synaptic information, suggesting that brain function arises from the activity of neuron-glia networks. However, the actual impact of astrocytes in neural network function is largely unknown and its application in artificial intelligence remains untested. We have investigated the consequences of including artificial astrocytes, which present the biologically defined properties involved in astrocyte-neuron communication, on artificial neural network performance. Using connectionist systems and evolutionary algorithms, we have compared the performance of artificial neural networks (NN) and artificial neuron-glia networks (NGN) to solve classification problems. We show that the degree of success of NGN is superior to NN. Analysis of performances of NN with different number of neurons or different architectures indicate that the effects of NGN cannot be accounted for an increased number of network elements, but rather they are specifically due to astrocytes. Furthermore, the relative efficacy of NGN vs. NN increases as the complexity of the network increases. These results indicate that artificial astrocytes improve neural network performance, and established the concept of Artificial Neuron-Glia Networks, which represents a novel concept in Artificial Intelligence with implications in computational science as well as in the understanding of brain function.	[Porto-Pazos, Ana B.; Veiguela, Noha; Mesejo, Pablo; Alvarellos, Alberto; Ibanez, Oscar; Pazos, Alejandro] Univ A Coruna, Fac Informat, Dept Tecnol Informac & Comunicac, La Coruna, Spain; [Navarrete, Marta; Araque, Alfonso] CSIC, Inst Cajal, E-28002 Madrid, Spain	Universidade da Coruna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Porto-Pazos, AB (corresponding author), Univ A Coruna, Fac Informat, Dept Tecnol Informac & Comunicac, Campus Elvina, La Coruna, Spain.	ana.portop@udc.es	Navarrete, Marta/E-9266-2013; Alvarellos, Alberto/L-9841-2019; Mesejo, Pablo/K-4589-2014; Pazos, Alejandro/AAI-5887-2020; Ibáñez, Oscar/B-2680-2015; Porto-Pazos, Ana/A-9971-2012; Sierra, Alejandro Pazos/K-8927-2017	Navarrete, Marta/0000-0003-2097-4788; Alvarellos, Alberto/0000-0002-3404-3354; Mesejo, Pablo/0000-0001-9955-2101; Ibáñez, Oscar/0000-0002-5301-8277; Porto-Pazos, Ana/0000-0003-1428-2523; Sierra, Alejandro Pazos/0000-0003-2324-238X; Araque, Alfonso/0000-0003-3840-1144	Ministry of Science and Innovation of Spain [TIN2009-07707, BFU2010-15832, CSD2010-00045]; Xunta de Galicia, Spain [REGICC 2009/58, 08SIN010105PR]; CYTED (Ibero-NBIC Network) [209RT0366]; Cajal Blue Brain, Spain; European Union [HEALTH-F2-2007-202167]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); CYTED (Ibero-NBIC Network); Cajal Blue Brain, Spain; European Union(European Commission)	The work was supported by grants from Ministry of Science and Innovation of Spain (TIN2009-07707, BFU2010-15832, CSD2010-00045), Xunta de Galicia, Spain (REGICC 2009/58, 08SIN010105PR), CYTED (Ibero-NBIC Network 209RT0366), Cajal Blue Brain, Spain, and European Union (HEALTH-F2-2007-202167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; *CESGA, 2010, COMP EQ WAS PROV CTR; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Holland JH., 1975, Q REV BIOL; HOLLAND JH, 1987, P 2 INT C GEN ALG, P82; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MERTZ CJ, 2002, U CALIFORNIA IRVINE; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Rabunal JR, 2004, NEURAL COMPUT, V16, P1483, DOI 10.1162/089976604323057461; Volterra A., 2002, TRIPARTITE SYNAPSE G, P164; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219	21	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19109	10.1371/journal.pone.0019109	http://dx.doi.org/10.1371/journal.pone.0019109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526157	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100052
J	Le, YL; Peng, JJ; Wu, HW; Sun, JZ; Shao, WL				Le, Yilin; Peng, Jingjing; Wu, Huawei; Sun, Jianzhong; Shao, Weilan			An Approach to the Production of Soluble Protein from a Fungal Gene Encoding an Aggregation-Prone Xylanase in Escherichia coli	PLOS ONE			English	Article							INCLUSION-BODY FORMATION; HIGH-LEVEL EXPRESSION; HEAT-SHOCK PROTEINS; THERMOANAEROBACTER-ETHANOLICUS; THERMOMYCES-LANUGINOSUS; CHAPERONE ACTIVITY; PERIPLASM; OVEREXPRESSION; XYLOSIDASE; ISOMERASE	The development of new procedures and protocols that allow researchers to obtain recombinant proteins is of fundamental importance in the biotechnology field. A strategy was explored to overcome inclusion-body formation observed when expressing an aggregation-prone fungal xylanase in Escherichia coli. pHsh is an expression plasmid that uses a synthetic heat-shock (Hsh) promoter, in which gene expression is regulated by an alternative sigma factor (sigma(32)). A derivative of pHsh was constructed by fusing a signal peptide to xynA2 gene to facilitate export of the recombinant protein to the periplasm. The xylanase was produced in a soluble form. Three factors were essential to achieving such soluble expression of the xylanase: 1) the target gene was under the control of the Hsh promoter, 2) the gene product was exported into the periplasm, and 3) gene expression was induced by a temperature upshift. For the first time we report the expression of periplasmic proteins under the control of an Hsh promoter regulated by sigma(32). One unique feature of this approach was that over 200 copies of the Hsh promoter in an E. coli cell significantly increased the concentration of sigma(32). The growth inhibition of the recombinant cells corresponded to an increase in the levels of soluble periplasmic protein. Therefore, an alternative protocol was designed to induce gene expression from pHsh-ex to obtain high levels of active soluble enzymes.	[Le, Yilin; Peng, Jingjing; Wu, Huawei; Shao, Weilan] Nanjing Normal Univ, Res Ctr Biotechnol & Biomass Energy, Nanjing, Jiangsu, Peoples R China; [Le, Yilin; Peng, Jingjing; Wu, Huawei; Shao, Weilan] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Sun, Jianzhong] Jiangsu Univ, Sch Environm, Biofuels Inst, Zhenjiang, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Jiangsu University	Le, YL (corresponding author), Nanjing Normal Univ, Res Ctr Biotechnol & Biomass Energy, Nanjing, Jiangsu, Peoples R China.	shaoweilan@njnu.edu.cn		le, yilin/0000-0002-1620-007X; Shao, Weilan/0000-0001-8067-3755	"973" of China [2004CB719600]; National Natural Science Foundation of China [30770061]	"973" of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from a sub-project of "973" of China (2004CB719600), and the National Natural Science Foundation of China (30770061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; GOMES J, 1993, J BIOTECHNOL, V30, P283, DOI 10.1016/0168-1656(93)90145-D; Hunke S, 2003, MOL MICROBIOL, V50, P1579, DOI 10.1046/j.1365-2958.2003.03785.x; Kadokura H, 2001, J GEN APPL MICROBIOL, V47, P133, DOI 10.2323/jgam.47.133; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; Missiakas D, 1997, TRENDS BIOCHEM SCI, V22, P59, DOI 10.1016/S0968-0004(96)10072-4; Pan KL, 2003, J BACTERIOL, V185, P3020, DOI 10.1128/JB.185.10.3020-3030.2003; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Sambrook J., MOL CLONING LAB MANU; Sevastsyanovich YR, 2010, BIOTECHNOL APPL BIOC, V55, P9, DOI 10.1042/BA20090174; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; SHAO WL, 1992, J BACTERIOL, V174, P5848, DOI 10.1128/jb.174.18.5848-5853.1992; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; SKELLY S, 1987, P NATL ACAD SCI USA, V84, P8365, DOI 10.1073/pnas.84.23.8365; STRANDBERG L, 1991, APPL ENVIRON MICROB, V57, P1669, DOI 10.1128/AEM.57.6.1669-1674.1991; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Thomas JG, 1996, MOL MICROBIOL, V21, P1185, DOI 10.1046/j.1365-2958.1996.651436.x; Thorstenson YR, 1997, J BACTERIOL, V179, P5333, DOI 10.1128/jb.179.17.5333-5339.1997; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; Wu HW, 2008, ENZYME MICROB TECH, V42, P230, DOI 10.1016/j.enzmictec.2007.09.013; Wu HW, 2010, BIOTECHNOL LETT, V32, P795, DOI 10.1007/s10529-010-0223-y; Yin E, 2008, WORLD J MICROB BIOT, V24, P275, DOI 10.1007/s11274-007-9469-5; Zhang Z, 2003, BIOTECHNIQUES, V35, P1032, DOI 10.2144/03355rr03	35	17	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18489	10.1371/journal.pone.0018489	http://dx.doi.org/10.1371/journal.pone.0018489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494625	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800024
J	Tank, J; Biller, H; Heusser, K; Holz, O; Diedrich, A; Framke, T; Koch, A; Grosshennig, A; Koch, W; Krug, N; Jordan, J; Hohlfeld, JM				Tank, Jens; Biller, Heike; Heusser, Karsten; Holz, Olaf; Diedrich, Andre; Framke, Theodor; Koch, Armin; Grosshennig, Anika; Koch, Wolfgang; Krug, Norbert; Jordan, Jens; Hohlfeld, Jens M.			Effect of Acute Ozone Induced Airway Inflammation on Human Sympathetic Nerve Traffic: A Randomized, Placebo Controlled, Crossover Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; OXIDATIVE STRESS; BRONCHIAL-MUCOSA; POLLUTION; EXPOSURE; ACTIVATION; INCREASES; RESPONSES; LAVAGE; ADULTS	Background: Ozone concentrations in ambient air are related to cardiopulmonary perturbations in the aging population. Increased central sympathetic nerve activity induced by local airway inflammation may be one possible mechanism. Methodology/Principal Findings: To elucidate this issue further, we performed a randomized, double-blind, cross-over study, including 14 healthy subjects (3 females, age 22-47 years), who underwent a 3 h exposure with intermittent exercise to either ozone (250 ppb) or clean air. Induced sputum was collected 3 h after exposure. Nineteen to 22 hours after exposure, we recorded ECG, finger blood pressure, brachial blood pressure, respiration, cardiac output, and muscle sympathetic nerve activity (MSNA) at rest, during deep breathing, maximum-inspiratory breath hold, and a Valsalva maneuver. While the ozone exposure induced the expected airway inflammation, as indicated by a significant increase in sputum neutrophils, we did not detect a significant estimated treatment effect adjusted for period on cardiovascular measurements. Resting heart rate (clean air: 59 +/- 62, ozone 60 +/- 62 bpm), blood pressure (clean air: 121 +/- 3/71 +/- 2 mmHg; ozone: 121 +/- 2/71 +/- 2mmHg), cardiac output (clean air: 7.42 +/- 0.29 mmHg; ozone: 7.98 +/- 0.60 l/min), and plasma norepinephrine levels (clean air: 213 +/- 21 pg/ml; ozone: 202 +/- 16 pg/ml), were similar on both study days. No difference of resting MSNA was observed between ozone and air exposure (air: 2362, ozone: 2362 bursts/min). Maximum MSNA obtained at the end of apnea (air: 44 +/- 4, ozone: 48 +/- 4 bursts/min) and during the phase II of the Valsalva maneuver (air: 64 +/- 5, ozone: 57 +/- 6 bursts/min) was similar. Conclusions/Significance: Our study suggests that acute ozone-induced airway inflammation does not increase resting sympathetic nerve traffic in healthy subjects, an observation that is relevant for environmental health. However, we can not exclude that chronic airway inflammation may contribute to sympathetic activation.	[Tank, Jens; Heusser, Karsten; Jordan, Jens] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; [Biller, Heike; Holz, Olaf; Koch, Wolfgang; Krug, Norbert; Hohlfeld, Jens M.] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Diedrich, Andre] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Med,Auton Dysfunct Ctr, Nashville, TN 37212 USA; [Diedrich, Andre] Vanderbilt Univ, Dept Biomed Engn, Sch Engn, Nashville, TN 37235 USA; [Framke, Theodor; Koch, Armin; Grosshennig, Anika] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany	Hannover Medical School; Fraunhofer Gesellschaft; Vanderbilt University; Vanderbilt University; Hannover Medical School	Tank, J (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	tank.jens@mh-hannover.de		Hohlfeld, Jens/0000-0003-2646-6186; Heusser, Karsten/0000-0002-2571-5585; Tank, Jens/0000-0002-5672-1187	Deutsche Forschungsgemeinschaft [BI 1403/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Project BI 1403/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363; Balmes J R, 1997, Res Rep Health Eff Inst, P1; Bernardi L, 2008, EUR RESPIR J, V32, P1458, DOI 10.1183/09031936.00066807; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Camm AJ, 1996, EUR HEART J, V17, P354; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; COLERIDGE JCG, 1993, J APPL PHYSIOL, V74, P2345, DOI 10.1152/jappl.1993.74.5.2345; Djukanovic R, 2002, EUR RESPIR J, V20, p1S, DOI 10.1183/09031936.02.00000102; Fagius J, 1993, Clin Auton Res, V3, P201; Fakhri AA, 2009, ENVIRON HEALTH PERSP, V117, P1287, DOI 10.1289/ehp.0900541; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Grassi G, 2005, HYPERTENSION, V46, P321, DOI 10.1161/01.HYP.0000174243.39897.6c; Hausberg M, 1997, CIRCULATION, V96, P282; Heindl S, 2001, AM J RESP CRIT CARE, V164, P597, DOI 10.1164/ajrccm.164.4.2007085; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Holguin F, 2003, EPIDEMIOLOGY, V14, P521, DOI 10.1097/01.ede.0000081999.15060.ae; Holz O, 1999, AM J RESP CRIT CARE, V159, P776, DOI 10.1164/ajrccm.159.3.9806098; Holz O, 2005, J CLIN PHARMACOL, V45, P498, DOI 10.1177/0091270004273527; Holz O, 2002, CLIN EXP ALLERGY, V32, P681, DOI 10.1046/j.1365-2222.2002.01358.x; Holz O, 1998, THORAX, V53, P83, DOI 10.1136/thx.53.2.83; Immink RV, 2004, CIRCULATION, V110, P2241, DOI 10.1161/01.CIR.0000144472.08647.40; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kim CS, 2011, AM J RESP CRIT CARE, V183; Krishna MT, 1998, EUR RESPIR J, V11, P1294, DOI 10.1183/09031936.98.11061294; Krishna MT, 1997, AM J RESP CRIT CARE, V156, P943, DOI 10.1164/ajrccm.156.3.9612088; Kumar Manoj, 2005, Indian J Physiol Pharmacol, V49, P89; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; Luttmann-Gibson H, 2006, J OCCUP ENVIRON MED, V48, P780, DOI 10.1097/01.jom.0000229781.27181.7d; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Narkiewicz K, 1998, CIRCULATION, V98, P528, DOI 10.1161/01.CIR.98.6.528; ORDWAY GA, 1988, AM J PHYSIOL, V254, pH354, DOI 10.1152/ajpheart.1988.254.2.H354; Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447; Peters A, 1999, AM J EPIDEMIOL, V150, P1094, DOI 10.1093/oxfordjournals.aje.a009934; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Power KL, 2008, J OCCUP ENVIRON MED, V50, P1253, DOI 10.1097/JOM.0b013e3181814239; Sayk F, 2008, AM J PHYSIOL-REG I, V295, pR891, DOI 10.1152/ajpregu.90444.2008; SOMERS VK, 1991, J CLIN INVEST, V87, P1953, DOI 10.1172/JCI115221; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; SOMERS VK, 1989, J APPL PHYSIOL, V67, P2101, DOI 10.1152/jappl.1989.67.5.2101; Stenfors N, 2002, RESP MED, V96, P352, DOI 10.1053/rmed.2001.1265; Tank J, 2003, CIRCULATION, V107, P2949, DOI 10.1161/01.CIR.0000072786.99163.FE; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Urch B, 2005, ENVIRON HEALTH PERSP, V113, P1052, DOI 10.1289/ehp.7785; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Ye SH, 1998, AM J HYPERTENS, V11, P723, DOI 10.1016/S0895-7061(98)00030-2	46	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18737	10.1371/journal.pone.0018737	http://dx.doi.org/10.1371/journal.pone.0018737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494635	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800042
J	Krenn, BM; Egorov, A; Romanovskaya-Romanko, E; Wolschek, M; Nakowitsch, S; Ruthsatz, T; Kiefmann, B; Morokutti, A; Humer, J; Geiler, J; Cinatl, J; Michaelis, M; Wressnigg, N; Sturlan, S; Ferko, B; Batishchev, OV; Indenbom, AV; Zhu, R; Kastner, M; Hinterdorfer, P; Kiselev, O; Muster, T; Romanova, J				Krenn, Brigitte M.; Egorov, Andrej; Romanovskaya-Romanko, Ekaterina; Wolschek, Markus; Nakowitsch, Sabine; Ruthsatz, Tanja; Kiefmann, Bettina; Morokutti, Alexander; Humer, Johannes; Geiler, Janina; Cinatl, Jindrich; Michaelis, Martin; Wressnigg, Nina; Sturlan, Sanda; Ferko, Boris; Batishchev, Oleg V.; Indenbom, Andrey V.; Zhu, Rong; Kastner, Markus; Hinterdorfer, Peter; Kiselev, Oleg; Muster, Thomas; Romanova, Julia			Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1	PLOS ONE			English	Article							A VIRUSES; NASAL PH; HEMAGGLUTININ; SAFETY; ACID; CONDUCTANCE; REASSORTANT; STABILITY; SECRETION; TRIVALENT	Background: H5N1 influenza vaccines, including live intranasal, appear to be relatively less immunogenic compared to seasonal analogs. The main influenza virus surface glycoprotein hemagglutinin (HA) of highly pathogenic avian influenza viruses (HPAIV) was shown to be more susceptible to acidic pH treatment than that of human or low pathogenic avian influenza viruses. The acidification machinery of the human nasal passageway in response to different irritation factors starts to release protons acidifying the mucosal surface (down to pH of 5.2). We hypothesized that the sensitivity of H5 HA to the acidic environment might be the reason for the low infectivity and immunogenicity of intranasal H5N1 vaccines for mammals. Methodology/Principal Findings: We demonstrate that original human influenza viruses infect primary human nasal epithelial cells at acidic pH (down to 5.4), whereas H5N1 HPAIVs lose infectivity at pH <= 5.6. The HA of A/Vietnam/1203/04 was modified by introducing the single substitution HA2 58K -> I, decreasing the pH of the HA conformational change. The H5N1 reassortants containing the indicated mutation displayed an increased resistance to acidic pH and high temperature treatment compared to those lacking modification. The mutation ensured a higher viral uptake as shown by immunohistochemistry in the respiratory tract of mice and 25 times lower mouse infectious dose(50). Moreover, the reassortants keeping 58K -> I mutation designed as a live attenuated vaccine candidate lacking an NS1 gene induced superior systemic and local antibody response after the intranasal immunization of mice. Conclusion/Significance: Our finding suggests that an efficient intranasal vaccination with a live attenuated H5N1 virus may require a certain level of pH and temperature stability of HA in order to achieve an optimal virus uptake by the nasal epithelial cells and induce a sufficient immune response. The pH of the activation of the H5 HA protein may play a substantial role in the infectivity of HPAIVs for mammals.	[Krenn, Brigitte M.; Egorov, Andrej; Wolschek, Markus; Nakowitsch, Sabine; Ruthsatz, Tanja; Kiefmann, Bettina; Morokutti, Alexander; Humer, Johannes; Wressnigg, Nina; Sturlan, Sanda; Ferko, Boris; Muster, Thomas; Romanova, Julia] Avir Green Hills Biotechnol AG, Vienna, Austria; [Romanovskaya-Romanko, Ekaterina; Kiselev, Oleg] Russian Acad Med Sci, Influenza Res Inst, St Petersburg, Russia; [Batishchev, Oleg V.; Indenbom, Andrey V.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow, Russia; [Zhu, Rong; Kastner, Markus; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, Christian Doppler Lab Nanoscop Methods Biophys, A-4040 Linz, Austria; [Geiler, Janina; Cinatl, Jindrich] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany	Russian Academy of Medical Sciences; Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Johannes Kepler University Linz; Goethe University Frankfurt	Krenn, BM (corresponding author), Avir Green Hills Biotechnol AG, Vienna, Austria.	a.egorov@greenhillsbiotech.com	Indenbom, Andrey V/J-8208-2018; Romanova, Julia R/M-9490-2016; Romanovskaya-Romanko, Ekaterina/J-1022-2018; Batishchev, Oleg V/L-1976-2013; Hinterdorfer, Peter/C-4235-2013	Romanova, Julia R/0000-0002-8114-4262; Romanovskaya-Romanko, Ekaterina/0000-0001-7560-398X; Batishchev, Oleg V/0000-0002-9581-2233; FERKO, Boris/0000-0001-5340-4437; Hinterdorfer, Peter/0000-0003-2583-1305; Kastner, Markus/0000-0003-2662-9344; Michaelis, Martin/0000-0002-5710-5888	European Commission [SP5B-CT-2007-044512, LSHB-CT-2005-518281]; AVIR Green Hills Biotechnology AG (AGHB); Russian Foundation for Basic Researches [08-03-00971]; Presidium of RAS [P337]; Austrian Institute for Biophysics, Christian Doppler Laboratory of Nanoscopic Methods in Biophysics (Johannes Kepler University Linz)	European Commission(European CommissionEuropean Commission Joint Research Centre); AVIR Green Hills Biotechnology AG (AGHB); Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Presidium of RAS(Russian Academy of Sciences); Austrian Institute for Biophysics, Christian Doppler Laboratory of Nanoscopic Methods in Biophysics (Johannes Kepler University Linz)	This work has been partially funded by the European Commission's 6th Framework Program projects "Intranasal H5 Vaccine'' (SP5B-CT-2007-044512) and "FLUVACC'' (LSHB-CT-2005-518281). Costs not covered by the European Grants are funded by AVIR Green Hills Biotechnology AG (AGHB) and in part by Russian Foundation for Basic Researches (project #08-03-00971), Program of Presidium of RAS "Molecular and Cell Biology,'' Federal Task Program "Scientific and Scientific-Pedagogic Personnel of Innovative Russia'' for 2009-2013 (state contract #P337) and Austrian Institute for Biophysics, Christian Doppler Laboratory of Nanoscopic Methods in Biophysics (Johannes Kepler University Linz). No additional external funding was received for this study. AGHB performed the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Cyranoski D, 2005, NATURE, V435, P1009, DOI 10.1038/4351009a; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39; England RJA, 1999, CLIN OTOLARYNGOL, V24, P67, DOI 10.1046/j.1365-2273.1999.00223.x; Ferko B, 2006, J VIROL, V80, P11621, DOI 10.1128/JVI.01645-06; Fischer H, 2002, AM J PHYSIOL-CELL PH, V282, pC736, DOI 10.1152/ajpcell.00369.2001; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hehar SS, 1999, CLIN OTOLARYNGOL, V24, P24, DOI 10.1046/j.1365-2273.1999.00190.x; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099; Limberis M, 2002, HUM GENE THER, V13, P1961, DOI 10.1089/10430340260355365; Lin YP, 1997, VIROLOGY, V233, P402, DOI 10.1006/viro.1997.8626; Lorenz R. J., 1973, Laboratory techniques in rabies. WHO Monograph Series No.23., P321; McShane D, 2003, EUR RESPIR J, V21, P37, DOI 10.1183/09031936.03.00027603; MUSTER T, 1995, J VIROL, V69, P6678, DOI 10.1128/JVI.69.11.6678-6686.1995; NAKOWITSCH SWM, 2011, VACCINE IN PRESS; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Romanova J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005984; Rudenko L, 2008, INFLUENZA OTHER RESP, V2, P203, DOI 10.1111/j.1750-2659.2008.00064.x; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SCHOLTISSEK C, 1985, ARCH VIROL, V85, P1, DOI 10.1007/BF01317001; SCHOLTISSEK C, 1985, VACCINE, V3, P215, DOI 10.1016/0264-410X(85)90109-4; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428; Washington N, 2000, INT J PHARM, V198, P139, DOI 10.1016/S0378-5173(99)00442-1; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	49	61	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18577	10.1371/journal.pone.0018577	http://dx.doi.org/10.1371/journal.pone.0018577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490925	Green Submitted, Green Published, gold			2022-12-27	WOS:000289238700024
J	Fang, F; Kasperzyk, JL; Shui, I; Hendrickson, W; Hollis, BW; Fall, K; Ma, J; Gaziano, JM; Stampfer, MJ; Mucci, LA; Giovannucci, E				Fang, Fang; Kasperzyk, Julie L.; Shui, Irene; Hendrickson, Whitney; Hollis, Bruce W.; Fall, Katja; Ma, Jing; Gaziano, J. Michael; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward			Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer	PLOS ONE			English	Article							SUBSEQUENT DEVELOPMENT; D-RECEPTOR; RISK; 1,25-DIHYDROXYVITAMIN-D; 25-HYDROXYVITAMIN-D; RADIOIMMUNOASSAY; CALCITRIOL; DIAGNOSIS; VARIANTS; SUNLIGHT	Background: Laboratory evidence suggests that vitamin D might influence prostate cancer prognosis. Methodology/Principal Findings: We examined the associations between prediagnostic plasma levels of 25(OH) vitamin D [25(OH)D] and 1,25(OH)(2)vitamin D [1,25(OH)(2)D] and mortality among 1822 participants of the Health Professionals Follow-up Study and Physicians' Health Study who were diagnosed with prostate cancer. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of total mortality (n = 595) and lethal prostate cancer (death from prostate cancer or development of bone metastases; n = 202). In models adjusted for age at diagnosis, BMI, physical activity, and smoking, we observed a HR of 1.22 (95% CI: 0.97, 1.54) for total mortality, comparing men in the lowest to the highest quartile of 25(OH) D. There was no association between 1,25(OH) 2D and total mortality. Men with the lowest 25(OH) D quartile were more likely to die of their cancer (HR: 1.59; 95% CI: 1.06, 2.39) compared to those in the highest quartile (P-trend = 0.006). This association was largely explained by the association between low 25(OH) D levels and advanced cancer stage and higher Gleason score, suggesting that these variables may mediate the influence of 25(OH) D on prognosis. The association also tended to be stronger among patients with samples collected within five years of cancer diagnosis. 1,25(OH)(2)D levels were not associated with lethal prostate cancer. Conclusions/Significance: Although potential bias of less advanced disease due to more screening activity among men with high 25(OH) D levels cannot be ruled out, higher prediagnostic plasma 25(OH) D might be associated with improved prostate cancer prognosis.	[Fang, Fang; Kasperzyk, Julie L.; Hendrickson, Whitney; Ma, Jing; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Fang, Fang; Kasperzyk, Julie L.; Hendrickson, Whitney; Ma, Jing; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kasperzyk, Julie L.; Shui, Irene; Hendrickson, Whitney; Fall, Katja; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hollis, Bruce W.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Fall, Katja] Orebro Univ Hosp, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Medical University of South Carolina; Orebro University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Fang, F (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	fang.fang@channing.harvard.edu	Fall, Katja/AAE-1876-2021; H, W/AAM-2887-2020	Fall, Katja/0000-0002-3649-2639; Fang, Fang/0000-0002-3310-6456; Hendrickson, Whitney/0000-0003-4603-2879	National Institutes of Health [CA133891, CA141298, CA34933, CA40360, CA091793, CA055075, CA42182, HL26490, HL34595]; Prostate Cancer Foundation, Santa Monica, CA, USA; National Cancer Institute National Research Service [T32 CA09001]; NATIONAL CANCER INSTITUTE [R01CA042182, R01CA133891, R01CA040360, T32CA009001, R01CA141298, P01CA055075, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation, Santa Monica, CA, USA; National Cancer Institute National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health research grants CA133891, CA141298, CA34933, CA40360, CA091793, CA055075, CA42182, HL26490 and HL34595; Prostate Cancer Foundation, Santa Monica, CA, USA and National Cancer Institute National Research Service Award T32 CA09001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Beer TM, 2006, ANTICANCER RES, V26, P2647; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; Chen L, 2009, CANCER EPIDEM BIOMAR, V18, P2874, DOI 10.1158/1055-9965.EPI-09-0544; CORDER EH, 1993, CANCER EPIDEM BIOMAR, V2, P467; Cowen ME, 1996, CANCER, V78, P1952, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1952::AID-CNCR16>3.0.CO;2-X; Dunlap N, 2003, BRIT J CANCER, V89, P746, DOI 10.1038/sj.bjc.6601161; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; HENDRICKSON WK, J CLIN ONCO IN PRESS; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hollis BW, 1996, CLIN CHEM, V42, P586; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Holmberg L, 2009, CANCER CAUSE CONTROL, V20, P663, DOI 10.1007/s10552-008-9279-6; Holt SK, 2010, PROSTATE, V70, P1448, DOI 10.1002/pros.21180; Jacobs ET, 2004, J STEROID BIOCHEM, V89-90, P533, DOI 10.1016/j.jsbmb.2004.03.063; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lim HS, 2006, INT J CANCER, V119, P1530, DOI 10.1002/ijc.22052; Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Robsahm TE, 2004, CANCER CAUSE CONTROL, V15, P149, DOI 10.1023/B:CACO.0000019494.34403.09; Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348; Schwartz GG, 2009, ANN EPIDEMIOL, V19, P96, DOI 10.1016/j.annepidem.2008.03.007; SCHWARTZ GG, 1990, ANTICANCER RES, V10, P1307; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tretli S, 2009, BRIT J CANCER, V100, P450, DOI 10.1038/sj.bjc.6604865; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375	29	78	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18625	10.1371/journal.pone.0018625	http://dx.doi.org/10.1371/journal.pone.0018625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494639	Green Submitted, gold, Green Published			2022-12-27	WOS:000289192400041
J	Roseboom, W; Nishida, S; Fujisaki, W; Arnold, DH				Roseboom, Warrick; Nishida, Shin'ya; Fujisaki, Waka; Arnold, Derek H.			Audio-Visual Speech Timing Sensitivity Is Enhanced in Cluttered Conditions	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; PERCEPTION; SYNCHRONY; RECALIBRATION; CAPTURE; ORDER; EXPOSURE; VISION; POP	Events encoded in separate sensory modalities, such as audition and vision, can seem to be synchronous across a relatively broad range of physical timing differences. This may suggest that the precision of audio-visual timing judgments is inherently poor. Here we show that this is not necessarily true. We contrast timing sensitivity for isolated streams of audio and visual speech, and for streams of audio and visual speech accompanied by additional, temporally offset, visual speech streams. We find that the precision with which synchronous streams of audio and visual speech are identified is enhanced by the presence of additional streams of asynchronous visual speech. Our data suggest that timing perception is shaped by selective grouping processes, which can result in enhanced precision in temporally cluttered environments. The imprecision suggested by previous studies might therefore be a consequence of examining isolated pairs of audio and visual events. We argue that when an isolated pair of cross-modal events is presented, they tend to group perceptually and to seem synchronous as a consequence. We have revealed greater precision by providing multiple visual signals, possibly allowing a single auditory speech stream to group selectively with the most synchronous visual candidate. The grouping processes we have identified might be important in daily life, such as when we attempt to follow a conversation in a crowded room.	[Roseboom, Warrick; Arnold, Derek H.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Nishida, Shin'ya] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa 24301, Japan; [Fujisaki, Waka] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Higashi Ku, Tsukuba, Ibaraki, Japan	University of Queensland; Nippon Telegraph & Telephone Corporation; National Institute of Advanced Industrial Science & Technology (AIST)	Roseboom, W (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	w.roseboom@psy.uq.edu.au	Fujisaki, Waka/N-6151-2016	Fujisaki, Waka/0000-0003-3844-5235; Arnold, Derek/0000-0003-1027-6222	Australian Research Council	Australian Research Council(Australian Research Council)	This project was funded by an Australian Research Council Discovery Grant and Fellowship awarded to DHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Arnold DH, 2007, P ROY SOC B-BIOL SCI, V274, P2331, DOI 10.1098/rspb.2007.0576; Arnold DH, 2009, J VISION, V9, DOI 10.1167/9.5.4; Arnold DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010217; Arnold DH, 2005, VISION RES, V45, P1275, DOI 10.1016/j.visres.2004.11.014; Arnold DH, 2005, VISION RES, V45, P3015, DOI 10.1016/j.visres.2005.06.031; Cook LA, 2009, PERCEPTION, V38, P1220, DOI 10.1068/p6344; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Green DM, 1966, SIGNAL DETECTION THE; Guski R, 2003, PERCEPT PSYCHOPHYS, V65, P789, DOI 10.3758/BF03194815; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Jackson C. V., 1953, Q J EXPT PSYCHOL, V5, P52, DOI [10.1080/17470215308416626, DOI 10.1080/17470215308416626]; Keetels M, 2007, EXP BRAIN RES, V180, P449, DOI 10.1007/s00221-007-0881-8; King AJ, 2005, CURR BIOL, V15, pR339, DOI 10.1016/j.cub.2005.04.022; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Lewald J, 2001, BEHAV BRAIN RES, V121, P69, DOI 10.1016/S0166-4328(00)00386-7; Macmillan N. A., 1991, DETECTION THEORY USE; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Miner N, 1998, PRESENCE-TELEOP VIRT, V7, P396, DOI 10.1162/105474698565802; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2010, BRAIN RES, V1323, P84, DOI 10.1016/j.brainres.2010.01.059; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; Roseboom W, 2009, J VISION, V9, DOI 10.1167/9.12.4; Sanabria D, 2005, NEUROSCI LETT, V377, P59, DOI 10.1016/j.neulet.2004.11.069; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2007, EXP BRAIN RES, V181, P173, DOI 10.1007/s00221-007-0918-z; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2006, J EXP PSYCHOL HUMAN, V32, P1063, DOI 10.1037/0096-1523.32.4.1063; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017	50	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18309	10.1371/journal.pone.0018309	http://dx.doi.org/10.1371/journal.pone.0018309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494684	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400018
J	Baker, A; Pearson, T; Price, EP; Dale, J; Keim, P; Hornstra, H; Greenhill, A; Padilla, G; Warner, J				Baker, Anthony; Pearson, Talima; Price, Erin P.; Dale, Julia; Keim, Paul; Hornstra, Heidie; Greenhill, Andrew; Padilla, Gabriel; Warner, Jeffrey			Molecular Phylogeny of Burkholderia pseudomallei from a Remote Region of Papua New Guinea	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; GENETIC DIVERSITY; AUSTRALIA; MELIOIDOSIS; MAXIMUM	Background: The island of New Guinea is located midway between the world's two major melioidosis endemic regions of Australia and Southeast Asia. Previous studies in Papua New Guinea have demonstrated autochthonous melioidosis in Balimo, Western province. In contrast to other regions of endemicity, isolates recovered from both environmental and clinical sources demonstrate narrow genetic diversity over large spatial and temporal scales. Methodology/Principal Findings: We employed molecular typing techniques to determine the phylogenetic relationships of these isolates to each other and to others worldwide to aid in understanding the origins of the Papua New Guinean isolates. Multi-locus sequence typing of the 39 isolates resolved three unique sequence types. Phylogenetic reconstruction and Structure analysis determined that all isolates were genetically closer to those from Australia than those from Southeast Asia. Gene cluster analysis however, identified a Yersinia-like fimbrial gene cluster predominantly found among Burkholderia pseudomallei derived from Southeast Asia. Higher resolution VNTR typing and phylogenetic reconstruction of the Balimo isolates resolved 24 genotypes with long branch lengths. These findings are congruent with long term persistence in the region and a high level of environmental stability. Conclusions/Significance: Given that anthropogenic influence has been hypothesized as a mechanism for the dispersal of B. pseudomallei, these findings correlate with limited movement of the indigenous people in the region. The palaeogeographical and anthropogenic history of Australasia and the results from this study indicate that New Guinea is an important region for the further study of B. pseudomallei origins and dissemination.	[Baker, Anthony; Greenhill, Andrew; Padilla, Gabriel; Warner, Jeffrey] James Cook Univ, Sch Vet & Biomed Sci, Environm & Publ Hlth Microbiol Res Grp, Townsville, Qld 4811, Australia; [Pearson, Talima; Price, Erin P.; Dale, Julia; Keim, Paul; Hornstra, Heidie] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Greenhill, Andrew] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea	James Cook University; Northern Arizona University; PNG Institute Of Medical Research	Baker, A (corresponding author), James Cook Univ, Sch Vet & Biomed Sci, Environm & Publ Hlth Microbiol Res Grp, Townsville, Qld 4811, Australia.	Anthony.Baker@jcu.edu.au	Pearson, Talima/O-7840-2019; Anderson, Julia/W-6122-2019; Price, Erin/N-2336-2013; Keim, Paul S/A-2269-2010; Padilla, Gabriel/C-6491-2012; Baker, Anthony/C-2433-2014; Padilla, Gabriel/M-2183-2016	Pearson, Talima/0000-0003-3696-041X; Anderson, Julia/0000-0001-5582-7206; Price, Erin/0000-0002-1079-4882; Baker, Anthony/0000-0001-5455-2271; Warner, Jeffrey/0000-0002-5869-8283; Greenhill, Andrew/0000-0001-5831-8714; Padilla, Gabriel/0000-0001-8086-3065	U.S. Department of Homeland Security S&T CB Division Bioforensics	U.S. Department of Homeland Security S&T CB Division Bioforensics(United States Department of Homeland Security (DHS))	This work was supported by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program. Use of products/names does not constitute endorsement by the DHS or USG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN B, 1983, J HUM EVOL, V12, P3, DOI 10.1016/S0047-2484(83)80010-4; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; Bird MI, 2004, QUATERN INT, V118, P145, DOI 10.1016/S1040-6182(03)00135-6; Cheng AC, 2008, J CLIN MICROBIOL, V46, P249, DOI 10.1128/JCM.01725-07; CURRIE B, 1994, EPIDEMIOL INFECT, V113, P307, DOI 10.1017/S0950268800051736; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Ouadah AHE, 2007, INTERNET J VET MED, V2; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Pritchard JK, 2000, GENETICS, V155, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; U'Ren JM, 2007, APPL ENVIRON MICROB, V73, P6678, DOI 10.1128/AEM.00986-07; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Warner JM, 2007, T ROY SOC TROP MED H, V101, P809, DOI 10.1016/j.trstmh.2007.02.024; Warner JM, 2007, EPIDEMIOL INFECT, P1; WUTHIEKANUN V, 1990, J MED MICROBIOL, V33, P121, DOI 10.1099/00222615-33-2-121; Yap E. H., 1995, Singapore Medical Journal, V36, P60; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	26	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18343	10.1371/journal.pone.0018343	http://dx.doi.org/10.1371/journal.pone.0018343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483841	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000289057200063
J	McLaren, CE; Garner, CP; Constantine, CC; McLachlan, S; Vulpe, CD; Snively, BM; Gordeuk, VR; Nickerson, DA; Cook, JD; Leiendecker-Foster, C; Beckman, KB; Eckfeldt, JH; Barcellos, LF; Murray, JA; Adams, PC; Acton, RT; Killeen, AA; McLaren, GD				McLaren, Christine E.; Garner, Chad P.; Constantine, Clare C.; McLachlan, Stela; Vulpe, Chris D.; Snively, Beverly M.; Gordeuk, Victor R.; Nickerson, Debbie A.; Cook, James D.; Leiendecker-Foster, Catherine; Beckman, Kenneth B.; Eckfeldt, John H.; Barcellos, Lisa F.; Murray, Joseph A.; Adams, Paul C.; Acton, Ronald T.; Killeen, Anthony A.; McLaren, Gordon D.			Genome-Wide Association Study Identifies Genetic Loci Associated with Iron Deficiency	PLOS ONE			English	Article							OVERLOAD SCREENING HEIRS; SERUM FERRITIN; TRANSFERRIN SATURATION; HFE HEMOCHROMATOSIS; BINDING-CAPACITY; COMMON VARIANTS; G277S MUTATION; TMPRSS6 GENE; METABOLISM; ANEMIA	The existence of multiple inherited disorders of iron metabolism in man, rodents and other vertebrates suggests genetic contributions to iron deficiency. To identify new genomic locations associated with iron deficiency, a genome-wide association study (GWAS) was performed using DNA collected from white men aged >= 25 y and women >= 50 y in the Hemochromatosis and Iron Overload Screening (HEIRS) Study with serum ferritin (SF) <= 12 mu g/L (cases) and iron replete controls (SF > 100 mu g/L in men, SF > 50 mu g/L in women). Regression analysis was used to examine the association between case-control status (336 cases, 343 controls) and quantitative serum iron measures and 331,060 single nucleotide polymorphism (SNP) genotypes, with replication analyses performed in a sample of 71 cases and 161 controls from a population of white male and female veterans screened at a US Veterans Affairs (VA) medical center. Five SNPs identified in the GWAS met genome-wide statistical significance for association with at least one iron measure, rs2698530 on chr. 2p14; rs3811647 on chr. 3q22, a known SNP in the transferrin (TF) gene region; rs1800562 on chr. 6p22, the C282Y mutation in the HFE gene; rs7787204 on chr. 7p21; and rs987710 on chr. 22q11 (GWAS observed P < 1.51x10(-7) for all). An association between total iron binding capacity and SNP rs3811647 in the TF gene (GWAS observed P = 7.0x10(-9), corrected P = 0.012) was replicated within the VA samples (observed P = 0.012). Associations with the C282Y mutation in the HFE gene also were replicated. The joint analysis of the HEIRS and VA samples revealed strong associations between rs2698530 on chr. 2p14 and iron status outcomes. These results confirm a previously-described TF polymorphism and implicate one potential new locus as a target for gene identification.	[McLaren, Christine E.; Garner, Chad P.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA; [Constantine, Clare C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Snively, Beverly M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27103 USA; [Gordeuk, Victor R.] Howard Univ, Dept Med, Washington, DC 20059 USA; [Nickerson, Debbie A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cook, James D.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Leiendecker-Foster, Catherine; Eckfeldt, John H.; Killeen, Anthony A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Beckman, Kenneth B.] Univ Minnesota, Dept Genet Cell Biol & Dev Biol, Minneapolis, MN USA; [Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Murray, Joseph A.] Mayo Clin, Coll Med, Div Gastroenterol Hepatol, Rochester, MN USA; [Adams, Paul C.] London Hlth Sci Ctr, London, ON, Canada; [Acton, Ronald T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [McLaren, Gordon D.] Long Beach Healthcare Syst, Dept Vet Affairs, Long Beach, CA USA; [McLaren, Gordon D.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of Melbourne; Wake Forest University; Wake Forest Baptist Medical Center; Howard University; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; Mayo Clinic; London Health Sciences Centre; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	McLaren, CE (corresponding author), Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA.	cmclaren@uci.edu	Vulpe, Chris/AAF-9170-2020; Gordeuk, Victor/AAG-6577-2019	Vulpe, Chris/0000-0001-5134-8929; murray, joseph/0000-0003-1941-9090; Adams, Paul/0000-0002-9921-2956	National Heart, Lung, and Blood Institute (NHLBI) [R01 HL083328, UH1-HL03679-05]; Department of Veterans Affairs; National Human Genome Research Institute (NHGRI); University of Minnesota [N01-HC-05185]; Howard University [N01-HC-05186]; University of Alabama at Birmingham [N01-HC-05188]; Kaiser Permanente Center for Health Research [N01-HC-05189]; University of California, Irvine [N01-HC-05190]; London Health Sciences Centre [N01-HC-05191]; Wake Forest University [N01-HC-05192]; University of Alabama at Birmingham General Clinical Research Center (GCRC) [M01-RR00032]; Southern Iron Disorders Center; Howard University GCRC [M01-RR10284]; Office of Research on Minority Health; National Center for Research Resources National Institutes of Health [UC Irvine M01RR 00827-29]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005189, N01HC005190, N01HC005188, N01HC005192, N01HC005191, N01HC005185, N01HC005186] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032, M01RR000827, M01RR010284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL003679, R01HL083328] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Minnesota(University of Minnesota System); Howard University; University of Alabama at Birmingham; Kaiser Permanente Center for Health Research; University of California, Irvine(University of California System); London Health Sciences Centre; Wake Forest University; University of Alabama at Birmingham General Clinical Research Center (GCRC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Southern Iron Disorders Center; Howard University GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by grant R01 HL083328 from the National Heart, Lung, and Blood Institute (NHLBI) (C.E.M.) and by a Merit Review award from the Department of Veterans Affairs (G.D.M.). The HEIRS Study was initiated and funded by NHLBI, in conjunction with National Human Genome Research Institute (NHGRI). Data collection for this study was supported by contracts N01-HC-05185 (University of Minnesota), N01-HC-05186 (Howard University), N01-HC-05188 (University of Alabama at Birmingham), N01-HC-05189 (Kaiser Permanente Center for Health Research), N01-HC-05190 (University of California, Irvine), N01-HC-05191 (London Health Sciences Centre), and N01-HC-05192 (Wake Forest University). Additional funding was provided by the University of Alabama at Birmingham General Clinical Research Center (GCRC) grant M01-RR00032, Southern Iron Disorders Center (J.C.B.), Howard University GCRC grant M01-RR10284, Howard University Research Scientist Award UH1-HL03679-05 from the NHLBI and the Office of Research on Minority Health (V.R.G.), and grant UC Irvine M01RR 00827-29 from the General Clinical Research Centers Program of the National Center for Research Resources National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Aisen P, 2003, BRIT J HAEMATOL, V121, P674, DOI 10.1046/j.1365-2141.2003.04347.x; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BALLAS SK, 1979, AM J CLIN PATHOL, V71, P401, DOI 10.1093/ajcp/71.4.401; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Beutler E, 2003, BRIT J HAEMATOL, V120, P887, DOI 10.1046/j.1365-2141.2003.04215.x; Bleackley MR, 2009, TRANSFUS MED REV, V23, P103, DOI 10.1016/j.tmrv.2008.12.001; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; Camaschella C, 2009, NAT GENET, V41, P386, DOI 10.1038/ng0409-386; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Constantine CC, 2009, BRIT J HAEMATOL, V147, P140, DOI 10.1111/j.1365-2141.2009.07843.x; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; CUSTER EM, 1995, J LAB CLIN MED, V126, P88; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Datz C, 1998, CLIN CHEM, V44, P2429; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; FLOWERS CA, 1986, AM J HEMATOL, V23, P141, DOI 10.1002/ajh.2830230209; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lee P, 2009, ACTA HAEMATOL-BASEL, V122, P87, DOI 10.1159/000243792; Lee PL, 2001, BRIT J HAEMATOL, V115, P329, DOI 10.1046/j.1365-2141.2001.03096.x; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P539, DOI 10.1006/bcmd.2001.0418; Lee PL, 1999, BLOOD CELL MOL DIS, V25, P374, DOI 10.1006/bcmd.1999.0267; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; McLaren CE, 2003, BLOOD, V102, P4563, DOI 10.1182/blood-2003-04-1278; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; McLaren CE, 2010, AM J HEMATOL, V85, P101, DOI 10.1002/ajh.21585; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Milet J, 2007, AM J HUM GENET, V81, P799, DOI 10.1086/520001; MILMAN N, 1983, DAN MED BULL, V30, P115; Morse AC, 1999, P SOC EXP BIOL MED, V220, P147, DOI 10.1046/j.1525-1373.1999.d01-22.x; Pfeiffer CM, 2007, CLIN CHIM ACTA, V382, P112, DOI 10.1016/j.cca.2007.04.008; Raddatz D, 2003, Z GASTROENTEROL, V41, P1069; Sarria B, 2007, EUR J NUTR, V46, P57, DOI 10.1007/s00394-006-0631-x; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Wallace DF, 2007, WORLD J GASTROENTERO, V13, P4690, DOI 10.3748/wjg.v13.i35.4690; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; World Health Organization, 2000, WHONHD007	44	49	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17390	10.1371/journal.pone.0017390	http://dx.doi.org/10.1371/journal.pone.0017390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483845	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200005
J	Steinstraesser, L; Hauk, J; Schubert, C; Al-Benna, S; Stricker, I; Hatt, H; Shai, Y; Steinau, HU; Jacobsen, F				Steinstraesser, Lars; Hauk, Jennifer; Schubert, Cornelius; Al-Benna, Sammy; Stricker, Ingo; Hatt, Hanns; Shai, Yechiel; Steinau, Hans-Ulrich; Jacobsen, Frank			Suppression of Soft Tissue Sarcoma Growth by a Host Defense-Like Lytic Peptide	PLOS ONE			English	Article							D-AMINO-ACID; ANTIMICROBIAL PEPTIDES; ANGIOGENESIS INHIBITOR; INNATE IMMUNITY; TUMOR-GROWTH; CELLS; CHEMOTHERAPY; RESISTANCE; MICE; EXPRESSION	Background: Soft tissue sarcoma (STS) is an anatomically and histologically heterogeneous neoplasia that shares a putative mesenchymal cell origin. The treatment with common chemotherapeutics is still unsatisfying because of association with poor response rates. Although evidence is accumulating for potent oncolytic activity of host defense peptides (HDPs), their potential therapeutic use is often limited by poor bioavailability and inactivation in serum. Therefore, we tested the designer host defense-like lytic D, L-amino acid peptide [D]-K3H3L9 on two STS cell lines in vitro and also in an athymic and syngeneic mouse model. In recent studies the peptide could show selectivity against prostate carcinoma cells and also an active state in serum. Methods: In vitro the human synovial sarcoma cell line SW982, the murine fibrosarcoma cell line BFS-1 and primary human fibroblasts as a control were exposed to [D]-K3H3L9, a 15mer D, L-amino acid designer HDP. Cell vitality in physiological and acidic conditions (MTT-assay), cell growth (BrdU) and DNA-fragmentation (TUNEL) were investigated. Membrane damage at different time points could be analyzed with LDH assay. An antibody against the tested peptide and recordings using scanning electron microscopy could give an inside in the mode of action. In vivo [D]-K3H3L9 was administered intratumorally in an athymic and syngeneic (immunocompetent) mouse model with SW982 and BFS-1 cells, respectively. After three weeks tumor sections were histologically analyzed. Results: The peptide exerts rapid and high significant cytotoxicity and antiproliferating activity against the malignant cell lines, apparently via a membrane disrupting mode of action. The local intratumoral administration of [D]-K3H3L9 in the athymic and syngeneic mice models significantly inhibited tumor progression. The histological analyses of the tumor sections revealed a significant antiproliferative, antiangiogenic activity of the treatment group. Conclusion: These findings demonstrate the in vitro and in vivo oncolytic activity of [D]-K3H3L9 in athymic and syngeneic mouse models.	[Steinstraesser, Lars; Hauk, Jennifer; Schubert, Cornelius; Al-Benna, Sammy; Steinau, Hans-Ulrich; Jacobsen, Frank] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Lab Wound Healing & Mol Oncol, Bochum, N Rhine Westpha, Germany; [Stricker, Ingo] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Pathol, Bochum, N Rhine Westpha, Germany; [Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, N Rhine Westpha, Germany; [Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Weizmann Institute of Science	Steinstraesser, L (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Lab Wound Healing & Mol Oncol, Bochum, N Rhine Westpha, Germany.	Lars.Steinstraesser@rub.de	Al-Benna, Sammy/AAG-1463-2019; Al-Benna, Sammy/G-1245-2013	Al-Benna, Sammy/0000-0003-4079-9286	German Research Foundation (DFG) [STE 1099/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG, reference number: STE 1099/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2009, PLAST RECONSTR SURG, V124, p463E, DOI 10.1097/PRS.0b013e3181bf7fe3; BAKER MA, 1993, CANCER RES, V53, P3052; BENKIRANE N, 1993, J BIOL CHEM, V268, P26279; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Billingsley KG, 1999, ANN SURG, V229, P602, DOI 10.1097/00000658-199905000-00002; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Chao Celia, 2002, J Ky Med Assoc, V100, P10; Cormier JN, 2004, J CLIN ONCOL, V22, P4567, DOI 10.1200/JCO.2004.02.057; Dennison SR, 2006, CURR PROTEIN PEPT SC, V7, P487, DOI 10.2174/138920306779025611; Eilber FC, 2004, ANN SURG, V240, P686, DOI 10.1109/01.sla.0000141710.74073.0d; Hirsch T, 2006, MOL MED, V12, P199, DOI 10.2119/2006-00031.Hirsch; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Kuenen BC, 2003, CLIN CANCER RES, V9, P1648; Lehmann J, 2006, EUR UROL, V50, P141, DOI 10.1016/j.eururo.2005.12.043; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lins L, 2006, BIOPHYS J, V90, P470, DOI 10.1529/biophysj.105.068213; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Moscow JA, 1997, CANCER CHEMOTHER BIO, V17, P139; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; PAN JG, 2007, SCI STKE, pPE14, DOI DOI 10.1126/STKE.3812007PE14; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Reichardt P, 2002, CRIT REV ONCOL HEMAT, V41, P157, DOI 10.1016/S1040-8428(01)00153-6; Saenz NC, 1998, ANN SURG ONCOL, V5, P48, DOI 10.1007/BF02303764; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Steinau HU, 2001, CHIRURG, V72, P501, DOI 10.1007/s001040051339; STEINSTRAESSER L, HUM CELL IN PRESS; STEINSTRAESSER L, IMMUNOBIOLO IN PRESS; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; TANNOCK IF, 1989, CANCER RES, V49, P4373; UTSUGI T, 1991, CANCER RES, V51, P3062; VAUPEL P, 1989, CANCER RES, V49, P6449; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18321	10.1371/journal.pone.0018321	http://dx.doi.org/10.1371/journal.pone.0018321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483840	Green Submitted, gold, Green Published			2022-12-27	WOS:000289057200058
J	Luijten, M; Littel, M; Franken, IHA				Luijten, Maartje; Littel, Marianne; Franken, Ingmar H. A.			Deficits in Inhibitory Control in Smokers During a Go/NoGo Task: An Investigation Using Event-Related Brain Potentials	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER; STOP-SIGNAL TASK; RESPONSE-INHIBITION; EXECUTIVE CONTROL; NICOTINE DEPENDENCE; ADDICTIVE BEHAVIORS; FAGERSTROM TEST; DRUG-ADDICTION; ERP COMPONENTS	Introduction: The role of inhibitory control in addictive behaviors is highlighted in several models of addictive behaviors. Although reduced inhibitory control has been observed in addictive behaviors, it is inconclusive whether this is evident in smokers. Furthermore, it has been proposed that drug abuse individuals with poor response inhibition may experience greater difficulties not consuming substances in the presence of drug cues. The major aim of the current study was to provide electrophysiological evidence for reduced inhibitory control in smokers and to investigate whether this is more pronounced during smoking cue exposure. Methods: Participants (19 smokers and 20 non-smoking controls) performed a smoking Go/NoGo task. Behavioral accuracy and amplitudes of the N2 and P3 event-related potential (ERP), both reflecting aspects of response inhibition, were the main variables of interest. Results: Reduced NoGo N2 amplitudes in smokers relative to controls were accompanied by decreased task performance, whereas no differences between groups were found in P3 amplitudes. This was found to represent a general lack of inhibition in smokers, and not dependent on the presence of smoking cues. Conclusions: The current results suggest that smokers have difficulties with response inhibition, which is an important finding that eventually can be implemented in smoking cessation programs. More research is needed to clarify the exact role of cue exposure on response inhibition.	[Luijten, Maartje; Littel, Marianne; Franken, Ingmar H. A.] Erasmus Univ, Inst Psychol, Rotterdam, Netherlands	Erasmus University Rotterdam	Luijten, M (corresponding author), Erasmus Univ, Inst Psychol, Rotterdam, Netherlands.	luijten@fsw.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Littel, Marianne/0000-0002-3741-6005	Netherlands Organization for Scientific Research (NWO) [016.08.322]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant of the Netherlands Organization for Scientific Research (NWO; VIDI grant number 016.08.322). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagot KS, 2007, AM J ADDICTION, V16, P62, DOI 10.1080/10550490601080100; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Burle B, 2004, NEUROSCI LETT, V360, P77, DOI 10.1016/j.neulet.2004.02.034; Chen CY, 2005, NEUROREPORT, V16, P1213, DOI 10.1097/00001756-200508010-00016; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Dinn WM, 2004, ADDICT BEHAV, V29, P107, DOI 10.1016/j.addbeh.2003.07.001; Evans DE, 2009, GENES BRAIN BEHAV, V8, P86, DOI 10.1111/j.1601-183X.2008.00445.x; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2006, CLIN NEUROPHYSIOL, V117, P1638, DOI 10.1016/j.clinph.2006.05.002; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Field M, 2007, ADDICTION, V102, P579, DOI 10.1111/j.1360-0443.2007.01743.x; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Gamma A, 2005, J PSYCHOPHARMACOL, V19, P504, DOI 10.1177/0269881105056535; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groman SM, 2009, NEUROSCI BIOBEHAV R, V33, P690, DOI 10.1016/j.neubiorev.2008.08.008; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heil M, 2000, J PSYCHOPHYSIOL, V14, P218, DOI 10.1027//0269-8803.14.4.218; Houlihan ME, 1996, PSYCHOPHARMACOLOGY, V123, P231, DOI 10.1007/BF02246577; Houlihan ME, 2001, PSYCHOPHARMACOLOGY, V156, P388, DOI 10.1007/s002130100751; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kaiser S, 2003, PSYCHIAT RES-NEUROIM, V122, P169, DOI 10.1016/S0925-4927(03)00004-0; Kaiser S, 2006, INT J PSYCHOPHYSIOL, V61, P279, DOI 10.1016/j.ijpsycho.2005.09.006; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Kiehl KA, 2000, BIOL PSYCHIAT, V48, P210, DOI 10.1016/S0006-3223(00)00834-9; Kim MS, 2007, DEPRESS ANXIETY, V24, P22, DOI 10.1002/da.20195; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Nakata H, 2004, CLIN NEUROPHYSIOL, V115, P361, DOI 10.1016/j.clinph.2003.09.013; Nakata H, 2006, CLIN NEUROPHYSIOL, V117, P1669, DOI 10.1016/j.clinph.2006.03.032; Olmstead MC, 2006, Q J EXP PSYCHOL, V59, P625, DOI 10.1080/17470210500356308; PFEFFERBAUM A, 1987, ALCOHOL, V4, P275, DOI 10.1016/0741-8329(87)90023-1; Reynolds B, 2007, EXP CLIN PSYCHOPHARM, V15, P264, DOI 10.1037/1064-1297.15.3.264; Rubio G, 2008, ALCOHOL CLIN EXP RES, V32, P1681, DOI 10.1111/j.1530-0277.2008.00746.x; Ruchsow M, 2008, J NEURAL TRANSM, V115, P127, DOI 10.1007/s00702-007-0819-0; Ruchsow M, 2007, J NEURAL TRANSM, V114, P1595, DOI 10.1007/s00702-007-0779-4; Ruchsow M, 2008, INT J PSYCHOPHYSIOL, V68, P209, DOI 10.1016/j.ijpsycho.2008.01.010; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Spinella M, 2002, ADDICT BIOL, V7, P381, DOI 10.1080/1355621021000005964; Tiffany ST, 1999, ALCOHOL RES HEALTH, V23, P215; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Vink JM, 2005, ADDICT BEHAV, V30, P575, DOI 10.1016/j.addbeh.2004.05.023; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Yang B, 2009, SCI CHINA SER C, V52, P780, DOI 10.1007/s11427-009-0106-4	54	107	115	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18898	10.1371/journal.pone.0018898	http://dx.doi.org/10.1371/journal.pone.0018898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MO	21526125	Green Published, gold			2022-12-27	WOS:000290015800020
J	Ackermann, J; Ashton, G; Lyons, S; James, D; Hornung, JP; Jones, N; Breitwieser, W				Ackermann, Julien; Ashton, Garry; Lyons, Steve; James, Dominic; Hornung, Jean-Pierre; Jones, Nic; Breitwieser, Wolfgang			Loss of ATF2 Function Leads to Cranial Motoneuron Degeneration during Embryonic Mouse Development	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATING TRANSCRIPTION FACTOR-2; SIGNAL-TRANSDUCTION PATHWAY; ELEMENT-BINDING PROTEIN; MOTOR-NEURON IDENTITY; N-TERMINAL KINASES; C-JUN; NERVOUS-SYSTEM; SEROTONERGIC NEURONS; SOMATIC MOTONEURONS	The AP-1 family transcription factor ATF2 is essential for development and tissue maintenance in mammals. In particular, ATF2 is highly expressed and activated in the brain and previous studies using mouse knockouts have confirmed its requirement in the cerebellum as well as in vestibular sense organs. Here we present the analysis of the requirement for ATF2 in CNS development in mouse embryos, specifically in the brainstem. We discovered that neuron-specific inactivation of ATF2 leads to significant loss of motoneurons of the hypoglossal, abducens and facial nuclei. While the generation of ATF2 mutant motoneurons appears normal during early development, they undergo caspase-dependent and independent cell death during later embryonic and foetal stages. The loss of these motoneurons correlates with increased levels of stress activated MAP kinases, JNK and p38, as well as aberrant accumulation of phosphorylated neurofilament proteins, NF-H and NF-M, known substrates for these kinases. This, together with other neuropathological phenotypes, including aberrant vacuolisation and lipid accumulation, indicates that deficiency in ATF2 leads to neurodegeneration of subsets of somatic and visceral motoneurons of the brainstem. It also confirms that ATF2 has a critical role in limiting the activities of stress kinases JNK and p38 which are potent inducers of cell death in the CNS.	[Ackermann, Julien; Ashton, Garry; Lyons, Steve; James, Dominic; Jones, Nic; Breitwieser, Wolfgang] Univ Manchester, Paterson Inst Canc Res, Cell Regulat Dept, Manchester, Lancs, England; [Ackermann, Julien; Hornung, Jean-Pierre] Inst Biol Cellulaire & Morphol, Lausanne, Switzerland	Paterson Institute for Cancer Research; University of Manchester	Ackermann, J (corresponding author), Univ Manchester, Paterson Inst Canc Res, Cell Regulat Dept, Manchester, Lancs, England.	wbreitwieser@picr.man.ac.uk	James, Dominic/G-6435-2016; Hornung, Jean-Pierre/O-7505-2015	James, Dominic/0000-0002-0452-2178; Hornung, Jean-Pierre/0000-0002-9229-7520; Jones, Nic/0000-0002-7619-8151	Cancer Research UK; European Science Foundation; Cancer Research UK [12485] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Science Foundation(European Science Foundation (ESF)European Commission); Cancer Research UK(Cancer Research UK)	The project was funded by Cancer Research UK. J.A. was funded by the European Science Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bayliss High OB, 1990, THEORY PRACTICE HIST, P215; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Blanchi B, 2005, TRENDS MOL MED, V11, P23, DOI 10.1016/j.molmed.2004.11.005; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Brownlees J, 2000, J CELL SCI, V113, P401; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; De Girolamo LA, 2006, J NEUROSCI RES, V83, P680, DOI 10.1002/jnr.20765; Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; DYKSTRA MJ, 1992, BIOL ELECT MICROSCOP; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gaufo GO, 2003, DEVELOPMENT, V130, P5191, DOI 10.1242/dev.00730; Gelderblom M, 2004, INT J DEV NEUROSCI, V22, P559, DOI 10.1016/j.ijdevneu.2004.07.014; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Holasek SS, 2005, BRAIN RES, V1045, P185, DOI 10.1016/j.brainres.2005.03.037; Hu BR, 1999, NEUROSCIENCE, V89, P437, DOI 10.1016/S0306-4522(98)00352-2; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kojima M, 2008, J NEUROSCI RES, V86, P544, DOI 10.1002/jnr.21510; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Martin-Villalba A, 1998, MOL BRAIN RES, V62, P158, DOI 10.1016/S0169-328X(98)00239-3; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Mechta-Grigoriou F, 2003, DEV BIOL, V258, P419, DOI 10.1016/S0012-1606(03)00135-0; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Ottaviani G, 2006, J CLIN PATHOL, V59, P497, DOI 10.1136/jcp.2005.032037; Ottaviani G, 2009, VIRCHOWS ARCH, V454, P451, DOI 10.1007/s00428-009-0754-6; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shibata N, 2001, BRAIN RES, V917, P97, DOI 10.1016/S0006-8993(01)02926-2; Talley EM, 2000, DEV BRAIN RES, V122, P1, DOI 10.1016/S0165-3806(00)00036-5; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	68	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19090	10.1371/journal.pone.0019090	http://dx.doi.org/10.1371/journal.pone.0019090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533046	Green Submitted, Green Published, gold			2022-12-27	WOS:000290014500023
J	Lin, JT; Bethell, D; Tyner, SD; Lon, C; Shah, NK; Saunders, DL; Sriwichai, S; Khemawoot, P; Kuntawunggin, W; Smith, BL; Noedl, H; Schaecher, K; Socheat, D; Se, Y; Meshnick, SR; Fukuda, MM				Lin, Jessica T.; Bethell, Delia; Tyner, Stuart D.; Lon, Chanthap; Shah, Naman K.; Saunders, David L.; Sriwichai, Sabaithip; Khemawoot, Phisit; Kuntawunggin, Worachet; Smith, Bryan L.; Noedl, Harald; Schaecher, Kurt; Socheat, Duong; Se, Youry; Meshnick, Steven R.; Fukuda, Mark M.			Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment	PLOS ONE			English	Article							MALARIA; ANTIMALARIAL; INFECTIONS	Mixed P. falciparum/P. vivax infections are common in southeast Asia. When patients with P. falciparum malaria are treated and followed for several weeks, a significant proportion will develop P. vivax malaria. In a combined analysis of 243 patients recruited to two malaria treatment trials in western Cambodia, 20/43 (47%) of those with P. falciparum gametocytes on admission developed P. vivax malaria by Day 28 of follow-up. The presence of Pf gametocytes on an initial blood smear was associated with a 3.5-fold greater rate of vivax parasitemia post-treatment (IRR = 3.5, 95% CI 2.0-6.0, p < 0.001). The increased rate of post-treatment P. vivax infection persisted when correlates of exposure and immunity such as a history of malaria, male gender, and age were controlled for (IRR = 3.0, 95% CI 1.9-4.7, p < 0.001). Polymerase chain reaction (PCR) confirmed that only a low proportion of subjects (5/55 or 9.1%) who developed vivax during follow-up had detectable Pv parasites in the peripheral blood at baseline. Molecular detection of falciparum gametocytes by reverse transcriptase PCR in a subset of patients strengthened the observed association, while PCR detection of Pv parasitemia at follow-up was similar to microscopy results. These findings suggest that the majority of vivax infections arising after treatment of falciparum malaria originate from relapsing liver-stage parasites. In settings such as western Cambodia, the presence of both sexual and asexual forms of P. falciparum on blood smear at presentation with acute falciparum malaria serves as a marker for possible occult P. vivax coinfection and subsequent relapse. These patients may benefit from empiric treatment with an 8-aminoquinolone such as primaquine.	[Lin, Jessica T.; Bethell, Delia; Tyner, Stuart D.; Lon, Chanthap; Saunders, David L.; Sriwichai, Sabaithip; Khemawoot, Phisit; Kuntawunggin, Worachet; Smith, Bryan L.; Schaecher, Kurt; Se, Youry; Fukuda, Mark M.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Noedl, Harald] Med Univ Vienna, Dept Specif Prophylaxis & Trop Med, Vienna, Austria; [Shah, Naman K.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Lin, Jessica T.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Fukuda, Mark M.] Armed Forces Hlth Surveillance Ctr, Div Global Emerging Infect Dis Operat, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Center Parasitology, Entomology & Malaria Control; Medical University of Vienna; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lin, JT (corresponding author), Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand.	jesstlin@gmail.com	Lin, Jessica/I-2705-2019; Khemawoot, Phisit/ABE-2110-2020		U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS); American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114] Funding Source: NIH RePORTER	U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS)(United States Department of Defense); American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS) Program (for funding of the clinical trial) and a Pfizer Centennial Travel Award sponsored by the American Society of Tropical Medicine and Hygiene granted to Dr. Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2011, CLIN INFECT DIS, V52, P621, DOI 10.1093/cid/ciq258; Bousema JT, 2008, AM J TROP MED HYG, V78, P442, DOI 10.4269/ajtmh.2008.78.442; BOYD MARK F., 1938, AMER JOUR TROP MED, V18, P505; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P534; Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; LOOAREESUWAN S, 1987, LANCET, V2, P1052, DOI 10.1016/S0140-6736(87)91479-6; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McKenzie FE, 2002, AM J TROP MED HYG, V67, P411, DOI 10.4269/ajtmh.2002.67.411; Mlambo G, 2008, AM J TROP MED HYG, V78, P114, DOI 10.4269/ajtmh.2008.78.114; Noedl H, 2004, ANTIMICROB AGENTS CH, V48, P4485, DOI 10.1128/AAC.48.11.4485-4487.2004; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Price RN, 2010, LANCET INFECT DIS, V10, P654, DOI 10.1016/S1473-3099(10)70192-4; Pukrittayakamee S, 2004, ACTA TROP, V89, P351, DOI 10.1016/j.actatropica.2003.10.012; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; SE Y, 2009, ANN M AM SOC TROP ME; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358	22	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18716	10.1371/journal.pone.0018716	http://dx.doi.org/10.1371/journal.pone.0018716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533092	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400021
J	Poplawski, MM; Mastaitis, JW; Isoda, F; Grosjean, F; Zheng, F; Mobbs, CV				Poplawski, Michal M.; Mastaitis, Jason W.; Isoda, Fumiko; Grosjean, Fabrizio; Zheng, Feng; Mobbs, Charles V.			Reversal of Diabetic Nephropathy by a Ketogenic Diet	PLOS ONE			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; MOUSE MODEL; APOPTOSIS; NEURONS; GLUCOSE; RESTRICTION; EXPRESSION; COMPLICATIONS; HYSTERESIS	Intensive insulin therapy and protein restriction delay the development of nephropathy in a variety of conditions, but few interventions are known to reverse nephropathy. Having recently observed that the ketone 3-beta-hydroxybutyric acid (3-OHB) reduces molecular responses to glucose, we hypothesized that a ketogenic diet, which produces prolonged elevation of 3-OHB, may reverse pathological processes caused by diabetes. To address this hypothesis, we assessed if prolonged maintenance on a ketogenic diet would reverse nephropathy produced by diabetes. In mouse models for both Type 1 (Akita) and Type 2 (db/db) diabetes, diabetic nephropathy (as indicated by albuminuria) was allowed to develop, then half the mice were switched to a ketogenic diet. After 8 weeks on the diet, mice were sacrificed to assess gene expression and histology. Diabetic nephropathy, as indicated by albumin/creatinine ratios as well as expression of stress-induced genes, was completely reversed by 2 months maintenance on a ketogenic diet. However, histological evidence of nephropathy was only partly reversed. These studies demonstrate that diabetic nephropathy can be reversed by a relatively simple dietary intervention. Whether reduced glucose metabolism mediates the protective effects of the ketogenic diet remains to be determined.	[Poplawski, Michal M.; Isoda, Fumiko; Mobbs, Charles V.] Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY USA; [Mastaitis, Jason W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Grosjean, Fabrizio; Zheng, Feng] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai	Poplawski, MM (corresponding author), Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY USA.	charles.mobbs@mssm.edu		Mobbs, Charles/0000-0002-5815-8711	Juvenile Diabetes Foundation International; NIH/NIDDK [1R01HD060914-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060914] Funding Source: NIH RePORTER	Juvenile Diabetes Foundation International; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported by the Juvenile Diabetes Foundation International. Grant support: NIH/NIDDK (1R01HD060914-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSL ENDOCRINO; Bailey EE, 2005, EPILEPSY BEHAV, V6, P4, DOI 10.1016/j.yebeh.2004.10.006; Barutta F, 2010, DIABETES, V59, P1046, DOI 10.2337/db09-1336; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cheng H, 2008, ENDOCRINOLOGY, V149, P703, DOI 10.1210/en.2007-0772; CROFFORD OB, 1995, ANNU REV MED, V46, P267; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Grant MM, 2005, PROTEOMICS, V5, P534, DOI 10.1002/pmic.200300924; Gum ET, 2004, STROKE, V35, P590, DOI 10.1161/01.STR.0000110790.05859.DA; Hamada Yasuhiro, 2007, Kobe J Med Sci, V53, P53; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kojima S, 2009, PEPTIDES, V30, P962, DOI 10.1016/j.peptides.2009.01.007; Kowluru RA, 2004, J DIABETES COMPLICAT, V18, P282, DOI 10.1016/j.jdiacomp.2004.03.002; Laurent M, 2005, CELL MOL BIOL, V51, P583, DOI 10.1170/T667; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Mercer LD, 2005, BIOCHEM PHARMACOL, V69, P339, DOI 10.1016/j.bcp.2004.09.018; Mobbs Charles V., 2007, V35, P39; Osakada F, 2004, J PHARMACOL EXP THER, V311, P51, DOI 10.1124/jpet.104.070334; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pelsman A, 2003, INT J DEV NEUROSCI, V21, P117, DOI 10.1016/S0736-5748(03)00031-5; Smith SL, 2005, CNS DRUG REV, V11, P113; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	33	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18604	10.1371/journal.pone.0018604	http://dx.doi.org/10.1371/journal.pone.0018604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533091	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400016
J	Catanzaro, JM; Guerriero, JL; Liu, JX; Ullman, E; Sheshadri, N; Chen, JJ; Zong, WX				Catanzaro, Joseph M.; Guerriero, Jennifer L.; Liu, Jingxuan; Ullman, Erica; Sheshadri, Namratha; Chen, John J.; Zong, Wei-Xing			Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; TREATMENT RESPONSE; CERVICAL-CANCER; LUNG-CANCER; SENSITIVITY; ORIGIN; LINES	Squamous cell carcinoma antigen (SCCA) belongs to the serine protease inhibitor (Serpin) family of proteins. Elevated expression of SCCA has been used as a biomarker for aggressive squamous cell carcinoma (SCC) in cancers of the cervix, lung, head and neck, and liver. However, SCCA expression in breast cancer has not been investigated. Immunohistochemical analysis of SCCA expression was performed on tissue microarrays containing breast tumor tissues (n = 1,360) and normal breast epithelium (n = 124). SCCA expression was scored on a tiered scale (0-3) independently by two evaluators blind to the patient's clinical status. SCCA expression was observed in Grade I (0.3%), Grade II (2.5%), and Grade III (9.4%) breast cancers (p < 0.0001). Comparing tissues categorized into the three non-metastatic TNM stages, I-III, SCCA positivity was seen in 2.4% of Stage I cancers, 3.1% of Stage II cancers, and 8.6% of Stage III breast cancers (p = 0.0005). No positive staining was observed in normal/non-neoplastic breast tissue (0 out of 124). SCCA expression also correlated to estrogen receptor/progesterone receptor (ER/PR) double-negative tumors (p = 0.0009). Compared to SCCA-negative patients, SCCA-positive patients had both a worse overall survival and recurrence-free survival (p < 0.0001 and p < 0.0001, respectively). This study shows that SCCA is associated with both advanced stage and high grade human breast carcinoma, and suggests the necessity to further explore the role of SCCA in breast cancer development and treatment.	[Catanzaro, Joseph M.; Guerriero, Jennifer L.; Ullman, Erica; Sheshadri, Namratha; Zong, Wei-Xing] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Liu, Jingxuan] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Chen, John J.] SUNY Stony Brook, Dept Preventat Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Catanzaro, JM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	wzong@notes.cc.sunysb.edu	Sheshadri, Namratha/AAM-7384-2021; chen, JJ/HGB-6029-2022	Sheshadri, Namratha/0000-0003-4912-7275; 	National Institutes of Health (NIH) [T32GM00796247, NIH T32CA009176, NIH CA098092, NIH CA129536, Susan Komen KG081538]; Carol Baldwin Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [K01CA098092, T32CA009176, R01CA129536] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) T32GM00796247, NIH T32CA009176, NIH CA098092, NIH CA129536, Susan Komen KG081538, and the Carol Baldwin Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIOSCHI PA, 1991, INT J CANCER, V47, P376, DOI 10.1002/ijc.2910470311; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Cataltepe S, 2000, CLIN CHIM ACTA, V295, P107, DOI 10.1016/S0009-8981(00)00197-2; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; CORNOG JL, 1971, AM J CLIN PATHOL, V55, P410; DEJAGER D, 1995, J SURG ONCOL, V59, P199, DOI 10.1002/jso.2930590313; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DUK JM, 1990, GYNECOL ONCOL, V39, P186, DOI 10.1016/0090-8258(90)90430-S; Edge SB, 2010, AJCC CANC STAGING MA; Einarsson R, 2005, ADV CLIN EXP MED, V14, P643; Guido M, 2008, J CLIN PATHOL, V61, P445, DOI 10.1136/jcp.2007.051383; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hennessy BT, 2005, J CLIN ONCOL, V23, P7827, DOI 10.1200/JCO.2004.00.9589; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Masumoto K, 2003, J BIOL CHEM, V278, P45296, DOI 10.1074/jbc.M307741200; Molina R, 2003, TUMOR BIOL, V24, P209, DOI 10.1159/000074432; NGAN HYS, 1990, GYNECOL ONCOL, V37, P260, DOI 10.1016/0090-8258(90)90344-K; Nustad K, 2004, TUMOR BIOL, V25, P69, DOI 10.1159/000077726; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Shimada H, 2003, SURGERY, V133, P486, DOI 10.1067/msy.2003.139; Takeshima N, 1998, GYNECOL ONCOL, V68, P263, DOI 10.1006/gyno.1998.4939; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vassilakopoulos T, 2001, LUNG CANCER, V32, P137, DOI 10.1016/S0169-5002(00)00225-7; YAZIGI R, 1991, GYNECOL ONCOL, V41, P135, DOI 10.1016/0090-8258(91)90272-7	26	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19096	10.1371/journal.pone.0019096	http://dx.doi.org/10.1371/journal.pone.0019096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526154	gold, Green Submitted, Green Published			2022-12-27	WOS:000289671100050
J	He, SP; Tan, GH; Liu, Q; Huang, KW; Ren, J; Zhang, X; Yu, XC; Huang, P; An, CC				He, Shanping; Tan, Guihong; Liu, Qian; Huang, Kuowei; Ren, Jiao; Zhang, Xu; Yu, Xiangchun; Huang, Ping; An, Chengcai			The LSD1-Interacting Protein GILP Is a LITAF Domain Protein That Negatively Regulates Hypersensitive Cell Death in Arabidopsis	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; GENE-EXPRESSION; RESISTANCE; THALIANA; PLANTS; IDENTIFICATION; MUTATION; DEFENSE; LSD1; LESION-SIMULATING-DISEASE1	Background: Hypersensitive cell death, a form of avirulent pathogen-induced programmed cell death (PCD), is one of the most efficient plant innate immunity. However, its regulatory mechanism is poorly understood. AtLSD1 is an important negative regulator of PCD and only two proteins, AtbZIP10 and AtMC1, have been reported to interact with AtLSD1. Methodology/Principal Findings: To identify a novel regulator of hypersensitive cell death, we investigate the possible role of plant LITAF domain protein GILP in hypersensitive cell death. Subcellular localization analysis showed that AtGILP is localized in the plasma membrane and its plasma membrane localization is dependent on its LITAF domain. Yeast two-hybrid and pull-down assays demonstrated that AtGILP interacts with AtLSD1. Pull-down assays showed that both the N-terminal and the C-terminal domains of AtGILP are sufficient for interactions with AtLSD1 and that the N-terminal domain of AtLSD1 is involved in the interaction with AtGILP. Real-time PCR analysis showed that AtGILP expression is up-regulated by the avirulent pathogen Pseudomonas syringae pv. tomato DC3000 avrRpt2 (Pst avrRpt2) and fumonisin B1 (FB1) that trigger PCD. Compared with wild-type plants, transgenic plants overexpressing AtGILP exhibited significantly less cell death when inoculated with Pst avrRpt2, indicating that AtGILP negatively regulates hypersensitive cell death. Conclusions/Significance: These results suggest that the LITAF domain protein AtGILP localizes in the plasma membrane, interacts with AtLSD1, and is involved in negatively regulating PCD. We propose that AtGILP functions as a membrane anchor, bringing other regulators of PCD, such as AtLSD1, to the plasma membrane. Human LITAF domain protein may be involved in the regulation of PCD, suggesting the evolutionarily conserved function of LITAF domain proteins in the regulation of PCD.	[He, Shanping; Tan, Guihong; Liu, Qian; Huang, Kuowei; Ren, Jiao; Zhang, Xu; Yu, Xiangchun; Huang, Ping; An, Chengcai] Peking Univ, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	He, SP (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China.	chcaian@pku.edu.cn			National Key Basic Science '973' Program [2006CB101905]; National Natural Science Foundation [90817001, 30671402]; National Special Projects for R&D of Transgenic Plants [2008ZX08009-004]; Chinese Government [2006AA06Z341]	National Key Basic Science '973' Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Special Projects for R&D of Transgenic Plants; Chinese Government	This work was supported by grants from the National Key Basic Science '973' Program (2006CB101905), the National Natural Science Foundation (90817001 and 30671402), the National Special Projects for R&D of Transgenic Plants (2008ZX08009-004), and the State '863' High Technology R&D Program (2006AA06Z341) of the Chinese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Bennett CL, 2004, ANN NEUROL, V55, P713, DOI 10.1002/ana.20094; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Dellagi A, 1998, MOL PLANT MICROBE IN, V11, P734, DOI 10.1094/MPMI.1998.11.8.734; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Epple P, 2003, P NATL ACAD SCI USA, V100, P6831, DOI 10.1073/pnas.1130421100; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gilchrist DG, 1997, CELL DEATH DIFFER, V4, P689, DOI 10.1038/sj.cdd.4400312; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Katagiri F., 2002, ARABIDOPSIS BOOK; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; KING EO, 1954, J LAB CLIN MED, V44, P301; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Malinovsky FG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012586; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Matsumura Y, 2004, INT J CANCER, V111, P218, DOI 10.1002/ijc.20251; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	48	17	26	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18750	10.1371/journal.pone.0018750	http://dx.doi.org/10.1371/journal.pone.0018750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526181	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100017
J	Garonna, E; Botham, KM; Birdsey, GM; Randi, AM; Gonzalez-Perez, RR; Wheeler-Jones, CPD				Garonna, Elena; Botham, Kathleen M.; Birdsey, Graeme M.; Randi, Anna M.; Gonzalez-Perez, Ruben R.; Wheeler-Jones, Caroline P. D.			Vascular Endothelial Growth Factor Receptor-2 Couples Cyclo-Oxygenase-2 with Pro-Angiogenic Actions of Leptin on Human Endothelial Cells	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; NITRIC-OXIDE SYNTHASE; P38 MAPK; IN-VIVO; VEGF; EXPRESSION; KINASE; CYCLOOXYGENASE-2; PROLIFERATION; TRANSACTIVATION	Background: The adipocyte-derived hormone leptin influences the behaviour of a wide range of cell types and is now recognised as a pro-angiogenic and pro-inflammatory factor. In the vasculature, these effects are mediated in part through its direct leptin receptor (ObRb)-driven actions on endothelial cells (ECs) but the mechanisms responsible for these activities have not been established. In this study we sought to more fully define the molecular links between inflammatory and angiogenic responses of leptin-stimulated human ECs. Methodology/Principal Findings: Immunoblotting studies showed that leptin increased cyclo-oxygenase-2 (COX-2) expression (but not COX-1) in cultured human umbilical vein ECs (HUVEC) through pathways that depend upon activation of both p38 mitogen-activated protein kinase (p38(MAPK)) and Akt, and stimulated rapid phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2) on Tyr(1175). Phosphorylation of VEGFR2, p38(MAPK) and Akt, and COX-2 induction in cells challenged with leptin were blocked by a specific leptin peptide receptor antagonist. Pharmacological inhibitors of COX-2, the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and p38(MAPK) abrogated leptin-induced EC proliferation (assessed by quantifying 5-bromo-2'-deoxyuridine incorporation, calcein fluorescence and propidium iodide staining), slowed the increased migration rate of leptin-stimulated cells (in vitro wound healing assay) and inhibited leptin-induced capillary-like tube formation by HUVEC on Matrigel. Inhibition of VEGFR2 tyrosine kinase activity reduced leptin-stimulated p38(MAPK) and Akt activation, COX-2 induction, and pro-angiogenic EC responses, and blockade of VEGFR2 or COX-2 activities abolished leptin-driven neo-angiogenesis in a chick chorioallantoic membrane vascularisation assay in vivo. Conclusions/Significance: We conclude that a functional endothelial p38(MAPK)/Akt/COX-2 signalling axis is required for leptin's pro-angiogenic actions and that this is regulated upstream by ObRb-dependent activation of VEGFR2. These studies identify a new function for VEGFR2 as a mediator of leptin-stimulated COX-2 expression and angiogenesis and have implications for understanding leptin's regulation of the vasculature in both non-obese and obese individuals.	[Garonna, Elena; Botham, Kathleen M.; Wheeler-Jones, Caroline P. D.] Univ London, Royal Vet Coll, Dept Basic Sci, London, England; [Birdsey, Graeme M.; Randi, Anna M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Vasc Sci Sect, Natl Heart & Lung Inst, London, England; [Gonzalez-Perez, Ruben R.] Morehouse Sch Med, Atlanta, GA 30310 USA	University of London; University of London Royal Veterinary College; Imperial College London; Morehouse School of Medicine	Garonna, E (corresponding author), Univ London, Royal Vet Coll, Dept Basic Sci, London, England.	cwheeler@rvc.ac.uk		Botham, Kathleen/0000-0002-0221-979X; Birdsey, Graeme M./0000-0002-0981-8672	Biotechnology and Biological Sciences Research Council; British Heart Foundation [PG/02/002, PG/07/063/23289]; NIH/NCI [1SC1CA138658-03]; Georgia Cancer Coalition; British Heart Foundation [PG/09/096/28114] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [SC1CA138658] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EG was supported by a studentship from the Biotechnology and Biological Sciences Research Council (to CW-J); http://www.bbsrc.ac.uk/funding/funding-index.aspx. The work was funded principally by grants (to CW-J) from the British Heart Foundation (PG/02/002 and PG/07/063/23289); http://www.bhf.org.uk/research/research-grants.aspx. Synthesis of the leptin antagonist is supported by grants from NIH/NCI 1SC1CA138658-03; the Georgia Cancer Coalition Distinguished Cancer Scholar Award (to RG-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2008, ARTERIOSCL THROM VAS, V28, P2042, DOI 10.1161/ATVBAHA.108.175109; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Bocci G, 2004, EUR J PHARMACOL, V498, P9, DOI 10.1016/j.ejphar.2004.07.062; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cirillo P, 2010, THROMB HAEMOSTASIS, V103, P1065, DOI 10.1160/TH09-06-0392; Clarkin CE, 2008, EXP CELL RES, V314, P3152, DOI 10.1016/j.yexcr.2008.07.027; Dashwood MR, 2011, INTERACT CARDIOV TH, V12, P170, DOI 10.1510/icvts.2010.247874; Eisenberg A, 2004, FEBS LETT, V565, P139, DOI 10.1016/j.febslet.2004.03.089; Elbatarny HS, 2005, AM J PHYSIOL-ENDOC M, V289, pE695, DOI 10.1152/ajpendo.00125.2005; Fischer C, 2006, Handb Exp Pharmacol, P157; Goetze S, 2002, HYPERTENSION, V40, P748, DOI 10.1161/01.HYP.0000035522.63647.D3; Gonzalez RR, 2003, ENDOCRINE, V21, P185, DOI 10.1385/ENDO:21:2:185; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Grethe S, 2006, BIOCHEM BIOPH RES CO, V347, P781, DOI 10.1016/j.bbrc.2006.06.159; Hamdulay SS, 2010, FREE RADICAL BIO MED, V48, P1013, DOI 10.1016/j.freeradbiomed.2010.01.017; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Houliston RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1266, DOI 10.1152/ajpcell.2001.281.4.C1266; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Leahy KM, 2002, CANCER RES, V62, P625; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lewthwaite JC, 2006, J BIOL CHEM, V281, P11011, DOI 10.1074/jbc.M510680200; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Lorenzi O, 2008, J THROMB HAEMOST, V6, P1962, DOI 10.1111/j.1538-7836.2008.03138.x; Matsuda K, 2003, HYPERTENS RES, V26, P147, DOI 10.1291/hypres.26.147; Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Ogunwobi O, 2006, ENDOCRINOLOGY, V147, P4505, DOI 10.1210/en.2006-0224; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Pula G, 2010, ARTERIOSCL THROM VAS, V30, P2631, DOI 10.1161/ATVBAHA.110.215855; Rajapurohitam V, 2003, CIRC RES, V93, P277, DOI 10.1161/01.RES.0000089255.37804.72; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Smith CCT, 2006, BRIT J PHARMACOL, V149, P5, DOI 10.1038/sj.bjp.0706834; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vecchione C, 2002, DIABETES, V51, P168, DOI 10.2337/diabetes.51.1.168; Wheeler-Jones CPD, 2008, PHARMACOL REP, V60, P109; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df	48	76	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18823	10.1371/journal.pone.0018823	http://dx.doi.org/10.1371/journal.pone.0018823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533119	Green Published, Green Submitted, gold			2022-12-27	WOS:000289620100024
J	Brembilla, NC; Ramirez, JM; Chicheportiche, R; Sorg, O; Saurat, JH; Chizzolini, C				Brembilla, Nicolo Costantino; Ramirez, Jean-Marie; Chicheportiche, Rachel; Sorg, Olivier; Saurat, Jean-Hilaire; Chizzolini, Carlo			In Vivo Dioxin Favors Interleukin-22 Production by Human CD4+T Cells in an Aryl Hydrocarbon Receptor (AhR)-Dependent Manner	PLOS ONE			English	Article							T-CELLS; CUTTING EDGE; IL-22; ACTIVATION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; DIFFERENTIATION; INFLAMMATION; POPULATION; DISTINCT; SUBSET	In Background: The transcription factor aryl hydrocarbon receptor (AhR) mediates the effects of a group of chemicals known as dioxins, ubiquitously present in our environment. However, it is poorly known how the in vivo exposure to these chemicals affects in humans the adaptive immune response. We therefore assessed the functional phenotype of T cells from an individual who developed a severe cutaneous and systemic syndrome after having been exposed to an extremely high dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Methodology/Principal Findings: T cells of the TCDD-exposed individual were studied for their capacity to produce cytokines in response to polyclonal and superantigenic stimulation, and for the expression of chemokine receptors involved in skin homing. The supernatants from T cells of the exposed individual contained a substantially increased amount of interleukin (IL)-22 but not of IL-17A, interferon (IFN)-gamma or IL-10 when compared to nine healthy controls. In vitro experiments confirmed a direct, AhR-dependent, enhancing effect of TCDD on IL-22 production by CD4+ T cells. The increased production of IL-22 was not dependent on AhR occupancy by residual TCDD molecules, as demonstrated in competition experiments with the specific AhR antagonist CH-223191. In contrast, it was due to an increased frequency of IL-22 single producing cells accompanied by an increased percentage of cells expressing the skin-homing chemokine receptors CCR6 and CCR4, identified through a multiparameter flow cytometry approach. Of interest, the frequency of CD4+ CD25 (hi)FoxP3+ T regulatory cells was similar in the TCDD-exposed and healthy individuals. Conclusions/Significance: This case strongly supports the contention that human exposure to persistent AhR ligands in vivo induce a long-lasting effect on the human adaptive immune system and specifically polarizes CD4+ T cells to produce IL-22 and not other T cell cytokines with no effect on T regulatory cells.	[Brembilla, Nicolo Costantino; Ramirez, Jean-Marie; Chicheportiche, Rachel; Chizzolini, Carlo] Univ Hosp, Dept Immunol & Allergy, Swiss Ctr Appl Human Toxicol, Geneva, Switzerland; [Brembilla, Nicolo Costantino; Ramirez, Jean-Marie; Chicheportiche, Rachel; Sorg, Olivier; Saurat, Jean-Hilaire; Chizzolini, Carlo] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Sorg, Olivier; Saurat, Jean-Hilaire] Univ Hosp, Dept Dermatotoxicol, Swiss Ctr Appl Human Toxicol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Brembilla, NC (corresponding author), Univ Hosp, Dept Immunol & Allergy, Swiss Ctr Appl Human Toxicol, Geneva, Switzerland.	nicolo.brembilla@hcuge.ch	Chizzolini, Carlo/V-4847-2019		Swiss National Science Foundation [31003A_124941/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grant 31003A_124941/1 from the Swiss National Science Foundation to C. C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Aylward LL, 2005, J EXPO ANAL ENV EPID, V15, P51, DOI 10.1038/sj.jea.7500370; Birnbaum LS, 2000, FOOD ADDIT CONTAM A, V17, P275, DOI 10.1080/026520300283351; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Brouwer A., 2005, ORGANOHALOGEN COMPOU, V67, P1705; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Deringer JR, 1996, MOL MICROBIOL, V22, P523, DOI 10.1046/j.1365-2958.1996.1381506.x; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fitzhugh DJ, 2000, J IMMUNOL, V165, P6677, DOI 10.4049/jimmunol.165.12.6677; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Michalek JE, 2002, J EXPO ANAL ENV EPID, V12, P44, DOI 10.1038/sj.jea.7500201; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Saurat JH, 2010, DERMATOLOGY, V221, P23, DOI 10.1159/000290672; Schecter A, 2001, J TOXICOL ENV HEAL A, V63, P1, DOI 10.1080/152873901750128326; Schecter A, 2006, ENVIRON RES, V101, P419, DOI 10.1016/j.envres.2005.12.003; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Sorg O, 2009, LANCET, V374, P1179, DOI 10.1016/S0140-6736(09)60912-0; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; STEELE EJ, 1990, TOXICOL LETT, V51, P261, DOI 10.1016/0378-4274(90)90068-W; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yoshimura T, 2003, IND HEALTH, V41, P139, DOI 10.2486/indhealth.41.139; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	41	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18741	10.1371/journal.pone.0018741	http://dx.doi.org/10.1371/journal.pone.0018741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525997	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600026
J	Kwon, HJ; Palnitkar, M; Deisenhofer, J				Kwon, Hyock Joo; Palnitkar, Maya; Deisenhofer, Johann			The Structure of the NPC1L1 N-Terminal Domain in a Closed Conformation	PLOS ONE			English	Article							CHOLESTEROL ABSORPTION; BINDING; EZETIMIBE; PROTEIN; REVEALS; TARGET	Background: NPC1L1 is the molecular target of the cholesterol lowering drug Ezetimibe and mediates the intestinal absorption of cholesterol. Inhibition or deletion of NPC1L1 reduces intestinal cholesterol absorption, resulting in reduction of plasma cholesterol levels. Principal Findings: Here we present the 2.8 angstrom crystal structure of the N-terminal domain (NTD) of NPC1L1 in the absence of cholesterol. The structure, combined with biochemical data, reveals the mechanism of cholesterol selectivity of NPC1L1. Comparison to the cholesterol free and bound structures of NPC1(NTD) reveals that NPC1L1(NTD) is in a closed conformation and the sterol binding pocket is occluded from solvent. Conclusion: The structure of NPC1L1(NTD) reveals a degree of flexibility surrounding the entrance to the sterol binding pocket, suggesting a gating mechanism that relies on multiple movements around the entrance to the sterol binding pocket.	[Kwon, Hyock Joo; Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Palnitkar, Maya; Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kwon, HJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	hyockjoo.kwon@gmail.com; johann.deisenhofer@utsouthwestern.edu			Welch Foundation [I-1185]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Welch Foundation(The Welch Foundation); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported in part by Welch Foundation Grant I-1185 (to J.D). J.D. is an Investigator in the Howard Hughes Medical Institute. Results shown in this article are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dixit SS, 2007, BIOCHEM J, V408, P1, DOI 10.1042/BJ20071167; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Haikal Z, 2008, LIPIDS, V43, P401, DOI 10.1007/s11745-008-3172-7; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; LUTJOHANN D, 1995, J LIPID RES, V36, P1763; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamanashi Y, 2007, J PHARMACOL EXP THER, V320, P559, DOI 10.1124/jpet.106.114181; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	23	41	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18722	10.1371/journal.pone.0018722	http://dx.doi.org/10.1371/journal.pone.0018722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525977	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600024
J	Skjorringe, T; Tumer, Z; Moller, LB				Skjorringe, Tina; Tumer, Zeynep; Moller, Lisbeth Birk			Splice Site Mutations in the ATP7A Gene	PLOS ONE			English	Article							OCCIPITAL-HORN-SYNDROME; CLASSICAL MENKES-DISEASE; JAPANESE PATIENTS; MESSENGER-RNA; IDENTIFICATION; PHENOTYPE; DIAGNOSIS; LEAD	Menkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate 12 mutations for their effect on the mRNA transcript in vivo. Transcriptional data from another 16 mutations were collected from the literature. The theoretical consequences of splice site mutations, predicted with the bioinformatics tool Human Splice Finder, were investigated and evaluated in relation to in vivo results. Ninety-six percent of the mutations identified in 45 patients with classical MD were predicted to have a significant effect on splicing, which concurs with the absence of any detectable wild-type transcript in all 19 patients investigated in vivo. Sixty-seven percent of the mutations identified in 12 patients with milder phenotypes were predicted to have no significant effect on splicing, which concurs with the presence of wild-type transcript in 7 out of 9 patients investigated in vivo. Both the in silico predictions and the in vivo results support the hypothesis previously suggested by us and others, that the presence of some wild-type transcript is correlated to a milder phenotype.	[Skjorringe, Tina; Tumer, Zeynep; Moller, Lisbeth Birk] Kennedy Ctr, Dept Appl Funct Human Genet, Glostrup, Denmark		Skjorringe, T (corresponding author), Kennedy Ctr, Dept Appl Funct Human Genet, Glostrup, Denmark.	lbm@kennedy.dk	Tumer, Zeynep/AAF-8501-2019; Tümer, Zeynep/C-4235-2014	Tumer, Zeynep/0000-0002-4777-5802; Moller, Lisbeth/0000-0002-9524-4301				BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Grange DK, 2005, AM J MED GENET A, V139A, P151, DOI 10.1002/ajmg.a.31001; Gu YH, 2001, AM J MED GENET, V99, P217, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1167>3.0.CO;2-R; Hubner CA, 2005, NEUROSCIENCE, V132, P697, DOI 10.1016/j.neuroscience.2005.01.042; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2008, NEW ENGL J MED, V358, P605, DOI 10.1056/NEJMoa070613; Moller LB, 2005, HUM MUTAT, V26, P84, DOI 10.1002/humu.20190; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Noordzij JG, 2002, J CLIN IMMUNOL, V22, P306, DOI 10.1023/A:1019982206951; Ogawa A, 1999, J HUM GENET, V44, P206, DOI 10.1007/s100380050144; Qi M, 1998, HUM MOL GENET, V7, P465, DOI 10.1093/hmg/7.3.465; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tumer Z, 1997, AM J HUM GENET, V60, P63; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Varon R, 2006, HUM MOL GENET, V15, P679, DOI 10.1093/hmg/ddi482; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Watanabe A, 2005, PEDIATR INT, V47, P1, DOI 10.1111/j.1442-200x.2004.02012.x	27	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18599	10.1371/journal.pone.0018599	http://dx.doi.org/10.1371/journal.pone.0018599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494555	Green Submitted, Green Published, gold			2022-12-27	WOS:000289354100025
J	Feng, RN; Zhao, C; Sun, CH; Li, Y				Feng, Ren-Nan; Zhao, Chen; Sun, Chang-Hao; Li, Ying			Meta-Analysis of TNF 308 G/A Polymorphism and Type 2 Diabetes Mellitus	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA GENE; CORONARY-HEART-DISEASE; PROMOTER POLYMORPHISM; INSULIN-RESISTANCE; G-308A POLYMORPHISM; METABOLIC SYNDROME; JAPANESE PATIENTS; ASSOCIATION; OBESITY	Background and Objectives: Many investigations have focused the association between TNF 308 G/A polymorphism and risk for type 2 diabetes mellitus (T2DM). However, the sample sizes of most of the studies were small. The aim of this study is to evaluate the precise association between this variant and risk for T2DM in a large-scale meta-analysis. Methods: All publications were searched on the association between TNF 308 G/A polymorphism and T2DM. The key words were as follows: diabetes, tumor necrosis factor and polymorphism/variant/genotype. This meta-analysis was assessed by Review manager 5.0. Results: There were 18 studies identified. The odd ritos (ORs) and 95% confidence intervals (CI) for GA+AA versus GG genotype of TNF 308 G/A polymorphism were 1.03 (0.95-1.12), 1.03 (0.94-1.13) and 1.03 (0.78-1.36) in overall, Caucasian and Asian populations, respectively. The sensitivity analysis further strengthened the validity of this association. No publication bias or heterogeneity was observed in this study. Conclusion: In summary, there was no significant association detected between the TNF 308 G/A polymorphism and risk for T2DM.	[Feng, Ren-Nan; Zhao, Chen; Sun, Chang-Hao; Li, Ying] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China	Harbin Medical University	Feng, RN (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China.	sun2001changhao@yahoo.com; liying2002helen@gmail.com	SUN, CHANG/GXM-3680-2022		National Natural Science Fund of China [30771804, 30872104]; Harbin Special Fund for the Technology Innovation Researchers [2009RFLXS203]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Harbin Special Fund for the Technology Innovation Researchers	This research was supported by the National Natural Science Fund of China (No. 30771804 and 30872104) and the Harbin Special Fund for the Technology Innovation Researchers (No. 2009RFLXS203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminkeng F, 2007, HUM IMMUNOL, V68, P690, DOI 10.1016/j.humimm.2007.05.001; Boraska V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-69; Bouhaha R, 2010, CLIN BIOCHEM, V43, P549, DOI 10.1016/j.clinbiochem.2010.01.008; Brand E, 2001, INT J OBESITY, V25, P581, DOI 10.1038/sj.ijo.0801576; Dahlen E, 1998, J IMMUNOL, V160, P3585; Dalziel B, 2002, OBES RES, V10, P401, DOI 10.1038/oby.2002.55; FENG R, 2009, ACTA DIABETOL; Feng Ren-Nan, 2009, Diabetes Res Clin Pract, V85, pe4, DOI 10.1016/j.diabres.2009.04.026; Furuta M, 2002, DIABETES RES CLIN PR, V56, P141, DOI 10.1016/S0168-8227(01)00358-8; HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887; Heijmans BT, 2002, GENES IMMUN, V3, P225, DOI 10.1038/sj.gene.6363859; Herrmann SM, 1998, EUR J CLIN INVEST, V28, P59; Hoffstedt J, 2000, DIABETOLOGIA, V43, P117, DOI 10.1007/s001250050015; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ishii T, 2000, METABOLISM, V49, P1616, DOI 10.1053/meta.2000.18560; Kim Hye Ryoun, 2006, Korean J Lab Med, V26, P58; Ko GTC, 2003, DIABETIC MED, V20, P167, DOI 10.1046/j.1464-5491.2003.00829_1.x; Lee SC, 2000, METABOLISM, V49, P1021, DOI 10.1053/meta.2000.7704; Li HY, 2003, J CLIN ENDOCR METAB, V88, P2767, DOI 10.1210/jc.2002-020506; Lindholm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002546; Liu HL, 2008, EUR J CLIN PHARMACOL, V64, P663, DOI 10.1007/s00228-008-0483-9; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Morris AM, 2003, DIABETES RES CLIN PR, V62, P197, DOI 10.1016/j.diabres.2003.08.002; Nishimura M, 2003, HUM IMMUNOL, V64, P302, DOI 10.1016/S0198-8859(02)00799-1; Padovani JC, 2000, THROMB RES, V100, P263, DOI 10.1016/S0049-3848(00)00315-7; POCIOT F, 1993, EUR J IMMUNOL, V23, P3050, DOI 10.1002/eji.1830231148; Santos JL, 2006, REV MED CHILE, V134, P1099; Shiau MY, 2003, TISSUE ANTIGENS, V61, P393, DOI 10.1034/j.1399-0039.2003.00059.x; Sookoian SC, 2005, OBES RES, V13, P2122, DOI 10.1038/oby.2005.263; Tsiavou A, 2004, J CLIN IMMUNOL, V24, P591, DOI 10.1007/s10875-004-6239-0; Vendrell J, 2003, ATHEROSCLEROSIS, V167, P257, DOI 10.1016/S0021-9150(02)00429-X; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; WU XW, 1992, HUM IMMUNOL, V33, P89, DOI 10.1016/0198-8859(92)90058-U; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zeggini E, 2005, DIABETOLOGIA, V48, P2013, DOI 10.1007/s00125-005-1902-4	37	85	89	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18480	10.1371/journal.pone.0018480	http://dx.doi.org/10.1371/journal.pone.0018480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494616	gold, Green Submitted, Green Published			2022-12-27	WOS:000289292800023
J	Hardiess, G; Basten, K; Mallot, HA				Hardiess, Gregor; Basten, Kai; Mallot, Hanspeter A.			Acquisition vs. Memorization Trade-Offs Are Modulated by Walking Distance and Pattern Complexity in a Large-Scale Copying Paradigm	PLOS ONE			English	Article							SHORT-TERM-MEMORY; VISUAL WORKING-MEMORY; INTERACTIVE BEHAVIOR; SOFT CONSTRAINTS; CAPACITY; INFORMATION; STORAGE; EYE; COORDINATION; CONJUNCTIONS	In a "block-copying paradigm", subjects were required to copy a configuration of colored blocks from a model area to a distant work area, using additional blocks provided at an equally distant resource area. Experimental conditions varied between the inter-area separation (walking distance) and the complexity of the block patterns to be copied. Two major behavioral strategies were identified: in the memory-intensive strategy, subjects memorize large parts of the pattern and rebuild them without intermediate visits at the model area. In the acquisition-intensive strategy, subjects memorize one block at a time and return to the model after having placed this block. Results show that the frequency of the memory-intensive strategy is increased for larger inter-area separations (larger walking distances) and for simpler block patterns. This strategy-shift can be interpreted as the result of an optimization process or trade-off, minimizing combined, condition-dependent costs of the two strategies. Combined costs correlate with overall response time. We present evidence that for the memory-intensive strategy, costs correlate with model visit duration, while for the acquisition-intensive strategy, costs correlate with inter-area transition (i.e., walking) times.	[Hardiess, Gregor] Univ Tubingen, Dept Biol, Tubingen, Germany; Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hardiess, G (corresponding author), Univ Tubingen, Dept Biol, Tubingen, Germany.	gregor.hardiess@uni-tuebingen.de	Mallot, Hanspeter A/H-7888-2016		Werner Reichardt Center for Integrative Neuroscience (CIN)	Werner Reichardt Center for Integrative Neuroscience (CIN)	This research was partially supported by the Deutsche Forschungsgemeinschaft within the Werner Reichardt Center for Integrative Neuroscience (CIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Ardila A, 2008, BRAIN COGNITION, V68, P92, DOI 10.1016/j.bandc.2008.03.003; Baddeley AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Barrouillet P, 2009, TRENDS COGN SCI, V13, P145, DOI 10.1016/j.tics.2009.01.002; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Carpenter RHS, 1988, MOVEMENTS EYES; Cary M, 1999, J EXP PSYCHOL LEARN, V25, P1053, DOI 10.1037/0278-7393.25.4.1053; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Droll JA, 2007, J EXP PSYCHOL HUMAN, V33, P1352, DOI 10.1037/0096-1523.33.6.1352; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Gray WD, 2005, COGN SYST RES, V6, P27, DOI 10.1016/j.cogsys.2004.09.004; Gray WD, 2004, COGNITIVE SCI, V28, P359, DOI 10.1016/j.cogsci.2003.12.001; Hardiess G, 2008, J VISION, V8, DOI 10.1167/8.1.7; Haxby JV, 2000, NEUROIMAGE, V11, P380, DOI 10.1006/nimg.2000.0592; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Inamdar S, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P599; Irwin DE., 1996, ATTENTION PERFORM, P125; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria A. R., 2012, HIGHER CORTICAL FUNC; Luria A.R., 1966, HUMAN BRAIN PSYCHOL; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; McAfoose J, 2009, NEUROPSYCHOL REV, V19, P130, DOI 10.1007/s11065-008-9063-0; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Montojo CA, 2008, NEURON, V59, P173, DOI 10.1016/j.neuron.2008.05.012; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Ploner CJ, 1998, EUR J NEUROSCI, V10, P794, DOI 10.1046/j.1460-9568.1998.00101.x; RAYNER K, 1995, STUD VIS INFORM PROC, V6, P3; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; SIMON HA, 1974, SCIENCE, V183, P482, DOI 10.1126/science.183.4124.482; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Xu YD, 2002, PERCEPT PSYCHOPHYS, V64, P1260, DOI 10.3758/BF03194770; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	42	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18494	10.1371/journal.pone.0018494	http://dx.doi.org/10.1371/journal.pone.0018494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	747AP	21494620	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800026
J	Van Raay, TJ; Fortino, NJ; Miller, BW; Ma, HT; Lau, G; Li, CX; Franklin, JL; Attisano, L; Solnica-Krezel, L; Coffey, RJ				Van Raay, Terence J.; Fortino, Nicholas J.; Miller, Bryan W.; Ma, Haiting; Lau, Garnet; Li, Cunxi; Franklin, Jeffery L.; Attisano, Liliana; Solnica-Krezel, Lilianna; Coffey, Robert J.			Naked1 Antagonizes Wnt Signaling by Preventing Nuclear Accumulation of beta-Catenin	PLOS ONE			English	Article							PLASMA-MEMBRANE; STEM-CELLS; IN-VIVO; EXOCYTIC VESICLES; CUTICLE NKD; ZEBRAFISH; PROTEINS; PATHWAY; DEGRADATION; EXPRESSION	Cyto-nuclear shuttling of beta-catenin is at the epicenter of the canonical Wnt pathway and mutations in genes that result in excessive nuclear accumulation of beta-catenin are the driving force behind the initiation of many cancers. Recently, Naked Cuticle homolog 1 (Nkd1) has been identified as a Wnt-induced intracellular negative regulator of canonical Wnt signaling. The current model suggests that Nkd1 acts between Disheveled (Dvl) and beta-catenin. Here, we employ the zebrafish embryo to characterize the cellular and biochemical role of Nkd1 in vivo. We demonstrate that Nkd1 binds to beta-catenin and prevents its nuclear accumulation. We also show that this interaction is conserved in mammalian cultured cells. Further, we demonstrate that Nkd1 function is dependent on its interaction with the cell membrane. Given the conserved nature of Nkd1, our results shed light on the negative feedback regulation of Wnt signaling through the Nkd1-mediated negative control of nuclear accumulation of beta-catenin.	[Van Raay, Terence J.; Li, Cunxi; Franklin, Jeffery L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Van Raay, Terence J.; Ma, Haiting; Solnica-Krezel, Lilianna] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Van Raay, Terence J.; Fortino, Nicholas J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Miller, Bryan W.; Lau, Garnet; Attisano, Liliana] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Miller, Bryan W.; Lau, Garnet; Attisano, Liliana] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Franklin, Jeffery L.; Solnica-Krezel, Lilianna; Coffey, Robert J.] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN USA; [Solnica-Krezel, Lilianna] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; University of Guelph; University of Toronto; University of Toronto; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Van Raay, TJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	tvanraay@uoguelph.ca; robert.coffey@vanderbilt.edu	Van Raay, Terry/AAA-7342-2021	Van Raay, Terence/0000-0003-0196-1041	University of Guelph; Canadian Foundation for Innovation; Canadian Cancer Society; National Institutes of Health (NIH) [GM55101]; NCI [CA46413]; Solnica-Krezel; Coffey; Attisano; Attisano and Van Raay labs; NATIONAL CANCER INSTITUTE [R01CA046413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055101] Funding Source: NIH RePORTER	University of Guelph; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Solnica-Krezel; Coffey; Attisano; Attisano and Van Raay labs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TVR acknowledges support from the University of Guelph and the Canadian Foundation for Innovation; LA acknowledges support from the Canadian Cancer Society; LSK acknowledges the support of National Institutes of Health (NIH) RO1 grant GM55101; RJC acknowledges the support of NCI CA46413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank members of the Solnica-Krezel, Coffey, Attisano and Van Raay labs for support and valuable comments.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Chan CC, 2007, DEV BIOL, V311, P538, DOI 10.1016/j.ydbio.2007.09.002; Chang JL, 2008, DEV BIOL, V321, P446, DOI 10.1016/j.ydbio.2008.05.551; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Ding W, 2008, P NATL ACAD SCI USA, V105, P13433, DOI 10.1073/pnas.0806298105; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fan LC, 2006, METHOD ENZYMOL, V418, P64, DOI 10.1016/S0076-6879(06)18004-0; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Guo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007982; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KANE DA, 1993, DEVELOPMENT, V119, P447; Katoh M, 2001, INT J ONCOL, V19, P963; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Lei HY, 2007, J EXP ZOOL PART A, V307A, P1, DOI 10.1002/jez.a.327; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Miller BW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.72; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rousset R, 2002, J BIOL CHEM, V277, P49019, DOI 10.1074/jbc.M203246200; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Schmidt C, 2006, ANAT EMBRYOL, V211, P525, DOI 10.1007/s00429-006-0102-4; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Waldrop S, 2006, GENETICS, V174, P331, DOI 10.1534/genetics.106.061853; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07	56	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18650	10.1371/journal.pone.0018650	http://dx.doi.org/10.1371/journal.pone.0018650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490931	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700033
J	Ban, HJ; Kim, SC; Seo, J; Kang, HB; Choi, JK				Ban, Hyo-Jeong; Kim, Sang Cheol; Seo, Jungmin; Kang, Ho-Bum; Choi, Jung Kyoon			Genetic and Metabolic Characterization of Insomnia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RESTLESS-LEGS-SYNDROME; BIPOLAR-DISORDER; SCHIZOAFFECTIVE DISORDER; CALCIUM; SCHIZOPHRENIA; EXPRESSION; SLEEP; TRANSCRIPTION; DISRUPTION	Insomnia is reported to chronically affect 10 similar to 15% of the adult population. However, very little is known about the genetics and metabolism of insomnia. Here we surveyed 10,038 Korean subjects whose genotypes have been previously profiled on a genome-wide scale. About 16.5% reported insomnia and displayed distinct metabolic changes reflecting an increase in insulin secretion, a higher risk of diabetes, and disrupted calcium signaling. Insomnia-associated genotypic differences were highly concentrated within genes involved in neural function. The most significant SNPs resided in ROR1 and PLCB1, genes known to be involved in bipolar disorder and schizophrenia, respectively. Putative enhancers, as indicated by the histone mark H3K4me1, were discovered within both genes near the significant SNPs. In neuronal cells, the enhancers were bound by PAX6, a neural transcription factor that is essential for central nervous system development. Open chromatin signatures were found on the enhancers in human pancreas, a tissue where PAX6 is known to play a role in insulin secretion. In PLCB1, CTCF was found to bind downstream of the enhancer and interact with PAX6, suggesting that it can probably inhibit gene activation by PAX6. PLCB4, a circadian gene that is closely located downstream of PLCB1, was identified as a candidate target gene. Hence, dysregulation of ROR1, PLCB1, or PLCB4 by PAX6 and CTCF may be one mechanism that links neural and pancreatic dysfunction not only in insomnia but also in the relevant psychiatric disorders that are accompanied with circadian rhythm disruption and metabolic syndrome.	[Ban, Hyo-Jeong] Korea Ctr Dis Control & Prevent, Div Biomed Informat, Ctr Genome Sci, Natl Inst Hlth, Choongchung Buk Do, South Korea; [Kim, Sang Cheol] Yonsei Univ, Dept Appl Stat, Seoul 120749, South Korea; [Seo, Jungmin] Korea Res Inst Biosci & Biotechnol, BVC, Res Inst Bioinformat, Omicsis Inc, Taejon, South Korea; [Kang, Ho-Bum] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Choi, Jung Kyoon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Jung Kyoon] Genome Inst Singapore, Singapore, Singapore	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ban, HJ (corresponding author), Korea Ctr Dis Control & Prevent, Div Biomed Informat, Ctr Genome Sci, Natl Inst Hlth, Choongchung Buk Do, South Korea.	jungkyoon@kaist.ac.kr	Choi, Jung Kyoon/C-2070-2011					Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Basu R, 2004, BIPOLAR DISORD, V6, P314, DOI 10.1111/j.1399-5618.2004.00126.x; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Hanahisa Y, 1996, MOL CELL BIOCHEM, V158, P1; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong HX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S17; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; JOBORN C, 1991, PSYCHONEUROENDOCRINO, V16, P311, DOI 10.1016/0306-4530(91)90017-N; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Katayama T, 2009, PHARMACOGENOMICS, V10, P1967, DOI [10.2217/pgs.09.147, 10.2217/PGS.09.147]; Klein DC, 2010, MOL CELL ENDOCRINOL, V314, P170, DOI 10.1016/j.mce.2009.07.010; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; MARCHEVA B, 2010, NATURE; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; MCINTYRE RS, 2010, J AFFECT DISORD; McOmish CE, 2008, HIPPOCAMPUS, V18, P824, DOI 10.1002/hipo.20443; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Paganoni S, 2010, NEUROSCIENCE, V165, P1261, DOI 10.1016/j.neuroscience.2009.11.056; Park D, 2003, NAT NEUROSCI, V6, P337, DOI 10.1038/nn1033; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reijo T, 2008, J AM GERIATR SOC, V56, P1573, DOI 10.1111/j.1532-5415.2008.01774.x; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Shin J, 2005, P NATL ACAD SCI USA, V102, P18165, DOI 10.1073/pnas.0505498102; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Tournier-Lasserve E, 1999, NEUROLOGY, V53, P3, DOI 10.1212/WNL.53.1.3; Watson NF, 2006, SLEEP, V29, P645, DOI 10.1093/sleep/29.5.645; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yamamoto N, 2010, J AM GERIATR SOC, V58, P801, DOI 10.1111/j.1532-5415.2010.02794.x; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888	38	37	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18455	10.1371/journal.pone.0018455	http://dx.doi.org/10.1371/journal.pone.0018455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494683	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400029
J	Hossain, M; Khan, AY; Kumar, GS				Hossain, Maidul; Khan, Asma Yasmeen; Kumar, Gopinatha Suresh			Interaction of the Anticancer Plant Alkaloid Sanguinarine with Bovine Serum Albumin	PLOS ONE			English	Article							DRUG BINDING-SITES; BENZOPHENANTHRIDINE ALKALOIDS; SPECTROSCOPIC APPROACH; ALKANOLAMINE FORM; MOLECULAR ASPECTS; INDUCED APOPTOSIS; DOWN-REGULATION; BCL-2 FAMILY; FLUORESCENCE; CELLS	Background: Interaction of the iminium and alkanolamine forms of sanguinarine with bovine serum albumin (BSA) was characterized by spectroscopic and calorimetric techniques. Methodology/Principal Findings: Formation of strong complexes of BSA with both iminium and alkanolamine forms was revealed from fluorescence quenching of sanguinarine. Binding parameters calculated from Stern-Volmer quenching method revealed that the neutral alkanolamine had higher affinity to BSA compared to the charged iminium form. Specific binding distances of 3.37 and 2.38 nm between Trp 212 (donor) and iminium and alkanolamine forms (acceptor), respectively, were obtained from Forster resonance energy transfer studies. Competitive binding using the site markers warfarin and ibuprofen, having definite binding sites, demonstrated that both forms of sanguinarine bind to site I (subdomain IIA) on BSA. Sanguinarine binding alters protein conformation by reducing the alpha-helical organization and increasing the coiled structure, indicating a small but definitive partial unfolding of the protein. Thermodynamic parameters evaluated from isothermal titration calorimetry suggested that the binding was enthalpy driven for the iminium form but favoured by negative enthalpy and strong favourable entropy contributions for the alkanolamine form, revealing the involvement of different molecular forces in the complexation. Conclusions/Significance: The results suggest that the neutral alkanolamine form binds to the protein more favourably compared to the charged iminium, in stark contrast to the reported DNA binding preference of sanguinarine.	[Hossain, Maidul; Khan, Asma Yasmeen; Kumar, Gopinatha Suresh] CSIR, Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Hossain, M (corresponding author), CSIR, Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, W Bengal, India.	gskumar@iicb.res.in	Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; Hossain, Maidul/AAW-7669-2021	Kumar, Dr Suresh/0000-0002-2539-6553; Hossain, Maidul/0000-0003-1408-2273	Council of Scientific and Industrial Research, Government of India [NWP0036]; University Grants Commission, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by grants from the project NWP0036 of the Council of Scientific and Industrial Research, Government of India, University Grants Commission, Government of India fellowship (to AYK). This work was performed during the tenure of MH as a Project Associate under NWP0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2004, MOL CANCER THER, V3, P933; Ahsan H, 2007, CANCER LETT, V249, P198, DOI 10.1016/j.canlet.2006.08.018; BHADRA K, 2011, MED RES REV IN PRESS; Bhadra K, 2011, BBA-GEN SUBJECTS, V1810, P485, DOI 10.1016/j.bbagen.2011.01.011; Bojko B, 2010, J PHARMACEUT BIOMED, V52, P384, DOI 10.1016/j.jpba.2009.09.004; Bose D, 2010, PHOTOCHEM PHOTOBIOL, V86, P538, DOI 10.1111/j.1751-1097.2009.00688.x; Bourassa P, 2010, J PHYS CHEM B, V114, P3348, DOI 10.1021/jp9115996; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chowdhury SR, 2010, MOL BIOSYST, V6, P1265, DOI 10.1039/b927001a; Cyril L., 1961, BIOCH HDB; DALVI RR, 1985, EXPERIENTIA, V41, P77, DOI 10.1007/BF02005884; Debiton E, 2003, CANCER CHEMOTH PHARM, V51, P474, DOI 10.1007/s00280-003-0609-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Foster J.F, 1977, ALBUMIN STRUCTURE FU, VFunction and Uses; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Giri P, 2010, MOL BIOSYST, V6, P81, DOI 10.1039/b910706a; GODOWSKI K C, 1989, Journal of Clinical Dentistry, V1, P96; Graf TN, 2007, J AGR FOOD CHEM, V55, P1205, DOI 10.1021/jf062498f; Han MH, 2007, ANTI-CANCER DRUG, V18, P913; Han XL, 2009, SPECTROCHIM ACTA A, V74, P781, DOI 10.1016/j.saa.2009.08.018; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hedoux A, 2009, J PHYS CHEM B, V113, P6119, DOI 10.1021/jp900330r; Hu YJ, 2010, J LUMIN, V130, P1394, DOI 10.1016/j.jlumin.2010.02.053; Hu YJ, 2010, PROTEIN J, V29, P234, DOI 10.1007/s10930-010-9244-6; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Katrahalli U, 2010, J LUMIN, V130, P211, DOI 10.1016/j.jlumin.2009.07.033; Kim S, 2008, J CELL BIOCHEM, V104, P895, DOI 10.1002/jcb.21672; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LENFELD J, 1981, PLANTA MED, V43, P161, DOI 10.1055/s-2007-971493; Liu BS, 2010, J LUMIN, V130, P859, DOI 10.1016/j.jlumin.2009.12.014; Maiti M, 2002, J BIOMOL STRUCT DYN, V20, P455, DOI 10.1080/07391102.2002.10506864; MAITI M, 1983, PHOTOCHEM PHOTOBIOL, V38, P245, DOI 10.1111/j.1751-1097.1983.tb03869.x; Maiti M, 2007, TOP HETEROCYCL CHEM, V10, P155, DOI 10.1007/7081_2007_071; Maiti M, 2007, MED RES REV, V27, P649, DOI 10.1002/med.20087; Maiti Motilal, 2009, Biophys Rev, V1, P119, DOI 10.1007/s12551-009-0014-7; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; MAURICE RE, 1981, ANAL BIOCHEM, V114, P199, DOI DOI 10.1016/0003-2697(81)90474-7; Monti S, 2009, PHYS CHEM CHEM PHYS, V11, P9104, DOI 10.1039/b906021a; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; O'Brien R, 1998, J MOL BIOL, V279, P117, DOI 10.1006/jmbi.1998.1743; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T, 1996, ALL ALBUMINS BIOCH G; Sahoo BK, 2008, BIOPHYS CHEM, V132, P81, DOI 10.1016/j.bpc.2007.10.007; SEN A, 1994, BIOCHEM PHARMACOL, V48, P2097, DOI 10.1016/0006-2952(94)90510-X; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sun Meng, 2010, Genes Cancer, V1, P283, DOI 10.1177/1947601910368849; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Thoppil AA, 2008, BIOPOLYMERS, V89, P831, DOI 10.1002/bip.21021; Uversky VN, 1997, BIOCHEMISTRY-US, V36, P13638, DOI 10.1021/bi970332p; Valeur B., 2001, NEW TRENDS FLUORESCE, VThird; Vogel M, 2010, J BIOL CHEM, V285, P18397, DOI 10.1074/jbc.M109.088989; WANWIMOLRUK S, 1983, MOL PHARMACOL, V24, P458; Zhang GW, 2010, SPECTROCHIM ACTA A, V76, P410, DOI 10.1016/j.saa.2010.04.009; Zhang QL, 2010, J PHARMACEUT BIOMED, V52, P280, DOI 10.1016/j.jpba.2010.01.006	62	72	72	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18333	10.1371/journal.pone.0018333	http://dx.doi.org/10.1371/journal.pone.0018333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494677	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400020
J	Deyle, ER; Sugihara, G				Deyle, Ethan R.; Sugihara, George			Generalized Theorems for Nonlinear State Space Reconstruction	PLOS ONE			English	Article							ECOLOGICAL TIME-SERIES; DELAY EMBEDDINGS; FORCED SYSTEMS; CHAOS; FLUCTUATIONS; PREDICTION; CLIMATE; ERROR	Takens' theorem (1981) shows how lagged variables of a single time series can be used as proxy variables to reconstruct an attractor for an underlying dynamic process. State space reconstruction (SSR) from single time series has been a powerful approach for the analysis of the complex, non-linear systems that appear ubiquitous in the natural and human world. The main shortcoming of these methods is the phenomenological nature of attractor reconstructions. Moreover, applied studies show that these single time series reconstructions can often be improved ad hoc by including multiple dynamically coupled time series in the reconstructions, to provide a more mechanistic model. Here we provide three analytical proofs that add to the growing literature to generalize Takens' work and that demonstrate how multiple time series can be used in attractor reconstructions. These expanded results (Takens' theorem is a special case) apply to a wide variety of natural systems having parallel time series observations for variables believed to be related to the same dynamic manifold. The potential information leverage provided by multiple embeddings created from different combinations of variables (and their lags) can pave the way for new applied techniques to exploit the time-limited, but parallel observations of natural systems, such as coupled ecological systems, geophysical systems, and financial systems. This paper aims to justify and help open this potential growth area for SSR applications in the natural sciences.	[Deyle, Ethan R.; Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Deyle, ER (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Deyle, Ethan R/AAR-8749-2021		National Science Foundation (NSF) [DEB1020372]; NSF-NOAA [NA08OAR4320894/CAMEO]; EPA-STAR; Sugihara Family Trust; Deutsche Bank-Jameson Complexity Studies Fund; McQuown Chair in Natural Sciences, University of California San Diego	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF-NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); EPA-STAR(United States Environmental Protection Agency); Sugihara Family Trust; Deutsche Bank-Jameson Complexity Studies Fund; McQuown Chair in Natural Sciences, University of California San Diego	This work was supported by National Science Foundation (NSF) DEB1020372, NSF-NOAA CAMEO program (a partnership between the NSF and NOAA) NA08OAR4320894/CAMEO, EPA-STAR Fellowship, Sugihara Family Trust, Deutsche Bank-Jameson Complexity Studies Fund, and the McQuown Chair in Natural Sciences, University of California San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brock W.A., 1991, NONLINEAR DYNAMICS C; BROCK WA, 1988, J MONETARY ECON, V22, P71, DOI 10.1016/0304-3932(88)90170-5; BROCK WA, 1989, ADV TXB EC, V27; CASDAGLI M, 1991, PHYSICA D, V51, P52, DOI 10.1016/0167-2789(91)90222-U; CASDAGLI M, 1989, PHYSICA D, V35, P335, DOI 10.1016/0167-2789(89)90074-2; Crutchfield J. P., 1987, Complex Systems, V1, P417; CRUTCHFIELD JP, 1979, THESIS U CALIFORNIA; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; GIBSON JF, 1992, PHYSICA D, V57, P1, DOI 10.1016/0167-2789(92)90085-2; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Huke J. P., 1993, EMBEDDING NONLINEAR; HUNT BR, 1992, B AM MATH SOC, V27, P217, DOI 10.1090/S0273-0979-1992-00328-2; Jenouvrier S, 2005, P ROY SOC B-BIOL SCI, V272, P887, DOI 10.1098/rspb.2004.2978; Lo TT, 2010, ATMOS SCI LETT, V11, P210, DOI 10.1002/asl.275; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Orstavik S, 1998, PHYS LETT A, V247, P145, DOI 10.1016/S0375-9601(98)00541-6; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Planque B, 2000, ICES J MAR SCI, V57, P1528, DOI 10.1006/jmsc.2000.0970; RAMANATHAN A, 2002, P NATL ACAD SCI USA, V102, P5992; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Ruelle D., 1989, CHAOTIC EVOLUTION ST; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; SCHAFFER WM, 1984, AM NAT, V124, P789; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Seth AK, 2006, P NATL ACAD SCI USA, V103, P10799, DOI 10.1073/pnas.0604347103; Soramaki K, 2007, PHYSICA A, V379, P317, DOI 10.1016/j.physa.2006.11.093; Stark J, 1997, NONLINEAR ANAL-THEOR, V30, P5303, DOI 10.1016/S0362-546X(96)00149-6; Stark J, 2003, J NONLINEAR SCI, V13, P519, DOI 10.1007/s00332-003-0534-4; Stark J, 1999, J NONLINEAR SCI, V9, P255, DOI 10.1007/s003329900072; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; SUGIHARA G, 2010, SEED MAGAZINE GLOBAL; SUGIHARA G, 2010, KYOTO J, V75, P56; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Whitney H, 1936, ANN MATH, V37, P645, DOI 10.2307/1968482; YE H, 2011, LEVERGING INFO UNPUB	41	181	183	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18295	10.1371/journal.pone.0018295	http://dx.doi.org/10.1371/journal.pone.0018295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483839	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200053
J	Dickens, LC; Goatley, CHR; Tanner, JK; Bellwood, DR				Dickens, Luke C.; Goatley, Christopher H. R.; Tanner, Jennifer K.; Bellwood, David R.			Quantifying Relative Diver Effects in Underwater Visual Censuses	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; MARINE RESERVE; SIZE-STRUCTURE; SCUBA-DIVERS; HABITAT USE; BEHAVIOR; DENSITY; ABUNDANCE; COUNTS; POPULATION	Diver-based Underwater Visual Censuses (UVCs), particularly transect-based surveys, are key tools in the study of coral reef fish ecology. These techniques, however, have inherent problems that make it difficult to collect accurate numerical data. One of these problems is the diver effect (defined as the reaction of fish to a diver). Although widely recognised, its effects have yet to be quantified and the extent of taxonomic variation remains to be determined. We therefore examined relative diver effects on a reef fish assemblage on the Great Barrier Reef. Using common UVC methods, the recorded abundance of seven reef fish groups were significantly affected by the ongoing presence of SCUBA divers. Overall, the diver effect resulted in a 52% decrease in the mean number of individuals recorded, with declines of up to 70% in individual families. Although the diver effect appears to be a significant problem, UVCs remain a useful approach for quantifying spatial and temporal variation in relative fish abundances, especially if using methods that minimise the exposure of fishes to divers. Fixed distance transects using tapes or lines deployed by a second diver (or GPS-calibrated timed swims) would appear to maximise fish counts and minimise diver effects.	[Dickens, Luke C.; Goatley, Christopher H. R.; Tanner, Jennifer K.; Bellwood, David R.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Dickens, Luke C.; Goatley, Christopher H. R.; Tanner, Jennifer K.; Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia	James Cook University; James Cook University	Dickens, LC (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.	david.bellwood@jcu.edu.au	Goatley, Christopher/C-1492-2016	Goatley, Christopher/0000-0002-2930-5591	ARC Centre of Excellence for Coral Reef Studies	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research received financial support from the ARC Centre of Excellence for Coral Reef Studies (DRB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Azzurro E, 2007, MAR BIOL, V151, P2245, DOI 10.1007/s00227-007-0661-9; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; BOHNSACK JA, 1986, NOOA TECHNICAL REPOR, V41; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Chapman C.J., 1986, Progress in Underwater Science, V11, P1; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Chateau O, 2009, ICES J MAR SCI, V66, P50, DOI 10.1093/icesjms/fsn165; Cole RG, 2007, MAR BIOL, V150, P1379, DOI 10.1007/s00227-006-0420-3; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; FOWLER AJ, 1987, CORAL REEFS, V6, P49, DOI 10.1007/BF00302212; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2008, MAR BIOL, V154, P325, DOI 10.1007/s00227-008-0927-x; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Fulton CJ, 2001, MAR BIOL, V139, P25; Goatley CHR, 2009, CORAL REEFS, V28, P449, DOI 10.1007/s00338-009-0477-9; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Jayewardene D, 2009, CORAL REEFS, V28, P499, DOI 10.1007/s00338-009-0475-y; JENNINGS S, 1995, J FISH BIOL, V47, P733, DOI 10.1111/j.1095-8649.1995.tb01938.x; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Lobel PS, 2001, MAR TECHNOL SOC J, V35, P19, DOI 10.4031/002533201788001884; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Myrberg AA., 2006, CORAL REEF FISHES, P123; Patterson HM, 2007, ENVIRON BIOL FISH, V78, P291, DOI 10.1007/s10641-006-9096-2; Radford CA, 2005, MAR FRESHW BEHAV PHY, V38, P259, DOI 10.1080/10236240500333908; Randall JE, 1997, FISHES GREAT BARRIER; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Sale Peter F., 1997, P1435; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sano M, 2000, MAR ECOL PROG SER, V198, P121, DOI 10.3354/meps198121; Schmidt MB, 2006, FISH RES, V82, P131, DOI 10.1016/j.fishres.2006.08.014; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; STANLEY DR, 1995, T AM FISH SOC, V124, P946, DOI 10.1577/1548-8659(1995)124<0946:EOSDOF>2.3.CO;2; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Thompson AA, 2002, MAR ECOL PROG SER, V232, P247, DOI 10.3354/meps232247; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790	56	133	134	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18965	10.1371/journal.pone.0018965	http://dx.doi.org/10.1371/journal.pone.0018965			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533039	Green Published, gold, Green Accepted			2022-12-27	WOS:000290014500017
J	Diaz, T; Navarro, A; Ferrer, G; Gel, B; Gaya, A; Artells, R; Bellosillo, B; Garcia-Garcia, M; Serrano, S; Martinez, A; Monzo, M				Diaz, Tania; Navarro, Alfons; Ferrer, Gerardo; Gel, Bernat; Gaya, Anna; Artells, Rosa; Bellosillo, Beatriz; Garcia-Garcia, Mar; Serrano, Sergi; Martinez, Antonio; Monzo, Mariano			Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis	PLOS ONE			English	Article							JAK2 INHIBITOR; FLOW-CYTOMETRY; THERAPY; CELLS; ABERRATIONS; EXPRESSION; FREQUENT; DISEASE; NODES	Standard cytotoxic chemotherapy for Hodgkin Lymphoma (HL) has changed little in 30 years; the treatment for patients with relapsed or refractory disease remains challenging and novel agents are under development. JAK/STAT constitutive activation plays an important role in the pathogenesis of HL. Lestaurtinib is an orally bioavailable multikinase inhibitor that has recently been shown to inhibit JAK2 in myeloproliferative disorders. The potential role of Lestaurtinib in HL therapy is unknown. We have analyzed the effect of Lestaurtinib treatment in five HL cell lines from refractory patients, L-428, L-1236, L-540, HDML-2 and HD-MY-Z. At 48 h, a dose-dependent cell growth inhibition (23%-66% at 300 nM) and apoptotic increment (10%-64% at 300 nM) were observed. Moreover, Lestaurtinib inhibited JAK2, STAT5 and STAT3 phosphorylation and reduced the mRNA expression of its downstream antiapoptotic target Bcl-xL. In addition, we have analyzed the effect of Lestaurtinib treatment in lymph nodes from four classic HL patients. We observed a decrease in cell viability at 24 hours of treatment in three patients (mean decrease of 27% at 300 nM). Our findings provide, for the first time, a molecular rationale for testing JAK2 inhibitors, specifically Lestaurtinib, in HL patients.	[Diaz, Tania; Navarro, Alfons; Artells, Rosa; Monzo, Mariano] Univ Barcelona, Sch Med, Human Anat Unit, Mol Oncol & Embryol Lab,IDIBAPS, Barcelona, Spain; [Ferrer, Gerardo; Gaya, Anna] Hosp Clin Barcelona, Inst Hematol & Oncol, IDIBAPS, Barcelona, Spain; [Gel, Bernat] Univ Politecn Cataluna, Software Dept, Barcelona, Spain; [Bellosillo, Beatriz; Garcia-Garcia, Mar; Serrano, Sergi] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Martinez, Antonio] Hosp Clin Barcelona, Pathol Lab, Hematopathol Sect, IDIBAPS, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Politecnica de Catalunya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Diaz, T (corresponding author), Univ Barcelona, Sch Med, Human Anat Unit, Mol Oncol & Embryol Lab,IDIBAPS, Barcelona, Spain.	anavarroponz@ub.edu	Ferrer, Gerardo/AAU-1173-2020; Martinez, Antonio/D-8188-2012; Gel Moreno, Bernat/B-8806-2016; Garcia, Mar/GOG-9086-2022; Navarro, Alfons/C-2453-2015; MARTINEZ, ANTONIO/AAB-2633-2020	Ferrer, Gerardo/0000-0002-4084-6815; Martinez, Antonio/0000-0003-0790-9017; Gel Moreno, Bernat/0000-0001-8878-349X; Garcia, Mar/0000-0003-2078-8205; Navarro, Alfons/0000-0001-6071-0926; MARTINEZ, ANTONIO/0000-0003-0790-9017; Artells Prats, Rosa/0000-0003-1745-9478; MONZO, MARIANO/0000-0003-2322-4851	Spanish Ministry of Public Health [FIS-PI0900547, FIS-PI080095]; SDCSD of the School of Medicine of the University of Barcelona; Instituto de Salud Carlos III [RD09/0076/00036]; Pla Director d'Oncologia de Catalunya (XBTC); AGAUR; Generalitat de Catalunya; Fondo Social Europeo	Spanish Ministry of Public Health; SDCSD of the School of Medicine of the University of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Pla Director d'Oncologia de Catalunya (XBTC); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya(Generalitat de Catalunya); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported in part by FIS-PI0900547 and by FIS-PI080095 from the Spanish Ministry of Public Health, by the SDCSD of the School of Medicine of the University of Barcelona, by Instituto de Salud Carlos III FEDER (RD09/0076/00036) and by the Xarxa de Bancs de Tumors sponsored by Pla Director d'Oncologia de Catalunya (XBTC). Tania Diaz and Bernat Gel are FI fellows supported by AGAUR, Generalitat de Catalunya and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Bai M, 2007, HUM PATHOL, V38, P103, DOI 10.1016/j.humpath.2006.06.017; Buglio D, 2007, EXPERT REV ANTICANC, V7, P735, DOI 10.1586/14737140.7.5.735; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Chu WS, 1999, HUM PATHOL, V30, P1065, DOI 10.1016/S0046-8177(99)90224-1; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Evens AM, 2008, NAT CLIN PRACT ONCOL, V5, P543, DOI 10.1038/ncponc1186; Fromm JR, 2006, AM J CLIN PATHOL, V126, P764, DOI 10.1309/7370XK6F6P7474XX; Fromm JR, 2009, AM J CLIN PATHOL, V131, P322, DOI 10.1309/AJCPW3UN9DYLDSPB; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Horning S, 2008, ANN ONCOL, V19, P120; HORNING SJ, 2007, HEMATOLOGY, V1, P197; Jemal Ahmedin, 2009, V471, P3, DOI 10.1007/978-1-59745-416-2_1; Joos S, 2000, CANCER RES, V60, P549; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Meier C, 2009, MODERN PATHOL, V22, P476, DOI 10.1038/modpathol.2008.207; Melzner I, 2006, LEUKEMIA, V20, P157, DOI 10.1038/sj.leu.2404036; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; YOUNES MFA, 2009, BLOOD, V114, P588	26	54	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18856	10.1371/journal.pone.0018856	http://dx.doi.org/10.1371/journal.pone.0018856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533094	gold, Green Submitted, Green Published			2022-12-27	WOS:000289719400031
J	Schrader, PS; Milligan, AJ; Behrenfeld, MJ				Schrader, Paul S.; Milligan, Allen J.; Behrenfeld, Michael J.			Surplus Photosynthetic Antennae Complexes Underlie Diagnostics of Iron Limitation in a Cyanobacterium	PLOS ONE			English	Article							CHLOROPHYLL-BINDING PROTEIN; SYNECHOCYSTIS SP PCC-6803; EQUATORIAL PACIFIC-OCEAN; PHYTOPLANKTON PHOTOSYNTHESIS; PHOTOSYSTEM-I; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; OXYGENIC PHOTOSYNTHESIS; ACTIVE FLUORESCENCE; ISIA	Chlorophyll fluorescence from phytoplankton provides a tool to assess iron limitation in the oceans, but the physiological mechanism underlying the fluorescence response is not understood. We examined fluorescence properties of the model cyanobacterium Synechocystis PCC6803 and a Delta isiA knock-out mutant of the same species grown under three culture conditions which simulate nutrient conditions found in the open ocean: (1) nitrate and iron replete, (2) limiting-iron and high-nitrate, representative of natural high-nitrate, low-chlorophyll regions, and (3) iron and nitrogen co-limiting. We show that low variable fluorescence, a key diagnostic of iron limitation, results from synthesis of antennae complexes far in excess of what can be accommodated by the iron-restricted pool of photosynthetic reaction centers. Under iron and nitrogen co-limiting conditions, there are no excess antennae complexes and variable fluorescence is high. These results help to explain the well-established fluorescence characteristics of phytoplankton in high-nutrient, low-chlorophyll ocean regions, while also accounting for the lack of these properties in low-iron, low-nitrogen regions. Importantly, our results complete the link between unique molecular consequences of iron stress in phytoplankton and global detection of iron stress in natural populations from space.	[Schrader, Paul S.; Milligan, Allen J.; Behrenfeld, Michael J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University	Schrader, PS (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu			National Science Foundation; Biological Oceanography [NSF-OCE 0726116]; National Aeronautics and Space Administration [NNX08AF72G]	National Science Foundation(National Science Foundation (NSF)); Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This research was funded through a grant from the National Science Foundation, Biological Oceanography (NSF-OCE 0726116) and the National Aeronautics and Space Administration (NNX08AF72G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Berera R, 2009, BIOPHYS J, V96, P2261, DOI 10.1016/j.bpj.2008.12.3905; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Bibby TS, 2001, J BIOL CHEM, V276, P43246, DOI 10.1074/jbc.M106541200; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; Cadoret JC, 2004, BBA-BIOENERGETICS, V1659, P100, DOI 10.1016/j.bbabio.2004.08.001; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; GREENE RM, 1994, LIMNOL OCEANOGR, V39, P1061, DOI 10.4319/lo.1994.39.5.1061; Gustafsson JP, 2009, VISUAL MINTEQ VER 2; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Jeanjean R, 2003, FEBS LETT, V549, P52, DOI 10.1016/S0014-5793(03)00769-5; Kojima K, 2006, PHYSIOL PLANTARUM, V128, P507, DOI 10.1111/j.1399-3054.2006.00781.x; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larbi A, 2004, PHOTOSYNTH RES, V79, P59, DOI 10.1023/B:PRES.0000011919.35309.5e; LaRoche J, 1996, NATURE, V382, P802; Le Bouteiller A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000914; Lopez-Gomollon S, 2007, J MOL BIOL, V374, P267, DOI 10.1016/j.jmb.2007.09.010; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Olson RJ, 2000, DEEP-SEA RES PT II, V47, P3181, DOI 10.1016/S0967-0645(00)00064-3; OQUIST G, 1974, PHYSIOL PLANTARUM, V31, P55, DOI 10.1111/j.1399-3054.1974.tb03677.x; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Singh AK, 2006, FEMS MICROBIOL LETT, V256, P159, DOI 10.1111/j.1574-6968.2006.00114.x; Singh AK, 2005, PHOTOSYNTH RES, V84, P65, DOI 10.1007/s11120-004-6429-x; Skolnick S, 2007, BBA-BIOENERGETICS, V1767, P814, DOI 10.1016/j.bbabio.2006.11.015; Varsano T, 2006, J BIOL CHEM, V281, P10305, DOI 10.1074/jbc.M511057200; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; Vavilin DV, 1999, BIOCHEMISTRY-US, V38, P14690, DOI 10.1021/bi9915622; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; YU JJ, 1993, J BIOL CHEM, V268, P7407	53	55	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18753	10.1371/journal.pone.0018753	http://dx.doi.org/10.1371/journal.pone.0018753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533084	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400023
J	Rodrigues, AJ; Neves-Carvalho, A; Teixeira-Castro, A; Rokka, A; Corthals, G; Logarinho, E; Maciel, P				Rodrigues, Ana Joao; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Rokka, Anne; Corthals, Garry; Logarinho, Elsa; Maciel, Patricia			Absence of Ataxin-3 Leads to Enhanced Stress Response in C. elegans	PLOS ONE			English	Article							HEAT-SHOCK-FACTOR; MACHADO-JOSEPH-DISEASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASE; PROTEIN ATAXIN-3; LONGEVITY; GENES; DAF-16	Ataxin-3, the protein involved in Machado-Joseph disease, is able to bind ubiquitylated substrates and act as a deubiquitylating enzyme in vitro, and it has been involved in the modulation of protein degradation by the ubiquitin-proteasome pathway. C. elegans and mouse ataxin-3 knockout models are viable and without any obvious phenotype in a basal condition however their phenotype in stress situations has never been described. Considering the role of ataxin-3 in the protein degradation pathway, we analyzed the effects of heat shock, a known protein homeostasis stressor, in C. elegans ataxin-3 (ATX-3) knockout animals. We found that ATX-3 mutants have an exacerbated stress response and survive significantly better than wild type animals when subjected to a noxious heat shock stimulus. This increased thermotolerance of mutants was further enhanced by pre-exposure to a mild heat shock. At a molecular level, ATX-3 mutants have a distinct transcriptomic and proteomic profile with several molecular chaperones abnormally up-regulated during heat shock and recovery, consistent with the observed resistance phenotype. The improved thermotolerancein ATX-3 mutants is independent of heat shock factor 1, the maestro of the heat shock response, but fully dependent on DAF-16, a critical stress responsive transcription factor involved in longevity and stress resistance. We also show that the increased thermotolerance of ATX-3 mutants is mainly due to HSP-16.2, C12C8.1 and F44E5.5 given that the knockdown of these heat shock proteins using RNA interference causes the phenotype to revert. This report suggests that the absence of ATX-3 activates the DAF-16 pathway leading to an overexpression of molecular chaperones, which yields knockout animals with an improved capacity for dealing with deleterious stimuli.	[Rodrigues, Ana Joao; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Logarinho, Elsa; Maciel, Patricia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Rokka, Anne; Corthals, Garry] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Rokka, Anne; Corthals, Garry] Abo Akad Univ, Turku, Finland; [Logarinho, Elsa] Inst Biol Mol & Celular IBMC, Oporto, Portugal	Universidade do Minho; University of Turku; Abo Akademi University; Universidade do Porto	Rodrigues, AJ (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	pmaciel@ecsaude.uminho.pt	Rodrigues, Ana João/D-3782-2012; Rodrigues, Ana/GYQ-6273-2022; Teixeira-Castro, Andreia/T-5167-2018; Carvalho, Andreia/T-5406-2018; Logarinho, Elsa/I-5616-2013; Corthals, Garry/G-9417-2016; Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020	Rodrigues, Ana João/0000-0003-1968-7968; Teixeira-Castro, Andreia/0000-0003-4999-5996; Carvalho, Andreia/0000-0002-5710-0040; Logarinho, Elsa/0000-0002-8741-0744; Corthals, Garry/0000-0001-9423-5596; Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Rokka, Anne/0000-0003-1482-9154	Fundacao Ciencia e Tecnologia (FCT) [POCI/SAU-MMO/60412/2004, PTDC/SAU-GMG/101572/2008]; Fundação para a Ciência e a Tecnologia [POCI/SAU-MMO/60412/2004, PTDC/SAU-GMG/101572/2008] Funding Source: FCT	Fundacao Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao Ciencia e Tecnologia (FCT) with project "POCI/SAU-MMO/60412/2004" and "PTDC/SAU-GMG/101572/2008". AJR and ATC received post-doctoral and PhD scholarships from FCT, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cypser J, 2001, HUM EXP TOXICOL, V20, P295, DOI 10.1191/096032701701548070; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; HESCHL MFP, 1989, DNA-J MOLEC CELL BIO, V8, P233, DOI 10.1089/dna.1.1989.8.233; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; KUHLBRODT K, 2011, NAT CELL BIOL; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee W, 2006, PROTEOMICS, V6, P1329, DOI 10.1002/pmic.200500320; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; REINA CP, 2009, HUM MOL GENET; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Stirling PC, 2003, EMBO REP, V4, P565, DOI 10.1038/sj.embor.embor869; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	48	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18512	10.1371/journal.pone.0018512	http://dx.doi.org/10.1371/journal.pone.0018512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526185	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100006
J	Amiel, JJ; Tingley, R; Shine, R				Amiel, Joshua J.; Tingley, Reid; Shine, Richard			Smart Moves: Effects of Relative Brain Size on Establishment Success of Invasive Amphibians and Reptiles	PLOS ONE			English	Article							FEEDING INNOVATIONS; REPRODUCTIVE RATES; FOREBRAIN SIZE; LIFE-HISTORY; EVOLUTION; BEHAVIOR; BIRDS; PATTERNS; ANURANS	Brain size relative to body size varies considerably among animals, but the ecological consequences of that variation remain poorly understood. Plausibly, larger brains confer increased behavioural flexibility, and an ability to respond to novel challenges. In keeping with that hypothesis, successful invasive species of birds and mammals that flourish after translocation to a new area tend to have larger brains than do unsuccessful invaders. We found the same pattern in ectothermic terrestrial vertebrates. Brain size relative to body size was larger in species of amphibians and reptiles reported to be successful invaders, compared to species that failed to thrive after translocation to new sites. This pattern was found in six of seven global biogeographic realms; the exception (where relatively larger brains did not facilitate invasion success) was Australasia. Establishment success was also higher in amphibian and reptile families with larger relative brain sizes. Future work could usefully explore whether invasion success is differentially associated with enlargement of specific parts of the brain (as predicted by the functional role of the forebrain in promoting behavioural flexibility), or with a general size increase (suggesting that invasion success is facilitated by enhanced perceptual and motor skills, as well as cognitive ability).	[Amiel, Joshua J.; Tingley, Reid; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Amiel, JJ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	jami3107@uni.sydney.edu.au	Tingley, Reid/D-7388-2011	Tingley, Reid/0000-0002-7630-7434	Richard Shine's Federation; University of Sydney; Australian Department of Education, Employment and Workplace Relations	Richard Shine's Federation; University of Sydney(University of Sydney); Australian Department of Education, Employment and Workplace Relations(Australian Government)	Funding was provided by Richard Shine's Federation Fellowship grant. Joshua Amiel and Reid Tingley are funded by IPA scholarships through the University of Sydney and EIPRS scholarships through the Australian Department of Education, Employment and Workplace Relations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; BAUCHOT R, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P383; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Byrne R., 1988, MACHIAVELLIAN INTELL; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Cassey P, 2002, BIOL J LINN SOC, V76, P465, DOI 10.1046/j.1095-8312.2002.00086.x; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Ewert JP, 2001, COMP BIOCHEM PHYS A, V128, P417, DOI 10.1016/S1095-6433(00)00333-0; Flannery T, 1994, FUTURE EATERS ECOLOG; FOX SF, LIZARD SOCIAL BEHAV; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Hurlburt G.R., 1996, THESIS U TORONTO; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007; Kraus Fred, 2009, V4, P1; KREBS JR, 1989, P NATL ACAD SCI USA, V86, P1388, DOI 10.1073/pnas.86.4.1388; LASHLEY KS, 1949, Q REV BIOL, V24, P28, DOI 10.1086/396806; Lefebvre L, 1998, BEHAVIOUR, V135, P1077, DOI 10.1163/156853998792913492; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lindenfors P, 2005, BIOL LETT-UK, V1, P407, DOI 10.1098/rsbl.2005.0362; Long JL, 2003, INTRO MAMMALS WORLD; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Northcutt R.G., 1978, P11; Nunn CL, 2000, AM NAT, V156, P519, DOI 10.1086/303405; PAGEL MD, 1988, AM NAT, V132, P344, DOI 10.1086/284857; Platel R., 1976, Journal fuer Hirnforschung, V17, P513; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; TAYLOR GM, 1995, BRAIN BEHAV EVOLUT, V45, P96, DOI 10.1159/000113543; THIREAU M, 1975, I B MUS NAT HIST NAT, V207, P467; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Watters JV, 2007, APPL ANIM BEHAV SCI, V102, P364, DOI 10.1016/j.applanim.2006.05.036; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; WYLES JS, 1983, P NATL ACAD SCI-BIOL, V80, P4394, DOI 10.1073/pnas.80.14.4394; YOMTOV Y, 1985, OECOLOGIA, V66, P250, DOI 10.1007/BF00379862; YOMTOV Y, 1987, AUST WILDLIFE RES, V14, P319, DOI 10.1071/WR9870319	44	106	106	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18277	10.1371/journal.pone.0018277	http://dx.doi.org/10.1371/journal.pone.0018277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494328	Green Published, gold			2022-12-27	WOS:000289192400014
J	Koole, O; Thai, S; Khun, KE; Pe, R; van Griensven, J; Apers, L; Van den Ende, J; Mao, TE; Lynen, L				Koole, Olivier; Thai, Sopheak; Khun, Kim Eam; Pe, Reaksmey; van Griensven, Johan; Apers, Ludwig; Van den Ende, Jef; Mao, Tan Eang; Lynen, Lutgarde			Evaluation of the 2007 WHO Guideline to Improve the Diagnosis of Tuberculosis in Ambulatory HIV-Positive Adults	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; INFECTED PERSONS; AFRICA; PEOPLE; DEATH; CAMBODIA; RATES	Background: In 2007 WHO issued a guideline to improve the diagnosis of smear-negative and extrapulmonary tuberculosis (EPTB) in HIV-positive patients. This guideline relies heavily on the acceptance of HIV-testing and availability of chest X-rays. Methods and Findings: Cohort study of TB suspects in four tuberculosis (TB) clinics in Phnom Penh, Cambodia. We assessed the operational performance of the guideline, the incremental yield of investigations, and the diagnostic accuracy for smear-negative tuberculosis in HIV-positive patients using culture positivity as reference standard. 1,147 (68.9%) of 1,665 TB suspects presented with unknown HIV status, 1,124 (98.0%) agreed to be tested, 79 (7.0%) were HIV-positive. Compliance with the guideline for chest X-rays and sputum culture requests was 97.1% and 98.3% respectively. Only 35 of 79 HIV-positive patients (44.3%) with a chest X-ray suggestive of TB started TB treatment within 10 days. 105 of 442 HIV-positive TB suspects started TB treatment (56.2% smear-negative pulmonary TB (PTB), 28.6% smear-positive PTB, 15.2% EPTB). The median time to TB treatment initiation was 5 days (IQR: 2-13 days), ranging from 2 days (IQR: 1-11.5 days) for EPTB, over 2.5 days (IQR: 1-4 days) for smear-positive PTB to 9 days (IQR: 3-17 days) for smear-negative PTB. Among the 34 smear-negative TB patients with a confirmed diagnosis, the incremental yield of chest X-ray, clinical suspicion or abdominal ultrasound, and culture was 41.2%, 17.6% and 41.2% respectively. The sensitivity and specificity of the algorithm to diagnose smear-negative TB in HIV-positive TB suspects was 58.8% (95% CI: 42.2%-73.6%) and 79.4% (95% CI: 74.8%-82.4%) respectively. Conclusions: Pending point-of-care rapid diagnostic tests for TB disease, diagnostic algorithms are needed. The diagnostic accuracy of the 2007 WHO guideline to diagnose smear-negative TB is acceptable. There is, however, reluctance to comply with the guideline in terms of immediate treatment initiation.	[Koole, Olivier; van Griensven, Johan; Apers, Ludwig; Van den Ende, Jef; Lynen, Lutgarde] Inst Trop Med, B-2000 Antwerp, Belgium; [Thai, Sopheak; Pe, Reaksmey] Sihanouk Hosp Ctr HOPE SHCH, Phnom Penh, Cambodia; [Khun, Kim Eam; Mao, Tan Eang] Natl Ctr TB & Leprosy Control CENAT, Phnom Penh, Cambodia	Institute of Tropical Medicine (ITM)	Koole, O (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	okoole@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Koole, Olivier/0000-0002-1122-5382	WHO [T9-181-298]; Belgian Development cooperation (DGDC); Institute of Tropical Medicine in Antwerp [920800]; Belgian National Association against Tuberculosis (BNBTTB)	WHO(World Health Organization); Belgian Development cooperation (DGDC); Institute of Tropical Medicine in Antwerp; Belgian National Association against Tuberculosis (BNBTTB)	The study was funded by WHO (WHO registry file number T9-181-298), with additional funding from the Belgian Development cooperation (DGDC) through a framework agreement with the Institute of Tropical Medicine in Antwerp (institutional strengthening project 920800) and the Belgian National Association against Tuberculosis (BNBTTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Banda H, 2000, INT J TUBERC LUNG D, V4, P968; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LUCAS SB, 1994, BRIT MED J, V308, P1531, DOI 10.1136/bmj.308.6943.1531; *MIN HLTH CAMB, 2008, TUB REP; MONKONGDEE P, 2009, AM J RESP CRIT CARE; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; National AIDS Authority, 2008, UNGASS COUNTR PROGR; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8; Ralph AP, 2009, CLIN INFECT DIS, V49, P574, DOI 10.1086/600889; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Sculier D, 2010, JAIDS-J ACQ IMM DEF, V55, P500, DOI 10.1097/QAI.0b013e3181e6a703; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; TRINH TT, 2007, PLOS ONE, V2, pE507; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2009, STRAT TECHN ADV GROU; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2009, GLOB TUB CONTR 2009; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	39	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18502	10.1371/journal.pone.0018502	http://dx.doi.org/10.1371/journal.pone.0018502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494694	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000289192400032
J	Shulman, M; Cohen, M; Soto-Gutierrez, A; Yagi, H; Wang, HY; Goldwasser, J; Lee-Parsons, CW; Benny-Ratsaby, O; Yarmush, ML; Nahmias, Y				Shulman, Maria; Cohen, Merav; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Wang, Hongyun; Goldwasser, Jonathan; Lee-Parsons, Carolyn W.; Benny-Ratsaby, Ofra; Yarmush, Martin L.; Nahmias, Yaakov			Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropoyl-beta-Cyclodextrin	PLOS ONE			English	Article							CITRUS FLAVONOID NARINGENIN; ORAL BIOAVAILABILITY; GRAPEFRUIT JUICE; INSULIN-RECEPTOR; B SECRETION; APO-B; HESPERETIN; INHIBITION; EXPRESSION; PHARMACOKINETICS	The abundant flavonoid aglycone, naringenin, which is responsible for the bitter taste in grapefruits, has been shown to possess hypolipidemic and anti-inflammatory effects both in vitro and in vivo. Recently, our group demonstrated that naringenin inhibits hepatitis C virus (HCV) production, while others demonstrated its potential in the treatment of hyperlipidemia and diabetes. However, naringenin suffers from low oral bioavailability critically limiting its clinical potential. In this study, we demonstrate that the solubility of naringenin is enhanced by complexation with beta-cyclodextrin, an FDA approved excipient. Hydroxypropoyl-beta-cyclodextrin (HP beta CD), specifically, increased the solubility of naringenin by over 400-fold, and its transport across a Caco-2 model of the gut epithelium by 11-fold. Complexation of naringenin with HP beta CD increased its plasma concentrations when fed to rats, with AUC values increasing by 7.4-fold and C-max increasing 14.6-fold. Moreover, when the complex was administered just prior to a meal it decreased VLDL levels by 42% and increased the rate of glucose clearance by 64% compared to naringenin alone. These effects correlated with increased expression of the PPAR co-activator, PGC1 alpha in both liver and skeletal muscle. Histology and blood chemistry analysis indicated this route of administration was not associated with damage to the intestine, kidney, or liver. These results suggest that the complexation of naringenin with HP beta CD is a viable option for the oral delivery of naringenin as a therapeutic entity with applications in the treatment of dyslipidemia, diabetes, and HCV infection.	[Shulman, Maria; Cohen, Merav; Nahmias, Yaakov] Hebrew Univ Jerusalem, Inst Life Sci, Sch Comp Sci & Engn, Ctr Bioengn, IL-91904 Jerusalem, Israel; [Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Wang, Hongyun; Goldwasser, Jonathan; Yarmush, Martin L.; Nahmias, Yaakov] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA USA; [Goldwasser, Jonathan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Benny-Ratsaby, Ofra] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Lee-Parsons, Carolyn W.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard Medical School; Northeastern University; Rutgers State University New Brunswick	Shulman, M (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Sch Comp Sci & Engn, Ctr Bioengn, IL-91904 Jerusalem, Israel.	ynahmias@cs.huji.ac.il	Nahmias, Yaakov/H-4725-2013; Nahmias, Yaakov/AAM-3872-2020	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	National Institute of Diabetes and Digestive and Kidney Diseases [K01DK080241]; Harvard Clinical Nutrition Research Center [P30-DK040561]; European Research Council [TMIHCV 242699]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080241, P30DK040561] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Clinical Nutrition Research Center; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK080241) and the Harvard Clinical Nutrition Research Center (P30-DK040561). Resources were provided by European Research Council Starting Grant (TMIHCV 242699), the BioMEMS Resource Center (P41 EB-002503), and the Alexander Silberman Institute of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Allister EM, 2008, J LIPID RES, V49, P2218, DOI 10.1194/jlr.M800297-JLR200; Borradaile NM, 2003, DIABETES, V52, P2554, DOI 10.2337/diabetes.52.10.2554; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Choudhury R, 1999, BIOCHEM BIOPH RES CO, V265, P410, DOI 10.1006/bbrc.1999.1695; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; FUHR U, 1995, CLIN PHARMACOL THER, V58, P365, DOI 10.1016/0009-9236(95)90048-9; GAO J, 2000, CURRENT PROTOCOLS PH; Goldwasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012399; Huong DTT, 2006, NUTRITION, V22, P546, DOI 10.1016/j.nut.2005.11.006; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jeon SM, 2007, TRANSL RES, V149, P15, DOI 10.1016/j.trsl.2006.08.001; Jung UJ, 2003, CLIN NUTR, V22, P561, DOI 10.1016/S0261-5614(03)00059-1; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kurowska EM, 2000, NUTR RES, V20, P121, DOI 10.1016/S0271-5317(99)00144-X; Liu L, 2008, PHYTOTHER RES, V22, P1400, DOI 10.1002/ptr.2504; Miyake K, 2000, PHARM DEV TECHNOL, V5, P399, DOI 10.1081/PDT-100100556; Mulvihill EE, 2009, DIABETES, V58, P2198, DOI 10.2337/db09-0634; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Renugadevi J, 2009, TOXICOLOGY, V256, P128, DOI 10.1016/j.tox.2008.11.012; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Stella VJ, 1997, PHARMACEUT RES, V14, P556, DOI 10.1023/A:1012136608249; Tommasini S, 2004, J PHARMACEUT BIOMED, V35, P379, DOI 10.1016/S0731-7085(03)00647-2; Wilcox LJ, 2001, J LIPID RES, V42, P725; Wilcox LJ, 1999, CARDIOVASC DRUG REV, V17, P160, DOI 10.1111/j.1527-3466.1999.tb00011.x; Yanez JA, 2008, BIOPHARM DRUG DISPOS, V29, P63, DOI 10.1002/bdd.588	31	114	123	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18033	10.1371/journal.pone.0018033	http://dx.doi.org/10.1371/journal.pone.0018033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494673	Green Submitted, gold, Green Published			2022-12-27	WOS:000289192400007
J	Watts, SM; Dodson, CD; Reichman, OJ				Watts, Sean M.; Dodson, Craig D.; Reichman, O. J.			The Roots of Defense: Plant Resistance and Tolerance to Belowground Herbivory	PLOS ONE			English	Article							POCKET GOPHER; EVOLUTION; RESPONSES; COSTS; STRATEGIES; PSEUDOREPLICATION; AVAILABILITY; DISTURBANCE; SELECTION; REGROWTH	Background: There is conclusive evidence that there are fitness costs of plant defense and that herbivores can drive selection for defense. However, most work has focused on above-ground interactions, even though belowground herbivory may have greater impacts on individual plants than above-ground herbivory. Given the role of belowground plant structures in resource acquisition and storage, research on belowground herbivores has much to contribute to theories on the evolution of plant defense. Pocket gophers (Geomyidae) provide an excellent opportunity to study root herbivory. These subterranean rodents spend their entire lives belowground and specialize on consuming belowground plant parts. Methodology and Principal Findings: We compared the root defenses of native forbs from mainland populations (with a history of gopher herbivory) to island populations (free from gophers for up to 500,000 years). Defense includes both resistance against herbivores and tolerance of herbivore damage. We used three approaches to compare these traits in island and mainland populations of two native California forbs: 1) Eschscholzia californica populations were assayed to compare alkaloid deterrents, 2) captive gophers were used to test the palatability of E. californica roots and 3) simulated root herbivory assessed tolerance to root damage in Deinandra fasciculata and E. californica. Mainland forms of E. californica contained 2.5 times greater concentration of alkaloids and were less palatable to gophers than island forms. Mainland forms of D. fasciculata and, to a lesser extent, E. californica were also more tolerant of root damage than island conspecifics. Interestingly, undamaged island individuals of D. fasciculata produced significantly more fruit than either damaged or undamaged mainland individuals. Conclusions and Significance: These results suggest that mainland plants are effective at deterring and tolerating pocket gopher herbivory. Results also suggest that both forms of defense are costly to fitness and thus reduced in the absence of the putative target herbivore.	[Watts, Sean M.] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Dodson, Craig D.] Mesa State Coll, Dept Phys & Environm Sci, Grand Junction, CO USA; [Reichman, O. J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Santa Clara University; University of California System; University of California Santa Barbara	Watts, SM (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	SWatts@scu.edu			University of California Natural Reserve System; Mellon Foundation; NSF [DEB 98-06377, DEB 02-35624]	University of California Natural Reserve System; Mellon Foundation; NSF(National Science Foundation (NSF))	This research was supported by a Mildred E. Mathias Graduate Student Research Grant from the University of California Natural Reserve System, Sigma Xi Grants-in-Aid-of-Research Award, The Mellon Foundation, and NSF (DEB 98-06377 & DEB 02-35624 to Reichman and Seabloom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Alm U, 2002, ANIM BEHAV, V64, P439, DOI 10.1006/anbe.2002.3057; ANDERSEN DC, 1981, ECOL MONOGR, V51, P179, DOI 10.2307/2937262; ANDERSEN DC, 1987, Q REV BIOL, V62, P261, DOI 10.1086/415512; BANDOLI JH, 1981, J MAMMAL, V62, P293, DOI 10.2307/1380706; BEHREND A F, 1988, Prairie Naturalist, V20, P99; BERLANDSON JM, 1984, AM ANTIQUITIES, V49, P785; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Bowen L, 1997, CONSERV BIOL, V11, P1249, DOI 10.1046/j.1523-1739.1997.96368.x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Carlquist S, 1965, ISLAND LIFE NATURAL; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; DOAK DF, 1992, ECOLOGY, V73, P2086, DOI 10.2307/1941457; Dudley JP, 1999, CONSERV BIOL, V13, P209, DOI 10.1046/j.1523-1739.1999.98008.x; Dyer LA, 2004, ECOLOGY, V85, P2795, DOI 10.1890/03-0233; Fabre T, 2000, J CHROMATOGR A, V904, P35, DOI 10.1016/S0021-9673(00)00919-5; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; HARGROVE WW, 1992, LANDSCAPE ECOL, V6, P251, DOI 10.1007/BF00129703; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOBBS RJ, 1991, ECOLOGY, V72, P59, DOI 10.2307/1938902; Hochwender CG, 2000, OECOLOGIA, V122, P361, DOI 10.1007/s004420050042; HOOVEN EF, 1971, J WILDLIFE MANAGE, V35, P346, DOI 10.2307/3799611; HUNTLY N, 1994, J MAMMAL, V75, P852, DOI 10.2307/1382467; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JANZEN D H, 1973, Biotropica, V5, P15, DOI 10.2307/2989677; JENKINS SH, 1989, J MAMMAL, V70, P406, DOI 10.2307/1381529; JONES CG, 1991, PHILOS T R SOC B, V333, P273, DOI 10.1098/rstb.1991.0077; JUNAK S, 1995, FLORA S CRUZ ISLAND; KARBAN R, 1993, ECOLOGY, V74, P39, DOI 10.2307/1939499; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Lidicker W. Z. Jr., 1989, Grassland structure and function: California annual grassland., P135; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; Major J., 1977, TERRESTRIAL VEGETATI; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; MOONEY HA, 1960, AM J BOT, V47, P594, DOI 10.2307/2439439; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; REICHMAN OJ, 1988, AM MIDL NAT, V120, P58, DOI 10.2307/2425887; REICHMAN OJ, 1985, J MAMMAL, V66, P720, DOI 10.2307/1380798; REICHMAN OJ, 1991, ECOLOGY, V72, P116, DOI 10.2307/1938907; Reichman OJ, 2002, TRENDS ECOL EVOL, V17, P44, DOI 10.1016/S0169-5347(01)02329-1; REICHMAN OJ, 1982, ECOLOGY, V63, P687, DOI 10.2307/1936789; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; RICKSON FR, 1977, AM J BOT, V64, P585, DOI 10.2307/2442007; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; SIMMS EL, 1989, EVOLUTION, V43, P573, DOI 10.1111/j.1558-5646.1989.tb04253.x; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; STOCK C, 1946, RANCHO BREA RECORD P; Stowe KA, 1998, EVOLUTION, V52, P703, DOI [10.2307/2411265, 10.1111/j.1558-5646.1998.tb03695.x]; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Stromberg MR, 1996, ECOL APPL, V6, P1189, DOI 10.2307/2269601; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; Van Der Meijden E, 2000, EVOL ECOL, V14, P439, DOI 10.1023/A:1010985028360; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; VLECK D, 1981, OECOLOGIA, V49, P391, DOI 10.1007/BF00347605; Vourc'h G, 2001, OECOLOGIA, V126, P84, DOI 10.1007/s004420000491; Wallace A. R., 1880; WILLIAMS LR, 1986, J MAMMAL, V67, P489, DOI 10.2307/1381280	68	14	15	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18463	10.1371/journal.pone.0018463	http://dx.doi.org/10.1371/journal.pone.0018463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494690	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400030
J	Dobson-Belaire, WN; Cochrane, A; Ostrowski, MA; Gray-Owen, SD				Dobson-Belaire, Wendy N.; Cochrane, Alan; Ostrowski, Mario A.; Gray-Owen, Scott D.			Differential Response of Primary and Immortalized CD4(+) T Cells to Neisseria gonorrhoeae-Induced Cytokines Determines the Effect on HIV-1 Replication	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS FACTOR-ALPHA; DENDRITIC CELLS; CANCER-CELLS; IFN-ALPHA; INFECTION; TRANSMISSION; EXPRESSION; INDUCTION	To compare the effect of gonococcal co-infection on immortalized versus primary CD4(+) T cells the Jurkat cell line or freshly isolated human CD4(+) T cells were infected with the HIV-1 X4 strain NL4-3. These cells were exposed to whole gonococci, supernatants from gonococcal-infected PBMCs, or N. gonorrhoeae-induced cytokines at varying levels. Supernatants from gonococcal-infected PBMCs stimulated HIV-1 replication in Jurkat cells while effectively inhibiting HIV-1 replication in primary CD4(+) T cells. ELISA-based analyses revealed that the gonococcal-induced supernatants contained high levels of proinflammatory cytokines that promote HIV-1 replication, as well as the HIV-inhibitory IFN alpha. While all the T cells responded to the HIV-stimulatory cytokines, albeit to differing degrees, the Jurkat cells were refractory to IFN alpha. Combined, these results indicate that N. gonorrhoeae elicits immune-modulating cytokines that both activate and inhibit HIV-production; the outcome of co-infection depending upon the balance between these opposing signals.	[Dobson-Belaire, Wendy N.; Cochrane, Alan; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Ostrowski, Mario A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Dobson-Belaire, WN (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Ontario HIV Treatment Network [ROGB-208]; Canadian Institutes for Health Research [HET-85518]	Ontario HIV Treatment Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Ontario HIV Treatment Network grant ROGB-208 (www.ohtn.on.ca) and the Canadian Institutes for Health Research grant HET-85518 (www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccellino M, 2004, J CELL PHYSIOL, V201, P71, DOI 10.1002/jcp.20058; Camargo JF, 2009, J IMMUNOL, V182, P171, DOI 10.4049/jimmunol.182.1.171; Caraglia M, 2009, CURR CANCER DRUG TAR, V9, P690, DOI 10.2174/156800909789056980; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Connolly NC, 2005, AIDS REV, V7, P168; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Dobson-Belaire WN, 2010, CELL MICROBIOL, V12, P1703, DOI 10.1111/j.1462-5822.2010.01502.x; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; Liu XY, 2006, J INFECT DIS, V194, P751, DOI 10.1086/506360; Naviglio S, 2007, J INTERF CYTOK RES, V27, P129, DOI 10.1089/jir.2006.0101; OKAMOTO T, 1989, AIDS RES HUM RETROV, V5, P131, DOI 10.1089/aid.1989.5.131; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; POLI G, 1992, AIDS RES HUM RETROV, V8, P191, DOI 10.1089/aid.1992.8.191; SALYERS AA, 2002, BACTERIAL PATHOGENES, P437; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18133	10.1371/journal.pone.0018133	http://dx.doi.org/10.1371/journal.pone.0018133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526113	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800005
J	Meriaux, C; Arafah, K; Tasiemski, A; Wisztorski, M; Bruand, J; Boidin-Wichlacz, C; Desmons, A; Debois, D; Laprevote, O; Brunelle, A; Gaasterland, T; Macagno, E; Fournier, I; Salzet, M				Meriaux, Celine; Arafah, Karim; Tasiemski, Aurelie; Wisztorski, Maxence; Bruand, Jocelyne; Boidin-Wichlacz, Celine; Desmons, Annie; Debois, Delphine; Laprevote, Olivier; Brunelle, Alain; Gaasterland, Terry; Macagno, Eduardo; Fournier, Isabelle; Salzet, Michel			Multiple Changes in Peptide and Lipid Expression Associated with Regeneration in the Nervous System of the Medicinal Leech	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; HIRUDO-MEDICINALIS; DIFFERENTIAL GLYCOSYLATION; MASS-SPECTROMETRY; SINGLE-CELL; FATTY-ACIDS; PROTEIN; NEURONS; GENES; BRAIN	BACKGROUND: The adult medicinal leech central nervous system (CNS) is capable of regenerating specific synaptic circuitry after a mechanical lesion, displaying evidence of anatomical repair within a few days and functional recovery within a few weeks. In the present work, spatiotemporal changes in molecular distributions during this phenomenon are explored. Moreover, the hypothesis that neural regeneration involves some molecular factors initially employed during embryonic neural development is tested. RESULTS: Imaging mass spectrometry coupled to peptidomic and lipidomic methodologies allowed the selection of molecules whose spatiotemporal pattern of expression was of potential interest. The identification of peptides was aided by comparing MS/MS spectra obtained for the peptidome extracted from embryonic and adult tissues to leech transcriptome and genome databases. Through the parallel use of a classical lipidomic approach and secondary ion mass spectrometry, specific lipids, including cannabinoids, gangliosides and several other types, were detected in adult ganglia following mechanical damage to connected nerves. These observations motivated a search for possible effects of cannabinoids on neurite outgrowth. Exposing nervous tissues to Transient Receptor Potential Vanilloid (TRPV) receptor agonists resulted in enhanced neurite outgrowth from a cut nerve, while exposure to antagonists blocked such outgrowth. CONCLUSION: The experiments on the regenerating adult leech CNS reported here provide direct evidence of increased titers of proteins that are thought to play important roles in early stages of neural development. Our data further suggest that endocannabinoids also play key roles in CNS regeneration, mediated through the activation of leech TRPVs, as a thorough search of leech genome databases failed to reveal any leech orthologs of the mammalian cannabinoid receptors but revealed putative TRPVs. In sum, our observations identify a number of lipids and proteins that may contribute to different aspects of the complex phenomenon of leech nerve regeneration, establishing an important base for future functional assays.	[Meriaux, Celine; Arafah, Karim; Tasiemski, Aurelie; Wisztorski, Maxence; Boidin-Wichlacz, Celine; Desmons, Annie; Fournier, Isabelle; Salzet, Michel] Univ Lille 1, Univ Lille Nord France, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA 4550, F-59655 Villeneuve Dascq, France; [Bruand, Jocelyne; Macagno, Eduardo] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA; [Debois, Delphine; Laprevote, Olivier; Brunelle, Alain] Ctr Rech Gif, Inst Chim Subst Nat, Gif Sur Yvette, France; [Laprevote, Olivier] Univ Paris 05, Fac Sci Pharmaceut & Biol, Paris, France; [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, Div Biol Sci,Inst Genom Med, La Jolla, CA 92093 USA	Universite de Lille - ISITE; Universite de Lille; University of California System; University of California San Diego; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; Scripps Institution of Oceanography	Meriaux, C (corresponding author), Univ Lille 1, Univ Lille Nord France, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA 4550, F-59655 Villeneuve Dascq, France.	isabelle.fournier@univ-lille1.fr; michel.salzet@univ-lille1.fr	Brunelle, Alain/L-3889-2013; Wisztorski, Maxence/F-4380-2010; FOURNIER, Isabelle/H-9195-2015; Arafah, Karim/ABE-1699-2021; Salzet, Michel/A-7675-2011; Tasiemski, Aurelie/S-2537-2016	Brunelle, Alain/0000-0001-6526-6481; Wisztorski, Maxence/0000-0003-1320-075X; FOURNIER, Isabelle/0000-0003-1096-5044; Salzet, Michel/0000-0003-4318-0817; Meriaux, Celine/0000-0002-2413-2599; Boidin, Capucine/0000-0002-4488-9361; Tasiemski, Aurelie/0000-0003-3559-5115; Wichlacz, Celine/0000-0002-0242-868X	Centre National de la Recherche Scientifique (CNRS); Ministere de l'Enseignement, de la Recherche et des Technologies (MERT); Genoscope; Agence Nationale de la Recherche (ANR); NSF [DBI-0852081]; National Institutes of Health [1RC2EY020678]; NATIONAL EYE INSTITUTE [RC2EY020678] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement, de la Recherche et des Technologies (MERT); Genoscope; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the Centre National de la Recherche Scientifique (CNRS), by the Ministere de l'Enseignement, de la Recherche et des Technologies (MERT), by the Genoscope, by the Agence Nationale de la Recherche (ANR), by NSF Grant DBI-0852081 and by National Institutes of Health Grant 1RC2EY020678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisemberg G.O., 1995, Experientia Supplementum (Basel), V72, P77; Aisemberg GO, 2001, DEV GENES EVOL, V211, P589, DOI 10.1007/s00427-001-0183-2; AISEMBERG GO, 1993, J NEUROBIOL, V24, P1423, DOI 10.1002/neu.480241012; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Baker MW, 2010, DEV BIOL, V344, P346, DOI 10.1016/j.ydbio.2010.06.005; Baker MW, 2000, CURR BIOL, V10, P1071, DOI 10.1016/S0960-9822(00)00674-6; Batchelor PE, 2003, J CLIN NEUROSCI, V10, P523, DOI 10.1016/S0967-5868(03)00004-3; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Biswas SC, 2002, MOL CELL NEUROSCI, V21, P657, DOI 10.1006/mcne.2002.1209; Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x; Blackshaw SE, 2003, J NEUROBIOL, V55, P355, DOI 10.1002/neu.10214; Bruand J., 2011, J PROTEOME IN PRESS; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Croq F, 2010, GLIA, V58, P1649, DOI 10.1002/glia.21036; DERIEMER SA, 1983, BRAIN RES, V272, P157, DOI 10.1016/0006-8993(83)90373-6; DROUET J, 1972, CR SOC BIOL, V166, P1585; Dykes IM, 2004, J NEUROSCI, V24, P886, DOI 10.1523/JNEUROSCI.3676-03.2004; Emes RD, 2003, FEBS LETT, V533, P124, DOI 10.1016/S0014-5793(02)03741-9; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Farooqui AA, 2007, BRAIN RES REV, V56, P443, DOI 10.1016/j.brainresrev.2007.09.004; FERNANDEZ J, 1982, J EMBRYOL EXP MORPH, V72, P71; Finger FP, 2003, DEV BIOL, V261, P220, DOI 10.1016/S0012-1606(03)00296-3; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Gan WB, 1999, J NEUROBIOL, V40, P103, DOI 10.1002/(SICI)1097-4695(199907)40:1<103::AID-NEU9>3.3.CO;2-X; GORIO A, 1986, CRC CR REV CL NEUROB, V2, P241; Guo LH, 2004, J NEUROIMMUNOL, V146, P39, DOI 10.1016/j.jneuroim.2003.09.017; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huang YQ, 1998, J COMP NEUROL, V397, P394; Huang YQ, 1997, J CELL BIOL, V138, P143, DOI 10.1083/jcb.138.1.143; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; *JGI, HELL ROB GEN VERS 1; Ji Y, 2005, J NEUROBIOL, V64, P157, DOI 10.1002/neu.20131; Ji Y, 2001, BBA-GENE STRUCT EXPR, V1519, P246, DOI 10.1016/S0167-4781(01)00234-2; Jie CF, 2000, BBA-PROTEIN STRUCT M, V1479, P1, DOI 10.1016/S0167-4838(00)00030-3; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Korneev Sergei, 1997, Invertebrate Neuroscience, V3, P185, DOI 10.1007/BF02480373; Lemaire R, 2006, ANAL CHEM, V78, P7145, DOI 10.1021/ac060565z; Liebrich M, 2007, ARCH IMMUNOL THER EX, V55, P41, DOI 10.1007/s00005-007-0003-0; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; Lopez-Vales R, 2008, BRAIN, V131, P2620, DOI 10.1093/brain/awn188; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Magnusson YK, 2008, OBESITY, V16, P2745, DOI 10.1038/oby.2008.424; Matias I, 2001, MOL BRAIN RES, V87, P145, DOI 10.1016/S0169-328X(00)00290-4; Mazza M, 2007, PROG NEURO-PSYCHOPH, V31, P12, DOI 10.1016/j.pnpbp.2006.07.010; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Mueller CA, 2006, J NEUROSURG-SPINE, V4, P233, DOI 10.3171/spi.2006.4.3.233; MULLER KJ, 1979, SCIENCE, V206, P87, DOI 10.1126/science.482931; NICHOLLS JG, 1989, Q J EXP PHYSIOL CMS, V74, P965, DOI 10.1113/expphysiol.1989.sp003372; NICHOLLS JG, 1968, J NEUROPHYSIOL, V31, P740, DOI 10.1152/jn.1968.31.5.740; Pereira LA, 2008, CELL BIOCHEM FUNCT, V26, P197, DOI 10.1002/cbf.1432; Popovich PG, 2000, PROG BRAIN RES, V128, P43; Salzet M, 2000, EUR J BIOCHEM, V267, P4917, DOI 10.1046/j.1432-1327.2000.01550.x; Salzet M, 2002, PROSTAG LEUKOTR ESS, V66, P353, DOI 10.1054/plef.2001.0347; Salzet M, 2000, BRAIN RES REV, V34, P69, DOI 10.1016/S0165-0173(00)00041-2; Salzet M, 2009, ANNELIDS IN MODERN BIOLOGY, P154; Samuels SE, 2010, J GEN PHYSIOL, V136, P425, DOI 10.1085/jgp.201010476; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Schikorski D, 2009, J IMMUNOL, V183, P7119, DOI 10.4049/jimmunol.0900538; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Sethi J, 2010, MOL CELL NEUROSCI, V45, P430, DOI 10.1016/j.mcn.2010.08.002; SHEFI O, 2008, J VIS EXP; Silverman-Gavrila LB, 2009, NEUROSCIENCE, V161, P621, DOI 10.1016/j.neuroscience.2009.03.043; Stefano GB, 1998, BRAIN RES, V793, P341, DOI 10.1016/S0006-8993(98)00273-X; Stefano GB, 1997, BRAIN RES, V763, P63, DOI 10.1016/S0006-8993(97)00403-4; Stefano GB, 1996, ADV NEUROIMMUNOL, V6, P265, DOI 10.1016/S0960-5428(96)00022-8; Stefano George B, 2002, Med Sci Monit, V8, pBR199; Stubiger G, 2008, ANAL CHEM, V80, P1664, DOI 10.1021/ac7018766; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Tahtouh M, 2009, EUR CYTOKINE NETW, V20, P95, DOI 10.1684/ecn.2009.0157; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; Tasiemski A, 2000, J NEUROIMMUNOL, V109, P228, DOI 10.1016/S0165-5728(00)00314-3; TASIEMSKI A, 2010, LANDES BIOSCIENCE DE, P708; Touboul D, 2005, J AM SOC MASS SPECTR, V16, P1608, DOI 10.1016/j.jasms.2005.06.005; *U MISS BIOINF CON, VELV OPT VERS 2 1 4; Venkitaramani DV, 2004, J NEUROBIOL, V60, P369, DOI 10.1002/neu.20035; Vergote D, 2004, J BIOL CHEM, V279, P43828, DOI 10.1074/jbc.M403073200; Vergote D, 2006, PROTEOMICS, V6, P4817, DOI 10.1002/pmic.200500902; Wang WZ, 2005, CELL MOL NEUROBIOL, V25, P427, DOI 10.1007/s10571-005-3151-y; Xu YZ, 2003, J BIOL CHEM, V278, P4322, DOI 10.1074/jbc.M210775200; Xu YZ, 1999, J NEUROBIOL, V40, P244, DOI 10.1002/(SICI)1097-4695(199908)40:2<244::AID-NEU10>3.0.CO;2-A; Young AL, 2010, GENOME RES, V20, P249, DOI 10.1101/gr.097956.109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x	89	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18359	10.1371/journal.pone.0018359	http://dx.doi.org/10.1371/journal.pone.0018359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526169	Green Published, gold			2022-12-27	WOS:000290015800007
J	Olsson, M; Pauliny, A; Wapstra, E; Uller, T; Schwartz, T; Blomqvist, D				Olsson, Mats; Pauliny, Angela; Wapstra, Erik; Uller, Tobias; Schwartz, Tonia; Blomqvist, Donald			Sex Differences in Sand Lizard Telomere Inheritance: Paternal Epigenetic Effects Increases Telomere Heritability and Offspring Survival	PLOS ONE			English	Article							LACERTA-AGILIS; OXIDATIVE STRESS; LIFE EXPECTANCY; X-CHROMOSOME; VIPERA-BERUS; LENGTH; AGE; POPULATION; LONGEVITY; SENESCENCE	BACKGROUND: To date, the only estimate of the heritability of telomere length in wild populations comes from humans. Thus, there is a need for analysis of natural populations with respect to how telomeres evolve. METHODOLOGY/PRINCIPAL FINDINGS: Here, we show that telomere length is heritable in free-ranging sand lizards, Lacerta agilis. More importantly, heritability estimates analysed within, and contrasted between, the sexes are markedly different; son-sire heritability is much higher relative to daughter-dam heritability. We assess the effect of paternal age on Telomere Length (TL) and show that in this species, paternal age at conception is the best predictor of TL in sons. Neither paternal age per se at blood sampling for telomere screening, nor corresponding age in sons impact TL in sons. Processes maintaining telomere length are also associated with negative fitness effects, most notably by increasing the risk of cancer and show variation across different categories of individuals (e.g. males vs. females). We therefore tested whether TL influences offspring survival in their first year of life. Indeed such effects were present and independent of sex-biased offspring mortality and offspring malformations. CONCLUSIONS/SIGNIFICANCE: TL show differences in sex-specific heritability with implications for differences between the sexes with respect to ongoing telomere selection. Paternal age influences the length of telomeres in sons and longer telomeres enhance offspring survival.	[Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Olsson, Mats; Pauliny, Angela; Blomqvist, Donald] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Schwartz, Tonia] Iowa State Univ, Ecol Evolut & Organismal Biol Dept, Interdept Genet Program, Ames, IA USA	University of Sydney; University of Gothenburg; University of Tasmania; University of Oxford; Iowa State University	Olsson, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	molsson@uow.edu.au	Olsson, Mats/AAK-5565-2021; Wapstra, Erik/J-7482-2014	Olsson, Mats/0000-0002-4130-1323; Wapstra, Erik/0000-0002-2050-8026; Schwartz, Tonia/0000-0002-7712-2810	Australian Research Council [LX 0774959]; Swedish Science Council	Australian Research Council(Australian Research Council); Swedish Science Council	This project was funded by the Australian Research Council, grant number:LX 0774959. www.arc.gov.au. The authors thank the Swedish Science Council for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001739; ARMANIOS M, 2004, GENETICS, V102, P15960; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Banerjee Partha P., 2009, V523, P383, DOI 10.1007/978-1-59745-190-1_25; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; BECK S, 1990, ANAL CHEM, V62, P2258, DOI 10.1021/ac00220a003; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Falconer D. S., 1981, INTRO QUANTITATIVE G; Francis N, 2006, FEBS LETT, V580, P4713, DOI 10.1016/j.febslet.2006.07.049; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Grant JD, 2001, BIOTECHNIQUES, V31, P1314, DOI 10.2144/01316bc02; Harlow Peter S., 1996, Herpetological Review, V27, P71; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009; Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036; Londono-Vallejo JA, 2010, EPIGENETICS OF AGING, P205, DOI 10.1007/978-1-4419-0639-7_12; Madsen T, 2000, BIOL CONSERV, V94, P257, DOI 10.1016/S0006-3207(99)00127-5; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; ODIERNA G, 1993, AMPHIBIA-REPTILIA, V4, P1; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; Olsson M, 2004, ECOL LETT, V7, P924, DOI 10.1111/j.1461-0248.2004.00652.x; Olsson M, 2001, J HERED, V92, P190, DOI 10.1093/jhered/92.2.190; Olsson M, 2005, EVOLUTION, V59, P221; Olsson M, 2010, BIOL LETTERS, V6, P651, DOI 10.1098/rsbl.2010.0126; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Perez-Rivero G, 2008, FREE RADICAL BIO MED, V45, P1243, DOI 10.1016/j.freeradbiomed.2008.07.017; Price DC, 1996, SCI JUSTICE, V36, P275, DOI 10.1016/S1355-0306(96)72614-X; Roff Derek A., 2006, P267; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schwartz TS, 2008, CONSERV GENET, V9, P715, DOI 10.1007/s10592-006-9238-2; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stindl R, 2004, MED HYPOTHESES, V62, P151, DOI 10.1016/S0306-9877(03)00316-5; Surralles J, 1999, AM J HUM GENET, V65, P1617, DOI 10.1086/302665; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Vogel G, 2009, SCIENCE, V326, P212, DOI 10.1126/science.326_212; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Woo J, 2008, MECH AGEING DEV, V129, P642, DOI 10.1016/j.mad.2008.08.003	51	67	67	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17473	10.1371/journal.pone.0017473	http://dx.doi.org/10.1371/journal.pone.0017473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526170	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800001
J	Vogt, L; Grobe, P; Quast, B; Bartolomaeus, T				Vogt, Lars; Grobe, Peter; Quast, Bjoern; Bartolomaeus, Thomas			Top-Level Categories of Constitutively Organized Material Entities - Suggestions for a Formal Top-Level Ontology	PLOS ONE			English	Article							BIOLOGY; FIAT	Background: Application oriented ontologies are important for reliably communicating and managing data in databases. Unfortunately, they often differ in the definitions they use and thus do not live up to their potential. This problem can be reduced when using a standardized and ontologically consistent template for the top-level categories from a top-level formal foundational ontology. This would support ontological consistency within application oriented ontologies and compatibility between them. The Basic Formal Ontology (BFO) is such a foundational ontology for the biomedical domain that has been developed following the single inheritance policy. It provides the top-level template within the Open Biological and Biomedical Ontologies Foundry. If it wants to live up to its expected role, its three top-level categories of material entity (i.e., 'object', 'fiat object part', 'object aggregate') must be exhaustive, i.e. every concrete material entity must instantiate exactly one of them. Methodology/Principal Findings: By systematically evaluating all possible basic configurations of material building blocks we show that BFO's top-level categories of material entity are not exhaustive. We provide examples from biology and everyday life that demonstrate the necessity for two additional categories: 'fiat object part aggregate' and 'object with fiat object part aggregate'. By distinguishing topological coherence, topological adherence, and metric proximity we furthermore provide a differentiation of clusters and groups as two distinct subcategories for each of the three categories of material entity aggregates, resulting in six additional subcategories of material entity. Conclusions/Significance: We suggest extending BFO to incorporate two additional categories of material entity as well as two subcategories for each of the three categories of material entity aggregates. With these additions, BFO would exhaustively cover all top-level types of material entity that application oriented ontologies may use as templates. Our result, however, depends on the premise that all material entities are organized according to a constitutive granularity.	[Vogt, Lars; Grobe, Peter; Quast, Bjoern; Bartolomaeus, Thomas] Univ Bonn, Inst Evolut Biol & Okol, D-5300 Bonn, Germany	University of Bonn	Vogt, L (corresponding author), Univ Bonn, Inst Evolut Biol & Okol, D-5300 Bonn, Germany.	lars.m.vogt@gmail.com	Vogt, Lars/K-4166-2012	Vogt, Lars/0000-0002-8280-0487; Quast, Bjorn/0000-0002-3760-5834	German Research Foundation DFG [VO 1244/3-2, VO 1244/3-3]	German Research Foundation DFG(German Research Foundation (DFG))	The study was supported by the German Research Foundation DFG (VO 1244/3-2 & VO 1244/3-3) granted to Lars Vogt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard J, 2003, BIOESSAYS, V25, P501, DOI 10.1002/bies.10260; Bard JBL, 2004, NAT REV GENET, V5, P213, DOI 10.1038/nrg1295; Brinkley James F, 2006, AMIA Annu Symp Proc, P96; Brooksbank C, 2006, OMICS, V10, P94, DOI 10.1089/omi.2006.10.94; CASATI R, 1996, PHILOS STUD, V82, P205, DOI 10.1007/BF00364776; Ceusters Werner, 2006, AMIA Annu Symp Proc, P121; DJEDIDI R, 2009, P I KNOW 09 I SEMANT, P611; Eldredge N., 1985, UNFINISHED SYNSIS; Flouris G, 2008, KNOWL ENG REV, V23, P117, DOI 10.1017/S0269888908001367; Gupta A, 2007, LECT NOTES COMPUT SC, V4802, P64; Javed M, 2009, LECT NOTES COMPUT SC, V5872, P544, DOI 10.1007/978-3-642-05290-3_68; Kumar A, 2004, COMP FUNCT GENOM, V5, P501, DOI 10.1002/cfg.429; LIANG Y, 2005, AKT DTA C MILT KEYN; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Mayr E., 1982, GROWTH BIOL THOUGHT; MEJINO JL, 2004, MED P, P48; Mejino Jose V Jr, 2003, AMIA Annu Symp Proc, P450; op Akkerhuis GAJMJ, 2008, BIOL REV, V83, P1, DOI 10.1111/j.1469-185X.2007.00023.x; ROSSE C, 2007, ANATOMY ONTOLOGIES B, P63; Rosse Cornelius, 2005, AMIA Annu Symp Proc, P639; Schulz S, 2009, METHOD INFORM MED, V48, P184, DOI 10.3414/ME9221; Schulz Stefan, 2009, Rev Electron Comun Inf Inov Saude, V3, P31; Smith B, 2005, LECT NOTES COMPUT SC, V3693, P149; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2001, TOPOI-INT REV PHILOS, V20, P131, DOI 10.1023/A:1017948522031; Smith B, 1999, LECT NOTES COMPUT SC, V1661, P267; Smith B, 1995, LECT NOTES COMPUT SC, V988, P475; Smith B, 1997, LECT NOTES COMPUT SC, V1329, P103; Smith B, 2000, PHILOS PHENOMEN RES, V60, P401, DOI 10.2307/2653492; SMITH B, 1994, PARTS WHOLES CONCEPT, P15; Smith B, 2005, J INFORM SYSTEMS, P1; Smith B., 2004, SPAT COGN COMPUT, V25, P25; SMITH B, 2009, ROUTLEDGE COMPANION; SMITH B, 2003, REV ESTETICA, V24, P129; Smith Barry, 2006, STUDIES HLTH TECHNOL, V2006, P57; Spear AD, 2006, ONTOLOGY 21 CENTURY; Stevens R, 2000, Brief Bioinform, V1, P398; STOJANOVIC L, 2002, EUR C KNOWL ENG MAN, P285; Valentine JW, 1996, PALEOBIOLOGY, V22, P23, DOI 10.1017/S0094837300015992; VALENTINE JW, 2004, ORIGIN PHYLA; Vogt L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-289; Vogt L, 2009, ZOOMORPHOLOGY, V128, P201, DOI 10.1007/s00435-008-0081-5	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18794	10.1371/journal.pone.0018794	http://dx.doi.org/10.1371/journal.pone.0018794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533043	Green Published, gold, Green Submitted			2022-12-27	WOS:000290014500011
J	Li, Y; Yi, HY; Yao, YX; Liao, XD; Xie, YQ; Yang, J; Yan, Z; Wang, L; Lu, SY; Kuang, Y; Gu, MM; Fei, J; Wang, ZG; Huang, L				Li, Yuan; Yi, Haiying; Yao, Yixin; Liao, Xiaodong; Xie, Yiqun; Yang, Jie; Yan, Zheng; Wang, Long; Lu, Shunyuan; Kuang, Ying; Gu, Mingmin; Fei, Jian; Wang, Zhugang; Huang, Lei			The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of beta-Catenin	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; TRANSGENIC MOUSE MODELS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; CYCLIN D1; C-MYC; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; EPITHELIAL-CELLS; MICE	MUC1 is an oncoprotein that is overexpressed in up to 90% of breast carcinomas. A previous in vitro study by our group demonstrated that the cytoplasmic domain of MUC1 (MUC1-CD), the minimal functional unit of MUC1, contributes to the malignant phenotype in cells by binding directly to beta-catenin and protecting beta-catenin from GSK3 beta-induced degradation. To understand the in vivo role of MUC1-CD in breast development, we generated a MUC1-CD transgenic mouse model under the control of the MMTV promoter in a C57BL/6J background, which is more resistant to breast tumor. We show that the expression of MUC1-CD in luminal epithelial cells of the mammary gland induced a hyperplasia phenotype characterized by the development of hyper-branching and extensive lobuloalveoli in transgenic mice. In addition to this hyperplasia, there was a marked increase in cellular proliferation in the mouse mammary gland. We further show that MUC1-CD induces nuclear localization of beta-catenin, which is associated with a significant increase of beta-catenin activity, as shown by the elevated expression of cyclin D1 and c-Myc in MMTV-MUC1-CD mice. Consistent with this finding, we observed that overexpression of MUC1-C is associated with beta-catenin nuclear localization in tumor tissues and increased expression of Cyclin D1 and c-Myc in breast carcinoma specimens. Collectively, our data indicate a critical role for MUC1-CD in the development of mammary gland preneoplasia and tumorigenesis, suggesting MUC1-CD as a potential target for the diagnosis and chemoprevention of human breast cancer.	[Li, Yuan; Yao, Yixin; Liao, Xiaodong; Yang, Jie; Yan, Zheng; Gu, Mingmin; Wang, Zhugang; Huang, Lei] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Yi, Haiying; Xie, Yiqun] Shanghai Huangpu Ctr Hosp, Dept Breast Surg, Shanghai, Peoples R China; [Wang, Long; Lu, Shunyuan; Kuang, Ying; Fei, Jian; Wang, Zhugang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University	Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	zhugangw@shsmu.edu.cn; leihuang@shsmu.edu.cn		Yao, Yixin/0000-0003-1891-7186; Huang, Lei/0000-0002-4851-4807	National Natural Science Foundation of China [30671169, 30871363]; New Century Excellent Talents in University; SRF for ROCS of State Education Ministry [NCET-08-0349]; Ministry of Science & Technology of China [2006BAI23B02]; Shanghai Pujiang Program [07pj14065]; Natural Science Foundation of Shanghai by Science and Technology Commission of Shanghai Municipality [06ZR14067]; Shanghai Municipal Education Commission [E03003]; National comprehensive technology platforms for innovative drug R D [2009ZX09301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); SRF for ROCS of State Education Ministry; Ministry of Science & Technology of China(Ministry of Science and Technology, China); Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai by Science and Technology Commission of Shanghai Municipality; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National comprehensive technology platforms for innovative drug R D	This work was supported by the National Natural Science Foundation of China (grant numbers 30671169, 30871363), the New Century Excellent Talents in University and SRF for ROCS of State Education Ministry grant number NCET-08-0349, the Ministry of Science & Technology of China (grant number 2006BAI23B02), the Shanghai Pujiang Program (grant number 07pj14065), the Natural Science Foundation of Shanghai by Science and Technology Commission of Shanghai Municipality (grant number 06ZR14067), the Shanghai Municipal Education Commission (grant number E03003) and the National comprehensive technology platforms for innovative drug R & D, 2009ZX09301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 1996, BREAST CANCER RES TR, V39, P119, DOI 10.1007/BF01806083; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blake JA, 1999, NUCLEIC ACIDS RES, V27, P95, DOI 10.1093/nar/27.1.95; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Brisken C, 2000, GENE DEV, V14, P650; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; GILLETT C, 1994, CANCER RES, V54, P1812; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Huang Lei, 2010, Genes Cancer, V1, P239; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2008, CANCER BIOL THER, V7, P81, DOI 10.4161/cbt.7.1.5631; Kumar R, 2000, ENDOCR-RELAT CANCER, V7, P257, DOI 10.1677/erc.0.0070257; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Medina D, 1996, J MAMMARY GLAND BIOL, V1, P5, DOI 10.1007/BF02096299; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Moser AR, 2001, CANCER RES, V61, P3480; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; PIERCE DF, 1993, GENE DEV, V7, P2308, DOI 10.1101/gad.7.12a.2308; Poh TW, 2009, CANCER RES, V69, P3554, DOI 10.1158/0008-5472.CAN-08-3806; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SPICER AP, 1995, MAMM GENOME, V6, P885, DOI 10.1007/BF00292441; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhao XD, 2006, INT J CANCER, V118, P643, DOI 10.1002/ijc.21400; ZOTTER S, 1988, Cancer Reviews, V11-12, P55	58	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19102	10.1371/journal.pone.0019102	http://dx.doi.org/10.1371/journal.pone.0019102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533058	Green Submitted, Green Published, gold			2022-12-27	WOS:000289719400059
J	Stapleton, CM; Mashek, DG; Wang, SL; Nagle, CA; Cline, GW; Thuillier, P; Leesnitzer, LM; Li, LO; Stimmel, JB; Shulman, GI; Coleman, RA				Stapleton, Cliona M.; Mashek, Douglas G.; Wang, Shuli; Nagle, Cynthia A.; Cline, Gary W.; Thuillier, Philippe; Leesnitzer, Lisa M.; Li, Lei O.; Stimmel, Julie B.; Shulman, Gerald I.; Coleman, Rosalind A.			Lysophosphatidic Acid Activates Peroxisome Proliferator Activated Receptor-gamma in CHO Cells That Over-Express Glycerol 3-Phosphate Acyltransferase-1	PLOS ONE			English	Article							PPAR-GAMMA; FATTY-ACIDS; ALPHA; DIACYLGLYCEROL; MECHANISMS; TRIACYLGLYCEROL; TISSUE; DOMAIN; GENES; LIVER	Lysophosphatidic acid (LPA) is an agonist for peroxisome proliferator activated receptor-gamma (PPAR gamma). Although glycerol-3-phosphate acyltransferase-1 (GPAT1) esterifies glycerol-3-phosphate to form LPA, an intermediate in the de novo synthesis of glycerolipids, it has been assumed that LPA synthesized by this route does not have a signaling role. The availability of Chinese Hamster Ovary (CHO) cells that stably overexpress GPAT1, allowed us to analyze PPAR gamma activation in the presence of LPA produced as an intracellular intermediate. LPA levels in CHO-GPAT1 cells were 6-fold higher than in wild-type CHO cells, and the mRNA abundance of CD36, a PPAR gamma target, was 2-fold higher. Transactivation assays showed that PPAR gamma activity was higher in the cells that overexpressed GPAT1. PPAR gamma activity was enhanced further in CHO-GPAT1 cells treated with the PPAR gamma ligand troglitazone. Extracellular LPA, phosphatidic acid (PA) or a membrane-permeable diacylglycerol had no effect, showing that PPAR gamma had been activated by LPA generated intracellularly. Transient transfection of a vector expressing 1-acylglycerol-3-phosphate acyltransferase-2, which converts endogenous LPA to PA, markedly reduced PPAR gamma activity, as did over-expressing diacylglycerol kinase, which converts DAG to PA, indicating that PA could be a potent inhibitor of PPAR gamma. These data suggest that LPA synthesized via the glycerol-3-phosphate pathway can activate PPAR gamma and that intermediates of de novo glycerolipid synthesis regulate gene expression.	[Stapleton, Cliona M.; Mashek, Douglas G.; Wang, Shuli; Nagle, Cynthia A.; Li, Lei O.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA; [Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Thuillier, Philippe] Oregon Hlth & Sci Univ, Oregon Canc Inst, Portland, OR USA; [Leesnitzer, Lisa M.; Stimmel, Julie B.] GlaxoSmithKline Inc, Dept Screening & Compound Profiling, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Yale University; Yale University; Oregon Health & Science University; GlaxoSmithKline	Stapleton, CM (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA.	rcoleman@unc.edu	Shulman, Gerald I./P-7176-2019; Mashek, Douglas/ABD-6844-2021	Shulman, Gerald I./0000-0003-1529-5668; Mashek, Douglas/0000-0001-7033-3386	NIH [DK56598, DK59935, DK68993, DK40936, U24 DK59635, P30 DK34987]; AICR/WRF; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, F32DK068993, P30DK034987, R01DK059935, R01DK056598, U24DK059635, R56DK056598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICR/WRF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH grants DK56598, DK59935, DK68993, DK40936, U24 DK59635, P30 DK34987; Marilyn Gentry Fellowship from AICR/WRF; Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DAVIS RJ, 1985, J BIOL CHEM, V260, P1562; DEUTSCH J, 1994, ANAL BIOCHEM, V220, P321, DOI 10.1006/abio.1994.1344; Gervois P, 2004, INT J CLIN PRACT, V58, P22, DOI 10.1111/j.1368-504X.2004.00376.x; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Guo W, 2006, AM J PHYSIOL-GASTR L, V290, pG528, DOI 10.1152/ajpgi.00386.2005; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Haque W, 2005, BIOCHEM BIOPH RES CO, V327, P446, DOI 10.1016/j.bbrc.2004.12.024; Holdsworth G, 2005, GENE, V350, P59, DOI 10.1016/j.gene.2005.01.016; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Nichols JS, 1998, ANAL BIOCHEM, V257, P112, DOI 10.1006/abio.1997.2557; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	34	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18932	10.1371/journal.pone.0018932	http://dx.doi.org/10.1371/journal.pone.0018932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533082	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400035
J	Mazandu, GK; Mulder, NJ				Mazandu, Gaston K.; Mulder, Nicola J.			Scoring Protein Relationships in Functional Interaction Networks Predicted from Sequence Data	PLOS ONE			English	Article							INTEGRATION; INTERPRO; INFORMATION; ANNOTATION; FRAMEWORK	The abundance of diverse biological data from various sources constitutes a rich source of knowledge, which has the power to advance our understanding of organisms. This requires computational methods in order to integrate and exploit these data effectively and elucidate local and genome wide functional connections between protein pairs, thus enabling functional inferences for uncharacterized proteins. These biological data are primarily in the form of sequences, which determine functions, although functional properties of a protein can often be predicted from just the domains it contains. Thus, protein sequences and domains can be used to predict protein pair-wise functional relationships, and thus contribute to the function prediction process of uncharacterized proteins in order to ensure that knowledge is gained from sequencing efforts. In this work, we introduce information-theoretic based approaches to score protein-protein functional interaction pairs predicted from protein sequence similarity and conserved protein signature matches. The proposed schemes are effective for data-driven scoring of connections between protein pairs. We applied these schemes to the Mycobacterium tuberculosis proteome to produce a homology-based functional network of the organism with a high confidence and coverage. We use the network for predicting functions of uncharacterised proteins.	[Mazandu, Gaston K.; Mulder, Nicola J.] Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Mazandu, GK (corresponding author), Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Nicola.Mulder@uct.ac.za	Mazandu, Gaston/AAH-6401-2019	Mazandu, Gaston/0000-0002-6441-8006; Mulder, Nicola J/0000-0003-4905-0941	National Bioinformatics Network in South Africa [NBN RFA2008]	National Bioinformatics Network in South Africa	This work was funded by the National Bioinformatics Network in South Africa, grant number NBN RFA2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON PG, 2008, BMC BIOINFORMATICS, V9, P198; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALDI P, 2001, BIOINFORMATICS MACHI; Bastien O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-49; Bastien O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-332; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Cho YR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-382; Chua HN, 2007, BIOINFORMATICS, V23, P3364, DOI 10.1093/bioinformatics/btm520; Chua HN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S8; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Deng MH, 2004, J COMPUT BIOL, V11, P463, DOI 10.1089/1066527041410346; Deng Minghua, 2003, Pac Symp Biocomput, P140; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Hartley RVL, 1928, BELL SYST TECH J, V7, P535, DOI 10.1002/j.1538-7305.1928.tb01236.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KRAWCZYK J, 2009, NUCLEIC ACIDS RES, P1; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; MACKAY JCD, 2004, INFORM THEORY INFERE; Mahdavi Mahmood A., 2007, Genomics Proteomics & Bioinformatics, V5, P177, DOI 10.1016/S1672-0229(08)60005-4; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Murali TM, 2006, NAT BIOTECHNOL, V24, P1474, DOI 10.1038/nbt1206-1474; Myers CL, 2007, BIOINFORMATICS, V23, P2322, DOI 10.1093/bioinformatics/btm332; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; PEARSON WR, TUT ISBM2000; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Subramanian G, 2000, INFECT IMMUN, V68, P1633, DOI 10.1128/IAI.68.3.1633-1648.2000; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; *UNIPROT CONS, 2007, NUCLEIC ACIDS RES, V35, pD224; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Xiong JH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-268; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607	43	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18607	10.1371/journal.pone.0018607	http://dx.doi.org/10.1371/journal.pone.0018607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526183	Green Published, gold			2022-12-27	WOS:000289671100012
J	Choi, CH; DeGuzman, JV; Lamont, RJ; Yilmaz, O				Choi, Chul Hee; DeGuzman, Jefferson V.; Lamont, Richard J.; Yilmaz, Ozlem			Genetic Transformation of an Obligate Anaerobe, P. gingivalis for FMN-Green Fluorescent Protein Expression in Studying Host-Microbe Interaction	PLOS ONE			English	Article							PATHOGEN PORPHYROMONAS-GINGIVALIS; CLPP SERINE-PROTEASE; EPITHELIAL-CELLS; LISTERIA-MONOCYTOGENES; PERIODONTAL-DISEASE; REPORTER PROTEINS; ORAL BACTERIA; SURVIVAL; INVASION; ACTIVATION	The recent introduction of "oxygen-independent" flavin mononucleotide (FMN)-based fluorescent proteins (FbFPs) is of major interest to both eukaryotic and prokaryotic microbial biologists. Accordingly, we demonstrate for the first time that an obligate anaerobe, the successful opportunistic pathogen of the oral cavity, Porphyromonas gingivalis, can be genetically engineered for expression of the non-toxic green FbFP. The resulting transformants are functional for studying dynamic bacterial processes in living host cells. The visualization of the transformed P. gingivalis (PgFbFP) revealed strong fluorescence that reached a maximum emission at 495 nm as determined by fluorescence microscopy and spectrofluorometry. Human primary gingival epithelial cells (GECs) were infected with PgFbFP and the bacterial invasion of host cells was analyzed by a quantitative fluorescence microscopy and antibiotic protection assays. The results showed similar levels of intracellular bacteria for both wild type and PgFbFP strains. In conjunction with organelle specific fluorescent dyes, utilization of the transformed strain provided direct and accurate determination of the live/metabolically active P. gingivalis' trafficking in the GECs over time. Furthermore, the GECs were co-infected with PgFbFP and the ATP-dependent Clp serine protease-deficient mutant (ClpP-) to study the differential fates of the two strains within the same host cells. Quantitative co-localization analyses displayed the intracellular PgFbFP significantly associated with the endoplasmic reticulum network, whereas the majority of ClpP- organisms trafficked into the lysosomes. Hence, we have developed a novel and reliable method to characterize live host cell-microbe interactions and demonstrated the adaptability of FMN-green fluorescent protein for studying persistent host infections induced by obligate anaerobic organisms.	[Choi, Chul Hee; DeGuzman, Jefferson V.; Yilmaz, Ozlem] Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA; [Lamont, Richard J.] Univ Louisville, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA; [Yilmaz, Ozlem] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; University of Louisville; State University System of Florida; University of Florida	Choi, CH (corresponding author), Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA.	oyilmaz@epi.ufl.edu	Yilmaz, Ozlem/ABG-5367-2021	Yilmaz, Ozlem/0000-0003-3487-7217; Choi, Chul Hee/0000-0003-2373-048X	United States National Institute of Dental and Craniofacial Research, National Institutes of Health [R01DE16593, R01DE11111]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011111, R01DE016593] Funding Source: NIH RePORTER	United States National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by the United States National Institute of Dental and Craniofacial Research, National Institutes of Health, R01DE16593 (OY) and R01DE11111(RJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Bajno L, 1999, J IMMUNOL METHODS, V232, P67, DOI 10.1016/S0022-1759(99)00155-6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chalmers NI, 2007, APPL ENVIRON MICROB, V73, P630, DOI 10.1128/AEM.02164-06; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Colombo AV, 2007, J PERIODONTAL RES, V42, P236, DOI 10.1111/j.1600-0765.2006.00938.x; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Gaillot O, 2000, MOL MICROBIOL, V35, P1286, DOI 10.1046/j.1365-2958.2000.01773.x; Gaillot O, 2001, INFECT IMMUN, V69, P4938, DOI 10.1128/IAI.69.8.4938-4943.2001; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Graves DT, 2008, J CLIN PERIODONTOL, V35, P89, DOI 10.1111/j.1600-051X.2007.01172.x; Hajishengallis G, 2007, FRONT BIOSCI-LANDMRK, V12, P4547, DOI 10.2741/2409; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kuboniwa M, 2008, MICROBES INFECT, V10, P122, DOI 10.1016/j.micinf.2007.10.011; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Rudney JD, 2005, J DENT RES, V84, P59, DOI 10.1177/154405910508400110; Scannapieco F A, 2001, Ann Periodontol, V6, P78, DOI 10.1902/annals.2001.6.1.78; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Shoemaker NB, 2000, J BACTERIOL, V182, P928, DOI 10.1128/JB.182.4.928-936.2000; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Valdivia RH, 1998, CURR OPIN MICROBIOL, V1, P359, DOI 10.1016/S1369-5274(98)80042-8; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225, DOI 10.1128/JCM.30.9.2225-2229.1992; Xia QW, 2007, PROTEOMICS, V7, P4323, DOI 10.1002/pmic.200700543; Xie H, 1999, INFECT IMMUN, V67, P3227, DOI 10.1128/IAI.67.7.3227-3235.1999; Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Zhang Y, 2005, PROTEOMICS, V5, P198, DOI 10.1002/pmic.200400922	42	39	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18499	10.1371/journal.pone.0018499	http://dx.doi.org/10.1371/journal.pone.0018499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525983	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600011
J	Jeong, HJ; Choi, Y; Kim, MH; Kang, IC; Lee, JH; Park, C; Park, R; Kim, HM				Jeong, Hyun-Ja; Choi, Youngjin; Kim, Min-Ho; Kang, In-Cheol; Lee, Jeong-Han; Park, Channy; Park, Raekil; Kim, Hyung-Min			Rosmarinic Acid, Active Component of Dansam-Eum Attenuates Ototoxicity of Cochlear Hair Cells through Blockage of Caspase-1 Activity	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; DEATH; HYPOXIA; LINE; SAGE	Cisplatin causes auditory impairment due to the apoptosis of auditory hair cells. There is no strategy to regulate ototoxicity by cisplatin thus far. Dansam-Eum (DSE) has been used for treating the central nerve system injury including hearing loss in Korea. However, disease-related scientific investigation by DSE has not been elucidated. Here, we demonstrated that DSE and its component rosmarinic acid (RA) were shown to inhibit apoptosis of the primary organ of Corti explants as well as the auditory cells. Administration of DSE and RA reduced the thresholds of the auditory brainstem response in cisplatin-injected mice. A molecular docking simulation and a kinetic assay show that RA controls the activity of caspase-1 by interaction with the active site of caspase-1. Pretreatment of RA inhibited caspase-1 downstream signal pathway, such as the activation of caspase-3 and 9, release of cytochrome c, translocation of apoptosis-inducing factor, up-regulation of Bax, down-regulation of Bcl-2, generation of reactive oxygen species, and activation of nuclear factor-kappa B. Anticancer activity by cisplatin was not affected by treatment with RA in SNU668, A549, HCT116, and HeLa cells but not B16F10 cells. These findings show that blocking a critical step by RA in apoptosis may be useful strategy to prevent harmful side effects of ototoxicity in patients with having to undergo chemotherapy.	[Jeong, Hyun-Ja; Choi, Youngjin; Kang, In-Cheol] Hoseo Univ, Biochip Res Ctr, Asan, Chungnam, South Korea; [Kim, Min-Ho] Chonbuk Natl Univ, High Enthalpy Plasma Res Ctr, Jeonju, South Korea; [Lee, Jeong-Han; Park, Raekil] Wonkwang Univ, Sch Med, Vestibulocochlear Res Ctr, Jeonbuk, South Korea; [Lee, Jeong-Han; Park, Raekil] Wonkwang Univ, Sch Med, Dept Microbiol, Jeonbuk, South Korea; [Park, Channy] Nambu Univ, Dept Audiol, Kwangju, Jeonnam, South Korea; [Kim, Hyung-Min] Kyung Hee Univ, Coll Oriental Med, Dept Pharmacol, Seoul, South Korea	Hoseo University; Jeonbuk National University; Wonkwang University; Wonkwang University; Nambu University; Kyung Hee University	Jeong, HJ (corresponding author), Hoseo Univ, Biochip Res Ctr, Asan, Chungnam, South Korea.	hmkim@khu.ac.kr			Ministry of Education, Science and Technology [2009-0067477]; Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Vestibulocochlear Research Center (VCRC) at Wonkwang University [R13-2002-055-00000-0]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Vestibulocochlear Research Center (VCRC) at Wonkwang University(Korea Science and Engineering Foundation)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0067477) and the Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Vestibulocochlear Research Center (VCRC) at Wonkwang University (R13-2002-055-00000-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SA, 2000, HEARING RES, V141, P28, DOI 10.1016/S0378-5955(99)00211-7; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cao H, 2005, J MOL STRUC-THEOCHEM, V719, P177, DOI 10.1016/j.theochem.2005.01.029; Cardinaal RM, 2000, HEARING RES, V144, P147, DOI 10.1016/S0378-5955(00)00060-5; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; Devarajan P, 2002, HEARING RES, V174, P45, DOI 10.1016/S0378-5955(02)00634-2; Exarchou V, 2002, J AGR FOOD CHEM, V50, P5294, DOI 10.1021/jf020408a; Feng Q, 2005, CANCER RES, V65, P8591, DOI 10.1158/0008-5472.CAN-05-0239; Fernandez-Luna JL, 2007, CLIN TRANSL ONCOL, V9, P555, DOI 10.1007/s12094-007-0103-7; Gao LP, 2005, PHARMAZIE, V60, P62; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HUANG Y S, 1992, Yaoxue Xuebao, V27, P96; Humes HD, 1999, ANN NY ACAD SCI, V884, P15, DOI 10.1111/j.1749-6632.1999.tb00278.x; Iuvone T, 2006, J PHARMACOL EXP THER, V317, P1143, DOI 10.1124/jpet.105.099317; Jeong HJ, 2007, J NEUROSCI RES, V85, P896, DOI 10.1002/jnr.21168; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; KIM BC, 2000, J KOREAN ORIENTAL ME, V21, P126; KONDO S, 1995, CANCER RES, V55, P6166; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2085, DOI 10.1093/ndt/gfl209; Li XC, 2007, DRUG METAB DISPOS, V35, P234, DOI 10.1124/dmd.106.013045; Liu W, 1998, NEUROREPORT, V9, P2609, DOI 10.1097/00001756-199808030-00034; Osakabe N, 2004, CARCINOGENESIS, V25, P549, DOI 10.1093/carcin/bgh034; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Renzulli C, 2004, J APPL TOXICOL, V24, P289, DOI 10.1002/jat.982; So HS, 2005, HEARING RES, V204, P127, DOI 10.1016/j.heares.2005.01.011; Takeda H, 2002, EUR J PHARMACOL, V449, P261, DOI 10.1016/S0014-2999(02)02037-X; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Trimmer EE, 1999, ESSAYS BIOCHEM, V34, P191, DOI 10.1042/bse0340191; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Youn J, 2003, J RHEUMATOL, V30, P1203; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100	34	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18815	10.1371/journal.pone.0018815	http://dx.doi.org/10.1371/journal.pone.0018815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526214	Green Submitted, Green Published, gold			2022-12-27	WOS:000289578600035
J	Li, Y; Yang, HA; Cao, J				Li, Ying; Yang, Huan; Cao, Jia			Association between Alcohol Consumption and Cancers in the Chinese Population-A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SQUAMOUS-CELL CARCINOMA; GREEN TEA DRINKING; LOW-RISK AREAS; ESOPHAGEAL CANCER; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; GENETIC POLYMORPHISMS; ALDEHYDE DEHYDROGENASE-2; JIANGSU PROVINCE; GASTRIC-CANCER	Background: Alcohol consumption is increasing worldwide and is associated with numerous cancers. This systematic review examined the role of alcohol in the incidence of cancer in the Chinese population. Methods: Medline/PubMed, EMBASE, CNKI and VIP were searched to identify relevant studies. Cohort and case-control studies on the effect of alcohol use on cancers in Chinese were included. Study quality was evaluated using the Newcastle-Ottawa Scale. Data were independently abstracted by two reviewers. Odds ratios (OR) or relative risks (RR) were pooled using RevMan 5.0. Heterogeneity was evaluated using the Q test and I-squared statistic. P<. 01 was considered statistically significant. Results: Pooled results from cohort studies indicated that alcohol consumption was not associated with gastric cancer, esophageal cancers (EC) or lung cancer. Meta-analysis of case-control studies showed that alcohol consumption was a significant risk factor for five cancers; the pooled ORs were 1.79 (99% CI, 1.47-2.17) EC, 1.40 (99% CI, 1.19-1.64) gastric cancer, 1.56 (99% CI, 1.16-2.09) hepatocellular carcinoma, 1.21 (99% CI, 1.00-1.46) nasopharyngeal cancer and 1.71 (99% CI, 1.20-2.44) oral cancer. Pooled ORs of the case-control studies showed that alcohol consumption was protective for female breast cancer and gallbladder cancer: OR 0.76 (99% CI, 0.60-0.97) and 0.70 (99% CI, 0.49-1.00) respectively. There was no significant correlation between alcohol consumption and lung cancer, colorectal cancer, pancreatic cancer, cancer of the ampulla of Vater, prostate cancer or extrahepatic cholangiocarcinoma. Combined results of case-control and cohort studies showed that alcohol consumption was associated with 1.78- and 1.40-fold higher risks of EC and gastric cancer but was not significantly associated with lung cancer. Conclusions: Health programs focused on limiting alcohol intake may be important for cancer control in China. Further studies are needed to examine the interaction between alcohol consumption and other risk factors for cancers in Chinese and other populations.	[Li, Ying] Third Mil Med Univ, Dept Social Med & Hlth Serv Management, Chongqing, Peoples R China; [Yang, Huan; Cao, Jia] Third Mil Med Univ, Dept Hyg Toxicol, Key Lab Med Protect Electromagnet Radiat, Minist Educ China, Chongqing, Peoples R China	Army Medical University; Army Medical University; Ministry of Education, China	Li, Y (corresponding author), Third Mil Med Univ, Dept Social Med & Hlth Serv Management, Chongqing, Peoples R China.	caojia1962@126.com			Major International (Regional) Joint Research Projects [30320140461]; National Natural Science Foundation of China (NSFC) [30630056, 30771841, 30700676, 30800933]; Ministry of Education, Culture, Sports, Science and Technology of Japan [12670383]	Major International (Regional) Joint Research Projects; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Major International (Regional) Joint Research Projects (30320140461) and National Natural Science Foundation of China (NSFC) (No. 30630056, No. 30771841, No. 30700676, No. 30800933), and by a Grant-in-Aid for Scientific Research on Special Priority Areas of Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12670383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2010, EUR REV MED PHARMACO, V14, P31; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; BI JP, 2005, CHINA PUBLIC HLTH, V26, P661; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Cai L, 2001, WORLD J GASTROENTERO, V7, P792, DOI 10.3748/wjg.v7.i6.792; Cai L, 2006, CANCER-AM CANCER SOC, V106, P2345, DOI 10.1002/cncr.21881; Chang CK, 2006, INT J EPIDEMIOL, V35, P361, DOI 10.1093/ije/dyi282; CHANGCLAUDE JC, 1990, CANCER RES, V50, P2268; CHEN FM, 2008, W CHINA MED J, V23, P1345; CHEN J, 2002, WORLD CHINESE J DIGE, V10, P105; CHEN JC, 2006, CHINESE J PREVENTION, V14, P311; Chen JS, 2002, CHIN J NAT MED, V4, P131; CHEN JS, 2000, STRAIL J PREVENTIVE, V6, P6; Chen K, 2005, EUR J EPIDEMIOL, V20, P149, DOI 10.1007/s10654-004-2953-4; CHEN MR, 2008, FUDAN U J MED SCI, V2, P273; CHEN SD, 2002, ACAD J GUANGDONG COL, V18, P220; CHENG KK, 1995, BRIT MED J, V310, P1094, DOI 10.1136/bmj.310.6987.1094; *CHIN NUTR SOC, 2008, DIET GUID CHIN PEOPL, P90; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DAI Q, 1996, TUMOR, V16, P5; DING JH, 2007, CHINESE J CANC PREVE, V14, P500; DING JH, 2002, B CHINESE CANC, V8, P450; Ding JH, 2009, WORLD J GASTROENTERO, V15, P2395, DOI 10.3748/wjg.15.2395; FAN LH, 2009, J HYGIENE RES, V1, P85; Fan YH, 2008, NUTR CANCER, V60, P354, DOI 10.1080/01635580701883011; FANG YQ, 2002, MED J CHINESE PEOPLE, V4, P289; FEI SJ, 2004, ACTA ACAD MED XUZHOU, V24, P379; FU G, 2007, J ENV OCCUPATIONAL M, V1, P32; Gao CM, 2008, WORLD J GASTROENTERO, V14, P5078, DOI 10.3748/wjg.14.5078; Gao CM, 2007, WORLD J GASTROENTERO, V13, P5725, DOI 10.3748/wjg.v13.i43.5725; Gao Chang-ming, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P599; Gao CM, 1999, JPN J CANCER RES, V90, P614, DOI 10.1111/j.1349-7006.1999.tb00791.x; GAO CM, 2002, J QILU ONCOLOGY, V2, P113; GAO YM, 2005, ACTA ACAD MED NEIMON, V27, P284; GONG Y, 2000, CHINESE PRIMARY HLTH, V5, P54; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guo YM, 2008, WORLD J GASTROENTERO, V14, P1444, DOI 10.3748/wjg.14.1444; [韩仁强 HAN Renqiang], 2008, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V28, P354; He ShuJia, 2008, Tumor, V28, P125; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; *HLTH DRINK ACT CO, 2007, SURV ALC DRINK HLTH; Huang G.Y., 2005, J QILU ONCOLOGY, V12, P405; Huang Gui-pei, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P420; HUANG X, 2009, CHINESE J GASTROENTE, V18, P97; Huang XM, 2006, CENTRAL PLAINS MED J, V33, P37; Hung HC, 1997, CANCER EPIDEM BIOMAR, V6, P901; Ji BT, 1996, CANCER, V77, P2449, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2449::AID-CNCR6>3.0.CO;2-H; Ji BT, 2002, EUR J CANCER PREV, V11, P237, DOI 10.1097/00008469-200206000-00007; JIANG AR, 2004, HEBEI MED J, V26, P851; JIANG XT, 2004, CHINESE J EPIDEMIOLO, V25, P612; Jin Ming-juan, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P370; Jin Ming-Juan, 2007, Ai Zheng, V26, P274; JIN MJ, 2006, J ZHEJIANG U MED SCI, V35, P376; Ke L, 2002, BRIT J CANCER, V86, P346, DOI 10.1038/sj.bjc.6600054; Key J, 2006, CANCER CAUSE CONTROL, V17, P759, DOI 10.1007/s10552-006-0011-0; Lei M. F., 2007, MODERN PREVENTIVE ME, V34, P724; Li H, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-145; Li SP, 2004, PRACT J CANC, V19, P229; Li XM, 2008, ASIAN J ANDROL, V10, P551, DOI 10.1111/j.1745-7262.2008.00384.x; LI Y, 2003, CHINESE J CLIN HEPAT, V3, P140; Liu TT, 2008, WORLD J GASTROENTERO, V14, P3059, DOI 10.3748/wjg.14.3059; LIU XM, 2001, MODERN PREVENTIVE ME, V3, P257; LONGNECKER MP, 1990, CANCER CAUSE CONTROL, V1, P59, DOI 10.1007/BF00053184; LU CD, 2007, J XIN XIANG MED COLL, V1, P66; LU QJ, 2000, CHINA PUBLIC HLTH, V16, P707; LU Y, 2006, CHINESE J PUBLIC HLT, V22, P1419; MA GS, 2009, ACTA NUTRIMENTA SINI, V3, P213; [孟庆玲 Meng qingling], 2008, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V28, P1258; MENG QL, 2008, ACTA U MED NANJING N, V28, P1278; Mu Li-na, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P192; Nichols HB, 2005, CANCER EPIDEM BIOMAR, V14, P41; Pan GW, 1999, AM J IND MED, V35, P272, DOI 10.1002/(SICI)1097-0274(199903)35:3<272::AID-AJIM7>3.0.CO;2-T; PEI GJ, 2008, MODERN PREVENTIVE ME, V14, P2626; Qin JM, 2008, WORLD J GASTROENTERO, V14, P6986, DOI 10.3748/wjg.14.6986; Ragin CC, 2010, GENET MED, V12, P12, DOI 10.1097/GIM.0b013e3181c8e160; Sakoda LC, 2005, INT J CANCER, V115, P618, DOI 10.1002/ijc.20937; Salaspuro MP, 2003, BEST PRACT RES CL GA, V17, P679, DOI 10.1016/S1521-6918(03)00035-0; Setiawan VW, 2000, CANCER EPIDEM BIOMAR, V9, P73; Shen J, 2004, WORLD J GASTROENTERO, V10, P3278, DOI 10.3748/wjg.v10.i22.3278; SHEN XB, 2005, CHINA J LABOUR MED, V22, P382; SHEN XB, 2005, CHINA J LABOUR MED, V22, P325; SHEN YP, 1999, TUMOR, V6, P363; SHI J, 2004, CHINESE J PANCREATOL, V3, P154; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; SUN XW, 2000, J PRACTICAL ONCOLOGY, V14, P181; SUN XW, 1999, J PRACTICAL ONCOLOGY, V17, P220; [付全航 Fu Quanhang], 2007, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V27, P196; TANG Y, 2001, ZHEJIANG J PREVENTIV, V13, P11; TAO LY, 2009, LIVER INT, V31, P759; TAO WH, 2007, ONCOLOGY PROGR, V5, P393; Tao XG, 1999, AM J EPIDEMIOL, V150, P443, DOI 10.1093/oxfordjournals.aje.a010032; Tramacere I, 2010, INT J CANCER, V126, P1474, DOI 10.1002/ijc.24936; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang AH, 2004, WORLD J GASTROENTERO, V10, P940; WANG B, 2004, J 4 MILITARY MED U, V51, P1952; Wang JM, 2007, EUR J GASTROEN HEPAT, V19, P171, DOI 10.1097/MEG.0b013e32800ff77a; Wang Li, 2006, Wei Sheng Yan Jiu, V35, P534; [王莉娜 WANG Lina], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P528; Wang LY, 2008, MATERN CHILD HLTH J, V23, P4630; WANG RD, 2008, CHINESE J PREVENTION, V1, P27; WANG W, 2004, ACTA ACAD MED NANJIN, V4, P344; Wang YP, 2008, CHIN J CANC PREV TRE, V17, P1294; Wang ZM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-287; WEI YH, 2006, CHINESE J DIS CONTRO, V10, P116; Wei YS, 2009, WORLD J GASTROENTERO, V15, P2526, DOI 10.3748/wjg.15.2526; World Health Organisation, 1999, GLOB STAT REP ALC; World Health Organization, 2000, INT GUID MON ALC CON; Wu CF, 2005, WORLD J GASTROENTERO, V11, P5103, DOI 10.3748/wjg.v11.i33.5103; WU J, 2009, CHINA CANC, V4, P322; WU JZ, 2002, TUMOR, V4, P268; WU JZ, 2001, B CHINESE CANC, V12, P705; Wu M, 2006, WORLD J GASTROENTERO, V12, P1686, DOI 10.3748/wjg.v12.i11.1686; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; Wu Y, 2007, WORLD J GASTROENTERO, V13, P6082, DOI 10.3748/wjg.13.6082; XU Z, 2007, NATL J ANDROLOGY, V4, P327; XUE JH, 2005, ZHEJIANG CLIN MED J, V12, P1249; YANG J, 2009, NATL J ANDROLOGY, V1, P7; YANG J, 2004, CHINESE J CLIN ONCOL, V1, P9; Yang J, 2006, INT J UROL, V13, P773, DOI 10.1111/j.1442-2042.2006.01401.x; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yang SJ, 2007, WORLD J GASTROENTERO, V13, P5760, DOI 10.3748/wjg.v13.i43.5760; Yang WJ, 2008, MOL CARCINOGEN, V47, P100, DOI 10.1002/mc.20368; YANG X, 1998, CHINESE J MED, V4, P5; Yang YF, 2008, DIS ESOPHAGUS, V21, P395, DOI 10.1111/j.1442-2050.2007.00789.x; Ye XP, 2008, J GUANGXI MED U, V25, P493; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607; YU SZ, 2001, CHINA ONCOLOGY, V11, P41; Yuan JM, 2006, JNCI-J NATL CANCER I, V98, P482, DOI 10.1093/jnci/djj104; Yuan JM, 2000, INT J CANCER, V85, P364, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;364::AID-IJC12&gt;3.0.CO;2-C; Zhang JY, 1998, AM J TROP MED HYG, V59, P947, DOI 10.4269/ajtmh.1998.59.947; Zhang M, 2007, CARCINOGENESIS, V28, P1074, DOI 10.1093/carcin/bgl252; Zhang P, 2008, JPN J CLIN ONCOL, V38, P861, DOI 10.1093/jjco/hyn111; ZHANG XA, 2008, MED J CHINESE PEOPLE, V8, P943; ZHANG XF, 2004, CANC RES PREVENTION, V31, P597; ZHANG XF, 2009, MODERN PREVENTIVE ME, V5, P819; Zhang XH, 2006, INT J CANCER, V118, P3089, DOI 10.1002/ijc.21748; Zhang YL, 2009, ZHONGHUA ZHONG LIU F, V16, P568; ZHAO DL, 2003, J QILU ONCOLOGY, V1, P27; ZHENG W, 1992, CANCER EPIDEM BIOMAR, V1, P441; Zhou JN, 2003, J ONCOL, V9, P285; Zhou Yan, 2007, Ai Zheng, V26, P581; [周炎 ZHOU Yan], 2006, [肿瘤, Tumor], V26, P1081; Zhu ZZ, 2007, JPN J CLIN ONCOL, V37, P385, DOI 10.1093/jjco/hym034; Zou J, 2000, J Radiat Res, V41 Suppl, P53; ZOU JM, 1999, CHIN J RADIOL MED PR, V19, P90; 鲍萍萍, 2001, 肿瘤, V21, P334	147	75	85	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18776	10.1371/journal.pone.0018776	http://dx.doi.org/10.1371/journal.pone.0018776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526212	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600031
J	Lian, P; Wei, DQ; Wang, JF; Chou, KC				Lian, Peng; Wei, Dong-Qing; Wang, Jing-Fang; Chou, Kuo-Chen			An Allosteric Mechanism Inferred from Molecular Dynamics Simulations on Phospholamban Pentamer in Lipid Membranes	PLOS ONE			English	Article							SOLID-STATE NMR; CARDIAC SARCOPLASMIC-RETICULUM; PERSONALIZED DRUG DESIGN; M2 PROTON CHANNEL; MONOMERIC PHOSPHOLAMBAN; CALCIUM-PUMP; DODECYLPHOSPHOCHOLINE MICELLES; DILATED CARDIOMYOPATHY; CONFORMATIONAL SWITCH; BINDING INTERACTIONS	Phospholamban functions as a regulator of Ca(2+) concentration of cardiac muscle cells by triggering the bioactivity of sarcoplasmic reticulum Ca(2+)-ATPase. In order to understand its dynamic mechanism in the environment of bilayer surroundings, we performed long time-scale molecular dynamic simulations based on the high-resolution NMR structure of phospholamban pentamer. It was observed from the molecular dynamics trajectory analyses that the conformational transitions between the "bellflower" and "pinwheel" modes were detected for phospholamban. Particularly, the two modes became quite similar to each other after phospholamban was phosphorylated at Ser16. Based on these findings, an allosteric mechanism was proposed to elucidate the dynamic process of phospholamban interacting with Ca(2+)-ATPase.	[Lian, Peng; Wei, Dong-Qing] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Lian, Peng; Wei, Dong-Qing] Shanghai Jiao Tong Univ, Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Lian, Peng; Wang, Jing-Fang] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Wei, Dong-Qing; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences	Lian, P (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	dqwei@sjtu.edu.cn; jfwang8113@sjtu.edu.cn	Chou, Kuo-Chen/A-8340-2009; Wang, Jingfang/Q-2597-2018; Lian, Peng/L-3862-2013	Wang, Jingfang/0000-0002-1355-5481; 	Chinese National Basic Research Program (973 Program) [2011CB707500]; Chinese National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX9301-007]; Chinses National Science Foundation [30870476]; Shanghai Natural Science Foundation [10ZR1421500]	Chinese National Basic Research Program (973 Program)(National Basic Research Program of China); Chinese National Comprehensive Technology Platforms for Innovative Drug RD; Chinses National Science Foundation; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by the grants from Chinese National Basic Research Program (973 Program, No. 2011CB707500), Chinese National Comprehensive Technology Platforms for Innovative Drug R&D (No. 2009ZX9301-007), Chinses National Science Foundation (No. 30870476), and Shanghai Natural Science Foundation (No. 10ZR1421500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Chen AA, 2007, J PHYS CHEM B, V111, P6469, DOI 10.1021/jp0708547; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; COLYER J, 1993, CARDIOVASC RES, V27, P1766, DOI 10.1093/cvr/27.10.1766; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Decrouy A, 1996, J MOL CELL CARDIOL, V28, P767, DOI 10.1006/jmcc.1996.0071; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Gong K, 2009, MED CHEM, V5, P242, DOI 10.2174/157340609788185936; Gu RX, 2009, MED CHEM, V5, P250, DOI 10.2174/157340609788185909; Guo XL, 2010, CURR COMPUT-AID DRUG, V6, P139, DOI 10.2174/157340910791202487; Haghighi K, 2004, BIOCHEM BIOPH RES CO, V322, P1214, DOI 10.1016/j.bbrc.2004.07.164; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Houndonougbo Y, 2005, BIOCHEMISTRY-US, V44, P1780, DOI 10.1021/bi0488404; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Kim T, 2009, PROTEINS, V76, P86, DOI 10.1002/prot.22322; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Lee SJ, 2008, BIOPHYS J, V94, P3565, DOI 10.1529/biophysj.107.116335; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maffeo C, 2009, BIOPHYS J, V96, P4853, DOI 10.1016/j.bpj.2009.03.053; Mascioni A, 2002, J AM CHEM SOC, V124, P9392, DOI 10.1021/ja026507m; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; Metcalfe EE, 2004, BIOPHYS J, V87, P1205, DOI 10.1529/biophysj.103.038844; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Oxenoid K, 2007, PROTEIN SCI, V16, P1977, DOI 10.1110/ps.072975107; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST RL, 1972, J BIOL CHEM, V247, P6530; Potluri S, 2006, PROTEINS, V65, P203, DOI 10.1002/prot.21091; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; SAYADI M, BIOPHYS J, V98, P805; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Sugita Y, 2006, BIOCHEMISTRY-US, V45, P11752, DOI 10.1021/bi061071z; Thomas DD, 1998, ANN NY ACAD SCI, V853, P186, DOI 10.1111/j.1749-6632.1998.tb08266.x; Traaseth NJ, 2006, BIOCHEMISTRY-US, V45, P13827, DOI 10.1021/bi0607610; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Wang JF, 2009, PHARMACOGENOMICS, V10, P1213, DOI 10.2217/PGS.09.81; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2009, INTERDISCIP SCI, V1, P214, DOI 10.1007/s12539-009-0047-4; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, MED CHEM, V5, P263, DOI 10.2174/157340609788185954; Wang JF, 2008, CURR TOP MED CHEM, V8, P1656, DOI 10.2174/156802608786786633; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	60	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18587	10.1371/journal.pone.0018587	http://dx.doi.org/10.1371/journal.pone.0018587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525996	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600016
J	Laczy, B; Fulop, N; Onay-Besikci, A; Rosiers, CD; Chatham, JC				Laczy, Boglarka; Fueloep, Norbert; Onay-Besikci, Arzu; Rosiers, Christine Des; Chatham, John C.			Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; FATTY-ACID TRANSLOCASE/CD36; NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; DIABETIC CARDIOMYOPATHY; CARDIOVASCULAR-SYSTEM; SUBSTRATE METABOLISM; ENDOTHELIAL-CELLS; RAT HEARTS; GLUCOSAMINE	Objective: The hexosamine biosynthesis pathway (HBP) flux and protein O-linked N-acetyl-glucosamine (O-GlcNAc) levels have been implicated in mediating the adverse effects of diabetes in the cardiovascular system. Activation of these pathways with glucosamine has been shown to mimic some of the diabetes-induced functional and structural changes in the heart; however, the effect on cardiac metabolism is not known. Therefore, the primary goal of this study was to determine the effects of glucosamine on cardiac substrate utilization. Methods: Isolated rat hearts were perfused with glucosamine (0-10 mM) to increase HBP flux under normoxic conditions. Metabolic fluxes were determined by C-13-NMR isotopomer analysis; UDP-GlcNAc a precursor of O-GlcNAc synthesis was assessed by HPLC and immunoblot analysis was used to determine O-GlcNAc levels, phospho-and total levels of AMPK and ACC, and membrane levels of FAT/CD36. Results: Glucosamine caused a dose dependent increase in both UDP-GlcNAc and O-GlcNAc levels, which was associated with a significant increase in palmitate oxidation with a concomitant decrease in lactate and pyruvate oxidation. There was no effect of glucosamine on AMPK or ACC phosphorylation; however, membrane levels of the fatty acid transport protein FAT/CD36 were increased and preliminary studies suggest that FAT/CD36 is a potential target for O-GlcNAcylation. Conclusion/Interpretation: These data demonstrate that acute modulation of HBP and protein O-GlcNAcylation in the heart stimulates fatty acid oxidation, possibly by increasing plasma membrane levels of FAT/CD36, raising the intriguing possibility that the HBP and O-GlcNAc turnover represent a novel, glucose dependent mechanism for regulating cardiac metabolism.	[Laczy, Boglarka; Fueloep, Norbert; Chatham, John C.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Fueloep, Norbert] Kaposi Mor Cty Hosp, Dept Nephrol, Kaposvar, Hungary; [Onay-Besikci, Arzu] Ankara Univ, Dept Pharmacol, TR-06100 Ankara, Turkey; [Rosiers, Christine Des] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Rosiers, Christine Des] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada	University of Alabama System; University of Alabama Birmingham; Ankara University; Universite de Montreal; Universite de Montreal	Laczy, B (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	jchatham@uab.edu	Onay-Besikci, Arzu/AAH-1413-2020; Rosiers, Christine Des/O-6285-2014	Onay-Besikci, Arzu/0000-0001-6883-1757; Chatham, John/0000-0001-7180-9948	National Institutes of Health [HL079364, HL067464, HL101192]; Canadian Institutes of Health Research (CIHR) [9575]; Scientific and Technological Research Council of Turkey (TUBITAK) [2219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067464, R01HL079364, R01HL101192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL079364, HL067464 and HL101192, JCC), Canadian Institutes of Health Research (CIHR Grants 9575 to CDR.) and The Scientific and Technological Research Council of Turkey (TUBITAK)-2219 (AOB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Arreola R, 2003, FEBS LETT, V551, P63, DOI 10.1016/S0014-5793(03)00896-2; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Chatham JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE342, DOI 10.1152/ajpendo.1999.277.2.E342; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; COMB DG, 1958, J BIOL CHEM, V232, P807; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Coort SLM, 2007, MOL CELL BIOCHEM, V299, P5, DOI 10.1007/s11010-005-9030-5; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gross BJ, 2008, J AM CHEM SOC, V130, P440, DOI 10.1021/ja078125s; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Lloyd SG, 2004, AM J PHYSIOL-HEART C, V287, pH351, DOI 10.1152/ajpheart.00983.2003; Lloyd SG, 2004, MAGN RESON MED, V51, P1279, DOI 10.1002/mrm.20075; LOPASCHUK GD, 1996, HEART DIABETES, P215; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; MARSH SA, AMINO ACIDS IN PRESS; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Onay-Besikci A, 2007, BASIC RES CARDIOL, V102, P436, DOI 10.1007/s00395-007-0661-4; Pang Y, 2004, DIABETES, V53, P1074, DOI 10.2337/diabetes.53.4.1074; RANDLE PJ, 1963, LANCET, V1, P785; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Virkamaki A, 1999, DIABETES, V48, P1101, DOI 10.2337/diabetes.48.5.1101; Wang PP, 2005, AM J PHYSIOL-HEART C, V288, pH2102, DOI 10.1152/ajpheart.00935.2004; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	52	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18417	10.1371/journal.pone.0018417	http://dx.doi.org/10.1371/journal.pone.0018417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494549	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100013
J	Li, XQ; Zhang, TL; Donnelly, D				Li, Xiu-Qing; Zhang, Tieling; Donnelly, Danielle			Selective Loss of Cysteine Residues and Disulphide Bonds in a Potato Proteinase Inhibitor II Family	PLOS ONE			English	Article							GENE; RECEPTOR; DATABASE; COMPLEX; BINDING; TRANSCRIPTS; EXPRESSION; GENERATION; EVOLUTION; PLANTS	Disulphide bonds between cysteine residues in proteins play a key role in protein folding, stability, and function. Loss of a disulphide bond is often associated with functional differentiation of the protein. The evolution of disulphide bonds is still actively debated; analysis of naturally occurring variants can promote understanding of the protein evolutionary process. One of the disulphide bond-containing protein families is the potato proteinase inhibitor II (PI-II, or Pin2, for short) superfamily, which is found in most solanaceous plants and participates in plant development, stress response, and defence. Each PI-II domain contains eight cysteine residues (8C), and two similar PI-II domains form a functional protein that has eight disulphide bonds and two non-identical reaction centres. It is still unclear which patterns and processes affect cysteine residue loss in PI-II. Through cDNA sequencing and data mining, we found six natural variants missing cysteine residues involved in one or two disulphide bonds at the first reaction centre. We named these variants Pi7C and Pi6C for the proteins missing one or two pairs of cysteine residues, respectively. This PI-II-7C/6C family was found exclusively in potato. The missing cysteine residues were in bonding pairs but distant from one another at the nucleotide/protein sequence level. The non-synonymous/synonymous substitution (Ka/Ks) ratio analysis suggested a positive evolutionary gene selection for Pi6C and various Pi7C. The selective deletion of the first reaction centre cysteine residues that are structure-level-paired but sequence-level-distant in PI-II illustrates the flexibility of PI-II domains and suggests the functionality of their transient gene versions during evolution.	[Li, Xiu-Qing; Zhang, Tieling] Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada; [Zhang, Tieling; Donnelly, Danielle] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); McGill University	Li, XQ (corresponding author), Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada.	xiu-qing.li@agr.gc.ca		Li, Xiu-Qing/0000-0002-7308-0596	Agriculture and Agri-Food Canada	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	The research was supported by the Agriculture and Agri-Food Canada A-base grant to XQL on plant molecular genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2005, PLANT MOL BIOL, V57, P189, DOI 10.1007/s11103-004-6959-9; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; Barrette-Ng IH, 2003, J BIOL CHEM, V278, P24062, DOI 10.1074/jbc.M302020200; Barta E, 2002, TRENDS GENET, V18, P600, DOI 10.1016/S0168-9525(02)02771-3; Beekwilder J, 2000, EUR J BIOCHEM, V267, P1975, DOI 10.1046/j.1432-1327.2000.01201.x; Behe MJ, 2004, PROTEIN SCI, V13, P2651, DOI 10.1110/ps.04802904; Belville C, 2009, HUM MOL GENET, V18, P3002, DOI 10.1093/hmg/ddp238; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Fahnoe DC, 2000, ARCH BIOCHEM BIOPHYS, V373, P385, DOI 10.1006/abbi.1999.1586; Fitton HL, 1997, BLOOD COAGUL FIBRIN, V8, P145, DOI 10.1097/00001721-199703000-00009; Flinn B, 2005, PLANT MOL BIOL, V59, P407, DOI 10.1007/s11103-005-0185-y; GREENBLATT HM, 1989, J MOL BIOL, V205, P201, DOI 10.1016/0022-2836(89)90376-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkes J. G., 1988, Kulturpflanze, V36, P189; JONGSMA MA, 1995, MOL BREEDING, V1, P181, DOI 10.1007/BF01249702; Knudsen SM, 1997, FEBS LETT, V412, P141, DOI 10.1016/S0014-5793(97)00714-X; KRYSTEK S, 1993, J MOL BIOL, V234, P661, DOI 10.1006/jmbi.1993.1619; Li XQ, 1998, P NATL ACAD SCI USA, V95, P10032, DOI 10.1073/pnas.95.17.10032; Li XQ, 2005, THEOR APPL GENET, V110, P1068, DOI 10.1007/s00122-005-1927-6; Li XQ, 1996, PLANT CELL, V8, P1961, DOI 10.1105/tpc.8.11.1961; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Lynch M, 2005, PROTEIN SCI, V14, P2217, DOI 10.1110/ps.041171805; MIYATA T, 1981, P NATL ACAD SCI-BIOL, V78, P450, DOI 10.1073/pnas.78.1.450; PENACORTES H, 1992, PLANTA, V186, P495, DOI 10.1007/BF00198028; PERLMAN JH, 1995, J BIOL CHEM, V270, P24682, DOI 10.1074/jbc.270.42.24682; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Schirra HJ, 2010, J MOL BIOL, V395, P609, DOI 10.1016/j.jmb.2009.11.031; Sin SF, 2006, PLANT J, V45, P58, DOI 10.1111/j.1365-313X.2005.02597.x; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thangudu RR, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-55; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van Vlijmen HWT, 2004, J MOL BIOL, V335, P1083, DOI 10.1016/j.jmb.2003.10.077; YOUNG RJ, 1994, PLANT PHYSIOL, V104, P811, DOI 10.1104/pp.104.2.811; ZHANG T, 2008, J HUAZHONG AGR U, V27, P10	38	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18615	10.1371/journal.pone.0018615	http://dx.doi.org/10.1371/journal.pone.0018615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494600	gold, Green Submitted, Green Published			2022-12-27	WOS:000289354100026
J	Dorr, J; Wernecke, KD; Bock, M; Gaede, G; Wuerfel, JT; Pfueller, CF; Bellmann-Strobl, J; Freing, A; Brandt, AU; Friedemann, P				Doerr, Jan; Wernecke, Klaus D.; Bock, Markus; Gaede, Gunnar; Wuerfel, Jens T.; Pfueller, Caspar F.; Bellmann-Strobl, Judith; Freing, Alina; Brandt, Alexander U.; Friedemann, Paul			Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; AXONAL DAMAGE; NEURONAL LOSS; DISABILITY; MS; ROBUST; ACCURATE; IMAGES; OPTIMIZATION	Neuroaxonal degeneration in the central nervous system contributes substantially to the long term disability in multiple sclerosis (MS) patients. However, in vivo determination and monitoring of neurodegeneration remain difficult. As the widely used MRI-based approaches, including the brain parenchymal fraction (BPF) have some limitations, complementary in vivo measures for neurodegeneration are necessary. Optical coherence tomography (OCT) is a potent tool for the detection of MS-related retinal neurodegeneration. However, crucial aspects including the association between OCT- and MRI-based atrophy measures or the impact of MS-related parameters on OCT parameters are still unclear. In this large prospective cross-sectional study on 104 relapsing remitting multiple sclerosis (RRMS) patients we evaluated the associations of retinal nerve fiber layer thickness (RNFLT) and total macular volume (TMV) with BPF and addressed the impact of disease-determining parameters on RNFLT, TMV or BPF. BPF, normalized for subject head size, was estimated with SIENAX. Relations were analyzed primarily by Generalized Estimating Equation (GEE) models considering within-patient inter-eye relations. We found that both RNFLT (p = 0.019, GEE) and TMV (p = 0.004, GEE) associate with BPF. RNFLT was furthermore linked to the disease duration (p<0.001, GEE) but neither to disease severity nor patients' age. Contrarily, BPF was rather associated with severity (p<0.001, GEE) than disease duration and was confounded by age (p<0.001, GEE). TMV was not associated with any of these parameters. Thus, we conclude that in RRMS patients with relatively short disease duration and rather mild disability RNFLT and TMV reflect brain atrophy and are thus promising parameters to evaluate neurodegeneration in MS. Furthermore, our data suggest that RNFLT and BPF reflect different aspects of MS. Whereas BPF best reflects disease severity, RNFLT might be the better parameter for monitoring axonal damage longitudinally. Longitudinal studies are necessary for validation of data and to further clarify the relevance of TMV.	[Doerr, Jan; Bock, Markus; Gaede, Gunnar; Pfueller, Caspar F.; Bellmann-Strobl, Judith; Freing, Alina; Brandt, Alexander U.; Friedemann, Paul] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Wernecke, Klaus D.] Sophisticated Stat Anal GmbH, Berlin, Germany; [Wuerfel, Jens T.] Med Univ Lubeck, Inst Neuroradiol, D-23538 Lubeck, Germany; [Bellmann-Strobl, Judith; Friedemann, Paul] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith; Friedemann, Paul] Max Delbruck Ctr Mol Med, Berlin, Germany; [Brandt, Alexander U.] Gfnmediber GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Dorr, J (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	jan-markus.doerr@charite.de		paul, friedemann/0000-0002-6378-0070; Wuerfel, Jens/0000-0002-0034-8053; Bellmann-Strobl, Judith/0000-0003-2615-1643	German Research Foundation; German Ministry of Economics to NeuroCure Clinical Research Center [KF2286101FO9]; gfnmediber GmbH; TEVA Pharma GmbH, Germany; German Ministry of Economics [KF2286101FO9]	German Research Foundation(German Research Foundation (DFG)); German Ministry of Economics to NeuroCure Clinical Research Center; gfnmediber GmbH; TEVA Pharma GmbH, Germany; German Ministry of Economics	This work was supported by grants from the Excellence Cluster 257 of the German Research Foundation to NeuroCure Clinical Research Center, grant KF2286101FO9 from the German Ministry of Economics to NeuroCure Clinical Research Center and gfnmediber GmbH (www.gfnmediber.de) and a limited research grant by TEVA Pharma GmbH, Germany (www.teva-deutschland.de). These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Besides their scientific affiliation at the Charite, Alexander U. Brandt and Klaus-Dieter Wernecke are employed by gfnmediber (AU Brandt) and SoStAna (KD Wernecke, www.sostana.com). Alexander U. Brandt contributed to this project (study design, statistical analysis and preparation of the manuscript) in his role as scientist and not as employee of gfnmediber GmbH. Apart from partial funding (grant KF2286101FO9 from the German Ministry of Economics) the company gfnmediber GmbH had no further role in this project. Klaus-Dieter Wernecke contributed to this project (study design, statistical analysis) in his role as scientist at the Charite and not as CEO of SoStAna. The company SoStAna itself had no role in this project.	Audoin B, 2007, MULT SCLER J, V13, P483, DOI 10.1177/1352458506070450; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; BOCK M, 2010, CLIN NEUROL NEUROSUR; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalkers NF, 2001, NEUROLOGY, V57, P1253, DOI 10.1212/WNL.57.7.1253; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pueyo V, 2008, MULT SCLER J, V14, P609, DOI 10.1177/1352458507087326; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Schirmer L, 2009, ANN NEUROL, V66, P698, DOI 10.1002/ana.21799; Sergott RC, 2007, J NEUROL SCI, V263, P3, DOI 10.1016/j.jns.2007.05.024; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	35	107	107	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18132	10.1371/journal.pone.0018132	http://dx.doi.org/10.1371/journal.pone.0018132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494659	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000289292800004
J	Liang, XD; Hall, JW; Yang, JS; Yan, MY; Doll, K; Bey, R; Ji, YD				Liang, Xudong; Hall, Jeffrey W.; Yang, Junshu; Yan, Meiying; Doll, Katherine; Bey, Russell; Ji, Yinduo			Identification of Single Nucleotide Polymorphisms Associated with Hyperproduction of Alpha-Toxin in Staphylococcus aureus	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; IN-VITRO; VIRULENCE DETERMINANTS; EPITHELIAL-CELLS; GENE-EXPRESSION; BETA-TOXIN; HEMOLYSIN; REGULATOR; APOPTOSIS; SARA	The virulence factor alpha-toxin (hla) is needed by Staphylococcus aureus in order to cause infections in both animals and humans. Although the complicated regulation of hla expression has been well studied in human S. aureus isolates, the mechanisms of of hla regulation in bovine S. aureus isolates remain undefined. In this study, we found that many bovine S. aureus isolates, including the RF122 strain, generate dramatic amounts of alpha-toxin in vitro compared with human clinical S. aureus isolates, including MRSA WCUH29 and MRSA USA300. To elucidate potential regulatory mechanisms, we analyzed the hla promoter regions and identified predominant single nucleotide polymorphisms (SNPs) at positions -376, -483, and -484 from the start codon in a-toxin hyper-producing isolates. Using site-directed mutagenesis and hla promoter-gfp-luxABCDE dual reporter approaches, we demonstrated that the SNPs contribute to the differential control of hla expression among bovine and human S. aureus isolates. Using a DNA affinity assay, gel-shift assays and a null mutant, we identified and revealed that an hla positive regulator, SarZ, contributes to the involvement of the SNPs in mediating hla expression. In addition, we found that the bovine S. aureus isolate RF122 exhibits higher transcription levels of hla positive regulators, including agrA, saeR, arlR and sarZ, but a lower expression level of hla repressor rot compared to the human S. aureus isolate WCUH29. Our results indicate alpha-toxin hyperproduction in bovine S. aureus is a multifactorial process, influenced at both the genomic and transcriptional levels. Moreover, the identification of predominant SNPs in the hla promoter region may provide a novel method for genotyping the S. aureus isolates.	[Liang, Xudong; Hall, Jeffrey W.; Yang, Junshu; Yan, Meiying; Doll, Katherine; Bey, Russell; Ji, Yinduo] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Liang, XD (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	jixxx002@umn.edu		Hall, Jeffrey/0000-0002-0214-4062	MAES Competitive Grants; NIH [AI057451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057451] Funding Source: NIH RePORTER	MAES Competitive Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the MAES Competitive Grants and partially by NIH grant AI057451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Bayer AS, 1997, INFECT IMMUN, V65, P4652, DOI 10.1128/IAI.65.11.4652-4660.1997; Bonnstetter KK, 2007, J CLIN MICROBIOL, V45, P141, DOI 10.1128/JCM.01228-06; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Guinane CM, 2008, J INFECT DIS, V197, P205, DOI 10.1086/524689; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; JONSSON P, 1985, INFECT IMMUN, V49, P765, DOI 10.1128/IAI.49.3.765-769.1985; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; KENNY K, 1992, CAN J VET RES, V56, P265; Kernodle DS, 1997, INFECT IMMUN, V65, P179, DOI 10.1128/IAI.65.1.179-184.1997; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kovacikova G, 2000, J BACTERIOL, V182, P3228, DOI 10.1128/JB.182.11.3228-3238.2000; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Larsen HD, 2002, VET MICROBIOL, V85, P61, DOI 10.1016/S0378-1135(01)00478-3; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Liang XD, 2007, CELL MICROBIOL, V9, P1809, DOI 10.1111/j.1462-5822.2007.00917.x; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; LOEFFLER DA, 1987, VET IMMUNOL IMMUNOP, V14, P145, DOI 10.1016/0165-2427(87)90049-3; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Nascimento JD, 2002, VET MICROBIOL, V85, P133, DOI 10.1016/S0378-1135(01)00476-X; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Patel D, 2006, INFECT IMMUN, V74, P2849, DOI 10.1128/IAI.74.5.2849-2855.2006; Qazi SNA, 2004, J BACTERIOL, V186, P1065, DOI 10.1128/JB.186.4.1065-1077.2004; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Sun JS, 2005, J BACTERIOL, V187, P7876, DOI 10.1128/JB.187.22.7876-7880.2005; Takeuchi S, 2001, VET MICROBIOL, V79, P267, DOI 10.1016/S0378-1135(00)00354-0; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210	56	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18428	10.1371/journal.pone.0018428	http://dx.doi.org/10.1371/journal.pone.0018428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494631	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800016
J	Walther, BD; Dempster, T; Letnic, M; McCulloch, MT				Walther, Benjamin D.; Dempster, Tim; Letnic, Mike; McCulloch, Malcolm T.			Movements of Diadromous Fish in Large Unregulated Tropical Rivers Inferred from Geochemical Tracers	PLOS ONE			English	Article							BARRAMUNDI LATES-CALCARIFER; STRONTIUM ISOTOPE COMPOSITION; SHAD ALOSA-SAPIDISSIMA; FRESH-WATER; OTOLITH CHEMISTRY; LIFE-HISTORY; JUVENILE BARRAMUNDI; MARINE FISH; SR ISOTOPES; ENVIRONMENTAL HISTORIES	Patterns of migration and habitat use in diadromous fishes can be highly variable among individuals. Most investigations into diadromous movement patterns have been restricted to populations in regulated rivers, and little information exists for those in unregulated catchments. We quantified movements of migratory barramundi Lates calcarifer (Bloch) in two large unregulated rivers in northern Australia using both elemental (Sr/Ba) and isotope ((87)Sr/(86)Sr) ratios in aragonitic ear stones, or otoliths. Chemical life history profiles indicated significant individual variation in habitat use, particularly among chemically distinct freshwater habitats within a catchment. A global zoning algorithm was used to quantify distinct changes in chemical signatures across profiles. This algorithm identified between 2 and 6 distinct chemical habitats in individual profiles, indicating variable movement among habitats. Profiles of (87)Sr/(86)Sr ratios were notably distinct among individuals, with highly radiogenic values recorded in some otoliths. This variation suggested that fish made full use of habitats across the entire catchment basin. Our results show that unrestricted movement among freshwater habitats is an important component of diadromous life histories for populations in unregulated systems.	[Walther, Benjamin D.; McCulloch, Malcolm T.] Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Coral Reef, Canberra, ACT, Australia; [Walther, Benjamin D.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Dempster, Tim] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Letnic, Mike] Univ Western Sydney, Sch Nat Sci, Penrith, NSW, Australia; [McCulloch, Malcolm T.] Univ Western Australia, Sch Earth & Environm, Australian Res Council Ctr Excellence Coral Reef, Crawley, WA, Australia	Australian National University; University of Texas System; University of Texas Austin; University of Melbourne; Western Sydney University; University of Western Australia	Walther, BD (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Coral Reef, Canberra, ACT, Australia.	bwalther@mail.utexas.edu	McCulloch, Malcolm T/C-3651-2009; Walther, Benjamin/W-2681-2019; Walther, Benjamin D/A-7284-2009; Dempster, Tim/E-9630-2011	McCulloch, Malcolm T/0000-0003-1538-1558; Walther, Benjamin D/0000-0002-2902-4001; Dempster, Tim/0000-0001-8041-426X; Letnic, Michael/0000-0003-4191-8427	ARC Centre of Excellence for Coral Reef Studies; Hermon Slade Foundation [HSF 07/10]	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Hermon Slade Foundation	BDW and MTM gratefully acknowledge support by the ARC Centre of Excellence for Coral Reef Studies (http://www.coralcoe.org.au/). ML and TD were supported by an award from the Hermon Slade Foundation, grant number HSF 07/10 (http://www.hermonslade.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG G, 1989, J HYDROL, V109, P65, DOI 10.1016/0022-1694(89)90007-3; Aubert D, 2002, APPL GEOCHEM, V17, P285, DOI 10.1016/S0883-2927(01)00080-4; BACON MP, 1972, EARTH PLANET SC LETT, V16, P66, DOI 10.1016/0012-821X(72)90237-3; Bailey SW, 1996, WATER RESOUR RES, V32, P707, DOI 10.1029/95WR03642; Bain DC, 1998, CATENA, V32, P143, DOI 10.1016/S0341-8162(97)00055-6; Banner JL, 2004, EARTH-SCI REV, V65, P141, DOI 10.1016/S0012-8252(03)00086-2; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Brown RJ, 2009, CAN J FISH AQUAT SCI, V66, P1790, DOI 10.1139/F09-112; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Cappo M, 2005, MAR FRESHWATER RES, V56, P713, DOI 10.1071/MF04218; CHAN LH, 1976, EARTH PLANET SC LETT, V32, P258, DOI 10.1016/0012-821X(76)90066-2; Coffey M, 1997, ESTUAR COAST SHELF S, V45, P113, DOI 10.1006/ecss.1996.0157; Cook PG, 2003, J HYDROL, V277, P74, DOI 10.1016/S0022-1694(03)00087-8; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; DAVIS TLO, 1988, ENVIRON BIOL FISH, V21, P161, DOI 10.1007/BF00004860; DAVIS TLO, 1985, AUST J MAR FRESH RES, V36, P177; Doupe RG, 2002, RIVER RES APPL, V18, P307, DOI 10.1002/rra.676; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2002, CAN J FISH AQUAT SCI, V59, P1796, DOI 10.1139/F02-154; Faure G., 1972, STRONTIUM ISOTOPE GE; Griffin R.K., 1987, AM FISH SOC S, V1, P358; Griffin RK, 1994, THIRD ASIAN FISHERIES FORUM, P472; GRIFFIN RK, 2007, 84 NO TERR DEP PRIM; Hedger RD, 2008, ECOL INFORM, V3, P207, DOI 10.1016/j.ecoinf.2008.04.001; Jonsson B, 1999, ICES J MAR SCI, V56, P405, DOI 10.1006/jmsc.1999.0483; KEENAN CP, 1994, AUST J MAR FRESH RES, V45, P1123, DOI 10.1071/MF9941123; Kennedy BP, 2002, CAN J FISH AQUAT SCI, V59, P925, DOI [10.1139/f02-070, 10.1139/F02-070]; Kennedy BP, 2000, CAN J FISH AQUAT SCI, V57, P2280, DOI 10.1139/cjfas-57-11-2280; KOWARSKY J, 1981, AUST J MAR FRESH RES, V32, P93; Krabbenhoft A, 2010, GEOCHIM COSMOCHIM AC, V74, P4097, DOI 10.1016/j.gca.2010.04.009; Kraus RT, 2004, J EXP MAR BIOL ECOL, V302, P85, DOI 10.1016/j.jembe.2003.10.004; Letnic M, 2006, WILDLIFE RES, V33, P529, DOI 10.1071/WR05090; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; LIMBURG KE, 1995, MAR ECOL PROG SER, V119, P25, DOI 10.3354/meps119025; Martin GB, 2004, CAN J FISH AQUAT SCI, V61, P34, DOI 10.1139/F03-143; McCulloch M, 2005, MAR FRESHWATER RES, V56, P637, DOI 10.1071/MF04184; McDowall RM, 1999, ICES J MAR SCI, V56, P410, DOI 10.1006/jmsc.1999.0450; McDowall RM, 2009, AM FISH S S, V69, P1; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Milton DA, 2005, MAR ECOL PROG SER, V301, P279, DOI 10.3354/meps301279; Milton DA, 2003, CAN J FISH AQUAT SCI, V60, P1376, DOI 10.1139/F03-133; Milton DA, 2001, J EXP MAR BIOL ECOL, V264, P47, DOI 10.1016/S0022-0981(01)00301-X; Milton D, 2008, ESTUAR COAST SHELF S, V78, P301, DOI 10.1016/j.ecss.2007.12.009; MOORE R, 1982, AUST J MAR FRESH RES, V33, P671, DOI 10.1071/MF9820671; Moore WS, 2008, MAR CHEM, V108, P236, DOI 10.1016/j.marchem.2007.03.004; PALMER MR, 1992, GEOCHIM COSMOCHIM AC, V56, P2099, DOI 10.1016/0016-7037(92)90332-D; Pender PJ, 1996, T AM FISH SOC, V125, P679, DOI 10.1577/1548-8659(1996)125<0679:HHOBCI>2.3.CO;2; Quinn TP, 2009, AM FISH S S, V69, P23; Robins J, 2006, J FISH BIOL, V69, P379, DOI 10.1111/j.1095-8649.2006.01100.x; Rose S, 2005, APPL GEOCHEM, V20, P1571, DOI 10.1016/j.apgeochem.2005.04.015; RUSSELL DJ, 1988, AUST J MAR FRESH RES, V39, P117; RUSSELL DJ, 1983, AUST J MAR FRESH RES, V34, P805; RUSSELL DJ, 1985, AUST J MAR FRESH RES, V36, P191, DOI 10.1071/MF9850191; SALINI J, 1988, AUST J MAR FRESH RES, V39, P317, DOI 10.1071/MF9880317; Secor DH, 2007, J SEA RES, V57, P91, DOI 10.1016/j.seares.2006.09.004; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Shand P, 2009, APPL GEOCHEM, V24, P574, DOI 10.1016/j.apgeochem.2008.12.011; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; Staunton-Smith J, 2004, MAR FRESHWATER RES, V55, P787, DOI 10.1071/MF03198; Tipper ET, 2006, GEOCHIM COSMOCHIM AC, V70, P2737, DOI 10.1016/j.gca.2006.03.005; WALKER KF, 1985, HYDROBIOLOGIA, V125, P111, DOI 10.1007/BF00045929; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Walther BD, 2010, ENVIRON BIOL FISH, V89, P441, DOI 10.1007/s10641-010-9661-6; Walther BD, 2008, CAN J FISH AQUAT SCI, V65, P2623, DOI 10.1139/F08-164; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Zar JH., 1999, BIOSTAT ANAL	72	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18351	10.1371/journal.pone.0018351	http://dx.doi.org/10.1371/journal.pone.0018351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494693	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400024
J	Molnar, F; Sigueiro, R; Sato, Y; Araujo, C; Schuster, I; Antony, P; Peluso, J; Muller, C; Mourino, A; Moras, D; Rochel, N				Molnar, Ferdinand; Sigueeiro, Rita; Sato, Yoshiteru; Araujo, Clarisse; Schuster, Inge; Antony, Pierre; Peluso, Jean; Muller, Christian; Mourino, Antonio; Moras, Dino; Rochel, Natacha			1 alpha,25(OH)(2)-3-Epi-Vitamin D-3, a Natural Physiological Metabolite of Vitamin D-3: Its Synthesis, Biological Activity and Crystal Structure with Its Receptor	PLOS ONE			English	Article							C-3 EPIMERIZATION PATHWAY; C-24 OXIDATION PATHWAY; A-RING DIASTEREOMERS; D-NUCLEAR-RECEPTOR; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1-ALPHA,25-DIHYDROXY-3-EPI-VITAMIN D-3; CALCIUM-TRANSPORT; ORGANIC-CHEMISTRY; PHOSPHINE OXIDE; GENE PROMOTER	Background: The 1 alpha,25-dihydroxy-3-epi-vitamin-D-3 (1 alpha,25(OH)(2)-3-epi-D-3), a natural metabolite of the seco-steroid vitamin D-3, exerts its biological activity through binding to its cognate vitamin D nuclear receptor (VDR), a ligand dependent transcription regulator. In vivo action of 1 alpha,25(OH)(2)-3-epi-D-3 is tissue-specific and exhibits lowest calcemic effect compared to that induced by 1 alpha,25(OH)(2)D-3. To further unveil the structural mechanism and structure-activity relationships of 1 alpha,25(OH)(2)-3-epi-D3 and its receptor complex, we characterized some of its in vitro biological properties and solved its crystal structure complexed with human VDR ligand-binding domain (LBD). Methodology/Principal Findings: In the present study, we report the more effective synthesis with fewer steps that provides higher yield of the 3-epimer of the 1 alpha,25(OH)(2)D-3. We solved the crystal structure of its complex with the human VDR-LBD and found that this natural metabolite displays specific adaptation of the ligand-binding pocket, as the 3-epimer maintains the number of hydrogen bonds by an alternative water-mediated interaction to compensate the abolished interaction with Ser278. In addition, the biological activity of the 1 alpha,25(OH)(2)-3-epi-D-3 in primary human keratinocytes and biochemical properties are comparable to 1 alpha,25(OH)(2)D-3. Conclusions/Significance: The physiological role of this pathway as the specific biological action of the 3-epimer remains unclear. However, its high metabolic stability together with its significant biologic activity makes this natural metabolite an interesting ligand for clinical applications. Our new findings contribute to a better understanding at molecular level how natural metabolites of 1 alpha,25(OH)(2)D-3 lead to significant activity in biological systems and we conclude that the C3-epimerization pathway produces an active metabolite with similar biochemical and biological properties to those of the 1 alpha,25(OH)(2)D-3.	[Molnar, Ferdinand; Sato, Yoshiteru; Antony, Pierre; Moras, Dino; Rochel, Natacha] Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR 7104, Illkirch Graffenstaden, France; [Molnar, Ferdinand] Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Sigueeiro, Rita; Araujo, Clarisse; Mourino, Antonio] Univ Santiago de Compostela, Dept Quim Organ, Santiago De Compostela, Spain; [Sigueeiro, Rita; Araujo, Clarisse; Mourino, Antonio] CSIC, Unidad Asociada, Santiago De Compostela, Spain; [Schuster, Inge] Univ Vienna, Inst Pharmaceut Chem, A-1090 Vienna, Austria; [Peluso, Jean; Muller, Christian] Univ Strasbourg, CNRS, Fac Pharm, Inst Gilbert Laustriat,UMR 7175, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Eastern Finland; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); University of Vienna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Molnar, F (corresponding author), Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR 7104, Illkirch Graffenstaden, France.	rochel@igbmc.fr	Molnár, Ferdinand/E-2290-2011; Rochel, Natacha/A-5718-2016; schuster, inge/B-5304-2013; MULLER, Christian D./F-8399-2010	Molnár, Ferdinand/0000-0001-9008-4233; Rochel, Natacha/0000-0002-3573-5889; MULLER, Christian D./0000-0002-3463-1025; Mourino, Antonio/0000-0003-4803-3883	CNRS; INSERM; ULP; European Commission [LSHG-CT-2006-031220]; Spanish Ministry of Education and Science [SAF2007-67205]; Xunta de Galicia [INCITE08PXIB-209130PR, ACEUIC-2006/XA050]; Spanish MEC; Academy of Finland [128226]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ULP; European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education and Science(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish MEC(Spanish Government); Academy of Finland(Academy of Finland)	This study received financial support from CNRS, INSERM, ULP, the European Commission as SPINE2-complexes (contract no. LSHG-CT-2006-031220) under the RDT programme 'Quality of Life and Management of Living Resources', the Spanish Ministry of Education and Science (Grant SAF2007-67205) and Xunta de Galicia (Projects INCITE08PXIB-209130PR and ACEUIC-2006/XA050). Dishman-Netherlands provided the gift of vitamin D2. R. S. thanks the Spanish MEC for a predoctoral fellowship. F. M. thanks the Academy of Finland for a postdoctoral fellowship (128226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; BIKLE DD, 1986, BIOCHEMISTRY-US, V25, P1545, DOI 10.1021/bi00355a013; Bischof MG, 1998, EXP CELL RES, V241, P194, DOI 10.1006/excr.1998.4044; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Brown AJ, 1999, J CELL BIOCHEM, V73, P106, DOI 10.1002/(SICI)1097-4644(19990401)73:1&lt;106::AID-JCB12&gt;3.0.CO;2-Q; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Choi MW, 2001, BIOORGAN MED CHEM, V9, P1721, DOI 10.1016/S0968-0896(01)00060-8; COREY EJ, 1972, TETRAHEDRON LETT, V13, P3769, DOI DOI 10.1016/S0040-4039(01)94157-7; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daniewski AR, 2002, J ORG CHEM, V67, P1580, DOI 10.1021/jo0161577; DeLuca HF, 2008, NUTR REV, V66, pS73, DOI 10.1111/j.1753-4887.2008.00105.x; Eelen G, 2008, CHEM BIOL, V15, P1029, DOI 10.1016/j.chembiol.2008.08.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleet JC, 1996, ARCH BIOCHEM BIOPHYS, V329, P228, DOI 10.1006/abbi.1996.0213; GARABEDIAN M, 1978, CLIN ORTHOP RELAT R, P241; Gogoi P, 2010, CHEM-EUR J, V16, P1432, DOI 10.1002/chem.200902972; Gomez-Reino C, 2005, ORG LETT, V7, P5885, DOI 10.1021/ol052489c; Harant H, 2000, J CELL BIOCHEM, V78, P112, DOI 10.1002/(SICI)1097-4644(20000701)78:1<112::AID-JCB10>3.0.CO;2-7; HOLICK MF, 1972, BIOCHEMISTRY-US, V11, P4251, DOI 10.1021/bi00773a009; HORST RL, 1979, BIOCHEM BIOPH RES CO, V89, P286, DOI 10.1016/0006-291X(79)90976-8; Hourai S, 2008, CHEM BIOL, V15, P383, DOI 10.1016/j.chembiol.2008.03.016; Hourai S, 2006, J MED CHEM, V49, P5199, DOI 10.1021/jm0604070; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; HYLEMON PB, 1985, COMPREHENSIVE BIOCH, V12, P331; ISHIZUKA S, 1987, J BIOL CHEM, V262, P7165; JONES G, 1987, Steroids, V49, P29, DOI 10.1016/0039-128X(87)90078-X; Kamao M, 2004, J BIOL CHEM, V279, P15897, DOI 10.1074/jbc.M311473200; Krause S., 2000, ORGANIC SYNTHESIS HI, P212; KUMAR R, 1978, J BIOL CHEM, V253, P3804; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LUCHE JL, 1978, J AM CHEM SOC, V100, P2226, DOI 10.1021/ja00475a040; Molnar F, 2006, J BIOL CHEM, V281, P10516, DOI 10.1074/jbc.M513609200; MORRISON NA, 1991, J BONE MINER RES, V6, P893; Mourino A, 1997, TETRAHEDRON LETT, V38, P4713, DOI 10.1016/S0040-4039(97)01005-8; MURALIDHARAN KR, 1993, J ORG CHEM, V58, P1895, DOI 10.1021/jo00059a048; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nakagawa K, 2001, STEROIDS, V66, P327, DOI 10.1016/S0039-128X(00)00142-2; NORMAN AW, 1993, J BIOL CHEM, V268, P20022; Penning TM, 1997, STEROIDS, V62, P101, DOI 10.1016/S0039-128X(96)00167-5; Pinette KV, 2003, MINI-REV MED CHEM, V3, P193, DOI 10.2174/1389557033488204; Posner GH, 2003, EUR J ORG CHEM, V2003, P3889, DOI 10.1002/ejoc.200300264; Reddy G.S., 2000, VITAMIN D ENDOCRINE, P139; Reddy GS, 2000, ARCH BIOCHEM BIOPHYS, V383, P197, DOI 10.1006/abbi.2000.2074; REDDY GS, 1994, VITAMIN D, P172; Reddy GS, 1997, VITAMIN D CHEM BIOL, P139; Reddy MD, 2007, J STEROID BIOCHEM, V103, P347, DOI 10.1016/j.jsbmb.2006.12.045; Rehan VK, 2002, MOL GENET METAB, V76, P46, DOI 10.1016/S1096-7192(02)00022-7; REINHARDT TA, 1981, BIOCHEMISTRY-US, V20, P6230, DOI 10.1021/bi00524a050; Rochel N, 2001, EUR J BIOCHEM, V268, P971, DOI 10.1046/j.1432-1327.2001.01953.x; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Sekimoto H, 1999, FEBS LETT, V448, P278, DOI 10.1016/S0014-5793(99)00377-4; SHARPLES.KB, 1973, J AM CHEM SOC, V95, P6136, DOI 10.1021/ja00799a061; Siu-Caldera ML, 1999, BONE, V24, P457, DOI 10.1016/S8756-3282(99)00019-8; SUDA T, 1970, BIOCHEMISTRY-US, V9, P4776, DOI 10.1021/bi00826a022; Takeyama KI, 1999, MOL CELL BIOL, V19, P1049; Tocchini-Valentini G, 2001, P NATL ACAD SCI USA, V98, P5491, DOI 10.1073/pnas.091018698; TROST BM, 1992, J AM CHEM SOC, V114, P9836, DOI 10.1021/ja00051a016; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; WICHMANN JK, 1979, BIOCHEMISTRY-US, V18, P4775, DOI 10.1021/bi00589a002; ZHU GD, 1995, CHEM REV, V95, P1877, DOI 10.1021/cr00038a007	65	67	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18124	10.1371/journal.pone.0018124	http://dx.doi.org/10.1371/journal.pone.0018124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483824	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200030
J	Nallaparaju, KC; Yu, JJ; Rodriguez, SA; Zogaj, X; Manam, S; Guentzel, MN; Seshu, J; Murthy, AK; Chambers, JP; Klose, KE; Arulanandam, BP				Nallaparaju, Kalyan C.; Yu, Jieh-Juen; Rodriguez, Stephen A.; Zogaj, Xhavit; Manam, Srikanth; Guentzel, M. Neal; Seshu, Janakiram; Murthy, Ashlesh K.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.			Evasion of IFN-gamma Signaling by Francisella novicida Is Dependent upon Francisella Outer Membrane Protein C	PLOS ONE			English	Article							LIVE VACCINE STRAIN; T-CELLS; INTRAMACROPHAGE SURVIVAL; CHLAMYDIA-TRACHOMATIS; PROTECTIVE IMMUNITY; MURINE MACROPHAGES; VIRULENCE FACTORS; EPITHELIAL-CELLS; TULARENSIS LVS; INFECTION	Background: Francisella tularensis is a Gram-negative facultative intracellular bacterium and the causative agent of the lethal disease tularemia. An outer membrane protein (FTT0918) of F. tularensis subsp. tularensis has been identified as a virulence factor. We generated a F. novicida (F. tularensis subsp. novicida) FTN_0444 (homolog of FTT0918) fopC mutant to study the virulence-associated mechanism(s) of FTT0918. Methods and Findings: The DfopC strain phenotype was characterized using immunological and biochemical assays. Attenuated virulence via the pulmonary route in wildtype C57BL/6 and BALB/c mice, as well as in knockout (KO) mice, including MHC I, MHC II, and mmT (B cell deficient), but not in IFN-gamma or IFN-gamma R KO mice was observed. Primary bone marrow derived macrophages (BMDM) prepared from C57BL/6 mice treated with rIFN-gamma exhibited greater inhibition of intracellular DfopC than wildtype U112 strain replication; whereas, IFN-gamma R KO macrophages showed no IFN-gamma-dependent inhibition of DfopC replication. Moreover, phosphorylation of STAT1 was downregulated by the wildtype strain, but not the fopC mutant, in rIFN-gamma treated macrophages. Addition of N G -monomethyl-L-arginine, an NOS inhibitor, led to an increase of DfopC replication to that seen in the BMDM unstimulated with rIFN-gamma. Enzymatic screening of DfopC revealed aberrant acid phosphatase activity and localization. Furthermore, a greater abundance of different proteins in the culture supernatants of DfopC than that in the wildtype U112 strain was observed. Conclusions: F. novicida FopC protein facilitates evasion of IFN-gamma-mediated immune defense(s) by down-regulation of STAT1 phosphorylation and nitric oxide production, thereby promoting virulence. Additionally, the FopC protein also may play a role in maintaining outer membrane stability (integrity) facilitating the activity and localization of acid phosphatases and other F. novicida cell components.	[Nallaparaju, Kalyan C.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Nallaparaju, KC (corresponding author), Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	Bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014; Manam, Srikanth/K-6265-2019	Manam, Srikanth/0000-0001-5682-1957	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [PO1 AI057986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986] Funding Source: NIH RePORTER	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part with federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Grant PO1 AI057986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Ekchariyawat P, 2005, INFECT IMMUN, V73, P7332, DOI 10.1128/IAI.73.11.7332-7339.2005; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Forsberg A, 2007, ANN NY ACAD SCI, V1105, P187, DOI 10.1196/annals.1409.016; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Frirdich E, 2005, J BIOL CHEM, V280, P27604, DOI 10.1074/jbc.M504987200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; Hrstka R, 2005, MICROBES INFECT, V7, P619, DOI 10.1016/j.micinf.2004.12.020; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Powell HJ, 2008, IMMUNOL CELL BIOL, V86, P515, DOI 10.1038/icb.2008.31; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Roth KM, 2009, INT IMMUNOL, V21, P19, DOI 10.1093/intimm/dxn119; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Sju┬stedt A.B., 2005, BERGEYS MANUAL SYSTE, P200; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Titball RW, 2003, TRENDS MICROBIOL, V11, P118, DOI 10.1016/S0966-842X(03)00020-9; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x	55	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18201	10.1371/journal.pone.0018201	http://dx.doi.org/10.1371/journal.pone.0018201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483828	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200042
J	Alvarez, ML; DiStefano, JK				Alvarez, M. Lucrecia; DiStefano, Johanna K.			Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HUMAN MESANGIAL CELLS; HIGH-GLUCOSE; MESSENGER-RNA; TGF-BETA; MAMMALIAN-CELLS; ANGIOTENSIN-II; PIMA-INDIANS; MICRORNAS; KIDNEY	We previously observed association between variants in the plasmacytoma variant translocation 1 gene (PVT1) and end-stage renal disease (ESRD) attributed to both type 1 and type 2 diabetes, and demonstrated PVT1 expression in a variety of renal cell types. While these findings suggest a role for PVT1 in the development of ESRD, potential mechanisms for involvement remain unknown. The goal of this study was to identify possible molecular mechanisms by which PVT1 may contribute to the development and progression of diabetic kidney disease. We knocked-down PVT1 expression in mesangial cells using RNA interference, and analyzed RNA and protein levels of fibronectin 1 (FN1), collagen, type IV, alpha 1 (COL4A1), transforming growth factor beta 1 (TGFB1) and plasminogen activator inhibitor-1 (SERPINE1 or PAI-1) by qPCR and ELISA, respectively. PVT1 expression was significantly upregulated by glucose treatment in human mesangial cells, as were levels of FN1, COL4A1, TGFB1, and PAI-1. Importantly, PVT1 knockdown significantly reduced mRNA and protein levels of the major ECM proteins, FN1 and COL4A1, and two key regulators of ECM proteins, TGFB1 and PAI-1. However, we observed a higher and more rapid reduction in levels of secreted FN1, COL4A1, and PAI-1 compared with TGFB1, suggesting that at least some of the PVT1 effects on ECM proteins may be independent of this cytokine. These results indicate that PVT1 may mediate the development and progression of diabetic nephropathy through mechanisms involving ECM accumulation.	[Alvarez, M. Lucrecia; DiStefano, Johanna K.] Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ 85004 USA	Translational Genomics Research Institute	Alvarez, ML (corresponding author), Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ 85004 USA.	jdistefano@tgen.org	DiStefano, Johanna K/V-7801-2019	DiStefano, Johanna K/0000-0002-3286-0270	American Diabetes Association	American Diabetes Association(American Diabetes Association)	This work was supported by the American Diabetes Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSIELLO DA, 1980, J CLIN INVEST, V65, P754, DOI 10.1172/JCI109723; AYO SH, 1991, AM J PHYSIOL, V260, pF185, DOI 10.1152/ajprenal.1991.260.2.F185; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLANTZ RC, 1976, J CLIN INVEST, V57, P419, DOI 10.1172/JCI108293; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Craig DW, 2009, DIABETIC MED, V26, P1090, DOI 10.1111/j.1464-5491.2009.02846.x; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; HANEDA M, 1991, DIABETOLOGIA, V34, P198, DOI 10.1007/BF00418276; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hoffman BB, 1998, KIDNEY INT, V54, P1107, DOI 10.1046/j.1523-1755.1998.00119.x; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Isono M, 2000, J AM SOC NEPHROL, V11, P2222, DOI 10.1681/ASN.V11122222; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Lee EA, 2005, KIDNEY INT, V67, P1762, DOI 10.1111/j.1523-1755.2005.00274.x; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; McLennan SV, 2000, KIDNEY INT, V58, pS81, DOI 10.1046/j.1523-1755.2000.07713.x; MENGLEGAW L, 1987, EMBO J, V6, P1959, DOI 10.1002/j.1460-2075.1987.tb02458.x; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; NELSON RG, 1995, DIABETES CARE, V18, P182, DOI 10.2337/diacare.18.2.182; Oh JH, 1998, KIDNEY INT, V54, P1872, DOI 10.1046/j.1523-1755.1998.00193.x; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; PETTITT DJ, 1990, DIABETOLOGIA, V33, P438, DOI 10.1007/BF00404096; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Quinn M, 1996, DIABETOLOGIA, V39, P940; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Rossi JJ, 2005, NAT CELL BIOL, V7, P643, DOI 10.1038/ncb0705-643; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shimazaki A, 2005, DIABETES, V54, P1171, DOI 10.2337/diabetes.54.4.1171; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; TADA H, 1994, DIABETES RES CLIN PR, V24, P33, DOI 10.1016/0168-8227(94)90083-3; *USRDS, 2002, US REN DAT SYST ANN, P296; Wahab NA, 1996, BIOCHEM J, V316, P985, DOI 10.1042/bj3160985; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; WOLF G, 1992, KIDNEY INT, V42, P647, DOI 10.1038/ki.1992.330	49	123	141	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18671	10.1371/journal.pone.0018671	http://dx.doi.org/10.1371/journal.pone.0018671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526116	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800012
J	Fiz, J; Duran, M; Capella, D; Carbonell, J; Farre, M				Fiz, Jimena; Duran, Marta; Capella, Dolors; Carbonell, Jordi; Farre, Magi			Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life	PLOS ONE			English	Article							SPANISH VERSION; PAIN; CLASSIFICATION; NABILONE	Background: The aim of this study was to describe the patterns of cannabis use and the associated benefits reported by patients with fibromyalgia (FM) who were consumers of this drug. In addition, the quality of life of FM patients who consumed cannabis was compared with FM subjects who were not cannabis users. Methods: Information on medicinal cannabis use was recorded on a specific questionnaire as well as perceived benefits of cannabis on a range of symptoms using standard 100-mm visual analogue scales (VAS). Cannabis users and non-users completed the Fibromyalgia Impact Questionnaire (FIQ), the Pittsburgh Sleep Quality Index (PSQI) and the Short Form 36 Health Survey (SF-36). Results: Twenty-eight FM patients who were cannabis users and 28 non-users were included in the study. Demographics and clinical variables were similar in both groups. Cannabis users referred different duration of drug consumption; the route of administration was smoking (54%), oral (46%) and combined (43%). The amount and frequency of cannabis use were also different among patients. After 2 hours of cannabis use, VAS scores showed a statistically significant (p < 0.001) reduction of pain and stiffness, enhancement of relaxation, and an increase in somnolence and feeling of well being. The mental health component summary score of the SF-36 was significantly higher (p < 0.05) in cannabis users than in non-users. No significant differences were found in the other SF-36 domains, in the FIQ and the PSQI. Conclusions: The use of cannabis was associated with beneficial effects on some FM symptoms. Further studies on the usefulness of cannabinoids in FM patients as well as cannabinoid system involvement in the pathophysiology of this condition are warranted.	[Fiz, Jimena; Farre, Magi] Inst Recerca Hosp Mar IMIM, Human Pharmacol & Neurosci Unit, Barcelona, Spain; [Fiz, Jimena; Capella, Dolors; Farre, Magi] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Duran, Marta; Capella, Dolors] Fundacio Inst Catala Farmacol, Barcelona, Spain; [Carbonell, Jordi] Rheumatol Unit, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Fiz, J (corresponding author), Inst Recerca Hosp Mar IMIM, Human Pharmacol & Neurosci Unit, Parc Salut Mar, Barcelona, Spain.	mfarre@imim.es			Ministerio de Sanidad - Plan Nacional sobre Drogas [SOC/3386/2004]; Instituto de Salud Carlos III (FIS-Red de Transtornos Adictivos) [RTA RD06/0001/1009]; Generalitat de Catalunya [AGAUR 2009 SGR 718]	Ministerio de Sanidad - Plan Nacional sobre Drogas; Instituto de Salud Carlos III (FIS-Red de Transtornos Adictivos)(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	The work was partially supported by grants from Ministerio de Sanidad - Plan Nacional sobre Drogas (SOC/3386/2004), Instituto de Salud Carlos III (FIS-Red de Transtornos Adictivos -RTA RD06/0001/1009) and Generalitat de Catalunya (AGAUR 2009 SGR 718). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Blackburn-Munro Gordon, 2004, Curr Pain Headache Rep, V8, P116, DOI 10.1007/s11916-004-0025-9; Buskila D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2720; Carrier EJ, 2005, CNS NEUROL DISORD-DR, V4, P657, DOI 10.2174/156800705774933023; Dadabhoy D, 2006, NAT CLIN PRACT RHEUM, V2, P364, DOI 10.1038/ncprheum0221; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Iskedjian M, 2007, CURR MED RES OPIN, V23, P17, DOI 10.1185/030079906X158066; Lynch ME, 2006, J PAIN SYMPTOM MANAG, V32, P497, DOI 10.1016/j.jpainsymman.2006.05.016; Martinez-Lavin M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2146; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; RICO AR, 1997, VIGILIA SUENO, V9, P81; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Russo EB, 2008, NEUROENDOCRINOL LETT, V29, P192; Schley M, 2006, CURR MED RES OPIN, V22, P1269, DOI 10.1185/030079906X112651; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Ware MA, 2010, ANESTH ANALG, V110, P604, DOI 10.1213/ANE.0b013e3181c76f70; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	18	80	87	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18440	10.1371/journal.pone.0018440	http://dx.doi.org/10.1371/journal.pone.0018440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533029	gold, Green Published, Green Submitted			2022-12-27	WOS:000290014500003
J	Cowley, M; de Burca, A; McCole, RB; Chahal, M; Saadat, G; Oakey, RJ; Schulz, R				Cowley, Michael; de Burca, Anna; McCole, Ruth B.; Chahal, Mandeep; Saadat, Ghazal; Oakey, Rebecca J.; Schulz, Reiner			Short Interspersed Element (SINE) Depletion and Long Interspersed Element (LINE) Abundance Are Not Features Universally Required for Imprinting	PLOS ONE			English	Article							L1 ELEMENTS; MOUSE; SEQUENCE; METHYLATION; GENES; RETROTRANSPOSITION; PROMOTER	Genomic imprinting is a form of gene dosage regulation in which a gene is expressed from only one of the alleles, in a manner dependent on the parent of origin. The mechanisms governing imprinted gene expression have been investigated in detail and have greatly contributed to our understanding of genome regulation in general. Both DNA sequence features, such as CpG islands, and epigenetic features, such as DNA methylation and non-coding RNAs, play important roles in achieving imprinted expression. However, the relative importance of these factors varies depending on the locus in question. Defining the minimal features that are absolutely required for imprinting would help us to understand how imprinting has evolved mechanistically. Imprinted retrogenes are a subset of imprinted loci that are relatively simple in their genomic organisation, being distinct from large imprinting clusters, and have the potential to be used as tools to address this question. Here, we compare the repeat element content of imprinted retrogene loci with non-imprinted controls that have a similar locus organisation. We observe no significant differences that are conserved between mouse and human, suggesting that the paucity of SINEs and relative abundance of LINEs at imprinted loci reported by others is not a sequence feature universally required for imprinting.	[Cowley, Michael; de Burca, Anna; McCole, Ruth B.; Chahal, Mandeep; Saadat, Ghazal; Oakey, Rebecca J.; Schulz, Reiner] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Cowley, M (corresponding author), Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England.	reiner.schulz@kcl.ac.uk	de Burca, Anna/GYV-1552-2022; Schulz, Reiner/A-5940-2011; Schulz, Reiner/H-4451-2011; Cowley, Mike/B-9425-2013; Oakey, Rebecca/A-5958-2011	Schulz, Reiner/0000-0001-5047-7921; Cowley, Michael/0000-0001-8564-4224; Oakey, Rebecca/0000-0003-2706-8139	Wellcome Trust [085448\Z\08\Z]; Philip Harris studentship; Research Councils UK; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Philip Harris studentship; Research Councils UK(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Wellcome Trust (http://www.wellcome.ac.uk/) for supporting this work (grant ref. no.: 085448\Z\08\Z). RBM is the recipient of a Philip Harris studentship. RS is the recipient of a Research Councils UK fellowship (http://www.rcuk.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY NB, 1994, P NATL ACAD SCI USA, V91, P1569, DOI 10.1073/pnas.91.4.1569; Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chai JH, 2001, MAMM GENOME, V12, P813, DOI 10.1007/s00335-001-2083-1; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Cowley M, 2010, BRIEF FUNCT GENOMICS, V9, P340, DOI 10.1093/bfgp/elq015; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Ding WY, 2006, IUBMB LIFE, V58, P677, DOI 10.1080/15216540601034856; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Greally JM, 2002, P NATL ACAD SCI USA, V99, P327, DOI 10.1073/pnas.012539199; HASSE A, 1994, J BIOL CHEM, V269, P1821; John RM, 2010, BRIEF FUNCT GENOMICS, V9, P294, DOI 10.1093/bfgp/elq010; JUBIERMAURIN V, 1992, MOL BIOL EVOL, V9, P41; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Ke XY, 2002, HUM GENET, V111, P511, DOI 10.1007/s00439-002-0822-3; Ke XY, 2002, MAMM GENOME, V13, P639, DOI 10.1007/s00335-002-3038-x; KITAGAWA K, 1995, GENOMICS, V30, P257, DOI 10.1006/geno.1995.9879; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; MCCOLE RB, 2011, EVOLUTION; Nabetani A, 1997, MOL CELL BIOL, V17, P789, DOI 10.1128/MCB.17.2.789; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Walter J, 2006, CYTOGENET GENOME RES, V113, P109, DOI 10.1159/000090821; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Yates PA, 1999, J BIOL CHEM, V274, P36357, DOI 10.1074/jbc.274.51.36357	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18953	10.1371/journal.pone.0018953	http://dx.doi.org/10.1371/journal.pone.0018953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533089	gold, Green Published, Green Submitted			2022-12-27	WOS:000289719400037
J	Salva, OR; Farroni, T; Regolin, L; Vallortigara, G; Johnson, MH				Salva, Orsola Rosa; Farroni, Teresa; Regolin, Lucia; Vallortigara, Giorgio; Johnson, Mark Henry			The Evolution of Social Orienting: Evidence from Chicks (Gallus gallus) and Human Newborns	PLOS ONE			English	Article							BIOLOGICAL MOTION; FILIAL PREFERENCES; FACE PERCEPTION; EXPERIENCE; RECOGNITION; PATHWAYS; STIMULI; UPRIGHT; GAZE; HENS	Background: Converging evidence from different species indicates that some newborn vertebrates, including humans, have visual predispositions to attend to the head region of animate creatures. It has been claimed that newborn preferences for faces are domain-relevant and similar in different species. One of the most common criticisms of the work supporting domain-relevant face biases in human newborns is that in most studies they already have several hours of visual experience when tested. This issue can be addressed by testing newly hatched face-naive chicks (Gallus gallus) whose preferences can be assessed prior to any other visual experience with faces. Methods: In the present study, for the first time, we test the prediction that both newly hatched chicks and human newborns will demonstrate similar preferences for face stimuli over spatial frequency matched structured noise. Chicks and babies were tested using identical stimuli for the two species. Chicks underwent a spontaneous preference task, in which they have to approach one of two stimuli simultaneously presented at the ends of a runway. Human newborns participated in a preferential looking task. Results and Significance: We observed a significant preference for orienting toward the face stimulus in both species. Further, human newborns spent more time looking at the face stimulus, and chicks preferentially approached and stood near the face-stimulus. These results confirm the view that widely diverging vertebrates possess similar domain-relevant biases toward faces shortly after hatching or birth and provide a behavioural basis for a comparison with neuroimaging studies using similar stimuli.	[Salva, Orsola Rosa; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Farroni, Teresa] Univ Padua, Dept Dev Psychol, Padua, Italy; [Farroni, Teresa; Johnson, Mark Henry] Univ London, Ctr Brain & Cognit Dev, London, England; [Regolin, Lucia] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Trento; University of Padua; University of London; Birkbeck University London; University of Padua	Salva, OR (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	orsola.rosasalva@unipd.it	Regolin, Lucia/N-9564-2019; Rosa Salva, Orsola/B-7831-2010; Farroni, Teresa/AAE-2219-2020	Regolin, Lucia/0000-0001-8960-0309; Rosa Salva, Orsola/0000-0003-1662-6094; Johnson, Mark/0000-0003-4229-2585	Medical Research Council [G0701484] Funding Source: Medline; MRC [G0701484] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acerra F, 2002, DEVELOPMENTAL SCI, V5, P98, DOI 10.1111/1467-7687.00215; BANKS MS, 1981, J EXP CHILD PSYCHOL, V31, P1, DOI 10.1016/0022-0965(81)90002-3; Blasi A, 2007, PHYS MED BIOL, V52, P6849, DOI 10.1088/0031-9155/52/23/005; Blasi CH, 2003, HUM DEV, V46, P259, DOI 10.1159/000071935; BOLHUIS JJ, 1985, DEV PSYCHOBIOL, V18, P299, DOI 10.1002/dev.420180403; Bolhuis JJ, 2009, NATURE, V458, P832, DOI 10.1038/458832a; Butler AB, 2006, BIOL BULL-US, V211, P106, DOI 10.2307/4134586; CANDLAND DK, 1969, J COMP PHYSIOL PSYCH, V69, P281, DOI 10.1037/h0028246; Clara E, 2007, J EXP PSYCHOL-ANIM B, V33, P12, DOI 10.1037/0097-7403.33.1.12; Csibra G, 2004, J PEDIAT NEUROL, V2, P85, DOI DOI 10.1055/S-0035-15; Dawkins MS, 1996, BEHAVIOUR, V133, P663, DOI 10.1163/156853996X00413; DAWKINS MS, 1995, BEHAVIOUR, V132, P591, DOI 10.1163/156853995X00225; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Forsman A, 2004, BEHAV ECOL, V15, P141, DOI 10.1093/beheco/arg092; GUHL A. M., 1953, CONDOR, V55, P287, DOI 10.2307/1365008; Horn G, 2004, NAT REV NEUROSCI, V5, P108, DOI 10.1038/nrn1324; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Johnson M. H., 1992, CURRENT DIRECTIONS P, V1, P52; Johnson MH, 2006, CURR BIOL, V16, pR376, DOI 10.1016/j.cub.2006.04.008; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; JOHNSON MH, 1988, ANIM BEHAV, V36, P675, DOI 10.1016/S0003-3472(88)80150-7; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KLEINER KA, 1987, INFANT BEHAV DEV, V10, P49, DOI 10.1016/0163-6383(87)90006-3; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Otsuka Y, 2007, NEUROIMAGE, V34, P399, DOI 10.1016/j.neuroimage.2006.08.013; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; PHELPS MT, 1994, J COMP PSYCHOL, V108, P114, DOI 10.1037/0735-7036.108.2.114; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Rosa-Salva O, 2010, DEVELOPMENTAL SCI, V13, P565, DOI 10.1111/j.1467-7687.2009.00914.x; Salva OR, 2007, BEHAV BRAIN RES, V177, P15, DOI 10.1016/j.bbr.2006.11.020; Sewards TV, 2002, COMP BIOCHEM PHYS A, V132, P861, DOI 10.1016/S1095-6433(02)00119-8; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Southgate V, 2008, J COGNITIVE NEUROSCI, V20, P741, DOI 10.1162/jocn.2008.20052; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Tovee MJ, 1998, NEURON, V21, P1239, DOI 10.1016/S0896-6273(00)80644-3; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Turati C, 2002, DEV PSYCHOL, V38, P875, DOI 10.1037//0012-1649.38.6.875; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Vallortigara G, 2006, CURR BIOL, V16, pR279, DOI 10.1016/j.cub.2006.03.052; VALLORTIGARA G, 1991, ANIM BEHAV, V41, P187, DOI 10.1016/S0003-3472(05)80470-1	53	74	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18802	10.1371/journal.pone.0018802	http://dx.doi.org/10.1371/journal.pone.0018802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533093	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000289719400026
J	Yoshida, I; Sugiura, W; Shibata, J; Ren, FR; Yang, ZH; Tanaka, H				Yoshida, Izumi; Sugiura, Wataru; Shibata, Junko; Ren, Fengrong; Yang, Ziheng; Tanaka, Hiroshi			Change of Positive Selection Pressure on HIV-1 Envelope Gene Inferred by Early and Recent Samples	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE NUCLEOTIDE POLYMORPHISMS; 41 CANDIDATE GENES; CD4 CELL COUNTS; REPLICATIVE FITNESS; LIKELIHOOD METHOD; TEMPORAL TRENDS; SEROCONVERSION; IDENTIFICATION; ASSOCIATION	HIV-1 infection has been on the rise in Japan recently, and the main transmission route has changed from blood transmission in the 1980s to homo- and/or hetero-sexual transmission in the 2000s. The lack of early viral samples with clinical information made it difficult to investigate the possible virological changes over time. In this study, we sequenced 142 full-length env genes collected from 16 Japanese subjects infected with HIV-1 in the 1980s and in the 2000s. We examined the diversity change in sequences and potential adaptive evolution of the virus to the host population. We used a codon-based likelihood method under the branch-site and clade models to detect positive selection operating on the virus. The clade model was extended to account for different positive selection pressures in different viral populations. The result showed that the selection pressure was weaker in the 2000s than in the 1980s, indicating that it might have become easier for the HIV to infect a new host and to develop into AIDS now than 20 years ago and that the HIV may be becoming more virulent in the Japanese population. The study provides useful information on the surveillance of HIV infection and highlights the utility of the extended clade models in analysis of virus populations which may be under different selection pressures.	[Yoshida, Izumi; Shibata, Junko; Ren, Fengrong; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Sugiura, Wataru; Shibata, Junko] Natl Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Yang, Ziheng] UCL, Dept Biol, London, England	Tokyo Medical & Dental University (TMDU); National Institute of Infectious Diseases (NIID); Nagoya Medical Center; University of London; University College London	Yoshida, I (corresponding author), Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan.	ren@bioinfo.tmd.ac.jp		TAKEUCHI, Junko S/0000-0002-4844-9013	Ministry of Education, Culture, Sports, and Technology of Japan [19510208]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology of Japan to F. R. and H.T (19510208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Crum-Cianflone N, 2009, CLIN INFECT DIS, V48, P1285, DOI 10.1086/597777; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dorrucci M, 2005, AIDS, V19, P331; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GOUDSMIT, 1998, VIRAL SEX NATURE AID; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; HOLMES EC, 1992, P NATL ACAD SCI USA, V89, P4835, DOI 10.1073/pnas.89.11.4835; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keet IPM, 1996, AIDS, V10, P1601, DOI 10.1097/00002030-199611000-00025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KNIPE D, FIELDS VIROLOGY LIPP, V1, P331; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kupfer B, 2007, J MED VIROL, V79, P1629, DOI 10.1002/jmv.20976; Leitner T, 1997, J VIROL, V71, P4761, DOI 10.1128/JVI.71.6.4761-4770.1997; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Ohnishi Y, 2000, HUM GENET, V106, P288, DOI 10.1007/s004390051039; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ross HA, 2002, J VIROL, V76, P11715, DOI 10.1128/JVI.76.22.11715-11720.2002; Shioda T, 1997, J VIROL, V71, P4871, DOI 10.1128/JVI.71.7.4871-4881.1997; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tokunaga K, 1997, IMMUNOGENETICS, V46, P199, DOI 10.1007/s002510050262; Vanhems P, 1999, J INFECT DIS, V180, P1803, DOI 10.1086/315110; Yamada R, 2000, HUM GENET, V106, P293; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yap VB, 2010, MOL BIOL EVOL, V27, P726, DOI 10.1093/molbev/msp232	45	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18630	10.1371/journal.pone.0018630	http://dx.doi.org/10.1371/journal.pone.0018630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526184	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100014
J	Arner, P; Arner, E; Hammarstedt, A; Smith, U				Arner, Peter; Arner, Erik; Hammarstedt, Ann; Smith, Ulf			Genetic Predisposition for Type 2 Diabetes, but Not for Overweight/Obesity, Is Associated with a Restricted Adipogenesis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ABDOMINAL OBESITY; DIFFERENTIATION; GLUCOSE; ACCUMULATION; MECHANISMS; WNT	Background: Development of Type 2 diabetes, like obesity, is promoted by a genetic predisposition. Although several genetic variants have been identified they only account for a small proportion of risk. We have asked if genetic risk is associated with abnormalities in storing excess lipids in the abdominal subcutaneous adipose tissue. Methodology/Principal Findings: We recruited 164 lean and 500 overweight/obese individuals with or without a genetic predisposition for Type 2 diabetes or obesity. Adipose cell size was measured in biopsies from the abdominal adipose tissue as well as insulin sensitivity (HOMA index), HDL-cholesterol and Apo AI and Apo B. 166 additional non-obese individuals with a genetic predisposition for Type 2 diabetes underwent a euglycemic hyperinsulinemic clamp to measure insulin sensitivity. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, was associated with inappropriate expansion of the adipose cells, reduced insulin sensitivity and a more proatherogenic lipid profile in non-obese individuals. However, obesity per se induced a similar expansion of adipose cells and dysmetabolic state irrespective of genetic predisposition. Conclusions/Significance: Genetic predisposition for Type 2 diabetes, but not obesity, is associated with an impaired ability to recruit new adipose cells to store excess lipids in the subcutaneous adipose tissue, thereby promoting ectopic lipid deposition. This becomes particularly evident in non-obese individuals since obesity per se promotes a dysmetabolic state irrespective of genetic predisposition. These results identify a novel susceptibility factor making individuals with a genetic predisposition for Type 2 diabetes particularly sensitive to the environment and caloric excess.	[Arner, Peter; Arner, Erik] Karolinska Inst, Karolinska Hosp, Dept Med, S-10401 Stockholm, Sweden; [Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Lundberg Lab Diabet Res,Dept Mol & Clin Med, Ctr Excellence Metab & Cardiovasc Res, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Arner, P (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Med, S-10401 Stockholm, Sweden.	ulf.smith@medic.gu.se	Arner, Erik/A-1895-2010; Northe, Hilda/I-1916-2012	Arner, Erik/0000-0003-1225-4908; Northe, Hilda/0000-0002-8873-5014; Arner, Peter/0000-0002-6208-6220	Novo Nordisk Foundation; Swedish Diabetes Association; Swedish Heart and Lung Foundation; Swedish Research Council [K2008-54X-01034-42-4, K2010-54X-03506-39-3]; Karolinska Institutet; Torsten and Ragnar Soderberg Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Torsten and Ragnar Soderberg Foundation	The study was funded by the Novo Nordisk Foundation, Swedish Diabetes Association, Swedish Heart and Lung Foundation, Swedish Research Council (K2008-54X-01034-42-4 and K2010-54X-03506-39-3), the Diabetes Research Program at Karolinska Institutet and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hellstrom L, 1996, DIABETOLOGIA, V39, P921; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wilding J, 2006, LANCET, V367, P1053, DOI 10.1016/S0140-6736(06)68463-8; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	93	96	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18284	10.1371/journal.pone.0018284	http://dx.doi.org/10.1371/journal.pone.0018284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532749	Green Submitted, gold, Green Published			2022-12-27	WOS:000289404700008
J	Wang, JF; Chou, KC				Wang, Jing-Fang; Chou, Kuo-Chen			Insights from Modeling the 3D Structure of New Delhi Metallo-beta-Lactamse and Its Binding Interactions with Antibiotic Drugs	PLOS ONE			English	Article							M2 PROTON CHANNEL; PSEUDOMONAS-AERUGINOSA; MOLECULAR-DYNAMICS; XYLOSE REDUCTASE; PICHIA-STIPITIS; MECHANISM; RECEPTOR; BIOINFORMATICS; PREDICTION; RESISTANCE	New Delhi metallo-beta-lactamase (NDM-1) is an enzyme that makes bacteria resistant to a broad range of beta-lactam antibiotic drugs. This is because it can inactivate most beta-lactam antibiotic drugs by hydrolyzing them. For in-depth understanding of the hydrolysis mechanism, the three-dimensional structure of NDM-1 was developed. With such a structural frame, two enzyme-ligand complexes were derived by respectively docking Imipenem and Meropenem (two typical beta-lactam antibiotic drugs) to the NDM-1 receptor. It was revealed from the NDM-1/Imipenem complex that the antibiotic drug was hydrolyzed while sitting in a binding pocket of NDM-1 formed by nine residues. And for the case of NDM-1/Meropenem complex, the antibiotic drug was hydrolyzed in a binding pocket formed by twelve residues. All these constituent residues of the two binding pockets were explicitly defined and graphically labeled. It is anticipated that the findings reported here may provide useful insights for developing new antibiotic drugs to overcome the resistance problem.	[Wang, Jing-Fang] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Wang, Jing-Fang; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University; Chinese Academy of Sciences	Wang, JF (corresponding author), Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China.	jfwang8113@sjtu.edu.cn; kcchou@gordonlifescience.org	Wang, Jingfang/Q-2597-2018; Chou, Kuo-Chen/A-8340-2009	Wang, Jingfang/0000-0002-1355-5481; 				Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a; Chou KC, 2004, J PROTEOME RES, V3, P1284, DOI 10.1021/pr049849v; CHOU KC, 1991, PROTEIN ENG, V4, P661, DOI 10.1093/protein/4.6.661; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; Chou KC, 1999, BIOCHEM BIOPH RES CO, V259, P420, DOI 10.1006/bbrc.1999.0792; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2006, CURR MED CHEM, V13, P3263, DOI 10.2174/092986706778773077; Colotta V, 2009, BIOORGAN MED CHEM, V17, P401, DOI 10.1016/j.bmc.2008.10.018; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009388; Du QS, 2009, J THEOR BIOL, V259, P159, DOI 10.1016/j.jtbi.2009.03.003; Garcia-Saez I, 2008, J MOL BIOL, V375, P604, DOI 10.1016/j.jmb.2007.11.012; Giamarellou H, 2009, DRUGS, V69, P1879, DOI 10.2165/11315690-000000000-00000; Gong K, 2009, MED CHEM, V5, P242, DOI 10.2174/157340609788185936; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; Gu RX, 2009, MED CHEM, V5, P250, DOI 10.2174/157340609788185909; Guo XL, 2010, CURR COMPUT-AID DRUG, V6, P139, DOI 10.2174/157340910791202487; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li L, 2007, BIOCHEM BIOPH RES CO, V358, P1102, DOI 10.1016/j.bbrc.2007.05.053; Livermore DM, 2009, CURR PROTEIN PEPT SC, V10, P397, DOI 10.2174/138920309789351994; Magdziarz T, 2009, J MOL MODEL, V15, P41, DOI 10.1007/s00894-008-0373-1; Maltezou HC, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.09.003; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; POIREL L, 2010, ANTIMICROB AGENTS CH; Ricchiuto P, 2008, J MOL RECOGNIT, V21, P347, DOI 10.1002/jmr.908; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Tamilselvi A, 2006, CHEM-EUR J, V12, P7797, DOI 10.1002/chem.200600629; Tang B, 2010, CHINESE SCI BULL, V55, P1619, DOI 10.1007/s11434-009-3700-8; Wang JF, 2009, PHARMACOGENOMICS, V10, P1213, DOI 10.2217/PGS.09.81; WANG JF, 2008, OPEN BIOINFORMATICS, V2, P72; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2009, INTERDISCIP SCI, V1, P214, DOI 10.1007/s12539-009-0047-4; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2010, CURR DRUG METAB, V11, P342, DOI 10.2174/138920010791514180; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, MED CHEM, V5, P263, DOI 10.2174/157340609788185954; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Wang JF, 2009, CURR MED CHEM, V16, P232, DOI 10.2174/092986709787002727; Wang JF, 2008, CURR TOP MED CHEM, V8, P1573, DOI 10.2174/156802608786786534; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zeng QK, 2009, BIOTECHNOL LETT, V31, P1025, DOI 10.1007/s10529-009-9980-x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	58	70	73	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18414	10.1371/journal.pone.0018414	http://dx.doi.org/10.1371/journal.pone.0018414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494599	Green Submitted, Green Published, gold			2022-12-27	WOS:000289354100012
J	Reilly, KT; Sirigu, A				Reilly, Karen T.; Sirigu, Angela			Motor Cortex Representation of the Upper-Limb in Individuals Born without a Hand	PLOS ONE			English	Article							PHANTOM-LIMB; CORTICAL REORGANIZATION; MAGNETIC STIMULATION; CORTICOMOTOR THRESHOLD; MUSCLE REPRESENTATION; OUTPUT MAPS; AMPUTEES; BODY; AMPUTATION; PAIN	The body schema is an action-related representation of the body that arises from activity in a network of multiple brain areas. While it was initially thought that the body schema developed with experience, the existence of phantom limbs in individuals born without a limb (amelics) led to the suggestion that it was innate. The problem with this idea, however, is that the vast majority of amelics do not report the presence of a phantom limb. Transcranial magnetic stimulation (TMS) applied over the primary motor cortex (M1) of traumatic amputees can evoke movement sensations in the phantom, suggesting that traumatic amputation does not delete movement representations of the missing hand. Given this, we asked whether the absence of a phantom limb in the majority of amelics means that the motor cortex does not contain a cortical representation of the missing limb, or whether it is present but has been deactivated by the lack of sensorimotor experience. In four upper-limb amelic subjects we directly stimulated the arm/hand region of M1 to see 1) whether we could evoke phantom sensations, and 2) whether muscle representations in the two cortices were organised asymmetrically. TMS applied over the motor cortex contralateral to the missing limb evoked contractions in stump muscles but did not evoke phantom movement sensations. The location and extent of muscle maps varied between hemispheres but did not reveal any systematic asymmetries. In contrast, forearm muscle thresholds were always higher for the missing limb side. We suggest that phantom movement sensations reported by some upper limb amelics are mostly driven by vision and not by the persistence of motor commands to the missing limb within the sensorimotor cortex. We propose that prewired movement representations of a limb need the experience of movement to be expressed within the primary motor cortex.	[Reilly, Karen T.; Sirigu, Angela] CNRS, Cognit Neurosci Ctr, UMR 5229, Bron, France; [Reilly, Karen T.; Sirigu, Angela] Univ Lyon 1, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Reilly, KT (corresponding author), CNRS, Cognit Neurosci Ctr, UMR 5229, Bron, France.	sirigu@isc.cnrs.fr	Reilly, Karen T/D-4423-2016; Sirigu, Angela/L-4683-2017	Reilly, Karen T/0000-0002-2840-1610; 	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR); Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants to AS from the Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR), and the Fondation pour la Recherche Medicale.	Bernard JA, 2011, J NEUROPHYSIOL, V105, P88, DOI 10.1152/jn.00512.2010; Brugger P, 2000, P NATL ACAD SCI USA, V97, P6167, DOI 10.1073/pnas.100510697; Chen R, 1998, J NEUROSCI, V18, P3443; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; Civardi C, 2000, CLIN NEUROPHYSIOL, V111, P624, DOI 10.1016/S1388-2457(99)00301-6; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; Dettmers C, 1999, NEUROSCI LETT, V263, P41, DOI 10.1016/S0304-3940(99)00105-6; DEVIGNEMONT F, 2009, NEUROPSYCHOLOGIA; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Funk M, 2008, NEUROIMAGE, V43, P121, DOI 10.1016/j.neuroimage.2008.06.011; Gagne M, 2009, NEUROSCIENCE, V162, P78, DOI 10.1016/j.neuroscience.2009.04.061; GAGNE M, 2010, HUMAN BRAIN MAPPING; Gallagher S, 1998, BRAIN COGNITION, V38, P53, DOI 10.1006/brcg.1998.1020; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; Irlbacher K, 2002, NEUROSCI LETT, V321, P129, DOI 10.1016/S0304-3940(02)00039-3; JENSEN TS, 1983, PAIN, V17, P243, DOI 10.1016/0304-3959(83)90097-0; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; KEW JJM, 1994, J NEUROPHYSIOL, V72, P2517, DOI 10.1152/jn.1994.72.5.2517; Kimiskidis VK, 2004, NEUROPHYSIOL CLIN, V34, P259, DOI 10.1016/j.neucli.2004.10.002; Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Matsunaga K, 1998, ELECTROMYOGR MOTOR C, V109, P502, DOI 10.1016/S1388-2457(98)00020-0; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Mercier C, 2006, BRAIN, V129, P2202, DOI 10.1093/brain/awl180; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.3.CO;2-F; Montoya P, 1998, EUR J NEUROSCI, V10, P1095, DOI 10.1046/j.1460-9568.1998.00122.x; MORASSO P, 1995, J MOTOR BEHAV, V27, P52, DOI 10.1080/00222895.1995.9941699; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; Park MC, 2001, J NEUROSCI, V21, P2784, DOI 10.1523/JNEUROSCI.21-08-02784.2001; PascualLeone A, 1996, NEUROREPORT, V7, P2068, DOI 10.1097/00001756-199609020-00002; Price EH, 2006, CONSCIOUS COGN, V15, P310, DOI 10.1016/j.concog.2005.07.003; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Reilly KT, 2008, NEUROSCIENTIST, V14, P195, DOI 10.1177/1073858407309466; Reilly KT, 2006, BRAIN, V129, P2211, DOI 10.1093/brain/awl154; Roricht S, 1999, NEUROLOGY, V53, P106, DOI 10.1212/WNL.53.1.106; ROSSINI PM, 1992, BRAIN RES, V593, P14, DOI 10.1016/0006-8993(92)91256-E; SAADAH ESM, 1994, CORTEX, V30, P479, DOI 10.1016/S0010-9452(13)80343-7; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Schilder, 1999, IMAGE APPEARANCE HUM; Schwenkreis P, 2001, CLIN NEUROPHYSIOL, V112, P627, DOI 10.1016/S1388-2457(01)00486-2; SIMMEL ML, 1962, SOC RES, V29, P337; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; TRIGGS WJ, 1994, BRAIN RES, V636, P270, DOI 10.1016/0006-8993(94)91026-X; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; vanderKamp W, 1996, J CLIN NEUROPHYSIOL, V13, P164, DOI 10.1097/00004691-199603000-00007; VETTER RJ, 1967, NEUROPSYCHOLOGIA, V5, P335, DOI 10.1016/0028-3932(67)90005-X; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Wilkins KL, 1998, PAIN, V78, P7, DOI 10.1016/S0304-3959(98)00109-2; WILSON SA, 1993, J NEUROL SCI, V118, P134, DOI 10.1016/0022-510X(93)90102-5	61	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18100	10.1371/journal.pone.0018100	http://dx.doi.org/10.1371/journal.pone.0018100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494663	gold, Green Published			2022-12-27	WOS:000289292800003
J	Monecke, S; Coombs, G; Shore, AC; Coleman, DC; Akpaka, P; Borg, M; Chow, H; Ip, M; Jatzwauk, L; Jonas, D; Kadlec, K; Kearns, A; Laurent, F; O'Brien, FG; Pearson, J; Ruppelt, A; Schwarz, S; Scicluna, E; Slickers, P; Tan, HL; Weber, S; Ehricht, R				Monecke, Stefan; Coombs, Geoffrey; Shore, Anna C.; Coleman, David C.; Akpaka, Patrick; Borg, Michael; Chow, Henry; Ip, Margaret; Jatzwauk, Lutz; Jonas, Daniel; Kadlec, Kristina; Kearns, Angela; Laurent, Frederic; O'Brien, Frances G.; Pearson, Julie; Ruppelt, Antje; Schwarz, Stefan; Scicluna, Elizabeth; Slickers, Peter; Tan, Hui-Leen; Weber, Stefan; Ehricht, Ralf			A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME MEC; MOLECULAR EPIDEMIOLOGY; ANTIMICROBIAL RESISTANCE; VIRULENCE DETERMINANTS; RAPID IDENTIFICATION; COMPARATIVE GENOMICS; GENETIC DIVERSITY; ANIMAL ORIGIN; FITNESS COST	In recent years, methicillin-resistant Staphylococcus aureus (MRSA) have become a truly global challenge. In addition to the long-known healthcare-associated clones, novel strains have also emerged outside of the hospital settings, in the community as well as in livestock. The emergence and spread of virulent clones expressing Panton-Valentine leukocidin (PVL) is an additional cause for concern. In order to provide an overview of pandemic, epidemic and sporadic strains, more than 3,000 clinical and veterinary isolates of MRSA mainly from Germany, the United Kingdom, Ireland, France, Malta, Abu Dhabi, Hong Kong, Australia, Trinidad & Tobago as well as some reference strains from the United States have been genotyped by DNA microarray analysis. This technique allowed the assignment of the MRSA isolates to 34 distinct lineages which can be clearly defined based on non-mobile genes. The results were in accordance with data from multilocus sequence typing. More than 100 different strains were distinguished based on affiliation to these lineages, SCCmec type and the presence or absence of PVL. These strains are described here mainly with regard to clinically relevant antimicrobial resistance-and virulence-associated markers, but also in relation to epidemiology and geographic distribution. The findings of the study show a high level of biodiversity among MRSA, especially among strains harbouring SCCmec IV and V elements. The data also indicate a high rate of genetic recombination in MRSA involving SCC elements, bacteriophages or other mobile genetic elements and large-scale chromosomal replacements.	[Monecke, Stefan; Ruppelt, Antje] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Coombs, Geoffrey; Pearson, Julie; Tan, Hui-Leen] Royal Perth Hosp, PathW Lab Med WA, Dept Microbiol & Infect Dis, Perth, WA, Australia; [Shore, Anna C.; Coleman, David C.] Univ Dublin, Trinity Coll, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 2, Ireland; [Akpaka, Patrick] Univ W Indies, Dept Para Clin Sci, St Augustine, Trinidad Tobago; [Borg, Michael; Scicluna, Elizabeth] Mater Dei Hosp, Infect Control Unit, Msida, Malta; [Chow, Henry; Ip, Margaret] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Jatzwauk, Lutz] Dresden Univ Hosp, Infect Control Unit, Dresden, Germany; [Jonas, Daniel] Univ Freiburg, Med Ctr, Dept Environm Hlth Sci, D-7800 Freiburg, Germany; [Kadlec, Kristina; Schwarz, Stefan] FLI, Inst Farm Anim Genet, Neustadt, Germany; [Kearns, Angela] Hlth Protect Agcy, Ctr Infect, Staphylococcus Reference Unit, London, England; [Laurent, Frederic] Univ Lyon, Ctr Natl Reference Staphylocoques, Lyon, France; [O'Brien, Frances G.] Curtin Univ Technol, Sch Biomed Sci, Perth, WA, Australia; [Monecke, Stefan; Slickers, Peter; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Weber, Stefan] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates	Technische Universitat Dresden; Royal Perth Hospital; University of Western Australia; Trinity College Dublin; University West Indies Mona Jamaica; University West Indies Saint Augustine; Chinese University of Hong Kong; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Freiburg; Friedrich Loeffler Institute; Health Protection Agency; Curtin University; Alere	Monecke, S (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany.	monecke@rocketmail.com	Ip, Margaret/K-1096-2013; Laurent, Frederic/M-4719-2014; Coleman, David C./C-2008-2009; LAURENT, Frederic/AGM-0706-2022	Ip, Margaret/0000-0003-1291-6537; Coleman, David C./0000-0003-1797-2888; Coombs, Geoffrey/0000-0003-1635-6506; Shore, Anna/0000-0002-6667-0918; laurent, frederic/0000-0003-0609-9091; Akpaka, Patrick Eberechi/0000-0001-9895-3077	Vice-Rectorate for Research of the Medical Faculty Dresden	Vice-Rectorate for Research of the Medical Faculty Dresden	R. Ehricht and P. Slickers are employees of Alere Technologies GmbH. The Vice-Rectorate for Research of the Medical Faculty Dresden partially financed this work. Each of the participating institutions regularly purchased test kits and reagents form commercial providers, which included Alere Technologies GmbH, and covered the costs of experiments performed in the respective institutions, as well as granting the time needed to perform this study. Decisions on study design, data collection and analysis, publication or preparation of the manuscript were agreed upon by the authors involved without influence by the funding institutions.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Akpaka PE, 2007, INT J INFECT DIS, V11, P544, DOI 10.1016/j.ijid.2007.03.004; Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; [Anonymous], 1999, JAMA, V282, P1123; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Aspiroz C, 2010, ENFERM INFEC MICR CL, V28, P70, DOI 10.1016/j.eimc.2009.01.016; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; BASSET P, 2010, INT S STAPH STAPH IN; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; BEISSER P, 2009, CLIN MICROBIOL INFEC, V15, pS22; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Berglund C, 2005, J CLIN MICROBIOL, V43, P4448, DOI 10.1128/JCM.43.9.4448-4454.2005; Berglund C, 2008, ANTIMICROB AGENTS CH, V52, P3512, DOI 10.1128/AAC.00087-08; Blanc DS, 2007, J CLIN MICROBIOL, V45, P3729, DOI 10.1128/JCM.00511-07; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; BUDIMIR A, 2009, CLIN MICROBIOL INFEC; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Chaberny IF, 2005, INT J HYG ENVIR HEAL, V208, P447, DOI 10.1016/j.ijheh.2005.08.004; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Chua T, 2008, J CLIN MICROBIOL, V46, P2345, DOI 10.1128/JCM.00154-08; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Coombs GW, 2007, INFECT CONT HOSP EP, V28, P845, DOI 10.1086/518726; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Cooper JE, 2006, MICROBIOL-SGM, V152, P1297, DOI 10.1099/mic.0.28620-0; Cuevas O, 2007, CLIN MICROBIOL INFEC, V13, P250, DOI 10.1111/j.1469-0691.2006.01672.x; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; DAWKINS R, 1994, EGOISTISCHE GEN; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; De Sousa MA, 2001, J CLIN MICROBIOL, V39, P2197, DOI 10.1128/JCM.39.6.2197-2205.2001; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Dijkshoorn L, 2000, J Med Microbiol, V49, P397, DOI 10.1099/0022-1317-49-5-397; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; DOMINGUEZ MA, 1994, J CLIN MICROBIOL, V32, P2081, DOI 10.1128/JCM.32.9.2081-2087.1994; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; El Solh A, 2009, EXPERT OPIN PHARMACO, V10, P1675, DOI 10.1517/14656560903048967; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P1009, DOI 10.1111/j.1469-0691.2009.02994.x; Ellington MJ, 2009, EUR J CLIN MICROBIOL, V28, P1113, DOI 10.1007/s10096-009-0757-x; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V60, P402, DOI 10.1093/jac/dkm206; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; ELLINGTON MJ, 2008, 18 EUR C CLIN MICR I; ENANY S, 2007, EUROSURVEILLANCE, V12; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fang H, 2008, CLIN MICROBIOL INFEC, V14, P370, DOI 10.1111/j.1469-0691.2007.01941.x; Faria NA, 2005, J CLIN MICROBIOL, V43, P1836, DOI 10.1128/JCM.43.4.1836-1842.2005; Fatholahzadeh B, 2009, JPN J INFECT DIS, V62, P309; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fessler AT, 2011, ANTIMICROB AGENTS CH, V55, P373, DOI 10.1128/AAC.01124-10; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; GARNIER F, 2006, EMERG INFECT DIS; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Ghebremedhin B, 2005, EUR J CLIN MICROBIOL, V24, P388, DOI 10.1007/s10096-005-1339-1; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gosbell IB, 2006, PATHOLOGY, V38, P239, DOI 10.1080/00313020600699227; Gould SWJ, 2008, J MED MICROBIOL, V57, P1394, DOI 10.1099/jmm.0.2008/003509-0; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Ho PL, 2008, DIAGN MICR INFEC DIS, V61, P135, DOI 10.1016/j.diagmicrobio.2007.12.017; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; HOLDEN MTG, 2009, J BACTERIOL; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; HOWDEN BP, 2010, J BACTERIOL; Hsu LY, 2007, J MED MICROBIOL, V56, P376, DOI 10.1099/jmm.0.46950-0; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Hulten KG, 2010, INFECT CONT HOSP EP, V31, P183, DOI 10.1086/649793; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ip M, 2005, J CLIN MICROBIOL, V43, P5069, DOI 10.1128/JCM.43.10.5069-5073.2005; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; *IWG SCC, 2009, ANTIMICROB AGENTS CH, V53; JEVONS MP, 1961, BRIT MED J, P1924; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P3589, DOI 10.1128/AAC.00570-09; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P776, DOI 10.1128/AAC.01128-08; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kanerva M, 2007, J HOSP INFECT, V66, P22, DOI 10.1016/j.jhin.2007.02.014; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Kerttula AM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-94; KINNEVEY P, 2010, ECCMID VIENN; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Krziwanek K, 2008, CLIN MICROBIOL INFEC, V14, P250, DOI 10.1111/j.1469-0691.2007.01896.x; Krziwanek K, 2007, EUR J CLIN MICROBIOL, V26, P931, DOI 10.1007/s10096-007-0391-4; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; KUPFER M, 2009, THESIS TU DRESDEN; Kwon NH, 2006, VET MICROBIOL, V117, P304, DOI 10.1016/j.vetmic.2006.05.006; LAYER F, 2010, DGHM HANN; Lee SM, 2007, ANTIMICROB AGENTS CH, V51, P1497, DOI 10.1128/AAC.01239-06; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lo WT, 2006, EMERG INFECT DIS, V12, P1267, DOI 10.3201/eid1708.051570; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Lozano C, 2009, J ANTIMICROB CHEMOTH, V64, P1325, DOI 10.1093/jac/dkp378; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Mato R, 2004, MICROB DRUG RESIST, V10, P106, DOI 10.1089/1076629041310109; Mayor L, 2007, J CLIN MICROBIOL, V45, P2298, DOI 10.1128/JCM.00040-07; McDonald M, 2006, J CLIN MICROBIOL, V44, P3720, DOI 10.1128/JCM.00836-06; Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Meyer E, 2006, INFECTION, V34, P303, DOI 10.1007/s15010-006-6619-x; Miklasevics E, 2004, Euro Surveill, V9, P29, DOI 10.2807/esm.09.11.00485-en; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; MOLINOS S, 2009, 13 REUN SEIMC SEV; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1383, DOI 10.1007/s10096-009-0796-3; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; MONECKE S, 2008, ISSSI PERTH; Monecke S, 2003, GENOME LETT, V2, P106; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014025; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Murchan S, 2004, J CLIN MICROBIOL, V42, P5154, DOI 10.1128/JCM.42.11.5154-5160.2004; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; NEJMA MB, 2008, DIAGN MICROBIOL INFE; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Nienhoff U, 2009, J ANTIMICROB CHEMOTH, V64, P660, DOI 10.1093/jac/dkp243; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; Nowak MA, 2002, Z PHYS CHEM, V216, P5, DOI 10.1524/zpch.2002.216.1.005; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Orth D, 2006, EUR J CLIN MICROBIOL, V25, P104, DOI 10.1007/s10096-006-0102-6; Otter JA, 2008, CLIN MICROBIOL INFEC, V14, P670, DOI 10.1111/j.1469-0691.2008.02017.x; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Ozaki K, 2009, J INFECT CHEMOTHER, V15, P84, DOI 10.1007/s10156-009-0668-x; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Panton PN, 1932, LANCET, V1, P506; Peck KR, 2009, J KOREAN MED SCI, V24, P585, DOI 10.3346/jkms.2009.24.4.585; Perez-Vazquez M, 2009, J ANTIMICROB CHEMOTH, V63, P21, DOI 10.1093/jac/dkn430; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Potel C, 2010, EUR J CLIN MICROBIOL, V29, P351, DOI 10.1007/s10096-009-0860-z; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rolain JM, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-1; ROSSNEY A, 2005, EUROSURVEILLANCE, V10; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; Rossney AS, 2003, EUR J CLIN MICROBIOL, V22, P379, DOI 10.1007/s10096-003-0917-3; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; SCHAEFLER S, 1981, J CLIN MICROBIOL, V13, P754, DOI 10.1128/JCM.13.4.754-759.1981; Schefold Joerg C, 2007, J Med Case Rep, V1, P165; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schwarz S, 2008, J ANTIMICROB CHEMOTH, V61, P282, DOI 10.1093/jac/dkm487; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shittu A, 2009, J MED MICROBIOL, V58, P1219, DOI 10.1099/jmm.0.011452-0; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; SHORE A, 2010, INT S STAPH STAPH IN; SHORE AC, 2010, ANTIMICROB AGENTS CH; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Smith Tara C, 2009, PLoS One, V4, pe4258, DOI 10.1371/journal.pone.0004258; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Soavi L, 2010, EMERG INFECT DIS, V16, P346, DOI 10.3201/eid1602.091478; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Stefani S, 2009, DIAGN MICR INFEC DIS, V63, P100, DOI 10.1016/j.diagmicrobio.2008.09.012; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2007, MICROBIOL IMMUNOL, V51, P627, DOI 10.1111/j.1348-0421.2007.tb03949.x; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; Udo EE, 2010, J MED MICROBIOL, V59, P193, DOI 10.1099/jmm.0.013268-0; Udo EE, 2006, CLIN MICROBIOL INFEC, V12, P262, DOI 10.1111/j.1469-0691.2005.01350.x; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; VANDEVELDE H, 1894, CELLULE, V10, P401; VANRENSBURG MJ, 2010, CLIN MICROBIOL INFEC; Vindel A, 2006, J CLIN MICROBIOL, V44, P266, DOI 10.1128/JCM.44.1.266-270.2006; Vivoni AM, 2006, J CLIN MICROBIOL, V44, P1686, DOI 10.1128/JCM.44.5.1686-1691.2006; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Vourli S, 2005, Euro Surveill, V10, P78; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Ward John M., 2009, American Fisheries Society Annual Meeting; WEBER S, 2010, ECCMID VIENN; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Welinder-Olsson C, 2008, EMERG INFECT DIS, V14, P1271, DOI 10.3201/eid1408.071427; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; WITTE W, 2000, BUNDESGESUNDHEITSBLA, V43, P633; Wolter DJ, 2008, J CLIN MICROBIOL, V46, P3548, DOI 10.1128/JCM.00985-08; Wulf M, 2006, EMERG INFECT DIS, V12, P1939; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zafar A, 2011, J MED MICROBIOL, V60, P56, DOI 10.1099/jmm.0.022707-0; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	244	584	596	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e17936	10.1371/journal.pone.0017936	http://dx.doi.org/10.1371/journal.pone.0017936			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494333	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400005
J	Nariai, Y; Hayashi, S; Morita, S; Umemura, Y; Tainaka, K; Sota, T; Cooley, JR; Yoshimura, J				Nariai, Yukiko; Hayashi, Saki; Morita, Satoru; Umemura, Yoshitaka; Tainaka, Kei-ichi; Sota, Teiji; Cooley, John R.; Yoshimura, Jin			Life Cycle Replacement by Gene Introduction under an Allee Effect in Periodical Cicadas	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; MAGICICADA SPP.; 13-YEAR; 17-YEAR; SPECIATION; HEMIPTERA; HOMOPTERA; SELECTION; CICADIDAE; EVOLUTION	Periodical cicadas (Magicicada spp.) in the USA are divided into three species groups (-decim, -cassini, -decula) of similar but distinct morphology and behavior. Each group contains at least one species with a 17-year life cycle and one with a 13-year cycle; each species is most closely related to one with the other cycle. One explanation for the apparent polyphyly of 13- and 17-year life cycles is that populations switch between the two cycles. Using a numerical model, we test the general feasibility of life cycle switching by the introduction of alleles for one cycle into populations of the other cycle. Our results suggest that fitness reductions at low population densities of mating individuals (the Allee effect) could play a role in life cycle switching. In our model, if the 13-year cycle is genetically dominant, a 17-year cycle population will switch to a 13-year cycle given the introduction of a few 13-year cycle alleles under a moderate Allee effect. We also show that under a weak Allee effect, different year-classes ("broods") with 17-year life cycles can be generated. Remarkably, the outcomes of our models depend only on the dominance relationships of the cycle alleles, irrespective of any fitness advantages.	[Nariai, Yukiko; Hayashi, Saki; Morita, Satoru; Umemura, Yoshitaka; Tainaka, Kei-ichi; Cooley, John R.; Yoshimura, Jin] Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka, Japan; [Hayashi, Saki] Shizuoka Univ, Fac Informat Sci, Hamamatsu, Shizuoka, Japan; [Sota, Teiji] Kyoto Univ, Dept Zool, Kyoto, Japan; [Cooley, John R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Shizuoka University; Shizuoka University; Kyoto University; University of Connecticut; Chiba University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nariai, Y (corresponding author), Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka, Japan.	jin@sys.eng.shizuoka.ac.jp	Morita, Satoru/W-7768-2018; Morita, Satoru/A-3736-2013	Morita, Satoru/0000-0001-5219-6218; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22255004, 22370010, 20500204]; Ryozo Yamada Funds; National Science Foundation [DEB04-22386, DEB05-29679, DEB07-20664, DEB07-22101]; Grants-in-Aid for Scientific Research [20405007, 21570100, 22370010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryozo Yamada Funds; National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to J. Y. (nos. 22255004 and 22370010) and K. T. (20500204), a research grant from Ryozo Yamada Funds to J. Y. and J. R. C. acknowledge support from National Science Foundation DEB04-22386, DEB05-29679, DEB07-20664, and DEB07-22101 to Chris Simon. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D., 1962, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 121, P1; Allee W.C, 1931, ANIMAL AGGREGATION S; ANDERSON E, 1949, INTROGRESSIVE HYBRID, P118; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Beamer R. H., 1931, Journal of the Kansas Entomological Society, V4, P53; Benko TP, 2006, J BIOL SYST, V14, P555, DOI 10.1142/S0218339006002008; Cooley JR, 2006, J EVOLUTION BIOL, V19, P855, DOI 10.1111/j.1420-9101.2005.01056.x; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; COX RT, 1991, AM MIDL NAT, V125, P63, DOI 10.2307/2426370; Cox RT, 2003, EVOLUTION, V57, P428; COX RT, 1992, EVOLUTION, V46, P845, DOI 10.1111/j.1558-5646.1992.tb02092.x; DYBAS HS, 1962, ECOLOGY, V43, P432, DOI 10.2307/1933372; DYBAS HS, 1969, FIELD MUS NAT HIST B, V40, P10; Gogala Matija, 1995, Malayan Nature Journal, V48, P297; HELIOVAARA K, 1994, TRENDS ECOL EVOL, V9, P475, DOI 10.1016/0169-5347(94)90312-3; KARBAN R, 1982, ECOLOGY, V63, P321, DOI 10.2307/1938949; Kato M., 1956, BIOL CICADAS, V1981; Kato M., 1932, MONOGRAPH CICADIDAE; Kritsky G., 1988, Proceedings of the Indiana Academy of Science, V97, P295; Kritsky G, 2004, PERIODICAL CICADAS P; KUNO E, 1992, RES POPUL ECOL, V34, P275, DOI 10.1007/BF02514797; LLOYD M, 1966, EVOLUTION, V20, P466, DOI 10.1111/j.1558-5646.1966.tb03381.x; LLOYD M, 1983, EVOLUTION, V37, P1162, DOI 10.1111/j.1558-5646.1983.tb00231.x; LLOYD M, 1966, EVOLUTION, V20, P133, DOI 10.1111/j.1558-5646.1966.tb03350.x; Marlatt CL, 1923, BUREAU ENTOMOLOGY B, V71, P1; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; MARTIN AP, 1988, NATURE, V336, P237, DOI 10.1038/336237a0; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Simon C, 2000, EVOLUTION, V54, P1326; Simon C., 1988, Bulletin of the Entomological Society of America, V34, P163; SIMON C, 1981, ECOLOGY, V62, P1525, DOI 10.2307/1941509; SIMON C, 1982, J NEW YORK ENTOMOL S, V90, P275; Smits A, 2010, ENTOMOL AM-NY, V116, P73, DOI 10.1664/09-RA-004R.1; Tanaka Y, 2009, P NATL ACAD SCI USA, V106, P8975, DOI 10.1073/pnas.0900215106; WASSERMAN M, 1977, EVOLUTION, V31, P812, DOI 10.1111/j.1558-5646.1977.tb01073.x; WHITE JA, 1975, AM MIDL NAT, V94, P127, DOI 10.2307/2424544; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Yoshimura J, 1997, AM NAT, V149, P112, DOI 10.1086/285981; YOSHIMURA J, 1994, THEOR POPUL BIOL, V45, P121, DOI 10.1006/tpbi.1994.1007; Yoshimura J, 1997, RES POPUL ECOL, V39, P191, DOI 10.1007/BF02765265; Yoshimura J, 2009, EVOLUTION, V63, P288, DOI 10.1111/j.1558-5646.2008.00545.x	44	8	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18347	10.1371/journal.pone.0018347	http://dx.doi.org/10.1371/journal.pone.0018347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494682	Green Submitted, gold, Green Published			2022-12-27	WOS:000289192400023
J	Thiam, S; Thior, M; Faye, B; Ndiop, M; Diouf, ML; Diouf, MB; Diallo, I; Fall, FB; Ndiaye, JL; Albertini, A; Lee, E; Jorgensen, P; Gaye, O; Bell, D				Thiam, Sylla; Thior, Moussa; Faye, Babacar; Ndiop, Medoune; Diouf, Mamadou Lamine; Diouf, Mame Birame; Diallo, Ibrahima; Fall, Fatou Ba; Ndiaye, Jean Louis; Albertini, Audrey; Lee, Evan; Jorgensen, Pernille; Gaye, Oumar; Bell, David			Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests	PLOS ONE			English	Article							COMBINATION THERAPY; COST-EFFECTIVENESS; RANDOMIZED-TRIAL; FEBRILE ILLNESS; TANZANIA; CHILDREN; ERA	Background: While WHO recently recommended universal parasitological confirmation of suspected malaria prior to treatment, debate has continued as to whether wide-scale use of rapid diagnostic tests (RDTs) can achieve this goal. Adherence of health service personnel to RDT results has been poor in some settings, with little impact on anti-malarial drug consumption. The Senegal national malaria control programme introduced universal parasite-based diagnosis using malaria RDTs from late 2007 in all public health facilities. This paper assesses the impact of this programme on anti-malarial drug consumption and disease reporting. Methods and Findings: Nationally-collated programme data from 2007 to 2009 including malaria diagnostic outcomes, prescription of artemisinin-based combination therapy (ACT) and consumption of RDTs in public health facilities, were reviewed and compared. Against a marked seasonal variation in all-cause out-patient visits, non-malarial fever and confirmed malaria, parasite-based diagnosis increased nationally from 3.9% of reported malaria-like febrile illness to 86.0% over a 3 year period. The prescription of ACT dropped throughout this period from 72.9% of malaria-like febrile illness to 31.5%, reaching close equivalence to confirmed malaria (29.9% of 584873 suspect fever cases). An estimated 516576 courses of inappropriate ACT prescription were averted. Conclusions: The data indicate high adherence of anti-malarial prescribing practice to RDT results after an initial run-in period. The large reduction in ACT consumption enabled by the move from symptom-based to parasite-based diagnosis demonstrates that effective roll-out and use of malaria RDTs is achievable on a national scale through well planned and structured implementation. While more detailed information on management of parasite-negative cases is required at point of care level to assess overall cost-benefits to the health sector, considerable cost-savings were achieved in ACT procurement. Programmes need to be allowed flexibility in management of these funds to address increases in other programmatic costs that may accrue from improved diagnosis of febrile disease.	[Thiam, Sylla; Thior, Moussa; Ndiop, Medoune; Diouf, Mamadou Lamine; Diouf, Mame Birame; Diallo, Ibrahima; Fall, Fatou Ba] Minist Sante, Programme Natl Lutte Paludisme, Dakar, Senegal; [Faye, Babacar; Ndiaye, Jean Louis; Gaye, Oumar] Univ Cheikh Anta Diop Dakar, Fac Med, Fann Dakar, Senegal; [Albertini, Audrey; Lee, Evan; Jorgensen, Pernille] FIND, Geneva, Switzerland; [Bell, David] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland	University Cheikh Anta Diop Dakar; Foundation For Innovative New Diagnostics; World Health Organization	Thiam, S (corresponding author), Minist Sante, Programme Natl Lutte Paludisme, Dakar, Senegal.	david.bell@finddiagnostics.org		Ndiaye, Jean/0000-0003-0450-5551	Global Fund to fight AIDS, Tuberculosis and Malaria; United States Presidents' Malaria Initiative; Foundation for Innovative New Diagnostics (FIND) through Bill and Melinda Gates Foundation	Global Fund to fight AIDS, Tuberculosis and Malaria; United States Presidents' Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Foundation for Innovative New Diagnostics (FIND) through Bill and Melinda Gates Foundation	This study was funded through pre-existing grants to the Senegal Programme National de lutte contre le Paludisme from the Global Fund to fight AIDS, Tuberculosis and Malaria and the United States Presidents' Malaria Initiative, and by the Foundation for Innovative New Diagnostics (FIND) through a grant from the Bill and Melinda Gates Foundation. The funding agencies had no role in the decision to undertake the study, study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2009, MAL MICR QUAL ASS MA; ANSAH EK, 2010, RAPID TESTING MALARI; Armstrong Schellenberg J. R. M., 1994, Parasitology Today, V10, P439; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Black RE, 2010, LANCET; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Faucher JF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-104; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Ly AB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-153; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; SABOT SYO, 2009, CONS FOR AMFM AFF ME; SENEGAL NMC, 2006, DIRECTIVES NATL TRAI; SENEGAL NMC, 2008, MANUEL PROCEDURES CO; SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; WHO, 2008, METH MAN LAB QUAL CO; *WHO FIND CDC TDR, 2010, MAL RAP DIAGN TEST P; *WHO WPRO, 2010, MAL RDT JOB AIDS TRA; WHO-TDR-FIND, 2010, METH MAN LAB QUAL CO; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; World Health Organization, 2009, MAL CAS MAN OP MAN; Yukich J, 2010, AM J TROP MED HYG, V83, P61, DOI 10.4269/ajtmh.2010.09-0632	32	118	119	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18419	10.1371/journal.pone.0018419	http://dx.doi.org/10.1371/journal.pone.0018419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494674	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400026
J	Walpita, P; Barr, J; Sherman, M; Basler, CF; Wang, LF				Walpita, Pramila; Barr, Jennifer; Sherman, Michael; Basler, Christopher F.; Wang, Linfa			Vaccine Potential of Nipah Virus-Like Particles	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; HENDRA-VIRUS; NEUTRALIZING ANTIBODIES; MEMBRANE-FUSION; ENCEPHALITIS; CELLS; INFECTION; PROTEINS; RECEPTOR; REQUIREMENTS	Nipah virus (NiV) was first recognized in 1998 in a zoonotic disease outbreak associated with highly lethal febrile encephalitis in humans and a predominantly respiratory disease in pigs. Periodic deadly outbreaks, documentation of person-to-person transmission, and the potential of this virus as an agent of agroterror reinforce the need for effective means of therapy and prevention. In this report, we describe the vaccine potential of NiV virus-like particles (NiV VLPs) composed of three NiV proteins G, F and M. Co-expression of these proteins under optimized conditions resulted in quantifiable amounts of VLPs with many virus-like/vaccine desirable properties including some not previously described for VLPs of any paramyxovirus: The particles were fusogenic, inducing syncytia formation; PCR array analysis showed NiV VLP-induced activation of innate immune defense pathways; the surface structure of NiV VLPs imaged by cryoelectron microscopy was dense, ordered, and repetitive, and consistent with similarly derived structure of paramyxovirus measles virus. The VLPs were composed of all the three viral proteins as designed, and their intracellular processing also appeared similar to NiV virions. The size, morphology and surface composition of the VLPs were consistent with the parental virus, and importantly, they retained their antigenic potential. Finally, these particles, formulated without adjuvant, were able to induce neutralizing antibody response in Balb/c mice. These findings indicate vaccine potential of these particles and will be the basis for undertaking future protective efficacy studies in animal models of NiV disease.	[Walpita, Pramila] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Microbiol, Galveston, TX USA; [Walpita, Pramila] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Immunol, Galveston, TX USA; [Barr, Jennifer; Wang, Linfa] Australian Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Sherman, Michael] Univ Texas Med Branch, Dept Biochem & Struct Biol, Galveston, TX USA; [Basler, Christopher F.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Texas System; University of Texas Medical Branch Galveston; Icahn School of Medicine at Mount Sinai	Walpita, P (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Microbiol, Galveston, TX USA.	prwalpit@utmb.edu	wang, lin/GSE-3040-2022; Basler, Christopher/AAG-8346-2019; Barr, Jennifer A/H-9254-2013	Basler, Christopher/0000-0003-4195-425X; Barr, Jennifer/0000-0001-5266-9142	NIH/WRCE [U54 AI057156-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NIH/WRCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Developmental grant to PW from NIH/WRCE U54 AI057156-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2005, HSB (Health Science Bulletin), V3, P1; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P168; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; BRATT MA, 1969, P NATL ACAD SCI USA, V64, P536, DOI 10.1073/pnas.64.2.536; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chan KP, 2002, EPIDEMIOL INFECT, V128, P93, DOI 10.1017/S0950268801006422; CHATTOPADHYAY A, 2010, J VIROL; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; Defang GN, 2010, VACCINE, V29, P212, DOI 10.1016/j.vaccine.2010.10.053; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Gilbert JM, 1997, J VIROL, V71, P4555, DOI 10.1128/JVI.71.6.4555-4563.1997; Goldsmith CS, 2003, VIRUS RES, V92, P89, DOI 10.1016/S0168-1702(02)00323-4; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Guillaume V, 2006, J VIROL, V80, P1972, DOI 10.1128/JVI.80.4.1972-1978.2006; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Gurley ES, 2007, INFECT CONT HOSP EP, V28, P740, DOI 10.1086/516665; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Hyatt AD, 2001, MICROBES INFECT, V3, P297, DOI 10.1016/S1286-4579(01)01383-1; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Jennings GT, 2007, CURR MOL MED, V7, P143, DOI 10.2174/156652407780059140; Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129; Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026; KNUTTON S, 1977, J CELL SCI, V28, P179; Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005; Lokugamage KG, 2008, VACCINE, V26, P797, DOI 10.1016/j.vaccine.2007.11.092; Mao CP, 2010, J VIROL, V84, P2331, DOI 10.1128/JVI.01954-09; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; McGinnes LW, 2010, J VIROL, V84, P4513, DOI 10.1128/JVI.01931-09; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Patch JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-1; PATTNAIK AK, 1991, P NATL ACAD SCI USA, V88, P1379, DOI 10.1073/pnas.88.4.1379; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; Schmitt AP, 2004, CURR TOP MICROBIOL, V283, P145; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Sherman MB, 2010, J VIROL, V84, P9775, DOI 10.1128/JVI.00876-10; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Teng MN, 1998, J VIROL, V72, P5707, DOI 10.1128/JVI.72.7.5707-5716.1998; Walpita P, 2005, FEMS MICROBIOL LETT, V244, P9, DOI 10.1016/j.femsle.2005.01.046; Walpita P, 2007, J GEN VIROL, V88, P2542, DOI 10.1099/vir.0.83035-0; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Whelan SPJ, 1999, J VIROL, V73, P307, DOI 10.1128/JVI.73.1.307-315.1999; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; 2004, HLTH SCI B, V2, P5; 2004, HLTH SCI B ICDDR B, V2, P7	77	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18437	10.1371/journal.pone.0018437	http://dx.doi.org/10.1371/journal.pone.0018437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494680	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400028
J	Jespersen, JG; Nedergaard, A; Reitelseder, S; Mikkelsen, UR; Dideriksen, KJ; Agergaard, J; Kreiner, F; Pott, FC; Schjerling, P; Kjaer, M				Jespersen, Jakob G.; Nedergaard, Anders; Reitelseder, Soren; Mikkelsen, Ulla R.; Dideriksen, Kasper J.; Agergaard, Jakob; Kreiner, Frederik; Pott, Frank C.; Schjerling, Peter; Kjaer, Michael			Activated Protein Synthesis and Suppressed Protein Breakdown Signaling in Skeletal Muscle of Critically Ill Patients	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; GROWTH-FACTOR-I; UBIQUITIN LIGASES; AMINO-ACID; IGF-I; BODY-COMPOSITION; GENE-EXPRESSION; SEVERE SEPSIS; CARE PATIENTS; ATROPHY	Background: Skeletal muscle mass is controlled by myostatin and Akt-dependent signaling on mammalian target of rapamycin (mTOR), glycogen synthase kinase 3 beta (GSK3 beta) and forkhead box O (FoxO) pathways, but it is unknown how these pathways are regulated in critically ill human muscle. To describe factors involved in muscle mass regulation, we investigated the phosphorylation and expression of key factors in these protein synthesis and breakdown signaling pathways in thigh skeletal muscle of critically ill intensive care unit (ICU) patients compared with healthy controls. Methodology/Principal Findings: ICU patients were systemically inflamed, moderately hyperglycemic, received insulin therapy, and showed a tendency to lower plasma branched chain amino acids compared with controls. Using Western blotting we measured Akt, GSK3 beta, mTOR, ribosomal protein S6 kinase (S6k), eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), and muscle ring finger protein 1 (MuRF1); and by RT-PCR we determined mRNA expression of, among others, insulin-like growth factor 1 (IGF-1), FoxO 1, 3 and 4, atrogin1, MuRF1, interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and myostatin. Unexpectedly, in critically ill ICU patients Akt-mTOR-S6k signaling was substantially higher compared with controls. FoxO1 mRNA was higher in patients, whereas FoxO3, atrogin1 and myostatin mRNAs and MuRF1 protein were lower compared with controls. A moderate correlation (r(2) = 0.36, p < 0.05) between insulin infusion dose and phosphorylated Akt was demonstrated. Conclusions/Significance: We present for the first time muscle protein turnover signaling in critically ill ICU patients, and we show signaling pathway activity towards a stimulation of muscle protein synthesis and a somewhat inhibited proteolysis.	[Jespersen, Jakob G.; Nedergaard, Anders; Reitelseder, Soren; Mikkelsen, Ulla R.; Dideriksen, Kasper J.; Agergaard, Jakob; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark; [Jespersen, Jakob G.; Nedergaard, Anders; Reitelseder, Soren; Mikkelsen, Ulla R.; Dideriksen, Kasper J.; Agergaard, Jakob; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth Sci, Copenhagen, Denmark; [Kreiner, Frederik] Rigshosp, Dept Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Pott, Frank C.] Bispebjerg Hosp, Dept Anesthesiol, DK-2400 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Jespersen, JG (corresponding author), Univ Copenhagen, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark.	jespersen.jakob@gmail.com	Kjaer, Michael/W-6842-2019; Schjerling, Peter/F-6194-2011; Agergaard, Jakob/ABF-2729-2020	Kjaer, Michael/0000-0002-4582-8755; Schjerling, Peter/0000-0001-7138-3211; Flindt Kreiner, Frederik/0000-0001-8296-453X; Agergaard, Jakob/0000-0003-3401-3144	Copenhagen Graduate School of Health Sciences; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Gigtforeningen; Nordea Foundation	Copenhagen Graduate School of Health Sciences; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Gigtforeningen; Nordea Foundation	This study was supported by a PhD fellowship from the Copenhagen Graduate School of Health Sciences (to JGJ) and grants from Danish Medical Research Council, The Novo Nordisk Foundation, The Lundbeck Foundation, Gigtforeningen and The Nordea Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Biolo G, 2002, J CLIN ENDOCR METAB, V87, P3378, DOI 10.1210/jc.87.7.3378; Biolo G, 2008, CRIT CARE MED, V36, P1768, DOI 10.1097/CCM.0b013e318174de32; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Cho JE, 2010, J APPL PHYSIOL, V108, P137, DOI 10.1152/japplphysiol.00704.2009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; Dehoux M, 2004, ENDOCRINOLOGY, V145, P4806, DOI 10.1210/en.2004-0406; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Druml W, 2001, AM J CLIN NUTR, V73, P908; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fang CH, 2007, AM J PHYSIOL-REG I, V293, pR1545, DOI 10.1152/ajpregu.00244.2007; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Frystyk J, 1995, GROWTH REGULAT, V5, P169; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Gamrin L, 1996, CRIT CARE MED, V24, P575, DOI 10.1097/00003246-199604000-00005; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gore DC, 2004, AM J PHYSIOL-ENDOC M, V286, pE529, DOI 10.1152/ajpendo.00258.2003; Grander W, 2010, CHEST, V138, P856, DOI 10.1378/chest.09-1677; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; HASSELGREN PO, 1987, ARCH SURG-CHICAGO, V122, P228; Helliwell TR, 1998, NEUROPATH APPL NEURO, V24, P507; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jespersen J, 2006, SCAND J MED SCI SPOR, V16, P74, DOI 10.1111/j.1600-0838.2005.00498.x; JESPERSEN JG, 2009, SCAND J MED IN PRESS; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE234, DOI 10.1152/ajpendo.00274.2003; Lang CH, 2005, INT J BIOCHEM CELL B, V37, P2180, DOI 10.1016/j.biocel.2005.04.013; Lang CH, 2005, J CELL PHYSIOL, V203, P144, DOI 10.1002/jcp.20207; Lang CH, 2004, AM J PHYSIOL-ENDOC M, V287, pE721, DOI 10.1152/ajpendo.00132.2004; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Lang CH, 2007, METABOLISM, V56, P49, DOI 10.1016/j.metabol.2006.08.025; Langouche L, 2007, J CLIN ENDOCR METAB, V92, P3890, DOI 10.1210/jc.2007-0813; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McLoughlin TJ, 2009, AM J PHYSIOL-CELL PH, V297, pC548, DOI 10.1152/ajpcell.00502.2008; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Mikura M, 2009, ANESTHESIOLOGY, V110, P81, DOI 10.1097/ALN.0b013e318190b6c1; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Plank LD, 2000, ANN NY ACAD SCI, V904, P592, DOI 10.1111/j.1749-6632.2000.tb06521.x; Plank LD, 2000, WORLD J SURG, V24, P630, DOI 10.1007/s002689910104; POULSEN JB, 2010, CRIT CARE M IN PRESS; Rabuel C, 2004, ANESTHESIOLOGY, V101, P583, DOI 10.1097/00000542-200409000-00006; Reitelseder S, 2011, AM J PHYSIOL-ENDOC M, V300, pE231, DOI 10.1152/ajpendo.00513.2010; ROTH E, 1985, CLIN CHEM, V31, P1305; Saberi F, 2008, JPEN-PARENTER ENTER, V32, P227, DOI 10.1177/0148607108316195; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Timmerman KL, 2010, J CLIN ENDOCR METAB, V95, P3848, DOI 10.1210/jc.2009-2696; TISCHLER ME, 1983, METABOLISM, V32, P853, DOI 10.1016/0026-0495(83)90198-1; Tjader I, 2004, INTENS CARE MED, V30, P266, DOI 10.1007/s00134-003-2048-9; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vary TC, 1998, AM J PHYSIOL-ENDOC M, V275, pE584, DOI 10.1152/ajpendo.1998.275.4.E584; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	83	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18090	10.1371/journal.pone.0018090	http://dx.doi.org/10.1371/journal.pone.0018090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483870	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200025
J	Sommi, P; Cheerambathur, D; Brust-Mascher, I; Mogilner, A				Sommi, Patrizia; Cheerambathur, Dhanya; Brust-Mascher, Ingrid; Mogilner, Alex			Actomyosin-Dependent Cortical Dynamics Contributes to the Prophase Force-Balance in the Early Drosophila Embryo	PLOS ONE			English	Article							NONMUSCLE MYOSIN-II; CENTROSOME SEPARATION; CHROMOSOME MOVEMENT; SPINDLE ORIENTATION; FURROW FORMATION; CLEAVAGE FURROW; ACTIN; CYTOKINESIS; MICROTUBULES; RECRUITMENT	Background: The assembly of the Drosophila embryo mitotic spindle during prophase depends upon a balance of outward forces generated by cortical dynein and inward forces generated by kinesin-14 and nuclear elasticity. Myosin II is known to contribute to the dynamics of the cell cortex but how this influences the prophase force-balance is unclear. Principal Findings: Here we investigated this question by injecting the myosin II inhibitor, Y27632, into early Drosophila embryos. We observed a significant increase in both the area of the dense cortical actin caps and in the spacing of the spindle poles. Tracking of microtubule plus ends marked by EB1-GFP and of actin at the cortex revealed that astral microtubules can interact with all regions of these expanded caps, presumably via their interaction with cortical dynein. In Scrambled mutants displaying abnormally small actin caps but normal prophase spindle length in late prophase, myosin II inhibition produced very short spindles. Conclusions: These results suggest that two complementary outward forces are exerted on the prophase spindle by the overlying cortex. Specifically, dynein localized on the mechanically firm actin caps and the actomyosin-driven contraction of the deformable soft patches of the actin cortex, cooperate to pull astral microtubules outward. Thus, myosin II controls the size and dynamic properties of the actin-based cortex to influence the spacing of the poles of the underlying spindle during prophase.	[Sommi, Patrizia] Univ Pavia, Human Physiol Sect, Dept Physiol, I-27100 Pavia, Italy; [Cheerambathur, Dhanya] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Brust-Mascher, Ingrid] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of Pavia; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Sommi, P (corresponding author), Univ Pavia, Human Physiol Sect, Dept Physiol, Via Palestro 3, I-27100 Pavia, Italy.	mogilner@math.ucdavis.edu	Mogilner, Alex/A-3135-2008	Cheerambathur, Dhanya/0000-0001-8525-8366	National Institutes of Health [GM 55507, GM068952, GM 068952]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health grants GM 55507 to Jonathan Scholey, GM068952 to Alex Mogilner, and GM 068952 to Alex Mogilner and Jonathan Scholey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Cytrynbaum EN, 2005, MOL BIOL CELL, V16, P4967, DOI 10.1091/mbc.E05-02-0154; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Fabian L, 2007, PROTOPLASMA, V231, P201, DOI 10.1007/s00709-007-0262-y; Foe VE, 2000, DEVELOPMENT, V127, P1767; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glover DM, 2005, ONCOGENE, V24, P230, DOI 10.1038/sj.onc.1208279; Halsell SR, 1998, GENETICS, V148, P1845; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; KIEHART DP, 1982, J CELL BIOL, V94, P165, DOI 10.1083/jcb.94.1.165; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Redemann S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012301; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; SULLIVAN W, 1993, DEVELOPMENT, V118, P1245; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; WHEATLEY S, 1995, DEVELOPMENT, V121, P1937; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wollman R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.23; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18366	10.1371/journal.pone.0018366	http://dx.doi.org/10.1371/journal.pone.0018366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483831	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200064
J	Wheatley, T; Weinberg, A; Looser, C; Moran, T; Hajcak, G				Wheatley, Thalia; Weinberg, Anna; Looser, Christine; Moran, Tim; Hajcak, Greg			Mind Perception: Real but Not Artificial Faces Sustain Neural Activity beyond the N170/VPP	PLOS ONE			English	Article							EMOTIONAL PICTURES; BRAIN PROCESSES; RESPONSES; POTENTIALS; VARIANCE; ANIMACY; ACCOUNT; AUTISM; ERP	Faces are visual objects that hold special significance as the icons of other minds. Previous researchers using event-related potentials (ERPs) have found that faces are uniquely associated with an increased N170/vertex positive potential (VPP) and a more sustained frontal positivity. Here, we examined the processing of faces as objects vs. faces as cues to minds by contrasting images of faces possessing minds (human faces), faces lacking minds (doll faces), and non-face objects (i.e., clocks). Although both doll and human faces were associated with an increased N170/VPP from 175-200 ms following stimulus onset, only human faces were associated with a sustained positivity beyond 400 ms. Our data suggest that the N170/VPP reflects the object-based processing of faces, whether of dolls or humans; on the other hand, the later positivity appears to uniquely index the processing of human faces-which are more salient and convey information about identity and the presence of other minds.	[Wheatley, Thalia; Looser, Christine] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Weinberg, Anna; Moran, Tim; Hajcak, Greg] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA	Dartmouth College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wheatley, T (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	thalia.p.wheatley@dartmouth.edu		Hajcak, Greg/0000-0002-5159-7180				Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2007, NAT NEUROSCI, V10, P801, DOI 10.1038/nn0707-801; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; BOTZEL K, 1989, EXP BRAIN RES, V77, P349, DOI 10.1007/BF00274992; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; GOREN CC, 1975, PEDIATRICS, V56, P544; Grasso DJ, 2009, BIOL PSYCHOL, V81, P95, DOI 10.1016/j.biopsycho.2009.03.001; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green DM, 1966, SIGNAL DETECTION THE; Guthrie Stewart E., 1993, FACES CLOUDS; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Helmholtz HV, 1867, HDB PHYSL OPTIK; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Jacques C, 2010, BRAIN RES, V1318, P96, DOI 10.1016/j.brainres.2009.12.070; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Langeslag SJE, 2009, NEUROPSYCHOLOGIA, V47, P887, DOI 10.1016/j.neuropsychologia.2008.12.024; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; MacNamara A, 2009, EMOTION, V9, P531, DOI 10.1037/a0016251; Martin A, 2003, COGN NEUROPSYCHOL, V20, P575, DOI 10.1080/02643290342000005; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	44	65	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17960	10.1371/journal.pone.0017960	http://dx.doi.org/10.1371/journal.pone.0017960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YU	21483856	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200013
J	Xu, CL; Bai, T; Iuliano, AD; Wang, M; Yang, L; Wen, LY; Zeng, YH; Li, XD; Chen, T; Wang, W; Hu, Y; Yang, LM; Li, Z; Zou, SM; Li, DX; Wang, SW; Feng, ZJ; Zhang, YP; Yu, HJ; Yang, WZ; Wang, Y; Widdowson, MA; Shu, YL				Xu, Cuiling; Bai, Tian; Iuliano, A. Danielle; Wang, Min; Yang, Lei; Wen, Leying; Zeng, Yuhong; Li, Xiaodan; Chen, Tao; Wang, Wei; Hu, Ying; Yang, Limei; Li, Zi; Zou, Shumei; Li, Dexin; Wang, Shiwen; Feng, Zijian; Zhang, Yanping; Yu, Hongjie; Yang, Weizhong; Wang, Yu; Widdowson, Marc-Alain; Shu, Yuelong			The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China	PLOS ONE			English	Article							A H1N1; ANTIBODIES; INFECTION; HUMANS	Background: Mainland China experienced pandemic influenza H1N1 (2009) virus (pH1N1) with peak activity during November-December 2009. To understand the geographic extent, risk factors, and attack rate of pH1N1 infection in China we conducted a nationwide serological survey to determine the prevalence of antibodies to pH1N1. Methodology/Principal Findings: Stored serum samples (n = 2,379) collected during 2006-2008 were used to estimate baseline serum reactogenicity to pH1N1. In January 2010, we used a multistage-stratified random sampling method to select 50,111 subjects who met eligibility criteria and collected serum samples and administered a standardized questionnaire. Antibody response to pH1N1 was measured using haemagglutination inhibition (HI) assay and the weighted seroprevalence was calculated using the Taylor series linearization method. Multivariable logistic regression analyses were used to examine risk factors for pH1N1 seropositivity. Baseline seroprevalence of pH1N1 antibody (HI titer >= 40) was 1.2%. The weighted seroprevalence of pH1N1 among the Chinese population was 21.5%(vaccinated: 62.0%; unvaccinated: 17.1%). Among unvaccinated participants, those aged 6-15 years (32.9%) and 16-24 years (30.3%) had higher seroprevalence compared with participants aged 25-59 years (10.7%) and >= 60 years (9.9%, P < 0.0001). Children in kindergarten and students had higher odds of seropositivity than children in family care (OR: 1.36 and 2.05, respectively). We estimated that 207.7 million individuals (15.9%) experienced pH1N1 infection in China. Conclusions/Significance: The Chinese population had low pre-existing immunity to pH1N1 and experienced a relatively high attack rate in 2009 of this virus. We recommend routine control measures such as vaccination to reduce transmission and spread of seasonal and pandemic influenza viruses.	[Xu, Cuiling; Bai, Tian; Wang, Min; Yang, Lei; Wen, Leying; Zeng, Yuhong; Li, Xiaodan; Chen, Tao; Wang, Wei; Hu, Ying; Yang, Limei; Li, Zi; Zou, Shumei; Li, Dexin; Wang, Shiwen; Zhang, Yanping; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Iuliano, A. Danielle; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Xu, CL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China.	yshu@cnic.org.cn	Yu, Hongjie/GZK-5351-2022; Yang, Wei/HIA-0360-2022; Yang, Lei/GSD-3834-2022	Widdowson, Marc-Alain/0000-0002-0682-6933	central government; NIH/NIAID [5-U54-AI-057157-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	central government; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was mainly supported by the financial allocation of the central government and partly supported by NIH/NIAID Grant 5-U54-AI-057157-08 (Epidemiology and Molecular Mechanism of Highly Pathogenic Avian Influenza H5N1 and Pandemic Influenza H1N1). None of the sponsors participated in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; Centers for Disease Control and Prevention, 2010, CDC EST 2009 H1N1 IN; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; *CHIN NAT INFL CTR, 2009, CHIN INFL WEEKL REP; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Protection Agency, 2009, PAND H1N1 2009 INFL; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; LIU J, 2008, CHINESE, V24, P377; Lohr Sharon L., 2002, SAMPLING DESIGN ANAL, P12; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *MIN HLTH PEOPL RE, BRIEF REP PAND H1N1; *NAT BUR STAT, 2010, PEOPL REP CHIN CHIN; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; ROSS T, 2010, PLOS CURR INFLUENZA; *SAS I INC, 2004, SAS STAT 9 1 US GUID; Tang JW, 2010, EMERG INFECT DIS, V16, P874, DOI 10.3201/eid1605.091678; Turbelin C, 2009, EURO SURVEILL, V14; *WHO, WHOCDSCSRNCS20025; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; WORLD NOW START 2009	32	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e17919	10.1371/journal.pone.0017919	http://dx.doi.org/10.1371/journal.pone.0017919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533034	Green Published, gold, Green Submitted			2022-12-27	WOS:000290014500001
J	He, B; Zhang, H; Shi, TL				He, Bing; Zhang, Hao; Shi, Tieliu			A Comprehensive Analysis of the Dynamic Biological Networks in HCV Induced Hepatocarcinogenesis	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CHRONIC HEPATITIS-C; PORTAL-VEIN THROMBOSIS; HEPATOCELLULAR-CARCINOMA; LIVER-CIRRHOSIS; FOLLOW-UP; EXPRESSION; LUMICAN; PROTEIN; GENE	Hepatocellular carcinoma (HCC) is a primary malignancy of the liver, which is closely related to hepatitis C and cirrhosis. The molecular mechanisms underlying the hepatocarcinogenesis induced by HCV infection remain clarified from a standpoint of systems biology. By integrating data from protein-protein interactions, transcriptional regulation, and disease related microarray analysis, we carried out a dynamic biological network analysis on the progression of HCV induced hepatocarcinogenesis, and systematically explored the potentially disease-related mechanisms through a network view. The dysfunctional interactions among proteins and deregulatory relationships between transcription factors and their target genes could be causes for the occurrence and progression of this disease. The six pathologically defined disease stages in the development and progression of HCC after HCV infection were included in this study. We constructed disease-related biological networks for each disease stage, and identified progression-related sub-networks that potentially play roles in the developmental stage of the corresponding disease and participate in the later stage of cancer progression. In addition, we identified novel risk factors related to HCC based on the analysis of the progression-related sub-networks. The dynamic characteristics of the network reflect important features of the disease development and progression, which provide important information for us to further explore underlying mechanisms of the disease.	[He, Bing; Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhang, Hao] Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai 200433, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China	East China Normal University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	He, B (corresponding author), E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Sch Life Sci, Shanghai 200062, Peoples R China.	tlshi@sibs.ac.cn		He, Bing/0000-0003-1719-9290	National 973 Key Basic Research Program [2010CB945400, 2008CB713807, 2007CB108800]; National Natural Science Foundation of China [30870575, 31071162, 31000590]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National 973 Key Basic Research Program (Grant Nos. 2010CB945400, 2008CB713807 and 2007CB108800), and the National Natural Science Foundation of China (Grant No. 30870575, 31071162, 31000590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albornoz L, 1999, J HEPATOL, V30, P451, DOI 10.1016/S0168-8278(99)80104-4; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; ARBUTHNOT P, 1991, ANTICANCER RES, V11, P921; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; CASELMANN WH, 1995, J HEPATOL, V22, P34; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chiba T, 2005, EUR J CANCER, V41, P1185, DOI 10.1016/j.ejca.2005.02.014; COE JE, 1990, HEPATOLOGY, V11, P570, DOI 10.1002/hep.1840110408; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; El-Chennawi FA, 2008, IMMUNOL INVEST, V37, P661, DOI 10.1080/08820130802111605; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Ferro D, 1996, HEPATOLOGY, V23, P1377, DOI 10.1053/jhep.1996.v23.pm0008675154; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Han ZG, 2009, SCI CHINA SER C, V52, P24, DOI 10.1007/s11427-009-0010-y; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He B, 2010, CELL RES, V20, P732, DOI 10.1038/cr.2010.67; Hohler T, 1997, J HEPATOL, V27, P259, DOI 10.1016/S0168-8278(97)80169-9; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Inagaki Y, 1998, BIOCHEM BIOPH RES CO, V250, P606, DOI 10.1006/bbrc.1998.9345; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; KNITTEL T, 1995, HEPATOLOGY, V21, P470, DOI 10.1002/hep.1840210231; KRULL NB, 1992, FEBS LETT, V312, P47, DOI 10.1016/0014-5793(92)81407-D; LANGLEY PG, 1985, THROMB HAEMOSTASIS, V54, P693; Liu C, 2007, INT J IMMUNOGENET, V34, P373, DOI 10.1111/j.1744-313X.2007.00702.x; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Monnier J, 2008, WORLD J GASTROENTERO, V14, P1182, DOI 10.3748/wjg.14.1182; Nelson R, 2002, LANCET, V360, P2053, DOI 10.1016/S0140-6736(02)12045-9; NEUBERGER J, 1986, BRIT MED J, V292, P1355, DOI 10.1136/bmj.292.6532.1355; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; OKA K, 1979, THROMB HAEMOSTASIS, V42, P564; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; RAKE MO, 1970, LANCET, V1, P533; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun CA, 2003, AM J EPIDEMIOL, V157, P674, DOI 10.1093/aje/kwg041; URASHIMA S, 1993, ALCOHOL ALCOHOLISM, V28, P77, DOI 10.1093/alcalc/28.Supplement_1B.77; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yu RB, 2008, J GASTROEN HEPATOL, V23, P1394, DOI 10.1111/j.1440-1746.2007.05215.x; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030; Zhao YP, 2009, DIGEST DIS SCI, V54, P369, DOI 10.1007/s10620-008-0340-9; Zhou HJ, 2007, J CANCER RES CLIN, V133, P663, DOI 10.1007/s00432-007-0218-9	49	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18516	10.1371/journal.pone.0018516	http://dx.doi.org/10.1371/journal.pone.0018516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526182	gold, Green Published, Green Submitted			2022-12-27	WOS:000289671100007
J	Battista, J; Badcock, DR; McKendrick, AM				Battista, Josephine; Badcock, David R.; McKendrick, Allison M.			Migraine Increases Centre-Surround Suppression for Drifting Visual Stimuli	PLOS ONE			English	Article							PARVOCELLULAR PATHWAYS; CONTRAST SENSITIVITY; CORTICAL INHIBITION; MOTION PERCEPTION; FIELD LOSS; DEFICITS; EPIDEMIOLOGY; DYSFUNCTION; ADAPTATION; ANTAGONISM	Background: The pathophysiology of migraine is incompletely understood, but evidence points to hyper-responsivity of cortical neurons being a key feature. The basis of hyper-responsiveness is not clear, with an excitability imbalance potentially arising from either reduced inhibition or increased excitation. In this study, we measure centre-surround contrast suppression in people with migraine as a perceptual analogue of the interplay between inhibition and excitation in cortical areas responsible for vision. We predicted that reduced inhibitory function in migraine would reduce perceptual surround suppression. Recent models of neuronal surround suppression incorporate excitatory feedback that drives surround inhibition. Consequently, an increase in excitation predicts an increase in perceptual surround suppression. Methods and Findings: Twenty-six people with migraine and twenty approximately age-and gender-matched non-headache controls participated. The perceived contrast of a central sinusoidal grating patch (4 c/deg stationary grating, or 2 c/deg drifting at 2 deg/sec, 40% contrast) was measured in the presence and absence of a 95% contrast annular grating (same orientation, spatial frequency, and drift rate). For the static grating, similar surround suppression strength was present in control and migraine groups with the presence of the surround resulting in the central patch appearing to be 72% and 65% of its true contrast for control and migraine groups respectively (t(44) = 0.81, p = 0.42). For the drifting stimulus, the migraine group showed significantly increased surround suppression (t(44) = 2.86, p < 0.01), with perceived contrast being on average 53% of actual contrast for the migraine group and 68% for non-headache controls. Conclusions: In between migraines, when asymptomatic, visual surround suppression for drifting stimuli is greater in individuals with migraine than in controls. The data provides evidence for a behaviourally measurable imbalance in inhibitory and excitatory visual processes in migraine and is incompatible with a simple model of reduced cortical inhibitory function within the visual system.	[Battista, Josephine; McKendrick, Allison M.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Badcock, David R.] Univ Western Australia, Sch Psychol, Nedlands, WA 6009, Australia	University of Melbourne; University of Western Australia	Battista, J (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	allisonm@unimelb.edu.au	McKendrick, Allison M/A-2114-2008; Badcock, David R/A-4913-2008	Badcock, David R/0000-0002-4517-435X; McKendrick, Allison/0000-0003-1972-1222	Australian National Health and Medical Research Council [509208]; Australian Research Council [FT0990930]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This project was supported by an Australian National Health and Medical Research Council Project Grant #509208 to authors AMM and DRB. Author AMM is supported by an Australian Research Council Future Fellowship #FT0990930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Antal A, 2005, CEPHALALGIA, V25, P788, DOI 10.1111/j.1468-2982.2005.00949.x; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Aurora SK, 2005, HEADACHE, V45, P546, DOI 10.1111/j.1526-4610.2005.05108.x; Battelli L, 2002, NEUROLOGY, V58, P1066, DOI 10.1212/WNL.58.7.1066; Battista J, 2010, INVEST OPHTH VIS SCI, V51, P6070, DOI 10.1167/iovs.10-5290; Benedek K, 2002, CEPHALALGIA, V22, P142, DOI 10.1046/j.1468-2982.2002.00351.x; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Brighina F, 2007, CEPHALALGIA, V27, P187, DOI 10.1111/j.1468-2982.2007.01276_1.x; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; COLESTON DM, 1995, CEPHALALGIA, V15, P396, DOI 10.1046/j.1468-2982.1995.1505396.x; Comoglu S, 2003, J NEUROL, V250, P201, DOI 10.1007/s00415-003-0975-6; Coppola G, 2007, Cephalalgia, V27, P1427, DOI 10.1111/j.1468-2982.2007.01500.x; Cuomo-Granston A, 2010, PROG NEUROBIOL, V91, P300, DOI 10.1016/j.pneurobio.2010.04.001; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Ditchfield JA, 2006, VISION RES, V46, P141, DOI 10.1016/j.visres.2005.09.014; DRUMMOND PD, 1992, CEPHALALGIA, V12, P349, DOI 10.1111/j.1468-2982.1992.00349.x; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Friedman DI, 2009, HEADACHE, V49, P941, DOI 10.1111/j.1526-4610.2009.01443.x; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; *INT HEAD SOC, 2004, CEPHALALGIA, V24; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; Karas R, 2009, J VISION, V9, DOI 10.1167/9.5.11; Kowacs PA, 2005, CEPHALALGIA, V25, P339, DOI 10.1111/j.1468-2982.2004.00861.x; Lambert GA, 2009, HEADACHE, V49, P253, DOI 10.1111/j.1526-4610.2008.01230.x; LAMME VAF, 2000, NEW COGNITIVE NEUROS, P279; LEWIS RA, 1989, OPHTHALMOLOGY, V96, P321, DOI 10.1016/S0161-6420(89)33069-7; Lipton RB, 2001, HEADACHE, V41, P854; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; MARCUS DA, 1989, ARCH NEUROL-CHICAGO, V46, P1129, DOI 10.1001/archneur.1989.00520460125024; McColl SL, 2000, CEPHALALGIA, V20, P74, DOI 10.1046/j.1468-2982.2000.00033.x; McKendrick AM, 2009, CEPHALALGIA, V29, P539, DOI 10.1111/j.1468-2982.2008.01817.x; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1846, DOI 10.1167/iovs.03-1225; McKendrick AM, 2004, CEPHALALGIA, V24, P389, DOI 10.1111/j.1468-2982.2004.00682.x; McKendrick AM, 2004, CEPHALALGIA, V24, P363, DOI 10.1111/j.1468-2982.2004.00679.x; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1061, DOI 10.1167/iovs.03-0936; McKendrick AM, 2003, INVEST OPHTH VIS SCI, V44, P442, DOI 10.1167/iovs.02-0630; McKendrick AM, 2001, INVEST OPHTH VIS SCI, V42, P626; Mulleners WM, 2001, NEUROLOGY, V56, P178, DOI 10.1212/WNL.56.2.178; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pastor MA, 2003, J NEUROSCI, V23, P11621; Pietrobon D, 2010, J PHYSIOL-LONDON, V588, P1871, DOI 10.1113/jphysiol.2010.188003; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Schoenen J, 2003, CLIN NEUROPHYSIOL, V114, P955, DOI 10.1016/S1388-2457(03)00024-5; Schwabe L, 2010, NEUROIMAGE, V52, P777, DOI 10.1016/j.neuroimage.2010.01.032; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; Shepherd AJ, 2006, BRAIN, V129, P1833, DOI 10.1093/brain/awl124; Shepherd AJ, 2000, CEPHALALGIA, V20, P865, DOI 10.1046/j.1468-2982.2000.00119.x; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Takeuchi T, 2000, VISION RES, V40, P2697, DOI 10.1016/S0042-6989(00)00129-2; Wagner D, 2010, INVEST OPHTH VIS SCI, V51, P2294, DOI 10.1167/iovs.09-4318; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilkinson F, 2008, CEPHALALGIA, V28, P1327, DOI 10.1111/j.1468-2982.2008.01696.x; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Yu C, 2001, J VISION, V1, P18, DOI 10.1167/1.1.3	63	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18211	10.1371/journal.pone.0018211	http://dx.doi.org/10.1371/journal.pone.0018211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494594	Green Published, gold			2022-12-27	WOS:000289354100007
J	Heupink, TH; Huynen, L; Lambert, DM				Heupink, Tim H.; Huynen, Leon; Lambert, David M.			Ancient DNA Suggests Dwarf and 'Giant' Emu Are Conspecific	PLOS ONE			English	Article							EVOLUTION; INSIGHTS; BROWN; MC1R	Background: The King Island Emu (Dromaius ater) of Australia is one of several extinct emu taxa whose taxonomic relationship to the modern Emu (D. novaehollandiae) is unclear. King Island Emu were mainly distinguished by their much smaller size and a reported darker colour compared to modern Emu. Methodology and Results: We investigated the evolutionary relationships between the King Island and modern Emu by the recovery of both nuclear and mitochondrial DNA sequences from sub-fossil remains. The complete mitochondrial control (1,094 bp) and cytochrome c oxidase subunit I (COI) region (1,544 bp), as well as a region of the melanocortin 1 receptor gene (57 bp) were sequenced using a multiplex PCR approach. The results show that haplotypes for King Island Emu fall within the diversity of modern Emu. Conclusions: These data show the close relationship of these emu when compared to other congeneric bird species and indicate that the King Island and modern Emu share a recent common ancestor. King Island emu possibly underwent insular dwarfism as a result of phenotypic plasticity. The close relationship between the King Island and the modern Emu suggests it is most appropriate that the former should be considered a subspecies of the latter. Although both taxa show a close genetic relationship they differ drastically in size. This study also suggests that rates of morphological and neutral molecular evolution are decoupled.	[Heupink, Tim H.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Heupink, TH (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au	Heupink, Tim/B-3609-2014	Heupink, Tim/0000-0001-6237-3898; Lambert, David/0000-0002-5821-3637	Griffith University	Griffith University(Griffith University)	This research was funded by Griffith University and specifically THH was supported by a PhD scholarship from Griffith University (www.griffith.edu.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER W, 1922, EMU, V21, P318; BALOUET JC, 1990, OISEAU REV FRANCAISE, P314; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EDWARDS MM, 1899, B MUSEUM HIST NATURE, V5, P206; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Ho SYW, 2007, MOL BIOL EVOL, V24, P1416, DOI 10.1093/molbev/msm062; HOPE J H, 1973, Proceedings of the Royal Society of Victoria, V85, P163; JOUANIN C, 1960, P 12 INT ORN C HELS, P363; Jouanin C., 1959, OISEAU REV FRANCAISE, V29, P168; Keogh JS, 2005, EVOLUTION, V59, P226; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; KUMAR S, 2008, MEGA BIOL CENTRIC SO; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2005, BIOL LETTERS, V1, P291, DOI 10.1098/rsbl.2005.0323; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; MORGAN A. M., 1928, EMU, V28, P1; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Parker S.A., 1984, Bulletin of the British Ornithologists' Club, V104, P19; PATTERSON C, 1987, Records of the South Australian Museum (Adelaide), V21, P85; Pfennigwerth S, 2010, ARCH NAT HIST, V37, P74, DOI 10.3366/E0260954109001661; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; ROWLEY MJ, 1986, NATURWISSENSCHAFTEN, V73, P620, DOI 10.1007/BF00368777; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Spencer B., 1910, Melbourne Mem Nat Mus, V3; Strachan Rob, 1995, P1; Subramanian S, 2009, TRENDS GENET, V25, P16, DOI 10.1016/j.tig.2008.11.001; Templeton AR, 2008, BIOESSAYS, V30, P470, DOI 10.1002/bies.20745; Wilson S. K., 1988, AUSTRALIAS REPTILES	37	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18728	10.1371/journal.pone.0018728	http://dx.doi.org/10.1371/journal.pone.0018728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494561	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100035
J	Ohno, T; Oboki, K; Morita, H; Kajiwara, N; Arae, K; Tanaka, S; Ikeda, M; Iikura, M; Akiyama, T; Inoue, J; Matsumoto, K; Sudo, K; Azuma, M; Okumura, K; Kamradt, T; Saito, H; Nakae, S				Ohno, Tatsukuni; Oboki, Keisuke; Morita, Hideaki; Kajiwara, Naoki; Arae, Ken; Tanaka, Shizuko; Ikeda, Masako; Iikura, Motoyasu; Akiyama, Taishin; Inoue, Jun-ichiro; Matsumoto, Kenji; Sudo, Katsuko; Azuma, Miyuki; Okumura, Ko; Kamradt, Thomas; Saito, Hirohisa; Nakae, Susumu			Paracrine IL-33 Stimulation Enhances Lipopolysaccharide-Mediated Macrophage Activation	PLOS ONE			English	Article							RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN-1 RECEPTOR; CYTOKINE PRODUCTION; MAST-CELLS; T-CELLS; ALLERGIC INFLAMMATION; T1/ST2 EXPRESSION; INDUCED ARTHRITIS; HUMAN BASOPHILS; CUTTING EDGE	Background: IL-33, a member of the IL-1 family of cytokines, provokes Th2-type inflammation accompanied by accumulation of eosinophils through IL-33R, which consists of ST2 and IL-1RAcP. We previously demonstrated that macrophages produce IL-33 in response to LPS. Some immune responses were shown to differ between ST2-deficient mice and soluble ST2-Fc fusion protein-treated mice. Even in anti-ST2 antibody (Ab)-treated mice, the phenotypes differed between distinct Ab clones, because the characterization of such Abs (i.e., depletion, agonistic or blocking Abs) was unclear in some cases. Methodology/Principal Findings: To elucidate the precise role of IL-33, we newly generated neutralizing monoclonal Abs for IL-33. Exogenous IL-33 potentiated LPS-mediated cytokine production by macrophages. That LPS-mediated cytokine production by macrophages was suppressed by inhibition of endogenous IL-33 by the anti-IL-33 neutralizing mAbs. Conclusions/Significance: Our findings suggest that LPS-mediated macrophage activation is accelerated by macrophage-derived paracrine IL-33 stimulation.	[Ohno, Tatsukuni; Oboki, Keisuke; Morita, Hideaki; Kajiwara, Naoki; Arae, Ken; Matsumoto, Kenji; Saito, Hirohisa; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Ohno, Tatsukuni; Azuma, Miyuki] Tokyo Med & Dent Univ, Dept Mol Immunol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Kajiwara, Naoki; Okumura, Ko; Saito, Hirohisa; Nakae, Susumu] Juntendo Univ, Atopy Res Ctr, Tokyo, Japan; [Tanaka, Shizuko; Ikeda, Masako] Med & Biol Labs Co Ltd, Ina Lab, Tech & Res Dept, Nagano, Japan; [Iikura, Motoyasu] Int Med Ctr Japan, Dept Resp Med, Tokyo, Japan; [Akiyama, Taishin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Lab Syst Biol, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo, Japan; [Kamradt, Thomas] Univ Klinikum Jena, Inst Immunol, Jena, Germany	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Juntendo University; National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical University; Friedrich Schiller University of Jena	Ohno, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan.	snakae@ims.u-tokyo.ac.jp	Kamradt, Thomas/E-9971-2018; Morita, Hideaki/ADL-2008-2022; Azuma, Miyuki/AAT-8928-2021; Oboki, Keisuke/AAR-1813-2020; Morita, Hideaki/S-2214-2016	Azuma, Miyuki/0000-0002-3529-4585; Morita, Hideaki/0000-0003-0928-8322; Kamradt, Thomas/0000-0001-8443-5893; Saito, Hirohisa/0000-0002-6630-8337; Akiyama, Taishin/0000-0002-0341-6154	Japan Chemical Industry Association; Program for Improvement of Research Environment for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [23590475, 22659094, 21390148, 23390262] Funding Source: KAKEN	Japan Chemical Industry Association; Program for Improvement of Research Environment for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Chemical Industry Association, Grants-in-Aid for Young Scientists (B) (T.O., K. Oboki. and S.N.), the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology (S.N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from the National Institute of Biomedical Innovation (H.S.). S.T. and M.I., who are the researchers in Medical & Biological Laboratories Co., Ltd., generated the anti-IL-33 mAb in the submitted manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, TISSUE ANTIGENS, V73, P206, DOI 10.1111/j.1399-0039.2008.01185.x; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; KAWAKAMI T, 2005, NOVART FDN SYMP, V271, P108; Kawakami T., 2005, NOVARTIS FDN S, V271, P145, DOI [10.1002/9780470033449.ch8, DOI 10.1002/9780470033449.CH8]; Kawakami Toshiaki, 2005, Novartis Found Symp, V271, P100; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kuroiwa K, 2000, HYBRIDOMA, V19, P151, DOI 10.1089/02724570050031194; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Leung BP, 2004, J IMMUNOL, V173, P145, DOI 10.4049/jimmunol.173.1.145; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Mangan NE, 2007, EUR J IMMUNOL, V37, P1302, DOI 10.1002/eji.200636520; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P4646, DOI 10.1167/iovs.08-3365; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Moritz DR, 1998, HYBRIDOMA, V17, P107, DOI 10.1089/hyb.1998.17.107; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Umetsu DT, 2006, NAT REV IMMUNOL, V6, P953, DOI 10.1038/nri1968; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	71	45	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18404	10.1371/journal.pone.0018404	http://dx.doi.org/10.1371/journal.pone.0018404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494550	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100010
J	Santini, S; Claverie, JM; Mouz, N; Rousselle, T; Maza, C; Monchois, V; Abergel, C				Santini, Sebastien; Claverie, Jean-Michel; Mouz, Nicolas; Rousselle, Tristan; Maza, Caroline; Monchois, Vincent; Abergel, Chantal			The Conserved Candida albicans CA3427 Gene Product Defines a New Family of Proteins Exhibiting the Generic Periplasmic Binding Protein Structural Fold	PLOS ONE			English	Article							FUNGAL-INFECTIONS; VENUS-FLYTRAP; WEB SERVER; EPIDEMIOLOGY; DIFFRACTION; DATABASE	Nosocomial diseases due to Candida albicans infections are in constant rise in hospitals, where they cause serious complications to already fragile intensive care patients. Antifungal drug resistance is fast becoming a serious issue due to the emergence of strains resistant to currently available antifungal agents. Thus the urgency to identify new potential protein targets, the function and structure of which may guide the development of new antifungal drugs. In this context, we initiated a comparative genomics study in search of promising protein coding genes among the most conserved ones in reference fungal genomes. The CA3427 gene was selected on the basis of its presence among pathogenic fungi contrasting with its absence in the non pathogenic Saccharomyces cerevisiae. We report the crystal 3D-structure of the Candida albicans CA3427 protein at 2.1 angstrom resolution. The combined analysis of its sequence and structure reveals a structural fold originally associated with periplasmic binding proteins. The CA3427 structure highlights a binding site located between the two protein domains, corresponding to a sequence segment conserved among fungi. Two crystal forms of CA3427 were found, suggesting that the presence or absence of a ligand at the proposed binding site might trigger a "Venus flytrap'' motion, coupled to the previously described activity of bacterial periplasmic binding proteins. The conserved binding site defines a new subfamily of periplasmic binding proteins also found in many bacteria of the bacteroidetes division, in a choanoflagellate (a free-living unicellular and colonial flagellate eukaryote) and in a placozoan (the closest multicellular relative of animals). A phylogenetic analysis suggests that this gene family originated in bacteria before its horizontal transfer to an ancestral eukaryote prior to the radiation of fungi. It was then lost by the Saccharomycetales which include Saccharomyces cerevisiae.	[Santini, Sebastien; Claverie, Jean-Michel; Maza, Caroline; Abergel, Chantal] Aix Marseille Univ, CNRS UPR2589, Mediterranean Inst Microbiol, Marseille, France; [Mouz, Nicolas; Rousselle, Tristan; Monchois, Vincent] PXTherapeut, Grenoble, France	UDICE-French Research Universities; Aix-Marseille Universite	Santini, S (corresponding author), Aix Marseille Univ, CNRS UPR2589, Mediterranean Inst Microbiol, Parc Sci Luminy, Marseille, France.	chantal.abergel@igs.cnrs-mrs.fr	Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; Abergel, Chantal/0000-0003-1875-4049; Santini, Sebastien/0000-0001-7087-1950	French ministry of research and education; Centre National de la Recherche Scientifique (CNRS)	French ministry of research and education; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The PROFUN project was supported by a grant from the French ministry of research and education and by Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALEGADO RA, J BACTERIOL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Chen PE, 2006, BRIT J PHARMACOL, V147, P839, DOI 10.1038/sj.bjp.0706689; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felder CB, 1999, AAPS PHARMSCI, V1; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 1998, CURR OPIN STRUC BIOL, V8, P372, DOI 10.1016/S0959-440X(98)80072-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, PROTEIN CRYSTALLOGRA, V26; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; MAO B, 1982, J BIOL CHEM, V257, P1131; OH BH, 1994, J BIOL CHEM, V269, P4135; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1592, DOI 10.1128/JCM.02445-09; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Santini S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-33; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vanden Bossche H, 1998, MED MYCOL, V36, P119; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; PROFUN PROJECT	39	1	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18528	10.1371/journal.pone.0018528	http://dx.doi.org/10.1371/journal.pone.0018528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494601	gold, Green Submitted, Green Published			2022-12-27	WOS:000289354100017
J	Bernabe-Ortiz, A; Carcamo, CP; Sanchez, JF; Rios, J				Bernabe-Ortiz, Antonio; Carcamo, Cesar P.; Sanchez, Juan F.; Rios, Julia			Weight Variation over Time and Its Association with Tuberculosis Treatment Outcome: A Longitudinal Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COURSE CHEMOTHERAPY PROGRAMS; PULMONARY TUBERCULOSIS; TREATMENT FAILURE; NUTRITIONAL-STATUS; IDENTIFY PATIENTS; HIV-INFECTION; RISK-FACTOR; GAIN; PERU	Objective: Weight variation during therapy has been described as a useful marker to predict TB treatment outcome. No previous study has used longitudinal analysis to corroborate this finding. The goal of this study was to evaluate change and trends of patients' bodyweight over time depending on TB treatment outcome. Methods and Findings: A retrospective cohort study with all TB cases diagnosed from 2000 to 2006 was carried out. Information from 5 public tuberculosis treatment facilities at Pampas de San Juan de Miraflores, Lima, Peru was analyzed. Poor outcome was defined as failure or death during TB therapy, and compared to good outcome defined as cured. Longitudinal analysis with a pre-specified marginal model was fitted using Generalized Estimating Equations to compare weight trends for patients with good and poor outcome adjusting for potential confounders. A total of 460 patients (55.4% males, mean age: 31.6 years) were included in the analysis: 42 (9.1%) had a poor outcome (17 failed and 25 died). Weight at baseline was not different comparing outcome groups (p = 0.17). After adjusting for age, gender, type of TB, scheme of treatment, HIV status and sputum variation during follow-up, after the first month of treatment, patients with good outcome gained, on average, almost 1 kg compared to their baseline weight (p < 0.001), whereas those with poor outcome lost 1 kg (p = 0.003). Similarly, after 4 months, a patient with good outcome increased 3 kg on average (p < 0.001), while those with poor outcome only gained 0.2 kg (p = 0.02). Conclusions: Weight variation during tuberculosis therapy follow-up can predict treatment outcome. Patients losing weight during TB treatment, especially in the first month, should be more closely followed as they are at risk of failure or death.	[Bernabe-Ortiz, Antonio; Carcamo, Cesar P.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Ctr Excellence Chron Dis, CRONICAS, Lima, Peru; [Sanchez, Juan F.] US Naval Med Res Unit 6, Dept Parasitol, Lima, Peru; [Rios, Julia] DISA II, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru.	antonio.bernabe@upch.pe		Bernabe-Ortiz, Antonio/0000-0002-6834-1376				Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278; Balding DJ, 2004, APPL LONGITUDINAL AN; Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Gillespie SH, 1998, INT J TUBERC LUNG D, V2, P522; Gupta R, 2000, INT J TUBERC LUNG D, V4, P1089; Hardin JW, 2012, GEN ESTIMATING EQUAT; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kennedy N, 1996, T ROY SOC TROP MED H, V90, P162, DOI 10.1016/S0035-9203(96)90123-6; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Ministerio de Salud, 2006, ESTR SAN NAC PREV CO; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Salaniponi FML, 1999, INT J TUBERC LUNG D, V3, P1047; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Schwenk A, 2004, AM J CLIN NUTR, V79, P1006; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721; Swaminathan S, 2008, CLIN INFECT DIS, V46, P946, DOI 10.1086/528860; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Vasantha M, 2009, Indian J Tuberc, V56, P5; Warmelink I, 2011, BRIT J NUTR, V105, P400, DOI 10.1017/S0007114510003636; World Health Organization, 2010, GLOB TUB CONTR; Yew WW, 2006, AM J RESP CRIT CARE, V174, P236, DOI 10.1164/rccm.200605-669ED; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; Zhao FZ, 1997, INT J TUBERC LUNG D, V1, P570	30	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18474	10.1371/journal.pone.0018474	http://dx.doi.org/10.1371/journal.pone.0018474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494617	Green Submitted, Green Published, gold			2022-12-27	WOS:000289292800021
J	Park, SB; Lin, CSY; Krishnan, AV; Goldstein, D; Friedlander, ML; Kiernan, MC				Park, Susanna B.; Lin, Cindy S-Y.; Krishnan, Arun V.; Goldstein, David; Friedlander, Michael L.; Kiernan, Matthew C.			Dose Effects of Oxaliplatin on Persistent and Transient Na+ Conductances and the Development of Neurotoxicity	PLOS ONE			English	Article							HUMAN PERIPHERAL-NERVE; GATED SODIUM-CHANNELS; METASTATIC COLORECTAL-CANCER; HUMAN MEDIAN NERVE; AXONAL EXCITABILITY; ANTICANCER AGENT; SENSORY NEURONS; LOW-THRESHOLD; MOTOR AXONS; LEUCOVORIN	Background: Oxaliplatin, a platinum-based chemotherapy utilised in the treatment of colorectal cancer, produces two forms of neurotoxicity-acute sensorimotor neuropathic symptoms and a dose-limiting chronic sensory neuropathy. Given that a Na+ channelopathy has been proposed as the mechanism underlying acute oxaliplatin-induced neuropathy, the present study aimed to determine specific mechanisms of Na+ channel dysfunction. Methodology/Principal Findings: Specifically the function of transient and persistent Na+ currents were followed during treatment and were investigated in relation to oxaliplatin dose level. Eighteen patients were assessed before and after a single oxaliplatin infusion with motor and sensory axonal excitability studies performed on the median nerve at the wrist. While refractoriness (associated with Na+ channel inactivation) was significantly altered post-oxaliplatin infusion in both motor (Pre: 31.7 +/- 6.4%; Post: 68.8 +/- 14.5%; P <=.001) and sensory axons (Pre: 31.4 +/- 5.4%; Post: 21.4 +/- 5.5%; P<.05), strength-duration time constant (marker of persistent Na+ conductances) was not significantly altered post-infusion (Motor Pre: 0.395 +/- 0.01 ms; Post: 0.394 +/- 0.02 ms; NS; Sensory Pre: 0.544 +/- 0.03 ms; Post: 0.535 +/- 0.05 ms; NS). However, changes in strength-duration time constant were significantly correlated with changes in refractoriness in motor and sensory axons (Motor correlation coefficient = -.65; P<.05; Sensory correlation coefficient =.67; P<.05). Conclusions/Significance: It is concluded that the predominant effect of acute oxaliplatin exposure in human motor and sensory axons is mediated through changes in transient rather than persistent Na+ conductances. These findings are likely to have implications for the design and trial of neuroprotective strategies.	[Park, Susanna B.; Kiernan, Matthew C.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Lin, Cindy S-Y.; Krishnan, Arun V.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Goldstein, David; Friedlander, Michael L.] Prince Wales Hosp, Dept Med Oncol, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Park, SB (corresponding author), Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	M.kiernan@unsw.edu.au	friedlander, michael l/G-3490-2013; Kiernan, Matthew C/E-4460-2011	friedlander, michael l/0000-0002-6488-0604; Kiernan, Matthew/0000-0001-9054-026X; Lin, Cindy Shin-Yi/0000-0003-2379-7369; Krishnan, Arun/0000-0001-8883-8825; friedlander, michael/0000-0003-3090-795X	National Heath and Medical Research Council of Australia [400938, 570233]; Sydney Foundation for Medical Research; Australian Postgraduate Award	National Heath and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sydney Foundation for Medical Research; Australian Postgraduate Award(Australian Government)	This work was supported by National Heath and Medical Research Council of Australia (Project grant 400938; 570233); the Sydney Foundation for Medical Research; and an Australian Postgraduate Award (S.B.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelsberger H, 2000, EUR J PHARMACOL, V406, P25, DOI 10.1016/S0014-2999(00)00667-1; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; [Anonymous], 1901, ARCH ITAL BIOL; Baker MD, 1997, J NEUROPHYSIOL, V77, P1503, DOI 10.1152/jn.1997.77.3.1503; Benoit E, 2006, GEN PHYSIOL BIOPHYS, V25, P263; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Cassidy J, 2004, J CLIN ONCOL, V22, P2084, DOI 10.1200/JCO.2004.11.069; Cassidy J, 2002, SEMIN ONCOL, V29, P11, DOI 10.1053/sonc.2002.35524; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DUBOIS JM, 1975, PFLUG ARCH EUR J PHY, V357, P145, DOI 10.1007/BF00584552; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Grolleau F, 2001, J NEUROPHYSIOL, V85, P2293, DOI 10.1152/jn.2001.85.5.2293; Karoly R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000818; Kiernan MC, 2005, ANN NEUROL, V57, P339, DOI 10.1002/ana.20395; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2003, NEUROSCIENCE, V119, P653, DOI 10.1016/S0306-4522(03)00194-5; Kiernan MC, 1996, BRAIN, V119, P1099, DOI 10.1093/brain/119.4.1099; Kiernan MC, 2001, MUSCLE NERVE, V24, P883; Krishnan AV, 2006, CLIN CANCER RES, V12, P4481, DOI 10.1158/1078-0432.CCR-06-0694; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Kuwabara S, 2001, J PHYSIOL-LONDON, V531, P265, DOI 10.1111/j.1469-7793.2001.0265j.x; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Maindrault-Goebel F, 1999, EUR J CANCER, V35, P1338, DOI 10.1016/S0959-8049(99)00149-5; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; Park SB, 2009, BRAIN, V132, P2712, DOI 10.1093/brain/awp219; Park SB, 2009, J CLIN ONCOL, V27, P1243, DOI 10.1200/JCO.2008.19.3425; Raymond E, 1998, SEMIN ONCOL, V25, P4; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tokuno HA, 2003, MUSCLE NERVE, V28, P212, DOI 10.1002/mus.10421; Trevillion L, 2010, J PHYSIOL-LONDON, V588, P2503, DOI 10.1113/jphysiol.2010.190884; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; von Delius S, 2007, INVEST NEW DRUG, V25, P173, DOI 10.1007/s10637-006-9010-y; Webster RG, 2005, BRIT J PHARMACOL, V146, P1027, DOI 10.1038/sj.bjp.0706407; Wicher D, 2001, PROG NEUROBIOL, V64, P431, DOI 10.1016/S0301-0082(00)00066-6; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Wu SN, 2009, NEUROTOXICOLOGY, V30, P677, DOI 10.1016/j.neuro.2009.04.010	40	62	68	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18469	10.1371/journal.pone.0018469	http://dx.doi.org/10.1371/journal.pone.0018469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494615	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800019
J	Makarova, N; Zhao, CX; Zhang, YY; Bhosle, S; Suppiah, S; Rhea, JM; Kozyr, N; Arnold, RS; Ly, H; Molinaro, RJ; Parslow, TG; Hunter, E; Liotta, D; Petros, J; Blackwell, JL				Makarova, Natalia; Zhao, Chunxia; Zhang, Yuanyuan; Bhosle, Sushma; Suppiah, Suganthi; Rhea, Jeanne M.; Kozyr, Natalia; Arnold, Rebecca S.; Ly, Hinh; Molinaro, Ross J.; Parslow, Tristram G.; Hunter, Eric; Liotta, Dennis; Petros, John; Blackwell, Jerry L.			Antibody Responses against Xenotropic Murine Leukemia Virus-Related Virus Envelope in a Murine Model	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; HIV-1-INFECTED PATIENTS; INFECTIOUS RETROVIRUS; XMRV INFECTION; IN-VIVO; CELLS; ADENOVIRUS; TYPE-1; HIV-1	Background: Xenotropic murine leukemia virus-related virus (XMRV) was recently discovered to be the first human gammaretrovirus that is associated with chronic fatigue syndrome and prostate cancer (PC). Although a mechanism for XMRV carcinogenesis is yet to be established, this virus belongs to the family of gammaretroviruses well known for their ability to induce cancer in the infected hosts. Since its original identification XMRV has been detected in several independent investigations; however, at this time significant controversy remains regarding reports of XMRV detection/prevalence in other cohorts and cell type/tissue distribution. The potential risk of human infection, coupled with the lack of knowledge about the basic biology of XMRV, warrants further research, including investigation of adaptive immune responses. To study immunogenicity in vivo, we vaccinated mice with a combination of recombinant vectors expressing codon-optimized sequences of XMRV gag and env genes and virus-like particles (VLP) that had the size and morphology of live infectious XMRV. Results: Immunization elicited Env-specific binding and neutralizing antibodies (NAb) against XMRV in mice. The peak titers for ELISA-binding antibodies and NAb were 1: 1024 and 1: 464, respectively; however, high ELISA-binding and NAb titers were not sustained and persisted for less than three weeks after immunizations. Conclusions: Vaccine-induced XMRV Env antibody titers were transiently high, but their duration was short. The relatively rapid diminution in antibody levels may in part explain the differing prevalences reported for XMRV in various prostate cancer and chronic fatigue syndrome cohorts. The low level of immunogenicity observed in the present study may be characteristic of a natural XMRV infection in humans.	[Makarova, Natalia; Zhao, Chunxia; Zhang, Yuanyuan; Kozyr, Natalia; Hunter, Eric; Blackwell, Jerry L.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Makarova, Natalia; Zhao, Chunxia; Zhang, Yuanyuan; Kozyr, Natalia; Hunter, Eric; Blackwell, Jerry L.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Blackwell, Jerry L.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Bhosle, Sushma; Suppiah, Suganthi; Rhea, Jeanne M.; Ly, Hinh; Molinaro, Ross J.; Parslow, Tristram G.; Hunter, Eric; Petros, John] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Arnold, Rebecca S.; Petros, John] Emory Univ, Dept Urol, Atlanta, GA 30322 USA; [Petros, John] Emory Univ, Dept Hematol Oncol, Atlanta, GA 30322 USA; [Liotta, Dennis] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Molinaro, Ross J.] Emory Univ, Core Labs Emory Univ Hosp Midtown, Atlanta, GA 30322 USA; [Petros, John] Atlanta Vet Affairs Med Ctr, Decatur, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Makarova, N (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	jerry.blackwell@emory.edu	zhang, yuanyuan/GYA-4428-2022	Rhea, Jeanne M/0000-0001-8107-6872	Emory Department of Chemistry, Immunology and Developmental Cores of the Emory CFAR [P30-AI050409]; Yerkes National Primate Research Center [RR-00165]; National Institutes of Health National Institute of Allergy and Infectious Diseases [R01-AI069987, R0-1AI076096-01, R21-AI076080]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069987, R21AI076080, R33AI076096, P30AI050409, R21AI076096] Funding Source: NIH RePORTER	Emory Department of Chemistry, Immunology and Developmental Cores of the Emory CFAR; Yerkes National Primate Research Center; National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Emory Department of Chemistry, Immunology and Developmental Cores of the Emory CFAR (P30-AI050409), Yerkes National Primate Research Center base grant (RR-00165) and National Institutes of Health National Institute of Allergy and Infectious Diseases grants (R01-AI069987, R0-1AI076096-01 and R21-AI076080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Blackwell JL, 1999, ARCH OTOLARYNGOL, V125, P856, DOI 10.1001/archotol.125.8.856; Blaise S, 2001, J GEN VIROL, V82, P1597, DOI 10.1099/0022-1317-82-7-1597; Bronte V, 2003, J IMMUNOL, V171, P6396, DOI 10.4049/jimmunol.171.12.6396; Burkhart MD, 2003, J VIROL, V77, P3993, DOI 10.1128/JVI.77.7.3993-4003.2003; CHESEBRO B, 1983, VIROLOGY, V127, P134, DOI 10.1016/0042-6822(83)90378-1; Crevar CJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-131; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; GRAHAM FL, 1991, GENE TRANSFER EXPRES, P109, DOI DOI 10.1385/0-89603-178-0:109; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Luo LX, 2003, VIRUS RES, V92, P75, DOI 10.1016/S0168-1702(02)00316-7; MAIZEL JV, 1968, VIROLOGY, V36, P126, DOI 10.1016/0042-6822(68)90122-0; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Quan FS, 2007, VACCINE, V25, P3841, DOI 10.1016/j.vaccine.2007.01.107; Sakuma T, 2011, J VIROL, V85, P1205, DOI 10.1128/JVI.00886-10; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Spearman P, 2006, CURR OPIN HIV AIDS, V1, P200, DOI 10.1097/01.COH.0000221592.49412.1f; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Stieler KSC, 2010, VIROLOGY; Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; VOGEL T, 1994, J IMMUNOL, V153, P1895; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xin KQ, 2005, GENE THER, V12, P1769, DOI 10.1038/sj.gt.3302590; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003; Ye L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/497219	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18272	10.1371/journal.pone.0018272	http://dx.doi.org/10.1371/journal.pone.0018272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494670	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400012
J	Sabbagh, A; Darlu, P; Crouau-Roy, B; Poloni, ES				Sabbagh, Audrey; Darlu, Pierre; Crouau-Roy, Brigitte; Poloni, Estella S.			Arylamine N-Acetyltransferase 2 (NAT2) Genetic Diversity and Traditional Subsistence: A Worldwide Population Survey	PLOS ONE			English	Article							LACTASE-PERSISTENCE; HUMAN ADAPTATION; CANCER-RISK; HISTORY; CULTURE; POLYMORPHISMS; EVOLUTION; AFRICA; DIET	Arylamine N-acetyltransferase 2 (NAT2) is involved in human physiological responses to a variety of xenobiotic compounds, including common therapeutic drugs and exogenous chemicals present in the diet and the environment. Many questions remain about the evolutionary mechanisms that have led to the high prevalence of slow acetylators in the human species. Evidence from recent surveys of NAT2 gene variation suggests that NAT2 slow-causing variants might have become targets of positive selection as a consequence of the shift in modes of subsistence and lifestyle in human populations in the last 10,000 years. We aimed to test more extensively the hypothesis that slow acetylation prevalence in humans is related to the subsistence strategy adopted by the past populations. To this end, published frequency data on the most relevant genetic variants of NAT2 were collected from 128 population samples (14,679 individuals) representing different subsistence modes and dietary habits, allowing a thorough analysis at both a worldwide and continent scale. A significantly higher prevalence of the slow acetylation phenotype was observed in populations practicing farming (45.4%) and herding (48.2%) as compared to populations mostly relying on hunting and gathering (22.4%) (P = 0.0007). This was closely mirrored by the frequency of the slow 590A variant that was found to occur at a three-fold higher frequency in food producers (25%) as compared to hunter-gatherers (8%). These findings are consistent with the hypothesis that the Neolithic transition to subsistence economies based on agricultural and pastoral resources modified the selective regime affecting the NAT2 acetylation pathway. Furthermore, the vast amount of data collected enabled us to provide a comprehensive and up-to-date description of NAT2 worldwide genetic diversity, thus building up a useful resource of frequency data for further studies interested in epidemiological or anthropological research questions involving NAT2.	[Sabbagh, Audrey] IRD, UMR 216, Paris, France; [Sabbagh, Audrey] Univ Paris 05, UMR 216, Paris, France; [Darlu, Pierre] Univ Paris 07, CNRS, MNHN, UMR Ecoanthropol & Ethnobiol 7206, Paris, France; [Crouau-Roy, Brigitte] CNRS, UMR 5174, EDB, Toulouse, France; [Crouau-Roy, Brigitte] Univ Toulouse 3, F-31062 Toulouse, France; [Poloni, Estella S.] Univ Geneva, Dept Genet & Evolut, Anthropol Unit, Lab Anthropol Genet & Peopling Hist, Geneva, Switzerland	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Geneva	Sabbagh, A (corresponding author), IRD, UMR 216, Paris, France.	audrey.sabbagh@parisdescartes.fr		Poloni, Estella S./0000-0002-8465-003X; SABBAGH, Audrey/0000-0003-0283-8803				Agundez JAG, 2008, CURR DRUG METAB, V9, P520, DOI 10.2174/138920008784892083; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fuselli S, 2007, PHARMACOGENOMICS J, V7, P144, DOI 10.1038/sj.tpj.6500407; Fuselli S, 2010, PHARMACOGENET GENOM, V20, P485, DOI 10.1097/FPC.0b013e32833bba25; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; GARCIACLOSAS M, 2010, PHARMACOGEN IN PRESS; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Ladero JM, 2008, CURR DRUG METAB, V9, P532, DOI 10.2174/138920008784892038; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Levinson D., 1991, ENCY WORLD CULTURES; Luca F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003136; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; Matimba Alice, 2009, Human Genomics, V3, P169; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Patin E, 2006, AM J HUM GENET, V78, P423, DOI 10.1086/500614; Patin E, 2006, HUM MUTAT, V27, P720, DOI 10.1002/humu.9438; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Sabbagh A, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-21; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Stanislawska-Sachadyn A, 2006, AM J MED GENET A, V140A, P2374, DOI 10.1002/ajmg.a.31475; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Wakefield L, 2010, GENE, V452, P16, DOI 10.1016/j.gene.2009.12.002; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	36	96	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18507	10.1371/journal.pone.0018507	http://dx.doi.org/10.1371/journal.pone.0018507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494681	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400034
J	Arnold, L; Tyagi, RK; Meija, P; Swetman, C; Gleeson, J; Perignon, JL; Druilhe, P				Arnold, Ludovic; Tyagi, Rajeev Kumar; Meija, Pedro; Swetman, Claire; Gleeson, James; Perignon, Jean-Louis; Druilhe, Pierre			Further Improvements of the P. falciparum Humanized Mouse Model	PLOS ONE			English	Article							ACUTE LUNG INJURY; RED-BLOOD-CELLS; IN-VIVO MODEL; PLASMODIUM-FALCIPARUM; HUMAN MALARIA; MURINE MODEL; IMMUNOCOMPROMISED MICE; CYTOKINE PRODUCTION; INNATE IMMUNITY; AOTUS MONKEYS	Background: It has been shown previously that it is possible to obtain growth of Plasmodium falciparum in human erythrocytes grafted in mice lacking adaptive immune responses by controlling, to a certain extent, innate defences with liposomes containing clodronate (clo-lip). However, the reproducibility of those models is limited, with only a proportion of animals supporting longstanding parasitemia, due to strong inflammation induced by P. falciparum. Optimisation of the model is much needed for the study of new anti-malarial drugs, drug combinations, and candidate vaccines. Materials/Methods: We investigated the possibility of improving previous models by employing the intravenous route (IV) for delivery of both human erythrocytes (huRBC) and P. falciparum, instead of the intraperitoneal route (IP), by testing various immunosuppressive drugs that might help to control innate mouse defences, and by exploring the potential benefits of using immunodeficient mice with additional genetic defects, such as those with IL-2R gamma deficiency (NSG mice). Results: We demonstrate here the role of aging, of inosine and of the IL-2 receptor gamma mutation in controlling P. falciparum induced inflammation. IV delivery of huRBC and P. falciparum in clo-lip treated NSG mice led to successful infection in 100% of inoculated mice, rapid rise of parasitemia to high levels (up to 40%), long-lasting parasitemia, and consistent results from mouse-to-mouse. Characteristics were closer to human infection than in previous models, with evidence of synchronisation, partial sequestration, and receptivity to various P. falciparum strains without preliminary adaptation. However, results show that a major IL-12p70 inflammatory response remains prevalent. Conclusion: The combination of the NSG mouse, clodronate loaded liposomes, and IV delivery of huRBC has produced a reliable and more relevant model that better meets the needs of Malaria research.	[Arnold, Ludovic; Tyagi, Rajeev Kumar; Meija, Pedro; Swetman, Claire; Gleeson, James; Perignon, Jean-Louis; Druilhe, Pierre] Inst Pasteur, Malaria Vaccine Dev Lab, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Arnold, L (corresponding author), Univ Paris 06, INSERM, Fac Med, UMR S 945, Paris, France.	druilhe@pasteur.fr	arnold, ludovic/ABI-1244-2020		French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded, in part, by a grant from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Arnold L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-197; BADELL E, 1995, PARASITOL TODAY, V11, P235, DOI 10.1016/0169-4758(95)80088-3; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; BARANKIEWICZ J, 1985, EUR J IMMUNOL, V15, P627, DOI 10.1002/eji.1830150618; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; BRUCE-CHWATT L. J., 1963, W AFRICAN MED JOUR, V12, P199; Chelvarajan RL, 2006, J LEUKOCYTE BIOL, V79, P1314, DOI 10.1189/jlb.0106024; Chelvarajan RL, 2005, J LEUKOCYTE BIOL, V77, P503, DOI 10.1189/jlb.0804449; Collins WE, 1997, J PARASITOL, V83, P1174, DOI 10.2307/3284381; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Druilhe P, 2002, TRENDS MICROBIOL, V10, pS38, DOI 10.1016/S0966-842X(02)02437-X; Druilhe P, 2007, CURR OPIN MICROBIOL, V10, P371, DOI 10.1016/j.mib.2007.07.009; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Hasko G, 1998, EUR J PHARMACOL, V358, P261, DOI 10.1016/S0014-2999(98)00619-0; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; INAMIZU T, 1985, IMMUNOLOGY, V55, P447; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; King M, 2007, ANN NY ACAD SCI, V1103, P90, DOI 10.1196/annals.1394.011; Liaudet L, 2002, ANN SURG, V235, P568, DOI 10.1097/00000658-200204000-00016; Liaudet L, 2001, AM J RESP CRIT CARE, V164, P1213, DOI 10.1164/ajrccm.164.7.2101013; Mabley JG, 2003, AM J PHYSIOL-GASTR L, V284, pG138, DOI 10.1152/ajpgi.00060.2002; Mabley JG, 2009, SHOCK, V32, P258, DOI 10.1097/SHK.0b013e31819c3414; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marton A, 2001, INT J MOL MED, V8, P617; Moreno A, 2006, INT J PARASITOL, V36, P361, DOI 10.1016/j.ijpara.2005.10.012; Moreno A, 2001, ANTIMICROB AGENTS CH, V45, P1847, DOI 10.1128/AAC.45.6.1847-1853.2001; Morosan S, 2006, J INFECT DIS, V193, P996, DOI 10.1086/500840; Nomellini Vanessa, 2008, V15, P188, DOI 10.1159/000136358; Obaldia N, 2009, AM J TROP MED HYG, V81, P587, DOI 10.4269/ajtmh.2009.08-0445; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; PUKRITTAYAKAMEE S, 1992, T ROY SOC TROP MED H, V86, P598, DOI 10.1016/0035-9203(92)90143-Z; PYE D, 1994, J PARASITOL, V80, P558, DOI 10.2307/3283191; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; SCHRIER DJ, 1990, J IMMUNOL, V145, P1874; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Shanks GD, 2006, J POSTGRAD MED, V52, P277; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; WAYMACK JP, 1987, ARCH SURG-CHICAGO, V122, P56; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHITE NJ, 2008, HARRISONS PRINCIPLES	53	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18045	10.1371/journal.pone.0018045	http://dx.doi.org/10.1371/journal.pone.0018045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483851	gold, Green Submitted, Green Published			2022-12-27	WOS:000289057200022
J	Chiu, YHC; Ong, J; Walker, S; Kumalawati, J; Gartinah, T; McPhee, DA; Dax, EM				Chiu, Yu-Ho C.; Ong, Joanna; Walker, Sandy; Kumalawati, July; Gartinah, Tintin; McPhee, Dale A.; Dax, Elizabeth M.			Photographed Rapid HIV Test Results Pilot Novel Quality Assessment and Training Schemes	PLOS ONE			English	Article							ASSAYS; SETTINGS	HIV rapid diagnostic tests (RDTs) are now used widely in non-laboratory settings by non-laboratory-trained operators. Quality assurance programmes are essential in ensuring the quality of HIV RDT outcomes. However, there is no cost-effective means of supplying the many operators of RDTs with suitable quality assurance schemes. Therefore, it was examined whether photograph-based RDT results could be used and correctly interpreted in the non-laboratory setting. Further it was investigated if a single training session improved the interpretation skills of RDT operators. The photographs were interpreted, a 10-minute tutorial given and then a second interpretation session was held. It was established that the results could be read with accuracy. The participants (n = 75) with a range of skills interpreted results (> 80% concordance with reference results) from a panel of 10 samples (three negative and seven positive) using four RDTs. Differences in accuracy of interpretation before and after the tutorial were marked in some cases. Training was more effective for improving the accurate interpretation of more complex results, e. g. results with faint test lines or for multiple test lines, and especially for improving interpretation skills of inexperienced participants. It was demonstrated that interpretation of RDTs was improved using photographed results allied to a 10-minute training session. It is anticipated that this method could be used for training but also for quality assessment of RDT operators without access to conventional quality assurance or training schemes requiring wet samples.	[Chiu, Yu-Ho C.; Ong, Joanna; Walker, Sandy; McPhee, Dale A.; Dax, Elizabeth M.] St Vincents Inst, NRL, Melbourne, Vic, Australia; [Kumalawati, July] Univ Indonesia, Dept Clin Pathol, Fac Med, Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Gartinah, Tintin] W Java Hlth Off, W Java Prov Hlth Lab, Bandung, Indonesia; [McPhee, Dale A.; Dax, Elizabeth M.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	St. Vincent's Institute of Medical Research; University of Indonesia; University of Melbourne	Chiu, YHC (corresponding author), St Vincents Inst, NRL, Melbourne, Vic, Australia.	liz@nrl.gov.au	McPhee, Dale A/D-1825-2011	Chiu, Yu Ho Chris/0000-0002-5380-1114	AusAID	AusAID(Australian Aid (AusAID))	HIV Consortium for Partnerships in Asia and the Pacific funded by AusAID supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; Bowles KE, 2008, PUBLIC HEALTH REP, V123, P78, DOI 10.1177/00333549081230S310; Chappel RJ, 2009, FUTURE MICROBIOL, V4, P963, DOI 10.2217/FMB.09.77; Everett DB, 2009, J CLIN MICROBIOL, V47, P1058, DOI 10.1128/JCM.01998-08; Ferreira Junior Orlando C, 2005, AIDS, V19 Suppl 4, pS70, DOI 10.1097/01.aids.0000191494.51489.75; Huebner DM, 2010, AIDS BEHAV, V14, P688, DOI 10.1007/s10461-008-9442-9; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Pai NP, 2008, PLOS MED, V5, P768, DOI 10.1371/journal.pmed.0050092; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; Tao GY, 1999, J ACQ IMMUN DEF SYND, V22, P395; *WHO, 2003, GUID APPR EV HIV TES; *WHO, 2009, HIV ASS OP CHAR RAP	15	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18294	10.1371/journal.pone.0018294	http://dx.doi.org/10.1371/journal.pone.0018294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483842	Green Published, gold			2022-12-27	WOS:000289057200052
J	Mihic, A; Chauhan, VS; Gao, XD; Oudit, GY; Tsushima, RG				Mihic, Anton; Chauhan, Vijay S.; Gao, Xiaodong; Oudit, Gavin Y.; Tsushima, Robert G.			Trafficking Defect and Proteasomal Degradation Contribute to the Phenotype of a Novel KCNH2 Long QT Syndrome Mutation	PLOS ONE			English	Article							HERG POTASSIUM CHANNEL; C-TERMINUS; PHARMACOLOGICAL RESCUE; MUTANT CHANNELS; K+ CHANNEL; WILD-TYPE; PROTEIN TRAFFICKING; EXTRACELLULAR K+; GENE HERG; I-KR	The Kv11.1 (hERG) K+ channel plays a fundamental role in cardiac repolarization. Missense mutations in KCNH2, the gene encoding Kv11.1, cause long QT syndrome (LQTS) and frequently cause channel trafficking-deficiencies. This study characterized the properties of a novel KCNH2 mutation discovered in a LQT2 patient resuscitated from a ventricular fibrillation arrest. Proband genotyping was performed by SSCP and DNA sequencing. The electrophysiological and biochemical properties of the mutant channel were investigated after expression in HEK293 cells. The proband manifested a QTc of 554 ms prior to electrolyte normalization. Mutation analysis revealed an autosomal dominant frameshift mutation at proline 1086 (P1086fs+32X; 3256InsG). Co-immunoprecipitation demonstrated that wild-type Kv11.1 and mutant channels coassemble. Western blot showed that the mutation did not produce mature complex-glycosylated Kv11.1 channels and coexpression resulted in reduced channel maturation. Electrophysiological recordings revealed mutant channel peak currents to be similar to untransfected cells. Co-expression of channels in a 1: 1 ratio demonstrated dominant negative suppression of peak Kv11.1 currents. Immunocytochemistry confirmed that mutant channels were not present at the plasma membrane. Mutant channel trafficking rescue was attempted by incubation at reduced temperature or with the pharmacological agents E-4031. These treatments did not significantly increase peak mutant currents or induce the formation of mature complex-glycosylated channels. The proteasomal inhibitor lactacystin increased the protein levels of the mutant channels demonstrating proteasomal degradation, but failed to induce mutant Kv11.1 protein trafficking. Our study demonstrates a novel dominant-negative Kv11.1 mutation, which results in degraded non-functional channels leading to a LQT2 phenotype.	[Mihic, Anton] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mihic, Anton] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Chauhan, Vijay S.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Oudit, Gavin Y.] Univ Alberta, Dept Med, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Oudit, Gavin Y.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Gao, Xiaodong; Tsushima, Robert G.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta; University of Alberta; York University - Canada	Mihic, A (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	gavin.oudit@ualberta.ca; tsushima@yorku.ca	Chauhan, Vijay/AAA-9872-2020		Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto; Heart and Stroke Foundation of Ontario [T5903]; Canadian Institutes of Health Research [86602]; Alberta Heritage Foundation for Medical Research	Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	AM received a studentship from the Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto. VSC is a Clinician Scientist Scholar of the Heart and Stroke Foundation of Ontario. GYO is a Clinician-Investigator Scholar of the Alberta Heritage Medical Research Foundation and RGT is a Career Investigator of the Heart and Stroke Foundation of Ontario. This work was supported by grants from the Heart and Stroke Foundation of Ontario T5903 to RGT) and the Canadian Institutes of Health Research (Grant 86602 to GYO). This work was also supported by a grant to GYO from the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Chapman H, 2005, J CELL SCI, V118, P5325, DOI 10.1242/jcs.02635; Chen MX, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-93; Christe G, 2008, HEART RHYTHM, V5, P1577, DOI 10.1016/j.hrthm.2008.08.031; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong QM, 2004, J MOL CELL CARDIOL, V37, P1225, DOI 10.1016/j.yjmcc.2004.10.002; Gong QM, 2004, AM J PHYSIOL-HEART C, V287, pH652, DOI 10.1152/ajpheart.00052.2004; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kapa S, 2009, CIRCULATION, V120, P1752, DOI 10.1161/CIRCULATIONAHA.109.863076; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Marr N, 2002, HUM MOL GENET, V11, P779, DOI 10.1093/hmg/11.7.779; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Moss AJ, 2003, JAMA-J AM MED ASSOC, V289, P2041, DOI 10.1001/jama.289.16.2041; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sasano T, 2004, J MOL CELL CARDIOL, V37, P1205, DOI 10.1016/j.yjmcc.2004.09.010; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Teng SY, 2004, J MOL MED, V82, P189, DOI 10.1007/s00109-003-0504-1; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; Verkerk AO, 2005, CARDIOVASC RES, V68, P441, DOI 10.1016/j.cardiores.2005.06.027; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wu ZY, 2008, ENDOCRINOLOGY, V149, P5061, DOI 10.1210/en.2007-1802; Yao Y, 2009, HEART RHYTHM, V6, P553, DOI 10.1016/j.hrthm.2009.01.017; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18273	10.1371/journal.pone.0018273	http://dx.doi.org/10.1371/journal.pone.0018273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483829	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200049
J	Fisher, M; Downie, H; Welten, MCM; Delgado, I; Bain, A; Planzer, T; Sherman, A; Sang, H; Tickle, C				Fisher, Malcolm; Downie, Helen; Welten, Monique C. M.; Delgado, Irene; Bain, Andrew; Planzer, Thorsten; Sherman, Adrian; Sang, Helen; Tickle, Cheryll			Comparative Analysis of 3D Expression Patterns of Transcription Factor Genes and Digit Fate Maps in the Developing Chick Wing	PLOS ONE			English	Article							VERTEBRATE LIMB DEVELOPMENT; TOWNES-BROCKS-SYNDROME; ULNAR-MAMMARY SYNDROME; SONIC-HEDGEHOG; T-BOX; TBX GENES; IDENTITY; BUD; SPECIFICATION; COMPLEX	Hoxd13, Tbx2, Tbx3, Sall1 and Sall3 genes are candidates for encoding antero-posterior positional values in the developing chick wing and specifying digit identity. In order to build up a detailed profile of gene expression patterns in cell lineages that give rise to each of the digits over time, we compared 3 dimensional (3D) expression patterns of these genes during wing development and related them to digit fate maps. 3D gene expression data at stages 21, 24 and 27 spanning early bud to digital plate formation, captured from in situ hybridisation whole mounts using Optical Projection Tomography (OPT) were mapped to reference wing bud models. Grafts of wing bud tissue from GFP chicken embryos were used to fate map regions of the wing bud giving rise to each digit; 3D images of the grafts were captured using OPT and mapped on to the same models. Computational analysis of the combined computerised data revealed that Tbx2 and Tbx3 are expressed in digit 3 and 4 progenitors at all stages, consistent with encod ng stable antero-posterior positional values established in the early bud; Hoxd13 and Sall1 expression is more dynamic, being associated with posterior digit 3 and 4 progenitors in the early bud but later becoming associated with anterior digit 2 progenitors in the digital plate. Sox9 expression in digit condensations lies within domains of digit progenitors defined by fate mapping; digit 3 condensations express Hoxd13 and Sall1, digit 4 condensations Hoxd13, Tbx3 and to a lesser extent Tbx2. Sall3 is only transiently expressed in digit 3 progenitors at stage 24 together with Sall1 and Hoxd13; then becomes excluded from the digital plate. These dynamic patterns of expression suggest that these genes may play different roles in digit identity either together or in combination at different stages including the digit condensation stage.	[Fisher, Malcolm; Bain, Andrew; Planzer, Thorsten; Tickle, Cheryll] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland; [Downie, Helen; Welten, Monique C. M.; Delgado, Irene; Tickle, Cheryll] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Edinburgh, Dept Genet & Genom, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Sherman, Adrian; Sang, Helen] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland	University of Dundee; University of Bath; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Fisher, M (corresponding author), Univ Edinburgh, Dept Genet & Genom, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.	mcmw20@bath.ac.uk	Delgado, Irene/L-9424-2014; Welten, Monique/ABC-2988-2020; Fisher, Malcolm Edgar/GQH-8954-2022	Delgado, Irene/0000-0002-0493-8261; Fisher, Malcolm Edgar/0000-0003-1074-8103; Laurie, Helen/0000-0002-8974-1168; Welten, Monique/0000-0001-8675-5700	Medical Research Council (MRC) [G9806660, G0801092]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G00093X, BB/E011276/2]; Royal Society; Spanish Ministry of Education Science;  [2008-00397]; BBSRC [BB/E011276/2] Funding Source: UKRI; MRC [G9806660, G0801092] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E011276/2] Funding Source: researchfish; Medical Research Council [G9806660, G0801092] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Spanish Ministry of Education Science(Spanish Government); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MF, HD, AAB and CT were supported by the Medical Research Council (MRC), grant numbers G9806660 and G0801092; MW, HD and CT by the Biotechnology and Biological Sciences Research Council (BBSRC), grant number BB/G00093X and CT by The Royal Society. AS and HS were supported by the BBSRC, grant number BB/E011276/2. ID is a recipient of a Formacion de Personal Investigador (FPI) grant from the Spanish Ministry of Education & Science and was supported by grant 2008-00397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bangs F, 2010, MECH DEVELOP, V127, P428, DOI 10.1016/j.mod.2010.08.001; Biehs B, 1998, DEVELOPMENT, V125, P4245; BOWEN J, 1989, ANAT EMBRYOL, V179, P269, DOI 10.1007/BF00326592; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Farrell ER, 2001, MECH DEVELOP, V102, P227, DOI 10.1016/S0925-4773(01)00296-9; Farrell ER, 2000, DEV BIOL, V225, P447, DOI 10.1006/dbio.2000.9852; Fisher ME, 2008, DEV BIOL, V317, P13, DOI 10.1016/j.ydbio.2008.01.031; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Isaac A, 1998, DEVELOPMENT, V125, P1867; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Logan M, 1998, DEVELOPMENT, V125, P2825; McDonald LA, 2010, J ANAT, V216, P683, DOI 10.1111/j.1469-7580.2010.01233.x; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nissim S, 2007, DEV BIOL, V304, P9, DOI 10.1016/j.ydbio.2006.12.010; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rodriguez DD, 2004, DEV BIOL, V268, P481, DOI 10.1016/j.ydbio.2004.01.005; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Sweetman D, 2003, J BIOL CHEM, V278, P6560, DOI 10.1074/jbc.M209066200; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Tumpel S, 2002, DEV BIOL, V250, P251, DOI 10.1006/dbio.2002.0762; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P86, DOI 10.1002/jez.b.21023; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; WELTEN MCM, 2011, DEV DYNAMIC IN PRESS; Yang Y, 1997, DEVELOPMENT, V124, P4393	45	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18661	10.1371/journal.pone.0018661	http://dx.doi.org/10.1371/journal.pone.0018661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526123	Green Submitted, Green Published, gold			2022-12-27	WOS:000290015800011
J	Mounier, A; Condemi, S; Manzi, G				Mounier, Aurelien; Condemi, Silvana; Manzi, Giorgio			The Stem Species of Our Species: A Place for the Archaic Human Cranium from Ceprano, Italy	PLOS ONE			English	Article							MIDDLE PLEISTOCENE; PHYLOGENETIC POSITION; HOMO-ERECTUS; RECONSTRUCTION; NEANDERTHALS; CALVARIUM; EVOLUTION; HOMININ	One of the present challenges in the study of human evolution is to recognize the hominin taxon that was ancestral to Homo sapiens. Some researchers regard H. heidelbergensis as the stem species involved in the evolutionary divergence leading to the emergence of H. sapiens in Africa, and to the evolution of the Neandertals in Europe. Nevertheless, the diagnosis and hypodigm of H. heidelbergensis still remain to be clarified. Here we evaluate the morphology of the incomplete cranium (calvarium) known as Ceprano whose age has been recently revised to the mid of the Middle Pleistocene, so as to test whether this specimen may be included in H. heidelbergensis. The analyses were performed according to a phenetic routine including geometric morphometrics and the evaluation of diagnostic discrete traits. The results strongly support the uniqueness of H. heidelbergensis on a wide geographical horizon, including both Eurasia and Africa. In this framework, the Ceprano calvarium - with its peculiar combination of archaic and derived traits - may represent, better than other penecontemporaneous specimens, an appropriate ancestral stock of this species, preceding the appearance of regional autapomorphic features.	[Mounier, Aurelien; Condemi, Silvana] Univ Aix Marseille 2, CNRS, Unite Anthropol Bioculturelle, Etab Francais Sang,UMR 6578, Marseille, France; [Manzi, Giorgio] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Manzi, Giorgio] Ist Italiano Paleontol Umana, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Sapienza University Rome	Mounier, A (corresponding author), Univ Aix Marseille 2, CNRS, Unite Anthropol Bioculturelle, Etab Francais Sang,UMR 6578, Marseille, France.	giorgio.manzi@uniroma1.it	Condemi, Silvana/ABE-2701-2021	Condemi, Silvana/0000-0002-6516-0879; Manzi, Giorgio/0000-0002-8611-1371; Mounier, Aurelien/0000-0001-9713-7246	Sapienza - University of Rome; Italian Ministry of University and Research (MIUR)	Sapienza - University of Rome; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was partly supported by resources of the Sapienza - University of Rome and co-financed by the Italian Ministry of University and Research (MIUR), including grants for Progetti di Rilevante Interesse Nazionale (PRIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Ascenzi A, 2000, J HUM EVOL, V39, P443, DOI 10.1006/jhev.2000.0425; ASCENZI A, 1996, J HUM EVOL, V31, P429; AUTON SC, 2003, YEARB PHYS ANTHROPOL, V46, P126; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Braun M., 1998, AM J PHYS ANTHROPOL, VS26, P113; Bruner E, 2005, ANAT REC PART A, V285A, P643, DOI 10.1002/ar.a.20205; Bruner E, 2007, AM J PHYS ANTHROPOL, V132, P355, DOI 10.1002/ajpa.20545; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Clarke RJ, 2000, J HUM EVOL, V39, P433, DOI 10.1006/jhev.2000.0426; Colley W, 1971, MULTIVARIATE DATA AN; Condemi S., 2001, NEANDERTHALIENS CHAI; Condemi S, 1992, HOMMES FOSSILES SACC; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; deCastro JMB, 1997, SCIENCE, V276, P1392; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Mallegni F, 2003, C R PALEVOL, V2, P153, DOI 10.1016/S1631-0683(03)00015-0; Manzi G, 2004, EVOL ANTHROPOL, V13, P11, DOI 10.1002/evan.10127; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; MANZI G, 2011, INT J EVOL IN PRESS; Manzi G, 2010, J HUM EVOL, V59, P580, DOI 10.1016/j.jhevol.2010.06.010; Marchal Francois, 2003, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V15, P7; MOUNIER A, 2009, THESIS U MEDITERRANN; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Muttoni G, 2009, EARTH PLANET SC LETT, V286, P255, DOI 10.1016/j.epsl.2009.06.032; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 1996, J HUM EVOL, V31, P21; ROEBROEKS W, 1994, ANTIQUITY, V68, P489, DOI 10.1017/S0003598X00047001; Rosas A, 1998, GEOBIOS-LYON, V31, P687, DOI 10.1016/S0016-6995(98)80055-7; Schoetensack O., 1908, LINKS, V5; Segre AG, 2009, ANTHROPOLOGIE, V113, P59, DOI 10.1016/j.anthro.2009.01.011; Stringer C.B., 1984, Courier Forschungsinstitut Senckenberg, V69, P131; Vandermeersch B., 1981, HOMMES QAFZEH ISRAEL; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Wilks SS, 1962, MATH STAT; Wolpoff MH, 2001, SCIENCE, V291, P293, DOI 10.1126/science.291.5502.293; Wood Bernard, 1994, Courier Forschungsinstitut Senckenberg, V171, P159; WU R, 1988, ACTA ANTHROPOL SINIC, V7, P101	44	35	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18821	10.1371/journal.pone.0018821	http://dx.doi.org/10.1371/journal.pone.0018821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533096	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400028
J	Altomare, DA; Menges, CW; Xu, JF; Pei, JM; Zhang, LL; Tadevosyan, A; Neumann-Domer, E; Liu, ZM; Carbone, M; Chudoba, I; Klein-Szanto, AJ; Testa, JR				Altomare, Deborah A.; Menges, Craig W.; Xu, Jinfei; Pei, Jianming; Zhang, Lili; Tadevosyan, Ara; Neumann-Domer, Erin; Liu, Zemin; Carbone, Michele; Chudoba, Ilse; Klein-Szanto, Andres J.; Testa, Joseph R.			Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis	PLOS ONE			English	Article							TUMOR SUPPRESSION; INK4A LOCUS; P16(INK4A)	The CDKN2A/ARF locus encompasses overlapping tumor suppressor genes p16(INK4A) and p14(ARF), which are frequently co-deleted in human malignant mesothelioma (MM). The importance of p16(INK4A) loss in human cancer is well established, but the relative significance of p14(ARF) loss has been debated. The tumor predisposition of mice singly deficient for either Ink4a or Arf, due to targeting of exons 1 alpha or 1 beta, respectively, supports the idea that both play significant and nonredundant roles in suppressing spontaneous tumors. To further test this notion, we exposed Ink4a(+/-) and Arf(+/-) mice to asbestos, the major cause of MM. Asbestos-treated Ink4a(+/-) and Arf(+/-) mice showed increased incidence and shorter latency of MM relative to wild-type littermates. MMs from Ink4a(+/-) mice exhibited biallelic inactivation of Ink4a, loss of Arf or p53 expression and frequent loss of p15(Ink4b). In contrast, MMs from Arf(+/-) mice exhibited loss of Arf expression, but did not require loss of Ink4a or Ink4b. Mice doubly deficient for Ink4a and Arf, due to deletion of Cdkn2a/Arf exon 2, showed accelerated asbestos-induced MM formation relative to mice deficient for Ink4a or Arf alone, and MMs exhibited biallelic loss of both tumor suppressor genes. The tumor suppressor function of Arf in MM was p53-independent, since MMs with loss of Arf retained functional p53. Collectively, these in vivo data indicate that both CDKN2A/ARF gene products suppress asbestos carcinogenicity. Furthermore, while inactivation of Arf appears to be crucial for MM pathogenesis, the inactivation of both p16(Ink4a) and p19(Arf) cooperate to accelerate asbestos-induced tumorigenesis.	[Altomare, Deborah A.; Menges, Craig W.; Xu, Jinfei; Pei, Jianming; Zhang, Lili; Tadevosyan, Ara; Neumann-Domer, Erin; Liu, Zemin; Klein-Szanto, Andres J.; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Carbone, Michele] Univ Hawaii, Canc Res Ctr Hawaii, Thorac Oncol Program, Honolulu, HI 96813 USA; [Chudoba, Ilse] MetaSystems, Altlussheim, Germany	Fox Chase Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System	Altomare, DA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	joseph.testa@fccc.edu			National Cancer Institute [P01CA114047, CA06927]; Commonwealth of Pennsylvania (Fox Chase Cancer Center) [CA009035]; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE [P01CA114047, P30CA006927, T32CA009035] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth of Pennsylvania (Fox Chase Cancer Center); International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the National Cancer Institute (P01CA114047 to J.R.T., M.C., CA06927 to J.R.T., A.J.K.-S.), and CA009035 (C.W.M.), by the Commonwealth of Pennsylvania (Fox Chase Cancer Center), and by the Local No. 14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Allied Workers (J.R.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Fleury-Feith J, 2003, ONCOGENE, V22, P3799, DOI 10.1038/sj.onc.1206593; Heintz NH, 2010, AM J RESP CELL MOL, V42, P133, DOI 10.1165/rcmb.2009-0206TR; Hopkins-Donaldson S, 2006, NEOPLASIA, V8, P551, DOI 10.1593/neo.06148; Jongsma J, 2008, CANCER CELL, V13, P261, DOI 10.1016/j.ccr.2008.01.030; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; TESTA JR, 1994, CANCER RES, V54, P2778	13	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18828	10.1371/journal.pone.0018828	http://dx.doi.org/10.1371/journal.pone.0018828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526190	Green Published, gold			2022-12-27	WOS:000289671100026
J	Lee, SB; Warthaka, M; Yan, CL; Kaoud, TS; Piserchio, A; Ghose, R; Ren, PY; Dalby, KN				Lee, Sunbae; Warthaka, Mangalika; Yan, Chunli; Kaoud, Tamer S.; Piserchio, Andrea; Ghose, Ranajeet; Ren, Pengyu; Dalby, Kevin N.			A Model of a MAPK center dot Substrate Complex in an Active Conformation: A Computational and Experimental Approach	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SIGNAL-REGULATED KINASE; TRANSCRIPTION FACTOR; DOCKING INTERACTIONS; KINETIC MECHANISM; POINTED DOMAIN; ERK2; PHOSPHORYLATION; BINDING; SITES	The mechanisms by which MAP kinases recognize and phosphorylate substrates are not completely understood. Efforts to understand the mechanisms have been compromised by the lack of MAPK-substrate structures. While MAPK-substrate docking is well established as a viable mechanism for bringing MAPKs and substrates into close proximity the molecular details of how such docking promotes phosphorylation is an unresolved issue. In the present study computer modeling approaches, with restraints derived from experimentally known interactions, were used to predict how the N-terminus of Ets-1 associates with ERK2. Interestingly, the N-terminus does not contain a consensus-docking site ((R/K)(2-3)-X2-6-Phi(A)-X-Phi(B), where Phi is aliphatic hydrophobic) for ERK2. The modeling predicts that the N-terminus of Ets-1 makes important contributions to the stabilization of the complex, but remains largely disordered. The computer-generated model was used to guide mutagenesis experiments, which support the notion that Leu-11 and possibly Ile-13 and Ile-14 of Ets-1 1-138 (Ets) make contributions through binding to the hydrophobic groove of the ERK2 D-recruiting site (DRS). Based on the modeling, a consensus-docking site was introduced through the introduction of an arginine at residue 7, to give the consensus (RK)-R-7-X-2-Phi(A)-X-Phi(13)(B). This results in a 2-fold increase in k(cat)/K-m for the phosphorylation of Ets by ERK2. Similarly, the substitution of the N-terminus for two different consensus docking sites derived from Elk-1 and MKK1 also improves k(cat)/K-m by two-fold compared to Ets. Disruption of the N-terminal docking through deletion of residues 1-23 of Ets results in a 14-fold decrease in k(cat)/K-m, with little apparent change in k(cat). A peptide that binds to the DRS of ERK2 affects K-m, but not k(cat). Our kinetic analysis suggests that the unstructured N-terminus provides 10-fold uniform stabilization of the ground state ERK2 center dot Ets center dot MgATP complex and intermediates of the enzymatic reaction.	[Lee, Sunbae; Warthaka, Mangalika; Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA; [Yan, Chunli; Ren, Pengyu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Pharm, Austin, TX 78712 USA; [Piserchio, Andrea; Ghose, Ranajeet] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Ghose, Ranajeet] CUNY, Grad Ctr, New York, NY USA; [Ren, Pengyu; Dalby, Kevin N.] Univ Texas Austin, Grad Program Biomed Engn, Austin, TX 78712 USA; [Dalby, Kevin N.] Univ Texas Austin, Grad Program Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, SB (corresponding author), Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA.	pren@mail.utexas.edu; kinases@me.com	Kaoud, Tamer S/C-3618-2019; Dalby, Kevin N/A-1905-2013; Ren, Pengyu/Q-6872-2017; Yan, Chunli/E-5292-2012	Kaoud, Tamer S/0000-0003-1298-8725; Dalby, Kevin N/0000-0001-9272-5129; Ren, Pengyu/0000-0002-5613-1910; Yan, Chunli/0000-0001-5742-120X	National Institute of General Medical Sciences [R01GM059802, R01 GM079686, R01 GM084278]; Welch Foundation [F-1390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802, R01GM079686, R01GM084278] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was from grants from the National Institute of General Medical Sciences to KND (R01GM059802) 2) to PR (R01 GM079686) and to RG (R01 GM084278). The Welch Foundation also supported KND (F-1390). Computing resources were provided by TeraGrid (MCB100057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramczyk O, 2007, BIOCHEMISTRY-US, V46, P9174, DOI 10.1021/bi7002058; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Callaway K, 2010, BIOCHEMISTRY-US, V49, P3619, DOI 10.1021/bi100199q; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hobeika M, 2009, J BIOL CHEM, V284, P17575, DOI 10.1074/jbc.M109.004374; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Waas WF, 2003, BIOCHEMISTRY-US, V42, P12273, DOI 10.1021/bi0348617; Waas WF, 2002, J BIOL CHEM, V277, P12532, DOI 10.1074/jbc.M110523200; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	36	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18594	10.1371/journal.pone.0018594	http://dx.doi.org/10.1371/journal.pone.0018594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494553	gold, Green Published			2022-12-27	WOS:000289354100024
J	Fu, JL; Reinhold, J; Woodbury, NW				Fu, Jinglin; Reinhold, Jeremy; Woodbury, Neal W.			Peptide-Modified Surfaces for Enzyme Immobilization	PLOS ONE			English	Article							ORIENTATION; PROTEINS	Background: Chemistry and particularly enzymology at surfaces is a topic of rapidly growing interest, both in terms of its role in biological systems and its application in biocatalysis. Existing protein immobilization approaches, including noncovalent or covalent attachments to solid supports, have difficulties in controlling protein orientation, reducing nonspecific absorption and preventing protein denaturation. New strategies for enzyme immobilization are needed that allow the precise control over orientation and position and thereby provide optimized activity. Methodology/Principal Findings: A method is presented for utilizing peptide ligands to immobilize enzymes on surfaces with improved enzyme activity and stability. The appropriate peptide ligands have been rapidly selected from high-density arrays and when desirable, the peptide sequences were further optimized by single-point variant screening to enhance both the affinity and activity of the bound enzyme. For proof of concept, the peptides that bound to beta-galactosidase and optimized its activity were covalently attached to surfaces for the purpose of capturing target enzymes. Compared to conventional methods, enzymes immobilized on peptide-modified surfaces exhibited higher specific activity and stability, as well as controlled protein orientation. Conclusions/Significance: A simple method for immobilizing enzymes through specific interactions with peptides anchored on surfaces has been developed. This approach will be applicable to the immobilization of a wide variety of enzymes on surfaces with optimized orientation, location and performance, and provides a potential mechanism for the patterned self-assembly of multiple enzymes on surfaces.	[Fu, Jinglin; Reinhold, Jeremy; Woodbury, Neal W.] Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA; [Fu, Jinglin] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, Tempe, AZ USA; [Fu, Jinglin; Reinhold, Jeremy; Woodbury, Neal W.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Fu, JL (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA.	nwoodbury@asu.edu	Fu, Jinglin/F-3589-2012		Technology and Research Initiative Funds (TRIF); National Science Foundation [SKS0045]	Technology and Research Initiative Funds (TRIF); National Science Foundation(National Science Foundation (NSF))	This work was supported by Technology and Research Initiative Funds (TRIF) provided to Dr. Neal Woodbury by ASU, the Edson Student Entrepreneur Initiative provided to Dr. Jinglin Fu at ASU, and the National Science Foundation (SKS0045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIODUPONT M, 1988, FEBS LETT, V240, P181, DOI 10.1016/0014-5793(88)80364-8; Boltz KW, 2009, ANALYST, V134, P650, DOI 10.1039/b823156g; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Clarizia LJ, 2009, ANAL BIOANAL CHEM, V393, P1531, DOI 10.1007/s00216-008-2567-x; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Fu JL, 2010, J AM CHEM SOC, V132, P6419, DOI 10.1021/ja100403a; GREVING MP, 2010, PLOS ONE IN PRESS; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jung YW, 2008, ANAL BIOCHEM, V374, P99, DOI 10.1016/j.ab.2007.10.022; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Laurent N, 2008, TRENDS BIOTECHNOL, V26, P328, DOI 10.1016/j.tibtech.2008.03.003; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Naffin JL, 2003, CHEM BIOL, V10, P251, DOI 10.1016/S1074-5521(03)00049-8; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735	18	39	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18692	10.1371/journal.pone.0018692	http://dx.doi.org/10.1371/journal.pone.0018692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494577	gold, Green Submitted, Green Published			2022-12-27	WOS:000289292800038
J	Kolatsi-Joannou, M; Price, KL; Winyard, PJ; Long, DA				Kolatsi-Joannou, Maria; Price, Karen L.; Winyard, Paul J.; Long, David A.			Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; PROSTATE-CANCER CELLS; FOLIC-ACID; GROWTH-FACTOR; MOUSE KIDNEY; RAT; APOPTOSIS; INHIBITION; FIBROSIS; PROLIFERATION	Galectin-3 is a beta-galactoside binding lectin with roles in diverse processes including proliferation, apoptosis, inflammation and fibrosis which are dependent on different domains of the molecule and subcellular distribution. Although galectin-3 is known to be upregulated in acute kidney injury, the relative importance of its different domains and functions are poorly understood in the underlying pathogenesis. Therefore we experimentally modulated galectin-3 in folic acid (FA)-induced acute kidney injury utilising modified citrus pectin (MCP), a derivative of pectin which can bind to the galectin-3 carbohydrate recognition domain thereby predominantly antagonising functions linked to this role. Mice were pre-treated with normal or 1% MCP-supplemented drinking water one week before FA injection. During the initial injury phase, all FA-treated mice lost weight whilst their kidneys enlarged secondary to the renal insult; these gross changes were significantly lessened in the MCP group but this was not associated with significant changes in galectin-3 expression. At a histological level, MCP clearly reduced renal cell proliferation but did not affect apoptosis. Later, during the recovery phase at two weeks, MCP-treated mice demonstrated reduced galectin-3 in association with decreased renal fibrosis, macrophages, proinflammatory cytokine expression and apoptosis. Other renal galectins, galectin-1 and -9, were unchanged. Our data indicates that MCP is protective in experimental nephropathy with modulation of early proliferation and later galectin-3 expression, apoptosis and fibrosis. This raises the possibility that MCP may be a novel strategy to reduce renal injury in the long term, perhaps via carbohydrate binding-related functions of galectin-3.	[Kolatsi-Joannou, Maria; Price, Karen L.; Winyard, Paul J.; Long, David A.] UCL, Inst Child Hlth, Nephrourol Unit, London, England	University of London; University College London	Kolatsi-Joannou, M (corresponding author), UCL, Inst Child Hlth, Nephrourol Unit, London, England.	d.long@ich.ucl.ac.uk	Price, Karen L/A-5323-2009; Long, David/I-3254-2019	Long, David/0000-0001-6580-3435; Price, Karen/0000-0002-8113-1461	Kidney Research UK [RP33/2008]; Senior Non-Clinical Fellowship [SF1/2008]; Kids Kidney Research; Kidney Research UK [SF1/2008] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Senior Non-Clinical Fellowship; Kids Kidney Research(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK))	This work was funded by Kidney Research UK (project grant to PJW and DAL (RP33/2008) and a Senior Non-Clinical Fellowship (to DAL, SF1/2008)) and Kids Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahani S, 1997, CANCER RES, V57, P5272; Baba M, 2005, J AM SOC NEPHROL, V16, P3222, DOI 10.1681/ASN.2004110915; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BASERGA R, 1968, LAB INVEST, V19, P92; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; Bullock SL, 2001, J AM SOC NEPHROL, V12, P515, DOI 10.1681/ASN.V123515; Chiu MG, 2006, AM J PATHOL, V169, P1925, DOI 10.2353/ajpath.2006.060245; COLES HSR, 1993, DEVELOPMENT, V118, P777; Davidson PJ, 2002, GLYCOBIOLOGY, V12, P329, DOI 10.1093/glycob/12.5.329; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Bertocchi APF, 2008, TRANSPL INT, V21, P999, DOI 10.1111/j.1432-2277.2008.00705.x; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Gunning AP, 2009, FASEB J, V23, P415, DOI 10.1096/fj.08-106617; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; INOHARA H, 1994, GLYCOCONJUGATE J, V11, P527, DOI 10.1007/BF00731303; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; JENG KCG, 1994, IMMUNOL LETT, V42, P113, DOI 10.1016/0165-2478(94)90072-8; Johnson KD, 2007, NEOPLASIA, V9, P662, DOI 10.1593/neo.07433; Kang EH, 2009, LUPUS, V18, P22, DOI 10.1177/0961203308094361; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; LIU FT, 1995, AM J PATHOL, V147, P1016; LIU FT, 2002, BIOCHIM BIOPHYS ACTA, V19, P263; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Long DA, 2008, KIDNEY INT, V74, P300, DOI 10.1038/ki.2008.179; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Morris VJ, 2011, FOOD HYDROCOLLOID, V25, P230, DOI 10.1016/j.foodhyd.2009.11.015; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishiyama J, 2000, AM J PATHOL, V157, P815, DOI 10.1016/S0002-9440(10)64595-6; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; Price KL, 2009, J UROLOGY, V181, P2366, DOI 10.1016/j.juro.2009.01.001; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sasaki S, 1999, J PATHOL, V187, P481, DOI 10.1002/(SICI)1096-9896(199903)187:4<481::AID-PATH263>3.0.CO;2-2; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Shimizu M, 2009, LAB INVEST, V89, P178, DOI 10.1038/labinvest.2008.125; Tsuchiyama Y, 2000, KIDNEY INT, V58, P1941, DOI 10.1111/j.1523-1755.2000.00366.x; Winyard PJD, 1997, J AM SOC NEPHROL, V8, P1647; Yan J, 2010, INTEGR CANCER THER, V9, P197, DOI 10.1177/1534735410369672; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; ZIMMERMANN HD, 1977, VIRCHOWS ARCH A, V376, P47, DOI 10.1007/BF00433084	50	104	118	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18683	10.1371/journal.pone.0018683	http://dx.doi.org/10.1371/journal.pone.0018683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494626	Green Published, gold			2022-12-27	WOS:000289292800036
J	Mallett, CL; Foster, PJ				Mallett, Christiane L.; Foster, Paula J.			Optimization of the Balanced Steady State Free Precession (bSSFP) Pulse Sequence for Magnetic Resonance Imaging of the Mouse Prostate at 3T	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; IN-VIVO; TRAMP MICE; TRANSGENIC ADENOCARCINOMA; CANCER CELLS; 1.5 T; MODEL; CARCINOGENESIS; TUMORS; SSFP	Introduction: MRI can be used to non-invasively monitor tumour growth and response to treatment in mouse models of prostate cancer, particularly for longitudinal studies of orthotopically-implanted models. We have optimized the balanced steady-state free precession (bSSFP) pulse sequence for mouse prostate imaging. Methods: Phase cycling, excitations, flip angle and receiver bandwidth parameters were optimized for signal to noise ratio and contrast to noise ratio of the prostate. The optimized bSSFP sequence was compared to T1- and T2-weighted spin echo sequences. Results: SNR and CNR increased with flip angle. As bandwidth increased, SNR, CNR and artifacts such as chemical shift decreased. The final optimized sequence was 4 PC, 2 NEX, FA 50 degrees, BW +/- 662.5 kHz and took 14-26 minutes with 200 mm isotropic resolution. The SNR efficiency of the bSSFP images was higher than for T1WSE and T2WSE. CNR was highest for T1WSE, followed closely by bSSFP, with the T2WSE having the lowest CNR. With the bSSFP images the whole body and organs of interest including renal, iliac, inguinal and popliteal lymph nodes were visible. Conclusion: We were able to obtain fast, high-resolution, high CNR images of the healthy mouse prostate with an optimized bSSFP sequence.	[Mallett, Christiane L.; Foster, Paula J.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Mallett, Christiane L.; Foster, Paula J.] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Mallett, CL (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	cmall@imaging.robarts.ca	Foster, Paula/M-2201-2013	Foster, Paula/0000-0002-4868-3395	Ontario Institute for Cancer Research; Canadian Institutes of Health Research	Ontario Institute for Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Ontario Institute for Cancer Research 1 mm Challenge (http://www.oicr.on.ca/Research/programs/millimetre/overview.htm). CLM is supported by a Doctoral Research Scholarship from the Canadian Institutes of Health Research. (www.cihr.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2009, CLIN CANCER RES, V15, P1947, DOI 10.1158/1078-0432.CCR-08-2332; Bangerter NK, 2004, MAGN RESON MED, V51, P1038, DOI 10.1002/mrm.20052; Bastide C, 2002, PROSTATE CANCER P D, V5, P311, DOI 10.1038/sj.pcan.4500606; Bernas LM, 2010, MAGN RESON MED, V64, P23, DOI 10.1002/mrm.22210; Canadian Cancer Society's Steering Committee, 2010, CAN CANC STAT 2010; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Deeb D, 2009, PROSTATE, V69, P851, DOI 10.1002/pros.20937; Degrassi A, 2007, PROSTATE, V67, P396, DOI 10.1002/pros.20511; Eng MH, 1999, UROLOGY, V54, P1112, DOI 10.1016/S0090-4295(99)00297-6; Foster-Gareau P, 2003, MAGN RESON MED, V49, P968, DOI 10.1002/mrm.10417; Fricke ST, 2006, PROSTATE, V66, P708, DOI 10.1002/pros.20392; Gonzalez-Lara LE, 2009, J NEUROTRAUM, V26, P753, DOI 10.1089/neu.2008.0704; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Gupta S, 2004, CANCER RES, V64, P3334, DOI 10.1158/0008-5472.CAN-03-2422; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; Hsu CX, 1998, J UROLOGY, V160, P1500, DOI 10.1016/S0022-5347(01)62603-X; Jennbacken K, 2009, PROSTATE, V69, P1164, DOI 10.1002/pros.20965; Jirak D, 2009, MAGN RESON MATER PHY, V22, P257, DOI 10.1007/s10334-009-0172-4; Kiss P, 2009, PROSTATE, V69, P449, DOI 10.1002/pros.20880; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kumar AP, 2007, CLIN CANCER RES, V13, P2784, DOI 10.1158/1078-0432.CCR-06-2974; Miraux S, 2008, J MAGN RESON IMAGING, V28, P497, DOI 10.1002/jmri.21449; Nastiuk Kent L, 2007, BMC Urol, V7, P12, DOI 10.1186/1471-2490-7-12; Rad A M, 2008, Open Magn Reson Rev, V1, P60, DOI 10.2174/1874769800801010060; Ramadan SS, 2008, MAGN RESON MATER PHY, V21, P251, DOI 10.1007/s10334-008-0118-2; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Song SK, 2002, CANCER RES, V62, P1555; Stadler A, 2007, EUR RADIOL, V17, P1242, DOI 10.1007/s00330-006-0470-4; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Stoyanova R, 2007, INT J RADIAT ONCOL, V68, P1151, DOI 10.1016/j.ijrobp.2007.03.047; Thalmann GN, 2000, PROSTATE, V44, P91; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wolf P, 2008, PROSTATE, V68, P129, DOI 10.1002/pros.20684	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18361	10.1371/journal.pone.0018361	http://dx.doi.org/10.1371/journal.pone.0018361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494660	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800010
J	Lugo, JE; Doti, R; Faubert, J				Lugo, Jesus Eduardo; Doti, Rafael; Faubert, Jocelyn			Negative Refraction Angular Characterization in One-Dimensional Photonic Crystals	PLOS ONE			English	Article							POROUS SILICON; BLOCH WAVES; MULTILAYERS; LIGHT	Background: Photonic crystals are artificial structures that have periodic dielectric components with different refractive indices. Under certain conditions, they abnormally refract the light, a phenomenon called negative refraction. Here we experimentally characterize negative refraction in a one dimensional photonic crystal structure; near the low frequency edge of the fourth photonic bandgap. We compare the experimental results with current theory and a theory based on the group velocity developed here. We also analytically derived the negative refraction correctness condition that gives the angular region where negative refraction occurs. Methodology/Principal Findings: By using standard photonic techniques we experimentally determined the relationship between incidence and negative refraction angles and found the negative refraction range by applying the correctness condition. In order to compare both theories with experimental results an output refraction correction was utilized. The correction uses Snell's law and an effective refractive index based on two effective dielectric constants. We found good agreement between experiment and both theories in the negative refraction zone. Conclusions/Significance: Since both theories and the experimental observations agreed well in the negative refraction region, we can use both negative refraction theories plus the output correction to predict negative refraction angles. This can be very useful from a practical point of view for space filtering applications such as a photonic demultiplexer or for sensing applications.	[Lugo, Jesus Eduardo; Doti, Rafael; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada	Universite de Montreal	Lugo, JE (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	je.lugo.arce@umontreal.ca	Faubert, Jocelyn/E-2207-2011		NSERC-Essilor Research Chair; NSERC	NSERC-Essilor Research Chair(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC-Essilor Research Chair and an NSERC operating grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, MRS BULL, V33, P927, DOI 10.1557/mrs2008.201; Boedecker G, 2003, OPT EXPRESS, V11, P1590, DOI 10.1364/OE.11.001590; Foteinopoulou S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165112; Gerken M, 2003, IEEE PHOTONIC TECH L, V15, P1097, DOI 10.1109/LPT.2003.815318; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Kavokin AV, 2005, PHYS LETT A, V339, P387, DOI 10.1016/j.physleta.2005.02.077; Kosaka H, 1999, APPL PHYS LETT, V74, P1212, DOI 10.1063/1.123502; Kosaka H, 1998, PHYS REV B, V58, P10096, DOI 10.1103/PhysRevB.58.R10096; Lugo J. E., 2009, OPT EXPRESS, V17, P3036; Nava R, 2009, PHYS STATUS SOLIDI C, V6, P1721, DOI 10.1002/pssc.200881090; Notomi M, 2002, OPT QUANT ELECTRON, V34, P133, DOI 10.1023/A:1013300825612; Pavesi L, 1997, RIV NUOVO CIMENTO, V20, P1, DOI 10.1007/BF02877374; Russell PS, 1996, NATO ADV SCI INST SE, V315, P71; RUSSELL PSJ, 1986, PHYS REV A, V33, P3232, DOI 10.1103/PhysRevA.33.3232; RUSSELL PSJ, 1995, NATO ADV SCI I B-PHY, V340, P585; Russell PStJ, 1986, APPL PHYS B, V39, P23; Srivastava R, 2008, SOLID STATE COMMUN, V147, P157, DOI 10.1016/j.ssc.2008.04.036; YUAN YC, 2007, CHINESE PHYS, V16, P173; Zeng Y, 2006, SOLID STATE COMMUN, V138, P205, DOI 10.1016/j.ssc.2006.02.019; ZENGERLE R, 1987, J MOD OPTIC, V34, P1589, DOI 10.1080/09500348714551531	20	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e17188	10.1371/journal.pone.0017188	http://dx.doi.org/10.1371/journal.pone.0017188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494332	gold, Green Submitted, Green Published			2022-12-27	WOS:000289192400003
J	Sun, MM; Abdula, SE; Lee, HJ; Cho, YC; Han, LZ; Koh, HJ; Cho, YG				Sun, Ming-Mao; Abdula, Sailila E.; Lee, Hye-Jung; Cho, Young-Chan; Han, Long-Zhi; Koh, Hee-Jong; Cho, Yong-Gu			Molecular Aspect of Good Eating Quality Formation in Japonica Rice	PLOS ONE			English	Article							ORYZA-SATIVA L.; STARCH BRANCHING ENZYME; SINGLE NUCLEOTIDE POLYMORPHISMS; PHYSICOCHEMICAL PROPERTIES; VISCOSITY CHARACTERISTICS; CARBOHYDRATE-METABOLISM; SYNTHESIZING GENES; SYNTHASE-IIA; ENDOSPERM; EXPRESSION	The composition of amylopectin is the determinant of rice eating quality under certain threshold of protein content and the ratio of amylose and amylopectin. In molecular biology level, the fine structure of amylopectin is determined by relative activities of starch branching enzyme (SBE), granule-bound starch synthase (GBSS), and soluble starch synthase (SSS) in rice grain under the same ADP-Glucose level. But the underlying mechanism of eating quality in molecular biology level remains unclear. This paper reports the differences on major parameters such as SNP and insertion-deletion sites, RNA expressions, and enzyme activities associated with eating quality of japonica varieties. Eight japonica rice varieties with significant differences in various eating quality parameters such as palatability and protein content were used in this experiment. Association analysis between nucleotide polymorphism and eating quality showed that S12 and S13 loci in SBE1, S55 in SSS1, S58 in SSS2A were significantly associated with apparent amylose content, alkali digestion value, setback viscosity, consistency viscosity, pasting temperature, which explained most of the variation in apparent amylose content, setback viscosity, and consistency viscosity; and explained almost all variations in alkali digestion value and pasting temperature. Thirty-five SNPs and insertion-deletions from SBE1, SBE3, GBSS1, SSS1, and SSS2A differentiated high or intermediate palatability rice varieties from low palatability rice varieties. Correlation analysis between enzyme activities and eating quality properties revealed that SBE25 and SSS15/W15 were positively correlated with palatability, whereas GBSS10 and GBSS15 were negatively correlated. Gene expressions showed that SBE1 and SBE3 expressions in high palatability varieties tended to be higher than middle and low palatability varieties. Collectively, SBE1, SBE3, SSS1, and SSS2A, especially SBE1 and SBE3 could improve eating quality, but GBSS1 decreased eating quality. The results indicated the possibility of developing high palatability cultivars through modification of key genes related to japonica rice eating quality formation in starch biosynthesis.	[Sun, Ming-Mao; Abdula, Sailila E.; Lee, Hye-Jung; Cho, Yong-Gu] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Cho, Young-Chan] Rural Dev Adm, Natl Inst Crop Sci, Suwon, South Korea; [Han, Long-Zhi] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Koh, Hee-Jong] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea	Chungbuk National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Seoul National University (SNU)	Sun, MM (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea.	ygcho@chungbuk.ac.kr	Cho, Yong-Gu/AAV-1904-2021		BioGreen 21 Program; Rural Development Administration; MIFAFF, Korea [306005-04-2-HD110]	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); MIFAFF, Korea	This work was supported by a grant from the BioGreen 21 Program, Rural Development Administration and by a grant (code # 306005-04-2-HD110) from MIFAFF, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1995, PROT CRUD AN FEED CO; Ayres NM, 1997, THEOR APPL GENET, V94, P773, DOI 10.1007/s001220050477; Bao JS, 2006, THEOR APPL GENET, V113, P1185, DOI 10.1007/s00122-006-0394-z; Bao JS, 2006, THEOR APPL GENET, V113, P1171, DOI 10.1007/s00122-006-0355-6; Bao JS, 2008, J AGR FOOD CHEM, V56, P1589, DOI 10.1021/jf073128+; Bao JS, 1999, THEOR APPL GENET, V98, P1120, DOI 10.1007/s001220051175; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Chen Neng, 2006, Acta Agronomica Sinica, V32, P1193; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; Dian WM, 2005, J EXP BOT, V56, P623, DOI 10.1093/jxb/eri065; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Han YP, 2004, PLANT SCI, V166, P357, DOI 10.1016/j.plantsci.2003.09.023; Hanashiro I, 2008, PLANT CELL PHYSIOL, V49, P925, DOI 10.1093/pcp/pcn066; Hansen J., 2002, RICE SITUATION OUTLO, P32; Harushima Y, 2002, GENETICS, V160, P313; HAWKER JS, 1974, ARCH BIOCHEM BIOPHYS, V160, P530, DOI 10.1016/0003-9861(74)90430-5; Hong HC, 2006, THESIS DONGGUK U KOR, P1; Hosoya LA, 2010, ARCHAEOL ANTHROP SCI, V2, P57, DOI 10.1007/s12520-010-0034-z; Huang YS, 1998, CHINESE J RICE SCI, V12, P172; Jiang HW, 2003, PHYTOCHEMISTRY, V63, P53, DOI 10.1016/S0031-9422(03)00005-0; Juliano B.O., 1985, RICE CHEM TECHNOLOGY, V2nd ed., P443; Lestari P, 2009, J AGR FOOD CHEM, V57, P2754, DOI 10.1021/jf803804k; LITTLE RR, 1958, CEREAL CHEM, V35, P111; LIU B, 2008, SCI SINICA VITAC, V38, P766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; NAKAMURA Y, 1992, PLANT SCI, V82, P15, DOI 10.1016/0168-9452(92)90003-5; Nakamura Y, 2005, PLANT MOL BIOL, V58, P213, DOI 10.1007/s11103-005-6507-2; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; NAKAMURA Y, 1989, PLANT CELL PHYSIOL, V30, P833, DOI 10.1093/oxfordjournals.pcp.a077813; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Oh-e I., 2007, Scientific Reports of the Faculty of Agriculture, Okayama University, V96, P13; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PEREZ CM, 1978, STARKE, V30, P424, DOI 10.1002/star.19780301206; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Ramesh M, 2000, CRIT REV FOOD SCI, V40, P449, DOI 10.1080/10408690091189220; SAKAMOTO S, 1996, REDEFINING NATURE EC, P215; SATOH H, 2000, POSSIBLE PATHWAY STA; Shen Bo, 1997, Chinese Journal of Rice Science, V11, P183; Shen Peng, 2006, Rice Science, V13, P43; SHUN QY, 1998, SCI AGR SINICA, V31, P25; TAKEDA Y, 1987, CARBOHYD RES, V168, P79, DOI 10.1016/0008-6215(87)80008-3; Tanaka N, 2004, PLANT BIOTECHNOL J, V2, P507, DOI 10.1111/j.1467-7652.2004.00097.x; Tanaka R., 1992, Report of the Tohoku Branch, the Crop Science Society of Japan, P45; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Umemoto T, 2002, FUNCT PLANT BIOL, V29, P1121, DOI 10.1071/PP01145; YAMANOUCHI H, 1992, PLANT CELL PHYSIOL, V33, P985; Yu TengQiong, 2008, Journal of Crop Science and Biotechnology, V11, P135; ZHANG Z, 2009, THESIS HUAZHONG AGR, P1; Zhao BuHong, 2005, Agricultural Sciences in China, V4, P26	53	53	60	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18385	10.1371/journal.pone.0018385	http://dx.doi.org/10.1371/journal.pone.0018385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494675	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400025
J	Kurita, S; Mott, JL; Cazanave, SC; Fingas, CD; Guicciardi, ME; Bronk, SF; Roberts, LR; Fernandez-Zapico, ME; Gores, GJ				Kurita, Satoshi; Mott, Justin L.; Cazanave, Sophie C.; Fingas, Christian D.; Guicciardi, Maria E.; Bronk, Steve F.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.; Gores, Gregory J.			Hedgehog Inhibition Promotes a Switch from Type II to Type I Cell Death Receptor Signaling in Cancer Cells	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; CHOLANGIOCARCINOMA CELLS; CYTOCHROME-C; RESISTANCE; PATHWAY; BAX; EXPRESSION; CARCINOMA; MCL-1; MITOCHONDRIA	TRAIL is a promising therapeutic agent for human malignancies. TRAIL often requires mitochondrial dysfunction, referred to as the Type II death receptor pathway, to promote cytotoxicity. However, numerous malignant cells are TRAIL resistant due to inhibition of this mitochondrial pathway. Using cholangiocarcinoma cells as a model of TRAIL resistance, we found that Hedgehog signaling blockade sensitized these cancer cells to TRAIL cytotoxicity independent of mitochondrial dysfunction, referred to as Type I death receptor signaling. This switch in TRAIL requirement from Type II to Type I death receptor signaling was demonstrated by the lack of functional dependence on Bid/Bim and Bax/Bak, proapoptotic components of the mitochondrial pathway. Hedgehog signaling modulated expression of X-linked inhibitor of apoptosis (XIAP), which serves to repress the Type I death receptor pathway. siRNA targeted knockdown of XIAP mimics sensitization to mitochondria-independent TRAIL killing achieved by Hedgehog inhibition. Regulation of XIAP expression by Hedgehog signaling is mediated by the glioma-associated oncogene 2 (GLI2), a downstream transcription factor of Hedgehog. In conclusion, these data provide additional mechanisms modulating cell death by TRAIL and suggest Hedgehog inhibition as a therapeutic approach for TRAIL-resistant neoplasms.	[Kurita, Satoshi; Mott, Justin L.; Cazanave, Sophie C.; Fingas, Christian D.; Guicciardi, Maria E.; Bronk, Steve F.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Kurita, S (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	gores.gregory@mayo.edu		Roberts, Lewis/0000-0001-7885-8574; Mott, Justin/0000-0002-2927-6962	National Institutes of Health [DK59427]; Division of Oncology Research, Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology NIDDK [P30 DK084567]; Mayo Foundation; NATIONAL CANCER INSTITUTE [P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059427, P30DK084567, K01DK079875, R56DK059427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Oncology Research, Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE; Mayo Clinic Center for Cell Signaling in Gastroenterology NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 Grants DK59427 (GJG), Division of Oncology Research, Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology NIDDK P30 DK084567 (MEF-Z) and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Becattini B, 2004, CHEM BIOL, V11, P1107, DOI 10.1016/j.chembiol.2004.05.022; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Eggert A, 2001, CANCER RES, V61, P1314; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kurita S, 2010, ONCOGENE, V29, P4848, DOI 10.1038/onc.2010.235; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Qiao L, 2009, DRUG RESIST UPDATE, V12, P55, DOI 10.1016/j.drup.2009.02.002; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; RUDIN CM, 2009, N ENGL J MED; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Varfolomeev E, 2009, J BIOL CHEM, V284, P34553, DOI 10.1074/jbc.M109.040139; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730	40	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18330	10.1371/journal.pone.0018330	http://dx.doi.org/10.1371/journal.pone.0018330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483830	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200060
J	Nepomnaschy, PA; Altman, RM; Watterson, R; Co, C; McConnell, DS; England, BG				Nepomnaschy, Pablo A.; Altman, Rachel M.; Watterson, Rita; Co, Caroll; McConnell, Daniel S.; England, Barry G.			Is Cortisol Excretion Independent of Menstrual Cycle Day? A Longitudinal Evaluation of First Morning Urinary Specimens	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GROWTH-HORMONE RESPONSES; PSYCHOLOGICAL STRESS; SALIVARY CORTISOL; SEX-DIFFERENCES; WOMEN; PHASE; EXERCISE; REACTIVITY; MOOD	Background: Cortisol is frequently used as a marker of physiologic stress levels. Using cortisol for that purpose, however, requires a thorough understanding of its normal longitudinal variability. The current understanding of longitudinal variability of basal cortisol secretion in women is very limited. It is often assumed, for example, that basal cortisol profiles do not vary across the menstrual cycle. This is a critical assumption: if cortisol were to follow a time dependent pattern during the menstrual cycle, then ignoring this cyclic variation could lead to erroneous imputation of physiologic stress. Yet, the assumption that basal cortisol levels are stable across the menstrual cycle rests on partial and contradictory evidence. Here we conduct a thorough test of that assumption using data collected for up to a year from 25 women living in rural Guatemala. Methodology: We apply a linear mixed model to describe longitudinal first morning urinary cortisol profiles, accounting for differences in both mean and standard deviation of cortisol among women. To that aim we evaluate the fit of two alternative models. The first model assumes that cortisol does not vary with menstrual cycle day. The second assumes that cortisol mean varies across the menstrual cycle. Menstrual cycles are aligned on ovulation day (day 0). Follicular days are assigned negative numbers and luteal days positive numbers. When we compared Models 1 and 2 restricting our analysis to days between 214 (follicular) and day 14 (luteal) then day of the menstrual cycle did not emerge as a predictor of urinary cortisol levels (p-value >0.05). Yet, when we extended our analyses beyond that central 28-day-period then day of the menstrual cycle become a statistically significant predictor of cortisol levels. Significance: The observed trend suggests that studies including cycling women should account for day dependent variation in cortisol in cycles with long follicular and luteal phases.	[Nepomnaschy, Pablo A.; Watterson, Rita] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Altman, Rachel M.; Co, Caroll] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [McConnell, Daniel S.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [England, Barry G.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Simon Fraser University; Simon Fraser University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	pablo_nepomnaschy@sfu.ca		Nepomnaschy, Pablo/0000-0002-8989-7381	Rackham Graduate School, the Department of Anthropology, and the School of Natural Resources and Environment at the University of Michigan; Simon Fraser University; CIHR [106705]; NSERC [RGPIN293140]	Rackham Graduate School, the Department of Anthropology, and the School of Natural Resources and Environment at the University of Michigan; Simon Fraser University; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The original data collection phase of this study was funded by grants to P.A.N. from Rackham Graduate School, the Department of Anthropology, and the School of Natural Resources and Environment at the University of Michigan. The data analysis phase was funded by a President's Research Start-up Grant from Simon Fraser University and a CIHR Operational Grant #106705 to P.A.N., and a NSERC Discovery Grant RGPIN293140 to R. M. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABPLANALP JM, 1977, PSYCHOSOM MED, V39, P158, DOI 10.1097/00006842-197705000-00002; Altemus M, 1997, NEUROPSYCHOPHARMACOL, V17, P100; Altemus M, 2001, PSYCHOSOM MED, V63, P814, DOI 10.1097/00006842-200109000-00015; ATKINSON HC, 1997, ENDOCRINOLOGY, V86, P220; Baerwald AR, 2004, ULTRASOUND OBST GYN, V24, P453, DOI 10.1002/uog.1123; Baerwald AR, 2003, FERTIL STERIL, V80, P116, DOI 10.1016/S0015-0282(03)00544-2; Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772; BAIRD DD, 1991, STAT MED, V10, P255, DOI 10.1002/sim.4780100209; BECK RP, 1972, AM J OBSTET GYNECOL, V112, P364, DOI 10.1016/0002-9378(72)90478-4; BONEN A, 1976, J APPL PHYSIOL, V40, P155, DOI 10.1152/jappl.1976.40.2.155; BUCKINGHAM JC, 1978, J ENDOCRINOL, V78, P359, DOI 10.1677/joe.0.0780359; CARR BR, 1979, J CLIN ENDOCR METAB, V49, P346, DOI 10.1210/jcem-49-3-346; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; COLLINS A, 1985, PSYCHOSOM MED, V47, P512, DOI 10.1097/00006842-198511000-00002; Critchley HOD, 2001, CLIN ENDOCRINOL, V55, P701, DOI 10.1046/j.1365-2265.2001.01432.x; CRITCHLOW V, 1963, AM J PHYSIOL, V205, P807, DOI 10.1152/ajplegacy.1963.205.5.807; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; FLINN MV, 1995, CURR ANTHROPOL, V36, P854, DOI 10.1086/204444; GENAZZANI AR, 1975, J CLIN ENDOCR METAB, V41, P431, DOI 10.1210/jcem-41-3-431; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; KAJANTIE, 2008, ASS PSYCHOL SCI, V17, P348; KANALEY JA, 1992, INT J SPORTS MED, V13, P332, DOI 10.1055/s-2007-1021276; Kanaley JA, 2002, ENDOCRINOLOGIST, V12, P421, DOI 10.1097/00019616-200209000-00010; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kassam A, 1996, ENVIRON HEALTH PERSP, V104, P408, DOI 10.2307/3432685; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KUBO C, 2003, JMAJ, V46, P50; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Kudielka BM, 2003, PSYCHOSOM MED, V65, P313, DOI 10.1097/01.PSY.0000058374.50240.BF; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kunz-Ebrecht SR, 2004, PSYCHONEUROENDOCRINO, V29, P516, DOI 10.1016/S0306-4530(03)00072-6; Lightman S L, 2001, Prog Brain Res, V133, P111; MALENDOWICZ LK, 1982, ENDOKRINOLOGIE, V79, P292; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; McCormick CM, 2001, HORM BEHAV, V39, P29, DOI 10.1006/hbeh.2000.1636; McLean M, 1999, TRENDS ENDOCRIN MET, V10, P174, DOI 10.1016/S1043-2760(98)00146-5; MEULENBERG EPMM, 1990, J CLIN CHEM CLIN BIO, V28, P923; Negrao AB, 2000, BIOMED PHARMACOTHER, V54, P122, DOI 10.1016/S0753-3322(00)89044-7; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Nepomnaschy PA, 2004, AM J HUM BIOL, V16, P523, DOI 10.1002/ajhb.20057; Nepomnaschy PA, 2007, ANN NY ACAD SCI, V1113, P350, DOI 10.1196/annals.1391.028; Odber J, 1998, J PSYCHOSOM RES, V45, P557, DOI 10.1016/S0022-3999(98)00061-0; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; SAXENA BN, 1974, J OBSTET GYN BR COMM, V81, P563; Seale JV, 2004, J NEUROENDOCRINOL, V16, P516, DOI 10.1111/j.1365-2826.2004.01195.x; SELYE H, 1970, AM J CARDIOL, V26, P289, DOI 10.1016/0002-9149(70)90796-4; Shanks N, 1999, J NEUROENDOCRINOL, V11, P857; Symonds CS, 2004, PSYCHOL MED, V34, P93, DOI 10.1017/S0033291703008535; Tu MT, 2006, J NEUROENDOCRINOL, V18, P494, DOI 10.1111/j.1365-2826.2006.01441.x; Walker CD, 2004, J PSYCHIATR NEUROSCI, V29, P364; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259; Xiao EN, 1998, J CLIN ENDOCR METAB, V83, P2454, DOI 10.1210/jc.83.7.2454	57	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18242	10.1371/journal.pone.0018242	http://dx.doi.org/10.1371/journal.pone.0018242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483825	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200047
J	Garnett, A; Whiteley, L; Piwowar, H; Rasmussen, E; Illes, J				Garnett, Alex; Whiteley, Louise; Piwowar, Heather; Rasmussen, Edie; Illes, Judy			Neuroethics and fMRI: Mapping a Fledgling Relationship	PLOS ONE			English	Article							INCIDENTAL FINDINGS; NEUROSCIENCE; ETHICS; COVERAGE; ISSUES; DAMAGE; STATE	Human functional magnetic resonance imaging (fMRI) informs the understanding of the neural basis of mental function and is a key domain of ethical enquiry. It raises questions about the practice and implications of research, and reflexively informs ethics through the empirical investigation of moral judgments. It is at the centre of debate surrounding the importance of neuroscience findings for concepts such as personhood and free will, and the extent of their practical consequences. Here, we map the landscape of fMRI and neuroethics, using citation analysis to uncover salient topics. We find that this landscape is sparsely populated: despite previous calls for debate, there are few articles that discuss both fMRI and ethical, legal, or social implications (ELSI), and even fewer direct citations between the two literatures. Recognizing that practical barriers exist to integrating ELSI discussion into the research literature, we argue nonetheless that the ethical challenges of fMRI, and controversy over its conceptual and practical implications, make this essential.	[Garnett, Alex; Whiteley, Louise; Illes, Judy] Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada; [Garnett, Alex; Rasmussen, Edie] Univ British Columbia, Sch Lib Archival & Informat Studies, Vancouver, BC V5Z 1M9, Canada; [Piwowar, Heather] Natl Evolutionary Synth Ctr, Durham, NC USA	University of British Columbia; University of British Columbia; The National Evolutionary Synthesis Center	Garnett, A (corresponding author), Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada.	jilles@interchange.ubc.ca	Whiteley, Louise/I-3772-2016; Kam, Grace/F-5364-2012; Piwowar, Heather A/A-4680-2009	Whiteley, Louise/0000-0001-9352-365X; Piwowar, Heather/0000-0003-1613-5981	NIH/NIMH [R01MH84282]; CIHR/INMHA CNE [85117]; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084282] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIHR/INMHA CNE(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Generously supported by NIH/NIMH RO1 #R01MH84282, CIHR/INMHA CNE #85117, the Canadian Foundation for Innovation, and the British Columbia Knowledge Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano B, 1997, Ann Ist Super Sanita, V33, P483; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; [Anonymous], 2006, NATURE, V441, P907, DOI 10.1038/441907a; Appiah K. A., 2008, EXPT ETHICS; Baskin JH, 2007, AM J LAW MED, V33, P239, DOI 10.1177/009885880703300205; Beaulieu A. E., 2000, WILD SCI READING FEM; Blakemore S.J., 2005, LEARNING BRAIN LESSO; Borgelt E, 2011, J BIOETHIC INQ, V8, P15, DOI 10.1007/s11673-010-9271-1; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyce AC, 2009, BIOETHICS, V23, P349, DOI 10.1111/j.1467-8519.2009.01724.x; Canli T, 2002, BRAIN COGNITION, V50, P414, DOI 10.1016/S0278-2626(02)00517-1; Chen CM, 2010, J AM SOC INF SCI TEC, V61, P1386, DOI 10.1002/asi.21309; Choudhury S, 2009, BIOSOCIETIES, V4, P61, DOI 10.1017/S1745855209006437; Cohn S., 2010, TECHNOLOGIZED IMAGES; COHN S, 2002, EC SOC, V33, P52; Conti F, 2008, NATURE, V451, P627, DOI 10.1038/451627b; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Daniels Norman, 1996, JUSTICE JUSTIFICATIO; De Bellis N., 2009, BIBLIOMETRICS CITATI; Deslauriers C, 2010, J EMPIR RES HUM RES, V5, P49, DOI 10.1525/jer.2010.5.1.49; Desmond JE, 2002, BRAIN COGNITION, V50, P482, DOI 10.1016/S0278-2626(02)00531-6; DUMIT J, 2004, PICTURING PRESONHOOD; EAGLEMAN DM, 2010, MINN J LAW SCI TECHN, V1, P7; Farah MJ, 2005, TRENDS COGN SCI, V9, P34, DOI 10.1016/j.tics.2004.12.001; Farah MJ, 2004, HASTINGS CENT REP, V34, P35, DOI 10.2307/3528418; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Garvin JH, 2010, PRINCIPLES OF GENDER-SPECIFIC MEDICINE, 2ND EDITION, P51, DOI 10.1016/B978-0-12-374271-1.00004-6; Greely HT, 2007, AM J LAW MED, V33, P377, DOI 10.1177/009885880703300211; Hallowell N., 2008, CLIN ETHICS, V3, P85, DOI [DOI 10.1258/ce.2008.008014, DOI 10.1258/CE.2008.008014]; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Illes J., 2006, NEUROETHICS DEFINING; ILLES J, 2005, NEUROSCIENCE IMAGING, V1, P5; Illes J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00167; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Insel TR, 2010, JAMA-J AM MED ASSOC, V303, P1970, DOI 10.1001/jama.2010.555; *J HOPK U, 2010, SCH ED J HOPK U MIND; KHUSHF G, 2011, OXFORD HDB NEUROETHI; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Levy N, 2007, NEUROETHICS, P1, DOI 10.1017/CBO9780511811890; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Marcus S, 2002, NEUROETHICS MAPPING; MCCAIN KW, 1988, J AM SOC INFORM SCI, V39, P428, DOI 10.1002/(SICI)1097-4571(198811)39:6<428::AID-ASI7>3.0.CO;2-P; Meegan DV, 2008, AM J BIOETHICS, V8, P9, DOI 10.1080/15265160701842007; Miller F., 2010, ETHICS CONSENT THEOR; Mobbs D, 2007, PLOS BIOL, V5, P693, DOI 10.1371/journal.pbio.0050103; Moll J, 2008, ANN NY ACAD SCI, V1124, P161, DOI 10.1196/annals.1440.005; Oullier O., 2010, IMPROVING PUBLIC HLT; Pearson H, 2006, NATURE, V441, P918, DOI 10.1038/441918a; PROCTOR JM, 2006, J AM SOC INFORM SCI, V43, P1; Racine E, 2008, NEUROLOGY, V71, P1027, DOI 10.1212/01.wnl.0000320507.64683.ee; Racine E, 2007, J EMPIR RES HUM RES, V2, P1, DOI 10.1525/jer.2007.2.2.1; Racine E, 2006, SCI COMMUN, V28, P122, DOI 10.1177/1075547006291990; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014; Roskies A, 2002, NEURON, V35, P21, DOI 10.1016/S0896-6273(02)00763-8; *RSA, 2010, RSA SOC BRAIN ROYAL; Salvador R, 2009, BUS ETHICS Q, V19, P1, DOI 10.5840/beq20091911; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; SCRUTON, 2009, SUNDAY TIMES MAGAZIN; Seixas D, 2008, CLIN NEURORADIOL, V18, P79, DOI 10.1007/s00062-008-8009-5; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Wolfe P., 2010, BRAIN MATTERS TRANSL	63	20	20	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18537	10.1371/journal.pone.0018537	http://dx.doi.org/10.1371/journal.pone.0018537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526115	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800008
J	Zhang, SD				Zhang, Shu-Dong			Towards Accurate Estimation of the Proportion of True Null Hypotheses in Multiple Testing	PLOS ONE			English	Article							FALSE DISCOVERY RATES; MICROARRAY DATA; POSITIVES	Background: Biomedical researchers are now often faced with situations where it is necessary to test a large number of hypotheses simultaneously, eg, in comparative gene expression studies using high-throughput microarray technology. To properly control false positive errors the FDR (false discovery rate) approach has become widely used in multiple testing. The accurate estimation of FDR requires the proportion of true null hypotheses being accurately estimated. To date many methods for estimating this quantity have been proposed. Typically when a new method is introduced, some simulations are carried out to show the improved accuracy of the new method. However, the simulations are often very limited to covering only a few points in the parameter space. Results: Here I have carried out extensive in silico experiments to compare some commonly used methods for estimating the proportion of true null hypotheses. The coverage of these simulations is unprecedented thorough over the parameter space compared to typical simulation studies in the literature. Thus this work enables us to draw conclusions globally as to the performance of these different methods. It was found that a very simple method gives the most accurate estimation in a dominantly large area of the parameter space. Given its simplicity and its overall superior accuracy I recommend its use as the first choice for estimating the proportion of true null hypotheses in multiple testing.	Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland	Queens University Belfast	Zhang, SD (corresponding author), Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland.	s.zhang@qub.ac.uk	Zhang, Shu-Dong/G-1269-2010	Zhang, Shu-Dong/0000-0002-7721-0167	Department for Employment and Learning through its "Strengthening the all-Island Research Base'' initiative	Department for Employment and Learning through its "Strengthening the all-Island Research Base'' initiative	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base'' initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black MA, 2004, J R STAT SOC B, V66, P297, DOI 10.1111/j.1369-7412.2003.05527.x; Bukszar J, 2010, BEHAV GENET, V40, P394, DOI 10.1007/s10519-009-9321-9; Cheng C, 2004, STAT APPL GENET MOL, V3, P36; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Jiao S, 2010, J COMPUT BIOL, V17, P177, DOI 10.1089/cmb.2009.0060; Lu X, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-157; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Pounds S, 2004, BIOINFORMATICS, V20, P1737, DOI 10.1093/bioinformatics/bth160; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Zhang SD, 2005, BIOINFORMATICS, V21, P4378, DOI 10.1093/bioinformatics/bti717; Zhang SD, 2004, BIOINFORMATICS, V20, P2821, DOI 10.1093/bioinformatics/bth336	14	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18874	10.1371/journal.pone.0018874	http://dx.doi.org/10.1371/journal.pone.0018874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526119	gold, Green Published, Green Submitted			2022-12-27	WOS:000290015800018
J	Guessous, I; Bonny, O; Paccaud, F; Mooser, V; Waeber, G; Vollenweider, P; Bochud, M				Guessous, Idris; Bonny, Olivier; Paccaud, Fred; Mooser, Vincent; Waeber, Gerard; Vollenweider, Peter; Bochud, Murielle			Serum Calcium Levels Are Associated with Novel Cardiometabolic Risk Factors in the Population-Based CoLaus Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE MORTALITY; BONE-MINERAL DENSITY; MIDDLE-AGED MEN; METABOLIC SYNDROME; URIC-ACID; INSULIN-RESISTANCE; PRIMARY HYPERPARATHYROIDISM; OXIDATIVE STRESS; HEART-DISEASE	Background: Associations of serum calcium levels with the metabolic syndrome and other novel cardio-metabolic risk factors not classically included in the metabolic syndrome, such as those involved in oxidative stress, are largely unexplored. We analyzed the association of albumin-corrected serum calcium levels with conventional and non-conventional cardio-metabolic risk factors in a general adult population. Methodology/Principal Findings: The CoLaus study is a population-based study including Caucasians from Lausanne, Switzerland. The metabolic syndrome was defined using the Adult Treatment Panel III criteria. Non-conventional cardio-metabolic risk factors considered included: fat mass, leptin, LDL particle size, apolipoprotein B, fasting insulin, adiponectin, ultrasensitive CRP, serum uric acid, homocysteine, and gamma-glutamyltransferase. We used adjusted standardized multivariable regression to compare the association of each cardio-metabolic risk factor with albumin-corrected serum calcium. We assessed associations of albumin-corrected serum calcium with the cumulative number of non-conventional cardio-metabolic risk factors. We analyzed 4,231 subjects aged 35 to 75 years. Corrected serum calcium increased with both the number of the metabolic syndrome components and the number of non-conventional cardio-metabolic risk factors, independently of the metabolic syndrome and BMI. Among conventional and non-conventional cardio-metabolic risk factors, the strongest positive associations were found for factors related to oxidative stress (uric acid, homocysteine and gamma-glutamyltransferase). Adiponectin had the strongest negative association with corrected serum calcium. Conclusions/Significance: Serum calcium was associated with the metabolic syndrome and with non-conventional cardio-metabolic risk factors independently of the metabolic syndrome. Associations with uric acid, homocysteine and gammaglutamyltransferase were the strongest. These novel findings suggest that serum calcium levels may be associated with cardiovascular risk via oxidative stress.	[Guessous, Idris; Paccaud, Fred; Bochud, Murielle] Univ Lausanne, Inst Social & Prevent Med, Community Prevent Unit, Ctr Hosp Univ Vaudois, CH-1000 Lausanne, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland; [Bonny, Olivier] Univ Lausanne Hosp, Serv Nephrol & Hypertens, Lausanne, Switzerland; [Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; GlaxoSmithKline Res & Dev Ltd, Div Genet, King Of Prussia, PA USA; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Guessous, I (corresponding author), Univ Lausanne, Inst Social & Prevent Med, Community Prevent Unit, Ctr Hosp Univ Vaudois, CH-1000 Lausanne, Switzerland.	Idris.Guessous@chuv.ch	Colaus, PsyColaus/K-6607-2013; paccaud, fred/M-7516-2019; Bochud, Murielle/A-3981-2010	Bochud, Murielle/0000-0002-5727-0218; Waeber, Gerard/0000-0003-4193-788X; bonny, olivier/0000-0003-4123-4279	GlaxoSmithKline (GSK); Swiss National Science Foundation [33CSCO-122661, SNF 33CM30-124087/1]	GlaxoSmithKline (GSK)(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The CoLaus study was sponsored in part by GlaxoSmithKline (GSK), and currently by the Swiss National Science Foundation (33CSCO-122661). IG is supported by a Swiss National Science Foundation grant (SNF 33CM30-124087/1). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VM is a full-time employee of GSK and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Ahlstrom T, 2009, CLIN ENDOCRINOL, V71, P673, DOI 10.1111/j.1365-2265.2009.03558.x; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Andre P, 2006, DIABETOLOGIA, V49, P2599, DOI 10.1007/s00125-006-0418-x; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Bjorck J, 2006, METABOLISM, V55, P1007, DOI 10.1016/j.metabol.2006.03.010; Dawson J, 2007, CURR MED CHEM, V14, P1879; DEBACQUER D, 1994, ATHEROSCLEROSIS, V108, P193, DOI 10.1016/0021-9150(94)90114-7; DUH QY, 1986, WORLD J SURG, V10, P729, DOI 10.1007/BF01655570; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Giral P, 2008, ARTERIOSCL THROM VAS, V28, P587, DOI 10.1161/ATVBAHA.107.157891; Giral P, 2010, ATHEROSCLEROSIS, V210, P607, DOI 10.1016/j.atherosclerosis.2009.12.026; Godsland IF, 2001, J CLIN ENDOCR METAB, V86, P719, DOI 10.1210/jc.86.2.719; GOLDBERG DM, 1980, CRC CR REV CL LAB SC, V12, P1, DOI 10.3109/10408368009108725; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guven A, 2005, HEART VESSELS, V20, P290, DOI 10.1007/s00380-004-0822-4; Hagstrom E, 2007, DIABETOLOGIA, V50, P317, DOI 10.1007/s00125-006-0532-9; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huschenbett J, 1998, BBA-BIOMEMBRANES, V1374, P34, DOI 10.1016/S0005-2736(98)00121-7; Jebb SA, 2007, INT J OBESITY, V31, P756, DOI 10.1038/sj.ijo.0803475; Jorde R, 1999, HYPERTENSION, V34, P484, DOI 10.1161/01.HYP.34.3.484; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kajikawa Y, 2011, INT HEART J, V52, P17, DOI 10.1536/ihj.52.17; Kawamoto R, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-87; KIM ES, 2010, J DIABETES COMPLICAT; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lee CT, 2009, J RENAL NUTR, V19, P220, DOI 10.1053/j.jrn.2008.11.004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Leyva F, 1998, ARTERIOSCL THROM VAS, V18, P928, DOI 10.1161/01.ATV.18.6.928; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; LIND L, 1988, BMJ-BRIT MED J, V297, P960, DOI 10.1136/bmj.297.6654.960; Lippi G, 2008, CLIN CHIM ACTA, V392, P1, DOI 10.1016/j.cca.2008.02.024; LJUNGHALL S, 1982, UROL INT, V37, P73, DOI 10.1159/000280800; Newaz MA, 1996, CLIN EXP HYPERTENS, V18, P1035, DOI 10.3109/10641969609081033; Okamoto Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/313179; Onat A, 2007, INT J OBESITY, V31, P1119, DOI 10.1038/sj.ijo.0803552; Onat A, 2006, PREV MED, V43, P136, DOI 10.1016/j.ypmed.2006.04.005; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; VONBANK A, 2011, CLIN CHIM ACTA; WANNAMETHEE G, 1995, AM J EPIDEMIOL, V142, P699, DOI 10.1093/oxfordjournals.aje.a117699; Wareham NJ, 1997, METABOLISM, V46, P1171, DOI 10.1016/S0026-0495(97)90212-2; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yilmaz N, 2009, AGING CLIN EXP RES, V21, P353; Zaidi A, 1999, FREE RADICAL BIO MED, V27, P810, DOI 10.1016/S0891-5849(99)00128-8; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18865	10.1371/journal.pone.0018865	http://dx.doi.org/10.1371/journal.pone.0018865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533040	Green Published, gold			2022-12-27	WOS:000290014500015
J	Ayala, VI; Teijaro, JR; Farber, DL; Dorsey, SG; Carbonetti, NH				Ayala, Victor I.; Teijaro, John R.; Farber, Donna L.; Dorsey, Susan G.; Carbonetti, Nicholas H.			Bordetella pertussis Infection Exacerbates Influenza Virus Infection through Pertussis Toxin-Mediated Suppression of Innate Immunity	PLOS ONE			English	Article							RESPIRATORY-TRACT COLONIZATION; ADENYLATE-CYCLASE TOXIN; 1918 SPANISH INFLUENZA; A-VIRUS; ALVEOLAR MACROPHAGES; LETHAL SYNERGISM; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL RECRUITMENT; BIOLOGICAL-ACTIVITIES; PULMONARY INFECTION	Pertussis (whooping cough) is frequently complicated by concomitant infections with respiratory viruses. Here we report the effect of Bordetella pertussis infection on subsequent influenza virus (PR8) infection in mouse models and the role of pertussis toxin (PT) in this effect. BALB/c mice infected with a wild-type strain of B. pertussis (WT) and subsequently (up to 14 days later) infected with PR8 had significantly increased pulmonary viral titers, lung pathology and mortality compared to mice similarly infected with a PT-deficient mutant strain (Delta PT) and PR8. Substitution of WT infection by intranasal treatment with purified active PT was sufficient to replicate the exacerbating effects on PR8 infection in BALB/c and C57/BL6 mice, but the effects of PT were lost when toxin was administered 24 h after virus inoculation. PT had no effect on virus titers in primary cultures of murine tracheal epithelial cells (mTECs) in vitro, suggesting the toxin targets an early immune response to increase viral titers in the mouse model. However, type I interferon responses were not affected by PT. Whole genome microarray analysis of gene expression in lung tissue from PT-treated and control PR8-infected mice at 12 and 36 h post-virus inoculation revealed that PT treatment suppressed numerous genes associated with communication between innate and adaptive immune responses. In mice depleted of alveolar macrophages, increase of pulmonary viral titers by PT treatment was lost. PT also suppressed levels of IL-1 beta, IL-12, IFN-gamma, IL-6, KC, MCP-1 and TNF-alpha in the airways after PR8 infection. Furthermore PT treatment inhibited early recruitment of neutrophils and NK cells to the airways. Together these findings demonstrate that infection with B. pertussis through PT activity predisposes the host to exacerbated influenza infection by countering protective innate immune responses that control virus titers.	[Ayala, Victor I.; Carbonetti, Nicholas H.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Teijaro, John R.; Farber, Donna L.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Dorsey, Susan G.] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ayala, VI (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	ncarbone@umaryland.edu		Farber, Donna/0000-0001-8236-9183	NIH [R01 AI063080, U19 AI083022, 1 P30 NR011396, F31 AI077320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022, F31AI077320, R01AI063080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM081803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR011396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by Public Health Service grants R01 AI063080 to NHC, U19 AI083022 to DLF, 1 P30 NR011396 to SGD, and F31 AI077320 to VIA from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1989, J VIROL, V63, P2252, DOI 10.1128/JVI.63.5.2252-2259.1989; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Byrne P, 2004, EUR J IMMUNOL, V34, P2579, DOI 10.1002/eji.200425092; CANDEIAS J, 1971, J HYGIENE, P399; Carbonetti NH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-7; Carbonetti NH, 2004, INFECT IMMUN, V72, P3350, DOI 10.1128/IAI.72.6.3350-3358.2004; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cosnes-Lambe C, 2008, PRESSE MED, V37, P1371, DOI 10.1016/j.lpm.2008.05.008; Cosnes-Lambe C, 2008, EUR J PEDIATR, V167, P1017, DOI 10.1007/s00431-007-0633-6; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; FELS AOS, 1986, J APPL PHYSIOL, V60, P353, DOI 10.1152/jappl.1986.60.2.353; Ferson MJ, 2004, INFECT CONT HOSP EP, V25, P962, DOI 10.1086/502327; Fischer JE, 2000, J INFECT DIS, V182, P1029, DOI 10.1086/315806; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Grantham ML, 2009, J VIROL, V83, P8655, DOI 10.1128/JVI.01129-09; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Harju TH, 2006, THORAX, V61, P579, DOI 10.1136/thx.2005.056291; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Jackson LA, 2000, CLIN INFECT DIS, V31, P3, DOI 10.1086/313911; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; KASUGA T, 1954, Kitasato Arch Exp Med, V27, P57; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; KIMURA A, 1990, INFECT IMMUN, V58, P3337, DOI 10.1128/IAI.58.10.3337-3347.1990; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; KLENK HD, 1977, J GEN VIROL, V36, P151, DOI 10.1099/0022-1317-36-1-151; Korppi M, 2007, PEDIATR INFECT DIS J, V26, P316, DOI 10.1097/01.inf.0000258690.06349.91; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lee LN, 2010, AM J PATHOL, V176, P800, DOI 10.2353/ajpath.2010.090596; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li R, 2010, J VIROL, V84, P7105, DOI 10.1128/JVI.02542-09; Lieberman D, 1998, EUR J CLIN MICROBIOL, V17, P685, DOI 10.1007/s100960050161; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; LUNDEEN A, 2010, WHOOPING COUGH EPIDE; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Martino A, 2006, J CLIN IMMUNOL, V26, P153, DOI 10.1007/s10875-006-9009-3; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; MOSS J, 1983, J BIOL CHEM, V258, P1879; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; NENCIONI L, 1990, INFECT IMMUN, V58, P1308, DOI 10.1128/IAI.58.5.1308-1315.1990; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Newby CM, 2007, J VIROL, V81, P9469, DOI 10.1128/JVI.00989-07; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; PARFENTJEV IA, 1955, P SOC EXP BIOL MED, V90, P373, DOI 10.3181/00379727-90-22037; Prabhakar S, 2003, INFECT IMMUN, V71, P2487, DOI 10.1128/IAI.71.5.2487-2497.2003; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Ronni T, 1997, J IMMUNOL, V158, P2363; Sawal M, 2009, PEDIATR PULM, V44, P970, DOI 10.1002/ppul.21082; SCHEIBLAUER H, 1992, J INFECT DIS, V166, P783, DOI 10.1093/infdis/166.4.783; SCHULMAN JL, 1963, J EXP MED, V118, P267, DOI 10.1084/jem.118.2.267; Seki M, 2004, CLIN EXP IMMUNOL, V137, P35, DOI 10.1111/j.1365-2249.2004.02481.x; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shumilla JA, 2004, INFECT IMMUN, V72, P1450, DOI 10.1128/IAI.72.3.1450-1462.2004; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Taubenberger JK, 2000, VIROLOGY, V274, P241, DOI 10.1006/viro.2000.0495; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Teijaro JR, 2009, J IMMUNOL, V182, P6834, DOI 10.4049/jimmunol.0803860; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Veckman V, 2006, VIROLOGY, V345, P96, DOI 10.1016/j.virol.2005.09.043; Versteegh F G A, 2006, Minerva Pediatr, V58, P131; Wareing MD, 2007, J LEUKOCYTE BIOL, V81, P793, DOI 10.1189/jlb.0506299; Webster R, 2002, WHO MANUAL ANIMAL IN; WESLEY AG, 1983, S AFR MED J, V64, P577; Wijburg OLC, 1997, J VIROL, V71, P9450, DOI 10.1128/JVI.71.12.9450-9457.1997; Winters A L, 1985, Dev Biol Stand, V61, P233; WINTERS AL, 1985, INFECT IMMUN, V47, P587, DOI 10.1128/IAI.47.3.587-591.1985; Wong WSF, 1996, CAN J PHYSIOL PHARM, V74, P559, DOI 10.1139/cjpp-74-5-559; WYDE PR, 1982, INFECT IMMUN, V38, P1249, DOI 10.1128/IAI.38.3.1249-1255.1982; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Zavitz CCJ, 2010, J IMMUNOL, V184, P2001, DOI 10.4049/jimmunol.0903304; Zhang WJ, 1996, J IMMUNOL, V157, P5049; 2010, PERTUSSIS OUTBREAKS	94	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19016	10.1371/journal.pone.0019016	http://dx.doi.org/10.1371/journal.pone.0019016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533103	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400049
J	Ding, LN; Xu, HB; Yi, HY; Yang, LM; Kong, ZX; Zhang, LX; Xue, SL; Jia, HY; Ma, ZQ				Ding, Lina; Xu, Haibin; Yi, Hongying; Yang, Liming; Kong, Zhongxin; Zhang, Lixia; Xue, Shulin; Jia, Haiyan; Ma, Zhengqiang			Resistance to Hemi-Biotrophic F-graminearum Infection Is Associated with Coordinated and Ordered Expression of Diverse Defense Signaling Pathways	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; PHOSPHATIDIC-ACID ACCUMULATION; PATTERN-RECOGNITION RECEPTORS; SYSTEMIC ACQUIRED-RESISTANCE; JASMONATE-DEPENDENT DEFENSE; HYPERSENSITIVE CELL-DEATH; X WANGSHUIBAI POPULATION; SALICYLIC-ACID; WHEAT SPIKES; OXIDATIVE BURST	Fusarium species cause serious diseases in cereal staple food crops such as wheat and maize. Currently, the mechanisms underlying resistance to Fusarium-caused diseases are still largely unknown. In the present study, we employed a combined proteomic and transcriptomic approach to investigate wheat genes responding to F. graminearum infection that causes Fusarium head blight (FHB). We found a total of 163 genes and 37 proteins that were induced by infection. These genes and proteins were associated with signaling pathways mediated by salicylic acid (SA), jasmonic acid (JA), ethylene (ET), calcium ions, phosphatidic acid (PA), as well as with reactive oxygen species (ROS) production and scavenging, antimicrobial compound synthesis, detoxification, and cell wall fortification. We compared the time-course expression profiles between FHB-resistant Wangshuibai plants and susceptible Meh0106 mutant plants of a selected set of genes that are critical to the plants' resistance and defense reactions. A biphasic phenomenon was observed during the first 24 h after inoculation (hai) in the resistant plants. The SA and Ca2+ signaling pathways were activated within 6 hai followed by the JA mediated defense signaling activated around 12 hai. ET signaling was activated between these two phases. Genes for PA and ROS synthesis were induced during the SA and JA phases, respectively. The delayed activation of the SA defense pathway in the mutant was associated with its susceptibility. After F. graminearum infection, the endogenous contents of SA and JA in Wangshuibai and the mutant changed in a manner similar to the investigated genes corresponding to the individual pathways. A few genes for resistance-related cell modification and phytoalexin production were also identified. This study provided important clues for designing strategies to curb diseases caused by Fusarium.	[Ding, Lina; Xu, Haibin; Yi, Hongying; Yang, Liming; Kong, Zhongxin; Zhang, Lixia; Xue, Shulin; Jia, Haiyan; Ma, Zhengqiang] Nanjing Agr Univ, Appl Plant Genom Lab, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Ding, Lina; Xu, Haibin; Yi, Hongying; Yang, Liming; Kong, Zhongxin; Zhang, Lixia; Xue, Shulin; Jia, Haiyan; Ma, Zhengqiang] Nanjing Agr Univ, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Yang, Liming] Huaiyin Normal Univ, Huaian, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Huaiyin Normal University	Ma, ZQ (corresponding author), Nanjing Agr Univ, Appl Plant Genom Lab, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.; Ma, ZQ (corresponding author), Nanjing Agr Univ, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China.	zqm2@njau.edu.cn	Ma, Zhengqiang/AAQ-9160-2021; Ma, Zhengqiang/AAI-9876-2020	Ma, Zhengqiang/0000-0003-4950-5387; 	'863' program [2006AA10A104]; '973' program [2004CB117205]; NSFC [31030054, 30430440, 30025030, 30721140555]; MOE	'863' program(National High Technology Research and Development Program of China); '973' program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR))	This study was partially supported by '863' program (2006AA10A104), '973' program (2004CB117205), NSFC programs (31030054, 30430440, 30025030, 30721140555), and '111' project of MOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABELES FB, 1971, PLANT PHYSIOL, V47, P129, DOI 10.1104/pp.47.1.129; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Bernardo A, 2007, FUNCT INTEGR GENOMIC, V7, P69, DOI 10.1007/s10142-006-0028-1; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Bogacki P, 2008, MOL PLANT PATHOL, V9, P645, DOI 10.1111/J.1364-3703.2008.00485.X; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chen J, 2007, PROTOPLASMA, V230, P13, DOI 10.1007/s00709-006-0195-x; Chen X, 2009, NEW PHYTOL, V182, P975, DOI 10.1111/j.1469-8137.2009.02821.x; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cuzick A, 2008, MOL PLANT PATHOL, V9, P697, DOI [10.1111/j.1364-3703.2008.00488.x, 10.1111/J.1364-3703.2008.00488.X]; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Fung F, 2004, J TOXICOL-CLIN TOXIC, V42, P217, DOI 10.1081/CLT-120030947; Geddes J, 2008, PROTEOMICS, V8, P545, DOI 10.1002/pmic.200700115; Geraats BPJ, 2002, MOL PLANT MICROBE IN, V15, P1078, DOI 10.1094/MPMI.2002.15.10.1078; Golkari S, 2007, PLANT BIOTECHNOL J, V5, P38, DOI 10.1111/j.1467-7652.2006.00213.x; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; He CY, 2001, EUR J PLANT PATHOL, V107, P473, DOI 10.1023/A:1011218304331; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jarosch B, 2003, MOL PLANT MICROBE IN, V16, P107, DOI 10.1094/MPMI.2003.16.2.107; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kang Z, 2000, PHYSIOL MOL PLANT P, V57, P255, DOI 10.1006/pmpp.2000.0305; Kang Z, 2003, J PHYTOPATHOL, V151, P120, DOI 10.1046/j.1439-0434.2003.00693.x; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kong L, 2007, GENOME, V50, P1038, DOI 10.1139/G07-085; Krinke O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/pp.108.133595; Kruger WM, 2002, MOL PLANT MICROBE IN, V15, P445, DOI 10.1094/MPMI.2002.15.5.445; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Laxalt AM, 2007, J BIOL CHEM, V282, P21160, DOI 10.1074/jbc.M701212200; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; LEE HI, 1995, P NATL ACAD SCI USA, V92, P4076, DOI 10.1073/pnas.92.10.4076; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Lherminier J, 2009, MOL PLANT MICROBE IN, V22, P868, DOI 10.1094/MPMI-22-7-0868; Li GL, 2008, CROP SCI, V48, P1888, DOI 10.2135/cropsci2008.02.0097; Li WL, 2001, THEOR APPL GENET, V102, P353, DOI 10.1007/s001220051653; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; LI Y, 2011, PHYTOCHEM A IN PRESS; Lin F, 2006, THEOR APPL GENET, V112, P528, DOI 10.1007/s00122-005-0156-3; Lin F, 2004, THEOR APPL GENET, V109, P1504, DOI 10.1007/s00122-004-1772-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu ZX, 2005, PHYSIOL MOL PLANT P, V67, P138, DOI 10.1016/j.pmpp.2005.12.001; Makandar R, 2006, MOL PLANT MICROBE IN, V19, P123, DOI 10.1094/MPMI-19-0123; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; MARTIN JT, 1964, ANNU REV PHYTOPATHOL, V2, P81100; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nganje W. E., 2002, 2002 NAT FUS HEAD BL, P275; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; OLSON PD, 1993, PLANT J, V4, P887, DOI 10.1046/j.1365-313X.1993.04050887.x; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHI JR, 1999, PLANT PROTECTION, V2, P17; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Steiner B, 2009, THEOR APPL GENET, V118, P753, DOI 10.1007/s00122-008-0935-8; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; WOLPERT TJ, 1994, PLANT CELL, V6, P1145, DOI 10.1105/tpc.6.8.1145; Xu HB, 2007, PROTEOMICS, V7, P177, DOI 10.1002/pmic.200600508; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yoda H, 2006, PLANT PHYSIOL, V142, P193, DOI 10.1104/pp.106.080515; Yu ZL, 2008, J INTEGR PLANT BIOL, V50, P157, DOI 10.1111/j.1744-7909.2007.00609.x; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041; Zuppini A, 2004, J CELL SCI, V117, P2591, DOI 10.1242/jcs.01126	107	155	170	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19008	10.1371/journal.pone.0019008	http://dx.doi.org/10.1371/journal.pone.0019008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533105	Green Submitted, Green Published, gold			2022-12-27	WOS:000289719400048
J	McGehee, AM; Strijbis, K; Guillen, E; Eng, T; Kirak, O; Ploegh, HL				McGehee, Annette M.; Strijbis, Karin; Guillen, Eduardo; Eng, Thomas; Kirak, Oktay; Ploegh, Hidde L.			Ubiquitin-Dependent Control of Class II MHC Localization Is Dispensable for Antigen Presentation and Antibody Production	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSGENIC MICE; MEMBRANE; EXPRESSION; MATURATION; TRANSPORT; SELECTION; SURFACE; GENES	Controlled localization of class II MHC molecules is essential for proper class II MHC-restricted antigen presentation and the subsequent initiation of an adaptive immune response. Ubiquitination of class II MHC molecules on cytosolic lysine (K225) of the beta-chain has been shown to affect localization of the complex. We generated mice in which the endogenous beta-chain locus is replaced with a GFP tagged mutant version that lacks the cytosolic lysine residue (I-A-beta-K225R-EGFP). These mice have elevated levels of class II MHC as compared to I-A-beta-EGFP mice, and immature bone marrow-derived dendritic cells show redistribution of class II MHC to the cell surface. Nonetheless, in these same cells efficiency of antigen presentation is unaffected in I-A-beta-K225R-EGFP mice, as assayed for presentation of ovalbumin to appropriately specific T cells. The I-A-beta-K225R-EGFP animals have normal CD4 T cell populations and are capable of generating antigen-specific antibody in response to model antigens and viral infection. We therefore conclude that in our experimental system modulation of trafficking by ubiquitination of residue K225 of the b-chain is not essential for the function of class II MHC products in antigen presentation or antibody production.	[McGehee, Annette M.; Strijbis, Karin; Guillen, Eduardo; Eng, Thomas; Kirak, Oktay; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	McGehee, AM (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	ploegh@wi.mit.edu	Kirak, Oktay/H-6347-2013; Eng, Thomas/AAV-5157-2020	Kirak, Oktay/0000-0002-6524-4685; Eng, Thomas/0000-0002-4974-3863; McGehee, Annette/0000-0002-8175-3404; Strijbis, Karin/0000-0001-9167-7137	National Science Foundation (NSF); Netherlands Science Organization NOW	National Science Foundation (NSF)(National Science Foundation (NSF)); Netherlands Science Organization NOW	M. M. was supported by a National Science Foundation (NSF) Graduate Research Fellowship. K. S. was supported by a Rubicon Fellowship from the Netherlands Science Organization NOW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Rehm A, 2001, EMBO J, V20, P1573, DOI 10.1093/emboj/20.7.1573; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Siemasko K, 2001, CURR OPIN IMMUNOL, V13, P32, DOI 10.1016/S0952-7915(00)00178-3; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	20	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18817	10.1371/journal.pone.0018817	http://dx.doi.org/10.1371/journal.pone.0018817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533087	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400027
J	Calderon-Cortes, N; Quesada, M; Escalera-Vazquez, LH				Calderon-Cortes, Nancy; Quesada, Mauricio; Escalera-Vazquez, Luis H.			Insects as Stem Engineers: Interactions Mediated by the Twig-Girdler Oncideres albomarginata chamela Enhance Arthropod Diversity	PLOS ONE			English	Article							TROPICAL DECIDUOUS FOREST; WOOD-BORING INSECTS; ECOSYSTEM ENGINEERS; HOST-PLANT; BORER; CERAMBYCIDAE; BIODIVERSITY; COLEOPTERA; HERBIVORY; MUTUALISM	Background: Ecosystem engineering may influence community structure and biodiversity by controlling the availability of resources and/or habitats used by other organisms. Insect herbivores may act as ecosystem engineers but there is still poor understanding of the role of these insects structuring arthropod communities. Methodology/Principal Findings: We evaluated the effect of ecosystem engineering by the stem-borer Oncideres albomarginata chamela on the arthropod community of a tropical dry forest for three consecutive years. The results showed that ecosystem engineering by O. albomarginata chamela had strong positive effects on the colonization, abundance, species richness and composition of the associated arthropod community, and it occurred mainly through the creation of a habitat with high availability of oviposition sites for secondary colonizers. These effects cascade upward to higher trophic levels. Overall, ecosystem engineering by O. albomarginata chamela was responsible for nearly 95% of the abundance of secondary colonizers and 82% of the species richness. Conclusions/Significance: Our results suggest that ecosystem engineering by O. albomarginata chamela is a keystone process structuring an arthropod community composed by xylovores, predators and parasitoids. This study is the first to empirically demonstrate the effect of the ecosystem engineering by stem-boring insects on important attributes of arthropod communities. The results of this study have important implications for conservation.	[Calderon-Cortes, Nancy; Quesada, Mauricio] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Escalera-Vazquez, Luis H.] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Calderon-Cortes, N (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	ncalderon@oikos.unam.mx		Quesada, Mauricio/0000-0002-7776-9286	Inter-American Institute for Global Change Research (IAI) by the US National Science Foundation [021, GEO-0452325]; National Council of Science and Technology (CONACyT), Mexico [CONACyT 31826-N, U50863Q, SEMARNAT-CONACyT 2002-C01-0597, 2002-C01-0544]; Direccion General de Asuntos del Personal Academico at the Universidad Nacional Autonoma de Mexico (UNAM) [IN221305, IN224108]; CONACyT [164921]; UNAM; Direccion General de Estudios en Posgrado (DGEP-UNAM)	Inter-American Institute for Global Change Research (IAI) by the US National Science Foundation; National Council of Science and Technology (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico at the Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico); Direccion General de Estudios en Posgrado (DGEP-UNAM)(Universidad Nacional Autonoma de Mexico)	This study was supported by Inter-American Institute for Global Change Research (IAI) CRN II # 021 by the US National Science Foundation (grant GEO-0452325), and by grants from the National Council of Science and Technology (CONACyT), Mexico (CONACyT 31826-N, U50863Q; SEMARNAT-CONACyT 2002-C01-0597 and 2002-C01-0544, and CONACyT sabbatical fellowship to MQ) and the Direccion General de Asuntos del Personal Academico at the Universidad Nacional Autonoma de Mexico (UNAM) (grants # IN221305 and IN224108). CONACyT (scholarship # 164921), the Graduate Program in Biological Sciences, UNAM, and the Direccion General de Estudios en Posgrado (DGEP-UNAM) provided financial support for graduate studies to NCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Amman GD., 1977, ROLE ARTHROPODS FORE, P3; [Anonymous], 2006, SAS MIXED MODELS; Arnett Jr RH, 1963, BEETLES US MANUAL ID; AUKEMA BH, 2002, POPUL ECOL, P483; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Binda F., 1991, Boletin de Entomologia Venezolana, V6, P83; BULLOCK SH, 1992, BIOTROPICA, V24, P140, DOI 10.2307/2388667; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; BULLOCK SH, 1988, FOLIA ENTOMOLOGICA M, V77, P5; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Chemsak John A., 1993, Folia Entomologica Mexicana, V0, P55; Daleo P, 2007, ECOL LETT, V10, P902, DOI 10.1111/j.1461-0248.2007.01082.x; Damman Hans, 1993, P132; DiIorio OR, 1996, REV BIOL TROP, V44, P551; Duffy E.A.J., 1960, MONOGRAPH IMMATURE S; Duval BD, 2008, ECOL ENTOMOL, V33, P161, DOI 10.1111/j.1365-2311.2007.00928.x; Equihua M. A., 1986, FL ENTOMOL, V69, P619; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Feller IC, 1997, BIOTROPICA, V29, P440, DOI 10.1111/j.1744-7429.1997.tb00038.x; Feller IC, 1999, BIOTROPICA, V31, P607, DOI 10.1111/j.1744-7429.1999.tb00408.x; Feller IC, 2002, OIKOS, V97, P167, DOI 10.1034/j.1600-0706.2002.970202.x; FORCELLA F, 1982, NATURWISSENSCHAFTEN, V69, P398, DOI 10.1007/BF00396699; GERBERG EUGENE J., 1957, U S DEPT AGRIC TECH BULL, V1157, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Hairston N. G., 1989, ECOLOGICAL EXPT PURP; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Helbig J, 1996, J STORED PROD RES, V32, P91, DOI 10.1016/0022-474X(95)00030-B; HOVORE FT, 1982, SOUTHWEST NAT, V27, P23, DOI 10.2307/3671403; Johnson SN, 2002, FUNCT ECOL, V16, P575, DOI 10.1046/j.1365-2435.2002.00654.x; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kagata H, 2004, ANN ENTOMOL SOC AM, V97, P923, DOI 10.1603/0013-8746(2004)097[0923:LMAAPE]2.0.CO;2; Kenis M, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P475; Lieutier F., 2004, BARK WOOD BORING INS, P1; Lill JT, 2003, ECOLOGY, V84, P682, DOI 10.1890/0012-9658(2003)084[0682:EEBCII]2.0.CO;2; Maass JM, 2002, J TROP ECOL, V18, P821, DOI 10.1017/S0266467402002535; Marquis Robert J., 2007, P246, DOI 10.1017/CBO9780511542701.012; Martinez AJ, 2009, POPUL ECOL, V51, P533, DOI 10.1007/s10144-009-0149-1; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.1890/0012-9658(1998)079[0192:IIMBCP]2.0.CO;2; Martinsen GD, 2000, OECOLOGIA, V123, P82, DOI 10.1007/s004420050992; Morin P., 1999, COMMUNITY ECOL; Noguera Felipe A., 1994, Folia Entomologica Mexicana, V88, P9; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; POLK KL, 1973, ANN ENTOMOL SOC AM, V66, P411, DOI 10.1093/aesa/66.2.411; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; RAMIREZMARTINEZ M, 1994, J APPL ENTOMOL, V118, P354, DOI 10.1111/j.1439-0418.1994.tb00811.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; *SAS I, 2010, SAS SOFTW VERS 9 2; SCHOWALTER TD, 1981, OIKOS, V37, P126, DOI 10.2307/3544083; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Tilman D., 1982, Monographs in Population Biology, pi; Uribe-Mu CA, 2006, OIKOS, V112, P691, DOI 10.1111/j.0030-1299.2006.13957.x; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Waltz AM, 1997, ECOLOGY, V78, P2133, DOI 10.1890/0012-9658(1997)078[2133:PDAACO]2.0.CO;2; Wright JP, 2004, ECOLOGY, V85, P2071, DOI 10.1890/02-8018	61	44	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19083	10.1371/journal.pone.0019083	http://dx.doi.org/10.1371/journal.pone.0019083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526161	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100048
J	Deribew, A; Negussu, N; Melaku, Z; Deribe, K				Deribew, Amare; Negussu, Nebiyu; Melaku, Zenebe; Deribe, Kebede			Investigation Outcomes of Tuberculosis Suspects in the Health Centers of Addis Ababa, Ethiopia	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; RISK-FACTORS; PREVENTIVE THERAPY; SOUTH-AFRICA; TB SUSPECTS; HIV; PREVALENCE; INFECTION	Background: Little is known about the prevalence of tuberculosis (TB) and HIV among TB suspects in primary health care units in Ethiopia. Methods: In the period of February to March, 2009, a cross sectional survey was done in 27 health centers of Addis Ababa to assess the prevalence of TB and HIV among TB suspects who have >= 2 weeks symptoms of TB such as cough, fever and weight loss. Diagnosis of TB and HIV was based on the national guidelines. Information concerning socio-demographic variables and knowledge of the respondents about TB was collected using pretested questionnaire. Results: Of the 545 TB suspects, 506 (92.7%) of them participated in the study. The prevalence of both pulmonary and extra pulmonary TB was 46.0% (233/506). The smear positivity rate among pulmonary TB suspect was 21.3%. Of the TB suspects, 298 (58.9%) of them were tested for HIV and 27.2% (81/298) were HIV seropositive. Fifty percent of the HIV positive TB suspects had TB. TB suspects who had a contact history with a TB patient in the family were 9 times more likely to have TB than those who did not have a contact history, [OR = 9.1, (95%CI:4.0, 20.5)]. Individuals who had poor [OR = 5.2, (95% CI: 2.3, 11.2)] and fair knowledge [OR = 3.7, (95% CI: 1.3, 10.4)] about TB were more likely to have TB than individuals who had good knowledge. Conclusion: In conclusion, the prevalence of TB among TB suspects with duration of 2 or more weeks is high. Fifty percent of the HIV positive TB suspects had TB. Case finding among TB suspects with duration of 2 or more weeks should be intensified particularly among those who have a contact history with a TB patient.	[Deribew, Amare] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Negussu, Nebiyu] Somali Reg Hlth Bur, Jijiga, Ethiopia; [Melaku, Zenebe] Int Ctr AIDS Care & Treatment Program ICAP, Addis Ababa, Ethiopia; [Deribe, Kebede] Jimma Univ, Dept Gen Publ Hlth, Jimma, Ethiopia	Jimma University; Jimma University	Deribew, A (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.	amare_deribew@yahoo.com	Deribe, Kebede/K-7055-2019; Deribe, Kebede/I-5422-2019	Deribe, Kebede/0000-0002-8526-6996; Deribew, Amare/0000-0003-2031-6080	Jimma University	Jimma University	The study was funded by Jimma University. The funder had no role in the study design, data collection, and analysis, decision to publish or preparation of the manuscript.	[Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Ariyothai Niorn, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P219; *AUTH ETH, 2000, SPUT EX TUB DIR MICR; Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Banda HT, 1998, T ROY SOC TROP MED H, V92, P161, DOI 10.1016/S0035-9203(98)90727-1; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; *CENTR STAT AUTH E, 2008, SUMM STAT REP 2007 P; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; *FED MIN HLTH ETH, 2005, BEH SURV SURV 2005; Federal Ministry of Health Ethiopia, 2007, TB LEPR TB HIV PREV; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Romero-Sandoval NC, 2007, INT J TUBERC LUNG D, V11, P550; Sanchez-Perez HJ, 2001, INT J EPIDEMIOL, V30, P386, DOI 10.1093/ije/30.2.386; SHABBIR I, 1995, J TROP MED HYG, V98, P338; Shah NS, 2008, INT J TUBERC LUNG D, V12, P404; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Wesen Amenu, 2009, Ethiop Med J, V47, P109; *WHO, 2004, INT POL COLL TB HIV; WHO, 2009, WHOHTMTB2009411; *WHO, 2004, WHOHTMTB200433; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399	37	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18614	10.1371/journal.pone.0018614	http://dx.doi.org/10.1371/journal.pone.0018614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526179	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100013
J	Eller, MA; Blom, KG; Gonzalez, VD; Eller, LA; Naluyima, P; Laeyendecker, O; Quinn, TC; Kiwanuka, N; Serwadda, D; Sewankambo, NK; Tasseneetrithep, B; Wawer, MJ; Gray, RH; Marovich, MA; Michael, NL; de Souza, MS; Wabwire-Mangen, F; Robb, ML; Currier, JR; Sandberg, JK				Eller, Michael A.; Blom, Kim G.; Gonzalez, Veronica D.; Eller, Leigh Anne; Naluyima, Prossy; Laeyendecker, Oliver; Quinn, Thomas C.; Kiwanuka, Noah; Serwadda, David; Sewankambo, Nelson K.; Tasseneetrithep, Boonrat; Wawer, Maria J.; Gray, Ronald H.; Marovich, Mary A.; Michael, Nelson L.; de Souza, Mark S.; Wabwire-Mangen, Fred; Robb, Merlin L.; Currier, Jeffrey R.; Sandberg, Johan K.			Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; AFRICAN-GREEN MONKEYS; MICROBIAL TRANSLOCATION; VIRAL LOAD; DISEASE PROGRESSION; PERIPHERAL-BLOOD; LYMPHOCYTE-ACTIVATION; VIRUS-INFECTIONS; PD-1 EXPRESSION; RAKAI DISTRICT	HIV-1 disease progression is associated with persistent immune activation. However, the nature of this association is incompletely understood. Here, we investigated immune activation in the CD4 T cell compartment of chronically HIV-1 infected individuals from Rakai, Uganda. Levels of CD4 T cell activation, assessed as co-expression of PD-1, CD38 and HLA-DR, correlated directly to viral load and inversely to CD4 count. Deeper characterization of these cells indicated an effector memory phenotype with relatively frequent expression of Ki67 despite their PD-1 expression, and levels of these cells were inversely associated with FoxP3+ regulatory T cells. We therefore use the term deregulated effector memory (DEM) cells to describe them. CD4 T cells with a DEM phenotype could be generated by antigen stimulation of recall responses in vitro. Responses against HIV-1 and CMV antigens were enriched among the DEM CD4 T cells in patients, and the diverse V beta repertoire of DEM CD4 T cells suggested they include diverse antigen-specificities. Furthermore, the levels of DEM CD4 T cells correlated directly to soluble CD14 (sCD14) and IL-6, markers of innate immune activation, in plasma. The size of the activated DEM CD4 T cell subset was predictive of the rate of disease progression, whereas IL-6 was only weakly predictive and sCD14 was not predictive. Taken together, these results are consistent with a model where systemic innate immune activation and chronic antigen stimulation of adaptive T cell responses both play important roles in driving pathological CD4 T cell immune activation in HIV-1 disease.	[Eller, Michael A.; Eller, Leigh Anne; Naluyima, Prossy; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Eller, Michael A.; Eller, Leigh Anne; Tasseneetrithep, Boonrat; Marovich, Mary A.; Michael, Nelson L.; de Souza, Mark S.; Robb, Merlin L.; Currier, Jeffrey R.] US Mil HIV Res Program, Rockville, MD USA; [Eller, Michael A.; Blom, Kim G.; Gonzalez, Veronica D.; Sandberg, Johan K.] Karolinska Inst, Ctr Infect Med, Dept Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Quinn, Thomas C.] Johns Hopkins Sch Med, Baltimore, MD USA; [Kiwanuka, Noah; Serwadda, David; Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Kiwanuka, Noah; Serwadda, David; Sewankambo, Nelson K.; Wawer, Maria J.; Gray, Ronald H.] Uganda Virus Res Inst, Rakai Hlth Sci Program, Entebbe, Uganda; [Sewankambo, Nelson K.] Makerere Univ, Fac Med, Coll Hlth Sci, Kampala, Uganda; [Tasseneetrithep, Boonrat] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Wawer, Maria J.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Gray, Ronald H.] Johns Hopkins Ctr Global Hlth, Baltimore, MD USA; [de Souza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand	Makerere University; Walter Reed Army Institute of Research (WRAIR); Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine; Makerere University; Rakai Health Sciences Program; Uganda Virus Research Institute; Makerere University; Mahidol University; Columbia University; Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Eller, MA (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	johan.sandberg@ki.se	Laeyendecker, Oliver B/B-9331-2009; Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Sewankambo, Nelson/0000-0001-9362-053X; Laeyendecker, Oliver/0000-0002-6429-4760; Sandberg, Johan/0000-0002-6275-0750; Blom, Kim/0000-0002-5286-3735; Naluyima, Prossy/0000-0001-6911-2199	National Institute of Allergy and Infectious Diseases (NIAID) [R01 A134826, R01 A134265]; National Institute of Child and Health Development [5P30HD06826]; Fogarty Foundation [5D43TW00010]; NIH [R01 A134826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child and Health Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary support was provided by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U. S. Department of Defense. Data collection was supported, in part, by grants R01 A134826 and R01 A134265 from the National Institute of Allergy and Infectious Diseases (NIAID); grant 5P30HD06826 from the National Institute of Child and Health Development; grant 5D43TW00010 from the Fogarty Foundation and NIH grant R01 A134826. Additional support was provided by the Swedish Research Council, the Swedish Cancer Foundation, the Stockholm County Council, Karolinska Institutet, and the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Barry SM, 2003, JAIDS-J ACQ IMM DEF, V34, P351, DOI 10.1097/00126334-200312010-00001; BIRX DL, 1990, BLOOD, V76, P2303; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; BREEN EC, 1990, J IMMUNOL, V144, P480; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Leinert C, 2010, J MED PRIMATOL, V39, P243, DOI 10.1111/j.1600-0684.2010.00429.x; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Milush JM, 2007, J IMMUNOL, V179, P3047, DOI 10.4049/jimmunol.179.5.3047; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Olemukan RE, 2010, CLIN VACCINE IMMUNOL, V17, P910, DOI 10.1128/CVI.00492-09; Onlamoon N, 2008, IMMUNOLOGY, V124, P277, DOI 10.1111/j.1365-2567.2007.02766.x; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662	49	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18779	10.1371/journal.pone.0018779	http://dx.doi.org/10.1371/journal.pone.0018779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526194	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100021
J	Mai, XQ; Tardif, T; Doan, SN; Liu, C; Gehring, WJ; Luo, YJ				Mai, Xiaoqin; Tardif, Twila; Doan, Stacey N.; Liu, Chao; Gehring, William J.; Luo, Yue-Jia			Brain Activity Elicited by Positive and Negative Feedback in Preschool-Aged Children	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; REWARD MAGNITUDE; ERROR; PICTURES; STIMULI; BAD; IMMATURITY; MATURATION; MOTIVATION; RESPONSES	To investigate the processing of positive vs. negative feedback in children aged 4-5 years, we devised a prize-guessing game that is analogous to gambling tasks used to measure feedback-related brain responses in adult studies. Unlike adult studies, the feedback-related negativity (FRN) elicited by positive feedback was as large as that elicited by negative feedback, suggesting that the neural system underlying the FRN may not process feedback valence in early childhood. In addition, positive feedback, compared with negative feedback, evoked a larger P1 over the occipital scalp area and a larger positive slow wave (PSW) over the right central-parietal scalp area. We believe that the PSW is related to emotional arousal and the intensive focus on positive feedback that is present in the preschool and early school years has adaptive significance for both cognitive and emotional development during this period.	[Mai, Xiaoqin; Tardif, Twila] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Tardif, Twila; Gehring, William J.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Doan, Stacey N.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Liu, Chao; Luo, Yue-Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston University; Beijing Normal University	Mai, XQ (corresponding author), Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA.	twila@umich.edu; luoyj@bnu.edu.cn	Liu, Chao/E-9068-2017	Liu, Chao/0000-0003-1149-2314; Doan, Stacey/0000-0003-3661-2175; Tardif, Twila Z/0000-0001-8739-9090	NSF on Emotion Regulation as a Complex System [SES-0527475]; Center for Human Growth and Development; NSFC [30930031]; Ministry of Sci Tech [2011CB711001]; National Key Technologies RD Program [2009BAI77B01]; NIH, USA [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	NSF on Emotion Regulation as a Complex System; Center for Human Growth and Development; NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Sci Tech; National Key Technologies RD Program(National Key Technology R&D Program); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by NSF grant SES-0527475 on Emotion Regulation as a Complex System, internal funding from the Center for Human Growth and Development to TT, and by NSFC (30930031), Ministry of Sci & Tech (973 Program, 2011CB711001), National Key Technologies R&D Program (2009BAI77B01) and Global Research Initiative Program, NIH, USA (1R01TW007897) to Y-JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2010, TOP COGN SCI, V2, P658, DOI 10.1111/j.1756-8765.2010.01085.x; Alorda C, 2007, NEUROPSYCHOLOGIA, V45, P3223, DOI 10.1016/j.neuropsychologia.2007.06.017; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bjorklund DF, 1997, PSYCHOL BULL, V122, P153, DOI 10.1037/0033-2909.122.2.153; BJORKLUND DF, 1992, AM PSYCHOL, V47, P46, DOI 10.1037/0003-066X.47.1.46; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COLE PM, 1986, CHILD DEV, V57, P1309, DOI 10.2307/1130411; Crone EA, 2004, DEVELOPMENTAL SCI, V7, P443, DOI 10.1111/j.1467-7687.2004.00365.x; Crone EA, 2008, COGN AFFECT BEHAV NE, V8, P165, DOI 10.3758/CABN.8.2.165; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Davies PL, 2004, ANN NY ACAD SCI, V1021, P324, DOI 10.1196/annals.1308.039; DeBoer T., 2005, EVENT RELATED POTENT, P263; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Eppinger B, 2009, PSYCHOPHYSIOLOGY, V46, P1043, DOI 10.1111/j.1469-8986.2009.00838.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Groen Y, 2008, CLIN NEUROPHYSIOL, V119, P2476, DOI 10.1016/j.clinph.2008.08.004; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2009, BIOL PSYCHOL, V80, P333, DOI 10.1016/j.biopsycho.2008.11.006; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; HARACKIEWICZ JM, 1986, J PERS SOC PSYCHOL, V51, P547; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI [10.1037/0894-4105.7.4.476, DOI 10.1037/0894-4105.7.4.476]; Hewig J, 2007, CEREB CORTEX, V17, P865, DOI 10.1093/cercor/bhk040; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hogan AM, 2005, DEVELOPMENTAL SCI, V8, P525, DOI 10.1111/j.1467-7687.2005.00444.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Lambe EK, 2000, J NEUROSCI, V20, P8780; Liu C, 2010, HUM BRAIN MAPP, V31, P1786, DOI 10.1002/hbm.20974; Liu YN, 2009, NEUROREPORT, V20, P632, DOI 10.1097/WNR.0b013e32832a3250; Luo Y.J., 2011, CULTURE NEURAL FRAME, P249, DOI [10.1007/978-3-642-15423-2_16, DOI 10.1007/978-3-642-15423-2_16]; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; ROSENBERG DR, 1995, J COMP NEUROL, V358, P383, DOI 10.1002/cne.903580306; SAARNI C, 1984, CHILD DEV, V55, P1504, DOI 10.2307/1130020; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; Van Strien JW, 2009, BRAIN RES, V1251, P223, DOI 10.1016/j.brainres.2008.11.027; Wiersema JR, 2007, NEUROPSYCHOLOGIA, V45, P1649, DOI 10.1016/j.neuropsychologia.2007.01.004; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	48	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18774	10.1371/journal.pone.0018774	http://dx.doi.org/10.1371/journal.pone.0018774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752EC	21526189	gold, Green Submitted, Green Published			2022-12-27	WOS:000289671100020
J	Feenders, G; Klaus, K; Bateson, M				Feenders, Gesa; Klaus, Kristel; Bateson, Melissa			Fear and Exploration in European Starlings (Sturnus vulgaris): A Comparison of Hand-Reared and Wild-Caught Birds	PLOS ONE			English	Article							WINGED AMAZON PARROTS; ENVIRONMENTAL ENRICHMENT; DOMESTIC-FOWL; OPEN-FIELD; MATERNAL SEPARATION; STRESS REACTIVITY; TONIC IMMOBILITY; BEHAVIOR; RATS; NEOPHOBIA	The revision of EU legislation will ban the use of wild-caught animals in scientific procedures. This change is partially predicated on the assumption that captive-rearing produces animals with reduced fearfulness. Previously, we have shown that hand-reared starlings (Sturnus vulgaris) indeed exhibit reduced fear of humans compared to wild-caught conspecifics. Here, we asked whether this reduction in fear in hand-reared birds is limited to fear of humans or extends more generally to fear of novel environments and novel objects. Comparing 6-8 month old birds hand-reared in the lab with age-matched birds caught from the wild as fledged juveniles a minimum of 1 month previously, we examined the birds' initial reactions in a novel environment (a small cage) and found that wild-caught starlings were faster to initiate movement compared to the hand-reared birds. We interpret this difference as evidence for greater escape motivation in the wild-caught birds. In contrast, we found no differences between hand-reared and wild-caught birds when tested in novel object tests assumed to measure neophobia and exploratory behaviour. Moreover, we found no correlations between individual bird's responses in the different tests, supporting the idea that these measure different traits (e. g. fear and exploration). In summary, our data show that developmental origin affects one measure of response to novelty in young starlings, indicative of a difference in either fear or coping style in a stressful situation. Our data contribute to a growing literature demonstrating effects of earlylife experience on later behaviour in a range of species. However, since we did not find consistent evidence for reduced fearfulness in hand-reared birds, we remain agnostic about the welfare benefits of hand-rearing as a method for sourcing wild birds for behavioural and physiological research.	[Feenders, Gesa; Klaus, Kristel; Bateson, Melissa] Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Feenders, G (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Melissa.Bateson@newcastle.ac.uk	Bateson, Melissa/B-1874-2008; Bateson, Melissa/AAE-7075-2022	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191	UK's Biotechnology and Biological Sciences Research Council [BB/05623/1]; BBSRC [BB/F015623/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015623/1] Funding Source: researchfish	UK's Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been funded by the UK's Biotechnology and Biological Sciences Research Council (grant BB/05623/1) (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aengus WL, 1999, ZOO BIOL, V18, P177; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Apfelbeck B, 2008, HORM BEHAV, V54, P435, DOI 10.1016/j.yhbeh.2008.04.003; Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; AULICH D, 1976, BEHAV PROCESS, V1, P153, DOI 10.1016/0376-6357(76)90035-8; BARNETT SA, 1978, BEHAV PROCESS, V3, P29, DOI 10.1016/0376-6357(78)90028-1; Bateson M, 2007, ANIM WELFARE, V16, P33; Bateson M., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P697, DOI 10.1002/9781444318777.ch45; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; BELZUNG C, 1994, PHYSIOL BEHAV, V56, P623, DOI 10.1016/0031-9384(94)90311-5; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; *COUNC EUR UN, 2010, DIR EUR PARL COUNC P; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017466; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Fox RA, 2004, APPL ANIM BEHAV SCI, V89, P117, DOI 10.1016/j.applanim.2004.05.002; Francis DD, 2002, J NEUROSCI, V22, P7840; Garamszegi LZ, 2009, ANIM BEHAV, V77, P803, DOI 10.1016/j.anbehav.2008.12.012; Greenberg R, 2001, CURR ORNITHOL, V16, P119; GREENBERG R, 1984, J COMP PSYCHOL, V98, P131, DOI 10.1037/0735-7036.98.2.131; GREENBERG R, 1983, AM NAT, V122, P444, DOI 10.1086/284148; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; HAWKINS P, 2003, FUTURE PRINCIPLES HO; Heiblum R, 1998, APPL ANIM BEHAV SCI, V60, P347, DOI 10.1016/S0168-1591(98)00157-9; Herborn KA, 2010, ANIM BEHAV, V79, P835, DOI 10.1016/j.anbehav.2009.12.026; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; JONES RB, 1986, BEHAV PROCESS, V13, P217, DOI 10.1016/0376-6357(86)90085-9; JONES RB, 1982, DEV PSYCHOBIOL, V15, P105, DOI 10.1002/dev.420150203; LESTER D, 1968, J GEN PSYCHOL, V79, P105, DOI 10.1080/00221309.1968.9710458; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Maddocks SA, 2002, J AVIAN BIOL, V33, P103, DOI 10.1034/j.1600-048X.2002.330117.x; Madruga C, 2006, BEHAV BRAIN RES, V166, P241, DOI 10.1016/j.bbr.2005.08.005; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Meehan CL, 2002, APPL ANIM BEHAV SCI, V79, P75, DOI 10.1016/S0168-1591(02)00118-1; Meerlo P, 1999, J NEUROENDOCRINOL, V11, P925; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Miller KA, 2006, ANIM BEHAV, V71, P1323, DOI 10.1016/j.anbehav.2005.08.018; MISSLIN R, 1986, BEHAV PROCESS, V12, P45, DOI 10.1016/0376-6357(86)90069-0; MURPHY LB, 1978, ANIM BEHAV, V26, P422, DOI 10.1016/0003-3472(78)90059-3; Newman JA, 1997, ECOLOGY, V78, P1312; OSBORNE GL, 1977, BEHAV BIOL, V19, P548, DOI 10.1016/S0091-6773(77)92068-5; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; RUSSELL PA, 1973, BRIT J PSYCHOL, V64, P417, DOI 10.1111/j.2044-8295.1973.tb01369.x; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Schmid R, 2006, APPL ANIM BEHAV SCI, V98, P293, DOI 10.1016/j.applanim.2005.09.002; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Vallee M, 1997, J NEUROSCI, V17, P2626; WELKER WI, 1957, PSYCHOL REP, V3, P95, DOI 10.2466/pr0.1957.3.g.95; Wemelsfelder F, 2000, ANIM BEHAV, V60, P385, DOI 10.1006/anbe.2000.1466; Whishaw IQ, 2006, BEHAV BRAIN RES, V171, P230, DOI 10.1016/j.bbr.2006.03.037; [No title captured]; [No title captured]	56	24	24	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e19074	10.1371/journal.pone.0019074	http://dx.doi.org/10.1371/journal.pone.0019074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526000	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600043
J	Matthaus, F; Mommer, MS; Curk, T; Dobnikar, J				Matthaeus, Franziska; Mommer, Mario S.; Curk, Tine; Dobnikar, Jure			On the Origin and Characteristics of Noise-Induced Levy Walks of E. Coli	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; ESCHERICHIA-COLI; BEHAVIORAL VARIABILITY; WANDERING ALBATROSSES; GENE-EXPRESSION; SCALING LAWS; CHEMOTAXIS; TRACKING; CELLS	Levy walks as a random search strategy have recently attracted a lot of attention, and have been described in many animal species. However, very little is known about one of the most important issues, namely how Levy walks are generated by biological organisms. We study a model of the chemotaxis signaling pathway of E. coli, and demonstrate that stochastic fluctuations and the specific design of the signaling pathway in concert enable the generation of Levy walks. We show that Levy walks result from the superposition of an ensemble of exponential distributions, which occurs due to the shifts in the internal enzyme concentrations following the stochastic fluctuations. With our approach we derive the power-law analytically from a model of the chemotaxis signaling pathway, and obtain a power-law exponent mu approximate to 2:2, which coincides with experimental results. This work provides a means to confirm Levy walks as natural phenomenon by providing understanding on the process through which they emerge. Furthermore, our results give novel insights into the design aspects of biological systems that are capable of translating additive noise on the microscopic scale into beneficial macroscopic behavior.	[Matthaeus, Franziska] Univ Heidelberg, Ctr Modeling & Simulat Biosci BIOMS, Heidelberg, Germany; [Mommer, Mario S.] Univ Heidelberg, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Curk, Tine] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Curk, Tine; Dobnikar, Jure] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Dobnikar, Jure] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Maribor; University of Cambridge; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Matthaus, F (corresponding author), Univ Heidelberg, Ctr Modeling & Simulat Biosci BIOMS, Heidelberg, Germany.	franziska.matthaeus@iwr.uni-heidelberg.de; jd489@cam.ac.uk	Dobnikar, Jure/C-8765-2011; Matthäus, Franziska/AAE-5523-2022	Dobnikar, Jure/0000-0002-1169-6619; Matthäus, Franziska/0000-0001-6042-1366	Center for Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg; German Ministry of Education and Research [03BOPAL1]; Slovenian Research Agency [P1-0055]; European Research Council [COLSTRUCTIION 227758]; 7th Framework Programme [ITN-COMPLOIDS 234810]	Center for Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Research Council(European Research Council (ERC)European Commission); 7th Framework Programme(European Commission)	This work was supported by the Center for Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg, the German Ministry of Education and Research (grant Nr. 03BOPAL1), the Slovenian Research Agency (P1-0055), the European Research Council (COLSTRUCTIION 227758), and the 7th Framework Programme (ITN-COMPLOIDS 234810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin A, 1998, GENETICS, V149, P1633; ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Beylkin G, 2005, APPL COMPUT HARMON A, V19, P17, DOI 10.1016/j.acha.2005.01.003; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Klafter J., 1990, LECT NOTES BIOMATHEM, VVolume 89; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Levin MD, 2003, FEBS LETT, V550, P135, DOI 10.1016/S0014-5793(03)00857-3; Matthaus F, 2009, BIOPHYS J, V97, P946, DOI 10.1016/j.bpj.2009.04.065; Mommer MS, 2009, SIAM J APPL MATH, V70, P112, DOI 10.1137/070681648; Park H, 2010, NATURE, V468, P819, DOI 10.1038/nature09551; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011906; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Wang JW, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-50; Wu MM, 2006, APPL ENVIRON MICROB, V72, P4987, DOI 10.1128/AEM.00158-06	28	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18623	10.1371/journal.pone.0018623	http://dx.doi.org/10.1371/journal.pone.0018623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494629	Green Submitted, Green Published, gold			2022-12-27	WOS:000289292800031
J	Cohen, D; Milman, D; Venturyera, V; Falissard, B				Cohen, David; Milman, Daniel; Venturyera, Valerie; Falissard, Bruno			Psychodynamic Experience Enhances Recognition of Hidden Childhood Trauma	PLOS ONE			English	Article							UNCONSCIOUS THOUGHT; UNWANTED MEMORIES; SYSTEMS; CHOICE	Background: Experimental psychology has only recently provided supporting evidence for Freud's and Janet's description of unconscious phenomena. Here, we aimed to assess whether specific abilities, such as personal psychodynamic experience, enhance the ability to recognize unconscious phenomena in peers - in other words, to better detect implicit knowledge related to individual self-experience. Methodology and Principal Findings: First, we collected 14 videos from seven healthy adults who had experienced a sibling's cancer during childhood and seven matched controls. Subjects and controls were asked to give a 5-minute spontaneous free-associating speech following specific instructions created in order to activate a buffer zone between fantasy and reality. Then, 18 raters (three psychoanalysts, six medical students, three oncologists, three cognitive behavioral therapists and three individuals with the same experience of trauma) were randomly shown the videos and asked to blindly classify them according to whether the speaker had a sibling with cancer using a Likert scale. Using a permutation test, we found a significant association between group and recognition score (ANOVA: p = .0006). Psychoanalysts were able to recognize, above chance levels, healthy adults who had experienced sibling cancer during childhood without explicit knowledge of this history (Power = 88%; p = .002). In contrast, medical students, oncologists, cognitive behavioral therapists and individuals who had the same history of a sibling's cancer were unable to do so. Conclusion: This experiment supports the view that implicit recognition of a subject's history depends on the rater's specific abilities. In the case of subjects who did have a sibling with cancer during childhood, psychoanalysts appear better able to recognize this particular history.	[Cohen, David; Milman, Daniel; Venturyera, Valerie] Hop La Pitie Salpetriere, Serv Psychiat Enfant & Adolescent, Paris, France; [Cohen, David] Univ Paris 06, Ctr Natl Rech Sci, Unite Mixte Rech 7222, Paris, France; [Falissard, Bruno] Univ Paris 05, Inst Natl Sante & Rech Med, Unite 699, Hop Paul Brousse, Paris, France; [Falissard, Bruno] Univ Paris 06, Inst Natl Sante & Rech Med, Unite 699, Hop Paul Brousse, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Cohen, D (corresponding author), Hop La Pitie Salpetriere, Serv Psychiat Enfant & Adolescent, Paris, France.	david.cohen@psl.aphp.fr			Centre d'Activites et de Recherches en Psychiatrie Infanto-Juvenile (CARPIJ)	Centre d'Activites et de Recherches en Psychiatrie Infanto-Juvenile (CARPIJ)	The study was funded by the Centre d'Activites et de Recherches en Psychiatrie Infanto-Juvenile (CARPIJ). The funders had no role in the study design, data collection and analysis, preparation of the MS and decision to publish.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; ANDERSON MC, 2001, J AGGRESS MALTREAT T, V4, P185; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BERLIN HA, 2009, SCI AM MIND, V7, P16; Carrion VG, 2002, J AM ACAD CHILD PSY, V41, P166, DOI 10.1097/00004583-200202000-00010; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Descartes Rene, 1996, LES PASSIONS DE LAME; Dijksterhuis A, 2006, CONSCIOUS COGN, V15, P135, DOI 10.1016/j.concog.2005.04.007; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Dijksterhuis A, 2006, PERSPECT PSYCHOL SCI, V1, P95, DOI 10.1111/j.1745-6916.2006.00007.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellenberger H., 1970, DISCOV UNCONSCIOUS; Erdelyi MH, 2006, BEHAV BRAIN SCI, V29, P499, DOI 10.1017/S0140525X06009113; FALISSARD B, 2007, CERVEAU PSYCHANALYSE; FALISSARD B, TESTING RANDOM UNPUB; Fisher RA, 1935, DESIGN EXPT; FREUD S, 1966, STANDARD EDITION COM, V15; Freud S, 1915, STANDARD EDITION COM, V14, P143; Gabbard G. O., 1994, PSYCHODYNAMIC PSYCHI; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Greenwald AG, 2003, J EXP PSYCHOL LEARN, V29, P235, DOI 10.1037/0278-7393.29.2.235; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Janet P., 1886, REV PHILOS, V22, P577; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Marcelli D., 2009, ENFANCE PSYCHOPATHOL; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Naccache L., 2004, COGNITION, V80, P223, DOI DOI 10.1016/S0010-0277(00)00139-6; Naccache L, 2006, NOUVEL INCONSCIENT F; R Development Core Team, 2001, R LANG ENV STAT COMP; Rao A, 2006, AM J PSYCHIAT, V163, P599, DOI 10.1176/appi.ajp.163.4.599; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; SHEVRIN H, 1968, SCIENCE, V161, P295, DOI 10.1126/science.161.3838.295; Shevrin H., 1996, CONSCIOUS UNCONSCIOU; Strachey J., 1900, STANDARD EDITION COM, VIV-V; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Waroquier L, 2010, SOC PSYCHOL PERS SCI, V1, P111, DOI 10.1177/1948550609356597; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Weisbuch M, 2009, SCIENCE, V326, P1711, DOI 10.1126/science.1178358; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617	40	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18470	10.1371/journal.pone.0018470	http://dx.doi.org/10.1371/journal.pone.0018470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746IN	21490974	gold, Green Published, Green Submitted			2022-12-27	WOS:000289238700016
J	Whitlock, JA				Whitlock, John A.			Inferences of Diplodocoid (Sauropoda: Dinosauria) Feeding Behavior from Snout Shape and Microwear Analyses	PLOS ONE			English	Article							JURASSIC MORRISON FORMATION; DENTAL MICROWEAR; INCISOR MICROWEAR; QUANTITATIVE-ANALYSIS; NECK POSTURE; EXTINCT RUMINANTS; LARGE CARNIVORES; GROWTH-RATES; LATE MIOCENE; DIET	Background: As gigantic herbivores, sauropod dinosaurs were among the most important members of Mesozoic communities. Understanding their ecology is fundamental to developing a complete picture of Jurassic and Cretaceous food webs. One group of sauropods in particular, Diplodocoidea, has long been a source of debate with regard to what and how they ate. Because of their long lineage duration (Late Jurassic-Late Cretaceous) and cosmopolitan distribution, diplodocoids formed important parts of multiple ecosystems. Additionally, fortuitous preservation of a large proportion of cranial elements makes them an ideal clade in which to examine feeding behavior. Methodology/Principal Findings: Hypotheses of various browsing behaviors (selective and nonselective browsing at ground-height, mid-height, or in the upper canopy) were examined using snout shape (square vs. round) and dental microwear. The square snouts, large proportion of pits, and fine subparallel scratches in Apatosaurus, Diplodocus, Nigersaurus, and Rebbachisaurus suggest ground-height nonselective browsing; the narrow snouts of Dicraeosaurus, Suuwassea, and Tornieria and the coarse scratches and gouges on the teeth of Dicraeosaurus suggest mid-height selective browsing in those taxa. Comparison with outgroups (Camarasaurus and Brachiosaurus) reinforces the inferences of ground- and mid-height browsing and the existence of both non-selective and selective browsing behaviors in diplodocoids. Conclusions/Significance: These results reaffirm previous work suggesting the presence of diverse feeding strategies in sauropods and provide solid evidence for two different feeding behaviors in Diplodocoidea. These feeding behaviors can subsequently be tied to paleoecology, such that non-selective, ground-height behaviors are restricted to open, savanna-type environments. Selective browsing behaviors are known from multiple sauropod clades and were practiced in multiple environments.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Whitlock, JA (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	jawhitl@umich.edu	Whitlock, John/A-3079-2009; Whitlock, John/G-5814-2018	Whitlock, John/0000-0002-1118-2925; Whitlock, John/0000-0002-1118-2925	University of Michigan; Jurassic Foundation; Geological Society of America [8689-07]	University of Michigan(University of Michigan System); Jurassic Foundation; Geological Society of America	Funding was provided by the Scott Turner Fund (University of Michigan), the Jurassic Foundation (http://jurassicfoundation.org/), and the Geological Society of America (8689-07; http://geosociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERHAN M, 2002, GEOWISSENSCHAFTLICHE, V5, P19; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Anyonge W, 1996, J MAMMAL, V77, P1059, DOI 10.2307/1382786; ASH SR, 1998, MOD GEOL, V22, P321; Bakker RT., 1986, DINOSAUR HERESIES; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barrett Paul M., 1994, Gaia, V10, P195; Barrett PM, 2001, LIFE O PAST, P25; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BODMER RE, 1990, OIKOS, V57, P319, DOI 10.2307/3565960; Boue C., 1970, Mammalia, V34, P696, DOI 10.1515/mamm.1970.34.4.696; Brown B, 1916, B AM MUS NAT HIST, V35, P701; Brown B, 1912, B AM MUS NAT HIST, V31, P131; Bunnell F.L., 1985, P53; Calvo Jorge O., 1994, Gaia, V10, P183; Campione N, 2010, J VERTEBRATE PALE S3, V30, p69A; CARPENTER K, 1982, CAN J EARTH SCI, V19, P689, DOI 10.1139/e82-058; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Chapman R.E., 1990, P163, DOI 10.1017/CBO9780511608377.015; Chin Karen, 1998, Modern Geology, V23, P249; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; CHRISTIAN A, BIOL LETT IN PRESS; Christian Andreas, 2007, Fossil Record, V10, P38; Christiansen Per, 1999, Historical Biology, V13, P269; Christiansen Per, 2000, Historical Biology, V14, P137; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; DEMIGUEL D, 2008, BMC EVOLUTIONARY BIO, V13, P1; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dodson P., 1990, P402; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Domning DP, 2007, ANAT REC, V290, P523, DOI 10.1002/ar.20540; Dompierre H, 1996, J VERTEBR PALEONTOL, V16, P141, DOI 10.1080/02724634.1996.10011292; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fastovsky DE, 2004, DINOSAURIA, 2ND EDITION, P614; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FIORILLO AR, 1991, 5 S MES TERR EC BIOT, P23; Foster J.R., 2003, NEW MEXICO MUSEUM NA, V23, P1; FOSTER JR, 2001, MESA SW MUSEUM B, V8, P47; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Garcia RA, 2010, AMEGHINIANA, V47, P45, DOI 10.5710/AMGH.v47i1.6; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1994, OECOLOGIA, V98, P167, DOI 10.1007/BF00341469; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Gunga HC, 2008, FOSS REC, V11, P33, DOI 10.1002/mmng.200700011; Gunga Hanns-Christian, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P91; Harris JD, 2004, ACTA PALAEONTOL POL, V49, P197; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hay OP, 1908, AM NAT, V42, P672, DOI 10.1086/278992; Hiiemae K.M., 1985, P262; HIIEMAE KM, 1968, J ZOOL, V154, P139; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Hoffman J, 2008, J VERTEBR PALEONTOL, V28, p92A; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; HOLLAND WJ, 1906, MEM CARNEGIE MUS, V2, P225; Horner J.R., 1983, J VERTEBR PALEONTOL, V3, P29, DOI [DOI 10.1080/02724634.1983.10011954, 10.1080/02724634.1983.10011954]; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner John R., 1994, P312; Hotton C.L., 2010, PLANTS MESOZOIC TIME, P295; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Janensch W., PALAEONTOGRAPHIC, V2, P147; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; JARMAN PJ, 1979, ZOOLOGICAL J LINNEAN, V92, P267; KELLEY J, 1990, FOLIA PRIMATOL, V55, P73, DOI 10.1159/000156502; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lockley M.G., 1991, TRACKING DINOSAURS; Lovelace David M., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P527; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mainland IL, 2003, J ARCHAEOL SCI, V30, P1513, DOI 10.1016/S0305-4403(03)00055-4; Mazumdar J, 2011, S AFR J BOT, V77, P10, DOI 10.1016/j.sajb.2010.07.020; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2007, GEODIVERSITAS, V29, P421; MIHLBACHLER M, 2010, J VERTEBRATE PALE S3, V30, pA134; Myers J.H., 1992, PHYTOCHEMICAL INDUCT, P325; Nelson S, 2005, PALAEONTOL ELECTRON, V8; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; Noto CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012553; OSBORN HF, 1899, MEMOIRS AM MUSEUM NA, V1, P189; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; OWENSMITH N, 1979, S AFR J WILDL RES, V9, P102; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; Parrish JT, 2004, SEDIMENT GEOL, V167, P137, DOI 10.1016/j.sedgeo.2004.01.004; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Puech P.-F., 1986, HUM EVOL, V1, P507, DOI DOI 10.1007/BF02437467; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Purnell MA, 2007, SCIENCE, V317, P1887, DOI 10.1126/science.1147337; Reilly SM, 2001, COMP BIOCHEM PHYS A, V128, P397, DOI 10.1016/S1095-6433(00)00326-3; Remes K, 2006, J VERTEBR PALEONTOL, V26, P651, DOI 10.1671/0272-4634(2006)26[651:ROTTSD]2.0.CO;2; Rivals F, 2010, MAMMALIA, V74, P401, DOI 10.1515/MAMM.2010.044; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; RUSSELL DA, 1980, MEMOIRS SOC GEOLOGIQ, P169; RYAN A S, 1981, Primates, V22, P533, DOI 10.1007/BF02381245; Rybczynski N, 2001, LIFE O PAST, P299; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Searle Kate R., 2008, V195, P117, DOI 10.1007/978-3-540-72422-3_5; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 2010, P ROY SOC B-BIOL SCI, V277, P199, DOI 10.1098/rspb.2009.0691; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Stephens D.W., 1986, pi; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; Thorington RW, 1996, J MORPHOL, V230, P145, DOI 10.1002/(SICI)1097-4687(199611)230:2<145::AID-JMOR3>3.0.CO;2-G; TIDWELL W. D., 1990, HUNTERIA, V2, P1, DOI DOI 10.1016/J.PALWOR.2008.10.004; TORNIER G, 1911, BERICHT SENCKENBERGI, V42, P112; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Turner CE, 2004, SEDIMENT GEOL, V167, P309, DOI 10.1016/j.sedgeo.2004.01.009; Ungar P, 1998, EVOL ANTHROPOL, V6, P205, DOI 10.1002/(SICI)1520-6505(1998)6:6<205::AID-EVAN3>3.3.CO;2-G; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; UNGAR PS, 1990, AM J PRIMATOL, V20, P43, DOI 10.1002/ajp.1350200107; Ungar PS, 1999, AM J PHYS ANTHROPOL, V109, P387, DOI 10.1002/(SICI)1096-8644(199907)109:3&lt;387::AID-AJPA7&gt;3.0.CO;2-F; UNGAR PS, 2002, MICROWARE 4 02; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; Walker A., 1984, P119; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; WEAVER JC, 1983, PALEOBIOLOGY, V9, P173, DOI 10.1017/S0094837300007557; Weishampel D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V167, P224; Weishampel David B., 1994, P229; Whitlock J.A., 2010, J VERTEBRATE PALE S3, V30, p186A; WHITLOCK JA, ZOOLOGICAL IN PRESS; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P1637, DOI 10.1080/02724634.2010.501452; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; You Hailu, 2004, P478; YOUNG W G, 1990, Memoirs of the Queensland Museum, V28, P337; YOUNG WG, 1986, CAN J ZOOL, V64, P2467, DOI 10.1139/z86-367; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226	153	80	80	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18304	10.1371/journal.pone.0018304	http://dx.doi.org/10.1371/journal.pone.0018304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494685	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400017
J	Li, DS; Aaskov, J; Lott, WB				Li, Dongsheng; Aaskov, John; Lott, William B.			Identification of a Cryptic Prokaryotic Promoter within the cDNA Encoding the 5 ' End of Dengue Virus RNA Genome	PLOS ONE			English	Article							TRANSLATION INITIATION; INFECTIOUS CLONE; GENE-EXPRESSION; MESSENGER-RNA; TYPE-2; LOCALIZATION; CONSTRUCTION; DETERMINANT; SUBUNITS; STRAIN	Infectious cDNA clones of RNA viruses are important research tools, but flavivirus cDNA clones have proven difficult to assemble and propagate in bacteria. This has been attributed to genetic instability and/or host cell toxicity, however the mechanism leading to these difficulties has not been fully elucidated. Here we identify and characterize an efficient cryptic bacterial promoter in the cDNA encoding the dengue virus (DENV) 59 UTR. Following cryptic transcription in E. coli, protein expression initiated at a conserved in-frame AUG that is downstream from the authentic DENV initiation codon, yielding a DENV polyprotein fragment that was truncated at the N-terminus. A more complete understanding of constitutive viral protein expression in E. coli might help explain the cloning and propagation difficulties generally observed with flavivirus cDNA.	[Li, Dongsheng; Aaskov, John; Lott, William B.] Queensland Univ Technol, Program Infect Dis, IHBI, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Li, DS (corresponding author), Queensland Univ Technol, Program Infect Dis, IHBI, Brisbane, Qld 4001, Australia.	b.lott@qut.edu.au	Lott, William B/J-1062-2012	Lott, William B/0000-0001-7118-7560	National Health and Medical Research Council (NHMRC) of Australia [497203]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (grant ID: 497203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONUCCI TK, 1989, J BIOL CHEM, V264, P17656; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; KOZAK M, 1978, J BIOL CHEM, V253, P6568; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Pierro DJ, 2006, J GEN VIROL, V87, P2263, DOI 10.1099/vir.0.81958-0; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Moreno ACR, 2009, FEMS MICROBIOL LETT, V301, P156, DOI 10.1111/j.1574-6968.2009.01815.x; RICE C M, 1989, New Biologist, V1, P285; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rossi SL, 2005, VIROLOGY, V331, P457, DOI 10.1016/j.virol.2004.10.046; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992; Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18197	10.1371/journal.pone.0018197	http://dx.doi.org/10.1371/journal.pone.0018197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483867	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200040
J	Ballanco, J; Mansfield, ML				Ballanco, Joshua; Mansfield, Marc L.			A Model for the Evolution of Nucleotide Polymerase Directionality	PLOS ONE			English	Article								Background: In all known living organisms, every enzyme that synthesizes nucleic acid polymers does so by adding nucleotide 5'-triphosphates to the 3'-hydroxyl group of the growing chain. This results in the well known 5'-> 3' directionality of all DNA and RNA Polymerases. The lack of any alternative mechanism, e. g. addition in a 3'-> 5' direction, may indicate a very early founder effect in the evolution of life, or it may be the result of a selective pressure against such an alternative. Methodology/Principal Findings: In an attempt to determine whether the lack of an alternative polymerase directionality is the result of a founder effect or evolutionary selection, we have constructed a basic model of early polymerase evolution. This model is informed by the essential chemical properties of the nucleotide polymerization reaction. With this model, we are able to simulate the growth of organisms with polymerases that synthesize either 5'-> 3' or 3'-> 5' in isolation or in competition with each other. Conclusions/Significance: We have found that a competition between organisms with 5'-> 3' polymerases and 3'-> 5' polymerases only results in a evolutionarily stable strategy under certain conditions. Furthermore, we have found that mutations lead to a much clearer delineation between conditions that lead to a stable coexistence of these populations and conditions which ultimately lead to success for the 5'-> 3' form. In addition to presenting a plausible explanation for the uniqueness of enzymatic polymerization reactions, we hope these results also provide an example of how whole organism evolution can be understood based on molecular details.	[Ballanco, Joshua] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Mansfield, Marc L.] Bingham Res Ctr, Energy Dynam Lab, Vernal, UT USA	Stevens Institute of Technology	Ballanco, J (corresponding author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.	jballanc@stevens.edu		Ballanco, Joshua/0000-0002-4684-7130				BAGSHAW CR, 1973, BIOCHEM J, V133, P323, DOI 10.1042/bj1330323; Cady F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036011; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Ferenci T, 1999, RES MICROBIOL, V150, P431, DOI 10.1016/S0923-2508(99)00114-X; Griep M, 2006, AICHE J, V52, P384, DOI 10.1002/aic.10604; Ihaka R., 1996, J COMPUTATIONAL GRAP; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Levene PA, 1934, J BIOL CHEM, V104, P299; NOWAK MA, 2006, EVOLUTIONARY DYNAMIC, pP363; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; SIGEL H, 1983, EUR J BIOCHEM, V132, P569, DOI 10.1111/j.1432-1033.1983.tb07401.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Zannis-Hadjopoulos M, 1999, J CELL BIOCHEM, P1	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18881	10.1371/journal.pone.0018881	http://dx.doi.org/10.1371/journal.pone.0018881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526126	Green Submitted, Green Published, gold			2022-12-27	WOS:000290015800019
J	Koblik, EA; Red'kin, YA; Meer, MS; Derelle, R; Golenkina, SA; Kondrashov, FA; Arkhipov, VY				Koblik, Evgeny A.; Red'kin, Yaroslav A.; Meer, Margarita S.; Derelle, Romain; Golenkina, Sofia A.; Kondrashov, Fyodor A.; Arkhipov, Vladimir Yu.			Acrocephalus orinus: A Case of Mistaken Identity	PLOS ONE			English	Article							IDENTIFICATION; DISCOVERY; FAMILY	Recent discovery of the Large-billed Reed Warbler (Acrocephalus orinus) in museums and in the wild significantly expanded our knowledge of its morphological traits and genetic variability, and revealed new data on geographical distribution of the breeding grounds, migration routes and wintering locations of this species. It is now certain that A. orinus is breeding in Central Asia; however, the precise area of distribution remains unclear. The difficulty in the further study of this species lies in the small number of known specimens, with only 13 currently available in museums, and in the relative uncertainty of the breeding area and habitat of this species. Following morphological and genetic analyses from Svensson, et al, we describe 14 new A. orinus specimens from collections of Zoological Museums of the former USSR from the territory of Central Asian states. All of these specimens were erroneously labeled as Blyth's Reed Warbler (A. dumetorum), which is thought to be a breeding species in these areas. The 14 new A. orinus specimens were collected during breeding season while most of the 85 A. dumetorum specimens from the same area were collected during the migration period. Our data indicate that the Central Asian territory previously attributed as breeding grounds of A. dumetorum is likely to constitute the breeding territory of A. orinus. This rare case of a re-description of the breeding territory of a lost species emphasizes the importance of maintenance of museum collections around the world. If the present data on the breeding grounds of A. orinus are confirmed with field observations and collections, the literature on the biology of A. dumetorum from the southern part of its range may have to be reconsidered.	[Koblik, Evgeny A.; Red'kin, Yaroslav A.] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [Meer, Margarita S.; Derelle, Romain; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [Golenkina, Sofia A.] Russian Acad Sci, Vavilov Inst Gen Genet, Lab Evolutionary Genom, Moscow, Russia; [Arkhipov, Vladimir Yu.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia	Lomonosov Moscow State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Koblik, EA (corresponding author), Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia.	v.arkhipov@rambler.ru	Kondrashov, Fyodor Alexeevich/H-6331-2015; Red'kin, Yaroslav/AAE-4218-2021; Arkhipov, Vladimir/B-4085-2010	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Arkhipov, Vladimir/0000-0001-9877-575X	Spanish Ministry of Science and Innovation [BFU2009-09271]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The work was supported by the Plan Nacional grant number BFU2009-09271 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDUSALYAMOV IA, 1973, FAUNA TADZHIK SSR 2, V19; Anderson A, 1875, STRAY FEATHERS, V3, P350; Aye R, 2010, J AVIAN BIOL, V41, P452, DOI 10.1111/j.1600-048X.2010.05031.x; DAVRANOV E, 1991, FAUNA ECOLOGY VERTER, P128; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fregin S, 2009, MOL PHYLOGENET EVOL, V52, P866, DOI 10.1016/j.ympev.2009.04.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; IVANOV AI, 1969, BIRDS PAMIR ALAI; Koblik E. A., 2006, CHECKLIST BIRDS RUSS; KOVSHAR AF, 1972, BIRDS KAZAKHSTAN, V5, P75; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; MEKLENBURTSEV RN, 1958, BIRDS UZBEKISTAN, P202; NIMNUAN S, 2008, BIRDING ASIA, V9, P10; Pearson D. J., 2008, Bulletin of the British Ornithologists' Club, V128, P136; PEKLO AM, 2008, CATALOGUE COLLECTION, V4; Portenko L. A., 1976, ATLAS VERBREITUNG PA, V5; Rogaev EI, 2009, P NATL ACAD SCI USA, V106, P5258, DOI 10.1073/pnas.0811190106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Round PD, 2007, J AVIAN BIOL, V38, P133, DOI 10.1111/j.2007.0908-8857.04064.x; SHNITNIKOV VN, 1949, BIRDS SEMYRECHYE; Stepanyan L.S., 1990, CONSPECTUS ORNITHOLO; Stepanyan L. S., 2003, CONSPECTUS ORNITHOLO; Svensson L., 1992, IDENTIFICATION GUIDE; Svensson L, 2010, IBIS, V152, P323; Svensson L, 2008, J AVIAN BIOL, V39, P605, DOI 10.1111/j.1600-048X.2008.04634.x; Timmins Robert J., 2009, BirdingASIA, V12, P42; YANUSHEVICH AI, 1960, BIRDS KIRGHIZIA, V2	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17716	10.1371/journal.pone.0017716	http://dx.doi.org/10.1371/journal.pone.0017716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526114	Green Published, gold, Green Submitted			2022-12-27	WOS:000290015800003
J	Fang, L; Hou, XL; Yen, L; Lee, C; Liu, L; Yan, XJ; Yu, H				Fang, Lei; Hou, Xingliang; Yen, Li; Lee, Candy; Liu, Lu; Yan, Xiaojing; Yu, Hao			AtPV42a and AtPV42b Redundantly Regulate Reproductive Development in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE SNF1; PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; GAMETOPHYTE DEVELOPMENT; POLLEN DEVELOPMENT; CARBON METABOLISM; GLOBAL REGULATORS; ENERGY CONTROL; SYNERGID CELL; CBS DOMAINS	Background: The conserved SNF1/AMPK/SnRK1 complexes are global regulators of metabolic responses in eukaryotes and play a key role in the control of energy balance. Although alpha-type subunits of the SnRK1 complex have been characterized in several plant species, the biological function of beta-type and gamma-type subunits remains largely unknown. Here, we characterized AtPV42a and AtPV42b, the two homologous genes in Arabidopsis, which encode cystathionine-beta-synthase (CBS) domain-containing proteins that belong to the PV42 class of gamma-type subunits of the plant SnRK1 complexes. Methodology/Principal Findings: Real-time polymerase chain reaction was performed to examine the expression of AtPV42a and AtPV42b in various tissues. Transgenic plants that expressed artificial microRNAs targeting these two genes were created. Reproductive organ development and fertilization in these plants were examined by various approaches, including histological analysis, scanning electron microscopy, transmission electron microscopy, and phenotypic analyses of reciprocal crosses between wild-type and transgenic plants. We found that AtPV42a and AtPV42b were expressed in various tissues during different developmental stages. Transgenic plants where AtPV42a and AtPV42b were simultaneously silenced developed shorter siliques and reduced seed sets. Such low fertility phenotype resulted from deregulation of late stamen development and impairment of pollen tube attraction conferred by the female gametophyte. Conclusions: Our results demonstrate that AtPV42a and AtPV42b play redundant roles in regulating male gametogenesis and pollen tube guidance, indicating that the Arabidopsis SnRK1 complexes might be involved in the control of reproductive development.	[Fang, Lei] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Fang, L (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsyuhao@nus.edu.sg	Yu, Hao/A-3867-2010; Liu, Lu/AAF-6465-2021	Yu, Hao/0000-0002-9778-8855; Liu, Lu/0000-0003-4353-1795; Lee, Candy/0000-0002-3297-4091	Ministry of Education, Singapore [T208B3113]; Temasek Life Sciences Laboratory	Ministry of Education, Singapore(Ministry of Education, Singapore); Temasek Life Sciences Laboratory(National University of Singapore)	This work was supported in the HY group by an Academic Research Fund T208B3113 from the Ministry of Education, Singapore, and the intramural research funds from Temasek Life Sciences Laboratory. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON A, 1991, P NATL ACAD SCI USA, V88, P8602, DOI 10.1073/pnas.88.19.8602; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Bouly JP, 1999, PLANT J, V18, P541, DOI 10.1046/j.1365-313X.1999.00476.x; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Capron A, 2008, PLANT CELL, V20, P3038, DOI 10.1105/tpc.108.061713; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; CELENZA JL, 1984, MOL CELL BIOL, V4, P54, DOI 10.1128/MCB.4.1.54; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Gissot L, 2006, PLANT PHYSIOL, V142, P931, DOI 10.1104/pp.106.087718; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Halford NG, 2003, PLANT BIOTECHNOL J, V1, P381, DOI 10.1046/j.1467-7652.2003.00046.x; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hedbacker K, 2004, MOL CELL BIOL, V24, P1836, DOI 10.1128/MCB.24.5.1836-1843.2004; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kleinow T, 2000, PLANT J, V23, P115, DOI 10.1046/j.1365-313x.2000.00809.x; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Lovas A, 2003, GENE, V321, P123, DOI 10.1016/j.gene.2003.08.001; Lu CA, 2007, PLANT CELL, V19, P2484, DOI 10.1105/tpc.105.037887; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; MURANAKA T, 1994, MOL CELL BIOL, V14, P2958, DOI 10.1128/MCB.14.5.2958; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Punwani JA, 2008, SEX PLANT REPROD, V21, P7, DOI 10.1007/s00497-007-0059-3; Punwani JA, 2007, PLANT CELL, V19, P2557, DOI 10.1105/tpc.107.052076; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Slocombe SP, 2002, PLANT MOL BIOL, V49, P31, DOI 10.1023/A:1014464314113; Takano M, 1998, MOL GEN GENET, V260, P388, DOI 10.1007/s004380050908; Thelander M, 2004, EMBO J, V23, P1900, DOI 10.1038/sj.emboj.7600182; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Weterings K, 2004, PLANT CELL, V16, pS107, DOI 10.1105/tpc.016873; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; Yu H, 2000, PLANT CELL, V12, P2143, DOI 10.1105/tpc.12.11.2143; Zhang YH, 2001, PLANT J, V28, P431, DOI 10.1046/j.1365-313X.2001.01167.x	52	12	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19033	10.1371/journal.pone.0019033	http://dx.doi.org/10.1371/journal.pone.0019033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533063	gold, Green Published, Green Submitted			2022-12-27	WOS:000289719400053
J	Schultheis, C; Liewald, JF; Bamberg, E; Nagel, G; Gottschalk, A				Schultheis, Christian; Liewald, Jana Fiona; Bamberg, Ernst; Nagel, Georg; Gottschalk, Alexander			Optogenetic Long-Term Manipulation of Behavior and Animal Development	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; MILLISECOND-TIMESCALE; CHEMOSENSORY NEURONS; GLUTAMATE-RECEPTOR; LARVAL DEVELOPMENT; OPTICAL CONTROL; DAUER FORMATION; CHANNELRHODOPSIN-2; PHEROMONE	Channelrhodopsin-2 (ChR2) is widely used for rapid photodepolarization of neurons, yet, as it requires high-intensity blue light for activation, it is not suited for long-term in vivo applications, e. g. for manipulations of behavior, or photoactivation of neurons during development. We used "slow" ChR2 variants with mutations in the C128 residue, that exhibit delayed off-kinetics and increased light sensitivity in Caenorhabditis elegans. Following a 1 s light pulse, we could photodepolarize neurons and muscles for minutes (and with repeated brief stimulation, up to days) with low-intensity light. Photoactivation of ChR2(C128S) in command interneurons elicited long-lasting alterations in locomotion. Finally, we could optically induce profound changes in animal development: Long-term photoactivation of ASJ neurons, which regulate larval growth, bypassed the constitutive entry into the "dauer" larval state in daf-11 mutants. These lack a guanylyl cyclase, which possibly renders ASJ neurons hyperpolarized. Furthermore, photostimulated ASJ neurons could acutely trigger dauer-exit. Thus, slow ChR2s can be employed to long-term photoactivate behavior and to trigger alternative animal development.	[Schultheis, Christian; Liewald, Jana Fiona; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Schultheis, Christian; Liewald, Jana Fiona; Gottschalk, Alexander] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Frankfurt, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, D-6000 Frankfurt, Germany; [Nagel, Georg] Univ Wurzburg, Wurzburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of Wurzburg	Schultheis, C (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119; Nagel, Georg/0000-0001-8174-8712	Deutsche Forschungsgemeinschaft [GO1011/2-1, GO1011/4-1 (FOR1279)]; SFB807 "Membrane Transport"; Cluster of Excellence Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB807 "Membrane Transport"; Cluster of Excellence Frankfurt	This work was funded by the Deutsche Forschungsgemeinschaft, grants GO1011/2-1, GO1011/4-1 (FOR1279), the SFB807 "Membrane Transport", and through the Cluster of Excellence Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Birnby DA, 2000, GENETICS, V155, P85; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; Zwaal RR, 1997, GENETICS, V145, P715	33	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18766	10.1371/journal.pone.0018766	http://dx.doi.org/10.1371/journal.pone.0018766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533086	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400024
J	Baker, AM; Fu, Q; Hayward, W; Victoria, S; Pedroso, IM; Lindsay, SM; Fletcher, TM				Baker, Asmaa M.; Fu, Qiang; Hayward, William; Victoria, Samuel; Pedroso, Ilene M.; Lindsay, Stuart M.; Fletcher, Terace M.			The Telomere Binding Protein TRF2 Induces Chromatin Compaction	PLOS ONE			English	Article							AGAROSE-GEL ELECTROPHORESIS; WERNER-SYNDROME HELICASE; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; SELF-ASSOCIATION; IN-VITRO; NUCLEOSOMAL ARRAYS; HOLLIDAY JUNCTIONS; IONIC-STRENGTH; FISSION YEAST	Mammalian telomeres are specialized chromatin structures that require the telomere binding protein, TRF2, for maintaining chromosome stability. In addition to its ability to modulate DNA repair activities, TRF2 also has direct effects on DNA structure and topology. Given that mammalian telomeric chromatin includes nucleosomes, we investigated the effect of this protein on chromatin structure. TRF2 bound to reconstituted telomeric nucleosomal fibers through both its basic N-terminus and its C-terminal DNA binding domain. Analytical agarose gel electrophoresis (AAGE) studies showed that TRF2 promoted the folding of nucleosomal arrays into more compact structures by neutralizing negative surface charge. A construct containing the N-terminal and TRFH domains together altered the charge and radius of nucleosomal arrays similarly to full-length TRF2 suggesting that TRF2-driven changes in global chromatin structure were largely due to these regions. However, the most compact chromatin structures were induced by the isolated basic N-terminal region, as judged by both AAGE and atomic force microscopy. Although the N-terminal region condensed nucleosomal array fibers, the TRFH domain, known to alter DNA topology, was required for stimulation of a strand invasion-like reaction with nucleosomal arrays. Optimal strand invasion also required the C-terminal DNA binding domain. Furthermore, the reaction was not stimulated on linear histone-free DNA. Our data suggest that nucleosomal chromatin has the ability to facilitate this activity of TRF2 which is thought to be involved in stabilizing looped telomere structures.	[Baker, Asmaa M.; Hayward, William; Victoria, Samuel; Pedroso, Ilene M.; Fletcher, Terace M.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Fu, Qiang; Lindsay, Stuart M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	University of Miami; Arizona State University; Arizona State University-Tempe	Baker, AM (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.	tfletcher@med.miami.edu	Fu, Qiang/ABE-5606-2021	Fu, Qiang/0000-0003-4554-0644; Hayward, William/0000-0002-9344-4203	James and Esther King [04NAR-06]; American Heart Association [07552813]; National Institutes of Health [F31-GM75427-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075427] Funding Source: NIH RePORTER	James and Esther King; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the James and Esther King, Florida Biomedical Research Program (04NAR-06; http://www.floridabiomed.com/about.html); the American Heart Association (Grant-in-aid, 07552813; http://www.americanheart.org/presenter.jhtml?identifier=3059871) to T. Fletcher; and a National Institutes of Health Fellowship (F31-GM75427-01) to A. Baker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Benetti R, 2008, CELL CYCLE, V7, P3461, DOI 10.4161/cc.7.21.7013; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Buscemi G, 2009, CURR BIOL, V19, P874, DOI 10.1016/j.cub.2009.03.064; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P10859, DOI 10.1021/bi00202a002; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P2226, DOI 10.1021/bi00174a032; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Galati A, 2006, J MOL BIOL, V360, P377, DOI 10.1016/j.jmb.2006.04.071; GRIESS GA, 1989, BIOPOLYMERS, V28, P1475, DOI 10.1002/bip.360280811; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Groff-Vindman C, 2005, MOL CELL BIOL, V25, P4406, DOI 10.1128/MCB.25.11.4406-4412.2005; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1994, P NATL ACAD SCI USA, V91, P2339, DOI 10.1073/pnas.91.6.2339; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Khan SJ, 2007, BIOCHEM BIOPH RES CO, V363, P44, DOI 10.1016/j.bbrc.2007.08.122; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Misri S, 2008, CYTOGENET GENOME RES, V122, P297, DOI 10.1159/000167816; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Nora GJ, 2010, NUCLEIC ACIDS RES, V38, P3984, DOI 10.1093/nar/gkq144; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Pedroso IM, 2009, NUCLEIC ACIDS RES, V37, P1541, DOI 10.1093/nar/gkn1081; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2010, NUCLEIC ACIDS RES, V38, P2247, DOI 10.1093/nar/gkp1228; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; Steger DJ, 1997, METHODS, V12, P276, DOI 10.1006/meth.1997.0479; STEIN A, 1979, P NATL ACAD SCI USA, V76, P5000, DOI 10.1073/pnas.76.10.5000; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wu P, 2008, MOL CELL BIOL, V28, P5724, DOI 10.1128/MCB.01764-07; Yanez GH, 2005, BIOCHEM BIOPH RES CO, V328, P49, DOI 10.1016/j.bbrc.2004.12.134; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Yoshimura SH, 2004, GENES CELLS, V9, P205, DOI 10.1111/j.1356-9597.2004.00719.x	76	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19124	10.1371/journal.pone.0019124	http://dx.doi.org/10.1371/journal.pone.0019124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526145	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100054
J	Hsieh, MT; Chen, RH				Hsieh, Meng-Ti; Chen, Rey-Huei			Cdc48 and Cofactors Npl4-Ufd1 Are Important for G1 Progression during Heat Stress by Maintaining Cell Wall Integrity in Saccharomyces cerevisiae	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; AAA-ATPASE CDC48/P97; MAP KINASE PATHWAY; PROTEIN-KINASE; UPSTREAM ACTIVATOR; POSITIVE FEEDBACK; MEMBRANE-PROTEIN; GENE-EXPRESSION; YEAST; CYCLE	The ubiquitin-selective chaperone Cdc48, a member of the AAA (ATPase Associated with various cellular Activities) ATPase superfamily, is involved in many processes, including endoplasmic reticulum-associated degradation (ERAD), ubiquitin-and proteasome-mediated protein degradation, and mitosis. Although Cdc48 was originally isolated as a cell cycle mutant in the budding yeast Saccharomyces cerevisiae, its cell cycle functions have not been well appreciated. We found that temperature-sensitive cdc48-3 mutant is largely arrested at mitosis at 37 degrees C, whereas the mutant is also delayed in G1 progression at 38.5 degrees C. Reporter assays show that the promoter activity of G1 cyclin CLN1, but not CLN2, is reduced in cdc48-3 at 38.5 degrees C. The cofactor npl4-1 and ufd1-2 mutants also exhibit G1 delay and reduced CLN1 promoter activity at 38.5 degrees C, suggesting that Npl4-Ufd1 complex mediates the function of Cdc48 at G1. The G1 delay of cdc48-3 at 38.5 degrees C is a consequence of cell wall defect that over-activates Mpk1, a MAPK family member important for cell wall integrity in response to stress conditions including heat shock. cdc48-3 is hypersensitive to cell wall perturbing agents and is synthetic-sick with mutations in the cell wall integrity signaling pathway. Our results suggest that the cell wall defect in cdc48-3 is exacerbated by heat shock, which sustains Mpk1 activity to block G1 progression. Thus, Cdc48-Npl4-Ufd1 is important for the maintenance of cell wall integrity in order for normal cell growth and division.	[Hsieh, Meng-Ti; Chen, Rey-Huei] Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan; [Hsieh, Meng-Ti; Chen, Rey-Huei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Hsieh, MT (corresponding author), Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan.	rhchen@imb.sinica.edu.tw	Chen, Rey-Huei/AAA-5087-2021	Chen, Rey-Huei/0000-0002-6006-2137	Academia Sinica; National Science Council, Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Academia Sinica and National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Breeden L, 1996, CURR TOP MICROBIOL, V208, P95; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Heubes S, 2007, J CELL SCI, V120, P1325, DOI 10.1242/jcs.006924; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ikai N, 2006, J STRUCT BIOL, V156, P50, DOI 10.1016/j.jsb.2006.04.003; JOHNSTON GC, 1980, MOL GEN GENET, V178, P357, DOI 10.1007/BF00270484; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Mai B, 1997, MOL CELL BIOL, V17, P6491, DOI 10.1128/MCB.17.11.6491; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MOIR D, 1982, GENETICS, V100, P547; Molina M, 2000, MICROSC RES TECHNIQ, V51, P601, DOI 10.1002/1097-0029(20001215)51:6<601::AID-JEMT9>3.3.CO;2-9; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; ROWLEY A, 1993, MOL CELL BIOL, V13, P1034, DOI 10.1128/MCB.13.2.1034; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037	55	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18988	10.1371/journal.pone.0018988	http://dx.doi.org/10.1371/journal.pone.0018988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526151	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100045
J	Nakata, I; Yamashiro, K; Yamada, R; Gotoh, N; Nakanishi, H; Hayashi, H; Tsujikawa, A; Otani, A; Saito, M; Iida, T; Oishi, A; Matsuo, K; Tajima, K; Matsuda, F; Yoshimura, N				Nakata, Isao; Yamashiro, Kenji; Yamada, Ryo; Gotoh, Norimoto; Nakanishi, Hideo; Hayashi, Hisako; Tsujikawa, Akitaka; Otani, Atsushi; Saito, Masaaki; Iida, Tomohiro; Oishi, Akio; Matsuo, Keitaro; Tajima, Kazuo; Matsuda, Fumihiko; Yoshimura, Nagahisa			Association between the SERPING1 Gene and Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; POLYMORPHISM; RISK; VARIANTS; CFH; MACULOPATHY; INCREASES	Purpose: Recently, a complement component 1 inhibitor (SERPING1) gene polymorphism was identified as a novel risk factor for age-related macular degeneration (AMD) in Caucasians. We aimed to investigate whether variations in SERPING1 are associated with typical AMD or with polypoidal choroidal vasculopathy (PCV) in a Japanese population. Methods: We performed a case-control study in a group of Japanese patients with typical AMD (n = 401) or PCV (n = 510) and in 2 independent control groups-336 cataract patients without age-related maculopathy and 1,194 healthy Japanese individuals. Differences in the observed genotypic distribution between the case and control groups were tested using chi-square test for trend. Age and gender were adjusted using logistic regression analysis. Results: We targeted rs2511989 as the haplotype-tagging single nucleotide polymorphism (SNP) for the SERPING1 gene, which was reported to be associated with the risk of AMD in Caucasians. Although we compared the genotypic distributions of rs2511989 in typical AMD and PCV patients against 2 independent control groups (cataract patients and healthy Japanese individuals), SERPING1 rs2511989 was not significantly associated with typical AMD (P = 0.932 and 0.513, respectively) or PCV (P = 0.505 and 0.141, respectively). After correction for age and gender differences based on a logistic regression model, the difference in genotypic distributions remained insignificant (P>0.05). Our sample size had a statistical power of more than 90% to detect an association of a risk allele with an odds ratio reported in the original studies for rs2511989 for developing AMD. Conclusions: In the present study, we could not replicate the reported association between SERPING1 and either neovascular AMD or PCV in a Japanese population; thus, the results suggest that SERPING1 does not play a significant role in the risk of developing AMD or PCV in Japanese.	[Nakata, Isao; Yamashiro, Kenji; Gotoh, Norimoto; Nakanishi, Hideo; Hayashi, Hisako; Tsujikawa, Akitaka; Otani, Atsushi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Nakata, Isao; Yamada, Ryo; Gotoh, Norimoto; Nakanishi, Hideo; Hayashi, Hisako; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, INSERM,U852, Kyoto, Japan; [Saito, Masaaki; Iida, Tomohiro] Fukushima Med Univ, Dept Ophthalmol, Fukushima, Japan; [Oishi, Akio] Kobe City Med Ctr Gen Hosp, Dept Ophthalmol, Kobe, Hyogo, Japan; [Matsuo, Keitaro; Tajima, Kazuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Fukushima Medical University; Kobe City Medical Center General Hospital; Aichi Cancer Center	Nakata, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	yamashro@kuhp.kyoto-u.ac.jp	Saito, Masaaki/ABI-2783-2020; Oishi, Akio/AAE-9996-2020; Matsuda, Fumihiko/B-9893-2009; Matsuo, Keitaro/H-6758-2019	Saito, Masaaki/0000-0003-1494-6350; Oishi, Akio/0000-0002-0977-9458; Matsuo, Keitaro/0000-0003-1761-6314; Yamada, Ryo/0000-0002-1587-630X; Tsujikawa, Akitaka/0000-0003-0779-7799; Yamashiro, Kenji/0000-0001-9354-8558	Japan Society for the Promotion of Science, Tokyo, Japan [19390442, 22791706, 27091294]; Japanese National Society for the Prevention of Blindness	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese National Society for the Prevention of Blindness	The study was supported in part by grants-in-aid for scientific research (Nos. 19390442, 22791706, and 27091294) from the Japan Society for the Promotion of Science, Tokyo, Japan, and by the Japanese National Society for the Prevention of Blindness. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 2009, LANCET, V374, P875, DOI 10.1016/S0140-6736(09)61618-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chang TS, 1999, CAN J OPHTHALMOL, V34, P266; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2008, LANCET, V372, P1828, DOI 10.1016/S0140-6736(08)61348-3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gotoh N, 2008, CLIN EXP OPHTHALMOL, V36, P437, DOI 10.1111/j.1442-9071.2008.01791.x; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1376, DOI 10.1016/j.ophtha.2007.11.015; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Lee AY, 2010, BRIT J OPHTHALMOL, V94, P915, DOI 10.1136/bjo.2009.172007; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Li M, 2010, MOL VIS, V16, P231; Lu F, 2010, MOL VIS, V16, P1; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Park KH, 2009, MOL VIS, V15, P200; Seitsonen S, 2006, MOL VIS, V12, P796; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	34	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19108	10.1371/journal.pone.0019108	http://dx.doi.org/10.1371/journal.pone.0019108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526158	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100051
J	Vasquez, SX; Gao, F; Su, F; Grijalva, V; Pope, J; Martin, B; Stinstra, J; Masner, M; Shah, N; Weinstein, DM; Farias-Eisner, R; Reddy, ST				Vasquez, Sergio X.; Gao, Feng; Su, Feng; Grijalva, Victor; Pope, John; Martin, Bill; Stinstra, Jeroen; Masner, Matthew; Shah, Neha; Weinstein, David M.; Farias-Eisner, Robin; Reddy, Srinivasa T.			Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium	PLOS ONE			English	Article								Vascular networks within a living organism are complex, multi-dimensional, and challenging to image capture. Radio-angiographic studies in live animals require a high level of infrastructure and technical investment in order to administer costly perfusion mediums whose signals metabolize and degrade relatively rapidly, diminishing within a few hours or days. Additionally, live animal specimens must not be subject to long duration scans, which can cause high levels of radiation exposure to the specimen, limiting the quality of images that can be captured. Lastly, despite technological advances in live-animal specimen imaging, it is quite difficult to minimize or prevent movement of a live animal, which can cause motion artifacts in the final data output. It is demonstrated here that through the use of postmortem perfusion protocols of radiopaque silicone polymer mediums and ex-vivo organ harvest, it is possible to acquire a high level of vascular signal in preclinical specimens through the use of micro-computed tomographic (microCT) imaging. Additionally, utilizing high-order rendering algorithms, it is possible to further derive vessel morphometrics for qualitative and quantitative analysis.	[Vasquez, Sergio X.; Martin, Bill; Stinstra, Jeroen; Masner, Matthew; Shah, Neha; Weinstein, David M.] Numira Biosci, Salt Lake City, UT 84108 USA; [Gao, Feng; Su, Feng; Farias-Eisner, Robin; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Grijalva, Victor; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Pope, John] Integrated Syst Lab, Durham, NC USA; [Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vasquez, SX (corresponding author), Numira Biosci, Salt Lake City, UT 84108 USA.	svasquez@numirabio.com			Women's Endowment; Roberta Deutsch Family Foundation; Joan English Fund for Women's Cancer Research; Ovarian Cancer Coalition; Helen Beller Foundation; USPHS [HL-082823]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082823] Funding Source: NIH RePORTER	Women's Endowment; Roberta Deutsch Family Foundation; Joan English Fund for Women's Cancer Research; Ovarian Cancer Coalition; Helen Beller Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from the Women's Endowment, Carl and Roberta Deutsch Family Foundation, the Joan English Fund for Women's Cancer Research, the Ovarian Cancer Coalition, the Helen Beller Foundation, and USPHS grant HL-082823 (STR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGER AC, 1966, ANN NY ACAD SCI, V139, P276, DOI 10.1111/j.1749-6632.1966.tb41202.x; Bui T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013082; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Ciszek B, 2007, J ANAT, V211, P53, DOI 10.1111/j.1469-7580.2007.00753.x; Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102; Hoff J, 2000, LAB ANIMAL, V29, P47; JIA Y, 2010, J NEUROSCI METHODS; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Liu P, 2010, J SYNCHROTRON RADIAT, V17, P517, DOI 10.1107/S0909049510018832; Malyar NM, 2004, AM J PHYSIOL-HEART C, V286, pH2386, DOI 10.1152/ajpheart.00682.2003; Moritz R, 2010, J COMPUT ASSIST TOMO, V34, P273, DOI 10.1097/RCT.0b013e3181bb0d32; Namati E, 2010, MED PHYS, V37, P4793, DOI 10.1118/1.3476454; RAGAN DK, 2010, NMR BIOMED; Rao B, 2010, OPT LETT, V35, P1521, DOI 10.1364/OL.35.001521; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003	16	44	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e19099	10.1371/journal.pone.0019099	http://dx.doi.org/10.1371/journal.pone.0019099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533123	Green Published, gold			2022-12-27	WOS:000289620100035
J	Malachowa, N; Whitney, AR; Kobayashi, SD; Sturdevant, DE; Kennedy, AD; Braughton, KR; Shabb, DW; Diep, BA; Chambers, HF; Otto, M; DeLeo, FR				Malachowa, Natalia; Whitney, Adeline R.; Kobayashi, Scott D.; Sturdevant, Daniel E.; Kennedy, Adam D.; Braughton, Kevin R.; Shabb, Duncan W.; Diep, Binh An; Chambers, Henry F.; Otto, Michael; DeLeo, Frank R.			Global Changes in Staphylococcus aureus Gene Expression in Human Blood	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; GAMMA-HEMOLYSIN; VIRULENCE DETERMINANT; IRON; IDENTIFICATION; USA300; INFECTION; PHAGOCYTOSIS; SIDEROPHORE; DESTRUCTION	Staphylococcus aureus is a leading cause of bloodstream infections worldwide. In the United States, many of these infections are caused by a strain known as USA300. Although progress has been made, our understanding of the S. aureus molecules that promote survival in human blood and ultimately facilitate metastases is incomplete. To that end, we analyzed the USA300 transcriptome during culture in human blood, human serum, and trypticase soy broth (TSB), a standard laboratory culture media. Notably, genes encoding several cytolytic toxins were up-regulated in human blood over time, and hlgA, hlgB, and hlgC (encoding gamma-hemolysin subunits HlgA, HlgB, and HlgC) were among the most highly up-regulated genes at all time points. Compared to culture supernatants from a wild-type USA300 strain (LAC), those derived from an isogenic hlgABC-deletion strain (LAC Delta hlgABC) had significantly reduced capacity to form pores in human neutrophils and ultimately cause neutrophil lysis. Moreover, LAC Delta hlgABC had modestly reduced ability to cause mortality in a mouse bacteremia model. On the other hand, wild-type and LAC Delta hlgABC strains caused virtually identical abscesses in a mouse skin infection model, and bacterial survival and neutrophil lysis after phagocytosis in vitro was similar between these strains. Comparison of the cytolytic capacity of culture supernatants from wild-type and isogenic deletion strains lacking hlgABC, lukS/F-PV (encoding PVL), and/or lukDE revealed functional redundancy among two-component leukotoxins in vitro. These findings, along with a requirement of specific growth conditions for leukotoxin expression, may explain the apparent limited contribution of any single two-component leukotoxin to USA300 immune evasion and virulence.	[Malachowa, Natalia; Whitney, Adeline R.; Kobayashi, Scott D.; Kennedy, Adam D.; Braughton, Kevin R.; DeLeo, Frank R.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT USA; [Sturdevant, Daniel E.; Shabb, Duncan W.] NIAID, Genom Unit, Res Technol Sect, Rocky Mt Labs,NIH, Hamilton, MT USA; [Diep, Binh An; Chambers, Henry F.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Malachowa, N (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT USA.	fdeleo@niaid.nih.gov		DeLeo, Frank/0000-0003-3150-2516; Kobayashi, Scott/0000-0002-5705-1381; Otto, Michael/0000-0002-2222-4115	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH); U.S. Public Health Service from National Institute of Allergy and Infectious Diseases, NIH [R01 AI070289, R01 AI087674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070289, ZIAAI000904, ZIAAI001079, R01AI087674] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Public Health Service from National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) and U.S. Public Health Service grants, R01 AI070289 (HFC) and R01 AI087674 (BAD), from the National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; COONEY J, 1993, INFECT IMMUN, V61, P768, DOI 10.1128/IAI.61.2.768-771.1993; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graves SF, 2010, MICROBES INFECT, V12, P446, DOI 10.1016/j.micinf.2010.02.005; Heinrichs JH, 1999, J BACTERIOL, V181, P1436, DOI 10.1128/JB.181.5.1436-1443.1999; Jenkins TC, 2009, INFECT CONT HOSP EP, V30, P233, DOI 10.1086/595963; Kempker RR, 2010, J INFECTION, V61, P372, DOI 10.1016/j.jinf.2010.09.021; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PREVOST G, 1995, INFECT IMMUN, V63, P4121; RAHMAN A, 1993, BIOSCI BIOTECH BIOCH, V57, P1234, DOI 10.1271/bbb.57.1234; Rosso ML, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-211; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Yamazaki K, 2006, FEMS MICROBIOL LETT, V259, P174, DOI 10.1111/j.1574-6968.2006.00236.x	46	159	166	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18617	10.1371/journal.pone.0018617	http://dx.doi.org/10.1371/journal.pone.0018617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525981	Green Submitted, Green Published, gold			2022-12-27	WOS:000289578600018
J	Martel, C; Cointe, S; Maurice, P; Matar, S; Ghitescu, M; Theroux, P; Bonnefoy, A				Martel, Catherine; Cointe, Sylvie; Maurice, Pascal; Matar, Said; Ghitescu, Marta; Theroux, Pierre; Bonnefoy, Arnaud			Requirements for Membrane Attack Complex Formation and Anaphylatoxins Binding to Collagen-Activated Platelets	PLOS ONE			English	Article							PROTEINS C5B-9; PROCOAGULANT ACTIVITY; BLOOD-PLATELETS; C5A RECEPTOR; EXPRESSION; SECRETION; PROTHROMBINASE; MICROPARTICLES; COMPONENT; PATHWAY	Background: The activation of complement during platelet activation is incompletely understood. Objectives: We sought to explore the formation of C5b-9 and anaphylatoxins binding to collagen-activated platelets. Methods: C5b-9, anaphylatoxins C3a, C4a and C5a, and anaphylatoxin receptors C3aR1 and C5aR were measured by flow cytometry and/or confocal microscopy. Platelet microparticles were quantified by flow cytometry, and their C5b-9 content was determined by western blot analyses. In all experiments, sodium citrate was used for blood anticoagulation. Results: C5b-9 rapidly formed on the platelet surface following activation with collagen, TRAP, ADP or A23187, but was surprisingly restricted to a subset of platelets (1 to 15%) independently of P-selectin or phosphatidylserine exposure. Following collagen activation, C5b-9-positive platelets in thrombi were found associated with collagen fibres. C5b-9 formation was obliterated by Mg(2+)-EGTA and significantly reduced by the thrombin inhibitor hirudin (237%, p<0.05), but was unaffected by chondroitinase, compstatin, SCH79797 (PAR-1 inhibitor), or in the PRP of a MBL-deficient donor. Compstatin and Mg(2+)-EGTA, but not hirudin, SCH79797 or chondroitinase, inhibited the formation of collagen-induced microparticles (-71% and -44%, respectively, p<0.04). These microparticles contained greater amounts of C5b-9 compared with the other agonists. Platelet activation by collagen or convulxin resulted in the strong binding of anaphylatoxins and the exposure of receptors C3aR1 and C5aR (CD88) on their surface. Conclusions: C5b-9 formation on collagen-activated platelets is i) partially controlled by thrombin, ii) restricted to a subset of platelets, and iii) can occur without P-selectin expression or phosphatidylserine exposure. Activated platelets bind anaphylatoxins on their surface and express C3a and C5a receptors, which may contribute to the localization of inflammatory processes during thrombosis.	[Martel, Catherine; Cointe, Sylvie; Maurice, Pascal; Matar, Said; Ghitescu, Marta; Theroux, Pierre; Bonnefoy, Arnaud] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Bonnefoy, Arnaud] Univ Montreal, INSERM, U743, Montreal, PQ, Canada	Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal	Martel, C (corresponding author), Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada.	arnaudbonnefoy@yahoo.fr	Maurice, Pascal/AAM-9126-2021	cointe, sylvie/0000-0001-6539-7879; MAURICE, Pascal/0000-0003-2167-4808	Agence Nationale de la Recherche [ANR-05-PCOD-031-02, ANR-07-PHYSIO-025-02]; Canadian Institutes of Health Research (CIHR)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Agence Nationale de la Recherche (grants ANR-05-PCOD-031-02 and ANR-07-PHYSIO-025-02). CM was the recipient of a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bexborn F, 2009, J BIOMED MATER RES A, V89A, P951, DOI 10.1002/jbm.a.32034; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; CHANG CP, 1993, J BIOL CHEM, V268, P7171; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; FROJMOVIC MM, 1990, THROMB HAEMOSTASIS, V64, P582; FUKUOKA Y, 1988, J IMMUNOL, V140, P3496; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810; HOULE JJ, 1989, CLIN IMMUNOL IMMUNOP, V50, P385, DOI 10.1016/0090-1229(89)90145-1; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; HUGO F, 1987, J IMMUNOL METHODS, V99, P243, DOI 10.1016/0022-1759(87)90134-7; KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Legler DF, 1996, EUR J IMMUNOL, V26, P753, DOI 10.1002/eji.1830260405; Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x; PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.009; POLLEY MJ, 1979, J EXP MED, V150, P633, DOI 10.1084/jem.150.3.633; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Siljander P, 1996, BLOOD, V87, P4651, DOI 10.1182/blood.V87.11.4651.bloodjournal87114651; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; TEDESCO F, 1986, CLIN EXP IMMUNOL, V66, P472; WATANABE H, 1995, J IMMUNOL METHODS, V185, P19, DOI 10.1016/0022-1759(95)00101-F; WIEDMER T, 1987, J BIOL CHEM, V262, P13674; WIEDMER T, 1985, J BIOL CHEM, V260, P8014; WIEDMER T, 1986, BLOOD, V68, P875; YANCEY KB, 1989, J INVEST DERMATOL, V92, P184, DOI 10.1111/1523-1747.ep12276710; Yin W, 2008, PLATELETS, V19, P225, DOI 10.1080/09537100701777311	30	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18812	10.1371/journal.pone.0018812	http://dx.doi.org/10.1371/journal.pone.0018812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526204	gold, Green Published			2022-12-27	WOS:000289578600034
J	Yatsushiro, S; Akamine, R; Yamamura, S; Hino, M; Kajimoto, K; Abe, K; Abe, H; Kido, J; Tanaka, M; Shinohara, Y; Baba, Y; Ooie, T; Kataoka, M				Yatsushiro, Shouki; Akamine, Rie; Yamamura, Shohei; Hino, Mami; Kajimoto, Kazuaki; Abe, Kaori; Abe, Hiroko; Kido, Jun-ichi; Tanaka, Masato; Shinohara, Yasuo; Baba, Yoshinobu; Ooie, Toshihiko; Kataoka, Masatoshi			Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip	PLOS ONE			English	Article							HUMAN PLASMA; MARKER; SYSTEM; BLOOD; INTEGRATION; SEPARATION; PROTEOME	Background: Sandwich enzyme-linked immunosorbent assay (ELISA) is one of the most frequently employed assays for clinical diagnosis, since this enables the investigator to identify specific protein biomarkers. However, the conventional assay using a 96-well microtitration plate is time-and sample-consuming, and therefore is not suitable for rapid diagnosis. To overcome these drawbacks, we performed a sandwich ELISA on a microchip. Methods and Findings: The microchip was made of cyclic olefin copolymer with straight microchannels that were 300 mu m wide and 100 mu m deep. For the construction of a sandwich ELISA for procollagen type I C-peptide (PICP), a biomarker for bone formation, we used a piezoelectric inkjet printing system for the deposition and fixation of the 1st anti-PICP antibody on the surface of the microchannel. After the infusion of the mixture of 2.0 mu l of peroxidase-labeled 2nd anti-PICP antibody and 0.4 mu l of sample to the microchannel and a 30-min incubation, the substrate for peroxidase was infused into the microchannel; and the luminescence intensity of each spot of 1st antibody was measured by CCD camera. A linear relationship was observed between PICP concentration and luminescence intensity over the range of 0 to 600 ng/ml (r(2) = 0.991), and the detection limit was 4.7 ng/ml. Blood PICP concentrations of 6 subjects estimated from microchip were compared with results obtained by the conventional method. Good correlation was observed between methods according to simple linear regression analysis (R-2 = 0.9914). The within-day and between-days reproducibilities were 3.2-7.4 and 4.4-6.8%, respectively. This assay reduced the time for the antigen-antibody reaction to 1/6, and the consumption of samples and reagents to 1/50 compared with the conventional method. Conclusion: This assay enabled us to determine serum PICP with accuracy, high sensitivity, time saving ability, and low consumption of sample and reagents, and thus will be applicable to clinic diagnosis.	[Yatsushiro, Shouki; Akamine, Rie; Yamamura, Shohei; Hino, Mami; Kajimoto, Kazuaki; Abe, Kaori; Abe, Hiroko; Tanaka, Masato; Baba, Yoshinobu; Ooie, Toshihiko; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tokyo, Japan; [Kido, Jun-ichi] Univ Tokushima, Inst Hlth Biosci, Dept Periodontol & Endodontol Oral & Maxillofacia, Div Medicodent Dynam & Reconstruct, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Tokushima University; Tokushima University; Nagoya University	Yatsushiro, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tokyo, Japan.	m-kataoka@aist.go.jp	Ooie, Toshihiko/J-1498-2018; Tanaka, Masato/P-6700-2016; Kataoka, Masatoshi/M-6925-2018; YATSUSHIRO, shouki/M-8155-2018; Kajimoto, Kazuaki/L-6418-2018; Kajimoto, Kazuaki/A-3799-2012; Abe, Hiroko/L-2116-2018; yamamura, shohei/M-8071-2018	Ooie, Toshihiko/0000-0001-8725-0691; Tanaka, Masato/0000-0002-6164-7786; Kataoka, Masatoshi/0000-0001-9779-8319; YATSUSHIRO, shouki/0000-0002-6123-1561; Kajimoto, Kazuaki/0000-0002-1636-4154; Abe, Hiroko/0000-0003-1779-6212; yamamura, shohei/0000-0002-4971-4560				Abe K, 2008, ANAL CHEM, V80, P6928, DOI 10.1021/ac800604v; Allain LR, 2004, ANAL CHIM ACTA, V518, P77, DOI 10.1016/j.aca.2004.04.065; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Briggs C, 2008, BRIT J HAEMATOL, V142, P904, DOI 10.1111/j.1365-2141.2008.07274.x; Di Serio F, 2006, CLIN CHEM LAB MED, V44, P768, DOI 10.1515/CCLM.2006.125; Doraiswamy A, 2009, J BIOMED MATER RES B, V89B, P28, DOI 10.1002/jbm.b.31183; Hasenbank MS, 2008, ANAL CHIM ACTA, V611, P80, DOI 10.1016/j.aca.2008.01.048; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; KOHDA K, 1991, GUT, V32, P624, DOI 10.1136/gut.32.6.624; Maeda E, 2008, ELECTROPHORESIS, V29, P1902, DOI 10.1002/elps.200700688; Maeda E, 2007, ELECTROPHORESIS, V28, P2927, DOI 10.1002/elps.200600795; Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663; Mohamadi MR, 2007, ANAL CHEM, V79, P3667, DOI 10.1021/ac0623890; Ohashi T, 2009, LAB CHIP, V9, P991, DOI 10.1039/b815475a; PARFITT AM, 1987, J BONE MINER RES, V2, P427; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; RISTELI J, 1991, CALCIFIED TISSUE INT, V49, pS24, DOI 10.1007/BF02555083; Sato K, 2004, LAB CHIP, V4, P570, DOI 10.1039/b411356j; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Sato K, 2001, ANAL CHEM, V73, P1213, DOI 10.1021/ac000991z; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; St-Louis P, 2000, CLIN BIOCHEM, V33, P427, DOI 10.1016/S0009-9120(00)00138-7; Stewart Thomas N., 2009, Biotechnology Journal, V4, P206, DOI 10.1002/biot.200800234; Tachi T, 2009, ANAL SCI, V25, P149, DOI 10.2116/analsci.25.149; Tachi T, 2009, LAB CHIP, V9, P966, DOI 10.1039/b813640h; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Thadikkaran L, 2005, PROTEOMICS, V5, P3019, DOI 10.1002/pmic.200402053; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Wehmeier M, 2006, CLIN CHEM LAB MED, V44, P888, DOI 10.1515/CCLM.2006.141; Yasukawa T, 2007, BIOSENS BIOELECTRON, V22, P2730, DOI 10.1016/j.bios.2006.11.010	31	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18807	10.1371/journal.pone.0018807	http://dx.doi.org/10.1371/journal.pone.0018807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533125	Green Submitted, Green Published, gold			2022-12-27	WOS:000289458800047
J	Necela, BM; Carr, JM; Asmann, YW; Thompson, EA				Necela, Brian M.; Carr, Jennifer M.; Asmann, Yan W.; Thompson, E. Aubrey			Differential Expression of MicroRNAs in Tumors from Chronically Inflamed or Genetic (APC(Min/+)) Models of Colon Cancer	PLOS ONE			English	Article							CHRONIC ULCERATIVE-COLITIS; GROWTH-INHIBITION; TARGETS; RNAS; PROLIFERATION; INFLAMMATION; TRANSCRIPTS; MECHANISM; MIGRATION; PROFILES	Background: Chronic inflammation associated with ulcerative colitis predisposes individuals to increased colon cancer risk. The aim of these studies was to identify microRNAs that are aberrantly regulated during inflammation and may participate in transformation of colonic epithelial cells in the inflammatory setting. Methodology/Principal Findings: We have use quantitative PCR arrays to compare microRNA (miRNA) expression in tumors and control colonic epithelial cells isolated from distal colons of chronically inflamed mice and APC(Min/+) mice. Rank order statistics was utilized to identify differentially regulated miRNAs in tumors that arose due to chronic inflammation and/or to germline APC mutation. Eight high priority miRNAs were identified: miR-215, miR-137, miR-708, miR-31, and miR-135b were differentially expressed in APC tumors and miR-215, miR-133a, miR-467d, miR-218, miR-708, miR-31, and miR-135b in colitis-associated tumors. Four of these (miR-215, miR-708, miR-31, and miR-135b) were common to both tumors types, and dysregulation of these miRNAs was confirmed in an independent sample set. Target prediction and pathway analysis suggests that these microRNAs, in the aggregate, regulate signaling pathways related to MAPK, PI3K, WNT, and TGF-beta, all of which are known to be involved in transformation. Conclusions/Significance: We conclude that these four miRNAs are dysregulated at some very early stage in transformation of colonic epithelial cells. This response is not dependent on the mechanism of initiation of transformation (inflammation versus germline mutation), suggesting that the miRNAs that we have identified are likely to regulate critical signaling pathways that are central to early events in transformation of colonic epithelial cells.	[Necela, Brian M.; Carr, Jennifer M.; Thompson, E. Aubrey] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Asmann, Yan W.] Mayo Clin, Coll Med, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Necela, BM (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	thompson.aubrey@mayo.edu			CCFA	CCFA	This work was funded in part by a CCFA Career Development Award to BMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BONI V, 2010, MOL CANC THER; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Earle JSL, 2010, J MOL DIAGN, V12, P433, DOI 10.2353/jmoldx.2010.090154; Fantini MC, 2008, CURR DRUG TARGETS, V9, P375, DOI 10.2174/138945008784221206; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; GUSEV Y, MICRORNA PROFILING C, P257; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; La Rocca G, 2009, CELL CYCLE, V8, P2255, DOI 10.4161/cc.8.14.9026; Lanza G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-54; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Maatouk D, 2006, THESCIENTIFICWORLDJO, V6, P1828, DOI 10.1100/tsw.2006.313; Michael MZ, 2003, MOL CANCER RES, V1, P882; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Seril DN, 2002, CARCINOGENESIS, V23, P993, DOI 10.1093/carcin/23.6.993; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007; Sun ZH, 2010, INT J CORROS, V2010, DOI 10.1155/2010/528573; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522	64	57	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18501	10.1371/journal.pone.0018501	http://dx.doi.org/10.1371/journal.pone.0018501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532750	gold, Green Published, Green Submitted			2022-12-27	WOS:000289404700015
J	Lorbeck, M; Pirooznia, K; Sarthi, J; Zhu, XM; Elefant, F				Lorbeck, Meridith; Pirooznia, Keerthy; Sarthi, Jessica; Zhu, Xianmin; Elefant, Felice			Microarray Analysis Uncovers a Role for Tip60 in Nervous System Function and General Metabolism	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; DOUBLE-STRAND BREAKS; RUBINSTEIN-TAYBI-SYNDROME; HISTONE ACETYLTRANSFERASE; DROSOPHILA-MELANOGASTER; SYNAPTIC PLASTICITY; CHROMATIN-STRUCTURE; CO-REPRESSOR; MYST FAMILY; GLIAL-CELLS	Background: Tip60 is a key histone acetyltransferase (HAT) enzyme that plays a central role in diverse biological processes critical for general cell function; however, the chromatin-mediated cell-type specific developmental pathways that are dependent exclusively upon the HAT activity of Tip60 remain to be explored. Methods and Findings: Here, we investigate the role of Tip60 HAT activity in transcriptional control during multicellular development in vivo by examining genome-wide changes in gene expression in a Drosophila model system specifically depleted for endogenous dTip60 HAT function. Conclusions: We show that amino acid residue E431 in the catalytic HAT domain of dTip60 is critical for the acetylation of endogenous histone H4 in our fly model in vivo, and demonstrate that dTip60 HAT activity is essential for multicellular development. Moreover, our results uncover a novel role for Tip60 HAT activity in controlling neuronal specific gene expression profiles essential for nervous system function as well as a central regulatory role for Tip60 HAT function in general metabolism.	[Lorbeck, Meridith; Pirooznia, Keerthy; Sarthi, Jessica; Zhu, Xianmin; Elefant, Felice] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Lorbeck, M (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	fe22@drexel.edu	Zhu, Xianmin/M-6437-2017	Zhu, Xianmin/0000-0003-1405-9700	National Institutes of Health [1R01HD057939]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a National Institutes of Health grant (www.nichd.nih.gov) 1R01HD057939 to FE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clarke AS, 2006, MOL BIOL CELL, V17, P1744, DOI 10.1091/mbc.E05-07-0613; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gorski MM, 2004, DNA REPAIR, V3, P603, DOI 10.1016/j.dnarep.2004.02.001; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; MATHIS DJ, 1978, NUCLEIC ACIDS RES, V5, P3523, DOI 10.1093/nar/5.10.3523; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Park JH, 2010, MOL CELL BIOL, V30, P2750, DOI 10.1128/MCB.00804-09; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; POULSON DF, 1994, BIOL DROSOPHILA, P168; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schirling C, 2010, CHROMOSOMA, V119, P99, DOI 10.1007/s00412-009-0247-z; Shilova VY, 2006, GENETICS, V173, P809, DOI 10.1534/genetics.105.053959; Singh N, 2010, J NEUROCHEM, V115, P493, DOI 10.1111/j.1471-4159.2010.06892.x; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sweatt JD, 2010, SCIENCE, V328, P701, DOI 10.1126/science.1189968; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Todd PK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001240; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063; Zhu XM, 2007, GENETICS, V175, P1229, DOI 10.1534/genetics.106.063685	79	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18412	10.1371/journal.pone.0018412	http://dx.doi.org/10.1371/journal.pone.0018412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494552	gold, Green Submitted, Green Published			2022-12-27	WOS:000289354100011
J	Tang, J; Yu, YZ; Wu, Y; Du, YK; Ma, Y; Zhu, HP; Zhang, P; Liu, ZY				Tang, Jie; Yu, Yizhen; Wu, Yu; Du, Yukai; Ma, Ying; Zhu, Huiping; Zhang, Ping; Liu, Zhuoya			Association between Non-Suicidal Self-Injuries and Suicide Attempts in Chinese Adolescents and College Students: A Cross-Section Study	PLOS ONE			English	Article							RISK-FACTORS; YOUNG-PEOPLE; HARM; POPULATION; PREVALENCE; BEHAVIOR; FEATURES; IDEATION; PATTERN	This study examined the association between non-suicidal self-injury (NSSI) and suicide attempts among Chinese adolescents and college students. Methods: A total sample of 2013 Chinese students were randomly selected from five schools in Wuhan, China, including 1101 boys and 912 girls with the age ranging between 10 and 24 years. NSSI, suicidal ideation, suicide attempts and depressive symptoms were measured by self-rated questionnaires. Self-reported suicide attempts were regressed on suicidal ideation and NSSI, controlling for participants' depressive symptoms, and demographic characteristics. Results: The self-reported prevalence rates of NSSI, suicidal ideation, suicide attempts were 15.5%, 8.8%, and 3.5%, respectively. Logistic regression analyses indicated that NSSI was significantly associated with self-reported suicide attempts. Analyses examining the conditional association of NSSI and suicidal ideation with self-reported suicide attempts revealed that NSSI was significantly associated with greater risk of suicide attempts in those not reporting suicidal ideation than those reporting suicidal ideation in the past year. Conclusions: These findings highlight the importance of NSSI as a potentially independent risk factor for suicide attempts among Chinese/Han adolescents and college students.	[Tang, Jie; Yu, Yizhen; Wu, Yu; Du, Yukai; Zhu, Huiping; Zhang, Ping; Liu, Zhuoya] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Hubei, Peoples R China; [Ma, Ying] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology	Tang, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Hubei, Peoples R China.	duyukai100@yahoo.com.cn	Jie, Tang/AAS-7192-2021	Tang, Jie/0000-0002-0568-8444	National High-Tech Research and Development Program [2006AA02Z427]	National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	The study was supported by the National High-Tech Research and Development Program ("863" Program) ( Grant No. 2006AA02Z427; http://www.nsfc.gov.cn/Portal0/default124.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETTE L, 2003, AM J PSYCHIAT, V160, P1093; Aseltine RH, 2004, AM J PUBLIC HEALTH, V94, P446, DOI 10.2105/AJPH.94.3.446; BENJAMIN N, 2007, PEDIATRICS, V120, P669; Borges G, 2008, J AFFECT DISORDERS, V105, P25, DOI 10.1016/j.jad.2007.01.036; Brener ND, 2000, SUICIDE LIFE-THREAT, V30, P304; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Brown MZ, 2002, J ABNORM PSYCHOL, V111, P198, DOI 10.1037//0021-843X.111.1.198; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P471; Chen JQ, 2006, J ADOLESCENT HEALTH, V38, P544, DOI 10.1016/j.jadohealth.2005.04.001; Conner KR, 2004, SUICIDE LIFE-THREAT, V34, P89, DOI 10.1521/suli.34.2.89.32780; ELIZABETH AS, 2009, J ADOLESCENT HEALTH, V44, P335, DOI DOI 10.1016/J.JADOHEALTH.2008.08.006; Evans E, 2005, SUICIDE LIFE-THREAT, V35, P239, DOI 10.1521/suli.2005.35.3.239; Gratz KL, 2003, CLIN PSYCHOL-SCI PR, V10, P192, DOI 10.1093/clipsy/bpg022; Greydanus Donald E., 2009, Keio Journal of Medicine, V58, P144; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; Isacsson G, 2001, BMJ-BRIT MED J, V322, P213, DOI 10.1136/bmj.322.7280.213; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Klonsky ED, 2008, J CONSULT CLIN PSYCH, V76, P22, DOI 10.1037/0022-006X.76.1.22; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; LI XY, 2001, CHINESE J PUBLIC HLT, V17, P658; Lloyd E. E., 1997, ANN M SOC BEHAV MED; Lloyd-Richardson EE, 2007, PSYCHOL MED, V37, P1183, DOI 10.1017/S003329170700027X; Murray Craig David, 2008, Psychol Health Med, V13, P29, DOI 10.1080/13548500701235757; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Nock MK, 2005, J ABNORM PSYCHOL, V114, P140, DOI 10.1037/0021-843X.114.1.140; PATRICK LK, 2010, JABFM, V23, P240; Penn JV, 2003, J AM ACAD CHILD PSY, V42, P762, DOI 10.1097/01.CHI.0000046869.56865.46; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2004, LANCET, V364, P1062, DOI 10.1016/S0140-6736(04)17061-X; Plener PL, 2009, PSYCHOL MED, V39, P1549, DOI 10.1017/S0033291708005114; Portzky G, 2008, EUR CHILD ADOLES PSY, V17, P179, DOI 10.1007/s00787-007-0652-x; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Shaffer D, 2001, J AM ACAD CHILD PSY, V40, p24S, DOI 10.1097/00004583-200107001-00003; SIMEON D, 2001, SELF INJURIOUS BEHAV, P25; Simon TR, 2001, SUICIDE LIFE-THREAT, V32, P49, DOI 10.1521/suli.32.1.5.49.24212; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; STANLEY B, 1992, International Review of Psychiatry, V4, P149, DOI 10.3109/09540269209066312; Syed EU, 2008, CRISIS, V29, P159, DOI 10.1027/0227-5910.29.3.159; TIAN Y, 2008, PIONEERING SCI TECHN, V3, P95; Whitlock J, 2008, J CLIN CHILD ADOLESC, V37, P725, DOI 10.1080/15374410802359734; YUAN C, 2008, CHINA J SCH HLTH, V29, P997	47	73	83	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e17977	10.1371/journal.pone.0017977	http://dx.doi.org/10.1371/journal.pone.0017977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	747AP	21494656	Green Published, gold			2022-12-27	WOS:000289292800002
J	Jiang, P; Li, JB; Han, F; Duan, GF; Lu, XZ; Gu, YC; Yu, WG				Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong			Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp QY101	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; STAPHYLOCOCCUS-EPIDERMIDIS; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; RESISTANCE; PROTECTS; ADHESION; AUREUS; IDENTIFICATION	Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.	[Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Peoples R China; [Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong] Ocean Univ China, Lab Glycobiol, Sch Med & Pharm, Qingdao, Peoples R China; [Li, Jingbao] Northwestern Polytech Univ, Fac Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Ocean University of China; Ocean University of China; Ocean University of China; Northwestern Polytechnical University	Jiang, P (corresponding author), Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.	yuwg66@ouc.edu.cn	Han, Feng/AAX-3761-2021	Han, Feng/0000-0001-5706-7028	National High-tech RD Program [2007AA09Z418, 2007AA091506]; National ST Major Project [2009ZX09301-013]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0944]; Special Fund for Marine Scientific Research in the Public Interest [201005024]	National High-tech RD Program(National High Technology Research and Development Program of China); National ST Major Project; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Marine Scientific Research in the Public Interest	This work was supported by the National High-tech R&D Program, number 2007AA09Z418 and 2007AA091506, http://www.most.gov.cn/? the National S&T Major Project, number 2009ZX09301-013, http://www.nmp.gov.cn/; the Program for Changjiang Scholars and Innovative Research Team in University, number IRT0944, http://www.dost.moe.edu.cn/; the Special Fund for Marine Scientific Research in the Public Interest, number 201005024?http://www.soa.gov.cn/soa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Antiporta MH, 2002, J BACTERIOL, V184, P1155, DOI 10.1128/jb.184.4.1155-1162.2002; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Bianciotto V, 2001, EUR J HISTOCHEM, V45, P39; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Carte Brad K., 1993, Current Opinion in Biotechnology, V4, P275, DOI 10.1016/0958-1669(93)90095-E; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Defives C, 1996, CURR MICROBIOL, V33, P371, DOI 10.1007/s002849900130; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FALCIERI E, 1987, J INFECT DIS, V155, P524, DOI 10.1093/infdis/155.3.524; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667; Gonzalez JE, 1996, GENE, V179, P141, DOI 10.1016/S0378-1119(96)00322-8; Greenberg EP, 2003, NATURE, V424, P134, DOI 10.1038/424134a; Guo SD, 2010, BIORESOURCE TECHNOL, V101, P4729, DOI 10.1016/j.biortech.2010.01.125; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoyle B D, 1991, Prog Drug Res, V37, P91; Hsieh YC, 2003, INFECT IMMUN, V71, P3329, DOI 10.1128/IAI.71.6.3329-3336.2003; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; JANN K, 1980, J BACTERIOL, V143, P1108, DOI 10.1128/JB.143.3.1108-1115.1980; JOHNSON MC, 1977, J BACTERIOL, V129, P351, DOI 10.1128/JB.129.1.351-357.1977; Joseph LA, 2004, J BACTERIOL, V186, P889, DOI 10.1128/JB.186.3.889-893.2004; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Kierek K, 2003, P NATL ACAD SCI USA, V100, P14357, DOI 10.1073/pnas.2334614100; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Langille SE, 2000, J IND MICROBIOL BIOT, V25, P81, DOI 10.1038/sj.jim.7000033; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007; Nemoto K, 2000, CHEMOTHERAPY, V46, P111, DOI 10.1159/000007264; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; PIER GB, 1994, INFECT IMMUN, V62, P3972, DOI 10.1128/IAI.62.9.3972-3979.1994; Pihl M, 2010, FEMS IMMUNOL MED MIC, V59, P439, DOI 10.1111/j.1574-695X.2010.00697.x; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; REDDY GP, 1993, ANAL BIOCHEM, V214, P106, DOI 10.1006/abio.1993.1463; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; Ruas-Madiedo P, 2006, J FOOD PROTECT, V69, P2011, DOI 10.4315/0362-028X-69.8.2011; Sahly H, 2008, INFECT IMMUN, V76, P1322, DOI 10.1128/IAI.00910-07; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Song K, 2003, ACTA BIOCH BIOPH SIN, V35, P473; Stapper AP, 2004, J MED MICROBIOL, V53, P679, DOI 10.1099/jmm.0.45539-0; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sun HH, 2009, CARBOHYD POLYM, V78, P117, DOI 10.1016/j.carbpol.2009.04.017; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yoshida Yasuo, 2006, BMC Oral Health, V6 Suppl 1, pS12, DOI 10.1186/1472-6831-6-S1-S12; You JL, 2007, APPL MICROBIOL BIOT, V76, P1137, DOI 10.1007/s00253-007-1074-x; ZAJAC E, 1983, J GEN MICROBIOL, V129, P3171	79	96	105	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18514	10.1371/journal.pone.0018514	http://dx.doi.org/10.1371/journal.pone.0018514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490923	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700018
J	Kelly, TR; Bloom, PH; Torres, SG; Hernandez, YZ; Poppenga, RH; Boyce, WM; Johnson, CK				Kelly, Terra R.; Bloom, Peter H.; Torres, Steve G.; Hernandez, Yvette Z.; Poppenga, Robert H.; Boyce, Walter M.; Johnson, Christine K.			Impact of the California Lead Ammunition Ban on Reducing Lead Exposure in Golden Eagles and Turkey Vultures	PLOS ONE			English	Article							BALD EAGLES; SHOT; INGESTION; CONDORS; HAZARDS; PELLETS; DUCKS	Predatory and scavenging birds may be exposed to high levels of lead when they ingest shot or bullet fragments embedded in the tissues of animals injured or killed with lead ammunition. Lead poisoning was a contributing factor in the decline of the endangered California condor population in the 1980s, and remains one of the primary factors threatening species recovery. In response to this threat, a ban on the use of lead ammunition for most hunting activities in the range of the condor in California was implemented in 2008. Monitoring of lead exposure in predatory and scavenging birds is essential for assessing the effectiveness of the lead ammunition ban in reducing lead exposure in these species. In this study, we assessed the effectiveness of the regulation in decreasing blood lead concentration in two avian sentinels, golden eagles and turkey vultures, within the condor range in California. We compared blood lead concentration in golden eagles and turkey vultures prior to the lead ammunition ban and one year following implementation of the ban. Lead exposure in both golden eagles and turkey vultures declined significantly post-ban. Our findings provide evidence that hunter compliance with lead ammunition regulations was sufficient to reduce lead exposure in predatory and scavenging birds at our study sites.	[Kelly, Terra R.; Hernandez, Yvette Z.; Boyce, Walter M.; Johnson, Christine K.] Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Bloom, Peter H.] Univ Idaho, Dept Fish & Wildlife, Moscow, ID 83843 USA; [Torres, Steve G.] Calif Dept Fish & Game, Wildlife Invest Lab, Rancho Cordova, CA 95670 USA	University of California System; University of California Davis; Idaho; University of Idaho	Kelly, TR (corresponding author), Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA.	trkelly@ucdavis.edu			California State Wildlife Grant [T-12-1]	California State Wildlife Grant	California State Wildlife Grant "Heavy Metal Contamination in Sentinel Wildlife Species," Grant # T-12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WL, 2000, J WILDLIFE MANAGE, V64, P848, DOI 10.2307/3802755; BELLROSE FRANK C., 1959, ILLINOIS NAT HIST SURV BULL, V27, P235; Bloom P., 1987, NATL WILDL FED SCI T, V10, P99; Bloom Peter H., 2001, North American Bird Bander, V26, P97; *CA DEP FISH GAM, 2008, ATT HUNT ITS TIM GET; *CA DEP FISH GAM, 2007, REP 2007 GAM TAK HUN; *CA DEP FISH GAM, 2009, 2008 CAL DEER KILL R; *CA DEP FISH GAM, 2008, 2008 2009 WILD PIG H; *CA DEP FISH GAM, 2009, 2007 2008 WILD PIG T; *CA DEP FISH GAM, 2010, CERT NONL AMM; *CA DEP FISH GAM, 2008, 2007 CAL DEER KILL R; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; Carpenter JW, 2003, J WILDLIFE DIS, V39, P96, DOI 10.7589/0090-3558-39.1.96; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Clark AJ, 2003, ECOTOXICOLOGY, V12, P23, DOI 10.1023/A:1022576510445; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; ESKILDSEN J, 1984, TOXICOL LETT, V21, P225, DOI 10.1016/0378-4274(84)90211-X; FEIERABEND JS, 1983, NATL WILDLIFE FEDERA, V8; Franson J. Christian, 1996, P265; FRY M.D., 2003, ASSESSMENT LEAD CONT; GarciaFernandez AJ, 1997, ARCH ENVIRON CON TOX, V33, P76, DOI 10.1007/s002449900226; GILL CE, 1994, CAN VET J, V35, P303; HAAS G H, 1977, Wildlife Society Bulletin, V5, P123; Henckel E, 1981, N AM BIRD BANDER, V6, P106; HOFFMAN DJ, 1981, J WILDLIFE DIS, V17, P423, DOI 10.7589/0090-3558-17.3.423; HOSMER DW, 2000, WILEY PS TX, P1; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; JACKMAN RE, 1994, J RAPTOR RES, V28, P268; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Kenntner N, 2001, ENVIRON TOXICOL CHEM, V20, P1831, DOI [10.1897/1551-5028(2001)020&lt;1831:HMISTO&gt;2.0.CO;2, 10.1002/etc.5620200829]; Kirk David A., 1998, BIRDS N AM; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Kochert M. N., 2002, BIRDS N AM ONLINE; Kramer JL, 1997, J RAPTOR RES, V31, P327; Krone O, 2006, AMBIO, V35, P98, DOI 10.1579/0044-7447(2006)35[98:MFHBAC]2.0.CO;2; Krone Oliver, 2009, P289, DOI 10.4080/ilsa.2009.0207; Locke Louis N., 1996, P108; LOPAKA L, 2009, NADA NONDETECTS DATA; Miller MJR, 1998, J WILDLIFE DIS, V34, P704, DOI 10.7589/0090-3558-34.4.704; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PAIN DJ, 1993, BIOL CONSERV, V81, P1; Pattee O.H., 1983, Transactions of the North American Wildlife and Natural Resources Conference, V48, P230; PATTEE OH, 1990, CONDOR, V92, P931, DOI 10.2307/1368729; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Core Team, 2020, R LANG ENV STAT COMP; Saito Keisuke, 2009, P302, DOI 10.4080/ilsa.2009.0304; Samuel MD, 2000, J WILDLIFE MANAGE, V64, P947, DOI 10.2307/3803203; Sanderson G.C., 1986, REV PROBLEM LEAD POI; Scheuhammer AM, 1996, ECOTOXICOLOGY, V5, P279, DOI 10.1007/BF00119051; SEIG R, 2009, INGESTION LEAD SPENT, P341, DOI DOI 10.4080/ILSA.2009.0309; Snyder NFR., 2000, CALIFORNIA CONDOR SA; STEPHENS R, 2009, INGESTION LEAD SPENT, P232, DOI DOI 10.4080/ILSA.2009.0212; *US FISH WILDL SER, 1986, US LEAD SHOT HUNT MI; *US FISH WILDL SER, 2009, NONT SHOT REG HUNT W; Wayland M, 1999, ENVIRON POLLUT, V104, P341, DOI 10.1016/S0269-7491(98)00201-2; Wayland M, 2003, J RAPTOR RES, V37, P8; 2009, SHOOTING SPORTS NEWS	58	42	42	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e17656	10.1371/journal.pone.0017656	http://dx.doi.org/10.1371/journal.pone.0017656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494329	Green Published, gold			2022-12-27	WOS:000289192400004
J	Lemaire, K; Moura, RF; Granvik, M; Igoillo-Esteve, M; Hohmeier, HE; Hendrickx, N; Newgard, CB; Waelkens, E; Cnop, M; Schuit, F				Lemaire, Katleen; Moura, Rodrigo F.; Granvik, Mikaela; Igoillo-Esteve, Mariana; Hohmeier, Hans E.; Hendrickx, Nico; Newgard, Christopher B.; Waelkens, Etienne; Cnop, Miriam; Schuit, Frans			Ubiquitin Fold Modifier 1 (UFM1) and Its Target UFBP1 Protect Pancreatic Beta Cells from ER Stress-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STIMULATED INSULIN-SECRETION; FREE FATTY-ACIDS; BINDING PROTEIN; TRANSLATIONAL CONTROL; DIABETES-MELLITUS; OXIDATIVE STRESS; MESSENGER-RNA; ISLET CELLS; KAPPA-B	UFM1 is a member of the ubiquitin like protein family. While the enzymatic cascade of UFM1 conjugation has been elucidated in recent years, the biological function remains largely unknown. In this report we demonstrate that the recently identified C20orf116 [1], which we name UFM1-binding protein 1 containing a PCI domain (UFBP1), and CDK5RAP3 interact with UFM1. Components of the UFM1 conjugation pathway (UFM1, UFBP1, UFL1 and CDK5RAP3) are highly expressed in pancreatic islets of Langerhans and some other secretory tissues. Co-localization of UFM1 with UFBP1 in the endoplasmic reticulum (ER) depends on UFBP1. We demonstrate that ER stress, which is common in secretory cells, induces expression of Ufm1, Ufbp1 and Ufl1 in the beta-cell line INS-1E. siRNA-mediated Ufm1 or Ufbp1knockdown enhances apoptosis upon ER stress. Silencing the E3 enzyme UFL1, results in similar outcomes, suggesting that UFM1-UFBP1 conjugation is required to prevent ER stress-induced apoptosis. Together, our data suggest that UFM1-UFBP1participate in preventing ER stress-induced apoptosis in protein secretory cells.	[Lemaire, Katleen; Granvik, Mikaela; Hendrickx, Nico; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium; [Moura, Rodrigo F.; Igoillo-Esteve, Mariana; Cnop, Miriam] Univ Libre Brussels, Expt Med Lab, Brussels, Belgium; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC USA; [Igoillo-Esteve, Mariana; Cnop, Miriam] Erasmus Hosp, Div Endocrinol, Brussels, Belgium	KU Leuven; Universite Libre de Bruxelles; Duke University; Duke University; Duke University; Universite Libre de Bruxelles	Lemaire, K (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium.	katleen.lemaire@med.kuleuven.be; frans.schuit@med.kuleuven.be		de Moura, Rodrigo Ferreira/0000-0002-6617-6434; Cnop, Miriam/0000-0002-5112-1692; Igoillo-Esteve, Mariana/0000-0002-3264-7912	F.W.O.-Vlaanderen [G.0733.09]; Interuniversity Attraction Poles [IAP6/14]; K.U.Leuven [GOA2009/10]; Juvenile Diabetes Research Foundation; European Foundation for the Study of Diabetes (EFSD) - Lilly European Diabetes Research Programme; CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel)	F.W.O.-Vlaanderen(FWO); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); K.U.Leuven(KU Leuven); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes (EFSD) - Lilly European Diabetes Research Programme; CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from F.W.O.-Vlaanderen (fellowship to KL and G.0733.09 to FS), Interuniversity Attraction Poles (IAP6/14 to FS and MC), the K.U.Leuven (GOA2009/10 to FS), the Juvenile Diabetes Research Foundation (to FS, HH and CBN) and the European Foundation for the Study of Diabetes (EFSD) - Lilly European Diabetes Research Programme (to MC). RFM. is the recipient of a fellowship from CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang XH, 2005, FEBS J, V272, P3909, DOI 10.1111/j.1742-4658.2005.04807.x; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	54	123	129	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18517	10.1371/journal.pone.0018517	http://dx.doi.org/10.1371/journal.pone.0018517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494687	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400035
J	Kansara, SG; Sukhodolets, MV				Kansara, Seema G.; Sukhodolets, Maxim V.			Oligomerization of the E-coli Core RNA Polymerase: Formation of (alpha(2)beta beta 'omega)(2)-DNA Complexes and Regulation of the Oligomerization by Auxiliary Subunits	PLOS ONE			English	Article							BACTERIAL HOMOLOG; PROTEIN; RAPA; ASSOCIATION; ELONGATION; COMPONENTS; MOLECULES; DYNAMICS; BINDING	In this work, using multiple, dissimilar physico-chemical techniques, we demonstrate that the Escherichia coli RNA polymerase core enzyme obtained through a classic purification procedure forms stable (alpha(2)beta beta'omega)(2) complexes in the presence or absence of short DNA probes. Multiple control experiments indicate that this self-association is unlikely to be mediated by RNA polymerase-associated non-protein molecules. We show that the formation of (alpha(2)beta beta'omega)(2) complexes is subject to regulation by known RNA polymerase interactors, such as the auxiliary SWI/SNF subunit of RNA polymerase RapA, as well as NusA and sigma(70). We also demonstrate that the separation of the core RNA polymerase and RNA polymerase holoenzyme species during Mono Q chromatography is likely due to oligomerization of the core enzyme. We have analyzed the oligomeric state of the polymerase in the presence or absence of DNA, an aspect that was missing from previous studies. Importantly, our work demonstrates that RNA polymerase oligomerization is compatible with DNA binding. Through in vitro transcription and in vivo experiments (utilizing a RapA(R599/Q602) mutant lacking transcription-stimulatory function), we demonstrate that the formation of tandem (alpha(2)beta beta'omega)(2)-DNA complexes is likely functionally significant and beneficial for the transcriptional activity of the polymerase. Taken together, our findings suggest a novel structural aspect of the E. coli elongation complex. We hypothesize that transcription by tandem RNA polymerase complexes initiated at hypothetical bidirectional "origins of transcription'' may explain recurring switches of the direction of transcription in bacterial genomes.	[Kansara, Seema G.; Sukhodolets, Maxim V.] Lamar Univ, Dept Chem & Biochem, Beaumont, TX 77710 USA	Texas State University System; Lamar University	Kansara, SG (corresponding author), Lamar Univ, Dept Chem & Biochem, Beaumont, TX 77710 USA.	msoukhodol@lamar.edu			National Institute of General Medical Sciences [R15GM081803]; Welch Foundation [V-0004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM081803] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant number R15GM081803 from the National Institute of General Medical Sciences (to M. V. S.) (the content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health), a Welch Foundation grant (V-0004), and departmental funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BERG D, 1970, BIOCHEMISTRY-US, V9, P5055; BURGESS R, 1987, RNA POLYMERASE REGUL; BURGESS RR, 1969, J BIOL CHEM, V244, P6168; Das A, 1996, METHOD ENZYMOL, V274, P374; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; HARRIS SJ, 1995, BIOCHEMISTRY-US, V34, P8752, DOI 10.1021/bi00027a026; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; McKinley BA, 2007, NUCLEIC ACIDS RES, V35, P7044, DOI 10.1093/nar/gkm747; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; RICHARDS.JP, 1966, P NATL ACAD SCI USA, V55, P1616, DOI 10.1073/pnas.55.6.1616; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; SQUIRES CL, 1993, P NATL ACAD SCI USA, V90, P970, DOI 10.1073/pnas.90.3.970; STEVENS A, 1966, BIOCHEM BIOPH RES CO, V24, P929, DOI 10.1016/0006-291X(66)90339-1; SUKHODOLETS MV, 1988, FEBS LETT, V238, P161, DOI 10.1016/0014-5793(88)80248-5; Sukhodolets MV, 1998, J BIOL CHEM, V273, P7018, DOI 10.1074/jbc.273.12.7018; Sukhodolets MV, 2003, METHOD ENZYMOL, V370, P283; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Sukhodolets MV, 2000, J BIOL CHEM, V275, P22090, DOI 10.1074/jbc.M000056200; TRAVERS AA, 1982, NUCLEIC ACIDS RES, V10, P5043, DOI 10.1093/nar/10.16.5043; Yawn B, 2009, BIOCHEMISTRY-US, V48, P7794, DOI 10.1021/bi9004123	25	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18990	10.1371/journal.pone.0018990	http://dx.doi.org/10.1371/journal.pone.0018990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533049	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400046
J	Zheng, ZJ; Ma, CQ; Gao, C; Li, FS; Qin, JY; Zhang, HW; Wang, K; Xu, P				Zheng, Zhaojuan; Ma, Cuiqing; Gao, Chao; Li, Fengsong; Qin, Jiayang; Zhang, Haiwei; Wang, Kai; Xu, Ping			Efficient Conversion of Phenylpyruvic Acid to Phenyllactic Acid by Using Whole Cells of Bacillus coagulans SDM	PLOS ONE			English	Article							D-LACTATE DEHYDROGENASE; ANTIFUNGAL ACTIVITY; LACTOBACILLUS; PURIFICATION; CATABOLISM; CATALYSIS	Background: Phenyllactic acid (PLA), a novel antimicrobial compound with broad and effective antimicrobial activity against both bacteria and fungi, can be produced by many microorganisms, especially lactic acid bacteria. However, the concentration and productivity of PLA have been low in previous studies. The enzymes responsible for conversion of phenylpyruvic acid (PPA) into PLA are equivocal. Methodology/Principal Findings: A novel thermophilic strain, Bacillus coagulans SDM, was isolated for production of PLA. When the solubility and dissolution rate of PPA were enhanced at a high temperature, whole cells of B. coagulans SDM could effectively convert PPA into PLA at a high concentration (37.3 g l(-1)) and high productivity (2.3 g l(-1) h(-1)) under optimal conditions. Enzyme activity staining and kinetic studies identified NAD-dependent lactate dehydrogenases as the key enzymes that reduced PPA to PLA. Conclusions/Significance: Taking advantage of the thermophilic character of B. coagulans SDM, a high yield and productivity of PLA were obtained. The enzymes involved in PLA production were identified and characterized, which makes possible the rational design and construction of microorganisms suitable for PLA production with metabolic engineering.	[Zheng, Zhaojuan; Ma, Cuiqing; Li, Fengsong; Qin, Jiayang; Zhang, Haiwei; Wang, Kai; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Gao, Chao; Xu, Ping] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Gao, Chao; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zheng, ZJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn; pingxu@sjtu.edu.cn		Gao, Chao/0000-0002-5205-0670; Ma, Cuiqing/0000-0002-7468-1027	National Basic Research Program of China [2007CB707803]; Chinese National Program for High Technology Research and Development [2006AA020102]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China (2007CB707803) and Chinese National Program for High Technology Research and Development (2006AA020102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2002, PROTEIN ENG, V15, P35, DOI 10.1093/protein/15.1.35; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUDT KH, 1991, Patent No. 4030350; Dieuleveux V, 1998, APPL ENVIRON MICROB, V64, P800; Dieuleveux V, 1998, INT J FOOD MICROBIOL, V40, P177, DOI 10.1016/S0168-1605(98)00031-2; DUNN CR, 1991, PHILOS T ROY SOC B, V332, P177, DOI 10.1098/rstb.1991.0047; Gummalla S, 2001, J DAIRY SCI, V84, P1011, DOI 10.3168/jds.S0022-0302(01)74560-2; HUMMEL W, 1983, EUR J APPL MICROBIOL, V18, P75, DOI 10.1007/BF00500828; KANO S, 1988, J ORG CHEM, V53, P3865, DOI 10.1021/jo00251a042; Lavermicocca P, 2003, APPL ENVIRON MICROB, V69, P634, DOI 10.1128/AEM.69.1.634-640.2003; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; Li XF, 2008, J AGR FOOD CHEM, V56, P2392, DOI 10.1021/jf0731503; Li XF, 2007, BIOTECHNOL LETT, V29, P593, DOI 10.1007/s10529-006-9275-4; Lind H, 2005, INT J FOOD MICROBIOL, V98, P157, DOI 10.1016/j.ijfoodmicro.2004.05.020; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; Marilley L, 2004, INT J FOOD MICROBIOL, V90, P139, DOI 10.1016/S0168-1605(03)00304-0; MORITA H, 1996, Patent No. 5684186; Mu WM, 2009, BIORESOURCE TECHNOL, V100, P5226, DOI 10.1016/j.biortech.2009.05.024; Razeto A, 2002, J MOL BIOL, V318, P109, DOI 10.1016/S0022-2836(02)00086-4; Stoll VS, 1996, STRUCTURE, V4, P437, DOI 10.1016/S0969-2126(96)00049-4; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; TAGUCHI H, 1993, J BIOL CHEM, V268, P18030; Thierry A, 2002, LAIT, V82, P17, DOI 10.1051/lait:2001002; Tokuda C, 2003, J BACTERIOL, V185, P5023, DOI 10.1128/JB.185.16.5023-5026.2003; URBAN FJ, 1992, J HETEROCYCLIC CHEM, V29, P431, DOI 10.1002/jhet.5570290223; Valerio F, 2004, FEMS MICROBIOL LETT, V233, P289, DOI [10.1016/j.femsle.2004.02.020, 10.1111/j.1574-6968.2004.tb09494.x]; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wong H. N. C., 1992, SYNTHESIS-STUTTGART, V8, P793, DOI DOI 10.1055/S-1992-26228; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Yang RX, 2010, ACTA PHARMACOL SIN, V31, P1395, DOI 10.1038/aps.2010.167; Yvon M, 2001, INT DAIRY J, V11, P185, DOI 10.1016/S0958-6946(01)00049-8; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	33	61	83	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19030	10.1371/journal.pone.0019030	http://dx.doi.org/10.1371/journal.pone.0019030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533054	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400052
J	Ball, S; Li, CL; Li, PK; Lin, JY				Ball, Sarah; Li, Chenglong; Li, Pui-Kai; Lin, Jiayuh			The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; MALIGNANT GLIOMA; GROWTH; TUMORS; SIGNAL-TRANSDUCER-AND-ACTIVATOR-OF-TRANSCRIPTION-3; EXPRESSION; INTERLEUKIN-6; TRANSLOCATION; STRATEGIES; SURVIVIN	Tumors of the central nervous system represent a major source of cancer-related deaths, with medulloblastoma and glioblastoma being the most common malignant brain tumors in children and adults respectively. While significant advances in treatment have been made, with the 5-year survival rate for medulloblastoma at 70-80%, treating patients under 3 years of age still poses a problem due to the deleterious effects of radiation on the developing brain, and the median survival for patients with glioblastoma is only 15 months. The transcription factor, STAT3, has been found constitutively activated in a wide variety of cancers and in recent years it has become an attractive therapeutic target. We designed a non-peptide small molecule STAT3 inhibitor, LLL12, using structure-based design. LLL12 was able to inhibit STAT3 phosphorylation, decrease cell viability and induce apoptosis in medulloblastoma and glioblastoma cell lines with elevated levels of p-STAT3 (Y705). IC50 values for LLL12 were found to be between 1.07 mu M and 5.98 mu M in the five cell lines expressing phosphorylated STAT3. STAT3 target genes were found to be downregulated and a decrease in STAT3 DNA binding was observed following LLL12 treatment, indicating that LLL12 is an effective STAT3 inhibitor. LLL12 was also able to inhibit colony formation, wound healing and decreased IL-6 and LIF secretion. Our results suggest that LLL12 is a potent STAT3 inhibitor and that it may be a potential therapeutic treatment for medulloblastoma and glioblastoma.	[Ball, Sarah; Lin, Jiayuh] Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Columbus, OH USA; [Ball, Sarah; Lin, Jiayuh] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Li, Chenglong; Li, Pui-Kai] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ball, S (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Columbus, OH USA.	lin.674@osu.edu	Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719; Li, Pui Kai/0000-0002-4831-7213	department of pediatrics at The Ohio State University	department of pediatrics at The Ohio State University	This research was funded by a start-up grant from the department of pediatrics at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bidros DS, 2009, NEUROTHERAPEUTICS, V6, P539, DOI 10.1016/j.nurt.2009.04.004; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Calvin D. P., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS297, DOI 10.1016/S0360-3016(03)01158-1; *CBTRUS, 2007, PRIM BRAIN TUM US ST; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Collins VP, 1998, CANCER SURV, V32, P37; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; DOHRMANN GJ, 1976, J NEUROSURG, V44, P442, DOI 10.3171/jns.1976.44.4.0442; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu J, 1999, J CANCER RES CLIN, V125, P475, DOI 10.1007/s004320050304; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Mueller S, 2009, NEUROTHERAPEUTICS, V6, P570, DOI 10.1016/j.nurt.2009.04.006; Nicholas M Kelly, 2007, Expert Rev Anticancer Ther, V7, pS23, DOI 10.1586/14737140.7.12s.S23; Pizem J, 2005, NEUROPATH APPL NEURO, V31, P422, DOI 10.1111/j.1365-2990.2005.00664.x; Rosen DG, 2006, CANCER-AM CANCER SOC, V107, P2730, DOI 10.1002/cncr.22293; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Stearns D, 2006, CANCER RES, V66, P673, DOI 10.1158/0008-5472.CAN-05-1580; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	44	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18820	10.1371/journal.pone.0018820	http://dx.doi.org/10.1371/journal.pone.0018820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526200	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100024
J	Isono, T				Isono, Takahiro			O-GlcNAc-Specific Antibody CTD110.6 Cross-Reacts with N-GlcNAc(2)-Modified Proteins Induced under Glucose Deprivation	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE; PROTEOMIC ANALYSIS; BLADDER-CANCER; GLYCOSYLATION; CALRETICULIN; DIVERSITY; PERIOSTIN; STRESS; KINASE; CELLS	Modification of serine and threonine residues in proteins by O-linked beta-N-acetylgulcosamine (O-GlcNAc) glycosylation is a feature of many cellular responses to the nutritional state and to stress. O-GlcNAc modification is reversibly regulated by O-linked beta-N-acetylgulcosamine transferase (OGT) and beta-D-N-acetylgulcosaminase (O-GlcNAcase). O-GlcNAc modification of proteins is dependent on the concentration of uridine 5`-diphospho-N-acetylgulcosamine (UDP-GlcNAc), which is a substrate of OGT and is synthesized via the hexosamine biosynthetic pathway. Immunoblot analysis using the O-GlcNAc-specific antibody CTD110.6 has indicated that glucose deprivation increases protein O-GlcNAcylation in some cancer cells. The mechanism of this paradoxical phenomenon has remained unclear. Here we show that the increased glycosylation induced by glucose deprivation and detected by CTD110.6 antibodies is actually modification by N-GlcNAc(2), rather than by O-GlcNAc. We found that this induced glycosylation was not regulated by OGT and O-GlcNAcase, unlike typical O-GlcNAcylation, and it was inhibited by treatment with tunicamycin, an N-glycosylation inhibitor. Proteomics analysis showed that proteins modified by this induced glycosylation were N-GlcNAc(2)-modified glycoproteins. Furthermore, CTD110.6 antibodies reacted with N-GlcNAc(2)-modified glycoproteins produced by a yeast strain with a ts-mutant of ALG1 that could not add a mannose residue to dolichol-PP-GlcNAc(2). Our results demonstrated that N-GlcNAc(2)-modified glycoproteins were induced under glucose deprivation and that they cross-reacted with the O-GlcNAc-specific antibody CTD110.6. We therefore propose that the glycosylation status of proteins previously classified as O-GlcNAc-modified proteins according to their reactivity with CTD110.6 antibodies must be re-examined. We also suggest that the repression of mature N-linked glycoproteins due to increased levels of N-GlcNAc(2)-modifed proteins is a newly recognized pathway for effective use of sugar under stress and deprivation conditions. Further research is needed to clarify the physiological and pathological roles of N-GlcNAc(2)-modifed proteins.	Shiga Univ Med Sci, Cent Res Lab, Shiga, Japan	Shiga University of Medical Science	Isono, T (corresponding author), Shiga Univ Med Sci, Cent Res Lab, Shiga, Japan.	isono@belle.shiga-med.ac.jp						Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; BUTKINAREE C, 2010, BIOCHIM BIOPHYS ACTA, P96; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cueva R, 1998, YEAST, V14, P773, DOI 10.1002/(SICI)1097-0061(19980615)14:8<773::AID-YEA284>3.3.CO;2-J; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Grubenmann CE, 2004, HUM MOL GENET, V13, P535, DOI 10.1093/hmg/ddh050; HAEUPTLE M, 2009, HUM MUTAT, V130, P1; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Isono T, 2002, CLIN CHEM, V48, P2187; Isono T, 2009, INT J ONCOL, V35, P425, DOI 10.3892/ijo_00000355; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Kageyama S, 2004, CLIN CHEM, V50, P857, DOI 10.1373/clinchem.2003.027425; Kageyama S, 2007, PROTEOM CLIN APPL, V1, P192, DOI 10.1002/prca.200600468; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kim CJ, 2008, INT J ONCOL, V32, P161; KUKURUZINSKA MA, 1994, GLYCOBIOLOGY, V4, P437, DOI 10.1093/glycob/4.4.437; Menniti M, 2005, AM J PHYSIOL-CELL PH, V288, pC148, DOI 10.1152/ajpcell.00284.2004; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	24	70	70	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18959	10.1371/journal.pone.0018959	http://dx.doi.org/10.1371/journal.pone.0018959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526146	Green Submitted, Green Published, gold			2022-12-27	WOS:000289671100041
J	Tractenberg, RE; Pietrzak, RH				Tractenberg, Rochelle E.; Pietrzak, Robert H.			Intra-Individual Variability in Alzheimer's Disease and Cognitive Aging: Definitions, Context, and Effect Sizes	PLOS ONE			English	Article							MINI-MENTAL-STATE; CROSS-DOMAIN VARIABILITY; OLDER-ADULTS; PERFORMANCE VARIABILITY; REACTION-TIME; IMPAIRMENT; DEMENTIA; DECLINE; UTILITY; SCALE	Background/Aims: To explore different definitions of intra-individual variability (IIV) to summarize performance on commonly utilized cognitive tests (Mini Mental State Exam; Clock Drawing Test); compare them and their potential to differentiate clinically-defined populations; and to examine their utility in predicting clinical change in individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Methods: Sample statistics were computed from ADNI cohorts with no cognitive diagnosis, a diagnosis of mild cognitive impairment (MCI), and a diagnosis of possible or probable Alzheimer's disease (AD). Nine different definitions of IIV were computed for each sample, and standardized effect sizes (Cohen's d) were computed for each of these definitions in 500 simulated replicates using scores on the Mini Mental State Exam and Clock Drawing Test. IIV was computed based on test items separately ('within test' IIV) and the two tests together ('across test' IIV). The best performing definition was then used to compute IIV for a third test, the Alzheimer's Disease Assessment Scale-Cognitive, and the simulations and effect sizes were again computed. All effect size estimates based on simulated data were compared to those computed based on the total scores in the observed data. Association between total score and IIV summaries of the tests and the Clinician's Dementia Rating were estimated to test the utility of IIV in predicting clinically meaningful changes in the cohorts over 12- and 24-month intervals. Results: ES estimates differed substantially depending on the definition of IIV and the test(s) on which IIV was based. IIV (coefficient of variation) summaries of MMSE and Clock-Drawing performed similarly to their total scores, the ADAS total performed better than its IIV summary. Conclusion: IIV can be computed within (items) or across (totals) items on commonly-utilized cognitive tests, and may provide a useful additional summary measure of neuropsychological test performance.	[Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Biostat, Washington, DC USA; [Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Bioinformat & Biomath, Washington, DC USA; [Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div,VA Connecticut Healthcare Syst, New Haven, CT USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Tractenberg, Rochelle E.; Pietrzak, Robert H.] Collaborat Res Outcomes & Metr, Washington, DC USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Tractenberg, RE (corresponding author), Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA.	ret7@georgetown.edu	Scharre, Douglas W/E-4030-2011		National Institute on Aging [K01 AG027172]; Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [U19AG010483, K01AG027172, K01AG030514, P30AG010129, U01AG024904] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grant K01 AG027172 from the National Institute on Aging (RET) and in part by the Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder and a private donation (RHP). Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904); ADNI was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. ADNI and its funders and investigators had no role in study design, data selection and analysis, decision to publish, or preparation of the manuscript. ADNI and its funders and investigators were wholly responsible for all data collection under the ADNI protocols. The co-authors have sole responsibility for this study's design, data analysis, decision to publish, and preparation of this manuscript.; RET is an academic editor at PLoS ONE. RHP declares no competing interests. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., and Wyeth, as well as nonprofit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U. S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro-Imaging at the University of California, Los Angeles. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allaire JC, 2005, PSYCHOL AGING, V20, P390, DOI 10.1037/0882-7974.20.3.390; BRITTON TC, 1991, ELECTROEN CLIN NEURO, V81, P186, DOI 10.1016/0168-5597(91)90071-5; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; COHEN J, 1988, STAT POWER ANAL BE E, V2; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIORDANI B, 1990, NEUROLOGY, V40, P1894, DOI 10.1212/WNL.40.12.1894; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Grissom R. J., 2005, EFFECT SIZES RES BRO; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hogan MJ, 2006, BRAIN RES, V1119, P215, DOI 10.1016/j.brainres.2006.08.075; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Hultsch DF., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Kliegel M, 2004, GERONTOLOGY, V50, P39, DOI 10.1159/000074388; LEZAK MD, 2004, NEUROPSYCHOLOGICAL E, V4; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; MOHS RC, 1988, PSYCHOPHARMACOL BULL, V24, P627; Nesselroade JR, 2004, J GERONTOL B-PSYCHOL, V59, pP49, DOI 10.1093/geronb/59.2.P49; Rabbitt P, 2001, Q J EXP PSYCHOL-A, V54, P981, DOI 10.1080/02724980042000534; Rapp MA, 2005, GERONTOLOGY, V51, P206, DOI 10.1159/000083995; Salthouse TA, 2006, J GERONTOL B-PSYCHOL, V61, pP144, DOI 10.1093/geronb/61.3.P144; Schmiedek F, 2009, PSYCHOL AGING, V24, P841, DOI 10.1037/a0017799; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Thomann PA, 2008, BRAIN COGNITION, V67, P88, DOI 10.1016/j.bandc.2007.11.008; Tierney MC, 1997, ARCH NEUROL-CHICAGO, V54, P713, DOI 10.1001/archneur.1997.00550180035009; TRACTENBERG RE, LATENT CLASS APPROAC	34	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e16973	10.1371/journal.pone.0016973	http://dx.doi.org/10.1371/journal.pone.0016973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752EC	21526188	Green Published, Green Submitted, gold			2022-12-27	WOS:000289671100001
J	Liang, SL; He, LJ; Zhao, XD; Miao, Y; Gu, Y; Guo, CC; Xue, ZF; Dou, WJ; Hu, FR; Wu, KC; Nie, YZ; Fan, DM				Liang, Shuli; He, Lijie; Zhao, Xiaodi; Miao, Yu; Gu, Yong; Guo, Changcun; Xue, Zengfu; Dou, Weijia; Hu, Fengrong; Wu, Kaichun; Nie, Yongzhan; Fan, Daiming			MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer	PLOS ONE			English	Article							HEAVY-CHAIN PHOSPHORYLATION; BREAST-CANCER; MYOSIN-IIA; CELL-PROLIFERATION; EXPRESSION; GROWTH; PROFILES; SEQUENCE; DISEASE; BINDING	Background: MicroRNAs (miRNAs) are important regulators that play key roles in tumorigenesis and tumor progression. A previous report has shown that let-7 family members can act as tumor suppressors in many cancers. Through miRNA array, we found that let-7f was downregulated in the highly metastatic potential gastric cancer cell lines GC9811-P and SGC7901-M, when compared with their parental cell lines, GC9811 and SGC7901-NM; however, the mechanism was not clear. In this study, we investigate whether let-7f acts as a tumor suppressor to inhibit invasion and metastasis in gastric cancers. Methodology/Principal: Real-time PCR showed decreased levels of let-7f expression in metastatic gastric cancer tissues and cell lines that are potentially highly metastatic. Cell invasion and migration were significantly impaired in GC9811-P and SGC7901-M cell lines after transfection with let-7f-mimics. Nude mice with xenograft models of gastric cancer confirmed that let-7f could inhibit gastric cancer metastasis in vivo after transfection by the lentivirus pGCsil-GFP-let-7f. Luciferase reporter assays demonstrated that let-7f directly binds to the 3'UTR of MYH9, which codes for myosin IIA, and real-time PCR and Western blotting further indicated that let-7f downregulated the expression of myosin IIA at the mRNA and protein levels. Conclusions/Significance: Our study demonstrated that overexpression of let-7f in gastric cancer could inhibit invasion and migration of gastric cancer cells through directly targeting the tumor metastasis-associated gene MYH9. These data suggest that let-7f may be a novel therapeutic candidate for gastric cancer, given its ability to reduce cell invasion and metastasis.	[Liang, Shuli; He, Lijie; Zhao, Xiaodi; Miao, Yu; Gu, Yong; Guo, Changcun; Xue, Zengfu; Dou, Weijia; Hu, Fengrong; Wu, Kaichun; Nie, Yongzhan; Fan, Daiming] Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China; [Liang, Shuli; He, Lijie; Zhao, Xiaodi; Miao, Yu; Gu, Yong; Guo, Changcun; Xue, Zengfu; Dou, Weijia; Hu, Fengrong; Wu, Kaichun; Nie, Yongzhan; Fan, Daiming] Xijing Hosp Digest Dis, Inst Digest Dis, Xian, Peoples R China; [He, Lijie] Fourth Mil Med Univ, Dept Nephrol, Xijing Hosp, Xian 710032, Peoples R China; [Miao, Yu] Ningxia Med Univ, Dept Gastroenterol, Affiliated Hosp, Yinchuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Ningxia Medical University	Liang, SL (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China.	nieyongzhan@gmail.com			National Natural Science Foundation of China [30801330, 30871143, 81030044]; National Basic Research Program of China [2010CB529300, 2010CB529306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (No. 30801330, No. 30871143, No. 81030044)) and the National Basic Research Program of China (No. 2010CB529300, No. 2010CB529306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Silva J, 2010, EUR RESP J; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	153	170	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18409	10.1371/journal.pone.0018409	http://dx.doi.org/10.1371/journal.pone.0018409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533124	Green Published, Green Submitted, gold			2022-12-27	WOS:000289620100004
J	Cirio, MC; Hui, Z; Haldin, CE; Cosentino, CC; Stuckenholz, C; Chen, XF; Hong, SK; Dawid, IB; Hukriede, NA				Cirio, M. Cecilia; Hui, Zhao; Haldin, Caroline E.; Cosentino, Chiara Cianciolo; Stuckenholz, Carsten; Chen, Xiongfong; Hong, Sung-Kook; Dawid, Igor B.; Hukriede, Neil A.			Lhx1 Is Required for Specification of the Renal Progenitor Cell Field	PLOS ONE			English	Article							CIS-ACTING ELEMENTS; IN-VITRO INDUCTION; HOMEOBOX GENE LIM1; RETINOIC ACID; INTERMEDIATE MESODERM; PRONEPHROS DEVELOPMENT; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; GROWTH-FACTOR; XENOPUS	In the vertebrate embryo, the kidney is derived from the intermediate mesoderm. The LIM-class homeobox transcription factor lhx1 is expressed early in the intermediate mesoderm and is one of the first genes to be expressed in the nephric mesenchyme. In this study, we investigated the role of Lhx1 in specification of the kidney field by either overexpressing or depleting lhx1 in Xenopus embryos or depleting lhx1 in an explant culture system. By overexpressing a constitutively-active form of Lhx1, we established its capacity to expand the kidney field during the specification stage of kidney organogenesis. In addition, the ability of Lhx1 to expand the kidney field diminishes as kidney organogenesis transitions to the morphogenesis stage. In a complimentary set of experiments, we determined that embryos depleted of lhx1, show an almost complete loss of the kidney field. Using an explant culture system to induce kidney tissue, we confirmed that expression of genes from both proximal and distal kidney structures is affected by the absence of lhx1. Taken together our results demonstrate an essential role for Lhx1 in driving specification of the entire kidney field from the intermediate mesoderm.	[Cirio, M. Cecilia; Haldin, Caroline E.; Cosentino, Chiara Cianciolo; Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Hui, Zhao] Chinese Univ Hong Kong, Sch Biomed Sci, Ma Liu Shui, Hong Kong, Peoples R China; [Stuckenholz, Carsten] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Chen, Xiongfong] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Unit Biol Computat, Bethesda, MD USA; [Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Mol Genet Lab, Bethesda, MD USA; [Hukriede, Neil A.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cirio, MC (corresponding author), Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA.	hukriede@pitt.edu	Zhao, Hui/B-8429-2016	Zhao, Hui/0000-0001-8160-6415; Cirio, Cecilia/0000-0001-7693-9792	National Institutes of Health [R01DK069403]; National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053287, ZIAHD001002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK069403 (NAH) and by the intramural research program of the National Institute of Child Health and Human Development (IBD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ariizumi T, 2001, INT J DEV BIOL, V45, P273; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Barnett MW, 1998, DEV GROWTH DIFFER, V40, P47; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Brandli AW, 1999, INT J DEV BIOL, V43, P381; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Brennan HC, 1998, MECH DEVELOP, V75, P127, DOI 10.1016/S0925-4773(98)00094-X; Brennan HC, 1999, DEVELOPMENT, V126, P5847; Carroll TJ, 1996, DEV DYNAM, V206, P131, DOI 10.1002/(SICI)1097-0177(199606)206:2<131::AID-AJA2>3.3.CO;2-I; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Carroll TJ, 1999, DEV GENET, V24, P199, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<199::AID-DVG3>3.0.CO;2-D; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Chan TC, 2000, DEV BIOL, V228, P256, DOI 10.1006/dbio.2000.9951; Chan TC, 1999, NATURWISSENSCHAFTEN, V86, P224, DOI 10.1007/s001140050602; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Cho GS, 2011, DEVELOPMENT, V138, P465, DOI 10.1242/dev.061234; Dagle JM, 2001, DIFFERENTIATION, V69, P75, DOI 10.1046/j.1432-0436.2001.690201.x; DALE L, 1987, DEVELOPMENT, V99, P527; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drews C, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-5; Eid SR, 2001, DIFFERENTIATION, V68, P115, DOI 10.1046/j.1432-0436.2001.680205.x; Faber J., 1994, NORMAL TABLE XENOPUS, P2; FUJII T, 1994, DEV DYNAM, V199, P73, DOI 10.1002/aja.1001990108; Gawantka V, 1998, MECH DEVELOP, V77, P95, DOI 10.1016/S0925-4773(98)00115-4; GODSAVE S, 1994, DEV BIOL, V166, P465, DOI 10.1006/dbio.1994.1330; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Guillaume R, 2009, DEV BIOL, V329, P169, DOI 10.1016/j.ydbio.2009.02.034; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; HERZLINGER D, 1995, SEMIN NEPHROL, V15, P255; Huang S, 1998, DEV GROWTH DIFFER, V40, P189; Hukriede NA, 2003, DEV CELL, V4, P83, DOI 10.1016/S1534-5807(02)00398-2; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; James RG, 2003, DEV BIOL, V253, P109, DOI 10.1006/dbio.2002.0863; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kodjabachian L, 2001, INT J DEV BIOL, V45, P209; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Lemaire P, 1996, TRENDS GENET, V12, P525, DOI 10.1016/S0168-9525(97)81401-1; Mauch TJ, 2000, DEV BIOL, V220, P62, DOI 10.1006/dbio.2000.9623; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MOHUN TJ, 1989, EMBO J, V8, P1153, DOI 10.1002/j.1460-2075.1989.tb03486.x; Moriya N, 2000, DEV GROWTH DIFFER, V42, P593; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Plaisier E, 2005, BBA-GENE STRUCT EXPR, V1727, P106, DOI 10.1016/j.bbaexp.2004.12.005; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Serluca FC, 2001, DEVELOPMENT, V128, P2233; Seufert DW, 1999, DEV BIOL, V215, P233, DOI 10.1006/dbio.1999.9476; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; SLACK JMW, 1993, MECH DEVELOP, V41, P91, DOI 10.1016/0925-4773(93)90040-5; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; Swanhart LM, 2010, INT J DEV BIOL, V54, P731, DOI 10.1387/ijdb.092969ls; TAIRA M, 1994, DEVELOPMENT, V120, P1525; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Toyama R, 1997, DEV DYNAM, V209, P406, DOI 10.1002/(SICI)1097-0177(199708)209:4<406::AID-AJA8>3.3.CO;2-T; Tsang TE, 2000, DEV BIOL, V223, P77, DOI 10.1006/dbio.2000.9733; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; VIZE PD, 1995, DEV BIOL, V171, P531, DOI 10.1006/dbio.1995.1302; VOGELS R, 1993, DEVELOPMENT, V118, P71; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Wu GZ, 2004, EUR J BIOCHEM, V271, P3715, DOI 10.1111/j.1432-1033.2004.04312.x	70	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18858	10.1371/journal.pone.0018858	http://dx.doi.org/10.1371/journal.pone.0018858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526205	Green Published, gold, Green Accepted			2022-12-27	WOS:000289578600036
J	Le Breton, C; Hennion, M; Arimondo, PB; Hyrien, O				Le Breton, Cyrille; Hennion, Magali; Arimondo, Paola B.; Hyrien, Olivier			Replication-Fork Stalling and Processing at a Single Psoralen Interstrand Crosslink in Xenopus Egg Extracts	PLOS ONE			English	Article							DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; FORMING OLIGONUCLEOTIDES; EXCISION-REPAIR; NUCLEASE; CELLS; CHECKPOINT; INITIATION; AGENTS; HELIX	Interstrand crosslink (ICL)-inducing agents block the separation of the two DNA strands. They prevent transcription and replication and are used in clinics for the treatment of cancer and skin diseases. Here, we have introduced a single psoralen ICL at a specific site in plasmid DNA using a triplex-forming-oligonucleotide (TFO)-psoralen conjugate and studied its repair in Xenopus egg extracts that support nuclear assembly and replication of plasmid DNA. Replication forks arriving from either side stalled at the psoralen ICL. In contrast to previous observations with other ICL-inducing agents, the leading strands advanced up to the lesion without any prior pausing. Subsequently, incisions were introduced on one parental strand on both sides of the ICL. These incisions could be detected whether one or both forks reached the ICL. Using small molecule inhibitors, we found that the ATR-Chk1 pathway, but not the ATM-Chk2 pathway, stimulated both the incision step and the subsequent processing of the broken replication intermediates. Our results highlight both similarities and differences in fork stalling and repair induced by psoralen and by other ICL-forming agents.	[Le Breton, Cyrille; Hennion, Magali; Hyrien, Olivier] Ecole Normale Super, CNRS, INSERM, Inst Biol,UMR 8197,U1024, Paris, France; [Hennion, Magali; Arimondo, Paola B.] Museum Natl Hist Nat, CNRS, INSERM, UMR 7196,U565, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN)	Le Breton, C (corresponding author), Ecole Normale Super, CNRS, INSERM, Inst Biol,UMR 8197,U1024, Paris, France.	hyrien@biologie.ens.fr	Hyrien, Olivier/R-5108-2017; Arimondo, Paola B/R-9095-2017	Hyrien, Olivier/0000-0001-8879-675X; Arimondo, Paola B/0000-0001-5175-4396; Hennion, Magali/0000-0002-0352-2790	Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM); Association pour la Recherche sur le Cancer; Ligue Contre le Cancer (Comite de Paris)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer)	This work was supported by fellowships of the Centre National de la Recherche Scientifique (CNRS-www.cnrs.fr) and of the Fondation pour la Recherche Medicale (FRM-www.frm.org) to CLB and grants from the Association pour la Recherche sur le Cancer (www.arc-cancer.net), the Ligue Contre le Cancer (www.ligue-cancer.net) (Comite de Paris) and the Fondation pour la Recherche Medicale (equipe labellisee) to OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Arimondo PB, 1999, CR ACAD SCI III-VIE, V322, P785, DOI 10.1016/S0764-4469(00)80037-2; Arimondo PB, 2002, J BIOL CHEM, V277, P3132, DOI 10.1074/jbc.M110181200; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Blow J J, 1987, Philos Trans R Soc Lond B Biol Sci, V317, P483, DOI 10.1098/rstb.1987.0075; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Christensen LA, 2008, NUCLEIC ACIDS RES, V36, P7136, DOI 10.1093/nar/gkn880; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; COUVEPRIVAT S, 2009, J BIOL CHEM; DARDALHON M, 1995, MUTAT RES-DNA REPAIR, V336, P49, DOI 10.1016/0921-8777(94)00037-7; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; Fierro-Fernandez M, 2007, J BIOL CHEM, V282, P18190, DOI 10.1074/jbc.M701559200; Grillari J, 2007, NUCLEIC ACIDS RES, V35, P7566, DOI 10.1093/nar/gkm1065; Guieysse AL, 2000, J MOL BIOL, V296, P373, DOI 10.1006/jmbi.1999.3466; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARAN TE, 1988, BIOCHEMISTRY-US, V27, P6967, DOI 10.1021/bi00418a044; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; KUMARESAN KR, 1992, BIOCHEMISTRY-US, V31, P6774, DOI 10.1021/bi00144a018; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lacroix L, 1999, BIOCHEMISTRY-US, V38, P1893, DOI 10.1021/bi982290q; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lu XY, 2005, BIOCHEM BIOPH RES CO, V336, P69, DOI 10.1016/j.bbrc.2005.08.042; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Malinge JM, 1999, J INORG BIOCHEM, V77, P23, DOI 10.1016/S0162-0134(99)00148-8; MALINGE JM, 1994, NUCLEIC ACIDS RES, V22, P3834, DOI 10.1093/nar/22.19.3834; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; McHugh PJ, 1999, NUCLEIC ACIDS RES, V27, P3259, DOI 10.1093/nar/27.16.3259; MILLER RD, 1982, MOL CELL BIOL, V2, P939, DOI 10.1128/MCB.2.8.939; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Oussedik K, 2010, FASEB J, V24, P2235, DOI 10.1096/fj.09-132324; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Rouse J, 2009, BIOCHEM SOC T, V37, P495, DOI 10.1042/BST0370495; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023	45	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18554	10.1371/journal.pone.0018554	http://dx.doi.org/10.1371/journal.pone.0018554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525992	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600014
J	Buclin, T; Telenti, A; Perera, R; Csajka, C; Furrer, H; Aronson, JK; Glasziou, PP				Buclin, Thierry; Telenti, Amalio; Perera, Rafael; Csajka, Chantal; Furrer, Hansjakob; Aronson, Jeffrey K.; Glasziou, Paul P.			Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; IMMUNODEFICIENCY-VIRUS-INFECTION; VIRAL LOAD; IMMUNOLOGICAL PROGRESSION; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; DISEASE PROGRESSION; RNA LEVELS; SEROCONVERSION; AIDS	Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therapy in patients with HIV-1 infection, there are no evidence-based recommendations regarding its optimal frequency. It is common practice to monitor every 3 to 6 months, often coupled with viral load monitoring. We developed rules to guide frequency of CD4 cell count monitoring in HIV infection before starting antiretroviral therapy, which we validated retrospectively in patients from the Swiss HIV Cohort Study. Methodology/Principal Findings: We built up two prediction rules ("Snap-shot rule" for a single sample and "Track-shot rule" for multiple determinations) based on a systematic review of published longitudinal analyses of CD4 cell count trajectories. We applied the rules in 2608 untreated patients to classify their 18 061 CD4 counts as either justifiable or superfluous, according to their prior >= 5% or < 5% chance of meeting predetermined thresholds for starting treatment. The percentage of measurements that both rules falsely deemed superfluous never exceeded 5%. Superfluous CD4 determinations represented 4%, 11%, and 39% of all actual determinations for treatment thresholds of 500, 350, and 200x10(6)/L, respectively. The Track-shot rule was only marginally superior to the Snap-shot rule. Both rules lose usefulness for CD4 counts coming near to treatment threshold. Conclusions/Significance: Frequent CD4 count monitoring of patients with CD4 counts well above the threshold for initiating therapy is unlikely to identify patients who require therapy. It appears sufficient to measure CD4 cell count 1 year after a count > 650 for a threshold of 200, > 900 for 350, or > 1150 for 500x10(6)/L, respectively. When CD4 counts fall below these limits, increased monitoring frequency becomes advisable. These rules offer guidance for efficient CD4 monitoring, particularly in resource-limited settings.	[Buclin, Thierry; Csajka, Chantal] Univ Hosp Ctr, Div Clin Pharmacol & Toxicol, Lausanne, Switzerland; [Buclin, Thierry; Telenti, Amalio; Csajka, Chantal] Univ Lausanne, Lausanne, Switzerland; [Telenti, Amalio] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Telenti, Amalio] Univ Hosp Ctr, Swiss HIV Cohort Study Board, Lausanne, Switzerland; [Buclin, Thierry; Perera, Rafael; Aronson, Jeffrey K.; Glasziou, Paul P.] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford, England; [Csajka, Chantal] Univ Geneva & Lausanne, Dept Pharmaceut Sci, Clin Pharm Unit, Lausanne, Switzerland; [Furrer, Hansjakob] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Hosp Bern, Swiss HIV Cohort Study Board, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland	University of Lausanne; University of Oxford; University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Buclin, T (corresponding author), Univ Hosp Ctr, Div Clin Pharmacol & Toxicol, Lausanne, Switzerland.	thierry.buclin@chuv.ch	Buclin, Thierry/P-1640-2014; Telenti, Amalio/AAY-1674-2021; VALLET, Yannick/F-9979-2011; Glasziou, Paul/A-7832-2008; Furrer, Hansjakob/G-6768-2013	Buclin, Thierry/0000-0003-0639-5536; Glasziou, Paul/0000-0001-7564-073X; Furrer, Hansjakob/0000-0002-1375-3146; Csajka, Chantal/0000-0002-0660-082X; Perera, Rafael/0000-0003-2418-2091	Faculty of Biology and Medicine of the University of Lausanne	Faculty of Biology and Medicine of the University of Lausanne	The study received financial support from the Faculty of Biology and Medicine of the University of Lausanne. The Centre for Evidence-Based Medicine at the University of Oxford provided logistic support and scientific supervision. The study was performed in the framework of the Swiss HIV Cohort Study (SHCS), supported by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Bakari M, 2008, SCAND J INFECT DIS, V40, P407, DOI 10.1080/00365540701708285; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Boscardin W J, 1998, Stat Methods Med Res, V7, P13; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; Daar ES, 2005, AIDS, V19, P871, DOI 10.1097/01.aids.0000171400.15619.e1; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DEGRUTTOLA V, 1991, J AM STAT ASSOC, V86, P569, DOI 10.2307/2290384; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Faucett CL, 1996, STAT MED, V15, P1663, DOI 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1; GLASZIOU P, 2008, EVIDENCE BASED MEDIC, P376; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Hammer SM, 2005, NEW ENGL J MED, V353, P1702, DOI 10.1056/NEJMcp051203; HOOVER DR, 1992, J ACQ IMMUN DEF SYND, V5, P794; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kent DM, 2003, CLIN INFECT DIS, V37, pS13, DOI 10.1086/375368; Kimmel AD, 2006, B WORLD HEALTH ORGAN, V84, P581, DOI 10.2471/BLT.05.021865; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; LANGE N, 1992, J AM STAT ASSOC, V87, P615, DOI 10.2307/2290194; Laurent C, 2002, J INFECT DIS, V186, P486, DOI 10.1086/341833; Lepri AC, 1997, J INFECT DIS, V175, P775, DOI 10.1086/513970; Lomax N, 2009, HIV MED, V10, P125, DOI 10.1111/j.1468-1293.2008.00642.x; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; May M, 2009, J INFECT DIS, V200, P1729, DOI 10.1086/648096; McNeil AJ, 1997, STAT MED, V16, P2555, DOI 10.1002/(SICI)1097-0258(19971130)16:22&lt;2555::AID-SIM690&gt;3.0.CO;2-Y; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Phair JP, 2002, AIDS, V16, P2455, DOI 10.1097/00002030-200212060-00011; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2007, BRIT MED J, V334, P76, DOI 10.1136/bmj.39064.406389.94; Piroth L, 2004, EUR J EPIDEMIOL, V19, P597, DOI 10.1023/B:EJEP.0000032378.98991.59; Raboud JM, 1996, J INFECT DIS, V174, P191, DOI 10.1093/infdis/174.1.191; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; SHEINER LB, 1979, CLIN PHARMACOL THER, V26, P294; Smit C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001949; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Stevens RJ, 2010, STAT METHODS MED RES, V19, P394, DOI 10.1177/0962280209359886; Taffe P, 2008, STAT MED, V27, P4837, DOI 10.1002/sim.3294; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Touloumi G, 1998, AIDS, V12, P1691, DOI 10.1097/00002030-199813000-00018; Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]; World Health Organization, 2006, WHO HIV AIDS PROGR A	48	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18578	10.1371/journal.pone.0018578	http://dx.doi.org/10.1371/journal.pone.0018578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494630	Green Submitted, gold, Green Published			2022-12-27	WOS:000289292800030
J	Porcu, P; O'Buckley, TK; Song, SC; Harenza, JL; Lu, L; Wang, XS; Williams, RW; Miles, MF; Morrow, AL				Porcu, Patrizia; O'Buckley, Todd K.; Song, Soomin C.; Harenza, Jo Lynne; Lu, Lu; Wang, Xusheng; Williams, Robert W.; Miles, Michael F.; Morrow, A. Leslie			Genetic Analysis of the Neurosteroid Deoxycorticosterone and Its Relation to Alcohol Phenotypes: Identification of QTLs and Downstream Gene Regulation	PLOS ONE			English	Article							RECOMBINANT INBRED STRAINS; QUANTITATIVE TRAIT LOCI; PITUITARY-ADRENAL AXIS; NEUROACTIVE STEROIDS; CYNOMOLGUS MONKEYS; PREFRONTAL CORTEX; COMPLEX TRAITS; ETHANOL ACTION; A RECEPTOR; RAT-BRAIN	Background: Deoxycorticosterone (DOC) is an endogenous neurosteroid found in brain and serum, precursor of the GABAergic neuroactive steroid (3 alpha,5 alpha)-3,21-dihydroxypregnan-20-one (tetrahydrodeoxycorticosterone, THDOC) and the glucocorticoid corticosterone. These steroids are elevated following stress or ethanol administration, contribute to ethanol sensitivity, and their elevation is blunted in ethanol dependence. Methodology/Principal Findings: To systematically define the genetic basis, regulation, and behavioral significance of DOC levels in plasma and cerebral cortex we examined such levels across 47 young adult males from C57BL/6J (B6) x 6DBA/2J (D2) (BXD) mouse strains for quantitative trait loci (QTL) and bioinformatics analyses of behavior and gene regulation. Mice were injected with saline or 0.075 mg/kg dexamethasone sodium salt at 8:00 am and were sacrificed 6 hours later. DOC levels were measured by radioimmunoassay. Basal cerebral cortical DOC levels ranged between 1.4 and 12.2 ng/g (8.7-fold variation, p<0.0001) with a heritability of, similar to 0.37. Basal plasma DOC levels ranged between 2.8 and 12.1 ng/ml (4.3-fold variation, p<0.0001) with heritability of similar to 0.32. QTLs for basal DOC levels were identified on chromosomes 4 (cerebral cortex) and 14 (plasma). Dexamethasone-induced changes in DOC levels showed a 4.4-fold variation in cerebral cortex and a 4.1-fold variation in plasma, but no QTLs were identified. DOC levels across BXD strains were further shown to be coregulated with networks of genes linked to neuronal, immune, and endocrine function. DOC levels and its responses to dexamethasone were associated with several behavioral measures of ethanol sensitivity previously determined across the BXD strains by multiple laboratories. Conclusions/Significance: Both basal and dexamethasone-suppressed DOC levels are positively correlated with ethanol sensitivity suggesting that the neurosteroid DOC may be a putative biomarker of alcohol phenotypes. DOC levels were also strongly correlated with networks of genes associated with neuronal function, innate immune pathways, and steroid metabolism, likely linked to behavioral phenotypes.	[Porcu, Patrizia; Morrow, A. Leslie] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA; [Porcu, Patrizia; O'Buckley, Todd K.; Song, Soomin C.; Morrow, A. Leslie] Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA; [Harenza, Jo Lynne; Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Harenza, Jo Lynne; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA USA; [Harenza, Jo Lynne; Miles, Michael F.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Morrow, A. Leslie] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Porcu, P (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA.	pporcu1@gmail.com	Porcu, Patrizia/B-8400-2015; Williams, Robert W./H-8789-2016	Porcu, Patrizia/0000-0003-0848-7258; Rokita, Jo Lynne/0000-0003-2171-3627; O'Buckley, Todd/0000-0001-8723-734X; Williams, Robert W./0000-0001-8924-4447	National Institutes of Health [INIA-NIAAA AA013614, AA016672, AA010564, AA016662, AA014425, AA13499, AA13513, AA017590]; University of North Carolina at Chapel Hill; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA013641, U01AA013513, U01AA014425, R37AA010564, R01AA013678, U01AA016672, P20AA017828, U01AA016667, U24AA013641, U01AA017590, U01AA013499, R01AA010564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the National Institutes of Health grants INIA-NIAAA AA013614 (PP), AA016672 and AA010564 (ALM), AA016662 (MFM), AA014425 (LL-RWW), AA13499, AA13513 and AA017590 (RWW) and by the University Research Council Grant from the University of North Carolina at Chapel Hill (PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Barbaccia ML, 1999, EUR J PHARMACOL, V384, pR1, DOI 10.1016/S0014-2999(99)00678-0; BELELLI D, 1989, EUR J PHARMACOL, V166, P325, DOI 10.1016/0014-2999(89)90077-0; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Boehm SL, 2002, PSYCHOPHARMACOLOGY, V161, P54, DOI 10.1007/s00213-002-1000-y; Boyd KN, 2010, J NEUROCHEM, V112, P784, DOI 10.1111/j.1471-4159.2009.06509.x; Cerqueira JJ, 2008, BRAIN BEHAV IMMUN, V22, P630, DOI 10.1016/j.bbi.2008.01.005; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Corpechot C, 1997, BRAIN RES, V766, P276, DOI 10.1016/S0006-8993(97)00749-X; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 1999, TRENDS NEUROSCI, V22, P173, DOI 10.1016/S0166-2236(99)01393-4; Crabbe JC, 2008, PHILOS T R SOC B, V363, P3201, DOI 10.1098/rstb.2008.0101; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; DICURZIO DL, 2011, MAMM GENOME IN PRESS; Doerge RW, 1996, GENETICS, V142, P285; Eser D, 2006, NEUROSCIENCE, V138, P1041, DOI 10.1016/j.neuroscience.2005.07.007; Gelernter J, 2009, HUM GENET, V126, P91, DOI 10.1007/s00439-009-0701-2; George O, 2010, NEUROSCI BIOBEHAV R, V35, P232, DOI 10.1016/j.neubiorev.2010.05.002; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; GORAMASLAK G, 1991, PSYCHOPHARMACOLOGY, V104, P413, DOI 10.1007/BF02245643; Groenink L, 2002, BIOL PSYCHIAT, V51, P875, DOI 10.1016/S0006-3223(02)01334-3; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hirani K, 2005, PSYCHOPHARMACOLOGY, V180, P267, DOI 10.1007/s00213-005-2169-7; Hirani K, 2002, NEUROPHARMACOLOGY, V43, P1339, DOI 10.1016/S0028-3908(02)00330-1; Khisti RT, 2005, BRAIN RES, V1049, P104, DOI 10.1016/j.brainres.2005.05.007; Khisti RT, 2003, BRAIN RES, V980, P255, DOI 10.1016/S0006-8993(03)02978-0; Kirstein SL, 2002, J PHARMACOL EXP THER, V302, P1238, DOI 10.1124/jpet.302.3.1238; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Matthews DB, 2002, ALCOHOL CLIN EXP RES, V26, P1747, DOI 10.1097/01.ALC.0000037219.79257.17; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; Morrow A Leslie, 2006, Dialogues Clin Neurosci, V8, P463; Morrow AL, 2009, ALCOHOL, V43, P521, DOI 10.1016/j.alcohol.2009.04.002; Morrow AL, 2001, BRAIN RES REV, V37, P98, DOI 10.1016/S0165-0173(01)00127-8; Morrow AL, 1999, ALCOHOL CLIN EXP RES, V23, P1933, DOI 10.1111/j.1530-0277.1999.tb04094.x; MORROW AL, 2009, NEUROPSYCHIATRIC BIO, P47; O'Dell LE, 2004, EUR J PHARMACOL, V484, P241, DOI 10.1016/j.ejphar.2003.11.031; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Pierucci-Lagha A, 2005, NEUROPSYCHOPHARMACOL, V30, P1193, DOI 10.1038/sj.npp.1300688; Porcu P, 2004, BRAIN RES, V1012, P160, DOI 10.1016/j.brainres.2004.03.059; Porcu P, 2008, PSYCHONEUROENDOCRINO, V33, P214, DOI 10.1016/j.psyneuen.2007.11.003; Porcu P, 2006, PSYCHOPHARMACOLOGY, V186, P293, DOI 10.1007/s00213-005-0132-2; Porcu P, 2010, ALCOHOL CLIN EXP RES, V34, P432, DOI 10.1111/j.1530-0277.2009.01123.x; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Reddy DS, 2002, J NEUROSCI, V22, P3795; RIVIER C, 1984, J PHARMACOL EXP THER, V229, P127; Roberts AJ, 1995, BEHAV NEUROSCI, V109, P1199, DOI 10.1037/0735-7044.109.6.1199; RODRIGUEZ LA, 1994, ALCOHOL CLIN EXP RES, V18, P1416, DOI 10.1111/j.1530-0277.1994.tb01444.x; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; Rosen Glenn D, 2007, Methods Mol Biol, V401, P287, DOI 10.1007/978-1-59745-520-6_16; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; SCHENKMAN JB, 1992, J STEROID BIOCHEM, V43, P1023, DOI 10.1016/0960-0760(92)90329-H; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; Schuckit MA, 2006, J STUD ALCOHOL, V67, P215, DOI 10.15288/jsa.2006.67.215; Schuckit MA, 2005, ALCOHOL CLIN EXP RES, V29, P1976, DOI 10.1097/01.alc.0000187598.82921.27; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; VanDoren MJ, 2000, J NEUROSCI, V20, P1982; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wilhelmsen KC, 2003, ALCOHOL CLIN EXP RES, V27, P1041, DOI 10.1097/01.ALC.0000075551.02714.63; Williams RW, 2001, GENOME BIOL, V2	74	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18405	10.1371/journal.pone.0018405	http://dx.doi.org/10.1371/journal.pone.0018405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494628	Green Published, gold			2022-12-27	WOS:000289292800013
J	Zhao, W; Dhar, S				Zhao, Wei; Dhar, Sumitrajit			Fast and Slow Effects of Medial Olivocochlear Efferent Activity in Humans	PLOS ONE			English	Article							SPONTANEOUS OTOACOUSTIC EMISSIONS; OTO-ACOUSTIC EMISSIONS; COCHLEAR HAIR-CELLS; GUINEA-PIG COCHLEA; STIMULATION; FREQUENCY; ACETYLCHOLINE; RECEPTOR; REFLEX; EAR	Background: The medial olivocochlear (MOC) pathway modulates basilar membrane motion and auditory nerve activity on both a fast (10-100 ms) and a slow (10-100 s) time scale in guinea pigs. The slow MOC modulation of cochlear activity is postulated to aide in protection against acoustic trauma. However in humans, the existence and functional roles of slow MOC effects remain unexplored. Methodology/Principal Findings: By employing contralateral noise at moderate to high levels (68 and 83 dB SPL) as an MOC reflex elicitor, and spontaneous otoacoustic emissions (SOAEs) as a non-invasive probe of the cochlea, we demonstrated MOC modulation of human cochlear output both on a fast and a slow time scale, analogous to the fast and slow MOC efferent effects observed on basilar membrane vibration and auditory nerve activity in guinea pigs. The magnitude of slow effects was minimal compared with that of fast effects. Consistent with basilar membrane and auditory nerve activity data, SOAE level was reduced by both fast and slow MOC effects, whereas SOAE frequency was elevated by fast and reduced by slow MOC effects. The magnitudes of fast and slow effects on SOAE level were positively correlated. Conclusions/Significance: Contralateral noise up to 83 dB SPL elicited minimal yet significant changes in both SOAE level and frequency on a slow time scale, consistent with a high threshold or small magnitude of slow MOC effects in humans.	[Zhao, Wei; Dhar, Sumitrajit] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Zhao, Wei; Dhar, Sumitrajit] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA; [Dhar, Sumitrajit] Northwestern Univ, Hugh Knowles Ctr, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University	Zhao, W (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	weizhao2008@u.northwestern.edu	Dhar, Sumit/B-6319-2009	Dhar, Sumitrajit/0000-0002-4496-6355	National Institute on Deafness and Other Communication Disorders [DC008420]; Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008420] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by grant number DC008420 from the National Institute on Deafness and Other Communication Disorders, and by Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper NP, 2003, J PHYSIOL-LONDON, V548, P307, DOI 10.1113/jphysiol.2003.039081; daCosta DL, 1997, J NEUROPHYSIOL, V78, P1826, DOI 10.1152/jn.1997.78.4.1826; Dallos P, 1997, J NEUROSCI, V17, P2212; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039; FUCHS PA, 1992, J NEUROSCI, V12, P800; Goodman SS, 2006, JARO-J ASSOC RES OTO, V7, P125, DOI 10.1007/s10162-006-0028-9; Guinan JJ, 2003, JARO-J ASSOC RES OTO, V4, P521, DOI 10.1007/s10162-002-3037-3; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; HARRISON WA, 1993, J ACOUST SOC AM, V94, P2649, DOI 10.1121/1.407349; HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065; Kalluri R, 2007, J ACOUST SOC AM, V122, P3562, DOI 10.1121/1.2793604; Kemp D. T., 1980, PSYCHOPHYSICAL PHYSL, P34; KEMP DT, 1979, SCAND AUDIOL, P35; KEMP DT, 1979, ARCH OTO-RHINO-LARYN, V224, P37, DOI 10.1007/BF00455222; Larsen E, 2009, HEARING RES, V256, P1, DOI 10.1016/j.heares.2009.02.002; Lilaonitkul W, 2009, J NEUROPHYSIOL, V101, P1394, DOI 10.1152/jn.90925.2008; Long GR, 1997, J ACOUST SOC AM, V102, P2831, DOI 10.1121/1.420339; Maison SF, 2007, J NEUROPHYSIOL, V97, P3269, DOI 10.1152/jn.00067.2007; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; MOTT JB, 1989, HEARING RES, V38, P229, DOI 10.1016/0378-5955(89)90068-3; Murugasu E, 1996, J NEUROSCI, V16, P325; RABINOWITZ WM, 1984, J ACOUST SOC AM, V76, P1713, DOI 10.1121/1.391618; REITER ER, 1995, J NEUROPHYSIOL, V73, P506, DOI 10.1152/jn.1995.73.2.506; ROBLES L, 2008, SENSES COMPREHENSIVE; SCHLOTH E, 1983, HEARING RES, V11, P285, DOI 10.1016/0378-5955(83)90063-1; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Shera CA, 2003, J ACOUST SOC AM, V114, P244, DOI 10.1121/1.1575750; SRIDHAR TS, 1995, J NEUROSCI, V15, P3667; Sridhar TS, 1997, J NEUROSCI, V17, P428, DOI 10.1523/JNEUROSCI.17-01-00428.1997; Talmadge CL, 1998, J ACOUST SOC AM, V104, P1517, DOI 10.1121/1.424364; Zhao W, 2010, JARO-J ASSOC RES OTO, V11, P53, DOI 10.1007/s10162-009-0189-4; ZWEIG G, 1995, J ACOUST SOC AM, V98, P2018, DOI 10.1121/1.413320	34	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18725	10.1371/journal.pone.0018725	http://dx.doi.org/10.1371/journal.pone.0018725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494578	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800040
J	Sighoko, D; Curado, MP; Bourgeois, D; Mendy, M; Hainaut, P; Bah, E				Sighoko, Dominique; Curado, Maria Paula; Bourgeois, Denis; Mendy, Maimuna; Hainaut, Pierre; Bah, Ebrima			Increase in Female Liver Cancer in The Gambia, West Africa: Evidence from 19 Years of Population-Based Cancer Registration (1988-2006)	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATITIS-B; TOBACCO USE; INFECTION; AFLATOXIN; OBESITY; METAANALYSIS; CHILDREN; ENZYMES; COUNTRY	Background: Hepatocellular Carcinoma (HCC) is a common malignancy worldwide with a high burden in West Africa. Male to female ratios show consistent bias toward males, the biological bases and variations of which are not well understood. We have used data from the Gambian National Cancer Registry to compare trends in incidence of HCC in both genders. Methods and Findings: Two periods were compared, 1988-1997 (early) and 1998-2006 (recent). In addition, the regression program joinpoint was used to assess trends over 19 years. Differences with self-reported ethnicity were assessed for the recent period using population data from 2003 census. Male to female ratio showed a significant decrease between the two periods from 3.28:1 (95% CI, [2.93-3.65]) to 2.2:1 (95% CI, [1.99-2.43]). Although rates in males were relatively stable (38.36 and 32.84 for, respectively, early and recent periods), they increased from 11.71 to 14.9 in females with a significant Annual Percentage Change of 3.01 [0.3-5.8] over 19 years and an increase in number of cases of 80.28% (compared to 26% in males). Significant variations in HCC risk, but not in gender ratio were observed in relation with ethnicity. Conclusion: This analysis of the only national, population-based cancer registry in West Africa shows a significant increase in HCC in females over recent years. This increase may be the consequence of major changes in lifestyle or viral risk factors, in particular obesity and hepatitis C, which have both been documented to increase in West Africa during recent years.	[Sighoko, Dominique; Curado, Maria Paula; Hainaut, Pierre; Bah, Ebrima] Int Agcy Res Canc, F-69372 Lyon, France; [Sighoko, Dominique; Bourgeois, Denis] Fac Odontol, Lyon, France; [Mendy, Maimuna] MRC, Fajara, Gambia; [Bah, Ebrima] Gambia Hepatitis Intervent Study, Fajara, Gambia	World Health Organization; International Agency for Research on Cancer (IARC); University of London; London School of Hygiene & Tropical Medicine	Sighoko, D (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	hainaut@iarc.fr	Mendy, Maimuna/ABD-5038-2021; Curado, Maria Paula/M-6200-2013; Bourgeois, Denis/AAH-9280-2020; Bourgeois, Denis/ABI-3060-2020; Hainaut, Pierre/B-6018-2012	Curado, Maria Paula/0000-0001-8172-2483; Bourgeois, Denis/0000-0003-4754-2512; Hainaut, Pierre/0000-0002-1303-1610	International Agency for Research on Cancer; Medical Research Council [MC_U190081996] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW009112] Funding Source: NIH RePORTER; MRC [MC_U190081996] Funding Source: UKRI	International Agency for Research on Cancer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; [Anonymous], 2006, CANC EPIDEMIOLOGY PR; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Coleman M P, 1991, IARC Sci Publ, P267; Curado MP, 2008, CANC INCIDENCE 5 CON, VIX, DOI 10.1007/978-3-642-85851-2; Souza PSD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-246; Jallow M, 2009, NAT GENET; JEANSELLIER, 2003, ATLAS PEUPLES AFRIQ, P115; JENSEN OM, 1996, ENREGISTREMENT CANCE, P142; Jie X, 2007, ONCOGENE, V26, P5741, DOI 10.1038/sj.onc.1210362; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Ocama P, 2009, BRIT J CANCER, V100, P799, DOI 10.1038/sj.bjc.6604893; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Siervo M, 2006, EUR J CLIN NUTR, V60, P455, DOI 10.1038/sj.ejcn.1602337; Sighoko D, 2010, INT J CANCER, V127, P2248, DOI 10.1002/ijc.25244; SILVA ID, 1999, EPIDEMIOLOGIE CANC P, P334; Szymanska K, 2004, INT J CANCER, V110, P374, DOI 10.1002/ijc.20103; Turner PC, 2000, TROP MED INT HEALTH, V5, P837, DOI 10.1046/j.1365-3156.2000.00664.x; Umoh NJ, 2011, LIVER INT, V31, P215, DOI 10.1111/j.1478-3231.2010.02418.x; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; *WHO, 2009, GLOB STAT REP ALC 20; WILD CP, 1993, CANCER EPIDEM BIOMAR, V2, P555; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252	27	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18415	10.1371/journal.pone.0018415	http://dx.doi.org/10.1371/journal.pone.0018415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490972	gold, Green Published, Green Submitted			2022-12-27	WOS:000289238700013
J	Cosgrove, L; Shi, L; Creasey, DE; Anaya-McKivergan, M; Myers, JA; Huybrechts, KF				Cosgrove, Lisa; Shi, Ling; Creasey, David E.; Anaya-McKivergan, Maria; Myers, Jessica A.; Huybrechts, Krista F.			Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry	PLOS ONE			English	Review							SEROTONIN REUPTAKE INHIBITORS; PSYCHOTROPIC MEDICATION USE; C6 GLIOMA-CELLS; TRICYCLIC ANTIDEPRESSANTS; DOSE-RESPONSES; UNITED-STATES; TUMOR-GROWTH; APOPTOSIS; FLUOXETINE; DRUGS	Background: Antidepressant (AD) use has been purported to increase the risk of breast and ovarian cancer, although both epidemiological and pre-clinical studies have reported mixed results [1-6]. Previous studies in a variety of biomedical fields have found that financial ties to drug companies are associated with favorable study conclusions [7]. Methods and Findings: We searched English-language articles in MEDLINE, PsychINFO, the Science Citations Index and the Cochrane Central Register of Controlled Clinical Trials (through November 2010). A total of 61 articles that assessed the relationship between breast and ovarian cancer and AD use and articles that examined the effect of ADs on cell growth were included. Multi-modal screening techniques were used to investigate researchers' financial ties with industry. A random effects meta-analysis was used to pool the findings from the epidemiological literature. Thirty-three percent (20/61) of the studies reported a positive association between ADs and cancer. Sixty-seven percent (41/61) of the studies reported no association or antiproliferative effect. The pooled odds ratio for the association between AD use and breast/ovarian cancer in the epidemiologic studies was 1.11 (95% CI, 1.03-1.20). Researchers with industry affiliations were significantly less likely than researchers without those ties to conclude that ADs increase the risk of breast or ovarian cancer. (0/15 [0%] vs 20/46 [43.5%] (Fisher's Exact test P = 0.0012). Conclusions: Both the pre-clinical and clinical data are mixed in terms of showing an association between AD use and breast and ovarian cancer. The possibility that ADs may exhibit a bi-phasic effect, whereby short-term use and/or low dose antidepressants may increase the risk of breast and ovarian cancer, warrants further investigation. Industry affiliations were significantly associated with negative conclusions regarding cancer risk. The findings have implications in light of the 2009 USPSTF guidelines for breast cancer screening and for the informed consent process.	[Cosgrove, Lisa] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Shi, Ling] Univ Massachusetts, Dept Nursing & Hlth Sci, Boston, MA 02125 USA; [Cosgrove, Lisa; Creasey, David E.] Univ Massachusetts, Dept Counseling, Boston, MA 02125 USA; [Cosgrove, Lisa; Creasey, David E.] Univ Massachusetts, Sch Psychol, Boston, MA 02125 USA; [Creasey, David E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Anaya-McKivergan, Maria] Univ Phoenix, Coll Social Sci, Yuma, AZ USA; [Myers, Jessica A.; Huybrechts, Krista F.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepiodemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Cosgrove, L (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA.	lcosgrove@ethics.harvard.edu			non-profit cancer foundation "Men with Heart"; University of Massachusetts-Boston	non-profit cancer foundation "Men with Heart"; University of Massachusetts-Boston	This study was funded in part by the non-profit cancer foundation "Men with Heart" by a grant awarded to Dr. Cosgrove. She also received two internal grants from the University of Massachusetts-Boston (a proposal development grant and the Endowed Faculty Career Development Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDUL N, 1995, J UROLOGY, V154, P247, DOI 10.1016/S0022-5347(01)67288-4; *AM CANC SOC, CANC BAS FACTS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Angell M., 2004, TRUTH DRUG CO THEY D; Arimochi H, 2008, PHARMACOLOGY, V81, P164, DOI 10.1159/000111144; AUBERT RE, 2009, J CLIN ONCOL S, V27, pNIL18; BASSO AM, 1992, LIFE SCI, V50, P1789, DOI 10.1016/0024-3205(92)90063-U; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; BENDELE RA, 1992, CANCER RES, V52, P6931; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; BRAMBILLA G, 1982, J TOXICOL ENV HEALTH, V9, P287, DOI 10.1080/15287398209530162; Brandes LJ, 2005, CRIT REV TOXICOL, V35, P587, DOI 10.1080/10408440500246801; BRANDES LJ, 1992, CANCER RES, V52, P3796; BROWN WR, 1991, BIOL BASIS RISK ASSE, P13; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Calabrese EJ, 2001, ANNU REV PUBL HEALTH, V22, P15, DOI 10.1146/annurev.publhealth.22.1.15; Chien C, 2006, BREAST CANCER RES TR, V95, P131, DOI 10.1007/s10549-005-9056-0; Chou CT, 2007, TOXICOL APPL PHARM, V218, P265, DOI 10.1016/j.taap.2006.11.012; CLAYSON DB, 1965, LUNG TUMOURS ANIMALS, P869; Cloonan SM, 2010, LEUKEMIA LYMPHOMA, V51, P523, DOI 10.3109/10428190903552112; Coogan PF, 2008, BREAST CANCER RES TR, V109, P527, DOI 10.1007/s10549-007-9664-y; Coogan PF, 2000, CANCER CAUSE CONTROL, V11, P839, DOI 10.1023/A:1008982417022; Coogan PF, 2005, AM J EPIDEMIOL, V162, P835, DOI 10.1093/aje/kwi301; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Cotterchio M, 2000, AM J EPIDEMIOL, V151, P951, DOI 10.1093/oxfordjournals.aje.a010138; Dalton SO, 2000, EPIDEMIOLOGY, V11, P171, DOI 10.1097/00001648-200003000-00015; DANIELSON DA, 1982, AM J EPIDEMIOL, V116, P329, DOI 10.1093/oxfordjournals.aje.a113416; Davis S, 2007, EUR J EPIDEMIOL, V22, P319, DOI 10.1007/s10654-007-9135-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Douglas H, 2000, PHILOS SCI, V67, P559, DOI 10.1086/392855; Douglas H., 2007, VALUE FREE SCI IDEAL, P120, DOI DOI 10.1093/ACPROF:OSO/9780195308969.003.0009; Dublin S, 2002, CANCER CAUSE CONTROL, V13, P35, DOI 10.1023/A:1013969611593; Dunikowski LG, 2005, CAN FAM PHYSICIAN, V51, P1191; Falit Benjamin P, 2007, Seton Hall Law Rev, V37, P969; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Fugh-Berman A, 2005, J GEN INTERN MED, V20, P546, DOI 10.1111/j.1525-1497.2005.05857.x; Fulton-Kehoe D, 2006, BRIT J CANCER, V94, P1071, DOI 10.1038/sj.bjc.6603017; Gil-Ad I, 2008, INT J ONCOL, V33, P277, DOI 10.3892/ijo_00000007; Gonzalez-Perez A, 2005, EPIDEMIOLOGY, V16, P101, DOI 10.1097/01.ede.0000147103.92638.c0; Haque R, 2005, CANCER LETT, V221, P61, DOI 10.1016/j.canlet.2004.11.003; Harlow BL, 1998, CANCER EPIDEM BIOMAR, V7, P697; HARLOW BL, 1995, CANCER CAUSE CONTROL, V6, P130, DOI 10.1007/BF00052773; Haukka J, 2010, INT J CANCER, V126, P285, DOI 10.1002/ijc.24537; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; HILAKIVICLARKE L, 1993, PHYSIOL BEHAV, V54, P229, DOI 10.1016/0031-9384(93)90104-N; IISHI H, 1993, CARCINOGENESIS, V14, P1837, DOI 10.1093/carcin/14.9.1837; Jia L, 2008, WORLD J GASTROENTERO, V14, P4377, DOI 10.3748/wjg.14.4377; Kato I, 2000, J PUBLIC HEALTH MED, V22, P155, DOI 10.1093/pubmed/22.2.155; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; Kelly JP, 1998, AM J EPIDEMIOL, V147, pS69; KELVIN AS, 1989, ACTA PSYCHIAT SCAND, V80, P34, DOI 10.1111/j.1600-0447.1989.tb07166.x; Lawlor DA, 2003, J CLIN EPIDEMIOL, V56, P155; Lee CS, 2010, BASIC CLIN PHARMACOL, V106, P446, DOI 10.1111/j.1742-7843.2009.00509.x; Lin CJ, 2010, CANCER RES, V70, P3199, DOI 10.1158/0008-5472.CAN-09-4072; MERRY S, 1991, EUR J CANCER, V27, P31, DOI 10.1016/0277-5379(91)90054-H; Moorman PG, 2005, OBSTET GYNECOL, V105, P725, DOI 10.1097/01.AOG.0000157113.98061.eb; Moorman PG, 2003, EPIDEMIOLOGY, V14, P307, DOI 10.1097/00001648-200305000-00010; *NAT CANC I SURV E, CANC FACTS SHEETS; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Roberts H, 2007, BMJ-BRIT MED J, V334, P736, DOI 10.1136/bmj.39153.522535.BE; Rosetti M, 2006, J Exp Ther Oncol, V6, P23; SAUTER C, 1989, ONCOLOGY, V46, P155; Serafeim A, 2003, BLOOD, V101, P3212, DOI 10.1182/blood-2002-07-2044; Sharpe CR, 2002, BRIT J CANCER, V86, P92, DOI 10.1038/sj.bjc.6600013; Sheldon T, 2005, PLOS MED, V2, P687, DOI 10.1371/journal.pmed.0020222; SHOYAB M, 1982, CANCER LETT, V16, P171, DOI 10.1016/0304-3835(82)90058-1; Slamon ND, 2001, ARCH TOXICOL, V75, P243; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Sonier B, 2006, BIOCHEM BIOPH RES CO, V343, P1053, DOI 10.1016/j.bbrc.2006.03.080; Spanova A, 1997, PHYSIOL RES, V46, P161; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Spina E, 2008, CLIN THER, V30, P1206, DOI 10.1016/S0149-2918(08)80047-1; Steingart A, 2003, INT J EPIDEMIOL, V32, P961, DOI 10.1093/ije/dyg155; STEINGART AB, 1995, J CLIN EPIDEMIOL, V48, P1407, DOI 10.1016/0895-4356(95)00545-5; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Stepulak A, 2008, CANCER BIOL THER, V7, P1685, DOI 10.4161/cbt.7.10.6664; Tamim H, 2006, PHARMACOEPIDEM DR S, V15, P689, DOI 10.1002/pds.1233; Thompson DF, 2009, Z EVIDENZ FORTBILD Q, V103, P136, DOI 10.1016/j.zefq.2009.02.021; TOTH B, 1975, CANCER RES, V35, P3693; TSURUO T, 1983, J PHARMACOBIO-DYNAM, V6, P145; TUCKER WE, 1983, J CLIN PSYCHIAT, V44, P60; TUTTON PJM, 1982, BRIT J CANCER, V46, P260, DOI 10.1038/bjc.1982.191; TUTTON PJM, 1976, VIRCHOWS ARCH B, V21, P161; Volpe Donna A, 2003, J Exp Ther Oncol, V3, P169, DOI 10.1046/j.1359-4117.2003.01091.x; WALLACE RB, 1982, ONCOLOGY-BASEL, V39, P279, DOI 10.1159/000225651; Wang PS, 2001, J CLIN EPIDEMIOL, V54, P728, DOI 10.1016/S0895-4356(00)00354-1; Weiss SR, 1998, CLIN PHARMACOL THER, V63, P594; Wernli KJ, 2009, PHARMACOEPIDEM DR S, V18, P284, DOI 10.1002/pds.1719; WRIGHT SC, 1994, FASEB J, V8, P654, DOI 10.1096/fasebj.8.9.8005393; Xia ZL, 1999, J BIOCHEM MOL TOXIC, V13, P338, DOI 10.1002/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.3.CO;2-Z; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	95	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18210	10.1371/journal.pone.0018210	http://dx.doi.org/10.1371/journal.pone.0018210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494667	Green Published, gold			2022-12-27	WOS:000289192400009
J	Dejean, A; Corbara, B; Leroy, C; Delabie, JHC; Rossi, V; Cereghino, R				Dejean, Alain; Corbara, Bruno; Leroy, Celine; Delabie, Jacques H. C.; Rossi, Vivien; Cereghino, Regis			Inherited Biotic Protection in a Neotropical Pioneer Plant	PLOS ONE			English	Article							OPTIMAL DEFENSE HYPOTHESIS; SPATIOTEMPORAL PATTERNS; EXTRAFLORAL NECTAR; IRLBACHIA-ALATA; ANT-ACACIA; VOLATILES; MUTUALISM; CONFLICT; BEHAVIOR; COSTS	Chelonanthus alatus is a bat-pollinated, pioneer Gentianaceae that clusters in patches where still-standing, dried-out stems are interspersed among live individuals. Flowers bear circum-floral nectaries (CFNs) that are attractive to ants, and seed dispersal is both barochorous and anemochorous. Although, in this study, live individuals never sheltered ant colonies, dried-out hollow stems - that can remain standing for 2 years - did. Workers from species nesting in dried-out stems as well as from ground-nesting species exploited the CFNs of live C. alatus individuals in the same patches during the daytime, but were absent at night (when bat pollination occurs) on 60.5% of the plants. By visiting the CFNs, the ants indirectly protect the flowers - but not the plant foliage - from herbivorous insects. We show that this protection is provided mostly by species nesting in dried-out stems, predominantly Pseudomyrmex gracilis. That dried-out stems remain standing for years and are regularly replaced results in an opportunistic, but stable association where colonies are sheltered by one generation of dead C. alatus while the live individuals nearby, belonging to the next generation, provide them with nectar; in turn, the ants protect their flowers from herbivores. We suggest that the investment in wood by C. alatus individuals permitting still-standing, dried-out stems to shelter ant colonies constitutes an extended phenotype because foraging workers protect the flowers of live individuals in the same patch. Also, through this process these dried-out stems indirectly favor the reproduction (and so the fitness) of the next generation including both their own offspring and that of their siblings, all adding up to a potential case of inclusive fitness in plants.	[Dejean, Alain; Leroy, Celine] CNRS, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Cereghino, Regis] Univ Toulouse, UPS, INPT, EcoLab, Toulouse, France; [Corbara, Bruno] CNRS, UMR 6023, LMGE, Aubiere, France; [Corbara, Bruno] Univ Clermont Ferrand, LMGE, Clermont Univ, Clermont Ferrand, France; [Delabie, Jacques H. C.] CEPLAC, Ctr Pesquisas Cacau, Convenio UESC CEPEC, Lab Mirmecol, Itabuna, BA, Brazil; [Rossi, Vivien] CIRAD, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Cereghino, Regis] CNRS, UMR 5245, EcoLab, Lab Ecol Fonct, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universidade Estadual de Santa Cruz; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Dejean, A (corresponding author), CNRS, Ecol Forets Guyane UMR CNRS 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr	CEREGHINO, Regis/G-9500-2011; Delabie, Jacques H C/F-3405-2010; Leroy, Celine/I-4857-2016; Rossi, Vivien/C-9721-2009	Delabie, Jacques H C/0000-0002-2695-1061; Leroy, Celine/0000-0003-4859-8040; Rossi, Vivien/0000-0001-5458-1523; CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248; Cereghino, Regis/0000-0003-3981-3159	French Centre National de la Recherche Scientifique [2ID]; European Community; Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq)	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission); Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). JHCD acknowledges the Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq) for his research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLABY M, 2004, INCLUSIVE FITNESS DI; Beattie Andrew J., 2002, P211; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; CHARLESDOMINIQU.P, 2001, PUBLICATIONS SCI MNH, V49, P188; Clement LW, 2008, BEHAV ECOL SOCIOBIOL, V62, P953, DOI 10.1007/s00265-007-0520-1; Coley Phyllis D., 1996, P305; DAWKINS, 1982, EXTENDED PHENOTYPE; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2008, BIOL J LINN SOC, V93, P63, DOI 10.1111/j.1095-8312.2007.00927.x; Delabie JHC, 2009, CR BIOL, V332, P673, DOI 10.1016/j.crvi.2009.01.006; Gibernau M, 2008, J TROP ECOL, V24, P689, DOI 10.1017/S0266467408005488; Heil M, 2004, J TROP ECOL, V20, P573, DOI 10.1017/S0266467404001567; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hernandez-Cumplido J, 2010, J TROP ECOL, V26, P555, DOI 10.1017/S0266467410000234; Holland JN, 2011, OIKOS, V120, P381, DOI 10.1111/j.1600-0706.2010.18958.x; Holland JN, 2009, J ECOL, V97, P89, DOI 10.1111/j.1365-2745.2008.01446.x; Hossaert-McKey M, 2001, ECOSCIENCE, V8, P325, DOI 10.1080/11956860.2001.11682660; Hunter P, 2009, EMBO REP, V10, P212, DOI 10.1038/embor.2009.18; Jensen SR, 2002, GENTIANACEAE SYSTEMA, P573, DOI DOI 10.1017/CBO9780511541865.007; Lu Q, 1999, J NAT PROD, V62, P824, DOI 10.1021/np980425n; Machado ICS, 1998, PLANT SYST EVOL, V209, P231, DOI 10.1007/BF00985230; McCullagh P, 1989, GEN LINEAR MODELS; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; McKey D, 1979, HERBIVORES THEIR INT, P55; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nicklen EF, 2006, OECOLOGIA, V148, P81, DOI 10.1007/s00442-006-0359-6; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Orivel J, 2002, SOCIOBIOLOGY, V39, P65; R Development Core Team, 2006, R LANG ENV STAT COMP; Radhika V, 2008, PLANTA, V228, P449, DOI 10.1007/s00425-008-0749-6; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; Rhoades DF, 1979, HERBIVORES THEIR INT, P4; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, BIOL J LINN SOC, V38, P173, DOI 10.1111/j.1095-8312.1989.tb01572.x; Romero GQ, 2004, J TROP ECOL, V20, P675, DOI 10.1017/S0266467404001749; Rostas M, 2008, CHEMOECOLOGY, V18, P29, DOI 10.1007/s00049-007-0390-z; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Sarthou C, 2009, FLORA, V204, P396, DOI 10.1016/j.flora.2008.05.004; SRUWE L, 2009, TAXON, V58, P479; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; TOTH PL, 2007, ELONGATE TWIG ANT ME; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Vogel S, 1998, FLORA, V193, P1; WARD PS, 1991, ANT - PLANT INTERACTIONS, P335; WHITCOMB W H, 1972, Florida Entomologist, V55, P31, DOI 10.2307/3493638; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	48	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18071	10.1371/journal.pone.0018071	http://dx.doi.org/10.1371/journal.pone.0018071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483861	Green Published, gold			2022-12-27	WOS:000289057200023
J	Johnson, KL; Ghavami, N				Johnson, Kerri L.; Ghavami, Negin			At the Crossroads of Conspicuous and Concealable: What Race Categories Communicate about Sexual Orientation	PLOS ONE			English	Article							PERCEPTION; DISCLOSURE; IMPRESSIONS; ACTIVATION; ACCURACY; LESBIANS; BEHAVIOR; MOTION; BLACK	We found that judgments of a perceptually ambiguous social category, sexual orientation, varied as a function of a perceptually obvious social category, race. Sexual orientation judgments tend to exploit a heuristic of gender inversion that often promotes accuracy. We predicted that an orthogonal social category that is itself gendered, race, would impact both sexual orientation categorizations and their accuracy. Importantly, overlaps in both the phenotypes and stereotypes associated with specific race and sex categories (e.g., the categories Black and Men and the categories Asian and Women) lead race categories to be decidedly gendered. Therefore, we reasoned that race categories would bias judgments of sexual orientation and their accuracy because of the inherent gendered nature. Indeed, both gay and straight perceivers in the United States were more likely to judge targets to be gay when target race was associated with gender-atypical stereotypes or phenotypes (e.g., Asian Men). Perceivers were also most accurate when judging the sexual orientation of the most strongly gender-stereotyped groups (i.e., Asian Women and Black Men), but least accurate when judging the sexual orientation of counter-stereotypical groups (i.e., Asian men and Black Women). Signal detection analyses confirmed that this pattern of accuracy was achieved because of heightened sensitivity to cues in groups who more naturally conform to gendered stereotypes (Asian Women and Black Men). Implications for social perception are discussed.	[Johnson, Kerri L.] Univ Calif Los Angeles, Dept Commun Studies, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Johnson, KL (corresponding author), Univ Calif Los Angeles, Dept Commun Studies, Los Angeles, CA 90095 USA.	Kerri.Johnson@ucla.edu						Allport G. W., 1954, NATURE PREJUDICE; Ambady N, 1999, J PERS SOC PSYCHOL, V77, P538, DOI 10.1037/0022-3514.77.3.538; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Balding DJ, 2004, APPL LONGITUDINAL AN; Bargh JA, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P361; BERENBAUM SA, 1995, DEV PSYCHOL, V31, P31, DOI 10.1037/0012-1649.31.1.31; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; Carroll L, 2002, PSYCHOL REP, V91, P115, DOI 10.2466/pr0.2002.91.1.115; Chaudoir SR, 2010, PSYCHOL BULL, V136, P236, DOI 10.1037/a0018193; Corby BC, 2007, DEV PSYCHOL, V43, P261, DOI 10.1037/0012-1649.43.1.261; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; DIGGLE PJ, 1994, ANAL LONGITUDINAL DA, P272; DOVIDIO JF, 1986, J EXP SOC PSYCHOL, V22, P22, DOI 10.1016/0022-1031(86)90039-9; Fazio RH, 1997, J EXP SOC PSYCHOL, V33, P451, DOI 10.1006/jesp.1997.1330; FEINMAN S, 1981, SEX ROLES, V7, P289, DOI 10.1007/BF00287543; FEINMAN S, 1984, SEX ROLES, V10, P445, DOI 10.1007/BF00287561; FRABLE DES, 1987, J PERS SOC PSYCHOL, V53, P391; Frable DES, 1998, J PERS SOC PSYCHOL, V74, P909, DOI 10.1037/0022-3514.74.4.909; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509; Goff PA, 2008, SEX ROLES, V59, P392, DOI 10.1007/s11199-008-9505-4; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; GRANT PR, 1981, SOC PSYCHOL QUART, V44, P107, DOI 10.2307/3033706; Griffith KH, 2002, J APPL PSYCHOL, V87, P1191, DOI 10.1037//0021-9010.87.6.1191; GROSS AE, 1980, PERS SOC PSYCHOL B, V6, P307, DOI 10.1177/014616728062020; Hughes EC, 1945, AM J SOCIOL, V50, P353, DOI 10.1086/219652; Johnson K. L., 2007, BODY BEAUTIFUL EVOLU, P159; Johnson KL, 2007, J PERS SOC PSYCHOL, V93, P321, DOI 10.1037/0022-3514.93.3.321; Johnson KL, 2007, P NATL ACAD SCI USA, V104, P5246, DOI 10.1073/pnas.0608181104; Johnson KL, 2005, PSYCHOL SCI, V16, P890, DOI 10.1111/j.1467-9280.2005.01633.x; JOHNSON KL, 2011, COGNITION IN PRESS, DOI DOI 10.1016/J.COGNITION.2011.01.016; JOHNSON KL, 2011, RACE GENDERED UNPUB; KITE ME, 1987, PSYCHOL WOMEN QUART, V11, P83, DOI 10.1111/j.1471-6402.1987.tb00776.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lippa RA, 2005, ANN REV SEX RES, V16, P119; Matthews A., 2003, J MENTAL HLTH, V12, P235, DOI DOI 10.1080/0963823031000118221; MCCREARY DR, 1994, SEX ROLES, V31, P517, DOI 10.1007/BF01544277; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; MONTEPARE JM, 1988, J PERS SOC PSYCHOL, V55, P547, DOI 10.1037/0022-3514.55.4.547; Oswald DL, 2007, J APPL SOC PSYCHOL, V37, P928, DOI 10.1111/j.1559-1816.2007.00193.x; Pauker Kristin, 2010, SOCIAL PSYCHOL VISUA; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Rieger G, 2008, DEV PSYCHOL, V44, P46, DOI 10.1037/0012-1649.44.1.46; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; RULE NO, 2011, MALE SEXUAL OR UNPUB; Sinclair L, 1999, J PERS SOC PSYCHOL, V77, P885, DOI 10.1037/0022-3514.77.5.885; Singh D, 1999, J PERS SOC PSYCHOL, V76, P1035, DOI 10.1037/0022-3514.76.6.1035; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; TAJFEL H, 1969, J SOC ISSUES, V25, P79, DOI 10.1111/j.1540-4560.1969.tb00620.x; TAJFEL H, 1974, SOC SCI INFORM, V13, P65, DOI 10.1177/053901847401300204; Vandello JA, 2008, J PERS SOC PSYCHOL, V95, P1325, DOI 10.1037/a0012453	54	57	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18025	10.1371/journal.pone.0018025	http://dx.doi.org/10.1371/journal.pone.0018025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YU	21483863	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200019
J	Ran, QA; Hao, P; Xiao, YN; Zhao, JA; Ye, XD; Li, ZJ				Ran, Qian; Hao, Ping; Xiao, Yanni; Zhao, Jiang; Ye, Xingde; Li, Zhongjun			Effect of Irradiation and/or Leucocyte Filtration on RBC Storage Lesions	PLOS ONE			English	Article							RED-BLOOD-CELLS; CLINICAL CONSEQUENCES; STATIC PRESSURE; STORED RBCS; SHEAR-RATE; TRANSFUSION; ACCUMULATION; CONCENTRATE; OXIDATION; VESICLES	Red blood cell (RBC) storage lesions have been shown to be associated with some adverse reactions; numerous studies have focused on the lesions caused by storage, and few data on the RBC storage lesions caused by prestorage treatments of leucocyte filtration and irradiation. In this study, we examined the changes related with the RBC storage lesions, including 2,3-diphosphatidylglyceric acid (2,3-DPG), pH, free hemoglobin (Hb), supernatant free K(+) and Na(+) concentration, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH). Along with the increasing storage time, decreases in 2, 3-DPG levels, pH and Na(+) concentration, increases in K(+) and free Hb concentrations, and significant morphological changes in RBC in all groups were found. The changes in the groups of irradiation, leucocyte filtration and the combined irradiation and leucocyte filtration were more significant than those in the untreated group. Meanwhile, the MCV levels of the three treated groups were significantly lower than those in the untreated group, while the MCH variations were significantly higher. Our results suggest that irradiation and leucocyte filtration before storage may aggravate blood storage lesions.	[Ran, Qian; Xiao, Yanni; Zhao, Jiang; Ye, Xingde; Li, Zhongjun] Third Mil Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China; [Hao, Ping] Third Mil Med Univ, Xinqiao Hosp, Ctr Oncol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Ran, QA (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China.	lizhungjun@yahoo.com.cn			XinQiao Hospital; Third Military Medical University of Chinese PLA [2007D046]	XinQiao Hospital; Third Military Medical University of Chinese PLA	This study was supported by XinQiao Hospital "1520 project" special foundation and Scientific Researching Fund Projects of the Third Military Medical University of Chinese PLA (NO:2007D046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2005, INDIAN J MED RES, V122, P385; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; BOTTER-JENSEN L, 1972, Acta Radiologica Supplementum, V313, P247; Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x; Hogman CF, 2006, TRANSFUSION, V46, P1543, DOI 10.1111/j.1537-2995.2006.00893.x; Holme S, 2005, TRANSFUS APHER SCI, V33, P55, DOI 10.1016/j.transci.2005.02.004; Karon BS, 2009, TRANSFUSION, V49, P1435, DOI 10.1111/j.1537-2995.2009.02133.x; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; Nielsen HJ, 1999, BURNS, V25, P162, DOI 10.1016/S0305-4179(98)00157-0; Niinisto K, 2008, VET J, V176, P227, DOI 10.1016/j.tvjl.2007.02.015; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Reverberi Roberto, 2007, Ann Ist Super Sanita, V43, P176; Sparrow RL, 2007, TRANSFUSION, V47, P966, DOI 10.1111/j.1537-2995.2007.01230.x; Sugawara A, 2010, ARCH PATHOL LAB MED, V134, P771, DOI 10.1043/1543-2165-134.5.771; Tinmouth A, 2001, TRANSFUS MED REV, V15, P91, DOI 10.1053/tmrv.2001.22613; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Williamson LM, 1995, BLOOD REV, V9, P251, DOI 10.1016/S0268-960X(95)90016-0; Yasuda T, 2002, ARTIF ORGANS, V26, P27, DOI 10.1046/j.1525-1594.2002.06786.x; Yasuda T, 2001, ASAIO J, V47, P351, DOI 10.1097/00002480-200107000-00011; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1; Zimmermann R, 2009, TRANSFUSION, V49, P75, DOI 10.1111/j.1537-2995.2008.01920.x	25	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18328	10.1371/journal.pone.0018328	http://dx.doi.org/10.1371/journal.pone.0018328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483835	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200059
J	Srinivasan, S; Patric, IRP; Somasundaram, K				Srinivasan, Sujaya; Patric, Irene Rosita Pia; Somasundaram, Kumaravel			A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; POOR-PROGNOSIS; MICRORNA; GLIOMA; ASTROCYTOMAS; P27(KIP1); PROLIFERATION; PROFILES	Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient median survival. To identify a microRNA (miRNA) expression signature that can predict GBM patient survival, we analyzed the miRNA expression data of GBM patients (n = 222) derived from The Cancer Genome Atlas (TCGA) dataset. We divided the patients randomly into training and testing sets with equal number in each group. We identified 10 significant miRNAs using Cox regression analysis on the training set and formulated a risk score based on the expression signature of these miRNAs that segregated the patients into high and low risk groups with significantly different survival times (hazard ratio [HR] = 2.4; 95% CI = 1.4-3.8; p < 0.0001). Of these 10 miRNAs, 7 were found to be risky miRNAs and 3 were found to be protective. This signature was independently validated in the testing set (HR = 1.7; 95% CI = 1.1-2.8; p = 0.002). GBM patients with high risk scores had overall poor survival compared to the patients with low risk scores. Overall survival among the entire patient set was 35.0% at 2 years, 21.5% at 3 years, 18.5% at 4 years and 11.8% at 5 years in the low risk group, versus 11.0%, 5.5%, 0.0 and 0.0% respectively in the high risk group (HR = 2.0; 95% CI = 1.4-2.8; p < 0.0001). Cox multivariate analysis with patient age as a covariate on the entire patient set identified risk score based on the 10 miRNA expression signature to be an independent predictor of patient survival (HR = 1.120; 95% CI = 1.04-1.20; p = 0.003). Thus we have identified a miRNA expression signature that can predict GBM patient survival. These findings may have implications in the understanding of gliomagenesis, development of targeted therapy and selection of high risk cancer patients for adjuvant therapy.	[Srinivasan, Sujaya; Patric, Irene Rosita Pia; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Srinivasan, S (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Department of Biotechnology, Government of India [BT/01/CEIB/09/VI/01]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study is supported by a grant from Department of Biotechnology, Government of India (D.O.No. BT/01/CEIB/09/VI/01; http://dbtindia.nic.in/index. asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Alonso MM, 2005, JNCI-J NATL CANCER I, V97, P1589, DOI 10.1093/jnci/dji340; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; CARAMUTA S, J INVEST DERMATOL, V130, P2062; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHOU CK, THYROID, V20, P489; CHUNZHI Z, BMC CANC, V10, P367; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Greither T, INT J CANC, V126, P73; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kirla RM, 2003, CANCER, V97, P644, DOI 10.1002/cncr.11079; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; LIU C, CLIN EXP MED; LIU CJ, CANC RES, V70, P1635; LIU X, J CLIN INVEST, V120, P1298; LOPEZROMERO P, BMC RES NOTES, V3, P18; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Mizumatsu S, 1999, CLIN CANCER RES, V5, P551; Noushmehr H, CANC CELL, V17, P510; Palanichamy Kamalakannan, 2006, Curr Treat Options Oncol, V7, P490, DOI 10.1007/s11864-006-0024-7; Pan W, J IMMUNOL, V184, P6773; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; PU XX, J GASTROENTEROL HEPA, V25, P1674; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sallinen SL, 1999, J PATHOL, V188, P289; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Simon R, 2007, CANCER INFORM, V3, P11; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tamiya T, 2001, ACTA NEUROPATHOL, V101, P334; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Verhaak RG, CANC CELL, V17, P98; WONG QW, CLIN CANC RES, V16, P867; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Yue JM, 2006, CANCER BIOL THER, V5, P573, DOI 10.4161/cbt.5.6.2872; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6; ZHI F, EUR J CANC, V46, P1640	56	156	160	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17438	10.1371/journal.pone.0017438	http://dx.doi.org/10.1371/journal.pone.0017438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483847	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000289057200006
J	Picard, M; Taivassalo, T; Ritchie, D; Wright, KJ; Thomas, MM; Romestaing, C; Hepple, RT				Picard, Martin; Taivassalo, Tanja; Ritchie, Darmyn; Wright, Kathryn J.; Thomas, Melissa M.; Romestaing, Caroline; Hepple, Russell T.			Mitochondrial Structure and Function Are Disrupted by Standard Isolation Methods	PLOS ONE			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; PERMEABILITY TRANSITION PORE; IN-VIVO; RETICULUM; CAPACITY; FIBERS; MOUSE; AGE; APOPTOSIS; DISEASES	Mitochondria regulate critical components of cellular function via ATP production, reactive oxygen species production, Ca(2+) handling and apoptotic signaling. Two classical methods exist to study mitochondrial function of skeletal muscles: isolated mitochondria and permeabilized myofibers. Whereas mitochondrial isolation removes a portion of the mitochondria from their cellular environment, myofiber permeabilization preserves mitochondrial morphology and functional interactions with other intracellular components. Despite this, isolated mitochondria remain the most commonly used method to infer in vivo mitochondrial function. In this study, we directly compared measures of several key aspects of mitochondrial function in both isolated mitochondria and permeabilized myofibers of rat gastrocnemius muscle. Here we show that mitochondrial isolation i) induced fragmented organelle morphology; ii) dramatically sensitized the permeability transition pore sensitivity to a Ca(2+) challenge; iii) differentially altered mitochondrial respiration depending upon the respiratory conditions; and iv) dramatically increased H(2)O(2) production. These alterations are qualitatively similar to the changes in mitochondrial structure and function observed in vivo after cellular stress-induced mitochondrial fragmentation, but are generally of much greater magnitude. Furthermore, mitochondrial isolation markedly altered electron transport chain protein stoichiometry. Collectively, our results demonstrate that isolated mitochondria possess functional characteristics that differ fundamentally from those of intact mitochondria in permeabilized myofibers. Our work and that of others underscores the importance of studying mitochondrial function in tissue preparations where mitochondrial structure is preserved and all mitochondria are represented.	[Picard, Martin; Taivassalo, Tanja] McGill Univ, Dept Kinesiol, Montreal, PQ, Canada; [Ritchie, Darmyn; Wright, Kathryn J.; Thomas, Melissa M.; Hepple, Russell T.] Univ Calgary, Muscle & Aging Lab, Fac Kinesiol, Calgary, AB, Canada; [Ritchie, Darmyn; Wright, Kathryn J.; Thomas, Melissa M.; Hepple, Russell T.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Romestaing, Caroline] Univ Lyon, Lab Physiol Integrat Cellulaire & Mol, Villeurbanne, France	McGill University; University of Calgary; University of Calgary	Picard, M (corresponding author), McGill Univ, Dept Kinesiol, Montreal, PQ, Canada.	hepple@ucalgary.ca	romestaing, caroline/O-8794-2017	romestaing, caroline/0000-0002-6877-9626; Picard, Martin/0000-0003-2835-0478; Jacob, Kathryn/0000-0001-8373-5915; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes for Health Research [MOP 57808, IAO 84673]; Alberta Heritage Foundation for Medical Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by operating grants from the Canadian Institutes for Health Research (MOP 57808 and IAO 84673 to RTH). RTH holds a Senior Scholar Award from the Alberta Heritage Foundation for Medical Research, MP holds a PhD fellowship from the Natural Sciences and Engineering Research Council of Canada and is a CIHR Fellow in Systems Biology. TT is a Chercheur Boursier Junior I Research Scholar from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; Burelle Y, 2002, J APPL PHYSIOL, V92, P2429, DOI 10.1152/japplphysiol.01024.2001; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350; Figueiredo PA, 2008, BIOGERONTOLOGY, V9, P67, DOI 10.1007/s10522-007-9121-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hom J, 2009, J MOL CELL CARDIOL, V46, P811, DOI 10.1016/j.yjmcc.2009.02.023; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002; Joseph AM, 2010, AM J PHYSIOL-CELL PH, V298, pC1308, DOI 10.1152/ajpcell.00644.2008; KAYAR SR, 1988, ANAT REC, V222, P333, DOI 10.1002/ar.1092220405; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lemieux H, 2010, J GERONTOL A-BIOL, DOI [DOI 10.1093/GERONA/GLQ1141, 10.1093/gerona/glq1141]; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Ogata T, 1997, ANAT REC, V248, P214; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Patel SP, 2009, INVEST OPHTH VIS SCI, V50, P180, DOI 10.1167/iovs.08-1911; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996; Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Seelert H, 2009, BBA-BIOENERGETICS, V1787, P657, DOI 10.1016/j.bbabio.2009.02.028; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WILLIAMS GR, 1965, CAN J BIOCHEM CELL B, V43, P603, DOI 10.1139/o65-070; WILSON EJ, 1987, NEUROCHEM RES, V12, P831; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	51	214	218	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18317	10.1371/journal.pone.0018317	http://dx.doi.org/10.1371/journal.pone.0018317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21512578	Green Submitted, Green Published, gold			2022-12-27	WOS:000289053800041
J	Edwards, AM; Potter, U; Meenan, NAG; Potts, JR; Massey, RC				Edwards, Andrew M.; Potter, Ursula; Meenan, Nicola A. G.; Potts, Jennifer R.; Massey, Ruth C.			Staphylococcus aureus Keratinocyte Invasion Is Dependent upon Multiple High-Affinity Fibronectin-Binding Repeats within FnBPA	PLOS ONE			English	Article							PROTEIN-A; BACTERIAL-INFECTIONS; LACTOCOCCUS-LACTIS; EXPRESSION; ADHESION; MECHANISMS; COMPLEX; CELLS; EPIDEMIOLOGY; CONSEQUENCES	Staphylococcus aureus is a commensal organism and a frequent cause of skin and soft tissue infections, which can progress to serious invasive disease. This bacterium uses its fibronectin binding proteins (FnBPs) to invade host cells and it has been hypothesised that this provides a protected niche from host antimicrobial defences, allows access to deeper tissues and provides a reservoir for persistent or recurring infections. FnBPs contain multiple tandem fibronectin-binding repeats (FnBRs) which bind fibronectin with varying affinity but it is unclear what selects for this configuration. Since both colonisation and skin infection are dependent upon the interaction of S. aureus with keratinocytes we hypothesised that this might select for FnBP function and thus composition of the FnBR region. Initial experiments revealed that S. aureus attachment to keratinocytes is rapid but does not require FnBRs. By contrast, invasion of keratinocytes was dependent upon the FnBR region and occurred via similar cellular processes to those described for endothelial cells. Despite this, keratinocyte invasion was relatively inefficient and appeared to include a lag phase, most likely due to very weak expression of alpha(5)beta(1) integrins. Molecular dissection of the role of the FnBR region revealed that efficient invasion of keratinocytes was dependent on the presence of at least three high-affinity (but not low-affinity) FnBRs. Over-expression of a single high-affinity or three low-affinity repeats promoted invasion but not to the same levels as S. aureus expressing an FnBPA variant containing three high-affinity repeats. In summary, invasion of keratinocytes by S. aureus requires multiple high-affinity FnBRs within FnBPA, and given the importance of the interaction between these cell types and S. aureus for both colonisation and infection, may have provided the selective pressure for the multiple binding repeats within FnBPA.	[Edwards, Andrew M.; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Meenan, Nicola A. G.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of Bath; University of York - UK; University of York - UK	Edwards, AM (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	ae248@bath.ac.uk	Massey, Ruth/AAT-6415-2021; Meenan, Nicola/A-4884-2010	Massey, Ruth/0000-0002-8154-4039; Edwards, Andrew/0000-0002-7173-7355; Meenan, Nicola/0000-0002-0294-4983	British Heart Foundation; Wellcome Trust [WT 079588]; Medical Research Council [G0700836] Funding Source: researchfish; MRC [G0700836] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JRP acknowledges the British Heart Foundation (http://www.bhf.org.uk/) for a Senior Basic Science Research Fellowship. This work was funded by the Wellcome Trust (http://www.wellcome.ac.uk/), grant number WT 079588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufiero B, 2007, INT J DERMATOL, V46, P687, DOI 10.1111/j.1365-4632.2007.03161.x; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brook I, 2002, J MED MICROBIOL, V51, P808, DOI 10.1099/0022-1317-51-10-808; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; FROMAN G, 1987, J BIOL CHEM, V262, P6564; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hirt H, 2000, J BACTERIOL, V182, P2299, DOI 10.1128/JB.182.8.2299-2306.2000; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Kisich KO, 2007, J INVEST DERMATOL, V127, P2368, DOI 10.1038/sj.jid.5700861; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; PELLEGRINI G, 1992, J CLIN INVEST, V89, P1783, DOI 10.1172/JCI115782; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schroder A, 2006, MOL BIOL CELL, V17, P5198, DOI 10.1091/mbc.E06-05-0463; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Sinha B, 2005, THROMB HAEMOSTASIS, V94, P266, DOI 10.1160/TH05-04-0235; von Eiff C, 2001, CLIN INFECT DIS, V32, P1643, DOI 10.1086/320519; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; Wang BN, 2007, CELL MICROBIOL, V9, P1519, DOI 10.1111/j.1462-5822.2007.00889.x; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Zautner AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009452	53	47	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18899	10.1371/journal.pone.0018899	http://dx.doi.org/10.1371/journal.pone.0018899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526122	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800021
J	Cairns, M; Ghani, A; Okell, L; Gosling, R; Carneiro, I; Anto, F; Asoala, V; Owusu-Agyei, S; Greenwood, B; Chandramohan, D; Milligan, P				Cairns, Matthew; Ghani, Azra; Okell, Lucy; Gosling, Roly; Carneiro, Ilona; Anto, Francis; Asoala, Victor; Owusu-Agyei, Seth; Greenwood, Brian; Chandramohan, Daniel; Milligan, Paul			Modelling the Protective Efficacy of Alternative Delivery Schedules for Intermittent Preventive Treatment of Malaria in Infants and Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; SULFADOXINE-PYRIMETHAMINE; COMBINATION THERAPY; INOCULATION RATE; TRANSMISSION; RATES; ARTESUNATE; MORBIDITY; MORTALITY; INDEXES	Background: Intermittent preventive treatment in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is recommended by WHO where malaria incidence in infancy is high and SP resistance is low. The current delivery strategy is via routine Expanded Program on Immunisation contacts during infancy (EPI-IPTi). However, improvements to this approach may be possible where malaria transmission is seasonal, or where the malaria burden lies mainly outside infancy. Methods and Findings: A mathematical model was developed to estimate the protective efficacy (PE) of IPT against clinical malaria in children aged 2-24 months, using entomological and epidemiological data from an EPI-IPTi trial in Navrongo, Ghana to parameterise the model. The protection achieved by seasonally-targeted IPT in infants (sIPTi), seasonal IPT in children (sIPTc), and by case-management with long-acting artemisinin combination therapies (LA-ACTs) was predicted for Navrongo and for sites with different transmission intensity and seasonality. In Navrongo, the predicted PE of sIPTi was 26% by 24 months of age, compared to 16% with EPI-IPTi. sIPTc given to all children under 2 years would provide PE of 52% by 24 months of age. Seasonally-targeted IPT retained its advantages in a range of transmission patterns. Under certain circumstances, LA-ACTs for case-management may provide similar protection to EPI-IPTi. However, EPI-IPTi or sIPT combined with LA-ACTs would be substantially more protective than either strategy used alone. Conclusion: Delivery of IPT to infants via the EPI is sub-optimal because individuals are not protected by IPT at the time of highest malaria risk, and because older children are not protected. Alternative delivery strategies to the EPI are needed where transmission varies seasonally or the malaria burden extends beyond infancy. Long-acting ACTs may also make important reductions in malaria incidence. However, delivery systems must be developed to ensure that both forms of chemoprevention reach the individuals who are most exposed to malaria.	[Cairns, Matthew; Gosling, Roly; Carneiro, Ilona; Greenwood, Brian; Chandramohan, Daniel; Milligan, Paul] London Sch Hyg & Trop Med, London WC1, England; [Ghani, Azra; Okell, Lucy] Univ London Imperial Coll Sci Technol & Med, London, England; [Anto, Francis; Asoala, Victor] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Navrongo Health Research Center; Kintampo Health Research Centre	Cairns, M (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	matthew.cairns@lshtm.ac.uk	Milligan, Paul/D-8985-2017; Ghani, Azra/B-8560-2009	Milligan, Paul/0000-0003-3430-3395; Ghani, Azra/0000-0002-0007-4910; Okell, Lucy/0000-0001-7202-6873; Owusu-Agyei, Seth/0000-0002-0807-1781	Medical Research Council; UK Department for International Development (DfID); Medical Research Council [G0700837, G0600719B] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DfID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Medical Research Council PhD studentship awarded to the first author (MC). The Navrongo IPTi Trial which provided data used in the present study was funded by the UK Department for International Development (DfID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-292; Alexander N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-9; ANTO F, 2004, ENTOMOLOGICAL UNPUB; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Cairns M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009467; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; CISSE B, 2007, EUR C TROP MED INT H; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Falk N, 2006, AM J TROP MED HYG, V74, P944, DOI 10.4269/ajtmh.2006.74.944; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Griffin JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012618; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; May J, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-198; Mwangi TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002196; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Oduro AR, 2005, TROP MED INT HEALTH, V10, P279, DOI 10.1111/j.1365-3156.2004.01382.x; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Pool R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-213; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Roca-Feltrer A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-276; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; SINDEN RE, 2002, ESSENTIAL MALARIOLOG; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith T, 2003, STAT MED, V22, P1709, DOI 10.1002/sim.1274; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; Smith T, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P247; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; TAGBOR H, 2010, TROP MED INT HLTH; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; *WHO, 2009, REP TECHN CONS INT P; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18947	10.1371/journal.pone.0018947	http://dx.doi.org/10.1371/journal.pone.0018947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533088	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000289719400036
J	Sun, LJ; Li, HM; Seufferheld, MJ; Walters, KR; Margam, VM; Jannasch, A; Diaz, N; Riley, CP; Sun, WL; Li, YF; Muir, WM; Xie, J; Wu, J; Zhang, F; Chen, JY; Barker, EL; Adamec, J; Pittendrigh, BR				Sun, Lijie; Li, Hong-Mei; Seufferheld, Manfredo J.; Walters, Kent R., Jr.; Margam, Venu M.; Jannasch, Amber; Diaz, Naomi; Riley, Catherine P.; Sun, Weilin; Li, Yueh-Feng; Muir, William M.; Xie, Jun; Wu, Jing; Zhang, Fan; Chen, Jake Y.; Barker, Eric L.; Adamec, Jiri; Pittendrigh, Barry R.			Systems-Scale Analysis Reveals Pathways Involved in Cellular Response to Methamphetamine	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; OXIDATIVE STRESS; GENE-EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CYTOSOLIC HEAT-SHOCK-PROTEIN-60; ALDEHYDE-DEHYDROGENASE; INDUCED NEUROTOXICITY; REACTIVE OXYGEN; PROTECTIVE ROLE; MESSENGER-RNA	Background: Methamphetamine (METH), an abused illicit drug, disrupts many cellular processes, including energy metabolism, spermatogenesis, and maintenance of oxidative status. However, many components of the molecular underpinnings of METH toxicity have yet to be established. Network analyses of integrated proteomic, transcriptomic and metabolomic data are particularly well suited for identifying cellular responses to toxins, such as METH, which might otherwise be obscured by the numerous and dynamic changes that are induced. Methodology/Results: We used network analyses of proteomic and transcriptomic data to evaluate pathways in Drosophila melanogaster that are affected by acute METH toxicity. METH exposure caused changes in the expression of genes involved with energy metabolism, suggesting a Warburg-like effect (aerobic glycolysis), which is normally associated with cancerous cells. Therefore, we tested the hypothesis that carbohydrate metabolism plays an important role in METH toxicity. In agreement with our hypothesis, we observed that increased dietary sugars partially alleviated the toxic effects of METH. Our systems analysis also showed that METH impacted genes and proteins known to be associated with muscular homeostasis/contraction, maintenance of oxidative status, oxidative phosphorylation, spermatogenesis, iron and calcium homeostasis. Our results also provide numerous candidate genes for the METH-induced dysfunction of spermatogenesis, which have not been previously characterized at the molecular level. Conclusion: Our results support our overall hypothesis that METH causes a toxic syndrome that is characterized by the altered carbohydrate metabolism, dysregulation of calcium and iron homeostasis, increased oxidative stress, and disruption of mitochondrial functions.	[Sun, Lijie; Li, Hong-Mei; Walters, Kent R., Jr.; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Sun, Lijie] J Craig Venter Inst, San Diego, CA USA; [Sun, Lijie; Margam, Venu M.; Li, Yueh-Feng] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Jannasch, Amber; Diaz, Naomi; Riley, Catherine P.] Purdue Univ, Bindley Biosci Ctr, Metabol Profiling Facil, W Lafayette, IN 47907 USA; [Li, Yueh-Feng] Chung Hwa Coll Med Technol, Tainan, Taiwan; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Xie, Jun] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Zhang, Fan; Chen, Jake Y.] Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA; [Adamec, Jiri] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Mellon University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Nebraska System; University of Nebraska Lincoln	Sun, LJ (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL USA.	pittendr@illinois.edu	Li-Byarlay, Hongmei/AAQ-1341-2020; Margam, Venu M/E-5876-2010	Li-Byarlay, Hongmei/0000-0001-6579-5172; Chen, Jake/0000-0001-8829-7504; Margam, Venu/0000-0001-6510-4618	Department of Entomology at the University of Illinois; C.W. Kearns endowment fund; C.L. Metcalf endowment fund; W.P. Flint endowment fund	Department of Entomology at the University of Illinois; C.W. Kearns endowment fund; C.L. Metcalf endowment fund; W.P. Flint endowment fund	Support was provided to BRP from the Department of Entomology at the University of Illinois and from the C.W. Kearns, C.L. Metcalf and W.P. Flint endowment funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Alavi SH, 2008, SYST BIOL REPROD MEC, V54, P85, DOI 10.1080/19396360801952078; Albers DS, 1996, BRAIN RES, V718, P217, DOI 10.1016/0006-8993(96)00135-7; Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Asanuma M, 2002, NEUROSCI LETT, V325, P191, DOI 10.1016/S0304-3940(02)00291-4; Asanuma M, 2007, NEUROSCI LETT, V414, P263, DOI 10.1016/j.neulet.2006.12.036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashburner M., 1989, DROSOPHILA LAB HDB; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Brown JM, 2005, J NEUROCHEM, V95, P429, DOI 10.1111/j.1471-4159.2005.03379.x; Burrows KB, 2000, EUR J PHARMACOL, V398, P11, DOI 10.1016/S0014-2999(00)00264-8; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; CADET JL, 1994, J NEUROCHEM, V62, P380; Campbell AM, 2008, J BIOENERG BIOMEMBR, V40, P193, DOI 10.1007/s10863-008-9138-x; Chen JSK, 2002, BREAST CANCER RES TR, V71, P237, DOI 10.1023/A:1014461832403; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Chin MH, 2008, J PROTEOME RES, V7, P666, DOI 10.1021/pr070546l; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Downing KH, 1998, CURR OPIN STRUC BIOL, V8, P785, DOI 10.1016/S0959-440X(98)80099-7; Du ZX, 2007, ENDOCRINOLOGY, V148, P4352, DOI 10.1210/en.2006-1511; Ejeskar K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-161; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; HASSETT CC, 1948, BIOL BULL, V95, P114, DOI 10.2307/1538158; Haughey HM, 1999, J NEUROCHEM, V72, P661, DOI 10.1046/j.1471-4159.1999.0720661.x; Herring NR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-49; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hsu KW, 2008, MOL CELL BIOL, V28, P4829, DOI 10.1128/MCB.00175-08; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Hutchens JA, 1997, MOL BIOL CELL, V8, P481, DOI 10.1091/mbc.8.3.481; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; Ito Y, 1996, AM J PHYSIOL-HEART C, V270, pH81, DOI 10.1152/ajpheart.1996.270.1.H81; Jacobs H, 1998, MOL GEN GENET, V259, P383, DOI 10.1007/s004380050826; Jang M, 2009, MOL CELLS, V28, P559, DOI 10.1007/s10059-009-0151-7; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jeng W, 2005, FREE RADICAL BIO MED, V39, P317, DOI 10.1016/j.freeradbiomed.2005.03.015; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim HJ, 2009, CELLS TISSUES ORGANS, V190, P1, DOI 10.1159/000153041; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; Liao WR, 2007, CARCINOGENESIS, V28, P1867, DOI 10.1093/carcin/bgm092; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; LUDWIG MZ, 1991, BIOCHEM GENET, V29, P215, DOI 10.1007/BF00590103; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; MEHTA CR, 1984, BIOMETRICS, V40, P819, DOI 10.2307/2530927; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Oku K, 2005, J PHYS CHEM B, V109, P3032, DOI 10.1021/jp045906w; Parsch J, 2001, MOL BIOL EVOL, V18, P801, DOI 10.1093/oxfordjournals.molbev.a003862; Pavlik P, 2006, GENOMICS, V88, P347, DOI 10.1016/j.ygeno.2006.04.009; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; PONTIERI FE, 1990, PSYCHOPHARMACOLOGY, V102, P175, DOI 10.1007/BF02245919; Quinton MS, 2006, AAPS J, V8, pE337, DOI 10.1208/aapsj080238; Russell K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-48; Ryu NK, 2007, J BIOCHEM MOL BIOL, V40, P475; SALIDO GM, 2009, OXIDATIVE STRESS INT; Salomon AR, 2000, P NATL ACAD SCI USA, V97, P14766, DOI 10.1073/pnas.97.26.14766; SARAH BB, 1999, J NEUROCHEM, V73, P1127; SCHIORRING E, 1981, PHARMACOL BIOCHEM BE, V14, P109, DOI 10.1016/S0091-3057(81)80018-4; Shaner John W, 2002, J Mich Dent Assoc, V84, P42; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Singh S, 2005, APOPTOSIS, V10, P1469, DOI 10.1007/s10495-005-1394-1; SMITH HJ, 1976, AM HEART J, V91, P792, DOI 10.1016/S0002-8703(76)80545-5; Specchia V, 2008, J BIOENERG BIOMEMBR, V40, P219, DOI 10.1007/s10863-008-9149-7; Stephans SE, 1998, J NEUROCHEM, V71, P613; STEPHEN RM, 1999, PROTEIN SCI, V8, P2444; STOCCHI V, 1994, ARCH BIOCHEM BIOPHYS, V311, P160, DOI 10.1006/abbi.1994.1221; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sucharov CC, 2003, J BIOL CHEM, V278, P31233, DOI 10.1074/jbc.M301917200; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Virmani A, 2002, ANN NY ACAD SCI, V965, P225; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Wilson KL, 2006, DEVELOPMENT, V133, P4871, DOI 10.1242/dev.02671; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; WOOD KA, 1995, J NEUROSCI, V15, P5851; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; Xie T, 2002, J NEUROSCI, V22, P274, DOI 10.1523/JNEUROSCI.22-01-00274.2002; Yamamoto Y, 1999, J Obstet Gynaecol Res, V25, P353; Yu QL, 2003, LIFE SCI, V73, P129, DOI 10.1016/S0024-3205(03)00260-1; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhang XC, 2005, J APPL PHYSIOL, V99, P2246, DOI 10.1152/japplphysiol.00750.2005; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhu Bao-Li, 2007, Legal Medicine, V9, P115, DOI 10.1016/j.legalmed.2006.10.002	97	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18215	10.1371/journal.pone.0018215	http://dx.doi.org/10.1371/journal.pone.0018215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533132	Green Published, gold			2022-12-27	WOS:000289719400006
J	Li, HL; Zhai, JF; Sun, XP				Li, Hailong; Zhai, Junfeng; Sun, Xuping			Electrostatic-Assembly-Driven Formation of Supramolecular Rhombus Microparticles and Their Application for Fluorescent Nucleic Acid Detection	PLOS ONE			English	Article							SENSING PLATFORM; CARBON NANOTUBES; DNA ANALYSIS; NANOPARTICLES; GRAPHENE; PROBES; OLIGONUCLEOTIDES; BIOMOLECULES	In this paper, we report on the large-scale formation of supramolecular rhombus microparticles (SRMs) driven by electrostatic assembly, carried out by direct mixing of an aqueous HAuCl4 solution and an ethanol solution of 4,4`-bipyridine at room temperature. We further demonstrate their use as an effective fluorescent sensing platform for nucleic acid detection with a high selectivity down to single-base mismatch. The general concept used in this approach is based on adsorption of the fluorescently labeled single-stranded DNA (ssDNA) probe by SRM, which is accompanied by substantial fluorescence quenching. In the following assay, specific hybridization with its target to form double-stranded DNA (dsDNA) results in desorption of ssDNA from SRM surface and subsequent fluorescence recovery.	[Li, Hailong; Zhai, Junfeng; Sun, Xuping] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Li, Hailong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, HL (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	sunxp@ciac.jl.cn	Li, Hailong/H-2527-2018; Zhai, Junfeng/D-9321-2016	Li, Hailong/0000-0002-1209-2315; Zhai, Junfeng/0000-0001-5421-6999	National Basic Research Program of China [2011CB935800]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (No. 2011CB935800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard Valeur, 2001, MOL FLUORESCENCE PRI; Boal AK, 2000, NATURE, V404, P746, DOI 10.1038/35008037; Brayner R, 2008, NANO TODAY, V3, P48, DOI 10.1016/S1748-0132(08)70015-X; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fendler JH, 2001, CHEM MATER, V13, P3196, DOI 10.1021/cm010165m; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li H., 2011, SMALL IN PRESS; Li H-Y, 2011, UNPUB; Li HL, 2011, ANAL METHODS-UK, V3, P1051, DOI 10.1039/c0ay00746c; Li HL, 2011, J MATER CHEM, V21, P824, DOI 10.1039/c0jm02695f; Li HL, 2011, J MATER CHEM, V21, P4663, DOI 10.1039/c0jm04107f; Li HL, 2011, CHEM COMMUN, V47, P2625, DOI 10.1039/c0cc05394e; Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g; Liu S, 2011, J MATER CHEM, V21, P339, DOI 10.1039/c0jm03337e; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; Ray PC, 2007, PLASMONICS, V2, P173, DOI 10.1007/s11468-007-9036-9; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Song SP, 2009, ANGEW CHEM INT EDIT, V48, P8670, DOI 10.1002/anie.200901887; Sun XP, 2007, ANAL CHEM, V79, P2588, DOI 10.1021/ac062130h; Sun XP, 2010, LANGMUIR, V26, P6133, DOI 10.1021/la100646e; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Tian JQ, 2011, LANGMUIR, V27, P874, DOI 10.1021/la103799e; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Yang RH, 2008, ANAL CHEM, V80, P7408, DOI 10.1021/ac801118p; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f	36	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18958	10.1371/journal.pone.0018958	http://dx.doi.org/10.1371/journal.pone.0018958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526152	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100040
J	Schibille, N				Schibille, Nadine			Late Byzantine Mineral Soda High Alumina Glasses from Asia Minor: A New Primary Glass Production Group	PLOS ONE			English	Article							ROMAN GLASS; ISLAMIC GLASS; OBSIDIAN CHARACTERIZATION; RAW GLASS; ICP-MS; ISOTOPES; PROVENANCE; PLANTS; EAST; TECHNOLOGY	The chemical characterisation of archaeological glass allows the discrimination between different glass groups and the identification of raw materials and technological traditions of their production. Several lines of evidence point towards the large-scale production of first millennium CE glass in a limited number of glass making factories from a mixture of Egyptian mineral soda and a locally available silica source. Fundamental changes in the manufacturing processes occurred from the eight/ninth century CE onwards, when Egyptian mineral soda was gradually replaced by soda-rich plant ash in Egypt as well as the Islamic Middle East. In order to elucidate the supply and consumption of glass during this transitional period, 31 glass samples from the assemblage found at Pergamon (Turkey) that date to the fourth to fourteenth centuries CE were analysed by electron microprobe analysis (EPMA) and by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). The statistical evaluation of the data revealed that the Byzantine glasses from Pergamon represent at least three different glass production technologies, one of which had not previously been recognised in the glass making traditions of the Mediterranean. While the chemical characteristics of the late antique and early medieval fragments confirm the current model of glass production and distribution at the time, the elemental make-up of the majority of the eighth-to fourteenth-century glasses from Pergamon indicate the existence of a late Byzantine glass type that is characterised by high alumina levels. Judging from the trace element patterns and elevated boron and lithium concentrations, these glasses were produced with a mineral soda different to the Egyptian natron from the Wadi Natrun, suggesting a possible regional Byzantine primary glass production in Asia Minor.	Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QJ, England	University of Oxford	Schibille, N (corresponding author), Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QJ, England.	nadine.schibille@rlaha.ox.ac.uk		Schibille, Nadine/0000-0001-9242-0392	Marie Curie Intra-European Fellowship for Career Development [FP7-PEOPLE-IEF-2008, 236809]	Marie Curie Intra-European Fellowship for Career Development	This work was supported by a Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-IEF-2008; Grant Agreement No. 236809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESCUTREADG.I, 2006, ARTE MEDIEVALE, V5, P87; [Anonymous], 2008, COMPOSITION PRODUCTI; Arletti R, 2010, ARCHAEOMETRY, V52, P796, DOI 10.1111/j.1475-4754.2009.00504.x; Arletti R., 2005, ANN 16 C ASS INT HIS, P80; Boulogne S, 2009, J GLASS STUD, V51, P53; Brill R.H., 1999, CHEM ANAL EARLY GLAS, V2; Brill R. H., 1968, P 8 INT C GLASS SHEF, P47; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Carter T, 2006, J ARCHAEOL SCI, V33, P893, DOI 10.1016/j.jas.2005.10.023; Degryse P, 2008, J ARCHAEOL SCI, V35, P1993, DOI 10.1016/j.jas.2008.01.002; Degryse P., 2010, GLASS BYZANTIUM PROD, P83; Dussubieux L, 2008, ARCHAEOMETRY, V50, P797, DOI 10.1111/j.1475-4754.2007.00350.x; Dussubieux L, 2010, J ARCHAEOL SCI, V37, P1646, DOI 10.1016/j.jas.2010.01.025; Dussubieux L, 2009, INT J MASS SPECTROM, V284, P152, DOI 10.1016/j.ijms.2008.11.003; FOSS C, 1977, AM J ARCHAEOL, V81, P469, DOI 10.2307/503279; Foy D., 2000, ANN 14 C ASS INT HIS, P51; Foy D., 2003, CHANGES COMMERCE VER, P41; Foy D, 2003, ANN 15E CONGRES LASS, P138; Freestone I.C., 2000, TRAVAUX MAISON ORIEN, P65; Freestone I. C., 2006, WEARMOUTH JARROW MON, P147; Freestone I.C., 2001, P HYAL VITR GLASS P, P167; Freestone IC, 2008, J GLASS STUD, V50, P67; Freestone IC, 2006, GEOL SOC SPEC PUBL, V257, P201, DOI 10.1144/GSL.SP.2006.257.01.16; Freestone IC, 2005, MATER RES SOC SYMP P, V852, P195; Freestone IC, 2003, ARCHAEOMETRY, V45, P19, DOI 10.1111/1475-4754.00094; Freestone IC, 2002, ARCHAEOMETRY, V44, P257, DOI 10.1111/1475-4754.t01-1-00058; Freestone IC, 1999, J GLASS STUD, V41, P105; Gorin-Rosen Y., 2000, ROUTE VERRE ATELIERS, P49; GORINROSEN Y, 1995, EXCAVATIONS SURVEYS, V13, P42; GRATUZE B, 1990, ARCHAEOMETRY, V32, P155, DOI 10.1111/j.1475-4754.1990.tb00462.x; Gratuze B, 1999, J ARCHAEOL SCI, V26, P869, DOI 10.1006/jasc.1999.0459; Helvaci C, 2004, INT GEOL REV, V46, P177, DOI 10.2747/0020-6814.46.2.177; Henderson J, 2004, ARCHAEOMETRY, V46, P439, DOI 10.1111/j.1475-4754.2004.00167.x; Henderson J, 2009, ANTIQUITY, V83, P414, DOI 10.1017/S0003598X00098525; HEVACI C, 2000, TURKISH J EARTH SCI, V9, P1; Jackson CM, 2003, ARCHAEOMETRY, V45, P435, DOI 10.1111/1475-4754.00120; JAPP S, 2010, ISTANBULER MITTEILUN, V60, P455; Kamber BS, 2005, GEOCHIM COSMOCHIM AC, V69, P1041, DOI 10.1016/j.gca.2004.08.020; Krom MD, 2002, GEOLOGY, V30, P71, DOI 10.1130/0091-7613(2002)030<0071:NRSFOT>2.0.CO;2; Lankton JW, 2006, J GLASS STUD, V48, P121; Leslie KA, 2006, ARCHAEOMETRY, V48, P253, DOI 10.1111/j.1475-4754.2006.00255.x; MIRTI P, 1993, ARCHAEOMETRY, V35, P225, DOI 10.1111/j.1475-4754.1993.tb01037.x; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Nenna M.D., 1997, REV ARCHAEOMETRIE, V21, P81, DOI [DOI 10.3406/arsci.1997.949, 10.3406/arsci.1997.949, DOI 10.3406/ARSCI.1997.949]; Nenna MD, 2000, ROUTE VERRE ATELIERS, P97; Paynter S, 2008, J GLASS STUD, V50, P271; Radt W., 1999, PERGAMON GESCHICHTE; Rehren T., 2008, ARCHAEOLOGY HIST SCI, P77; Rehren T, 2008, J ARCHAEOL SCI, V35, P1345, DOI 10.1016/j.jas.2007.09.005; RHEIDT K, 1991, ALTERTUMER PERGAMON; SAYRE EV, 1961, SCIENCE, V133, P1824, DOI 10.1126/science.133.3467.1824; Schwarzer H., 2009, LATE ANTIQUE EARLY B, P85; Shennan S., 1997, QUANTIFYING ARCHAEOL; Shortland A, 2006, J ARCHAEOL SCI, V33, P521, DOI 10.1016/j.jas.2005.09.011; Silvestri A, 2008, J ARCHAEOL SCI, V35, P1489, DOI 10.1016/j.jas.2007.10.014; Silvestri A, 2008, J ARCHAEOL SCI, V35, P331, DOI 10.1016/j.jas.2007.03.010; Silvestri A, 2005, ARCHAEOMETRY, V47, P797, DOI 10.1111/j.1475-4754.2005.00233.x; Tanimoto S, 2008, J ARCHAEOL SCI, V35, P2566, DOI 10.1016/j.jas.2008.04.016; Wedepohl KH, 2010, CHEM ERDE-GEOCHEM, V70, P89, DOI 10.1016/j.chemer.2009.12.006; Wedepohl KH, 2000, NATURWISSENSCHAFTEN, V87, P129, DOI 10.1007/s001140050690; Whitehouse D, 2002, J GLASS STUD, V44, P193	61	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18970	10.1371/journal.pone.0018970	http://dx.doi.org/10.1371/journal.pone.0018970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	752EC	21526144	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000289671100042
J	Lloyd, DJ; Helmering, J; Kaufman, SA; Turk, J; Silva, M; Vasquez, S; Weinstein, D; Johnston, B; Hale, C; Veniant, MM				Lloyd, David J.; Helmering, Joan; Kaufman, Stephen A.; Turk, James; Silva, Matt; Vasquez, Sergio; Weinstein, David; Johnston, Brad; Hale, Clarence; Veniant, Murielle M.			A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; COMPUTED TOMOGRAPHY; APOLIPOPROTEIN B100; METABOLIC SYNDROME; VIRTUAL HISTOLOGY; LESIONS; QUANTIFICATION; DISEASE; MODELS; ARTERY	Precise quantification of atherosclerotic plaque in preclinical models of atherosclerosis requires the volumetric assessment of the lesion(s) while maintaining in situ architecture. Here we use micro-computed tomography (microCT) to detect ex vivo aortic plaque established in three dyslipidemic mouse models of atherosclerosis. All three models lack the low-density lipoprotein receptor (Ldlr(-/-)), each differing in plaque severity, allowing the evaluation of different plaque volumes using microCT technology. From clearly identified lesions in the thoracic aorta from each model, we were able to determine plaque volume (0.04-3.1 mm(3)), intimal surface area (0.5-30 mm(2)), and maximum plaque (intimal-medial) thickness (0.1-0.7 mm). Further, quantification of aortic volume allowed calculation of vessel occlusion by the plaque. To validate microCT for future preclinical studies, we compared microCT data to intimal surface area (by using en face methodology). Both plaque surface area and plaque volume were in excellent correlation between microCT assessment and en face surface area (r(2) = 0.99, p<0.0001 and r(2) = 0.95, p < 0.0001, respectively). MicroCT also identified internal characteristics of the lipid core and fibrous cap, which were confirmed pathologically as Stary type III-V lesions. These data validate the use of microCT technology to provide a more exact empirical measure of ex vivo plaque volume throughout the entire intact aorta in situ for the quantification of atherosclerosis in preclinical models.	[Lloyd, David J.; Helmering, Joan; Hale, Clarence; Veniant, Murielle M.] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [Kaufman, Stephen A.; Turk, James] Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA; [Silva, Matt] Amgen Inc, Dept Res Imaging, Thousand Oaks, CA 91320 USA; [Vasquez, Sergio; Weinstein, David; Johnston, Brad] Numira Biosci, Salt Lake City, UT USA	Amgen; Amgen; Amgen	Lloyd, DJ (corresponding author), Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA.	dlloyd@amgen.com		Lloyd, David/0000-0001-5924-0672	Amgen Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	Amgen Inc.(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barck KH, 2004, ARTHRITIS RHEUM-US, V50, P3377, DOI 10.1002/art.20557; Chen ZP, 2002, CIRCULATION, V106, P20, DOI 10.1161/01.CIR.0000022843.76104.01; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; de Crespigny A, 2008, J NEUROSCI METH, V171, P207, DOI 10.1016/j.jneumeth.2008.03.006; Garcia-Sanz A, 1998, HYPERTENSION, V31, P440, DOI 10.1161/01.HYP.31.1.440; Hartvigsen K, 2007, ARTERIOSCL THROM VAS, V27, P878, DOI 10.1161/01.ATV.0000258790.35810.02; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Krucker T, 2004, NEUROL RES, V26, P507, DOI 10.1179/016164104225016281; Langheinrich AC, 2004, RADIOLOGY, V231, P675, DOI 10.1148/radiol.2313021718; Li X, J BONE MINER RES, V25, P2371; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lloyd DJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE496, DOI 10.1152/ajpendo.00509.2007; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martinez HG, 2009, CIRCULATION, V120, P821, DOI 10.1161/CIRCULATIONAHA.108.829531; McAteer MA, 2004, ARTERIOSCL THROM VAS, V24, P2384, DOI 10.1161/01.ATV.0000146811.19029.fb; MITTAL R, AM J PATHOL, V176, P1292; OMINSKY MS, J BONE MINER RES; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; PRAJAPATI SI, 2010, MOL IMAGING BIOL; Silva MD, 2004, MOL IMAGING, V3, P312, DOI 10.1162/1535350042973562; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Veniant MM, 1997, J CLIN INVEST, V100, P180, DOI 10.1172/JCI119511; Veniant MM, 2000, J CLIN INVEST, V106, P1501, DOI 10.1172/JCI10695; Williamson MJ, 2009, MOL CANCER THER, V8, P3234, DOI 10.1158/1535-7163.MCT-09-0239	28	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18800	10.1371/journal.pone.0018800	http://dx.doi.org/10.1371/journal.pone.0018800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533112	gold, Green Published, Green Submitted			2022-12-27	WOS:000289620100021
J	Geisel, N; Vilar, JMG; Rubi, JM				Geisel, Nico; Vilar, Jose M. G.; Miguel Rubi, J.			Optimal Resting-Growth Strategies of Microbial Populations in Fluctuating Environments	PLOS ONE			English	Article							VIBRIO SP S14; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; CHANGING ENVIRONMENTS; GENE-EXPRESSION; STRESS-RESPONSE; CELL-CYCLE; STARVATION; SURVIVAL; PROTEIN	Bacteria spend most of their lifetime in non-growing states which allow them to survive extended periods of stress and starvation. When environments improve, they must quickly resume growth to maximize their share of limited nutrients. Cells with higher stress resistance often survive longer stress durations at the cost of needing more time to resume growth, a strong disadvantage in competitive environments. Here we analyze the basis of optimal strategies that microorganisms can use to cope with this tradeoff. We explicitly show that the prototypical inverse relation between stress resistance and growth rate can explain much of the different types of behavior observed in stressed microbial populations. Using analytical mathematical methods, we determine the environmental parameters that decide whether cells should remain vegetative upon stress exposure, downregulate their metabolism to an intermediate optimum level, or become dormant. We find that cell-cell variability, or intercellular noise, is consistently beneficial in the presence of extreme environmental fluctuations, and that it provides an efficient population-level mechanism for adaption in a deteriorating environment. Our results reveal key novel aspects of responsive phenotype switching and its role as an adaptive strategy in changing environments.	[Geisel, Nico; Miguel Rubi, J.] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Geisel, Nico] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Vilar, Jose M. G.] Univ Basque Country, Biophys Unit, CSIC, UPV,EHU,Dept Biochem & Mol Biol, Bilbao, Spain; [Vilar, Jose M. G.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	University of Barcelona; Princeton University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Basque Foundation for Science	Geisel, N (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain.	Nico.Geisel@ffn.ub.es	Vilar, Jose MG/A-9069-2013	Vilar, Jose MG/0000-0003-4037-0746	Spanish Ministry of Education [FPU AP-2007-00975]; Spanish Ministry of Science [FIS 2008-04386]	Spanish Ministry of Education(Spanish Government); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by the Spanish Ministry of Education grant no. FPU AP-2007-00975 and the Spanish Ministry of Science grant no. FIS 2008-04386. Nico Geisel would like to thank Matthias Kaschube for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ALBERTSON NH, 1990, J GEN MICROBIOL, V136, P2201, DOI 10.1099/00221287-136-11-2201; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cole JJ, 1999, ECOSYSTEMS, V2, P215, DOI 10.1007/s100219900069; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dupont C, 2009, APPL ENVIRON MICROB, V75, P3069, DOI 10.1128/AEM.02864-08; ELLIOTT B, 1993, YEAST, V9, P33, DOI 10.1002/yea.320090105; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; KJELLEBERG S, 1993, ANTON LEEUW INT J G, V63, P333, DOI 10.1007/BF00871228; Koch AL, 1997, MICROBIOL MOL BIOL R, V61, P305, DOI 10.1128/.61.3.305-318.1997; Kolter R, 1999, J BACTERIOL, V181, P697, DOI 10.1128/JB.181.3.697-699.1999; Konopka A, 2002, J IND MICROBIOL BIOT, V29, P286, DOI 10.1038/sj.jim.7000322; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LACHMANN M, 1995, J THEOR BIOL, V181, P1; LEGEWIE S, 2010, BIOPHYS J, V95, P3232; LENGELER JW, 1998, BIOL PROKARYOTES, P655; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Li YQ, 2006, INT J FOOD MICROBIOL, V110, P278, DOI 10.1016/j.ijfoodmicro.2006.04.029; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; MCCANN MP, 1991, J BACTERIOL, V173, P4188, DOI 10.1128/jb.173.13.4188-4194.1991; MCCLURE PJ, 1993, INT J FOOD MICROBIOL, V19, P161, DOI 10.1016/0168-1605(93)90074-Q; NYSTROM T, 1990, FEMS MICROBIOL ECOL, V74, P129, DOI 10.1111/j.1574-6968.1990.tb04059.x; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; REEVE CA, 1984, J BACTERIOL, V160, P1041, DOI 10.1128/JB.160.3.1041-1046.1984; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SCHULTZ D, 2009, P NATL ACAD SCI USA, V106; SHLEEVA M, 2002, MICROBIOLOGY, P148; SIEGELE DA, 1992, J BACTERIOL, V174, P345, DOI 10.1128/jb.174.2.345-348.1992; Su SSY, 1996, J CELL SCI, V109, P1347; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; VASI F, 1994, AM NATURALIST, V144; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105	43	12	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18622	10.1371/journal.pone.0018622	http://dx.doi.org/10.1371/journal.pone.0018622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525975	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600020
J	Sneve, MH; Alnaes, D; Endestad, T; Greenlee, MW; Magnussen, S				Sneve, Markus H.; Alnaes, Dag; Endestad, Tor; Greenlee, Mark W.; Magnussen, Svein			Modulation of Activity in Human Visual Area V1 during Memory Masking	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; MOTION INFORMATION; SPATIAL-FREQUENCY; CORTEX; REPRESENTATION; ADAPTATION; ACTIVATION; PSYCHOPHYSICS; SUPPRESSION	Neurons in the primary visual cortex, V1, are specialized for the processing of elemental features of the visual stimulus, such as orientation and spatial frequency. Recent fMRI evidence suggest that V1 neurons are also recruited in visual perceptual memory; a number of studies using multi-voxel pattern analysis have successfully decoded stimulus-specific information from V1 activity patterns during the delay phase in memory tasks. However, consistent fMRI signal modulations reflecting the memory process have not yet been demonstrated. Here, we report evidence, from three subjects, that the low V1 BOLD activity during retention of low-level visual features is caused by competing interactions between neural populations coding for different values along the spectrum of the dimension remembered. We applied a memory masking paradigm in which the memory representation of a masker stimulus interferes with a delayed spatial frequency discrimination task when its frequency differs from the discriminanda with +/- 1 octave and found that impaired behavioral performance due to masking is reflected in weaker V1 BOLD signals. This cross-channel inhibition in V1 only occurs with retinotopic overlap between the masker and the sample stimulus of the discrimination task. The results suggest that memory for spatial frequency is a local process in the retinotopically organized visual cortex.	[Sneve, Markus H.; Alnaes, Dag; Endestad, Tor; Magnussen, Svein] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Greenlee, Mark W.] Univ Regensburg, Dept Expt Psychol, Regensburg, Germany	University of Oslo; University of Regensburg	Sneve, MH (corresponding author), Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway.	m.h.sneve@psykologi.uio.no	Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Endestad, Tor/0000-0002-4403-6887; Alnaes, Dag/0000-0001-7361-5418	University of Oslo	University of Oslo	This work was supported by a grant from the University of Oslo (www.uio.no) to the Center for the Study of Human Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PJ, 1996, VISION RES, V36, P233, DOI 10.1016/0042-6989(95)00085-E; Boynton GM, 2003, J NEUROSCI, V23, P8781; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Cattaneo Z, 2009, EUR J NEUROSCI, V30, P1393, DOI 10.1111/j.1460-9568.2009.06911.x; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Danilova MV, 2003, PERCEPTION, V32, P395, DOI 10.1068/p3393; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Fang F, 2005, J NEUROPHYSIOL, V94, P4188, DOI 10.1152/jn.00378.2005; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Issa NP, 2008, J NEUROPHYSIOL, V99, P2745, DOI 10.1152/jn.90211.2008; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Lakha L, 2004, VISION RES, V44, P1707, DOI 10.1016/j.visres.2004.02.006; Lalonde J, 2002, VISION RES, V42, P1759, DOI 10.1016/S0042-6989(02)00111-6; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; MAGNUSSEN S, 1992, J EXP PSYCHOL LEARN, V18, P151, DOI 10.1037/0278-7393.18.1.151; Magnussen S, 2000, TRENDS NEUROSCI, V23, P247, DOI 10.1016/S0166-2236(00)01569-1; Magnussen S, 2010, MEMORY, AGING AND THE BRAIN: A FESTSCHRIFT IN HONOUR OF LARS-GORAN NILSSON, P53; McKeefry DJ, 2007, VISION RES, V47, P2418, DOI 10.1016/j.visres.2007.05.011; Meese TS, 2007, P ROY SOC B-BIOL SCI, V274, P127, DOI 10.1098/rspb.2006.3697; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Ogmen H, 2003, VISION RES, V43, P1337, DOI 10.1016/S0042-6989(03)00138-X; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; PASTERNAK T, 2003, HDB PSYCHOL BIOL PSY, P139; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Qiu AQ, 2006, NEUROIMAGE, V31, P125, DOI 10.1016/j.neuroimage.2005.11.049; Ruge H, 2009, NEUROIMAGE, V47, P501, DOI 10.1016/j.neuroimage.2009.04.075; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sligte IG, 2009, J NEUROSCI, V29, P7432, DOI 10.1523/JNEUROSCI.0784-09.2009; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P2874, DOI 10.1016/j.neuropsychologia.2006.06.021; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Smith AT, 2006, NEUROIMAGE, V29, P328, DOI 10.1016/j.neuroimage.2005.07.003; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Veltman DJ, 2002, NEUROIMAGE, V17, P1203, DOI 10.1006/nimg.2002.1242; Vidyasagar TR, 2007, EUR J NEUROSCI, V25, P2547, DOI 10.1111/j.1460-9568.2007.05483.x; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Zaksas D, 2001, J NEUROPHYSIOL, V86, P912, DOI 10.1152/jn.2001.86.2.912	57	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18651	10.1371/journal.pone.0018651	http://dx.doi.org/10.1371/journal.pone.0018651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525988	gold, Green Submitted, Green Published			2022-12-27	WOS:000289578600022
J	Giuffre, C; Hinow, P; Vogel, R; Ahmed, T; Stocker, R; Consi, TR; Strickler, JR				Giuffre, Carl; Hinow, Peter; Vogel, Ryan; Ahmed, Tanvir; Stocker, Roman; Consi, Thomas R.; Strickler, J. Rudi			The Ciliate Paramecium Shows Higher Motility in Non-Uniform Chemical Landscapes	PLOS ONE			English	Article							CHEMOTAXIS; MICROORGANISMS; TRANSDUCTION; MEMBRANE; CELLS; MODEL	We study the motility behavior of the unicellular protozoan Paramecium tetraurelia in a microfluidic device that can be prepared with a landscape of attracting or repelling chemicals. We investigate the spatial distribution of the positions of the individuals at different time points with methods from spatial statistics and Poisson random point fields. This makes quantitative the informal notion of ``uniform distribution'' (or lack thereof). Our device is characterized by the absence of large systematic biases due to gravitation and fluid flow. It has the potential to be applied to the study of other aquatic chemosensitive organisms as well. This may result in better diagnostic devices for environmental pollutants.	[Giuffre, Carl; Consi, Thomas R.; Strickler, J. Rudi] Univ Wisconsin, Great Lakes WATER Inst, Milwaukee, WI 53201 USA; [Hinow, Peter] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Vogel, Ryan] St Louis Univ, Sch Med, St Louis, MO USA; [Ahmed, Tanvir; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Saint Louis University; Massachusetts Institute of Technology (MIT)	Giuffre, C (corresponding author), Univ Wisconsin, Great Lakes WATER Inst, Milwaukee, WI 53201 USA.	hinow@uwm.edu	Strickler, J. Rudi/A-8926-2009; Ahmed, Tanvir/AAL-3026-2020; Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017	Stocker, Roman/0000-0002-3199-0508	University of Wisconsin-Milwaukee; National Science Foundation [DMS-016214, OCE-0744641-CAREER]	University of Wisconsin-Milwaukee; National Science Foundation(National Science Foundation (NSF))	We thank Dr. Thomas Doak (University of Indiana) for providing us with Paramecium tetraurelia type 51s and for helpful suggestions, Greg Barske for constructing our actuator, and Tracy Harvey for helping to maintain the cell cultures. CG and RV were supported by a SURF (Salary for Undergraduate Research Fellows) Award from the University of Wisconsin-Milwaukee. PH is partially supported by NSF grant DMS-016214 and RS acknowledges support from NSF grant OCE-0744641-CAREER.	Bell WE, 2007, J EXP BIOL, V210, P357, DOI 10.1242/jeb.02642; Diggle P., 2003, STAT ANAL SPATIAL PO; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Erban R, 2007, J MATH BIOL, V54, P847, DOI 10.1007/s00285-007-0070-1; HENNESSEY TM, 1994, J COMP PHYSIOL A, V175, P655; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; HINRICHSEN RD, 1988, TRENDS NEUROSCI, V11, P27, DOI 10.1016/0166-2236(88)90046-X; Illian J, 2008, STAT ANAL MODELLING; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Kingman J., 1993, POISSON PROCESSES; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pearse V., 1987, LIVING INVERTEBRATES; PRESTON RR, 1987, J COMP PHYSIOL A, V160, P537, DOI 10.1007/BF00615087; Seymour JR, 2008, LIMNOL OCEANOGR-METH, V6, P477, DOI 10.4319/lom.2008.6.477; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Stoyan D., 1994, FRACTALS RANDOM SHAP; VANHOUTEN J, 1994, TRENDS NEUROSCI, V17, P62, DOI 10.1016/0166-2236(94)90076-0; WINET H, 1973, J EXP BIOL, V59, P753; Yang WQ, 1997, J CELL SCI, V110, P2567	20	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e15274	10.1371/journal.pone.0015274	http://dx.doi.org/10.1371/journal.pone.0015274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494596	gold, Green Published			2022-12-27	WOS:000289354100001
J	Merlini, E; Bai, F; Bellistri, GM; Tincati, C; Monforte, AD; Marchetti, G				Merlini, Esther; Bai, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Monforte, Antonella d'Arminio; Marchetti, Giulia			Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy	PLOS ONE			English	Article							MICROBIAL TRANSLOCATION; ACTIVATION; RECONSTITUTION	In advanced HIV infection, the homeostatic balance between gastrointestinal indigenous bacteria and gut immunity fails and microbes are able to overcome the intestinal barrier and gain the systemic circulation. Because microbial translocation is not fully controlled by antiviral therapy and is associated with inefficient CD4+ reconstitution, we investigated the profile of translocating bacteria in peripheral blood of 44 HIV-infected patients starting therapy with advanced CD4+ T-lymphopenia and displaying poor CD4+ recovery on virologically suppressive HAART. According to CD4+ reconstitution at 12-months HAART, patients were considered Partial Immunological Responders, PIRs (CD4+>= 250/mu l, n = 29) and Immunological non Responders, INRs (CD4+< 200/mu l, n = 15)). We show that PIRs and INRs present similarly elevated plasma levels of lipopolysaccharide (LPS) and its ligand sCD14 that were not lowered by virologically suppressive therapy. Bacterial 16S rRNA gene amplification and sequencing resulted in a highly polymicrobic peripheral blood microbiota both prior and after 12-month HAART. Several differences in bacterial composition were shown between patients' groups, mainly the lack of probiotic Lactobacillaceae both prior and after therapy in INRs. Failure to control microbial translocation on HAART is associated with a polymicrobic flora circulating in peripheral blood that is not substantially modified by therapy.	[Merlini, Esther; Bai, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Monforte, Antonella d'Arminio; Marchetti, Giulia] Univ Milan, Dept Med Surg & Dent, Clin Infect Dis, San Paolo Hosp, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan	Merlini, E (corresponding author), Univ Milan, Dept Med Surg & Dent, Clin Infect Dis, San Paolo Hosp, Milan, Italy.	giulia.marchetti@unimi.it	Marchetti, Giulia/GPX-7655-2022; Bai, Francesca/K-4823-2018; Gori, Andrea/AAC-6078-2022; TINCATI, CAMILLA/K-4501-2018; MARCHETTI, GIULIA CARLA/K-4384-2018	TINCATI, CAMILLA/0000-0002-3083-2962; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST); Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy [30G.50, 30G.63, 50G]	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST); Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy	The work was supported by grants from Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) 2009 Universita degli Studi di Milano, and from Istituto Superiore di Sanita, National research program on AIDS, grants #30G.50; 30G.63, 50G; 2006, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Diggle MA, 2004, MOL BIOTECHNOL, V28, P129, DOI 10.1385/MB:28:2:129; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; FERRI E, J INFECT DIS, V202, P178; Ferri E, 2010, J INFECT DIS, V202, P176, DOI 10.1086/653215; GORI A, 2007, J CLIN MICROBIOL; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MARCHETTI G, 2010, ROLE MICROBIAL TRANS; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Paiardini M, 2008, AIDS REV, V10, P36; Perdigon G, 1999, J DAIRY SCI, V82, P1108, DOI 10.3168/jds.S0022-0302(99)75333-6; SANDLER NG, J INFECT DIS; VANTLAND B, 2008, SPECIFIC MIXTURE PRE	26	92	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18580	10.1371/journal.pone.0018580	http://dx.doi.org/10.1371/journal.pone.0018580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494598	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100023
J	Zhou, ZQ; Shung, CY; Ota, S; Akiyama, H; Keene, DR; Hurlin, PJ				Zhou, Zi-Qiang; Shung, Chia-Yi; Ota, Sara; Akiyama, Haruhiko; Keene, Douglas R.; Hurlin, Peter J.			Sequential and Coordinated Actions of c-Myc and N-Myc Control Appendicular Skeletal Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; ENDOCHONDRAL BONE-FORMATION; CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; LIMB DEVELOPMENT; STEM-CELLS; EXPRESSION; CARTILAGE; SOX9; VEGF	Background: During limb development, chondrocytes and osteoblasts emerge from condensations of limb bud mesenchyme. These cells then proliferate and differentiate in separate but adjacent compartments and function cooperatively to promote bone growth through the process of endochondral ossification. While many aspects of limb skeletal formation are understood, little is known about the mechanisms that link the development of undifferentiated limb bud mesenchyme with formation of the precartilaginous condensation and subsequent proliferative expansion of chondrocyte and osteoblast lineages. The aim of this study was to gain insight into these processes by examining the roles of c-Myc and N-Myc in morphogenesis of the limb skeleton. Methodology/Principal Findings: To investigate c-Myc function in skeletal development, we characterized mice in which floxed c-Myc alleles were deleted in undifferentiated limb bud mesenchyme with Prx1-Cre, in chondro-osteoprogenitors with Sox9-Cre and in osteoblasts with Osx1-Cre. We show that c-Myc promotes the proliferative expansion of both chondrocytes and osteoblasts and as a consequence controls the process of endochondral growth and ossification and determines bone size. The control of proliferation by c-Myc was related to its effects on global gene transcription, as phosphorylation of the C-Terminal Domain (pCTD) of RNA Polymerase II, a marker of general transcription initiation, was tightly coupled to cell proliferation of growth plate chondrocytes where c-Myc is expressed and severely downregulated in the absence of c-Myc. Finally, we show that combined deletion of N-Myc and c-Myc in early limb bud mesenchyme gives rise to a severely hypoplastic limb skeleton that exhibits features characteristic of individual c-Myc and N-Myc mutants. Conclusions/Significance: Our results show that N-Myc and c-Myc act sequentially during limb development to coordinate the expansion of key progenitor populations responsible for forming the limb skeleton.	[Zhou, Zi-Qiang; Shung, Chia-Yi; Ota, Sara; Keene, Douglas R.; Hurlin, Peter J.] Shriners Hosp Children Portland, Portland, OR USA; [Shung, Chia-Yi; Hurlin, Peter J.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Akiyama, Haruhiko] Kyoto Univ, Dept Orthopaed, Kyoto, Japan	Oregon Health & Science University; Kyoto University	Zhou, ZQ (corresponding author), Shriners Hosp Children Portland, Portland, OR USA.	pjh@shcc.org			Shriners Hospitals for Children	Shriners Hospitals for Children	This study was funded by a grant from Shriners Hospitals for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Carlevaro MF, 2000, J CELL SCI, V113, P59; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; Huang RJ, 2006, ANAT EMBRYOL, V211, pS65, DOI 10.1007/s00429-006-0126-9; IWAMOTO M, 1993, J BIOL CHEM, V268, P9645; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Malynn BA, 2000, GENE DEV, V14, P1390; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MOTOYAMA J, 1994, FEBS LETT, V338, P323, DOI 10.1016/0014-5793(94)80292-0; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Piedra ME, 2002, CELL GROWTH DIFFER, V13, P185; Queva C, 1998, ONCOGENE, V16, P967, DOI 10.1038/sj.onc.1201611; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Varlakhanova NV, 2009, CANCER RES, V69, P7487, DOI 10.1158/0008-5472.CAN-08-4832; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	44	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18795	10.1371/journal.pone.0018795	http://dx.doi.org/10.1371/journal.pone.0018795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494559	Green Submitted, Green Published, gold			2022-12-27	WOS:000289354100041
J	Khare, G; Gupta, V; Nangpal, P; Gupta, RK; Sauter, NK; Tyagi, AK				Khare, Garima; Gupta, Vibha; Nangpal, Prachi; Gupta, Rakesh K.; Sauter, Nicholas K.; Tyagi, Anil K.			Ferritin Structure from Mycobacterium tuberculosis: Comparative Study with Homologues Identifies Extended C-Terminus Involved in Ferroxidase Activity	PLOS ONE			English	Article							H-CHAIN FERRITINS; CRYSTAL-STRUCTURE; IRON-METABOLISM; METAL-BINDING; CRYSTALLOGRAPHIC STRUCTURE; HYPOXIC RESPONSE; GENE-EXPRESSION; SMEGMATIS DPS; CATION-PI; ANION-PI	Ferritins are recognized as key players in the iron storage and detoxification processes. Iron acquisition in the case of pathogenic bacteria has long been established as an important virulence mechanism. Here, we report a 3.0 angstrom crystal structure of a ferritin, annotated as Bacterioferritin B (BfrB), from Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis that continues to be one of the world's deadliest diseases. Similar to the other members of ferritin family, the Mtb BfrB subunit exhibits the characteristic fold of a four-helical bundle that possesses the ferroxidase catalytic centre. We compare the structure of Mtb BfrB with representatives of the ferritin family belonging to the archaea, eubacteria and eukarya. Unlike most other ferritins, Mtb BfrB has an extended C-terminus. To dissect the role of this extended C-terminus, truncated Mtb BfrB was purified and biochemical studies implicate this region in ferroxidase activity and iron release in addition to providing stability to the protein. Functionally important regions in a protein of known 3D-structure can be determined by estimating the degree of conservation of the amino-acid sites with its close homologues. Based on the comparative studies, we identify the slowly evolving conserved sites as well as the rapidly evolving variable sites and analyze their role in relation to structure and function of Mtb BfrB. Further, electrostatic computations demonstrate that although the electrostatic environment of catalytic residues is preserved within the family, extensive variability is exhibited by residues defining the channels and pores, in all likelihood keeping up with the diverse functions executed by these ferritins in varied environments.	[Khare, Garima; Gupta, Vibha; Nangpal, Prachi; Gupta, Rakesh K.; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Ram Lal Anand Coll, New Delhi, India; [Sauter, Nicholas K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of Delhi; University of Delhi; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Khare, G (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Sauter, Nicholas K/K-3430-2012		National Institutes of Health (USA) [1R01GM077071]; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077071] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a financial grant received from the Department of Biotechnology, Government of India. G. K. is grateful to the Council of Scientific and Industrial Research, India, for a fellowship. N.K.S. thanks the National Institutes of Health (USA) for financial support (grant number 1R01GM077071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cho KJ, 2009, J MOL BIOL, V390, P83, DOI 10.1016/j.jmb.2009.04.078; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garbe TR, 1999, INFECT IMMUN, V67, P460, DOI 10.1128/IAI.67.1.460-465.1999; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Granier T, 2003, J BIOL INORG CHEM, V8, P105, DOI 10.1007/s00775-002-0389-4; Granier T, 1997, ACTA CRYSTALLOGR D, V53, P580, DOI 10.1107/S0907444997003314; Granier T, 2001, ACTA CRYSTALLOGR D, V57, P1491, DOI 10.1107/S0907444901008897; Gupta V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008028; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Janowski R, 2008, PROTEIN SCI, V17, P1138, DOI 10.1110/ps.034819.108; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Kim D, 2007, J PHYS CHEM A, V111, P7980, DOI 10.1021/jp073337x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Michaux MA, 1996, PROTEINS, V24, P314; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Quinonero D, 2006, CHEMPHYSCHEM, V7, P2487, DOI 10.1002/cphc.200600343; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ratnayake DB, 2000, MICROBIOL-UK, V146, P1119, DOI 10.1099/00221287-146-5-1119; Ren B, 2003, J MOL BIOL, V329, P467, DOI 10.1016/S0022-2836(03)00466-2; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; Santambrogio P, 1997, BIOCHEM J, V322, P461, DOI 10.1042/bj3220461; Sauter NK, 2010, J APPL CRYSTALLOGR, V43, P611, DOI 10.1107/S0021889810010782; Schottel BL, 2008, CHEM SOC REV, V37, P68, DOI 10.1039/b614208g; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Stillman TJ, 2003, J BIOL CHEM, V278, P26275, DOI 10.1074/jbc.M207354200; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Toussaint L, 2007, J MOL BIOL, V365, P440, DOI 10.1016/j.jmb.2006.10.010; TREFFRY A, 1989, FEBS LETT, V247, P268, DOI 10.1016/0014-5793(89)81350-X; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; TRIKHA J, 1994, PROTEINS, V18, P107, DOI 10.1002/prot.340180204; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2004, TUBERCULOSIS, V84, P138, DOI 10.1016/j.tube.2003.12.008; Waidner B, 2002, INFECT IMMUN, V70, P3923, DOI 10.1128/IAI.70.7.3923-3929.2002; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Yamamoto Y, 1999, BBA-PROTEIN STRUCT M, V1433, P27, DOI 10.1016/S0167-4838(99)00125-9	76	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18570	10.1371/journal.pone.0018570	http://dx.doi.org/10.1371/journal.pone.0018570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494619	Green Submitted, gold, Green Published			2022-12-27	WOS:000289292800029
J	Rosvall, M; Bergstrom, CT				Rosvall, Martin; Bergstrom, Carl T.			Multilevel Compression of Random Walks on Networks Reveals Hierarchical Organization in Large Integrated Systems	PLOS ONE			English	Article							COMMUNITY STRUCTURE	To comprehend the hierarchical organization of large integrated systems, we introduce the hierarchical map equation, which reveals multilevel structures in networks. In this information-theoretic approach, we exploit the duality between compression and pattern detection; by compressing a description of a random walker as a proxy for real flow on a network, we find regularities in the network that induce this system-wide flow. Finding the shortest multilevel description of the random walker therefore gives us the best hierarchical clustering of the network - the optimal number of levels and modular partition at each level - with respect to the dynamics on the network. With a novel search algorithm, we extract and illustrate the rich multilevel organization of several large social and biological networks. For example, from the global air traffic network we uncover countries and continents, and from the pattern of scientific communication we reveal more than 100 scientific fields organized in four major disciplines: life sciences, physical sciences, ecology and earth sciences, and social sciences. In general, we find shallow hierarchical structures in globally interconnected systems, such as neural networks, and rich multilevel organizations in systems with highly separated regions, such as road networks.	[Rosvall, Martin] Umea Univ, Dept Phys, Integrated Sci Lab, Umea, Sweden; [Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	Umea University; University of Washington; University of Washington Seattle; The Santa Fe Institute	Rosvall, M (corresponding author), Umea Univ, Dept Phys, Integrated Sci Lab, Umea, Sweden.	martin.rosvall@physics.umu.se	Bergstrom, Carl T./H-2299-2011; Rosvall, Martin/ABD-6411-2020; Rosvall, Martin/A-9488-2015	Bergstrom, Carl T./0000-0002-2070-385X; Rosvall, Martin/0000-0002-7181-9940	Swedish Research Council [2009-5344]; National Science Foundation [SBE-0915005]; US NIGMS MIDAS Center at Harvard University [1U54GM088588]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Science Foundation(National Science Foundation (NSF)); US NIGMS MIDAS Center at Harvard University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MR was supported by the Swedish Research Council grant 2009-5344. CTB was supported by National Science Foundation grant SBE-0915005 and by US NIGMS MIDAS Center for Communicable Disease Dynamics 1U54GM088588 at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grunwald P.D., 2005, ADV MINIMUM DESCRIPT; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Ronhovde P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016109; Rosvall M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028701; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Schlosser G., 2004, MODULARITY DEV EVOLU; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; WAKITA K, 2007, ARXIVCS07020480; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winther RG, 2001, J EXP ZOOL, V291, P116, DOI 10.1002/jez.1064	29	239	247	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18209	10.1371/journal.pone.0018209	http://dx.doi.org/10.1371/journal.pone.0018209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494658	Green Submitted, gold, Green Published			2022-12-27	WOS:000289292800005
J	Clemente-Casares, P; Lopez-Jimenez, AJ; Bellon-Echeverria, I; Encinar, JA; Martinez-Alfaro, E; Perez-Flores, R; Mas, A				Clemente-Casares, Pilar; Lopez-Jimenez, Alberto J.; Bellon-Echeverria, Itxaso; Antonio Encinar, Jose; Martinez-Alfaro, Elisa; Perez-Flores, Ricardo; Mas, Antonio			De Novo Polymerase Activity and Oligomerization of Hepatitis C Virus RNA-Dependent RNA-Polymerases from Genotypes 1 to 5	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; BINDING-SITE; IDENTIFICATION; NS5B; REPLICATION; INHIBITORS; INITIATION; COMPLEX; GENOME	Hepatitis C virus (HCV) shows a great geographical diversity reflected in the high number of circulating genotypes and subtypes. The response to HCV treatment is genotype specific, with the predominant genotype 1 showing the lowest rate of sustained virological response. Virally encoded enzymes are candidate targets for intervention. In particular, promising antiviral molecules are being developed to target the viral NS3/4A protease and NS5B polymerase. Most of the studies with the NS5B polymerase have been done with genotypes 1b and 2a, whilst information about other genotypes is scarce. Here, we have characterized the de novo activity of NS5B from genotypes 1 to 5, with emphasis on conditions for optimum activity and kinetic constants. Polymerase cooperativity was determined by calculating the Hill coefficient and oligomerization through a new FRET-based method. The V-max/K-m ratios were statistically different between genotype 1 and the other genotypes (p<0.001), mainly due to differences in V-max values, but differences in the Hill coefficient and NS5B oligomerization were noted. Analysis of sequence changes among the studied polymerases and crystal structures show the alpha F helix as a structural component probably involved in NS5B-NS5B interactions. The viability of the interaction of alpha F and alpha T helixes was confirmed by docking studies and calculation of electrostatic surface potentials for genotype 1 and point mutants corresponding to mutations from different genotypes. Results presented in this study reveal the existence of genotypic differences in NS5B de novo activity and oligomerization. Furthermore, these results allow us to define two regions, one consisting of residues Glu128, Asp129, and Glu248, and the other consisting of residues of alpha T helix possibly involved in NS5B-NS5B interactions.	[Clemente-Casares, Pilar; Lopez-Jimenez, Alberto J.; Bellon-Echeverria, Itxaso; Mas, Antonio] Univ Castilla La Mancha, Ctr Reg Invest Biomed CRIB, Albacete, Spain; [Lopez-Jimenez, Alberto J.; Martinez-Alfaro, Elisa] Complejo Hosp Univ Albacete, Infect Dis Unit, Albacete, Spain; [Perez-Flores, Ricardo] Complejo Hosp Univ Albacete, Digest Dept, Albacete, Spain; [Antonio Encinar, Jose] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain	Universidad de Castilla-La Mancha; Universidad Miguel Hernandez de Elche	Clemente-Casares, P (corresponding author), Univ Castilla La Mancha, Ctr Reg Invest Biomed CRIB, Albacete, Spain.	Antonio.Mas@uclm.es	Romo, José A./J-3024-2012; Lopez, Alberto/GWC-5652-2022; Mas, Antonio/F-2505-2011; Clemente-Casares, Pilar/M-3738-2018; Encinar, José Antonio/AAE-9141-2020; Encinar, José A/F-2946-2013	Romo, José A./0000-0003-2907-580X; Mas, Antonio/0000-0003-2563-570X; Encinar, José Antonio/0000-0002-7219-3863; Encinar, José A/0000-0002-7219-3863; Bellon-Echeverria, Itxaso/0000-0002-3135-8799; Lopez Jimenez, Alberto Jose/0000-0002-4992-631X	Fondo de Investigaciones Sanitarias [PI060584]; Consejeria de Educacion de Castilla La Mancha [PPII10-0243-6857]; Fundacion para la Investigacion Sanitaria de Castilla-La Mancha [MOV-2006_JI/06, MOV-2008_JI/1]; Fondo de Investigaciones Sanitarias and a Ramon y Cajal; Ministerio de Ciencia e Innovacion	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Consejeria de Educacion de Castilla La Mancha; Fundacion para la Investigacion Sanitaria de Castilla-La Mancha; Fondo de Investigaciones Sanitarias and a Ramon y Cajal; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Fondo de Investigaciones Sanitarias [grant number PI060584], and Consejeria de Educacion de Castilla La Mancha [grant number PPII10-0243-6857]. I. B. E. and A.J.L.J. were supported by predoctoral fellowships from Fundacion para la Investigacion Sanitaria de Castilla-La Mancha [grant numbers MOV-2006_JI/06 and MOV-2008_JI/1]. P. C. C. and A. M. were supported by a "Sara Borrell" contract from Fondo de Investigaciones Sanitarias and a Ramon y Cajal contract (Ministerio de Ciencia e Innovacion cofinanced with FEDER funds), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bellon-Echeverria I, 2010, ANTIVIR RES, V87, P57, DOI 10.1016/j.antiviral.2010.04.009; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; COPELAND RA, 1996, ENZYMES; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Fan XF, 2006, BIOCHEM BIOPH RES CO, V346, P1163, DOI 10.1016/j.bbrc.2006.06.039; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; Huang PY, 2008, ANTIMICROB AGENTS CH, V52, P1419, DOI 10.1128/AAC.00525-07; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Kaiser WJ, 2006, J GEN VIROL, V87, P363, DOI 10.1099/vir.0.81456-0; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu Y, 2008, BIOORG MED CHEM LETT, V18, P3173, DOI 10.1016/j.bmcl.2008.04.068; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2003, J VIROL, V77, P7575, DOI 10.1128/JVI.77.13.7575-7581.2003; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Maulik A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S19; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; PATA JD, 1995, RNA, V1, P466; Pauwels F, 2007, J VIROL, V81, P6909, DOI 10.1128/JVI.01543-06; Perelson AS, 2005, HEPATOLOGY, V42, P749, DOI 10.1002/hep.20882; Poranen MM, 2008, NUCLEIC ACIDS RES, V36, P6633, DOI 10.1093/nar/gkn632; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Versieck J., 1989, TRACE ELEMENTS HUMAN; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	59	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18515	10.1371/journal.pone.0018515	http://dx.doi.org/10.1371/journal.pone.0018515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490973	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700019
J	Kao, CF; Fang, YS; Zhao, ZM; Kuo, PH				Kao, Chung-Feng; Fang, Yu-Sheng; Zhao, Zhongming; Kuo, Po-Hsiu			Prioritization and Evaluation of Depression Candidate Genes by Combining Multidimensional Data Resources	PLOS ONE			English	Article							WIDE LINKAGE ANALYSIS; DISORDER; POLYMORPHISM; NEUROTICISM; PREVALENCE; EXPRESSION; GENETICS; ASSOCIATION; LIFETIME; DISEASES	Background: Large scale and individual genetic studies have suggested numerous susceptible genes for depression in the past decade without conclusive results. There is a strong need to review and integrate multi-dimensional data for follow up validation. The present study aimed to apply prioritization procedures to build-up an evidence-based candidate genes dataset for depression. Methods: Depression candidate genes were collected in human and animal studies across various data resources. Each gene was scored according to its magnitude of evidence related to depression and was multiplied by a source-specific weight to form a combined score measure. All genes were evaluated through a prioritization system to obtain an optimal weight matrix to rank their relative importance with depression using the combined scores. The resulting candidate gene list for depression (DEPgenes) was further evaluated by a genome-wide association (GWA) dataset and microarray gene expression in human tissues. Results: A total of 5,055 candidate genes (4,850 genes from human and 387 genes from animal studies with 182 being overlapped) were included from seven data sources. Through the prioritization procedures, we identified 169 DEPgenes, which exhibited high chance to be associated with depression in GWA dataset (Wilcoxon rank-sum test, p = 0.00005). Additionally, the DEPgenes had a higher percentage to express in human brain or nerve related tissues than non-DEPgenes, supporting the neurotransmitter and neuroplasticity theories in depression. Conclusions: With comprehensive data collection and curation and an application of integrative approach, we successfully generated DEPgenes through an effective gene prioritization system. The prioritized DEPgenes are promising for future biological experiments or replication efforts to discoverthe underlying molecular mechanisms for depression.	[Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Fang, Yu-Sheng; Kuo, Po-Hsiu] Natl Cheng Kung Univ, Sch Med, Inst Clin Med, Tainan 70101, Taiwan; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Cheng Kung University; Vanderbilt University; Vanderbilt University; National Taiwan University	Kao, CF (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan.	phkuo@ntu.edu.tw	Kuo, Po-Hsiu/H-9882-2013	Kuo, Po-Hsiu/0000-0003-0365-3587	National Science Council [NSC 99-2314-B-002-140-MY3]; National Health Research Institute [NHRI-EX99-9918NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3) and National Health Research Institute (NHRI-EX99-9918NC) grants to Dr. P-H Kuo (PI). The URL of National Science Council is http://web1.nsc.gov.tw/mp.aspx?mp=7, and the URL of National Health Research Institute is http://english.nhri.org.tw/. There were no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Blaveri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012596; BOSKER F, 2010, MOL PSYCHIATR, P1; Cubells JF, 2004, PSYCHOPHARMACOLOGY, V174, P463, DOI 10.1007/s00213-004-1840-8; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; ERTENLI I, 2010, RHEUMATOLOGY INT; EUTENEUER F, 2010, J AFFECT DISORDERS, P1; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Harvey M, 2007, TRENDS GENET, V23, P547, DOI 10.1016/j.tig.2007.08.011; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kunugi H, 2004, AM J MED GENET B, V129B, P44, DOI 10.1002/ajmg.b.30062; Kuo PH, 2007, AM J MED GENET B, V144B, P463, DOI 10.1002/ajmg.b.30478; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Ma XT, 2007, BIOINFORMATICS, V23, P215, DOI 10.1093/bioinformatics/btl569; MacMaster FP, 2006, BIOL PSYCHIAT, V60, P862, DOI 10.1016/j.biopsych.2006.04.013; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Nash MW, 2004, HUM MOL GENET, V13, P2173, DOI 10.1093/hmg/ddh239; Nurnberg HG, 1999, J CLIN PSYCHIAT, V60, P574, DOI 10.4088/JCP.v60n0902; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; SHI J, 2010, MAGNETIC BEARINGS TH, P1; SHYN S, 2009, MOL PSYCHIATR, P1; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Uriguen L, 2008, GENES BRAIN BEHAV, V7, P649, DOI 10.1111/j.1601-183X.2008.00402.x; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; Wood JG, 2002, BIOL PSYCHIAT, V51, P365, DOI 10.1016/S0006-3223(01)01367-1; WRAY N, 2010, MOL PSYCHIATR, P1; Wray NR, 2008, ARCH GEN PSYCHIAT, V65, P649, DOI 10.1001/archpsyc.65.6.649; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang KR, 2010, J NEURAL TRANSM, V117, P393, DOI 10.1007/s00702-009-0360-4	47	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18696	10.1371/journal.pone.0018696	http://dx.doi.org/10.1371/journal.pone.0018696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494644	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400045
J	Kelly, TR; Johnson, CK				Kelly, Terra R.; Johnson, Christine K.			Lead Exposure in Free-Flying Turkey Vultures Is Associated with Big Game Hunting in California	PLOS ONE			English	Article							COEUR-DALENE RIVER; SHOT INGESTION; MINING SITE; ACCUMULATION; AMMUNITION; WATERFOWL; HAZARDS; EAGLES; SWANS; BIRDS	Predatory and scavenging birds are at risk of lead exposure when they feed on animals injured or killed by lead ammunition. While lead ammunition has been banned from waterfowl hunting in North America for almost two decades, lead ammunition is still widely used for hunting big game and small game animals. In this study, we evaluated the association between big game hunting and blood lead concentration in an avian scavenger species that feeds regularly on large mammals in California. We compared blood lead concentration in turkey vultures within and outside of the deer hunting season, and in areas with varying wild pig hunting intensity. Lead exposure in turkey vultures was significantly higher during the deer hunting season compared to the off-season, and blood lead concentration was positively correlated with increasing wild pig hunting intensity. Our results link lead exposure in turkey vultures to deer and wild pig hunting activity at these study sites, and we provide evidence that spent lead ammunition in carrion poses a significant risk of lead exposure to scavengers.	[Kelly, Terra R.; Johnson, Christine K.] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis	Kelly, TR (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.	trkelly@ucdavis.edu			State Wildlife Grant [T-12-1]	State Wildlife Grant	This research was funded by a State Wildlife Grant # T-12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WL, 2000, J WILDLIFE MANAGE, V64, P848, DOI 10.2307/3802755; [Anonymous], [No title captured]; BATES F Y, 1968, Bulletin of the Wildlife Disease Association, V4, P116; BELLROSE FRANK C., 1959, ILLINOIS NAT HIST SURV BULL, V27, P235; BLUS L, 1991, ARCH ENV CONTAMINATI, V48, P108; Blus LJ, 1999, ECOTOXICOLOGY, V8, P125, DOI 10.1023/A:1008918819661; BUERGER TT, 1986, J WILDLIFE MANAGE, V50, P1, DOI 10.2307/3801479; Burger J, 2005, NEUROTOXICOLOGY, V26, P615, DOI 10.1016/j.neuro.2005.01.005; *CA DEP FISH GAM, 2007, HUNT SPORT FISH REG; *CA DEP FISH GAM, 2010, CERT NONL AMM; *CA DEP FISH GAM, 2006, REP 2006 GAM TAK HUN; Carpenter JW, 2003, J WILDLIFE DIS, V39, P96, DOI 10.7589/0090-3558-39.1.96; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Clark AJ, 2003, ECOTOXICOLOGY, V12, P23, DOI 10.1023/A:1022576510445; Colegrove Kathleen M., 2005, Aquatic Mammals, V31, P1, DOI 10.1578/AM.31.1.2005.1; COLEMAN JS, 1989, J WILDLIFE MANAGE, V53, P782, DOI 10.2307/3809213; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Craighead Derek, 2009, P202, DOI 10.4080/ilsa.2009.0206; CUSTER TW, 1984, J WILDLIFE DIS, V20, P39, DOI 10.7589/0090-3558-20.1.39; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Franson J. Christian, 1996, P265; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; GARDNER IA, 1990, PREV VET MED, V8, P157, DOI 10.1016/0167-5877(90)90008-6; GILL CE, 1994, CAN VET J, V35, P303; HALL MJ, 2007, SERIES ORNITHOLOGY, V2, P163; Henckel E, 1981, N AM BIRD BANDER, V6, P106; HENNY CJ, 1994, ENVIRON MONIT ASSESS, V29, P267, DOI 10.1007/BF00547991; HENNY CJ, 1991, ARCH ENVIRON CON TOX, V21, P415, DOI 10.1007/BF01060365; HOFFMAN DJ, 1981, J WILDLIFE DIS, V17, P423, DOI 10.7589/0090-3558-17.3.423; HOFFMAN DJ, 1985, ARCH ENVIRON CON TOX, V14, P89, DOI 10.1007/BF01055766; HOLM S, 1979, SCAND J STAT, V6, P65; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt W. Grainger, 2007, P79; IRWIN J C, 1972, Journal of Wildlife Diseases, V8, P149; Kelly A, 2005, WATERBIRDS, V28, P331, DOI 10.1675/1524-4695(2005)028[0331:AMSWEB]2.0.CO;2; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Kirk David A., 1998, BIRDS N AM; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Kramer JL, 1997, J RAPTOR RES, V31, P327; Locke Louis N., 1996, P108; LOPAKA L, 2009, NADA NONDETECTS DATA; Martina PA, 2008, SCI TOTAL ENVIRON, V391, P96, DOI 10.1016/j.scitotenv.2007.11.012; Pain Deborah J., 1996, P251; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PAIN DJ, 1993, IBIS, V135, P379, DOI 10.1111/j.1474-919X.1993.tb02109.x; PATTEE OH, 1990, CONDOR, V92, P931, DOI 10.2307/1368729; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Pineda-Krch M, 2010, AM J VET RES, V71, P82, DOI 10.2460/ajvr.71.1.82; R Core Team, 2020, R LANG ENV STAT COMP; REDIG PT, 1991, ARCH ENVIRON CON TOX, V21, P72, DOI 10.1007/BF01055559; ROGERS T, 2009, INGESTION LEAD SPENT, P206, DOI DOI 10.4080/ILSA.2009.0121; Sileo L, 2001, ARCH ENVIRON CON TOX, V41, P364, DOI 10.1007/s002440010260; Snoeijs T, 2004, ARCH ENVIRON CON TOX, V46, P399, DOI 10.1007/s00244-003-2195-6; Snyder NFR., 2000, CALIFORNIA CONDOR SA; Sorenson Kelly J., 2007, P185; STEPHENS R, 2009, INGESTION LEAD SPENT, P232, DOI DOI 10.4080/ILSA.2009.0212; Tranel Molly A., 2009, P318, DOI 10.4080/ilsa.2009.0307; *UN FISH WILDL SER, 1986, US LEAD SHOT HUNT S; *US FISH WILDL SER, 2010, NONT SHOT REG HUNT W; USDA, 2010, MORT CALV CATTL US B; *USDA, 2005, SHEEP LAMB DEATH LOS; WAITHMAN J, 2001, GUIDE HUNTING WILD P, P44; Wayland M, 1999, ENVIRON POLLUT, V104, P341, DOI 10.1016/S0269-7491(98)00201-2; WIEMEYER SN, 1986, ENVIRON MONIT ASSESS, V6, P91, DOI 10.1007/BF00394290	64	36	38	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e15350	10.1371/journal.pone.0015350	http://dx.doi.org/10.1371/journal.pone.0015350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494326	gold, Green Published			2022-12-27	WOS:000289192400001
J	Brenner, DR; McLaughlin, JR; Hung, RJ				Brenner, Darren R.; McLaughlin, John R.; Hung, Rayjean J.			Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; FORCED EXPIRATORY VOLUME; CHLAMYDIA-PNEUMONIAE INFECTION; ENVIRONMENTAL TOBACCO-SMOKE; NONSMOKING WOMEN; NORTHEAST CHINA; UNITED-STATES; RESPIRATORY SYMPTOMS; CHRONIC BRONCHITIS; FAMILY-HISTORY	Background: In order to review the epidemiologic evidence concerning previous lung diseases as risk factors for lung cancer, a meta-analysis and systematic review was conducted. Methods: Relevant studies were identified through MEDLINE searches. Using random effects models, summary effects of specific previous conditions were evaluated separately and combined. Stratified analyses were conducted based on smoking status, gender, control sources and continent. Results: A previous history of COPD, chronic bronchitis or emphysema conferred relative risks (RR) of 2.22 (95% confidence interval (CI): 1.66, 2.97) (from 16 studies), 1.52 (95% CI: 1.25, 1.84) (from 23 studies) and 2.04 (95% CI: 1.72, 2.41) (from 20 studies), respectively, and for all these diseases combined 1.80 (95% CI: 1.60, 2.11) (from 39 studies). The RR of lung cancer for subjects with a previous history of pneumonia was 1.43 (95% CI: 1.22-1.68) (from 22 studies) and for subjects with a previous history of tuberculosis was 1.76 (95% CI = 1.49, 2.08), (from 30 studies). Effects were attenuated when restricting analysis to never smokers only for COPD/emphysema/chronic bronchitis (RR = 1.22, 0.97-1.53), however remained significant for pneumonia 1.36 (95% CI: 1.10, 1.69) (from 8 studies) and tuberculosis 1.90 (95% CI: 1.45, 2.50) (from 11 studies). Conclusions: Previous lung diseases are associated with an increased risk of lung cancer with the evidence among never smokers supporting a direct relationship between previous lung diseases and lung cancer.	[Brenner, Darren R.; McLaughlin, John R.; Hung, Rayjean J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Brenner, Darren R.; McLaughlin, John R.; Hung, Rayjean J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McLaughlin, John R.] Canc Care Ontario, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario	Brenner, DR (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	Rayjean.Hung@lunenfeld.ca	McLaughlin, John R/E-4577-2013; Hung, Rayjean J/A-7439-2013	Hung, Rayjean/0000-0002-4486-7496	Canadian Cancer Society Research Institute [020214]; Canadian Institutes of Health Research Canada	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research Canada(Canadian Institutes of Health Research (CIHR))	RJH holds a Cancer Care Ontario Chair in Population Studies. The study was supported by a Canadian Cancer Society Research Institute grant (no. 020214). DB holds a Canadian Institutes of Health Research Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAVANJA MCR, 1992, AM J EPIDEMIOL, V136, P623, DOI 10.1093/oxfordjournals.aje.a116542; *AM LUNG ASS, 2007, PNUEM FACT SHEET; Anttila T, 2003, INT J CANCER, V107, P681, DOI 10.1002/ijc.11353; Apfalter P, 2003, J CLIN MICROBIOL, V41, P592, DOI 10.1128/JCM.41.2.592-600.2003; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Boffetta P, 2002, EUR RESPIR J, V19, P127, DOI 10.1183/09031936.02.00245802; BOUCOT KR, 1977, ENVIRON RES, V13, P451, DOI 10.1016/0013-9351(77)90025-1; Brenner AV, 2001, INT J EPIDEMIOL, V30, P118, DOI 10.1093/ije/30.1.118; Brenner DR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-285; Brownson RC, 2000, CANCER CAUSE CONTROL, V11, P853, DOI 10.1023/A:1008999202040; CAMPBELL AH, 1963, BRIT J DIS CHEST, V57, P113, DOI 10.1016/S0366-0850(63)80055-1; CAMPBELL AH, 1961, BRIT J CANCER, V15, P10, DOI 10.1038/bjc.1961.2; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; CHANYEUNG M, 2003, INT J CANCER, V40, P131, DOI DOI 10.1002/IJC.24042; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; Cocco P, 2000, J OCCUP ENVIRON MED, V42, P639, DOI 10.1097/00043764-200006000-00014; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAVIS AL, 1976, JAMA-J AM MED ASSOC, V256, P621; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; DEAN G, 1966, J THORAC ONCOL, V1, P1506; DEFRANCES CJ, 2007, ADV DATA VITAL HLTH, V385; Di Dio R, 1994, Rev Assoc Med Bras (1992), V40, P225; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Engels EA, 2009, INT J CANCER, V124, P1183, DOI 10.1002/ijc.24042; Fitzpatrick FA, 2001, INT IMMUNOPHARMACOL, V1, P1651, DOI 10.1016/S1567-5769(01)00102-3; Galeone C, 2008, EUR J CANCER PREV, V17, P473, DOI 10.1097/CEJ.0b013e328305a0b9; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; GER LP, 1993, ANTICANCER RES, V13, P1491; Gorlova OY, 2006, INT J CANCER, V118, P1798, DOI 10.1002/ijc.21561; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HINDS MW, 1982, AM REV RESPIR DIS, V125, P776; Jackson LA, 2000, CANCER EPIDEM BIOMAR, V9, P1263; Kishi K, 2002, EUR RESPIR J, V19, P1093, DOI 10.1183/09031936.02.00264202; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; Kocazeybek B, 2003, J MED MICROBIOL, V52, P721, DOI 10.1099/jmm.0.04845-0; Koshiol J, 2010, CANCER EPIDEM BIOMAR, V19, P716, DOI 10.1158/1055-9965.EPI-09-0873; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Koyi H, 2001, APMIS, V109, P572, DOI 10.1034/j.1600-0463.2001.d01-177.x; Kreuzer M, 2002, INT J CANCER, V100, P706, DOI 10.1002/ijc.10549; Kreuzer M, 2001, BRIT J CANCER, V84, P134, DOI 10.1054/bjoc.2000.1518; KULLER LH, 1990, AM J EPIDEMIOL, V132, P265, DOI 10.1093/oxfordjournals.aje.a115656; Laurila AL, 1997, INT J CANCER, V74, P31, DOI 10.1002/(SICI)1097-0215(19970220)74:1&lt;31::AID-IJC6&gt;3.0.CO;2-1; Lee CH, 2001, CANCER CAUSE CONTROL, V12, P289, DOI 10.1023/A:1011270521900; Liang HY, 2009, J WOMENS HEALTH, V18, P1989, DOI 10.1089/jwh.2008.1355; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lindberg A, 2005, RESPIRATION, V72, P471, DOI 10.1159/000087670; Littman AJ, 2004, CANCER EPIDEM BIOMAR, V13, P1624; Littman AJ, 2004, CANCER CAUSE CONTROL, V15, P819, DOI 10.1023/B:CACO.0000043432.71626.45; LIU ZY, 1991, INT J EPIDEMIOL, V20, P26, DOI 10.1093/ije/20.1.26; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Marsh S, 2006, EUR RESPIR J, V28, P883, DOI 10.1183/09031936.06.00074806; Mayne ST, 1999, AM J EPIDEMIOL, V149, P13; Moldoveanu B, 2009, J INFLAMM RES, V2, P1; Mortensen EM, 2010, AM J MED, V123, P66, DOI 10.1016/j.amjmed.2009.08.009; Moulin JJ, 1997, SCAND J WORK ENV HEA, V23, P104, DOI 10.5271/sjweh.187; Neuberger JS, 2006, CANCER DETECT PREV, V30, P158, DOI 10.1016/j.cdp.2006.03.001; NOMURA A, 1991, AM REV RESPIR DIS, V144, P307, DOI 10.1164/ajrccm/144.2.307; OSANN KE, 2000, EUR RESPIR J, V28, P1; Parmet Sharon, 2003, JAMA, V290, P2362, DOI 10.1001/jama.290.17.2362; Peek RM, 2005, CANCER RES, V65, P8583, DOI 10.1158/0008-5472.CAN-05-1777; Purdue MP, 2007, THORAX, V62, P51, DOI 10.1136/thx.2006.064196; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; RAMANAKUMAR AV, 2006, AM J EPIDEMIOL, V53, P5; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Reardon JZ, 2007, CLIN CHEST MED, V28, P559, DOI 10.1016/j.ccm.2007.06.006; Rennard SI, 1998, CHEST, V113, p235S, DOI 10.1378/chest.113.4_Supplement.235S; RIMINGTON J, 1971, BMJ-BRIT MED J, V2, P373, DOI 10.1136/bmj.2.5758.373; Rutgers SR, 2000, CHEST, V117, p262S, DOI 10.1378/chest.117.5_suppl_1.262S; SAMET JM, 1986, AM REV RESPIR DIS, V134, P466; Sasco AJ, 2002, CANCER CAUSE CONTROL, V13, P609, DOI 10.1023/A:1019504210176; Schabath MB, 2005, AM J EPIDEMIOL, V161, P412, DOI 10.1093/aje/kwi063; Schwartz AG, 1996, AM J EPIDEMIOL, V144, P554, DOI 10.1093/oxfordjournals.aje.a008965; Schwartz AG, 2009, J THORAC ONCOL, V4, P291, DOI 10.1097/JTO.0b013e3181951cd1; Shen XB, 1996, LUNG CANCER-J IASLC, V14, pS107, DOI 10.1016/S0169-5002(96)90216-0; SKILLRUD D M, 1986, Comprehensive Therapy, V12, P13; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Stang P, 2000, CHEST, V117, p354S, DOI 10.1378/chest.117.5_suppl_2.354S; Stayner L, 2007, AM J PUBLIC HEALTH, V97, P545, DOI 10.2105/AJPH.2004.061275; STEINITZ R, 1965, AM REV RESPIR DIS, V92, P758; Stewart B.W., 2003, WORLD CANC REPORT; TENKANEN L, 1987, INT J EPIDEMIOL, V16, P509, DOI 10.1093/ije/16.4.509; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; *US SURG GEN, 1984, DLIHS PUBL; VANDENEEDEN SK, 1992, EPIDEMIOLOGY, V3, P253, DOI 10.1097/00001648-199205000-00011; VESTBO J, 1991, INT J EPIDEMIOL, V20, P375, DOI 10.1093/ije/20.2.375; Wang SY, 1996, LUNG CANCER-J IASLC, V14, pS99, DOI 10.1016/S0169-5002(96)90215-9; Wang TJ, 1996, LUNG CANCER-J IASLC, V14, pS93, DOI 10.1016/S0169-5002(96)90214-7; Wang XR, 2009, CANCER CAUSE CONTROL, V20, P757, DOI 10.1007/s10552-008-9289-4; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; WEITZMAN SA, 1990, BLOOD, V76, P655; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; WU AH, 1995, AM J EPIDEMIOL, V141, P1023, DOI 10.1093/oxfordjournals.aje.a117366; WU AH, 1988, CANCER RES, V48, P7279; Yang P, 2008, ARCH INTERN MED, V168, P1097, DOI 10.1001/archinte.168.10.1097; ZATLOUKAL P, 2003, INT J CANCER, V41, P283, DOI DOI 10.1002/IJC.21561; ZHENG W, 1987, BRIT J CANCER, V56, P501, DOI 10.1038/bjc.1987.233; 2004, LANCET, V364, P417, DOI DOI 10.1136/THX.2004.037135	105	201	216	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17479	10.1371/journal.pone.0017479	http://dx.doi.org/10.1371/journal.pone.0017479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483846	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200007
J	de Picoli, S; Teixeira, JJV; Ribeiro, HV; Malacarne, LC; dos Santos, RPB; Mendes, RD				de Picoli Junior, Sergio; Vieira Teixeira, Jorge Juarez; Ribeiro, Haroldo Valentin; Malacarne, Luis Carlos; Barbosa dos Santos, Ricardo Paupitz; Mendes, Renio dos Santos			Spreading Patterns of the Influenza A (H1N1) Pandemic	PLOS ONE			English	Article							VIRUS; TRAVEL; WILL; LAWS	We investigate the dynamics of the 2009 influenza A (H1N1/S-OIV) pandemic by analyzing data obtained from World Health Organization containing the total number of laboratory-confirmed cases of infections - by country - in a period of 69 days, from 26 April to 3 July, 2009. Specifically, we find evidence of exponential growth in the total number of confirmed cases and linear growth in the number of countries with confirmed cases. We also find that, i) at early stages, the cumulative distribution of cases among countries exhibits linear behavior on log-log scale, being well approximated by a power law decay; ii) for larger times, the cumulative distribution presents a systematic curvature on log-log scale, indicating a gradual change to lognormal behavior. Finally, we compare these empirical findings with the predictions of a simple stochastic model. Our results could help to select more realistic models of the dynamics of influenza-type pandemics.	[de Picoli Junior, Sergio; Ribeiro, Haroldo Valentin; Malacarne, Luis Carlos; Barbosa dos Santos, Ricardo Paupitz; Mendes, Renio dos Santos] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Vieira Teixeira, Jorge Juarez] Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil; [Ribeiro, Haroldo Valentin; Mendes, Renio dos Santos] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Picoli, S (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	junior@dfi.uem.br	Malacarne, Luis Carlos/D-7286-2018; Ribeiro, Haroldo Valentin/C-8614-2012; Paupitz, Ricardo/D-9594-2013	Malacarne, Luis Carlos/0000-0002-9436-6497; Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Paupitz, Ricardo/0000-0003-1254-6353				Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Butler D, 2009, NATURE, V459, P14, DOI 10.1038/459014a; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cohen J, 2009, SCIENCE, V324, P572, DOI 10.1126/science.324_572; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Flahault A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-129; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gurevich KG, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-23; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Liao CM, 2009, INT J INFECT DIS, V13, P589, DOI 10.1016/j.ijid.2008.09.019; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Michaelis M, 2009, INFECTION, V37, P381, DOI 10.1007/s15010-009-9181-5; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; Somette D., 2006, CRITICAL PHENOMENA N; *WHO, 2010, INFL; World Health Organization (WHO), 2009, SIT UPD PAND H1N1; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	20	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17823	10.1371/journal.pone.0017823	http://dx.doi.org/10.1371/journal.pone.0017823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483857	Green Published, gold, Green Submitted			2022-12-27	WOS:000289057200010
J	Queiros, SMD; Curado, EMF; Nobre, FD				Duarte Queiros, Silvio M.; Curado, Evaldo M. F.; Nobre, Fernando D.			Minding Impacting Events in a Model of Stochastic Variance	PLOS ONE			English	Article							VOLATILITY; EXPONENT; TAIL	We introduce a generalization of the well-known ARCH process, widely used for generating uncorrelated stochastic time series with long-term non-Gaussian distributions and long-lasting correlations in the (instantaneous) standard deviation exhibiting a clustering profile. Specifically, inspired by the fact that in a variety of systems impacting events are hardly forgot, we split the process into two different regimes: a first one for regular periods where the average volatility of the fluctuations within a certain period of time W is below a certain threshold, phi, and another one when the local standard deviation outnumbers phi. In the former situation we use standard rules for heteroscedastic processes whereas in the latter case the system starts recalling past values that surpassed the threshold. Our results show that for appropriate parameter values the model is able to provide fat tailed probability density functions and strong persistence of the instantaneous variance characterized by large values of the Hurst exponent (H>0.8), which are ubiquitous features in complex systems.	[Duarte Queiros, Silvio M.] Ctr Fis Porto, Oporto, Portugal; [Curado, Evaldo M. F.; Nobre, Fernando D.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil; [Curado, Evaldo M. F.; Nobre, Fernando D.] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	Universidade do Porto; Centro Brasileiro de Pesquisas Fisicas	Queiros, SMD (corresponding author), CNR, Ist Sistemi Complessi, Rome, Italy.	sdqueiro@gmail.com	Queirós, Sílvio M. Duarte/L-1170-2016; Curado, E./N-1808-2013	Queirós, Sílvio M. Duarte/0000-0001-6915-1892; 	Conselho Nacional de Desensolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Marie Curie Actions [250589]	Conselho Nacional de Desensolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Marie Curie Actions(European Commission)	This work was funded by Conselho Nacional de Desensolvimento Cientifico e Tecnologico (www.cnpq.br); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br); and Marie Curie Actions FP7-PEOPLE-2009-IEF (contract nr 250589) (http://ec.europa.eu/research/mariecurieactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TG, 2010, HANDB FINANC, P67, DOI 10.1016/B978-0-444-50897-3.50005-5; Barunik J, 2010, PHYSICA A, V389, P3844, DOI 10.1016/j.physa.2010.05.025; Beck C, 2003, PHYSICA A, V322, P267, DOI 10.1016/S0378-4371(03)00019-0; Beck C, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.180601; Beck C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.064502; BOLLERSLEV T, 1992, J ECONOMETRICS, V52, P5, DOI 10.1016/0304-4076(92)90064-X; BORLAND L, 2005, ARXIVPHYSICS0507073V; BORLAND L, 2010, COMMUNICATION; BORLAND L, 2004, ARXIVCONDMAT0412526; Bouchaud J. P., 2000, THEORY FINANCIAL RIS; Bouchaud JP, 2002, PHYSICA A, V313, P238, DOI 10.1016/S0378-4371(02)01039-7; Campbell SD, 2005, J AM STAT ASSOC, V100, P6, DOI 10.1198/016214504000001051; Clementi F, 2006, PHYSICA A, V370, P49, DOI 10.1016/j.physa.2006.04.027; Dacorogna M. M., 2001, INTRO HIGH FREQUENCY; DeGroot M, 1991, PROBABILITY STAT, V3rd; Ding Z, 1993, J EMPIR FINANC, V1, P83, DOI [10.1016/0927-5398(93)90006-D, DOI 10.1016/0927-5398(93)90006-D]; Donaldson RG, 1996, REV FINANC STUD, V9, P333, DOI 10.1093/rfs/9.2.333; Dose C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.067103; Embrechts P., 1997, MODELLING EXTREMAL E, DOI 10.1007/978-3-642-33483-2; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Flake Gary William, 2000, COMPUTATIONAL BEAUTY; Gell-Mann M., 2004, NONEXTENSIVE ENTROPY; Gell-Mann M, 1996, QUARK JAGUAR ADVENTU; Giardina I, 2003, EUR PHYS J B, V31, P421, DOI 10.1140/epjb/e2003-00050-6; GOURIEROUX C, 1996, STAT ECONOMETRIC MOD; Gradshteyn I. S., 1965, TABLES INTEGRALS SER; Granger CWJ, 1996, J ECONOMETRICS, V73, P61, DOI 10.1016/0304-4076(95)01733-X; Gronke P, 2002, ELECT STUD, V21, P425, DOI 10.1016/S0261-3794(01)00003-8; Hauser MA, 2001, J FORECASTING, V20, P501, DOI 10.1002/for.803; HILL BM, 1975, ANN STAT, V3, P1163, DOI 10.1214/aos/1176343247; Hoskins B, 2006, PREDICTABILITY OF WEATHER AND CLIMATE, P30, DOI 10.1017/CBO9780511617652.003; Khrennikov A., 2004, INFORM DYNAMICS COGN, DOI [10.1007/978-94-017-0479-3, DOI 10.1007/978-94-017-0479-3]; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012522; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Martin-Guerrero JD, 2003, IEEE T BIO-MED ENG, V50, P1136, DOI 10.1109/TBME.2003.816084; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; POBODNIK B, 2000, EPL-EUROPHYS LETT, V50, P711; Podobnik B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026121; PORTO M, 2001, PHYS REV E, V63; Queiros SMD, 2008, EUR PHYS J B, V66, P137, DOI 10.1140/epjb/e2008-00387-2; Queiros SMD, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/30005; Queiros SMD, 2005, EUR PHYS J B, V48, P139, DOI 10.1140/epjb/e2205-00366-1; Queiros SMD, 2005, EUROPHYS LETT, V69, P893, DOI 10.1209/epl/i2004-10436-6; Reynolds AM, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/058; Roman HE, 2008, INT J MOD PHYS C, V19, P1221, DOI 10.1142/S0129183108012820; SKJELTORP AT, 2002, COMPLEXITY MICROSCOP; Thurner S., 2009, ARXIV09081555; Tsallis C, 1999, BRAZ J PHYS, V29, P1, DOI 10.1590/S0103-97331999000100002; VOIT J, 2003, STAT MECH FINANCIAL; *WOLFR FUNCT SIT, 2010, MEIJ G FUNCT; Zumbach G, 2004, QUANT FINANC, V4, P70, DOI 10.1088/1469-7688/4/1/007	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18149	10.1371/journal.pone.0018149	http://dx.doi.org/10.1371/journal.pone.0018149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YU	21483864	Green Submitted, gold, Green Published			2022-12-27	WOS:000289057200032
J	Thormann, B; Raupach, MJ; Wagner, T; Wagele, JW; Peters, MK				Thormann, Birthe; Raupach, Michael J.; Wagner, Thomas; Waegele, Johann W.; Peters, Marcell K.			Testing a Short Nuclear Marker for Inferring Staphylinid Beetle Diversity in an African Tropical Rain Forest	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; SPECIES RICHNESS; DNA BARCODES; BIODIVERSITY; TAXONOMY; PARATAXONOMY; CONSERVATION; ASSEMBLAGES; DISTURBANCE; COLEOPTERA	Background: The use of DNA based methods for assessing biodiversity has become increasingly common during the last years. Especially in speciose biomes as tropical rain forests and/or in hyperdiverse or understudied taxa they may efficiently complement morphological approaches. The most successful molecular approach in this field is DNA barcoding based on cytochrome c oxidase I (COI) marker, but other markers are used as well. Whereas most studies aim at identifying or describing species, there are only few attempts to use DNA markers for inventorying all animal species found in environmental samples to describe variations of biodiversity patterns. Methodology/Principal Findings: In this study, an analysis of the nuclear D3 region of the 28S rRNA gene to delimit species-like units is compared to results based on distinction of morphospecies. Data derived from both approaches are used to assess diversity and composition of staphylinid beetle communities of a Guineo-Congolian rain forest in Kenya. Beetles were collected with a standardized sampling design across six transects in primary and secondary forests using pitfall traps. Sequences could be obtained of 99% of all individuals. In total, 76 molecular operational taxonomic units (MOTUs) were found in contrast to 70 discernible morphospecies. Despite this difference both approaches revealed highly similar biodiversity patterns, with species richness being equal in primary and secondary forests, but with divergent species communities in different habitats. The D3-MOTU approach proved to be an efficient tool for biodiversity analyses. Conclusions/Significance: Our data illustrate that the use of MOTUs as a proxy for species can provide an alternative to morphospecies identification for the analysis of changes in community structure of hyperdiverse insect taxa. The efficient amplification of the D3-marker and the ability of the D3-MOTUs to reveal similar biodiversity patterns as analyses of morphospecies recommend its use in future molecular studies on biodiversity.	[Thormann, Birthe; Waegele, Johann W.] Zool Res Museum Alexander Koenig, Bonn, Germany; [Raupach, Michael J.] German Ctr Marine Biodivers Res, Res Inst Senckenberg, Wilhelmshaven, Germany; [Wagner, Thomas] Univ Koblenz Landau, Abt Biol, Inst Integrierte Nat Wissensch, Koblenz, Germany; [Peters, Marcell K.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Koblenz & Landau; University of Wurzburg	Thormann, B (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	birthe.thormann.zfmk@uni-bonn.de	Raupach, Michael J./AAF-7566-2020; Raupach, Michael/G-7072-2012	Raupach, Michael J./0000-0001-8299-6697; Peters, Marcell/0000-0002-1262-0827	German Federal Ministry of Education and Research (BMBF) [E16 [01LC0625A2]]; German Science Foundation (DFG) [INST 427/1-1, INST 427/1-2]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG)(German Research Foundation (DFG))	Funding for this study was provided by the BIOTA East Africa project within the BIOLOG Program of the German Federal Ministry of Education and Research (BMBF; BIOTA subproject E16 [01LC0625A2]) as well as by grants of the German Science Foundation (DFG) to J.W.W. (INST 427/1-1,1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; ALTHOF AJ, 2005, THESIS U KOBLENZLAND; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Bestelmeyer Brandon T., 2000, P122; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FRANK JH, 1999, EENY114 U FLOR I FOO, P1; Garcia Francisco Hita, 2009, Journal of East African Natural History, V98, P147; Grebennikov VV, 2009, EUR J ENTOMOL, V106, P275, DOI 10.14411/eje.2009.035; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lomolino MV, 2006, BIOGEOGRAPHY; LUFF ML, 1975, OECOLOGIA, V19, P345, DOI 10.1007/BF00348110; Majka C. G., 2006, Animal Biodiversity and Conservation, V29, P149; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; PRIMACK R, 2005, TROPICAL RAIN FOREST, P336; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SMETANA A, 1995, INSECTS SO AFRICA, P210; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; THAYER MK, 2005, HDB ZOOLOGY, V4, P296, DOI 10.1515/9783110904550; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wagner P, 2008, J BIOGEOGR, V35, P1349, DOI 10.1111/j.1365-2699.2008.01883.x; Wagner T, 2000, BIOTROPICA, V32, P502, DOI 10.1111/j.1744-7429.2000.tb00496.x; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; Ward Darren F., 2005, New Zealand Entomologist, V27, P3; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WHITMORE TC, 1990, INTRO TROPICAL RAIN; Work TT, 2002, ENVIRON ENTOMOL, V31, P438, DOI 10.1603/0046-225X-31.3.438; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x	61	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18101	10.1371/journal.pone.0018101	http://dx.doi.org/10.1371/journal.pone.0018101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483872	gold, Green Published, Green Submitted			2022-12-27	WOS:000289057200028
J	Haque, U; Sunahara, T; Hashizume, M; Shields, T; Yamamoto, T; Haque, R; Glass, GE				Haque, Ubydul; Sunahara, Toshihiko; Hashizume, Masahiro; Shields, Timothy; Yamamoto, Taro; Haque, Rashidul; Glass, Gregory E.			Malaria Prevalence, Risk Factors and Spatial Distribution in a Hilly Forest Area of Bangladesh	PLOS ONE			English	Article								Background: Malaria is a major public health concern in Bangladesh and it is highly endemic in the Chittagong Hill Tracts where prevalence was 11.7% in 2007. One sub-district, Rajasthali, had a prevalence of 36%. Several interventions were introduced in early 2007 to control malaria. This study was undertaken to evaluate the impacts of these intensive early stage interventions on malaria in Bangladesh. This prevalence study assesses whether or not high malaria prevalence remains, and if so, which areas and individuals remain at high risk of infection. Methods and Principal Findings: A 2-stage cluster sampling technique was used to sample 1,400 of 5,322 (26.3%) households in Rajasthali, and screened using a rapid diagnostic test (Falci-vax). Overall malaria prevalence was 11.5%. The proportions of Plasmodium falciparum, Plasmodium vivax and infection with both species were 93.2%, 1.9% and 5.0%, respectively. Univariate, multivariate logistic regression, and spatial cluster analyses were performed separately. Sex, age, number of bed nets, forest cover, altitude and household density were potential risk factors. A statistically significant malaria cluster was identified. Significant differences among risk factors were observed between cluster and non-cluster areas. Conclusion and Significance: Malaria has significantly decreased within 2 years after onset of intervention program. Both aspects of the physical and social environment, as well as demographic characteristics are associated with spatial heterogeneity of risk. The ability to identify and locate these areas provides a strategy for targeting interventions during initial stages of intervention programs. However, in high risk clusters of transmission, even extensive coverage by current programs leaves transmission ongoing at reduced levels. This indicates the need for continued development of new strategies for identification and treatment as well as improved understanding of the patterns and determinants of parasitaemia.	[Haque, Ubydul; Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Haque, Ubydul; Sunahara, Toshihiko; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, Dept Int Hlth, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Haque, Ubydul; Sunahara, Toshihiko; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Shields, Timothy; Glass, Gregory E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Nagasaki University; Nagasaki University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Haque, U (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	uhicddrb@yahoo.com		Hashizume, Masahiro/0000-0003-4720-1750	ICDDR,B; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	ICDDR,B; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by ICDDR,B and its donors which provide unrestricted support to ICDDR,B for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to ICDDR,B's research efforts. TS and GG were supported by the Johns Hopkins Malaria Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Alam MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-15; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Dysoley L, 2008, ACTA TROP, V106, P207, DOI 10.1016/j.actatropica.2007.01.007; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Garros C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-11; Haque U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-156; Haque U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-120; Haque U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006737; JASMIN A, 2010, MALAR J S2, V9, pP2; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; *M PDC, 2009, MAL COUNTR REP BANGL; *M PDC, 2010, MAL COUNTR REP BAN 2; Maude Richard J, 2008, Bangladesh Med Res Counc Bull, V34, P87; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Rahman A, 2006, AM J TROP MED HYG, V74, P17, DOI 10.4269/ajtmh.2006.74.17; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; UBYDUL H, 2010, PLOS ONE, V5; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2004, US MAL RAP DIAGN TES; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5	25	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18908	10.1371/journal.pone.0018908	http://dx.doi.org/10.1371/journal.pone.0018908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533048	gold, Green Submitted, Green Published			2022-12-27	WOS:000290014500016
J	Cardy, AH; Sharp, L; Torrance, N; Hennekam, RC; Miedzybrodzka, Z				Cardy, Amanda H.; Sharp, Linda; Torrance, Nicola; Hennekam, Raoul C.; Miedzybrodzka, Zosia			Is There Evidence for Aetiologically Distinct Subgroups of Idiopathic Congenital Talipes Equinovarus? A Case-Only Study and Pedigree Analysis	PLOS ONE			English	Article							MATERNAL SMOKING; CLUB FOOT; EPIDEMIOLOGY; MALFORMATIONS; INHERITANCE; DEFORMITIES; ANOMALIES; GENETICS; RISK	Background: Idiopathic congenital talipes equinovarus (CTEV) is a common developmental foot disorder, the aetiology of which remains largely unknown. Some aspects of the epidemiology suggest the possibility of aetiologically distinct subgroups. Previous studies consider CTEV as a homogenous entity which may conceal risk factors in particular subgroups. We investigate evidence for aetiologically distinct subgroups of CTEV. Methods: Parents of 785 probands completed a postal questionnaire. Family pedigrees were compiled by telephone. Case-only analysis was used to investigate interactions between risk factors and sex of the proband, CTEV laterality and CTEV family history. Results: The male: female ratio was 2.3:1, 58% of probands were affected bilaterally and 11% had a first-second degree family history. There were modest interactions between family history and twin births (multivariate case - only odds ratio [ORca] = 3.87, 95%CI 1.19-12.62) and family history and maternal use of folic acid supplements in early pregnancy (ORca = 0.62, 95%CI 0.38-1.01); and between sex of the proband and maternal alcohol consumption during pregnancy (female, positive history and alcohol consumed: ORca = 0.33, 95%CI 0.12-0.89). Previous reports of an interaction between maternal smoking and family history were not confirmed. Relatives of female probands were affected more often than relatives of male probands. Conclusions: These results provide tentative evidence for aetiologically distinct CTEV subgroups. They support the 'Carter effect', suggesting CTEV develops though a multifactorial threshold model with females requiring a higher risk factor 'load', and suggest areas where future aetiological investigation might focus. Large multi-centre studies are needed to further advance understanding of this common condition.	[Cardy, Amanda H.; Torrance, Nicola; Miedzybrodzka, Zosia] Univ Aberdeen, Clubfoot Res Grp, Aberdeen, Scotland; [Sharp, Linda] Natl Canc Registry Ireland, Cork, Ireland; [Hennekam, Raoul C.] Univ Amsterdam, Dept Pediat, Amsterdam, Netherlands	University of Aberdeen; University of Amsterdam	Cardy, AH (corresponding author), Univ Aberdeen, Clubfoot Res Grp, Aberdeen, Scotland.	a.h.cardy@abdn.ac.uk		Torrance, Nicola/0000-0002-7856-7408	Sports Action Research for Kids (Sparks); Chief Scientist Office	Sports Action Research for Kids (Sparks); Chief Scientist Office	This work was supported by Sports Action Research for Kids (Sparks) and the Chief Scientist Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687; Alderman B W, 1991, Epidemiology, V2, P289, DOI 10.1097/00001648-199107000-00009; Barker S, 2003, J PEDIATR ORTHOPED, V23, P265, DOI 10.1097/00004694-200303000-00025; BELLYEI A, 1983, HUM HERED, V33, P58, DOI 10.1159/000153349; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brent RL, 2005, BIRTH DEFECTS RES A, V73, P906, DOI 10.1002/bdra.20184; Byron-Scott R, 2005, PAEDIATR PERINAT EP, V19, P227, DOI 10.1111/j.1365-3016.2005.00647.x; CARDY AH, 1997, BMC MUSCULOSKEL DIS, V5, P62; Carey M, 2005, PAEDIATR PERINAT EP, V19, P238, DOI 10.1111/j.1365-3016.2005.00648.x; Carey M, 2003, PAEDIATR PERINAT EP, V17, P187, DOI 10.1046/j.1365-3016.2003.00477.x; CARTLIDGE I, 1984, J MED GENET, V21, P290, DOI 10.1136/jmg.21.4.290; Chapman C, 2000, J MED GENET, V37, P680, DOI 10.1136/jmg.37.9.680; Cornel M C, 1996, Int J Risk Saf Med, V8, P197, DOI 10.3233/JRS-1996-8302; CZEIZEL AE, 1995, CONTRACEPTION, V51, P19, DOI 10.1016/0010-7824(94)00008-K; DANIELSSON LG, 1992, ACTA ORTHOP SCAND, V63, P424, DOI 10.3109/17453679209154759; Duce S, 2010, J ANAT, V216, P108, DOI 10.1111/j.1469-7580.2009.01163.x; Engell V, 2006, J BONE JOINT SURG BR, V88B, P374, DOI 10.1302/0301-620X.88B3.16685; Honein MA, 2000, AM J EPIDEMIOL, V152, P658, DOI 10.1093/aje/152.7.658; KRICKER A, 1986, AM J OBSTET GYNECOL, V155, P1072, DOI 10.1016/0002-9378(86)90352-2; Kruse LM, 2008, J BONE JOINT SURG AM, V90A, P2688, DOI 10.2106/JBJS.G.01346; Lochmiller C, 1998, AM J MED GENET, V79, P90, DOI 10.1002/(SICI)1096-8628(19980901)79:2<90::AID-AJMG3>3.3.CO;2-M; MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P91, DOI 10.2105/AJPH.82.1.91; Miedzybrodzka Z, 2003, J ANAT, V202, P37, DOI 10.1046/j.1469-7580.2003.00147.x; Moorthi RN, 2005, AM J MED GENET A, V132A, P376, DOI 10.1002/ajmg.a.30505; PALMER RM, 1974, ORTHOP CLIN N AM, V5, P99; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; PRYOR GA, 1991, J BONE JOINT SURG BR, V73, P632, DOI 10.1302/0301-620X.73B4.2071648; REBBECK TR, 1993, AM J HUM GENET, V53, P1051; Reefhuis J, 1998, AM J PUBLIC HEALTH, V88, P1554, DOI 10.2105/AJPH.88.10.1554; Sharp L, 2006, AM J EPIDEMIOL, V164, P852, DOI 10.1093/aje/kwj285; SHIONO PH, 1986, TERATOLOGY, V34, P65, DOI 10.1002/tera.1420340109; Skelly AC, 2002, TERATOLOGY, V66, P91, DOI 10.1002/tera.10071; Somppi E, 1984, Acta Orthop Scand Suppl, V209, P1; Ulrich M, 1999, EUR J OBSTET GYN R B, V87, P111, DOI 10.1016/S0301-2115(99)00085-8; Umbach DM, 1997, STAT MED, V16, P1731, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S; Van den Eeden S K, 1990, Paediatr Perinat Epidemiol, V4, P147; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P464, DOI 10.1302/0301-620X.46B3.464; WYNNEDAVIES R, 1972, CLIN ORTHOP RELAT R, P9, DOI 10.1097/00003086-197205000-00003; 2007, NEUROSCI BIOBEHAV RE, V3	39	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e17895	10.1371/journal.pone.0017895	http://dx.doi.org/10.1371/journal.pone.0017895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533128	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400003
J	Guinane, CM; Kent, RM; Norberg, S; Hill, C; Fitzgerald, GF; Stanton, C; Ross, RP				Guinane, Caitriona M.; Kent, Robert M.; Norberg, Sarah; Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul			Host Specific Diversity in Lactobacillus johnsonii as Evidenced by a Major Chromosomal Inversion and Phage Resistance Mechanisms	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GENOME SEQUENCE; IDENTIFICATION; EVOLUTION; REVEALS; STRAINS; NCC533; LA1; COMBINATION; ANNOTATION	Genetic diversity and genomic rearrangements are a driving force in bacterial evolution and niche adaptation. We sequenced and annotated the genome of Lactobacillus johnsonii DPC6026, a strain isolated from the porcine intestinal tract. Although the genome of DPC6026 is similar in size (1.97mbp) and GC content (34.8%) to the sequenced human isolate L. johnsonii NCC 533, a large symmetrical inversion of approximately 750 kb differentiated the two strains. Comparative analysis among 12 other strains of L. johnsonii including 8 porcine, 3 human and 1 poultry isolate indicated that the genome architecture found in DPC6026 is more common within the species than that of NCC 533. Furthermore a number of unique features were annotated in DPC6026, some of which are likely to have been acquired by horizontal gene transfer (HGT) and contribute to protection against phage infection. A putative type III restriction-modification system was identified, as were novel Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) elements. Interestingly, these particular elements are not widely distributed among L. johnsonii strains. Taken together these data suggest intra-species genomic rearrangements and significant genetic diversity within the L. johnsonii species and indicate towards a host-specific divergence of L. johnsonii strains with respect to genome inversion and phage exposure.	[Guinane, Caitriona M.; Kent, Robert M.; Stanton, Catherine; Ross, R. Paul] TEAGASC, Food Res Ctr, Food Biosci Dept, Cork, Ireland; [Kent, Robert M.; Norberg, Sarah; Hill, Colin; Fitzgerald, Gerald F.; Ross, R. Paul] Univ Coll, Dept Microbiol, Cork, Ireland; [Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul] Univ Coll, Alimentary Pharmabiot Ctr, Cork, Ireland	Teagasc; University College Cork; University College Cork	Guinane, CM (corresponding author), TEAGASC, Food Res Ctr, Food Biosci Dept, Cork, Ireland.	paul.ross@teagasc.ie	Hill, Colin/A-5611-2012; Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015	Hill, Colin/0000-0002-8527-1445; Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Guinane, Caitriona/0000-0001-8215-1387	Enterprise Ireland commercialisation fund [CFTD/07/116]; Teagasc Walsh Fellowship	Enterprise Ireland commercialisation fund; Teagasc Walsh Fellowship	This work was funded by an Enterprise Ireland commercialisation fund CFTD/07/116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge E. Barrett for technical assistance. R. Kent is in receipt of a Teagasc Walsh Fellowship. We also gratefully acknowledge the use of the Nestle NCC 533 strain.	Achaz G, 2003, GENETICS, V164, P1279; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Canchaya C, 2006, MICROBIOL-SGM, V152, P3185, DOI 10.1099/mic.0.29140-0; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Darling Aaron E., 2007, V396, P135; Daveran-Mingot ML, 1998, J BACTERIOL, V180, P4834, DOI 10.1128/JB.180.18.4834-4842.1998; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Denou E, 2008, J BACTERIOL, V190, P5806, DOI 10.1128/JB.01802-07; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hayes A, 2006, APPL ENVIRON MICROB, V72, P2260, DOI 10.1128/AEM.72.3.2260-2264.2006; HILL CW, 1988, GENETICS, V119, P771; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Inoue R, 2007, FEMS IMMUNOL MED MIC, V50, P67, DOI 10.1111/j.1574-695X.2007.00233.x; Kaburagi T, 2007, NUTRITION, V23, P342, DOI 10.1016/j.nut.2007.02.001; Klaenhammer T, 2002, ANTON LEEUW INT J G, V82, P29, DOI 10.1023/A:1020638309912; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; O'Shea EF, 2009, FEMS MICROBIOL LETT, V291, P24, DOI 10.1111/j.1574-6968.2008.01427.x; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Rozen S, 2000, Methods Mol Biol, V132, P365; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Ventura M, 2004, VIROLOGY, V320, P229, DOI 10.1016/j.virol.2003.11.034; Ventura M, 2003, J BACTERIOL, V185, P4603, DOI 10.1128/JB.185.15.4603-4608.2003; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wegmann U, 2009, J BACTERIOL, V191, P7142, DOI 10.1128/JB.01182-09; Zhang ZG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-1	61	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18740	10.1371/journal.pone.0018740	http://dx.doi.org/10.1371/journal.pone.0018740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533100	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400022
J	Buckley, JG; Timmis, MA; Scally, AJ; Elliott, DB				Buckley, John G.; Timmis, Matthew A.; Scally, Andy J.; Elliott, David B.			When Is Visual Information Used to Control Locomotion When Descending a Kerb?	PLOS ONE			English	Article							ADAPTIVE LOCOMOTION; APPROACH PHASE; STEP DESCENT; OBSTACLE; VISION; FALLS; GAIT; MECHANICS; MOVEMENTS; FEEDBACK	Background: Descending kerbs during locomotion involves the regulation of appropriate foot placement before the kerb-edge and foot clearance over it. It also involves the modulation of gait output to ensure the body-mass is safely and smoothly lowered to the new level. Previous research has shown that vision is used in such adaptive gait tasks for feedforward planning, with vision from the lower visual field (lvf) used for online updating. The present study determined when lvf information is used to control/update locomotion when stepping from a kerb. Methodology/Principal Findings: 12 young adults stepped down a kerb during ongoing gait. Force sensitive resistors (attached to participants' feet) interfaced with an high-speed PDLC 'smart glass' sheet, allowed the lvf to be unpredictably occluded at either heel-contact of the penultimate or final step before the kerb-edge up to contact with the lower level. Analysis focussed on determining changes in foot placement distance before the kerb-edge, clearance over it, and in kinematic measures of the step down. Lvf occlusion from the instant of final step contact had no significant effect on any dependant variable (p>0.09). Occlusion of the lvf from the instant of penultimate step contact had a significant effect on foot clearance and on several kinematic measures, with findings consistent with participants becoming uncertain regarding relative horizontal location of the kerb-edge. Conclusion/Significance: These findings suggest concurrent feedback of the lower limb, kerb-edge, and/or floor area immediately in front/below the kerb is not used when stepping from a kerb during ongoing gait. Instead heel-clearance and pre-landing-kinematic parameters are determined/planned using lvf information acquired in the penultimate step during the approach to the kerb-edge, with information related to foot placement before the kerb-edge being the most salient.	[Buckley, John G.] Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England; [Timmis, Matthew A.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, Cambs, England; [Scally, Andy J.] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England; [Elliott, David B.] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; Anglia Ruskin University; University of Bradford; University of Bradford	Buckley, JG (corresponding author), Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England.	j.buckley@bradford.ac.uk	Elliott, David/B-1806-2009	Elliott, David/0000-0001-9959-6841; Scally, Andy/0000-0002-6189-2247; Buckley, John/0000-0002-4085-4743	Health Foundation [3991/3322]; RCUK (Research Councils, UK)	Health Foundation; RCUK (Research Councils, UK)(UK Research & Innovation (UKRI))	Mat Timmis was supported by a studentship furnished from a grant from The Health Foundation (3991/3322, grant awarded to John Buckley). John Buckley is supported by an RCUK Academic Fellowship (Research Councils, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Buckley JG, 2005, GAIT POSTURE, V21, P65, DOI 10.1016/j.gaitpost.2003.12.001; Buckley JG, 2008, EXP BRAIN RES, V184, P223, DOI 10.1007/s00221-007-1096-8; Cowie D, 2008, EXP BRAIN RES, V186, P343, DOI 10.1007/s00221-008-1320-1; CRAIK RL, 1982, EXP BRAIN RES, V45, P399, DOI 10.1007/BF01208600; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Gallagher EM, 1997, CAN J PUBLIC HEALTH, V88, P129, DOI 10.1007/BF03403876; Graci V, 2010, OPTOMETRY VISION SCI, V87, P21, DOI 10.1097/OPX.0b013e3181c1d547; Hansen S, 2006, CAN J EXP PSYCHOL, V60, P200, DOI 10.1037/cjep2006019; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; JACK CIA, 1995, GERONTOLOGY, V41, P280; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 1998, ECOL PSYCHOL, V10, P287, DOI 10.1207/s15326969eco103&4_7; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Patla AE, 2002, EXP BRAIN RES, V142, P551, DOI 10.1007/s00221-001-0948-x; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Rhea CK, 2007, NEUROSCI LETT, V418, P60, DOI 10.1016/j.neulet.2007.02.063; Rietdyk S, 2006, EXP BRAIN RES, V169, P272, DOI 10.1007/s00221-005-0345-y; Santello M, 1998, EXP PHYSIOL, V83, P857, DOI 10.1113/expphysiol.1998.sp004165; TIMMIS MA, 2010, VISUOMOTOR CONTROL S; Timmis MA, 2009, EXP BRAIN RES, V195, P219, DOI 10.1007/s00221-009-1773-x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1207, DOI 10.1111/j.1532-5415.1995.tb07395.x; van Dieen JH, 2008, J BIOMECH, V41, P2417, DOI 10.1016/j.jbiomech.2008.05.022; ZELAZNIK HN, 1983, J MOTOR BEHAV, V15, P217	27	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e19079	10.1371/journal.pone.0019079	http://dx.doi.org/10.1371/journal.pone.0019079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	751LS	21533113	gold, Green Published, Green Submitted			2022-12-27	WOS:000289620100034
J	Akca, S; Foroughi, A; Frochtzwajg, D; Postma, HWC				Akca, Saliha; Foroughi, Ashkan; Frochtzwajg, Daniel; Postma, Henk W. Ch.			Competing Interactions in DNA Assembly on Graphene	PLOS ONE			English	Article							ORIENTED PYROLYTIC-GRAPHITE; ATOMIC-FORCE MICROSCOPY; WALLED CARBON NANOTUBES; SINGLE-STRANDED-DNA; ELECTRODE SURFACE; HOPG ELECTRODE; ADSORPTION; BINDING	We study the patterns that short strands of single-stranded DNA form on the top graphene surface of graphite. We find that the DNA assembles into two distinct patterns, small spherical particles and elongated networks. Known interaction models based on DNA-graphene binding, hydrophobic interactions, or models based on the purine/pyrimidine nature of the bases do not explain our observed crossover in pattern formation. We argue that the observed assembly behavior is caused by a crossover in the competition between base-base pi stacking and base-graphene pi stacking and we infer a critical crossover energy of 0.3-0.5 eV. The experiments therefore provide a projective measurement of the base-base interaction strength.	[Akca, Saliha; Foroughi, Ashkan; Frochtzwajg, Daniel; Postma, Henk W. Ch.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	California State University System; California State University Northridge	Akca, S (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	postma@csun.edu	Postma, Henk W.Ch./A-8770-2014	Postma, Henk/0000-0003-4349-9406	National Science Foundation [DMR-1034937]; Division Of Materials Research [1034937] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge financial support from the National Science Foundation under award DMR-1034937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcik J, 2006, FEBS LETT, V580, P5671, DOI 10.1016/j.febslet.2006.09.017; Antony J, 2008, PHYS CHEM CHEM PHYS, V10, P2722, DOI 10.1039/b718788b; Brett AMO, 2005, BIOELECTROCHEMISTRY, V66, P117, DOI 10.1016/j.bioelechem.2004.05.009; Brett AMO, 2003, LANGMUIR, V19, P3830, DOI 10.1021/la027047d; Brett AMO, 2003, ELECTROCHEM COMMUN, V5, P178, DOI 10.1016/S1388-2481(03)00014-6; Paquim AMC, 2006, BIOPHYS CHEM, V121, P131, DOI 10.1016/j.bpc.2005.12.017; Gorodetsky AA, 2006, LANGMUIR, V22, P7917, DOI 10.1021/la0611054; Gowtham S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.033401; Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k; Manohar S, 2008, NANO LETT, V8, P4365, DOI 10.1021/nl8022143; Mascini M, 2001, FRESEN J ANAL CHEM, V369, P15, DOI 10.1007/s002160000629; Matta CF, 2006, J PHYS CHEM B, V110, P563, DOI 10.1021/jp054986g; Mohanty N, 2008, NANO LETT, V8, P4469, DOI 10.1021/nl802412n; Murakami H, 2003, CHEM PHYS LETT, V378, P481, DOI 10.1016/S0009-2614(03)01329-0; Paquim AMC, 2006, ELECTROCHIM ACTA, V51, P5037, DOI 10.1016/j.electacta.2006.03.041; Penazova H, 1997, BIOPHYS J, V73, P2054, DOI 10.1016/S0006-3495(97)78235-3; Postma HWC, 2010, NANO LETT, V10, P420, DOI 10.1021/nl9029237; Postma HWC, 2000, ADV MATER, V12, P1299, DOI 10.1002/1521-4095(200009)12:17<1299::AID-ADMA1299>3.0.CO;2-O; Saenger W., 1984, PRINCIPLES NUCL ACID; Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103; Tang LAL, 2010, J AM CHEM SOC, V132, P10976, DOI 10.1021/ja104017y; Tang ZW, 2010, SMALL, V6, P1205, DOI 10.1002/smll.201000024; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	25	78	79	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18442	10.1371/journal.pone.0018442	http://dx.doi.org/10.1371/journal.pone.0018442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532757	Green Published, gold			2022-12-27	WOS:000289404700013
J	Dean, RT; Bailes, F; Schubert, E				Dean, Roger T.; Bailes, Freya; Schubert, Emery			Acoustic Intensity Causes Perceived Changes in Arousal Levels in Music: An Experimental Investigation	PLOS ONE			English	Article							EMOTIONAL RESPONSES; PERCEPTION; SOUNDS; LOUDNESS; MODEL; CUES	Listener perceptions of changes in the arousal expressed by classical music have been found to correlate with changes in sound intensity/loudness over time. This study manipulated the intensity profiles of different pieces of music in order to test the causal nature of this relationship. Listeners (N = 38) continuously rated their perceptions of the arousal expressed by each piece. An extract from Dvorak's Slavonic Dance Opus 46 No 1 was used to create a variant in which the direction of change in intensity was inverted, while other features were retained. Even though it was only intensity that was inverted, perceived arousal was also inverted. The original intensity profile was also superimposed on three new pieces of music. The time variation in the perceived arousal of all pieces was similar to their intensity profile. Time series analyses revealed that intensity variation was a major influence on the arousal perception in all pieces, in spite of their stylistic diversity.	[Dean, Roger T.; Bailes, Freya] Univ Western Sydney, MARCS Auditory Labs, Milperra, NSW, Australia; [Schubert, Emery] Univ New S Wales, Empir Musicol Grp, Sydney, NSW, Australia	Western Sydney University; University of New South Wales Sydney	Dean, RT (corresponding author), Univ Western Sydney, MARCS Auditory Labs, Milperra, NSW, Australia.	f.bailes@uws.edu.au	Bailes, Freya/C-6932-2008	Dean, Roger Thornton/0000-0002-8859-8902; Schubert, Emery/0000-0002-6541-8083; Bailes, Freya/0000-0003-2723-3579				Bailes F, 2009, PERCEPTION, V38, P1386, DOI 10.1068/p6063; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; BREWSTER A, 2003, AFFECTIONS FRIENDSHI; CABRERA D, 2010, 129 CONV AUD ENG SOC; Dean RT, 2010, ORGAN SOUND, V15, P147, DOI 10.1017/S1355771810000142; DEAN RT, EMPIRICAL M IN PRESS; Dubnov S, 2006, J AM SOC INF SCI TEC, V57, P1526, DOI 10.1002/asi.20429; Evans P, 2008, MUSIC SCI, V12, P75, DOI 10.1177/102986490801200105; Gabrielsson Alf, 2010, HDB MUSIC EMOTION TH, P367, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0014; Geringer J. M., 1993, PSYCHOMUSICOLOGY, V12, P22, DOI 10.1037/h0094120; Glasberg BR, 2002, J AUDIO ENG SOC, V50, P331; Gower J.C., 2004, PROCRUSTES PROBLEMS; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Leman M, 2005, J NEW MUSIC RES, V34, P39, DOI 10.1080/09298210500123978; Mertens Wim., 1983, AM MINIMAL MUSIC; Namba S, 2008, JPN PSYCHOL RES, V50, P154, DOI 10.1111/j.1468-5884.2008.00372.x; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Ollen J. E., 2006, CRITERION RELATED VA; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; SCHUBERT E, 2001, MUSIC EMOTION THEORY, P393; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Todd NPM, 2000, J ACOUST SOC AM, V107, P496, DOI 10.1121/1.428317; VIEMEISTER NF, 1991, J ACOUST SOC AM, V90, P858, DOI 10.1121/1.401953; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; Zwicker E., 1999, PSYCHOACOUSTICS, DOI [10.1007/978-3-662-09562-1, DOI 10.1007/978-3-662-09562-1]	32	42	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18591	10.1371/journal.pone.0018591	http://dx.doi.org/10.1371/journal.pone.0018591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533095	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400014
J	Taglialatela, JP; Russell, JL; Schaeffer, JA; Hopkins, WD				Taglialatela, Jared P.; Russell, Jamie L.; Schaeffer, Jennifer A.; Hopkins, William D.			Chimpanzee Vocal Signaling Points to a Multimodal Origin of Human Language	PLOS ONE			English	Article							PAN-TROGLODYTES; SQUIRREL-MONKEYS; ATTENTIONAL STATUS; DIFFERENTIAL USE; MANUAL GESTURES; BROCAS AREA; CHUCK CALL; COO CALLS; COMMUNICATION; EXCHANGES	The evolutionary origin of human language and its neurobiological foundations has long been the object of intense scientific debate. Although a number of theories have been proposed, one particularly contentious model suggests that human language evolved from a manual gestural communication system in a common ape-human ancestor. Consistent with a gestural origins theory are data indicating that chimpanzees intentionally and referentially communicate via manual gestures, and the production of manual gestures, in conjunction with vocalizations, activates the chimpanzee Broca's area homologue - a region in the human brain that is critical for the planning and execution of language. However, it is not known if this activity observed in the chimpanzee Broca's area is the result of the chimpanzees producing manual communicative gestures, communicative sounds, or both. This information is critical for evaluating the theory that human language evolved from a strictly manual gestural system. To this end, we used positron emission tomography ( PET) to examine the neural metabolic activity in the chimpanzee brain. We collected PET data in 4 subjects, all of whom produced manual communicative gestures. However, 2 of these subjects also produced so-called attention-getting vocalizations directed towards a human experimenter. Interestingly, only the two subjects that produced these attention-getting sounds showed greater mean metabolic activity in the Broca's area homologue as compared to a baseline scan. The two subjects that did not produce attention-getting sounds did not. These data contradict an exclusive "gestural origins'' theory for they suggest that it is vocal signaling that selectively activates the Broca's area homologue in chimpanzees. In other words, the activity observed in the Broca's area homologue reflects the production of vocal signals by the chimpanzees, suggesting thast this critical human language region was involved in vocal signaling in the common ancestor of both modern humans and chimpanzees.	[Taglialatela, Jared P.; Russell, Jamie L.] Kennesaw State Univ, Dept Biol & Phys, Kennesaw, GA USA; [Taglialatela, Jared P.; Russell, Jamie L.; Schaeffer, Jennifer A.; Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA	University System of Georgia; Kennesaw State University	Taglialatela, JP (corresponding author), Kennesaw State Univ, Dept Biol & Phys, Kennesaw, GA USA.	jtaglial@kennesaw.edu			National Institute on Deafness and Other Communication Disorders [R15DC011005]; National Institute of Neurological Disorders and Stroke [NS42867, NS36605]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD56232]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867, R01NS036605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC011005] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by Award Numbers R15DC011005 from the National Institute on Deafness and Other Communication Disorders to JPT, and NS42867 and NS36605 from the National Institute of Neurological Disorders and Stroke and HD56232 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to WDH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Deafness and Other Communication Disorders, the National Institute of Neurological Disorders and Stroke, the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; Becker M, 2003, FOLIA PRIMATOL, V74, P301, DOI 10.1159/000073316; BIBEN M, 1991, BEHAVIOUR, V117, P1, DOI 10.1163/156853991X00094; BIBEN M, 1986, BEHAVIOUR, V98, P259, DOI 10.1163/156853986X00991; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Crockford C, 2003, ANIM BEHAV, V66, P115, DOI 10.1006/anbe.2003.2166; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hopkins WD, 2005, PSYCHOL SCI, V16, P487; Hopkins WD, 2003, DEVELOPMENTAL SCI, V6, P55, DOI 10.1111/1467-7687.00254; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Iverson JM, 2005, PSYCHOL SCI, V16, P367, DOI 10.1111/j.0956-7976.2005.01542.x; Iverson JM, 2004, CHILD DEV, V75, P1053, DOI 10.1111/j.1467-8624.2004.00725.x; Kaufman JA, 2003, AM J PHYS ANTHROPOL, V121, P369, DOI 10.1002/ajpa.10181; KIMURA D, 1973, NEUROPSYCHOLOGIA, V11, P45, DOI 10.1016/0028-3932(73)90063-8; Krause MA, 1997, J COMP PSYCHOL, V111, P330, DOI 10.1037/0735-7036.111.4.330; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Leavens DA, 1996, J COMP PSYCHOL, V110, P346, DOI 10.1037/0735-7036.110.4.346; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 1998, DEV PSYCHOL, V34, P813, DOI 10.1037/0012-1649.34.5.813; Martinez ZA, 1997, AM J PRIMATOL, V42, P215, DOI 10.1002/(SICI)1098-2345(1997)42:3<215::AID-AJP4>3.0.CO;2-#; MASATAKA N, 1987, BEHAVIOUR, V101, P311, DOI 10.1163/156853987X00035; McCowan B, 2000, BEHAVIOUR, V137, P279, DOI 10.1163/156853900502088; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Schenker NM, 2010, CEREB CORTEX, V20, P730, DOI 10.1093/cercor/bhp138; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; SMITH HJ, 1982, PRIMATE COMMUNICATIO; Snowdon CT, 2009, ADV STUD BEHAV, V40, P239, DOI 10.1016/S0065-3454(09)40007-X; SNOWDON CT, 1984, AM J PRIMATOL, V7, P15, DOI 10.1002/ajp.1350070104; Soltis J, 2002, AM J PRIMATOL, V57, P119, DOI 10.1002/ajp.10039; Sugiura H, 1998, ANIM BEHAV, V55, P673, DOI 10.1006/anbe.1997.0602; Sugiura H, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P135; SUGIURA H, 1993, BEHAVIOUR, V124, P207, DOI 10.1163/156853993X00588; SYMMES D, 1988, PRIMATE VOCAL COMMUN; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; Taglialatela JP, 2003, INT J PRIMATOL, V24, P1, DOI 10.1023/A:1021487710547; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; Zuberbuhler K, 2005, CURR DIR PSYCHOL SCI, V14, P126, DOI 10.1111/j.0963-7214.2005.00357.x	44	69	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18852	10.1371/journal.pone.0018852	http://dx.doi.org/10.1371/journal.pone.0018852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533079	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400030
J	Bertini, I; Chevance, S; Del Conte, R; Lalli, D; Turano, P				Bertini, Ivano; Chevance, Soizic; Del Conte, Rebecca; Lalli, Daniela; Turano, Paola			The Anti-Apoptotic Bcl-x(L) Protein, a New Piece in the Puzzle of Cytochrome C Interactome	PLOS ONE			English	Article							BCL-X-L; ESCHERICHIA-COLI; PEPTIDE COMPLEX; CELL-SURVIVAL; BINDING; FAMILY; NMR; ACTIVATION; REGULATORS; CASPASE-9	A structural model of the adduct between human cytochrome c and the human anti-apoptotic protein Bcl-x(L), which defines the protein-protein interaction surface, was obtained from solution NMR chemical shift perturbation data. The atomic level information reveals key intermolecular contacts identifying new potentially druggable areas on cytochrome c and Bcl-x(L). Involvement of residues on cytochrome c other than those in its complexes with electron transfer partners is apparent. Key differences in the contact area also exist between the Bcl-x(L) adduct with the Bak peptide and that with cytochrome c. The present model provides insights to the mechanism by which cytochrome c translocated to cytosol can be intercepted, so that the apoptosome is not assembled.	[Bertini, Ivano; Chevance, Soizic; Del Conte, Rebecca; Lalli, Daniela; Turano, Paola] Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy; [Bertini, Ivano; Lalli, Daniela; Turano, Paola] Univ Florence, Dept Chem, Florence, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy.	bertini@cerm.unifi.it	chevance, soizic/AAC-4249-2019; Turano, Paola/F-9089-2011	Turano, Paola/0000-0002-7683-8614	European Community [LSHG-CT-2006-031220S]; Italian MIUR [RBRN07BMCT]; Progetto FIRB [RBNE03PX83]	European Community(European Commission); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Progetto FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	The research was funded thanks to the European Community-SPINE II-COMPLEXES Contract LSHG-CT-2006-031220S, the Italian MIUR contract FIRB PROTEOMICA - RBRN07BMCT and the financial support of Ente Cassa di Risparmio di Firenze. S. C. was the recipient of a fellowship provided by Progetto FIRB 2003 - RBNE03PX83. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; [Anonymous], [No title captured]; Banci L, 1999, J BIOL INORG CHEM, V4, P824, DOI 10.1007/s007750050356; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Bertini I, 2005, J BIOL INORG CHEM, V10, P613, DOI 10.1007/s00775-005-0011-7; Bertini I, 2011, METALLOMICS, V3, P354, DOI 10.1039/c0mt00108b; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Jeng WY, 2002, J BIOENERG BIOMEMBR, V34, P423, DOI 10.1023/A:1022561924392; KELLER R, 2002, NEW SOFTWARE ANAL PR; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Petros AM, 2005, J BIOMOL NMR, V32, P260, DOI 10.1007/s10858-005-7957-1; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SCOTT RA, 1996, CYTOCHROME C MULTIDI; Shao WP, 2003, BIOCHEMISTRY-US, V42, P14774, DOI 10.1021/bi030145t; Volkov AN, 2005, PROTEIN SCI, V14, P799, DOI 10.1110/ps.041150205; Wegerich F, 2009, ANAL CHEM, V81, P2976, DOI 10.1021/ac802571h; Yadaiah M, 2007, BBA-PROTEINS PROTEOM, V1774, P1370, DOI 10.1016/j.bbapap.2007.08.005; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; [No title captured]	38	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18329	10.1371/journal.pone.0018329	http://dx.doi.org/10.1371/journal.pone.0018329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533126	gold, Green Published			2022-12-27	WOS:000289620100003
J	Davies, AJ; Guinotte, JM				Davies, Andrew J.; Guinotte, John M.			Global Habitat Suitability for Framework-Forming Cold-Water Corals	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; PREDICTING SUITABLE HABITAT; SPECIES DISTRIBUTIONS; NORTHEAST ATLANTIC; OCEAN ACIDIFICATION; REEFS; CONSERVATION; PERFORMANCE; BATHYMETRY; IMPACTS	Predictive habitat models are increasingly being used by conservationists, researchers and governmental bodies to identify vulnerable ecosystems and species' distributions in areas that have not been sampled. However, in the deep sea, several limitations have restricted the widespread utilisation of this approach. These range from issues with the accuracy of species presences, the lack of reliable absence data and the limited spatial resolution of environmental factors known or thought to control deep-sea species' distributions. To address these problems, global habitat suitability models have been generated for five species of framework-forming scleractinian corals by taking the best available data and using a novel approach to generate high resolution maps of seafloor conditions. High-resolution global bathymetry was used to resample gridded data from sources such as World Ocean Atlas to produce continuous 30-arc second (similar to 1 km(2)) global grids for environmental, chemical and physical data of the world's oceans. The increased area and resolution of the environmental variables resulted in a greater number of coral presence records being incorporated into habitat models and higher accuracy of model predictions. The most important factors in determining cold-water coral habitat suitability were depth, temperature, aragonite saturation state and salinity. Model outputs indicated the majority of suitable coral habitat is likely to occur on the continental shelves and slopes of the Atlantic, South Pacific and Indian Oceans. The North Pacific has very little suitable scleractinian coral habitat. Numerous small scale features (i.e., seamounts), which have not been sampled or identified as having a high probability of supporting cold-water coral habitat were identified in all ocean basins. Field validation of newly identified areas is needed to determine the accuracy of model results, assess the utility of modelling efforts to identify vulnerable marine ecosystems for inclusion in future marine protected areas and reduce coral bycatch by commercial fisheries.	[Davies, Andrew J.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Guinotte, John M.] Marine Conservat Biol Inst, Bellevue, WA USA	Bangor University	Davies, AJ (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	andrew.j.davies@bangor.ac.uk	Davies, Andrew/A-4222-2008	Davies, Andrew/0000-0002-2087-0885	Winston Churchill Memorial Fellowship; Arcadia Foundation; Sally Brown Foundation; Curtis and Edith Munson Foundation; Henry Foundation; Herbert W. Hoover Foundation; International Union for the Conservation of Nature; J.M. Kaplan Fund; Naomi and Nehemiah Cohen Foundation; Oak Foundation; Pew Charitable Trusts; Richard and Rhoda Goldman Fund; Tiffany Co. Foundation	Winston Churchill Memorial Fellowship; Arcadia Foundation; Sally Brown Foundation; Curtis and Edith Munson Foundation; Henry Foundation; Herbert W. Hoover Foundation; International Union for the Conservation of Nature; J.M. Kaplan Fund; Naomi and Nehemiah Cohen Foundation; Oak Foundation; Pew Charitable Trusts; Richard and Rhoda Goldman Fund; Tiffany Co. Foundation	The up-scaling approach was devised during a Winston Churchill Memorial Fellowship awarded to AJD. The ESRI Conservation Program provided ArcGIS software to MCBI. MCBI would like to thank the following foundations, organizations, and individuals for their support: Arcadia, Sally Brown, Curtis and Edith Munson and Henry Foundations, Jonathan Edwards, Ben and Ruth Hammett, Herbert W. Hoover Foundation, International Union for the Conservation of Nature, J.M. Kaplan Fund, Naomi and Nehemiah Cohen Foundation, Oak Foundation, Pew Charitable Trusts, Richard and Rhoda Goldman Fund, and the Tiffany & Co. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Becker JJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003879; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Cairns SD., 1995, NZ OCEANOGRAPHIC I M, V103, P210, DOI DOI 10.1017/CBO9781107415324.004; Carton JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002817; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Edinger EN, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P101; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Freiwald A., 2004, COLD WATER CORAL REE; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Garcia H. E., 2006, NOAA ATLAS NESDIS, V64; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; KAMPSTRA P, 2008, J STAT SOFTW, V28, pCS1; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; Riordan EC, 2009, J BIOGEOGR, V36, P2176, DOI 10.1111/j.1365-2699.2009.02151.x; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; Roberts JM, 2003, MAR POLLUT BULL, V46, P7, DOI 10.1016/S0025-326X(02)00259-X; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 2007, SCI GUIDELINES SCI G; Ross S. W., 2007, STATE DEEP CORAL ECO, P233; SABINE CL, 2005, ORNLCDIAC145 US DEP; Schroder-Ritzrau A, 2005, ERLANGEN EARTH C SER, P157, DOI 10.1007/3-540-27673-4_8; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Thiem O, 2006, CONT SHELF RES, V26, P1481, DOI 10.1016/j.csr.2006.02.016; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Wright D.J., 2005, ARCGIS BENTHIC TERRA	57	243	247	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18483	10.1371/journal.pone.0018483	http://dx.doi.org/10.1371/journal.pone.0018483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525990	gold, Green Published			2022-12-27	WOS:000289578600010
J	Lin, ZF; Zhou, ZH; Liu, YL; Gong, Q; Yan, XX; Xiao, J; Wang, XJ; Lin, SQ; Feng, WK; Li, XK				Lin, Zhuofeng; Zhou, Zhihong; Liu, Yanlong; Gong, Qi; Yan, Xinxin; Xiao, Jian; Wang, Xiaojie; Lin, Shaoqiang; Feng, Wenke; Li, Xiaokun			Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; LEFT-VENTRICULAR HYPERTROPHY; SERUM CYSTATIN-C; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INSULIN SENSITIVITY; FIBROBLAST-GROWTH-FACTOR-23; BETA-2-MICROGLOBULIN; OBESITY; HEALTH	Background: Fibroblast growth factor 21 (FGF21) is a hepatic hormone involved in the regulation of lipid and carbohydrate metabolism. This study aims to test the hypothesis that elevated FGF21 concentrations are associated with the change of renal function and the presence of left ventricular hypertrophy (LVH) in the different stages of chronic kidney disease (CKD) progression. Methodology/Principal Findings: 240 subjects including 200 CKD patients (146 outpatients and 54 long-term hemodialytic patients) and 40 healthy control subjects were recruited. All CKD subjects underwent echocardiograms to assess left ventricular mass index. Plasma FGF21 levels and other clinical and biochemical parameters in all subjects were obtained based on standard clinical examination methods. Plasma FGF21 levels were significantly increased with the development of CKD from early-and end-stage (P < 0.001 for trend), and significantly higher in CKD subjects than those in healthy subjects (P < 0.001). Plasma FGF21 levels in CKD patients with LVH were higher than those in patients without LVH (P=0.001). Furthermore, plasma FGF21 level correlated positively with creatinine, blood urea nitrogen (BUN), beta 2 microglobulin, systolic pressure, adiponectin, phosphate, proteinuria, CRP and triglyceride, but negatively with creatinine clearance rate (CCR), estimated glomerular filtrate rate (eGFR), HDL-c, LDL-c, albumin and LVH after adjusting for BMI, gender, age and the presence of diabetes mellitus. Multiple stepwise regression analyses indicated that FGF21 was independently associated with BUN, Phosphate, LVMI and beta 2 microglobulin (all P < 0.05). Conclusion: Plasma FGF21 levels are significantly increased with the development of early-to end-stage CKD and are independently associated with renal function and adverse lipid profiles in Chinese population. Understanding whether increased FGF21 is associated with myocardial hypertrophy in CKD requires further study.	[Lin, Zhuofeng; Liu, Yanlong; Gong, Qi; Yan, Xinxin; Xiao, Jian; Wang, Xiaojie; Lin, Shaoqiang; Feng, Wenke; Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Lin, Zhuofeng] Jinan Univ, Sch Pharm, Guanghzou, Peoples R China; [Zhou, Zhihong] Wenzhou Med Coll, Div Kidney, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Li, Xiaokun] Jilin Univ, Key Lab Pathobiol, Natl Minist Educ, Changchun 130023, Peoples R China; [Feng, Wenke] Univ Louisville, Sch Med, Louisville, KY 40292 USA	Wenzhou Medical University; Jinan University; Wenzhou Medical University; Jilin University; University of Louisville	Lin, ZF (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	xiaokunli@163.com	Lin, Zhuofeng/K-2431-2013		Changjiang Scholars and Innovative Research Team; Zhejiang Provincial Natural Science Foundation of China [R2090550, Y2100048]; Natural Science Grant of Zhejiang Province, China [2009J1-C451]	Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Grant of Zhejiang Province, China	This work was supported by grants from Changjiang Scholars and Innovative Research Team (to XL), Zhejiang Provincial Natural Science Foundation of China (R2090550, Y2100048), and Natural Science Grant of Zhejiang Province, China (2009J1-C451). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplin IR, 2001, BLOOD, V97, P3450, DOI 10.1182/blood.V97.11.3450; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Corda S, 1997, CIRC RES, V81, P679; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; DEVEREUX RB, 1986, AM J CARDIOL, V57, P1388, DOI 10.1016/0002-9149(86)90224-9; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; FU XB, 1995, CHINESE MED J-PEKING, V108, P209; Fu Xiaobing, 1996, Wound Repair and Regeneration, V4, P297, DOI 10.1046/j.1524-475X.1996.40219.x; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; HAN SH, 2010, METABOLISM; Hei ZQ, 2008, CHINESE MED J-PEKING, V121, P1251, DOI 10.1097/00029330-200807020-00001; HOLZMANN MJ, 2010, ANN MED; Hostetter TH, 2004, NEW ENGL J MED, V351, P1344, DOI 10.1056/NEJMe048211; Imel EA, 2005, J AM SOC NEPHROL, V16, P2565, DOI 10.1681/ASN.2005050573; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Jovanovic D, 2003, RENAL FAILURE, V25, P123, DOI 10.1081/JDI-120017475; Khan IA, 2006, AM J CARDIOL, V97, P1530, DOI 10.1016/j.amjcard.2005.11.090; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kida Y, 2003, NEW ENGL J MED, V349, P505; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; Liu YB, 2006, J FORMOS MED ASSOC, V105, P17, DOI 10.1016/S0929-6646(09)60104-2; Michelis R, 2007, BLOOD PURIFICAT, V25, P505, DOI 10.1159/000113010; Middleton RJ, 2001, J AM SOC NEPHROL, V12, P1079, DOI 10.1681/ASN.V1251079; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; *NAT KIDN FDN, 2010, DIAB KIDN DIS; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Scheinowitz M, 2002, ISRAEL MED ASSOC J, V4, P109; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Stein S, 2010, METABOLISM, V59, P33, DOI 10.1016/j.metabol.2009.07.003; Suzuki G, 2005, CIRC RES, V96, P767, DOI 10.1161/01.RES.0000162099.01268.d1; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Vaziri ND, 2010, J RENAL NUTR, V20, pS35, DOI 10.1053/j.jrn.2010.05.010; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Whaley-Connell A, 2009, AM J KIDNEY DIS, V53, pS11, DOI 10.1053/j.ajkd.2009.01.004; WIBELL L, 1978, PATHOL BIOL, V26, P295; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; YU Y, 2000, HYPERTENSION, P1428; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	48	75	83	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18398	10.1371/journal.pone.0018398	http://dx.doi.org/10.1371/journal.pone.0018398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525989	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600008
J	Guan, RL; Purohit, S; Wang, HJ; Bode, B; Reed, JC; Steed, RD; Anderson, SW; Steed, L; Hopkins, D; Xia, C; She, JX				Guan, Ruili; Purohit, Sharad; Wang, Hongjie; Bode, Bruce; Reed, John Chip; Steed, R. Dennis; Anderson, Stephen W.; Steed, Leigh; Hopkins, Diane; Xia, Chun; She, Jin-Xiong			Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SYSTEMIC-SCLEROSIS; HIGH VALUES; TH1 CXCL10; MCP-1; POLYMORPHISM; EXPRESSION; ABSENCE; RISK; CRYOGLOBULINEMIA	Background: Chemokine (C-C motif) ligand 2 (CCL2), commonly known as monocyte chemoattractant protein-1 (MCP-1), has been implicated in the pathogenesis of many diseases characterized by monocytic infiltration. However, limited data have been reported on MCP-1 in type 1 diabetes (T1D) and the findings are inconclusive and inconsistent. Methods: In this study, MCP-1 was measured in the sera from 2,472 T1D patients and 2,654 healthy controls using a Luminex assay. The rs1024611 SNP in the promoter region of MCP-1 was genotyped for a subset of subjects (1764 T1D patients and 1323 controls) using the TaqMan-assay. Results: Subject age, sex or genotypes of MCP-1 rs1024611SNP did not have a major impact on serum MCP-1 levels in either healthy controls or patients. While hemoglobin A1c levels did not have a major influence on serum MCP-1 levels, the mean serum MCP-1 levels are significantly higher in patients with multiple complications (mean = 242 ng/ml) compared to patients without any complications (mean = 201 ng/ml) (p = 3.5x10(-6)). Furthermore, mean serum MCP-1 is higher in controls (mean = 261 ng/ml) than T1D patients (mean = 208 ng/ml) (p, 10 223). More importantly, the frequency of subjects with extremely high levels (> 99(th) percentile of patients or 955 ng/ml) of serum MCP-1 is significantly lower in the T1D group compared to the control group (odds ratio = 0.11, p < 10(-33)). Conclusion: MCP-1may have a dual role in T1D and its complications. While very high levels of serum MCP-1may be protective against the development of T1D, complications are associated with higher serum MCP-1 levels within the T1D group.	[Guan, Ruili] Nanjing Univ Technol, Inst Translat Med, Nanjing 210009, Jiangsu, Peoples R China; [Guan, Ruili] Nanjing Univ Technol, Sch Pharmaceut Sci, Nanjing 210009, Jiangsu, Peoples R China; [Guan, Ruili; Xia, Chun] China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Guan, Ruili; Purohit, Sharad; Wang, Hongjie; Steed, Leigh; Hopkins, Diane; Xia, Chun; She, Jin-Xiong] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Purohit, Sharad; She, Jin-Xiong] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA; [Reed, John Chip; Steed, R. Dennis] SE Endocrine & Diabet, Atlanta, GA USA; [Anderson, Stephen W.] Pediat Endocrine Associates, Atlanta, GA USA	Nanjing Tech University; Nanjing Tech University; China Agricultural University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Guan, RL (corresponding author), Nanjing Univ Technol, Inst Translat Med, Nanjing 210009, Jiangsu, Peoples R China.	jshe@georgiahealth.edu	Purohit, Sharad/ABA-8054-2021	Purohit, Sharad/0000-0003-0385-3829	National Institutes of Health [4R33HD050196, 4R33-DK069878, 2RO1HD37800]; JDRF [1-2004-661, JDRF 10-2006-792]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD050196, R33HD050196, R01HD037800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK069878, R21DK069878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (4R33HD050196, 4R33-DK069878 and 2RO1HD37800) and JDRF (1-2004-661) to JXS. Sharad Purohit was supported by a JDRF senior postdoctoral fellowship (JDRF 10-2006-792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Antonelli A, 2008, DIABETIC MED, V25, P1349, DOI 10.1111/j.1464-5491.2008.02577.x; Antonelli A, 2008, RHEUMATOLOGY, V47, P45, DOI 10.1093/rheumatology/kem313; Antonelli A, 2009, CLIN EXP RHEUMATOL, V27, P22; Antonelli A, 2009, DIGEST LIVER DIS, V41, P42, DOI 10.1016/j.dld.2008.04.009; Antonelli A, 2008, AUTOIMMUNITY, V41, P537, DOI 10.1080/08916930802170401; Antonelli A, 2008, METABOLISM, V57, P1270, DOI 10.1016/j.metabol.2008.04.023; Antonelli A, 2008, J RHEUMATOL, V35, P1809; Antonelli A, 2009, J INTERF CYTOK RES, V29, P345, DOI 10.1089/jir.2008.0090; Berman MA, 1996, J IMMUNOL, V157, P4690; Del Guerra S, 2010, TRANSPL P, V42, P2247, DOI 10.1016/j.transproceed.2010.05.039; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1997, J LEUKOCYTE BIOL, V62, P577, DOI 10.1002/jlb.62.5.577; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Harsimran K, 2009, DIABETES VASC DIS RE, V6, P288, DOI 10.1177/1479164109346364; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kiyici S, 2006, ARCH MED RES, V37, P998, DOI 10.1016/j.arcmed.2006.06.002; Kokkotou E, 2002, METABOLISM, V51, P1489, DOI 10.1053/meta.2002.34717; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Martinovic I, 2005, CIRC J, V69, P1484, DOI 10.1253/circj.69.1484; Mazur G, 2007, NEOPLASMA, V54, P285; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Park HJ, 2007, SCAND J RHEUMATOL, V36, P299, DOI 10.1080/03009740701288165; Piemonti L, 2009, DIABETES CARE, V32, P2105, DOI 10.2337/dc09-0763; Radstake TRDJ, 2009, HUM IMMUNOL, V70, P130, DOI 10.1016/j.humimm.2008.10.012; ROLLINS BJ, 1991, AM J PATHOL, V138, P1315; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Scarpini E, 2002, J NEUROL SCI, V195, P41, DOI 10.1016/S0022-510X(01)00680-3; Sia Charles, 2005, Rev Diabet Stud, V2, P182, DOI 10.1900/RDS.2005.2.182; Stankovic A, 2009, BRATISL MED J, V110, P641; Tarabra E, 2009, DIABETES, V58, P2109, DOI 10.2337/db08-0895; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Zineh I, 2009, DIABETES CARE, V32, P465, DOI 10.2337/dc08-1849; [No title captured]; [No title captured]	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e17822	10.1371/journal.pone.0017822	http://dx.doi.org/10.1371/journal.pone.0017822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532752	Green Published, gold, Green Submitted			2022-12-27	WOS:000289404700006
J	Mac Kenzie, WR; Heilig, CM; Bozeman, L; Johnson, JL; Muzanye, G; Dunbar, D; Jost, KC; Diem, L; Metchock, B; Eisenach, K; Dorman, S; Goldberg, S				Mac Kenzie, William R.; Heilig, Charles M.; Bozeman, Lorna; Johnson, John L.; Muzanye, Grace; Dunbar, Denise; Jost, Kenneth C., Jr.; Diem, Lois; Metchock, Beverly; Eisenach, Kathleen; Dorman, Susan; Goldberg, Stefan			Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DIABETES-MELLITUS; SPUTUM CONVERSION; INTENSIVE PHASE; MOXIFLOXACIN; ADULTS; SMEAR; DECONTAMINATION; ETHAMBUTOL	Background: Tuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2 clinical trial examining smear positive pulmonary Mycobacterium tuberculosis. Over the course of intensive phase therapy, patients from African sites had substantially delayed and lower rates of culture conversion to negative in liquid media compared to non-African patients. We explored potential explanations of this finding. Methods: In TBTC Study 28, protocol-correct patients (n = 328) provided spot sputum specimens for M. tuberculosis culture in liquid media, at baseline and weeks 2, 4, 6 and 8 of study therapy. We compared sputum culture conversion for African and non-African patients stratified by four baseline measures of disease severity: AFB smear quantification, extent of disease on chest radiograph, cavity size and the number of days to detection of M. tuberculosis in liquid media using the Kaplan-Meier product-limit method. We evaluated specimen processing and culture procedures used at 29 study laboratories serving 27 sites. Results: African TB patients had more extensive disease at enrollment than non-African patients. However, African patients with the least disease by the 4 measures of disease severity had conversion rates on liquid media that were substantially lower than conversion rates in non-African patients with the greatest extent of disease. HIV infection, smoking and diabetes did not explain delayed conversion in Africa. Some inter-site variation in laboratory processing and culture procedures within accepted practice for clinical diagnostic laboratories was found. Conclusions: Compared with patients from non-African sites, African patients being treated for TB had delayed sputum culture conversion and lower sputum conversion rates in liquid media that were not explained by baseline severity of disease, HIV status, age, smoking, diabetes or race. Further investigation is warranted into whether modest variation in laboratory processes substantially influences the efficacy outcomes of phase 2 TB treatment trials or if other factors (e.g., nutrition, host response) are involved.	[Mac Kenzie, William R.; Heilig, Charles M.; Bozeman, Lorna; Goldberg, Stefan] Ctr Dis Control, TB Trials Consortium, Div TB Eliminat, Atlanta, GA 30333 USA; [Johnson, John L.] Case Western Reserve Univ, Sch Med, TB Res Unit, Cleveland, OH USA; [Muzanye, Grace] Makerere Univ, Mulago Hosp, Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda; [Dunbar, Denise; Jost, Kenneth C., Jr.] Texas Dept State Hlth Serv, Mycobacteriol Mycol Lab, Austin, TX USA; [Diem, Lois; Metchock, Beverly] Ctr Dis Control, Branch Lab, Div TB Eliminat, Atlanta, GA 30333 USA; [Eisenach, Kathleen] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Dorman, Susan] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Case Western Reserve University; Case Western Reserve University; Makerere University; Mulago National Referral Hospital; Texas Department of State Health Services; Centers for Disease Control & Prevention - USA; University of Arkansas System; University of Arkansas Medical Sciences; Johns Hopkins University	Mac Kenzie, WR (corresponding author), Ctr Dis Control, TB Trials Consortium, Div TB Eliminat, Atlanta, GA 30333 USA.	wrm0@cdc.gov	Kenzie, William R Mac/F-1528-2013; Heilig, Charles M/C-2753-2008	Kenzie, William R Mac/0000-0001-7723-0339; Heilig, Charles M/0000-0003-1075-1310	Tuberculosis Trials Consortium	Tuberculosis Trials Consortium	Funding for this study was provided by the Tuberculosis Trials Consortium, CRB/DTBE/NCHHSTP/CDC. As a part of public scientific agency, CDC employees were directly involved in the study design, analysis, decision to publish and preparation of the manuscript.	Abal AT, 2005, RESP MED, V99, P415, DOI 10.1016/j.rmed.2004.08.016; Burdz TVN, 2003, DIAGN MICR INFEC DIS, V47, P503, DOI 10.1016/S0732-8893(03)00138-X; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Clinical and Laboratory Standards Institute (CLSI), 2008, LAB DET ID MYC APPR; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; FOX W, 1956, Tubercle, V37, P435; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Joloba ML, 2000, INT J TUBERC LUNG D, V4, P528; Maalej S, 2009, PRESSE MED, V38, P20, DOI 10.1016/j.lpm.2008.05.011; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Molhuizen HOF, 1998, METH MOL B, V101, P381, DOI 10.1385/0-89603-471-2:381; Peres RL, 2009, INT J TUBERC LUNG D, V13, P1572; Rekha VVB, 2007, INDIAN J MED RES, V126, P452; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Salihu HM, 2003, INT J TUBERC LUNG D, V7, P1070; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Telzak EE, 1998, CLIN INFECT DIS, V26, P775, DOI 10.1086/517133; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Weiner M, 2010, ANTIMICROB AGENTS CH, V54, P4192, DOI 10.1128/AAC.00353-10; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	27	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18358	10.1371/journal.pone.0018358	http://dx.doi.org/10.1371/journal.pone.0018358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494548	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100008
J	Maltby, S; Freeman, S; Gold, MJ; Baker, JHE; Minchinton, AI; Gold, MR; Roskelley, CD; McNagny, KM				Maltby, Steven; Freeman, Spencer; Gold, Matthew J.; Baker, Jennifer H. E.; Minchinton, Andrew I.; Gold, Michael R.; Roskelley, Calvin D.; McNagny, Kelly M.			Opposing Roles for CD34 in B16 Melanoma Tumor Growth Alter Early Stage Vasculature and Late Stage Immune Cell Infiltration	PLOS ONE			English	Article							MAST-CELLS; ALLERGEN EXPOSURE; SOLID TUMORS; ANGIOGENESIS; MICE; EOSINOPHILS; EXPRESSION; CARCINOGENESIS; ADHESION	Tumor growth and metastasis are determined by the complex interplay of factors, including those intrinsic to tumor cells and extrinsic factors associated with the tumor microenvironment. Our previous work demonstrated key roles for CD34 in the maintenance of vascular integrity and eosinophil and mast cell homing. Since both of these functions affect tumor development, we characterized the effect of CD34 ablation on tumor growth using the B16F1 melanoma model. Intriguingly, we found that CD34 plays a biphasic role in tumor progression. In early growth, both subcutaneous-injected tumors and intravenous-injected lung metastases grew more slowly in Cd34(-/-) mice. This correlated with abnormal vessel morphology and increased vascular permeability in these mice. Bone marrow transplantation experiments confirmed that this reflects a non-hematopoietic function of CD34. At later stages, subcutaneous tumor growth was accelerated in Cd34(-/-) mice and surpassed growth in wildtype mice. Bone marrow chimera experiments demonstrated this difference was due to a hematopoietic function for CD34 and, correspondingly we found reduced intra-tumor mast cell numbers in Cd34(-/-) mice. In aggregate, our analysis reveals a novel role for CD34 in both early and late tumor growth and provides novel insights into the role of the tumor microenvironment in tumor progression.	[Maltby, Steven; Gold, Matthew J.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Freeman, Spencer; Gold, Michael R.; Roskelley, Calvin D.] Univ British Columbia, I3 Grp, Vancouver, BC, Canada; [Freeman, Spencer; Gold, Michael R.; Roskelley, Calvin D.] Univ British Columbia, CELL Res Grp, Vancouver, BC, Canada; [Baker, Jennifer H. E.; Minchinton, Andrew I.] Univ British Columbia, Dept Med Biophys, British Columbia Canc Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Maltby, S (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	kelly@brc.ubc.ca	Gold, Michael/AAF-2081-2021; MALTBY, STEVEN/G-8368-2013; McNagny, Kelly/P-5239-2014; Roskelley, Calvin D/F-4630-2011; Hughes, Michael/N-6039-2015	Gold, Michael/0000-0003-1222-3191; McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Maltby, Steven/0000-0003-1240-5964	CIHR [MIF-79631/M0P-84545]; AllerGen [3.14]; Centre for Blood Research (CBR); CIHR/Michael Smith Foundation for Health Research (MSFHR); AllerGen's Canadian Allergy and Immune Diseases Advanced Training Initiative (CAIDATI)	CIHR(Canadian Institutes of Health Research (CIHR)); AllerGen; Centre for Blood Research (CBR); CIHR/Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); AllerGen's Canadian Allergy and Immune Diseases Advanced Training Initiative (CAIDATI)	Research was funded through the following sources: CIHR Grant #MIF-79631/M0P-84545; AllerGen Grant #3.14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr Chris Parish for providing the B16F1-OVA cells, Takahide Murakami for genotyping, Lori Zbytnuik for technical expertise, Vicki MacDonald for producing the model figure and the BRC Animal Care Facility. SM held a Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation of Canada Transfusion Science Fellowship from the Centre for Blood Research (CBR) and MG holds fellowships from the CIHR/Michael Smith Foundation for Health Research (MSFHR) Transplantation Training Program and AllerGen's Canadian Allergy and Immune Diseases Advanced Training Initiative (CAIDATI). KMM is a MSFHR Scholar (Senior) and CBR Member.	Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Blanchet MR, 2007, BLOOD, V110, P2005, DOI 10.1182/blood-2006-12-062448; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Chen L, 2009, BIOCHEM BIOPH RES CO, V386, P374, DOI 10.1016/j.bbrc.2009.06.042; Cormier SA, 2006, J LEUKOCYTE BIOL, V79, P1131, DOI 10.1189/jlb.0106027; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; DELIA D, 1993, BLOOD, V81, P1001; Drew E, 2005, BLOOD, V106, P1885, DOI 10.1182/blood-2005-03-1291; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Freeman SA, 2010, CANCER RES, V70, P4590, DOI 10.1158/0008-5472.CAN-09-3414; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Murakami J, 2009, INT J CANCER, V124, P1685, DOI 10.1002/ijc.24085; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Quon H, 2010, J NEURO-ONCOL, V96, P277, DOI 10.1007/s11060-009-9961-x; Radinger M, 2004, J ALLERGY CLIN IMMUN, V113, P1109, DOI 10.1016/j.jaci.2004.03.022; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; STARKEY JR, 1988, INT J CANCER, V42, P48, DOI 10.1002/ijc.2910420110; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Tardio JC, 2008, J CUTAN PATHOL, V35, P1079, DOI 10.1111/j.1600-0560.2008.01124.x; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128	31	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18160	10.1371/journal.pone.0018160	http://dx.doi.org/10.1371/journal.pone.0018160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494591	Green Submitted, Green Published, gold			2022-12-27	WOS:000289354100005
J	Rodriguez, I				Rodriguez, Isabel			Drosophila TIEG Is a Modulator of Different Signalling Pathways Involved in Wing Patterning and Cell Proliferation	PLOS ONE			English	Article							INDUCIBLE EARLY GENE; FINGER TRANSCRIPTION FACTOR; MORPHOGEN GRADIENT; GROWTH-REGULATION; IMAGINAL DISCS; DPP TARGETS; BETA; IDENTIFICATION; BRINKER; BMP	Acquisition of a final shape and size during organ development requires a regulated program of growth and patterning controlled by a complex genetic network of signalling molecules that must be coordinated to provide positional information to each cell within the corresponding organ or tissue. The mechanism by which all these signals are coordinated to yield a final response is not well understood. Here, I have characterized the Drosophila ortholog of the human TGF-beta Inducible Early Gene 1 (dTIEG). TIEG are zinc-finger proteins that belong to the Kruppel-like factor (KLF) family and were initially identified in human osteoblasts and pancreatic tumor cells for the ability to enhance TGF-beta response. Using the developing wing of Drosophila as "in vivo" model, the dTIEG function has been studied in the control of cell proliferation and patterning. These results show that dTIEG can modulate Dpp signalling. Furthermore, dTIEG also regulates the activity of JAK/STAT pathway suggesting a conserved role of TIEG proteins as positive regulators of TGF-beta signalling and as mediators of the crosstalk between signalling pathways acting in a same cellular context.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez, I (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	irodriguez@cbm.uam.es	Rodriguez, Isabel/J-2636-2017	Rodriguez, Isabel/0000-0002-7322-4756	Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Fundacion Areces	Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Fundacion Areces(Comunidad de MadridMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Fundacion Areces. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alvarez-Rodiguez R, 2007, J BIOL CHEM, V282, P37170, DOI 10.1074/jbc.M705414200; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675; Estella C, 2003, DEVELOPMENT, V130, P5929, DOI 10.1242/dev.00832; Gohla G, 2008, J CELL BIOCHEM, V104, P850, DOI 10.1002/jcb.21669; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Johnsen SA, 2002, J CELL BIOCHEM, V87, P233, DOI 10.1002/jcb.10299; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Lopez-Onieva L, 2008, DEVELOPMENT, V135, P533, DOI 10.1242/dev.016121; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Miyake M, 2010, BIOCHEM BIOPH RES CO, V393, P762, DOI 10.1016/j.bbrc.2010.02.077; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Munoz-Descalzo S, 2007, DEV GENES EVOL, V217, P289, DOI 10.1007/s00427-007-0144-5; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Parker L, 2004, PROG MOLEC, V34, P73; PFLUGFELDER GO, 1990, GENETICS, V126, P91; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sander V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010383; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spittau B, 2007, J CELL BIOCHEM, V101, P712, DOI 10.1002/jcb.21228; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2010, BIOCHEM BIOPH RES CO, V392, P72, DOI 10.1016/j.bbrc.2009.12.171; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Terriente-Felix A, 2010, GENETICS, V185, P671, DOI 10.1534/genetics.109.113670; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Wang ZY, 2004, GENE, V325, P25, DOI 10.1016/j.gene.2003.09.045; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	59	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18418	10.1371/journal.pone.0018418	http://dx.doi.org/10.1371/journal.pone.0018418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494610	Green Published, gold			2022-12-27	WOS:000289292800015
J	Menoni, V; Lucas, N; Leforestier, JF; Doz, F; Chatellier, G; Jacqz-Aigain, E; Giraud, C; Treluyer, JM; Chappuy, H				Menoni, Veronique; Lucas, Noel; Leforestier, Jean-Francois; Doz, Francois; Chatellier, Gilles; Jacqz-Aigain, Evelyne; Giraud, Carole; Treluyer, Jean-Marc; Chappuy, Helene			Readability of the Written Study Information in Pediatric Research in France	PLOS ONE			English	Article							INFORMED-CONSENT FORMS; BIOMEDICAL-RESEARCH; CLINICAL-TRIALS; STANDARDS; ASSENT; HEALTH	Background: The aim was to evaluate the readability of research information leaflets (RIL) for minors asked to participate in biomedical research studies and to assess the factors influencing this readability. Methods and Findings: All the pediatric protocols from three French pediatric clinical research units were included (N = 104). Three criteria were used to evaluate readability: length of the text, Flesch's readability score and presence of illustrations. We compared the readability of RIL to texts specifically written for children (school textbooks, school exams or extracts from literary works). We assessed the effect of protocol characteristics on readability. The RIL had a median length of 608 words [350 words, 25(th) percentile; 1005 words, 75(th) percentile], corresponding to two pages. The readability of the RIL, with a median Flesch score of 40 [30; 47], was much poorer than that of pediatric reference texts, with a Flesch score of 67 [60; 73]. A small proportion of RIL (13/91; 14%) were illustrated. The RIL were longer (p<0.001), more readable (p<0.001) and more likely to be illustrated (p<0.009) for industrial than for institutional sponsors. Conclusion: Researchers should routinely compute the reading ease of study information sheets and make greater efforts to improve the readability of written documents for potential participants.	[Menoni, Veronique; Giraud, Carole; Treluyer, Jean-Marc; Chappuy, Helene] Hop Necker Enfants Malad, AP HP, Unite Rech Clin Paris Ctr, Paris, France; [Menoni, Veronique; Chappuy, Helene] Univ Paris 05, Lab Eth Med, Paris, France; [Menoni, Veronique; Giraud, Carole; Treluyer, Jean-Marc] Univ Paris 05, Hop Necker Enfants Malad, AP HP, INSERM,CIC Mere Enfant P0901, Paris, France; [Lucas, Noel; Leforestier, Jean-Francois; Chatellier, Gilles] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, CIC Inserm E4, Paris, France; [Doz, Francois] Univ Paris 05, Inst Curie, Serv Pediat, Paris, France; [Jacqz-Aigain, Evelyne] Hop Robert Debre, AP HP, Ctr Invest Clin Inserm 9202, F-75019 Paris, France; [Treluyer, Jean-Marc] Grp Hosp Broca Cochin Hotel Dieu, AP HP, Paris, France; [Giraud, Carole; Treluyer, Jean-Marc; Chappuy, Helene] Univ Paris 05, EA3620, Paris, France; [Chappuy, Helene] Hop Necker Enfants Malad, AP HP, Serv Urgences Pediat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Menoni, V (corresponding author), Hop Necker Enfants Malad, AP HP, Unite Rech Clin Paris Ctr, Paris, France.	helene.chappuy@nck.aphp.fr	treluyer, Jean-Marc/F-8036-2010; Doz, Francois P/K-8616-2012	Doz, Francois/0000-0001-9286-4831	Assistance Publique des Hopitaux de Paris as a Programme Hospitalier de Recherche Clinique	Assistance Publique des Hopitaux de Paris as a Programme Hospitalier de Recherche Clinique	This study was funded by the Assistance Publique des Hopitaux de Paris as a Programme Hospitalier de Recherche Clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung WY, 2010, AM J CLIN ONCOL-CANC, V33, P387, DOI 10.1097/COC.0b013e3181b20641; Christopher PP, 2007, PSYCHIAT SERV, V58, P227, DOI 10.1176/appi.ps.58.2.227; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; GRUNDNER TM, 1980, NEW ENGL J MED, V302, P900, DOI 10.1056/NEJM198004173021606; HOPPER KD, 1995, AM J ROENTGENOL, V164, P493, DOI 10.2214/ajr.164.2.7839996; Houts PS, 2001, PATIENT EDUC COUNS, V43, P231, DOI 10.1016/S0738-3991(00)00171-3; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; Kimberly MB, 2006, PEDIATRICS, V117, P1706, DOI 10.1542/peds.2005-1233; Mader TJ, 1997, ANN EMERG MED, V29, P534, DOI 10.1016/S0196-0644(97)70229-4; MENONI V, 2010, PLOS ONE, V11, P5; MORROW GR, 1980, JAMA-J AM MED ASSOC, V244, P56, DOI 10.1001/jama.244.1.56; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Paris A, 2005, PRESSE MED, V34, P13, DOI 10.1016/S0755-4982(05)83877-1; PHILIPSON SJ, 1995, J INVEST MED, V43, P459; Sanders LM, 2009, ARCH PEDIAT ADOL MED, V163, P131, DOI 10.1001/archpediatrics.2008.539; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Tait AR, 2007, ANESTH ANALG, V105, P358, DOI 10.1213/01.ane.0000270326.44507.11; TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58; White LJ, 1996, ACAD EMERG MED, V3, P745, DOI 10.1111/j.1553-2712.1996.tb03509.x; Whittle A, 2004, PEDIATRICS, V113, P1747, DOI 10.1542/peds.113.6.1747; World Health Organization, 1981, WHO CIOMS GUID PROP	22	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18484	10.1371/journal.pone.0018484	http://dx.doi.org/10.1371/journal.pone.0018484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494689	gold, Green Submitted, Green Published			2022-12-27	WOS:000289192400031
J	Meijaard, E; Mengersen, K; Buchori, D; Nurcahyo, A; Ancrenaz, M; Wich, S; Atmoko, SSU; Tjiu, A; Prasetyo, D; Nardiyono; Hadiprakarsa, Y; Christy, L; Wells, J; Albar, G; Marshall, AJ				Meijaard, Erik; Mengersen, Kerrie; Buchori, Damayanti; Nurcahyo, Anton; Ancrenaz, Marc; Wich, Serge; Atmoko, Sri Suci Utami; Tjiu, Albertus; Prasetyo, Didik; Nardiyono; Hadiprakarsa, Yokyok; Christy, Lenny; Wells, Jessie; Albar, Guillaume; Marshall, Andrew J.			Why Don't We Ask? A Complementary Method for Assessing the Status of Great Apes	PLOS ONE			English	Article							TROPICAL CONSERVATION; POPULATION-DENSITY; PONGO-PYGMAEUS; AERIAL SURVEYS; ORANGUTANS; SUMATRA; TRENDS; BIODIVERSITY; KALIMANTAN; KNOWLEDGE	Species conservation is difficult. Threats to species are typically high and immediate. Effective solutions for counteracting these threats, however, require synthesis of high quality evidence, appropriately targeted activities, typically costly implementation, and rapid re-evaluation and adaptation. Conservation management can be ineffective if there is insufficient understanding of the complex ecological, political, socio-cultural, and economic factors that underlie conservation threats. When information about these factors is incomplete, conservation managers may be unaware of the most urgent threats or unable to envision all consequences of potential management strategies. Conservation research aims to address the gap between what is known and what knowledge is needed for effective conservation. Such research, however, generally addresses a subset of the factors that underlie conservation threats, producing a limited, simplistic, and often biased view of complex, real world situations. A combination of approaches is required to provide the complete picture necessary to engage in effective conservation. Orangutan conservation (Pongo spp.) offers an example: standard conservation assessments employ survey methods that focus on ecological variables, but do not usually address the socio-cultural factors that underlie threats. Here, we evaluate a complementary survey method based on interviews of nearly 7,000 people in 687 villages in Kalimantan, Indonesia. We address areas of potential methodological weakness in such surveys, including sampling and questionnaire design, respondent biases, statistical analyses, and sensitivity of resultant inferences. We show that interview-based surveys can provide cost-effective and statistically robust methods to better understand poorly known populations of species that are relatively easily identified by local people. Such surveys provide reasonably reliable estimates of relative presence and relative encounter rates of such species, as well as quantifying the main factors that threaten them. We recommend more extensive use of carefully designed and implemented interview surveys, in conjunction with more traditional field methods.	[Meijaard, Erik] People & Nat Consulting Int, Bali, Indonesia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Palaeoanthropol, Canberra, ACT, Australia; [Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Buchori, Damayanti; Nardiyono; Hadiprakarsa, Yokyok; Christy, Lenny] Nature Conservancy, Indonesia Program, Jakarta, Indonesia; [Nurcahyo, Anton] Borneo Orangutan Survival Fdn, Orangutan Reintro Program Cent Kalimantan, Palangka Raya, Indonesia; [Ancrenaz, Marc] Kinabatangan Orang Utan Conservat Project, Sandakan, Sabah, Malaysia; [Wich, Serge] Sumatran Orangutan Conservat Program PanEco YEL, Medan, Indonesia; [Wich, Serge] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Atmoko, Sri Suci Utami] Univ Nas, Fak Biol, Jakarta, Indonesia; [Atmoko, Sri Suci Utami; Prasetyo, Didik] Perhimpunan Ahli Dan Pemerhati Primata Indonesia, Bogor, Indonesia; [Tjiu, Albertus] World Wide Fund Nat Indonesia, Pontianak, Indonesia; [Wells, Jessie] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Albar, Guillaume] Soc Ornithol Polynesie, Taravao, Tahiti, France; [Marshall, Andrew J.] Univ Calif Davis, Grad Grp Ecol, Dept Anthropol, Davis, CA 95616 USA; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Anim Behav Grad Grp, Davis, CA 95616 USA	People & Nature Consulting International; Australian National University; Queensland University of Technology (QUT); The Nature Conservancy Indonesia; University of Zurich; Universitas Nasional Pionir Perubahan; University of Queensland; University of California System; University of California Davis; University of California System; University of California Davis	Meijaard, E (corresponding author), People & Nat Consulting Int, Bali, Indonesia.	emeijaard@pnc-int.com	Mengersen, Kerrie/AHC-4096-2022; Meijaard, Erik/A-2687-2016; Buchori, Damayanti/L-5878-2017; Wells, Jessie A/F-7318-2010	Meijaard, Erik/0000-0001-8685-3685; Buchori, Damayanti/0000-0002-2843-0737; Wells, Jessie A/0000-0002-3555-5108; Mengersen, Kerrie/0000-0001-8625-9168; Prasetyo, Didik/0000-0001-5486-2624; Wich, Serge/0000-0003-3954-5174; Hadiprakarsa, Yokyok/0000-0001-5186-6742	Nature Conservancy's Adopt and Acre program; United States Agency for International Development (USAID); Sall Family Foundation; Indonesian Ministry of Forestry	Nature Conservancy's Adopt and Acre program; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Sall Family Foundation(European Commission); Indonesian Ministry of Forestry(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	The studies were financially supported by donors of the Nature Conservancy's Adopt and Acre program, the United States Agency for International Development (USAID) (www.usaid.gov/), and the Sall Family Foundation, who paid the salaries of Erik Meijaard and Nardiyono. USAID agreed to the study being conducted. USAID, the Sall Family Foundation, and PNCI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the 18 NGOs who conducted the surveys, the Directorate General for Forest Protection and Nature Conservation (PHKA) of the Indonesian Ministry of Forestry for their support, and our many interview respondents for providing their time and knowledge.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Anderman E., 2006, PSYCHOL ACAD CHEATIN; [Anonymous], 1985, J OFF STAT; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Boyko RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010754; Brncic TM., 2010, SIERRA LEONE NATL CH; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; CHAMBLESS LE, 1985, COMMUN STAT-THEOR M, V14, P1377, DOI 10.1080/03610928508828982; Connelly N.A., 2000, HUM DIMENS WILDL, V5, P19, DOI DOI 10.1080/10871200009359192; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; FREY R, 1978, BIOTROP SPECIAL PUBL, P199; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Groves RM., 2011, SURV METHODOL; Hellier A, 1999, BIODIVERS CONSERV, V8, P869, DOI 10.1023/A:1008862005556; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones JPG, 2008, J APPL ECOL, V45, P1205, DOI 10.1111/j.1365-2664.2008.01487.x; Kainer KA, 2006, CONSERV BIOL, V20, P3, DOI 10.1111/j.1523-1739.2006.00356.x; Kroll AJ, 2007, J WILDLIFE MANAGE, V71, P226, DOI 10.2193/2005-714; Lury, 1987, DATA COLLECTION DEV; MARSHALL AJ, 2008, ASSESSING ACCURACY S; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; Marshall AJ, 2009, ORYX, V43, P416, DOI 10.1017/S0030605309001513; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; Meijaard E, 2007, BIODIVERS CONSERV, V16, P3053, DOI 10.1007/s10531-007-9161-y; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Muir MJ, 2009, CONSERV BIOL, V23, P1357, DOI 10.1111/j.1523-1739.2009.01325.x; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Nyhus PJ, 2003, ENVIRON CONSERV, V30, P192, DOI 10.1017/S0376892903000183; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Rijksen HD, 1999, OUR VANISHING RELATI; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; SINGLETON I, 2004, ORANGUTAN P IN PRESS; Singleton I., 2004, ORANGUTAN POPULATION; Spehar SN, 2010, BIOTROPICA, V42, P748, DOI 10.1111/j.1744-7429.2010.00651.x; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; TILSON R, 1993, OR UT POP HAB QUAL A; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; van der Hoeven Christiaan A., 2004, Journal for Nature Conservation (Jena), V12, P193, DOI 10.1016/j.jnc.2004.06.003; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Whitten T, 2001, CONSERV BIOL, V15, P1, DOI 10.1046/j.1523-1739.2001.01_01.x; Wich S. A., 2009, ORANGUTANS GEOGRAPHI; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Zhang YH, 2010, NATURE, V467, P153, DOI 10.1038/467153d	50	41	47	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18008	10.1371/journal.pone.0018008	http://dx.doi.org/10.1371/journal.pone.0018008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483859	Green Published, Green Accepted, gold			2022-12-27	WOS:000289057200018
J	Chen, JQ; Lee, SK; Abd-Elgaliel, WR; Liang, LF; Galende, EY; Hajjar, RJ; Tung, CH				Chen, Jiqiu; Lee, Seung Koo; Abd-Elgaliel, Wael R.; Liang, Lifan; Galende, Elisa-Yaniz; Hajjar, Roger J.; Tung, Ching-Hsuan			Assessment of Cardiovascular Fibrosis Using Novel Fluorescent Probes	PLOS ONE			English	Article							HEART-FAILURE; DIASTOLIC DYSFUNCTION; GENE-TRANSFER; HUG MODEL; COLLAGEN; HYPERTROPHY; BINDING; MECHANISMS; DISEASE	Cardiovascular fibrosis resulted from pressure overload or ischemia could alter myocardial stiffness and lead to ventricular dysfunction. Fluorescently labeled collagen-binding protein CNA 35, derived from the surface component of Staphylococcus aureus, and a novel synthetic biphenylalanine containing peptide are applied to stain fibrosis associated collagen and myocytes, respectively. Detailed pathological characteristics of cardiovascular fibrosis could be identified clearly in 2 hours. This staining pair requires only simple staining and brief washing, generating less than 10 ml of waste. The image information collected by this novel fluorescent staining pair is compatible with it collected by the traditional Masson's Trichrome and Picrosirius Red staining which are widely used to stain cardiovascular fibrosis and isolated cells.	[Chen, Jiqiu; Liang, Lifan; Galende, Elisa-Yaniz; Hajjar, Roger J.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Lee, Seung Koo; Abd-Elgaliel, Wael R.; Tung, Ching-Hsuan] Cornell Univ, Methodist Hosp, Weill Med Coll, Dept Radiol,Res Inst, Houston, TX USA	Icahn School of Medicine at Mount Sinai; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Chen, JQ (corresponding author), Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA.	Roger.hajjar@mssm.edu; ctung@tmhs.org	Tung, Ching-Hsuan/AIE-6009-2022; Lee, Seung Koo/GMX-2610-2022; Tung, Ching-Hsuan/AHC-5070-2022	Tung, Ching-Hsuan/0000-0001-6648-6195; Lee, Seung Koo/0000-0001-9279-8176; Tung, Ching-Hsuan/0000-0001-6648-6195	National Institutes of Health [R01HL088434, R01HL093183, P20HL100396, CA135312]; Transatlantic Leducq Foundation; NATIONAL CANCER INSTITUTE [R01CA135312] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL100396, R01HL093183, R01HL088434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transatlantic Leducq Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Institutes of Health R01HL088434, R01HL093183, P20HL100396 (RJH), CA135312 (CHT), and the Transatlantic Leducq Foundation (RJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5; Burlew BS, 2002, HERZ, V27, P92, DOI 10.1007/s00059-002-2354-y; Chen JQ, 2010, AM J PATHOL, V176, P1705, DOI 10.2353/ajpath.2010.090451; Gradman AH, 2006, PROG CARDIOVASC DIS, V48, P326, DOI 10.1016/j.pcad.2006.02.001; Helms BA, 2009, J AM CHEM SOC, V131, P11683, DOI 10.1021/ja902285m; Huq F, 2004, CIRCULATION, V109, P2780, DOI 10.1161/01.CIR.0000131764.62242.96; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Megens RTA, 2007, MOL IMAGING, V6, P247, DOI 10.2310/7290.2007.00021; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Sanders HMHF, 2009, CONTRAST MEDIA MOL I, V4, P81, DOI 10.1002/cmmi.266; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	19	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19097	10.1371/journal.pone.0019097	http://dx.doi.org/10.1371/journal.pone.0019097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533060	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400057
J	Zhang, Z; Zhang, P; Hu, HY				Zhang, Zhen; Zhang, Peng; Hu, Huaiyu			LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to alpha-Dystroglycan Conferring Laminin Binding	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCAN; CONGENITAL MUSCULAR-DYSTROPHY; HUMAN LARGE GENE; FUNCTIONAL-ANALYSIS; BRAIN; PROTEIN; MUTATIONS; OLIGOSACCHARIDES; GLYCOSYLTRANSFERASE	Mutations in genes encoding glycosyltransferases (and presumed glycosyltransferases) that affect glycosylation and extracellular matrix binding activity of alpha-dystroglycan (alpha-DG) cause congenital muscular dystrophies (CMDs) with central nervous system manifestations. Among the identified genes, LARGE is of particular interest because its overexpression rescues glycosylation defects of a-DG in mutations of not only LARGE but also other CMD-causing genes and restores laminin binding activity of a-DG. It is not known whether LARGE protein glycosylates other proteins in addition to alpha-DG. In this study, we overexpressed LARGE in DG-deficient cells and analyzed glycosylated proteins by Western blot analysis. Surprisingly, overexpression of LARGE in alpha-DG-deficient cells led to glycosylation dependent IIH6C4 and VIA4-1 immunoreactivity, despite the prevailing view that these antibodies only recognize glycosylated alpha-DG. Furthermore, the hyperglycosylated proteins in LARGE-overexpressing cells demonstrated the functional capacity to bind the extracellular matrix molecule laminin and promote laminin assembly at the cell surface, an effect that was blocked by IIH6C4 antibodies. These results indicate that overexpression of LARGE catalyzes the glycosylation of at least one other glycoprotein in addition to alpha-DG, and that this glycosylation(s) promotes laminin binding activity.	[Zhang, Zhen; Zhang, Peng; Hu, Huaiyu] Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Zhang, Z (corresponding author), Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA.	huh@upstate.edu			National Institutes of Health [HD060458, NS066582]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health grants (HD060458 and NS066582 to H. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brown SC, 1999, J CELL SCI, V112, P209; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; Currier SC, 2005, AM J MED GENET A, V133A, P53, DOI 10.1002/ajmg.a.30487; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Bernabe DBV, 2003, J MED GENET, V40, P845; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Fujimura K, 2005, BIOCHEM BIOPH RES CO, V329, P1162, DOI 10.1016/j.bbrc.2005.02.082; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Hu HY, 2011, NEUROSCI LETT, V489, P10, DOI 10.1016/j.neulet.2010.11.056; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2010, J BIOL CHEM, V285, P31208, DOI 10.1074/jbc.M110.116343; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kim DS, 2004, NEUROLOGY, V62, P1009, DOI 10.1212/01.WNL.0000115386.28769.65; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang WL, 2002, BIOCHEM J, V361, P153, DOI 10.1042/0264-6021:3610153	61	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19080	10.1371/journal.pone.0019080	http://dx.doi.org/10.1371/journal.pone.0019080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533062	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400056
J	Funato, H; Oda, S; Yokofujita, J; Igarashi, H; Kuroda, M				Funato, Hiromasa; Oda, Satoko; Yokofujita, Junko; Igarashi, Hiroaki; Kuroda, Masaru			Fasting and High-Fat Diet Alter Histone Deacetylase Expression in the Medial Hypothalamus	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; EPIGENETIC REGULATION; LEPTIN RESISTANCE; INDUCED OBESITY; FOOD-INTAKE; FEMALE RAT; NEURONS; HDAC10; TRANSCRIPTION; REPRODUCTION	Increasing attention is now being given to the epigenetic regulation of animal and human behaviors including the stress response and drug addiction. Epigenetic factors also influence feeding behavior and metabolic phenotypes, such as obesity and insulin sensitivity. In response to fasting and high-fat diets, the medial hypothalamus changes the expression of neuropeptides regulating feeding, metabolism, and reproductive behaviors. Histone deacetylases (HDACs) are involved in the epigenetic control of gene expression and alter behavior in response to a variety of environmental factors. Here, we examined the expression of HDAC family members in the medial hypothalamus of mice in response to either fasting or a high-fat diet. In response to fasting, HDAC3 and -4 expression levels increased while HDAC10 and -11 levels decreased. Four weeks on a high-fat diet resulted in the increased expression of HDAC5 and -8. Moreover, fasting decreased the number of acetylated histone H3- and acetylated histone H4-positive cells in the ventrolateral subdivision of the ventromedial hypothalamus. Therefore, HDACs may be implicated in altered gene expression profiles in the medial hypothalamus under different metabolic states.	[Funato, Hiromasa; Oda, Satoko; Yokofujita, Junko; Igarashi, Hiroaki; Kuroda, Masaru] Toho Univ, Sch Med, Dept Anat, Tokyo, Japan	Toho University	Funato, H (corresponding author), Toho Univ, Sch Med, Dept Anat, Tokyo, Japan.	hiromasa.funato@med.toho-u.ac.jp	Satoko, Oda/J-8508-2016	Funato, Hiromasa/0000-0002-2787-9700	Toho University School of Medicine; Tanita Healthy Weight Community Trust; Ministry of Education, Culture, Sports, Science and Technology of Japan [22590228]	Toho University School of Medicine(Toho University); Tanita Healthy Weight Community Trust; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Project Research from Toho University School of Medicine (H. F.; http://www.med.toho-u.ac.jp/), a Grant-in-Aid for Research from the Tanita Healthy Weight Community Trust (H. F.; http://www.tanita-grant.com/), and a Grant-in-Aid for Scientific Research (C) 22590228 (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/grants.html). These funders gave the authors financial support to proceed with their project which they designed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Jones JE, 2002, PHYSIOL BEHAV, V77, P19, DOI 10.1016/S0031-9384(02)00780-1; Kaelin CB, 2006, MOL ENDOCRINOL, V20, P2591, DOI 10.1210/me.2006-0107; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Northrop LE, 2008, ENDOCRINOLOGY, V149, P836, DOI 10.1210/en.2007-1040; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	41	67	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18950	10.1371/journal.pone.0018950	http://dx.doi.org/10.1371/journal.pone.0018950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526203	Green Published, gold, Green Submitted			2022-12-27	WOS:000289578600041
J	Barba, I; del Blanco, BG; Abdul-Jawad, O; Barrabes, JA; Marti, G; Domingo, E; Angel, J; Garcia-Dorado, D				Barba, Ignasi; Garcia del Blanco, Bruno; Abdul-Jawad, Omar; Barrabes, Jose A.; Marti, Gerard; Domingo, Enric; Angel, Joan; Garcia-Dorado, David			MRI Discriminates Thrombus Composition and ST Resolution after Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ATHEROSCLEROTIC PLAQUE; PRIMARY ANGIOPLASTY; ARTERIAL THROMBUS; RUPTURE; DEATH	Histological composition of material obtained by thrombus aspiration during percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) is highly variable. We aimed to characterize this material using magnetic resonance imaging (MRI) and to correlate MRI findings with the success of PCI in terms of ST-segment resolution. Thrombus aspiration during primary or rescue PCI was attempted in 100 consecutive STEMI patients, of whom enough material for MRI was obtained in 59. MR images were obtained at 9.4T and T1 and T2 values were measured. Patients with (n = 31) and without (n = 28) adequate ST resolution 120 min after PCI (>= 70% of pre-PCI value) had similar baseline characteristics except for a higher prevalence of diabetes mellitus in the latter (10 vs. 43%, p = 0.003). T1 values were similar in both groups (1248 +/- 112 vs. 1307 +/- 85 ms, respectively, p = 0.7). T2 values averaged 31.2 +/- 10.3 and 36.6 +/- 12.2 ms; in thrombus from patients with and without adequate ST resolution (p = 0.09). After adjusting for diabetes and other baseline characteristics, lower T2 values were significantly associated with inadequate ST resolution (odds ratio for 1 ms increase 1.08, CI 95% 1.01-1.16, p = 0.027). Histology classified thrombus in 3 groups: coagulated blood (n = 38), fibrin rich (n = 9) and lipid-rich (n = 3). Thrombi composed mostly of coagulated blood were characterized as being of short (n = 10), intermediate (n = 15) or long evolution (n = 13), T2 values being 34.0 +/- 13.2, 31.9 +/- 8.3 and 31.5 +/- 7.9 ms respectively (p = NS). In this subgroup, T2 was significantly higher in specimens from patients with inadequate perfusion (35.9 +/- 10.3 versus 28.6 +/- 6.7 ms, p = 0.02). This can be of clinical interest as it provides information on the probability of adequate ST resolution, a surrogate for effective myocardial reperfusion.	[Barba, Ignasi] Univ Autonoma Barcelona, Dept Cardiol, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Res Inst, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Barba, I (corresponding author), Univ Autonoma Barcelona, Dept Cardiol, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain.	dgdorado@vhebron.net	Barba, Ignasi/A-5221-2011; Barba, Ignasi/H-5104-2013	Barba, Ignasi/0000-0001-9886-3776; Garcia del Blanco, Bruno/0000-0002-4527-1600; Barrabes, Jose A./0000-0001-7062-6277	Spanish Ministries of Science [SAF2008-03067]; Redes tematicas de investigacion cooperativa sanitaria-Red investigacion enfermedades cardiovasculares, RETICS-RECAVA [RD06/0014/0025]; Ramon y Cajal fellowship	Spanish Ministries of Science; Redes tematicas de investigacion cooperativa sanitaria-Red investigacion enfermedades cardiovasculares, RETICS-RECAVA; Ramon y Cajal fellowship(Spanish Government)	This work was supported by the Spanish Ministries of Science (SAF2008-03067 and Redes tematicas de investigacion cooperativa sanitaria-Red investigacion enfermedades cardiovasculares, RETICS-RECAVA, RD06/0014/0025); I. Barba is a recipient of a Ramon y Cajal fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corti R, 2006, PHARMACOL THERAPEUT, V110, P57, DOI 10.1016/j.pharmthera.2005.09.004; Corti R, 2002, J AM COLL CARDIOL, V39, P1366, DOI 10.1016/S0735-1097(02)01754-0; Corti R, 2001, CIRCULATION, V103, P2420; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; FALK E, 1983, BRIT HEART J, V50, P127; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Fayad ZA, 2001, CIRC RES, V89, P305, DOI 10.1161/hh1601.095596; Fuster V, 2005, CIRCULATION, V112, P135, DOI 10.1161/01.CIR.0000155618.37779.A0; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hore P.J., 1995, NUCL MAGNETIC RESONA; Jaffe R, 2009, J AM COLL CARDIOL, V53, P1148, DOI 10.1016/j.jacc.2008.09.064; Kawasaki T, 2009, JACC-CARDIOVASC IMAG, V2, P720, DOI 10.1016/j.jcmg.2009.01.016; Kelle S, 2009, MAGN RESON IMAGING C, V17, P145, DOI 10.1016/j.mric.2008.12.003; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Kramer MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005817; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Ojio S, 2000, CIRCULATION, V102, P2063, DOI 10.1161/01.CIR.102.17.2063; Prasad A, 2005, J AM COLL CARDIOL, V45, P508, DOI 10.1016/j.jacc.2004.10.054; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Sharma Rakesh, 2004, Thromb J, V2, P5, DOI 10.1186/1477-9560-2-5; Shinnar M, 1999, ARTERIOSCL THROM VAS, V19, P2756, DOI 10.1161/01.ATV.19.11.2756; Sirol M, 2005, CIRCULATION, V112, P1594, DOI 10.1161/CIRCULATIONAHA.104.522110; Stuber M, 1999, J AM COLL CARDIOL, V34, P524, DOI 10.1016/S0735-1097(99)00223-5; Stuber M, 2007, J MAGN RESON IMAGING, V26, P219, DOI 10.1002/jmri.20949; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Worthley SG, 2000, ATHEROSCLEROSIS, V150, P321, DOI 10.1016/S0021-9150(99)00386-X	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18459	10.1371/journal.pone.0018459	http://dx.doi.org/10.1371/journal.pone.0018459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494632	gold, Green Submitted, Green Published			2022-12-27	WOS:000289292800018
J	Deng, Y; Zhang, WY; Farhat, K; Oberland, S; Gisselmann, G; Neuhaus, EM				Deng, Ying; Zhang, Weiyi; Farhat, Katja; Oberland, Sonja; Gisselmann, Guenter; Neuhaus, Eva M.			The Stimulatory G alpha(s) Protein Is Involved in Olfactory Signal Transduction in Drosophila	PLOS ONE			English	Article							MOSQUITO ANOPHELES-GAMBIAE; HAWKMOTH MANDUCA-SEXTA; ODORANT RECEPTOR; ADULT DROSOPHILA; PHOSPHOLIPASE-C; MOLECULAR-BASIS; IN-VIVO; CHEMOSENSORY RECEPTORS; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY	Seven-transmembrane receptors typically mediate olfactory signal transduction by coupling to G-proteins. Although insect odorant receptors have seven transmembrane domains like G-protein coupled receptors, they have an inverted membrane topology, constituting a key difference between the olfactory systems of insects and other animals. While heteromeric insect ORs form ligand-activated non-selective cation channels in recombinant expression systems, the evidence for an involvement of cyclic nucleotides and G-proteins in odor reception is inconsistent. We addressed this question in vivo by analyzing the role of G-proteins in olfactory signaling using electrophysiological recordings. We found that G alpha(s) plays a crucial role for odorant induced signal transduction in OR83b expressing olfactory sensory neurons, but not in neurons expressing CO2 responsive proteins GR21a/GR63a. Moreover, signaling of Drosophila ORs involved G alpha(s) also in a heterologous expression system. In agreement with these observations was the finding that elevated levels of cAMP result in increased firing rates, demonstrating the existence of a cAMP dependent excitatory signaling pathway in the sensory neurons. Together, we provide evidence that G alpha(s) plays a role in the OR mediated signaling cascade in Drosophila.	[Deng, Ying] Huazhong Univ Sci & Technol, Sino France Joint Ctr Drug Res & Screening, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Deng, Ying; Zhang, Weiyi; Farhat, Katja; Gisselmann, Guenter] Ruhr Univ Bochum, Bochum, Germany; [Zhang, Weiyi] Bioduro Beijing Co Ltd, Changping, Peoples R China; [Farhat, Katja] Univ Gottingen, Dept Cardiovasc Physiol, Gottingen, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Charite, Neurosci Res Ctr, Berlin, Germany	Huazhong University of Science & Technology; Ruhr University Bochum; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Deng, Y (corresponding author), Huazhong Univ Sci & Technol, Sino France Joint Ctr Drug Res & Screening, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	eva.neuhaus@charite.de	Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231	NE [755/3-1]; Max-Planck-Research School for Chemical Biology (IMPRS-CB)	NE; Max-Planck-Research School for Chemical Biology (IMPRS-CB)	Funding was provided by NE 755/3-1 www.dfg.de, EXC257 www.dfg.de, and Max-Planck-Research School for Chemical Biology (IMPRS-CB)www.mpg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BOEKHOFF I, 1990, CELL SIGNAL, V2, P49, DOI 10.1016/0898-6568(90)90032-6; Boto T, 2010, CHEM SENSES, V35, P183, DOI 10.1093/chemse/bjp095; BREDENDIEK N, 2010, CHEM SENSES IN PRESS; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chambers RS, 2003, NAT BIOTECHNOL, V21, P1088, DOI 10.1038/nbt858; Chatterjee Abhishek, 2009, BMC Physiology, V9, P22, DOI 10.1186/1472-6793-9-22; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Deckert CM, 2006, J RECEPT SIG TRANSD, V26, P647, DOI 10.1080/10799890600920670; Dubin AE, 1998, J NEUROSCI, V18, P5603; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Ge H, 2006, CHEM SENSES, V31, P49, DOI 10.1093/chemse/bjj005; Gisselmann GN, 2005, INSECT BIOCHEM MOLEC, V35, P505, DOI 10.1016/j.ibmb.2005.02.001; Gomez-Diaz C, 2004, BEHAV GENET, V34, P395, DOI 10.1023/B:BEGE.0000023645.02710.fe; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krishnan P, 2008, CURR BIOL, V18, P803, DOI 10.1016/j.cub.2008.04.060; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laue M, 1997, CELL TISSUE RES, V288, P149, DOI 10.1007/s004410050802; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Marx Thomas, 1999, Invertebrate Neuroscience, V4, P55, DOI 10.1007/s101580050007; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; Merrill CE, 2005, J NEUROBIOL, V63, P15, DOI 10.1002/neu.20113; Merrill CE, 2002, P NATL ACAD SCI USA, V99, P1633, DOI 10.1073/pnas.022505499; Miura N, 2005, J COMP NEUROL, V485, P143, DOI 10.1002/cne.20488; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Pelz D, 2006, J NEUROBIOL, V66, P1544, DOI 10.1002/neu.20333; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Rutzler M, 2006, J COMP NEUROL, V499, P533, DOI 10.1002/cne.21083; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; TALLURI S, 1995, P NATL ACAD SCI USA, V92, P11475, DOI 10.1073/pnas.92.25.11475; Tanoue S, 2008, CURR BIOL, V18, P787, DOI 10.1016/j.cub.2008.04.062; Ueda T, 2003, J NEUROSCI, V23, P7376; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; VAUGHAN J, 1988, ADV ENZYMOL RELAT AR, V61, P303; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Walker WB, 2008, J INSECT PHYSIOL, V54, P680, DOI 10.1016/j.jinsphys.2008.01.007; WEST RE, 1985, J BIOL CHEM, V260, P4428; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wolfgang WJ, 2001, GENETICS, V158, P1189; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	83	57	58	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18605	10.1371/journal.pone.0018605	http://dx.doi.org/10.1371/journal.pone.0018605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490930	Green Submitted, gold, Green Published			2022-12-27	WOS:000289238700028
J	Hautier, L; Lebrun, R; Saksiri, S; Michaux, J; Vianey-Liaud, M; Marivaux, L				Hautier, Lionel; Lebrun, Renaud; Saksiri, Soonchan; Michaux, Jacques; Vianey-Liaud, Monique; Marivaux, Laurent			Hystricognathy vs Sciurognathy in the Rodent Jaw: A New Morphometric Assessment of Hystricognathy Applied to the Living Fossil Laonastes (Diatomyidae)	PLOS ONE			English	Article							MASTICATORY MUSCLE ARCHITECTURE; CAVIOMORPH RODENTS; MOLECULAR EVIDENCE; EVOLUTION; MAMMALIA; EOCENE; PHYLOGENY; TIMESCALE; THAILAND	While exceptional for an intense diversification of lineages, the evolutionary history of the order Rodentia comprises only a limited number of morphological morphotypes for the mandible. This situation could partly explain the intense debates about the taxonomic position of the latest described member of this clade, the Laotian rock rat Laonastes aenigmamus (Diatomyidae). This discovery has re-launched the debate on the definition of the Hystricognathi suborder identified using the angle of the jaw relative to the plane of the incisors. Our study aims to end this ambiguity. For clarity, it became necessary to revisit the entire morphological diversity of the mandible in extant and extinct rodents. However, current and past rodent diversity brings out the limitations of the qualitative descriptive approach and highlights the need for a quantitative approach. Here, we present the first descriptive comparison of the masticatory apparatus within the Ctenohystrica clade, in combining classic comparative anatomy with morphometrical methods. First, we quantified the shape of the mandible in rodents using 3D landmarks. Then, the analysis of osteological features was compared to myological features in order to understand the biomechanical origin of this morphological diversity. Among the morphological variation observed, the mandible of Laonastes aenigmamus displays an intermediate association of features that could be considered neither as sciurognathous nor as hystricognathous.	[Hautier, Lionel] Univ Cambridge, Museum Zool, Cambridge, England; [Lebrun, Renaud] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Lebrun, Renaud; Michaux, Jacques; Vianey-Liaud, Monique; Marivaux, Laurent] Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, UMR CNRS 5554, Montpellier, France; [Saksiri, Soonchan] Mahasarakham Univ, Dept Biol, Fac Sci, Maha Sarakham, Thailand	University of Cambridge; University of Zurich; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Mahasarakham University	Hautier, L (corresponding author), Univ Cambridge, Museum Zool, Cambridge, England.	ljh75@cam.ac.uk	Kostur, Karol/F-8212-2010	Kostur, Karol/0000-0002-5789-7184; Lebrun, Renaud/0000-0002-5819-2653; Hautier, Lionel/0000-0001-8701-5421	University of Montpellier; French government; MRT; Leverhulme Trust	University of Montpellier; French government; MRT; Leverhulme Trust(Leverhulme Trust)	The University of Montpellier and French government (via a ministerial fellowship, MRT), the European Commission's Research Infrastructure Action (via the SYNTHESYS Project), ANR-PALASIAFRICA Program (ANR-08-JCJC-0017, ANR-ERC), and the Leverhulme Trust have supported the present work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becht G., 1953, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V56C, P508; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brandt JF., 1855, MEM ACAD IMP ST PETE, V7, P1; Bryant J. Daniel, 1995, American Museum Novitates, V3156, P1; Bugge J., 1985, EVOLUTIONARY RELATIO, P381; BUTLER PM, 1980, FUNCTIONAL ASPECTS E, P249; Carleton M.D., 1984, P255; CROMPTON AW, 1969, NATURE, V222, P678, DOI 10.1038/222678b0; Dawson Mary R., 2010, Vertebrata Palasiatica, V48, P328; Dawson MR, 2006, SCIENCE, V311, P1456, DOI 10.1126/science.1124187; de Leon MSP, 2007, VERTEBR PALEOBIOL PA, P71; DEQUEIROZ K, 1994, SYST BIOL, V43, P497, DOI 10.1093/sysbio/43.4.497; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GREAVES WS, 1980, AM NAT, V116, P432, DOI 10.1086/283636; Hautier L, 2010, MAMMALIA, V74, P153, DOI 10.1515/MAMM.2010.025; Hautier L, 2010, PALAIOS, V25, P6, DOI 10.2110/palo.2009.p09-047r; Hautier L, 2009, J ANAT, V215, P401, DOI 10.1111/j.1469-7580.2009.01130.x; Hautier L, 2008, ZOOL J LINN SOC-LOND, V154, P807, DOI 10.1111/j.1096-3642.2008.00453.x; Hiiemae K.M., 1978, P359; HIIEMAE KM, 1967, J DENT RES, V46, P883; Honeycutt RL, 2003, MOL PHYLOGENET EVOL, V26, P476, DOI 10.1016/S1055-7903(02)00368-8; Huchon D, 2000, P ROY SOC B-BIOL SCI, V267, P393, DOI 10.1098/rspb.2000.1014; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Jaeger J.-J., 1985, EVOLUTIONARY RELATIO, P567; Jaeger JJ, 2010, ZOOL J LINN SOC-LOND, V160, P195, DOI 10.1111/j.1096-3642.2009.00600.x; Jenkins PD, 2004, SYST BIODIVERS, V2, P419, DOI DOI 10.1017/S1477200004001549; LANDRY SO, 1999, MITT MUS NAT BERL ZO, V2, P283; LANDRY STUART O., 1957, UNIV CALIFORNIA PUBL ZOOL, V56, P1; Lavocat R., 1976, Palaeovertebrata, V7, P15; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; Lebrun R, 2008, THESIS U MONTPELLIER; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Luckett WP, 1985, EVOLUTIONARY RELATIO, P685; MARCUS LF, 1996, ADV MORPHOMETRICS; Marivaux L, 2000, CR ACAD SCI II A, V331, P427, DOI 10.1016/S1251-8050(00)01427-0; Marivaux L, 2004, GEODIVERSITAS, V26, P493; Marivaux L, 2002, ZOOL SCR, V31, P225, DOI 10.1046/j.1463-6409.2002.00074.x; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Mouchaty SK, 2001, MOL PHYLOGENET EVOL, V18, P127, DOI 10.1006/mpev.2000.0870; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nedbal Michael A., 1996, Journal of Mammalian Evolution, V3, P201, DOI 10.1007/BF01458181; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; Opazo JC, 2005, MOL PHYLOGENET EVOL, V37, P932, DOI 10.1016/j.ympev.2005.05.002; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rowe DL, 2002, MOL BIOL EVOL, V19, P263, DOI 10.1093/oxfordjournals.molbev.a004080; Sallam HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016525; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Specht M, 2007, THESIS U ZURICH IRCH; Specht M, 2007, VISUAL COMPUT, V23, P743, DOI 10.1007/s00371-007-0156-1; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Tullberg T., 1899, NOVA ACTA REG SOC, V3, P1; Vassallo Aldo I., 2001, Boletin de la Sociedad de Biologia de Concepcion, V72, P145; Wang Banyue, 2001, American Museum Novitates, V3317, P1, DOI 10.1206/0003-0082(2001)317<0001:OTRMOA>2.0.CO;2; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson L. A. B., 2009, P ROYAL SOC B, V277, P1227; Wood A.E., 1968, EARLY CENOZOIC MAMMA, P23; WOOD AE, 1972, SCIENCE, V175, P1250, DOI 10.1126/science.175.4027.1250; WOOD AE, 1965, EVOLUTION, V19, P115, DOI 10.2307/2406300; WOOD AE, 1958, SYST ZOOL, V7, P169, DOI 10.2307/2411716; WOOD AE, 1975, STUDIES CENOZOIC PAL, P75; WOOD ALBERT E., 1962, TRANS AMER PHIL SOC, V52, P1; Woods CA., 1982, MAMMALIAN BIOL S AM, P377; Woods CA., 1985, EVOLUTIONARY RELATIO, P515	66	49	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18698	10.1371/journal.pone.0018698	http://dx.doi.org/10.1371/journal.pone.0018698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490933	Green Published, Green Submitted, gold			2022-12-27	WOS:000289238700038
J	Lewis, J; Abas, Z; Dadousis, C; Lykidis, D; Paschou, P; Drineas, P				Lewis, Jamey; Abas, Zafiris; Dadousis, Christos; Lykidis, Dimitrios; Paschou, Peristera; Drineas, Petros			Tracing Cattle Breeds with Principal Components Analysis Ancestry Informative SNPs	PLOS ONE			English	Article							MICROSATELLITE DNA VARIATION; EUROPEAN CATTLE; GENETIC-STRUCTURE; POPULATION-STRUCTURE; BEEF-CATTLE; MARKERS; ADMIXTURE; FOOD; IDENTIFICATION; EVOLUTION	The recent release of the Bovine HapMap dataset represents the most detailed survey of bovine genetic diversity to date, providing an important resource for the design and development of livestock production. We studied this dataset, comprising more than 30,000 Single Nucleotide Polymorphisms (SNPs) for 19 breeds (13 taurine, three zebu, and three hybrid breeds), seeking to identify small panels of genetic markers that can be used to trace the breed of unknown cattle samples. Taking advantage of the power of Principal Components Analysis and algorithms that we have recently described for the selection of Ancestry Informative Markers from genomewide datasets, we present a decision-tree which can be used to accurately infer the origin of individual cattle. In doing so, we present a thorough examination of population genetic structure in modern bovine breeds. Performing extensive cross-validation experiments, we demonstrate that 250-500 carefully selected SNPs suffice in order to achieve close to 100% prediction accuracy of individual ancestry, when this particular set of 19 breeds is considered. Our methods, coupled with the dense genotypic data that is becoming increasingly available, have the potential to become a valuable tool and have considerable impact in worldwide livestock production. They can be used to inform the design of studies of the genetic basis of economically important traits in cattle, as well as breeding programs and efforts to conserve biodiversity. Furthermore, the SNPs that we have identified can provide a reliable solution for the traceability of breed-specific branded products.	[Lewis, Jamey; Drineas, Petros] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Abas, Zafiris; Dadousis, Christos] Democritus Univ Thrace, Dept Agr Dev, Orestiada, Greece; [Lykidis, Dimitrios; Paschou, Peristera] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece	Rensselaer Polytechnic Institute; Democritus University of Thrace; Democritus University of Thrace	Lewis, J (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.	ppaschou@mbg.duth.gr; drinep@cs.rpi.edu		DADOUSIS, CHRISTOS/0000-0002-7689-6443; Paschou, Peristera/0000-0002-9783-1024	National Science Foundation (NSF) [CCF 0447950, CCF 0824684]; EMBO [ASTF 235-2009]	National Science Foundation (NSF)(National Science Foundation (NSF)); EMBO(European Molecular Biology Organization (EMBO))	This work was supported, in part, by a National Science Foundation (NSF) CCF 0447950 CAREER award to PD, an NSF CCF 0824684 award to PD, and an EMBO ASTF 235-2009 Short Term Fellowship to PD. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja-Pereira A, 2003, J HERED, V94, P243, DOI 10.1093/jhered/esg055; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Canon J, 2001, GENET SEL EVOL, V33, P311, DOI 10.1051/gse:2001121; Capoferri R, 2006, J FOOD PROTECT, V69, P1971, DOI 10.4315/0362-028X-69.8.1971; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; DEAN M, 1994, AM J HUM GENET, V55, P788; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Edwards CJ, 2000, ANIM GENET, V31, P329, DOI 10.1046/j.1365-2052.2000.00651.x; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Goodman D, 2004, SOCIOL RURALIS, V44, P3, DOI 10.1111/j.1467-9523.2004.00258.x; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Ilbery B, 2005, LAND USE POLICY, V22, P331, DOI 10.1016/j.landusepol.2004.06.002; Ilbery B, 2000, J RURAL STUD, V16, P217, DOI 10.1016/S0743-0167(99)00041-8; Khatkar MS, 2007, GENETICS, V176, P763, DOI 10.1534/genetics.106.069369; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MACHUGH DE, 1994, P ROY SOC B-BIOL SCI, V256, P25, DOI 10.1098/rspb.1994.0044; MacHugh DE, 1997, GENETICS, V146, P1071; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Negrini R, 2008, MEAT SCI, V80, P1212, DOI 10.1016/j.meatsci.2008.05.021; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parrott N, 2002, EUR URBAN REG STUD, V9, P241, DOI 10.1177/096977640200900304; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rischkowsky B, 2007, STAT WORLDS AN GEN R; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WILLHAM RL, 1986, J ANIM SCI, V62, P1742, DOI 10.2527/jas1986.6261742x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	42	29	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18007	10.1371/journal.pone.0018007	http://dx.doi.org/10.1371/journal.pone.0018007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490966	Green Submitted, gold, Green Published			2022-12-27	WOS:000289238700003
J	Nishiyama, T; Kii, I; Kashima, TG; Kikuchi, Y; Ohazama, A; Shimazaki, M; Fukayama, M; Kudo, A				Nishiyama, Takashi; Kii, Isao; Kashima, Takeshi G.; Kikuchi, Yoshinao; Ohazama, Atsushi; Shimazaki, Masashi; Fukayama, Masashi; Kudo, Akira			Delayed Re-Epithelialization in Periostin-Deficient Mice during Cutaneous Wound Healing	PLOS ONE			English	Article							LAMININ-5 GAMMA-2 CHAIN; STEM-CELLS; EXTRACELLULAR-MATRIX; HAIR FOLLICLE; KERATINOCYTE MIGRATION; SKIN; EXPRESSION; PROTEIN; GROWTH; DEFECTS	Background: Matricellular proteins, including periostin, are important for tissue regeneration. Methods and Findings: Presently we investigated the function of periostin in cutaneous wound healing by using periostin-deficient (-/-) mice. Periostin mRNA was expressed in both the epidermis and hair follicles, and periostin protein was located at the basement membrane in the hair follicles together with fibronectin and laminin gamma 2. Periostin was associated with laminin gamma 2, and this association enhanced the proteolytic cleavage of the laminin gamma 2 long form to produce its short form. To address the role of periostin in wound healing, we employed a wound healing model using WT and periostin-/- mice and the scratch wound assay in vitro. We found that the wound closure was delayed in the periostin-/- mice coupled with a delay in re-epithelialization and with reduced proliferation of keratinocytes. Furthermore, keratinocyte proliferation was enhanced in periostin-overexpressing HaCaT cells along with up-regulation of phosphorylated NF-kappa B. Conclusion: These results indicate that periostin was essential for keratinocyte proliferation for re-epithelialization during cutaneous wound healing.	[Nishiyama, Takashi; Kii, Isao; Shimazaki, Masashi; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Kashima, Takeshi G.; Kikuchi, Yoshinao; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Human Pathol, Tokyo, Japan; [Ohazama, Atsushi] Showa Univ, Sch Dent, Dept Pediodontol, Tokyo 142, Japan	Tokyo Institute of Technology; University of Tokyo; Showa University	Nishiyama, T (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 227, Japan.	akudo@bio.titech.ac.jp	KII, Isao/C-4117-2017; Nishiyama, Takashi/ABC-8965-2021; Kikuchi, Yoshinao/AAH-1914-2020; Kudo, Akira/C-7340-2015	KII, Isao/0000-0002-6153-6250; Nishiyama, Takashi/0000-0002-4496-240X; Kudo, Akira/0000-0001-6289-3391	Ministry of Education, Science, Culture, and Sports of Japan; Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan, and by grants from the Ground-based Research Program for Space Utilization promoted by Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BLANPAIN C, 2010, SCIENCE, V464, P686; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Decline F, 2001, J CELL SCI, V114, P811; DIPIETRO LA, 2003, WOUND HEALING METHOD, P17; Eyden B, 2009, INT J CANCER, V125, P1743, DOI 10.1002/ijc.24550; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tanabe H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012234; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; WATT FM, 1993, J CELL SCI, V106, P175; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2	38	99	99	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18410	10.1371/journal.pone.0018410	http://dx.doi.org/10.1371/journal.pone.0018410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490918	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700012
J	Lee, J; Repasy, T; Papavinasasundaram, K; Sassetti, C; Kornfeld, H				Lee, Jinhee; Repasy, Teresa; Papavinasasundaram, Kadamba; Sassetti, Christopher; Kornfeld, Hardy			Mycobacterium tuberculosis Induces an Atypical Cell Death Mode to Escape from Infected Macrophages	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; CYTOCHROME-C RELEASE; DEPENDENT FASHION; TRANSITION PORE; APOPTOSIS; VIRULENCE; MITOCHONDRIA; MECHANISM; INVASION; NECROSIS	Background: Macrophage cell death following infection with Mycobacterium tuberculosis plays a central role in tuberculosis disease pathogenesis. Certain attenuated strains induce extrinsic apoptosis of infected macrophages but virulent strains of M. tuberculosis suppress this host response. We previously reported that virulent M. tuberculosis induces cell death when bacillary load exceeds,20 per macrophage but the precise nature of this demise has not been defined. Methodology/Principal Findings: We analyzed the characteristics of cell death in primary murine macrophages challenged with virulent or attenuated M. tuberculosis complex strains. We report that high intracellular bacillary burden causes rapid and primarily necrotic death via lysosomal permeabilization, releasing hydrolases that promote Bax/Bak-independent mitochondrial damage and necrosis. Cell death was independent of cathepsins B or L and notable for ultrastructural evidence of damage to lipid bilayers throughout host cells with depletion of several host phospholipid species. These events require viable bacteria that can respond to intracellular cues via the PhoPR sensor kinase system but are independent of the ESX1 system. Conclusions/Significance: Cell death caused by virulent M. tuberculosis is distinct from classical apoptosis, pyroptosis or pyronecrosis. Mycobacterial genes essential for cytotoxicity are regulated by the PhoPR two-component system. This atypical death mode provides a mechanism for viable bacilli to exit host macrophages for spreading infection and the eventual transition to extracellular persistence that characterizes advanced pulmonary tuberculosis.	[Lee, Jinhee; Repasy, Teresa; Kornfeld, Hardy] Univ Massachusetts Med Sch, Dept Med, Worcester, MA 01655 USA; [Papavinasasundaram, Kadamba; Sassetti, Christopher] Univ Massachusetts Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Sassetti, Christopher] Univ Massachusetts Med Sch, Howard Hughes Med Inst, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Lee, J (corresponding author), Univ Massachusetts Med Sch, Dept Med, Worcester, MA 01655 USA.	hardy.kornfeld@umassmed.edu	Kornfeld, Hardy/AAS-2903-2021	PAPAVINASASUNDARAM, KADAMBA/0000-0001-7837-1344	National Institutes of Health [HL064884, AI064282, DK32520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grants HL064884, AI064282, and DK32520(http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2004, J LIPID RES, V45, P667, DOI 10.1194/jlr.M300342-JLR200; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Dhillon J, 2001, J ANTIMICROB CHEMOTH, V48, P869, DOI 10.1093/jac/48.6.869; Dini L, 1996, EXP CELL RES, V223, P340, DOI 10.1006/excr.1996.0089; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Ferrer NL, 2009, MICROBES INFECT, V11, P115, DOI 10.1016/j.micinf.2008.10.013; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; KRISTIANSEN JE, 1986, ACTA PATH MICRO IM B, V94, P393; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lahiri R, 2010, J INFECT DIS, V201, P1736, DOI 10.1086/652499; Larsen MH, 2009, VACCINE, V27, P4709, DOI 10.1016/j.vaccine.2009.05.050; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; MELLORS A, 1967, BIOCHIM BIOPHYS ACTA, V143, P299, DOI 10.1016/0005-2728(67)90084-9; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Pelicic V, 1996, FEMS MICROBIOL LETT, V144, P161, DOI 10.1016/0378-1097(96)00354-0; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; PERI P, 2010, J GEN VIROL     0929; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; RUTH RC, 1980, J PHARMACOL EXP THER, V212, P361; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Willhite DC, 2004, CELL MICROBIOL, V6, P143, DOI 10.1046/j.1462-5822.2003.00347.x; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	43	65	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18367	10.1371/journal.pone.0018367	http://dx.doi.org/10.1371/journal.pone.0018367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483832	Green Published, gold			2022-12-27	WOS:000289057200065
J	Bourquard, T; Bernauer, J; Aze, J; Poupon, A				Bourquard, Thomas; Bernauer, Julie; Aze, Jerome; Poupon, Anne			A Collaborative Filtering Approach for Protein-Protein Docking Scoring Functions	PLOS ONE			English	Article							CAPRI; PRINCIPLES; PROGRESS	A protein-protein docking procedure traditionally consists in two successive tasks: a search algorithm generates a large number of candidate conformations mimicking the complex existing in vivo between two proteins, and a scoring function is used to rank them in order to extract a native-like one. We have already shown that using Voronoi constructions and a well chosen set of parameters, an accurate scoring function could be designed and optimized. However to be able to perform large-scale in silico exploration of the interactome, a near-native solution has to be found in the ten best-ranked solutions. This cannot yet be guaranteed by any of the existing scoring functions. In this work, we introduce a new procedure for conformation ranking. We previously developed a set of scoring functions where learning was performed using a genetic algorithm. These functions were used to assign a rank to each possible conformation. We now have a refined rank using different classifiers (decision trees, rules and support vector machines) in a collaborative filtering scheme. The scoring function newly obtained is evaluated using 10 fold cross-validation, and compared to the functions obtained using either genetic algorithms or collaborative filtering taken separately. This new approach was successfully applied to the CAPRI scoring ensembles. We show that for 10 targets out of 12, we are able to find a near-native conformation in the 10 best ranked solutions. Moreover, for 6 of them, the near-native conformation selected is of high accuracy. Finally, we show that this function dramatically enriches the 100 best-ranking conformations in near-native structures.	[Bourquard, Thomas; Aze, Jerome] Univ Paris 11, Rech Informat Lab, INRIA AMIB, Bioinformat Grp, F-91405 Orsay, France; [Bourquard, Thomas; Bernauer, Julie] Ecole Polytech, Lab Informat LIX, INRIA AMIB, Bioinformat Grp, Palaiseau, France; [Bourquard, Thomas] LORIA, INRIA Nancy Grand Est, Vandoeuvre Les Nancy, France; [Poupon, Anne] INRA, BIOS Grp, UMR85, Unite Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Poupon, Anne] CNRS, UMR6175, Nouzilly, France; [Poupon, Anne] Univ Tours, Tours, France	UDICE-French Research Universities; Universite Paris Saclay; Institut Polytechnique de Paris; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours	Bourquard, T (corresponding author), Univ Paris 11, Rech Informat Lab, INRIA AMIB, Bioinformat Grp, Bat 490, F-91405 Orsay, France.	Anne.Poupon@tours.inra.fr	Bernauer, Julie/M-7518-2014	Bernauer, Julie/0000-0003-2345-995X; Poupon, Anne/0000-0003-0617-0935				Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; [Anonymous], 2009, ADV ARTIFICIAL INTEL; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernauer J, 2007, BIOINFORMATICS, V23, P555, DOI 10.1093/bioinformatics/btl654; Bernauer J, 2005, PHYS BIOL, V2, pS17, DOI 10.1088/1478-3975/2/2/S02; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Boissonnat JD, 2002, COMP GEOM-THEOR APPL, V22, P5, DOI 10.1016/S0925-7721(01)00054-2; Bourquard T, 2009, 2009 6TH INTERNATIONAL SYMPOSIUM ON VORONOI DIAGRAMS (ISVD 2009), P225, DOI 10.1109/ISVD.2009.11; Chen R, 2003, PROTEINS, V52, P88, DOI 10.1002/prot.10390; COHEN WW, 1995, INT C MACH LEARN, P115; FRANK IHW, 1998, 15 INT C MACH LEARN, P144; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Joachims, 1999, MAKING LARGE SCALE S, P169; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Sanderson Christopher M., 2009, Briefings in Functional Genomics & Proteomics, V8, P1, DOI 10.1093/bfgp/elp003; Scholkopf B., 1998, ADV KERNEL METHODS S; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9	28	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18541	10.1371/journal.pone.0018541	http://dx.doi.org/10.1371/journal.pone.0018541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526112	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800009
J	Kokkinopoulos, I; Shahabi, G; Colman, A; Jeffery, G				Kokkinopoulos, Ioannis; Shahabi, Golnaz; Colman, Alan; Jeffery, Glen			Mature Peripheral RPE Cells Have an Intrinsic Capacity to Proliferate; A Potential Regulatory Mechanism for Age-Related Cell Loss	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; BETA-CATENIN; TIGHT JUNCTIONS; E-CADHERIN; EXPRESSION; P27(KIP1); APOPTOSIS; DEFECTS; CYCLE; MTOR	BACKGROUND: Mammalian peripheral retinal pigmented epithelium (RPE) cells proliferate throughout life, while central cells are senescent. It is thought that some peripheral cells migrate centrally to correct age-related central RPE loss. METHODOLOGY/PRINCIPAL FINDINGS: We ask whether this proliferative capacity is intrinsic to such cells and whether cells located centrally produce diffusible signals imposing senescence upon the former once migrated. We also ask whether there are regional differences in expression patterns of key genes involved in these features between the centre and the periphery in vivo and in vitro. Low density RPE cultures obtained from adult mice revealed significantly greater levels of proliferation when derived from peripheral compared to central tissue, but this significance declined with increasing culture density. Further, exposure to centrally conditioned media had no influence on proliferation in peripheral RPE cell cultures at the concentrations examined. Central cells expressed significantly higher levels of E-Cadherin revealing a tighter cell adhesion than in the peripheral regions. Fluorescence-labelled staining for E-Cadherin, F-actin and ZO-1 in vivo revealed different patterns with significantly increased expression on central RPE cells than those in the periphery or differences in junctional morphology. A range of other genes were investigated both in vivo and in vitro associated with RPE proliferation in order to identify gene expression differences between the centre and the periphery. Specifically, the cell cycle inhibitor p27(Kip1) was significantly elevated in central senescent regions in vivo and mTOR, associated with RPE cell senescence, was significantly elevated in the centre in comparison to the periphery. CONCLUSIONS: These data show that the proliferative capacity of peripheral RPE cells is intrinsic and cell-autonomous in adult mice. These differences between centre and periphery are reflected in distinct patterns in junctional markers. The regional proliferation differences may be inversely dependent to cell-cell contact.	[Kokkinopoulos, Ioannis; Shahabi, Golnaz; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Kokkinopoulos, Ioannis] Kings Coll London, Sch Biomed & Hlth Sci Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Colman, Alan] Singapore Stem Cell Consortium, Singapore, Singapore	University of London; University College London; University of London; King's College London	Kokkinopoulos, I (corresponding author), UCL, Inst Ophthalmol, London, England.	g.jeffery@ucl.ac.uk			Medical Research Council UK [G03000341]; Rosetree Trust; MRC [G0701114] Funding Source: UKRI; Medical Research Council [G0701114] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetree Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an MRC grant [the Medical Research Council UK (G03000341)] and The Rosetree Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2010, EXP EYE RES, V90, P368, DOI 10.1016/j.exer.2009.10.002; Al-Hussaini H, 2008, MOL VIS, V14, P1784; Amemiya K, 2004, BIOCHEM BIOPH RES CO, V316, P1, DOI 10.1016/j.bbrc.2004.01.172; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Assimakopoulos SF, 2011, EUR J CLIN INVEST, V41, P117, DOI 10.1111/j.1365-2362.2010.02379.x; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; CHEN Y, 2010, INVEST OPHTHALMOL VI; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Chiba C, 2006, J COMP NEUROL, V495, P391, DOI 10.1002/cne.20880; Defoe DM, 2007, MOL VIS, V13, P273; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; ELMAN MJ, 1986, OPHTHALMOLOGY, V93, P224; Fischer AJ, 2001, DEV NEUROSCI-BASEL, V23, P268, DOI 10.1159/000048710; Galluzzi L, 2010, AGING-US, V2, P535, DOI 10.18632/aging.100202; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Kiilgaard JF, 2007, INVEST OPHTH VIS SCI, V48, P355, DOI 10.1167/iovs.05-1565; KONARI K, 1995, EXP EYE RES, V61, P99, DOI 10.1016/S0014-4835(95)80063-8; LAI YL, 1986, P SOC EXP BIOL MED, V181, P371; Mann I., 1964, DEV HUMAN EYE; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Parrales A, 2010, J CELL PHYSIOL, V222, P302, DOI 10.1002/jcp.21951; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Steindl-Kuscher K, 2009, INVEST OPHTH VIS SCI, V50, P4471, DOI 10.1167/iovs.08-3139; STREETEN BW, 1969, ARCH OPHTHALMOL-CHIC, V81, P383; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; VANDEKERCKHOVE J, 1985, EMBO J, V4, P2815, DOI 10.1002/j.1460-2075.1985.tb04008.x; von Leithner PL, 2010, MOL VIS, V16, P570; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yoshida K, 2004, ANAT EMBRYOL, V208, P145, DOI 10.1007/s00429-004-0382-5; Young R W, 1983, Trans Am Ophthalmol Soc, V81, P193; Yu AL, 2009, INVEST OPHTH VIS SCI, V50, P926, DOI 10.1167/iovs.07-1003; Zygar CA, 2005, DEV BRAIN RES, V154, P91, DOI 10.1016/j.devbrainres.2004.10.009	40	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18921	10.1371/journal.pone.0018921	http://dx.doi.org/10.1371/journal.pone.0018921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526120	Green Published, Green Submitted, gold			2022-12-27	WOS:000290015800022
J	Peleg, B; Disanza, A; Scita, G; Gov, N				Peleg, Barak; Disanza, Andrea; Scita, Giorgio; Gov, Nir			Propagating Cell-Membrane Waves Driven by Curved Activators of Actin Polymerization	PLOS ONE			English	Article							PROTEIN; IRSP53; LINKS; CYTOKINESIS; CURVATURE; DYNAMICS; DOMAINS; TUBA	Cells exhibit propagating membrane waves which involve the actin cytoskeleton. One type of such membranal waves are Circular Dorsal Ruffles (CDR) which are related to endocytosis and receptor internalization. Experimentally, CDRs have been associated with membrane bound activators of actin polymerization of concave shape. We present experimental evidence for the localization of convex membrane proteins in these structures, and their insensitivity to inhibition of myosin II contractility in immortalized mouse embryo fibroblasts cell cultures. These observations lead us to propose a theoretical model which explains the formation of these waves due to the interplay between complexes that contain activators of actin polymerization and membrane-bound curved proteins of both types of curvature (concave and convex). Our model predicts that the activity of both types of curved proteins is essential for sustaining propagating waves, which are abolished when one type of curved activator is removed. Within this model waves are initiated when the level of actin polymerization induced by the curved activators is higher than some threshold value, which allows the cell to control CDR formation. We demonstrate that the model can explain many features of CDRs, and give several testable predictions. This work demonstrates the importance of curved membrane proteins in organizing the actin cytoskeleton and cell shape.	[Peleg, Barak; Gov, Nir] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Disanza, Andrea; Scita, Giorgio] FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; [Scita, Giorgio] Univ Milan, Dept Med Surg & Dent, Milan, Italy	Weizmann Institute of Science; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Peleg, B (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	nir.gov@weizmann.ac.il	Scita, Giorgio/J-9670-2012; GOV, NIR/K-1415-2012	Disanza, Andrea/0000-0001-5101-2907; Scita, Giorgio/0000-0001-7984-1889; GOV, NIR/0000-0001-7774-1139	Alvin and Gertrude Levine Career Development Chair; BSF [2006285]; AIRC (Associazione Italiana Ricerca sul Cancro) [4874, 8678]; PRIN (progetti di ricerca di interesse nazionale); International Association for Cancer Research [AICR 09-0582]	Alvin and Gertrude Levine Career Development Chair; BSF(US-Israel Binational Science Foundation); AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); PRIN (progetti di ricerca di interesse nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); International Association for Cancer Research	N.G. thanks the Alvin and Gertrude Levine Career Development Chair, and the BSF grant No. 2006285 for their support. This research is made possible in part by the historic generosity of the Harold Perlman Family. G.S. and A.D. thank the AIRC (Associazione Italiana Ricerca sul Cancro) grants No. 4874 and 8678 for their support. G.S. thanks the PRIN2007 (progetti di ricerca di interesse nazionale) and the International Association for Cancer Research (AICR 09-0582) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio E, 2010, EMBO J, V29, P292, DOI 10.1038/emboj.2009.341; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; Chen CH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238101; Coelho Neto J, 2005, EXP CELL RES, V303, P207, DOI 10.1016/j.yexcr.2004.09.002; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dobereiner H. G., 2006, PHYS REV LETT, V97, P10; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gov N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011104; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Kovacs EM, 2006, J CELL SCI, V119, P2715, DOI 10.1242/jcs.03005; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Sens P, 1998, EUROPHYS LETT, V43, P95, DOI 10.1209/epl/i1998-00325-6; Shlomovitz R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168103; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suetsugu S, 2010, J BIOCHEM, V148, P1, DOI 10.1093/jb/mvq049; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Veksler A, 2007, BIOPHYS J, V93, P3798, DOI 10.1529/biophysj.107.113282; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	32	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18635	10.1371/journal.pone.0018635	http://dx.doi.org/10.1371/journal.pone.0018635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533032	Green Submitted, Green Published, gold			2022-12-27	WOS:000290014500008
J	Cerezo, M; Cerny, V; Carracedo, A; Salas, A				Cerezo, Maria; Cerny, Viktor; Carracedo, Angel; Salas, Antonio			New Insights into the Lake Chad Basin Population Structure Revealed by High-Throughput Genotyping of Mitochondrial DNA Coding SNPs	PLOS ONE			English	Article							SUB-SAHARAN; GENE FLOW; AFRICAN; ANCESTRY; SEQUENCE; HERITAGE; NETWORK; EASTERN; LEGACY	Background: Located in the Sudan belt, the Chad Basin forms a remarkable ecosystem, where several unique agricultural and pastoral techniques have been developed. Both from an archaeological and a genetic point of view, this region has been interpreted to be the center of a bidirectional corridor connecting West and East Africa, as well as a meeting point for populations coming from North Africa through the Saharan desert. Methodology/Principal Findings: Samples from twelve ethnic groups from the Chad Basin (n = 542) have been high-throughput genotyped for 230 coding region mitochondrial DNA (mtDNA) Single Nucleotide Polymorphisms (mtSNPs) using Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) mass spectrometry. This set of mtSNPs allowed for much better phylogenetic resolution than previous studies of this geographic region, enabling new insights into its population history. Notable haplogroup (hg) heterogeneity has been observed in the Chad Basin mirroring the different demographic histories of these ethnic groups. As estimated using a Bayesian framework, nomadic populations showed negative growth which was not always correlated to their estimated effective population sizes. Nomads also showed lower diversity values than sedentary groups. Conclusions/Significance: Compared to sedentary population, nomads showed signals of stronger genetic drift occurring in their ancestral populations. These populations, however, retained more haplotype diversity in their hypervariable segments I (HVS-I), but not their mtSNPs, suggesting a more ancestral ethnogenesis. Whereas the nomadic population showed a higher Mediterranean influence signaled mainly by sub-lineages of M1, R0, U6, and U5, the other populations showed a more consistent sub-Saharan pattern. Although lifestyle may have an influence on diversity patterns and hg composition, analysis of molecular variance has not identified these differences. The present study indicates that analysis of mtSNPs at high resolution could be a fast and extensive approach for screening variation in population studies where labor-intensive techniques such as entire genome sequencing remain unfeasible.	[Cerezo, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, CIBERER, Dept Anat Patolox & Ciencias Forenses, Inst Med Legal,Fac Med,Unidade Xenet, Galicia, Spain; [Cerny, Viktor] Acad Sci Czech Republ, Inst Archaeol, Archaeogenet Lab, Prague, Czech Republic	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Prague	Cerezo, M (corresponding author), Univ Santiago de Compostela, CIBERER, Dept Anat Patolox & Ciencias Forenses, Inst Med Legal,Fac Med,Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Carracedo, Angel/D-4257-2012; Cerny, Viktor/G-7842-2014; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012	Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Cerezo Fernandez, Maria/0000-0003-3073-1130	Xunta de Galicia [2008/XA122]; Fundacion de Investigacion Medica Mutua Madrilena; Grant Agency of the Czech Republic [206/08/1587]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This research received support from Xunta de Galicia (Grupos Emerxentes; 2008/XA122), two grants from the Fundacion de Investigacion Medica Mutua Madrilena given to AS, and a Grant Agency of the Czech Republic (Grant no. 206/08/1587) given to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Batello C, 2004, FUTURE IS ANCIENT LA; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Bereir RE, 2007, EUR J HUM GENET, V15, P1183, DOI 10.1038/sj.ejhg.5201892; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Cerezo M, 2009, ELECTROPHORESIS, V30, P3665, DOI 10.1002/elps.200900294; CERNY V, 2009, J PHYS, V138, P439; CERNY V, 2008, J PHYS, V136, P128; Cerny V, 2011, MOL BIOL EVOL, V28, P71, DOI 10.1093/molbev/msq178; COBLE M, 2004, IDENTIFICATION SINGL; Coble MD, 2006, INT J LEGAL MED, V120, P27, DOI 10.1007/s00414-005-0044-z; Elson JL, 2007, AM J HUM GENET, V80, P378, DOI 10.1086/511652; EXCOFFIER L, 1992, GENETICS, V131, P479; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; GERNY V, 2007, ANN HUM GENET, V71, P433; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; GULDEMANN T, 2008, MACROSUDAN BELT IDEN; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mosquera-Miguel A, 2009, FORENSIC SCI INT-GEN, V3, P261, DOI 10.1016/j.fsigen.2009.04.006; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; RICHARDS M, 2004, STUDIES HONOUR COLIN, P1363; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V75, P524, DOI 10.1086/423824; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010218; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18682	10.1371/journal.pone.0018682	http://dx.doi.org/10.1371/journal.pone.0018682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533064	Green Submitted, gold, Green Published			2022-12-27	WOS:000289719400020
J	Fernandez-Calvino, L; Faulkner, C; Walshaw, J; Saalbach, G; Bayer, E; Benitez-Alfonso, Y; Maule, A				Fernandez-Calvino, Lourdes; Faulkner, Christine; Walshaw, John; Saalbach, Gerhard; Bayer, Emmanuelle; Benitez-Alfonso, Yoselin; Maule, Andrew			Arabidopsis Plasmodesmal Proteome	PLOS ONE			English	Article							CELL-TO-CELL; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; STATISTICAL-MODEL; WALL PROTEINS; PLANT-CELLS; IDENTIFICATION; TOBACCO; CALLOSE; POLYPEPTIDE	The multicellular nature of plants requires that cells should communicate in order to coordinate essential functions. This is achieved in part by molecular flux through pores in the cell wall, called plasmodesmata. We describe the proteomic analysis of plasmodesmata purified from the walls of Arabidopsis suspension cells. Isolated plasmodesmata were seen as membrane-rich structures largely devoid of immunoreactive markers for the plasma membrane, endoplasmic reticulum and cytoplasmic components. Using nano-liquid chromatography and an Orbitrap ion-trap tandem mass spectrometer, 1341 proteins were identified. We refer to this list as the plasmodesmata- or PD-proteome. Relative to other cell wall proteomes, the PD-proteome is depleted in wall proteins and enriched for membrane proteins, but still has a significant number (35%) of putative cytoplasmic contaminants, probably reflecting the sensitivity of the proteomic detection system. To validate the PD-proteome we searched for known plasmodesmal proteins and used molecular and cell biological techniques to identify novel putative plasmodesmal proteins from a small subset of candidates. The PD-proteome contained known plasmodesmal proteins and some inferred plasmodesmal proteins, based upon sequence or functional homology with examples identified in different plant systems. Many of these had a membrane association reflecting the membranous nature of isolated structures. Exploiting this connection we analysed a sample of the abundant receptor-like class of membrane proteins and a small random selection of other membrane proteins for their ability to target plasmodesmata as fluorescently-tagged fusion proteins. From 15 candidates we identified three receptor-like kinases, a tetraspanin and a protein of unknown function as novel potential plasmodesmal proteins. Together with published work, these data suggest that the membranous elements in plasmodesmata may be rich in receptor-like functions, and they validate the content of the PD-proteome as a valuable resource for the further uncovering of the structure and function of plasmodesmata as key components in cell-to-cell communication in plants.	[Fernandez-Calvino, Lourdes; Faulkner, Christine; Walshaw, John; Saalbach, Gerhard; Benitez-Alfonso, Yoselin; Maule, Andrew] John Innes Ctr, Norwich, Norfolk, England; [Bayer, Emmanuelle] CNRS, UMR5200, Lab Biogenese Membranaire, Bordeaux, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Fernandez-Calvino, L (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain.	andy.maule@bbsrc.ac.uk	Faulkner, Christine/K-4165-2015; Fernandez-Calvino, Lourdes/K-9805-2014; bayer, emmanuelle/V-1329-2017; Walshaw, John/D-6309-2015	Faulkner, Christine/0000-0003-3905-8077; Fernandez-Calvino, Lourdes/0000-0003-0988-401X; bayer, emmanuelle/0000-0001-8642-5293; Walshaw, John/0000-0002-9357-469X; Benitez-Alfonso, Yoselin/0000-0001-9779-0413	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D017998/1]; BBSRC; BBSRC [BB/D017998/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D017998/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LF-C was fully supported and CF and AJM were part-supported by a UK Biotechnology and Biological Sciences Research Council (BBSRC) responsive mode grant (Grant No. BB/D017998/1). John Innes Centre is grant-aided by the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 2002, P NATL ACAD SCI USA, V99, P16342, DOI 10.1073/pnas.252427999; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avisar D, 2008, J VIROL, V82, P2836, DOI 10.1128/JVI.02246-07; Baluska F, 1999, PLANT J, V19, P481, DOI 10.1046/j.1365-313X.1999.00530.x; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bayer E, 2004, PROTOPLASMA, V223, P93, DOI 10.1007/s00709-004-0044-8; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benitez-Alfonso Y, 2009, PLANT SIGNAL BEHAV, V4, P655, DOI [10.4161/psb.4.7.8992, 10.1073/pnas.0808717106]; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Blackman LM, 1998, PLANT J, V14, P733, DOI 10.1046/j.1365-313x.1998.00161.x; Blackman LM, 1999, EUR J CELL BIOL, V78, P297, DOI 10.1016/S0171-9335(99)80063-6; Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608; Botha CEJ, 2000, MICRON, V31, P713, DOI 10.1016/S0968-4328(99)00108-0; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Burch-Smith TM, 2010, CURR BIOL, V20, P989, DOI 10.1016/j.cub.2010.03.064; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chen MH, 2005, PLANT PHYSIOL, V138, P1866, DOI 10.1104/pp.105.064386; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DELMER DP, 1993, PROTOPLASMA, V176, P33, DOI 10.1007/BF01378937; Dhugga KS, 1997, P NATL ACAD SCI USA, V94, P7679, DOI 10.1073/pnas.94.14.7679; Ding B, 1996, PLANT J, V10, P157, DOI 10.1046/j.1365-313X.1996.10010157.x; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Ehlers K, 2010, PLANTA, V231, P371, DOI 10.1007/s00425-009-1046-8; Elortza F, 2006, J PROTEOME RES, V5, P935, DOI 10.1021/pr050419u; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Faulkner C, 2011, PROTOPLASMA, V248, P27, DOI 10.1007/s00709-010-0213-x; Faulkner CR, 2009, EUR J CELL BIOL, V88, P357, DOI 10.1016/j.ejcb.2009.02.184; Faulkner CR, 2005, PROTEOMICS, V5, P2866, DOI 10.1002/pmic.200401186; Golomb L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-3; Guseman JM, 2010, DEVELOPMENT, V137, P1731, DOI 10.1242/dev.049197; Hesketh John, 1996, Biochemical Society Transactions, V24, p187S; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; HOFTE H, 1992, PLANT CELL, V4, P995, DOI 10.1105/tpc.4.8.995; Hong ZL, 2001, PLANT CELL, V13, P769, DOI 10.1105/tpc.13.4.769; Ishiwatari Y, 1998, PLANTA, V205, P12, DOI 10.1007/s004250050291; Jo Y, 2011, PROTOPLASMA, V248, P191, DOI 10.1007/s00709-010-0251-4; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kobayashi K, 2007, PLANT CELL, V19, P1885, DOI 10.1105/tpc.106.045666; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KRONEG J, 1999, DETECTION PREDICTION; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamesch Philippe, 2010, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0111s30; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Levy A, 2007, PLANT J, V49, P669, DOI 10.1111/j.1365-313X.2006.02986.x; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Minic Z, 2007, J EXP BOT, V58, P2503, DOI 10.1093/jxb/erm082; Mongrand S, 2010, TRENDS PLANT SCI, V15, P656, DOI 10.1016/j.tplants.2010.09.003; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; NORTHCOTE DH, 1989, PLANTA, V178, P353, DOI 10.1007/BF00391863; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oparka KJ, 2004, TRENDS PLANT SCI, V9, P33, DOI 10.1016/j.tplants.2003.11.001; Overall RL, 1996, TRENDS PLANT SCI, V1, P307, DOI 10.1016/S1360-1385(96)88177-0; Radford JE, 1998, PROTOPLASMA, V201, P30, DOI 10.1007/BF01280708; Radford JE, 1998, PLANT J, V14, P743, DOI 10.1046/j.1365-313x.1998.00162.x; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Reichelt S, 1999, PLANT J, V19, P555, DOI 10.1046/j.1365-313X.1999.00553.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sagi G, 2005, PLANT CELL, V17, P1788, DOI 10.1105/tpc.105.031823; Simpson C, 2009, PLANT CELL, V21, P581, DOI 10.1105/tpc.108.060145; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; Stonebloom S, 2009, P NATL ACAD SCI USA, V106, P17229, DOI 10.1073/pnas.0909229106; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas CL, 2008, PLOS BIOL, V6, P180, DOI 10.1371/journal.pbio.0060007; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; VALLON O, 1986, PHOTOBIOCH PHOTOBIOP, V12, P203; Van Gestel K, 2003, PROTOPLASMA, V222, P45, DOI 10.1007/s00709-003-0004-8; WALKER JC, 1994, PLANT MOL BIOL, V26, P1599, DOI 10.1007/BF00016492; WHITE RG, 1994, PROTOPLASMA, V180, P169, DOI 10.1007/BF01507853; Wrzaczek M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-95; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zappel NF, 2008, CURR OPIN PLANT BIOL, V11, P632, DOI 10.1016/j.pbi.2008.07.002; Zavaliev R, 2010, J EXP BOT, V61, P131, DOI 10.1093/jxb/erp301	91	180	184	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18880	10.1371/journal.pone.0018880	http://dx.doi.org/10.1371/journal.pone.0018880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533090	Green Published, Green Submitted, gold			2022-12-27	WOS:000289719400034
J	Matschiner, M; Hanel, R; Salzburger, W				Matschiner, Michael; Hanel, Reinhold; Salzburger, Walter			On the Origin and Trigger of the Notothenioid Adaptive Radiation	PLOS ONE			English	Article							FISHES TELEOSTEI; NEW-ZEALAND; EVOLUTION; MITOCHONDRIAL; PHYLOGENIES; PERSPECTIVE; SELECTION; DECLINE; GENE	Adaptive radiation is usually triggered by ecological opportunity, arising through (i) the colonization of a new habitat by its progenitor; (ii) the extinction of competitors; or (iii) the emergence of an evolutionary key innovation in the ancestral lineage. Support for the key innovation hypothesis is scarce, however, even in textbook examples of adaptive radiation. Antifreeze glycoproteins (AFGPs) have been proposed as putative key innovation for the adaptive radiation of notothenioid fishes in the ice-cold waters of Antarctica. A crucial prerequisite for this assumption is the concurrence of the notothenioid radiation with the onset of Antarctic sea ice conditions. Here, we use a fossil-calibrated multi-marker phylogeny of nothothenioid and related acanthomorph fishes to date AFGP emergence and the notothenioid radiation. All time-constraints are cross-validated to assess their reliability resulting in six powerful calibration points. We find that the notothenioid radiation began near the Oligocene-Miocene transition, which coincides with the increasing presence of Antarctic sea ice. Divergence dates of notothenioids are thus consistent with the key innovation hypothesis of AFGP. Early notothenioid divergences are furthermore congruent with vicariant speciation and the breakup of Gondwana.	[Matschiner, Michael; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Hanel, Reinhold] Johann Heinrich von Thunen Inst, Inst Fisheries Ecol, Fed Res Inst Rural Areas Forestry & Fisheries, Hamburg, Germany	University of Basel; Johann Heinrich von Thunen Institute	Matschiner, M (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	walter.salzburger@unibas.ch	Salzburger, Walter/G-1598-2011; Hanel, Reinhold/AAO-4887-2021	Salzburger, Walter/0000-0002-9988-1674; Matschiner, Michael/0000-0003-4741-3884	German Research Foundation (DFG); European Research Council (ERC)	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC))	This study was supported by a PhD scholarship of the VolkswagenStiftung priority program 'Evolutionary Biology' for M. M., a grant from the German Research Foundation (DFG) to R. H., and funding from the European Research Council (ERC; Starting Grant 'INTERGENADAPT') to W. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-255; Anderson J.B., 1999, ANTARCTIC MARINE GEO; Anderson M. Eric, 1994, Ichthyological Bulletin of the J. L. B. Smith Institute of Ichthyology, V60, P1; Bakke I, 2005, MAR BIOTECHNOL, V7, P61, DOI 10.1007/s10126-004-3131-0; Balushkin A. V., 1994, Voprosy Ikhtiologii, V34, P298; Balushkin AV, 2000, J ICHTHYOL S1, V40, pS74; BARGELLONI L, 1994, MOL BIOL EVOL, V11, P854; Bargelloni L, 2000, SYST BIOL, V49, P114, DOI 10.1080/10635150050207429; Barker PF, 2007, DEEP-SEA RES PT II, V54, P2388, DOI 10.1016/j.dsr2.2007.07.028; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bilyk KT, 2010, POLAR BIOL, V33, P203, DOI 10.1007/s00300-009-0697-z; CAPE ROBERTS SCIENCE TEAM, 2000, TERRA ANTARTICA, V7, P1; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Chen Wei-Jen, 1998, P287; Cheng CHC, 2003, MOL BIOL EVOL, V20, P1897, DOI 10.1093/molbev/msg208; Cheng Chi-Hing C., 1998, P311; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eastman J. T, 1993, ANTARCTIC FISH BIOL; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; EASTMAN JT, 1991, ANTARCT SCI, V3, P87, DOI 10.1017/S0954102091000123; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Hanel R, 2002, J MOL EVOL, V55, P776, DOI 10.1007/s00239-002-2373-6; Heard Stephen B., 1995, Historical Biology, V10, P151; Henderiks J, 2008, EARTH PLANET SC LETT, V269, P575, DOI 10.1016/j.epsl.2008.03.016; Hofmann GE, 2005, J EXP MAR BIOL ECOL, V316, P79, DOI 10.1016/j.jembe.2004.10.007; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kazancioglu E, 2009, P ROY SOC B-BIOL SCI, V276, P3439, DOI 10.1098/rspb.2009.0876; KENNETT JP, 2004, GEOPHYS MONOGRAPH AM, P345; Lack D., 1947, DARWINS FINCHES; Larter RD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000052; Livermore R, 2005, EARTH PLANET SC LETT, V236, P459, DOI 10.1016/j.epsl.2005.03.027; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Near TJ, 2008, MOL PHYLOGENET EVOL, V47, P832, DOI 10.1016/j.ympev.2007.11.027; Near TJ, 2005, EVOLUTION, V59, P1768, DOI 10.1111/j.0014-3820.2005.tb01825.x; Near TJ, 2004, ANTARCT SCI, V16, P37, DOI 10.1017/S0954102004001798; Nong GT, 2000, GEOPHYS RES LETT, V27, P2689, DOI 10.1029/1999GL011072; OGRADY SM, 1982, J EXP ZOOL, V224, P177, DOI 10.1002/jez.1402240207; Olney MP, 2009, DIATOM RES, V24, P357; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Patterson C., 1993, P621; Pointer MA, 2005, J EXP BIOL, V208, P2363, DOI 10.1242/jeb.01647; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2008, MOL ECOL, V17, P1397, DOI 10.1111/j.1365-294X.2008.03711.x; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Shevenell AE, 2007, DEEP-SEA RES PT II, V54, P2308, DOI 10.1016/j.dsr2.2007.07.018; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stickley CE, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001022; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zwickl DJ., 2006, THESIS	69	91	92	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18911	10.1371/journal.pone.0018911	http://dx.doi.org/10.1371/journal.pone.0018911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533117	Green Published, gold			2022-12-27	WOS:000289620100028
J	Nielsen, JS; Larsen, MH; Lillebaek, EMS; Bergholz, TM; Christiansen, MHG; Boor, KJ; Wiedmann, M; Kallipolitis, BH				Nielsen, Jesper S.; Larsen, Marianne Halberg; Lillebaek, Eva Maria Sternkopf; Bergholz, Teresa M.; Christiansen, Mie H. G.; Boor, Kathryn J.; Wiedmann, Martin; Kallipolitis, Birgitte H.			A Small RNA Controls Expression of the Chitinase ChiA in Listeria monocytogenes	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; MESSENGER-RNA; BACILLUS-SUBTILIS; VIBRIO-CHOLERAE; GENE-EXPRESSION; REGULATORY RNA; NONCODING RNA; PROTEIN HFQ; VIRULENCE; PROMOTERS	In recent years, more than 60 small RNAs (sRNAs) have been identified in the gram-positive human pathogen Listeria monocytogenes, but their putative roles and mechanisms of action remain largely unknown. The sRNA LhrA was recently shown to be a post-transcriptional regulator of a single gene, lmo0850, which encodes a small protein of unknown function. LhrA controls the translation and degradation of the lmo0850 mRNA by an antisense mechanism, and it depends on the RNA chaperone Hfq for efficient binding to its target. In the present study, we sought to gain more insight into the functional role of LhrA in L. monocytogenes. To this end, we determined the effects of LhrA on global-wide gene expression. We observed that nearly 300 genes in L. monocytogenes are either positively or negatively affected by LhrA. Among these genes, we identified lmo0302 and chiA as direct targets of LhrA, thus establishing LhrA as a multiple target regulator. Lmo0302 encodes a hypothetical protein with no known function, whereas chiA encodes one of two chitinases present in L. monocytogenes. We show here that LhrA acts as a post-transcriptional regulator of lmo0302 and chiA by interfering with ribosome recruitment, and we provide evidence that both LhrA and Hfq act to down-regulate the expression of lmo0302 and chiA. Furthermore, in vitro binding experiments show that Hfq stimulates the base pairing of LhrA to chiA mRNA. Finally, we demonstrate that LhrA has a negative effect on the chitinolytic activity of L. monocytogenes. In marked contrast to this, we found that Hfq has a stimulating effect on the chitinolytic activity, suggesting that Hfq plays multiple roles in the complex regulatory pathways controlling the chitinases of L. monocytogenes.	[Nielsen, Jesper S.; Lillebaek, Eva Maria Sternkopf; Christiansen, Mie H. G.; Kallipolitis, Birgitte H.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Larsen, Marianne Halberg] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg, Denmark; [Bergholz, Teresa M.; Boor, Kathryn J.; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	University of Southern Denmark; University of Copenhagen; Cornell University	Nielsen, JS (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	bhk@bmb.sdu.dk	Wiedmann, Martin/A-9683-2008; Bergholz, Teresa M./A-2815-2010; Boor, Kathryn/B-3545-2009	Wiedmann, Martin/0000-0002-4168-5662; Bergholz, Teresa M./0000-0002-3976-5858; Boor, Kathryn/0000-0001-6810-3434; Kallipolitis, Birgitte H./0000-0003-1233-9776; Larsen, Marianne Halberg/0000-0001-6242-6937	Danish Agency for Science Technology and Innovation; National Institutes of Health-National Institute of Allergy and Infectious Diseases [R01 AI052151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052151] Funding Source: NIH RePORTER	Danish Agency for Science Technology and Innovation; National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the Danish Agency for Science Technology and Innovation (to BHK) and National Institutes of Health-National Institute of Allergy and Infectious Diseases R01 AI052151 (to KJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Caramori T, 1998, MOL GEN GENET, V258, P385, DOI 10.1007/s004380050745; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Chaudhuri S, 2010, APPL ENVIRON MICROB, V76, P7302, DOI 10.1128/AEM.01338-10; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gorke B, 2008, GENE DEV, V22, P2914, DOI 10.1101/gad.1717808; Gottesman S., 2010, COLD SPRING HARB PER, DOI [10.1101/cshperspect.a003798, DOI 10.1101/CSHPERSPECT.A003798]; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Larsen MH, 2010, APPL ENVIRON MICROB, V76, P6470, DOI 10.1128/AEM.00297-10; Larsen MH, 2006, MOL MICROBIOL, V61, P1622, DOI 10.1111/j.1365-2958.2006.05328.x; Larsen T, 2011, GLYCOBIOLOGY, V21, P426, DOI 10.1093/glycob/cwq174; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Leisner JJ, 2008, APPL ENVIRON MICROB, V74, P3823, DOI 10.1128/AEM.02701-07; Leisner JJ, 2009, J APPL MICROBIOL, V107, P2080, DOI 10.1111/j.1365-2672.2009.04420.x; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Milner MG, 2001, MICROBIOL-SGM, V147, P2689, DOI 10.1099/00221287-147-10-2689; Nielsen JS, 2008, J BACTERIOL, V190, P6264, DOI 10.1128/JB.00740-08; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Obana N, 2010, MOL MICROBIOL, V77, P1416, DOI 10.1111/j.1365-2958.2010.07258.x; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Ollinger J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	49	54	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e19019	10.1371/journal.pone.0019019	http://dx.doi.org/10.1371/journal.pone.0019019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533114	Green Published, gold			2022-12-27	WOS:000289620100033
J	Valsesia, A; Rimoldi, D; Martinet, D; Ibberson, M; Benaglio, P; Quadroni, M; Waridel, P; Gaillard, M; Pidoux, M; Rapin, B; Rivolta, C; Xenarios, I; Simpson, AJG; Antonarakis, SE; Beckmann, JS; Jongeneel, CV; Iseli, C; Stevenson, BJ				Valsesia, Armand; Rimoldi, Donata; Martinet, Danielle; Ibberson, Mark; Benaglio, Paola; Quadroni, Manfredo; Waridel, Patrice; Gaillard, Muriel; Pidoux, Mireille; Rapin, Blandine; Rivolta, Carlo; Xenarios, Ioannis; Simpson, Andrew J. G.; Antonarakis, Stylianos E.; Beckmann, Jacques S.; Jongeneel, C. Victor; Iseli, Christian; Stevenson, Brian J.			Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic Melanoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CIRCULAR BINARY SEGMENTATION; PROTEIN-COUPLED RECEPTORS; FIBROBLAST-GROWTH-FACTOR; ARRAY CGH DATA; SIGNALING PATHWAYS; HUMAN BREAST; HUMAN CANCER; FRS2 FAMILY; CELL-LINES	Cancer genomes frequently contain somatic copy number alterations (SCNA) that can significantly perturb the expression level of affected genes and thus disrupt pathways controlling normal growth. In melanoma, many studies have focussed on the copy number and gene expression levels of the BRAF, PTEN and MITF genes, but little has been done to identify new genes using these parameters at the genome-wide scale. Using karyotyping, SNP and CGH arrays, and RNA-seq, we have identified SCNA affecting gene expression ('SCNA-genes') in seven human metastatic melanoma cell lines. We showed that the combination of these techniques is useful to identify candidate genes potentially involved in tumorigenesis. Since few of these alterations were recurrent across our samples, we used a protein network-guided approach to determine whether any pathways were enriched in SCNA-genes in one or more samples. From this unbiased genome-wide analysis, we identified 28 significantly enriched pathway modules. Comparison with two large, independent melanoma SCNA datasets showed less than 10% overlap at the individual gene level, but network-guided analysis revealed 66% shared pathways, including all but three of the pathways identified in our data. Frequently altered pathways included WNT, cadherin signalling, angiogenesis and melanogenesis. Additionally, our results emphasize the potential of the EPHA3 and FRS2 gene products, involved in angiogenesis and migration, as possible therapeutic targets in melanoma. Our study demonstrates the utility of network-guided approaches, for both large and small datasets, to identify pathways recurrently perturbed in cancer.	[Valsesia, Armand; Rimoldi, Donata; Jongeneel, C. Victor; Iseli, Christian; Stevenson, Brian J.] Ludwig Inst Canc Res, Lausanne, Switzerland; [Valsesia, Armand; Ibberson, Mark; Xenarios, Ioannis; Jongeneel, C. Victor; Iseli, Christian; Stevenson, Brian J.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Valsesia, Armand; Benaglio, Paola; Rivolta, Carlo; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Martinet, Danielle; Gaillard, Muriel; Pidoux, Mireille; Rapin, Blandine; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Quadroni, Manfredo; Waridel, Patrice] Ctr Integrat Genom, Prot Anal Facil, Lausanne, Switzerland; [Simpson, Andrew J. G.] Ludwig Inst Canc Res, New York, NY USA; [Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Jongeneel, C. Victor] Univ Illinois, Inst Genom Biol, Champaign, IL USA; [Jongeneel, C. Victor] Univ Illinois, Natl Ctr Supercomp Applicat, Champaign, IL USA	Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ludwig Institute for Cancer Research; University of Geneva; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Valsesia, A (corresponding author), Ludwig Inst Canc Res, Lausanne, Switzerland.	Christian.Iseli@unil.ch; Brian.Stevenson@unil.ch	Xenarios, Ioannis/ABD-5045-2021; Beckmann, Jacques S/A-9772-2008; Jongeneel, Cornelis V/B-2135-2012; Antonarakis, Stylianos E/N-8866-2014; Iseli, Christian/AAM-3878-2020; Valsesia, Armand/F-1724-2010	Xenarios, Ioannis/0000-0002-3413-6841; Beckmann, Jacques S/0000-0002-9741-1900; Antonarakis, Stylianos E/0000-0001-8907-5823; Iseli, Christian/0000-0002-2296-2863; Rivolta, Carlo/0000-0002-0733-9950; Jongeneel, Cornelis Victor/0000-0002-3922-1906; Quadroni, Manfredo/0000-0002-2720-4084; Ibberson, Mark/0000-0003-3152-5670; Valsesia, Armand/0000-0003-0746-9664	Ludwig Institute for Cancer Research Ltd.	Ludwig Institute for Cancer Research Ltd.	This work was supported by the Ludwig Institute for Cancer Research Ltd. (www.licr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PMS, 2003, CANCER RES, V63, P8476; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BECHER R, 1983, CANCER RES, V43, P5010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen HIH, 2008, BIOINFORMATICS, V24, P1749, DOI 10.1093/bioinformatics/btn321; Chiari R, 2000, CANCER RES, V60, P4855; Colzani M, 2008, MOL CELL PROTEOMICS, V7, P927, DOI 10.1074/mcp.M700440-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gast A, 2010, GENE CHROMOSOME CANC, V49, P733, DOI 10.1002/gcc.20785; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiser LM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r31; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Jin M, 2008, CANCER SCI, V99, P1656, DOI 10.1111/j.1349-7006.2008.00866.x; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klijn C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000631; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lee HJ, 2008, PIGM CELL MELANOMA R, V21, P415, DOI 10.1111/j.1755-148X.2008.00478.x; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Ma DX, 2010, ANN HEMATOL, V89, P155, DOI 10.1007/s00277-009-0790-y; Martinet D, 2008, AM J MED GENET A, V146A, P2094, DOI 10.1002/ajmg.a.32414; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mitelman F, 2010, MITELMAN DATABASE CH; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OZISIK YY, 1994, CANCER GENET CYTOGEN, V77, P69, DOI 10.1016/0165-4608(94)90152-X; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pende D, 2002, CANCER RES, V62, P6178; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Sato T, 2009, EXPERT OPIN THER TAR, V13, P689, DOI 10.1517/14728220902942330; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Staaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-382; Stahl JM, 2003, CANCER RES, V63, P2881; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tatsumi T, 2003, CANCER RES, V63, P4481; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VANRAAMSDONK CD, 2010, N ENGL J MED; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	93	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18369	10.1371/journal.pone.0018369	http://dx.doi.org/10.1371/journal.pone.0018369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494657	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000289292800011
J	Bertolo, A; Pepino, M; Adams, J; Magnan, P				Bertolo, Andrea; Pepino, Marc; Adams, Julie; Magnan, Pierre			Behavioural Thermoregulatory Tactics in Lacustrine Brook Charr, Salvelinus fontinalis	PLOS ONE			English	Article							THERMAL BIOLOGY; TEMPERATURE REGULATION; LOCOMOTOR-ACTIVITY; NEIGHBOR MATRICES; ECOLOGICAL DATA; BROWN TROUT; GROWTH; PHYSIOLOGY; FISHES; SALMON	The need to vary body temperature to optimize physiological processes can lead to thermoregulatory behaviours, particularly in ectotherms. Despite some evidence of within-population phenotypic variation in thermal behaviour, the occurrence of alternative tactics of this behaviour is rarely explicitly considered when studying natural populations. The main objective of this study was to determine whether different thermal tactics exist among individuals of the same population. We studied the behavioural thermoregulation of 33 adult brook charr in a stratified lake using thermo-sensitive radio transmitters that measured hourly individual temperature over one month. The observed behavioural thermoregulatory patterns were consistent between years and suggest the existence of four tactics: two "warm'' tactics with both crepuscular and finer periodicities, with or without a diel periodicity, and two "cool'' tactics, with or without a diel periodicity. Telemetry data support the above findings by showing that the different tactics are associated with different patterns of diel horizontal movements. Taken together, our results show a clear spatio-temporal segregation of individuals displaying different tactics, suggesting a reduction of niche overlap. To our knowledge, this is the first study showing the presence of behavioural thermoregulatory tactics in a vertebrate.	[Bertolo, Andrea; Pepino, Marc; Adams, Julie; Magnan, Pierre] Univ Quebec, Ctr Rech Interact Basins Versants Ecosyst Aquat R, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Magnan, P (corresponding author), Univ Quebec, Ctr Rech Interact Basins Versants Ecosyst Aquat R, Trois Rivieres, PQ GA9 5H7, Canada.	Pierre.Magnan@uqtr.ca	Magnan, Pierre/U-9342-2019	Magnan, Pierre/0000-0003-3122-7163; Bertolo, Andrea/0000-0002-6018-816X	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs)	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair Program to P. Magnan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Aubret F, 2010, J EXP BIOL, V213, P242, DOI 10.1242/jeb.035931; Azumaya T, 2005, FISH OCEANOGR, V14, P81, DOI 10.1111/j.1365-2419.2004.00323.x; BEAMISH FWH, 1964, CAN J ZOOLOG, V42, P177, DOI 10.1139/z64-016; Besson AA, 2010, OECOLOGIA, V163, P571, DOI 10.1007/s00442-010-1571-y; BEUCHAT CA, 1987, ECOL MONOGR, V57, P45, DOI 10.2307/1942638; Bicego KC, 2007, COMP BIOCHEM PHYS A, V147, P616, DOI 10.1016/j.cbpa.2006.06.032; Biro PA, 1998, T AM FISH SOC, V127, P212, DOI 10.1577/1548-8659(1998)127<0212:SCBTDS>2.0.CO;2; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BOUJARD T, 1992, ENVIRON BIOL FISH, V35, P109, DOI 10.1007/BF00002186; Bourke P, 1996, J FISH BIOL, V49, P1174; Bourke P, 1997, J FISH BIOL, V51, P783, DOI 10.1111/j.1095-8649.1997.tb01999.x; BRANDT SB, 1980, T AM FISH SOC, V109, P469, DOI 10.1577/1548-8659(1980)109<469:SSOAAY>2.0.CO;2; BRETT JR, 1971, AM ZOOL, V11, P99; Dorcas ME, 1997, PHYSIOL ZOOL, V70, P292, DOI 10.1086/639601; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; Fry F.E.J., 1947, U TORONTO STUD BIOL, V55, P1; Fry F.E.J, 1947, U TORONTO STUDIES BI, V55; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Grans A, 2010, J EXP BIOL, V213, P3198, DOI 10.1242/jeb.043570; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2006, ANAL STAT DONNEES SP, P425; MAGNAN P, 1988, CAN J FISH AQUAT SCI, V45, P999, DOI 10.1139/f88-123; MAGNUSON JJ, 1990, T AM FISH SOC, V119, P254, DOI 10.1577/1548-8659(1990)119<0254:PCITTH>2.3.CO;2; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Magoulick DD, 1998, T AM FISH SOC, V127, P708, DOI 10.1577/1548-8659(1998)127<0708:EOTAMO>2.0.CO;2; MEDVICK PA, 1981, COPEIA, P9; NEILL WH, 1974, T AM FISH SOC, V103, P663, DOI 10.1577/1548-8659(1974)103<663:DEABTO>2.0.CO;2; NEVERMAN D, 1994, OECOLOGIA, V98, P247, DOI 10.1007/BF00324211; Ojanguren AF, 2001, J THERM BIOL, V26, P165, DOI 10.1016/S0306-4565(00)00038-3; Oksanen J, 2007, MULTIVARIATE ANAL EC; Power G, 1980, CHARRS SALMONID FISH, P141; Proulx R, 2004, EVOL ECOL RES, V6, P503; R Development Core Team, 2007, R LANG ENV STAT COMP; REYNOLDS WW, 1978, COMP BIOCHEM PHYS A, V59, P225, DOI 10.1016/0300-9629(78)90211-6; REYNOLDS WW, 1979, HYDROBIOLOGIA, V62, P79, DOI 10.1007/BF00012567; Roscoe DW, 2010, ECOL FRESHW FISH, V19, P51, DOI 10.1111/j.1600-0633.2009.00388.x; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; SCHWARZKOPF L, 1991, OECOLOGIA, V88, P562, DOI 10.1007/BF00317720; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; WINTER DW, 1983, FISHERIES TECHNIQUES, P371; Wismer DA, 1987, GREAT LAKES FISHERY, V87-3; Xu CL, 2010, FRESHWATER BIOL, V55, P2253, DOI 10.1111/j.1365-2427.2010.02430.x	52	25	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18603	10.1371/journal.pone.0018603	http://dx.doi.org/10.1371/journal.pone.0018603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490935	Green Submitted, Green Published, gold			2022-12-27	WOS:000289238700027
J	Yi, JZ; Liu, CQ				Yi, Jianzhong; Liu, Chengqian			Efficient Silencing of Gene Expression by an ASON-Bulge-DNAzyme Complex	PLOS ONE			English	Article							CLEAVING DNA ENZYME; NUCLEIC-ACIDS; MESSENGER-RNA; ANTISENSE OLIGONUCLEOTIDES; HAMMERHEAD RIBOZYMES; CELLULAR UPTAKE; INTERFERENCE; DEOXYRIBOZYMES; INHIBITION; MECHANISM	Background: DNAzymes are DNA molecules that can directly cleave cognate mRNA, and have been developed to silence gene expression for research and clinical purposes. The advantage of DNAzymes over ribozymes is that they are inexpensive to produce and exhibit good stability. The "10-23 DNA enzyme'' is composed of a catalytic domain of 15 deoxynucleotides, flanked by two substrate-recognition domains of approximately eight nucleotides in each direction, which provides the complementary sequence required for specific binding to RNA substrates. However, these eight nucleotides might not afford sufficient binding energy to hold the RNA substrate along with the DNAzyme, which would interfere with the efficiency of the DNAzyme or cause side effects, such as the cleavage of non-cognate mRNAs. Methodology: In this study, we inserted a nonpairing bulge at the 59 end of the "10-23 DNA enzyme'' to enhance its efficiency and specificity. Different sizes of bulges were inserted at different positions in the 59 end of the DNAzyme. The non-matching bulge will avoid strong binding between the DNAzyme and target mRNA, which may interfere with the efficiency of the DNAzyme. Conclusions: Our novel DNAzyme constructs could efficiently silence the expression of target genes, proving a powerful tool for gene silencing. The results showed that the six oligo bulge was the most effective when the six oligo bulge was 12-15 bp away from the core catalytic domain.	[Yi, Jianzhong; Liu, Chengqian] Shanghai Acad Agr Sci, Inst Anim Husb Vet Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Yi, JZ (corresponding author), Shanghai Acad Agr Sci, Inst Anim Husb Vet Sci, Shanghai, Peoples R China.	yijianzhong@yahoo.com			Science and Technology Commission of Shanghai Municipality [07pj14074]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was sponsored by the Pujiang Program from Science and Technology Commission of Shanghai Municipality (Project no. 07pj14074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 1998, CURR OPIN CHEM BIOL, V2, P519, DOI 10.1016/S1367-5931(98)80129-4; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Breaker RR, 2000, SCIENCE, V290, P2095, DOI 10.1126/science.290.5499.2095; Breaker RR, 2004, NATURE, V432, P838, DOI 10.1038/nature03195; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chan SH, 2011, NUCLEIC ACIDS RES, V39, P1, DOI 10.1093/nar/gkq742; Dass CR, 2002, ANTISENSE NUCLEIC A, V12, P289, DOI 10.1089/108729002761381276; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Emilsson GM, 2002, CELL MOL LIFE SCI, V59, P596, DOI 10.1007/s00018-002-8452-4; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Franzen S, 2010, CURR OPIN MOL THER, V12, P223; GALDERISI U, 1990, J CELL PHYSL, V181, P251; GAO WY, 1992, MOL PHARMACOL, V41, P223; Gewirtz A M, 1998, Curr Opin Hematol, V5, P59; GUVAKOVA MA, 1995, J BIOL CHEM, V270, P2620, DOI 10.1074/jbc.270.6.2620; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; Lam JCF, 2010, J MOL BIOL, V400, P689, DOI 10.1016/j.jmb.2010.05.047; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Mastroyiannopoulos NP, 2010, MOLECULES, V15, P5460, DOI 10.3390/molecules15085460; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; NIELSEN PE, 1993, ANTI-CANCER DRUG DES, V8, P53; Ota N, 1998, NUCLEIC ACIDS RES, V26, P3385, DOI 10.1093/nar/26.14.3385; PATERSON BM, 1977, P NATL ACAD SCI USA, V74, P4370, DOI 10.1073/pnas.74.10.4370; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2009, NUCLEIC ACIDS RES, V37, P413, DOI 10.1093/nar/gkn930; Schubert S, 2003, NUCLEIC ACIDS RES, V31, P5982, DOI 10.1093/nar/gkg791; Schubert S, 2004, CURR DRUG TARGETS, V5, P667, DOI 10.2174/1389450043345092; Silverman SK, 2010, ANGEW CHEM INT EDIT, V49, P7180, DOI 10.1002/anie.200906345; Sun LQ, 2000, PHARMACOL REV, V52, P325; Wang TH, 2008, OLIGONUCLEOTIDES, V18, P295, DOI 10.1089/oli.2008.0138; WERNER M, 1995, NUCLEIC ACIDS RES, V23, P2092, DOI 10.1093/nar/23.12.2092; Wong Jonathan P, 2010, Front Biosci (Schol Ed), V2, P791; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280	43	2	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18629	10.1371/journal.pone.0018629	http://dx.doi.org/10.1371/journal.pone.0018629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490924	Green Submitted, Green Published, gold			2022-12-27	WOS:000289238700030
J	Campbell, JH; Burdo, TH; Autissier, P; Bombardier, JP; Westmoreland, SV; Soulas, C; Gonzalez, RG; Ratai, EM; Williams, KC				Campbell, Jennifer H.; Burdo, Tricia H.; Autissier, Patrick; Bombardier, Jeffrey P.; Westmoreland, Susan V.; Soulas, Caroline; Gonzalez, R. Gilberto; Ratai, Eva-Maria; Williams, Kenneth C.			Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; AMYOTROPHIC-LATERAL-SCLEROSIS; PERIVASCULAR MACROPHAGES; NONHUMAN PRIMATE; HIV-INFECTION; CD8(+) LYMPHOCYTES; TYPE-1 INFECTION; T-CELLS; DEMENTIA; DISEASE	Background: Minocycline is a tetracycline antibiotic that has been proposed as a potential conjunctive therapy for HIV-1 associated cognitive disorders. Precise mechanism(s) of minocycline's functions are not well defined. Methods: Fourteen rhesus macaques were SIV infected and neuronal metabolites measured by proton magnetic resonance spectroscopy ((1)H MRS). Seven received minocycline (4 mg/kg) daily starting at day 28 post-infection (pi). Monocyte expansion and activation were assessed by flow cytometry, cell traffic to lymph nodes, CD16 regulation, viral replication, and cytokine production were studied. Results: Minocycline treatment decreased plasma virus and pro-inflammatory CD14+CD16+ and CD14(lo)CD16+ monocytes, and reduced their expression of CD11b, CD163, CD64, CCR2 and HLA-DR. There was reduced recruitment of monocyte/macrophages and productively infected cells in axillary lymph nodes. There was an inverse correlation between brain NAA/Cr (neuronal injury) and circulating CD14+CD16+ and CD14(lo)CD16+ monocytes. Minocycline treatment in vitro reduced SIV replication CD16 expression on activated CD14+CD16+ monocytes, and IL-6 production by monocytes following LPS stimulation. Conclusion: Neuroprotective effects of minocycline are due in part to reduction of activated monocytes, monocyte traffic. Mechanisms for these effects include CD16 regulation, reduced viral replication, and inhibited immune activation.	[Campbell, Jennifer H.; Burdo, Tricia H.; Autissier, Patrick; Soulas, Caroline; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Gonzalez, R. Gilberto; Ratai, Eva-Maria] Harvard Univ, Sch Med, Boston, MA USA; [Bombardier, Jeffrey P.; Westmoreland, Susan V.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gonzalez, R. Gilberto; Ratai, Eva-Maria] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Gonzalez, R. Gilberto; Ratai, Eva-Maria] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Boston College; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Campbell, JH (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	williauy@bc.edu		Ratai, Eva-Maria/0000-0001-9476-6207	NIH [RO1NS40237, R01NS37654, U19MH081835, R01NS06897, R21NS059331, R01NS050041]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081835, R25MH080663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059331, R01NS040237, R01NS050041, R01NS037654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (www.nih.gov) grants RO1NS40237 (KCW), R01NS37654(KCW), U19MH081835 (KCW), R01NS06897 (KCW), R21NS059331 (EMR), and R01NS050041 (RGG). In vivo CD8 T lymphocyte depletion antibodies used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (nhpreagents.bidmc.harvard.edu; R24 RR016001, N01 AI040101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061; BROGDEN RN, 1975, DRUGS, V9, P251, DOI 10.2165/00003495-197509040-00005; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Chen-Roetling J, 2009, BIOCHEM BIOPH RES CO, V386, P322, DOI 10.1016/j.bbrc.2009.06.026; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; GRANT I, 1987, ANN INTERN MED, V107, P828, DOI 10.7326/0003-4819-107-6-828; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kim WK, 2005, NEUROTOX RES, V8, P107, DOI 10.1007/BF03033823; Kim WK, 2003, J LEUKOCYTE BIOL, V74, P650, DOI 10.1189/jlb.0503207; Kim WK, 2010, J LEUKOCYTE BIOL, V87, P557, DOI 10.1189/jlb.0209082; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Otani I, 1999, MICROBES INFECT, V1, P977, DOI 10.1016/S1286-4579(99)80515-2; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rappaport J, 1999, J LEUKOCYTE BIOL, V65, P458, DOI 10.1002/jlb.65.4.458; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; RINGLER DJ, 1989, AM J PATHOL, V134, P373; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Sakellari D, 2000, J CLIN PERIODONTOL, V27, P53, DOI 10.1034/j.1600-051x.2000.027001053.x; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; SHAN S, 2009, NEUROBIOL AGING; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Soulas C, 2009, AM J PATHOL, V174, P1808, DOI 10.2353/ajpath.2009.081010; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zhao CH, 2007, NEUROBIOL DIS, V26, P36, DOI 10.1016/j.nbd.2006.11.012; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	55	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18688	10.1371/journal.pone.0018688	http://dx.doi.org/10.1371/journal.pone.0018688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494695	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400043
J	Yuan, YY; Li, CT; Windram, O				Yuan, Yinyin; Li, Chang-Tsun; Windram, Oliver			Directed Partial Correlation: Inferring Large-Scale Gene Regulatory Network through Induced Topology Disruptions	PLOS ONE			English	Article							METABOLISM; COLD; ABA; DNA	Inferring regulatory relationships among many genes based on their temporal variation in transcript abundance has been a popular research topic. Due to the nature of microarray experiments, classical tools for time series analysis lose power since the number of variables far exceeds the number of the samples. In this paper, we describe some of the existing multivariate inference techniques that are applicable to hundreds of variables and show the potential challenges for small-sample, large-scale data. We propose a directed partial correlation (DPC) method as an efficient and effective solution to regulatory network inference using these data. Specifically for genomic data, the proposed method is designed to deal with large-scale datasets. It combines the efficiency of partial correlation for setting up network topology by testing conditional independence, and the concept of Granger causality to assess topology change with induced interruptions. The idea is that when a transcription factor is induced artificially within a gene network, the disruption of the network by the induction signifies a genes role in transcriptional regulation. The benchmarking results using GeneNetWeaver, the simulator for the DREAM challenges, provide strong evidence of the outstanding performance of the proposed DPC method. When applied to real biological data, the inferred starch metabolism network in Arabidopsis reveals many biologically meaningful network modules worthy of further investigation. These results collectively suggest DPC is a versatile tool for genomics research. The R package DPC is available for download (http://code.google.com/p/dpcnet/).	[Yuan, Yinyin] Cambridge Res Inst, Canc Res UK, Cambridge, England; [Yuan, Yinyin] Univ Cambridge, Dept Oncol, Cambridge, England; [Li, Chang-Tsun] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Windram, Oliver] Univ Warwick, Warwick Hort Res Inst, Wellesbourne, Warwick, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Warwick; University of Warwick	Yuan, YY (corresponding author), Cambridge Res Inst, Canc Res UK, Cambridge, England.	yy341@cam.ac.uk	Li, Chang-Tsun/C-1125-2018	Li, Chang-Tsun/0000-0003-4735-6138; Yuan, Yinyin/0000-0002-8556-4707	Department of Computer Science at the University of Warwick; Warwick HRI	Department of Computer Science at the University of Warwick; Warwick HRI	This work was supported by the Department of Computer Science at the University of Warwick through a PhD Studentship for Yinyin Yuan to conduct the work under Chang-Tsun Li's supervision. Oliver Windram is supported by Warwick HRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P459; Bro R, 2002, J CHEMOMETR, V16, P387, DOI 10.1002/cem.734; Egan J., 1975, SERIES COGNITION PER; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Lebre S, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1294; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; LIN CT, 1992, PLANT PHYSIOL, V99, P519, DOI 10.1104/pp.99.2.519; LTKEPOHL H, 2006, INTRO MULTIPLE TIME; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Marinazzo D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056215; MUKHOPADHYAY NDD, 2006, CAUSALITY PATHWAY SE; Opgen-Rhein R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S3; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Veiga DFT, 2007, GENET MOL RES, V6, P730; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	30	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e16835	10.1371/journal.pone.0016835	http://dx.doi.org/10.1371/journal.pone.0016835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494330	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400002
J	Arama, C; Giusti, P; Bostrom, S; Dara, V; Traore, B; Dolo, A; Doumbo, O; Varani, S; Troye-Blomberg, M				Arama, Charles; Giusti, Pablo; Bostrom, Stephanie; Dara, Victor; Traore, Boubacar; Dolo, Amagana; Doumbo, Ogobara; Varani, Stefania; Troye-Blomberg, Marita			Interethnic Differences in Antigen-Presenting Cell Activation and TLR Responses in Malian Children during Plasmodium falciparum Malaria	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSES; SYMPATRIC ETHNIC-GROUPS; CEREBRAL MALARIA; WEST-AFRICA; PERIPHERAL-BLOOD; T-LYMPHOCYTES; INFECTION; INTERFERON	The Fulani ethnic group from West Africa is relatively better protected against Plasmodium falciparum malaria as compared to other sympatric ethnic groups, such as the Dogon. However, the mechanisms behind this lower susceptibility to malaria are largely unknown, particularly those concerning innate immunity. Antigen-presenting cells (APCs), and in particular dendritic cells (DCs) are important components of the innate and adaptive immune systems. Therefore, in this study we investigated whether APCs obtained from Fulani and Dogon children exhibited differences in terms of activation status and toll-like receptor (TLR) responses during malaria infection. Lower frequency and increased activation was observed in circulating plasmacytoid DCs and BDCA-3(+) myeloid DCs of infected Fulani as compared to their uninfected counterparts. Conversely, a higher frequency and reduced activation was observed in the same DC subsets obtained from peripheral blood of P. falciparum-infected Dogon children as compared to their uninfected peers. Moreover, infected individuals of both ethnic groups exhibited higher percentages of both classical and inflammatory monocytes that were less activated as compared to their non-infected counterparts. In line with APC impairment during malaria infection, TLR4, TLR7 and TLR9 responses were strongly inhibited by P. falciparum infection in Dogon children, while no such TLR inhibition was observed in the Fulani children. Strikingly, the TLR-induced IFN-gamma release was completely abolished in the Dogon undergoing infection while no difference was seen within infected and non-infected Fulani. Thus, P. falciparum infection is associated with altered activation status of important APC subsets and strongly inhibited TLR responses in peripheral blood of Dogon children. In contrast, P. falciparum induces DC activation and does not affect the innate response to specific TLR ligands in Fulani children. These findings suggest that DCs and TLR signalling may be of importance for the protective immunity against malaria observed in the Fulani.	[Arama, Charles; Giusti, Pablo; Bostrom, Stephanie; Varani, Stefania; Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Arama, Charles; Dara, Victor; Traore, Boubacar; Dolo, Amagana; Doumbo, Ogobara] Univ Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali; [Varani, Stefania] Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Huddinge, Sweden; [Varani, Stefania] Univ Bologna, Dept Haematol & Clin Oncol, Bologna, Italy	Stockholm University; University of Bamako; Karolinska Institutet; Karolinska University Hospital; University of Bologna	Arama, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden.	charles.arama@wgi.su.se	Troye-Blomberg, Marita/B-9210-2016; Varani, Stefania/AAZ-1856-2021	Troye-Blomberg, Marita/0000-0002-2804-0325; VARANI, STEFANIA/0000-0003-0862-4937	Swedish Agency for Research and Development [Sida/SAREC SWE 1995-117]; European and Developing Countries [EDCTP CG-TA 05 40204_003]; BioMalPar European Network of Excellence [LSHP-CT-2004-503578]; European Community [FP7/2007-2013, 242095]	Swedish Agency for Research and Development; European and Developing Countries; BioMalPar European Network of Excellence; European Community(European Commission)	This work was supported by grants from the Swedish Agency for Research and Development with Developing Countries, http://www.sida.se (Sida/SAREC SWE 1995-117), the European and Developing Countries Clinical Partnership's grant, http://www.edctp.org (EDCTP CG-TA 05 40204_003), as well as a grant within the BioMalPar European Network of Excellence, http://www.biomalpar.org (LSHP-CT-2004-503578) and from the European Community's Seventh Framework Programme, http://www.evimalar.org/ (FP7/2007-2013) under grant agreement No 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bereczky S, 2006, T ROY SOC TROP MED H, V100, P248, DOI 10.1016/j.trstmh.2005.03.011; Bolad A, 2005, SCAND J IMMUNOL, V61, P380, DOI 10.1111/j.1365-3083.2005.01587.x; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Chimma P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000631; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; DeSouza JB, 1997, INFECT IMMUN, V65, P1593, DOI 10.1128/IAI.65.5.1593-1598.1997; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Farouk SE, 2005, MICROBES INFECT, V7, P110, DOI 10.1016/j.micinf.2004.09.012; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Israelsson E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-175; Jaworowski A, 2007, J INFECT DIS, V196, P38, DOI 10.1086/518443; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Luoni G, 2001, GENES IMMUN, V2, P411, DOI 10.1038/sj.gene.6363797; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; McCall MBB, 2010, J INFECT DIS, V201, P142, DOI 10.1086/648596; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Ogonda LA, 2010, INFECT IMMUN, V78, P2173, DOI 10.1128/IAI.01078-09; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Pinto LA, 2005, CYTOM PART B-CLIN CY, V63B, P47, DOI 10.1002/cyto.b.20038; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Todryk SM, 2008, FUTURE MICROBIOL, V3, P279, DOI 10.2217/17460913.3.3.279; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Vafa M, 2009, ACTA TROP, V109, P12, DOI 10.1016/j.actatropica.2008.09.001; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	63	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18319	10.1371/journal.pone.0018319	http://dx.doi.org/10.1371/journal.pone.0018319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483827	Green Published, gold			2022-12-27	WOS:000289057200056
J	Cheng, SB; Ferland, P; Webster, P; Bearer, EL				Cheng, Shi-Bin; Ferland, Paulette; Webster, Paul; Bearer, Elaine L.			Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; TYPE-1 GLYCOPROTEIN-E; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; ANTEROGRADE TRANSPORT; PSEUDORABIES VIRUS; NEURONAL AXONS; FC-RECEPTOR; IN-VITRO; IMMUNOELECTRON MICROSCOPY	Herpes simplex type 1 (HSV1) replicates in epithelial cells and secondarily enters local sensory neuronal processes, traveling retrograde to the neuronal nucleus to enter latency. Upon reawakening newly synthesized viral particles travel anterograde back to the epithelial cells of the lip, causing the recurrent cold sore. HSV1 co-purifies with amyloid precursor protein (APP), a cellular transmembrane glycoprotein and receptor for anterograde transport machinery that when proteolyzed produces A-beta, the major component of senile plaques. Here we focus on transport inside epithelial cells of newly synthesized virus during its transit to the cell surface. We hypothesize that HSV1 recruits cellular APP during transport. We explore this with quantitative immuno-fluorescence, immuno-gold electron-microscopy and live cell confocal imaging. After synchronous infection most nascent VP26-GFP-labeled viral particles in the cytoplasm co-localize with APP (72.8+/-6.7%) and travel together with APP inside living cells (81.1+/-28.9%). This interaction has functional consequences: HSV1 infection decreases the average velocity of APP particles (from 1.1+/-0.2 to 0.3+/-0.1 mu m/s) and results in APP mal-distribution in infected cells, while interplay with APP-particles increases the frequency (from 10% to 81% motile) and velocity (from 0.3+/-0.1 to 0.4+/-0.1 mu m/s) of VP26-GFP transport. In cells infected with HSV1 lacking the viral Fc receptor, gE, an envelope glycoprotein also involved in viral axonal transport, APP-capsid interactions are preserved while the distribution and dynamics of dual-label particles differ from wild-type by both immuno-fluorescence and live imaging. Knock-down of APP with siRNA eliminates APP staining, confirming specificity. Our results indicate that most intracellular HSV1 particles undergo frequent dynamic interplay with APP in a manner that facilitates viral transport and interferes with normal APP transport and distribution. Such dynamic interactions between APP and HSV1 suggest a mechanistic basis for the observed clinical relationship between HSV1 seropositivity and risk of Alzheimer's disease.	[Cheng, Shi-Bin; Ferland, Paulette; Bearer, Elaine L.] Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02912 USA; [Webster, Paul] House Ear Res Inst, Los Angeles, CA USA; [Bearer, Elaine L.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Bearer, Elaine L.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA	Brown University; House Research Institute; University of New Mexico; University of New Mexico	Cheng, SB (corresponding author), Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02912 USA.	ebearer@salud.unm.edu		Webster, Paul/0000-0002-1980-6931	NIDCD [5 P-30 DC006276-03]; Ahmanson Foundation; Lucille Markey Foundation; NIGMS [GM47368]; NINDS [NS046810, NS062184]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062184, R01NS046810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC006276] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ahmanson Foundation; Lucille Markey Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Grants from the NIDCD (5 P-30 DC006276-03) and the Ahmanson Foundation supported the Imaging Core where the immunoEM part of this work was performed; the Zeiss confocal microscope at Brown University was purchased with funds from the Lucille Markey Foundation (ELB); and the Bearer Laboratories at Brown University and at University of New Mexico are supported by NIGMS GM47368 (ELB), and NINDS NS046810 (ELB) and NS062184 (ELB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinone SE, 2006, J VIROL, V80, P11235, DOI 10.1128/JVI.01441-06; AVITABILE E, 1995, J VIROL, V69, P7472, DOI 10.1128/JVI.69.12.7472-7482.1995; Baker ML, 2006, PLOS COMPUT BIOL, V2, P1313, DOI 10.1371/journal.pcbi.0020146; BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; BAUCKE RB, 1979, J VIROL, V32, P779, DOI 10.1128/JVI.32.3.779-789.1979; Bearer EL, 2000, P NATL ACAD SCI USA, V97, P8146, DOI 10.1073/pnas.97.14.8146; BEARER EL, 1992, J NEUROSCI, V12, P750; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Brown WD, 2010, J CHILD NEUROL, V25, P901, DOI 10.1177/0883073809353449; CAI WZ, 1988, J MOL BIOL, V201, P575, DOI 10.1016/0022-2836(88)90639-0; CAMPADELLI G, 1993, P NATL ACAD SCI USA, V90, P2798, DOI 10.1073/pnas.90.7.2798; CAMPADELLIFIUME G, 1990, J VIROL, V64, P6070, DOI 10.1128/JVI.64.12.6070-6079.1990; CAMPADELLIFIUME G, 1988, J VIROL, V62, P159, DOI 10.1128/JVI.62.1.159-167.1988; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Carter CJ, 2008, NEUROCHEM INT, V52, P920, DOI 10.1016/j.neuint.2007.11.003; Ch'ng TH, 2005, J VIROL, V79, P10875, DOI 10.1128/JVI.79.17.10875-10889.2005; Chermann J C, 1987, Antibiot Chemother (1971), V38, P13; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; del Rio T, 2005, J VIROL, V79, P3903, DOI 10.1128/JVI.79.7.3903-3919.2005; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; DOLLERY SJ, J VIROL IN PRESS; Enquist LW, 2002, VET MICROBIOL, V86, P5, DOI 10.1016/S0378-1135(01)00486-2; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Farnsworth A, 2006, J VIROL, V80, P3167, DOI 10.1128/JVI.80.7.3167-3179.2006; GAJDUSEK DC, 1967, SCIENCE, V155, P212; GERSHON AA, 1994, J VIROL, V68, P6372, DOI 10.1128/JVI.68.10.6372-6390.1994; Granzow H, 2001, J VIROL, V75, P3675, DOI 10.1128/JVI.75.8.3675-3684.2001; Harley CA, 2001, J VIROL, V75, P1236, DOI 10.1128/JVI.75.3.1236-1251.2001; Holland DJ, 1999, J VIROL, V73, P8503, DOI 10.1128/JVI.73.10.8503-8511.1999; HONESS RW, 1973, J VIROL, V12, P1347, DOI 10.1128/JVI.12.6.1347-1365.1973; JOHANSSON PJH, 1985, J VIROL, V56, P489, DOI 10.1128/JVI.56.2.489-494.1985; JOHNSON DC, 1983, CELL, V32, P987, DOI 10.1016/0092-8674(83)90083-1; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KOMURO M, 1989, EUR J CELL BIOL, V50, P398; Kotsakis A, 2001, J VIROL, V75, P8697, DOI 10.1128/JVI.75.18.8697-8711.2001; KRISTENSSON K, 1986, J GEN VIROL, V67, P2023, DOI 10.1099/0022-1317-67-9-2023; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LaVail JH, 2007, NEUROSCIENCE, V146, P974, DOI 10.1016/j.neuroscience.2007.02.010; Lee GE, 2006, J VIROL, V80, P4264, DOI 10.1128/JVI.80.9.4264-4275.2006; Lengyel J, 2002, J VIROL, V76, P11866, DOI 10.1128/JVI.76.23.11866-11879.2002; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; LYCKE E, 1984, J GEN VIROL, V65, P55, DOI 10.1099/0022-1317-65-1-55; LYCKE E, 1988, ARCH VIROL, V101, P87, DOI 10.1007/BF01314654; MARESCH C, 2010, J VIROL; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Ohara PT, 2000, J VIROL, V74, P4776, DOI 10.1128/JVI.74.10.4776-4786.2000; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Remillard-Labrosse G, 2009, TRAFFIC, V10, P1074, DOI 10.1111/j.1600-0854.2009.00939.x; Saldanha CE, 2000, J VIROL, V74, P6712, DOI 10.1128/JVI.74.15.6712-6719.2000; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Satpute-Krishnan P, 2003, AGING CELL, V2, P305, DOI 10.1046/j.1474-9728.2003.00069.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; SNYDER A, 2008, J VIROL; Snyder A, 2008, J VIROL, V82, P10613, DOI 10.1128/JVI.01241-08; Snyder A, 2007, J VIROL, V81, P8337, DOI 10.1128/JVI.00520-07; Snyder A, 2006, J VIROL, V80, P11165, DOI 10.1128/JVI.01107-06; Sprague ER, 2006, PLOS BIOL, V4, P975, DOI 10.1371/journal.pbio.0040148; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2006, J PHYSIOL-PARIS, V99, P193, DOI 10.1016/j.jphysparis.2005.12.085; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Tomishima MJ, 2002, J VIROL, V76, P8310, DOI 10.1128/JVI.76.16.8310-8317.2002; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Wang FS, 2005, J VIROL, V79, P13362, DOI 10.1128/JVI.79.21.13362-13372.2005; Wang F, 2010, VIROLOGY, V405, P269, DOI 10.1016/j.virol.2010.06.006; Ward PL, 1998, VIROLOGY, V241, P189, DOI 10.1006/viro.1997.8972; WASCO W, 1993, ANN NY ACAD SCI, V695, P203, DOI 10.1111/j.1749-6632.1993.tb23053.x; WHEALY ME, 1992, J VIROL, V66, P3803, DOI 10.1128/JVI.66.6.3803-3810.1992; Whiteley A, 1999, J VIROL, V73, P9515, DOI 10.1128/JVI.73.11.9515-9520.1999; Willard M, 2002, J VIROL, V76, P5220, DOI 10.1128/JVI.76.10.5220-5232.2002; Wisner T, 2000, J VIROL, V74, P2278, DOI 10.1128/JVI.74.5.2278-2287.2000; Wisner TW, 2004, J VIROL, V78, P11519, DOI 10.1128/JVI.78.21.11519-11535.2004; Wolfstein A, 2006, TRAFFIC, V7, P227, DOI 10.1111/j.1600-0854.2005.00379.x; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	100	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17966	10.1371/journal.pone.0017966	http://dx.doi.org/10.1371/journal.pone.0017966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483850	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200015
J	Mochel, F; Durant, B; Durr, A; Schiffmann, R				Mochel, Fanny; Durant, Brandon; Durr, Alexandra; Schiffmann, Raphael			Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 Mice	PLOS ONE			English	Article							PRECLINICAL HUNTINGTONS-DISEASE; FOCUSED MICROWAVE IRRADIATION; TRANSGENIC MOUSE MODEL; EXPRESSION; STRIATUM; CHOREA; DYSREGULATION; NEUROGENESIS; SYMPTOMS; BEHAVIOR	The pattern of cerebral dopamine (DA) abnormalities in Huntington disease (HD) is complex, as reflected by the variable clinical benefit of both DA antagonists and agonists in treating HD symptoms. In addition, little is known about serotonin metabolism despite the early occurrence of anxiety and depression in HD. Post-mortem enzymatic changes are likely to interfere with the in vivo profile of biogenic amines. Hence, in order to reliably characterize the regional and chronological profile of brain neurotransmitters in a HD mouse model, we used a microwave fixation system that preserves in vivo concentrations of dopaminergic and serotoninergic amines. DA was decreased in the striatum of R6/2 mice at 8 and 12 weeks of age while DA metabolites, 3-methoxytyramine and homovanillic acid, were already significantly reduced in 4-week-old motorically asymptomatic R6/2 mice. In the striatum, hippocampus and frontal cortex of 4, 8 and 12-week-old R6/2 mice, serotonin and its metabolite 5-hydroxyindoleacetic acid were significantly decreased in association with a decreased turnover of serotonin. In addition, automated high-resolution behavioural analyses displayed stress-like behaviours such as jumping and grooming and altered spatial learning in R6/2 mice at age 4 and 6 weeks respectively. Therefore, we describe the earliest alterations of DA and serotonin metabolism in a HD murine model. Our findings likely underpin the neuropsychological symptoms at time of disease onset in HD.	[Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, Inst Cerveau & Moelle, INSERM UMR S975, Paris, France; [Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Mochel, Fanny] Univ Paris 06, Paris, France; [Mochel, Fanny; Durant, Brandon; Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Baylor Scott & White Health; Baylor University Medical Center	Mochel, F (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle, INSERM UMR S975, Paris, France.	fanny.mochel@upmc.fr	Durant, Brandon/HCH-8003-2022	Durant, Brandon/0000-0003-3028-6161	Cure Huntington's Disease Initiative Foundation (CHDI) in New York	Cure Huntington's Disease Initiative Foundation (CHDI) in New York	This work was funded by the Cure Huntington's Disease Initiative Foundation (CHDI) in New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1987, J NEUROCHEM, V48, P390, DOI 10.1111/j.1471-4159.1987.tb04106.x; CARACENI T, 1977, J NEUROL NEUROSUR PS, V40, P581, DOI 10.1136/jnnp.40.6.581; CROSS A, 1983, EUR J PHARMACOL, V88, P223, DOI 10.1016/0014-2999(83)90009-2; CUNHA L, 1981, J NEUROL NEUROSUR PS, V44, P258, DOI 10.1136/jnnp.44.3.258; Delaney SM, 1996, J NEUROSCI METH, V64, P151, DOI 10.1016/0165-0270(95)00119-0; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Gonzalez-Burgos I, 2008, PROG BRAIN RES, V172, P603, DOI 10.1016/S0079-6123(08)00928-X; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haskins, 2000, Curr Treat Options Neurol, V2, P243, DOI 10.1007/s11940-000-0007-0; Hickey MA, 2002, J NEUROCHEM, V81, P46, DOI 10.1046/j.1471-4159.2002.00804.x; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Johnson MA, 2007, J NEUROCHEM, V103, P2102, DOI 10.1111/j.1471-4159.2007.04908.x; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Karolewicz B, 1998, POL J PHARMACOL, V50, P425; Kloppel S, 2010, NEUROPSYCHOLOGIA, V48, P549, DOI 10.1016/j.neuropsychologia.2009.10.016; Lawrence AD, 1998, BRAIN, V121, P1343, DOI 10.1093/brain/121.7.1343; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; Ortiz AN, 2010, J NEUROCHEM, V112, P755, DOI 10.1111/j.1471-4159.2009.06501.x; Pandaranandaka J, 2009, BEHAV BRAIN RES, V198, P142, DOI 10.1016/j.bbr.2008.10.043; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Peng Q, 2008, EXP NEUROL, V210, P154, DOI 10.1016/j.expneurol.2007.10.015; Reynolds GP, 1999, J NEUROCHEM, V72, P1773, DOI 10.1046/j.1471-4159.1999.721773.x; Rudenko O, 2009, BEHAV BRAIN RES, V203, P188, DOI 10.1016/j.bbr.2009.04.034; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; STAHL SM, 1986, ARCH GEN PSYCHIAT, V43, P161; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEWARD LJ, 1993, EUR J PHARMACOL, V242, P137, DOI 10.1016/0014-2999(93)90073-Q; Tedroff J, 1999, NEUROLOGY, V53, P1605, DOI 10.1212/WNL.53.7.1605; van Oostrom JCH, 2005, NEUROLOGY, V65, P941, DOI 10.1212/01.wnl.0000176071.08694.cc; Vetter JM, 2003, J NEUROCHEM, V85, P1054, DOI 10.1046/j.1471-4159.2003.01704.x; Wolf RC, 2008, EXP NEUROL, V213, P137, DOI 10.1016/j.expneurol.2008.05.017; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104	36	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18336	10.1371/journal.pone.0018336	http://dx.doi.org/10.1371/journal.pone.0018336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483838	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200062
J	Nelson, CE; Carlson, CA				Nelson, Craig E.; Carlson, Craig A.			Differential Response of High-Elevation Planktonic Bacterial Community Structure and Metabolism to Experimental Nutrient Enrichment	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; SIERRA-NEVADA; BACTERIOPLANKTON GROWTH; PHOSPHORUS LIMITATION; NITROGEN DEPOSITION; MOUNTAIN LAKES; COLORADO; CATCHMENTS; CALIFORNIA; RETENTION	Nutrient enrichment of high-elevation freshwater ecosystems by atmospheric deposition is increasing worldwide, and bacteria are a key conduit for the metabolism of organic matter in these oligotrophic environments. We conducted two distinct in situ microcosm experiments in a high-elevation lake (Emerald Lake, Sierra Nevada, California, USA) to evaluate responses in bacterioplankton growth, carbon utilization, and community structure to short-term enrichment by nitrate and phosphate. The first experiment, conducted just following ice-off, employed dark dilution culture to directly assess the impact of nutrients on bacterioplankton growth and consumption of terrigenous dissolved organic matter during snowmelt. The second experiment, conducted in transparent microcosms during autumn overturn, examined how bacterioplankton in unmanipulated microbial communities responded to nutrients concomitant with increasing phytoplankton-derived organic matter. In both experiments, phosphate enrichment (but not nitrate) caused significant increases in bacterioplankton growth, changed particulate organic stoichiometry, and induced shifts in bacterial community composition, including consistent declines in the relative abundance of Actinobacteria. The dark dilution culture showed a significant increase in dissolved organic carbon removal in response to phosphate enrichment. In transparent microcosms nutrient enrichment had no effect on concentrations of chlorophyll, carbon, or the fluorescence characteristics of dissolved organic matter, suggesting that bacterioplankton responses were independent of phytoplankton responses. These results demonstrate that bacterioplankton communities in unproductive high-elevation habitats can rapidly alter their taxonomic composition and metabolism in response to short-term phosphate enrichment. Our results reinforce the key role that phosphorus plays in oligotrophic lake ecosystems, clarify the nature of bacterioplankton nutrient limitation, and emphasize that evaluation of eutrophication in these habitats should incorporate heterotrophic microbial communities and processes.	[Nelson, Craig E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Nelson, CE (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	craig.nelson@lifesci.ucsb.edu	Nelson, Craig E/H-3323-2019	Nelson, Craig E/0000-0003-2525-3496	University of California Center for Water Resources [W988]; NSF DDIG [0709975]; NSF LTREB [0614207]; NSF Santa Barbara Channel LTER [OCE-0620276]	University of California Center for Water Resources(University of California System); NSF DDIG(National Science Foundation (NSF)); NSF LTREB(National Science Foundation (NSF)); NSF Santa Barbara Channel LTER	Financial support was provided by the University of California Center for Water Resources grant W988 to John M. Melack and CAC, NSF DDIG grant 0709975 to CEN, NSF LTREB grant 0614207 to John M. Melack and James O. Sickman and the NSF Santa Barbara Channel LTER grant OCE-0620276. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Biddanda B, 2001, LIMNOL OCEANOGR, V46, P730, DOI 10.4319/lo.2001.46.3.0730; BRATBAK G, 1985, MAR ECOL PROG SER, V25, P23, DOI 10.3354/meps025023; Burns DA, 2004, ENVIRON POLLUT, V127, P257, DOI 10.1016/S0269-7491(03)00264-1; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; Carlsson P, 2001, LIMNOL OCEANOGR, V46, P108, DOI 10.4319/lo.2001.46.1.0108; Carrera G, 2002, ENVIRON SCI TECHNOL, V36, P2581, DOI 10.1021/es0102585; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; DETTINGER MD, 1995, J CLIMATE, V8, P606, DOI 10.1175/1520-0442(1995)008<0606:LSAFOR>2.0.CO;2; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; Hood E, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001738; Jansson M, 2006, MICROB ECOL, V52, P358, DOI 10.1007/s00248-006-9013-4; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Matz C, 2003, MICROB ECOL, V45, P384, DOI 10.1007/s00248-003-2000-0; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; McCune B., 1999, MULTIVARIATE ANAL EC; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MELACK JM, 1991, REGIONAL CASE STUDIE, P503; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; MORRIS DP, 1992, LIMNOL OCEANOGR, V37, P1179, DOI 10.4319/lo.1992.37.6.1179; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Olsen LM, 2002, MICROBIAL ECOL, V43, P353, DOI 10.1007/s00248-002-2009-9; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Perez MT, 2006, LIMNOL OCEANOGR, V51, P2527, DOI 10.4319/lo.2006.51.6.2527; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sadro S, 2011, LIMNOL OCEANOGR, V56, P540, DOI 10.4319/lo.2011.56.2.0540; Salcher MM, 2007, FEMS MICROBIOL ECOL, V60, P40, DOI 10.1111/j.1574-6941.2006.00274.x; Sickman JO, 2003, LIMNOL OCEANOGR, V48, P1885, DOI 10.4319/lo.2003.48.5.1885; Sickman JO, 2003, BIOGEOCHEMISTRY, V64, P1, DOI 10.1023/A:1024928317057; Sickman JO, 2002, BIOGEOCHEMISTRY, V57, P341, DOI 10.1023/A:1016564816701; Sickman JO, 2001, WATER RESOUR RES, V37, P1445, DOI 10.1029/2000WR900371; SICKMAN JO, 2001, THESIS U CALIFORNIA; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith EM, 2004, LIMNOL OCEANOGR, V49, P137, DOI 10.4319/lo.2004.49.1.0137; SommarugaWograth S, 1997, NATURE, V387, P64, DOI 10.1038/387064a0; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Vadstein O, 2003, FEMS MICROBIOL ECOL, V46, P307, DOI 10.1016/S0168-6496(03)00195-8; Vadstein O, 2000, ADV MICROB ECOL, V16, P115; Villar-Argaiz M, 2002, AQUAT MICROB ECOL, V29, P253, DOI 10.3354/ame029253; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2005, APPL ENVIRON MICROB, V71, P5551, DOI 10.1128/AEM.71.9.5551-5559.2005; WILLIAMS MW, 1991, WATER RESOUR RES, V27, P1575, DOI [10.1029/90WR02774, 10.1029/90WR02773]; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005	54	21	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18320	10.1371/journal.pone.0018320	http://dx.doi.org/10.1371/journal.pone.0018320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483836	Green Published, Green Submitted, gold			2022-12-27	WOS:000289057200057
J	Rueckert, S; Simdyanov, TG; Aleoshin, VV; Leander, BS				Rueckert, Sonja; Simdyanov, Timur G.; Aleoshin, Vladimir V.; Leander, Brian S.			Identification of a Divergent Environmental DNA Sequence Clade Using the Phylogeny of Gregarine Parasites (Apicomplexa) from Crustacean Hosts	PLOS ONE			English	Article							MICROBIAL EUKARYOTES; LIFE-CYCLE; DIVERSITY; INFECTION; TAXONOMY; REVISION; MORPHOLOGY; INFERENCE; CHECKLIST; KINGDOMS	Background: Environmental SSU rDNA surveys have significantly improved our understanding of microeukaryotic diversity. Many of the sequences acquired using this approach are closely related to lineages previously characterized at both morphological and molecular levels, making interpretation of these data relatively straightforward. Some sequences, by contrast, appear to be phylogenetic orphans and are sometimes inferred to represent "novel lineages" of unknown cellular identity. Consequently, interpretation of environmental DNA surveys of cellular diversity rely on an adequately comprehensive database of DNA sequences derived from identified species. Several major taxa of microeukaryotes, however, are still very poorly represented in these databases, and this is especially true for diverse groups of single-celled parasites, such as gregarine apicomplexans. Methodology/Principal Findings: This study attempts to address this paucity of DNA sequence data by characterizing four different gregarine species, isolated from the intestines of crustaceans, at both morphological and molecular levels: Thiriotia pugettiae sp. n. from the graceful kelp crab (Pugettia gracilis), Cephaloidophora cf. communis from two different species of barnacles (Balanus glandula and B. balanus), Heliospora cf. longissima from two different species of freshwater amphipods (Eulimnogammarus verrucosus and E. vittatus), and Heliospora caprellae comb. n. from a skeleton shrimp (Caprella alaskana). SSU rDNA sequences were acquired from isolates of these gregarine species and added to a global apicomplexan alignment containing all major groups of gregarines characterized so far. Molecular phylogenetic analyses of these data demonstrated that all of the gregarines collected from crustacean hosts formed a very strongly supported clade with 48 previously unidentified environmental DNA sequences. Conclusions/Significance: This expanded molecular phylogenetic context enabled us to establish a major clade of intestinal gregarine parasites and infer the cellular identities of several previously unidentified environmental SSU rDNA sequences, including several sequences that have formerly been discussed broadly in the literature as a suspected "novel" lineage of eukaryotes.	[Rueckert, Sonja; Leander, Brian S.] Univ British Columbia, Dept Bot, Program Integrated Microbial Biodivers, Canadian Inst Adv Res, Vancouver, BC, Canada; [Rueckert, Sonja; Leander, Brian S.] Univ British Columbia, Dept Zool, Canadian Inst Adv Res, Vancouver, BC, Canada; [Rueckert, Sonja] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka, Japan; [Simdyanov, Timur G.] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Fac Biol, Moscow, Russia; [Aleoshin, Vladimir V.] Moscow MV Lomonosov State Univ, Dept Evolutionary Biochem, Belozersky Inst Physicochem Biol, Moscow, Russia	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of Tsukuba; Lomonosov Moscow State University; Lomonosov Moscow State University	Rueckert, S (corresponding author), Univ British Columbia, Dept Bot, Program Integrated Microbial Biodivers, Canadian Inst Adv Res, Vancouver, BC, Canada.	bleander@interchange.ubc.ca	Rueckert, Sonja/E-4695-2011; Aleoshin, Vladimir/AAE-9707-2022; Aleoshin, Vladimir/AFE-8409-2022; Simdyanov, Timur G/H-8279-2012	Aleoshin, Vladimir/0000-0002-3299-9950; Simdyanov, Timur G/0000-0003-2478-9301	Tula Foundation (Centre for Microbial Diversity and Evolution); National Science and Engineering Research Council of Canada (NSERC) [283091-09]; Canadian Institute for Advanced Research; Russian Foundation of Basic Researches [RFBR 09-04-01682, 09-04-01150, 09-04-92741]; Ministry of Education and Science of Russia	Tula Foundation (Centre for Microbial Diversity and Evolution); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation)	SR and BSL were supported by grants from the Tula Foundation (Centre for Microbial Diversity and Evolution), the National Science and Engineering Research Council of Canada (NSERC 283091-09) and the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. TGS and VVA were supported by grants from Russian Foundation of Basic Researches (RFBR 09-04-01682, 09-04-01150, and 09-04-92741), and Ministry of Education and Science of Russia (Federal Target Program "Scientific and scientific-pedagogical personnel of innovative Russia" for 2009-2013). In this study the authors used the resources of the Chebyshov Supercomputer Center of Moscow State University (http://parallel.ru/cluster) and the University of Oslo Bioportal (www.bioportal.uio.no) for tree inferences. DNA sequencing was performed in the Interinstitutional Center of collective usage "GENOM" (http://www.genome-centre.narod.ru/) of the Institute for Molecular Biology (Russian Academy of Sciences), established by support of Russian Foundation of Basic Researches. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2007, SYST BIOL, V56, P684, DOI 10.1080/10635150701494127; Avdeev V.V., 1989, P40; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; CHAKRAVARTY M. M., 1959, PROC ZOOL SOC, V12, P71; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; CLEARY AC, 2011, ASLO 2011 AQ SCI M S; CLEARY AC, 2010, OC SCI 2010 M PORTL; Clopton RE, 2009, COMP PARASITOL, V76, P167, DOI 10.1654/4388.1; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; DESPORTES I, 1977, ANN SCI NAT ZOOL, V19, P261; Duplessis MR, 2004, MAR BIOL, V145, P551, DOI 10.1007/s00227-004-1350-6; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; EDGCOMB VP, 2010, ENV MICROBI IN PRESS; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FRENZEL J, 1848, ARCH MIKROSK ANAT, V24, P545; GOODRICH HP, 1949, Q J MICROSC SCI, V90, P27; Grasse P.-P., 1953, TRAITE ZOOL, P590; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harada A, 2007, PROTIST, V158, P337, DOI 10.1016/j.protis.2007.03.005; HENRY DORA PRIAULX, 1938, ARCH PROTISTENK, V90, P414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huxley JS, 1910, Q J MICROSC SCI, V55, P155; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; JONES I, 1968, J PROTOZOOL, V15, P414, DOI 10.1111/j.1550-7408.1968.tb02150.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Lecroq B., 2009, Marine Biodiversity, V39, P45; Lee JJ, 2000, ILLUSTRATED GUIDE PR; Leger L., 1925, Travaux de la Station Zoologique de Wimereux, V9, P126; LEVINE ND, 1977, J PROTOZOOL, V24, P41, DOI 10.1111/j.1550-7408.1977.tb05279.x; LEVINE ND, 1971, J PROTOZOOL, V18, P704, DOI 10.1111/j.1550-7408.1971.tb03401.x; LEVINE ND, 1976, T AM MICROSC SOC, V95, P695, DOI 10.2307/3225395; LEVINE ND, 1979, J PROTOZOOL, V26, P532, DOI 10.1111/j.1550-7408.1979.tb04190.x; LEVINE ND, 1985, ILLUSTRATED GUIDE PR, P322; LIPA JERZY J., 1968, ACTA PROTOZOOL, V5, P257; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; MADDISON DR, 2000, MACCLADE 4; Martin DL, 2006, MAR ECOL PROG SER, V319, P155, DOI 10.3354/meps319155; MAWRODIADI P, 1908, MEM SOC NAT NOUVELLE, V32, P101; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mingazzini P., 1891, ATTI R ACCAD LINCEI, V7, P407; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Mori KI, 2007, FISH PATHOL, V42, P49, DOI 10.3147/jsfp.42.49; PATIL CC, 1985, ARCH PROTISTENKD, V129, P179, DOI 10.1016/S0003-9365(85)80019-1; Perkins Frank O., 2002, P190; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prokopowicz AJ, 2010, POLAR BIOL, V33, P1339, DOI 10.1007/s00300-010-0821-0; Prytherch HF, 1940, J MORPHOL, V66, P39, DOI 10.1002/jmor.1050660106; REGER JF, 1966, J CELL BIOL, V31, pA134; Richards TA, 2005, CURR OPIN MICROBIOL, V8, P240, DOI 10.1016/j.mib.2005.04.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rueckert S, 2010, INT J SYST EVOL MICR, V60, P2681, DOI 10.1099/ijs.0.016436-0; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Simdyanov T. G., 2009, Parazitologiya (St. Petersburg), V43, P273; Skovgaard A, 2005, PROTIST, V156, P413, DOI 10.1016/j.protis.2005.08.002; Skovgaard A, 2008, PROTIST, V159, P401, DOI 10.1016/j.protis.2008.02.003; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Takishita K, 2007, EXTREMOPHILES, V11, P563, DOI 10.1007/s00792-007-0068-z; THEODORIDES J, 1975, Protistologica, V11, P205; THEODORIDES J, 1972, CR ACAD SCI D NAT, V274, P3251; TUZET ODETTE, 1956, ANN PARASITOL HUMAINE ET COMP, V31, P317; WALSH RD, 1976, MOSQ NEWS, V36, P154; Wise MR, 2000, J PARASITOL, V86, P602, DOI 10.1645/0022-3395(2000)086[0602:HSIMSN]2.0.CO;2; ZVETKOV V, 1928, ZWEI NEUE GREGARINEN, P47	70	53	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18163	10.1371/journal.pone.0018163	http://dx.doi.org/10.1371/journal.pone.0018163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483868	Green Published, gold			2022-12-27	WOS:000289057200037
J	Zhuang, QY; Li, J; Wu, ZH; Zhang, JG; Sun, W; Li, T; Yan, YJ; Jiang, Y; Zhao, RC; Qiu, GX				Zhuang, Qianyu; Li, Jing; Wu, Zhihong; Zhang, Jianguo; Sun, Wei; Li, Tao; Yan, Yujuan; Jiang, Ying; Zhao, Robert Chunhua; Qiu, Guixing			Differential Proteome Analysis of Bone Marrow Mesenchymal Stem Cells from Adolescent Idiopathic Scoliosis Patients	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GROWTH-RELATED PROTEIN; EHRLICH ASCITES TUMOR; PYRUVATE-KINASE; RETINOIC ACID; HL-60 CELLS; OSTEOGENIC DIFFERENTIATION; MINERAL DENSITY; LEUKEMIA-CELLS; CALCIUM INTAKE	Adolescent idiopathic scoliosis (AIS) is a complex three-dimensional deformity of the spine. The cause and pathogenesis of scoliosis and the accompanying generalized osteopenia remain unclear despite decades of extensive research. In this study, we utilized two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) coupled with mass spectrometry (MS) to analyze the differential proteome of bone marrow mesenchymal stem cells (BM-MSCs) from AIS patients. In total, 41 significantly altered protein spots were detected, of which 34 spots were identified by MALDI-TOF/TOF analysis and found to represent 25 distinct gene products. Among these proteins, five related to bone growth and development, including pyruvate kinase M2, annexin A2, heat shock 27 kDa protein, gamma-actin, and beta-actin, were found to be dysregulated and therefore selected for further validation by Western blot analysis. At the protein level, our results supported the previous hypothesis that decreased osteogenic differentiation ability of MSCs is one of the mechanisms leading to osteopenia in AIS. In summary, we analyzed the differential BM-MSCs proteome of AIS patients for the first time, which may help to elucidate the underlying molecular mechanisms of bone loss in AIS and also increase understanding of the etiology and pathogenesis of AIS.	[Zhuang, Qianyu; Wu, Zhihong; Zhang, Jianguo; Li, Tao; Qiu, Guixing] Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China; [Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Excellence Tissue Engn, Beijing 100730, Peoples R China; [Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Sch Basic Med, Beijing 100037, Peoples R China; [Li, Jing; Zhao, Robert Chunhua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Wei; Yan, Yujuan; Jiang, Ying] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Zhuang, QY (corresponding author), Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China.	qiuguixingpumch@gmail.com	wu, zhi/GXH-3041-2022	Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of P.R. China [30700856, 30772191]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 30700856, 30772191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Uri Michael, 2002, Am J Orthop (Belle Mead NJ), V31, P387; BENNDORF R, 1988, BIOCHEM INT, V17, P225; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chai YH, 1999, J NEUROSCI, V19, P10338; Chaufour S, 1996, CELL STRESS CHAPERON, V1, P225, DOI 10.1379/1466-1268(1996)001<0225:TAPACI>2.3.CO;2; Cheng J C, 2001, Spine (Phila Pa 1976), V26, pE19; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Cheung CSK, 2006, SPINE, V31, P330, DOI 10.1097/01.brs.0000197410.92525.10; Cheung KMC, 2008, INT ORTHOP, V32, P729, DOI 10.1007/s00264-007-0393-y; Chu WCW, 2008, SCOLIOSIS SPINAL DIS, V3, DOI 10.1186/1748-7161-3-8; Coillard C, 1996, Eur Spine J, V5, P91, DOI 10.1007/BF00298387; CROMPTON MR, 1988, CELL, V55, P1, DOI 10.1016/0092-8674(88)90002-5; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GHOSH P, 1980, SPINE, V5, P310, DOI 10.1097/00007632-198007000-00004; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Gilmore WS, 2004, BIOCHEM SOC T, V32, P1122, DOI 10.1042/BST0321122; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Hermus JPS, 2007, EUR SPINE J, V16, pS338, DOI 10.1007/s00586-007-0335-9; HEYDARI AR, 1994, EXPERIENTIA, V50, P1092, DOI 10.1007/BF01923466; Hicks JM, 2010, SPINE, V35, pE465, DOI 10.1097/BRS.0b013e3181d1021a; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Ilharreborde B, 2009, J SPINAL DISORD TECH, V22, P530, DOI 10.1097/BSD.0b013e31818d64b7; KANE WJ, 1977, CLIN ORTHOP RELAT R, P43; Kirsch T, 2006, CURR OPIN RHEUMATOL, V18, P174, DOI 10.1097/01.bor.0000209431.59226.46; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1024, DOI 10.1007/s00198-004-1792-1; Li D, 2005, PROG BIOCHEM BIOPHYS, V32, P1026; Liang CRMY, 2005, PROTEOMICS, V5, P2258, DOI 10.1002/pmic.200401256; LONCARDUSEK M, 1991, CLIN ORTHOP RELAT R, P278; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; LONSTEIN JE, 1994, LANCET, V344, P1407; Loones MT, 1998, CELL STRESS CHAPERON, V3, P237, DOI 10.1379/1466-1268(1998)003<0237:HACDDE>2.3.CO;2; MACHIDA M, 1993, SPINE, V18, P1609, DOI 10.1097/00007632-199309000-00007; Mansilla E, 2006, TRANSPL P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; MISOL S, 1971, CLIN ORTHOP RELAT R, P122, DOI 10.1097/00003086-197111000-00019; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Negrini S, 2010, SPINE, V35, P1285, DOI 10.1097/BRS.0b013e3181dc48f4; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P471, DOI 10.1677/erc.1.00956; Ogilvie J, 2010, CURR OPIN PEDIATR, V22, P67, DOI 10.1097/MOP.0b013e32833419ac; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Park WW, 2009, EUR SPINE J, V18, P1920, DOI 10.1007/s00586-009-1129-z; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; REINACHER M, 1981, VIRCHOWS ARCH B, V37, P79, DOI 10.1007/BF02892557; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; SAKIC K, 1992, INT ORTHOP, V16, P207, DOI 10.1007/BF00182695; Sakic K, 1993, Lijec Vjesn, V115, P268; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; SPECTOR NL, 1994, FEBS LETT, V337, P184, DOI 10.1016/0014-5793(94)80270-X; SPECTOR NL, 1993, J CELL PHYSIOL, V156, P619, DOI 10.1002/jcp.1041560322; SPECTOR NL, 1995, J BIOL CHEM, V270, P1003, DOI 10.1074/jbc.270.3.1003; SPECTOR NL, 1992, J IMMUNOL, V148, P1668; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; STAHL J, 1992, DIFFERENTIATION, V51, P33, DOI 10.1111/j.1432-0436.1992.tb00677.x; SUAREZ F, 1993, J BONE MINER RES, V8, P1201; Suh KT, 2007, EUR SPINE J, V16, P1563, DOI 10.1007/s00586-007-0390-2; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; van Rhijn L W, 2001, Spine (Phila Pa 1976), V26, pE373, DOI 10.1097/00007632-200108150-00021; van Rhijn LW, 2001, ACTA ORTHOP SCAND, V72, P621, DOI 10.1080/000164701317269058; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Wang WJ, 2010, EUR SPINE J, V19, P726, DOI 10.1007/s00586-009-1247-7; Ward K, 2010, AM J MED GENET A, V152A, P1178, DOI 10.1002/ajmg.a.33145; Weinstein S L, 1989, Instr Course Lect, V38, P115; Wever DJ, 1999, EUR SPINE J, V8, P252, DOI 10.1007/s005860050169; Yang ZD, 2009, MED HYPOTHESES, V73, P709, DOI 10.1016/j.mehy.2009.02.046; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P599; Zhou H, 2010, BIOL BLOOD MARROW TR, V16, P403, DOI 10.1016/j.bbmt.2009.11.006	81	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18834	10.1371/journal.pone.0018834	http://dx.doi.org/10.1371/journal.pone.0018834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526124	gold, Green Published, Green Submitted			2022-12-27	WOS:000290015800014
J	Sabri, A; Hance, T; Leroy, PD; Frere, I; Haubruge, E; Destain, J; Compere, P; Thonart, P				Sabri, Ahmed; Hance, Thierry; Leroy, Pascal D.; Frere, Isabelle; Haubruge, Eric; Destain, Jacqueline; Compere, Philippe; Thonart, Philippe			Placenta-Like Structure of the Aphid Endoparasitic Wasp Aphidius ervi: A Strategy of Optimal Resources Acquisition	PLOS ONE			English	Article							CROCEIPES CRESSON BRACONIDAE; DIAPETIMORPHA-INTROITA; ACYRTHOSIPHON-PISUM; COTESIA-CONGREGATA; BIOLOGICAL-CONTROL; PROTEIN-SYNTHESIS; ARTIFICIAL DIET; HOST REGULATION; TERATOCYTES; HYMENOPTERA	Aphidius ervi (Hymenoptera: Braconidae) is an entomophagous parasitoid known to be an effective parasitoid of several aphid species of economic importance. A reduction of its production cost during mass rearing for inundative release is needed to improve its use in biological control of pests. In these contexts, a careful analysis of its entire development phases within its host is needed. This paper shows that this parasitoid has some characteristics in its embryological development rather complex and different from most other reported insects, which can be phylogenetically very close. First, its yolkless egg allows a high fecundity of the female but force them to hatch from the egg shell rapidly to the host hemocoel. An early cellularisation allowing a rapid differentiation of a serosa membrane seems to confirm this hypothesis. The serosa wraps the developing embryo until the first instar larva stage and invades the host tissues by microvilli projections and form a placenta like structure able to divert host resources and allowing nutrition and respiration of embryo. Such interspecific invasion, at the cellular level, recalls mammal's trophoblasts that anchors maternal uterine wall and underlines the high adaptation of A. ervi to develop in the host body.	[Sabri, Ahmed; Destain, Jacqueline; Thonart, Philippe] Univ Liege, Ctr Wallon Biol Ind, Liege, Belgium; [Hance, Thierry; Frere, Isabelle] Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Louvain, Belgium; [Leroy, Pascal D.; Haubruge, Eric] Univ Liege Gembloux Agro Bio Tech, Dept Funct & Evolutionary Entomol, Gembloux, Belgium; [Compere, Philippe] Univ Liege, Lab Morphol Ultrastruct, Liege, Belgium	University of Liege; University of Liege	Sabri, A (corresponding author), Univ Liege, Ctr Wallon Biol Ind, Liege, Belgium.	a.sabri@ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476	la Region Wallonne de Belgique [061/6288]	la Region Wallonne de Belgique	This work was supported by "la Region Wallonne de Belgique" convention Waleo2 no061/6288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1973, P1; BECKAGE NE, 1994, J PARASITOL, V80, P389, DOI 10.2307/3283409; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Cecchettini A, 2001, EUR J CELL BIOL, V80, P458, DOI 10.1078/0171-9335-00179; Consoli FL, 1999, ENTOMOL EXP APPL, V91, P327, DOI 10.1046/j.1570-7458.1999.00499.x; Dahlman Douglas L., 1993, P145; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; DeBuron I, 1997, J INSECT PHYSIOL, V43, P915, DOI 10.1016/S0022-1910(97)00056-5; Digilio MC, 2000, J INSECT PHYSIOL, V46, P1041, DOI 10.1016/S0022-1910(99)00216-4; Digilio MC, 1998, J INSECT PHYSIOL, V44, P779, DOI 10.1016/S0022-1910(98)00010-9; Falabella P, 2000, ENTOMOL EXP APPL, V97, P1, DOI 10.1023/A:1004097427267; Fedoroff S, 2001, PROTOCOLS NEURAL CEL; FERKOVICH SM, 1986, INSECT BIOCHEM, V16, P337, DOI 10.1016/0020-1790(86)90045-4; Ferkovich SM, 1999, BIOCONTROL, V44, P29, DOI 10.1023/A:1009939028766; FRESHNEY R, 2005, CULTURE CELL ANIMAL; Gelman DB, 2000, J INSECT PHYSIOL, V46, P457, DOI 10.1016/S0022-1910(99)00132-8; Giordana B, 2003, J INSECT PHYSIOL, V49, P1115, DOI 10.1016/j.jinsphys.2003.08.010; Giorgi F, 1999, MICRON, V30, P579, DOI 10.1016/S0968-4328(99)00054-2; GONZALEZ D, 1978, ENTOMOPHAGA, V23, P239, DOI 10.1007/BF02373098; Grbic M, 2000, BIOESSAYS, V22, P920, DOI 10.1002/1521-1878(200010)22:10&lt;920::AID-BIES7&gt;3.0.CO;2-Q; Grbic M, 1998, P NATL ACAD SCI USA, V95, P1097, DOI 10.1073/pnas.95.3.1097; GREANY P, 1986, J INSECT PHYSL, V32, P419; GREANY PD, 1984, BIOSCIENCE, V34, P690, DOI 10.2307/1309661; Grenier S., 1994, P181; Grimaldi A, 2006, J INSECT PHYSIOL, V52, P870, DOI 10.1016/j.jinsphys.2006.05.011; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; JOHNSTON DS, 1992, CELL, V68, P201; LERALEC A, 1995, BIOCONTROL, V40, P87; Machida R., 1998, P ARTHROPOD EMBRYOL, V33, P1; Masumoto M, 2006, TISSUE CELL, V38, P159, DOI 10.1016/j.tice.2006.01.004; NORDIN JH, 1990, ARCH INSECT BIOCHEM, V15, P119, DOI 10.1002/arch.940150302; Panfilio KA, 2006, DEV BIOL, V292, P226, DOI 10.1016/j.ydbio.2005.12.028; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; Pedata PA, 2003, J INSECT PHYSIOL, V49, P1063, DOI 10.1016/j.jinsphys.2003.08.003; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; PENNACCHIO F, 1994, INT J INSECT MORPHOL, V23, P93, DOI 10.1016/0020-7322(94)90003-5; Rafiqi AM, 2008, P NATL ACAD SCI USA, V105, P234, DOI 10.1073/pnas.0709145105; Rahbe Y, 2002, J INSECT PHYSIOL, V48, P507, DOI 10.1016/S0022-1910(02)00053-7; Speicher BR, 1936, J MORPHOL, V59, P401, DOI 10.1002/jmor.1050590208; Stilmant D, 2008, OECOLOGIA, V156, P905, DOI 10.1007/s00442-008-1036-8; Strand Michael R., 2008, P113, DOI 10.1002/9780470696200.ch6; Suzuki M, 2007, J INSECT PHYSIOL, V53, P1072, DOI 10.1016/j.jinsphys.2007.06.006; Thompson SN, 1999, ANNU REV ENTOMOL, V44, P561, DOI 10.1146/annurev.ento.44.1.561; TILDEN RL, 1987, INSECT BIOCHEM, V17, P783, DOI 10.1016/0020-1790(87)90012-6; TREMBLAY E, 1973, ANNU REV ENTOMOL, V18, P421, DOI 10.1146/annurev.en.18.010173.002225; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; VINSON S, 1994, PARASITOID IN VITRO, P49; VINSON S, 1988, ANIM PLANT SCI, V1, P25; Vinson S.B., 1984, Symposia of the Royal Entomological Society of London, V12, P325; VINSON SB, 1981, SEMIOCHEMICALS THEIR, P51; ZEH D, 1989, Q REV BIOL, P147; ZHANG DQ, 1994, INT J INSECT MORPHOL, V23, P173, DOI 10.1016/0020-7322(94)90016-7	53	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18847	10.1371/journal.pone.0018847	http://dx.doi.org/10.1371/journal.pone.0018847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526196	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100029
J	Suen, G; Weimer, PJ; Stevenson, DM; Aylward, FO; Boyum, J; Deneke, J; Drinkwater, C; Ivanova, NN; Mikhailova, N; Chertkov, O; Goodwin, LA; Currie, CR; Mead, D; Brumm, PJ				Suen, Garret; Weimer, Paul J.; Stevenson, David M.; Aylward, Frank O.; Boyum, Julie; Deneke, Jan; Drinkwater, Colleen; Ivanova, Natalia N.; Mikhailova, Natalia; Chertkov, Olga; Goodwin, Lynne A.; Currie, Cameron R.; Mead, David; Brumm, Phillip J.			The Complete Genome Sequence of Fibrobacter succinogenes S85 Reveals a Cellulolytic and Metabolic Specialist	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; RUMINOCOCCUS-FLAVEFACIENS; SYNERGISTIC INTERACTIONS; SIGNATURE SEQUENCES; ENDOGLUCANASE GENE; RUMINAL BACTERIUM; MOLECULAR-CLONING; CELLULASE GENE; ANNOTATION; EXPRESSION	Fibrobacter succinogenes is an important member of the rumen microbial community that converts plant biomass into nutrients usable by its host. This bacterium, which is also one of only two cultivated species in its phylum, is an efficient and prolific degrader of cellulose. Specifically, it has a particularly high activity against crystalline cellulose that requires close physical contact with this substrate. However, unlike other known cellulolytic microbes, it does not degrade cellulose using a cellulosome or by producing high extracellular titers of cellulase enzymes. To better understand the biology of F. succinogenes, we sequenced the genome of the type strain S85 to completion. A total of 3,085 open reading frames were predicted from its 3.84 Mbp genome. Analysis of sequences predicted to encode for carbohydrate-degrading enzymes revealed an unusually high number of genes that were classified into 49 different families of glycoside hydrolases, carbohydrate binding modules (CBMs), carbohydrate esterases, and polysaccharide lyases. Of the 31 identified cellulases, none contain CBMs in families 1, 2, and 3, typically associated with crystalline cellulose degradation. Polysaccharide hydrolysis and utilization assays showed that F. succinogenes was able to hydrolyze a number of polysaccharides, but could only utilize the hydrolytic products of cellulose. This suggests that F. succinogenes uses its array of hemicellulose-degrading enzymes to remove hemicelluloses to gain access to cellulose. This is reflected in its genome, as F. succinogenes lacks many of the genes necessary to transport and metabolize the hydrolytic products of non-cellulose polysaccharides. The F. succinogenes genome reveals a bacterium that specializes in cellulose as its sole energy source, and provides insight into a novel strategy for cellulose degradation.	[Suen, Garret; Aylward, Frank O.; Currie, Cameron R.; Mead, David; Brumm, Phillip J.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Suen, Garret; Aylward, Frank O.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Weimer, Paul J.; Stevenson, David M.] ARS, US Dairy Forage Res Ctr, USDA, Madison, WI USA; [Boyum, Julie; Deneke, Jan; Drinkwater, Colleen; Mead, David] Lucigen Corp, Middleton, WI USA; [Ivanova, Natalia N.; Mikhailova, Natalia; Goodwin, Lynne A.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Chertkov, Olga; Goodwin, Lynne A.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Brumm, Phillip J.] C5 6 Technol, Middleton, WI USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Department of Energy (DOE); United States Department of Energy (DOE); Los Alamos National Laboratory	Suen, G (corresponding author), Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	pbrumm@c56technologies.com	Weimer, Paul James/AAY-6485-2020; Suen, Garret/AAF-2080-2019	Weimer, Paul James/0000-0002-9278-6535; Suen, Garret/0000-0002-6170-711X; MEAD, David/0000-0003-1982-9356; Ivanova, Natalia/0000-0002-5802-9485; Aylward, Frank/0000-0002-1279-4050	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; USDA ARS [3655-41000-005-00D]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) supporting GS, FOA, CRC, DM, and PJB. This work was also funded by a USDA ARS CRIS project 3655-41000-005-00D supported DMS and PJW. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. All work performed by employees of Lucigen or C5-6 Technologies was performed under and supported by subcontract to the GLBRC. Neither corporation was a funder of the work; no funds of either corporation was used for this research or to support the researchers during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1961, J BACTERIOL, V81, P903, DOI 10.1128/JB.81.6.903-910.1961; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asanuma N, 2000, J GEN APPL MICROBIOL, V46, P119, DOI 10.2323/jgam.46.119; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; BROUSSOLLE V, 1994, FEMS MICROBIOL LETT, V124, P439; BRUMM P, 2010, APPL BIOCHEM BIOTECH, DOI DOI 10.1007/S12010-12010-19070-12015; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAVICCHIOLI R, 1991, APPL ENVIRON MICROB, V57, P359, DOI 10.1128/AEM.57.2.359-365.1991; Centeno MSJ, 2006, FEMS MICROBIOL LETT, V265, P26, DOI 10.1111/j.1574-6968.2006.00464.x; Cho KK, 2000, ENZYME MICROB TECH, V27, P475, DOI 10.1016/S0141-0229(00)00256-8; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; COSTERTON JW, 1992, INT BIODETER BIODEGR, V30, P123; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; GONG JH, 1993, J BACTERIOL, V175, P6810, DOI 10.1128/jb.175.21.6810-6821.1993; Gong JH, 1996, CAN J MICROBIOL, V42, P453, DOI 10.1139/m96-062; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Griffiths E, 2001, MICROBIOL-SGM, V147, P2611, DOI 10.1099/00221287-147-9-2611; GROLEAU D, 1981, CAN J MICROBIOL, V27, P517, DOI 10.1139/m81-077; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Han C., 2006, P 2006 INT C BIOINF, P141; Han SO, 2003, J BACTERIOL, V185, P2520, DOI 10.1128/JB.185.8.2520-2527.2003; Hashimoto W, 2005, BIOCHEMISTRY-US, V44, P13783, DOI 10.1021/bi050873b; Hashimoto W, 2005, BIOSCI BIOTECH BIOCH, V69, P673, DOI 10.1271/bbb.69.673; HUANG L, 1990, APPL ENVIRON MICROB, V56, P1229, DOI 10.1128/AEM.56.5.1229-1234.1990; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iyo AH, 1996, CAN J MICROBIOL, V42, P934, DOI 10.1139/m96-120; IYO AH, 1994, CAN J MICROBIOL, V40, P592, DOI 10.1139/m94-094; Jun HS, 2007, ASIAN AUSTRAL J ANIM, V20, P802, DOI 10.5713/ajas.2007.802; Jun HS, 2003, CAN J MICROBIOL, V49, P171, DOI 10.1139/W03-024; Jun HS, 2007, J BACTERIOL, V189, P6806, DOI 10.1128/JB.00560-07; Kam DK, 2005, CAN J MICROBIOL, V51, P821, DOI [10.1139/w05-074, 10.1139/W05-074]; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kobayashi Y, 2008, FOLIA MICROBIOL, V53, P195, DOI 10.1007/s12223-008-0024-z; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; KUDO H, 1987, CAN J MICROBIOL, V33, P267, DOI 10.1139/m87-045; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LIN CZ, 1995, APPL ENVIRON MICROB, V61, P1348, DOI 10.1128/AEM.61.4.1348-1351.1995; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maglione G, 1997, APPL MICROBIOL BIOT, V48, P720, DOI 10.1007/s002530051122; Malburg LM, 1996, APPL ENVIRON MICROB, V62, P898, DOI 10.1128/AEM.62.3.898-906.1996; Malburg SRC, 1997, APPL ENVIRON MICROB, V63, P2449, DOI 10.1128/AEM.63.6.2449-2453.1997; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsui H, 2010, ANAEROBE, V16, P83, DOI 10.1016/j.anaerobe.2009.07.005; MCDERMID KP, 1990, APPL ENVIRON MICROB, V56, P3805, DOI 10.1128/AEM.56.12.3805-3810.1990; MCGAVIN MJ, 1989, J BACTERIOL, V171, P5587, DOI 10.1128/jb.171.10.5587-5595.1989; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; MILLER TL, 1978, ARCH MICROBIOL, V117, P145, DOI 10.1007/BF00402302; Mitsumori M, 1996, FEMS MICROBIOL LETT, V139, P43; MONTGOMERY L, 1988, INT J SYST BACTERIOL, V38, P430, DOI 10.1099/00207713-38-4-430; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Ogata K, 1997, CURR MICROBIOL, V35, P22, DOI 10.1007/s002849900205; Ozcan N, 1996, LETT APPL MICROBIOL, V22, P85, DOI 10.1111/j.1472-765X.1996.tb01114.x; PARADIS FW, 1993, J BACTERIOL, V175, P7666, DOI 10.1128/JB.175.23.7666-7672.1993; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; PURUSHE J, 2010, MICROB ECOL, DOI DOI 10.1007/S00248-00010-09692-00248; Qi M, 2008, J BACTERIOL, V190, P1976, DOI 10.1128/JB.01667-07; Qi M, 2007, APPL ENVIRON MICROB, V73, P6098, DOI 10.1128/AEM.01037-07; Russell J. B., 2002, RUMEN MICROBIOLOGY I; RUSSELL JB, 1985, APPL ENVIRON MICROB, V49, P572, DOI 10.1128/AEM.49.3.572-576.1985; Shi Y, 1996, APPL ENVIRON MICROB, V62, P1084, DOI 10.1128/AEM.62.3.1084-1088.1996; Spiridonov NA, 1999, J BIOL CHEM, V274, P13127, DOI 10.1074/jbc.274.19.13127; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tamaru Y, 2000, J BACTERIOL, V182, P5906, DOI 10.1128/JB.182.20.5906-5910.2000; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TEATHER RM, 1990, J BACTERIOL, V172, P3837, DOI 10.1128/jb.172.7.3837-3841.1990; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; WEIMER PJ, 1991, APPL MICROBIOL BIOT, V36, P178, DOI 10.1007/BF00164416; WEIMER PJ, 1991, APPL ENVIRON MICROB, V57, P3101, DOI 10.1128/AEM.57.11.3101-3106.1991; WEIMER PJ, 1993, ARCH MICROBIOL, V160, P288, DOI 10.1007/BF00292079; WEIMER PJ, 1996, ENZYMATIC DEGRADATIO, P291; WELLS JE, 1995, APPL ENVIRON MICROB, V61, P1757, DOI 10.1128/AEM.61.5.1757-1762.1995; Wilson DB, 2009, CELLULOSE, V16, P723, DOI 10.1007/s10570-009-9326-9; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; YOSHIDA S, 2010, J BACTERIOL, DOI DOI 10.1128/JB.00503-00510; Yoshida S, 2010, J BACTERIOL, V192, P483, DOI 10.1128/JB.00935-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [No title captured]	95	141	147	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18814	10.1371/journal.pone.0018814	http://dx.doi.org/10.1371/journal.pone.0018814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526192	Green Submitted, Green Published, gold			2022-12-27	WOS:000289671100023
J	Wolff, RF; Reinders, S; Barth, M; Antes, G				Wolff, Robert F.; Reinders, Stefan; Barth, Michael; Antes, Gerd			Distribution of Country of Origin in Studies Used in Cochrane Reviews	PLOS ONE			English	Review							CLINICAL-TRIAL REGISTRATION; SYSTEMATIC-REVIEWS; RADIOLOGY	Background and Objective: Inclusion in systematic reviews is one important component in judging the potential impact of clinical studies upon practice and hence the 'value for money' of spending for clinical research. This study aims to quantify the distribution of countries of origin of clinical studies used in Cochrane Reviews (CRs), and to link these data to the size of a country and to its spending on research. Methods: Random sample of publications used for CRs published in Issue 1 2008 and of publications used in CRs in the field of complementary and alternative medicine (CAM). Publications without original data were excluded. Likely countries of origin determined based on abstracts/full texts. CIA World Factbook (population data) and OECD database (economic data) were used. Results: 1,000 random entries out of 140,005 references available in all specialities. In 876 (91.4%) of 959 eligible studies, country of origin was determined. The USA was the leading contributor (36.0% of the studies), followed by UK (13.4%), Canada (5.3%), Australia and Sweden (3.7%). In the CAM sample, country of origin was determined in 458 (93.5%) of 497 assessed studies. Again, the USA was the leading contributor (24.9%), with China also emerging as a significant contributor (24.7%) in this field. For both samples, the contribution of smaller countries (especially Scandinavian countries, Greece, and Ireland) became more noteworthy when considered in relation to population size and research spending. Conclusions: Our results support the leading roles of both the USA and the UK in publishing clinical papers. The emerging role of China can be seen, particularly related to CAM studies. Taking into account size of population and economic power, countries like France, Germany, Italy, and Spain provide small contributions. In contrast, smaller countries like Australia, Denmark, Finland, Ireland, New Zealand, and Sweden also play major roles.	[Wolff, Robert F.; Reinders, Stefan; Barth, Michael; Antes, Gerd] Univ Hosp Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, Dept Med Biometry & Stat, Freiburg, Germany; [Reinders, Stefan] Bielefeld Sch Publ Hlth, Fac Hlth Sci, Bielefeld, Germany; [Barth, Michael] Univ Munich, Inst Med Informationsverabt Biomet & Epidemi, Munich, Germany	University of Freiburg; University of Munich	Wolff, RF (corresponding author), Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England.	robert@systematic-reviews.com	Wolff, Robert F/E-2322-2016	Wolff, Robert F/0000-0003-3270-7791				*CIA, 2008, WORLD FACTB; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; *COCHR COLL, 2011, COCHR LIB; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; deJong JW, 1996, EUR HEART J, V17, P35; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Einhaupl K, 2003, SCIENCE, V302, P1115, DOI 10.1126/science.302.5648.1115; GLUUD C, 2007, LIKELY COUNTRY ORIGI; Grossi F, 2003, EUR J CANCER, V39, P106, DOI 10.1016/S0959-8049(02)00239-3; Haines T, 2008, CLIN PLAST SURG, V35, P207, DOI 10.1016/j.cps.2007.10.003; Hawke F, 2009, J AM PODIAT MED ASSN, V99, P260, DOI 10.7547/0980260; Higgins JP, 2011, COCHRANE HDB SYSTE 2; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Johnson CD, 2008, J CHIPROPR EDUC, V22, P4, DOI 10.7899/1042-5055-22.1.4; Laine C, 2007, ANN INTERN MED, V147, P275, DOI 10.7326/0003-4819-147-4-200708210-00166; Lambers Heerspink HJ, 2008, BRIT J CLIN PHARMACO, V66, P774, DOI 10.1111/j.1365-2125.2008.03296.x; Lind J, 1753, TREATISE SCURVY 3 PA; MANHEIMER E, 2008, CAM RELATED REV COCH; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; *ORG EC COOP DEV, 2008, STAT PORT; Ozsunar Y, 2001, AM J ROENTGENOL, V177, P1281; Rahman M, 2005, ACAD RADIOL, V12, P825, DOI 10.1016/j.acra.2005.03.061; Rahman M, 2003, PUBLIC HEALTH, V117, P274, DOI 10.1016/S0033-3506(03)00068-4; Soteriades ES, 2006, FASEB J, V20, P29, DOI 10.1096/fj.05-4711lsf; 2004, NATNEUROSCI, V7, P895	27	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18798	10.1371/journal.pone.0018798	http://dx.doi.org/10.1371/journal.pone.0018798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526195	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100022
J	Jonckers, E; Van Audekerke, J; De Visscher, G; Van der Linden, A; Verhoye, M				Jonckers, Elisabeth; Van Audekerke, Johan; De Visscher, Geofrey; Van der Linden, Annemie; Verhoye, Marleen			Functional Connectivity fMRI of the Rodent Brain: Comparison of Functional Connectivity Networks in Rat and Mouse	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; RESTING-STATE CONNECTIVITY; LOW-FREQUENCY FLUCTUATIONS; BOLD FMRI; STRUCTURAL CONNECTIVITY; CORTEX; ARCHITECTURE; STIMULATION; ANESTHESIA; PROTOCOL	At present, resting state functional MRI (rsfMRI) is increasingly used in human neuropathological research. The present study aims at implementing rsfMRI in mice, a species that holds the widest variety of neurological disease models. Moreover, by acquiring rsfMRI data with a comparable protocol for anesthesia, scanning and analysis, in both rats and mice we were able to compare findings obtained in both species. The outcome of rsfMRI is different for rats and mice and depends strongly on the applied number of components in the Independent Component Analysis (ICA). The most important difference was the appearance of unilateral cortical components for the mouse resting state data compared to bilateral rat cortical networks. Furthermore, a higher number of components was needed for the ICA analysis to separate different cortical regions in mice as compared to rats.	[Jonckers, Elisabeth; Van Audekerke, Johan; De Visscher, Geofrey; Van der Linden, Annemie; Verhoye, Marleen] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium	University of Antwerp	Jonckers, E (corresponding author), Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium.	elisabeth.jonckers@ua.ac.be	De Visscher, Geofrey/ABH-8607-2020; De Visscher, geofrey/B-9318-2012; Van der Linden, Annemie/L-7855-2017	Van der Linden, Annemie/0000-0003-2941-6520; De Visscher, Geofrey/0000-0002-2317-392X; Verhoye, Marleen/0000-0002-6267-0611	SBO [IWT-60838: BRAINSTIM]; Flemish Institute; EC [LSHB-CT-2005-512146]; Inter University Attraction Poles [IUAP-NIMI-P6/38]	SBO; Flemish Institute; EC(European CommissionEuropean Commission Joint Research Centre); Inter University Attraction Poles(Belgian Federal Science Policy Office)	This work was funded in part by SBO grant (IWT-60838: BRAINSTIM) from the Flemish Institute supporting scientific-technological research in industry (IWT), by the EC-FP6-project DiMI (LSHB-CT-2005-512146) and by the Inter University Attraction Poles (IUAP-NIMI-P6/38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; ADAMS N, 1983, J COMP PSYCHOL, V97, P24, DOI 10.1037/0735-7036.97.1.24; Ahrens ET, 2001, NMR BIOMED, V14, P318, DOI 10.1002/nbm.709; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal Bharat B., 2009, V489, P255, DOI 10.1007/978-1-59745-543-5_12; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Buchel C, 1996, NEUROIMAGE, V4, P60, DOI 10.1006/nimg.1996.0029; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DIYKOV DG, 2005, INTERNET J OPHTHALMO, V3; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; KALTHOFF D, 2010, NEUROIMAGE; Magnuson M, 2010, J MAGN RESON IMAGING, V32, P584, DOI 10.1002/jmri.22295; Majeed W, 2009, J MAGN RESON IMAGING, V30, P384, DOI 10.1002/jmri.21848; Moeller S, 2009, J NEUROSCI, V29, P5897, DOI 10.1523/JNEUROSCI.0220-09.2009; Mohammadi B, 2009, J NEUROL, V256, P1263, DOI 10.1007/s00415-009-5112-8; Nair G, 2004, MAGN RESON MED, V52, P430, DOI 10.1002/mrm.20158; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G., 2004, J CHEM INF MODEL, V5th; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; SILVERMAN J, 1993, LAB ANIM SCI, V43, P210; Teichert T, 2010, NEUROPSYCHOLOGIA, V48, P1886, DOI 10.1016/j.neuropsychologia.2009.11.026; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	47	158	160	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18876	10.1371/journal.pone.0018876	http://dx.doi.org/10.1371/journal.pone.0018876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533116	Green Published, Green Submitted, gold			2022-12-27	WOS:000289620100026
J	Rapali, P; Radnai, L; Suveges, D; Harmat, V; Tolgyesi, F; Wahlgren, WY; Katona, G; Nyitray, L; Pal, G				Rapali, Peter; Radnai, Laszlo; Sueveges, Daniel; Harmat, Veronika; Toelgyesi, Ferenc; Wahlgren, Weixiao Y.; Katona, Gergely; Nyitray, Laszlo; Pal, Gabor			Directed Evolution Reveals the Binding Motif Preference of the LC8/DYNLL Hub Protein and Predicts Large Numbers of Novel Binders in the Human Proteome	PLOS ONE			English	Article							DYNEIN LIGHT-CHAIN; MOLECULAR RECOGNITION FEATURES; SPLICED EXON-B; PHAGE-DISPLAY; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; COILED-COIL; MYOSIN-VA; FUNCTIONAL-ANALYSIS; LIGAND SPECIFICITY	LC8 dynein light chain (DYNLL) is a eukaryotic hub protein that is thought to function as a dimerization engine. Its interacting partners are involved in a wide range of cellular functions. In its dozens of hitherto identified binding partners DYNLL binds to a linear peptide segment. The known segments define a loosely characterized binding motif: [D/S](-4)K-3X-2[T/V/I](-1)Q(0)[T/V](1)[D/E](2). The motifs are localized in disordered segments of the DYNLL-binding proteins and are often flanked by coiled coil or other potential dimerization domains. Based on a directed evolution approach, here we provide the first quantitative characterization of the binding preference of the DYNLL binding site. We displayed on M13 phage a naive peptide library with seven fully randomized positions around a fixed, naturally conserved glutamine. The peptides were presented in a bivalent manner fused to a leucine zipper mimicking the natural dimer to dimer binding stoichiometry of DYNLL-partner complexes. The phage-selected consensus sequence V(-5)S(-4)R(-3)G(-2)T(-1)Q(0)T(1)E(2) resembles the natural one, but is extended by an additional N-terminal valine, which increases the affinity of the monomeric peptide twentyfold. Leu-zipper dimerization increases the affinity into the subnanomolar range. By comparing crystal structures of an SRGTQTE-DYNLL and a dimeric VSRGTQTE-DYNLL complex we find that the affinity enhancing valine is accommodated in a binding pocket on DYNLL. Based on the in vitro evolved sequence pattern we predict a large number of novel DYNLL binding partners in the human proteome. Among these EML3, a microtubule-binding protein involved in mitosis contains an exact match of the phage-evolved consensus and binds to DYNLL with nanomolar affinity. These results significantly widen the scope of the human interactome around DYNLL and will certainly shed more light on the biological functions and organizing role of DYNLL in the human and other eukaryotic interactomes.	[Rapali, Peter; Radnai, Laszlo; Sueveges, Daniel; Nyitray, Laszlo; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Inst Chem, Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Res Grp, Budapest, Hungary; [Toelgyesi, Ferenc] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary; [Wahlgren, Weixiao Y.; Katona, Gergely] Univ Gothenburg, Dept Chem, Gothenburg, Sweden	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Semmelweis University; University of Gothenburg	Rapali, P (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	nyitray@elte.hu; palgabor@elte.hu	Nyitray, László/AAE-5910-2020; Pal, Gabor/A-6244-2009; Harmat, Veronika/B-8033-2016; Katona, Gergely/B-3491-2008; Yuan Wahlgren, Weixiao/D-5589-2011	Nyitray, László/0000-0003-4717-5994; Pal, Gabor/0000-0001-7868-7971; Harmat, Veronika/0000-0002-1866-9904; Katona, Gergely/0000-0002-2031-8716; Radnai, Laszlo/0000-0001-6843-3740; Suveges, Daniel/0000-0003-4133-0447; Rapali, Peter/0000-0003-1422-6660	Hungarian Scientific Research Fund (OTKA) [NI49812, K81784, NK81950, K68408]; European Union; European Social Fund (TAMOP) [4.2.1./B-09/KMR-2010-0003]; Janos Bolyai Research Fellowship; Swedish Research Council [2008-4248, 2009-350]; Harald and Greta Jeanssons Foundation	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund (TAMOP)(European Social Fund (ESF)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald and Greta Jeanssons Foundation	The work was supported by the Hungarian Scientific Research Fund (OTKA) NI49812; K81784; NK81950 (L.N.); and K68408 (G. P.) (www.otka.hu); as well as by the European Union and the European Social Fund (TAMOP) 4.2.1./B-09/KMR-2010-0003 (www.nfu.hu). G. P. is supported by the Janos Bolyai Research Fellowship (www.mta.hu). W.Y.W. and G. K. are supported by the Swedish Research Council (2008-4248, 2009-350) (www.vr.se) and the Harald and Greta Jeanssons Foundation (www.jeanssonsstiftelser.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Beekwilder J, 1999, GENE, V228, P23, DOI 10.1016/S0378-1119(99)00013-X; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Dick T, 1996, MOL CELL BIOL, V16, P1966; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; FUH G, 1990, J BIOL CHEM, V265, P3111; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Herzig RP, 2000, J CELL SCI, V113, P4263; HODI Z, 2007, FEBS J S1, V274, P106; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lajoix AD, 2004, MOL DIVERS, V8, P281, DOI 10.1023/B:MODI.0000036242.01129.27; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Lo KWH, 2007, J BIOL CHEM, V282, P36871, DOI 10.1074/jbc.M705991200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Lyon RP, 2003, BIOCHEMISTRY-US, V42, P10418, DOI 10.1021/bi0346188; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MIAGNM MW, 2000, ACTA CRYSTALLOGR, V57, P122; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Pal G, 2005, J MOL BIOL, V347, P489, DOI 10.1016/j.jmb.2005.01.040; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; RADNAI L, 2010, J BIOL CHEM; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; Sidhu SS, 2003, CHEMBIOCHEM, V4, P14, DOI 10.1002/cbic.200390008; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Szappanos B, 2010, FEBS LETT, V584, P1623, DOI 10.1016/j.febslet.2010.03.026; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	84	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18818	10.1371/journal.pone.0018818	http://dx.doi.org/10.1371/journal.pone.0018818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533121	Green Published, gold, Green Submitted			2022-12-27	WOS:000289620100023
J	Sanders, LH; Devadoss, B; Raja, GV; O'Connor, J; Su, SC; Wozniak, DJ; Hassett, DJ; Berdis, AJ; Sutton, MD				Sanders, Laurie H.; Devadoss, Babho; Raja, Geraldine V.; O'Connor, Jaime; Su, Shengchang; Wozniak, Daniel J.; Hassett, Daniel J.; Berdis, Anthony J.; Sutton, Mark D.			Epistatic Roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in Coping with Reactive Oxygen Species-Induced DNA Damage	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; MISMATCH REPAIR SYSTEM; POLYMERASE-KAPPA; Y-FAMILY; GENETIC ADAPTATION; BIOFILM INFECTIONS; HIGH-FREQUENCY; LESION-BYPASS; MUTAGENESIS; HYPERMUTATION	Pseudomonas aeruginosa is especially adept at colonizing the airways of individuals afflicted with the autosomal recessive disease cystic fibrosis (CF). CF patients suffer from chronic airway inflammation, which contributes to lung deterioration. Once established in the airways, P. aeruginosa continuously adapts to the changing environment, in part through acquisition of beneficial mutations via a process termed pathoadaptation. MutS and DinB are proposed to play opposing roles in P. aeruginosa pathoadaptation: MutS acts in replication-coupled mismatch repair, which acts to limit spontaneous mutations; in contrast, DinB (DNA polymerase IV) catalyzes error-prone bypass of DNA lesions, contributing to mutations. As part of an ongoing effort to understand mechanisms underlying P. aeruginosa pathoadaptation, we characterized hydrogen peroxide (H2O2)-induced phenotypes of isogenic P. aeruginosa strains bearing different combinations of mutS and dinB alleles. Our results demonstrate an unexpected epistatic relationship between mutS and dinB with respect to H2O2-induced cell killing involving error-prone repair and/or tolerance of oxidized DNA lesions. In striking contrast to these error-prone roles, both MutS and DinB played largely accurate roles in coping with DNA lesions induced by ultraviolet light, mitomycin C, or 4-nitroquinilone 1-oxide. Models discussing roles for MutS and DinB functionality in DNA damage-induced mutagenesis, particularly during CF airway colonization and subsequent P. aeruginosa pathoadaptation are discussed.	[Sanders, Laurie H.; Raja, Geraldine V.; O'Connor, Jaime; Sutton, Mark D.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Sanders, Laurie H.; Sutton, Mark D.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Devadoss, Babho; Berdis, Anthony J.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Su, Shengchang; Hassett, Daniel J.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Wozniak, Daniel J.] Ohio State Univ, Dept Infect Dis & Microbiol, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Case Western Reserve University; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University	Sanders, LH (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	mdsutton@buffalo.edu			Cystic Fibrosis Foundation [SUTTON07I0]; Public Health Service [RO1 GM066094, RO1 CA118408, RO1 GM069845, RO1 AI061396, RO1 HL58334]; NATIONAL CANCER INSTITUTE [R01CA118408] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069845, R56GM066094, R01GM066094] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Pilot and Feasibility grant SUTTON07I0 from the Cystic Fibrosis Foundation to MDS, as well as Public Health Service grants RO1 GM066094 to MDS, RO1 CA118408 to AJB, and RO1 GM069845 to DJH. DJW is supported by Public Health Service grants RO1 AI061396 and RO1 HL58334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai HB, 2007, J BACTERIOL, V189, P902, DOI 10.1128/JB.01513-06; Barone F, 2007, DNA REPAIR, V6, P355, DOI 10.1016/j.dnarep.2006.11.002; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Devadoss B, 2007, BIOCHEMISTRY-US, V46, P4486, DOI 10.1021/bi602438t; Dixon W. J., 1969, INTRO STAT ANAL; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Galan JC, 2007, FEMS MICROBIOL LETT, V275, P263, DOI 10.1111/j.1574-6968.2007.00902.x; Galhardo RS, 2005, NUCLEIC ACIDS RES, V33, P2603, DOI 10.1093/nar/gki551; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hori M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/807579; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jarosz DF, 2007, CELL CYCLE, V6, P817, DOI 10.4161/cc.6.7.4065; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JOHNSON WS, 1995, BIOORGAN MED CHEM, V3, P851, DOI 10.1016/0968-0896(95)00067-Q; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Koorits L, 2007, DNA REPAIR, V6, P863, DOI 10.1016/j.dnarep.2007.01.010; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Kumari A, 2008, J BIOL CHEM, V283, P27433, DOI 10.1074/jbc.M801237200; Ma S, 1998, J BACTERIOL, V180, P956, DOI 10.1128/JB.180.4.956-968.1998; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Macia MD, 2004, ANTIMICROB AGENTS CH, V48, P2665, DOI 10.1128/AAC.48.7.2665-2672.2004; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Mena A, 2007, J BACTERIOL, V189, P3665, DOI 10.1128/JB.00120-07; Miller JH, 1999, SHORT COURSE BACTERI; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Morero NR, 2009, FEMS MICROBIOL LETT, V290, P217, DOI 10.1111/j.1574-6968.2008.01411.x; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; RUSH J, 1989, PREP BIOCHEM, V19, P329, DOI 10.1080/10826068908544921; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; Sanders LH, 2009, FEMS MICROBIOL LETT, V294, P89, DOI 10.1111/j.1574-6968.2009.01550.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Washington MT, 2002, P NATL ACAD SCI USA, V99, P1910, DOI 10.1073/pnas.032594399; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yamada M, 2006, J BACTERIOL, V188, P4992, DOI 10.1128/JB.00281-06; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138	69	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18824	10.1371/journal.pone.0018824	http://dx.doi.org/10.1371/journal.pone.0018824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533111	Green Submitted, Green Published, gold			2022-12-27	WOS:000289620100025
J	Go, YM; Kang, SM; Roede, JR; Orr, M; Jones, DP				Go, Young-Mi; Kang, Sang-Moo; Roede, James R.; Orr, Michael; Jones, Dean P.			Increased Inflammatory Signaling and Lethality of Influenza H1N1 by Nuclear Thioredoxin-1	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL-SPECIFIC EXPRESSION; RECEPTOR-ACTIVATING FACTOR; DNA-BINDING ACTIVITY; GLUCOCORTICOID-RECEPTOR; REDOX REGULATION; TRANSCRIPTION FACTOR; TRANSGENIC MICE; MITOCHONDRIAL THIOREDOXIN; DIRECT ASSOCIATION	Background: Cell culture studies show that the antioxidant thiol protein, thioredoxin-1 (Trx1), translocates to cell nuclei during stress, facilitates DNA binding of transcription factors NF-kappa B and glucocorticoid receptor (GR) and potentiates signaling in immune cells. Excessive proinflammatory signaling in vivo contributes to immune hyper-responsiveness and disease severity, but no studies have addressed whether nuclear Trx1 mediates such responses. Methodology/Principal Findings: Transgenic mice (Tg) expressing human Trx1 (hTrx1) with added nuclear localization signal (NLS) showed broad tissue expression and nuclear localization. The role of nuclear Trx1 in inflammatory signaling was examined in Tg and wild-type (WT) mice following infection with influenza (H1N1) virus. Results showed that Tg mice had earlier and more extensive NF-kappa B activation, increased TNF-alpha and IL-6 expression, greater weight loss, slower recovery and increased mortality compared to WT. Decreased plasma glutathione (GSH) and oxidized plasma GSH/GSSG redox potential (EhGSSG) following infection in Tg mice showed that the increased nuclear thiol antioxidant caused a paradoxical downstream oxidative stress. An independent test of this nuclear reductive stress showed that glucocorticoid-induced thymocyte apoptosis was increased by NLS-Trx1. Conclusion/Significance: Increased Trx1 in cell nuclei can increase severity of disease responses by potentiation of redoxsensitive transcription factor activation.	[Go, Young-Mi; Roede, James R.; Orr, Michael; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	Emory University	Go, YM (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	dpjones@emory.edu			National Institute of Environmental Health Sciences [ES011195, ES009047]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047, R01ES011195] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences Grants ES011195 and ES009047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Dai SC, 2009, ARTERIOSCL THROM VAS, V29, P495, DOI 10.1161/ATVBAHA.108.180349; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Gasdaska JR, 1996, BIOCHEM PHARMACOL, V52, P1741, DOI 10.1016/S0006-2952(96)00595-3; Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; Goldsack NR, 2003, SEX TRANSM INFECT, V79, P337, DOI 10.1136/sti.79.4.337; GRIPPO JF, 1985, J BIOL CHEM, V260, P93; GRIPPO JF, 1983, J BIOL CHEM, V258, P3658; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Harper R, 2001, AM J RESP CELL MOL, V25, P178, DOI 10.1165/ajrcmb.25.2.4471; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; He M, 2008, TOXICOL SCI, V105, P44, DOI 10.1093/toxsci/kfn116; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kim YC, 2003, ONCOGENE, V22, P1860, DOI 10.1038/sj.onc.1206369; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; Malik G, 2006, ANTIOXID REDOX SIGN, V8, P2101, DOI 10.1089/ars.2006.8.2101; Marques AH, 2009, ANN NY ACAD SCI, V1179, P1, DOI 10.1111/j.1749-6632.2009.04987.x; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; Nakamura H, 2002, IMMUNOL LETT, V82, P165, DOI 10.1016/S0165-2478(02)00033-0; Okamoto K, 1999, J BIOL CHEM, V274, P10363, DOI 10.1074/jbc.274.15.10363; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Powis G, 2004, MOL CANCER THER, V3, P647; Psarra AMG, 2009, BIOCHEM J, V422, P521, DOI 10.1042/BJ20090107; Quan FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009161; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schroeder P, 2007, ARTERIOSCL THROM VAS, V27, P2325, DOI 10.1161/ATVBAHA.107.149419; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Spielberger JC, 2008, J CELL BIOCHEM, V104, P1879, DOI 10.1002/jcb.21762; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Ueno M, 2000, IMMUNOL LETT, V75, P15, DOI 10.1016/S0165-2478(00)00284-4; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; Zhang HF, 2007, AM J PATHOL, V170, P1108, DOI 10.2353/ajpath.2007.060960; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066	59	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18918	10.1371/journal.pone.0018918	http://dx.doi.org/10.1371/journal.pone.0018918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526215	Green Published, Green Submitted, gold			2022-12-27	WOS:000289578600038
J	Mota, BEF; Gallardo-Romero, N; Trindade, G; Keckler, MS; Karem, K; Carroll, D; Campos, MA; Vieira, LQ; da Fonseca, FG; Ferreira, PCP; Bonjardim, CA; Damon, IK; Kroon, EG				Mota, Bruno E. F.; Gallardo-Romero, Nadia; Trindade, Giliane; Keckler, M. Shannon; Karem, Kevin; Carroll, Darin; Campos, Marco A.; Vieira, Leda Q.; da Fonseca, Flavio G.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Damon, Inger K.; Kroon, Erna G.			Adverse Events Post Smallpox-Vaccination: Insights from Tail Scarification Infection in Mice with Vaccinia virus	PLOS ONE			English	Article							CELL-DEFICIENT MICE; IMMUNE-RESPONSE; POXVIRUS INFECTION; PROGRESSIVE VACCINIA; ANTIBODY; REPLICATION; INHIBITION; PROTECTION; CLEARANCE; MONKEYPOX	Adverse events upon smallpox vaccination with fully-replicative strains of Vaccinia virus (VACV) comprise an array of clinical manifestations that occur primarily in immunocompromised patients leading to significant host morbidity/mortality. The expansion of immune-suppressed populations and the possible release of Variola virus as a bioterrorist act have given rise to concerns over vaccination complications should more widespread vaccination be reinitiated. Our goal was to evaluate the components of the host immune system that are sufficient to prevent morbidity/mortality in a murine model of tail scarification, which mimics immunological and clinical features of smallpox vaccination in humans. Infection of C57BL/6 wild-type mice led to a strictly localized infection, with complete viral clearance by day 28 p.i. On the other hand, infection of T and B-cell deficient mice (Rag1(-/-)) produced a severe disease, with uncontrolled viral replication at the inoculation site and dissemination to internal organs. Infection of B-cell deficient animals (mu MT) produced no mortality. However, viral clearance in mMT animals was delayed compared to WT animals, with detectable viral titers in tail and internal organs late in infection. Treatment of Rag1(-/-) with rabbit hyperimmune anti-vaccinia serum had a subtle effect on the morbidity/mortality of this strain, but it was effective in reduce viral titers in ovaries. Finally, NUDE athymic mice showed a similar outcome of infection as Rag1(-/-), and passive transfer of WT T cells to Rag1(-/-) animals proved fully effective in preventing morbidity/mortality. These results strongly suggest that both T and B cells are important in the immune response to primary VACV infection in mice, and that T-cells are required to control the infection at the inoculation site and providing help for B-cells to produce antibodies, which help to prevent viral dissemination. These insights might prove helpful to better identify individuals with higher risk of complications after infection with poxvirus.	[Mota, Bruno E. F.; Trindade, Giliane; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil; [Gallardo-Romero, Nadia; Keckler, M. Shannon; Karem, Kevin; Carroll, Darin; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus Program, Atlanta, GA USA; [Campos, Marco A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Vieira, Leda Q.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [da Fonseca, Flavio G.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virol Comparada, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Centers for Disease Control & Prevention - USA; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Mota, BEF (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.	kroone@icb.ufmg.br	Keckler, M. Shannon/S-8970-2019; Vieira, Leda Q/G-7487-2014; Vieira, Leda Quercia/AAD-3424-2019; Campos, Marco Antonio/AAU-6229-2021; Kroon, Erna/V-5444-2019; Campos, Marco A/C-4000-2013; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015; Keckler, M. Shannon/C-3864-2009	Vieira, Leda Quercia/0000-0001-5481-9618; Campos, Marco Antonio/0000-0003-4683-0176; Campos, Marco A/0000-0003-4683-0176; Kroon, Erna Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875; Keckler, M. Shannon/0000-0002-2275-4730	Brazilian Ministry of Agriculture, Livestock and Supply (MAPA); Brazilian National Council for Scientific and Technological Development; Brazilian Coordination for Improvement of Graduated Personnel; Foundation for Research Development of Minas Gerais; Oak Ridge Institute for Science and Education; CDC	Brazilian Ministry of Agriculture, Livestock and Supply (MAPA); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for Improvement of Graduated Personnel; Foundation for Research Development of Minas Gerais; Oak Ridge Institute for Science and Education(General Electric); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by funds from the Brazilian Ministry of Agriculture, Livestock and Supply (MAPA), Brazilian National Council for Scientific and Technological Development (CNPq-http://www.cnpq.br), Brazilian Coordination for Improvement of Graduated Personnel (CAPES-http://www.capes.gov.br), Foundation for Research Development of Minas Gerais (FAPEMIG-http://www.fapemig.br), the Oak Ridge Institute for Science and Education (ORISE-http://www.orise.orau.gov) and CDC intramural funds. GT, MAC, LQV, FGF, PCPF, CAB and EGK are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Freyschmidt EJ, 2007, J ALLERGY CLIN IMMUN, V119, P671, DOI 10.1016/j.jaci.2006.12.645; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; HARRIS N, 1995, J VIROL, V69, P910, DOI 10.1128/JVI.69.2.910-915.1995; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Jezek Z, 1988, HUMAN MONKEYPOX; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kohno K, 1998, CLIN IMMUNOL IMMUNOP, V86, P11, DOI 10.1006/clin.1997.4475; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lustig S, 2009, VACCINE, V27, P1691, DOI 10.1016/j.vaccine.2009.01.038; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mortimer PP, 2003, CLIN MED, V3, P255, DOI 10.7861/clinmedicine.3-3-255; MOSS B, 2001, FUNDAMENTAL VIROLOGY; Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3; Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Perera LP, 2001, P NATL ACAD SCI USA, V98, P5146, DOI 10.1073/pnas.081080298; Puissant-Lubrano B, 2010, J CLIN INVEST, V120, P1636, DOI 10.1172/JCI38506; Ramirez JC, 2002, J GEN VIROL, V83, P1059, DOI 10.1099/0022-1317-83-5-1059; Rolph MS, 1996, VIROLOGY, V217, P470, DOI 10.1006/viro.1996.0141; Saito T, 2009, JAMA-J AM MED ASSOC, V301, P1025, DOI 10.1001/jama.2009.289; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sharon M, 2007, VACCINE, V25, P7743, DOI 10.1016/j.vaccine.2007.09.023; SPRIGGS MK, 1992, P NATL ACAD SCI USA, V89, P6070, DOI 10.1073/pnas.89.13.6070; Tian T, 2009, J INVEST DERMATOL, V129, P70, DOI 10.1038/jid.2008.191; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Worthington M, 2003, CLIN INFECT DIS, V37, P864, DOI 10.1086/377275; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768	42	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18924	10.1371/journal.pone.0018924	http://dx.doi.org/10.1371/journal.pone.0018924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526210	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600039
J	Scheeren, FA; van Geelen, CMM; Yasuda, E; Spits, H; Beaumont, T				Scheeren, Ferenc A.; van Geelen, Caroline M. M.; Yasuda, Etsuko; Spits, Hergen; Beaumont, Tim			Antigen-Specific Monoclonal Antibodies Isolated from B Cells Expressing Constitutively Active STAT5	PLOS ONE			English	Article							TERMINAL DIFFERENTIATION; IMMUNOGLOBULIN GENE; INFECTIOUS-DISEASES; BCL-6 EXPRESSION; HODGKIN LYMPHOMA; IL-21; TRANSCRIPTION; CHAIN; PROLIFERATION; MECHANISM	Background: Fully human monoclonal antibodies directed against specific pathogens have a high therapeutic potential, but are difficult to generate. Methodology/Principal Findings: Memory B cells were immortalized by expressing an inducible active mutant of the transcription factor Signal Transducer and Activator of Transcription 5 (STAT5). Active STAT5 inhibits the differentiation of B cells while increasing their replicative life span. We obtained cloned B cell lines, which produced antibodies in the presence of interleukin 21 after turning off STAT5. We used this method to obtain monoclonal antibodies against the model antigen tetanus toxin. Conclusions/Significance: Here we describe a novel and relatively simple method of immortalizing antigen-specific human B cells for isolation of human monoclonal antibodies. These results show that STAT5 overexpression can be employed to isolate antigen specific antibodies from human memory B cells.	[Scheeren, Ferenc A.; van Geelen, Caroline M. M.; Yasuda, Etsuko; Spits, Hergen; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van Geelen, Caroline M. M.; Yasuda, Etsuko; Spits, Hergen; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, NL-1105 AZ Amsterdam, Netherlands; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scheeren, FA (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA.	beaumont@aimmtherapeutics.com	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338; Scheeren, Ferenc/0000-0002-8304-9023	Netherlands Organization for Scientific Research (NWO); AIMM therapeutics	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); AIMM therapeutics	The study was financially supported by the Netherlands Organization for Scientific Research (NWO) and by AIMM therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BURTON DR, 1994, ADV IMMUNOL, V57, P191, DOI 10.1016/S0065-2776(08)60674-4; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; HENDRIKSEN CFM, 1989, J BIOL STAND, V17, P241, DOI 10.1016/0092-1157(89)90016-4; HENDRIKSEN CFM, 1988, J BIOL STAND, V16, P287, DOI 10.1016/0092-1157(88)90017-0; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Scheeren FA, 2008, BLOOD, V111, P4706, DOI 10.1182/blood-2007-08-105643; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; STEINITZ M, 1977, NATURE, V269, P420, DOI 10.1038/269420a0; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Ushmorov A, 2004, BLOOD, V104, P3326, DOI 10.1182/blood-2003-04-1197; Wagner EF, 1998, J IMMUNOL, V161, P1123; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEZEL AL, 1979, NED TIJDSCHR GENEES, V123, P466; WRAMMERT J, 2008, NATURE; YAMAMURA K, 1986, P NATL ACAD SCI USA, V83, P2152, DOI 10.1073/pnas.83.7.2152; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	44	3	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e17189	10.1371/journal.pone.0017189	http://dx.doi.org/10.1371/journal.pone.0017189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525985	Green Submitted, gold, Green Published			2022-12-27	WOS:000289578600004
J	Wang, F; Xu, L; Guo, CY; Ke, AW; Hu, GY; Xu, XF; Mo, WH; Yang, LJ; Huang, YS; He, SS; Wang, XP				Wang, Feng; Xu, Ling; Guo, Chuanyong; Ke, Aiwu; Hu, Guoyong; Xu, Xuanfu; Mo, Wenhui; Yang, Lijuan; Huang, Yinshi; He, Shanshan; Wang, Xingpeng			Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer	PLOS ONE			English	Article							SONIC HEDGEHOG; DUCTAL ADENOCARCINOMA; GASTRIC-CANCER; IV; EXPRESSION; TUMOR; SERUM; CARCINOGENESIS; METASTASIS; ACTIVATION	Background and Aims: GLI1 is the key transcriptional factor in the Hedgehog signaling pathway in pancreatic cancer. RegIV is associated with regeneration, and cell growth, survival, adhesion and resistance to apoptosis. We aimed to study RegIV expression in pancreatic cancer and its relationship to GLI1. Methods: GLI1 and RegIV expression were evaluated in tumor tissue and adjacent normal tissues of pancreatic cancer patients and 5 pancreatic cancer cell lines by qRT-PCR, Western blot, and immunohistochemistry (IHC), and the correlation between them. The GLI1-shRNA lentiviral vector was constructed and transfected into PANC-1, and lentiviral vector containing the GLI1 expression sequence was constructed and transfected into BxPC-3. GLI1 and RegIV expression were evaluated by qRT-PCR and Western blot. Finally we demonstrated RegIV to be the target of GLI1 by chromatin immunoprecipitation (CHIP) and electrophoretic mobility shift assays (EMSA). Results: The results of IHC and qRT-PCR showed that RegIV and GLI1 expression was higher in pancreatic cancer tissues versus adjacent normal tissues (p < 0.001). RegIV expression correlated with GLI1 expression in these tissues (R = 0.795, p < 0.0001). These results were verified for protein (R = 0.939, p = 0.018) and mRNA expression (R = 0.959, p = 0.011) in 5 pancreatic cancer cell lines. RegIV mRNA and protein expression was decreased (94.7 +/- 0.3%, 84.1 +/- 0.5%; respectively) when GLI1 was knocked down (82.1 +/- 3.2%, 76.7 +/- 2.2%; respectively) by the RNAi technique. GLI1 overexpression in mRNA and protein level (924.5 +/- 5.3%, 362.1 +/- 3.5%; respectively) induced RegIV overexpression (729.1 +/- 4.3%, 339.0 +/- 3.7%; respectively). Moreover, CHIP and EMSA assays showed GLI1 protein bound to RegIV promotor regions (GATCATCCA) in pancreatic cancer cells. Conclusion: GLI1 promotes RegIV transcription by binding to the RegIV gene promoter in pancreatic cancer.	[Wang, Feng; Yang, Lijuan; Wang, Xingpeng] Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Xu, Ling; Guo, Chuanyong; Ke, Aiwu; Hu, Guoyong; Xu, Xuanfu; Mo, Wenhui; Huang, Yinshi; He, Shanshan; Wang, Xingpeng] Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Wang, F (corresponding author), Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	wangxingpeng@hotmail.com	He, Shanshan/P-5691-2014	wang, feng/0000-0003-4068-3339; Guo, Chuanyong/0000-0002-6527-4673; Ke, Ai-Wu/0000-0002-7964-6909	National Natural Science Foundation of China [81072065]; Foundation for Shanghai Science and Technology Committee [09JC1412200, 09410705400]; Ministry of Education of China [20090072110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Shanghai Science and Technology Committee; Ministry of Education of China(Ministry of Education, China)	This work was supported in part by National Natural Science Foundation of China (No. 81072065), Foundation for Shanghai Science and Technology Committee (No. 09JC1412200, No. 09410705400), and Doctoral Fund of Ministry of Education of China (No. 20090072110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Bishnupuri KS, 2010, GASTROENTEROLOGY, V138, P616, DOI 10.1053/j.gastro.2009.10.050; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Eguchi H, 2009, PANCREAS, V38, P791, DOI 10.1097/MPA.0b013e3181ac5337; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Klein WM, 2002, MODERN PATHOL, V15, P441, DOI 10.1038/modpathol.3880544; Kuniyasu H, 2009, CELL PROLIFERAT, V42, P110, DOI 10.1111/j.1365-2184.2008.00577.x; Lee J, 1997, DEVELOPMENT, V124, P2537; Legoffic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007495; Li FY, 2010, J ZHEJIANG UNIV-SC B, V11, P258, DOI 10.1631/jzus.B0900383; Li XH, 2010, HISTOL HISTOPATHOL, V25, P473, DOI 10.14670/HH-25.473; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Sekikawa A, 2005, GASTROENTEROLOGY, V128, P642, DOI 10.1053/j.gastro.2004.12.045; Takayama R, 2010, J GASTROENTEROL, V45, P52, DOI 10.1007/s00535-009-0114-y; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Violette S, 2003, INT J CANCER, V103, P185, DOI 10.1002/ijc.10788; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635; Zhang YW, 2003, CANCER LETT, V200, P69, DOI 10.1016/S0304-3835(03)00460-9	44	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18434	10.1371/journal.pone.0018434	http://dx.doi.org/10.1371/journal.pone.0018434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494603	Green Submitted, Green Published, gold			2022-12-27	WOS:000289354100014
J	Burridge, PW; Thompson, S; Millrod, MA; Weinberg, S; Yuan, XA; Peters, A; Mahairaki, V; Koliatsos, VE; Tung, L; Zambidis, ET				Burridge, Paul W.; Thompson, Susan; Millrod, Michal A.; Weinberg, Seth; Yuan, Xuan; Peters, Ann; Mahairaki, Vasiliki; Koliatsos, Vassilis E.; Tung, Leslie; Zambidis, Elias T.			A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability	PLOS ONE			English	Article							CARDIOMYOCYTE DIFFERENTIATION; FUNCTIONAL-PROPERTIES; DEFINED MEDIUM; LINES; MESODERM; INDUCTION; ENDODERM	Background: The production of cardiomyocytes from human induced pluripotent stem cells (hiPSC) holds great promise for patient-specific cardiotoxicity drug testing, disease modeling, and cardiac regeneration. However, existing protocols for the differentiation of hiPSC to the cardiac lineage are inefficient and highly variable. We describe a highly efficient system for differentiation of human embryonic stem cells (hESC) and hiPSC to the cardiac lineage. This system eliminated the variability in cardiac differentiation capacity of a variety of human pluripotent stem cells (hPSC), including hiPSC generated from CD34(+) cord blood using non-viral, non-integrating methods. Methodology/Principal Findings: We systematically and rigorously optimized > 45 experimental variables to develop a universal cardiac differentiation system that produced contracting human embryoid bodies (hEB) with an improved efficiency of 94.7 +/- 2.4% in an accelerated nine days from four hESC and seven hiPSC lines tested, including hiPSC derived from neonatal CD34+ cord blood and adult fibroblasts using non-integrating episomal plasmids. This cost-effective differentiation method employed forced aggregation hEB formation in a chemically defined medium, along with staged exposure to physiological (5%) oxygen, and optimized concentrations of mesodermal morphogens BMP4 and FGF2, polyvinyl alcohol, serum, and insulin. The contracting hEB derived using these methods were composed of high percentages (64-89%) of cardiac troponin I+ cells that displayed ultrastructural properties of functional cardiomyocytes and uniform electrophysiological profiles responsive to cardioactive drugs. Conclusion/Significance: This efficient and cost-effective universal system for cardiac differentiation of hiPSC allows a potentially unlimited production of functional cardiomyocytes suitable for application to hPSC-based drug development, cardiac disease modeling, and the future generation of clinically-safe nonviral human cardiac cells for regenerative medicine.	[Burridge, Paul W.; Millrod, Michal A.; Yuan, Xuan; Peters, Ann; Zambidis, Elias T.] Johns Hopkins Univ, Sch Med, Johns Hopkins Inst Cell Engn, Baltimore, MD 21218 USA; [Thompson, Susan; Weinberg, Seth; Tung, Leslie] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mahairaki, Vasiliki; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Burridge, PW (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Inst Cell Engn, Baltimore, MD 21218 USA.	paul.burridge@jhmi.edu; ezambid1@jhmi.edu	Burridge, Paul Wesley/AAI-2717-2021	Weinberg, Seth/0000-0003-1170-0419	Maryland Stem Cell Research Fund; NHLBI Progenitor Biology Consortium (National Institutes of Health) [U01HL099775, U01HL100397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775, R03HL096220, U01HL100397, K08HL077595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund; NHLBI Progenitor Biology Consortium (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Maryland Stem Cell Research Fund (E.T.Z., L.T.), and the NHLBI Progenitor Biology Consortium (National Institutes of Health U01HL099775 and U01HL100397 (E.T.Z)). P.W.B. and V.M. are supported by postdoctoral fellowship grants from the Maryland Stem Cell Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Bettiol E, 2007, DIFFERENTIATION, V75, P669, DOI 10.1111/j.1432-0436.2007.00174.x; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chen Chi-Shuo, 2008, J Vis Exp, DOI 10.3791/692; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; FRESHNEY RI, 2005, CULTURE ANIMAL CELLS, pR26; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; ITZHAKI I, 2011, NATURE; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Kaichi S, 2010, CARDIOVASC RES, V88, P314, DOI 10.1093/cvr/cvq189; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lowry WE, 2010, J CELL SCI, V123, P643, DOI 10.1242/jcs.054304; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Moore JC, 2008, BIOCHEM BIOPH RES CO, V372, P553, DOI 10.1016/j.bbrc.2008.05.076; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Niebruegge S, 2009, BIOTECHNOL BIOENG, V102, P493, DOI 10.1002/bit.22065; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542; PETERS A, 2011, METHODS MOL IN PRESS; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Proetzel G, 2002, Methods Mol Biol, V185, P17; Pryzhkova MV, 2010, REPROD BIOMED ONLINE, V21, P196, DOI 10.1016/j.rbmo.2010.04.017; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Segev H, 2005, DEV GROWTH DIFFER, V47, P295; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weinberg S, 2010, METHODS MOL BIOL, V660, P215, DOI 10.1007/978-1-60761-705-1_14; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2006, STEM CELLS DEV, V15, P931, DOI 10.1089/scd.2006.15.931; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	56	286	308	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18293	10.1371/journal.pone.0018293	http://dx.doi.org/10.1371/journal.pone.0018293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494607	Green Submitted, gold, Green Published			2022-12-27	WOS:000289292800007
J	Tennant, SM; Zhang, YX; Galen, JE; Geddes, CD; Levine, MM				Tennant, Sharon M.; Zhang, Yongxia; Galen, James E.; Geddes, Chris D.; Levine, Myron M.			Ultra-Fast and Sensitive Detection of Non-Typhoidal Salmonella Using Microwave-Accelerated Metal-Enhanced Fluorescence ("MAMEF")	PLOS ONE			English	Article							REAL-TIME PCR; COMMUNITY-ACQUIRED BACTEREMIA; POLYMERASE-CHAIN-REACTION; LABORATORY DIAGNOSIS; RAPID DETECTION; MULTIPLEX PCR; BLOOD; CHILDREN; TYPHI; INFECTIONS	Certain serovars of Salmonella enterica subsp. enterica cause invasive disease (e.g., enteric fever, bacteremia, septicemia, meningitis, etc.) in humans and constitute a global public health problem. A rapid, sensitive diagnostic test is needed to allow prompt initiation of therapy in individual patients and for measuring disease burden at the population level. An innovative and promising new rapid diagnostic technique is microwave-accelerated metal-enhanced fluorescence (MAMEF). We have adapted this assay platform to detect the chromosomal oriC locus common to all Salmonella enterica subsp. enterica serovars. We have shown efficient lysis of biologically relevant concentrations of Salmonella spp. suspended in bacteriological media using microwave-induced lysis. Following lysis and DNA release, as little as 1 CFU of Salmonella in 1 ml of medium can be detected in < 30 seconds. Furthermore the assay is sensitive and specific: it can detect oriC from Salmonella serovars Typhi, Paratyphi A, Paratyphi B, Paratyphi C, Typhimurium, Enteritidis and Choleraesuis but does not detect Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae or Acinetobacter baumanii. We have also performed preliminary experiments using a synthetic Salmonella oriC oligonucleotide suspended in whole human blood and observed rapid detection when the sample was diluted 1: 1 with PBS. These pre-clinical data encourage progress to the next step to detect Salmonella in blood ( and other ordinarily sterile, clinically relevant body fluids).	[Tennant, Sharon M.; Galen, James E.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Zhang, Yongxia; Geddes, Chris D.] Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Tennant, SM (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	stennant@medicine.umaryland.edu			National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) [2 U54 AI057168-06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Middle Atlantic RCE Program, National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) 2 U54 AI057168-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Ali A, 2009, EPIDEMIOL INFECT, V137, P102, DOI 10.1017/S0950268808000654; Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; Aslan K, 2005, J FLUORESC, V15, P643, DOI 10.1007/s10895-005-2970-z; Aslan K, 2008, ANALYST, V133, P1469, DOI 10.1039/b808292h; Aslan K, 2008, PLASMONICS, V3, P89, DOI 10.1007/s11468-008-9059-x; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Aslan K, 2007, ANALYST, V132, P1130, DOI 10.1039/b707876e; Aslan Kadir, 2010, Nano Biomed Eng, V2, P1; Aslan K, 2006, J IMMUNOL METHODS, V312, P137, DOI 10.1016/j.jim.2006.03.009; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; DRAGAN AI, 2011, J IMMUNOL METHODS; Durmaz G, 2003, J CLIN MICROBIOL, V41, P819, DOI 10.1128/JCM.41.2.819-821.2003; FRANKEL G, 1994, J CLIN MICROBIOL, V32, P1415, DOI 10.1128/JCM.32.5.1415-.1994; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Gradel KO, 2006, EUR J CLIN MICROBIOL, V25, P151, DOI 10.1007/s10096-006-0110-6; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Haque A, 2001, JPN J INFECT DIS, V54, P237; Hatta M, 2007, AM J TROP MED HYG, V76, P139, DOI 10.4269/ajtmh.2007.76.139; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Kumar A, 2002, INFECT GENET EVOL, V2, P107, DOI 10.1016/S1567-1348(02)00090-4; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; LEPAGE P, 1987, LANCET, V1, P1458; LEVINE MM, 2004, VACCINES, P1057; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Malorny B, 2008, APPL ENVIRON MICROB, V74, P1299, DOI 10.1128/AEM.02489-07; Malorny B, 2009, FOOD ANAL METHOD, V2, P81, DOI 10.1007/s12161-008-9057-9; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Massi Muhammad Nasrum, 2003, Journal of Infection and Chemotherapy, V9, P233, DOI 10.1007/s10156-003-0256-4; Michota A, 2001, J RAMAN SPECTROSC, V32, P345, DOI 10.1002/jrs.703; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Paolucci M, 2009, J MED MICROBIOL, V58, P533, DOI 10.1099/jmm.0.003848-0; Papaevangelou V, 2004, SCAND J INFECT DIS, V36, P547, DOI 10.1080/00365540410016744; Prakash P, 2005, J CLIN MICROBIOL, V43, P431, DOI 10.1128/JCM.43.1.431-432.2005; Reisner BS, 1999, J CLIN MICROBIOL, V37, P2024, DOI 10.1128/JCM.37.6.2024-2026.1999; Sanchez-Jimenez MM, 2004, J MED MICROBIOL, V53, P875, DOI 10.1099/jmm.0.45630-0; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; SONG JH, 1993, J CLIN MICROBIOL, V31, P1439, DOI 10.1128/JCM.31.6.1439-1443.1993; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; THRELFALL EJ, 1992, J CLIN PATHOL, V45, P34, DOI 10.1136/jcp.45.1.34; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wain J, 2008, J INFECT DEV COUNTR, V2, P421, DOI 10.3855/jidc.164; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; WATSON KC, 1955, J LAB CLIN MED, V46, P128; WIDJOJOATMODJO MN, 1991, EUR J CLIN MICROBIOL, V10, P935, DOI 10.1007/BF02005447; Woods DF, 2008, J CLIN MICROBIOL, V46, P4018, DOI 10.1128/JCM.01229-08; ZHANG Y, 2010, IEEE T BIOMED ENG; Zhou LQ, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-14	59	27	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18700	10.1371/journal.pone.0018700	http://dx.doi.org/10.1371/journal.pone.0018700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494634	gold, Green Published, Green Submitted			2022-12-27	WOS:000289292800039
J	Baxter, EJ; Sturt, MM; Ruane, NM; Doyle, TK; McAllen, R; Harman, L; Rodger, HD				Baxter, Emily J.; Sturt, Michael M.; Ruane, Neil M.; Doyle, Thomas K.; McAllen, Rob; Harman, Luke; Rodger, Hamish D.			Gill Damage to Atlantic Salmon (Salmo salar) Caused by the Common Jellyfish (Aurelia aurita) under Experimental Challenge	PLOS ONE			English	Article							BLOOMS; WATERS; POPULATIONS; SCYPHOZOA; ABUNDANCE; COASTAL; DISEASE	Background: Over recent decades jellyfish have caused fish kill events and recurrent gill problems in marine-farmed salmonids. Common jellyfish (Aurelia spp.) are among the most cosmopolitan jellyfish species in the oceans, with populations increasing in many coastal areas. The negative interaction between jellyfish and fish in aquaculture remains a poorly studied area of science. Thus, a recent fish mortality event in Ireland, involving Aurelia aurita, spurred an investigation into the effects of this jellyfish on marine-farmed salmon. Methodology/Principal Findings: To address the in vivo impact of the common jellyfish (A. aurita) on salmonids, we exposed Atlantic salmon (Salmo salar) smolts to macerated A. aurita for 10 hrs under experimental challenge. Gill tissues of control and experimental treatment groups were scored with a system that rated the damage between 0 and 21 using a range of primary and secondary parameters. Our results revealed that A. aurita rapidly and extensively damaged the gills of S. salar, with the pathogenesis of the disorder progressing even after the jellyfish were removed. After only 2 hrs of exposure, significant multi-focal damage to gill tissues was apparent. The nature and extent of the damage increased up to 48 hrs from the start of the challenge. Although the gills remained extensively damaged at 3 wks from the start of the challenge trial, shortening of the gill lamellae and organisation of the cells indicated an attempt to repair the damage suffered. Conclusions: Our findings clearly demonstrate that A. aurita can cause severe gill problems in marine-farmed fish. With aquaculture predicted to expand worldwide and evidence suggesting that jellyfish populations are increasing in some areas, this threat to aquaculture is of rising concern as significant losses due to jellyfish could be expected to increase in the future.	[Baxter, Emily J.] Univ Coll Cork, Environm Res Inst, Coastal & Marine Res Ctr, Cork, Ireland; [Baxter, Emily J.; Sturt, Michael M.; McAllen, Rob; Harman, Luke] Univ Coll Cork, Sch Biol Earth & Environm Sci, Dept Zool Ecol & Plant Sci, Cork, Ireland; [Baxter, Emily J.] Univ Coll Cork, Sch Biol Earth & Environm Sci, Aquaculture & Fisheries Dev Ctr, Cork, Ireland; [Ruane, Neil M.] Marine Inst Co, Fish Hlth Unit, Galway, Ireland; [Rodger, Hamish D.] Vet Aqua Int Co, Galway, Ireland	University College Cork; University College Cork; University College Cork; Marine Institute Ireland	Baxter, EJ (corresponding author), Univ Coll Cork, Environm Res Inst, Coastal & Marine Res Ctr, Cork, Ireland.	e.baxter@ucc.ie		Ruane, Neil/0000-0002-2001-9652; Rodger, Hamish/0000-0002-5336-8912; Doyle, Thomas/0000-0003-1616-5590	Marine Institute [PBA/AF/08/002(01)]; Marine Research Sub-Programme of the National Development Plan; European Regional Development Fund	Marine Institute; Marine Research Sub-Programme of the National Development Plan; European Regional Development Fund(European Commission)	This project [Grant-Aid Agreement No PBA/AF/08/002(01)] was carried out under the Sea Change strategy with the support of the Marine Institute and the Marine Research Sub-Programme of the National Development Plan 2007-2013, co-financed under the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamstedt U, 1998, SARSIA, V83, P79, DOI 10.1080/00364827.1998.10413673; Burke W. A., 2002, DERMATOL THER, V15, P18, DOI DOI 10.1046/J.1529-8019.2002.01508.X; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; FAO, 2009, STAT WORLD FISH AQ 2; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Fossa J., 2003, FISK HAVET, V2, P99; Graham WM, 2001, HYDROBIOLOGIA, V451, P97, DOI 10.1023/A:1011844208119; HAMNER WM, 1994, MAR BIOL, V119, P347, DOI 10.1007/BF00347531; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; Lo WT, 2008, ICES J MAR SCI, V65, P453, DOI 10.1093/icesjms/fsm185; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Purcell JE, 2000, MAR ECOL PROG SER, V195, P145, DOI 10.3354/meps195145; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Roberts R.J., 2001, P55; Rodger H, 2007, J FISH DIS, V30, P157, DOI 10.1111/j.1365-2761.2007.00799.x; Rodger H. D., 2007, Fish Veterinary Journal, P38; RODGER HD, 2011, REV FISH BI IN PRESS, DOI DOI 10.1007/S11160-11010-19182-11166; Suchman CL, 2005, DEEP-SEA RES PT II, V52, P51, DOI 10.1016/j.dsr2.2004.09.017; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Yasuda T, 1988, STUDIES COMMON JELLY	22	53	53	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18529	10.1371/journal.pone.0018529	http://dx.doi.org/10.1371/journal.pone.0018529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490977	gold, Green Submitted, Green Published			2022-12-27	WOS:000289238700020
J	Begovic, E; Lindberg, DR				Begovic, Emina; Lindberg, David R.			Genetic Population Structure of Tectura paleacea: Implications for the Mechanisms Regulating Population Structure in Patchy Coastal Habitats	PLOS ONE			English	Article							LARVAL DISPERSAL; DNA-SEQUENCES; MARINE; FLOW; PATTERNS; GROWTH; SHELL; PHYLOGEOGRAPHY; INVERTEBRATES; SPECIATION	The seagrass limpet Tectura paleacea (Gastropoda; Patellogastropoda) belongs to a seagrass obligate lineage that has shifted from the Caribbean in the late Miocene, across the Isthmus of Panama prior to the closing of the Panamanian seaway, and then northward to its modern Baja California - Oregon distribution. To address whether larval entrainment by seagrass beds contributes to population structuring, populations were sampled at six California/Oregon localities approximately 2 degrees latitude apart during two post-settlement periods in July 2002 and June 2003. Partial cytochrome oxidase b (Cytb) sequences were obtained from 20 individuals (10 per year) from each population in order to determine the levels of population subdivision/connectivity. From the 120 individuals sequenced, there were eighty-one unique haplotypes, with the greatest haplotype diversity occurring in southern populations. The only significant genetic break detected was consistent with a peri-Point Conception (PPC) biogeographic boundary while populations north and south of Point Conception were each panmictic. The data further indicate that populations found south of the PPC biogeographic boundary originated from northern populations. This pattern of population structure suggests that seagrass patches are not entraining the larvae of T. paleacea by altering flow regimes within their environment; a process hypothesized to produce extensive genetic subdivision on fine geographic scales. In contrast to the haplotype data, morphological patterns vary significantly over very fine geographic scales that are inconsistent with the observed patterns of genetic population structure, indicating that morphological variation in T. paleacea might be attributed to differential ecophenotypic expression in response to local habitat variability throughout its distribution. These results suggest that highly localized conservation efforts may not be as effective as large-scale conservation efforts in near shore marine environments.	[Begovic, Emina] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Begovic, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	emina@Berkeley.edu	Lindberg, David R/D-8138-2011		Lerner-Gray Fund; Sigma-Xi; University of California Museum of Paleontology; Department of Integrative Biology at UC Berkeley	Lerner-Gray Fund; Sigma-Xi; University of California Museum of Paleontology; Department of Integrative Biology at UC Berkeley	Funding for this research was provided by grants in part by the Lerner-Gray Fund, Sigma-Xi, the University of California Museum of Paleontology, and the Department of Integrative Biology at UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Arsenault DJ, 2001, P ROY SOC B-BIOL SCI, V268, P2149, DOI 10.1098/rspb.2001.1776; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1994, MOL MARKERS NATURAL, V14; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; BARBOUR MG, 1979, AM J BOT, V66, P301, DOI 10.2307/2442606; BEGOVIC E, 2004, POPULATION STRUCTURI; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Coates Anthony G., 1996, P21; Collins TM, 1996, EVOLUTION, V50, P2287, DOI 10.1111/j.1558-5646.1996.tb03617.x; DAVIS BJ, 1981, MAR BIOL, V65, P17, DOI 10.1007/BF00397063; Dawson MN, 2001, EVOLUTION, V55, P1167; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; DenHartog C, 1970, SEA GRASSES WORLD; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duda TF, 1999, MAR BIOL, V134, P705, DOI 10.1007/s002270050586; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FISHLYN DA, 1980, BIOL B WOODS HOLE, V158; FISHLYN DA, 1976, W SOC MALACOLOGISTS, V16; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; FRITCHMAN HARRY K., 1962, VELIGER, V4, P134; FRITCHMAN HARRY K. II, 1961, VELIGER, V3, P95; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Gilg MR, 2003, EVOLUTION, V57, P1061, DOI 10.1111/j.0014-3820.2003.tb00316.x; GRANT AR, 1938, SYSTEMATIC REVISION; Hamm DE, 2000, J EXP MAR BIOL ECOL, V254, P235, DOI 10.1016/S0022-0981(00)00283-5; HARVEY PH, 1996, NEW USES NEW PHYLOGE, V11; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; HORGAN DA, 1976, POPULATION STUDIES S, P17; Kay MC, 2002, INVERTEBR BIOL, V121, P11; KEEN AM, 1942, OREGON STATE MONOGRA, V3, P1; Kelly RP, 2007, EVOLUTION, V61, P700, DOI 10.1111/j.1558-5646.2007.00055.x; KEMP P, 1984, P NATL ACAD SCI-BIOL, V81, P811, DOI 10.1073/pnas.81.3.811; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; KUO J, 1995, CAN J BOT, V73, P827, DOI 10.1139/b95-091; LINDBERG D R, 1982, Bulletin Southern California Academy of Sciences, V81, P87; LINDBERG DR, 1987, AM MALACOLOGIC UNION; LINDBERG DR, 2007, LIGHT SMITHS MANUAL; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; MCMILLAN C, 1981, CAN J BOT, V59, P1494, DOI 10.1139/b81-203; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Moberg PE, 2000, MAR BIOL, V136, P773, DOI 10.1007/s002270000281; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; PALUMBI SR, 1984, SCIENCE, V225, P1478, DOI 10.1126/science.225.4669.1478; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 1996, SEQUENCE ALIGNMENT E; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schneider S., 2000, ARLEQUIN VER 2 000 S; SLATKIN M, 1991, GENETICS, V129, P555; Sober E, 2002, PHILOS SCI, V69, pS112, DOI 10.1086/341839; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; STEWART JG, 1980, AQUAT BOT, V9, P73, DOI 10.1016/0304-3770(80)90006-6; STRATHMANN MF, 1987, REPROD DEV MARINE IN, V12; Swofford DL, 1998, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TEST AR, 1945, ECOLOGY, V26, P395; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Todd CD, 1998, HYDROBIOLOGIA, V375-76, P1, DOI 10.1023/A:1017007527490; Trussell GC, 2001, GENETICA, V112, P321, DOI 10.1023/A:1013364527698; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Verduin JJ, 2000, ESTUAR COAST SHELF S, V50, P185, DOI 10.1006/ecss.1999.0567; VERMEIJ GJ, 1973, MAR BIOL, V20, P319, DOI 10.1007/BF00354275; Wares JP, 2001, EVOLUTION, V55, P295; Wright S., 1978, EVOLUTION GENETICS P	76	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18408	10.1371/journal.pone.0018408	http://dx.doi.org/10.1371/journal.pone.0018408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490969	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700011
J	Badar, A; DeFreitas, S; McDonnell, JM; Yahya, N; Thakor, D; Razavi, R; Smith, R; Sacks, S; Mullen, GED				Badar, Adam; DeFreitas, Sarah; McDonnell, James M.; Yahya, Norhakim; Thakor, David; Razavi, Reza; Smith, Richard; Sacks, Steven; Mullen, Gregory E. D.			Recombinant Complement Receptor 2 Radiolabeled with [Tc-99m(CO)(3)](+): A Potential New Radiopharmaceutical for Imaging Activated Complement	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; RENAL-TRANSPLANTATION; C3; INJURY; INFLAMMATION; INHIBITOR; ISCHEMIA; PROTEINS; CR2/CD21; VACCINE	We describe the design and synthesis of a new Tc-99m labeled bioconjugate for imaging activated complement, based on Short Consensus Repeats 1 and 2 of Complement Receptor 2 (CR2), the binding domain for C3d. To avoid non specific modification of CR2 and the potential for modifying lysine residues critical to the CR2/C3d contact surface, we engineered a new protein, recombinant CR2 (rCR2), to include the C-terminal sequence VFPLECHHHHHH, a hexahistidine tag (for site-specific radiolabeling with [Tc-99m(CO)(3)(OH2)(3)](+)). The protein was characterized by N-terminal sequencing, SDS-PAGE and size exclusion chromatography. To test the function of the recombinant CR2, binding to C3d was confirmed by enzyme-linked immunosorbent assay (ELISA). The function was further confirmed by binding of rCR2 to C3d(+) red blood cells (RBC) which were generated by deposition of human or rat C3d and analyzed by fluorescence microscopy and flow cytometry. The affinity of rCR2 for C3d(+), in presence of 150 mM NaCl, was measured using surface plasma resonance giving rise to a K-D approximate to 500 nM. Radiolabeling of rCR2 or an inactive mutant of rCR2 (K41E CR2) or an unrelated protein of a similar size (C2A) with [Tc-99m(CO)(3)(OH2)(3)](+) at gave radiochemical yields >95%. Site-specifically radiolabeled rCR2 bound to C3d to C3d(+) RBC. Binding of radiolabeled rCR2 to C3d was inhibited by anti-C3d and the radiolabeled inactive mutant K41E CR2 and C2A did not bind to C3d(+) RBCs. We conclude that rCR2-Tc-99m has excellent radiolabeling, stability and C3d binding characteristics and warrants in vivo evaluation as an activated complement imaging agent.	[Badar, Adam; DeFreitas, Sarah; Smith, Richard; Sacks, Steven; Mullen, Gregory E. D.] Kings Coll London, Guys Hosp, Med Res Council Ctr Transplantat, London WC2R 2LS, England; [Badar, Adam; Thakor, David; Razavi, Reza; Mullen, Gregory E. D.] Kings Coll London, St Thomas Hosp, Div Imaging Sci, London WC2R 2LS, England; [McDonnell, James M.; Yahya, Norhakim] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Badar, A (corresponding author), Kings Coll London, Guys Hosp, Med Res Council Ctr Transplantat, London WC2R 2LS, England.	stephen.sacks@kcl.ac.uk; greg.mullen@kcl.ac.uk		Razavi, Reza/0000-0003-1065-3008; McDonnell, James/0000-0001-9037-2980; Sacks, Steven/0000-0001-6361-9095	King's College London, Division of Imaging Sciences, MRC Centre of Transplantation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; MRC [G0600892, G0501494] Funding Source: UKRI; Medical Research Council [G1000758, G0600892, G1000758B, G0501494] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	King's College London, Division of Imaging Sciences, MRC Centre of Transplantation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge financial support from King's College London, Division of Imaging Sciences, MRC Centre of Transplantation, The Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atary JZ, 2010, EUROPACE, V12, P378, DOI 10.1093/europace/eup420; Banz Y, 2007, CARDIOVASC RES, V76, P482, DOI 10.1016/j.cardiores.2007.07.016; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Cai WB, 2007, J NUCL MED, V48, P304; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Dodd I, 1995, PROTEIN EXPRES PURIF, V6, P727, DOI 10.1006/prep.1995.0003; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; HEARSE DJ, 1992, CARDIOVASC RES, V26, P101, DOI 10.1093/cvr/26.2.101; KILGORE KS, 1994, CARDIOVASC RES, V28, P437, DOI 10.1093/cvr/28.4.437; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; KORTHUIS RJ, 1989, AM J PHYSIOL, V256, pH315, DOI 10.1152/ajpheart.1989.256.1.H315; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; Law SKA, 1997, PROTEIN SCI, V6, P263; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Springall T, 2001, NAT MED, V7, P801, DOI 10.1038/89923; Tavare R, 2009, BIOCONJUGATE CHEM, V20, P2071, DOI 10.1021/bc900160j; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wijns W, 2010, EUR HEART J; Zhou WD, 2006, BLOOD, V107, P2461, DOI 10.1182/blood-2005-08-3144	35	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18275	10.1371/journal.pone.0018275	http://dx.doi.org/10.1371/journal.pone.0018275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494666	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400013
J	Subbiah, V; Naing, A; Brown, RE; Chen, H; Doyle, L; LoRusso, P; Benjamin, R; Anderson, P; Kurzrock, R				Subbiah, Vivek; Naing, Aung; Brown, Robert E.; Chen, Helen; Doyle, Laurence; LoRusso, Patricia; Benjamin, Robert; Anderson, Pete; Kurzrock, Razelle			Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures	PLOS ONE			English	Article							FACTOR-I RECEPTOR; MONOCLONAL-ANTIBODY; TUMORS; RESISTANCE; PATHWAYS; AKT/PKB; MTORC2; RICTOR; CELLS	Background: Insulin-like growth factor 1 receptor (IGF1R) targeted therapies have resulted in responses in a small number of patients with advanced metastatic Ewing's sarcoma. We performed morphoproteomic profiling to better understand response/resistance mechanisms of Ewing's sarcoma to IGF1R inhibitor-based therapy. Methodology/Principal Findings: This pilot study assessed two patients with advanced Ewing's sarcoma treated with IGF1R antibody alone followed by combined IGF1R inhibitor plus mammalian target of rapamycin (mTOR) inhibitor treatment once resistance to single-agent IGF1R inhibitor developed. Immunohistochemical probes were applied to detect p-mTOR (Ser2448), p-Akt (Ser473), p-ERK1/2 (Thr202/Tyr204), nestin, and p-STAT3 (Tyr 705) in the original and recurrent tumor. The initial remarkable radiographic responses to IGF1R-antibody therapy was followed by resistance and then response to combined IGF1R plus mTOR inhibitor therapy in both patients, and then resistance to the combination regimen in one patient. In patient 1, upregulation of p-Akt and p-mTOR in the tumor that relapsed after initial response to IGF1R antibody might explain the resistance that developed, and the subsequent response to combined IGF1R plus mTOR inhibitor therapy. In patient 2, upregulation of mTOR was seen in the primary tumor, perhaps explaining the initial response to the IGF1R and mTOR inhibitor combination, while the resistant tumor that emerged showed activation of the ERK pathway as well. Conclusion/Significance: Morphoproteomic analysis revealed that the mTOR pathway was activated in these two patients with advanced Ewing's sarcoma who showed response to combined IGF1R and mTOR inhibition, and the ERK pathway in the patient in whom resistance to this combination emerged. Our pilot results suggests that morphoproteomic assessment of signaling pathway activation in Ewing's sarcoma merits further investigation as a guide to understanding response and resistance signatures.	[Subbiah, Vivek; Anderson, Pete] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Subbiah, Vivek; Naing, Aung; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Brown, Robert E.] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, UT Hlth, Houston, TX 77030 USA; [Chen, Helen; Doyle, Laurence] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [LoRusso, Patricia] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Benjamin, Robert] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Texas System; UTMD Anderson Cancer Center	Subbiah, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA.	vsubbiah@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020; Subbiah, Vivek/O-3347-2019	Subbiah, Vivek/0000-0002-6064-6837; Naing, Aung/0000-0002-4803-8513	NCI-CTEP [R21-CA13763301A1]; National Center for Research Resources (NCRR) [RR024148]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; NIH through Cancer Center [CA 016672];  [U01 CA062461-17]; NATIONAL CANCER INSTITUTE [P30CA016672, U01CA062461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	NCI-CTEP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH through Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by in part by U01 CA062461-17 (RK) and NCI-CTEP R21-CA13763301A1 (AN). This work was also supported by Grant RR024148 from the National Center for Research Resources (NCRR), National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Reengineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp. The University of Texas MD Anderson Cancer Center is supported in part by the NIH through Cancer Center Support Grant no. CA 016672. Presented in part as a platform presentation at the 16th Annual Meeting of the Connective Tissue Oncologic Society, November 11-13, 2010, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Bertrand FE, 2006, LEUKEMIA, V20, P1254, DOI 10.1038/sj.leu.2404217; Brown RE, 2005, EXPERT REV PROTEOMIC, V2, P337, DOI 10.1586/14789450.2.3.337; Brown RE, 2009, ARCH PATHOL LAB MED, V133, P568, DOI 10.1043/1543-2165-133.4.568; Galli S, 2010, MODERN PATHOL, V23, p394A; Kurzrock R, 2010, CLIN CANCER RES, V16, P2458, DOI 10.1158/1078-0432.CCR-09-3220; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mateo-Lozano S, 2003, ONCOGENE, V22, P9282, DOI 10.1038/sj.onc.1207081; Naing A, 2010, CLIN COLORECTAL CANC, V9, pE1, DOI 10.3816/CCC.2010.n.026; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Rodon J, 2010, ONCOLOGIST, V15, P37, DOI 10.1634/theoncologist.2009-0117; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Rowinsky EK, 2007, CLIN CANCER RES, V13, p5549S, DOI 10.1158/1078-0432.CCR-07-1109; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shen Q, 2011, INT J CLIN EXP PATHO, V4, P13; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Subbiah Vivek, 2011, Sarcoma, V2011, P686985, DOI 10.1155/2011/686985; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Wang YL, 2010, MOL CANCER THER, V9, P410, DOI 10.1158/1535-7163.MCT-09-0555; Zenali MJ, 2009, ANN CLIN LAB SCI, V39, P160	27	59	62	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18424	10.1371/journal.pone.0018424	http://dx.doi.org/10.1371/journal.pone.0018424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494688	Green Submitted, Green Published, gold			2022-12-27	WOS:000289192400027
J	Drevillon, L; Tanguy, G; Hinzpeter, A; Arous, N; de Becdelievre, A; Aissat, A; Tarze, A; Goossens, M; Fanen, P				Drevillon, Loic; Tanguy, Gaelle; Hinzpeter, Alexandre; Arous, Nicole; de Becdelievre, Alix; Aissat, Abdel; Tarze, Agathe; Goossens, Michel; Fanen, Pascale			COMMD1-Mediated Ubiquitination Regulates CFTR Trafficking	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM-CHANNEL; NF-KAPPA-B; CYSTIC-FIBROSIS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; COPPER TOXICOSIS; COMMD PROTEINS; WILD-TYPE; MURR1; DEGRADATION	The CFTR (cystic fibrosis transmembrane conductance regulator) protein is a large polytopic protein whose biogenesis is inefficient. To better understand the regulation of CFTR processing and trafficking, we conducted a genetic screen that identified COMMD1 as a new CFTR partner. COMMD1 is a protein associated with multiple cellular pathways, including the regulation of hepatic copper excretion, sodium uptake through interaction with ENaC (epithelial sodium channel) and NF-kappaB signaling. In this study, we show that COMMD1 interacts with CFTR in cells expressing both proteins endogenously. This interaction promotes CFTR cell surface expression as assessed by biotinylation experiments in heterologously expressing cells through regulation of CFTR ubiquitination. In summary, our data demonstrate that CFTR is protected from ubiquitination by COMMD1, which sustains CFTR expression at the plasma membrane. Thus, increasing COMMD1 expression may provide an approach to simultaneously inhibit ENaC absorption and enhance CFTR trafficking, two major issues in cystic fibrosis.	[Drevillon, Loic; Tanguy, Gaelle; Hinzpeter, Alexandre; Arous, Nicole; de Becdelievre, Alix; Aissat, Abdel; Tarze, Agathe; Goossens, Michel; Fanen, Pascale] Hop Henri Mondor, INSERM, Unite U955, F-94010 Creteil, France; [Drevillon, Loic; Tanguy, Gaelle; de Becdelievre, Alix; Aissat, Abdel; Tarze, Agathe; Goossens, Michel; Fanen, Pascale] Univ Paris Est, Fac Med, UMR S 955, Creteil, France; [de Becdelievre, Alix; Goossens, Michel; Fanen, Pascale] AP HP, Grp Henri Mondor Albert Chenevier, Serv Biochim Genet, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Drevillon, L (corresponding author), Hop Henri Mondor, INSERM, Unite U955, F-94010 Creteil, France.	pascale.fanen@inserm.fr	de Becdelievre, Alix/R-6745-2018; Tarze, Agathe/R-4379-2018	de Becdelievre, Alix/0000-0002-0488-3475; Tarze, Agathe/0000-0001-6101-069X; Fanen, Pascale/0000-0002-3273-5349	Institut National de la Sante et de la Recherche Medicale (INSERM); Chancellerie des Universites de Paris; French Association "Vaincre la Mucoviscidose"	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Chancellerie des Universites de Paris; French Association "Vaincre la Mucoviscidose"	This work was supported by public grants from Institut National de la Sante et de la Recherche Medicale (INSERM) and Chancellerie des Universites de Paris, and the French Association "Vaincre la Mucoviscidose". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; BOMBERGER JM, 2009, J BIOL CHEM; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clain J, 2001, J BIOL CHEM, V276, P9045, DOI 10.1074/jbc.M008979200; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Himmel B, 2004, EMBO REP, V5, P85, DOI 10.1038/sj.embor.7400034; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Tanguy G, 2008, BBA-MOL CELL RES, V1783, P1189, DOI 10.1016/j.bbamcr.2008.01.010; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; YE S, 2010, J BIOL CHEM; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	36	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18334	10.1371/journal.pone.0018334	http://dx.doi.org/10.1371/journal.pone.0018334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483833	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200061
J	Qian, D; Jiang, L; Lu, L; Wei, CH; Li, Y				Qian, Dan; Jiang, Lin; Lu, Lu; Wei, Chunhong; Li, Yi			Biochemical and Structural Properties of Cyanases from Arabidopsis thaliana and Oryza sativa	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; ALKALINE CONDITIONS; CYANIDE OXYGENASE; PLANT-RESPONSES; ETHYLENE; ENZYME; STRESS; GENE; THIOCYANATE; METABOLISM	Cyanate is toxic to all organisms. Cyanase converts cyanate to CO2 and NH3 in a bicarbonate-dependent reaction. The biophysical functions and biochemical characteristics of plant cyanases are poorly studied, although it has been investigated in a variety of proteobacteria, cyanobacteria and fungi. In this study, we characterised plant cyanases from Arabidopsis thaliana and Oryza sativa (AtCYN and OsCYN). Prokaryotic-expressed AtCYN and OsCYN both showed cyanase activity in vitro. Temperature had a similar influence on the activity of both cyanases, but pH had a differential impact on AtCYN and OsCYN activity. Homology modelling provided models of monomers of AtCYN and OsCYN, and a coimmunoprecipitation assay and gel filtration indicated that AtCYN and OsCYN formed homodecamers. The analysis of single-residue mutants of AtCYN indicated that the conserved catalytic residues also contributed to the stability of the homodecamer. KCNO treatment inhibited Arabidopsis germination and early seedling growth. Plants containing AtCYN or OsCYN exhibited resistance to KCNO stress, which demonstrated that one role of cyanases in plants is detoxification. Transcription level of AtCYN was higher in the flower than in other organs of Arabidopsis. AtCYN transcription was not significantly affected by KCNO treatment in Arabidopsis, but was induced by salt stress. This research broadens our knowledge on plant detoxification of cyanate via cyanase.	[Qian, Dan; Jiang, Lin; Lu, Lu; Wei, Chunhong; Li, Yi] Peking Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Qian, D (corresponding author), Peking Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	liyi@pku.edu.cn			Ministry of Agriculture; Transgenic program [2008ZX08010-001, 2008ZX08011-001]; National Basic Research Program of China (973 Program) [2006CB10195]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Transgenic program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Ministry of Agriculture, The Transgenic program (2008ZX08010-001 and 2008ZX08011-001) and the National Basic Research Program of China (973 Program) (No. 2006CB10195) http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Aichi Makiko, 1998, Plant and Cell Physiology, V39, pS135; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON PM, 1980, BIOCHEMISTRY-US, V19, P2882, DOI 10.1021/bi00554a010; ANDERSON PM, 1986, BIOCHEMISTRY-US, V25, P1621, DOI 10.1021/bi00355a026; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; CHIN CCQ, 1983, J BIOL CHEM, V258, P276; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DIRNHUBER P, 1948, BIOCHEM J, V42, P628, DOI 10.1042/bj0420628; DORR PK, 1989, FEMS MICROBIOL LETT, V60, P289; Ebbs S, 2004, CURR OPIN BIOTECH, V15, P231, DOI 10.1016/j.copbio.2004.03.006; Elleuche S, 2008, FUNGAL GENET BIOL, V45, P1458, DOI 10.1016/j.fgb.2008.08.005; Espie GS, 2007, J BACTERIOL, V189, P1013, DOI 10.1128/JB.01328-06; Grigor'eva NV, 2006, MICROBIOLOGY+, V75, P266, DOI 10.1134/S0026261706030040; Gyorgyey J, 2000, MOL PLANT MICROBE IN, V13, P62, DOI 10.1094/MPMI.2000.13.1.62; Harano Y, 1997, J BACTERIOL, V179, P5744, DOI 10.1128/jb.179.18.5744-5750.1997; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; JOHNSON WV, 1987, J BIOL CHEM, V262, P9021; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; KUNZ DA, 1989, APPL ENVIRON MICROB, V55, P256, DOI 10.1128/AEM.55.1.256-258.1989; Kunz DA, 2001, BIOCHEM BIOPH RES CO, V287, P514, DOI 10.1006/bbrc.2001.5611; LAWRIE AC, 1979, J BACTERIOL, V139, P115, DOI 10.1128/JB.139.1.115-119.1979; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Luque-Almagro VM, 2008, APPL ENVIRON MICROB, V74, P6280, DOI 10.1128/AEM.00916-08; Luque-Almagro VM, 2005, APPL ENVIRON MICROB, V71, P940, DOI 10.1128/AEM.71.2.940-947.2005; Malhotra S, 2005, J CHEM TECHNOL BIOT, V80, P13, DOI 10.1002/jctb.1127; MILLER AG, 1994, ARCH MICROBIOL, V162, P151, DOI 10.1007/BF00314468; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potel F, 2009, FEBS J, V276, P4061, DOI 10.1111/j.1742-4658.2009.07114.x; RADER WS, 1995, ENVIRON POLLUT, V90, P331, DOI 10.1016/0269-7491(95)00020-R; Sancho J, 2005, 19 INT MIN WAT C, P413; Siegien I, 2006, ACTA PHYSIOL PLANT, V28, P483, DOI 10.1007/BF02706632; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Sorokin DY, 2001, APPL ENVIRON MICROB, V67, P528, DOI 10.1128/AEM.67.2.528-538.2001; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; SUNG YC, 1992, J BACTERIOL, V174, P3645, DOI 10.1128/JB.174.11.3645-3650.1992; SUNG YC, 1987, J BACTERIOL, V169, P2639, DOI 10.1128/jb.169.6.2639-2642.1987; TAUSSIG A, 1960, BIOCHIM BIOPHYS ACTA, V44, P510, DOI 10.1016/0006-3002(60)91605-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walsh MA, 2000, STRUCTURE, V8, P505, DOI 10.1016/S0969-2126(00)00134-9; Wang HH, 2009, PLANTA, V230, P293, DOI 10.1007/s00425-009-0946-y; Wood AP, 1998, ARCH MICROBIOL, V169, P148, DOI 10.1007/s002030050554; Wu Z, 2007, PARASITOL RES, V101, P1567, DOI 10.1007/s00436-007-0677-6; YIP WK, 1988, PLANT PHYSIOL, V88, P473, DOI 10.1104/pp.88.2.473; Zanetti ME, 2002, J EXP BOT, V53, P2455, DOI 10.1093/jxb/; Zhao XC, 2004, FEBS LETT, V562, P189, DOI 10.1016/S0014-5793(04)00238-8; ZIMMERMAN WM. E., 1950, GREENKEEPERS REPORTER, V18, P5	55	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18300	10.1371/journal.pone.0018300	http://dx.doi.org/10.1371/journal.pone.0018300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21494323	Green Submitted, Green Published, gold			2022-12-27	WOS:000289057200054
J	Gutekunst, M; Oren, M; Weilbacher, A; Dengler, MA; Markwardt, C; Thomale, J; Aulitzky, WE; van der Kuip, H				Gutekunst, Matthias; Oren, Moshe; Weilbacher, Andrea; Dengler, Michael A.; Markwardt, Christiane; Thomale, Juergen; Aulitzky, Walter E.; van der Kuip, Heiko			p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin	PLOS ONE			English	Article							DNA-DAMAGE; INDUCED APOPTOSIS; FAMILY PROTEINS; XPA PROTEIN; SENSITIVITY; GENE; PHOSPHORYLATION; BORTEZOMIB; RESISTANCE; CANCER	Consistent with the excellent clinical results in testicular germ cell tumors (TGCT), most cell lines derived from this cancer show an exquisite sensitivity to Cisplatin. It is well accepted that the high susceptibility of TGCT cells to apoptosis plays a central role in this hypersensitive phenotype. The role of the tumor suppressor p53 in this response, however, remains controversial. Here we show that siRNA-mediated silencing of p53 is sufficient to completely abrogate hypersensitivity not only to Cisplatin but also to non-genotoxic inducers of p53 such as the Mdm2 antagonist Nutlin-3 and the proteasome inhibitor Bortezomib. The close relationship between p53 protein levels and induction of apoptosis is lost upon short-term differentiation, indicating that this predominant pro-apoptotic function of p53 is unique in pluripotent embryonal carcinoma (EC) cells. RNA interference experiments as well as microarray analysis demonstrated a central role of the proapoptotic p53 target gene NOXA in the p53-dependent apoptotic response of these cells. In conclusion, our data indicate that the hypersensitivity of TGCT cells is a result of their unique sensitivity to p53 activation. Furthermore, in the very specific cellular context of germ cell-derived pluripotent EC cells, p53 function appears to be limited to induction of apoptosis.	[Gutekunst, Matthias; Weilbacher, Andrea; Dengler, Michael A.; Markwardt, Christiane; van der Kuip, Heiko] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Gutekunst, Matthias; Weilbacher, Andrea; Dengler, Michael A.; Markwardt, Christiane; van der Kuip, Heiko] Univ Tubingen, Stuttgart, Germany; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Thomale, Juergen] Univ Duisburg Essen, Inst Cell Biol, Sch Med, Essen, Germany; [Aulitzky, Walter E.] Robert Bosch Krankenhaus, Dept Internal Med 2, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Weizmann Institute of Science; University of Duisburg Essen; Bosch; Robert Bosch Krankenhaus	Gutekunst, M (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-7000 Stuttgart, Germany.	heiko.van-der-kuip@ikp-stuttgart.de	Dengler, Michael/AFR-3509-2022	Oren, Moshe/0000-0003-4311-7172; Markwardt, Craig/0000-0001-9803-3879; Dengler, Michael/0000-0002-1693-1761	Robert-Bosch foundation [11.5.8000.0083.0, O2A]	Robert-Bosch foundation	This work was supported by the Robert-Bosch foundation (11.5.8000.0083.0 and O2A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Bauer S, 2010, EUR UROL, V57, P679, DOI 10.1016/j.eururo.2009.06.014; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.3.CO;2-J; Burger H, 1997, INT J CANCER, V73, P592, DOI 10.1002/(SICI)1097-0215(19971114)73:4<592::AID-IJC22>3.0.CO;2-A; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Chresta CM, 1996, CANCER RES, V56, P1834; Datta MW, 2001, MODERN PATHOL, V14, P437, DOI 10.1038/modpathol.3880331; di Pietro A, 2005, INT J BIOCHEM CELL B, V37, P2437, DOI 10.1016/j.biocel.2005.06.014; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Gosland M, 1996, PHARMACOTHERAPY, V16, P16; Guillou L, 1996, AM J PATHOL, V149, P1221; Houldsworth J, 1998, ONCOGENE, V16, P2345, DOI 10.1038/sj.onc.1201770; HUDDART RA, 1995, EUR J CANCER, V31A, P739, DOI 10.1016/0959-8049(95)00047-M; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Koberle B, 1997, INT J CANCER, V70, P551, DOI 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; KOBERLE B, 2010, BIOCH BIOPHYS ACTA; Koberle B, 2008, MOL CARCINOGEN, V47, P580, DOI 10.1002/mc.20418; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lutzker SG, 1998, APMIS, V106, P85, DOI 10.1111/j.1699-0463.1998.tb01323.x; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Lutzker SG, 2001, ONCOGENE, V20, P2982, DOI 10.1038/sj.onc.1204394; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Masters JRW, 1996, EUR J CANCER, V32A, P1248, DOI 10.1016/0959-8049(96)00033-0; MASTERS JRW, 1993, INT J CANCER, V53, P340, DOI 10.1002/ijc.2910530228; Nakajima Wataru, 2007, Journal of Nippon Medical School, V74, P148, DOI 10.1272/jnms.74.148; PENG HQ, 1993, CANCER RES, V53, P3574; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Spierings DCJ, 2004, ONCOGENE, V23, P4862, DOI 10.1038/sj.onc.1207617; Spierings DCJ, 2003, J PATHOL, V200, P137, DOI 10.1002/path.1373; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; van der Kuip H, 2001, BLOOD, V98, P1532, DOI 10.1182/blood.V98.5.1532; Vaziri SAJ, 2009, ANTICANCER RES, V29, P2961; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Williams SA, 2003, CANCER RES, V63, P7338	55	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19198	10.1371/journal.pone.0019198	http://dx.doi.org/10.1371/journal.pone.0019198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532991	Green Published, gold			2022-12-27	WOS:000290014500025
J	Ai, EK; Poole, DS; Skop, AR				Ai, Erkang; Poole, Daniel S.; Skop, Ahna R.			Long Astral Microtubules and RACK-1 Stabilize Polarity Domains during Maintenance Phase in Caenorhabditis elegans Embryos	PLOS ONE			English	Article							ANTERIOR-POSTERIOR AXIS; C-ELEGANS; PAR PROTEINS; CELL POLARITY; ANTEROPOSTERIOR AXIS; RECYCLING ENDOSOME; ESTABLISHMENT; POLARIZATION; CYTOKINESIS; TRANSPORT	Cell polarity is a very well conserved process important for cell differentiation, cell migration, and embryonic development. After the establishment of distinct cortical domains, polarity cues have to be stabilized and maintained within a fluid and dynamic membrane to achieve proper cell asymmetry. Microtubules have long been thought to deliver the signals required to polarize a cell. While previous studies suggest that microtubules play a key role in the establishment of polarity, the requirement of microtubules during maintenance phase remains unclear. In this study, we show that depletion of Caenorhabditis elegans RACK-1, which leads to short astral microtubules during prometaphase, specifically affects maintenance of cortical PAR domains and Dynamin localization. We then investigated the consequence of knocking down other factors that also abolish astral microtubule elongation during polarity maintenance phase. We found a correlation between short astral microtubules and the instability of PAR-6 and PAR-2 domains during maintenance phase. Our data support a necessary role for astral microtubules in the maintenance phase of cell polarity.	[Ai, Erkang; Poole, Daniel S.; Skop, Ahna R.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ai, EK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019	Skop, Ahna Renee/0000-0003-3522-4939	NSF [MCB-0546398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092583] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an NSF CAREER award (MCB-0546398) to A. R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aceto D, 2006, DEV BIOL, V299, P386, DOI 10.1016/j.ydbio.2006.08.002; Ai E, 2009, MOL BIOL CELL, V20, P1629, DOI 10.1091/mbc.E08-09-0917; Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kimura A, 2007, J CELL BIOL, V179, P1347, DOI 10.1083/jcb.200706005; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Portereiko MF, 2004, CURR BIOL, V14, P932, DOI 10.1016/j.cub.2004.05.052; Schenk C, 2010, DEVELOPMENT, V137, P1743, DOI 10.1242/dev.040436; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wittmann T, 2001, J CELL SCI, V114, P3795; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862	50	9	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19020	10.1371/journal.pone.0019020	http://dx.doi.org/10.1371/journal.pone.0019020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533050	Green Published, gold			2022-12-27	WOS:000289719400050
J	Zimmer, C; Boos, M; Bertrand, F; Robin, JP; Petit, O				Zimmer, Cedric; Boos, Mathieu; Bertrand, Frederic; Robin, Jean-Patrice; Petit, Odile			Behavioural Adjustment in Response to Increased Predation Risk: A Study in Three Duck Species	PLOS ONE			English	Article							VIGILANCE TRADE-OFF; ANAS-CRECCA-CRECCA; ALLOCATION HYPOTHESIS; TEMPORAL VARIATION; FOOD AVAILABILITY; FORAGING ACTIVITY; BODY-MASS; SLEEP; BIRDS; MORTALITY	Predation directly triggers behavioural decisions designed to increase immediate survival. However, these behavioural modifications can have long term costs. There is therefore a trade-off between antipredator behaviours and other activities. This trade-off is generally considered between vigilance and only one other behaviour, thus neglecting potential compensations. In this study, we considered the effect of an increase in predation risk on the diurnal time-budget of three captive duck species during the wintering period. We artificially increased predation risk by disturbing two groups of 14 mallard and teals at different frequencies, and one group of 14 tufted ducks with a radio-controlled stressor. We recorded foraging, vigilance, preening and sleeping durations the week before, during and after disturbance sessions. Disturbed groups were compared to an undisturbed control group. We showed that in all three species, the increase in predation risk resulted in a decrease in foraging and preening and led to an increase in sleeping. It is worth noting that contrary to common observations, vigilance did not increase. However, ducks are known to be vigilant while sleeping. This complex behavioural adjustment therefore seems to be optimal as it may allow ducks to reduce their predation risk. Our results highlight the fact that it is necessary to encompass the whole individual time-budget when studying behavioural modifications under predation risk. Finally, we propose that studies of behavioural time-budget changes under predation risk should be included in the more general framework of the starvation-predation risk trade-off.	[Zimmer, Cedric; Robin, Jean-Patrice; Petit, Odile] Univ Strasbourg, CNRS, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Boos, Mathieu] Naturaconst Res Agcy Appl Ecol, Wilshausen, France; [Bertrand, Frederic] Univ Strasbourg, CNRS, Inst Rech Math Avancee, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zimmer, C (corresponding author), Univ Strasbourg, CNRS, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	cedric.zimmer@c-strasbourg.fr	Bertrand, Frédéric/ABA-2622-2020; Zimmer, Cédric/C-5654-2011	Bertrand, Frédéric/0000-0002-0837-8281; Zimmer, Cedric/0000-0001-8160-2836	Region Alsace; National Fund for Biological Research on Game and Wildlife Species; CNRS	Region Alsace(Region Grand-Est); National Fund for Biological Research on Game and Wildlife Species; CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by grants from "Region Alsace'' (http://www.region-alsace.eu/), National Fund for Biological Research on Game and Wildlife Species, and CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AMLANER CJ, 1983, BEHAVIOUR, V87, P85, DOI 10.1163/156853983X00138; Anholt BR, 1998, EVOL ECOL, V12, P729, DOI 10.1023/A:1006589616931; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Arzel C, 2007, CAN J ZOOL, V85, P81, DOI 10.1139/Z06-201; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Belden LK, 2000, ANIM BEHAV, V59, P871, DOI 10.1006/anbe.1999.1398; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Carey C., 1996, AVIAN ENERGETICS NUT; Cresswell W, 2008, IBIS, V150, P209, DOI 10.1111/j.1474-919X.2008.00784.x; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; De Leeuw JJ, 1999, ARDEA, V87, P15; Dekker D, 2003, J RAPTOR RES, V37, P161; del Hoyo J, 2013, HDB BIRDS WORLD; Fernandez-Juricic E, 2007, WATERBIRDS, V30, P554, DOI 10.1675/1524-4695(2007)030[0554:RONBNH]2.0.CO;2; Frid A, 2002, CONSERV ECOL, V6; Fritz H, 2000, ARDEA, V88, P9; Gagliardi A, 2006, WATERBIRDS, V29, P105, DOI 10.1675/1524-4695(2006)29[105:BROWGC]2.0.CO;2; Gauthier-Clerc M, 1998, CAN J ZOOL, V76, P2214, DOI 10.1139/cjz-76-12-2214; Gauthier-Clerc M, 2000, CONDOR, V102, P307, DOI 10.1650/0010-5422(2000)102[0307:SVTOIG]2.0.CO;2; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; JORDE DG, 1984, CONDOR, V86, P258, DOI 10.2307/1366993; Laursen K, 2005, WILDLIFE BIOL, V11, P13, DOI 10.2981/0909-6396(2005)11[13:FAEDOS]2.0.CO;2; LENDREM DW, 1983, ANIM BEHAV, V31, P532, DOI 10.1016/S0003-3472(83)80076-1; LENDREM DW, 1984, ANIM BEHAV, V32, P243, DOI 10.1016/S0003-3472(84)80343-7; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2007, ANIM BEHAV, V74, P189, DOI 10.1016/j.anbehav.2006.12.007; Lind J, 2006, J ORNITHOL, V147, P310, DOI 10.1007/s10336-005-0051-3; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; MacLeod R, 2006, ANIM BEHAV, V71, P523, DOI 10.1016/j.anbehav.2005.04.020; Marsden SJ, 2000, ENVIRON MANAGE, V26, P207, DOI 10.1007/s002670010082; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MEDDIS R, 1975, ANIM BEHAV, V23, P676, DOI 10.1016/0003-3472(75)90144-X; Mirza RS, 2006, ETHOLOGY, V112, P44, DOI 10.1111/j.1439-0310.2006.01111.x; Murphy Mary E., 1996, P158; NILSSON L, 1970, OIKOS, V21, P145, DOI 10.2307/3543670; Norberg Ulla M., 1996, P199; Nudds RL, 2000, J EXP BIOL, V203, P1561; Owen M, 1990, WATERFOWL ECOLOGY; PAULUS S L, 1988, P135; PEDROLI JC, 1981, RELATIONS ENTRE MOUL; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Roth TC, 2006, J SLEEP RES, V15, P395, DOI 10.1111/j.1365-2869.2006.00559.x; SARGEANT AB, 1973, AM MIDL NAT, V89, P208, DOI 10.2307/2424149; SARGEANT AB, 1984, WILDL MONOGR, V1; Steer D, 2009, ANIM BEHAV, V78, P1071, DOI 10.1016/j.anbehav.2009.07.024; Tamisier A., 1999, CAMARGUE CANARDS FOU; TAMISIER A, 1972, ALAUDA, V10, P107; TAMISIER A, 1972, ALAUDA, V10, P235; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zimmer C, 2010, J AVIAN BIOL, V41, P637, DOI 10.1111/j.1600-048X.2010.05110.x	62	12	14	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18977	10.1371/journal.pone.0018977	http://dx.doi.org/10.1371/journal.pone.0018977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533055	gold, Green Published			2022-12-27	WOS:000289719400043
J	Hahn, MA; Wu, XW; Li, AX; Hahn, T; Pfeifer, GP				Hahn, Maria A.; Wu, Xiwei; Li, Arthur X.; Hahn, Torsten; Pfeifer, Gerd P.			Relationship between Gene Body DNA Methylation and Intragenic H3K9me3 and H3K36me3 Chromatin Marks	PLOS ONE			English	Article							HISTONE H3 LYSINE-9; HUMAN CANCER-CELLS; RNA-POLYMERASE-II; ARABIDOPSIS-THALIANA; STEM-CELLS; GENOME; METHYLTRANSFERASE; TRANSCRIPTION; DISTINCT; DNMT1	To elucidate the relationship between intragenic DNA methylation and chromatin marks, we performed epigenetic profiling of chromosome 19 in human bronchial epithelial cells (HBEC) and in the colorectal cancer cell line HCT116 as well as its counterpart with double knockout of DNMT1 and DNMT3B (HCT116-DKO). Analysis of H3K36me3 profiles indicated that this intragenic mark of active genes is associated with two categories of genes: (i) genes with low CpG density and H3K9me3 in the gene body or (ii) genes with high CpG density and DNA methylation in the gene body. We observed that a combination of low CpG density in gene bodies together with H3K9me3 and H3K36me3 occupancy is a specific epigenetic feature of zinc finger (ZNF) genes, which comprise 90% of all genes carrying both histone marks on chromosome 19. For genes with high intragenic CpG density, transcription and H3K36me3 occupancy were not changed in conditions of partial or intensive loss of DNA methylation in gene bodies. siRNA knockdown of SETD2, the major histone methyltransferase responsible for production of H3K36me3, did not reduce DNA methylation in gene bodies. Our study suggests that the H3K36me3 and DNA methylation marks in gene bodies are established largely independently of each other and points to similar functional roles of intragenic DNA methylation and intragenic H3K9me3 for CpG-rich and CpG-poor genes, respectively.	[Hahn, Maria A.; Hahn, Torsten; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA; [Wu, Xiwei] City Hope Natl Med Ctr, Dept Mol Med, Beckman Res Inst, Duarte, CA USA; [Li, Arthur X.] City Hope Natl Med Ctr, Dept Informat Sci, Beckman Res Inst, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Hahn, MA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA.	gpfeifer@coh.org			NIH [CA084469, AG036041]; NATIONAL CANCER INSTITUTE [R01CA084469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants CA084469 and AG036041 to GPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DHAYALAN A, 2010, J BIOL CHEM; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He XJ, 2009, GENE DEV, V23, P2717, DOI 10.1101/gad.1851809; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lohmann F, 2010, STEM CELLS, V28, P201, DOI 10.1002/stem.278; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; RAUCH TA, 2010, METHODS IN PRESS; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	53	96	102	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18844	10.1371/journal.pone.0018844	http://dx.doi.org/10.1371/journal.pone.0018844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526191	Green Submitted, gold, Green Published			2022-12-27	WOS:000289671100028
J	Rogue, A; Lambert, C; Josse, R; Antherieu, S; Spire, C; Claude, N; Guillouzo, A				Rogue, Alexandra; Lambert, Carine; Josse, Rozenn; Antherieu, Sebastien; Spire, Catherine; Claude, Nancy; Guillouzo, Andre			Comparative Gene Expression Profiles Induced by PPAR gamma and PPAR alpha/gamma Agonists in Human Hepatocytes	PLOS ONE			English	Article							NUCLEAR RECEPTORS; CYTOCHROMES P450; CELL-LINE; HEPARG; ALPHA; TROGLITAZONE; LIVER; THIAZOLIDINEDIONE; MURAGLITAZAR; TESAGLITAZAR	Background: Several glitazones (PPAR gamma agonists) and glitazars (dual PPAR alpha/gamma agonists) have been developed to treat hyperglycemia and, simultaneously, hyperglycemia and dyslipidemia, respectively. However, most have caused idiosyncratic hepatic or extrahepatic toxicities through mechanisms that remain largely unknown. Since the liver plays a key role in lipid metabolism, we analyzed changes in gene expression profiles induced by these two types of PPAR agonists in human hepatocytes. Methodology/Principal Findings: Primary human hepatocytes and the well-differentiated human hepatoma HepaRG cells were exposed to different concentrations of two PPAR gamma (troglitazone and rosiglitazone) and two PPAR alpha/gamma (muraglitazar and tesaglitazar) agonists for 24 h and their transcriptomes were analyzed using human pangenomic Agilent microarrays. Principal Component Analysis, hierarchical clustering and Ingenuity Pathway Analysis (R) revealed large inter-individual variability in the response of the human hepatocyte populations to the different compounds. Many genes involved in lipid, carbohydrate, xenobiotic and cholesterol metabolism, as well as inflammation and immunity, were regulated by both PPAR gamma and PPAR alpha/gamma agonists in at least a number of human hepatocyte populations and/or HepaRG cells. Only a few genes were selectively deregulated by glitazars when compared to glitazones, indicating that PPAR alpha and PPAR alpha/gamma agonists share most of their target genes. Moreover, some target genes thought to be regulated only in mouse or to be expressed in Kupffer cells were also found to be responsive in human hepatocytes and HepaRG cells. Conclusions/Significance: This first comprehensive analysis of gene regulation by PPAR gamma and PPAR alpha/gamma agonists favor the conclusion that glitazones and glitazars share most of their target genes and induce large differential changes in gene profiles in human hepatocytes depending on hepatocyte donor, the compound class and/or individual compound, thereby supporting the occurrence of idiosyncratic toxicity in some patients.	[Rogue, Alexandra; Lambert, Carine; Josse, Rozenn; Antherieu, Sebastien; Guillouzo, Andre] Fac Sci Pharmaceut & Biol, INSERM, UMR U991, Rennes, France; [Rogue, Alexandra; Lambert, Carine; Josse, Rozenn; Antherieu, Sebastien; Guillouzo, Andre] Univ Rennes 1, Rennes, France; [Rogue, Alexandra; Spire, Catherine] Biol Servier, Gidy, France; [Claude, Nancy] Inst Rech Servier, Courbevoie, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Servier; Servier; Institut de Recherches Internationales Servier	Rogue, A (corresponding author), Fac Sci Pharmaceut & Biol, INSERM, UMR U991, Rennes, France.	catherine.spire@fr.netgrs.com; andre.guillouzo@univ-rennes1.fr	GUILLOUZO, Andre/Z-2373-2019; Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973	Biologie Servier (Gidy, France); European Economic Community [20222]; ARNT (French Ministry of Research); CIFRE	Biologie Servier (Gidy, France); European Economic Community; ARNT (French Ministry of Research)(Ministry of Research, France); CIFRE	The funders are Biologie Servier (Gidy, France), European Economic Community, contract Predict-IV, number 20222, and ARNT (French Ministry of Research), CIFRE contract. The funders had a role in study design but not in data collection and analysis, decision to publish, or preparation of the manuscript.	Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Anwer MS, 2004, HEPATOLOGY, V39, P581, DOI 10.1002/hep.20090; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CAMPS L, 1991, J LIPID RES, V32, P1877; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Devasthale PV, 2005, J MED CHEM, V48, P2248, DOI 10.1021/jm0496436; Ericsson H, 2004, DRUG METAB DISPOS, V32, P923; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Fievet C, 2006, CURR OPIN PHARMACOL, V6, P606, DOI 10.1016/j.coph.2006.06.009; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gould Rothberg Bonnie E., 2001, Functional and Integrative Genomics, V1, P294, DOI 10.1007/s101420000022; Goyak KMO, 2008, TOXICOL APPL PHARM, V231, P216, DOI 10.1016/j.taap.2008.04.024; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; Guo L, 2006, MOL DIVERS, V10, P349, DOI 10.1007/s11030-006-9038-0; Hellmold H, 2007, TOXICOL SCI, V98, P63, DOI 10.1093/toxsci/kfm094; Isley William L, 2003, Expert Opin Drug Saf, V2, P581, DOI 10.1517/14740338.2.6.581; Jennen DGJ, 2010, TOXICOL SCI, V115, P66, DOI 10.1093/toxsci/kfq026; Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762; Josse R, 2008, DRUG METAB DISPOS, V36, P1111, DOI 10.1124/dmd.107.019901; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P137, DOI 10.1124/dmd.107.017418; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Lambert CB, 2009, TOXICOL APPL PHARM, V234, P345, DOI 10.1016/j.taap.2008.11.008; Lauer B, 2009, CHEM-BIOL INTERACT, V179, P17, DOI 10.1016/j.cbi.2008.10.031; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Malik AH, 2000, DIGEST DIS SCI, V45, P210, DOI 10.1023/A:1005450519498; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Sahi J, 2000, XENOBIOTICA, V30, P273, DOI 10.1080/004982500237668; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Shishido S, 2003, HEPATOLOGY, V37, P136, DOI 10.1053/jhep.2003.50014; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Yamamoto Y, 2001, LIFE SCI, V70, P471, DOI 10.1016/S0024-3205(01)01432-1; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206	42	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18816	10.1371/journal.pone.0018816	http://dx.doi.org/10.1371/journal.pone.0018816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533120	Green Published, gold			2022-12-27	WOS:000289620100022
J	Park, DS; Foottit, R; Maw, E; Hebert, PDN				Park, Doo-Sang; Foottit, Robert; Maw, Eric; Hebert, Paul D. N.			Barcoding Bugs: DNA-Based Identification of the True Bugs (Insecta: Hemiptera: Heteroptera)	PLOS ONE			English	Article								Background: DNA barcoding, the analysis of sequence variation in the 59 region of the mitochondrial cytochrome c oxidase COI) gene, has been shown to provide an efficient method for the identification of species in a wide range of animal taxa. In order to assess the effectiveness of barcodes in the discrimination of Heteroptera, we examined 344 species belonging to 178 genera, drawn from specimens in the Canadian National Collection of Insects. Methodology/Principal Findings: Analysis of the COI gene revealed less than 2% intra-specific divergence in 90% of the taxa examined, while minimum interspecific distances exceeded 3% in 77% of congeneric species pairs. Instances where barcodes fail to distinguish species represented clusters of morphologically similar species, except one case of barcode identity between species in different genera. Several instances of deep intraspecific divergence were detected suggesting possible cryptic species. Conclusions/Significance: Although this analysis encompasses 0.8% of the described global fauna, our results indicate that DNA barcodes will aid the identification of Heteroptera. This advance will be useful in pest management, regulatory and environmental applications and will also reveal species that require further taxonomic research.	[Park, Doo-Sang] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea; [Foottit, Robert; Maw, Eric] Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON, Canada; [Foottit, Robert; Maw, Eric] Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Park, Doo-Sang; Hebert, Paul D. N.] Biodivers Inst Ontario, Guelph, ON, Canada	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Agriculture & Agri Food Canada	Park, DS (corresponding author), Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea.	Robert.Foottit@agr.gc.ca	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	NSERC, Genome Canada (through the Ontario Genomics Institute); Agriculture and Agri-Food Canada	NSERC, Genome Canada (through the Ontario Genomics Institute)(Natural Sciences and Engineering Research Council of Canada (NSERC)Genome Canada); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was supported by funding to the Canadian Barcode of Life Network from NSERC, Genome Canada (through the Ontario Genomics Institute), and by Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Damgaard J, 2008, INSECT SYST EVOL, V39, P107, DOI 10.1163/187631208788784156; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Henry Thomas J., 2009, P223, DOI 10.1002/9781444308211.ch10; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Memon N, 2006, SYST ENTOMOL, V31, P703, DOI 10.1111/j.1365-3113.2006.00350.x; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaeffer CW, 2000, HETEROPTERA EC IMPOR; Schuh Randall T., 2001, Bulletin of the American Museum of Natural History, V266, P1, DOI 10.1206/0003-0090(2001)266<0001:RONWPF>2.0.CO;2; Schwartz M.D., 1998, MEMOIRS ENTOMOLOGY I, V10, P1	17	128	139	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18749	10.1371/journal.pone.0018749	http://dx.doi.org/10.1371/journal.pone.0018749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526211	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600029
J	Huijbers, W; Pennartz, CMA; Cabeza, R; Daselaar, SM				Huijbers, Willem; Pennartz, Cyriel M. A.; Cabeza, Roberto; Daselaar, Sander M.			The Hippocampus Is Coupled with the Default Network during Memory Retrieval but Not during Memory Encoding	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE NETWORKS; EPISODIC MEMORY; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; BRAIN; FMRI; ATTENTION; SYSTEM; CORTEX	The brain's default mode network (DMN) is activated during internally-oriented tasks and shows strong coherence in spontaneous rest activity. Despite a surge of recent interest, the functional role of the DMN remains poorly understood. Interestingly, the DMN activates during retrieval of past events but deactivates during encoding of novel events into memory. One hypothesis is that these opposing effects reflect a difference between attentional orienting towards internal events, such as retrieved memories, vs. external events, such as to-be-encoded stimuli. Another hypothesis is that hippocampal regions are coupled with the DMN during retrieval but decoupled from the DMN during encoding. The present fMRI study investigated these two hypotheses by combining a resting-state coherence analysis with a task that measured the encoding and retrieval of both internally-generated and externally-presented events. Results revealed that the main DMN regions were activated during retrieval but deactivated during encoding. Counter to the internal orienting hypothesis, this pattern was not modulated by whether memory events were internal or external. Consistent with the hippocampal coupling hypothesis, the hippocampus behaved like other DMN regions during retrieval but not during encoding. Taken together, our findings clarify the relationship between the DMN and the neural correlates of memory retrieval and encoding.	[Huijbers, Willem; Pennartz, Cyriel M. A.; Daselaar, Sander M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Cabeza, Roberto] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Cabeza, Roberto] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of Amsterdam; Duke University; Duke University	Huijbers, W (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	s.m.daselaar@uva.nl	daselaar, sander/J-3054-2012; Huijbers, Willem/D-5273-2013; Pennartz, Cyriel/B-7508-2015	daselaar, sander/0000-0003-2995-6877; Huijbers, Willem/0000-0003-3958-4069; Pennartz, Cyriel/0000-0001-8328-1175	The Netherlands Organisation for Scientific Research (NWO) [918.46.609, 916.66.022]; National Institutes of Health [AG19731, AG23770]; NATIONAL INSTITUTE ON AGING [R01AG023770, R01AG019731, R56AG023770] Funding Source: NIH RePORTER	The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CP was supported by The Netherlands Organisation for Scientific Research (NWO) grant 918.46.609 (VICI); RC was supported by the National Institutes of Health grants AG19731 and AG23770; SD was supported by NWO grant 916.66.022 (VENI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daselaar SM, 2008, CEREB CORTEX, V18, P217, DOI 10.1093/cercor/bhm048; Daselaar SM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.013.2009; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; DAVACHI L, 2003, P NATL ACAD SCI US; Eichenbaum H, 2006, CURR BIOL, V16, pR643, DOI 10.1016/j.cub.2006.07.026; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wagner AD, 2001, CURR BIOL, V11, pR964, DOI 10.1016/S0960-9822(01)00575-9; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	49	94	94	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e17463	10.1371/journal.pone.0017463	http://dx.doi.org/10.1371/journal.pone.0017463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494597	Green Published, gold			2022-12-27	WOS:000289354100002
J	Lundin, V; Herland, A; Berggren, M; Jager, EWH; Teixeira, AI				Lundin, Vanessa; Herland, Anna; Berggren, Magnus; Jager, Edwin W. H.; Teixeira, Ana I.			Control of Neural Stem Cell Survival by Electroactive Polymer Substrates	PLOS ONE			English	Article							BENDING BEAM METHOD; ELECTROCHEMICAL APPLICATIONS; POLYPYRROLE ACTUATORS; DOPED POLYPYRROLE; DIFFERENTIATION; SURFACE; FILMS; SPECIFICATION; BIOMATERIALS; FABRICATION	Stem cell function is regulated by intrinsic as well as microenvironmental factors, including chemical and mechanical signals. Conducting polymer-based cell culture substrates provide a powerful tool to control both chemical and physical stimuli sensed by stem cells. Here we show that polypyrrole (PPy), a commonly used conducting polymer, can be tailored to modulate survival and maintenance of rat fetal neural stem cells (NSCs). NSCs cultured on PPy substrates containing different counter ions, dodecylbenzenesulfonate (DBS), tosylate (TsO), perchlorate (ClO(4)) and chloride (Cl), showed a distinct correlation between PPy counter ion and cell viability. Specifically, NSC viability was high on PPy(DBS) but low on PPy containing TsO, ClO(4) and Cl. On PPy(DBS), NSC proliferation and differentiation was comparable to standard NSC culture on tissue culture polystyrene. Electrical reduction of PPy(DBS) created a switch for neural stem cell viability, with widespread cell death upon polymer reduction. Coating the PPy(DBS) films with a gel layer composed of a basement membrane matrix efficiently prevented loss of cell viability upon polymer reduction. Here we have defined conditions for the biocompatibility of PPy substrates with NSC culture, critical for the development of devices based on conducting polymers interfacing with NSCs.	[Lundin, Vanessa; Herland, Anna; Teixeira, Ana I.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Berggren, Magnus; Jager, Edwin W. H.] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden	Karolinska Institutet; Linkoping University	Lundin, V (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Ana.Teixeira@ki.se	Berggren, Magnus/J-6401-2015; Jager, Edwin/F-1481-2013; Herland, Anna/J-2923-2012	Berggren, Magnus/0000-0001-5154-0291; Jager, Edwin/0000-0002-2071-7768; Teixeira, Ana/0000-0001-8169-8815; Herland, Anna/0000-0002-5002-2537	Swedish Research Council (VR); Swedish Foundation for Strategic Research (SSF; the OBOE center); Karolinska Institute; VR; Onnesjo Foundation; Linkoping University	Swedish Research Council (VR)(Swedish Research Council); Swedish Foundation for Strategic Research (SSF; the OBOE center)(Swedish Foundation for Strategic Research); Karolinska Institute(Karolinska Institutet); VR(Swedish Research Council); Onnesjo Foundation; Linkoping University	The authors would like to acknowledge funding from the Swedish Research Council (VR) and the Swedish Foundation for Strategic Research (SSF; the OBOE center). V.L. was supported by a KID fellowship from the Karolinska Institute and A.H. was supported by a post-doctoral grant from VR. M.B. wishes to thank the Onnesjo Foundation and Linkoping University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay L, 2002, POLYMER, V43, P3527, DOI 10.1016/S0032-3861(02)00105-2; Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419; Causley J, 2005, SYNTHETIC MET, V151, P60, DOI 10.1016/j.synthmet.2005.04.001; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fonner JM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034124; Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040; George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037; Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Jager EWH, 2000, SCIENCE, V288, P2335, DOI 10.1126/science.288.5475.2335; Johanson U, 2005, ELECTROCHIM ACTA, V50, P1523, DOI 10.1016/j.electacta.2004.10.016; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6; PEI QB, 1993, SOLID STATE IONICS, V60, P161, DOI 10.1016/0167-2738(93)90291-A; PEI QB, 1993, J PHYS CHEM-US, V97, P6034, DOI 10.1021/j100124a041; Pyo M, 2003, CHEM MATER, V15, P916, DOI 10.1021/cm020312w; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Robinson L, 2006, SURF SCI, V600, pL148, DOI 10.1016/j.susc.2006.03.039; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Salto C, 2008, LANGMUIR, V24, P14133, DOI 10.1021/la8028337; Svennersten K, 2009, BIOMATERIALS, V30, P6257, DOI 10.1016/j.biomaterials.2009.07.059; Tamm J, 2004, RUSS J ELECTROCHEM+, V40, P344, DOI 10.1023/B:RUEL.0000019674.41564.01; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; Wanekaya AK, 2006, ELECTROANAL, V18, P1047, DOI 10.1002/elan.200603507; Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176	28	64	66	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18624	10.1371/journal.pone.0018624	http://dx.doi.org/10.1371/journal.pone.0018624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494605	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100027
J	Schmidt, JP; Drake, JM				Schmidt, John Paul; Drake, John M.			Why Are Some Plant Genera More Invasive Than Others?	PLOS ONE			English	Article							PREDICTING INVASIONS; BIOLOGICAL INVASIONS; NATURALIZATION; PATTERNS; SUCCESS; TREES; RISK	Determining how biological traits are related to the ability of groups of organisms to become economically damaging when established outside of their native ranges is a major goal of population biology, and important in the management of invasive species. Little is known about why some taxonomic groups are more likely to become pests than others among plants. We investigated traits that discriminate vascular plant genera, a level of taxonomic generality at which risk assessment and screening could be more effectively performed, according to the proportion of naturalized species which are pests. We focused on the United States and Canada, and, because our purpose is ultimately regulatory, considered species classified as weeds or noxious. Using contingency tables, we identified 11 genera of vascular plants that are disproportionately represented by invasive species. Results from boosted regression tree analyses show that these categories reflect biological differences. In summary, approximately 25% of variation in genus proportions of weeds or noxious species was explained by biological covariates. Key explanatory traits included genus means for wetland habitat affinity, chromosome number, and seed mass.	[Schmidt, John Paul; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schmidt, JP (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jps@uga.edu	Schmidt, John Paul/A-3583-2013; Drake, John/D-6622-2012	Drake, John/0000-0003-4646-1235; Schmidt, John Paul/0000-0001-8549-0587	U.S. Department of Agriculture [10-21-RR551]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Research was funded by U.S. Department of Agriculture (http://www.usda.gov/wps/portal/usda/usdahome) agreement no. 10-21-RR551. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AM, 2008, EVOLUTION PHYLOGENY, P73; [Anonymous], 2001, GREAT RESHUFFLING HU; APGII, 2003, LINNEAN, V141, P399; Barrett S.C.H., 1986, P21; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Goldblatt P., 1979, INDEX PLANT CHROMOSO; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; HOLM S, 1979, SCAND J STAT, V6, P65; HOTHORN T, 2009, CONDITIONAL INFERENC; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Liu K., 2008, SEED INFORM DATABASE; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Mooney H.A., 2000, INVASIVE SPECIES CHA; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pemberton RW, 2009, ECOLOGY, V90, P69, DOI 10.1890/07-1516.1; Pessarakli M., 1997, HDB PHOTOSYNTHESIS, V2nd; PYSEK P, 2007, ECOL STU AN, V193; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Sage R., 1999, C4 PLANT BIOL, P551, DOI DOI 10.1016/B978-012614440-6/50017-3; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stacey G., 1992, BIOL NITROGEN FIXATI; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Zar J.H., 2010, BIOSTAT ANAL	49	20	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18654	10.1371/journal.pone.0018654	http://dx.doi.org/10.1371/journal.pone.0018654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494563	Green Published, gold, Green Submitted			2022-12-27	WOS:000289354100029
J	Wang, YB; Zhang, H; Li, HC; Miao, XX				Wang, Yubing; Zhang, Hao; Li, Haichao; Miao, Xuexia			Second-Generation Sequencing Supply an Effective Way to Screen RNAi Targets in Large Scale for Potential Application in Pest Insect Control	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE; COTTON BOLLWORM; TRYPSIN-LIKE; BT CROPS; RESISTANCE; MIDGUT; LEPIDOPTERA; KNOCKDOWN; INGESTION	The key of RNAi approach success for potential insect pest control is mainly dependent on careful target selection and a convenient delivery system. We adopted second-generation sequencing technology to screen RNAi targets. Illumina's RNA-seq and digital gene expression tag profile (DGE-tag) technologies were used to screen optimal RNAi targets from Ostrinia furnalalis. Total 14690 stage specific genes were obtained which can be considered as potential targets, and 47 were confirmed by qRT-PCR. Ten larval stage specific expression genes were selected for RNAi test. When 50 ng/mu l dsRNAs of the genes DS10 and DS28 were directly sprayed on the newly hatched larvae which placed on the filter paper, the larval mortalities were around 40 similar to 50%, while the dsRNAs of ten genes were sprayed on the larvae along with artificial diet, the mortalities reached 73% to 100% at 5 d after treatment. The qRT-PCR analysis verified the correlation between larval mortality and the down-regulation of the target gene expression. Topically applied fluorescent dsRNA confirmed that dsRNA did penetrate the body wall and circulate in the body cavity. It seems likely that the combination of DGE-tag with RNA-seq is a rapid, high-throughput, cost less and an easy way to select the candidate target genes for RNAi. More importantly, it demonstrated that dsRNAs are able to penetrate the integument and cause larval developmental stunt and/or death in a lepidopteron insect. This finding largely broadens the target selection for RNAi from just gut-specific genes to the targets in whole insects and may lead to new strategies for designing RNAi-based technology against insect damage.	[Wang, Yubing; Zhang, Hao; Li, Haichao; Miao, Xuexia] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, YB (corresponding author), Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	xxm@sippe.ac.cn	WANG, Yubing/GYV-3345-2022; Li, Haichao/AGY-6004-2022	Li, Haichao/0000-0002-1359-4640	Ministry of Agriculture of China [2008ZX08009-003-001]; National Natural Foundation of China [31030060]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Transgenic Great Subject from the Ministry of Agriculture of China (2008ZX08009-003-001) and the National Natural Foundation Key Program of China (31030060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Broehan G, 2007, J EXP BIOL, V210, P3636, DOI 10.1242/jeb.008334; Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281; Coates BS, 2006, INSECT MOL BIOL, V15, P13, DOI 10.1111/j.1365-2583.2006.00598.x; Dawid IB, 1998, TRENDS GENET, V14, P480, DOI 10.1016/S0168-9525(98)01615-1; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gallagher SR, 1992, GUS PROTOCOLS USING; GAUR RK, 1993, FEBS LETT, V315, P56, DOI 10.1016/0014-5793(93)81132-J; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hegedus D, 2003, ARCH INSECT BIOCHEM, V53, P30, DOI 10.1002/arch.10084; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Joanisse DR, 1996, PHYSIOL ZOOL, V69, P1079, DOI 10.1086/physzool.69.5.30164247; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu Y, 2009, ARCH INSECT BIOCHEM, V72, P74, DOI 10.1002/arch.20324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Pechanova O, 2008, INSECT MOL BIOL, V17, P261, DOI 10.1111/j.1365-2583.2008.00801.x; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Zhang C, 2010, J INSECT PHYSIOL, V56, P788, DOI 10.1016/j.jinsphys.2010.02.001	46	109	137	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18644	10.1371/journal.pone.0018644	http://dx.doi.org/10.1371/journal.pone.0018644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494551	Green Published, Green Submitted, gold			2022-12-27	WOS:000289354100028
J	Rimbert, M; Hamidou, M; Braudeau, C; Puechal, X; Teixeira, L; Caillon, H; Neel, A; Audrain, M; Guillevin, L; Josien, R				Rimbert, Marie; Hamidou, Mohamed; Braudeau, Cecile; Puechal, Xavier; Teixeira, Luis; Caillon, Helene; Neel, Antoine; Audrain, Marie; Guillevin, Loic; Josien, Regis			Decreased Numbers of Blood Dendritic Cells and Defective Function of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANCA-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; SUPPRESSOR FUNCTION; IMMUNE SUPPRESSION; TH17 CELLS; EXPRESSION; AUTOANTIBODIES	Background: Dendritic cells (DC) and regulatory cells (Treg) play pivotal roles in controlling both normal and autoimmune adaptive immune responses. DC are the main antigen-presenting cells to T cells, and they also control Treg functions. In this study, we examined the frequency and phenotype of DC subsets, and the frequency and function of Treg from patients with ANCA-associated vasculitis (AAV). Methodology/Principal Findings: Blood samples from 19 untreated patients with AAV during flares and before any immunosuppressive treatment were analyzed, along with 15 AAV patients in remission and 18 age-matched healthy controls. DC and Treg numbers, and phenotypes were assessed by flow cytometry, and in vitro suppressive function of Treg was determined by co-culture assay. When compared to healthy volunteers, absolute numbers of conventional and plasmacytoid DC were decreased in AAV patients. During the acute phase this decrease was significantly more pronounced and was associated with an increased DC expression of CD62L. Absolute numbers of Treg (CD4(+)CD25(high)CD127(low/-) Tcells) were moderately decreased in patients. FOXP3 and CD39 were expressed at similar levels on Treg from patients as compared to controls. The suppressive function of Treg from AAV patients was dramatically decreased as compared to controls, and this defect was more pronounced during flares than remission. This Treg functional deficiency occurred in the absence of obvious Th17 deviation. Conclusion: In conclusion, these data show that AAV flares are associated with both a decrease number and altered phenotype of circulating DC and point to a role for Treg functional deficiency in the pathogenesis of AAV.	[Rimbert, Marie; Braudeau, Cecile; Caillon, Helene; Audrain, Marie; Josien, Regis] CHU Nantes, Immunol Lab, F-44035 Nantes 01, France; [Rimbert, Marie; Braudeau, Cecile; Josien, Regis] ITUN, Nantes, France; [Rimbert, Marie; Josien, Regis] INSERM, UMR643, Nantes, France; [Rimbert, Marie; Hamidou, Mohamed; Neel, Antoine; Josien, Regis] Univ Nantes, Fac Med, Nantes, France; [Hamidou, Mohamed; Neel, Antoine] CHU Nantes, Serv Med Interne, F-44035 Nantes 01, France; [Puechal, Xavier] CH Le Mans, Le Mans, France; [Teixeira, Luis; Guillevin, Loic] Hop Cochin, AP HP, Serv Med Interne, F-75674 Paris, France; [Teixeira, Luis; Guillevin, Loic] Univ Paris 05, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rimbert, M (corresponding author), CHU Nantes, Immunol Lab, F-44035 Nantes 01, France.	Regis.josien@univ-nantes.fr	Josien, Regis/U-4405-2019; Josien, Regis/L-7468-2015; Puéchal, Xavier/P-1555-2017	Josien, Regis/0000-0001-7900-7413; Puéchal, Xavier/0000-0003-3573-9203; Neel, Antoine/0000-0002-7707-5794; Teixeira, Luis/0000-0003-1049-9661	Delegation Regionale a la Recherche Clinique et Innovation (DRCI) [05/2-J, 09/06-A]; Region des Pays de la Loire	Delegation Regionale a la Recherche Clinique et Innovation (DRCI); Region des Pays de la Loire(Region Pays de la Loire)	This work was supported by grants from the Delegation Regionale a la Recherche Clinique et Innovation (DRCI), Appel d'offre Interne # 05/2-J and # 09/06-A, CHU Nantes. This study was also supported in part by a grant from the Region des Pays de la Loire (IMBIO project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulahad WH, 2006, KIDNEY INT, V70, P938, DOI 10.1038/sj.ki.5001670; Abdulahad WH, 2008, ARTHRITIS RHEUM-US, V58, P2196, DOI 10.1002/art.23557; Abdulahad WH, 2007, ARTHRITIS RHEUM, V56, P2080, DOI 10.1002/art.22692; Abdulahad WH, 2009, NEPHROLOGY, V14, P26, DOI 10.1111/j.1440-1797.2008.01069.x; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Blomberg S, 2003, ARTHRITIS RHEUM, V48, P2524, DOI 10.1002/art.11225; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; BROUWER E, 1991, CLIN EXP IMMUNOL, V83, P379; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Ciccocioppo R, 2007, CLIN EXP IMMUNOL, V149, P487, DOI 10.1111/j.1365-2249.2007.03431.x; Clayton AR, 2000, ARTHRITIS RES, V2, P260, DOI 10.1186/ar98; Csernok E, 2006, BLOOD, V107, P4440, DOI 10.1182/blood-2005-05-1875; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gomez-Puerta JA, 2009, AM J PATHOL, V175, P1790, DOI 10.2353/ajpath.2009.090533; Huang Zhi-xiang, 2009, Zhonghua Yi Xue Za Zhi, V89, P2476; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Klapa S, 2010, CLIN EXP RHEUMATOL, V28, pS72; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Lamprecht P, 2005, CLIN EXP IMMUNOL, V141, P201, DOI 10.1111/j.1365-2249.2005.02808.x; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marinaki S, 2005, CLIN EXP IMMUNOL, V140, P181, DOI 10.1111/j.1365-2249.2005.02731.x; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Migita K, 2005, CLIN EXP IMMUNOL, V142, P84, DOI 10.1111/j.1365-2249.2005.02897.X; MORGAN MD, 2010, IMMUNOLOGY; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; NOGUEIRA E, 2010, NEPHROL DIAL TRANSPL; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilde B, 2009, NEPHROL DIAL TRANSPL, V24, P2151, DOI 10.1093/ndt/gfp019; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499	63	56	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18734	10.1371/journal.pone.0018734	http://dx.doi.org/10.1371/journal.pone.0018734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494636	Green Published, gold, Green Submitted			2022-12-27	WOS:000289292800041
J	Ross, A; Maire, N; Sicuri, E; Smith, T; Conteh, L				Ross, Amanda; Maire, Nicolas; Sicuri, Elisa; Smith, Thomas; Conteh, Lesong			Determinants of the Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants and Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RANDOMIZED CONTROLLED-TRIAL; ANEMIA CONTROL; DOUBLE-BLIND; ANTIMALARIAL TREATMENT; ROUTINE VACCINATIONS; EPIDEMIOLOGIC MODEL; TANZANIAN INFANTS; HEALTH; AMODIAQUINE	Background: Trials of intermittent preventive treatment in infants (IPTi) and children (IPTc) have shown promising results in reducing malaria episodes but with varying efficacy and cost-effectiveness. The effects of different intervention and setting characteristics are not well known. We simulate the effects of the different target age groups and delivery channels, seasonal or year-round delivery, transmission intensity, seasonality, proportions of malaria fevers treated and drug characteristics. Methods: We use a dynamic, individual-based simulation model of Plasmodium falciparum malaria epidemiology, antimalarial drug action and case management to simulate DALYs averted and the cost per DALY averted by IPTi and IPTc. IPT cost components were estimated from economic studies alongside trials. Results: IPTi and IPTc were predicted to be cost-effective in most of the scenarios modelled. The cost-effectiveness is driven by the impact on DALYs, particularly for IPTc, and the low costs, particularly for IPTi which uses the existing delivery strategy, EPI. Cost-effectiveness was predicted to decrease with low transmission, badly timed seasonal delivery in a seasonal setting, short-acting and more expensive drugs, high frequencies of drug resistance and high levels of treatment of malaria fevers. Seasonal delivery was more cost-effective in seasonal settings, and year-round in constant transmission settings. The difference was more pronounced for IPTc than IPTi due to the different proportions of fixed costs and also different assumed drug spacing during the transmission season. The number of DALYs averted was predicted to decrease as a target five-year age-band for IPTc was shifted from children under 5 years into older ages, except at low transmission intensities. Conclusions: Modelling can extend the information available by predicting impact and cost-effectiveness for scenarios, for outcomes and for multiple strategies where, for practical reasons, trials cannot be carried out. Both IPTi and IPTc are generally cost-effective but could be rendered cost-ineffective by characteristics of the setting, drug or implementation.	[Ross, Amanda; Maire, Nicolas; Smith, Thomas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ross, Amanda; Maire, Nicolas; Smith, Thomas] Univ Basel, Basel, Switzerland; [Sicuri, Elisa] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Sicuri, Elisa] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London	Ross, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	amanda.ross@unibas.ch	Sicuri, Elisa/L-8012-2014; Smith, Thomas/B-5569-2015; Conteh, Lesong/ABE-9550-2020; Agyemang, Samuel/H-8377-2014	Sicuri, Elisa/0000-0002-2499-2732; Smith, Thomas/0000-0002-3650-9381; Conteh, Lesong/0000-0002-0719-3672; Ross, Amanda/0000-0001-6027-5645	Bill and Melinda Gates Foundation [39777, 38479, 33679]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by The Bill and Melinda Gates Foundation grant numbers 39777, 38479 and 33679. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006627; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Aponte JJ, 2007, PLOS MED, V4, P2014, DOI 10.1371/journal.pmed.0040359; Arnesen T, 1999, BMJ-BRIT MED J, V319, P1423, DOI 10.1136/bmj.319.7222.1423; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; Barger B, 2009, TROP MED INT HEALTH, V14, P784, DOI 10.1111/j.1365-3156.2009.02294.x; Beeson JG, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000410; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Buffet PA, 2008, TRENDS PARASITOL, V24, P482, DOI 10.1016/j.pt.2008.07.007; Bureau of Labor Statistics, 2010, CPI INFL CALC; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; de Sousa A, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60047-5; Deressa W, 2007, TROP MED INT HEALTH, V12, P1148, DOI 10.1111/j.1365-3156.2007.01901.x; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Gold MR, 1996, COST EFFECTIVENESS H; Goodman C, 2000, EC ANAL MALARIA CONT; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; GROBUSCH M, 2006, J INFECT DIS, V196, P1595; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Hastings IM, 2006, TRENDS PARASITOL, V22, P71, DOI 10.1016/j.pt.2005.12.011; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Manzi F, 2009, T ROY SOC TROP MED H, V103, P79, DOI 10.1016/j.trstmh.2008.08.014; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; McGready R, 2009, LANCET, V374, P1478, DOI 10.1016/S0140-6736(09)61629-9; Meremikwu MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub3; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; O'Meara Wendy Prudhomme, 2005, Malar J, V4, P33, DOI 10.1186/1475-2875-4-33; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Orrell C, 2008, EUR J CLIN PHARMACOL, V64, P683, DOI 10.1007/s00228-007-0452-8; Owusu-Agyei S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-103; PATOUILLARD E, 2011, COVERAGE COSTS UNPUB; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; PUSSARD E, 1987, EUR J CLIN PHARMACOL, V33, P409, DOI 10.1007/BF00637639; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Rohner F, 2010, J NUTR, V140, P635, DOI 10.3945/jn.109.114256; Ross A, 2006, AM J TROP MED HYG, V75, P74, DOI 10.4269/ajtmh.2006.75.74; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sachs JD, 2001, MACR HLTH INV HLTH E; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; TAGBOR H, 2011, TROP MED INT HLTH; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; Tediosi F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-127; Temperley M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-196; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Vinetz JM, 2010, AM J TROP MED HYG, V82, P755, DOI 10.4269/ajtmh.2010.825editorial; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WILSON A, 2010, PLOS ONE, V6; WINSTANLEY PA, 1990, BRIT J CLIN PHARMACO, V29, P695, DOI 10.1111/j.1365-2125.1990.tb03690.x; Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x; *WORLD BANK, 1993, WORLD DEV REP; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	87	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18391	10.1371/journal.pone.0018391	http://dx.doi.org/10.1371/journal.pone.0018391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746IN	21490967	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700009
J	Rudolphi, J; Gustafsson, L				Rudolphi, Jorgen; Gustafsson, Lena			Forests Regenerating after Clear-Cutting Function as Habitat for Bryophyte and Lichen Species of Conservation Concern	PLOS ONE			English	Article							PICEA-ABIES; EPIPHYTIC LICHENS; OLD-GROWTH; POPULUS-TREMULA; SPATIAL SCALES; BOREAL FOREST; LANDSCAPE; RICHNESS; FRAGMENTATION; COLONIZATION	The majority of managed forests in Fennoscandia are younger than 70 years old but yet little is known about their potential to host rare and threatened species. In this study, we examined red-listed bryophytes and lichens in 19 young stands originating from clear-cutting (30-70 years old) in the boreal region, finding 19 red-listed species (six bryophytes and 13 lichens). We used adjoining old stands, which most likely never had been clear-cut, as reference. The old stands contained significantly more species, but when taking the amount of biological legacies (i.e., remaining deciduous trees and dead wood) from the previous forest generation into account, bryophyte species number did not differ between old and young stands, and lichen number was even higher in young stands. No dispersal effect could be detected from the old to the young stands. The amount of wetlands in the surroundings was important for bryophytes, as was the area of old forest for both lichens and bryophytes. A cardinal position of young stands to the north of old stands was beneficial to red-listed bryophytes as well as lichens. We conclude that young forest plantations may function as habitat for red-listed species, but that this depends on presence of structures from the previous forest generation, and also on qualities in the surrounding landscape. Nevertheless, at repeated clear-cuttings, a successive decrease in species populations in young production stands is likely, due to increased fragmentation and reduced substrate amounts. Retention of dead wood and deciduous trees might be efficient conservation measures. Although priority needs to be given to preservation of remnant old-growth forests, we argue that young forests rich in biological legacies and located in landscapes with high amounts of old forests may have a conservation value.	[Rudolphi, Jorgen; Gustafsson, Lena] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Rudolphi, J (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	jorgen.rudolphi@slu.se	Rudolphi, Jörgen/C-9363-2013; Sjögren, Jörgen/GXG-8007-2022	Rudolphi, Jörgen/0000-0002-0538-8265; Sjögren, Jörgen/0000-0002-0538-8265; Gustafsson, Lena/0000-0003-2467-7289	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	Funding for this study was received from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (www.formas.se), grant to L. Gustafsson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; AXELSSON AL, 2001, THESIS SWEDISH U AGR; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Berg D.R., 1997, CREATING FORESTRY 21, P111; Botting RS, 2006, CAN J BOT, V84, P120, DOI [10.1139/B05-146, 10.1139/b05-146]; Bunnell FL, 2008, CAN J FOREST RES, V38, P1033, DOI 10.1139/X07-206; Bunnell FL, 2007, WEST J APPL FOR, V22, P94, DOI 10.1093/wjaf/22.2.94; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BUSBY JR, 1978, CAN J BOT, V56, P1551, DOI 10.1139/b78-184; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caruso A, 2007, SCAND J FOREST RES, V22, P219, DOI 10.1080/02827580701346031; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Coxson DS, 2005, FOREST ECOL MANAG, V204, P97, DOI 10.1016/j.foreco.2004.09.002; De Vries P.G., 1986, SAMPLING THEORY FORE; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; FRIES C, 2000, DIFFERENT MANAGEMENT, P1; G?rdenfors U, 2000, RODLISTADE ARTER SVE; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gregoire T.G., 2008, SAMPLING STRATEGIES; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hallingback T., 1998, RODLISTADE MOSSOR SV; Hedenas H, 2003, ECOL APPL, V13, P1124, DOI 10.1890/1051-0761(2003)13[1124:ROELOP]2.0.CO;2; Hilmo O, 2001, BIOL CONSERV, V102, P251, DOI 10.1016/S0006-3207(01)00100-8; Hilmo O, 2009, LICHENOLOGIST, V41, P97, DOI 10.1017/S0024282909007865; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Hylander K, 2009, ECOLOGY, V90, P160, DOI 10.1890/08-0042.1; Jasinski JPP, 2005, ECOL MONOGR, V75, P561, DOI 10.1890/04-1621; Kivisto L, 2000, LICHENOLOGIST, V32, P387, DOI 10.1006/lich.2000.0282; Kruys N, 1999, CAN J FOREST RES, V29, P1295, DOI 10.1139/cjfr-29-8-1295; LESICA P, 1991, CAN J BOT, V69, P1745, DOI 10.1139/b91-222; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; Lohmus A, 2008, RESTOR ECOL, V16, P231, DOI 10.1111/j.1526-100X.2007.00266.x; Lohmus A, 2007, BIOL CONSERV, V135, P405, DOI 10.1016/j.biocon.2006.10.015; Longton Royce E., 1992, P32; McCullagh P, 1989, GEN LINEAR MODELS; McGee GG, 2002, CAN J FOREST RES, V32, P1562, DOI 10.1139/X02-083; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; Palmqvist K, 2000, PLANT CELL ENVIRON, V23, P1, DOI 10.1046/j.1365-3040.2000.00529.x; Pharo EJ, 2004, J APPL ECOL, V41, P910, DOI 10.1111/j.0021-8901.2004.00947.x; Pharo EJ, 2007, BIOL CONSERV, V135, P315, DOI 10.1016/j.biocon.2006.10.016; Proctor MCF, 2008, BRYOPHYTE BIOL, P237, DOI [10.1017/CBO9780511754807.007, DOI 10.1017/CBO9780511754807.007]; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; Reese H, 2003, AMBIO, V32, P542, DOI 10.1639/0044-7447(2003)032[0542:CEOFVU]2.0.CO;2; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Sillett SC, 1998, BRYOLOGIST, V101, P20, DOI 10.1639/0007-2745(1998)101[20:SAGOCT]2.0.CO;2; Sillett SC, 2000, BRYOLOGIST, V103, P661, DOI 10.1639/0007-2745(2000)103[0661:FYOECI]2.0.CO;2; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; SODERSTROM L, 1988, BIOL CONSERV, V45, P169, DOI 10.1016/0006-3207(88)90137-1; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Thor G., 1999, RODLISTADE LAVAR SVE; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Ulanova NG, 2000, FOREST ECOL MANAG, V135, P155, DOI 10.1016/S0378-1127(00)00307-8; Walser JC, 2001, MOL ECOL, V10, P2129, DOI 10.1046/j.1365-294X.2001.01353.x; 2007, WARSZ MIN C PROT FOR	63	32	33	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18639	10.1371/journal.pone.0018639	http://dx.doi.org/10.1371/journal.pone.0018639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490926	Green Published, gold, Green Submitted			2022-12-27	WOS:000289238700031
J	Zheng, ZZ; MacDonald, EN; Munhall, KG; Johnsrude, IS				Zheng, Zane Z.; MacDonald, Ewen N.; Munhall, Kevin G.; Johnsrude, Ingrid S.			Perceiving a Stranger's Voice as Being One's Own: A 'Rubber Voice' Illusion?	PLOS ONE			English	Article							SPEECH PRODUCTION; SELF-RECOGNITION; VERBAL FEEDBACK; BODY-OWNERSHIP; PERCEPTION; AWARENESS; RESPONSES; HAND; ABNORMALITIES; DISSOCIATION	We describe an illusion in which a stranger's voice, when presented as the auditory concomitant of a participant's own speech, is perceived as a modified version of their own voice. When the congruence between utterance and feedback breaks down, the illusion is also broken. Compared to a baseline condition in which participants heard their own voice as feedback, hearing a stranger's voice induced robust changes in the fundamental frequency (F0) of their production. Moreover, the shift in F0 appears to be feedback dependent, since shift patterns depended reliably on the relationship between the participant's own F0 and the stranger-voice F0. The shift in F0 was evident both when the illusion was present and after it was broken, suggesting that auditory feedback from production may be used separately for self-recognition and for vocal motor control. Our findings indicate that self-recognition of voices, like other body attributes, is malleable and context dependent.	[Zheng, Zane Z.; Munhall, Kevin G.; Johnsrude, Ingrid S.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [MacDonald, Ewen N.; Munhall, Kevin G.; Johnsrude, Ingrid S.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Munhall, Kevin G.] Queens Univ, Dept Otolaryngol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Zheng, ZZ (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.	5zz2@queensu.ca; Ingrid.johnsrude@queensu.ca	MacDonald, Ewen N/B-8841-2013; Johnsrude, Ingrid S/G-4694-2011; MacDonald, Ewen/AAJ-3688-2020	MacDonald, Ewen N/0000-0002-6973-2926; Johnsrude, Ingrid S/0000-0002-7810-1333; MacDonald, Ewen/0000-0002-6973-2926	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; United States National Institutes of Health; Canadian Foundation for Innovation; Ontario Innovation Trust; Ontario Ministry of Research and Innovation; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research, and the Natural Sciences and Engineering Research Council, through grants to IJ, and by a United States National Institutes of Health grant to KM and IJ, and by Canadian Foundation for Innovation and Ontario Innovation Trust grants to KM and IJ. ZZ was supported through a training award from the Ontario Ministry of Research and Innovation (to IJ). IJ is supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRICK LE, 1985, DEV PSYCHOL, V21, P963, DOI 10.1037/0012-1649.21.6.963; Barany E., 1938, ACTA OTO-LARYNGOL, V26, P1; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Boersma P., 2016, PRAAT DOING PHONETIC; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Cahill C, 1996, Cogn Neuropsychiatry, V1, P201, DOI 10.1080/135468096396505; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; Johns LC, 2006, PSYCHOL MED, V36, P465, DOI 10.1017/S0033291705006628; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Larson CR, 2000, J ACOUST SOC AM, V107, P559, DOI 10.1121/1.428323; MACDONALD EN, J ACOUST SO IN PRESS; MELLOR CS, 1970, BRIT J PSYCHIAT, V117, P15, DOI 10.1192/S0007125000192116; Mitchell R W, 1997, Ann N Y Acad Sci, V818, P38; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; Purcell DW, 2006, J ACOUST SOC AM, V119, P2288, DOI 10.1121/1.2173514; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324	39	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18655	10.1371/journal.pone.0018655	http://dx.doi.org/10.1371/journal.pone.0018655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746IN	21490928	Green Submitted, gold, Green Published			2022-12-27	WOS:000289238700034
J	Derrick, GE; Haynes, A; Chapman, S; Hall, WD				Elizabeth Derrick, Gemma; Haynes, Abby; Chapman, Simon; Hall, Wayne D.			The Association between Four Citation Metrics and Peer Rankings of Research Influence of Australian Researchers in Six Fields of Public Health	PLOS ONE			English	Article							H-INDEX; HIRSCH-INDEX; INDICATORS; VARIANTS	Doubt about the relevance, appropriateness and transparency of peer review has promoted the use of citation metrics as a viable adjunct or alternative in the assessment of research impact. It is also commonly acknowledged that research metrics will not replace peer review unless they are shown to correspond with the assessment of peers. This paper evaluates the relationship between researchers' influence as evaluated by their peers and various citation metrics representing different aspects of research output in 6 fields of public health in Australia. For four fields, the results showed a modest positive correlation between different research metrics and peer assessments of research influence. However, for two fields, tobacco and injury, negative or no correlations were found. This suggests a peer understanding of research influence within these fields differed from visibility in the mainstream, peer-reviewed scientific literature. This research therefore recommends the use of both peer review and metrics in a combined approach in assessing research influence. Future research evaluation frameworks intent on incorporating metrics should first analyse each field closely to determine what measures of research influence are valued highly by members of that research community. This will aid the development of comprehensive and relevant frameworks with which to fairly and transparently distribute research funds or approve promotion applications.	[Elizabeth Derrick, Gemma; Haynes, Abby; Chapman, Simon] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Elizabeth Derrick, Gemma] CSIC, Ctr Ciencias Humanas & Sociales, Inst Politcas & Bienes Publ, Madrid, Spain; [Hall, Wayne D.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	University of Sydney; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Ciencias Humanas y Sociales (CCHS); CSIC - Instituto de Politicas y Bienes Publicos (IPP); University of Queensland	Derrick, GE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	gemma.derrick@cchs.csic.es	Hall, Wayne D/A-3283-2008; White, Howard D/A-7034-2009; Chapman, Simon/D-4114-2009; Haynes, Abby/D-3618-2016; Derrick, Gemma/D-8970-2018	Hall, Wayne D/0000-0003-1984-0096; Haynes, Abby/0000-0001-5703-5683; Derrick, Gemma/0000-0001-5386-8653	Australian National Health; Medical Research Council	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been funded by a project grant from the Australian National Health and Medical Research Council (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornmann L, 2008, RES EVALUAT, V17, P149, DOI 10.3152/095820208X319166; Bornmann L, 2007, J INFORMETR, V1, P204, DOI 10.1016/j.joi.2007.01.002; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bornmann L, 2009, J AM SOC INF SCI TEC, V60, P1286, DOI 10.1002/asi.21016; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Burrell QL, 2007, J INFORMETR, V1, P16, DOI 10.1016/j.joi.2006.07.001; Cabrerizo FJ, 2010, J INFORMETR, V4, P23, DOI 10.1016/j.joi.2009.06.005; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; Derrick GE, 2010, SCIENTOMETRICS, V84, P317, DOI 10.1007/s11192-009-0118-7; DERRICK GE, CHALLENGES ASS UNPUB; Donovan C, 2007, SCI PUBL POLICY, V34, P538, DOI [10.3152/030234207X256529, DOI 10.3152/030234207X256529]; HAYNES AS, SOCIAL SCI IN PRESS; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Kosmulski M., 2006, ISSI NEWSLETTER, V2, P4; Langfeldt L, 2001, SOC STUD SCI, V31, P820, DOI 10.1177/030631201031006002; MARTIN BR, 1983, RES POLICY, V12, P61, DOI 10.1016/0048-7333(83)90005-7; Moed H.F., 2007, SCI PUBL POLICY, V34, P575, DOI [10.3152/030234207X255179, DOI 10.3152/030234207X255179]; RAVICHANDRARAO IK, 2007, P 11 C INT SOC SCI I, P655; ROUSSEAU R, 2008, P WIS 2008 4 INT C W; Rousseau R., 2006, SCI FOCUS, V1, P23; Schreiber M, 2008, J AM SOC INF SCI TEC, V59, P1513, DOI 10.1002/asi.20856; Schreiber M, 2010, ANN PHYS-BERLIN, V522, P536, DOI 10.1002/andp.201000046; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; White H. D., 1990, SCHOLARLY COMMUNICAT, P84	25	36	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18521	10.1371/journal.pone.0018521	http://dx.doi.org/10.1371/journal.pone.0018521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494691	Green Published, gold, Green Submitted			2022-12-27	WOS:000289192400036
J	Ramonet, D; Daher, JPL; Lin, BM; Stafa, K; Kim, J; Banerjee, R; Westerlund, M; Pletnikova, O; Glauser, L; Yang, LC; Liu, Y; Swing, DA; Beal, MF; Troncoso, JC; McCaffery, JM; Jenkins, NA; Copeland, NG; Galter, D; Thomas, B; Lee, MK; Dawson, TM; Dawson, VL; Moore, DJ				Ramonet, David; Daher, Joao Paulo L.; Lin, Brian M.; Stafa, Klodjan; Kim, Jaekwang; Banerjee, Rebecca; Westerlund, Marie; Pletnikova, Olga; Glauser, Liliane; Yang, Lichuan; Liu, Ying; Swing, Deborah A.; Beal, M. Flint; Troncoso, Juan C.; McCaffery, J. Michael; Jenkins, Nancy A.; Copeland, Neal G.; Galter, Dagmar; Thomas, Bobby; Lee, Michael K.; Dawson, Ted M.; Dawson, Valina L.; Moore, Darren J.			Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; ALPHA-SYNUCLEIN; R1441C MUTATION; GTP-BINDING; GENE LRRK2; LOCALIZATION; NEURODEGENERATION; MODELS	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause late-onset, autosomal dominant familial Parkinson's disease (PD) and also contribute to idiopathic PD. LRRK2 mutations represent the most common cause of PD with clinical and neurochemical features that are largely indistinguishable from idiopathic disease. Currently, transgenic mice expressing wild-type or disease-causing mutants of LRRK2 have failed to produce overt neurodegeneration, although abnormalities in nigrostriatal dopaminergic neurotransmission have been observed. Here, we describe the development and characterization of transgenic mice expressing human LRRK2 bearing the familial PD mutations, R1441C and G2019S. Our study demonstrates that expression of G2019S mutant LRRK2 induces the degeneration of nigrostriatal pathway dopaminergic neurons in an age-dependent manner. In addition, we observe autophagic and mitochondrial abnormalities in the brains of aged G2019S LRRK2 mice and markedly reduced neurite complexity of cultured dopaminergic neurons. These new LRRK2 transgenic mice will provide important tools for understanding the mechanism(s) through which familial mutations precipitate neuronal degeneration and PD.	[Ramonet, David; Stafa, Klodjan; Glauser, Liliane; Moore, Darren J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Daher, Joao Paulo L.; Lin, Brian M.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, Baltimore, MD USA; [Daher, Joao Paulo L.; Lin, Brian M.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Daher, Joao Paulo L.; Lin, Brian M.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Daher, Joao Paulo L.] Univ Fed Fluminense, Sch Med, Dept Pathol, Niteroi, RJ, Brazil; [Kim, Jaekwang; Pletnikova, Olga; Liu, Ying; Troncoso, Juan C.; Lee, Michael K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kim, Jaekwang; Lee, Michael K.] Univ Minnesota, Dept Neurosci, Inst Translat Neurosci, Minneapolis, MN USA; [Banerjee, Rebecca; Yang, Lichuan; Beal, M. Flint; Thomas, Bobby] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [Westerlund, Marie; Galter, Dagmar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [McCaffery, J. Michael] Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Swing, Deborah A.; Jenkins, Nancy A.; Copeland, Neal G.] NCI, Mouse Canc Genet Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidade Federal Fluminense; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Karolinska Institutet; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Johns Hopkins University	Ramonet, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.	vdawson@jhmi.edu; darren.moore@epfl.ch	Lee, Michael K/D-9491-2013; Galter, Dagmar/C-4826-2011; Dawson, Valina/Y-9757-2019	Lee, Michael K/0000-0001-5865-9682; Galter, Dagmar/0000-0001-6485-6244; Kim, Jaekwang/0000-0002-7312-4077; Dawson, Valina/0000-0002-2915-3970; Moore, Darren/0000-0003-2359-5679; Ramonet, David/0000-0002-5058-7757	National Parkinson Foundation; Swiss National Science Foundation [310030_127478]; Parkinson Schweiz; American Parkinson Disease Association; Ecole Polytechnique Federale de Lausanne; Swedish Research Council; National Institutes of Health [NS060885, NS062165, NS03877]; NATIONAL CANCER INSTITUTE [ZICBC010903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS060885, R21NS062165] Funding Source: NIH RePORTER	National Parkinson Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Parkinson Schweiz; American Parkinson Disease Association; Ecole Polytechnique Federale de Lausanne; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Parkinson Foundation (D.J.M., V. L. D.); Swiss National Science Foundation (grant no. 310030_127478 to D.J.M.); Parkinson Schweiz (D.J.M.); American Parkinson Disease Association (D.J.M.); Ecole Polytechnique Federale de Lausanne (D.J.M.); Swedish Research Council (D.G.); and the National Institutes of Health (grant no. NS060885 and NS062165 to B. T., and NS03877 to T. M. D. and V. L. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Geyer MA, 2006, NEUROTOX RES, V10, P211, DOI 10.1007/BF03033358; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Haugarvoll K, 2006, CURR NEUROL NEUROSCI, V6, P287, DOI 10.1007/s11910-006-0020-0; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Higashi S, 2007, BRAIN RES, V1155, P208, DOI 10.1016/j.brainres.2007.04.034; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Marin I, 2006, MOL BIOL EVOL, V23, P2423, DOI 10.1093/molbev/msl114; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Moore DJ, 2008, CURR NEUROL NEUROSCI, V8, P288, DOI 10.1007/s11910-008-0045-7; Moore Darren J, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS92, DOI 10.1016/j.parkreldis.2008.04.010; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wang CY, 2005, J GENE MED, V7, P945, DOI 10.1002/jgm.742; Wang DL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-3; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	61	289	292	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18568	10.1371/journal.pone.0018568	http://dx.doi.org/10.1371/journal.pone.0018568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494637	Green Published, Green Submitted, gold			2022-12-27	WOS:000289192400039
J	Jang, Y; Waterworth, D; Lee, JE; Song, K; Kim, S; Kim, HS; Park, KW; Cho, HJ; Oh, IY; Park, JE; Lee, BS; Ku, HJ; Shin, DJ; Lee, JH; Jee, SH; Han, BG; Jang, HY; Cho, EY; Vallance, P; Whittaker, J; Cardon, L; Mooser, V				Jang, Yangsoo; Waterworth, Dawn; Lee, Jong-Eun; Song, Kijoung; Kim, Sujin; Kim, Hyo-Soo; Park, Kyung Woo; Cho, Hyun-Jai; Oh, Il-Young; Park, Jeong Euy; Lee, Bok-Soo; Ku, Hyo Jeong; Shin, Dong-Jik; Lee, Jong Ho; Jee, Sun Ha; Han, Bok-Ghee; Jang, Hye-Yoon; Cho, Eun-Young; Vallance, Patrick; Whittaker, John; Cardon, Lon; Mooser, Vincent			Carriage of the V279F Null Allele within the Gene Encoding Lp-PLA(2) Is Protective from Coronary Artery Disease in South Korean Males	PLOS ONE			English	Article							FACTOR ACETYLHYDROLASE DEFICIENCY; PHOSPHOLIPASE A(2) ACTIVITY; HEART-DISEASE; CHROMOSOME 9P21; MISSENSE MUTATION; CARDIOVASCULAR-DISEASE; PAF ACETYLHYDROLASE; QUANTITATIVE TRAITS; JAPANESE POPULATION; ASSOCIATION	Background: The Asia-specific PLA2G7 994G-T transversion leads to V279F substitution within the lipoprotein-associated phospholipase-A2 (Lp-PLA(2)) and to absence of enzyme activity in plasma. This variant offers a unique natural experiment to assess the role of Lp-PLA(2) in the pathogenesis of coronary artery disease (CAD) in humans. Given conflicting results from mostly small studies, a large two-stage case-control study was warranted. Methodology/Principal Findings: PLA2G7 V279F genotypes were initially compared in 2890 male cases diagnosed with CAD before age 60 with 3128 male controls without CAD at age 50 and above and subsequently in a second independent male dataset of 877 CAD cases and 1230 controls. In the first dataset, the prevalence of the 279F null allele was 11.5% in cases and 12.8% in controls. After adjustment for age, body mass index, diabetes, smoking, glucose and lipid levels, the OR (95% CI) for CAD for this allele was 0.80 (0.66-0.97, p = 0.02). The results were very similar in the second dataset, despite lower power, with an allele frequency of 11.2% in cases and 12.5% in controls, leading to a combined OR of 0.80 (0.69-0.92), p = 0.002. The magnitude and direction of this genetic effect were fully consistent with large epidemiological studies on plasma Lp-PLA(2) activity and CAD risk. Conclusions: Natural deficiency in Lp-PLA(2) activity due to carriage of PLA2G7 279F allele protects from CAD in Korean men. These results provide evidence for a causal relationship between Lp-PLA(2) and CAD, and support pharmacological inhibition of this enzyme as an innovative way to prevent CAD.	[Jang, Yangsoo; Shin, Dong-Jik] Yonsei Univ, Coll Med, Cardiovasc Genome Ctr, Div Cardiol, Yonsei, South Korea; [Waterworth, Dawn; Song, Kijoung; Whittaker, John; Cardon, Lon; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, Med Discovery & Dev, Res & Dev, Philadelphia, PA USA; [Waterworth, Dawn; Song, Kijoung; Whittaker, John; Cardon, Lon; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, Med Discovery & Dev, Res & Dev, Greenford, Middx, England; [Lee, Jong-Eun; Kim, Sujin; Jang, Hye-Yoon; Cho, Eun-Young] DNA Link Inc, Seoul, South Korea; [Kim, Hyo-Soo; Park, Kyung Woo; Cho, Hyun-Jai; Oh, Il-Young] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Kim, Hyo-Soo; Park, Kyung Woo; Cho, Hyun-Jai; Oh, Il-Young] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea; [Park, Jeong Euy; Lee, Bok-Soo; Ku, Hyo Jeong] Sungkyunkwan Univ, Samsung Med Ctr, Div Cardiovasc Dis, Seoul, South Korea; [Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Han, Bok-Ghee] Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; GlaxoSmithKline; GlaxoSmithKline; DNA Link, Inc.; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Jang, Y (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Genome Ctr, Div Cardiol, Yonsei, South Korea.	Dawn.M.Waterworth@gsk.com	Park, Kyung Woo/AAX-3046-2020; Jang, Yang Soo/D-4803-2012; Kim, Hyo Soo/J-2753-2012; Whittaker, John C/B-8609-2012	Whittaker, John C/0000-0002-3529-2379; Jee, Sun Ha/0000-0001-9519-3068; Jang, Yangsoo/0000-0002-2169-3112	Ministry of Health and Welfare, Republic of Korea [A050558]; GlaxoSmithKline	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); GlaxoSmithKline(GlaxoSmithKline)	This work was funded in part by a grant (A050558 to J.E. Lee) from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea. The present study was also sponsored in part by GlaxoSmithKline which funded genotyping of the samples. Scientists at GlaxoSmithKline and DNA Link, Inc. designed together the study, performed collaboratively the analysis and were involved in the interpretation of the data. GlaxoSmithKline scientists wrote the first draft of the manuscript. Decision to submit the manuscript for publication was made collaboratively. Samples were stored and genotyped at DNA Link, Inc. in Seoul, South Korea.	Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Balta G, 2001, THROMB RES, V101, P231, DOI 10.1016/S0049-3848(00)00394-7; Casas JP, 2010, CIRCULATION, V121, P2284, DOI 10.1161/CIRCULATIONAHA.109.923383; Cha SH, 2007, CLIN CHIM ACTA, V382, P129, DOI 10.1016/j.cca.2007.03.017; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Hou LP, 2009, HUM GENET, V125, P11, DOI 10.1007/s00439-008-0587-4; Jang Y, 2006, J CLIN ENDOCR METAB, V91, P3521, DOI 10.1210/jc.2006-0116; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Orwin R.G., 1994, HDB RES SYNTHESIS; Packard CJ, 2009, CURR OPIN CARDIOL, V24, P358, DOI 10.1097/HCO.0b013e32832bcb22; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Park KW, 2003, J BIOCHEM MOL BIOL, V36, P237; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shimokata K, 2004, ATHEROSCLEROSIS, V172, P167, DOI 10.1016/j.atherosclerosis.2003.09.019; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Unno N, 2002, ANN SURG, V235, P297, DOI 10.1097/00000658-200202000-00020; Wang T, 2009, AM J HYPERTENS, V22, P742, DOI 10.1038/ajh.2009.70; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; Yamada Y, 2000, ATHEROSCLEROSIS, V150, P209, DOI 10.1016/S0021-9150(99)00385-8; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yoon SJ, 2008, METABOLISM, V57, P853, DOI 10.1016/j.metabol.2008.01.031; Zhang SY, 2007, HYPERTENS RES, V30, P403, DOI 10.1291/hypres.30.403; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	36	34	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18208	10.1371/journal.pone.0018208	http://dx.doi.org/10.1371/journal.pone.0018208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21490708	Green Published, Green Submitted, gold			2022-12-27	WOS:000289191300011
J	Liu, Z; Luo, WR; Zhou, Y; Zhen, Y; Yang, HL; Yu, XL; Ye, YF; Li, X; Wang, H; Jiang, QP; Zhang, YJ; Yao, KT; Fang, WY				Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yang, Huiling; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Jiang, Qinping; Zhang, Yajie; Yao, Kaitai; Fang, Weiyi			Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							EXPRESSION; GROWTH; PROLIFERATION; KINASE; ATF-2; CELLS; GENE	Background: Recently we identified nasopharyngeal epithelium specific protein 1 (NESG1) as a potential tumor suppressor in nasopharyngeal carcinoma (NPC). The purpose of this study is to investigate the involvement of NESG1 in tumor progression and prognosis of human NPC. Methodology/Principal Findings: NESG1 protein expression in NPC was examined. Survival analysis was performed using Kaplan-Meier method. The effect of NESG1 on cell proliferation, migration, and invasion were also investigated. Results: NESG1 expression was downregulated in atypical hyperplasia and NPC samples compared to normal and squamous nasopharynx tissues. Reduced protein expression was negatively associated with the status of NPC progression. Patients with lower NESG1 expression had a shorter overall survival and disease-free time than did patients with higher NESG1 expression. Multivariate analysis suggested NESG1 expression as an independent prognostic indicator for NPC patient survival. Proliferation, migration, and invasion ability were significantly increased in cell lines following lentiviral-mediated shRNA suppression of NESG1 expression. Microarray analysis indicated that NESG1 participated in multiple pathways, including MAPK signaling and cell cycle regulation. Finally, DNA methylation microarray examination revealed a lack of hypermethylation at the NESG1 promoter, suggesting other mechanisms are involved in suppressing NESG1 expression in NPC. Conclusion: Our studies are the first to demonstrate that decreased NESG1 expression is an unfavorable prognostic factor for NPC.	[Liu, Zhen; Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Yao, Kaitai; Fang, Weiyi] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Luo, Weiren] Guangdong Med Coll, Dept Pathol, Dongguan, Peoples R China; [Jiang, Qinping] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Yang, Huiling] Guangdong Med Coll, Sch Pharm, Dongguan, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Guangdong Medical University; Guangzhou Medical University; Guangdong Medical University	Liu, Z (corresponding author), Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China.	fangweiyi1975@yahoo.com.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Nature Science Fund of China [81071632, 30870973]; Natural Science Fund of Guangdong Province [8451051501000314]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Nature Science Fund of China (NO. 81071632 and NO. 30870973)(http://www.nsfc.gov.cn), Natural Science Fund of Guangdong Province (NO. 8451051501000314) (http://www.gdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010493; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dong WJ, 2010, INT J CANCER, V127, P1526, DOI 10.1002/ijc.25161; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Johansen C, 2009, CARCINOGENESIS, V30, P2100, DOI 10.1093/carcin/bgp238; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Knippen S, 2009, ANTICANCER RES, V29, P183; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Li ZK, 1999, GENE, V237, P235, DOI 10.1016/S0378-1119(99)00234-6; Liu Z, 2011, INT J CANCER, V128, P2562, DOI 10.1002/ijc.25595; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Modi H, 2011, LEUKEMIA, V25, P305, DOI 10.1038/leu.2010.257; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Ungefroren H, 2007, INT J CANCER, V120, P1641, DOI 10.1002/ijc.22393; Wang SA, 2011, HISTOPATHOLOGY, V58, P217, DOI 10.1111/j.1365-2559.2010.03739.x; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	31	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27887	10.1371/journal.pone.0027887	http://dx.doi.org/10.1371/journal.pone.0027887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140479	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163400020
J	Perrin, RJ; Craig-Schapiro, R; Malone, JP; Shah, AR; Gilmore, P; Davis, AE; Roe, CM; Peskind, ER; Li, G; Galasko, DR; Clark, CM; Quinn, JF; Kaye, JA; Morris, JC; Holtzman, DM; Townsend, RR; Fagan, AM				Perrin, Richard J.; Craig-Schapiro, Rebecca; Malone, James P.; Shah, Aarti R.; Gilmore, Petra; Davis, Alan E.; Roe, Catherine M.; Peskind, Elaine R.; Li, Ge; Galasko, Douglas R.; Clark, Christopher M.; Quinn, Joseph F.; Kaye, Jeffrey A.; Morris, John C.; Holtzman, David M.; Townsend, R. Reid; Fagan, Anne M.			Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EPITHELIUM-DERIVED FACTOR; CELL-ADHESION MOLECULE; AMYLOID-BETA-PROTEIN; IMMUNODEFICIENCY-VIRUS ENCEPHALITIS; FRONTOTEMPORAL LOBAR DEGENERATION; SECRETORY GRANULE MEMBRANE; CEREBRAL-ARTERY OCCLUSION; GENOME-WIDE ASSOCIATION; CARBONIC-ANHYDRASE-IV	Background: Ideally, disease modifying therapies for Alzheimer disease (AD) will be applied during the 'preclinical' stage (pathology present with cognition intact) before severe neuronal damage occurs, or upon recognizing very mild cognitive impairment. Developing and judiciously administering such therapies will require biomarker panels to identify early AD pathology, classify disease stage, monitor pathological progression, and predict cognitive decline. To discover such biomarkers, we measured AD-associated changes in the cerebrospinal fluid (CSF) proteome. Methods and Findings: CSF samples from individuals with mild AD (Clinical Dementia Rating [CDR] 1) (n = 24) and cognitively normal controls (CDR 0) (n = 24) were subjected to two-dimensional difference-in-gel electrophoresis. Within 119 differentially-abundant gel features, mass spectrometry (LC-MS/MS) identified 47 proteins. For validation, eleven proteins were re-evaluated by enzyme-linked immunosorbent assays (ELISA). Six of these assays (NrCAM, YKL-40, chromogranin A, carnosinase I, transthyretin, cystatin C) distinguished CDR 1 and CDR 0 groups and were subsequently applied (with tau, p-tau181 and A beta 42 ELISAs) to a larger independent cohort (n = 292) that included individuals with very mild dementia (CDR 0.5). Receiver-operating characteristic curve analyses using stepwise logistic regression yielded optimal biomarker combinations to distinguish CDR 0 from CDR. 0 (tau, YKL-40, NrCAM) and CDR 1 from CDR, 1 (tau, chromogranin A, carnosinase I) with areas under the curve of 0.90 (0.85-0.94 95% confidence interval [CI]) and 0.88 (0.81-0.94 CI), respectively. Conclusions: Four novel CSF biomarkers for AD (NrCAM, YKL-40, chromogranin A, carnosinase I) can improve the diagnostic accuracy of A beta 42 and tau. Together, these six markers describe six clinicopathological stages from cognitive normalcy to mild dementia, including stages defined by increased risk of cognitive decline. Such a panel might improve clinical trial efficiency by guiding subject enrollment and monitoring disease progression. Further studies will be required to validate this panel and evaluate its potential for distinguishing AD from other dementing conditions.	[Perrin, Richard J.] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA; [Perrin, Richard J.; Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Perrin, Richard J.; Roe, Catherine M.; Morris, John C.; Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA; [Craig-Schapiro, Rebecca; Shah, Aarti R.; Roe, Catherine M.; Morris, John C.; Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Div Metab, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Prote Ctr, St Louis, MO USA; [Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Peskind, Elaine R.] Univ Washington, Sch Med, Dept Vet Affairs, NW Network,Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Peskind, Elaine R.; Li, Ge] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Galasko, Douglas R.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Clark, Christopher M.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Clark, Christopher M.] Univ Penn, Rush Alzheimers Dis Ctr, Philadelphia, PA 19104 USA; [Clark, Christopher M.] Avid Radiopharmaceut, Philadelphia, PA USA; [Quinn, Joseph F.; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Layton Aging & Alzheimers Dis Ctr, Portland, OR USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Pennsylvania; University of Pennsylvania; Oregon Health & Science University	Perrin, RJ (corresponding author), Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA.	rperrin@path.wustl.edu	Morris, John C/A-1686-2012	Roe, Catherine/0000-0002-1405-0485; Kaye, Jeffrey/0000-0002-9971-3478; Misko, Thomas/0000-0001-7917-422X; Quinn, Joseph/0000-0001-7305-2256; Kuhn, Max/0000-0003-2402-136X	National Alzheimer's Coordinating Center (NACC) [U01 AG16976, P50 AG05681, P01 AG026276, P50 AG05136, P01 AG03991, P30 NS057105, UL1 RR024992]; W.M. Keck Foundation [P41 RR00954]; Dept. of Veterans Affairs [AG020020, AG23185, AG08017, AG10124, T32 NS007205]; Charles and Joanne Knight Alzheimer Research Initiative; Avid Radiopharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007205, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P50AG005681, P30AG008017, P50AG005136, P01AG026276, R01AG023185, K23AG020020, P01AG003991, U01AG016976] Funding Source: NIH RePORTER	National Alzheimer's Coordinating Center (NACC); W.M. Keck Foundation(W.M. Keck Foundation); Dept. of Veterans Affairs(US Department of Veterans Affairs); Charles and Joanne Knight Alzheimer Research Initiative; Avid Radiopharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Alzheimer's Coordinating Center (NACC) Grant U01 AG16976 (A.M.F.); P50 AG05681 (C.M.R., E.A.G.); P01 AG026276 (C.M.R., E.A.G.); P50 AG05136; P01 AG03991(J.C.M.); P30 NS057105 (D.M.H.); UL1 RR024992 (R.R.T.; C.M.R.); W.M. Keck Foundation (R.R.T.); P41 RR00954 (R.R.T); Dept. of Veterans Affairs (E.R.P.); AG020020 (G.L.); AG23185 (D.R.G.); AG08017 (J.F.Q.); AG08017 (J.A.K.); AG10124 (C.M.C); T32 NS007205 (R.J.P.); and the Charles and Joanne Knight Alzheimer Research Initiative (A.M.F.); Avid Radiopharmaceuticals (C.M.C., employment unrelated to this study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Abraham CR, 2000, ANN NY ACAD SCI, V920, P245; Aisa B, 2010, J ALZHEIMERS DIS, V20, P659, DOI 10.3233/JAD-2010-1398; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alder J, 2003, J NEUROSCI, V23, P10800; Antequera D, 2009, NEUROBIOL DIS, V36, P42, DOI 10.1016/j.nbd.2009.06.018; Arun P, 2009, NEUROCHEM INT, V55, P219, DOI 10.1016/j.neuint.2009.03.003; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Bergamaschini L, 2001, MECH AGEING DEV, V122, P1971, DOI 10.1016/S0047-6374(01)00311-6; BERGGARD I, 1968, J BIOL CHEM, V243, P4095; Bian H, 2008, NEUROLOGY, V70, P1827, DOI 10.1212/01.wnl.0000311445.21321.fc; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Biroccio A, 2006, PROTEOMICS, V6, P2305, DOI 10.1002/pmic.200500285; BLENNOW K, 1995, DEMENTIA, V6, P306, DOI 10.1159/000106963; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Castellani RJ, 1999, FREE RADICAL BIO MED, V26, P1508, DOI 10.1016/S0891-5849(99)00016-7; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Choi-Miura N.-H., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P239, DOI 10.2174/1568016043356327; Choi-Miura NH, 2000, INFLAMM RES, V49, P305, DOI 10.1007/PL00000211; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Costa R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002899; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; D'Aniello A, 2005, NEUROSCI LETT, V388, P49, DOI 10.1016/j.neulet.2005.06.030; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Eder U, 1998, J NEURAL TRANSM, V105, P39, DOI 10.1007/s007020050036; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Finehout EJ, 2005, DIS MARKERS, V21, P93, DOI 10.1155/2005/806573; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Gao J, 2008, BBA-BIOMEMBRANES, V1778, P1429, DOI 10.1016/j.bbamem.2008.03.013; Gasser MC, 2003, J NEUROCHEM, V85, P662, DOI 10.1046/j.1471-4159.2003.01677.x; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Gunzburg MJ, 2007, J BIOL CHEM, V282, P35831, DOI 10.1074/jbc.M706425200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; HARIGAYA Y, 1995, INTERNAL MED, V34, P481, DOI 10.2169/internalmedicine.34.481; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harr SD, 1996, J NEUROCHEM, V66, P2429; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2010, ENDOCR J, V57, P275, DOI 10.1507/endocrj.K10E-038; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; HOULDEN H, 1995, NEUROSCI LETT, V188, P202, DOI 10.1016/0304-3940(95)11422-S; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Ji LN, 2009, J ALZHEIMERS DIS, V18, P105, DOI 10.3233/JAD-2009-1127; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kaneko K, 2002, J NEUROPATH EXP NEUR, V61, P1069, DOI 10.1093/jnen/61.12.1069; Kapaki E, 2008, ALZ DIS ASSOC DIS, V22, P47, DOI 10.1097/WAD.0b013e3181610fea; KATZAV A, 2009, NEUROBIOL AGING; Kaufmann WA, 1998, EUR J NEUROSCI, V10, P1084, DOI 10.1046/j.1460-9568.1998.00121.x; Kaynar MY, 2005, J CLIN NEUROSCI, V12, P754, DOI 10.1016/j.jocn.2005.06.001; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kessler H, 2006, J NEURAL TRANSM, V113, P1763, DOI 10.1007/s00702-006-0485-7; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Koch S, 2001, J LIPID RES, V42, P1143; Kolson DL, 2008, AM J PATHOL, V173, P25, DOI 10.2353/ajpath.2008.080389; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; Kubota K, 2009, J NEUROCHEM, V110, P496, DOI 10.1111/j.1471-4159.2009.06099.x; Kuncl RW, 2002, J NEUROCHEM, V81, P178, DOI 10.1046/j.1471-4159.2002.00813.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LASSMANN H, 1992, NEUROSCIENCE, V46, P1, DOI 10.1016/0306-4522(92)90003-K; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Levin Edward D., 2005, Current Alzheimer Research, V2, P191; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Li L, 2008, CELL DEATH DIFFER, V15, P879, DOI 10.1038/cdd.2008.8; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; LOB HE, HYPERTENSION, V55, P283; Lob HE, 2010, HYPERTENSION, V55, P277, DOI 10.1161/HYPERTENSIONAHA.109.142646; Loeffler DA, 2004, NEUROBIOL AGING, V25, P1001, DOI 10.1016/j.neurobiolaging.2003.11.003; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Lovell MA, 2008, NEUROLOGY, V70, P2212, DOI 10.1212/01.wnl.0000312383.39973.88; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; MASAKI T, 1992, J BIOCHEM-TOKYO, V111, P573, DOI 10.1093/oxfordjournals.jbchem.a123799; Massaro AR, 2009, EUR REV MED PHARMACO, V13, P397; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Misasi Roberta, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P119; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Montine TJ, 1997, AM J PATHOL, V151, P1571; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Narita M, 1997, J NEUROCHEM, V69, P1904; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Okii N, 2007, ACTA HISTOCHEM CYTOC, V40, P113, DOI 10.1267/ahc.07011; Ostergaard C, 2002, CLIN DIAGN LAB IMMUN, V9, P598, DOI 10.1128/CDLI.9.3.598-604.2002; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Paco S, 2010, CEREB CORTEX, V20, P1386, DOI 10.1093/cercor/bhp202; PALMER RH, 1995, BIOCHEM J, V309, P315, DOI 10.1042/bj3090315; Pan S, 2008, J PROTEOME RES, V7, P720, DOI 10.1021/pr700630x; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; PERARNAU B, 1990, NATURE, V346, P751, DOI 10.1038/346751a0; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Puche AC, 1997, NEUROREPORT, V8, P3183, DOI 10.1097/00001756-199710200-00001; Ray I, 2000, BRAIN RES, V853, P344, DOI 10.1016/S0006-8993(99)02315-X; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Riemenschneider M, 1998, LANCET, V351, P63, DOI 10.1016/S0140-6736(05)78060-0; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Sanagi T, 2005, NEUROSCI LETT, V380, P105, DOI 10.1016/j.neulet.2005.01.035; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; SCHMIDBAUER JM, 1990, HISTOCHEMISTRY, V94, P427; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; SCHWEDEN J, 1989, BIOCHEM J, V264, P347, DOI 10.1042/bj2640347; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Simonsen AH, 2008, NEUROBIOL AGING, V29, P961, DOI 10.1016/j.neurobiolaging.2007.01.011; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Squitti R, 2009, NEUROLOGY, V72, P50, DOI 10.1212/01.wnl.0000338568.28960.3f; Squitti R, 2008, PRION, V2, P23, DOI 10.4161/pri.2.1.6297; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Steur EJ, 1998, LANCET, V351, P1105, DOI 10.1016/S0140-6736(05)79387-9; Stoltzner SE, 2000, AM J PATHOL, V156, P489, DOI 10.1016/S0002-9440(10)64753-0; Storan MJ, 2004, J COMP NEUROL, V475, P289, DOI 10.1002/cne.20167; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; Svichar N, 2009, J NEUROSCI, V29, P3252, DOI 10.1523/JNEUROSCI.0036-09.2009; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Takanohashi A, 2005, GLIA, V51, P266, DOI 10.1002/glia.20203; Tapiola T, 1998, LANCET, V352, P287, DOI 10.1016/S0140-6736(05)60260-7; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Todaro L, 2004, NEUROBIOL DIS, V15, P387, DOI 10.1016/j.nbd.2003.11.014; Tolboom N, 2009, J NUCL MED, V50, P1464, DOI 10.2967/jnumed.109.064360; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Ueyama T, 2001, J NEUROCHEM, V79, P903, DOI 10.1046/j.1471-4159.2001.00624.x; UMEZAWA Y, 1991, JPN J CLIN ONCOL, V21, P251; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593; Vukovic J, 2009, MATRIX BIOL, V28, P406, DOI 10.1016/j.matbio.2009.06.001; Wati H, 2009, BRAIN PATHOL, V19, P48, DOI 10.1111/j.1750-3639.2008.00166.x; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Woronowicz A, 2010, J NEUROSCI RES, V88, P64, DOI 10.1002/jnr.22174; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; WURDIG S, 1991, NEUROSCI LETT, V130, P165, DOI 10.1016/0304-3940(91)90388-A; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; Yamagishi S, 2004, MED HYPOTHESES, V63, P115, DOI 10.1016/j.mehy.2004.02.022; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236; Zhu XM, 2005, J NEUROCHEM, V95, P1351, DOI 10.1111/j.1471-4159.2005.03460.x; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	230	155	162	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16032	10.1371/journal.pone.0016032	http://dx.doi.org/10.1371/journal.pone.0016032			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264269	gold, Green Published, Green Submitted			2022-12-27	WOS:000286514300004
J	Liu, ZX; Cao, J; Gao, XJ; Ma, Q; Ren, J; Xue, Y				Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian; Ren, Jian; Xue, Yu			GPS-CCD: A Novel Computational Program for the Prediction of Calpain Cleavage Sites	PLOS ONE			English	Article							PHOSPHORYLATION SITES; MEDIATED CLEAVAGE; PEPTIDE LIBRARY; PROTEIN; DATABASE; IDENTIFICATION; APOPTOSIS; SUBSTRATE; AUTOPHAGY; PATHWAY	As one of the most essential post-translational modifications (PTMs) of proteins, proteolysis, especially calpain-mediated cleavage, plays an important role in many biological processes, including cell death/apoptosis, cytoskeletal remodeling, and the cell cycle. Experimental identification of calpain targets with bona fide cleavage sites is fundamental for dissecting the molecular mechanisms and biological roles of calpain cleavage. In contrast to time-consuming and labor-intensive experimental approaches, computational prediction of calpain cleavage sites might more cheaply and readily provide useful information for further experimental investigation. In this work, we constructed a novel software package of GPS-CCD (Calpain Cleavage Detector) for the prediction of calpain cleavage sites, with an accuracy of 89.98%, sensitivity of 60.87% and specificity of 90.07%. With this software, we annotated potential calpain cleavage sites for hundreds of calpain substrates, for which the exact cleavage sites had not been previously determined. In this regard, GPS-CCD 1.0 is considered to be a useful tool for experimentalists. The online service and local packages of GPS-CCD 1.0 were implemented in JAVA and are freely available at: http://ccd.biocuckoo.org/.	[Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Liu, Zexian; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Syst Biol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology; Sun Yat Sen University	Liu, ZX (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	renjian.sysu@gmail.com; xueyu@mail.hust.edu.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Basic Research Program (973 project) [2010CB945400, 2011CB910400]; National Natural Science Foundation of China [90919001, 31071154, 30900835, 30830036, 91019020, 21075045]; Fundamental Research Funds for the Central Universities [HUST: 2010JC049, 2010ZD018, SYSU: 11lgzd11, 11lgjc09]	National Basic Research Program (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program (973 project) (2010CB945400, 2011CB910400), National Natural Science Foundation of China (90919001, 31071154, 30900835, 30830036, 91019020, 21075045), and Fundamental Research Funds for the Central Universities (HUST: 2010JC049, 2010ZD018; SYSU: 11lgzd11, 11lgjc09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Boyd SE, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P372; Chen Q, 2006, J NEUROCHEM, V99, P1133, DOI 10.1111/j.1471-4159.2006.04160.x; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; duVerle David, 2010, V22, P202; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Rawlings ND, 2009, LARGE ACCURATE COLLE; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhou FF, 2005, FEBS LETT, V579, P3369, DOI 10.1016/j.febslet.2005.04.076	37	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19001	10.1371/journal.pone.0019001	http://dx.doi.org/10.1371/journal.pone.0019001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	22140479	Green Published, gold, Green Submitted			2022-12-27	WOS:000289719400047
J	Michalik, P; Rittschof, CC				Michalik, Peter; Rittschof, Clare C.			A Comparative Analysis of the Morphology and Evolution of Permanent Sperm Depletion in Spiders	PLOS ONE			English	Article							ORB-WEAVING SPIDER; NEPHILA PLUMIPES ARANEOIDEA; ARGIOPE-BRUENNICHI ARANEAE; MALE COPULATION FREQUENCY; SEXUAL CANNIBALISM; WEB SPIDER; MATING-BEHAVIOR; CLAVIPES ARANEAE; SIZE DIMORPHISM; NATURAL-HISTORY	Once thought to be energetically cheap and easy to produce, empirical work has shown that sperm is a costly and limited resource for males. In some spider species, there is behavioral evidence that sperm are permanently depleted after a single mating. This extreme degree of mating investment appears to co-occur with other reproductive strategies common to spiders, e. g. genital mutilation and sexual cannibalism. Here we corroborate that sperm depletion in the golden orb-web spider Nephila clavipes is permanent by uncovering its mechanistic basis using light and electron microscopy. In addition, we use a phylogeny-based statistical analysis to test the evolutionary relationships between permanent sperm depletion (PSD) and other reproductive strategies in spiders. Male testes do not produce sperm during adulthood, which is unusual in spiders. Instead, spermatogenesis is nearly synchronous and ends before the maturation molt. Testis size decreases as males approach their maturation molt and reaches its lowest point after sperm is transferred into the male copulatory organs (pedipalps). As a consequence, the amount of sperm available to males for mating is limited to the sperm contained in the pedipalps, and once it is used, males lose their ability to fertilize eggs. Our data suggest that PSD has evolved independently at least three times within web-building spiders and is significantly correlated with the evolution of other mating strategies that limit males to monogamy, including genital mutilation and sexual cannibalism. We conclude that PSD may be an energy-saving adaptation in species where males are limited to monogamy. This could be particularly important in web-building spiders where extreme sexual size dimorphism results in large, sedentary females and small, searching males who rarely feed as adults and are vulnerable to starvation. Future work will explore possible energetic benefits and the evolutionary lability of PSD relative to other mate-limiting reproductive behaviors.	[Michalik, Peter] Ernst Moritz Arndt Univ Greifswald, Zoolog Inst & Museum, Greifswald, Germany; [Michalik, Peter] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Rittschof, Clare C.] Univ Florida, Dept Biol, Gainesville, FL USA	Ernst Moritz Arndt Universitat Greifswald; American Museum of Natural History (AMNH); State University System of Florida; University of Florida	Michalik, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zoolog Inst & Museum, Greifswald, Germany.	michalik@uni-greifswald.de	Michalik, Peter/E-6757-2010	Michalik, Peter/0000-0003-2459-9153	NSF-DDIG [IOS-0909367]; University of Greifswald	NSF-DDIG(National Science Foundation (NSF)); University of Greifswald	NSF-DDIG Grant No. IOS-0909367. Travel grant by the University of Greifswald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI G, 1990, ACTA ZOOL FENN, V190, P17; Andrade MCB, 2005, INTEGR COMP BIOL, V45, P838, DOI 10.1093/icb/45.5.838; Andrade MCB, 2002, ANIM BEHAV, V63, P857, DOI 10.1006/anbe.2002.2003; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Bateman PW, 2001, ETHOLOGY, V107, P1087, DOI 10.1046/j.1439-0310.2001.00756.x; Boivin G, 2005, OECOLOGIA, V143, P198, DOI 10.1007/s00442-004-1800-3; Bukowski TC, 2001, ANIM BEHAV, V62, P887, DOI 10.1006/anbe.2001.1834; Bukowski TC, 1997, J ARACHNOL, V25, P307; CHRISTENSON T, 1989, J ARACHNOL, V17, P115; CHRISTENSON TE, 1979, BEHAV ECOL SOCIOBIOL, V5, P87, DOI 10.1007/BF00302697; CHRISTENSON TE, 1985, J COMP PSYCHOL, V99, P160, DOI 10.1037/0735-7036.99.2.160; CHRISTENSON TE, 1988, J COMP PSYCHOL, V102, P312, DOI 10.1037/0735-7036.102.4.312; Coddington JA, 1997, NATURE, V385, P687, DOI 10.1038/385687a0; Corcobado G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-236; Costa FG, 1998, J ARACHNOL, V26, P106; Danielson-Francois AM, 2006, J ARACHNOL, V34, P387, DOI 10.1636/S04-46.1; Danielson-Francois AM, 2005, J INSECT BEHAV, V18, P131, DOI 10.1007/s10905-005-9352-x; DEWSBURY DA, 1983, J COMP PSYCHOL, V97, P34, DOI 10.1037/0735-7036.97.1.34; Eberhard WG, 2004, J ARACHNOL, V32, P545, DOI 10.1636/0161-8202(2004)032[0545:WSSSST]2.0.CO;2; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Engqvist L, 2006, J EVOLUTION BIOL, V19, P1448, DOI 10.1111/j.1420-9101.2006.01134.x; Foelix R., 2011, BIOL SPIDERS, V3; Foellmer MW, 2004, EVOL ECOL RES, V6, P163; FOELLMER MW, 2003, P ROYAL SOC LONDON B; FORSTER LM, 1992, AUST J ZOOL, V40, P1, DOI 10.1071/ZO9920001; Fromhage L, 2003, BEHAV ECOL SOCIOBIOL, V55, P60, DOI 10.1007/s00265-003-0656-6; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2005, EVOLUTION, V59, P1400; GAGE MJG, 1994, FUNCT ECOL, V8, P594, DOI 10.2307/2389920; Herberstein ME, 2005, ETHOLOGY, V111, P1050, DOI 10.1111/j.1439-0310.2005.01114.x; Herberstein ME, 2002, BEHAV ECOL SOCIOBIOL, V51, P440, DOI 10.1007/s00265-002-0460-8; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; HUBER BA, 1995, J ZOOL, V235, P689, DOI 10.1111/j.1469-7998.1995.tb01778.x; Huber Bernhard A., 1998, Bulletin of the British Arachnological Society, V11, P81; Knoflach B, 2000, J NAT HIST, V34, P1639, DOI 10.1080/00222930050117530; Knoflach B, 2001, J ZOOL, V254, P449, DOI 10.1017/S0952836901000954; Knoflach B., 2004, Denisia, P161; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, 2009, J ARACHNOL, V37, P266, DOI 10.1636/St08-67.1; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lemaitre JF, 2009, ANIM BEHAV, V77, P49, DOI 10.1016/j.anbehav.2008.08.028; Linn CD, 2007, ANIM BEHAV, V74, P481, DOI 10.1016/j.anbehav.2007.02.004; MADDISON WP, 1990, EVOLUTION, V44, P539, DOI 10.2307/2409434; MADDISON WP, 2000, MACCLADE VERSION 4; MADDISON WP, 2010, MESQUITE; Michalik P, 2006, ZOOLOGY, V109, P14, DOI 10.1016/j.zool.2005.09.010; Michalik P, 2006, J MORPHOL, V267, P129, DOI 10.1002/jmor.10226; MICHALIK P, 2006, THESIS ERNST MORITZ; Michalik Peter, 2005, Front Zool, V2, P12, DOI 10.1186/1742-9994-2-12; Michalik P, 2010, AM MUS NOVIT, P1, DOI 10.1206/680.1; Michalik Peter, 2009, Contributions to Natural History (Bern), V12, P959; Michalik P, 2010, TISSUE CELL, V42, P32, DOI 10.1016/j.tice.2009.06.004; Miller JA, 2007, EVOLUTION, V61, P1301, DOI 10.1111/j.1558-5646.2007.00115.x; Molina Y, 2008, ANIM BEHAV, V76, P1327, DOI 10.1016/j.anbehav.2008.04.021; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MYERS L, 1988, J ARACHNOL, V16, P254; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Nessler SH, 2007, P R SOC B, V274, P2337, DOI 10.1098/rspb.2007.0585; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler S, 2009, BEHAV ECOL SOCIOBIOL, V63, P355, DOI 10.1007/s00265-008-0669-2; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Radhakrishnan P, 2009, ANIM BEHAV, V78, P839, DOI 10.1016/j.anbehav.2009.07.002; Ramos M, 2004, P NATL ACAD SCI USA, V101, P4883, DOI 10.1073/pnas.0400324101; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Schneider JM, 2005, J ARACHNOL, V33, P663, DOI 10.1636/S03-32.1; Schneider JM, 2006, ANIM BEHAV, V71, P781, DOI 10.1016/j.anbehav.2005.05.012; Schneider JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P410, DOI 10.1007/s002650000307; Schneider JM, 2001, BEHAV ECOL, V12, P547, DOI 10.1093/beheco/12.5.547; Schneider JM, 2008, AUST J ZOOL, V56, P233, DOI 10.1071/ZO08041; SIMMONS LW, 1993, P ROY SOC B-BIOL SCI, V251, P183, DOI 10.1098/rspb.1993.0027; Smith C, 2009, ANIM BEHAV, V77, P1227, DOI 10.1016/j.anbehav.2009.01.027; Snow LSE, 2006, ETHOLOGY, V112, P379, DOI 10.1111/j.1439-0310.2006.01163.x; Snow LSE, 2004, BEHAV ECOL, V15, P785, DOI 10.1093/beheco/arh080; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stoltz JA, 2010, P ROY SOC B-BIOL SCI, V277, P585, DOI 10.1098/rspb.2009.1554; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	81	69	72	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16014	10.1371/journal.pone.0016014	http://dx.doi.org/10.1371/journal.pone.0016014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21525987	Green Submitted, Green Published, gold			2022-12-27	WOS:000286514000016
J	Campbell, MS; Mullins, JI; Hughes, JP; Celum, C; Wong, KG; Raugi, DN; Sorensen, S; Stoddard, JN; Zhao, H; Deng, WJ; Kahle, E; Panteleeff, D; Baeten, JM; McCutchan, FE; Albert, J; Leitner, T; Wald, A; Corey, L; Lingappa, JR				Campbell, Mary S.; Mullins, James I.; Hughes, James P.; Celum, Connie; Wong, Kim G.; Raugi, Dana N.; Sorensen, Stefanie; Stoddard, Julia N.; Zhao, Hong; Deng, Wenjie; Kahle, Erin; Panteleeff, Dana; Baeten, Jared M.; McCutchan, Francine E.; Albert, Jan; Leitner, Thomas; Wald, Anna; Corey, Lawrence; Lingappa, Jairam R.		Partners Prevention HSV HIV	Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HETEROSEXUAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; INFECTED INDIVIDUALS; SEQUENCE ALIGNMENT; WEB SERVER; VARIANTS; IDENTIFICATION; PROGRESSION; EVOLUTION	Background: Characterization of viruses in HIV-1 transmission pairs will help identify biological determinants of infectiousness and evaluate candidate interventions to reduce transmission. Although HIV-1 sequencing is frequently used to substantiate linkage between newly HIV-1 infected individuals and their sexual partners in epidemiologic and forensic studies, viral sequencing is seldom applied in HIV-1 prevention trials. The Partners in Prevention HSV/HIV Transmission Study (ClinicalTrials.gov #NCT00194519) was a prospective randomized placebo-controlled trial that enrolled serodiscordant heterosexual couples to determine the efficacy of genital herpes suppression in reducing HIV-1 transmission; as part of the study analysis, HIV-1 sequences were examined for genetic linkage between seroconverters and their enrolled partners. Methodology/Principal Findings: We obtained partial consensus HIV-1 env and gag sequences from blood plasma for 151 transmission pairs and performed deep sequencing of env in some cases. We analyzed sequences with phylogenetic techniques and developed a Bayesian algorithm to evaluate the probability of linkage. For linkage, we required monophyletic clustering between enrolled partners' sequences and a Bayesian posterior probability of >= 50%. Adjudicators classified each seroconversion, finding 108 (71.5%) linked, 40 (26.5%) unlinked, and 3 (2.0%) indeterminate transmissions, with linkage determined by consensus env sequencing in 91 (84%). Male seroconverters had a higher frequency of unlinked transmissions than female seroconverters. The likelihood of transmission from the enrolled partner was related to time on study, with increasing numbers of unlinked transmissions occurring after longer observation periods. Finally, baseline viral load was found to be significantly higher among linked transmitters. Conclusions/Significance: In this first use of HIV-1 sequencing to establish endpoints in a large clinical trial, more than one-fourth of transmissions were unlinked to the enrolled partner, illustrating the relevance of these methods in the design of future HIV-1 prevention trials in serodiscordant couples. A hierarchy of sequencing techniques, analysis methods, and expert adjudication contributed to the linkage determination process.	[Campbell, Mary S.; Mullins, James I.; Celum, Connie; Baeten, Jared M.; Wald, Anna; Corey, Lawrence; Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.; Wong, Kim G.; Raugi, Dana N.; Sorensen, Stefanie; Stoddard, Julia N.; Zhao, Hong; Deng, Wenjie] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.; Corey, Lawrence] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA USA; [Celum, Connie; Kahle, Erin; Panteleeff, Dana; Baeten, Jared M.; Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA; [McCutchan, Francine E.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Wald, Anna] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; [Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Inst, Vaccine & Infect Dis Div, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Campbell, MS (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	jmullins@uw.edu	Corey, Lawrence/AAE-1796-2020; Lingappa, Jairam/N-7760-2017; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Campbell, Matthew/0000-0002-4469-5209; Were, Edwin/0000-0002-4783-0795; Kapiga, Saidi/0000-0003-1753-4060; , Erin/0000-0001-6060-9852	Bill and Melinda Gates Foundation [26469]; University of Washington Center for AIDS Research (UW CFAR) [AI-27757]; National Institutes of Health [AI029168, AI074424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, R01AI029168, P30AI027757, R37AI029168, K08AI074424] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM011509] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Washington Center for AIDS Research (UW CFAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was part of the Partners in Prevention HSV/HIV Transmission Study funded by the Bill and Melinda Gates Foundation (grant ID #26469). Some computational analyses were also supported by a grant through the University of Washington Center for AIDS Research (UW CFAR, AI-27757) Computational Biology Core. National Institutes of Health grants to JPH (AI029168) and MSC (AI074424) provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; ALBERT J, 1993, NATURE, V361, P595, DOI 10.1038/361595b0; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Bull ME, 2009, J VIROL, V83, P6020, DOI 10.1128/JVI.02664-08; Celum C, N ENGL J MED, V362, P427; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FISCHER W, PLOS ONE, V5; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hahn T, 1999, AIDS RES HUM RETROV, V15, P875, DOI 10.1089/088922299310584; HOLMES EC, 1993, J INFECT DIS, V167, P1411, DOI 10.1093/infdis/167.6.1411; HOLMES EC, 1993, NATURE, V364, P766, DOI 10.1038/364766b0; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Learn G.H., 2003, HIV SEQUENCE COMPEND, P22; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Leitner T., 2000, AIDS REV, V2, P241; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; MADDISON W.P., 2001, MACCLADE ANAL PHYLOG; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shankarappa R, 1998, VIROLOGY, V241, P251, DOI 10.1006/viro.1997.8996; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; STROMBERG M, 2007, MOSAIK IS SUITE COMP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Truong HHM, 2002, J ACQ IMMUN DEF SYND, V29, P232, DOI 10.1097/00042560-200203010-00003; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006	42	138	140	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16986	10.1371/journal.pone.0016986	http://dx.doi.org/10.1371/journal.pone.0016986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399681	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300004
J	Michelena, P; Deneubourg, JL				Michelena, Pablo; Deneubourg, Jean-Louis			How Group Size Affects Vigilance Dynamics and Time Allocation Patterns: The Key Role of Imitation and Tempo	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; SOCIAL FACILITATION; PUBLIC INFORMATION; SPATIAL POSITION; FLOCK SIZE; BEHAVIOR; MAMMALS; ATTACK; FLIGHT	In the context of social foraging, predator detection has been the subject of numerous studies, which acknowledge the adaptive response of the individual to the trade-off between feeding and vigilance. Typically, animals gain energy by increasing their feeding time and decreasing their vigilance effort with increasing group size, without increasing their risk of predation ('group size effect'). Research on the biological utility of vigilance has prevailed over considerations of the mechanistic rules that link individual decisions to group behavior. With sheep as a model species, we identified how the behaviors of conspecifics affect the individual decisions to switch activity. We highlight a simple mechanism whereby the group size effect on collective vigilance dynamics is shaped by two key features: the magnitude of social amplification and intrinsic differences between foraging and scanning bout durations. Our results highlight a positive correlation between the duration of scanning and foraging bouts at the level of the group. This finding reveals the existence of groups with high and low rates of transition between activies, suggesting individual variations in the transition rate, or 'tempo'. We present a mathematical model based on behavioral rules derived from experiments. Our theoretical predictions show that the system is robust in respect to variations in the propensity to imitate scanning and foraging, yet flexible in respect to differences in the duration of activity bouts. The model shows how individual decisions contribute to collective behavior patterns and how the group, in turn, facilitates individual-level adaptive responses.	[Michelena, Pablo; Deneubourg, Jean-Louis] ULB, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Michelena, P (corresponding author), ULB, Unit Social Ecol, Brussels, Belgium.	Pablo.Michelena@ulb.ac.be	Michalik, Peter/E-6757-2010	Michalik, Peter/0000-0003-2459-9153	Universite libre de Bruxelles (ULB); European Community [IST-2001-35506]	Universite libre de Bruxelles (ULB); European Community(European Commission)	This study was supported by a post doctoral fellow of the Universite libre de Bruxelles (ULB) and the experiments were sponsored by the the LEURRE project of the Future and Emerging Technologies program of the European Community (IST-2001-35506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DB, 1999, ANIM BEHAV, V58, P831, DOI 10.1006/anbe.1999.1227; Beauchamp G, 2003, BEHAV PROCESS, V63, P111, DOI 10.1016/S0376-6357(03)00002-0; Beauchamp G, 2002, CAN J ZOOL, V80, P1634, DOI 10.1139/Z02-156; Beauchamp G, 2007, ANIM BEHAV, V73, P445, DOI 10.1016/j.anbehav.2006.09.004; BEKOFF M, 1995, ETHOLOGY, V99, P150, DOI 10.1111/j.1439-0310.1995.tb01096.x; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Blanchard P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1863, DOI 10.1007/s00265-008-0615-3; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fernandez-Juricic E, 2008, ETHOLOGY, V114, P105, DOI 10.1111/j.1439-0310.2007.01433.x; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Geist V., 1971, MOUNTAIN SHEEP STUDY; Hilton GM, 1999, BEHAV ECOL, V10, P391, DOI 10.1093/beheco/10.4.391; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Jewell P.A., 1974, ISLAND SURVIVORS ECO; KAUTZ MA, 1982, J WILDLIFE MANAGE, V46, P704, DOI 10.2307/3808562; Krause J, 2002, LIVING GROUPS; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; LAWRENCE AB, 1984, APPL ANIM BEHAV SCI, V13, P176, DOI 10.1016/0168-1591(84)90075-3; LAZARUS J, 1979, BEHAVIOUR, V71, P127, DOI 10.1163/156853979X00133; LIMA SL, 1995, ANIM BEHAV, V50, P1097, DOI 10.1016/0003-3472(95)80109-X; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Michelena P, 2006, OECOLOGIA, V148, P170, DOI 10.1007/s00442-005-0347-2; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; NICOLIS G, 1971, P NATL ACAD SCI USA, V68, P2102, DOI 10.1073/pnas.68.9.2102; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; Periquet S, 2010, ANIM BEHAV, V79, P665, DOI 10.1016/j.anbehav.2009.12.016; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; QUENETTE PY, 1990, ACTA OECOL, V11, P801; QUENETTE PY, 1992, CAN J ZOOL, V70, P1632, DOI 10.1139/z92-226; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rieucau G, 2009, ANIM BEHAV, V78, P961, DOI 10.1016/j.anbehav.2009.06.023; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sumpter D. J. T., 2009, COLLECTIVE ANIMAL BE; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; [No title captured]; [No title captured]	56	69	72	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18631	10.1371/journal.pone.0018631	http://dx.doi.org/10.1371/journal.pone.0018631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525987	gold, Green Published, Green Submitted			2022-12-27	WOS:000289578600021
J	Kumar, A; Gao, H; Xu, J; Reuben, J; Yu, DH; Mehta, K				Kumar, Anupam; Gao, Hui; Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil			Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DRUG-RESISTANT; GLAND CELLS; BREAST; PROLIFERATION; MECHANISMS	Cancer stem cells (CSCs) or tumor initiating cells (TICs) make up only a small fraction of total tumor cell population, but recent evidence suggests that they are responsible for tumor initiation and the maintenance of tumor growth. Whether CSCs/TICs originate from normal stem cells or result from the dedifferentiation of terminally differentiated cells remains unknown. Here we provide evidence that sustained expression of the proinflammatory protein tissue transglutaminase (TG2) confers stem cell like properties in non-transformed and transformed mammary epithelial cells. Sustained expression of TG2 was associated with increase in CD44(high)/CD24(low/-) subpopulation, increased ability of cells to form mammospheres, and acquisition of self-renewal ability. Mammospheres derived from TG2-transfected mammary epithelial cells (MCF10A) differentiated into complex secondary structures when grown in Matrigel cultures. Cells in these secondary structures differentiated into Muc1-positive (luminal marker) and integrin alpha 6-positive (basal marker) cells in response to prolactin treatment. Highly aggressive MDA-231 and drug-resistant MCF-7/RT breast cancer cells, which express high basal levels of TG2, shared many traits with TG2-transfected MCF10A stem cells but unlike MCF10A-derived stem cells they failed to form the secondary structures and to differentiate into Muc1-positive luminal cells when grown in Matrigel culture. Downregulation of TG2 attenuated stem cell properties in both non-transformed and transformed mammary epithelial cells. Taken together, these results suggested a new function for TG2 and revealed a novel mechanism responsible for promoting the stem cell characteristics in adult mammary epithelial cells.	[Kumar, Anupam; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Susan G. Komen for the Cure Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from Susan G. Komen for the Cure Foundation (http://ww5.komen.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	31	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20701	10.1371/journal.pone.0020701	http://dx.doi.org/10.1371/journal.pone.0020701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21526230	Green Published, gold, Green Submitted			2022-12-27	WOS:000291611500037
J	Kumar, A; Bullard, RL; Patel, P; Paslay, LC; Singh, D; Bienkiewicz, EA; Morgan, SE; Rangachari, V				Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Paslay, Lea C.; Singh, Dipti; Bienkiewicz, Ewa A.; Morgan, Sarah E.; Rangachari, Vijayaraghavan			Non-Esterified Fatty Acids Generate Distinct Low-Molecular Weight Amyloid-beta (A beta 42) Oligomers along Pathway Different from Fibril Formation	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; ALPHA-SYNUCLEIN; IN-VITRO; CONTAINING MEMBRANES; APOLIPOPROTEIN-E; ENDOGENOUS SEED; LIPID-MEMBRANES; TRANSGENIC MICE	Amyloid-beta (A beta) peptide aggregation is known to play a central role in the etiology of Alzheimer's disease (AD). Among various aggregates, low-molecular weight soluble oligomers of A beta are increasingly believed to be the primary neurotoxic agents responsible for memory impairment. Anionic interfaces are known to influence the A beta aggregation process significantly. Here, we report the effects of interfaces formed by medium-chain (C9-C12), saturated non-esterified fatty acids (NEFAs) on A beta 42 aggregation. NEFAs uniquely affected A beta 42 aggregation rates that depended on both the ratio of A beta:NEFA as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we observed that two distinct oligomers, 12-18 mers and 4-5 mers were formed via different pathway of aggregation under specific experimental conditions: (i) 12-18 mers were generated near the CMC in which NEFAs augment the rate of A beta 42 aggregation towards fibril formation, and, (ii) 4-5 mers were formed above the CMC, where NEFAs inhibit fibril formation. The data indicated that both 12-18 mers and 4-5 mers are formed along an alternate pathway called 'off-pathway' that did not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk molecular behavior. These observations, (i) reflect the possible mechanism of A beta aggregation in physiological lipid-rich environments, and (ii) reiterate the fact that all oligomeric forms of A beta need not be obligatory intermediates of the fibril formation pathway.	[Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Singh, Dipti; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Bienkiewicz, Ewa A.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; Florida State University	Kumar, A (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Alzheimer's Association [NIRG-09-132721]; American Heart Association [0535185N]; National Science Foundation [DMR-0213883]; National Center for Research Resources, National Institutes of Health [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIRG grant from Alzheimer's Association (NIRG-09-132721) (www.Alz.org) and an American Heart Association SDG award (0535185N) for VR (www.AHA.org). Partial support by the MRSEC program of the National Science Foundation (DMR-0213883) as well as Mississippi INBRE funded by the National Center for Research Resources, National Institutes of Health (award# P20RR016476) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Carpentier YA, 2006, PROSTAG LEUKOTR ESS, V75, P145, DOI 10.1016/j.plefa.2006.05.004; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hagihara Y, 2002, BIOCHEMISTRY-US, V41, P1020, DOI 10.1021/bi015693q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; LUZZATI V, 1966, ANN NY ACAD SCI, V137, P409, DOI 10.1111/j.1749-6632.1966.tb50172.x; Ma Z, 2002, MOL MED, V8, P863, DOI 10.1007/BF03402092; Mandal PK, 2004, NEUROCHEM RES, V29, P2273, DOI 10.1007/s11064-004-7036-0; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MAYES PA, 2000, LANGE MED BOOKS, P268; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MICHAEL R, 2005, BIOCHEMISTRY-US, V44, P165; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; REISSHUSSON F, 1966, J COLLOID INTERF SCI, V21, P534, DOI 10.1016/0095-8522(66)90051-1; Ross BP, 2004, MOL PHARMACEUT, V1, P233, DOI 10.1021/mp049964d; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schlame M, 1996, J LIPID RES, V37, P2608; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; SOLFRIZZI V, 2009, AGEING RES REV; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Waiter MF, 1997, BIOCHEM BIOPH RES CO, V233, P760, DOI 10.1006/bbrc.1997.6547; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Wood SJ, 1996, J BIOL CHEM, V271, P4086; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	71	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18759	10.1371/journal.pone.0018759	http://dx.doi.org/10.1371/journal.pone.0018759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526230	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100019
